sample,patient_id,cancer_type_abbreviation,age_at_initial_pathologic_diagnosis,gender,race,ajcc_pathologic_tumor_stage,clinical_stage,histological_type,histological_grade,initial_pathologic_dx_year,menopause_status,birth_days_to,vital_status,tumor_status,last_contact_days_to,death_days_to,cause_of_death,new_tumor_event_type,new_tumor_event_site,new_tumor_event_site_other,new_tumor_event_dx_days_to,treatment_outcome,margin_status,residual_tumor,os_event,os_time,dss_event,dss_time,dfi_event,dfi_time,pfi_event,pfi_time,cluster
TCGA-OR-A5J1-01,TCGA-OR-A5J1,ACC,58.0,MALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2000.0,nan,-21496.0,Dead,WITH TUMOR,nan,1355.0,nan,Distant Metastasis,Peritoneal Surfaces,nan,754.0,Complete Remission/Response,nan,nan,1.0,1355.0,1.0,1355.0,1.0,754.0,1.0,754.0,1
TCGA-OR-A5J2-01,TCGA-OR-A5J2,ACC,44.0,FEMALE,WHITE,Stage IV,nan,Adrenocortical carcinoma- Usual Type,nan,2004.0,nan,-16090.0,Dead,WITH TUMOR,nan,1677.0,nan,Distant Metastasis,Soft Tissue,nan,289.0,Progressive Disease,nan,nan,1.0,1677.0,1.0,1677.0,nan,nan,1.0,289.0,1
TCGA-OR-A5J3-01,TCGA-OR-A5J3,ACC,23.0,FEMALE,WHITE,Stage III,nan,Adrenocortical carcinoma- Usual Type,nan,2008.0,nan,-8624.0,Alive,WITH TUMOR,2091.0,nan,nan,Distant Metastasis,Lung,nan,53.0,Complete Remission/Response,nan,nan,0.0,2091.0,0.0,2091.0,1.0,53.0,1.0,53.0,2
TCGA-OR-A5J4-01,TCGA-OR-A5J4,ACC,23.0,FEMALE,WHITE,Stage IV,nan,Adrenocortical carcinoma- Usual Type,nan,2000.0,nan,-8451.0,Dead,WITH TUMOR,nan,423.0,nan,Locoregional Recurrence,Peritoneal Surfaces,nan,126.0,Progressive Disease,nan,nan,1.0,423.0,1.0,423.0,nan,nan,1.0,126.0,1
TCGA-OR-A5J5-01,TCGA-OR-A5J5,ACC,30.0,MALE,WHITE,Stage III,nan,Adrenocortical carcinoma- Usual Type,nan,2000.0,nan,-11171.0,Dead,WITH TUMOR,nan,365.0,nan,Locoregional Recurrence,"Other, specify",vena cava thrombus,50.0,Progressive Disease,nan,nan,1.0,365.0,1.0,365.0,nan,nan,1.0,50.0,1
TCGA-OR-A5J6-01,TCGA-OR-A5J6,ACC,29.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2006.0,nan,-10839.0,Alive,TUMOR FREE,2703.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2703.0,0.0,2703.0,0.0,2703.0,0.0,2703.0,0
TCGA-OR-A5J7-01,TCGA-OR-A5J7,ACC,30.0,FEMALE,WHITE,Stage III,nan,Adrenocortical carcinoma- Usual Type,nan,2009.0,nan,-11279.0,Dead,WITH TUMOR,nan,490.0,nan,Locoregional Recurrence,Retroperitoneal lymph nodes,nan,162.0,Progressive Disease,nan,nan,1.0,490.0,1.0,490.0,nan,nan,1.0,162.0,1
TCGA-OR-A5J8-01,TCGA-OR-A5J8,ACC,66.0,MALE,WHITE,Stage III,nan,Adrenocortical carcinoma- Usual Type,nan,2011.0,nan,-24266.0,Dead,WITH TUMOR,nan,579.0,nan,Locoregional Recurrence,Peritoneal Surfaces,nan,530.0,Complete Remission/Response,nan,nan,1.0,579.0,1.0,579.0,1.0,530.0,1.0,530.0,1
TCGA-OR-A5J9-01,TCGA-OR-A5J9,ACC,22.0,FEMALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2010.0,nan,-8175.0,Alive,WITH TUMOR,1352.0,nan,nan,Distant Metastasis,Lung,nan,414.0,Complete Remission/Response,nan,nan,0.0,1352.0,0.0,1352.0,1.0,414.0,1.0,414.0,2
TCGA-OR-A5JA-01,TCGA-OR-A5JA,ACC,53.0,FEMALE,WHITE,Stage IV,nan,Adrenocortical carcinoma- Usual Type,nan,2004.0,nan,-19436.0,Dead,WITH TUMOR,nan,922.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,922.0,1.0,922.0,nan,nan,1.0,922.0,1
TCGA-OR-A5JB-01,TCGA-OR-A5JB,ACC,52.0,MALE,WHITE,Stage IV,nan,Adrenocortical carcinoma- Usual Type,nan,2000.0,nan,-19172.0,Dead,nan,nan,551.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,551.0,nan,551.0,nan,nan,0.0,551.0,1
TCGA-OR-A5JC-01,TCGA-OR-A5JC,ACC,37.0,MALE,WHITE,nan,nan,Adrenocortical carcinoma- Usual Type,nan,2001.0,nan,-13862.0,Dead,nan,nan,1750.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1750.0,nan,1750.0,nan,nan,0.0,1750.0,1
TCGA-OR-A5JD-01,TCGA-OR-A5JD,ACC,57.0,FEMALE,WHITE,Stage II,nan,Adrenocortical Carcinoma- Oncocytic Type,nan,2005.0,nan,-20989.0,Alive,TUMOR FREE,3038.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3038.0,0.0,3038.0,0.0,3038.0,0.0,3038.0,0
TCGA-OR-A5JE-01,TCGA-OR-A5JE,ACC,17.0,FEMALE,WHITE,Stage I,nan,Adrenocortical carcinoma- Usual Type,nan,2005.0,nan,-6455.0,Dead,WITH TUMOR,nan,2105.0,nan,Locoregional Recurrence,nan,nan,477.0,[Unknown],nan,nan,1.0,2105.0,1.0,2105.0,nan,nan,1.0,477.0,1
TCGA-OR-A5JF-01,TCGA-OR-A5JF,ACC,69.0,FEMALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2007.0,nan,-25502.0,Alive,TUMOR FREE,2015.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2015.0,0.0,2015.0,0.0,2015.0,0.0,2015.0,0
TCGA-OR-A5JG-01,TCGA-OR-A5JG,ACC,61.0,MALE,WHITE,Stage IV,nan,Adrenocortical carcinoma- Usual Type,nan,2008.0,nan,-22390.0,Dead,WITH TUMOR,nan,541.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,541.0,1.0,541.0,nan,nan,1.0,541.0,1
TCGA-OR-A5JH-01,TCGA-OR-A5JH,ACC,32.0,FEMALE,WHITE,Stage II,nan,Adrenocortical Carcinoma- Oncocytic Type,nan,2008.0,nan,-11994.0,Alive,TUMOR FREE,2110.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2110.0,0.0,2110.0,0.0,2110.0,0.0,2110.0,0
TCGA-OR-A5JI-01,TCGA-OR-A5JI,ACC,22.0,MALE,WHITE,Stage I,nan,Adrenocortical carcinoma- Usual Type,nan,2008.0,nan,-8177.0,Alive,TUMOR FREE,2331.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2331.0,0.0,2331.0,0.0,2331.0,0.0,2331.0,0
TCGA-OR-A5JJ-01,TCGA-OR-A5JJ,ACC,65.0,MALE,WHITE,Stage IV,nan,Adrenocortical carcinoma- Usual Type,nan,2009.0,nan,-24082.0,Dead,WITH TUMOR,nan,490.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,490.0,1.0,490.0,nan,nan,1.0,490.0,1
TCGA-OR-A5JK-01,TCGA-OR-A5JK,ACC,49.0,MALE,WHITE,Stage IV,nan,Adrenocortical carcinoma- Usual Type,nan,2009.0,nan,-18214.0,Alive,TUMOR FREE,1497.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,1497.0,0.0,1497.0,nan,nan,0.0,1497.0,0
TCGA-OR-A5JL-01,TCGA-OR-A5JL,ACC,36.0,FEMALE,WHITE,Stage I,nan,Adrenocortical carcinoma- Usual Type,nan,2009.0,nan,-13155.0,Alive,TUMOR FREE,2056.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2056.0,0.0,2056.0,0.0,2056.0,0.0,2056.0,0
TCGA-OR-A5JM-01,TCGA-OR-A5JM,ACC,25.0,FEMALE,WHITE,Stage IV,nan,Adrenocortical carcinoma- Usual Type,nan,2011.0,nan,-9359.0,Dead,WITH TUMOR,nan,562.0,nan,Distant Metastasis,Liver,nan,72.0,Progressive Disease,nan,nan,1.0,562.0,1.0,562.0,nan,nan,1.0,72.0,1
TCGA-OR-A5JO-01,TCGA-OR-A5JO,ACC,26.0,FEMALE,WHITE,Stage I,nan,Adrenocortical carcinoma- Usual Type,nan,2005.0,nan,-9547.0,Alive,TUMOR FREE,1194.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1194.0,0.0,1194.0,0.0,1194.0,0.0,1194.0,0
TCGA-OR-A5JP-01,TCGA-OR-A5JP,ACC,40.0,MALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2012.0,nan,-14667.0,Alive,TUMOR FREE,464.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,464.0,0.0,464.0,0.0,464.0,0.0,464.0,0
TCGA-OR-A5JQ-01,TCGA-OR-A5JQ,ACC,26.0,FEMALE,WHITE,Stage II,nan,Adrenocortical Carcinoma- Myxoid Type,nan,2006.0,nan,-9667.0,Alive,TUMOR FREE,1103.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1103.0,0.0,1103.0,0.0,1103.0,0.0,1103.0,0
TCGA-OR-A5JR-01,TCGA-OR-A5JR,ACC,45.0,MALE,WHITE,Stage I,nan,Adrenocortical carcinoma- Usual Type,nan,2002.0,nan,-16604.0,Alive,TUMOR FREE,3688.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3688.0,0.0,3688.0,0.0,3688.0,0.0,3688.0,0
TCGA-OR-A5JS-01,TCGA-OR-A5JS,ACC,65.0,FEMALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2011.0,nan,-24017.0,Alive,WITH TUMOR,383.0,nan,nan,Distant Metastasis,Lung,nan,166.0,nan,nan,nan,0.0,383.0,0.0,383.0,nan,nan,1.0,166.0,2
TCGA-OR-A5JT-01,TCGA-OR-A5JT,ACC,65.0,FEMALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2011.0,nan,-23794.0,Alive,WITH TUMOR,907.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,907.0,0.0,907.0,nan,nan,0.0,907.0,0
TCGA-OR-A5JU-01,TCGA-OR-A5JU,ACC,58.0,FEMALE,WHITE,Stage III,nan,Adrenocortical carcinoma- Usual Type,nan,2010.0,nan,-21292.0,Dead,WITH TUMOR,nan,289.0,nan,Distant Metastasis,"Other, specify",Ovarian,268.0,Progressive Disease,nan,nan,1.0,289.0,1.0,289.0,nan,nan,1.0,268.0,1
TCGA-OR-A5JV-01,TCGA-OR-A5JV,ACC,55.0,MALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2008.0,nan,-20319.0,Alive,TUMOR FREE,2023.0,nan,nan,New Primary Tumor,Lymph Node(s),nan,953.0,Complete Remission/Response,nan,nan,0.0,2023.0,0.0,2023.0,0.0,2023.0,1.0,953.0,0
TCGA-OR-A5JW-01,TCGA-OR-A5JW,ACC,47.0,MALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2008.0,nan,-17513.0,Alive,TUMOR FREE,2202.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2202.0,0.0,2202.0,0.0,2202.0,0.0,2202.0,0
TCGA-OR-A5JX-01,TCGA-OR-A5JX,ACC,50.0,MALE,WHITE,Stage III,nan,Adrenocortical carcinoma- Usual Type,nan,2009.0,nan,-18402.0,Alive,TUMOR FREE,950.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,950.0,0.0,950.0,nan,nan,0.0,950.0,0
TCGA-OR-A5JY-01,TCGA-OR-A5JY,ACC,68.0,FEMALE,WHITE,Stage IV,nan,Adrenocortical carcinoma- Usual Type,nan,2011.0,nan,-25190.0,Dead,WITH TUMOR,nan,552.0,nan,Distant Metastasis,Liver,nan,75.0,Progressive Disease,nan,nan,1.0,552.0,1.0,552.0,nan,nan,1.0,75.0,1
TCGA-OR-A5JZ-01,TCGA-OR-A5JZ,ACC,60.0,MALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2011.0,nan,-22218.0,Alive,WITH TUMOR,822.0,nan,nan,Distant Metastasis,Liver,nan,247.0,Progressive Disease,nan,nan,0.0,822.0,0.0,822.0,nan,nan,1.0,247.0,0
TCGA-OR-A5K0-01,TCGA-OR-A5K0,ACC,69.0,FEMALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2009.0,nan,-25400.0,Alive,WITH TUMOR,1029.0,nan,nan,Distant Metastasis,Lung,nan,659.0,Progressive Disease,nan,nan,0.0,1029.0,0.0,1029.0,nan,nan,1.0,659.0,2
TCGA-OR-A5K1-01,TCGA-OR-A5K1,ACC,48.0,MALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2006.0,nan,-17596.0,Alive,TUMOR FREE,3289.0,nan,nan,Locoregional Recurrence,Peritoneal Surfaces,nan,826.0,Complete Remission/Response,nan,nan,0.0,3289.0,0.0,3289.0,1.0,826.0,1.0,826.0,0
TCGA-OR-A5K2-01,TCGA-OR-A5K2,ACC,32.0,FEMALE,WHITE,Stage III,nan,Adrenocortical carcinoma- Usual Type,nan,2010.0,nan,-11970.0,Dead,WITH TUMOR,nan,994.0,nan,Distant Metastasis,Lung,nan,97.0,Progressive Disease,nan,nan,1.0,994.0,1.0,994.0,nan,nan,1.0,97.0,1
TCGA-OR-A5K3-01,TCGA-OR-A5K3,ACC,53.0,MALE,WHITE,Stage II,nan,Adrenocortical Carcinoma- Oncocytic Type,nan,2005.0,nan,-19375.0,Alive,TUMOR FREE,3465.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3465.0,0.0,3465.0,0.0,3465.0,0.0,3465.0,0
TCGA-OR-A5K4-01,TCGA-OR-A5K4,ACC,64.0,FEMALE,WHITE,Stage III,nan,Adrenocortical carcinoma- Usual Type,nan,2011.0,nan,-23481.0,Alive,TUMOR FREE,1082.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1082.0,0.0,1082.0,0.0,1082.0,0.0,1082.0,0
TCGA-OR-A5K5-01,TCGA-OR-A5K5,ACC,59.0,FEMALE,WHITE,Stage III,nan,Adrenocortical carcinoma- Usual Type,nan,2012.0,nan,-21907.0,Dead,WITH TUMOR,nan,498.0,nan,Distant Metastasis,Lung,nan,108.0,Progressive Disease,nan,nan,1.0,498.0,1.0,498.0,nan,nan,1.0,108.0,1
TCGA-OR-A5K6-01,TCGA-OR-A5K6,ACC,56.0,FEMALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2010.0,nan,-20657.0,Alive,WITH TUMOR,1493.0,nan,nan,Distant Metastasis,Liver,nan,391.0,Complete Remission/Response,nan,nan,0.0,1493.0,0.0,1493.0,1.0,391.0,1.0,391.0,2
TCGA-OR-A5K8-01,TCGA-OR-A5K8,ACC,39.0,MALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2012.0,nan,-14435.0,Alive,TUMOR FREE,749.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,749.0,0.0,749.0,0.0,749.0,0.0,749.0,0
TCGA-OR-A5K9-01,TCGA-OR-A5K9,ACC,61.0,FEMALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2002.0,nan,-22596.0,Dead,WITH TUMOR,nan,344.0,nan,Locoregional Recurrence,Peritoneal Surfaces,nan,236.0,nan,nan,nan,1.0,344.0,1.0,344.0,nan,nan,1.0,236.0,1
TCGA-OR-A5KB-01,TCGA-OR-A5KB,ACC,61.0,FEMALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2011.0,nan,-22550.0,Alive,WITH TUMOR,741.0,nan,nan,Distant Metastasis,Soft Tissue,nan,214.0,Progressive Disease,nan,nan,0.0,741.0,0.0,741.0,nan,nan,1.0,214.0,2
TCGA-OR-A5KO-01,TCGA-OR-A5KO,ACC,39.0,FEMALE,WHITE,Stage IV,nan,Adrenocortical carcinoma- Usual Type,nan,2009.0,nan,-14606.0,Alive,WITH TUMOR,1414.0,nan,nan,Distant Metastasis,Lung,nan,541.0,Progressive Disease,nan,nan,0.0,1414.0,0.0,1414.0,nan,nan,1.0,541.0,2
TCGA-OR-A5KP-01,TCGA-OR-A5KP,ACC,45.0,FEMALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2006.0,nan,-16702.0,Alive,TUMOR FREE,2777.0,nan,nan,Distant Metastasis,Liver,nan,1250.0,Complete Remission/Response,nan,nan,0.0,2777.0,0.0,2777.0,1.0,1250.0,1.0,1250.0,2
TCGA-OR-A5KQ-01,TCGA-OR-A5KQ,ACC,20.0,FEMALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2006.0,nan,-7459.0,Alive,TUMOR FREE,2677.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2677.0,0.0,2677.0,0.0,2677.0,0.0,2677.0,0
TCGA-OR-A5KS-01,TCGA-OR-A5KS,ACC,72.0,MALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2006.0,nan,-26404.0,Alive,TUMOR FREE,2549.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2549.0,0.0,2549.0,0.0,2549.0,0.0,2549.0,0
TCGA-OR-A5KT-01,TCGA-OR-A5KT,ACC,44.0,FEMALE,WHITE,Stage I,nan,Adrenocortical carcinoma- Usual Type,nan,2006.0,nan,-16217.0,Alive,TUMOR FREE,2895.0,nan,nan,Distant Metastasis,"Other, specify",Pancreas,2099.0,Complete Remission/Response,nan,nan,0.0,2895.0,0.0,2895.0,1.0,2099.0,1.0,2099.0,2
TCGA-OR-A5KU-01,TCGA-OR-A5KU,ACC,37.0,FEMALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2000.0,nan,-13559.0,Alive,TUMOR FREE,4673.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4673.0,0.0,4673.0,0.0,4673.0,0.0,4673.0,0
TCGA-OR-A5KV-01,TCGA-OR-A5KV,ACC,17.0,FEMALE,WHITE,Stage III,nan,Adrenocortical carcinoma- Usual Type,nan,2003.0,nan,-6250.0,Alive,TUMOR FREE,3878.0,nan,nan,Distant Metastasis,Lung,nan,1116.0,Complete Remission/Response,nan,nan,0.0,3878.0,0.0,3878.0,1.0,1116.0,1.0,1116.0,2
TCGA-OR-A5KW-01,TCGA-OR-A5KW,ACC,55.0,FEMALE,WHITE,Stage III,nan,Adrenocortical carcinoma- Usual Type,nan,2009.0,nan,-20328.0,Alive,TUMOR FREE,2076.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2076.0,0.0,2076.0,0.0,2076.0,0.0,2076.0,0
TCGA-OR-A5KX-01,TCGA-OR-A5KX,ACC,25.0,FEMALE,WHITE,Stage III,nan,Adrenocortical carcinoma- Usual Type,nan,2010.0,nan,-9298.0,Alive,WITH TUMOR,1364.0,nan,nan,Distant Metastasis,Bone,nan,62.0,Progressive Disease,nan,nan,0.0,1364.0,0.0,1364.0,nan,nan,1.0,62.0,2
TCGA-OR-A5KY-01,TCGA-OR-A5KY,ACC,23.0,FEMALE,WHITE,Stage IV,nan,Adrenocortical carcinoma- Usual Type,nan,2010.0,nan,-8745.0,Dead,WITH TUMOR,nan,391.0,nan,Locoregional Recurrence,Peritoneal Surfaces,nan,178.0,Progressive Disease,nan,nan,1.0,391.0,1.0,391.0,nan,nan,1.0,178.0,1
TCGA-OR-A5KZ-01,TCGA-OR-A5KZ,ACC,42.0,MALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2012.0,nan,-15594.0,Dead,WITH TUMOR,nan,125.0,nan,Locoregional Recurrence,"Other, specify",abdomen,36.0,Progressive Disease,nan,nan,1.0,125.0,1.0,125.0,nan,nan,1.0,36.0,1
TCGA-OR-A5L1-01,TCGA-OR-A5L1,ACC,37.0,FEMALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2000.0,nan,-13840.0,Alive,WITH TUMOR,1781.0,nan,nan,Distant Metastasis,Bone,nan,685.0,Complete Remission/Response,nan,nan,0.0,1781.0,0.0,1781.0,1.0,685.0,1.0,685.0,2
TCGA-OR-A5L2-01,TCGA-OR-A5L2,ACC,83.0,FEMALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2001.0,nan,-30535.0,Dead,TUMOR FREE,nan,1852.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1852.0,0.0,1852.0,0.0,1852.0,0.0,1852.0,0
TCGA-OR-A5L3-01,TCGA-OR-A5L3,ACC,67.0,FEMALE,WHITE,Stage I,nan,Adrenocortical carcinoma- Usual Type,nan,2000.0,nan,-24763.0,Alive,TUMOR FREE,4628.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4628.0,0.0,4628.0,0.0,4628.0,0.0,4628.0,0
TCGA-OR-A5L4-01,TCGA-OR-A5L4,ACC,48.0,FEMALE,WHITE,Stage III,nan,Adrenocortical carcinoma- Usual Type,nan,2011.0,nan,-17819.0,Alive,TUMOR FREE,967.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,967.0,0.0,967.0,0.0,967.0,0.0,967.0,0
TCGA-OR-A5L5-01,TCGA-OR-A5L5,ACC,77.0,FEMALE,WHITE,Stage I,nan,Adrenocortical carcinoma- Usual Type,nan,2010.0,nan,-28270.0,Alive,TUMOR FREE,1317.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1317.0,0.0,1317.0,0.0,1317.0,0.0,1317.0,0
TCGA-OR-A5L6-01,TCGA-OR-A5L6,ACC,60.0,MALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2011.0,nan,-22057.0,Alive,TUMOR FREE,861.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,861.0,0.0,861.0,0.0,861.0,0.0,861.0,0
TCGA-OR-A5L8-01,TCGA-OR-A5L8,ACC,36.0,FEMALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2011.0,nan,-13472.0,Alive,TUMOR FREE,885.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,885.0,0.0,885.0,0.0,885.0,0.0,885.0,0
TCGA-OR-A5L9-01,TCGA-OR-A5L9,ACC,53.0,FEMALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2011.0,nan,-19526.0,Alive,TUMOR FREE,871.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,871.0,0.0,871.0,0.0,871.0,0.0,871.0,0
TCGA-OR-A5LA-01,TCGA-OR-A5LA,ACC,52.0,FEMALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2012.0,nan,-19242.0,Alive,TUMOR FREE,719.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,719.0,0.0,719.0,0.0,719.0,0.0,719.0,0
TCGA-OR-A5LB-01,TCGA-OR-A5LB,ACC,59.0,MALE,WHITE,Stage IV,nan,Adrenocortical carcinoma- Usual Type,nan,2006.0,nan,-21565.0,Dead,WITH TUMOR,nan,1204.0,nan,Distant Metastasis,Liver,nan,611.0,Progressive Disease,nan,nan,1.0,1204.0,1.0,1204.0,nan,nan,1.0,611.0,1
TCGA-OR-A5LC-01,TCGA-OR-A5LC,ACC,71.0,FEMALE,WHITE,Stage IV,nan,Adrenocortical carcinoma- Usual Type,nan,2011.0,nan,-26084.0,Dead,WITH TUMOR,nan,159.0,nan,Distant Metastasis,Lung,nan,50.0,Progressive Disease,nan,nan,1.0,159.0,1.0,159.0,nan,nan,1.0,50.0,1
TCGA-OR-A5LD-01,TCGA-OR-A5LD,ACC,52.0,MALE,WHITE,Stage III,nan,Adrenocortical carcinoma- Usual Type,nan,1998.0,nan,-19111.0,Dead,WITH TUMOR,nan,1197.0,nan,Distant Metastasis,Lung,nan,444.0,[Unknown],nan,nan,1.0,1197.0,1.0,1197.0,nan,nan,1.0,444.0,1
TCGA-OR-A5LE-01,TCGA-OR-A5LE,ACC,14.0,MALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,1997.0,nan,-5383.0,Dead,WITH TUMOR,nan,662.0,nan,Locoregional Recurrence,Peritoneal Surfaces,nan,265.0,[Unknown],nan,nan,1.0,662.0,1.0,662.0,nan,nan,1.0,265.0,1
TCGA-OR-A5LF-01,TCGA-OR-A5LF,ACC,74.0,FEMALE,WHITE,Stage III,nan,Adrenocortical carcinoma- Usual Type,nan,2002.0,nan,-27179.0,Dead,TUMOR FREE,nan,445.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,445.0,0.0,445.0,0.0,445.0,0.0,445.0,0
TCGA-OR-A5LG-01,TCGA-OR-A5LG,ACC,46.0,MALE,WHITE,Stage III,nan,Adrenocortical carcinoma- Usual Type,nan,2008.0,nan,-16875.0,Alive,WITH TUMOR,1589.0,nan,nan,Distant Metastasis,Lung,nan,1393.0,Complete Remission/Response,nan,nan,0.0,1589.0,0.0,1589.0,1.0,1393.0,1.0,1393.0,2
TCGA-OR-A5LH-01,TCGA-OR-A5LH,ACC,36.0,FEMALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2005.0,nan,-13182.0,Dead,WITH TUMOR,nan,2385.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,2385.0,1.0,2385.0,nan,nan,1.0,2385.0,1
TCGA-OR-A5LI-01,TCGA-OR-A5LI,ACC,42.0,FEMALE,WHITE,Stage IV,nan,Adrenocortical carcinoma- Usual Type,nan,1998.0,nan,-15536.0,Dead,WITH TUMOR,nan,436.0,nan,Distant Metastasis,Bone,nan,61.0,Progressive Disease,nan,nan,1.0,436.0,1.0,436.0,nan,nan,1.0,61.0,1
TCGA-OR-A5LJ-01,TCGA-OR-A5LJ,ACC,54.0,FEMALE,WHITE,Stage IV,nan,Adrenocortical carcinoma- Usual Type,nan,2005.0,nan,-20069.0,Dead,WITH TUMOR,nan,1105.0,nan,Distant Metastasis,Lung,nan,98.0,Progressive Disease,nan,nan,1.0,1105.0,1.0,1105.0,nan,nan,1.0,98.0,1
TCGA-OR-A5LK-01,TCGA-OR-A5LK,ACC,62.0,MALE,[Not Evaluated],Stage II,nan,Adrenocortical Carcinoma- Oncocytic Type,nan,2007.0,nan,-22919.0,Alive,TUMOR FREE,2740.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2740.0,0.0,2740.0,0.0,2740.0,0.0,2740.0,0
TCGA-OR-A5LL-01,TCGA-OR-A5LL,ACC,75.0,FEMALE,[Not Evaluated],Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2007.0,nan,-27607.0,Dead,WITH TUMOR,nan,1613.0,nan,Distant Metastasis,Liver,nan,213.0,Complete Remission/Response,nan,nan,1.0,1613.0,1.0,1613.0,1.0,213.0,1.0,213.0,1
TCGA-OR-A5LM-01,TCGA-OR-A5LM,ACC,23.0,MALE,[Not Evaluated],Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2008.0,nan,-8735.0,Alive,TUMOR FREE,1858.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1858.0,0.0,1858.0,0.0,1858.0,0.0,1858.0,0
TCGA-OR-A5LN-01,TCGA-OR-A5LN,ACC,31.0,FEMALE,[Not Evaluated],Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2008.0,nan,-11414.0,Alive,TUMOR FREE,2342.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2342.0,0.0,2342.0,0.0,2342.0,0.0,2342.0,0
TCGA-OR-A5LO-01,TCGA-OR-A5LO,ACC,61.0,FEMALE,[Not Evaluated],Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2008.0,nan,-22370.0,Dead,WITH TUMOR,nan,2405.0,nan,Distant Metastasis,Lung,nan,153.0,Complete Remission/Response,nan,nan,1.0,2405.0,1.0,2405.0,1.0,153.0,1.0,153.0,1
TCGA-OR-A5LP-01,TCGA-OR-A5LP,ACC,37.0,FEMALE,[Not Evaluated],Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2009.0,nan,-13574.0,Alive,TUMOR FREE,1857.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1857.0,0.0,1857.0,0.0,1857.0,0.0,1857.0,0
TCGA-OR-A5LR-01,TCGA-OR-A5LR,ACC,30.0,FEMALE,[Not Evaluated],Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2011.0,nan,-11261.0,Alive,TUMOR FREE,853.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,853.0,0.0,853.0,0.0,853.0,0.0,853.0,0
TCGA-OR-A5LS-01,TCGA-OR-A5LS,ACC,34.0,FEMALE,[Not Evaluated],Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2011.0,nan,-12663.0,Alive,TUMOR FREE,1096.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1096.0,0.0,1096.0,0.0,1096.0,0.0,1096.0,0
TCGA-OR-A5LT-01,TCGA-OR-A5LT,ACC,57.0,MALE,[Not Evaluated],Stage III,nan,Adrenocortical carcinoma- Usual Type,nan,2012.0,nan,-21032.0,Alive,TUMOR FREE,549.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,549.0,0.0,549.0,0.0,549.0,0.0,549.0,0
TCGA-OU-A5PI-01,TCGA-OU-A5PI,ACC,53.0,FEMALE,WHITE,Stage IV,nan,Adrenocortical carcinoma- Usual Type,nan,2011.0,nan,-19492.0,Alive,WITH TUMOR,1171.0,nan,nan,Distant Metastasis,Lung,nan,351.0,Stable Disease,nan,nan,0.0,1171.0,0.0,1171.0,nan,nan,1.0,351.0,2
TCGA-P6-A5OF-01,TCGA-P6-A5OF,ACC,55.0,FEMALE,WHITE,Stage III,nan,Adrenocortical carcinoma- Usual Type,nan,2010.0,nan,-20106.0,Dead,WITH TUMOR,nan,207.0,nan,Distant Metastasis,Lung,nan,143.0,[Unknown],nan,nan,1.0,207.0,1.0,207.0,nan,nan,1.0,143.0,1
TCGA-P6-A5OG-01,TCGA-P6-A5OG,ACC,45.0,FEMALE,WHITE,Stage IV,nan,Adrenocortical carcinoma- Usual Type,nan,2011.0,nan,-16659.0,Dead,WITH TUMOR,nan,383.0,nan,Distant Metastasis,Lung,nan,11.0,Complete Remission/Response,nan,nan,1.0,383.0,1.0,383.0,nan,nan,1.0,11.0,1
TCGA-P6-A5OH-01,TCGA-P6-A5OH,ACC,59.0,FEMALE,WHITE,Stage IV,nan,Adrenocortical carcinoma- Usual Type,nan,2010.0,nan,-21627.0,Dead,WITH TUMOR,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,0.0,1.0,0.0,nan,nan,1.0,0.0,1
TCGA-PA-A5YG-01,TCGA-PA-A5YG,ACC,51.0,MALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2012.0,nan,-18926.0,Alive,TUMOR FREE,756.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,756.0,0.0,756.0,0.0,756.0,0.0,756.0,0
TCGA-PK-A5H8-01,TCGA-PK-A5H8,ACC,42.0,MALE,WHITE,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2004.0,nan,-15373.0,Alive,TUMOR FREE,3623.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3623.0,0.0,3623.0,0.0,3623.0,0.0,3623.0,0
TCGA-PK-A5H9-01,TCGA-PK-A5H9,ACC,27.0,FEMALE,ASIAN,Stage II,nan,Adrenocortical carcinoma- Usual Type,nan,2012.0,nan,-10173.0,Alive,TUMOR FREE,616.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,616.0,0.0,616.0,0.0,616.0,0.0,616.0,0
TCGA-PK-A5HA-01,TCGA-PK-A5HA,ACC,63.0,MALE,[Unknown],Stage I,nan,Adrenocortical carcinoma- Usual Type,nan,2011.0,nan,-23345.0,Alive,TUMOR FREE,1201.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1201.0,0.0,1201.0,0.0,1201.0,0.0,1201.0,0
TCGA-PK-A5HB-01,TCGA-PK-A5HB,ACC,63.0,MALE,[Unknown],nan,nan,Adrenocortical carcinoma- Usual Type,nan,2003.0,nan,-23293.0,Alive,WITH TUMOR,1293.0,nan,nan,Distant Metastasis,Lung,nan,213.0,nan,nan,nan,0.0,1293.0,0.0,1293.0,nan,nan,1.0,213.0,0
TCGA-PK-A5HC-01,TCGA-PK-A5HC,ACC,44.0,FEMALE,ASIAN,Stage III,nan,Adrenocortical carcinoma- Usual Type,nan,2011.0,nan,-16182.0,Alive,WITH TUMOR,679.0,nan,nan,Distant Metastasis,Lung,nan,131.0,Complete Remission/Response,nan,nan,0.0,679.0,0.0,679.0,1.0,131.0,1.0,131.0,2
TCGA-2F-A9KO-01,TCGA-2F-A9KO,BLCA,63.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-23323.0,Dead,WITH TUMOR,nan,734.0,nan,Distant Metastasis,Liver,nan,651.0,Progressive Disease,nan,nan,1.0,734.0,1.0,734.0,nan,nan,1.0,651.0,1
TCGA-2F-A9KP-01,TCGA-2F-A9KP,BLCA,66.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-24428.0,Dead,WITH TUMOR,nan,364.0,nan,Distant Metastasis,Liver,nan,343.0,Progressive Disease,nan,nan,1.0,364.0,1.0,364.0,nan,nan,1.0,343.0,1
TCGA-2F-A9KQ-01,TCGA-2F-A9KQ,BLCA,69.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,nan,-25259.0,Alive,TUMOR FREE,2886.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2886.0,0.0,2886.0,0.0,2886.0,0.0,2886.0,0
TCGA-2F-A9KR-01,TCGA-2F-A9KR,BLCA,59.0,FEMALE,[Not Evaluated],Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2000.0,nan,-21848.0,Dead,WITH TUMOR,nan,3183.0,nan,Distant Metastasis,Lung,nan,3086.0,Complete Remission/Response,nan,nan,1.0,3183.0,1.0,3183.0,1.0,3086.0,1.0,3086.0,1
TCGA-2F-A9KT-01,TCGA-2F-A9KT,BLCA,83.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-30520.0,Alive,TUMOR FREE,3314.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3314.0,0.0,3314.0,0.0,3314.0,0.0,3314.0,0
TCGA-2F-A9KW-01,TCGA-2F-A9KW,BLCA,67.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-24703.0,Dead,WITH TUMOR,nan,254.0,nan,Distant Metastasis,Bone,nan,85.0,Stable Disease,nan,nan,1.0,254.0,1.0,254.0,nan,nan,1.0,85.0,1
TCGA-4Z-AA7M-01,TCGA-4Z-AA7M,BLCA,65.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-23817.0,Alive,TUMOR FREE,495.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,495.0,0.0,495.0,0.0,495.0,0.0,495.0,0
TCGA-4Z-AA7N-01,TCGA-4Z-AA7N,BLCA,65.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-24090.0,Dead,TUMOR FREE,nan,1367.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1367.0,0.0,1367.0,0.0,1367.0,0.0,1367.0,0
TCGA-4Z-AA7O-01,TCGA-4Z-AA7O,BLCA,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-23645.0,Alive,TUMOR FREE,512.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,512.0,0.0,512.0,0.0,512.0,0.0,512.0,0
TCGA-4Z-AA7Q-01,TCGA-4Z-AA7Q,BLCA,79.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-28981.0,Dead,TUMOR FREE,nan,510.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,510.0,0.0,510.0,nan,nan,0.0,510.0,0
TCGA-4Z-AA7R-01,TCGA-4Z-AA7R,BLCA,73.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-26781.0,Dead,WITH TUMOR,nan,522.0,nan,Locoregional (Urothelial tumor event),Lymph Node Only,nan,353.0,Partial Remission/Response,nan,nan,1.0,522.0,1.0,522.0,nan,nan,1.0,353.0,1
TCGA-4Z-AA7S-01,TCGA-4Z-AA7S,BLCA,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-24111.0,Dead,TUMOR FREE,nan,1064.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1064.0,0.0,1064.0,nan,nan,0.0,1064.0,0
TCGA-4Z-AA7W-01,TCGA-4Z-AA7W,BLCA,55.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-20424.0,Alive,WITH TUMOR,840.0,nan,nan,Locoregional (Urothelial tumor event),"Other, specify",Rectum,760.0,Complete Remission/Response,nan,nan,0.0,840.0,0.0,840.0,1.0,760.0,1.0,760.0,2
TCGA-4Z-AA7Y-01,TCGA-4Z-AA7Y,BLCA,60.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-22056.0,Alive,TUMOR FREE,1522.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1522.0,0.0,1522.0,0.0,1522.0,0.0,1522.0,0
TCGA-4Z-AA80-01,TCGA-4Z-AA80,BLCA,73.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-26873.0,Dead,TUMOR FREE,nan,19.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,19.0,0.0,19.0,nan,nan,0.0,19.0,0
TCGA-4Z-AA81-01,TCGA-4Z-AA81,BLCA,80.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-29457.0,Dead,TUMOR FREE,nan,1270.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1270.0,0.0,1270.0,0.0,1270.0,0.0,1270.0,0
TCGA-4Z-AA82-01,TCGA-4Z-AA82,BLCA,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-21893.0,Dead,WITH TUMOR,nan,1556.0,nan,Distant Metastasis,Bone,nan,1150.0,Complete Remission/Response,nan,nan,1.0,1556.0,1.0,1556.0,nan,nan,1.0,1150.0,1
TCGA-4Z-AA83-01,TCGA-4Z-AA83,BLCA,52.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-19280.0,Alive,TUMOR FREE,2024.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2024.0,0.0,2024.0,0.0,2024.0,0.0,2024.0,0
TCGA-4Z-AA84-01,TCGA-4Z-AA84,BLCA,61.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-22397.0,Alive,WITH TUMOR,460.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,460.0,0.0,460.0,nan,nan,0.0,460.0,0
TCGA-4Z-AA86-01,TCGA-4Z-AA86,BLCA,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-24465.0,Dead,WITH TUMOR,nan,311.0,nan,Locoregional (Urothelial tumor event),"Other, specify",Pelvis,136.0,Complete Remission/Response,nan,nan,1.0,311.0,1.0,311.0,nan,nan,1.0,136.0,1
TCGA-4Z-AA87-01,TCGA-4Z-AA87,BLCA,72.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-26430.0,Alive,WITH TUMOR,1454.0,nan,nan,Distant Metastasis,Bone,nan,221.0,[Unknown],nan,nan,0.0,1454.0,0.0,1454.0,nan,nan,1.0,221.0,2
TCGA-4Z-AA89-01,TCGA-4Z-AA89,BLCA,60.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-22271.0,Alive,WITH TUMOR,1029.0,nan,nan,New Primary Tumor,Lung,nan,648.0,Complete Remission/Response,nan,nan,0.0,1029.0,0.0,1029.0,nan,nan,1.0,648.0,2
TCGA-5N-A9KI-01,TCGA-5N-A9KI,BLCA,76.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-27777.0,Dead,TUMOR FREE,nan,76.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,76.0,0.0,76.0,0.0,76.0,0.0,76.0,0
TCGA-5N-A9KM-01,TCGA-5N-A9KM,BLCA,73.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-26906.0,Dead,WITH TUMOR,nan,530.0,nan,nan,nan,nan,276.0,Complete Remission/Response,nan,nan,1.0,530.0,1.0,530.0,1.0,276.0,1.0,276.0,1
TCGA-BL-A0C8-01,TCGA-BL-A0C8,BLCA,73.0,MALE,WHITE,Stage I,nan,nan,High Grade,2009.0,nan,-26819.0,Alive,nan,1219.0,nan,nan,Locoregional (Urothelial tumor event),Bladder,nan,630.0,Complete Remission/Response,nan,nan,0.0,1219.0,0.0,1219.0,1.0,630.0,1.0,630.0,2
TCGA-BL-A13I-01,TCGA-BL-A13I,BLCA,57.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-20885.0,Dead,WITH TUMOR,nan,223.0,nan,Metastatic,nan,nan,216.0,Progressive Disease,nan,nan,1.0,223.0,1.0,223.0,nan,nan,1.0,216.0,1
TCGA-BL-A13J-01,TCGA-BL-A13J,BLCA,65.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-23927.0,Dead,WITH TUMOR,nan,81.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,81.0,1.0,81.0,nan,nan,1.0,81.0,1
TCGA-BL-A13J-11,TCGA-BL-A13J,BLCA,65.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-23927.0,Dead,WITH TUMOR,nan,81.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,81.0,1.0,81.0,nan,nan,1.0,81.0,1
TCGA-BL-A3JM-01,TCGA-BL-A3JM,BLCA,62.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-23000.0,Dead,WITH TUMOR,nan,205.0,nan,Metastatic,Bone,nan,111.0,Progressive Disease,nan,nan,1.0,205.0,1.0,205.0,nan,nan,1.0,111.0,1
TCGA-BL-A5ZZ-01,TCGA-BL-A5ZZ,BLCA,80.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-29247.0,Alive,WITH TUMOR,377.0,nan,nan,Distant Metastasis,Lung,nan,242.0,Complete Remission/Response,nan,nan,0.0,377.0,0.0,377.0,1.0,242.0,1.0,242.0,2
TCGA-BT-A0S7-01,TCGA-BT-A0S7,BLCA,75.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,nan,-27533.0,Dead,WITH TUMOR,nan,200.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,200.0,1.0,200.0,nan,nan,1.0,200.0,1
TCGA-BT-A0YX-01,TCGA-BT-A0YX,BLCA,70.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-25570.0,Dead,WITH TUMOR,nan,400.0,nan,Metastatic,"Other, specify",lower abdominal wall and right pelvis,326.0,Progressive Disease,nan,nan,1.0,400.0,1.0,400.0,nan,nan,1.0,326.0,1
TCGA-BT-A20J-01,TCGA-BT-A20J,BLCA,75.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,1999.0,nan,-27646.0,Dead,WITH TUMOR,nan,579.0,nan,Distant Metastasis,"Other, specify",Adrenal,254.0,Progressive Disease,nan,nan,1.0,579.0,1.0,579.0,nan,nan,1.0,254.0,1
TCGA-BT-A20J-11,TCGA-BT-A20J,BLCA,75.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,1999.0,nan,-27646.0,Dead,WITH TUMOR,nan,579.0,nan,Distant Metastasis,"Other, specify",Adrenal,254.0,Progressive Disease,nan,nan,1.0,579.0,1.0,579.0,nan,nan,1.0,254.0,1
TCGA-BT-A20N-01,TCGA-BT-A20N,BLCA,72.0,MALE,nan,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2003.0,nan,-26456.0,Dead,WITH TUMOR,nan,795.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,795.0,1.0,795.0,nan,nan,1.0,795.0,1
TCGA-BT-A20N-11,TCGA-BT-A20N,BLCA,72.0,MALE,nan,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2003.0,nan,-26456.0,Dead,WITH TUMOR,nan,795.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,795.0,1.0,795.0,nan,nan,1.0,795.0,1
TCGA-BT-A20O-01,TCGA-BT-A20O,BLCA,75.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2003.0,nan,-27534.0,Dead,WITH TUMOR,nan,370.0,nan,Locoregional (Urothelial tumor event),Lymph Node Only,nan,315.0,Progressive Disease,nan,nan,1.0,370.0,1.0,370.0,nan,nan,1.0,315.0,1
TCGA-BT-A20P-01,TCGA-BT-A20P,BLCA,81.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005.0,nan,-29634.0,Dead,nan,nan,544.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,544.0,nan,544.0,nan,nan,0.0,544.0,1
TCGA-BT-A20P-11,TCGA-BT-A20P,BLCA,81.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005.0,nan,-29634.0,Dead,nan,nan,544.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,544.0,nan,544.0,nan,nan,0.0,544.0,1
TCGA-BT-A20Q-01,TCGA-BT-A20Q,BLCA,73.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-26778.0,Dead,WITH TUMOR,nan,593.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,593.0,1.0,593.0,nan,nan,1.0,593.0,1
TCGA-BT-A20Q-11,TCGA-BT-A20Q,BLCA,73.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-26778.0,Dead,WITH TUMOR,nan,593.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,593.0,1.0,593.0,nan,nan,1.0,593.0,1
TCGA-BT-A20R-01,TCGA-BT-A20R,BLCA,79.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-28987.0,Dead,nan,nan,154.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,154.0,nan,154.0,nan,nan,0.0,154.0,1
TCGA-BT-A20R-11,TCGA-BT-A20R,BLCA,79.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-28987.0,Dead,nan,nan,154.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,154.0,nan,154.0,nan,nan,0.0,154.0,1
TCGA-BT-A20T-01,TCGA-BT-A20T,BLCA,63.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,nan,-23220.0,Dead,WITH TUMOR,nan,453.0,nan,Distant Metastasis,Liver,nan,314.0,Progressive Disease,nan,nan,1.0,453.0,1.0,453.0,nan,nan,1.0,314.0,1
TCGA-BT-A20U-01,TCGA-BT-A20U,BLCA,70.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-25761.0,Dead,TUMOR FREE,nan,455.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,455.0,0.0,455.0,0.0,455.0,0.0,455.0,0
TCGA-BT-A20U-11,TCGA-BT-A20U,BLCA,70.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-25761.0,Dead,TUMOR FREE,nan,455.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,455.0,0.0,455.0,0.0,455.0,0.0,455.0,0
TCGA-BT-A20V-01,TCGA-BT-A20V,BLCA,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-21551.0,Dead,nan,nan,154.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,154.0,nan,154.0,nan,nan,0.0,154.0,1
TCGA-BT-A20V-11,TCGA-BT-A20V,BLCA,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-21551.0,Dead,nan,nan,154.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,154.0,nan,154.0,nan,nan,0.0,154.0,1
TCGA-BT-A20W-01,TCGA-BT-A20W,BLCA,71.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-26078.0,Dead,TUMOR FREE,nan,254.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,254.0,0.0,254.0,0.0,254.0,0.0,254.0,0
TCGA-BT-A20W-11,TCGA-BT-A20W,BLCA,71.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-26078.0,Dead,TUMOR FREE,nan,254.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,254.0,0.0,254.0,0.0,254.0,0.0,254.0,0
TCGA-BT-A20X-01,TCGA-BT-A20X,BLCA,56.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-20519.0,Dead,WITH TUMOR,nan,251.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,251.0,1.0,251.0,nan,nan,1.0,251.0,1
TCGA-BT-A20X-11,TCGA-BT-A20X,BLCA,56.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-20519.0,Dead,WITH TUMOR,nan,251.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,251.0,1.0,251.0,nan,nan,1.0,251.0,1
TCGA-BT-A2LA-01,TCGA-BT-A2LA,BLCA,54.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-20032.0,Alive,TUMOR FREE,522.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,522.0,0.0,522.0,0.0,522.0,0.0,522.0,0
TCGA-BT-A2LA-11,TCGA-BT-A2LA,BLCA,54.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-20032.0,Alive,TUMOR FREE,522.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,522.0,0.0,522.0,0.0,522.0,0.0,522.0,0
TCGA-BT-A2LB-01,TCGA-BT-A2LB,BLCA,73.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-26846.0,Dead,TUMOR FREE,nan,492.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,492.0,0.0,492.0,0.0,492.0,0.0,492.0,0
TCGA-BT-A2LB-11,TCGA-BT-A2LB,BLCA,73.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-26846.0,Dead,TUMOR FREE,nan,492.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,492.0,0.0,492.0,0.0,492.0,0.0,492.0,0
TCGA-BT-A2LD-01,TCGA-BT-A2LD,BLCA,78.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-28673.0,Dead,WITH TUMOR,nan,623.0,nan,Distant Metastasis,"Other, specify",brain and spinal cord,555.0,Progressive Disease,nan,nan,1.0,623.0,1.0,623.0,nan,nan,1.0,555.0,1
TCGA-BT-A3PH-01,TCGA-BT-A3PH,BLCA,76.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-28030.0,Dead,WITH TUMOR,nan,142.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,142.0,1.0,142.0,nan,nan,1.0,142.0,1
TCGA-BT-A3PJ-01,TCGA-BT-A3PJ,BLCA,76.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-27821.0,Alive,TUMOR FREE,789.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,789.0,0.0,789.0,0.0,789.0,0.0,789.0,0
TCGA-BT-A3PK-01,TCGA-BT-A3PK,BLCA,80.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-29314.0,Dead,WITH TUMOR,nan,303.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,303.0,1.0,303.0,nan,nan,1.0,303.0,1
TCGA-BT-A42B-01,TCGA-BT-A42B,BLCA,59.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-21788.0,Dead,WITH TUMOR,nan,534.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,534.0,1.0,534.0,nan,nan,1.0,534.0,1
TCGA-BT-A42C-01,TCGA-BT-A42C,BLCA,64.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-23584.0,Alive,TUMOR FREE,873.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,873.0,0.0,873.0,0.0,873.0,0.0,873.0,0
TCGA-BT-A42E-01,TCGA-BT-A42E,BLCA,74.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-27045.0,Alive,TUMOR FREE,1108.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1108.0,0.0,1108.0,0.0,1108.0,0.0,1108.0,0
TCGA-BT-A42F-01,TCGA-BT-A42F,BLCA,64.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-23713.0,Alive,TUMOR FREE,864.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,864.0,0.0,864.0,nan,nan,0.0,864.0,0
TCGA-C4-A0EZ-01,TCGA-C4-A0EZ,BLCA,69.0,FEMALE,nan,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-25202.0,Dead,WITH TUMOR,nan,273.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,273.0,1.0,273.0,nan,nan,1.0,273.0,1
TCGA-C4-A0F0-01,TCGA-C4-A0F0,BLCA,60.0,MALE,nan,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,nan,-22068.0,Alive,TUMOR FREE,59.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,59.0,0.0,59.0,nan,nan,0.0,59.0,0
TCGA-C4-A0F1-01,TCGA-C4-A0F1,BLCA,71.0,MALE,nan,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-26178.0,Alive,TUMOR FREE,89.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,89.0,0.0,89.0,nan,nan,0.0,89.0,0
TCGA-C4-A0F6-01,TCGA-C4-A0F6,BLCA,82.0,FEMALE,nan,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-29951.0,Alive,TUMOR FREE,700.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,700.0,0.0,700.0,nan,nan,0.0,700.0,0
TCGA-C4-A0F7-01,TCGA-C4-A0F7,BLCA,77.0,MALE,nan,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-28428.0,Dead,WITH TUMOR,nan,62.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,62.0,1.0,62.0,nan,nan,1.0,62.0,1
TCGA-CF-A1HR-01,TCGA-CF-A1HR,BLCA,62.0,MALE,ASIAN,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-22777.0,Alive,WITH TUMOR,389.0,nan,nan,Distant Metastasis,Liver,nan,294.0,Complete Remission/Response,nan,nan,0.0,389.0,0.0,389.0,1.0,294.0,1.0,294.0,2
TCGA-CF-A1HS-01,TCGA-CF-A1HS,BLCA,75.0,FEMALE,ASIAN,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-27565.0,Alive,WITH TUMOR,382.0,nan,nan,Distant Metastasis,"Other, specify",Pelvis,133.0,Complete Remission/Response,nan,nan,0.0,382.0,0.0,382.0,1.0,133.0,1.0,133.0,2
TCGA-CF-A27C-01,TCGA-CF-A27C,BLCA,52.0,MALE,ASIAN,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-19270.0,Alive,TUMOR FREE,425.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,425.0,0.0,425.0,0.0,425.0,0.0,425.0,0
TCGA-CF-A3MF-01,TCGA-CF-A3MF,BLCA,34.0,MALE,ASIAN,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2011.0,nan,-12557.0,Alive,TUMOR FREE,383.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,0
TCGA-CF-A3MG-01,TCGA-CF-A3MG,BLCA,48.0,MALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2011.0,nan,-17600.0,Alive,TUMOR FREE,369.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,369.0,0.0,369.0,0.0,369.0,0.0,369.0,0
TCGA-CF-A3MH-01,TCGA-CF-A3MH,BLCA,75.0,MALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2011.0,nan,-27458.0,Alive,TUMOR FREE,398.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,398.0,0.0,398.0,0.0,398.0,0.0,398.0,0
TCGA-CF-A3MI-01,TCGA-CF-A3MI,BLCA,62.0,MALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2011.0,nan,-22716.0,Alive,TUMOR FREE,370.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,370.0,0.0,370.0,0.0,370.0,0.0,370.0,0
TCGA-CF-A47S-01,TCGA-CF-A47S,BLCA,41.0,MALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2011.0,nan,-15225.0,Alive,TUMOR FREE,333.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,333.0,0.0,333.0,0.0,333.0,0.0,333.0,0
TCGA-CF-A47T-01,TCGA-CF-A47T,BLCA,58.0,FEMALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2011.0,nan,-21347.0,Dead,WITH TUMOR,nan,385.0,nan,Distant Metastasis,Bone,nan,139.0,Complete Remission/Response,nan,nan,1.0,385.0,1.0,385.0,1.0,139.0,1.0,139.0,1
TCGA-CF-A47V-01,TCGA-CF-A47V,BLCA,52.0,MALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-19265.0,Alive,TUMOR FREE,379.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,0
TCGA-CF-A47W-01,TCGA-CF-A47W,BLCA,42.0,MALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012.0,nan,-15497.0,Alive,TUMOR FREE,368.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,368.0,0.0,368.0,0.0,368.0,0.0,368.0,0
TCGA-CF-A47X-01,TCGA-CF-A47X,BLCA,60.0,MALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012.0,nan,-22200.0,Alive,TUMOR FREE,384.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,384.0,0.0,384.0,0.0,384.0,0.0,384.0,0
TCGA-CF-A47Y-01,TCGA-CF-A47Y,BLCA,55.0,MALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012.0,nan,-20432.0,Alive,TUMOR FREE,373.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,373.0,0.0,373.0,0.0,373.0,0.0,373.0,0
TCGA-CF-A5U8-01,TCGA-CF-A5U8,BLCA,59.0,MALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012.0,nan,-21734.0,Alive,TUMOR FREE,399.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,399.0,0.0,399.0,0.0,399.0,0.0,399.0,0
TCGA-CF-A5UA-01,TCGA-CF-A5UA,BLCA,67.0,MALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012.0,nan,-24625.0,Alive,TUMOR FREE,365.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,365.0,0.0,365.0,0.0,365.0,0.0,365.0,0
TCGA-CF-A7I0-01,TCGA-CF-A7I0,BLCA,54.0,MALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2013.0,nan,-20059.0,Alive,TUMOR FREE,368.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,368.0,0.0,368.0,0.0,368.0,0.0,368.0,0
TCGA-CF-A8HX-01,TCGA-CF-A8HX,BLCA,55.0,FEMALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-20259.0,Alive,TUMOR FREE,345.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,345.0,0.0,345.0,0.0,345.0,0.0,345.0,0
TCGA-CF-A8HY-01,TCGA-CF-A8HY,BLCA,59.0,MALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-21636.0,Alive,TUMOR FREE,345.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,345.0,0.0,345.0,0.0,345.0,0.0,345.0,0
TCGA-CF-A9FF-01,TCGA-CF-A9FF,BLCA,52.0,MALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-19195.0,Alive,TUMOR FREE,361.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,361.0,0.0,361.0,0.0,361.0,0.0,361.0,0
TCGA-CF-A9FH-01,TCGA-CF-A9FH,BLCA,85.0,MALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2013.0,nan,-31236.0,Alive,TUMOR FREE,-64.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0
TCGA-CF-A9FL-01,TCGA-CF-A9FL,BLCA,85.0,MALE,ASIAN,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-31099.0,Dead,WITH TUMOR,nan,565.0,nan,Locoregional (Urothelial tumor event),nan,nan,322.0,Complete Remission/Response,nan,nan,1.0,565.0,1.0,565.0,1.0,322.0,1.0,322.0,1
TCGA-CF-A9FM-01,TCGA-CF-A9FM,BLCA,50.0,MALE,ASIAN,Stage I,nan,nan,High Grade,2013.0,nan,-18445.0,Alive,TUMOR FREE,398.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,398.0,0.0,398.0,0.0,398.0,0.0,398.0,0
TCGA-CU-A0YN-01,TCGA-CU-A0YN,BLCA,60.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005.0,nan,-21927.0,Dead,nan,nan,393.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,393.0,nan,393.0,nan,nan,0.0,393.0,1
TCGA-CU-A0YN-11,TCGA-CU-A0YN,BLCA,60.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005.0,nan,-21927.0,Dead,nan,nan,393.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,393.0,nan,393.0,nan,nan,0.0,393.0,1
TCGA-CU-A0YO-01,TCGA-CU-A0YO,BLCA,84.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-30817.0,Dead,WITH TUMOR,nan,149.0,nan,Metastatic,"Other, specify",peritoneum,118.0,Complete Remission/Response,nan,nan,1.0,149.0,1.0,149.0,nan,nan,1.0,118.0,1
TCGA-CU-A0YR-01,TCGA-CU-A0YR,BLCA,83.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-30674.0,Dead,WITH TUMOR,nan,460.0,nan,Metastatic,Lymph Node Only,nan,219.0,Complete Remission/Response,nan,nan,1.0,460.0,1.0,460.0,nan,nan,1.0,219.0,1
TCGA-CU-A0YR-11,TCGA-CU-A0YR,BLCA,83.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-30674.0,Dead,WITH TUMOR,nan,460.0,nan,Metastatic,Lymph Node Only,nan,219.0,Complete Remission/Response,nan,nan,1.0,460.0,1.0,460.0,nan,nan,1.0,219.0,1
TCGA-CU-A3KJ-01,TCGA-CU-A3KJ,BLCA,75.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-27692.0,Alive,WITH TUMOR,562.0,nan,nan,Distant Metastasis,Lung,nan,166.0,Progressive Disease,nan,nan,0.0,562.0,0.0,562.0,nan,nan,1.0,166.0,0
TCGA-CU-A3QU-01,TCGA-CU-A3QU,BLCA,58.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-21233.0,Alive,TUMOR FREE,158.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,158.0,0.0,158.0,nan,nan,0.0,158.0,0
TCGA-CU-A3YL-01,TCGA-CU-A3YL,BLCA,67.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-24524.0,Alive,TUMOR FREE,906.0,nan,nan,Distant Metastasis,Lung,nan,370.0,Complete Remission/Response,nan,nan,0.0,906.0,0.0,906.0,1.0,370.0,1.0,370.0,0
TCGA-CU-A5W6-01,TCGA-CU-A5W6,BLCA,70.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-25706.0,Dead,TUMOR FREE,nan,56.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,56.0,0.0,56.0,0.0,56.0,0.0,56.0,0
TCGA-CU-A72E-01,TCGA-CU-A72E,BLCA,76.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-27963.0,Dead,WITH TUMOR,nan,413.0,nan,New Primary Tumor,Lymph Node Only,nan,256.0,Partial Remission/Response,nan,nan,1.0,413.0,1.0,413.0,nan,nan,1.0,256.0,1
TCGA-DK-A1A3-01,TCGA-DK-A1A3,BLCA,60.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-22235.0,Dead,WITH TUMOR,nan,665.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,665.0,1.0,665.0,nan,nan,1.0,665.0,1
TCGA-DK-A1A5-01,TCGA-DK-A1A5,BLCA,79.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-29111.0,Dead,TUMOR FREE,nan,65.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,65.0,0.0,65.0,0.0,65.0,0.0,65.0,0
TCGA-DK-A1A6-06,TCGA-DK-A1A6,BLCA,53.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-19554.0,Alive,TUMOR FREE,2020.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2020.0,0.0,2020.0,nan,nan,0.0,2020.0,0
TCGA-DK-A1A6-01,TCGA-DK-A1A6,BLCA,53.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-19554.0,Alive,TUMOR FREE,2020.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2020.0,0.0,2020.0,nan,nan,0.0,2020.0,0
TCGA-DK-A1A7-01,TCGA-DK-A1A7,BLCA,67.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-24499.0,Alive,WITH TUMOR,560.0,nan,nan,Metastatic,Lung,nan,112.0,nan,nan,nan,0.0,560.0,0.0,560.0,nan,nan,1.0,112.0,2
TCGA-DK-A1AA-01,TCGA-DK-A1AA,BLCA,57.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-21093.0,Alive,TUMOR FREE,578.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,578.0,0.0,578.0,0.0,578.0,0.0,578.0,0
TCGA-DK-A1AB-01,TCGA-DK-A1AB,BLCA,74.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-27126.0,Dead,nan,nan,508.0,nan,Metastatic,Lung,nan,364.0,Progressive Disease,nan,nan,1.0,508.0,nan,508.0,nan,nan,1.0,364.0,1
TCGA-DK-A1AC-01,TCGA-DK-A1AC,BLCA,72.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2000.0,nan,-26307.0,Alive,TUMOR FREE,3981.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3981.0,0.0,3981.0,0.0,3981.0,0.0,3981.0,0
TCGA-DK-A1AD-01,TCGA-DK-A1AD,BLCA,69.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2002.0,nan,-25317.0,Alive,TUMOR FREE,3420.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3420.0,0.0,3420.0,nan,nan,0.0,3420.0,0
TCGA-DK-A1AE-01,TCGA-DK-A1AE,BLCA,84.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-30707.0,Alive,WITH TUMOR,491.0,nan,nan,Metastatic,Bone,nan,211.0,Progressive Disease,nan,nan,0.0,491.0,0.0,491.0,nan,nan,1.0,211.0,2
TCGA-DK-A1AF-01,TCGA-DK-A1AF,BLCA,84.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-30914.0,Alive,TUMOR FREE,536.0,nan,nan,Metastatic,Lymph Node Only,nan,283.0,Progressive Disease,nan,nan,0.0,536.0,0.0,536.0,nan,nan,1.0,283.0,2
TCGA-DK-A1AG-01,TCGA-DK-A1AG,BLCA,65.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-24095.0,Alive,TUMOR FREE,475.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,475.0,0.0,475.0,0.0,475.0,0.0,475.0,0
TCGA-DK-A2HX-01,TCGA-DK-A2HX,BLCA,80.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-29332.0,Dead,TUMOR FREE,nan,1420.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1420.0,0.0,1420.0,nan,nan,0.0,1420.0,1
TCGA-DK-A2I1-01,TCGA-DK-A2I1,BLCA,73.0,FEMALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-26726.0,Alive,TUMOR FREE,546.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,546.0,0.0,546.0,0.0,546.0,0.0,546.0,0
TCGA-DK-A2I2-01,TCGA-DK-A2I2,BLCA,63.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-23116.0,Dead,WITH TUMOR,nan,237.0,nan,Distant Metastasis,Liver,nan,163.0,Complete Remission/Response,nan,nan,1.0,237.0,1.0,237.0,nan,nan,1.0,163.0,1
TCGA-DK-A2I4-01,TCGA-DK-A2I4,BLCA,79.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2001.0,nan,-29037.0,Alive,TUMOR FREE,4343.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4343.0,0.0,4343.0,0.0,4343.0,0.0,4343.0,0
TCGA-DK-A2I6-01,TCGA-DK-A2I6,BLCA,81.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005.0,nan,-29789.0,Alive,TUMOR FREE,2656.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2656.0,0.0,2656.0,nan,nan,0.0,2656.0,0
TCGA-DK-A3IK-01,TCGA-DK-A3IK,BLCA,87.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-32076.0,Dead,TUMOR FREE,nan,146.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,146.0,0.0,146.0,nan,nan,0.0,146.0,0
TCGA-DK-A3IL-01,TCGA-DK-A3IL,BLCA,79.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-29047.0,Dead,TUMOR FREE,nan,413.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,413.0,0.0,413.0,nan,nan,0.0,413.0,0
TCGA-DK-A3IM-01,TCGA-DK-A3IM,BLCA,76.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-28106.0,Dead,WITH TUMOR,nan,248.0,nan,Locoregional (Urothelial tumor event),Lymph Node Only,nan,201.0,Complete Remission/Response,nan,nan,1.0,248.0,1.0,248.0,1.0,201.0,1.0,201.0,1
TCGA-DK-A3IN-01,TCGA-DK-A3IN,BLCA,72.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-26562.0,Dead,TUMOR FREE,nan,250.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,250.0,0.0,250.0,0.0,250.0,0.0,250.0,0
TCGA-DK-A3IQ-01,TCGA-DK-A3IQ,BLCA,74.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-27194.0,Dead,WITH TUMOR,nan,539.0,nan,Locoregional (Urothelial tumor event),Lymph Node Only,nan,250.0,Complete Remission/Response,nan,nan,1.0,539.0,1.0,539.0,1.0,250.0,1.0,250.0,1
TCGA-DK-A3IS-01,TCGA-DK-A3IS,BLCA,68.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-25098.0,Alive,TUMOR FREE,1529.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1529.0,0.0,1529.0,0.0,1529.0,0.0,1529.0,0
TCGA-DK-A3IT-01,TCGA-DK-A3IT,BLCA,62.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-22786.0,Alive,TUMOR FREE,648.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,648.0,0.0,648.0,0.0,648.0,0.0,648.0,0
TCGA-DK-A3IU-01,TCGA-DK-A3IU,BLCA,58.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-21369.0,Dead,WITH TUMOR,nan,706.0,nan,Distant Metastasis,Lung,nan,462.0,Complete Remission/Response,nan,nan,1.0,706.0,1.0,706.0,1.0,462.0,1.0,462.0,1
TCGA-DK-A3IV-01,TCGA-DK-A3IV,BLCA,60.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-22237.0,Dead,WITH TUMOR,nan,294.0,nan,Locoregional (Urothelial tumor event),Lymph Node Only,nan,212.0,Stable Disease,nan,nan,1.0,294.0,1.0,294.0,nan,nan,1.0,212.0,1
TCGA-DK-A3WW-01,TCGA-DK-A3WW,BLCA,57.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-20909.0,Alive,TUMOR FREE,633.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,633.0,0.0,633.0,0.0,633.0,0.0,633.0,0
TCGA-DK-A3WX-01,TCGA-DK-A3WX,BLCA,67.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-24553.0,Dead,WITH TUMOR,nan,321.0,nan,Locoregional (Urothelial tumor event),Bladder,nan,167.0,Progressive Disease,nan,nan,1.0,321.0,1.0,321.0,nan,nan,1.0,167.0,1
TCGA-DK-A3WY-01,TCGA-DK-A3WY,BLCA,67.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2001.0,nan,-24536.0,Alive,TUMOR FREE,4967.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4967.0,0.0,4967.0,0.0,4967.0,0.0,4967.0,0
TCGA-DK-A3X1-01,TCGA-DK-A3X1,BLCA,78.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-28757.0,Alive,TUMOR FREE,2009.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2009.0,0.0,2009.0,0.0,2009.0,0.0,2009.0,0
TCGA-DK-A3X2-01,TCGA-DK-A3X2,BLCA,85.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-31160.0,Dead,WITH TUMOR,nan,547.0,nan,Distant Metastasis,Liver,nan,533.0,Complete Remission/Response,nan,nan,1.0,547.0,1.0,547.0,nan,nan,1.0,533.0,1
TCGA-DK-A6AV-01,TCGA-DK-A6AV,BLCA,82.0,FEMALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-30089.0,Alive,TUMOR FREE,1952.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1952.0,0.0,1952.0,0.0,1952.0,0.0,1952.0,0
TCGA-DK-A6AW-01,TCGA-DK-A6AW,BLCA,70.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-25644.0,Alive,TUMOR FREE,1621.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1621.0,0.0,1621.0,0.0,1621.0,0.0,1621.0,0
TCGA-DK-A6B0-01,TCGA-DK-A6B0,BLCA,61.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,nan,-22439.0,Alive,TUMOR FREE,2330.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2330.0,0.0,2330.0,0.0,2330.0,0.0,2330.0,0
TCGA-DK-A6B1-01,TCGA-DK-A6B1,BLCA,67.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,nan,-24607.0,Alive,TUMOR FREE,2049.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2049.0,0.0,2049.0,0.0,2049.0,0.0,2049.0,0
TCGA-DK-A6B2-01,TCGA-DK-A6B2,BLCA,70.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-25625.0,Alive,WITH TUMOR,477.0,nan,nan,Distant Metastasis,Liver,nan,268.0,Complete Remission/Response,nan,nan,0.0,477.0,0.0,477.0,nan,nan,1.0,268.0,2
TCGA-DK-A6B5-01,TCGA-DK-A6B5,BLCA,45.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-16453.0,Alive,TUMOR FREE,1542.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1542.0,0.0,1542.0,nan,nan,0.0,1542.0,0
TCGA-DK-A6B6-01,TCGA-DK-A6B6,BLCA,57.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-21007.0,Alive,TUMOR FREE,1115.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1115.0,0.0,1115.0,0.0,1115.0,0.0,1115.0,0
TCGA-DK-AA6L-01,TCGA-DK-AA6L,BLCA,48.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-17635.0,Dead,WITH TUMOR,nan,1163.0,nan,Distant Metastasis,Bone,nan,920.0,Progressive Disease,nan,nan,1.0,1163.0,1.0,1163.0,nan,nan,1.0,920.0,1
TCGA-DK-AA6M-01,TCGA-DK-AA6M,BLCA,64.0,FEMALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-23574.0,Alive,TUMOR FREE,1582.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,1582.0,0.0,1582.0,nan,nan,0.0,1582.0,0
TCGA-DK-AA6P-01,TCGA-DK-AA6P,BLCA,72.0,FEMALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-26560.0,Alive,TUMOR FREE,457.0,nan,nan,Distant Metastasis,Bone,nan,16.0,Partial Remission/Response,nan,nan,0.0,457.0,0.0,457.0,nan,nan,1.0,16.0,2
TCGA-DK-AA6Q-01,TCGA-DK-AA6Q,BLCA,61.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-22314.0,Dead,WITH TUMOR,nan,413.0,nan,Distant Metastasis,Liver,nan,285.0,Progressive Disease,nan,nan,1.0,413.0,1.0,413.0,nan,nan,1.0,285.0,1
TCGA-DK-AA6R-01,TCGA-DK-AA6R,BLCA,68.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2001.0,nan,-25196.0,Alive,WITH TUMOR,5041.0,nan,nan,New Primary Tumor,"Other, specify",Colon,4907.0,Stable Disease,nan,nan,0.0,5041.0,0.0,5041.0,nan,nan,1.0,4907.0,2
TCGA-DK-AA6S-01,TCGA-DK-AA6S,BLCA,60.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2000.0,nan,-22027.0,Alive,TUMOR FREE,5050.0,nan,nan,Distant Metastasis,"Other, specify",soft tissue pelvic mass,539.0,Complete Remission/Response,nan,nan,0.0,5050.0,0.0,5050.0,1.0,539.0,1.0,539.0,2
TCGA-DK-AA6T-01,TCGA-DK-AA6T,BLCA,63.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-23198.0,Alive,TUMOR FREE,572.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,572.0,0.0,572.0,0.0,572.0,0.0,572.0,0
TCGA-DK-AA6U-01,TCGA-DK-AA6U,BLCA,64.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),[Unknown],2013.0,nan,-23611.0,Alive,TUMOR FREE,578.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,578.0,0.0,578.0,0.0,578.0,0.0,578.0,0
TCGA-DK-AA6W-01,TCGA-DK-AA6W,BLCA,78.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-28853.0,Dead,WITH TUMOR,nan,415.0,nan,Distant Metastasis,Lung,nan,379.0,Stable Disease,nan,nan,1.0,415.0,1.0,415.0,nan,nan,1.0,379.0,1
TCGA-DK-AA6X-01,TCGA-DK-AA6X,BLCA,63.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-23208.0,Alive,TUMOR FREE,467.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,467.0,0.0,467.0,nan,nan,0.0,467.0,0
TCGA-DK-AA71-01,TCGA-DK-AA71,BLCA,71.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-25950.0,Alive,WITH TUMOR,415.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,415.0,0.0,415.0,nan,nan,0.0,415.0,0
TCGA-DK-AA74-01,TCGA-DK-AA74,BLCA,75.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-27730.0,Alive,TUMOR FREE,1708.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1708.0,0.0,1708.0,0.0,1708.0,0.0,1708.0,0
TCGA-DK-AA75-01,TCGA-DK-AA75,BLCA,82.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-30090.0,Dead,WITH TUMOR,nan,340.0,nan,Distant Metastasis,Bone,nan,328.0,Stable Disease,nan,nan,1.0,340.0,1.0,340.0,nan,nan,1.0,328.0,1
TCGA-DK-AA76-01,TCGA-DK-AA76,BLCA,64.0,FEMALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-23542.0,Alive,WITH TUMOR,366.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,366.0,0.0,366.0,0.0,366.0,0.0,366.0,2
TCGA-DK-AA77-01,TCGA-DK-AA77,BLCA,61.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-22365.0,Alive,TUMOR FREE,618.0,nan,nan,Distant Metastasis,"Other, specify",Pelvis,467.0,Stable Disease,nan,nan,0.0,618.0,0.0,618.0,nan,nan,1.0,467.0,0
TCGA-E5-A2PC-01,TCGA-E5-A2PC,BLCA,61.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-22308.0,Alive,TUMOR FREE,1326.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1326.0,0.0,1326.0,nan,nan,0.0,1326.0,0
TCGA-E5-A4TZ-01,TCGA-E5-A4TZ,BLCA,64.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-23566.0,Dead,WITH TUMOR,nan,467.0,nan,Locoregional (Urothelial tumor event),"Other, specify",soft tissue pelvic mass,435.0,Progressive Disease,nan,nan,1.0,467.0,1.0,467.0,nan,nan,1.0,435.0,1
TCGA-E5-A4U1-01,TCGA-E5-A4U1,BLCA,72.0,MALE,[Unknown],Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-26305.0,Alive,WITH TUMOR,1181.0,nan,nan,Distant Metastasis,Bone,nan,705.0,Complete Remission/Response,nan,nan,0.0,1181.0,0.0,1181.0,1.0,705.0,1.0,705.0,2
TCGA-E7-A3X6-01,TCGA-E7-A3X6,BLCA,70.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2011.0,nan,-25584.0,Dead,WITH TUMOR,nan,904.0,nan,Distant Metastasis,Bone,nan,369.0,Complete Remission/Response,nan,nan,1.0,904.0,1.0,904.0,1.0,369.0,1.0,369.0,1
TCGA-E7-A3Y1-01,TCGA-E7-A3Y1,BLCA,57.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012.0,nan,-20917.0,Alive,TUMOR FREE,163.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,163.0,0.0,163.0,0.0,163.0,0.0,163.0,0
TCGA-E7-A4IJ-01,TCGA-E7-A4IJ,BLCA,56.0,MALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-20723.0,Dead,WITH TUMOR,nan,674.0,nan,Distant Metastasis,Bone,nan,620.0,Complete Remission/Response,nan,nan,1.0,674.0,1.0,674.0,1.0,620.0,1.0,620.0,1
TCGA-E7-A4XJ-01,TCGA-E7-A4XJ,BLCA,66.0,MALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-24279.0,Dead,TUMOR FREE,nan,68.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,68.0,0.0,68.0,0.0,68.0,0.0,68.0,0
TCGA-E7-A519-01,TCGA-E7-A519,BLCA,72.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-26427.0,Alive,TUMOR FREE,508.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,508.0,0.0,508.0,0.0,508.0,0.0,508.0,0
TCGA-E7-A541-01,TCGA-E7-A541,BLCA,66.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-24206.0,Dead,TUMOR FREE,nan,778.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,778.0,0.0,778.0,0.0,778.0,0.0,778.0,0
TCGA-E7-A5KE-01,TCGA-E7-A5KE,BLCA,78.0,FEMALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-28714.0,Alive,TUMOR FREE,17.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,17.0,0.0,17.0,nan,nan,0.0,17.0,0
TCGA-E7-A5KF-01,TCGA-E7-A5KF,BLCA,67.0,MALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012.0,nan,-24528.0,Alive,TUMOR FREE,20.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,20.0,0.0,20.0,nan,nan,0.0,20.0,0
TCGA-E7-A677-01,TCGA-E7-A677,BLCA,81.0,MALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012.0,nan,-29613.0,Alive,TUMOR FREE,820.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,820.0,0.0,820.0,0.0,820.0,0.0,820.0,0
TCGA-E7-A678-01,TCGA-E7-A678,BLCA,55.0,MALE,ASIAN,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2012.0,nan,-20169.0,Alive,TUMOR FREE,798.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,798.0,0.0,798.0,0.0,798.0,0.0,798.0,0
TCGA-E7-A6MD-01,TCGA-E7-A6MD,BLCA,66.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-24180.0,Alive,nan,129.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,129.0,0.0,129.0,nan,nan,0.0,129.0,0
TCGA-E7-A6ME-01,TCGA-E7-A6ME,BLCA,75.0,MALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-27670.0,Alive,TUMOR FREE,731.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,731.0,0.0,731.0,0.0,731.0,0.0,731.0,0
TCGA-E7-A6MF-01,TCGA-E7-A6MF,BLCA,37.0,MALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2013.0,nan,-13867.0,Alive,TUMOR FREE,750.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,750.0,0.0,750.0,0.0,750.0,0.0,750.0,0
TCGA-E7-A7DU-01,TCGA-E7-A7DU,BLCA,73.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2013.0,nan,-27000.0,Alive,TUMOR FREE,28.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,28.0,0.0,28.0,0.0,28.0,0.0,28.0,0
TCGA-E7-A7DV-01,TCGA-E7-A7DV,BLCA,44.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-16145.0,Alive,WITH TUMOR,37.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,37.0,0.0,37.0,nan,nan,0.0,37.0,0
TCGA-E7-A7PW-01,TCGA-E7-A7PW,BLCA,63.0,MALE,ASIAN,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-23057.0,Alive,TUMOR FREE,416.0,nan,nan,Distant Metastasis,Bone,nan,174.0,Complete Remission/Response,nan,nan,0.0,416.0,0.0,416.0,1.0,174.0,1.0,174.0,0
TCGA-E7-A7XN-01,TCGA-E7-A7XN,BLCA,66.0,MALE,ASIAN,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-24466.0,Alive,WITH TUMOR,428.0,nan,nan,Locoregional (Urothelial tumor event),Bladder,nan,190.0,Progressive Disease,nan,nan,0.0,428.0,0.0,428.0,nan,nan,1.0,190.0,2
TCGA-E7-A85H-01,TCGA-E7-A85H,BLCA,64.0,MALE,ASIAN,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-23497.0,Alive,TUMOR FREE,394.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,394.0,0.0,394.0,0.0,394.0,0.0,394.0,0
TCGA-E7-A8O7-01,TCGA-E7-A8O7,BLCA,52.0,MALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),Low Grade,2013.0,nan,-19063.0,Alive,TUMOR FREE,466.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,466.0,0.0,466.0,0.0,466.0,0.0,466.0,0
TCGA-E7-A8O8-01,TCGA-E7-A8O8,BLCA,59.0,MALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-21629.0,Alive,TUMOR FREE,13.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,13.0,0.0,13.0,0.0,13.0,0.0,13.0,0
TCGA-E7-A97P-01,TCGA-E7-A97P,BLCA,73.0,MALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-26956.0,Dead,TUMOR FREE,nan,437.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,437.0,0.0,437.0,0.0,437.0,0.0,437.0,0
TCGA-E7-A97Q-01,TCGA-E7-A97Q,BLCA,60.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-22249.0,Dead,WITH TUMOR,nan,246.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,246.0,1.0,246.0,nan,nan,1.0,246.0,1
TCGA-FD-A3B3-01,TCGA-FD-A3B3,BLCA,74.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-27068.0,Dead,TUMOR FREE,nan,974.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,974.0,0.0,974.0,0.0,974.0,0.0,974.0,0
TCGA-FD-A3B4-01,TCGA-FD-A3B4,BLCA,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-20379.0,Dead,WITH TUMOR,nan,510.0,nan,Locoregional (Urothelial tumor event),"Other, specify",Left posterior pelvic wall,359.0,Complete Remission/Response,nan,nan,1.0,510.0,1.0,510.0,1.0,359.0,1.0,359.0,1
TCGA-FD-A3B5-01,TCGA-FD-A3B5,BLCA,86.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-31442.0,Dead,WITH TUMOR,nan,272.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,272.0,1.0,272.0,nan,nan,1.0,272.0,1
TCGA-FD-A3B6-01,TCGA-FD-A3B6,BLCA,75.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-27541.0,Dead,TUMOR FREE,nan,1005.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1005.0,0.0,1005.0,0.0,1005.0,0.0,1005.0,0
TCGA-FD-A3B7-01,TCGA-FD-A3B7,BLCA,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-24245.0,Dead,WITH TUMOR,nan,122.0,nan,Distant Metastasis,Lymph Node Only,nan,110.0,Progressive Disease,nan,nan,1.0,122.0,1.0,122.0,nan,nan,1.0,110.0,1
TCGA-FD-A3B8-01,TCGA-FD-A3B8,BLCA,56.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-20555.0,Alive,TUMOR FREE,384.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,384.0,0.0,384.0,0.0,384.0,0.0,384.0,0
TCGA-FD-A3N5-01,TCGA-FD-A3N5,BLCA,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-25342.0,Dead,WITH TUMOR,nan,685.0,nan,Locoregional (Urothelial tumor event),"Other, specify",Pelvis,346.0,nan,nan,nan,1.0,685.0,1.0,685.0,nan,nan,1.0,346.0,1
TCGA-FD-A3N6-01,TCGA-FD-A3N6,BLCA,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-15758.0,Alive,TUMOR FREE,851.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,851.0,0.0,851.0,0.0,851.0,0.0,851.0,0
TCGA-FD-A3NA-01,TCGA-FD-A3NA,BLCA,60.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-21936.0,Alive,TUMOR FREE,1845.0,nan,nan,New Primary Tumor,Lung,nan,1338.0,Complete Remission/Response,nan,nan,0.0,1845.0,0.0,1845.0,0.0,1845.0,1.0,1338.0,0
TCGA-FD-A3SJ-01,TCGA-FD-A3SJ,BLCA,59.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-21615.0,Dead,WITH TUMOR,nan,739.0,nan,Distant Metastasis,Lymph Node Only,nan,281.0,nan,nan,nan,1.0,739.0,1.0,739.0,nan,nan,1.0,281.0,1
TCGA-FD-A3SL-01,TCGA-FD-A3SL,BLCA,60.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-22020.0,Dead,WITH TUMOR,nan,712.0,nan,Distant Metastasis,Lung,nan,260.0,Progressive Disease,nan,nan,1.0,712.0,1.0,712.0,nan,nan,1.0,260.0,1
TCGA-FD-A3SM-01,TCGA-FD-A3SM,BLCA,70.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-25852.0,Dead,WITH TUMOR,nan,547.0,nan,Distant Metastasis,Lymph Node Only,nan,144.0,[Unknown],nan,nan,1.0,547.0,1.0,547.0,nan,nan,1.0,144.0,1
TCGA-FD-A3SN-01,TCGA-FD-A3SN,BLCA,79.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-29169.0,Alive,TUMOR FREE,887.0,nan,nan,Distant Metastasis,Lung,nan,110.0,Progressive Disease,nan,nan,0.0,887.0,0.0,887.0,nan,nan,1.0,110.0,0
TCGA-FD-A3SO-01,TCGA-FD-A3SO,BLCA,68.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-25147.0,Dead,WITH TUMOR,nan,168.0,nan,Locoregional (Urothelial tumor event),Renal Pelvis,nan,143.0,Progressive Disease,nan,nan,1.0,168.0,1.0,168.0,nan,nan,1.0,143.0,1
TCGA-FD-A3SP-01,TCGA-FD-A3SP,BLCA,60.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-22005.0,Alive,TUMOR FREE,783.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,783.0,0.0,783.0,0.0,783.0,0.0,783.0,0
TCGA-FD-A3SQ-01,TCGA-FD-A3SQ,BLCA,62.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-22687.0,Dead,WITH TUMOR,nan,1423.0,nan,Locoregional (Urothelial tumor event),"Other, specify",sigmoid colon,991.0,Stable Disease,nan,nan,1.0,1423.0,1.0,1423.0,nan,nan,1.0,991.0,1
TCGA-FD-A3SR-01,TCGA-FD-A3SR,BLCA,68.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-24979.0,Dead,WITH TUMOR,nan,602.0,nan,Locoregional (Urothelial tumor event),"Other, specify",pelvis,372.0,[Unknown],nan,nan,1.0,602.0,1.0,602.0,nan,nan,1.0,372.0,1
TCGA-FD-A3SS-01,TCGA-FD-A3SS,BLCA,66.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-24408.0,Dead,WITH TUMOR,nan,391.0,nan,Locoregional (Urothelial tumor event),"Other, specify",local & retroperitonium,220.0,[Unknown],nan,nan,1.0,391.0,1.0,391.0,nan,nan,1.0,220.0,1
TCGA-FD-A43N-01,TCGA-FD-A43N,BLCA,76.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-27833.0,Alive,TUMOR FREE,699.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,699.0,0.0,699.0,nan,nan,0.0,699.0,0
TCGA-FD-A43P-01,TCGA-FD-A43P,BLCA,74.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-27201.0,Alive,TUMOR FREE,832.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,832.0,0.0,832.0,0.0,832.0,0.0,832.0,0
TCGA-FD-A43S-01,TCGA-FD-A43S,BLCA,71.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-25993.0,Alive,TUMOR FREE,455.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,455.0,0.0,455.0,0.0,455.0,0.0,455.0,0
TCGA-FD-A43U-01,TCGA-FD-A43U,BLCA,70.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-25841.0,Alive,WITH TUMOR,636.0,nan,nan,Distant Metastasis,Bone,nan,497.0,Complete Remission/Response,nan,nan,0.0,636.0,0.0,636.0,nan,nan,1.0,497.0,2
TCGA-FD-A43X-01,TCGA-FD-A43X,BLCA,84.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-30764.0,Alive,TUMOR FREE,110.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,110.0,0.0,110.0,0.0,110.0,0.0,110.0,0
TCGA-FD-A43Y-01,TCGA-FD-A43Y,BLCA,65.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-23889.0,Dead,TUMOR FREE,nan,474.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,474.0,0.0,474.0,0.0,474.0,0.0,474.0,0
TCGA-FD-A5BR-01,TCGA-FD-A5BR,BLCA,57.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-20964.0,Alive,TUMOR FREE,813.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,813.0,0.0,813.0,0.0,813.0,0.0,813.0,0
TCGA-FD-A5BS-01,TCGA-FD-A5BS,BLCA,68.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-24963.0,Alive,TUMOR FREE,1639.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1639.0,0.0,1639.0,0.0,1639.0,0.0,1639.0,0
TCGA-FD-A5BT-01,TCGA-FD-A5BT,BLCA,84.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-30686.0,Dead,TUMOR FREE,nan,328.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,328.0,0.0,328.0,nan,nan,0.0,328.0,0
TCGA-FD-A5BU-01,TCGA-FD-A5BU,BLCA,76.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-27882.0,Alive,TUMOR FREE,588.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,588.0,0.0,588.0,0.0,588.0,0.0,588.0,0
TCGA-FD-A5BV-01,TCGA-FD-A5BV,BLCA,47.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-17501.0,Dead,WITH TUMOR,nan,163.0,nan,Locoregional (Urothelial tumor event),"Other, specify",Peritoneal carcinomatosis,134.0,Progressive Disease,nan,nan,1.0,163.0,1.0,163.0,nan,nan,1.0,134.0,1
TCGA-FD-A5BX-01,TCGA-FD-A5BX,BLCA,82.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-30276.0,Dead,WITH TUMOR,nan,173.0,nan,Locoregional (Urothelial tumor event),Lymph Node Only,nan,99.0,Progressive Disease,nan,nan,1.0,173.0,1.0,173.0,nan,nan,1.0,99.0,1
TCGA-FD-A5BY-01,TCGA-FD-A5BY,BLCA,63.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-23080.0,Alive,TUMOR FREE,251.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,251.0,0.0,251.0,0.0,251.0,0.0,251.0,0
TCGA-FD-A5BZ-01,TCGA-FD-A5BZ,BLCA,77.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-28451.0,Dead,WITH TUMOR,nan,835.0,nan,Locoregional (Urothelial tumor event),Lymph Node Only,nan,533.0,nan,nan,nan,1.0,835.0,1.0,835.0,nan,nan,1.0,533.0,1
TCGA-FD-A5C0-01,TCGA-FD-A5C0,BLCA,61.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-22500.0,Dead,WITH TUMOR,nan,550.0,nan,New Primary Tumor,Lung,nan,27.0,Complete Remission/Response,nan,nan,1.0,550.0,1.0,550.0,nan,nan,1.0,27.0,1
TCGA-FD-A5C1-01,TCGA-FD-A5C1,BLCA,61.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-22505.0,Alive,TUMOR FREE,1792.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1792.0,0.0,1792.0,0.0,1792.0,0.0,1792.0,0
TCGA-FD-A62N-01,TCGA-FD-A62N,BLCA,69.0,MALE,ASIAN,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-25297.0,Alive,TUMOR FREE,82.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,82.0,0.0,82.0,0.0,82.0,0.0,82.0,0
TCGA-FD-A62O-01,TCGA-FD-A62O,BLCA,74.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-27310.0,Dead,TUMOR FREE,nan,216.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,216.0,0.0,216.0,nan,nan,0.0,216.0,0
TCGA-FD-A62P-01,TCGA-FD-A62P,BLCA,76.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-27843.0,Dead,WITH TUMOR,nan,191.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,191.0,1.0,191.0,nan,nan,1.0,191.0,1
TCGA-FD-A62S-01,TCGA-FD-A62S,BLCA,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-22000.0,Dead,WITH TUMOR,nan,406.0,nan,Distant Metastasis,"Other, specify",sigmoid colon,306.0,Progressive Disease,nan,nan,1.0,406.0,1.0,406.0,nan,nan,1.0,306.0,1
TCGA-FD-A6TA-01,TCGA-FD-A6TA,BLCA,58.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-21196.0,Alive,TUMOR FREE,1912.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1912.0,0.0,1912.0,nan,nan,0.0,1912.0,0
TCGA-FD-A6TB-01,TCGA-FD-A6TB,BLCA,82.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-30185.0,Alive,TUMOR FREE,572.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,572.0,0.0,572.0,0.0,572.0,0.0,572.0,0
TCGA-FD-A6TC-01,TCGA-FD-A6TC,BLCA,79.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-28963.0,Alive,TUMOR FREE,187.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,187.0,0.0,187.0,0.0,187.0,0.0,187.0,0
TCGA-FD-A6TD-01,TCGA-FD-A6TD,BLCA,77.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-28328.0,Dead,TUMOR FREE,nan,386.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,386.0,0.0,386.0,0.0,386.0,0.0,386.0,0
TCGA-FD-A6TE-01,TCGA-FD-A6TE,BLCA,54.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-19874.0,Alive,TUMOR FREE,376.0,nan,nan,Distant Metastasis,"Other, specify",sacrum,321.0,[Unknown],nan,nan,0.0,376.0,0.0,376.0,nan,nan,1.0,321.0,0
TCGA-FD-A6TF-01,TCGA-FD-A6TF,BLCA,80.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-29317.0,Dead,TUMOR FREE,nan,69.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,69.0,0.0,69.0,nan,nan,0.0,69.0,1
TCGA-FD-A6TG-01,TCGA-FD-A6TG,BLCA,73.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-26893.0,Dead,TUMOR FREE,nan,93.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,93.0,0.0,93.0,nan,nan,0.0,93.0,0
TCGA-FD-A6TH-01,TCGA-FD-A6TH,BLCA,63.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-23236.0,Dead,WITH TUMOR,nan,131.0,nan,Distant Metastasis,Lung,nan,126.0,Complete Remission/Response,nan,nan,1.0,131.0,1.0,131.0,nan,nan,1.0,126.0,1
TCGA-FD-A6TI-01,TCGA-FD-A6TI,BLCA,73.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-26874.0,Dead,TUMOR FREE,nan,294.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,294.0,0.0,294.0,nan,nan,0.0,294.0,0
TCGA-FD-A6TK-01,TCGA-FD-A6TK,BLCA,60.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-21942.0,Alive,TUMOR FREE,330.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,330.0,0.0,330.0,0.0,330.0,0.0,330.0,0
TCGA-FJ-A3Z7-01,TCGA-FJ-A3Z7,BLCA,76.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-28052.0,Alive,TUMOR FREE,945.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,945.0,0.0,945.0,nan,nan,0.0,945.0,0
TCGA-FJ-A3Z9-01,TCGA-FJ-A3Z9,BLCA,72.0,MALE,WHITE,nan,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-26515.0,Dead,TUMOR FREE,nan,385.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,0
TCGA-FJ-A3ZE-01,TCGA-FJ-A3ZE,BLCA,65.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-23866.0,Dead,WITH TUMOR,nan,324.0,nan,Distant Metastasis,Bone,nan,152.0,Progressive Disease,nan,nan,1.0,324.0,1.0,324.0,nan,nan,1.0,152.0,1
TCGA-FJ-A3ZF-01,TCGA-FJ-A3ZF,BLCA,73.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-26825.0,Alive,TUMOR FREE,524.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,524.0,0.0,524.0,0.0,524.0,0.0,524.0,0
TCGA-FJ-A871-01,TCGA-FJ-A871,BLCA,49.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-18051.0,Dead,WITH TUMOR,nan,272.0,nan,Locoregional (Urothelial tumor event),"Other, specify",Pelvic,106.0,Progressive Disease,nan,nan,1.0,272.0,1.0,272.0,nan,nan,1.0,106.0,1
TCGA-FT-A3EE-01,TCGA-FT-A3EE,BLCA,80.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-29293.0,Dead,TUMOR FREE,nan,99.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,99.0,0.0,99.0,nan,nan,0.0,99.0,0
TCGA-FT-A61P-01,TCGA-FT-A61P,BLCA,76.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-28082.0,Alive,TUMOR FREE,337.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,337.0,0.0,337.0,nan,nan,0.0,337.0,0
TCGA-G2-A2EC-01,TCGA-G2-A2EC,BLCA,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-21215.0,Dead,WITH TUMOR,nan,696.0,nan,Distant Metastasis,"Other, specify",small bowel,679.0,Partial Remission/Response,nan,nan,1.0,696.0,1.0,696.0,nan,nan,1.0,679.0,1
TCGA-G2-A2EF-01,TCGA-G2-A2EF,BLCA,50.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,nan,-18467.0,Alive,TUMOR FREE,1884.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,1884.0,0.0,1884.0,nan,nan,0.0,1884.0,0
TCGA-G2-A2EJ-01,TCGA-G2-A2EJ,BLCA,56.0,FEMALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-20649.0,Alive,TUMOR FREE,1460.0,nan,nan,Distant Metastasis,Lung,nan,910.0,Complete Remission/Response,nan,nan,0.0,1460.0,0.0,1460.0,1.0,910.0,1.0,910.0,2
TCGA-G2-A2EK-01,TCGA-G2-A2EK,BLCA,57.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-20995.0,Alive,WITH TUMOR,485.0,nan,nan,Distant Metastasis,Renal Pelvis,nan,485.0,Stable Disease,nan,nan,0.0,485.0,0.0,485.0,nan,nan,1.0,485.0,2
TCGA-G2-A2EL-01,TCGA-G2-A2EL,BLCA,77.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-28370.0,Dead,WITH TUMOR,nan,819.0,nan,Distant Metastasis,Bone,nan,105.0,Stable Disease,nan,nan,1.0,819.0,1.0,819.0,nan,nan,1.0,105.0,1
TCGA-G2-A2EO-01,TCGA-G2-A2EO,BLCA,69.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-25440.0,Dead,TUMOR FREE,nan,1804.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1804.0,0.0,1804.0,0.0,1804.0,0.0,1804.0,0
TCGA-G2-A2ES-01,TCGA-G2-A2ES,BLCA,85.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-31293.0,Dead,WITH TUMOR,nan,1004.0,nan,New Primary Tumor,"Other, specify",nan,897.0,Progressive Disease,nan,nan,1.0,1004.0,1.0,1004.0,nan,nan,1.0,897.0,1
TCGA-G2-A3IB-01,TCGA-G2-A3IB,BLCA,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-24149.0,Dead,WITH TUMOR,nan,220.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,220.0,1.0,220.0,nan,nan,1.0,220.0,1
TCGA-G2-A3IE-01,TCGA-G2-A3IE,BLCA,51.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,nan,-18983.0,Dead,WITH TUMOR,nan,612.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,612.0,1.0,612.0,nan,nan,1.0,612.0,1
TCGA-G2-A3VY-01,TCGA-G2-A3VY,BLCA,66.0,MALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-24112.0,Alive,WITH TUMOR,536.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,536.0,0.0,536.0,nan,nan,0.0,536.0,0
TCGA-G2-AA3B-01,TCGA-G2-AA3B,BLCA,75.0,FEMALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-27646.0,Alive,TUMOR FREE,2008.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2008.0,0.0,2008.0,0.0,2008.0,0.0,2008.0,0
TCGA-G2-AA3C-01,TCGA-G2-AA3C,BLCA,66.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-24267.0,Dead,WITH TUMOR,nan,211.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,211.0,1.0,211.0,nan,nan,1.0,211.0,1
TCGA-G2-AA3D-01,TCGA-G2-AA3D,BLCA,60.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-22205.0,Alive,TUMOR FREE,2139.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2139.0,0.0,2139.0,nan,nan,0.0,2139.0,0
TCGA-G2-AA3F-01,TCGA-G2-AA3F,BLCA,77.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-28457.0,Alive,TUMOR FREE,893.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,893.0,0.0,893.0,nan,nan,0.0,893.0,0
TCGA-GC-A3BM-01,TCGA-GC-A3BM,BLCA,70.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-25609.0,Dead,WITH TUMOR,nan,651.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,651.0,1.0,651.0,nan,nan,1.0,651.0,1
TCGA-GC-A3BM-11,TCGA-GC-A3BM,BLCA,70.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-25609.0,Dead,WITH TUMOR,nan,651.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,651.0,1.0,651.0,nan,nan,1.0,651.0,1
TCGA-GC-A3I6-01,TCGA-GC-A3I6,BLCA,45.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-16504.0,Dead,WITH TUMOR,nan,630.0,nan,Locoregional (Urothelial tumor event),Bladder,nan,546.0,Progressive Disease,nan,nan,1.0,630.0,1.0,630.0,nan,nan,1.0,546.0,1
TCGA-GC-A3OO-01,TCGA-GC-A3OO,BLCA,79.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-29065.0,Alive,TUMOR FREE,481.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,481.0,0.0,481.0,0.0,481.0,0.0,481.0,0
TCGA-GC-A3RB-01,TCGA-GC-A3RB,BLCA,54.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-20021.0,Alive,TUMOR FREE,582.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,582.0,0.0,582.0,0.0,582.0,0.0,582.0,0
TCGA-GC-A3RC-01,TCGA-GC-A3RC,BLCA,59.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-21668.0,Alive,TUMOR FREE,484.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,484.0,0.0,484.0,0.0,484.0,0.0,484.0,0
TCGA-GC-A3RD-01,TCGA-GC-A3RD,BLCA,83.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-30529.0,Alive,TUMOR FREE,428.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,428.0,0.0,428.0,0.0,428.0,0.0,428.0,0
TCGA-GC-A3WC-01,TCGA-GC-A3WC,BLCA,80.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-29295.0,Alive,TUMOR FREE,540.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,540.0,0.0,540.0,0.0,540.0,0.0,540.0,0
TCGA-GC-A3WC-11,TCGA-GC-A3WC,BLCA,80.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-29295.0,Alive,TUMOR FREE,540.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,540.0,0.0,540.0,0.0,540.0,0.0,540.0,0
TCGA-GC-A3YS-01,TCGA-GC-A3YS,BLCA,61.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-22515.0,Alive,TUMOR FREE,758.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,758.0,0.0,758.0,nan,nan,0.0,758.0,0
TCGA-GC-A4ZW-01,TCGA-GC-A4ZW,BLCA,71.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-25964.0,Alive,TUMOR FREE,15.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,15.0,0.0,15.0,nan,nan,0.0,15.0,0
TCGA-GC-A6I1-01,TCGA-GC-A6I1,BLCA,90.0,FEMALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-32873.0,Dead,TUMOR FREE,nan,272.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,272.0,0.0,272.0,0.0,272.0,0.0,272.0,0
TCGA-GC-A6I3-01,TCGA-GC-A6I3,BLCA,90.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-32873.0,Alive,TUMOR FREE,423.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,423.0,0.0,423.0,nan,nan,0.0,423.0,0
TCGA-GC-A6I3-11,TCGA-GC-A6I3,BLCA,90.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-32873.0,Alive,TUMOR FREE,423.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,423.0,0.0,423.0,nan,nan,0.0,423.0,0
TCGA-GD-A2C5-01,TCGA-GD-A2C5,BLCA,53.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-19498.0,Alive,WITH TUMOR,812.0,nan,nan,Metastatic,Lung,nan,214.0,Progressive Disease,nan,nan,0.0,812.0,0.0,812.0,nan,nan,1.0,214.0,2
TCGA-GD-A2C5-11,TCGA-GD-A2C5,BLCA,53.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-19498.0,Alive,WITH TUMOR,812.0,nan,nan,Metastatic,Lung,nan,214.0,Progressive Disease,nan,nan,0.0,812.0,0.0,812.0,nan,nan,1.0,214.0,2
TCGA-GD-A3OP-01,TCGA-GD-A3OP,BLCA,84.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-30956.0,Alive,nan,64.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,64.0,0.0,64.0,nan,nan,0.0,64.0,0
TCGA-GD-A3OP-11,TCGA-GD-A3OP,BLCA,84.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-30956.0,Alive,nan,64.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,64.0,0.0,64.0,nan,nan,0.0,64.0,0
TCGA-GD-A3OQ-01,TCGA-GD-A3OQ,BLCA,48.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-17682.0,Alive,nan,95.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,95.0,0.0,95.0,nan,nan,0.0,95.0,0
TCGA-GD-A3OQ-11,TCGA-GD-A3OQ,BLCA,48.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-17682.0,Alive,nan,95.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,95.0,0.0,95.0,nan,nan,0.0,95.0,0
TCGA-GD-A3OS-01,TCGA-GD-A3OS,BLCA,54.0,FEMALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-19776.0,Alive,WITH TUMOR,638.0,nan,nan,Locoregional (Urothelial tumor event),Bladder,nan,223.0,Progressive Disease,nan,nan,0.0,638.0,0.0,638.0,nan,nan,1.0,223.0,2
TCGA-GD-A6C6-01,TCGA-GD-A6C6,BLCA,64.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-23631.0,Alive,TUMOR FREE,67.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,67.0,0.0,67.0,0.0,67.0,0.0,67.0,0
TCGA-GD-A76B-01,TCGA-GD-A76B,BLCA,86.0,FEMALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-31571.0,Alive,TUMOR FREE,224.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,224.0,0.0,224.0,0.0,224.0,0.0,224.0,0
TCGA-GU-A42P-01,TCGA-GU-A42P,BLCA,72.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-26546.0,Dead,TUMOR FREE,nan,332.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,332.0,0.0,332.0,nan,nan,0.0,332.0,0
TCGA-GU-A42Q-01,TCGA-GU-A42Q,BLCA,67.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-24534.0,Dead,TUMOR FREE,nan,344.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,344.0,0.0,344.0,0.0,344.0,0.0,344.0,0
TCGA-GU-A42R-01,TCGA-GU-A42R,BLCA,68.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-25134.0,Dead,WITH TUMOR,nan,577.0,nan,Distant Metastasis,Lung,nan,91.0,Progressive Disease,nan,nan,1.0,577.0,1.0,577.0,nan,nan,1.0,91.0,1
TCGA-GU-A762-01,TCGA-GU-A762,BLCA,87.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-31812.0,Dead,WITH TUMOR,nan,232.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,232.0,1.0,232.0,nan,nan,1.0,232.0,1
TCGA-GU-A763-01,TCGA-GU-A763,BLCA,72.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-26527.0,Alive,WITH TUMOR,997.0,nan,nan,Distant Metastasis,Lung,nan,303.0,Stable Disease,nan,nan,0.0,997.0,0.0,997.0,nan,nan,1.0,303.0,2
TCGA-GU-A764-01,TCGA-GU-A764,BLCA,66.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-24343.0,Alive,TUMOR FREE,610.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,610.0,0.0,610.0,0.0,610.0,0.0,610.0,0
TCGA-GU-A766-01,TCGA-GU-A766,BLCA,62.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-22774.0,Alive,WITH TUMOR,480.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,480.0,0.0,480.0,nan,nan,0.0,480.0,0
TCGA-GU-A767-01,TCGA-GU-A767,BLCA,81.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-29739.0,Dead,WITH TUMOR,nan,144.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,144.0,1.0,144.0,nan,nan,1.0,144.0,1
TCGA-GU-AATO-01,TCGA-GU-AATO,BLCA,75.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-27684.0,Dead,WITH TUMOR,nan,324.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,324.0,1.0,324.0,nan,nan,1.0,324.0,1
TCGA-GU-AATP-01,TCGA-GU-AATP,BLCA,74.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-27049.0,Alive,WITH TUMOR,1003.0,nan,nan,New Primary Tumor,Urethra,nan,596.0,Progressive Disease,nan,nan,0.0,1003.0,0.0,1003.0,nan,nan,1.0,596.0,2
TCGA-GU-AATQ-01,TCGA-GU-AATQ,BLCA,68.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-25185.0,Dead,WITH TUMOR,nan,213.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,213.0,1.0,213.0,nan,nan,1.0,213.0,1
TCGA-GV-A3JV-01,TCGA-GV-A3JV,BLCA,66.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-24243.0,Dead,WITH TUMOR,nan,434.0,nan,Locoregional (Urothelial tumor event),Bladder,nan,134.0,Partial Remission/Response,nan,nan,1.0,434.0,1.0,434.0,nan,nan,1.0,134.0,1
TCGA-GV-A3JW-01,TCGA-GV-A3JW,BLCA,74.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-27091.0,Alive,WITH TUMOR,649.0,nan,nan,Distant Metastasis,Bone,nan,271.0,Stable Disease,nan,nan,0.0,649.0,0.0,649.0,nan,nan,1.0,271.0,0
TCGA-GV-A3JX-01,TCGA-GV-A3JX,BLCA,59.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-21888.0,Alive,TUMOR FREE,581.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,581.0,0.0,581.0,0.0,581.0,0.0,581.0,0
TCGA-GV-A3JZ-01,TCGA-GV-A3JZ,BLCA,55.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-20420.0,Alive,WITH TUMOR,603.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,603.0,0.0,603.0,nan,nan,0.0,603.0,0
TCGA-GV-A3QF-01,TCGA-GV-A3QF,BLCA,79.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-28890.0,Dead,TUMOR FREE,nan,617.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,617.0,0.0,617.0,nan,nan,0.0,617.0,0
TCGA-GV-A3QG-01,TCGA-GV-A3QG,BLCA,65.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-23847.0,Dead,WITH TUMOR,nan,nan,nan,Distant Metastasis,"Other, specify",Brain,84.0,nan,nan,nan,1.0,nan,1.0,nan,nan,nan,1.0,84.0,1
TCGA-GV-A3QH-01,TCGA-GV-A3QH,BLCA,67.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-24681.0,Dead,TUMOR FREE,nan,258.0,nan,Locoregional (Urothelial tumor event),Bladder,nan,125.0,Stable Disease,nan,nan,1.0,258.0,0.0,258.0,nan,nan,1.0,125.0,0
TCGA-GV-A3QI-01,TCGA-GV-A3QI,BLCA,47.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-17383.0,Alive,WITH TUMOR,1110.0,nan,nan,Distant Metastasis,"Other, specify",Abdominal wall,768.0,Complete Remission/Response,nan,nan,0.0,1110.0,0.0,1110.0,1.0,768.0,1.0,768.0,2
TCGA-GV-A3QK-01,TCGA-GV-A3QK,BLCA,56.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-20802.0,Alive,WITH TUMOR,832.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,832.0,0.0,832.0,nan,nan,0.0,832.0,2
TCGA-GV-A40E-01,TCGA-GV-A40E,BLCA,75.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-27569.0,Dead,WITH TUMOR,nan,261.0,nan,Distant Metastasis,Lung,nan,219.0,Stable Disease,nan,nan,1.0,261.0,1.0,261.0,nan,nan,1.0,219.0,1
TCGA-GV-A40G-01,TCGA-GV-A40G,BLCA,77.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-28204.0,Alive,TUMOR FREE,580.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,580.0,0.0,580.0,0.0,580.0,0.0,580.0,0
TCGA-GV-A6ZA-01,TCGA-GV-A6ZA,BLCA,54.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-19871.0,Alive,TUMOR FREE,691.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,691.0,0.0,691.0,0.0,691.0,0.0,691.0,0
TCGA-H4-A2HO-01,TCGA-H4-A2HO,BLCA,53.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-19630.0,Alive,TUMOR FREE,46.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,46.0,0.0,46.0,0.0,46.0,0.0,46.0,0
TCGA-H4-A2HQ-01,TCGA-H4-A2HQ,BLCA,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-23538.0,Alive,WITH TUMOR,590.0,nan,nan,Distant Metastasis,Lung,nan,318.0,Complete Remission/Response,nan,nan,0.0,590.0,0.0,590.0,nan,nan,1.0,318.0,2
TCGA-HQ-A2OE-01,TCGA-HQ-A2OE,BLCA,69.0,MALE,[Not Evaluated],nan,nan,Muscle invasive urothelial carcinoma (pT2 or above),[Unknown],2007.0,nan,nan,Alive,nan,1174.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1174.0,0.0,1174.0,nan,nan,0.0,1174.0,0
TCGA-HQ-A2OF-01,TCGA-HQ-A2OF,BLCA,52.0,FEMALE,[Not Evaluated],Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,nan,nan,-19016.0,Alive,TUMOR FREE,1947.0,nan,nan,Locoregional (Urothelial tumor event),Lymph Node Only,nan,907.0,Complete Remission/Response,nan,nan,0.0,1947.0,0.0,1947.0,1.0,907.0,1.0,907.0,2
TCGA-HQ-A5ND-01,TCGA-HQ-A5ND,BLCA,78.0,MALE,[Not Evaluated],Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,nan,nan,-28555.0,Dead,WITH TUMOR,nan,274.0,nan,Distant Metastasis,Lymph Node Only,nan,84.0,Progressive Disease,nan,nan,1.0,274.0,1.0,274.0,nan,nan,1.0,84.0,1
TCGA-HQ-A5NE-01,TCGA-HQ-A5NE,BLCA,57.0,MALE,[Not Evaluated],Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,nan,nan,-20647.0,Dead,WITH TUMOR,nan,370.0,nan,Distant Metastasis,Renal Pelvis,nan,211.0,Complete Remission/Response,nan,nan,1.0,370.0,1.0,370.0,1.0,211.0,1.0,211.0,1
TCGA-K4-A3WS-01,TCGA-K4-A3WS,BLCA,66.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-24124.0,Alive,TUMOR FREE,761.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,761.0,0.0,761.0,0.0,761.0,0.0,761.0,0
TCGA-K4-A3WU-01,TCGA-K4-A3WU,BLCA,87.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-32134.0,Alive,TUMOR FREE,105.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,105.0,0.0,105.0,nan,nan,0.0,105.0,0
TCGA-K4-A3WV-01,TCGA-K4-A3WV,BLCA,77.0,FEMALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-28444.0,Alive,TUMOR FREE,646.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,646.0,0.0,646.0,nan,nan,0.0,646.0,0
TCGA-K4-A3WV-11,TCGA-K4-A3WV,BLCA,77.0,FEMALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-28444.0,Alive,TUMOR FREE,646.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,646.0,0.0,646.0,nan,nan,0.0,646.0,0
TCGA-K4-A4AB-01,TCGA-K4-A4AB,BLCA,76.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-27922.0,Alive,nan,84.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,84.0,0.0,84.0,nan,nan,0.0,84.0,0
TCGA-K4-A4AC-01,TCGA-K4-A4AC,BLCA,83.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-30655.0,Dead,WITH TUMOR,nan,278.0,nan,Distant Metastasis,"Other, specify",psoas,170.0,Partial Remission/Response,nan,nan,1.0,278.0,1.0,278.0,nan,nan,1.0,170.0,1
TCGA-K4-A54R-01,TCGA-K4-A54R,BLCA,59.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-21601.0,Alive,TUMOR FREE,842.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,842.0,0.0,842.0,0.0,842.0,0.0,842.0,0
TCGA-K4-A54R-11,TCGA-K4-A54R,BLCA,59.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-21601.0,Alive,TUMOR FREE,842.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,842.0,0.0,842.0,0.0,842.0,0.0,842.0,0
TCGA-K4-A5RH-01,TCGA-K4-A5RH,BLCA,69.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-25305.0,Alive,WITH TUMOR,276.0,nan,nan,Distant Metastasis,Lung,nan,196.0,Progressive Disease,nan,nan,0.0,276.0,0.0,276.0,nan,nan,1.0,196.0,2
TCGA-K4-A5RI-01,TCGA-K4-A5RI,BLCA,67.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-24614.0,Dead,WITH TUMOR,nan,356.0,nan,Locoregional (Urothelial tumor event),"Other, specify",ileum,236.0,Progressive Disease,nan,nan,1.0,356.0,1.0,356.0,nan,nan,1.0,236.0,1
TCGA-K4-A5RI-11,TCGA-K4-A5RI,BLCA,67.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-24614.0,Dead,WITH TUMOR,nan,356.0,nan,Locoregional (Urothelial tumor event),"Other, specify",ileum,236.0,Progressive Disease,nan,nan,1.0,356.0,1.0,356.0,nan,nan,1.0,236.0,1
TCGA-K4-A5RJ-01,TCGA-K4-A5RJ,BLCA,75.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-27518.0,Alive,TUMOR FREE,539.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,539.0,0.0,539.0,0.0,539.0,0.0,539.0,0
TCGA-K4-A6FZ-01,TCGA-K4-A6FZ,BLCA,75.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-27686.0,Alive,TUMOR FREE,55.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,55.0,0.0,55.0,0.0,55.0,0.0,55.0,0
TCGA-K4-A6MB-01,TCGA-K4-A6MB,BLCA,64.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-23664.0,Alive,TUMOR FREE,469.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,469.0,0.0,469.0,nan,nan,0.0,469.0,0
TCGA-K4-A83P-01,TCGA-K4-A83P,BLCA,77.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),[Unknown],2013.0,nan,-28463.0,Alive,WITH TUMOR,495.0,nan,nan,Distant Metastasis,Liver,nan,70.0,Partial Remission/Response,nan,nan,0.0,495.0,0.0,495.0,nan,nan,1.0,70.0,2
TCGA-K4-AAQO-01,TCGA-K4-AAQO,BLCA,56.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-20683.0,Alive,nan,359.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,359.0,0.0,359.0,nan,nan,0.0,359.0,0
TCGA-KQ-A41N-01,TCGA-KQ-A41N,BLCA,73.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-26837.0,Alive,TUMOR FREE,1604.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1604.0,0.0,1604.0,0.0,1604.0,0.0,1604.0,0
TCGA-KQ-A41O-01,TCGA-KQ-A41O,BLCA,84.0,MALE,[Unknown],Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-30774.0,Alive,TUMOR FREE,1538.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1538.0,0.0,1538.0,nan,nan,0.0,1538.0,0
TCGA-KQ-A41P-01,TCGA-KQ-A41P,BLCA,76.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-27816.0,Alive,WITH TUMOR,1094.0,nan,nan,Locoregional (Urothelial tumor event),Lymph Node Only,nan,178.0,Stable Disease,nan,nan,0.0,1094.0,0.0,1094.0,nan,nan,1.0,178.0,0
TCGA-KQ-A41Q-01,TCGA-KQ-A41Q,BLCA,89.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-32511.0,Alive,nan,1429.0,nan,nan,Locoregional (Urothelial tumor event),Lymph Node Only,nan,1314.0,[Unknown],nan,nan,0.0,1429.0,0.0,1429.0,nan,nan,1.0,1314.0,2
TCGA-KQ-A41R-01,TCGA-KQ-A41R,BLCA,80.0,FEMALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-29351.0,Alive,TUMOR FREE,1350.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1350.0,0.0,1350.0,0.0,1350.0,0.0,1350.0,0
TCGA-KQ-A41S-01,TCGA-KQ-A41S,BLCA,87.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-32041.0,Alive,TUMOR FREE,35.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,35.0,0.0,35.0,0.0,35.0,0.0,35.0,0
TCGA-LC-A66R-01,TCGA-LC-A66R,BLCA,78.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-28793.0,Alive,TUMOR FREE,466.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,466.0,0.0,466.0,nan,nan,0.0,466.0,0
TCGA-LT-A5Z6-01,TCGA-LT-A5Z6,BLCA,56.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-20746.0,Alive,TUMOR FREE,474.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,474.0,0.0,474.0,0.0,474.0,0.0,474.0,0
TCGA-LT-A8JT-01,TCGA-LT-A8JT,BLCA,69.0,FEMALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-25498.0,Alive,TUMOR FREE,641.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,641.0,0.0,641.0,0.0,641.0,0.0,641.0,0
TCGA-MV-A51V-01,TCGA-MV-A51V,BLCA,75.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-27430.0,Alive,TUMOR FREE,410.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,410.0,0.0,410.0,0.0,410.0,0.0,410.0,0
TCGA-PQ-A6FI-01,TCGA-PQ-A6FI,BLCA,70.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-25672.0,Alive,TUMOR FREE,372.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,372.0,0.0,372.0,0.0,372.0,0.0,372.0,0
TCGA-PQ-A6FN-01,TCGA-PQ-A6FN,BLCA,78.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-28546.0,Alive,nan,507.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,507.0,0.0,507.0,nan,nan,0.0,507.0,0
TCGA-R3-A69X-01,TCGA-R3-A69X,BLCA,70.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-25576.0,Alive,TUMOR FREE,433.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,433.0,0.0,433.0,0.0,433.0,0.0,433.0,0
TCGA-S5-A6DX-01,TCGA-S5-A6DX,BLCA,83.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-30594.0,Dead,WITH TUMOR,nan,56.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,56.0,1.0,56.0,nan,nan,1.0,56.0,1
TCGA-S5-AA26-01,TCGA-S5-AA26,BLCA,46.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-16972.0,Alive,TUMOR FREE,503.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,503.0,0.0,503.0,0.0,503.0,0.0,503.0,0
TCGA-SY-A9G0-01,TCGA-SY-A9G0,BLCA,82.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-30205.0,Dead,TUMOR FREE,nan,1008.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1008.0,0.0,1008.0,nan,nan,0.0,1008.0,0
TCGA-SY-A9G5-01,TCGA-SY-A9G5,BLCA,66.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-24260.0,Alive,TUMOR FREE,1186.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1186.0,0.0,1186.0,0.0,1186.0,0.0,1186.0,0
TCGA-UY-A78K-01,TCGA-UY-A78K,BLCA,60.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,nan,nan,-22020.0,Dead,nan,nan,536.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,536.0,nan,536.0,nan,nan,0.0,536.0,1
TCGA-UY-A78L-01,TCGA-UY-A78L,BLCA,62.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,nan,nan,-22717.0,Alive,WITH TUMOR,1127.0,nan,nan,nan,nan,nan,355.0,Progressive Disease,nan,nan,0.0,1127.0,0.0,1127.0,nan,nan,1.0,355.0,2
TCGA-UY-A78M-01,TCGA-UY-A78M,BLCA,81.0,FEMALE,ASIAN,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,nan,nan,-29706.0,Dead,WITH TUMOR,nan,690.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,690.0,1.0,690.0,nan,nan,1.0,690.0,1
TCGA-UY-A78N-01,TCGA-UY-A78N,BLCA,80.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,nan,nan,-29132.0,Dead,WITH TUMOR,nan,2641.0,nan,Distant Metastasis,Renal Pelvis,nan,2472.0,Complete Remission/Response,nan,nan,1.0,2641.0,1.0,2641.0,nan,nan,1.0,2472.0,1
TCGA-UY-A78O-01,TCGA-UY-A78O,BLCA,75.0,FEMALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,nan,nan,-27234.0,Alive,TUMOR FREE,2312.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2312.0,0.0,2312.0,0.0,2312.0,0.0,2312.0,0
TCGA-UY-A78P-01,TCGA-UY-A78P,BLCA,78.0,FEMALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,nan,nan,-28719.0,Alive,TUMOR FREE,2380.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2380.0,0.0,2380.0,0.0,2380.0,0.0,2380.0,0
TCGA-UY-A8OB-01,TCGA-UY-A8OB,BLCA,63.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,nan,nan,-23360.0,Alive,TUMOR FREE,2109.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2109.0,0.0,2109.0,nan,nan,0.0,2109.0,0
TCGA-UY-A8OC-01,TCGA-UY-A8OC,BLCA,90.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,nan,nan,-32918.0,Dead,WITH TUMOR,nan,92.0,nan,Distant Metastasis,Lymph Node Only,nan,32.0,Partial Remission/Response,nan,nan,1.0,92.0,1.0,92.0,nan,nan,1.0,32.0,1
TCGA-UY-A8OD-01,TCGA-UY-A8OD,BLCA,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,nan,nan,-24588.0,Alive,TUMOR FREE,3432.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3432.0,0.0,3432.0,0.0,3432.0,0.0,3432.0,0
TCGA-UY-A9PA-01,TCGA-UY-A9PA,BLCA,48.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,nan,nan,-17520.0,Alive,TUMOR FREE,1072.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1072.0,0.0,1072.0,0.0,1072.0,0.0,1072.0,0
TCGA-UY-A9PB-01,TCGA-UY-A9PB,BLCA,49.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,nan,nan,-17885.0,Alive,TUMOR FREE,899.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,899.0,0.0,899.0,0.0,899.0,0.0,899.0,0
TCGA-UY-A9PD-01,TCGA-UY-A9PD,BLCA,80.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,nan,nan,-29565.0,Alive,TUMOR FREE,542.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,542.0,0.0,542.0,0.0,542.0,0.0,542.0,0
TCGA-UY-A9PE-01,TCGA-UY-A9PE,BLCA,86.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,nan,nan,-31755.0,Alive,WITH TUMOR,189.0,nan,nan,Distant Metastasis,Lung,nan,473.0,Complete Remission/Response,nan,nan,0.0,189.0,0.0,189.0,nan,nan,1.0,473.0,2
TCGA-UY-A9PF-01,TCGA-UY-A9PF,BLCA,77.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,nan,nan,-28470.0,Alive,TUMOR FREE,117.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,117.0,0.0,117.0,nan,nan,0.0,117.0,0
TCGA-UY-A9PH-01,TCGA-UY-A9PH,BLCA,73.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,nan,nan,-26654.0,Alive,TUMOR FREE,1561.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1561.0,0.0,1561.0,0.0,1561.0,0.0,1561.0,0
TCGA-XF-A8HB-01,TCGA-XF-A8HB,BLCA,50.0,FEMALE,[Unknown],Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-18544.0,Alive,TUMOR FREE,1370.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1370.0,0.0,1370.0,0.0,1370.0,0.0,1370.0,0
TCGA-XF-A8HC-01,TCGA-XF-A8HC,BLCA,79.0,MALE,ASIAN,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005.0,nan,-28996.0,Dead,nan,nan,200.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,200.0,nan,200.0,nan,nan,0.0,200.0,1
TCGA-XF-A8HD-01,TCGA-XF-A8HD,BLCA,77.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-28305.0,Alive,TUMOR FREE,2964.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2964.0,0.0,2964.0,0.0,2964.0,0.0,2964.0,0
TCGA-XF-A8HE-01,TCGA-XF-A8HE,BLCA,47.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004.0,nan,-17212.0,Alive,TUMOR FREE,3817.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3817.0,0.0,3817.0,0.0,3817.0,0.0,3817.0,0
TCGA-XF-A8HF-01,TCGA-XF-A8HF,BLCA,80.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004.0,nan,-29288.0,Dead,TUMOR FREE,nan,2954.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2954.0,0.0,2954.0,0.0,2954.0,0.0,2954.0,0
TCGA-XF-A8HG-01,TCGA-XF-A8HG,BLCA,69.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005.0,nan,-25421.0,Dead,WITH TUMOR,nan,467.0,nan,Distant Metastasis,Liver,nan,398.0,Complete Remission/Response,nan,nan,1.0,467.0,1.0,467.0,1.0,398.0,1.0,398.0,1
TCGA-XF-A8HH-01,TCGA-XF-A8HH,BLCA,61.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004.0,nan,-22393.0,Dead,WITH TUMOR,nan,57.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,57.0,1.0,57.0,nan,nan,1.0,57.0,1
TCGA-XF-A8HI-01,TCGA-XF-A8HI,BLCA,57.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005.0,nan,-21059.0,Dead,WITH TUMOR,nan,544.0,nan,Distant Metastasis,Lung,nan,468.0,Progressive Disease,nan,nan,1.0,544.0,1.0,544.0,nan,nan,1.0,468.0,1
TCGA-XF-A9SG-01,TCGA-XF-A9SG,BLCA,81.0,MALE,[Unknown],Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-29825.0,Alive,TUMOR FREE,1479.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1479.0,0.0,1479.0,0.0,1479.0,0.0,1479.0,0
TCGA-XF-A9SH-01,TCGA-XF-A9SH,BLCA,65.0,FEMALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005.0,nan,-24060.0,Dead,WITH TUMOR,nan,1971.0,nan,Locoregional (Urothelial tumor event),Lymph Node Only,nan,547.0,Stable Disease,nan,nan,1.0,1971.0,1.0,1971.0,nan,nan,1.0,547.0,1
TCGA-XF-A9SI-01,TCGA-XF-A9SI,BLCA,73.0,FEMALE,ASIAN,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-26719.0,Alive,TUMOR FREE,2423.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2423.0,0.0,2423.0,0.0,2423.0,0.0,2423.0,0
TCGA-XF-A9SJ-01,TCGA-XF-A9SJ,BLCA,83.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004.0,nan,-30362.0,Dead,WITH TUMOR,nan,98.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,98.0,1.0,98.0,nan,nan,1.0,98.0,1
TCGA-XF-A9SK-01,TCGA-XF-A9SK,BLCA,65.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004.0,nan,-24019.0,Dead,WITH TUMOR,nan,486.0,nan,Distant Metastasis,Bone,nan,382.0,Stable Disease,nan,nan,1.0,486.0,1.0,486.0,nan,nan,1.0,382.0,1
TCGA-XF-A9SL-01,TCGA-XF-A9SL,BLCA,69.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004.0,nan,-25460.0,Dead,TUMOR FREE,nan,2020.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2020.0,0.0,2020.0,nan,nan,0.0,2020.0,0
TCGA-XF-A9SM-01,TCGA-XF-A9SM,BLCA,76.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004.0,nan,-27826.0,Alive,TUMOR FREE,1048.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1048.0,0.0,1048.0,0.0,1048.0,0.0,1048.0,0
TCGA-XF-A9SP-01,TCGA-XF-A9SP,BLCA,59.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004.0,nan,-21776.0,Dead,WITH TUMOR,nan,454.0,nan,Locoregional (Urothelial tumor event),Renal Pelvis,nan,310.0,Stable Disease,nan,nan,1.0,454.0,1.0,454.0,nan,nan,1.0,310.0,1
TCGA-XF-A9ST-01,TCGA-XF-A9ST,BLCA,68.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005.0,nan,-25080.0,Dead,nan,nan,128.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,128.0,nan,128.0,nan,nan,0.0,128.0,1
TCGA-XF-A9SU-01,TCGA-XF-A9SU,BLCA,74.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-27068.0,Dead,WITH TUMOR,nan,182.0,nan,Distant Metastasis,Liver,nan,103.0,Progressive Disease,nan,nan,1.0,182.0,1.0,182.0,nan,nan,1.0,103.0,1
TCGA-XF-A9SV-01,TCGA-XF-A9SV,BLCA,82.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-30265.0,Dead,WITH TUMOR,nan,388.0,nan,Distant Metastasis,Lung,nan,237.0,Progressive Disease,nan,nan,1.0,388.0,1.0,388.0,nan,nan,1.0,237.0,1
TCGA-XF-A9SW-01,TCGA-XF-A9SW,BLCA,85.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-31049.0,Dead,WITH TUMOR,nan,362.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,362.0,1.0,362.0,nan,nan,1.0,362.0,1
TCGA-XF-A9SX-01,TCGA-XF-A9SX,BLCA,63.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-23349.0,Dead,WITH TUMOR,nan,719.0,nan,Distant Metastasis,Lung,nan,475.0,Progressive Disease,nan,nan,1.0,719.0,1.0,719.0,nan,nan,1.0,475.0,1
TCGA-XF-A9SY-01,TCGA-XF-A9SY,BLCA,60.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-22212.0,Alive,WITH TUMOR,640.0,nan,nan,Distant Metastasis,"Other, specify",Groin,168.0,Progressive Disease,nan,nan,0.0,640.0,0.0,640.0,nan,nan,1.0,168.0,2
TCGA-XF-A9SZ-01,TCGA-XF-A9SZ,BLCA,79.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,nan,-29100.0,Dead,WITH TUMOR,nan,859.0,nan,Distant Metastasis,Lung,nan,854.0,Complete Remission/Response,nan,nan,1.0,859.0,1.0,859.0,nan,nan,1.0,854.0,1
TCGA-XF-A9T0-01,TCGA-XF-A9T0,BLCA,68.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,nan,-25190.0,Alive,TUMOR FREE,799.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,799.0,0.0,799.0,0.0,799.0,0.0,799.0,0
TCGA-XF-A9T2-01,TCGA-XF-A9T2,BLCA,54.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,nan,-19945.0,Dead,nan,nan,575.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,575.0,nan,575.0,nan,nan,0.0,575.0,1
TCGA-XF-A9T3-01,TCGA-XF-A9T3,BLCA,69.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-25532.0,Alive,TUMOR FREE,68.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,68.0,0.0,68.0,nan,nan,0.0,68.0,0
TCGA-XF-A9T4-01,TCGA-XF-A9T4,BLCA,48.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-17728.0,Dead,WITH TUMOR,nan,495.0,nan,Distant Metastasis,Lung,nan,182.0,Partial Remission/Response,nan,nan,1.0,495.0,1.0,495.0,nan,nan,1.0,182.0,1
TCGA-XF-A9T5-01,TCGA-XF-A9T5,BLCA,78.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-28578.0,Alive,TUMOR FREE,2027.0,nan,nan,Locoregional (Urothelial tumor event),"Other, specify",Vagina,664.0,Complete Remission/Response,nan,nan,0.0,2027.0,0.0,2027.0,nan,nan,1.0,664.0,2
TCGA-XF-A9T6-01,TCGA-XF-A9T6,BLCA,88.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-32207.0,Alive,nan,64.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,64.0,0.0,64.0,nan,nan,0.0,64.0,0
TCGA-XF-A9T8-01,TCGA-XF-A9T8,BLCA,64.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-23403.0,Dead,nan,nan,418.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,418.0,nan,418.0,nan,nan,0.0,418.0,1
TCGA-XF-AAME-01,TCGA-XF-AAME,BLCA,64.0,FEMALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-23448.0,Dead,WITH TUMOR,nan,2828.0,nan,Locoregional (Urothelial tumor event),"Other, specify",Vagina,1651.0,Progressive Disease,nan,nan,1.0,2828.0,1.0,2828.0,nan,nan,1.0,1651.0,1
TCGA-XF-AAMF-01,TCGA-XF-AAMF,BLCA,68.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004.0,nan,-25023.0,Dead,WITH TUMOR,nan,329.0,nan,Distant Metastasis,Lung,nan,157.0,Stable Disease,nan,nan,1.0,329.0,1.0,329.0,nan,nan,1.0,157.0,1
TCGA-XF-AAMG-01,TCGA-XF-AAMG,BLCA,49.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2004.0,nan,-18021.0,Alive,TUMOR FREE,3364.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3364.0,0.0,3364.0,0.0,3364.0,0.0,3364.0,0
TCGA-XF-AAMH-01,TCGA-XF-AAMH,BLCA,80.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2005.0,nan,-29547.0,Dead,WITH TUMOR,nan,344.0,nan,Distant Metastasis,"Other, specify",lumbar spine and right hemipelvis,313.0,Progressive Disease,nan,nan,1.0,344.0,1.0,344.0,nan,nan,1.0,313.0,1
TCGA-XF-AAMJ-01,TCGA-XF-AAMJ,BLCA,70.0,MALE,ASIAN,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-25838.0,Dead,TUMOR FREE,nan,1670.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1670.0,0.0,1670.0,0.0,1670.0,0.0,1670.0,0
TCGA-XF-AAML-01,TCGA-XF-AAML,BLCA,75.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,nan,-27422.0,Dead,TUMOR FREE,nan,232.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,232.0,0.0,232.0,0.0,232.0,0.0,232.0,0
TCGA-XF-AAMQ-01,TCGA-XF-AAMQ,BLCA,59.0,FEMALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-21660.0,Alive,TUMOR FREE,2177.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2177.0,0.0,2177.0,0.0,2177.0,0.0,2177.0,0
TCGA-XF-AAMR-01,TCGA-XF-AAMR,BLCA,48.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-17670.0,Alive,TUMOR FREE,2790.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2790.0,0.0,2790.0,0.0,2790.0,0.0,2790.0,0
TCGA-XF-AAMT-01,TCGA-XF-AAMT,BLCA,75.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-27397.0,Dead,WITH TUMOR,nan,90.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,90.0,1.0,90.0,nan,nan,1.0,90.0,1
TCGA-XF-AAMW-01,TCGA-XF-AAMW,BLCA,79.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-28903.0,Dead,WITH TUMOR,nan,253.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,253.0,1.0,253.0,nan,nan,1.0,253.0,1
TCGA-XF-AAMX-01,TCGA-XF-AAMX,BLCA,87.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-31884.0,Dead,TUMOR FREE,nan,206.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,206.0,0.0,206.0,0.0,206.0,0.0,206.0,0
TCGA-XF-AAMY-01,TCGA-XF-AAMY,BLCA,78.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-28509.0,Alive,TUMOR FREE,3011.0,nan,nan,Distant Metastasis,Lung,nan,637.0,Complete Remission/Response,nan,nan,0.0,3011.0,0.0,3011.0,1.0,637.0,1.0,637.0,2
TCGA-XF-AAMZ-01,TCGA-XF-AAMZ,BLCA,81.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,nan,-29667.0,Dead,WITH TUMOR,nan,1348.0,nan,Locoregional (Urothelial tumor event),Lymph Node Only,nan,1344.0,Partial Remission/Response,nan,nan,1.0,1348.0,1.0,1348.0,nan,nan,1.0,1344.0,1
TCGA-XF-AAN0-01,TCGA-XF-AAN0,BLCA,68.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,nan,-24877.0,Dead,WITH TUMOR,nan,1718.0,nan,Locoregional (Urothelial tumor event),"Other, specify",Scrotum and Perineum,603.0,Complete Remission/Response,nan,nan,1.0,1718.0,1.0,1718.0,nan,nan,1.0,603.0,1
TCGA-XF-AAN1-01,TCGA-XF-AAN1,BLCA,75.0,FEMALE,[Unknown],Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2006.0,nan,-27687.0,Dead,WITH TUMOR,nan,941.0,nan,Locoregional (Urothelial tumor event),"Other, specify",Pelvis and vagina,650.0,Partial Remission/Response,nan,nan,1.0,941.0,1.0,941.0,nan,nan,1.0,650.0,1
TCGA-XF-AAN2-01,TCGA-XF-AAN2,BLCA,73.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,nan,-26720.0,Dead,TUMOR FREE,nan,1869.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1869.0,0.0,1869.0,0.0,1869.0,0.0,1869.0,0
TCGA-XF-AAN3-01,TCGA-XF-AAN3,BLCA,76.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,nan,-27909.0,Alive,TUMOR FREE,2625.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2625.0,0.0,2625.0,nan,nan,0.0,2625.0,0
TCGA-XF-AAN4-01,TCGA-XF-AAN4,BLCA,77.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,nan,-28302.0,Dead,TUMOR FREE,nan,823.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,823.0,0.0,823.0,0.0,823.0,0.0,823.0,0
TCGA-XF-AAN5-01,TCGA-XF-AAN5,BLCA,61.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-22411.0,Alive,TUMOR FREE,2293.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2293.0,0.0,2293.0,0.0,2293.0,0.0,2293.0,0
TCGA-XF-AAN7-01,TCGA-XF-AAN7,BLCA,60.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-21951.0,Dead,WITH TUMOR,nan,565.0,nan,Locoregional (Urothelial tumor event),Bladder,nan,321.0,Complete Remission/Response,nan,nan,1.0,565.0,1.0,565.0,nan,nan,1.0,321.0,1
TCGA-XF-AAN8-01,TCGA-XF-AAN8,BLCA,74.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,nan,-27309.0,Dead,nan,nan,118.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,118.0,nan,118.0,nan,nan,0.0,118.0,1
TCGA-YC-A89H-01,TCGA-YC-A89H,BLCA,78.0,FEMALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-28741.0,Alive,TUMOR FREE,573.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,573.0,0.0,573.0,0.0,573.0,0.0,573.0,0
TCGA-YC-A8S6-01,TCGA-YC-A8S6,BLCA,71.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-26130.0,Alive,TUMOR FREE,293.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,293.0,0.0,293.0,0.0,293.0,0.0,293.0,0
TCGA-YC-A9TC-01,TCGA-YC-A9TC,BLCA,71.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-26283.0,Dead,WITH TUMOR,nan,20.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,20.0,1.0,20.0,nan,nan,1.0,20.0,1
TCGA-YF-AA3L-01,TCGA-YF-AA3L,BLCA,47.0,FEMALE,[Unknown],Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-17268.0,Alive,TUMOR FREE,364.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,364.0,0.0,364.0,0.0,364.0,0.0,364.0,0
TCGA-YF-AA3M-01,TCGA-YF-AA3M,BLCA,57.0,MALE,[Unknown],Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-21097.0,Alive,WITH TUMOR,415.0,nan,nan,Locoregional (Urothelial tumor event),"Other, specify",Pelvis,381.0,Complete Remission/Response,nan,nan,0.0,415.0,0.0,415.0,1.0,381.0,1.0,381.0,2
TCGA-ZF-A9R0-01,TCGA-ZF-A9R0,BLCA,82.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-30222.0,Dead,WITH TUMOR,nan,680.0,nan,Locoregional (Urothelial tumor event),"Other, specify",right hemipelvis,559.0,Progressive Disease,nan,nan,1.0,680.0,1.0,680.0,nan,nan,1.0,559.0,1
TCGA-ZF-A9R1-01,TCGA-ZF-A9R1,BLCA,81.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-29610.0,Alive,WITH TUMOR,773.0,nan,nan,Distant Metastasis,Bone,nan,758.0,Complete Remission/Response,nan,nan,0.0,773.0,0.0,773.0,nan,nan,1.0,758.0,2
TCGA-ZF-A9R2-01,TCGA-ZF-A9R2,BLCA,75.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-27537.0,Alive,TUMOR FREE,642.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,642.0,0.0,642.0,0.0,642.0,0.0,642.0,0
TCGA-ZF-A9R3-01,TCGA-ZF-A9R3,BLCA,53.0,FEMALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-19384.0,Dead,WITH TUMOR,nan,949.0,nan,Distant Metastasis,Bone,nan,917.0,Complete Remission/Response,nan,nan,1.0,949.0,1.0,949.0,1.0,917.0,1.0,917.0,1
TCGA-ZF-A9R4-01,TCGA-ZF-A9R4,BLCA,83.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-30398.0,Alive,TUMOR FREE,921.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,921.0,0.0,921.0,0.0,921.0,0.0,921.0,0
TCGA-ZF-A9R5-01,TCGA-ZF-A9R5,BLCA,59.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-21811.0,Alive,TUMOR FREE,1090.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1090.0,0.0,1090.0,0.0,1090.0,0.0,1090.0,0
TCGA-ZF-A9R7-01,TCGA-ZF-A9R7,BLCA,76.0,FEMALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2011.0,nan,-28063.0,Alive,TUMOR FREE,665.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,665.0,0.0,665.0,0.0,665.0,0.0,665.0,0
TCGA-ZF-A9R9-01,TCGA-ZF-A9R9,BLCA,58.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-21491.0,Dead,WITH TUMOR,nan,864.0,nan,Distant Metastasis,"Other, specify",penis,629.0,Complete Remission/Response,nan,nan,1.0,864.0,1.0,864.0,nan,nan,1.0,629.0,1
TCGA-ZF-A9RC-01,TCGA-ZF-A9RC,BLCA,77.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,nan,-28275.0,Alive,TUMOR FREE,2868.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2868.0,0.0,2868.0,0.0,2868.0,0.0,2868.0,0
TCGA-ZF-A9RD-01,TCGA-ZF-A9RD,BLCA,75.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-27496.0,Dead,nan,nan,408.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,408.0,nan,408.0,nan,nan,0.0,408.0,1
TCGA-ZF-A9RE-01,TCGA-ZF-A9RE,BLCA,78.0,FEMALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-28622.0,Dead,WITH TUMOR,nan,106.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,106.0,1.0,106.0,nan,nan,1.0,106.0,1
TCGA-ZF-A9RF-01,TCGA-ZF-A9RF,BLCA,74.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-27281.0,Alive,TUMOR FREE,1949.0,nan,nan,Locoregional (Urothelial tumor event),Bladder,nan,1565.0,Complete Remission/Response,nan,nan,0.0,1949.0,0.0,1949.0,1.0,1565.0,1.0,1565.0,2
TCGA-ZF-A9RG-01,TCGA-ZF-A9RG,BLCA,70.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-25656.0,Alive,WITH TUMOR,1786.0,nan,nan,Distant Metastasis,"Other, specify",neck lymph node,440.0,Complete Remission/Response,nan,nan,0.0,1786.0,0.0,1786.0,1.0,440.0,1.0,440.0,2
TCGA-ZF-A9RL-01,TCGA-ZF-A9RL,BLCA,61.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2007.0,nan,-22480.0,Alive,TUMOR FREE,2703.0,nan,nan,Locoregional (Urothelial tumor event),Bladder,nan,1064.0,Complete Remission/Response,nan,nan,0.0,2703.0,0.0,2703.0,1.0,1064.0,1.0,1064.0,2
TCGA-ZF-A9RM-01,TCGA-ZF-A9RM,BLCA,70.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-25642.0,Alive,TUMOR FREE,1455.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1455.0,0.0,1455.0,0.0,1455.0,0.0,1455.0,0
TCGA-ZF-A9RN-01,TCGA-ZF-A9RN,BLCA,67.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-24795.0,Dead,WITH TUMOR,nan,615.0,nan,Distant Metastasis,Lung,nan,516.0,Partial Remission/Response,nan,nan,1.0,615.0,1.0,615.0,nan,nan,1.0,516.0,1
TCGA-ZF-AA4N-01,TCGA-ZF-AA4N,BLCA,74.0,MALE,WHITE,Stage II,nan,nan,High Grade,2011.0,nan,-27056.0,Dead,WITH TUMOR,nan,88.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,88.0,1.0,88.0,nan,nan,1.0,88.0,1
TCGA-ZF-AA4R-01,TCGA-ZF-AA4R,BLCA,67.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-24537.0,Dead,WITH TUMOR,nan,1036.0,nan,Locoregional (Urothelial tumor event),Lymph Node Only,nan,750.0,[Unknown],nan,nan,1.0,1036.0,1.0,1036.0,nan,nan,1.0,750.0,1
TCGA-ZF-AA4T-01,TCGA-ZF-AA4T,BLCA,65.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-23974.0,Dead,WITH TUMOR,nan,599.0,nan,Distant Metastasis,Lung,nan,511.0,[Unknown],nan,nan,1.0,599.0,1.0,599.0,nan,nan,1.0,511.0,1
TCGA-ZF-AA4U-01,TCGA-ZF-AA4U,BLCA,70.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-25682.0,Dead,WITH TUMOR,nan,262.0,nan,Distant Metastasis,Bone,nan,199.0,Progressive Disease,nan,nan,1.0,262.0,1.0,262.0,nan,nan,1.0,199.0,1
TCGA-ZF-AA4V-01,TCGA-ZF-AA4V,BLCA,66.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2008.0,nan,-24448.0,Alive,TUMOR FREE,1806.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1806.0,0.0,1806.0,0.0,1806.0,0.0,1806.0,0
TCGA-ZF-AA4W-01,TCGA-ZF-AA4W,BLCA,56.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-20611.0,Alive,nan,1830.0,nan,nan,Locoregional (Urothelial tumor event),"Other, specify",penile urethra,1679.0,Complete Remission/Response,nan,nan,0.0,1830.0,0.0,1830.0,1.0,1679.0,1.0,1679.0,2
TCGA-ZF-AA4X-01,TCGA-ZF-AA4X,BLCA,56.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-20579.0,Alive,WITH TUMOR,2044.0,nan,nan,Locoregional (Urothelial tumor event),Bladder,nan,1665.0,Complete Remission/Response,nan,nan,0.0,2044.0,0.0,2044.0,1.0,1665.0,1.0,1665.0,2
TCGA-ZF-AA51-01,TCGA-ZF-AA51,BLCA,69.0,FEMALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-25484.0,Alive,TUMOR FREE,1714.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1714.0,0.0,1714.0,0.0,1714.0,0.0,1714.0,0
TCGA-ZF-AA52-01,TCGA-ZF-AA52,BLCA,70.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-25579.0,Dead,nan,nan,1077.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,1077.0,nan,1077.0,nan,nan,0.0,1077.0,1
TCGA-ZF-AA53-01,TCGA-ZF-AA53,BLCA,60.0,MALE,WHITE,Stage II,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-22035.0,Alive,TUMOR FREE,1761.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1761.0,0.0,1761.0,0.0,1761.0,0.0,1761.0,0
TCGA-ZF-AA54-01,TCGA-ZF-AA54,BLCA,71.0,MALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2009.0,nan,-26128.0,Dead,nan,nan,590.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,590.0,nan,590.0,nan,nan,0.0,590.0,1
TCGA-ZF-AA56-01,TCGA-ZF-AA56,BLCA,79.0,FEMALE,WHITE,Stage III,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-28937.0,Dead,WITH TUMOR,nan,259.0,nan,Distant Metastasis,Liver,nan,248.0,Progressive Disease,nan,nan,1.0,259.0,1.0,259.0,nan,nan,1.0,248.0,1
TCGA-ZF-AA58-01,TCGA-ZF-AA58,BLCA,61.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2010.0,nan,-22549.0,Alive,TUMOR FREE,1649.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1649.0,0.0,1649.0,nan,nan,0.0,1649.0,0
TCGA-ZF-AA5H-01,TCGA-ZF-AA5H,BLCA,60.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2012.0,nan,-22122.0,Alive,WITH TUMOR,897.0,nan,nan,Locoregional (Urothelial tumor event),"Other, specify",peritoneum,177.0,Stable Disease,nan,nan,0.0,897.0,0.0,897.0,nan,nan,1.0,177.0,2
TCGA-ZF-AA5N-01,TCGA-ZF-AA5N,BLCA,62.0,FEMALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-22741.0,Dead,WITH TUMOR,nan,168.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,168.0,1.0,168.0,nan,nan,1.0,168.0,1
TCGA-ZF-AA5P-01,TCGA-ZF-AA5P,BLCA,65.0,MALE,WHITE,Stage IV,nan,Muscle invasive urothelial carcinoma (pT2 or above),High Grade,2013.0,nan,-23971.0,Alive,TUMOR FREE,372.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,372.0,0.0,372.0,nan,nan,0.0,372.0,0
TCGA-3C-AAAU-01,TCGA-3C-AAAU,BRCA,55.0,FEMALE,WHITE,Stage X,nan,Infiltrating Lobular Carcinoma,nan,2004.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20211.0,Alive,WITH TUMOR,4047.0,nan,nan,Distant Metastasis,Lung,nan,1808.0,nan,Negative,nan,0.0,4047.0,0.0,4047.0,1.0,1808.0,1.0,1808.0,2
TCGA-3C-AALI-01,TCGA-3C-AALI,BRCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18538.0,Alive,TUMOR FREE,4005.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,4005.0,0.0,4005.0,0.0,4005.0,0.0,4005.0,0
TCGA-3C-AALJ-01,TCGA-3C-AALJ,BRCA,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22848.0,Alive,TUMOR FREE,1474.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1474.0,0.0,1474.0,0.0,1474.0,0.0,1474.0,0
TCGA-3C-AALK-01,TCGA-3C-AALK,BRCA,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,[Unknown],-19074.0,Alive,TUMOR FREE,1448.0,nan,nan,nan,nan,nan,nan,nan,Close,nan,0.0,1448.0,0.0,1448.0,nan,nan,0.0,1448.0,0
TCGA-4H-AAAK-01,TCGA-4H-AAAK,BRCA,50.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18371.0,Alive,TUMOR FREE,348.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,348.0,0.0,348.0,0.0,348.0,0.0,348.0,0
TCGA-5L-AAT0-01,TCGA-5L-AAT0,BRCA,42.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-15393.0,Alive,TUMOR FREE,1477.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,1477.0,0.0,1477.0,nan,nan,0.0,1477.0,0
TCGA-5L-AAT1-01,TCGA-5L-AAT1,BRCA,63.0,FEMALE,WHITE,Stage IV,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23225.0,Alive,WITH TUMOR,1471.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1471.0,0.0,1471.0,nan,nan,0.0,1471.0,0
TCGA-5T-A9QA-01,TCGA-5T-A9QA,BRCA,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,"Other, specify",nan,2013.0,[Unknown],-19031.0,Alive,nan,303.0,nan,nan,nan,nan,nan,nan,nan,[Unknown],nan,0.0,303.0,0.0,303.0,nan,nan,0.0,303.0,0
TCGA-A1-A0SB-01,TCGA-A1-A0SB,BRCA,70.0,FEMALE,WHITE,Stage I,nan,"Other, specify",nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25833.0,Alive,TUMOR FREE,259.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,259.0,0.0,259.0,0.0,259.0,0.0,259.0,0
TCGA-A1-A0SD-01,TCGA-A1-A0SD,BRCA,59.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2005.0,nan,-21793.0,Alive,nan,437.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,437.0,0.0,437.0,0.0,437.0,0.0,437.0,0
TCGA-A1-A0SE-01,TCGA-A1-A0SE,BRCA,56.0,FEMALE,WHITE,Stage I,nan,Mixed Histology (please specify),nan,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20717.0,Alive,TUMOR FREE,1321.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1321.0,0.0,1321.0,0.0,1321.0,0.0,1321.0,0
TCGA-A1-A0SF-01,TCGA-A1-A0SF,BRCA,54.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19731.0,Alive,TUMOR FREE,1463.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1463.0,0.0,1463.0,0.0,1463.0,0.0,1463.0,0
TCGA-A1-A0SG-01,TCGA-A1-A0SG,BRCA,61.0,FEMALE,WHITE,Stage IIB,nan,"Other, specify",nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22380.0,Alive,nan,434.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,434.0,0.0,434.0,0.0,434.0,0.0,434.0,0
TCGA-A1-A0SH-01,TCGA-A1-A0SH,BRCA,39.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14595.0,Alive,TUMOR FREE,1437.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1437.0,0.0,1437.0,0.0,1437.0,0.0,1437.0,0
TCGA-A1-A0SI-01,TCGA-A1-A0SI,BRCA,52.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2007.0,nan,-19250.0,Alive,TUMOR FREE,635.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,635.0,0.0,635.0,0.0,635.0,0.0,635.0,0
TCGA-A1-A0SJ-01,TCGA-A1-A0SJ,BRCA,39.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,nan,-14383.0,Alive,TUMOR FREE,416.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,416.0,0.0,416.0,0.0,416.0,0.0,416.0,0
TCGA-A1-A0SK-01,TCGA-A1-A0SK,BRCA,54.0,FEMALE,ASIAN,Stage IIA,nan,"Other, specify",nan,2007.0,Indeterminate (neither Pre or Postmenopausal),-20048.0,Dead,WITH TUMOR,nan,967.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,967.0,1.0,967.0,nan,nan,1.0,967.0,1
TCGA-A1-A0SM-01,TCGA-A1-A0SM,BRCA,77.0,MALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,nan,-28198.0,Alive,TUMOR FREE,242.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,242.0,0.0,242.0,0.0,242.0,0.0,242.0,0
TCGA-A1-A0SN-01,TCGA-A1-A0SN,BRCA,50.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18401.0,Alive,TUMOR FREE,1196.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1196.0,0.0,1196.0,0.0,1196.0,0.0,1196.0,0
TCGA-A1-A0SO-01,TCGA-A1-A0SO,BRCA,67.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24826.0,Alive,TUMOR FREE,852.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,852.0,0.0,852.0,0.0,852.0,0.0,852.0,0
TCGA-A1-A0SP-01,TCGA-A1-A0SP,BRCA,40.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,nan,-14954.0,Alive,TUMOR FREE,584.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,584.0,0.0,584.0,0.0,584.0,0.0,584.0,0
TCGA-A1-A0SQ-01,TCGA-A1-A0SQ,BRCA,45.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16458.0,Alive,TUMOR FREE,554.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,554.0,0.0,554.0,0.0,554.0,0.0,554.0,0
TCGA-A2-A04N-01,TCGA-A2-A04N,BRCA,66.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24155.0,Alive,TUMOR FREE,4354.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,4354.0,0.0,4354.0,0.0,4354.0,0.0,4354.0,0
TCGA-A2-A04P-01,TCGA-A2-A04P,BRCA,36.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2003.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13238.0,Dead,WITH TUMOR,nan,548.0,nan,Distant Metastasis,Bone,nan,102.0,nan,Positive,nan,1.0,548.0,1.0,548.0,nan,nan,1.0,102.0,1
TCGA-A2-A04Q-01,TCGA-A2-A04Q,BRCA,48.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17660.0,Alive,TUMOR FREE,2385.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2385.0,0.0,2385.0,0.0,2385.0,0.0,2385.0,0
TCGA-A2-A04R-01,TCGA-A2-A04R,BRCA,36.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2004.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13483.0,Alive,TUMOR FREE,3709.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3709.0,0.0,3709.0,0.0,3709.0,0.0,3709.0,0
TCGA-A2-A04T-01,TCGA-A2-A04T,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22707.0,Alive,TUMOR FREE,2246.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2246.0,0.0,2246.0,0.0,2246.0,0.0,2246.0,0
TCGA-A2-A04U-01,TCGA-A2-A04U,BRCA,47.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2004.0,Peri (6-12 months since last menstrual period),-17474.0,Alive,TUMOR FREE,2654.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2654.0,0.0,2654.0,0.0,2654.0,0.0,2654.0,0
TCGA-A2-A04V-01,TCGA-A2-A04V,BRCA,39.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14250.0,Dead,WITH TUMOR,nan,1920.0,nan,nan,nan,nan,1470.0,nan,Negative,nan,1.0,1920.0,1.0,1920.0,1.0,1470.0,1.0,1470.0,1
TCGA-A2-A04W-01,TCGA-A2-A04W,BRCA,50.0,FEMALE,WHITE,Stage IIB,nan,"Other, specify",nan,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18345.0,Alive,TUMOR FREE,3102.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3102.0,0.0,3102.0,0.0,3102.0,0.0,3102.0,0
TCGA-A2-A04X-01,TCGA-A2-A04X,BRCA,34.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12642.0,Alive,TUMOR FREE,1686.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1686.0,0.0,1686.0,0.0,1686.0,0.0,1686.0,0
TCGA-A2-A04Y-01,TCGA-A2-A04Y,BRCA,53.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19533.0,Alive,TUMOR FREE,1099.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1099.0,0.0,1099.0,0.0,1099.0,0.0,1099.0,0
TCGA-A2-A0CK-01,TCGA-A2-A0CK,BRCA,60.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2001.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22094.0,Alive,TUMOR FREE,4159.0,nan,nan,New Primary Tumor,"Other, specify",LEFT BREAST,1364.0,nan,Negative,nan,0.0,4159.0,0.0,4159.0,1.0,1364.0,1.0,1364.0,0
TCGA-A2-A0CL-01,TCGA-A2-A0CL,BRCA,37.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13556.0,Alive,TUMOR FREE,3015.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,3015.0,0.0,3015.0,nan,nan,0.0,3015.0,0
TCGA-A2-A0CM-01,TCGA-A2-A0CM,BRCA,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2003.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14969.0,Dead,WITH TUMOR,nan,754.0,nan,nan,nan,nan,382.0,nan,Negative,nan,1.0,754.0,1.0,754.0,1.0,382.0,1.0,382.0,1
TCGA-A2-A0CO-01,TCGA-A2-A0CO,BRCA,85.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31404.0,Dead,TUMOR FREE,nan,3492.0,nan,nan,nan,nan,nan,nan,Positive,nan,1.0,3492.0,0.0,3492.0,nan,nan,0.0,3492.0,0
TCGA-A2-A0CP-01,TCGA-A2-A0CP,BRCA,60.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22133.0,Alive,TUMOR FREE,2813.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2813.0,0.0,2813.0,0.0,2813.0,0.0,2813.0,0
TCGA-A2-A0CQ-01,TCGA-A2-A0CQ,BRCA,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22810.0,Alive,TUMOR FREE,2695.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2695.0,0.0,2695.0,0.0,2695.0,0.0,2695.0,0
TCGA-A2-A0CR-01,TCGA-A2-A0CR,BRCA,54.0,FEMALE,ASIAN,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20075.0,Alive,TUMOR FREE,3283.0,nan,nan,nan,nan,nan,nan,nan,Close,nan,0.0,3283.0,0.0,3283.0,nan,nan,0.0,3283.0,0
TCGA-A2-A0CS-01,TCGA-A2-A0CS,BRCA,73.0,FEMALE,WHITE,Stage IV,nan,Infiltrating Ductal Carcinoma,nan,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26817.0,Dead,TUMOR FREE,nan,2348.0,nan,nan,nan,nan,nan,nan,Positive,nan,1.0,2348.0,0.0,2348.0,nan,nan,0.0,2348.0,0
TCGA-A2-A0CT-01,TCGA-A2-A0CT,BRCA,71.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25959.0,Alive,TUMOR FREE,2289.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2289.0,0.0,2289.0,0.0,2289.0,0.0,2289.0,0
TCGA-A2-A0CU-01,TCGA-A2-A0CU,BRCA,73.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26823.0,Dead,TUMOR FREE,nan,158.0,nan,nan,nan,nan,nan,nan,Close,nan,1.0,158.0,0.0,158.0,nan,nan,0.0,158.0,0
TCGA-A2-A0CV-01,TCGA-A2-A0CV,BRCA,41.0,FEMALE,ASIAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-15289.0,Alive,TUMOR FREE,3011.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3011.0,0.0,3011.0,0.0,3011.0,0.0,3011.0,0
TCGA-A2-A0CW-01,TCGA-A2-A0CW,BRCA,67.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24541.0,Alive,TUMOR FREE,3283.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3283.0,0.0,3283.0,0.0,3283.0,0.0,3283.0,0
TCGA-A2-A0CX-01,TCGA-A2-A0CX,BRCA,52.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19152.0,Alive,TUMOR FREE,1728.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1728.0,0.0,1728.0,0.0,1728.0,0.0,1728.0,0
TCGA-A2-A0CY-01,TCGA-A2-A0CY,BRCA,63.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23229.0,Alive,TUMOR FREE,1673.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1673.0,0.0,1673.0,0.0,1673.0,0.0,1673.0,0
TCGA-A2-A0CZ-01,TCGA-A2-A0CZ,BRCA,46.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Peri (6-12 months since last menstrual period),-17026.0,Alive,TUMOR FREE,1616.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,1616.0,0.0,1616.0,nan,nan,0.0,1616.0,0
TCGA-A2-A0D0-01,TCGA-A2-A0D0,BRCA,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22115.0,Alive,TUMOR FREE,2048.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2048.0,0.0,2048.0,0.0,2048.0,0.0,2048.0,0
TCGA-A2-A0D1-01,TCGA-A2-A0D1,BRCA,76.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28084.0,Alive,TUMOR FREE,1051.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1051.0,0.0,1051.0,0.0,1051.0,0.0,1051.0,0
TCGA-A2-A0D2-01,TCGA-A2-A0D2,BRCA,45.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16623.0,Alive,TUMOR FREE,1027.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1027.0,0.0,1027.0,0.0,1027.0,0.0,1027.0,0
TCGA-A2-A0D3-01,TCGA-A2-A0D3,BRCA,42.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-15524.0,Alive,TUMOR FREE,1873.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1873.0,0.0,1873.0,0.0,1873.0,0.0,1873.0,0
TCGA-A2-A0D4-01,TCGA-A2-A0D4,BRCA,37.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13805.0,Alive,TUMOR FREE,767.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,767.0,0.0,767.0,0.0,767.0,0.0,767.0,0
TCGA-A2-A0EM-01,TCGA-A2-A0EM,BRCA,73.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26845.0,Alive,TUMOR FREE,3094.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3094.0,0.0,3094.0,0.0,3094.0,0.0,3094.0,0
TCGA-A2-A0EN-01,TCGA-A2-A0EN,BRCA,70.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25771.0,Alive,TUMOR FREE,4088.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,4088.0,0.0,4088.0,0.0,4088.0,0.0,4088.0,0
TCGA-A2-A0EO-01,TCGA-A2-A0EO,BRCA,54.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2003.0,Peri (6-12 months since last menstrual period),-19880.0,Alive,TUMOR FREE,2442.0,nan,nan,nan,nan,nan,nan,nan,Close,nan,0.0,2442.0,0.0,2442.0,nan,nan,0.0,2442.0,0
TCGA-A2-A0EP-01,TCGA-A2-A0EP,BRCA,56.0,FEMALE,WHITE,Stage I,nan,Infiltrating Lobular Carcinoma,nan,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20585.0,Alive,TUMOR FREE,3603.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3603.0,0.0,3603.0,0.0,3603.0,0.0,3603.0,0
TCGA-A2-A0EQ-01,TCGA-A2-A0EQ,BRCA,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23543.0,Alive,TUMOR FREE,2426.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2426.0,0.0,2426.0,0.0,2426.0,0.0,2426.0,0
TCGA-A2-A0ER-01,TCGA-A2-A0ER,BRCA,63.0,FEMALE,WHITE,Stage IB,nan,Infiltrating Ductal Carcinoma,nan,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23021.0,Alive,TUMOR FREE,2263.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2263.0,0.0,2263.0,0.0,2263.0,0.0,2263.0,0
TCGA-A2-A0ES-01,TCGA-A2-A0ES,BRCA,52.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19160.0,Alive,TUMOR FREE,2190.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2190.0,0.0,2190.0,0.0,2190.0,0.0,2190.0,0
TCGA-A2-A0ET-01,TCGA-A2-A0ET,BRCA,58.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21464.0,Alive,TUMOR FREE,1066.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1066.0,0.0,1066.0,0.0,1066.0,0.0,1066.0,0
TCGA-A2-A0EU-01,TCGA-A2-A0EU,BRCA,79.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29144.0,Alive,TUMOR FREE,1043.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1043.0,0.0,1043.0,0.0,1043.0,0.0,1043.0,0
TCGA-A2-A0EV-01,TCGA-A2-A0EV,BRCA,80.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29285.0,Alive,TUMOR FREE,968.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,968.0,0.0,968.0,0.0,968.0,0.0,968.0,0
TCGA-A2-A0EW-01,TCGA-A2-A0EW,BRCA,53.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19413.0,Dead,WITH TUMOR,nan,1884.0,nan,Distant Metastasis,Bone,nan,1353.0,nan,Positive,nan,1.0,1884.0,1.0,1884.0,nan,nan,1.0,1353.0,1
TCGA-A2-A0EX-01,TCGA-A2-A0EX,BRCA,46.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16858.0,Alive,TUMOR FREE,752.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,752.0,0.0,752.0,0.0,752.0,0.0,752.0,0
TCGA-A2-A0EY-01,TCGA-A2-A0EY,BRCA,62.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22872.0,Alive,TUMOR FREE,1925.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1925.0,0.0,1925.0,0.0,1925.0,0.0,1925.0,0
TCGA-A2-A0ST-01,TCGA-A2-A0ST,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22922.0,Alive,WITH TUMOR,3017.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3017.0,0.0,3017.0,0.0,3017.0,0.0,3017.0,0
TCGA-A2-A0SU-01,TCGA-A2-A0SU,BRCA,66.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24219.0,Alive,TUMOR FREE,1662.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1662.0,0.0,1662.0,0.0,1662.0,0.0,1662.0,0
TCGA-A2-A0SV-01,TCGA-A2-A0SV,BRCA,63.0,FEMALE,WHITE,Stage IV,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23126.0,Dead,WITH TUMOR,nan,825.0,nan,nan,nan,nan,nan,nan,Positive,nan,1.0,825.0,1.0,825.0,nan,nan,1.0,825.0,1
TCGA-A2-A0SW-01,TCGA-A2-A0SW,BRCA,82.0,FEMALE,WHITE,Stage IV,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30085.0,Dead,WITH TUMOR,nan,1365.0,nan,nan,nan,nan,653.0,nan,Negative,nan,1.0,1365.0,1.0,1365.0,nan,nan,1.0,653.0,1
TCGA-A2-A0SX-01,TCGA-A2-A0SX,BRCA,48.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17774.0,Alive,WITH TUMOR,1534.0,nan,nan,nan,nan,nan,1239.0,nan,Negative,nan,0.0,1534.0,0.0,1534.0,1.0,1239.0,1.0,1239.0,0
TCGA-A2-A0SY-01,TCGA-A2-A0SY,BRCA,62.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22928.0,Alive,TUMOR FREE,1347.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1347.0,0.0,1347.0,0.0,1347.0,0.0,1347.0,0
TCGA-A2-A0T0-01,TCGA-A2-A0T0,BRCA,59.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21575.0,Alive,TUMOR FREE,533.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,533.0,0.0,533.0,0.0,533.0,0.0,533.0,0
TCGA-A2-A0T1-01,TCGA-A2-A0T1,BRCA,55.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20227.0,Alive,TUMOR FREE,521.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,521.0,0.0,521.0,0.0,521.0,0.0,521.0,0
TCGA-A2-A0T2-01,TCGA-A2-A0T2,BRCA,66.0,FEMALE,WHITE,Stage IV,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24235.0,Dead,WITH TUMOR,nan,255.0,nan,nan,nan,nan,nan,nan,Close,nan,1.0,255.0,1.0,255.0,nan,nan,1.0,255.0,1
TCGA-A2-A0T3-01,TCGA-A2-A0T3,BRCA,37.0,FEMALE,WHITE,Stage IB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13680.0,Alive,TUMOR FREE,1516.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1516.0,0.0,1516.0,0.0,1516.0,0.0,1516.0,0
TCGA-A2-A0T4-01,TCGA-A2-A0T4,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22849.0,Alive,TUMOR FREE,624.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,624.0,0.0,624.0,0.0,624.0,0.0,624.0,0
TCGA-A2-A0T5-01,TCGA-A2-A0T5,BRCA,39.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14503.0,Alive,TUMOR FREE,531.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,531.0,0.0,531.0,0.0,531.0,0.0,531.0,0
TCGA-A2-A0T6-01,TCGA-A2-A0T6,BRCA,50.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18334.0,Alive,TUMOR FREE,575.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,575.0,0.0,575.0,0.0,575.0,0.0,575.0,0
TCGA-A2-A0T7-01,TCGA-A2-A0T7,BRCA,51.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18756.0,Alive,TUMOR FREE,631.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,631.0,0.0,631.0,0.0,631.0,0.0,631.0,0
TCGA-A2-A0YC-01,TCGA-A2-A0YC,BRCA,59.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21685.0,Alive,WITH TUMOR,990.0,nan,nan,Locoregional Disease,nan,nan,756.0,nan,Close,nan,0.0,990.0,0.0,990.0,nan,nan,1.0,756.0,0
TCGA-A2-A0YD-01,TCGA-A2-A0YD,BRCA,63.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23021.0,Alive,TUMOR FREE,769.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,769.0,0.0,769.0,0.0,769.0,0.0,769.0,0
TCGA-A2-A0YE-01,TCGA-A2-A0YE,BRCA,48.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17727.0,Alive,TUMOR FREE,554.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,554.0,0.0,554.0,0.0,554.0,0.0,554.0,0
TCGA-A2-A0YF-01,TCGA-A2-A0YF,BRCA,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24660.0,Alive,TUMOR FREE,1535.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1535.0,0.0,1535.0,0.0,1535.0,0.0,1535.0,0
TCGA-A2-A0YG-01,TCGA-A2-A0YG,BRCA,63.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23058.0,Alive,TUMOR FREE,666.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,666.0,0.0,666.0,0.0,666.0,0.0,666.0,0
TCGA-A2-A0YH-01,TCGA-A2-A0YH,BRCA,53.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19596.0,Alive,TUMOR FREE,659.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,659.0,0.0,659.0,0.0,659.0,0.0,659.0,0
TCGA-A2-A0YI-01,TCGA-A2-A0YI,BRCA,62.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22961.0,Alive,TUMOR FREE,1505.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1505.0,0.0,1505.0,0.0,1505.0,0.0,1505.0,0
TCGA-A2-A0YJ-01,TCGA-A2-A0YJ,BRCA,39.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14448.0,Alive,WITH TUMOR,566.0,nan,nan,Distant Metastasis,"Other, specify",Left Cervical Lymph Node,559.0,nan,Negative,nan,0.0,566.0,0.0,566.0,1.0,559.0,1.0,559.0,0
TCGA-A2-A0YK-01,TCGA-A2-A0YK,BRCA,61.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22625.0,Alive,TUMOR FREE,588.0,nan,nan,nan,nan,nan,nan,nan,Close,nan,0.0,588.0,0.0,588.0,nan,nan,0.0,588.0,0
TCGA-A2-A0YL-01,TCGA-A2-A0YL,BRCA,48.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17702.0,Alive,TUMOR FREE,1474.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1474.0,0.0,1474.0,0.0,1474.0,0.0,1474.0,0
TCGA-A2-A0YM-01,TCGA-A2-A0YM,BRCA,67.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24831.0,Alive,TUMOR FREE,965.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,965.0,0.0,965.0,0.0,965.0,0.0,965.0,0
TCGA-A2-A0YT-01,TCGA-A2-A0YT,BRCA,56.0,FEMALE,WHITE,Stage IIIB,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20482.0,Dead,TUMOR FREE,nan,723.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,723.0,0.0,723.0,0.0,723.0,0.0,723.0,0
TCGA-A2-A1FV-01,TCGA-A2-A1FV,BRCA,74.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27287.0,Alive,TUMOR FREE,714.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,714.0,0.0,714.0,0.0,714.0,0.0,714.0,0
TCGA-A2-A1FW-01,TCGA-A2-A1FW,BRCA,62.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22779.0,Alive,TUMOR FREE,528.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,528.0,0.0,528.0,0.0,528.0,0.0,528.0,0
TCGA-A2-A1FX-01,TCGA-A2-A1FX,BRCA,61.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22344.0,Alive,TUMOR FREE,1847.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1847.0,0.0,1847.0,0.0,1847.0,0.0,1847.0,0
TCGA-A2-A1FZ-01,TCGA-A2-A1FZ,BRCA,63.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23055.0,Alive,TUMOR FREE,683.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,683.0,0.0,683.0,0.0,683.0,0.0,683.0,0
TCGA-A2-A1G0-01,TCGA-A2-A1G0,BRCA,49.0,FEMALE,WHITE,Stage IIB,nan,"Other, specify",nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18002.0,Alive,TUMOR FREE,616.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,616.0,0.0,616.0,0.0,616.0,0.0,616.0,0
TCGA-A2-A1G1-01,TCGA-A2-A1G1,BRCA,85.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31223.0,Alive,TUMOR FREE,584.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,584.0,0.0,584.0,0.0,584.0,0.0,584.0,0
TCGA-A2-A1G4-01,TCGA-A2-A1G4,BRCA,71.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25966.0,Alive,TUMOR FREE,595.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,595.0,0.0,595.0,0.0,595.0,0.0,595.0,0
TCGA-A2-A1G6-01,TCGA-A2-A1G6,BRCA,50.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18514.0,Alive,TUMOR FREE,501.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,501.0,0.0,501.0,0.0,501.0,0.0,501.0,0
TCGA-A2-A259-01,TCGA-A2-A259,BRCA,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25666.0,Alive,TUMOR FREE,1596.0,nan,nan,nan,nan,nan,nan,nan,Close,nan,0.0,1596.0,0.0,1596.0,nan,nan,0.0,1596.0,0
TCGA-A2-A25A-01,TCGA-A2-A25A,BRCA,44.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2003.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16084.0,Alive,TUMOR FREE,3276.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3276.0,0.0,3276.0,0.0,3276.0,0.0,3276.0,0
TCGA-A2-A25B-01,TCGA-A2-A25B,BRCA,39.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14454.0,Alive,WITH TUMOR,1291.0,nan,nan,Distant Metastasis,Bone,nan,1290.0,nan,Close,nan,0.0,1291.0,0.0,1291.0,nan,nan,1.0,1290.0,0
TCGA-A2-A25C-01,TCGA-A2-A25C,BRCA,50.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18508.0,Alive,TUMOR FREE,523.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,523.0,0.0,523.0,0.0,523.0,0.0,523.0,0
TCGA-A2-A25D-01,TCGA-A2-A25D,BRCA,90.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32872.0,Alive,TUMOR FREE,552.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,552.0,0.0,552.0,nan,nan,0.0,552.0,0
TCGA-A2-A25E-01,TCGA-A2-A25E,BRCA,34.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2004.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12601.0,Alive,TUMOR FREE,3204.0,nan,nan,Locoregional Recurrence,"Other, specify",Left Chest Wall,2989.0,nan,Negative,nan,0.0,3204.0,0.0,3204.0,1.0,2989.0,1.0,2989.0,0
TCGA-A2-A25F-01,TCGA-A2-A25F,BRCA,66.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24319.0,Alive,TUMOR FREE,322.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,322.0,0.0,322.0,0.0,322.0,0.0,322.0,0
TCGA-A2-A3KC-01,TCGA-A2-A3KC,BRCA,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20401.0,Alive,TUMOR FREE,1102.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1102.0,0.0,1102.0,0.0,1102.0,0.0,1102.0,0
TCGA-A2-A3KD-01,TCGA-A2-A3KD,BRCA,47.0,FEMALE,WHITE,Stage IIIA,nan,Mucinous Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17372.0,Alive,TUMOR FREE,1206.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,1206.0,0.0,1206.0,nan,nan,0.0,1206.0,0
TCGA-A2-A3XS-01,TCGA-A2-A3XS,BRCA,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23000.0,Dead,WITH TUMOR,nan,1032.0,nan,Distant Metastasis,Lung,nan,682.0,nan,Negative,nan,1.0,1032.0,1.0,1032.0,1.0,682.0,1.0,682.0,1
TCGA-A2-A3XT-01,TCGA-A2-A3XT,BRCA,45.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16649.0,Alive,TUMOR FREE,2770.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2770.0,0.0,2770.0,0.0,2770.0,0.0,2770.0,0
TCGA-A2-A3XU-01,TCGA-A2-A3XU,BRCA,35.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-13046.0,Dead,WITH TUMOR,nan,912.0,nan,Distant Metastasis,Bone,nan,574.0,nan,Negative,nan,1.0,912.0,1.0,912.0,1.0,574.0,1.0,574.0,1
TCGA-A2-A3XV-01,TCGA-A2-A3XV,BRCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16971.0,Alive,TUMOR FREE,996.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,996.0,0.0,996.0,0.0,996.0,0.0,996.0,0
TCGA-A2-A3XW-01,TCGA-A2-A3XW,BRCA,42.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15670.0,Alive,TUMOR FREE,1712.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1712.0,0.0,1712.0,0.0,1712.0,0.0,1712.0,0
TCGA-A2-A3XX-01,TCGA-A2-A3XX,BRCA,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17981.0,Dead,TUMOR FREE,nan,1439.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,1439.0,0.0,1439.0,0.0,1439.0,0.0,1439.0,0
TCGA-A2-A3XY-01,TCGA-A2-A3XY,BRCA,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18059.0,Dead,WITH TUMOR,nan,1093.0,nan,Distant Metastasis,Lung,nan,802.0,nan,Negative,nan,1.0,1093.0,1.0,1093.0,1.0,802.0,1.0,802.0,1
TCGA-A2-A3XZ-01,TCGA-A2-A3XZ,BRCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16978.0,Alive,TUMOR FREE,1532.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1532.0,0.0,1532.0,0.0,1532.0,0.0,1532.0,0
TCGA-A2-A3Y0-01,TCGA-A2-A3Y0,BRCA,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21024.0,Alive,TUMOR FREE,1546.0,nan,nan,nan,nan,nan,nan,nan,Close,nan,0.0,1546.0,0.0,1546.0,nan,nan,0.0,1546.0,0
TCGA-A2-A4RW-01,TCGA-A2-A4RW,BRCA,49.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18060.0,Alive,TUMOR FREE,222.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,222.0,0.0,222.0,0.0,222.0,0.0,222.0,0
TCGA-A2-A4RX-01,TCGA-A2-A4RX,BRCA,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Metaplastic Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24779.0,Alive,TUMOR FREE,742.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,742.0,0.0,742.0,0.0,742.0,0.0,742.0,0
TCGA-A2-A4RY-01,TCGA-A2-A4RY,BRCA,46.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17157.0,Alive,TUMOR FREE,648.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,648.0,0.0,648.0,0.0,648.0,0.0,648.0,0
TCGA-A2-A4S0-01,TCGA-A2-A4S0,BRCA,77.0,FEMALE,WHITE,Stage IIA,nan,Mucinous Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28416.0,Alive,TUMOR FREE,706.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,706.0,0.0,706.0,0.0,706.0,0.0,706.0,0
TCGA-A2-A4S1-01,TCGA-A2-A4S1,BRCA,66.0,FEMALE,WHITE,Stage IIA,nan,Metaplastic Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24353.0,Alive,TUMOR FREE,820.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,820.0,0.0,820.0,0.0,820.0,0.0,820.0,0
TCGA-A2-A4S2-01,TCGA-A2-A4S2,BRCA,62.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22936.0,Alive,TUMOR FREE,643.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,643.0,0.0,643.0,0.0,643.0,0.0,643.0,0
TCGA-A2-A4S3-01,TCGA-A2-A4S3,BRCA,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21762.0,Alive,TUMOR FREE,666.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,666.0,0.0,666.0,0.0,666.0,0.0,666.0,0
TCGA-A7-A0CD-01,TCGA-A7-A0CD,BRCA,66.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Indeterminate (neither Pre or Postmenopausal),-24242.0,Alive,TUMOR FREE,1165.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1165.0,0.0,1165.0,0.0,1165.0,0.0,1165.0,0
TCGA-A7-A0CE-01,TCGA-A7-A0CE,BRCA,57.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Indeterminate (neither Pre or Postmenopausal),-20863.0,Alive,TUMOR FREE,1074.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1074.0,0.0,1074.0,0.0,1074.0,0.0,1074.0,0
TCGA-A7-A0CE-11,TCGA-A7-A0CE,BRCA,57.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Indeterminate (neither Pre or Postmenopausal),-20863.0,Alive,TUMOR FREE,1074.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1074.0,0.0,1074.0,0.0,1074.0,0.0,1074.0,0
TCGA-A7-A0CG-01,TCGA-A7-A0CG,BRCA,78.0,FEMALE,WHITE,Stage IIA,nan,Mixed Histology (please specify),nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28596.0,Alive,TUMOR FREE,1043.0,nan,nan,nan,nan,nan,nan,nan,Close,nan,0.0,1043.0,0.0,1043.0,nan,nan,0.0,1043.0,0
TCGA-A7-A0CH-01,TCGA-A7-A0CH,BRCA,79.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29104.0,Alive,TUMOR FREE,1079.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1079.0,0.0,1079.0,0.0,1079.0,0.0,1079.0,0
TCGA-A7-A0CH-11,TCGA-A7-A0CH,BRCA,79.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29104.0,Alive,TUMOR FREE,1079.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1079.0,0.0,1079.0,0.0,1079.0,0.0,1079.0,0
TCGA-A7-A0CJ-01,TCGA-A7-A0CJ,BRCA,57.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21014.0,Alive,TUMOR FREE,931.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,931.0,0.0,931.0,nan,nan,0.0,931.0,0
TCGA-A7-A0D9-01,TCGA-A7-A0D9,BRCA,37.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13836.0,Alive,TUMOR FREE,1139.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1139.0,0.0,1139.0,0.0,1139.0,0.0,1139.0,0
TCGA-A7-A0D9-11,TCGA-A7-A0D9,BRCA,37.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13836.0,Alive,TUMOR FREE,1139.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1139.0,0.0,1139.0,0.0,1139.0,0.0,1139.0,0
TCGA-A7-A0DA-01,TCGA-A7-A0DA,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22708.0,Alive,TUMOR FREE,1085.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1085.0,0.0,1085.0,0.0,1085.0,0.0,1085.0,0
TCGA-A7-A0DB-11,TCGA-A7-A0DB,BRCA,56.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20570.0,Alive,TUMOR FREE,1007.0,nan,nan,nan,nan,nan,nan,nan,Close,nan,0.0,1007.0,0.0,1007.0,nan,nan,0.0,1007.0,0
TCGA-A7-A0DB-01,TCGA-A7-A0DB,BRCA,56.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20570.0,Alive,TUMOR FREE,1007.0,nan,nan,nan,nan,nan,nan,nan,Close,nan,0.0,1007.0,0.0,1007.0,nan,nan,0.0,1007.0,0
TCGA-A7-A0DC-01,TCGA-A7-A0DC,BRCA,63.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23294.0,Alive,TUMOR FREE,906.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,906.0,0.0,906.0,0.0,906.0,0.0,906.0,0
TCGA-A7-A0DC-11,TCGA-A7-A0DC,BRCA,63.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23294.0,Alive,TUMOR FREE,906.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,906.0,0.0,906.0,0.0,906.0,0.0,906.0,0
TCGA-A7-A13D-01,TCGA-A7-A13D,BRCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17070.0,Alive,TUMOR FREE,965.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,965.0,0.0,965.0,0.0,965.0,0.0,965.0,0
TCGA-A7-A13E-11,TCGA-A7-A13E,BRCA,62.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22690.0,Dead,WITH TUMOR,nan,614.0,nan,Distant Metastasis,"Other, specify","Lung, Bone, Liver, Brain and Skin Nodules",556.0,nan,Negative,nan,1.0,614.0,1.0,614.0,1.0,556.0,1.0,556.0,1
TCGA-A7-A13E-01,TCGA-A7-A13E,BRCA,62.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22690.0,Dead,WITH TUMOR,nan,614.0,nan,Distant Metastasis,"Other, specify","Lung, Bone, Liver, Brain and Skin Nodules",556.0,nan,Negative,nan,1.0,614.0,1.0,614.0,1.0,556.0,1.0,556.0,1
TCGA-A7-A13F-01,TCGA-A7-A13F,BRCA,44.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16363.0,Alive,TUMOR FREE,765.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,765.0,0.0,765.0,0.0,765.0,0.0,765.0,0
TCGA-A7-A13F-11,TCGA-A7-A13F,BRCA,44.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16363.0,Alive,TUMOR FREE,765.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,765.0,0.0,765.0,0.0,765.0,0.0,765.0,0
TCGA-A7-A13G-01,TCGA-A7-A13G,BRCA,79.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28969.0,Alive,TUMOR FREE,718.0,nan,nan,New Primary Tumor,"Other, specify","Skin, right leg",586.0,nan,Negative,nan,0.0,718.0,0.0,718.0,0.0,718.0,1.0,586.0,0
TCGA-A7-A13G-11,TCGA-A7-A13G,BRCA,79.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28969.0,Alive,TUMOR FREE,718.0,nan,nan,New Primary Tumor,"Other, specify","Skin, right leg",586.0,nan,Negative,nan,0.0,718.0,0.0,718.0,0.0,718.0,1.0,586.0,0
TCGA-A7-A13H-01,TCGA-A7-A13H,BRCA,61.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22643.0,Alive,TUMOR FREE,899.0,nan,nan,New Primary Tumor,"Other, specify",Skin lesion-Basal Cell Left Lower Lateral Back,795.0,nan,Negative,nan,0.0,899.0,0.0,899.0,0.0,899.0,1.0,795.0,0
TCGA-A7-A26E-01,TCGA-A7-A26E,BRCA,71.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26274.0,Alive,TUMOR FREE,954.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,954.0,0.0,954.0,0.0,954.0,0.0,954.0,0
TCGA-A7-A26F-01,TCGA-A7-A26F,BRCA,55.0,FEMALE,WHITE,Stage IA,nan,"Other, specify",nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20210.0,Alive,TUMOR FREE,738.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,738.0,0.0,738.0,0.0,738.0,0.0,738.0,0
TCGA-A7-A26G-01,TCGA-A7-A26G,BRCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,"Other, specify",nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18362.0,Alive,TUMOR FREE,722.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,722.0,0.0,722.0,0.0,722.0,0.0,722.0,0
TCGA-A7-A26H-01,TCGA-A7-A26H,BRCA,72.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26423.0,Alive,WITH TUMOR,724.0,nan,nan,Distant Metastasis,Liver,nan,291.0,nan,Negative,nan,0.0,724.0,0.0,724.0,1.0,291.0,1.0,291.0,0
TCGA-A7-A26I-01,TCGA-A7-A26I,BRCA,65.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23948.0,Alive,TUMOR FREE,661.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,661.0,0.0,661.0,0.0,661.0,0.0,661.0,0
TCGA-A7-A26J-01,TCGA-A7-A26J,BRCA,49.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17930.0,Alive,TUMOR FREE,627.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,627.0,0.0,627.0,0.0,627.0,0.0,627.0,0
TCGA-A7-A2KD-01,TCGA-A7-A2KD,BRCA,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19563.0,Alive,TUMOR FREE,679.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,679.0,0.0,679.0,0.0,679.0,0.0,679.0,0
TCGA-A7-A3IY-01,TCGA-A7-A3IY,BRCA,71.0,FEMALE,WHITE,Stage I,nan,Mucinous Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26042.0,Alive,TUMOR FREE,345.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,345.0,0.0,345.0,0.0,345.0,0.0,345.0,0
TCGA-A7-A3IZ-01,TCGA-A7-A3IZ,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22997.0,Alive,TUMOR FREE,322.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,322.0,0.0,322.0,0.0,322.0,0.0,322.0,0
TCGA-A7-A3J0-01,TCGA-A7-A3J0,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Mucinous Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22672.0,Alive,TUMOR FREE,313.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,313.0,0.0,313.0,0.0,313.0,0.0,313.0,0
TCGA-A7-A3J1-01,TCGA-A7-A3J1,BRCA,63.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23209.0,Alive,TUMOR FREE,343.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,343.0,0.0,343.0,0.0,343.0,0.0,343.0,0
TCGA-A7-A3RF-01,TCGA-A7-A3RF,BRCA,79.0,FEMALE,WHITE,Stage IIA,nan,Mucinous Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29184.0,Alive,WITH TUMOR,408.0,nan,nan,Distant Metastasis,Bone,nan,174.0,nan,Negative,nan,0.0,408.0,0.0,408.0,1.0,174.0,1.0,174.0,2
TCGA-A7-A425-01,TCGA-A7-A425,BRCA,70.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25678.0,Alive,WITH TUMOR,447.0,nan,nan,Locoregional Recurrence,"Other, specify",Left Breast,419.0,nan,Negative,nan,0.0,447.0,0.0,447.0,1.0,419.0,1.0,419.0,2
TCGA-A7-A426-01,TCGA-A7-A426,BRCA,50.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18296.0,Alive,TUMOR FREE,364.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,364.0,0.0,364.0,0.0,364.0,0.0,364.0,0
TCGA-A7-A4SA-01,TCGA-A7-A4SA,BRCA,40.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14906.0,Alive,TUMOR FREE,454.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,454.0,0.0,454.0,0.0,454.0,0.0,454.0,0
TCGA-A7-A4SB-01,TCGA-A7-A4SB,BRCA,56.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20539.0,Alive,TUMOR FREE,418.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,418.0,0.0,418.0,0.0,418.0,0.0,418.0,0
TCGA-A7-A4SC-01,TCGA-A7-A4SC,BRCA,62.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23008.0,Alive,TUMOR FREE,446.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,446.0,0.0,446.0,0.0,446.0,0.0,446.0,0
TCGA-A7-A4SD-01,TCGA-A7-A4SD,BRCA,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19131.0,Alive,TUMOR FREE,441.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,441.0,0.0,441.0,0.0,441.0,0.0,441.0,0
TCGA-A7-A4SE-01,TCGA-A7-A4SE,BRCA,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20080.0,Alive,TUMOR FREE,644.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,644.0,0.0,644.0,0.0,644.0,0.0,644.0,0
TCGA-A7-A4SF-01,TCGA-A7-A4SF,BRCA,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19985.0,Alive,TUMOR FREE,545.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,545.0,0.0,545.0,nan,nan,0.0,545.0,0
TCGA-A7-A56D-01,TCGA-A7-A56D,BRCA,84.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30783.0,Alive,TUMOR FREE,448.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,448.0,0.0,448.0,0.0,448.0,0.0,448.0,0
TCGA-A7-A5ZV-01,TCGA-A7-A5ZV,BRCA,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Carcinoma NOS,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22966.0,Alive,TUMOR FREE,368.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,368.0,0.0,368.0,0.0,368.0,0.0,368.0,0
TCGA-A7-A5ZW-01,TCGA-A7-A5ZW,BRCA,47.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2012.0,Peri (6-12 months since last menstrual period),-17529.0,Alive,TUMOR FREE,326.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,326.0,0.0,326.0,0.0,326.0,0.0,326.0,0
TCGA-A7-A5ZX-01,TCGA-A7-A5ZX,BRCA,48.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17683.0,Alive,TUMOR FREE,336.0,nan,nan,nan,nan,nan,nan,nan,[Unknown],nan,0.0,336.0,0.0,336.0,nan,nan,0.0,336.0,0
TCGA-A7-A6VV-01,TCGA-A7-A6VV,BRCA,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Peri (6-12 months since last menstrual period),-18695.0,Alive,TUMOR FREE,313.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,313.0,0.0,313.0,0.0,313.0,0.0,313.0,0
TCGA-A7-A6VW-01,TCGA-A7-A6VW,BRCA,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17539.0,Alive,TUMOR FREE,285.0,nan,nan,nan,nan,nan,nan,nan,Close,nan,0.0,285.0,0.0,285.0,nan,nan,0.0,285.0,0
TCGA-A7-A6VX-01,TCGA-A7-A6VX,BRCA,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25066.0,Alive,TUMOR FREE,317.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,317.0,0.0,317.0,0.0,317.0,0.0,317.0,0
TCGA-A7-A6VY-01,TCGA-A7-A6VY,BRCA,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17640.0,Alive,TUMOR FREE,266.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,266.0,0.0,266.0,0.0,266.0,0.0,266.0,0
TCGA-A8-A06N-01,TCGA-A8-A06N,BRCA,66.0,FEMALE,nan,Stage IIIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24288.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0
TCGA-A8-A06O-01,TCGA-A8-A06O,BRCA,60.0,FEMALE,nan,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22157.0,Alive,TUMOR FREE,396.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,396.0,0.0,396.0,0.0,396.0,0.0,396.0,0
TCGA-A8-A06P-01,TCGA-A8-A06P,BRCA,63.0,FEMALE,nan,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23011.0,Alive,TUMOR FREE,396.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,396.0,0.0,396.0,0.0,396.0,0.0,396.0,0
TCGA-A8-A06Q-01,TCGA-A8-A06Q,BRCA,63.0,FEMALE,nan,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23164.0,Alive,TUMOR FREE,31.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,31.0,0.0,31.0,0.0,31.0,0.0,31.0,0
TCGA-A8-A06R-01,TCGA-A8-A06R,BRCA,69.0,FEMALE,nan,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25477.0,Alive,TUMOR FREE,547.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,547.0,0.0,547.0,0.0,547.0,0.0,547.0,0
TCGA-A8-A06T-01,TCGA-A8-A06T,BRCA,75.0,FEMALE,nan,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27393.0,Alive,TUMOR FREE,1614.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1614.0,0.0,1614.0,0.0,1614.0,0.0,1614.0,0
TCGA-A8-A06U-01,TCGA-A8-A06U,BRCA,80.0,FEMALE,nan,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29525.0,Dead,TUMOR FREE,nan,883.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,883.0,0.0,883.0,0.0,883.0,0.0,883.0,0
TCGA-A8-A06X-01,TCGA-A8-A06X,BRCA,77.0,FEMALE,nan,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28338.0,Dead,TUMOR FREE,nan,943.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,943.0,0.0,943.0,0.0,943.0,0.0,943.0,0
TCGA-A8-A06Y-01,TCGA-A8-A06Y,BRCA,66.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24442.0,Alive,TUMOR FREE,791.0,nan,nan,nan,nan,nan,791.0,nan,Negative,nan,0.0,791.0,0.0,791.0,1.0,791.0,1.0,791.0,0
TCGA-A8-A06Z-01,TCGA-A8-A06Z,BRCA,84.0,FEMALE,nan,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30984.0,Alive,nan,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-A8-A075-01,TCGA-A8-A075,BRCA,42.0,FEMALE,nan,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15369.0,Alive,TUMOR FREE,518.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,518.0,0.0,518.0,0.0,518.0,0.0,518.0,0
TCGA-A8-A076-01,TCGA-A8-A076,BRCA,66.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24230.0,Alive,TUMOR FREE,1642.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1642.0,0.0,1642.0,0.0,1642.0,0.0,1642.0,0
TCGA-A8-A079-01,TCGA-A8-A079,BRCA,69.0,FEMALE,nan,Stage IIIB,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25294.0,Alive,TUMOR FREE,274.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,274.0,0.0,274.0,0.0,274.0,0.0,274.0,0
TCGA-A8-A07B-01,TCGA-A8-A07B,BRCA,69.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25475.0,Alive,TUMOR FREE,1308.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1308.0,0.0,1308.0,0.0,1308.0,0.0,1308.0,0
TCGA-A8-A07C-01,TCGA-A8-A07C,BRCA,57.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20820.0,Alive,TUMOR FREE,1034.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1034.0,0.0,1034.0,0.0,1034.0,0.0,1034.0,0
TCGA-A8-A07E-01,TCGA-A8-A07E,BRCA,81.0,FEMALE,nan,Stage X,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29800.0,Alive,TUMOR FREE,608.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,608.0,0.0,608.0,0.0,608.0,0.0,608.0,0
TCGA-A8-A07F-01,TCGA-A8-A07F,BRCA,65.0,FEMALE,nan,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23742.0,Alive,TUMOR FREE,577.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,577.0,0.0,577.0,0.0,577.0,0.0,577.0,0
TCGA-A8-A07G-01,TCGA-A8-A07G,BRCA,65.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23926.0,Alive,TUMOR FREE,577.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,577.0,0.0,577.0,0.0,577.0,0.0,577.0,0
TCGA-A8-A07I-01,TCGA-A8-A07I,BRCA,69.0,FEMALE,nan,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25263.0,Alive,TUMOR FREE,426.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,426.0,0.0,426.0,0.0,426.0,0.0,426.0,0
TCGA-A8-A07J-01,TCGA-A8-A07J,BRCA,35.0,FEMALE,nan,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12965.0,Alive,TUMOR FREE,365.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,365.0,0.0,365.0,0.0,365.0,0.0,365.0,0
TCGA-A8-A07L-01,TCGA-A8-A07L,BRCA,58.0,FEMALE,nan,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21428.0,Alive,TUMOR FREE,975.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,975.0,0.0,975.0,0.0,975.0,0.0,975.0,0
TCGA-A8-A07O-01,TCGA-A8-A07O,BRCA,51.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18870.0,Alive,TUMOR FREE,304.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,304.0,0.0,304.0,0.0,304.0,0.0,304.0,0
TCGA-A8-A07P-01,TCGA-A8-A07P,BRCA,68.0,FEMALE,nan,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24929.0,Alive,TUMOR FREE,334.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,334.0,0.0,334.0,0.0,334.0,0.0,334.0,0
TCGA-A8-A07R-01,TCGA-A8-A07R,BRCA,80.0,FEMALE,nan,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2009.0,nan,-29251.0,Alive,nan,273.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,273.0,0.0,273.0,nan,nan,0.0,273.0,0
TCGA-A8-A07S-01,TCGA-A8-A07S,BRCA,73.0,FEMALE,nan,Stage IIA,nan,Mixed Histology (please specify),nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26998.0,Alive,WITH TUMOR,243.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,243.0,0.0,243.0,nan,nan,0.0,243.0,0
TCGA-A8-A07U-01,TCGA-A8-A07U,BRCA,66.0,FEMALE,nan,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24411.0,Alive,TUMOR FREE,760.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,760.0,0.0,760.0,0.0,760.0,0.0,760.0,0
TCGA-A8-A07W-01,TCGA-A8-A07W,BRCA,76.0,FEMALE,nan,Stage IV,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27942.0,Alive,WITH TUMOR,304.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,304.0,0.0,304.0,nan,nan,0.0,304.0,0
TCGA-A8-A07Z-01,TCGA-A8-A07Z,BRCA,85.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31351.0,Alive,TUMOR FREE,1371.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1371.0,0.0,1371.0,0.0,1371.0,0.0,1371.0,0
TCGA-A8-A081-01,TCGA-A8-A081,BRCA,80.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29555.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0
TCGA-A8-A082-01,TCGA-A8-A082,BRCA,58.0,FEMALE,nan,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21338.0,Alive,TUMOR FREE,549.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,549.0,0.0,549.0,0.0,549.0,0.0,549.0,0
TCGA-A8-A083-01,TCGA-A8-A083,BRCA,67.0,FEMALE,nan,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24746.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0
TCGA-A8-A084-01,TCGA-A8-A084,BRCA,81.0,FEMALE,nan,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29858.0,Alive,WITH TUMOR,458.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,458.0,0.0,458.0,nan,nan,0.0,458.0,0
TCGA-A8-A085-01,TCGA-A8-A085,BRCA,44.0,MALE,nan,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2008.0,nan,-16377.0,Alive,TUMOR FREE,1124.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1124.0,0.0,1124.0,0.0,1124.0,0.0,1124.0,0
TCGA-A8-A086-01,TCGA-A8-A086,BRCA,59.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21731.0,Alive,TUMOR FREE,396.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,396.0,0.0,396.0,0.0,396.0,0.0,396.0,0
TCGA-A8-A08A-01,TCGA-A8-A08A,BRCA,89.0,FEMALE,nan,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32750.0,Alive,TUMOR FREE,30.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,30.0,0.0,30.0,0.0,30.0,0.0,30.0,0
TCGA-A8-A08B-01,TCGA-A8-A08B,BRCA,52.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19114.0,Alive,TUMOR FREE,1156.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1156.0,0.0,1156.0,0.0,1156.0,0.0,1156.0,0
TCGA-A8-A08C-01,TCGA-A8-A08C,BRCA,65.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24017.0,Alive,TUMOR FREE,881.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,881.0,0.0,881.0,0.0,881.0,0.0,881.0,0
TCGA-A8-A08F-01,TCGA-A8-A08F,BRCA,59.0,FEMALE,nan,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21641.0,Alive,TUMOR FREE,1004.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1004.0,0.0,1004.0,0.0,1004.0,0.0,1004.0,0
TCGA-A8-A08G-01,TCGA-A8-A08G,BRCA,41.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14976.0,Alive,TUMOR FREE,607.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,607.0,0.0,607.0,0.0,607.0,0.0,607.0,0
TCGA-A8-A08H-01,TCGA-A8-A08H,BRCA,66.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24137.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0
TCGA-A8-A08I-01,TCGA-A8-A08I,BRCA,53.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19389.0,Alive,TUMOR FREE,365.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,365.0,0.0,365.0,0.0,365.0,0.0,365.0,0
TCGA-A8-A08J-01,TCGA-A8-A08J,BRCA,52.0,FEMALE,nan,Stage IV,nan,Infiltrating Ductal Carcinoma,nan,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19266.0,Dead,WITH TUMOR,nan,1127.0,nan,nan,nan,nan,nan,nan,Positive,nan,1.0,1127.0,1.0,1127.0,nan,nan,1.0,1127.0,1
TCGA-A8-A08L-01,TCGA-A8-A08L,BRCA,89.0,FEMALE,nan,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32842.0,Dead,TUMOR FREE,nan,304.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,304.0,0.0,304.0,0.0,304.0,0.0,304.0,0
TCGA-A8-A08O-01,TCGA-A8-A08O,BRCA,45.0,FEMALE,nan,Stage IV,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16681.0,Alive,WITH TUMOR,943.0,nan,nan,nan,nan,nan,762.0,nan,Positive,nan,0.0,943.0,0.0,943.0,nan,nan,1.0,762.0,0
TCGA-A8-A08P-01,TCGA-A8-A08P,BRCA,70.0,FEMALE,nan,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25598.0,Alive,TUMOR FREE,943.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,943.0,0.0,943.0,0.0,943.0,0.0,943.0,0
TCGA-A8-A08R-01,TCGA-A8-A08R,BRCA,52.0,FEMALE,nan,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19298.0,Alive,TUMOR FREE,30.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,30.0,0.0,30.0,0.0,30.0,0.0,30.0,0
TCGA-A8-A08S-01,TCGA-A8-A08S,BRCA,71.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25994.0,Alive,TUMOR FREE,1004.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1004.0,0.0,1004.0,0.0,1004.0,0.0,1004.0,0
TCGA-A8-A08T-01,TCGA-A8-A08T,BRCA,64.0,FEMALE,nan,Stage IV,nan,Infiltrating Ductal Carcinoma,nan,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23560.0,Dead,WITH TUMOR,nan,3409.0,nan,nan,nan,nan,2557.0,nan,Positive,nan,1.0,3409.0,1.0,3409.0,nan,nan,1.0,2557.0,1
TCGA-A8-A08X-01,TCGA-A8-A08X,BRCA,43.0,FEMALE,nan,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15705.0,Alive,TUMOR FREE,1308.0,nan,nan,nan,nan,nan,366.0,nan,Negative,nan,0.0,1308.0,0.0,1308.0,1.0,366.0,1.0,366.0,0
TCGA-A8-A08Z-01,TCGA-A8-A08Z,BRCA,76.0,FEMALE,nan,[Discrepancy],nan,Infiltrating Ductal Carcinoma,nan,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28003.0,Alive,TUMOR FREE,1217.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1217.0,0.0,1217.0,0.0,1217.0,0.0,1217.0,0
TCGA-A8-A090-01,TCGA-A8-A090,BRCA,74.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27121.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0
TCGA-A8-A091-01,TCGA-A8-A091,BRCA,61.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22554.0,Alive,TUMOR FREE,1004.0,nan,nan,nan,nan,nan,243.0,nan,Negative,nan,0.0,1004.0,0.0,1004.0,1.0,243.0,1.0,243.0,0
TCGA-A8-A092-01,TCGA-A8-A092,BRCA,48.0,FEMALE,nan,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17807.0,Alive,TUMOR FREE,942.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,942.0,0.0,942.0,0.0,942.0,0.0,942.0,0
TCGA-A8-A093-01,TCGA-A8-A093,BRCA,61.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22373.0,Alive,TUMOR FREE,546.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,546.0,0.0,546.0,0.0,546.0,0.0,546.0,0
TCGA-A8-A094-01,TCGA-A8-A094,BRCA,75.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27729.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0
TCGA-A8-A095-01,TCGA-A8-A095,BRCA,45.0,FEMALE,nan,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16742.0,Alive,TUMOR FREE,1277.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1277.0,0.0,1277.0,0.0,1277.0,0.0,1277.0,0
TCGA-A8-A096-01,TCGA-A8-A096,BRCA,73.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26723.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0
TCGA-A8-A097-01,TCGA-A8-A097,BRCA,65.0,FEMALE,nan,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23741.0,Alive,TUMOR FREE,365.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,365.0,0.0,365.0,0.0,365.0,0.0,365.0,0
TCGA-A8-A099-01,TCGA-A8-A099,BRCA,76.0,FEMALE,nan,Stage X,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28063.0,Alive,nan,304.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,304.0,0.0,304.0,nan,nan,0.0,304.0,0
TCGA-A8-A09A-01,TCGA-A8-A09A,BRCA,40.0,FEMALE,nan,Stage X,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14883.0,Alive,WITH TUMOR,304.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,304.0,0.0,304.0,nan,nan,0.0,304.0,0
TCGA-A8-A09B-01,TCGA-A8-A09B,BRCA,58.0,FEMALE,nan,Stage IIIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21520.0,Alive,TUMOR FREE,365.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,365.0,0.0,365.0,0.0,365.0,0.0,365.0,0
TCGA-A8-A09C-01,TCGA-A8-A09C,BRCA,69.0,FEMALE,nan,Stage X,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25355.0,Alive,nan,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-A8-A09D-01,TCGA-A8-A09D,BRCA,47.0,FEMALE,nan,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17440.0,Alive,TUMOR FREE,1522.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1522.0,0.0,1522.0,0.0,1522.0,0.0,1522.0,0
TCGA-A8-A09E-01,TCGA-A8-A09E,BRCA,73.0,FEMALE,nan,Stage IIIB,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26724.0,Alive,WITH TUMOR,1492.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,1492.0,0.0,1492.0,nan,nan,0.0,1492.0,0
TCGA-A8-A09G-01,TCGA-A8-A09G,BRCA,79.0,FEMALE,nan,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29006.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0
TCGA-A8-A09I-01,TCGA-A8-A09I,BRCA,84.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30711.0,Alive,TUMOR FREE,1371.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1371.0,0.0,1371.0,0.0,1371.0,0.0,1371.0,0
TCGA-A8-A09K-01,TCGA-A8-A09K,BRCA,68.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24960.0,Alive,TUMOR FREE,912.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,912.0,0.0,912.0,0.0,912.0,0.0,912.0,0
TCGA-A8-A09M-01,TCGA-A8-A09M,BRCA,75.0,FEMALE,nan,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27455.0,Alive,TUMOR FREE,1006.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1006.0,0.0,1006.0,0.0,1006.0,0.0,1006.0,0
TCGA-A8-A09N-01,TCGA-A8-A09N,BRCA,57.0,FEMALE,nan,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21002.0,Alive,TUMOR FREE,31.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,31.0,0.0,31.0,0.0,31.0,0.0,31.0,0
TCGA-A8-A09Q-01,TCGA-A8-A09Q,BRCA,83.0,FEMALE,nan,Stage IIIB,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30528.0,Alive,WITH TUMOR,761.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,761.0,0.0,761.0,nan,nan,0.0,761.0,0
TCGA-A8-A09R-01,TCGA-A8-A09R,BRCA,82.0,FEMALE,nan,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30196.0,Alive,TUMOR FREE,273.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,273.0,0.0,273.0,0.0,273.0,0.0,273.0,0
TCGA-A8-A09T-01,TCGA-A8-A09T,BRCA,68.0,FEMALE,nan,[Discrepancy],nan,Infiltrating Lobular Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25110.0,Alive,TUMOR FREE,579.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,579.0,0.0,579.0,0.0,579.0,0.0,579.0,0
TCGA-A8-A09V-01,TCGA-A8-A09V,BRCA,51.0,FEMALE,nan,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18628.0,Alive,TUMOR FREE,457.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,457.0,0.0,457.0,0.0,457.0,0.0,457.0,0
TCGA-A8-A09W-01,TCGA-A8-A09W,BRCA,70.0,FEMALE,nan,Stage IIIB,nan,Infiltrating Lobular Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25659.0,Alive,nan,30.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,30.0,0.0,30.0,nan,nan,0.0,30.0,0
TCGA-A8-A09X-01,TCGA-A8-A09X,BRCA,62.0,FEMALE,nan,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22858.0,Dead,nan,nan,426.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,426.0,nan,426.0,nan,nan,0.0,426.0,1
TCGA-A8-A09Z-01,TCGA-A8-A09Z,BRCA,83.0,FEMALE,nan,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30590.0,Alive,WITH TUMOR,0.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-A8-A0A1-01,TCGA-A8-A0A1,BRCA,84.0,FEMALE,nan,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30742.0,Alive,TUMOR FREE,365.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,365.0,0.0,365.0,0.0,365.0,0.0,365.0,0
TCGA-A8-A0A2-01,TCGA-A8-A0A2,BRCA,66.0,FEMALE,nan,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24380.0,Alive,TUMOR FREE,579.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,579.0,0.0,579.0,0.0,579.0,0.0,579.0,0
TCGA-A8-A0A4-01,TCGA-A8-A0A4,BRCA,73.0,FEMALE,nan,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26693.0,Alive,TUMOR FREE,396.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,396.0,0.0,396.0,0.0,396.0,0.0,396.0,0
TCGA-A8-A0A6-01,TCGA-A8-A0A6,BRCA,64.0,FEMALE,nan,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23404.0,Alive,TUMOR FREE,640.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,640.0,0.0,640.0,0.0,640.0,0.0,640.0,0
TCGA-A8-A0A7-01,TCGA-A8-A0A7,BRCA,57.0,FEMALE,nan,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20940.0,Alive,TUMOR FREE,30.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,30.0,0.0,30.0,0.0,30.0,0.0,30.0,0
TCGA-A8-A0A9-01,TCGA-A8-A0A9,BRCA,80.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29370.0,Alive,TUMOR FREE,822.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,822.0,0.0,822.0,0.0,822.0,0.0,822.0,0
TCGA-A8-A0AB-01,TCGA-A8-A0AB,BRCA,54.0,FEMALE,nan,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19814.0,Alive,TUMOR FREE,518.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,518.0,0.0,518.0,0.0,518.0,0.0,518.0,0
TCGA-A8-A0AD-01,TCGA-A8-A0AD,BRCA,83.0,FEMALE,nan,Stage I,nan,Mixed Histology (please specify),nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30407.0,Alive,TUMOR FREE,1157.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1157.0,0.0,1157.0,0.0,1157.0,0.0,1157.0,0
TCGA-AC-A23C-01,TCGA-AC-A23C,BRCA,62.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22751.0,Alive,TUMOR FREE,585.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,585.0,0.0,585.0,0.0,585.0,0.0,585.0,0
TCGA-AC-A23E-01,TCGA-AC-A23E,BRCA,50.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,nan,-18500.0,Alive,TUMOR FREE,698.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,698.0,0.0,698.0,0.0,698.0,0.0,698.0,0
TCGA-AC-A23G-01,TCGA-AC-A23G,BRCA,76.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27934.0,Alive,TUMOR FREE,2248.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2248.0,0.0,2248.0,0.0,2248.0,0.0,2248.0,0
TCGA-AC-A23H-01,TCGA-AC-A23H,BRCA,90.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32873.0,Dead,WITH TUMOR,nan,174.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,174.0,1.0,174.0,nan,nan,1.0,174.0,1
TCGA-AC-A23H-11,TCGA-AC-A23H,BRCA,90.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32873.0,Dead,WITH TUMOR,nan,174.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,174.0,1.0,174.0,nan,nan,1.0,174.0,1
TCGA-AC-A2B8-01,TCGA-AC-A2B8,BRCA,84.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31003.0,Alive,TUMOR FREE,677.0,nan,nan,New Primary Tumor,"Other, specify",Rectum,654.0,nan,Negative,nan,0.0,677.0,0.0,677.0,0.0,677.0,1.0,654.0,0
TCGA-AC-A2BK-01,TCGA-AC-A2BK,BRCA,78.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28625.0,Alive,TUMOR FREE,2222.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2222.0,0.0,2222.0,0.0,2222.0,0.0,2222.0,0
TCGA-AC-A2BM-01,TCGA-AC-A2BM,BRCA,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2005.0,nan,-15212.0,Alive,TUMOR FREE,3022.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3022.0,0.0,3022.0,0.0,3022.0,0.0,3022.0,0
TCGA-AC-A2FB-01,TCGA-AC-A2FB,BRCA,65.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2009.0,nan,-23851.0,Alive,TUMOR FREE,1234.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1234.0,0.0,1234.0,0.0,1234.0,0.0,1234.0,0
TCGA-AC-A2FB-11,TCGA-AC-A2FB,BRCA,65.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2009.0,nan,-23851.0,Alive,TUMOR FREE,1234.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1234.0,0.0,1234.0,0.0,1234.0,0.0,1234.0,0
TCGA-AC-A2FE-01,TCGA-AC-A2FE,BRCA,62.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22746.0,Dead,WITH TUMOR,nan,2636.0,nan,Distant Metastasis,Bone,nan,766.0,nan,Negative,nan,1.0,2636.0,1.0,2636.0,1.0,766.0,1.0,766.0,1
TCGA-AC-A2FF-01,TCGA-AC-A2FF,BRCA,40.0,FEMALE,ASIAN,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2006.0,nan,nan,Alive,TUMOR FREE,2759.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2759.0,0.0,2759.0,0.0,2759.0,0.0,2759.0,0
TCGA-AC-A2FF-11,TCGA-AC-A2FF,BRCA,40.0,FEMALE,ASIAN,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2006.0,nan,nan,Alive,TUMOR FREE,2759.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2759.0,0.0,2759.0,0.0,2759.0,0.0,2759.0,0
TCGA-AC-A2FG-01,TCGA-AC-A2FG,BRCA,79.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29211.0,Alive,TUMOR FREE,1853.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1853.0,0.0,1853.0,0.0,1853.0,0.0,1853.0,0
TCGA-AC-A2FG-11,TCGA-AC-A2FG,BRCA,79.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29211.0,Alive,TUMOR FREE,1853.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1853.0,0.0,1853.0,0.0,1853.0,0.0,1853.0,0
TCGA-AC-A2FK-01,TCGA-AC-A2FK,BRCA,45.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2006.0,nan,-16627.0,Alive,TUMOR FREE,2650.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2650.0,0.0,2650.0,0.0,2650.0,0.0,2650.0,0
TCGA-AC-A2FM-01,TCGA-AC-A2FM,BRCA,87.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31805.0,Dead,WITH TUMOR,nan,792.0,nan,Distant Metastasis,"Other, specify",Bone Marrow,780.0,nan,Negative,nan,1.0,792.0,1.0,792.0,1.0,780.0,1.0,780.0,1
TCGA-AC-A2FM-11,TCGA-AC-A2FM,BRCA,87.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31805.0,Dead,WITH TUMOR,nan,792.0,nan,Distant Metastasis,"Other, specify",Bone Marrow,780.0,nan,Negative,nan,1.0,792.0,1.0,792.0,1.0,780.0,1.0,780.0,1
TCGA-AC-A2FO-01,TCGA-AC-A2FO,BRCA,65.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23928.0,Alive,TUMOR FREE,2255.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2255.0,0.0,2255.0,0.0,2255.0,0.0,2255.0,0
TCGA-AC-A2QH-01,TCGA-AC-A2QH,BRCA,58.0,FEMALE,WHITE,Stage IIB,nan,Metaplastic Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21488.0,Alive,TUMOR FREE,1005.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1005.0,0.0,1005.0,0.0,1005.0,0.0,1005.0,0
TCGA-AC-A2QI-01,TCGA-AC-A2QI,BRCA,76.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27865.0,Alive,TUMOR FREE,588.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,588.0,0.0,588.0,0.0,588.0,0.0,588.0,0
TCGA-AC-A2QJ-01,TCGA-AC-A2QJ,BRCA,48.0,FEMALE,WHITE,Stage IIIB,nan,Metaplastic Carcinoma,nan,2011.0,Peri (6-12 months since last menstrual period),-17569.0,Dead,WITH TUMOR,nan,446.0,nan,Distant Metastasis,Bone,nan,237.0,nan,Negative,nan,1.0,446.0,1.0,446.0,1.0,237.0,1.0,237.0,1
TCGA-AC-A3BB-01,TCGA-AC-A3BB,BRCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2011.0,nan,-16983.0,Alive,TUMOR FREE,987.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,987.0,0.0,987.0,0.0,987.0,0.0,987.0,0
TCGA-AC-A3EH-01,TCGA-AC-A3EH,BRCA,79.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29014.0,Dead,TUMOR FREE,nan,197.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,197.0,0.0,197.0,0.0,197.0,0.0,197.0,0
TCGA-AC-A3HN-01,TCGA-AC-A3HN,BRCA,87.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32061.0,Alive,TUMOR FREE,496.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,496.0,0.0,496.0,0.0,496.0,0.0,496.0,0
TCGA-AC-A3OD-01,TCGA-AC-A3OD,BRCA,68.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25186.0,Alive,TUMOR FREE,451.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,451.0,0.0,451.0,0.0,451.0,0.0,451.0,0
TCGA-AC-A3QP-01,TCGA-AC-A3QP,BRCA,79.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29113.0,Alive,TUMOR FREE,675.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,675.0,0.0,675.0,0.0,675.0,0.0,675.0,0
TCGA-AC-A3QQ-01,TCGA-AC-A3QQ,BRCA,54.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Peri (6-12 months since last menstrual period),-19723.0,Alive,TUMOR FREE,734.0,nan,nan,nan,nan,nan,nan,nan,Close,nan,0.0,734.0,0.0,734.0,nan,nan,0.0,734.0,0
TCGA-AC-A3TM-01,TCGA-AC-A3TM,BRCA,50.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Peri (6-12 months since last menstrual period),-18535.0,Alive,TUMOR FREE,762.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,762.0,0.0,762.0,0.0,762.0,0.0,762.0,0
TCGA-AC-A3TN-01,TCGA-AC-A3TN,BRCA,75.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27421.0,Alive,TUMOR FREE,456.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,456.0,0.0,456.0,0.0,456.0,0.0,456.0,0
TCGA-AC-A3W5-01,TCGA-AC-A3W5,BRCA,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2011.0,[Not Evaluated],-24029.0,Alive,TUMOR FREE,504.0,nan,nan,nan,nan,nan,nan,nan,Close,nan,0.0,504.0,0.0,504.0,nan,nan,0.0,504.0,0
TCGA-AC-A3W6-01,TCGA-AC-A3W6,BRCA,90.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32872.0,Alive,TUMOR FREE,602.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,602.0,0.0,602.0,0.0,602.0,0.0,602.0,0
TCGA-AC-A3W7-01,TCGA-AC-A3W7,BRCA,66.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24327.0,Alive,TUMOR FREE,471.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,471.0,0.0,471.0,0.0,471.0,0.0,471.0,0
TCGA-AC-A3YI-01,TCGA-AC-A3YI,BRCA,74.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27143.0,Alive,TUMOR FREE,707.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,707.0,0.0,707.0,0.0,707.0,0.0,707.0,0
TCGA-AC-A3YJ-01,TCGA-AC-A3YJ,BRCA,66.0,FEMALE,WHITE,Stage IIA,nan,"Other, specify",nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24439.0,Alive,TUMOR FREE,754.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,754.0,0.0,754.0,0.0,754.0,0.0,754.0,0
TCGA-AC-A4ZE-01,TCGA-AC-A4ZE,BRCA,63.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23284.0,Alive,TUMOR FREE,890.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,890.0,0.0,890.0,0.0,890.0,0.0,890.0,0
TCGA-AC-A5EH-01,TCGA-AC-A5EH,BRCA,76.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2012.0,nan,-27964.0,Alive,TUMOR FREE,511.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,511.0,0.0,511.0,0.0,511.0,0.0,511.0,0
TCGA-AC-A5EI-01,TCGA-AC-A5EI,BRCA,88.0,FEMALE,WHITE,Stage IB,nan,"Other, specify",nan,2012.0,nan,-32375.0,Alive,TUMOR FREE,442.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,442.0,0.0,442.0,0.0,442.0,0.0,442.0,0
TCGA-AC-A5XS-01,TCGA-AC-A5XS,BRCA,74.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2012.0,nan,-27160.0,Alive,TUMOR FREE,588.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,588.0,0.0,588.0,0.0,588.0,0.0,588.0,0
TCGA-AC-A5XU-01,TCGA-AC-A5XU,BRCA,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2013.0,nan,-27191.0,Alive,TUMOR FREE,455.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,455.0,0.0,455.0,0.0,455.0,0.0,455.0,0
TCGA-AC-A62V-01,TCGA-AC-A62V,BRCA,58.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Infiltrating Ductal Carcinoma,nan,2013.0,[Not Evaluated],-21389.0,Dead,WITH TUMOR,nan,348.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,348.0,1.0,348.0,nan,nan,1.0,348.0,1
TCGA-AC-A62X-01,TCGA-AC-A62X,BRCA,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26627.0,Alive,TUMOR FREE,417.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,417.0,0.0,417.0,0.0,417.0,0.0,417.0,0
TCGA-AC-A62Y-01,TCGA-AC-A62Y,BRCA,79.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28876.0,Alive,TUMOR FREE,530.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,530.0,0.0,530.0,nan,nan,0.0,530.0,0
TCGA-AC-A6IV-01,TCGA-AC-A6IV,BRCA,47.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2012.0,nan,-17521.0,Alive,TUMOR FREE,568.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,568.0,0.0,568.0,0.0,568.0,0.0,568.0,0
TCGA-AC-A6IW-01,TCGA-AC-A6IW,BRCA,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26896.0,Alive,TUMOR FREE,413.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,413.0,0.0,413.0,0.0,413.0,0.0,413.0,0
TCGA-AC-A6IX-06,TCGA-AC-A6IX,BRCA,49.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2013.0,Peri (6-12 months since last menstrual period),-17969.0,Alive,TUMOR FREE,373.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,373.0,0.0,373.0,0.0,373.0,0.0,373.0,0
TCGA-AC-A6IX-01,TCGA-AC-A6IX,BRCA,49.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2013.0,Peri (6-12 months since last menstrual period),-17969.0,Alive,TUMOR FREE,373.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,373.0,0.0,373.0,0.0,373.0,0.0,373.0,0
TCGA-AC-A6NO-01,TCGA-AC-A6NO,BRCA,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2011.0,[Unknown],-15996.0,Alive,TUMOR FREE,51.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,51.0,0.0,51.0,0.0,51.0,0.0,51.0,0
TCGA-AC-A7VB-01,TCGA-AC-A7VB,BRCA,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2013.0,[Unknown],-18806.0,Alive,TUMOR FREE,250.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,250.0,0.0,250.0,0.0,250.0,0.0,250.0,0
TCGA-AC-A7VC-01,TCGA-AC-A7VC,BRCA,56.0,FEMALE,WHITE,Stage IIB,nan,Metaplastic Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20479.0,Alive,TUMOR FREE,1.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,0
TCGA-AC-A8OP-01,TCGA-AC-A8OP,BRCA,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26550.0,Alive,TUMOR FREE,614.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,614.0,0.0,614.0,0.0,614.0,0.0,614.0,0
TCGA-AC-A8OQ-01,TCGA-AC-A8OQ,BRCA,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26535.0,Alive,TUMOR FREE,34.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,34.0,0.0,34.0,0.0,34.0,0.0,34.0,0
TCGA-AC-A8OR-01,TCGA-AC-A8OR,BRCA,75.0,FEMALE,WHITE,Stage IA,nan,Mucinous Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27605.0,Alive,TUMOR FREE,40.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,40.0,0.0,40.0,0.0,40.0,0.0,40.0,0
TCGA-AC-A8OS-01,TCGA-AC-A8OS,BRCA,71.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26248.0,Alive,TUMOR FREE,70.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,70.0,0.0,70.0,0.0,70.0,0.0,70.0,0
TCGA-AN-A03X-01,TCGA-AN-A03X,BRCA,74.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27163.0,Alive,TUMOR FREE,10.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,0
TCGA-AN-A03Y-01,TCGA-AN-A03Y,BRCA,66.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24232.0,Alive,TUMOR FREE,10.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,0
TCGA-AN-A041-01,TCGA-AN-A041,BRCA,29.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10812.0,Alive,TUMOR FREE,7.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,7.0,0.0,7.0,0.0,7.0,0.0,7.0,0
TCGA-AN-A046-01,TCGA-AN-A046,BRCA,68.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25158.0,Alive,TUMOR FREE,10.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,0
TCGA-AN-A049-01,TCGA-AN-A049,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22710.0,Alive,TUMOR FREE,19.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,19.0,0.0,19.0,nan,nan,0.0,19.0,0
TCGA-AN-A04A-01,TCGA-AN-A04A,BRCA,36.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Peri (6-12 months since last menstrual period),-13445.0,Alive,TUMOR FREE,90.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,90.0,0.0,90.0,nan,nan,0.0,90.0,0
TCGA-AN-A04C-01,TCGA-AN-A04C,BRCA,51.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18851.0,Alive,TUMOR FREE,54.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,54.0,0.0,54.0,nan,nan,0.0,54.0,0
TCGA-AN-A04D-01,TCGA-AN-A04D,BRCA,58.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21426.0,Alive,TUMOR FREE,52.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,52.0,0.0,52.0,nan,nan,0.0,52.0,0
TCGA-AN-A0AJ-01,TCGA-AN-A0AJ,BRCA,79.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29131.0,Alive,TUMOR FREE,303.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,303.0,0.0,303.0,0.0,303.0,0.0,303.0,0
TCGA-AN-A0AK-01,TCGA-AN-A0AK,BRCA,76.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27977.0,Alive,TUMOR FREE,224.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,224.0,0.0,224.0,0.0,224.0,0.0,224.0,0
TCGA-AN-A0AL-01,TCGA-AN-A0AL,BRCA,41.0,FEMALE,WHITE,Stage IIIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15286.0,Alive,TUMOR FREE,227.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,227.0,0.0,227.0,0.0,227.0,0.0,227.0,0
TCGA-AN-A0AM-01,TCGA-AN-A0AM,BRCA,56.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20713.0,Alive,TUMOR FREE,5.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,5.0,0.0,5.0,0.0,5.0,0.0,5.0,0
TCGA-AN-A0AR-01,TCGA-AN-A0AR,BRCA,55.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20152.0,Alive,TUMOR FREE,10.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,0
TCGA-AN-A0AS-01,TCGA-AN-A0AS,BRCA,70.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25658.0,Alive,TUMOR FREE,10.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,0
TCGA-AN-A0AT-01,TCGA-AN-A0AT,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22798.0,Alive,TUMOR FREE,10.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,0
TCGA-AN-A0FD-01,TCGA-AN-A0FD,BRCA,71.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26007.0,Alive,TUMOR FREE,196.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,196.0,0.0,196.0,0.0,196.0,0.0,196.0,0
TCGA-AN-A0FF-01,TCGA-AN-A0FF,BRCA,32.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11929.0,Alive,TUMOR FREE,172.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,172.0,0.0,172.0,0.0,172.0,0.0,172.0,0
TCGA-AN-A0FJ-01,TCGA-AN-A0FJ,BRCA,59.0,FEMALE,WHITE,Stage IV,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Peri (6-12 months since last menstrual period),-21910.0,Alive,TUMOR FREE,242.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,242.0,0.0,242.0,nan,nan,0.0,242.0,0
TCGA-AN-A0FK-01,TCGA-AN-A0FK,BRCA,88.0,FEMALE,WHITE,Stage IIIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32462.0,Alive,TUMOR FREE,213.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,213.0,0.0,213.0,0.0,213.0,0.0,213.0,0
TCGA-AN-A0FL-01,TCGA-AN-A0FL,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22805.0,Alive,TUMOR FREE,231.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,231.0,0.0,231.0,0.0,231.0,0.0,231.0,0
TCGA-AN-A0FN-01,TCGA-AN-A0FN,BRCA,61.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22629.0,Alive,TUMOR FREE,218.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,218.0,0.0,218.0,0.0,218.0,0.0,218.0,0
TCGA-AN-A0FS-01,TCGA-AN-A0FS,BRCA,55.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Peri (6-12 months since last menstrual period),-20352.0,Alive,TUMOR FREE,210.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,210.0,0.0,210.0,0.0,210.0,0.0,210.0,0
TCGA-AN-A0FT-01,TCGA-AN-A0FT,BRCA,63.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23300.0,Alive,TUMOR FREE,214.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,214.0,0.0,214.0,0.0,214.0,0.0,214.0,0
TCGA-AN-A0FV-01,TCGA-AN-A0FV,BRCA,58.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21479.0,Alive,TUMOR FREE,10.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,0
TCGA-AN-A0FW-01,TCGA-AN-A0FW,BRCA,67.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24692.0,Alive,TUMOR FREE,11.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,11.0,0.0,11.0,0.0,11.0,0.0,11.0,0
TCGA-AN-A0FX-01,TCGA-AN-A0FX,BRCA,52.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19309.0,Alive,TUMOR FREE,10.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,0
TCGA-AN-A0FY-01,TCGA-AN-A0FY,BRCA,55.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20347.0,Alive,TUMOR FREE,10.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,0
TCGA-AN-A0FZ-01,TCGA-AN-A0FZ,BRCA,45.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16533.0,Alive,TUMOR FREE,10.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,0
TCGA-AN-A0G0-01,TCGA-AN-A0G0,BRCA,56.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20504.0,Alive,TUMOR FREE,16.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,16.0,0.0,16.0,0.0,16.0,0.0,16.0,0
TCGA-AN-A0XL-01,TCGA-AN-A0XL,BRCA,61.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22341.0,Alive,TUMOR FREE,163.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,163.0,0.0,163.0,0.0,163.0,0.0,163.0,0
TCGA-AN-A0XN-01,TCGA-AN-A0XN,BRCA,68.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25029.0,Alive,TUMOR FREE,10.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,0
TCGA-AN-A0XO-01,TCGA-AN-A0XO,BRCA,59.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21640.0,Alive,TUMOR FREE,375.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,375.0,0.0,375.0,0.0,375.0,0.0,375.0,0
TCGA-AN-A0XP-01,TCGA-AN-A0XP,BRCA,69.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25305.0,Alive,TUMOR FREE,9.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,9.0,0.0,9.0,0.0,9.0,0.0,9.0,0
TCGA-AN-A0XR-01,TCGA-AN-A0XR,BRCA,55.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20381.0,Alive,TUMOR FREE,10.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,0
TCGA-AN-A0XS-01,TCGA-AN-A0XS,BRCA,63.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23358.0,Alive,TUMOR FREE,10.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,0
TCGA-AN-A0XT-01,TCGA-AN-A0XT,BRCA,54.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19794.0,Alive,TUMOR FREE,10.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,0
TCGA-AN-A0XU-01,TCGA-AN-A0XU,BRCA,54.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20052.0,Alive,TUMOR FREE,10.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,0
TCGA-AN-A0XV-01,TCGA-AN-A0XV,BRCA,67.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24779.0,Alive,TUMOR FREE,162.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,162.0,0.0,162.0,0.0,162.0,0.0,162.0,0
TCGA-AN-A0XW-01,TCGA-AN-A0XW,BRCA,36.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13208.0,Alive,TUMOR FREE,170.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,170.0,0.0,170.0,0.0,170.0,0.0,170.0,0
TCGA-AO-A03L-01,TCGA-AO-A03L,BRCA,34.0,FEMALE,ASIAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2003.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12443.0,Alive,TUMOR FREE,2442.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2442.0,0.0,2442.0,0.0,2442.0,0.0,2442.0,0
TCGA-AO-A03M-01,TCGA-AO-A03M,BRCA,29.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10616.0,Alive,TUMOR FREE,1866.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1866.0,0.0,1866.0,0.0,1866.0,0.0,1866.0,0
TCGA-AO-A03N-01,TCGA-AO-A03N,BRCA,59.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21816.0,Alive,WITH TUMOR,2031.0,nan,nan,Locoregional Disease,nan,nan,1645.0,nan,Negative,nan,0.0,2031.0,0.0,2031.0,1.0,1645.0,1.0,1645.0,0
TCGA-AO-A03O-01,TCGA-AO-A03O,BRCA,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25362.0,Dead,TUMOR FREE,nan,2483.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,2483.0,0.0,2483.0,0.0,2483.0,0.0,2483.0,0
TCGA-AO-A03P-01,TCGA-AO-A03P,BRCA,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19724.0,Dead,WITH TUMOR,nan,2911.0,nan,Distant Metastasis,Liver,nan,1922.0,nan,Close,nan,1.0,2911.0,1.0,2911.0,nan,nan,1.0,1922.0,1
TCGA-AO-A03R-01,TCGA-AO-A03R,BRCA,57.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20930.0,Alive,TUMOR FREE,2091.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2091.0,0.0,2091.0,0.0,2091.0,0.0,2091.0,0
TCGA-AO-A03T-01,TCGA-AO-A03T,BRCA,42.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15540.0,Alive,TUMOR FREE,2124.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2124.0,0.0,2124.0,0.0,2124.0,0.0,2124.0,0
TCGA-AO-A03U-01,TCGA-AO-A03U,BRCA,31.0,FEMALE,WHITE,Stage I,nan,"Other, specify",nan,2001.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11354.0,Dead,TUMOR FREE,nan,1793.0,nan,New Primary Tumor,Lung,nan,1614.0,nan,Negative,nan,1.0,1793.0,0.0,1793.0,0.0,1793.0,1.0,1614.0,0
TCGA-AO-A03V-01,TCGA-AO-A03V,BRCA,41.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Peri (6-12 months since last menstrual period),-15284.0,Alive,TUMOR FREE,1351.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1351.0,0.0,1351.0,0.0,1351.0,0.0,1351.0,0
TCGA-AO-A0J2-01,TCGA-AO-A0J2,BRCA,41.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15324.0,Alive,TUMOR FREE,997.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,997.0,0.0,997.0,0.0,997.0,0.0,997.0,0
TCGA-AO-A0J3-01,TCGA-AO-A0J3,BRCA,67.0,FEMALE,WHITE,Stage IIB,nan,"Other, specify",nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24519.0,Alive,TUMOR FREE,651.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,651.0,0.0,651.0,0.0,651.0,0.0,651.0,0
TCGA-AO-A0J4-01,TCGA-AO-A0J4,BRCA,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15052.0,Alive,TUMOR FREE,1587.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1587.0,0.0,1587.0,0.0,1587.0,0.0,1587.0,0
TCGA-AO-A0J5-01,TCGA-AO-A0J5,BRCA,48.0,FEMALE,WHITE,Stage IV,nan,"Other, specify",nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17815.0,Dead,WITH TUMOR,nan,792.0,nan,nan,nan,nan,nan,nan,Close,nan,1.0,792.0,1.0,792.0,nan,nan,1.0,792.0,1
TCGA-AO-A0J6-01,TCGA-AO-A0J6,BRCA,61.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22462.0,Alive,TUMOR FREE,1140.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1140.0,0.0,1140.0,0.0,1140.0,0.0,1140.0,0
TCGA-AO-A0J7-01,TCGA-AO-A0J7,BRCA,71.0,FEMALE,WHITE,Stage IIB,nan,"Other, specify",nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26281.0,Alive,TUMOR FREE,618.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,618.0,0.0,618.0,0.0,618.0,0.0,618.0,0
TCGA-AO-A0J8-01,TCGA-AO-A0J8,BRCA,61.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22284.0,Alive,TUMOR FREE,680.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,680.0,0.0,680.0,0.0,680.0,0.0,680.0,0
TCGA-AO-A0J9-01,TCGA-AO-A0J9,BRCA,61.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22642.0,Alive,WITH TUMOR,1613.0,nan,nan,Distant Metastasis,Bone,nan,1066.0,nan,Negative,nan,0.0,1613.0,0.0,1613.0,1.0,1066.0,1.0,1066.0,2
TCGA-AO-A0JA-01,TCGA-AO-A0JA,BRCA,36.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13307.0,Alive,WITH TUMOR,655.0,nan,nan,Distant Metastasis,Bone,nan,143.0,nan,Negative,nan,0.0,655.0,0.0,655.0,1.0,143.0,1.0,143.0,2
TCGA-AO-A0JB-01,TCGA-AO-A0JB,BRCA,50.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18561.0,Alive,TUMOR FREE,1542.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1542.0,0.0,1542.0,0.0,1542.0,0.0,1542.0,0
TCGA-AO-A0JC-01,TCGA-AO-A0JC,BRCA,64.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23404.0,Alive,TUMOR FREE,1547.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1547.0,0.0,1547.0,0.0,1547.0,0.0,1547.0,0
TCGA-AO-A0JD-01,TCGA-AO-A0JD,BRCA,59.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21831.0,Alive,TUMOR FREE,2190.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2190.0,0.0,2190.0,0.0,2190.0,0.0,2190.0,0
TCGA-AO-A0JE-01,TCGA-AO-A0JE,BRCA,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19516.0,Alive,TUMOR FREE,2335.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,2335.0,0.0,2335.0,nan,nan,0.0,2335.0,0
TCGA-AO-A0JF-01,TCGA-AO-A0JF,BRCA,68.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24923.0,Alive,TUMOR FREE,1980.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1980.0,0.0,1980.0,0.0,1980.0,0.0,1980.0,0
TCGA-AO-A0JG-01,TCGA-AO-A0JG,BRCA,49.0,FEMALE,WHITE,Stage IIIA,nan,"Other, specify",nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18021.0,Alive,TUMOR FREE,798.0,nan,nan,nan,nan,nan,nan,nan,Close,nan,0.0,798.0,0.0,798.0,nan,nan,0.0,798.0,0
TCGA-AO-A0JI-01,TCGA-AO-A0JI,BRCA,56.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20694.0,Alive,TUMOR FREE,1528.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1528.0,0.0,1528.0,0.0,1528.0,0.0,1528.0,0
TCGA-AO-A0JJ-01,TCGA-AO-A0JJ,BRCA,54.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19758.0,Alive,TUMOR FREE,1887.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1887.0,0.0,1887.0,0.0,1887.0,0.0,1887.0,0
TCGA-AO-A0JL-01,TCGA-AO-A0JL,BRCA,59.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21895.0,Alive,TUMOR FREE,1683.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1683.0,0.0,1683.0,0.0,1683.0,0.0,1683.0,0
TCGA-AO-A0JM-01,TCGA-AO-A0JM,BRCA,40.0,FEMALE,nan,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14653.0,Alive,TUMOR FREE,2184.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2184.0,0.0,2184.0,0.0,2184.0,0.0,2184.0,0
TCGA-AO-A124-01,TCGA-AO-A124,BRCA,38.0,FEMALE,WHITE,Stage IIA,nan,"Other, specify",nan,2002.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14174.0,Alive,TUMOR FREE,3506.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3506.0,0.0,3506.0,0.0,3506.0,0.0,3506.0,0
TCGA-AO-A125-01,TCGA-AO-A125,BRCA,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,"Other, specify",nan,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26466.0,Alive,TUMOR FREE,3456.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3456.0,0.0,3456.0,0.0,3456.0,0.0,3456.0,0
TCGA-AO-A126-01,TCGA-AO-A126,BRCA,39.0,FEMALE,ASIAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2002.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14264.0,Alive,TUMOR FREE,3307.0,nan,nan,Locoregional Disease,nan,nan,267.0,nan,Negative,nan,0.0,3307.0,0.0,3307.0,1.0,267.0,1.0,267.0,0
TCGA-AO-A128-01,TCGA-AO-A128,BRCA,61.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22340.0,Alive,TUMOR FREE,3248.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3248.0,0.0,3248.0,0.0,3248.0,0.0,3248.0,0
TCGA-AO-A129-01,TCGA-AO-A129,BRCA,29.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2002.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10898.0,Alive,TUMOR FREE,3286.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3286.0,0.0,3286.0,0.0,3286.0,0.0,3286.0,0
TCGA-AO-A12A-01,TCGA-AO-A12A,BRCA,47.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2003.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17420.0,Alive,TUMOR FREE,3112.0,nan,nan,nan,nan,nan,nan,nan,Close,nan,0.0,3112.0,0.0,3112.0,nan,nan,0.0,3112.0,0
TCGA-AO-A12B-01,TCGA-AO-A12B,BRCA,63.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23150.0,Alive,TUMOR FREE,2989.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2989.0,0.0,2989.0,0.0,2989.0,0.0,2989.0,0
TCGA-AO-A12C-01,TCGA-AO-A12C,BRCA,42.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15469.0,Alive,TUMOR FREE,2372.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2372.0,0.0,2372.0,0.0,2372.0,0.0,2372.0,0
TCGA-AO-A12D-01,TCGA-AO-A12D,BRCA,43.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15774.0,Alive,TUMOR FREE,2515.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2515.0,0.0,2515.0,0.0,2515.0,0.0,2515.0,0
TCGA-AO-A12E-01,TCGA-AO-A12E,BRCA,51.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18721.0,Alive,TUMOR FREE,2142.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2142.0,0.0,2142.0,0.0,2142.0,0.0,2142.0,0
TCGA-AO-A12F-01,TCGA-AO-A12F,BRCA,36.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13409.0,Alive,TUMOR FREE,1842.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1842.0,0.0,1842.0,0.0,1842.0,0.0,1842.0,0
TCGA-AO-A12G-01,TCGA-AO-A12G,BRCA,75.0,FEMALE,WHITE,Stage IIA,nan,"Other, specify",nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27705.0,Alive,TUMOR FREE,1639.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1639.0,0.0,1639.0,0.0,1639.0,0.0,1639.0,0
TCGA-AO-A12H-01,TCGA-AO-A12H,BRCA,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,"Other, specify",nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-25515.0,Alive,TUMOR FREE,1234.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1234.0,0.0,1234.0,0.0,1234.0,0.0,1234.0,0
TCGA-AO-A1KO-01,TCGA-AO-A1KO,BRCA,46.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16817.0,Alive,TUMOR FREE,622.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,622.0,0.0,622.0,0.0,622.0,0.0,622.0,0
TCGA-AO-A1KP-01,TCGA-AO-A1KP,BRCA,77.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28247.0,Alive,TUMOR FREE,2953.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2953.0,0.0,2953.0,0.0,2953.0,0.0,2953.0,0
TCGA-AO-A1KQ-01,TCGA-AO-A1KQ,BRCA,84.0,MALE,WHITE,Stage IIIB,nan,Infiltrating Ductal Carcinoma,nan,2006.0,nan,-30859.0,Alive,TUMOR FREE,1882.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1882.0,0.0,1882.0,0.0,1882.0,0.0,1882.0,0
TCGA-AO-A1KR-01,TCGA-AO-A1KR,BRCA,51.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18900.0,Alive,TUMOR FREE,2513.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2513.0,0.0,2513.0,0.0,2513.0,0.0,2513.0,0
TCGA-AO-A1KS-01,TCGA-AO-A1KS,BRCA,69.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25230.0,Alive,TUMOR FREE,350.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,350.0,0.0,350.0,0.0,350.0,0.0,350.0,0
TCGA-AO-A1KT-01,TCGA-AO-A1KT,BRCA,78.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28660.0,Alive,TUMOR FREE,541.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,541.0,0.0,541.0,0.0,541.0,0.0,541.0,0
TCGA-AQ-A04H-01,TCGA-AQ-A04H,BRCA,61.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22539.0,Alive,TUMOR FREE,754.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,754.0,0.0,754.0,0.0,754.0,0.0,754.0,0
TCGA-AQ-A04J-01,TCGA-AQ-A04J,BRCA,45.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16615.0,Alive,TUMOR FREE,819.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,819.0,0.0,819.0,0.0,819.0,0.0,819.0,0
TCGA-AQ-A04L-01,TCGA-AQ-A04L,BRCA,48.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2001.0,Peri (6-12 months since last menstrual period),-17759.0,Alive,TUMOR FREE,3957.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3957.0,0.0,3957.0,0.0,3957.0,0.0,3957.0,0
TCGA-AQ-A0Y5-01,TCGA-AQ-A0Y5,BRCA,70.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25793.0,Dead,TUMOR FREE,nan,172.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,172.0,0.0,172.0,0.0,172.0,0.0,172.0,0
TCGA-AQ-A1H2-01,TCGA-AQ-A1H2,BRCA,84.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30958.0,Alive,TUMOR FREE,475.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,475.0,0.0,475.0,0.0,475.0,0.0,475.0,0
TCGA-AQ-A1H3-01,TCGA-AQ-A1H3,BRCA,49.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18177.0,Alive,TUMOR FREE,989.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,989.0,0.0,989.0,0.0,989.0,0.0,989.0,0
TCGA-AQ-A54N-01,TCGA-AQ-A54N,BRCA,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18741.0,Alive,TUMOR FREE,78.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,78.0,0.0,78.0,0.0,78.0,0.0,78.0,0
TCGA-AQ-A54O-01,TCGA-AQ-A54O,BRCA,51.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,nan,-18694.0,Alive,TUMOR FREE,1001.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1001.0,0.0,1001.0,0.0,1001.0,0.0,1001.0,0
TCGA-AQ-A7U7-01,TCGA-AQ-A7U7,BRCA,55.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20239.0,Dead,TUMOR FREE,nan,584.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,584.0,0.0,584.0,0.0,584.0,0.0,584.0,0
TCGA-AR-A0TP-01,TCGA-AR-A0TP,BRCA,43.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2003.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15812.0,Alive,TUMOR FREE,4275.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,4275.0,0.0,4275.0,0.0,4275.0,0.0,4275.0,0
TCGA-AR-A0TQ-01,TCGA-AR-A0TQ,BRCA,27.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9873.0,Alive,TUMOR FREE,2991.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2991.0,0.0,2991.0,0.0,2991.0,0.0,2991.0,0
TCGA-AR-A0TR-01,TCGA-AR-A0TR,BRCA,68.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25190.0,Dead,nan,nan,160.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,160.0,nan,160.0,0.0,160.0,0.0,160.0,0
TCGA-AR-A0TS-01,TCGA-AR-A0TS,BRCA,46.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17141.0,Alive,TUMOR FREE,2558.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2558.0,0.0,2558.0,0.0,2558.0,0.0,2558.0,0
TCGA-AR-A0TT-01,TCGA-AR-A0TT,BRCA,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19679.0,Alive,TUMOR FREE,3316.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3316.0,0.0,3316.0,0.0,3316.0,0.0,3316.0,0
TCGA-AR-A0TU-01,TCGA-AR-A0TU,BRCA,35.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13039.0,Alive,TUMOR FREE,709.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,709.0,0.0,709.0,0.0,709.0,0.0,709.0,0
TCGA-AR-A0TV-01,TCGA-AR-A0TV,BRCA,66.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24279.0,Alive,TUMOR FREE,2288.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2288.0,0.0,2288.0,0.0,2288.0,0.0,2288.0,0
TCGA-AR-A0TW-01,TCGA-AR-A0TW,BRCA,50.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18263.0,Alive,TUMOR FREE,3009.0,nan,nan,nan,nan,nan,739.0,nan,Negative,nan,0.0,3009.0,0.0,3009.0,1.0,739.0,1.0,739.0,0
TCGA-AR-A0TX-01,TCGA-AR-A0TX,BRCA,64.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23653.0,Alive,TUMOR FREE,1972.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1972.0,0.0,1972.0,0.0,1972.0,0.0,1972.0,0
TCGA-AR-A0TY-01,TCGA-AR-A0TY,BRCA,54.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19836.0,Dead,WITH TUMOR,nan,1699.0,nan,Distant Metastasis,Bone,nan,544.0,nan,Negative,nan,1.0,1699.0,1.0,1699.0,1.0,544.0,1.0,544.0,1
TCGA-AR-A0TZ-01,TCGA-AR-A0TZ,BRCA,43.0,FEMALE,WHITE,[Discrepancy],nan,Infiltrating Ductal Carcinoma,nan,2004.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15720.0,Dead,nan,nan,3262.0,nan,Distant Metastasis,Bone,nan,1313.0,nan,Negative,nan,1.0,3262.0,nan,3262.0,1.0,1313.0,1.0,1313.0,1
TCGA-AR-A0U0-01,TCGA-AR-A0U0,BRCA,73.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26993.0,Alive,TUMOR FREE,1988.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1988.0,0.0,1988.0,0.0,1988.0,0.0,1988.0,0
TCGA-AR-A0U1-01,TCGA-AR-A0U1,BRCA,36.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2004.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13467.0,Alive,TUMOR FREE,4052.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,4052.0,0.0,4052.0,0.0,4052.0,0.0,4052.0,0
TCGA-AR-A0U2-01,TCGA-AR-A0U2,BRCA,47.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2004.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17390.0,Dead,WITH TUMOR,nan,2551.0,nan,Distant Metastasis,Bone,Liver,1609.0,nan,Negative,nan,1.0,2551.0,1.0,2551.0,1.0,1609.0,1.0,1609.0,1
TCGA-AR-A0U3-01,TCGA-AR-A0U3,BRCA,59.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21755.0,Alive,TUMOR FREE,4080.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,4080.0,0.0,4080.0,0.0,4080.0,0.0,4080.0,0
TCGA-AR-A0U4-01,TCGA-AR-A0U4,BRCA,54.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19729.0,Alive,TUMOR FREE,3261.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3261.0,0.0,3261.0,0.0,3261.0,0.0,3261.0,0
TCGA-AR-A1AH-01,TCGA-AR-A1AH,BRCA,51.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18991.0,Alive,TUMOR FREE,3807.0,nan,nan,New Primary Tumor,"Other, specify",Renal,1136.0,nan,Negative,nan,0.0,3807.0,0.0,3807.0,0.0,3807.0,1.0,1136.0,0
TCGA-AR-A1AI-01,TCGA-AR-A1AI,BRCA,47.0,FEMALE,WHITE,Stage IIA,nan,Medullary Carcinoma,nan,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17229.0,Alive,TUMOR FREE,3296.0,nan,nan,New Primary Tumor,"Other, specify",Contralateral Breast,588.0,nan,Negative,nan,0.0,3296.0,0.0,3296.0,1.0,588.0,1.0,588.0,0
TCGA-AR-A1AJ-01,TCGA-AR-A1AJ,BRCA,83.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30489.0,Alive,TUMOR FREE,3072.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3072.0,0.0,3072.0,0.0,3072.0,0.0,3072.0,0
TCGA-AR-A1AK-01,TCGA-AR-A1AK,BRCA,70.0,FEMALE,WHITE,Stage I,nan,Infiltrating Lobular Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25825.0,Alive,TUMOR FREE,3159.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3159.0,0.0,3159.0,0.0,3159.0,0.0,3159.0,0
TCGA-AR-A1AL-01,TCGA-AR-A1AL,BRCA,60.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22023.0,Alive,TUMOR FREE,2971.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2971.0,0.0,2971.0,0.0,2971.0,0.0,2971.0,0
TCGA-AR-A1AM-01,TCGA-AR-A1AM,BRCA,52.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19123.0,Alive,TUMOR FREE,2991.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2991.0,0.0,2991.0,0.0,2991.0,0.0,2991.0,0
TCGA-AR-A1AN-01,TCGA-AR-A1AN,BRCA,46.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16974.0,Alive,TUMOR FREE,2920.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2920.0,0.0,2920.0,0.0,2920.0,0.0,2920.0,0
TCGA-AR-A1AO-01,TCGA-AR-A1AO,BRCA,47.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17332.0,Alive,TUMOR FREE,2618.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2618.0,0.0,2618.0,0.0,2618.0,0.0,2618.0,0
TCGA-AR-A1AP-01,TCGA-AR-A1AP,BRCA,80.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29406.0,Alive,TUMOR FREE,2856.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2856.0,0.0,2856.0,0.0,2856.0,0.0,2856.0,0
TCGA-AR-A1AQ-01,TCGA-AR-A1AQ,BRCA,49.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18109.0,Alive,TUMOR FREE,3021.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3021.0,0.0,3021.0,0.0,3021.0,0.0,3021.0,0
TCGA-AR-A1AR-01,TCGA-AR-A1AR,BRCA,50.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18482.0,Dead,WITH TUMOR,nan,524.0,nan,New Primary Tumor,"Other, specify",Breast,268.0,nan,Negative,nan,1.0,524.0,1.0,524.0,1.0,268.0,1.0,268.0,1
TCGA-AR-A1AS-01,TCGA-AR-A1AS,BRCA,54.0,FEMALE,ASIAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20028.0,Alive,TUMOR FREE,1150.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1150.0,0.0,1150.0,0.0,1150.0,0.0,1150.0,0
TCGA-AR-A1AT-01,TCGA-AR-A1AT,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22942.0,Dead,nan,nan,1272.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,1272.0,nan,1272.0,0.0,1272.0,0.0,1272.0,0
TCGA-AR-A1AU-01,TCGA-AR-A1AU,BRCA,39.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14564.0,Alive,TUMOR FREE,2868.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2868.0,0.0,2868.0,0.0,2868.0,0.0,2868.0,0
TCGA-AR-A1AV-01,TCGA-AR-A1AV,BRCA,68.0,MALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2007.0,nan,-24875.0,Alive,TUMOR FREE,1864.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1864.0,0.0,1864.0,0.0,1864.0,0.0,1864.0,0
TCGA-AR-A1AW-01,TCGA-AR-A1AW,BRCA,65.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23855.0,Alive,TUMOR FREE,2632.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2632.0,0.0,2632.0,0.0,2632.0,0.0,2632.0,0
TCGA-AR-A1AX-01,TCGA-AR-A1AX,BRCA,64.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23507.0,Alive,TUMOR FREE,2629.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2629.0,0.0,2629.0,0.0,2629.0,0.0,2629.0,0
TCGA-AR-A1AY-01,TCGA-AR-A1AY,BRCA,65.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23927.0,Alive,TUMOR FREE,1026.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1026.0,0.0,1026.0,0.0,1026.0,0.0,1026.0,0
TCGA-AR-A24H-01,TCGA-AR-A24H,BRCA,65.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2001.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24046.0,Alive,TUMOR FREE,4894.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,4894.0,0.0,4894.0,0.0,4894.0,0.0,4894.0,0
TCGA-AR-A24K-01,TCGA-AR-A24K,BRCA,46.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2004.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16961.0,Alive,TUMOR FREE,1548.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1548.0,0.0,1548.0,0.0,1548.0,0.0,1548.0,0
TCGA-AR-A24L-01,TCGA-AR-A24L,BRCA,26.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9706.0,Dead,WITH TUMOR,nan,2866.0,nan,Locoregional Disease,nan,nan,1414.0,nan,Negative,nan,1.0,2866.0,1.0,2866.0,1.0,1414.0,1.0,1414.0,1
TCGA-AR-A24M-01,TCGA-AR-A24M,BRCA,38.0,FEMALE,WHITE,Stage IIIA,nan,Mixed Histology (please specify),nan,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14119.0,Alive,TUMOR FREE,3660.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3660.0,0.0,3660.0,0.0,3660.0,0.0,3660.0,0
TCGA-AR-A24N-01,TCGA-AR-A24N,BRCA,54.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2005.0,Peri (6-12 months since last menstrual period),-19989.0,Alive,TUMOR FREE,3035.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3035.0,0.0,3035.0,0.0,3035.0,0.0,3035.0,0
TCGA-AR-A24O-01,TCGA-AR-A24O,BRCA,43.0,FEMALE,WHITE,Stage IIIA,nan,Mixed Histology (please specify),nan,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15977.0,Alive,WITH TUMOR,3607.0,nan,nan,nan,nan,nan,2561.0,nan,Negative,nan,0.0,3607.0,0.0,3607.0,1.0,2561.0,1.0,2561.0,2
TCGA-AR-A24P-01,TCGA-AR-A24P,BRCA,47.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17490.0,Alive,nan,84.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,84.0,0.0,84.0,0.0,84.0,0.0,84.0,0
TCGA-AR-A24Q-01,TCGA-AR-A24Q,BRCA,49.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18084.0,Alive,TUMOR FREE,3172.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3172.0,0.0,3172.0,0.0,3172.0,0.0,3172.0,0
TCGA-AR-A24R-01,TCGA-AR-A24R,BRCA,45.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16642.0,Alive,TUMOR FREE,3430.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3430.0,0.0,3430.0,0.0,3430.0,0.0,3430.0,0
TCGA-AR-A24S-01,TCGA-AR-A24S,BRCA,61.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22587.0,Alive,nan,2976.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2976.0,0.0,2976.0,0.0,2976.0,0.0,2976.0,0
TCGA-AR-A24T-01,TCGA-AR-A24T,BRCA,46.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17135.0,Alive,TUMOR FREE,3202.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3202.0,0.0,3202.0,0.0,3202.0,0.0,3202.0,0
TCGA-AR-A24U-01,TCGA-AR-A24U,BRCA,47.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17523.0,Alive,TUMOR FREE,3128.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3128.0,0.0,3128.0,0.0,3128.0,0.0,3128.0,0
TCGA-AR-A24V-01,TCGA-AR-A24V,BRCA,52.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Peri (6-12 months since last menstrual period),-19027.0,Alive,TUMOR FREE,3203.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3203.0,0.0,3203.0,0.0,3203.0,0.0,3203.0,0
TCGA-AR-A24W-01,TCGA-AR-A24W,BRCA,55.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20123.0,Alive,TUMOR FREE,1550.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1550.0,0.0,1550.0,0.0,1550.0,0.0,1550.0,0
TCGA-AR-A24X-01,TCGA-AR-A24X,BRCA,52.0,FEMALE,WHITE,Stage IIA,nan,Mixed Histology (please specify),nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19030.0,Alive,TUMOR FREE,3004.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3004.0,0.0,3004.0,0.0,3004.0,0.0,3004.0,0
TCGA-AR-A24Z-01,TCGA-AR-A24Z,BRCA,57.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20900.0,Alive,TUMOR FREE,3001.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3001.0,0.0,3001.0,0.0,3001.0,0.0,3001.0,0
TCGA-AR-A250-01,TCGA-AR-A250,BRCA,58.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21309.0,Alive,TUMOR FREE,2707.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2707.0,0.0,2707.0,0.0,2707.0,0.0,2707.0,0
TCGA-AR-A251-01,TCGA-AR-A251,BRCA,51.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18771.0,Alive,TUMOR FREE,3030.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3030.0,0.0,3030.0,0.0,3030.0,0.0,3030.0,0
TCGA-AR-A252-01,TCGA-AR-A252,BRCA,50.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18611.0,Alive,TUMOR FREE,2838.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2838.0,0.0,2838.0,0.0,2838.0,0.0,2838.0,0
TCGA-AR-A254-01,TCGA-AR-A254,BRCA,50.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18270.0,Alive,TUMOR FREE,2605.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2605.0,0.0,2605.0,0.0,2605.0,0.0,2605.0,0
TCGA-AR-A255-01,TCGA-AR-A255,BRCA,62.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22809.0,Alive,TUMOR FREE,2161.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2161.0,0.0,2161.0,0.0,2161.0,0.0,2161.0,0
TCGA-AR-A256-01,TCGA-AR-A256,BRCA,45.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2001.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16642.0,Dead,nan,nan,2854.0,nan,Locoregional Disease,nan,nan,1640.0,nan,Negative,nan,1.0,2854.0,nan,2854.0,1.0,1640.0,1.0,1640.0,1
TCGA-AR-A2LE-01,TCGA-AR-A2LE,BRCA,69.0,FEMALE,WHITE,Stage I,nan,Infiltrating Lobular Carcinoma,nan,2001.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25499.0,Alive,TUMOR FREE,5062.0,nan,nan,New Primary Tumor,"Other, specify",Endometrium,4203.0,nan,Negative,nan,0.0,5062.0,0.0,5062.0,0.0,5062.0,1.0,4203.0,0
TCGA-AR-A2LH-01,TCGA-AR-A2LH,BRCA,55.0,FEMALE,WHITE,Stage III,nan,Infiltrating Lobular Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20288.0,Dead,nan,nan,616.0,nan,Distant Metastasis,Bone,nan,434.0,nan,Negative,nan,1.0,616.0,nan,616.0,1.0,434.0,1.0,434.0,1
TCGA-AR-A2LJ-01,TCGA-AR-A2LJ,BRCA,40.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14723.0,Alive,TUMOR FREE,2632.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2632.0,0.0,2632.0,0.0,2632.0,0.0,2632.0,0
TCGA-AR-A2LK-01,TCGA-AR-A2LK,BRCA,62.0,FEMALE,WHITE,Stage III,nan,Infiltrating Lobular Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22800.0,Dead,nan,nan,1649.0,nan,Distant Metastasis,Bone,nan,1304.0,nan,Negative,nan,1.0,1649.0,nan,1649.0,1.0,1304.0,1.0,1304.0,1
TCGA-AR-A2LL-01,TCGA-AR-A2LL,BRCA,70.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25747.0,Alive,TUMOR FREE,2012.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2012.0,0.0,2012.0,0.0,2012.0,0.0,2012.0,0
TCGA-AR-A2LM-01,TCGA-AR-A2LM,BRCA,49.0,FEMALE,WHITE,Stage II,nan,Infiltrating Lobular Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18053.0,Alive,TUMOR FREE,1935.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1935.0,0.0,1935.0,0.0,1935.0,0.0,1935.0,0
TCGA-AR-A2LN-01,TCGA-AR-A2LN,BRCA,65.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23992.0,Alive,TUMOR FREE,1161.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1161.0,0.0,1161.0,0.0,1161.0,0.0,1161.0,0
TCGA-AR-A2LO-01,TCGA-AR-A2LO,BRCA,46.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17080.0,Alive,TUMOR FREE,1198.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1198.0,0.0,1198.0,0.0,1198.0,0.0,1198.0,0
TCGA-AR-A2LQ-01,TCGA-AR-A2LQ,BRCA,59.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21865.0,Alive,TUMOR FREE,1233.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1233.0,0.0,1233.0,0.0,1233.0,0.0,1233.0,0
TCGA-AR-A2LR-01,TCGA-AR-A2LR,BRCA,49.0,FEMALE,WHITE,Stage I,nan,Metaplastic Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18214.0,Alive,TUMOR FREE,1742.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1742.0,0.0,1742.0,0.0,1742.0,0.0,1742.0,0
TCGA-AR-A5QM-01,TCGA-AR-A5QM,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22780.0,Alive,TUMOR FREE,2231.0,nan,nan,New Primary Tumor,"Other, specify",Malignant melanoma,968.0,nan,nan,nan,0.0,2231.0,0.0,2231.0,nan,nan,1.0,968.0,0
TCGA-AR-A5QN-01,TCGA-AR-A5QN,BRCA,68.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25089.0,Alive,TUMOR FREE,1013.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1013.0,0.0,1013.0,nan,nan,0.0,1013.0,0
TCGA-AR-A5QP-01,TCGA-AR-A5QP,BRCA,54.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19805.0,Alive,TUMOR FREE,1185.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1185.0,0.0,1185.0,nan,nan,0.0,1185.0,0
TCGA-AR-A5QQ-01,TCGA-AR-A5QQ,BRCA,68.0,FEMALE,WHITE,Stage IIIA,nan,"Other, specify",nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24841.0,Dead,WITH TUMOR,nan,322.0,nan,Distant Metastasis,Lung,"Liver, bone, chest wall, adrenal glands",301.0,nan,nan,nan,1.0,322.0,1.0,322.0,nan,nan,1.0,301.0,1
TCGA-B6-A0I1-01,TCGA-B6-A0I1,BRCA,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,1998.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26902.0,Dead,TUMOR FREE,nan,2361.0,nan,Distant Metastasis,Lung,nan,1120.0,nan,Negative,nan,1.0,2361.0,0.0,2361.0,1.0,1120.0,1.0,1120.0,0
TCGA-B6-A0I2-01,TCGA-B6-A0I2,BRCA,45.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,1995.0,Indeterminate (neither Pre or Postmenopausal),-16702.0,Alive,TUMOR FREE,4361.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4361.0,0.0,4361.0,nan,nan,0.0,4361.0,0
TCGA-B6-A0I5-01,TCGA-B6-A0I5,BRCA,49.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,1988.0,Indeterminate (neither Pre or Postmenopausal),-18038.0,Alive,TUMOR FREE,8556.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,8556.0,0.0,8556.0,0.0,8556.0,0.0,8556.0,0
TCGA-B6-A0I6-01,TCGA-B6-A0I6,BRCA,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,1990.0,Indeterminate (neither Pre or Postmenopausal),-18014.0,Dead,WITH TUMOR,nan,991.0,nan,Distant Metastasis,"Other, specify",Skin and bone,859.0,nan,Negative,nan,1.0,991.0,1.0,991.0,1.0,859.0,1.0,859.0,1
TCGA-B6-A0I8-01,TCGA-B6-A0I8,BRCA,46.0,FEMALE,WHITE,Stage X,nan,Infiltrating Ductal Carcinoma,nan,1992.0,Indeterminate (neither Pre or Postmenopausal),-17073.0,Dead,WITH TUMOR,nan,749.0,nan,Locoregional Disease,"Other, specify",Pectoral muscle,746.0,nan,nan,nan,1.0,749.0,1.0,749.0,nan,nan,1.0,746.0,1
TCGA-B6-A0I9-01,TCGA-B6-A0I9,BRCA,62.0,FEMALE,WHITE,Stage IV,nan,Infiltrating Ductal Carcinoma,nan,1992.0,Indeterminate (neither Pre or Postmenopausal),-22798.0,Dead,WITH TUMOR,nan,362.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,362.0,1.0,362.0,nan,nan,1.0,362.0,1
TCGA-B6-A0IA-01,TCGA-B6-A0IA,BRCA,51.0,FEMALE,WHITE,Stage IIA,nan,"Other, specify",nan,1992.0,Indeterminate (neither Pre or Postmenopausal),-18748.0,Alive,TUMOR FREE,8391.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,8391.0,0.0,8391.0,0.0,8391.0,0.0,8391.0,0
TCGA-B6-A0IB-01,TCGA-B6-A0IB,BRCA,64.0,FEMALE,WHITE,Stage IV,nan,Infiltrating Ductal Carcinoma,nan,1992.0,Indeterminate (neither Pre or Postmenopausal),-23646.0,Dead,WITH TUMOR,nan,3941.0,nan,Distant Metastasis,"Other, specify","lung, bone, liver",2717.0,nan,Negative,nan,1.0,3941.0,1.0,3941.0,nan,nan,1.0,2717.0,1
TCGA-B6-A0IC-01,TCGA-B6-A0IC,BRCA,90.0,FEMALE,WHITE,Stage X,nan,"Other, specify",nan,1992.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32872.0,Dead,TUMOR FREE,nan,1542.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,1542.0,0.0,1542.0,0.0,1542.0,0.0,1542.0,0
TCGA-B6-A0IE-01,TCGA-B6-A0IE,BRCA,38.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Mixed Histology (please specify),nan,1995.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13982.0,Dead,WITH TUMOR,nan,1993.0,nan,Distant Metastasis,Bone,nan,834.0,nan,Negative,nan,1.0,1993.0,1.0,1993.0,1.0,834.0,1.0,834.0,1
TCGA-B6-A0IG-01,TCGA-B6-A0IG,BRCA,50.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,1994.0,Indeterminate (neither Pre or Postmenopausal),-18433.0,Dead,WITH TUMOR,nan,4456.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,4456.0,1.0,4456.0,nan,nan,1.0,4456.0,1
TCGA-B6-A0IH-01,TCGA-B6-A0IH,BRCA,81.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,1995.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29907.0,Dead,nan,nan,3418.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,3418.0,nan,3418.0,0.0,3418.0,0.0,3418.0,0
TCGA-B6-A0IJ-01,TCGA-B6-A0IJ,BRCA,42.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,1995.0,Indeterminate (neither Pre or Postmenopausal),-15625.0,Alive,TUMOR FREE,7106.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,7106.0,0.0,7106.0,0.0,7106.0,0.0,7106.0,0
TCGA-B6-A0IK-01,TCGA-B6-A0IK,BRCA,63.0,FEMALE,WHITE,Stage IIIB,nan,Infiltrating Ductal Carcinoma,nan,1994.0,Indeterminate (neither Pre or Postmenopausal),-23150.0,Dead,WITH TUMOR,nan,571.0,nan,Distant Metastasis,Brain,nan,489.0,nan,Negative,nan,1.0,571.0,1.0,571.0,1.0,489.0,1.0,489.0,1
TCGA-B6-A0IM-01,TCGA-B6-A0IM,BRCA,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,"Other, specify",nan,1997.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27557.0,Dead,TUMOR FREE,nan,3873.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,3873.0,0.0,3873.0,0.0,3873.0,0.0,3873.0,0
TCGA-B6-A0IN-01,TCGA-B6-A0IN,BRCA,45.0,FEMALE,WHITE,Stage X,nan,"Other, specify",nan,1996.0,Indeterminate (neither Pre or Postmenopausal),-16705.0,Dead,WITH TUMOR,nan,2573.0,nan,Distant Metastasis,"Other, specify","bone, brain",1412.0,nan,Negative,nan,1.0,2573.0,1.0,2573.0,1.0,1412.0,1.0,1412.0,1
TCGA-B6-A0IO-01,TCGA-B6-A0IO,BRCA,66.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2001.0,Indeterminate (neither Pre or Postmenopausal),-24322.0,Alive,TUMOR FREE,5042.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,5042.0,0.0,5042.0,0.0,5042.0,0.0,5042.0,0
TCGA-B6-A0IP-01,TCGA-B6-A0IP,BRCA,74.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Lobular Carcinoma,nan,1997.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27047.0,Dead,TUMOR FREE,nan,3926.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,3926.0,0.0,3926.0,0.0,3926.0,0.0,3926.0,0
TCGA-B6-A0IQ-01,TCGA-B6-A0IQ,BRCA,40.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,1996.0,Indeterminate (neither Pre or Postmenopausal),-14669.0,Alive,TUMOR FREE,4285.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,4285.0,0.0,4285.0,0.0,4285.0,0.0,4285.0,0
TCGA-B6-A0RE-01,TCGA-B6-A0RE,BRCA,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage X,nan,Infiltrating Ductal Carcinoma,nan,1989.0,Indeterminate (neither Pre or Postmenopausal),-22449.0,Alive,TUMOR FREE,7777.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,7777.0,0.0,7777.0,0.0,7777.0,0.0,7777.0,0
TCGA-B6-A0RG-01,TCGA-B6-A0RG,BRCA,26.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,1991.0,Indeterminate (neither Pre or Postmenopausal),-9840.0,Alive,TUMOR FREE,2082.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2082.0,0.0,2082.0,0.0,2082.0,0.0,2082.0,0
TCGA-B6-A0RH-01,TCGA-B6-A0RH,BRCA,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,1991.0,Indeterminate (neither Pre or Postmenopausal),-18759.0,Dead,TUMOR FREE,nan,6456.0,nan,Locoregional Disease,"Other, specify",Chest Wall,2165.0,nan,Negative,nan,1.0,6456.0,0.0,6456.0,1.0,2165.0,1.0,2165.0,0
TCGA-B6-A0RI-01,TCGA-B6-A0RI,BRCA,44.0,FEMALE,WHITE,Stage IIIB,nan,Infiltrating Ductal Carcinoma,nan,1992.0,Indeterminate (neither Pre or Postmenopausal),-16138.0,Alive,WITH TUMOR,7126.0,nan,nan,Locoregional Disease,"Other, specify",Chest Wall,1100.0,nan,Negative,nan,0.0,7126.0,0.0,7126.0,1.0,1100.0,1.0,1100.0,0
TCGA-B6-A0RL-01,TCGA-B6-A0RL,BRCA,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,1993.0,nan,-22238.0,Dead,TUMOR FREE,nan,2469.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,2469.0,0.0,2469.0,0.0,2469.0,0.0,2469.0,0
TCGA-B6-A0RM-01,TCGA-B6-A0RM,BRCA,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage X,nan,Infiltrating Ductal Carcinoma,nan,1993.0,Indeterminate (neither Pre or Postmenopausal),-21047.0,Dead,TUMOR FREE,nan,2373.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2373.0,0.0,2373.0,nan,nan,0.0,2373.0,0
TCGA-B6-A0RN-01,TCGA-B6-A0RN,BRCA,60.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,1993.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22077.0,Alive,TUMOR FREE,8008.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,8008.0,0.0,8008.0,0.0,8008.0,0.0,8008.0,0
TCGA-B6-A0RO-01,TCGA-B6-A0RO,BRCA,71.0,FEMALE,WHITE,Stage IIIB,nan,Infiltrating Ductal Carcinoma,nan,1993.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26269.0,Alive,TUMOR FREE,4929.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,4929.0,0.0,4929.0,0.0,4929.0,0.0,4929.0,0
TCGA-B6-A0RP-01,TCGA-B6-A0RP,BRCA,73.0,FEMALE,WHITE,[Discrepancy],nan,Mixed Histology (please specify),nan,1994.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26941.0,Dead,WITH TUMOR,nan,3126.0,nan,Distant Metastasis,Bone,nan,2787.0,nan,Negative,nan,1.0,3126.0,1.0,3126.0,1.0,2787.0,1.0,2787.0,1
TCGA-B6-A0RQ-01,TCGA-B6-A0RQ,BRCA,68.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,1994.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25010.0,Dead,TUMOR FREE,nan,4267.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,4267.0,0.0,4267.0,0.0,4267.0,0.0,4267.0,0
TCGA-B6-A0RS-01,TCGA-B6-A0RS,BRCA,38.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,1988.0,Indeterminate (neither Pre or Postmenopausal),-14134.0,Dead,WITH TUMOR,nan,3063.0,nan,New Primary Tumor,"Other, specify",Breast,2041.0,nan,Negative,nan,1.0,3063.0,1.0,3063.0,1.0,2041.0,1.0,2041.0,1
TCGA-B6-A0RT-01,TCGA-B6-A0RT,BRCA,39.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,1996.0,Indeterminate (neither Pre or Postmenopausal),-14374.0,Alive,TUMOR FREE,2721.0,nan,nan,nan,nan,nan,nan,nan,Close,nan,0.0,2721.0,0.0,2721.0,nan,nan,0.0,2721.0,0
TCGA-B6-A0RU-01,TCGA-B6-A0RU,BRCA,40.0,FEMALE,WHITE,Stage IA,nan,"Other, specify",nan,1990.0,Indeterminate (neither Pre or Postmenopausal),-14920.0,Alive,TUMOR FREE,8605.0,nan,nan,New Primary Tumor,"Other, specify",Right Breast,3076.0,nan,Negative,nan,0.0,8605.0,0.0,8605.0,1.0,3076.0,1.0,3076.0,0
TCGA-B6-A0RV-01,TCGA-B6-A0RV,BRCA,42.0,FEMALE,WHITE,Stage IIIA,nan,Mixed Histology (please specify),nan,1996.0,Indeterminate (neither Pre or Postmenopausal),-15507.0,Alive,TUMOR FREE,5156.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,5156.0,0.0,5156.0,0.0,5156.0,0.0,5156.0,0
TCGA-B6-A0WS-01,TCGA-B6-A0WS,BRCA,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage X,nan,Infiltrating Ductal Carcinoma,nan,1996.0,Indeterminate (neither Pre or Postmenopausal),-21230.0,Dead,TUMOR FREE,nan,2965.0,nan,nan,nan,nan,nan,nan,Positive,nan,1.0,2965.0,0.0,2965.0,nan,nan,0.0,2965.0,0
TCGA-B6-A0WT-01,TCGA-B6-A0WT,BRCA,61.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,1995.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22362.0,Alive,TUMOR FREE,5739.0,nan,nan,New Primary Tumor,"Other, specify",right breast cancer contralateral,3862.0,nan,Negative,nan,0.0,5739.0,0.0,5739.0,1.0,3862.0,1.0,3862.0,0
TCGA-B6-A0WV-01,TCGA-B6-A0WV,BRCA,67.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,1995.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24803.0,Dead,TUMOR FREE,nan,2417.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,2417.0,0.0,2417.0,0.0,2417.0,0.0,2417.0,0
TCGA-B6-A0WW-01,TCGA-B6-A0WW,BRCA,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage X,nan,Infiltrating Ductal Carcinoma,nan,1997.0,Indeterminate (neither Pre or Postmenopausal),-21479.0,Dead,WITH TUMOR,nan,558.0,nan,Distant Metastasis,Liver,nan,447.0,nan,Negative,nan,1.0,558.0,1.0,558.0,1.0,447.0,1.0,447.0,1
TCGA-B6-A0WX-01,TCGA-B6-A0WX,BRCA,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,"Other, specify",nan,1998.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14784.0,Dead,WITH TUMOR,nan,639.0,nan,Distant Metastasis,Bone,nan,563.0,nan,Negative,nan,1.0,639.0,1.0,639.0,1.0,563.0,1.0,563.0,1
TCGA-B6-A0WY-01,TCGA-B6-A0WY,BRCA,40.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,1996.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14778.0,Dead,WITH TUMOR,nan,3461.0,nan,Distant Metastasis,Bone,nan,2011.0,nan,Negative,nan,1.0,3461.0,1.0,3461.0,1.0,2011.0,1.0,2011.0,1
TCGA-B6-A0WZ-01,TCGA-B6-A0WZ,BRCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Infiltrating Ductal Carcinoma,nan,1996.0,Indeterminate (neither Pre or Postmenopausal),-18584.0,Alive,TUMOR FREE,6292.0,nan,nan,New Primary Tumor,Bone,nan,5117.0,nan,Negative,nan,0.0,6292.0,0.0,6292.0,0.0,6292.0,1.0,5117.0,0
TCGA-B6-A0X0-01,TCGA-B6-A0X0,BRCA,54.0,FEMALE,WHITE,Stage I,nan,"Other, specify",nan,1996.0,Indeterminate (neither Pre or Postmenopausal),-19802.0,Dead,nan,nan,3945.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,3945.0,nan,3945.0,0.0,3945.0,0.0,3945.0,0
TCGA-B6-A0X1-01,TCGA-B6-A0X1,BRCA,48.0,FEMALE,WHITE,[Discrepancy],nan,Infiltrating Ductal Carcinoma,nan,1994.0,Indeterminate (neither Pre or Postmenopausal),-17624.0,Dead,TUMOR FREE,nan,7455.0,nan,Distant Metastasis,Brain,nan,490.0,nan,Negative,nan,1.0,7455.0,0.0,7455.0,1.0,490.0,1.0,490.0,0
TCGA-B6-A0X4-01,TCGA-B6-A0X4,BRCA,62.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,1996.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22688.0,Dead,WITH TUMOR,nan,860.0,nan,Distant Metastasis,Bone,nan,716.0,nan,Negative,nan,1.0,860.0,1.0,860.0,1.0,716.0,1.0,716.0,1
TCGA-B6-A0X5-01,TCGA-B6-A0X5,BRCA,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,1995.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22380.0,Dead,WITH TUMOR,nan,2097.0,nan,Distant Metastasis,"Other, specify",Liver and Pleura and Bone,1343.0,nan,Negative,nan,1.0,2097.0,1.0,2097.0,1.0,1343.0,1.0,1343.0,1
TCGA-B6-A0X7-01,TCGA-B6-A0X7,BRCA,62.0,FEMALE,WHITE,Stage X,nan,Mixed Histology (please specify),nan,1994.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22723.0,Dead,TUMOR FREE,nan,1781.0,nan,New Primary Tumor,"Other, specify",colon,1104.0,nan,nan,nan,1.0,1781.0,0.0,1781.0,nan,nan,1.0,1104.0,1
TCGA-B6-A1KC-01,TCGA-B6-A1KC,BRCA,67.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24791.0,Alive,TUMOR FREE,1326.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1326.0,0.0,1326.0,0.0,1326.0,0.0,1326.0,0
TCGA-B6-A1KF-01,TCGA-B6-A1KF,BRCA,68.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,1998.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24891.0,Alive,TUMOR FREE,3088.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3088.0,0.0,3088.0,0.0,3088.0,0.0,3088.0,0
TCGA-B6-A1KI-01,TCGA-B6-A1KI,BRCA,63.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23031.0,Alive,TUMOR FREE,2236.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2236.0,0.0,2236.0,0.0,2236.0,0.0,2236.0,0
TCGA-B6-A1KN-01,TCGA-B6-A1KN,BRCA,57.0,FEMALE,WHITE,Stage IIIB,nan,Infiltrating Ductal Carcinoma,nan,1998.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21183.0,Alive,TUMOR FREE,4233.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,4233.0,0.0,4233.0,0.0,4233.0,0.0,4233.0,0
TCGA-B6-A2IU-01,TCGA-B6-A2IU,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,1998.0,Indeterminate (neither Pre or Postmenopausal),-22905.0,Alive,WITH TUMOR,5176.0,nan,nan,New Primary Tumor,"Other, specify",Lung,4224.0,nan,Negative,nan,0.0,5176.0,0.0,5176.0,0.0,5176.0,1.0,4224.0,0
TCGA-B6-A3ZX-01,TCGA-B6-A3ZX,BRCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Mixed Histology (please specify),nan,2007.0,[Unknown],-18434.0,Dead,WITH TUMOR,nan,1152.0,nan,Distant Metastasis,Bone,nan,994.0,nan,Negative,nan,1.0,1152.0,1.0,1152.0,nan,nan,1.0,994.0,1
TCGA-B6-A400-01,TCGA-B6-A400,BRCA,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,[Unknown],-16022.0,Alive,TUMOR FREE,215.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,215.0,0.0,215.0,0.0,215.0,0.0,215.0,0
TCGA-B6-A401-01,TCGA-B6-A401,BRCA,47.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,[Unknown],-17438.0,Alive,TUMOR FREE,2596.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2596.0,0.0,2596.0,0.0,2596.0,0.0,2596.0,0
TCGA-B6-A402-01,TCGA-B6-A402,BRCA,47.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2008.0,[Unknown],-17314.0,Alive,WITH TUMOR,2281.0,nan,nan,Locoregional Recurrence,"Other, specify",breast,1516.0,nan,Negative,nan,0.0,2281.0,0.0,2281.0,1.0,1516.0,1.0,1516.0,0
TCGA-B6-A408-01,TCGA-B6-A408,BRCA,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,nan,Mixed Histology (please specify),nan,2008.0,[Unknown],-20102.0,Alive,TUMOR FREE,2072.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2072.0,0.0,2072.0,0.0,2072.0,0.0,2072.0,0
TCGA-B6-A409-01,TCGA-B6-A409,BRCA,44.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16178.0,Dead,WITH TUMOR,nan,573.0,nan,Distant Metastasis,Lung,nan,456.0,nan,Negative,nan,1.0,573.0,1.0,573.0,1.0,456.0,1.0,456.0,1
TCGA-B6-A40B-01,TCGA-B6-A40B,BRCA,76.0,FEMALE,WHITE,Stage I,nan,Infiltrating Lobular Carcinoma,nan,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27811.0,Alive,TUMOR FREE,3152.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3152.0,0.0,3152.0,0.0,3152.0,0.0,3152.0,0
TCGA-B6-A40C-01,TCGA-B6-A40C,BRCA,51.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2005.0,[Unknown],-18852.0,Alive,TUMOR FREE,2164.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2164.0,0.0,2164.0,0.0,2164.0,0.0,2164.0,0
TCGA-BH-A0AU-01,TCGA-BH-A0AU,BRCA,45.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16688.0,Alive,TUMOR FREE,1914.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1914.0,0.0,1914.0,0.0,1914.0,0.0,1914.0,0
TCGA-BH-A0AU-11,TCGA-BH-A0AU,BRCA,45.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16688.0,Alive,TUMOR FREE,1914.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1914.0,0.0,1914.0,0.0,1914.0,0.0,1914.0,0
TCGA-BH-A0AV-01,TCGA-BH-A0AV,BRCA,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2008.0,nan,-19314.0,Alive,TUMOR FREE,1820.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1820.0,0.0,1820.0,0.0,1820.0,0.0,1820.0,0
TCGA-BH-A0AW-01,TCGA-BH-A0AW,BRCA,56.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20468.0,Alive,TUMOR FREE,622.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,622.0,0.0,622.0,0.0,622.0,0.0,622.0,0
TCGA-BH-A0AY-01,TCGA-BH-A0AY,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22703.0,Alive,TUMOR FREE,777.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,777.0,0.0,777.0,0.0,777.0,0.0,777.0,0
TCGA-BH-A0AY-11,TCGA-BH-A0AY,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22703.0,Alive,TUMOR FREE,777.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,777.0,0.0,777.0,0.0,777.0,0.0,777.0,0
TCGA-BH-A0AZ-01,TCGA-BH-A0AZ,BRCA,47.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17465.0,Alive,TUMOR FREE,1919.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1919.0,0.0,1919.0,0.0,1919.0,0.0,1919.0,0
TCGA-BH-A0AZ-11,TCGA-BH-A0AZ,BRCA,47.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17465.0,Alive,TUMOR FREE,1919.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1919.0,0.0,1919.0,0.0,1919.0,0.0,1919.0,0
TCGA-BH-A0B0-01,TCGA-BH-A0B0,BRCA,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Peri (6-12 months since last menstrual period),-20776.0,Alive,TUMOR FREE,2477.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2477.0,0.0,2477.0,0.0,2477.0,0.0,2477.0,0
TCGA-BH-A0B1-01,TCGA-BH-A0B1,BRCA,66.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24315.0,Alive,TUMOR FREE,1148.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1148.0,0.0,1148.0,0.0,1148.0,0.0,1148.0,0
TCGA-BH-A0B3-01,TCGA-BH-A0B3,BRCA,53.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19479.0,Alive,TUMOR FREE,1203.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1203.0,0.0,1203.0,0.0,1203.0,0.0,1203.0,0
TCGA-BH-A0B3-11,TCGA-BH-A0B3,BRCA,53.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19479.0,Alive,TUMOR FREE,1203.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1203.0,0.0,1203.0,0.0,1203.0,0.0,1203.0,0
TCGA-BH-A0B4-01,TCGA-BH-A0B4,BRCA,65.0,MALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,nan,-23980.0,Alive,TUMOR FREE,1191.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1191.0,0.0,1191.0,0.0,1191.0,0.0,1191.0,0
TCGA-BH-A0B5-01,TCGA-BH-A0B5,BRCA,40.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14920.0,Alive,TUMOR FREE,2136.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,2136.0,0.0,2136.0,nan,nan,0.0,2136.0,0
TCGA-BH-A0B5-11,TCGA-BH-A0B5,BRCA,40.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14920.0,Alive,TUMOR FREE,2136.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,2136.0,0.0,2136.0,nan,nan,0.0,2136.0,0
TCGA-BH-A0B6-01,TCGA-BH-A0B6,BRCA,47.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2006.0,nan,-17346.0,Alive,TUMOR FREE,2483.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2483.0,0.0,2483.0,0.0,2483.0,0.0,2483.0,0
TCGA-BH-A0B7-01,TCGA-BH-A0B7,BRCA,42.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15593.0,Alive,TUMOR FREE,2559.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2559.0,0.0,2559.0,0.0,2559.0,0.0,2559.0,0
TCGA-BH-A0B7-11,TCGA-BH-A0B7,BRCA,42.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15593.0,Alive,TUMOR FREE,2559.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2559.0,0.0,2559.0,0.0,2559.0,0.0,2559.0,0
TCGA-BH-A0B8-01,TCGA-BH-A0B8,BRCA,64.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23380.0,Alive,TUMOR FREE,1569.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1569.0,0.0,1569.0,0.0,1569.0,0.0,1569.0,0
TCGA-BH-A0B8-11,TCGA-BH-A0B8,BRCA,64.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23380.0,Alive,TUMOR FREE,1569.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1569.0,0.0,1569.0,0.0,1569.0,0.0,1569.0,0
TCGA-BH-A0B9-01,TCGA-BH-A0B9,BRCA,44.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16310.0,Alive,TUMOR FREE,1572.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1572.0,0.0,1572.0,0.0,1572.0,0.0,1572.0,0
TCGA-BH-A0BA-01,TCGA-BH-A0BA,BRCA,51.0,FEMALE,WHITE,Stage IIIC,nan,Mixed Histology (please specify),nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18839.0,Alive,TUMOR FREE,1132.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1132.0,0.0,1132.0,0.0,1132.0,0.0,1132.0,0
TCGA-BH-A0BA-11,TCGA-BH-A0BA,BRCA,51.0,FEMALE,WHITE,Stage IIIC,nan,Mixed Histology (please specify),nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18839.0,Alive,TUMOR FREE,1132.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1132.0,0.0,1132.0,0.0,1132.0,0.0,1132.0,0
TCGA-BH-A0BC-01,TCGA-BH-A0BC,BRCA,60.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21949.0,Alive,TUMOR FREE,974.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,974.0,0.0,974.0,0.0,974.0,0.0,974.0,0
TCGA-BH-A0BC-11,TCGA-BH-A0BC,BRCA,60.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21949.0,Alive,TUMOR FREE,974.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,974.0,0.0,974.0,0.0,974.0,0.0,974.0,0
TCGA-BH-A0BD-01,TCGA-BH-A0BD,BRCA,47.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17275.0,Alive,TUMOR FREE,554.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,554.0,0.0,554.0,0.0,554.0,0.0,554.0,0
TCGA-BH-A0BF-01,TCGA-BH-A0BF,BRCA,56.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20691.0,Dead,TUMOR FREE,nan,1324.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,1324.0,0.0,1324.0,0.0,1324.0,0.0,1324.0,0
TCGA-BH-A0BF-11,TCGA-BH-A0BF,BRCA,56.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20691.0,Dead,TUMOR FREE,nan,1324.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,1324.0,0.0,1324.0,0.0,1324.0,0.0,1324.0,0
TCGA-BH-A0BG-01,TCGA-BH-A0BG,BRCA,73.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26988.0,Alive,TUMOR FREE,1871.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1871.0,0.0,1871.0,0.0,1871.0,0.0,1871.0,0
TCGA-BH-A0BJ-01,TCGA-BH-A0BJ,BRCA,41.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15027.0,Alive,TUMOR FREE,660.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,660.0,0.0,660.0,0.0,660.0,0.0,660.0,0
TCGA-BH-A0BJ-11,TCGA-BH-A0BJ,BRCA,41.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15027.0,Alive,TUMOR FREE,660.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,660.0,0.0,660.0,0.0,660.0,0.0,660.0,0
TCGA-BH-A0BL-01,TCGA-BH-A0BL,BRCA,35.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12841.0,Alive,TUMOR FREE,2278.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2278.0,0.0,2278.0,0.0,2278.0,0.0,2278.0,0
TCGA-BH-A0BL-11,TCGA-BH-A0BL,BRCA,35.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12841.0,Alive,TUMOR FREE,2278.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2278.0,0.0,2278.0,0.0,2278.0,0.0,2278.0,0
TCGA-BH-A0BM-01,TCGA-BH-A0BM,BRCA,54.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20049.0,Alive,TUMOR FREE,1876.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1876.0,0.0,1876.0,0.0,1876.0,0.0,1876.0,0
TCGA-BH-A0BM-11,TCGA-BH-A0BM,BRCA,54.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20049.0,Alive,TUMOR FREE,1876.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1876.0,0.0,1876.0,0.0,1876.0,0.0,1876.0,0
TCGA-BH-A0BO-01,TCGA-BH-A0BO,BRCA,54.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19767.0,Alive,TUMOR FREE,2197.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2197.0,0.0,2197.0,0.0,2197.0,0.0,2197.0,0
TCGA-BH-A0BO-11,TCGA-BH-A0BO,BRCA,54.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19767.0,Alive,TUMOR FREE,2197.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2197.0,0.0,2197.0,0.0,2197.0,0.0,2197.0,0
TCGA-BH-A0BP-01,TCGA-BH-A0BP,BRCA,76.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27917.0,Dead,TUMOR FREE,nan,2296.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,2296.0,0.0,2296.0,0.0,2296.0,0.0,2296.0,0
TCGA-BH-A0BQ-01,TCGA-BH-A0BQ,BRCA,39.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14494.0,Alive,TUMOR FREE,2255.0,nan,nan,Locoregional Recurrence,"Other, specify",Dermis and epidermis,1709.0,nan,Negative,nan,0.0,2255.0,0.0,2255.0,1.0,1709.0,1.0,1709.0,0
TCGA-BH-A0BQ-11,TCGA-BH-A0BQ,BRCA,39.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14494.0,Alive,TUMOR FREE,2255.0,nan,nan,Locoregional Recurrence,"Other, specify",Dermis and epidermis,1709.0,nan,Negative,nan,0.0,2255.0,0.0,2255.0,1.0,1709.0,1.0,1709.0,0
TCGA-BH-A0BR-01,TCGA-BH-A0BR,BRCA,59.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21622.0,Alive,TUMOR FREE,2330.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2330.0,0.0,2330.0,0.0,2330.0,0.0,2330.0,0
TCGA-BH-A0BS-01,TCGA-BH-A0BS,BRCA,55.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20374.0,Alive,TUMOR FREE,2612.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2612.0,0.0,2612.0,0.0,2612.0,0.0,2612.0,0
TCGA-BH-A0BS-11,TCGA-BH-A0BS,BRCA,55.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20374.0,Alive,TUMOR FREE,2612.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2612.0,0.0,2612.0,0.0,2612.0,0.0,2612.0,0
TCGA-BH-A0BT-01,TCGA-BH-A0BT,BRCA,56.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,nan,-20625.0,Alive,TUMOR FREE,2365.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2365.0,0.0,2365.0,0.0,2365.0,0.0,2365.0,0
TCGA-BH-A0BT-11,TCGA-BH-A0BT,BRCA,56.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,nan,-20625.0,Alive,TUMOR FREE,2365.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2365.0,0.0,2365.0,0.0,2365.0,0.0,2365.0,0
TCGA-BH-A0BV-01,TCGA-BH-A0BV,BRCA,78.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28699.0,Alive,TUMOR FREE,1519.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1519.0,0.0,1519.0,0.0,1519.0,0.0,1519.0,0
TCGA-BH-A0BV-11,TCGA-BH-A0BV,BRCA,78.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28699.0,Alive,TUMOR FREE,1519.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1519.0,0.0,1519.0,0.0,1519.0,0.0,1519.0,0
TCGA-BH-A0BW-01,TCGA-BH-A0BW,BRCA,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25974.0,Alive,TUMOR FREE,2371.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2371.0,0.0,2371.0,0.0,2371.0,0.0,2371.0,0
TCGA-BH-A0BW-11,TCGA-BH-A0BW,BRCA,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25974.0,Alive,TUMOR FREE,2371.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2371.0,0.0,2371.0,0.0,2371.0,0.0,2371.0,0
TCGA-BH-A0BZ-01,TCGA-BH-A0BZ,BRCA,59.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21856.0,Alive,TUMOR FREE,2255.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2255.0,0.0,2255.0,0.0,2255.0,0.0,2255.0,0
TCGA-BH-A0BZ-11,TCGA-BH-A0BZ,BRCA,59.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21856.0,Alive,TUMOR FREE,2255.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2255.0,0.0,2255.0,0.0,2255.0,0.0,2255.0,0
TCGA-BH-A0C0-01,TCGA-BH-A0C0,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23006.0,Alive,TUMOR FREE,1270.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1270.0,0.0,1270.0,0.0,1270.0,0.0,1270.0,0
TCGA-BH-A0C0-11,TCGA-BH-A0C0,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23006.0,Alive,TUMOR FREE,1270.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1270.0,0.0,1270.0,0.0,1270.0,0.0,1270.0,0
TCGA-BH-A0C1-01,TCGA-BH-A0C1,BRCA,61.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22377.0,Dead,WITH TUMOR,nan,1411.0,nan,Distant Metastasis,Bone,nan,1123.0,nan,Negative,nan,1.0,1411.0,1.0,1411.0,1.0,1123.0,1.0,1123.0,1
TCGA-BH-A0C3-01,TCGA-BH-A0C3,BRCA,47.0,FEMALE,WHITE,Stage I,nan,Mixed Histology (please specify),nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17221.0,Alive,WITH TUMOR,2709.0,nan,nan,Distant Metastasis,Bone,nan,2674.0,nan,Negative,nan,0.0,2709.0,0.0,2709.0,1.0,2674.0,1.0,2674.0,2
TCGA-BH-A0C3-11,TCGA-BH-A0C3,BRCA,47.0,FEMALE,WHITE,Stage I,nan,Mixed Histology (please specify),nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17221.0,Alive,WITH TUMOR,2709.0,nan,nan,Distant Metastasis,Bone,nan,2674.0,nan,Negative,nan,0.0,2709.0,0.0,2709.0,1.0,2674.0,1.0,2674.0,2
TCGA-BH-A0C7-01,TCGA-BH-A0C7,BRCA,48.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Peri (6-12 months since last menstrual period),-17871.0,Alive,TUMOR FREE,2767.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2767.0,0.0,2767.0,0.0,2767.0,0.0,2767.0,0
TCGA-BH-A0DD-01,TCGA-BH-A0DD,BRCA,58.0,MALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2006.0,nan,-21386.0,Alive,TUMOR FREE,2486.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2486.0,0.0,2486.0,0.0,2486.0,0.0,2486.0,0
TCGA-BH-A0DD-11,TCGA-BH-A0DD,BRCA,58.0,MALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2006.0,nan,-21386.0,Alive,TUMOR FREE,2486.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2486.0,0.0,2486.0,0.0,2486.0,0.0,2486.0,0
TCGA-BH-A0DE-01,TCGA-BH-A0DE,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22656.0,Alive,TUMOR FREE,2372.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2372.0,0.0,2372.0,0.0,2372.0,0.0,2372.0,0
TCGA-BH-A0DE-11,TCGA-BH-A0DE,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22656.0,Alive,TUMOR FREE,2372.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2372.0,0.0,2372.0,0.0,2372.0,0.0,2372.0,0
TCGA-BH-A0DG-01,TCGA-BH-A0DG,BRCA,30.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11204.0,Alive,TUMOR FREE,2041.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2041.0,0.0,2041.0,0.0,2041.0,0.0,2041.0,0
TCGA-BH-A0DG-11,TCGA-BH-A0DG,BRCA,30.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11204.0,Alive,TUMOR FREE,2041.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2041.0,0.0,2041.0,0.0,2041.0,0.0,2041.0,0
TCGA-BH-A0DH-01,TCGA-BH-A0DH,BRCA,63.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23366.0,Alive,TUMOR FREE,1156.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1156.0,0.0,1156.0,0.0,1156.0,0.0,1156.0,0
TCGA-BH-A0DH-11,TCGA-BH-A0DH,BRCA,63.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23366.0,Alive,TUMOR FREE,1156.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1156.0,0.0,1156.0,0.0,1156.0,0.0,1156.0,0
TCGA-BH-A0DI-01,TCGA-BH-A0DI,BRCA,63.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23327.0,Alive,TUMOR FREE,912.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,912.0,0.0,912.0,0.0,912.0,0.0,912.0,0
TCGA-BH-A0DI-11,TCGA-BH-A0DI,BRCA,63.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23327.0,Alive,TUMOR FREE,912.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,912.0,0.0,912.0,0.0,912.0,0.0,912.0,0
TCGA-BH-A0DK-01,TCGA-BH-A0DK,BRCA,49.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18237.0,Alive,TUMOR FREE,423.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,423.0,0.0,423.0,0.0,423.0,0.0,423.0,0
TCGA-BH-A0DK-11,TCGA-BH-A0DK,BRCA,49.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18237.0,Alive,TUMOR FREE,423.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,423.0,0.0,423.0,0.0,423.0,0.0,423.0,0
TCGA-BH-A0DL-01,TCGA-BH-A0DL,BRCA,64.0,FEMALE,WHITE,Stage IIA,nan,"Other, specify",nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23628.0,Alive,TUMOR FREE,2381.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2381.0,0.0,2381.0,0.0,2381.0,0.0,2381.0,0
TCGA-BH-A0DL-11,TCGA-BH-A0DL,BRCA,64.0,FEMALE,WHITE,Stage IIA,nan,"Other, specify",nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23628.0,Alive,TUMOR FREE,2381.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2381.0,0.0,2381.0,0.0,2381.0,0.0,2381.0,0
TCGA-BH-A0DO-01,TCGA-BH-A0DO,BRCA,78.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28529.0,Alive,TUMOR FREE,1644.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1644.0,0.0,1644.0,0.0,1644.0,0.0,1644.0,0
TCGA-BH-A0DO-11,TCGA-BH-A0DO,BRCA,78.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28529.0,Alive,TUMOR FREE,1644.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1644.0,0.0,1644.0,0.0,1644.0,0.0,1644.0,0
TCGA-BH-A0DP-01,TCGA-BH-A0DP,BRCA,60.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22199.0,Alive,TUMOR FREE,476.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,476.0,0.0,476.0,0.0,476.0,0.0,476.0,0
TCGA-BH-A0DP-11,TCGA-BH-A0DP,BRCA,60.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22199.0,Alive,TUMOR FREE,476.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,476.0,0.0,476.0,0.0,476.0,0.0,476.0,0
TCGA-BH-A0DQ-01,TCGA-BH-A0DQ,BRCA,42.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15533.0,Alive,TUMOR FREE,98.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,98.0,0.0,98.0,0.0,98.0,0.0,98.0,0
TCGA-BH-A0DQ-11,TCGA-BH-A0DQ,BRCA,42.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15533.0,Alive,TUMOR FREE,98.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,98.0,0.0,98.0,0.0,98.0,0.0,98.0,0
TCGA-BH-A0DS-01,TCGA-BH-A0DS,BRCA,71.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25944.0,Alive,TUMOR FREE,78.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,78.0,0.0,78.0,0.0,78.0,0.0,78.0,0
TCGA-BH-A0DT-01,TCGA-BH-A0DT,BRCA,41.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15078.0,Alive,TUMOR FREE,2403.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2403.0,0.0,2403.0,0.0,2403.0,0.0,2403.0,0
TCGA-BH-A0DT-11,TCGA-BH-A0DT,BRCA,41.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15078.0,Alive,TUMOR FREE,2403.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2403.0,0.0,2403.0,0.0,2403.0,0.0,2403.0,0
TCGA-BH-A0DV-01,TCGA-BH-A0DV,BRCA,54.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Peri (6-12 months since last menstrual period),-19781.0,Alive,TUMOR FREE,2064.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2064.0,0.0,2064.0,0.0,2064.0,0.0,2064.0,0
TCGA-BH-A0DV-11,TCGA-BH-A0DV,BRCA,54.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Peri (6-12 months since last menstrual period),-19781.0,Alive,TUMOR FREE,2064.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2064.0,0.0,2064.0,0.0,2064.0,0.0,2064.0,0
TCGA-BH-A0DX-01,TCGA-BH-A0DX,BRCA,62.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22833.0,Alive,TUMOR FREE,2156.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2156.0,0.0,2156.0,0.0,2156.0,0.0,2156.0,0
TCGA-BH-A0DZ-01,TCGA-BH-A0DZ,BRCA,43.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15980.0,Alive,TUMOR FREE,495.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,495.0,0.0,495.0,0.0,495.0,0.0,495.0,0
TCGA-BH-A0DZ-11,TCGA-BH-A0DZ,BRCA,43.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15980.0,Alive,TUMOR FREE,495.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,495.0,0.0,495.0,0.0,495.0,0.0,495.0,0
TCGA-BH-A0E0-01,TCGA-BH-A0E0,BRCA,38.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14175.0,Alive,TUMOR FREE,134.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,134.0,0.0,134.0,0.0,134.0,0.0,134.0,0
TCGA-BH-A0E0-11,TCGA-BH-A0E0,BRCA,38.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14175.0,Alive,TUMOR FREE,134.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,134.0,0.0,134.0,0.0,134.0,0.0,134.0,0
TCGA-BH-A0E1-01,TCGA-BH-A0E1,BRCA,52.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Peri (6-12 months since last menstrual period),-19192.0,Alive,TUMOR FREE,477.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,477.0,0.0,477.0,0.0,477.0,0.0,477.0,0
TCGA-BH-A0E1-11,TCGA-BH-A0E1,BRCA,52.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Peri (6-12 months since last menstrual period),-19192.0,Alive,TUMOR FREE,477.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,477.0,0.0,477.0,0.0,477.0,0.0,477.0,0
TCGA-BH-A0E2-01,TCGA-BH-A0E2,BRCA,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18152.0,Alive,TUMOR FREE,435.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,435.0,0.0,435.0,0.0,435.0,0.0,435.0,0
TCGA-BH-A0E6-01,TCGA-BH-A0E6,BRCA,69.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25408.0,Alive,TUMOR FREE,293.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,293.0,0.0,293.0,0.0,293.0,0.0,293.0,0
TCGA-BH-A0E7-01,TCGA-BH-A0E7,BRCA,79.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29115.0,Alive,TUMOR FREE,1363.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1363.0,0.0,1363.0,0.0,1363.0,0.0,1363.0,0
TCGA-BH-A0E9-01,TCGA-BH-A0E9,BRCA,53.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19415.0,Alive,TUMOR FREE,2489.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2489.0,0.0,2489.0,0.0,2489.0,0.0,2489.0,0
TCGA-BH-A0EA-01,TCGA-BH-A0EA,BRCA,72.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26548.0,Dead,TUMOR FREE,nan,991.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,991.0,0.0,991.0,0.0,991.0,0.0,991.0,0
TCGA-BH-A0EB-01,TCGA-BH-A0EB,BRCA,69.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25259.0,Alive,TUMOR FREE,745.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,745.0,0.0,745.0,0.0,745.0,0.0,745.0,0
TCGA-BH-A0EE-01,TCGA-BH-A0EE,BRCA,68.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24850.0,Alive,TUMOR FREE,943.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,943.0,0.0,943.0,0.0,943.0,0.0,943.0,0
TCGA-BH-A0EI-01,TCGA-BH-A0EI,BRCA,51.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Peri (6-12 months since last menstrual period),-18741.0,Alive,TUMOR FREE,1926.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1926.0,0.0,1926.0,0.0,1926.0,0.0,1926.0,0
TCGA-BH-A0GY-01,TCGA-BH-A0GY,BRCA,67.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24493.0,Alive,TUMOR FREE,923.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,923.0,0.0,923.0,0.0,923.0,0.0,923.0,0
TCGA-BH-A0GZ-01,TCGA-BH-A0GZ,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22714.0,Alive,TUMOR FREE,328.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,328.0,0.0,328.0,0.0,328.0,0.0,328.0,0
TCGA-BH-A0H0-01,TCGA-BH-A0H0,BRCA,69.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25223.0,Alive,TUMOR FREE,461.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,461.0,0.0,461.0,0.0,461.0,0.0,461.0,0
TCGA-BH-A0H3-01,TCGA-BH-A0H3,BRCA,46.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17152.0,Alive,TUMOR FREE,1928.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1928.0,0.0,1928.0,0.0,1928.0,0.0,1928.0,0
TCGA-BH-A0H5-01,TCGA-BH-A0H5,BRCA,45.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16719.0,Alive,TUMOR FREE,1620.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1620.0,0.0,1620.0,0.0,1620.0,0.0,1620.0,0
TCGA-BH-A0H5-11,TCGA-BH-A0H5,BRCA,45.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16719.0,Alive,TUMOR FREE,1620.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1620.0,0.0,1620.0,0.0,1620.0,0.0,1620.0,0
TCGA-BH-A0H6-01,TCGA-BH-A0H6,BRCA,82.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30125.0,Alive,TUMOR FREE,747.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,747.0,0.0,747.0,0.0,747.0,0.0,747.0,0
TCGA-BH-A0H7-01,TCGA-BH-A0H7,BRCA,65.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23972.0,Alive,TUMOR FREE,702.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,702.0,0.0,702.0,0.0,702.0,0.0,702.0,0
TCGA-BH-A0H7-11,TCGA-BH-A0H7,BRCA,65.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23972.0,Alive,TUMOR FREE,702.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,702.0,0.0,702.0,0.0,702.0,0.0,702.0,0
TCGA-BH-A0H9-01,TCGA-BH-A0H9,BRCA,69.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25289.0,Alive,TUMOR FREE,1247.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1247.0,0.0,1247.0,0.0,1247.0,0.0,1247.0,0
TCGA-BH-A0H9-11,TCGA-BH-A0H9,BRCA,69.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25289.0,Alive,TUMOR FREE,1247.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1247.0,0.0,1247.0,0.0,1247.0,0.0,1247.0,0
TCGA-BH-A0HA-01,TCGA-BH-A0HA,BRCA,31.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11379.0,Alive,TUMOR FREE,1611.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1611.0,0.0,1611.0,0.0,1611.0,0.0,1611.0,0
TCGA-BH-A0HA-11,TCGA-BH-A0HA,BRCA,31.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11379.0,Alive,TUMOR FREE,1611.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1611.0,0.0,1611.0,0.0,1611.0,0.0,1611.0,0
TCGA-BH-A0HB-01,TCGA-BH-A0HB,BRCA,55.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20448.0,Alive,TUMOR FREE,806.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,806.0,0.0,806.0,0.0,806.0,0.0,806.0,0
TCGA-BH-A0HF-01,TCGA-BH-A0HF,BRCA,77.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28233.0,Alive,TUMOR FREE,727.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,727.0,0.0,727.0,0.0,727.0,0.0,727.0,0
TCGA-BH-A0HI-01,TCGA-BH-A0HI,BRCA,78.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28644.0,Alive,TUMOR FREE,620.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,620.0,0.0,620.0,0.0,620.0,0.0,620.0,0
TCGA-BH-A0HK-01,TCGA-BH-A0HK,BRCA,81.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29751.0,Alive,TUMOR FREE,178.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,178.0,0.0,178.0,0.0,178.0,0.0,178.0,0
TCGA-BH-A0HK-11,TCGA-BH-A0HK,BRCA,81.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29751.0,Alive,TUMOR FREE,178.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,178.0,0.0,178.0,0.0,178.0,0.0,178.0,0
TCGA-BH-A0HL-01,TCGA-BH-A0HL,BRCA,56.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20804.0,Alive,TUMOR FREE,72.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,72.0,0.0,72.0,0.0,72.0,0.0,72.0,0
TCGA-BH-A0HN-01,TCGA-BH-A0HN,BRCA,67.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24731.0,Alive,TUMOR FREE,516.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,516.0,0.0,516.0,0.0,516.0,0.0,516.0,0
TCGA-BH-A0HO-01,TCGA-BH-A0HO,BRCA,48.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17710.0,Alive,TUMOR FREE,76.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,76.0,0.0,76.0,0.0,76.0,0.0,76.0,0
TCGA-BH-A0HP-01,TCGA-BH-A0HP,BRCA,65.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23883.0,Alive,TUMOR FREE,414.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,414.0,0.0,414.0,0.0,414.0,0.0,414.0,0
TCGA-BH-A0HQ-01,TCGA-BH-A0HQ,BRCA,56.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20719.0,Alive,TUMOR FREE,1121.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1121.0,0.0,1121.0,0.0,1121.0,0.0,1121.0,0
TCGA-BH-A0HU-01,TCGA-BH-A0HU,BRCA,52.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Peri (6-12 months since last menstrual period),-19216.0,Alive,TUMOR FREE,392.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,392.0,0.0,392.0,0.0,392.0,0.0,392.0,0
TCGA-BH-A0HW-01,TCGA-BH-A0HW,BRCA,62.0,FEMALE,ASIAN,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22962.0,Alive,TUMOR FREE,1561.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1561.0,0.0,1561.0,0.0,1561.0,0.0,1561.0,0
TCGA-BH-A0HX-01,TCGA-BH-A0HX,BRCA,54.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19900.0,Alive,TUMOR FREE,829.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,829.0,0.0,829.0,0.0,829.0,0.0,829.0,0
TCGA-BH-A0HY-01,TCGA-BH-A0HY,BRCA,60.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22179.0,Alive,TUMOR FREE,1545.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1545.0,0.0,1545.0,0.0,1545.0,0.0,1545.0,0
TCGA-BH-A0RX-01,TCGA-BH-A0RX,BRCA,59.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21857.0,Alive,TUMOR FREE,170.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,170.0,0.0,170.0,0.0,170.0,0.0,170.0,0
TCGA-BH-A0W3-01,TCGA-BH-A0W3,BRCA,58.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Indeterminate (neither Pre or Postmenopausal),-21369.0,Alive,TUMOR FREE,728.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,728.0,0.0,728.0,nan,nan,0.0,728.0,0
TCGA-BH-A0W4-01,TCGA-BH-A0W4,BRCA,46.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,nan,-16911.0,Alive,TUMOR FREE,759.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,759.0,0.0,759.0,nan,nan,0.0,759.0,0
TCGA-BH-A0W5-01,TCGA-BH-A0W5,BRCA,77.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,nan,-28304.0,Alive,TUMOR FREE,1288.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1288.0,0.0,1288.0,0.0,1288.0,0.0,1288.0,0
TCGA-BH-A0W7-01,TCGA-BH-A0W7,BRCA,49.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2008.0,nan,-17996.0,Alive,TUMOR FREE,1363.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1363.0,0.0,1363.0,0.0,1363.0,0.0,1363.0,0
TCGA-BH-A0WA-01,TCGA-BH-A0WA,BRCA,82.0,FEMALE,WHITE,Stage I,nan,nan,nan,2008.0,nan,-30025.0,Alive,TUMOR FREE,701.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,701.0,0.0,701.0,0.0,701.0,0.0,701.0,0
TCGA-BH-A18F-01,TCGA-BH-A18F,BRCA,50.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Peri (6-12 months since last menstrual period),-18594.0,Alive,TUMOR FREE,1001.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1001.0,0.0,1001.0,0.0,1001.0,0.0,1001.0,0
TCGA-BH-A18F-11,TCGA-BH-A18F,BRCA,50.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Peri (6-12 months since last menstrual period),-18594.0,Alive,TUMOR FREE,1001.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1001.0,0.0,1001.0,0.0,1001.0,0.0,1001.0,0
TCGA-BH-A18G-01,TCGA-BH-A18G,BRCA,81.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29820.0,Alive,TUMOR FREE,149.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,149.0,0.0,149.0,0.0,149.0,0.0,149.0,0
TCGA-BH-A18H-01,TCGA-BH-A18H,BRCA,63.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23065.0,Alive,TUMOR FREE,652.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,652.0,0.0,652.0,0.0,652.0,0.0,652.0,0
TCGA-BH-A18I-01,TCGA-BH-A18I,BRCA,53.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19489.0,Alive,TUMOR FREE,1093.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1093.0,0.0,1093.0,0.0,1093.0,0.0,1093.0,0
TCGA-BH-A18J-01,TCGA-BH-A18J,BRCA,56.0,FEMALE,WHITE,Stage IV,nan,Infiltrating Ductal Carcinoma,nan,2000.0,nan,-20678.0,Dead,WITH TUMOR,nan,612.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,612.0,1.0,612.0,nan,nan,1.0,612.0,1
TCGA-BH-A18J-11,TCGA-BH-A18J,BRCA,56.0,FEMALE,WHITE,Stage IV,nan,Infiltrating Ductal Carcinoma,nan,2000.0,nan,-20678.0,Dead,WITH TUMOR,nan,612.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,612.0,1.0,612.0,nan,nan,1.0,612.0,1
TCGA-BH-A18K-01,TCGA-BH-A18K,BRCA,46.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,1999.0,nan,-16824.0,Dead,WITH TUMOR,nan,2763.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,2763.0,1.0,2763.0,nan,nan,1.0,2763.0,1
TCGA-BH-A18K-11,TCGA-BH-A18K,BRCA,46.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,1999.0,nan,-16824.0,Dead,WITH TUMOR,nan,2763.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,2763.0,1.0,2763.0,nan,nan,1.0,2763.0,1
TCGA-BH-A18L-01,TCGA-BH-A18L,BRCA,50.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2003.0,nan,-18519.0,Dead,nan,nan,811.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,811.0,nan,811.0,0.0,811.0,0.0,811.0,0
TCGA-BH-A18L-11,TCGA-BH-A18L,BRCA,50.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2003.0,nan,-18519.0,Dead,nan,nan,811.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,811.0,nan,811.0,0.0,811.0,0.0,811.0,0
TCGA-BH-A18M-01,TCGA-BH-A18M,BRCA,39.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2001.0,nan,-14532.0,Dead,nan,nan,2207.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,2207.0,nan,2207.0,0.0,2207.0,0.0,2207.0,0
TCGA-BH-A18M-11,TCGA-BH-A18M,BRCA,39.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2001.0,nan,-14532.0,Dead,nan,nan,2207.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,2207.0,nan,2207.0,0.0,2207.0,0.0,2207.0,0
TCGA-BH-A18N-01,TCGA-BH-A18N,BRCA,88.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2001.0,nan,-32404.0,Dead,nan,nan,1148.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,1148.0,nan,1148.0,0.0,1148.0,0.0,1148.0,0
TCGA-BH-A18N-11,TCGA-BH-A18N,BRCA,88.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2001.0,nan,-32404.0,Dead,nan,nan,1148.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,1148.0,nan,1148.0,0.0,1148.0,0.0,1148.0,0
TCGA-BH-A18P-01,TCGA-BH-A18P,BRCA,60.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2003.0,nan,-22222.0,Dead,WITH TUMOR,nan,921.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,921.0,1.0,921.0,nan,nan,1.0,921.0,1
TCGA-BH-A18P-11,TCGA-BH-A18P,BRCA,60.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2003.0,nan,-22222.0,Dead,WITH TUMOR,nan,921.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,921.0,1.0,921.0,nan,nan,1.0,921.0,1
TCGA-BH-A18Q-01,TCGA-BH-A18Q,BRCA,56.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2001.0,nan,-20675.0,Dead,nan,nan,1692.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,1692.0,nan,1692.0,0.0,1692.0,0.0,1692.0,0
TCGA-BH-A18Q-11,TCGA-BH-A18Q,BRCA,56.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2001.0,nan,-20675.0,Dead,nan,nan,1692.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,1692.0,nan,1692.0,0.0,1692.0,0.0,1692.0,0
TCGA-BH-A18R-01,TCGA-BH-A18R,BRCA,50.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2001.0,nan,-18524.0,Dead,TUMOR FREE,nan,1142.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,1142.0,0.0,1142.0,0.0,1142.0,0.0,1142.0,0
TCGA-BH-A18R-11,TCGA-BH-A18R,BRCA,50.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2001.0,nan,-18524.0,Dead,TUMOR FREE,nan,1142.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,1142.0,0.0,1142.0,0.0,1142.0,0.0,1142.0,0
TCGA-BH-A18S-01,TCGA-BH-A18S,BRCA,79.0,FEMALE,WHITE,Stage I,nan,Mucinous Carcinoma,nan,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28974.0,Dead,TUMOR FREE,nan,2009.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,2009.0,0.0,2009.0,0.0,2009.0,0.0,2009.0,0
TCGA-BH-A18S-11,TCGA-BH-A18S,BRCA,79.0,FEMALE,WHITE,Stage I,nan,Mucinous Carcinoma,nan,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28974.0,Dead,TUMOR FREE,nan,2009.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,2009.0,0.0,2009.0,0.0,2009.0,0.0,2009.0,0
TCGA-BH-A18T-01,TCGA-BH-A18T,BRCA,70.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25674.0,Dead,WITH TUMOR,nan,224.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,224.0,1.0,224.0,nan,nan,1.0,224.0,1
TCGA-BH-A18U-01,TCGA-BH-A18U,BRCA,72.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26426.0,Dead,TUMOR FREE,nan,1563.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,1563.0,0.0,1563.0,0.0,1563.0,0.0,1563.0,0
TCGA-BH-A18U-11,TCGA-BH-A18U,BRCA,72.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26426.0,Dead,TUMOR FREE,nan,1563.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,1563.0,0.0,1563.0,0.0,1563.0,0.0,1563.0,0
TCGA-BH-A18V-06,TCGA-BH-A18V,BRCA,48.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2001.0,nan,-17682.0,Dead,nan,nan,1556.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,1556.0,nan,1556.0,0.0,1556.0,0.0,1556.0,0
TCGA-BH-A18V-01,TCGA-BH-A18V,BRCA,48.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2001.0,nan,-17682.0,Dead,nan,nan,1556.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,1556.0,nan,1556.0,0.0,1556.0,0.0,1556.0,0
TCGA-BH-A18V-11,TCGA-BH-A18V,BRCA,48.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2001.0,nan,-17682.0,Dead,nan,nan,1556.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,1556.0,nan,1556.0,0.0,1556.0,0.0,1556.0,0
TCGA-BH-A1EN-01,TCGA-BH-A1EN,BRCA,78.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,1999.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28724.0,Dead,TUMOR FREE,nan,2127.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,2127.0,0.0,2127.0,0.0,2127.0,0.0,2127.0,0
TCGA-BH-A1EN-11,TCGA-BH-A1EN,BRCA,78.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,1999.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28724.0,Dead,TUMOR FREE,nan,2127.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,2127.0,0.0,2127.0,0.0,2127.0,0.0,2127.0,0
TCGA-BH-A1EO-01,TCGA-BH-A1EO,BRCA,68.0,FEMALE,WHITE,Stage IIA,nan,Mixed Histology (please specify),nan,1999.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25136.0,Dead,TUMOR FREE,nan,2798.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2798.0,0.0,2798.0,nan,nan,0.0,2798.0,0
TCGA-BH-A1EO-11,TCGA-BH-A1EO,BRCA,68.0,FEMALE,WHITE,Stage IIA,nan,Mixed Histology (please specify),nan,1999.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25136.0,Dead,TUMOR FREE,nan,2798.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2798.0,0.0,2798.0,nan,nan,0.0,2798.0,0
TCGA-BH-A1ES-06,TCGA-BH-A1ES,BRCA,35.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,1999.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13138.0,Dead,WITH TUMOR,nan,3462.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,3462.0,1.0,3462.0,nan,nan,1.0,3462.0,1
TCGA-BH-A1ES-01,TCGA-BH-A1ES,BRCA,35.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,1999.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13138.0,Dead,WITH TUMOR,nan,3462.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,3462.0,1.0,3462.0,nan,nan,1.0,3462.0,1
TCGA-BH-A1ES-11,TCGA-BH-A1ES,BRCA,35.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,1999.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13138.0,Dead,WITH TUMOR,nan,3462.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,3462.0,1.0,3462.0,nan,nan,1.0,3462.0,1
TCGA-BH-A1ET-01,TCGA-BH-A1ET,BRCA,55.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,1999.0,nan,-20425.0,Dead,TUMOR FREE,nan,2520.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2520.0,0.0,2520.0,nan,nan,0.0,2520.0,0
TCGA-BH-A1ET-11,TCGA-BH-A1ET,BRCA,55.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,1999.0,nan,-20425.0,Dead,TUMOR FREE,nan,2520.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2520.0,0.0,2520.0,nan,nan,0.0,2520.0,0
TCGA-BH-A1EU-01,TCGA-BH-A1EU,BRCA,83.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,1999.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30339.0,Dead,TUMOR FREE,nan,1286.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1286.0,0.0,1286.0,nan,nan,0.0,1286.0,0
TCGA-BH-A1EU-11,TCGA-BH-A1EU,BRCA,83.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,1999.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30339.0,Dead,TUMOR FREE,nan,1286.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1286.0,0.0,1286.0,nan,nan,0.0,1286.0,0
TCGA-BH-A1EV-01,TCGA-BH-A1EV,BRCA,45.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,1999.0,nan,-16504.0,Dead,WITH TUMOR,nan,365.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,365.0,1.0,365.0,nan,nan,1.0,365.0,1
TCGA-BH-A1EV-11,TCGA-BH-A1EV,BRCA,45.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,1999.0,nan,-16504.0,Dead,WITH TUMOR,nan,365.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,365.0,1.0,365.0,nan,nan,1.0,365.0,1
TCGA-BH-A1EW-01,TCGA-BH-A1EW,BRCA,38.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,1999.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14090.0,Dead,WITH TUMOR,nan,1694.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1694.0,1.0,1694.0,nan,nan,1.0,1694.0,1
TCGA-BH-A1EW-11,TCGA-BH-A1EW,BRCA,38.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,1999.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14090.0,Dead,WITH TUMOR,nan,1694.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1694.0,1.0,1694.0,nan,nan,1.0,1694.0,1
TCGA-BH-A1EX-01,TCGA-BH-A1EX,BRCA,67.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2000.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24544.0,Dead,WITH TUMOR,nan,1508.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1508.0,1.0,1508.0,nan,nan,1.0,1508.0,1
TCGA-BH-A1EY-01,TCGA-BH-A1EY,BRCA,79.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2000.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28940.0,Dead,WITH TUMOR,nan,538.0,nan,Distant Metastasis,Lung,Liver,396.0,nan,nan,nan,1.0,538.0,1.0,538.0,nan,nan,1.0,396.0,1
TCGA-BH-A1EY-11,TCGA-BH-A1EY,BRCA,79.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2000.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28940.0,Dead,WITH TUMOR,nan,538.0,nan,Distant Metastasis,Lung,Liver,396.0,nan,nan,nan,1.0,538.0,1.0,538.0,nan,nan,1.0,396.0,1
TCGA-BH-A1F0-01,TCGA-BH-A1F0,BRCA,80.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2000.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29335.0,Dead,WITH TUMOR,nan,785.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,785.0,1.0,785.0,nan,nan,1.0,785.0,1
TCGA-BH-A1F0-11,TCGA-BH-A1F0,BRCA,80.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2000.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29335.0,Dead,WITH TUMOR,nan,785.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,785.0,1.0,785.0,nan,nan,1.0,785.0,1
TCGA-BH-A1F2-01,TCGA-BH-A1F2,BRCA,53.0,FEMALE,WHITE,Stage IIIB,nan,Infiltrating Ductal Carcinoma,nan,1999.0,nan,-19701.0,Dead,TUMOR FREE,nan,959.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,959.0,0.0,959.0,nan,nan,0.0,959.0,0
TCGA-BH-A1F2-11,TCGA-BH-A1F2,BRCA,53.0,FEMALE,WHITE,Stage IIIB,nan,Infiltrating Ductal Carcinoma,nan,1999.0,nan,-19701.0,Dead,TUMOR FREE,nan,959.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,959.0,0.0,959.0,nan,nan,0.0,959.0,0
TCGA-BH-A1F5-01,TCGA-BH-A1F5,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2002.0,nan,-22842.0,Dead,TUMOR FREE,nan,2712.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2712.0,0.0,2712.0,nan,nan,0.0,2712.0,0
TCGA-BH-A1F5-11,TCGA-BH-A1F5,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2002.0,nan,-22842.0,Dead,TUMOR FREE,nan,2712.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2712.0,0.0,2712.0,nan,nan,0.0,2712.0,0
TCGA-BH-A1F6-01,TCGA-BH-A1F6,BRCA,51.0,FEMALE,WHITE,nan,nan,Infiltrating Ductal Carcinoma,nan,1996.0,nan,-18691.0,Dead,nan,nan,2965.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2965.0,nan,2965.0,nan,nan,0.0,2965.0,1
TCGA-BH-A1F6-11,TCGA-BH-A1F6,BRCA,51.0,FEMALE,WHITE,nan,nan,Infiltrating Ductal Carcinoma,nan,1996.0,nan,-18691.0,Dead,nan,nan,2965.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2965.0,nan,2965.0,nan,nan,0.0,2965.0,1
TCGA-BH-A1F8-01,TCGA-BH-A1F8,BRCA,90.0,FEMALE,WHITE,Stage IIIB,nan,Infiltrating Ductal Carcinoma,nan,1999.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32871.0,Dead,WITH TUMOR,nan,763.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,763.0,1.0,763.0,nan,nan,1.0,763.0,1
TCGA-BH-A1F8-11,TCGA-BH-A1F8,BRCA,90.0,FEMALE,WHITE,Stage IIIB,nan,Infiltrating Ductal Carcinoma,nan,1999.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32871.0,Dead,WITH TUMOR,nan,763.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,763.0,1.0,763.0,nan,nan,1.0,763.0,1
TCGA-BH-A1FB-01,TCGA-BH-A1FB,BRCA,60.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2000.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21933.0,Dead,WITH TUMOR,nan,3669.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,3669.0,1.0,3669.0,nan,nan,1.0,3669.0,1
TCGA-BH-A1FB-11,TCGA-BH-A1FB,BRCA,60.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2000.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21933.0,Dead,WITH TUMOR,nan,3669.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,3669.0,1.0,3669.0,nan,nan,1.0,3669.0,1
TCGA-BH-A1FC-01,TCGA-BH-A1FC,BRCA,78.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Medullary Carcinoma,nan,1998.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28706.0,Dead,TUMOR FREE,nan,3472.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,3472.0,0.0,3472.0,nan,nan,0.0,3472.0,0
TCGA-BH-A1FC-11,TCGA-BH-A1FC,BRCA,78.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Medullary Carcinoma,nan,1998.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28706.0,Dead,TUMOR FREE,nan,3472.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,3472.0,0.0,3472.0,nan,nan,0.0,3472.0,0
TCGA-BH-A1FD-01,TCGA-BH-A1FD,BRCA,68.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,1998.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24940.0,Dead,WITH TUMOR,nan,1009.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1009.0,1.0,1009.0,nan,nan,1.0,1009.0,1
TCGA-BH-A1FD-11,TCGA-BH-A1FD,BRCA,68.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,1998.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24940.0,Dead,WITH TUMOR,nan,1009.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1009.0,1.0,1009.0,nan,nan,1.0,1009.0,1
TCGA-BH-A1FE-06,TCGA-BH-A1FE,BRCA,31.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,1998.0,nan,-11650.0,Dead,WITH TUMOR,nan,2273.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2273.0,1.0,2273.0,nan,nan,1.0,2273.0,1
TCGA-BH-A1FE-01,TCGA-BH-A1FE,BRCA,31.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,1998.0,nan,-11650.0,Dead,WITH TUMOR,nan,2273.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2273.0,1.0,2273.0,nan,nan,1.0,2273.0,1
TCGA-BH-A1FE-11,TCGA-BH-A1FE,BRCA,31.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,1998.0,nan,-11650.0,Dead,WITH TUMOR,nan,2273.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2273.0,1.0,2273.0,nan,nan,1.0,2273.0,1
TCGA-BH-A1FG-01,TCGA-BH-A1FG,BRCA,88.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,1998.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32295.0,Dead,nan,nan,3736.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,3736.0,nan,3736.0,nan,nan,0.0,3736.0,1
TCGA-BH-A1FG-11,TCGA-BH-A1FG,BRCA,88.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,1998.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32295.0,Dead,nan,nan,3736.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,3736.0,nan,3736.0,nan,nan,0.0,3736.0,1
TCGA-BH-A1FH-01,TCGA-BH-A1FH,BRCA,47.0,FEMALE,WHITE,Stage IV,nan,Infiltrating Ductal Carcinoma,nan,1998.0,nan,-17172.0,Dead,WITH TUMOR,nan,1034.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1034.0,1.0,1034.0,nan,nan,1.0,1034.0,1
TCGA-BH-A1FH-11,TCGA-BH-A1FH,BRCA,47.0,FEMALE,WHITE,Stage IV,nan,Infiltrating Ductal Carcinoma,nan,1998.0,nan,-17172.0,Dead,WITH TUMOR,nan,1034.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1034.0,1.0,1034.0,nan,nan,1.0,1034.0,1
TCGA-BH-A1FJ-01,TCGA-BH-A1FJ,BRCA,66.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,1998.0,nan,-24262.0,Dead,nan,nan,1927.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1927.0,nan,1927.0,nan,nan,0.0,1927.0,1
TCGA-BH-A1FJ-11,TCGA-BH-A1FJ,BRCA,66.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,1998.0,nan,-24262.0,Dead,nan,nan,1927.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1927.0,nan,1927.0,nan,nan,0.0,1927.0,1
TCGA-BH-A1FL-01,TCGA-BH-A1FL,BRCA,69.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,1998.0,nan,-25558.0,Dead,WITH TUMOR,nan,1673.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1673.0,1.0,1673.0,nan,nan,1.0,1673.0,1
TCGA-BH-A1FM-01,TCGA-BH-A1FM,BRCA,44.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,1998.0,nan,-16289.0,Dead,nan,nan,1388.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1388.0,nan,1388.0,nan,nan,0.0,1388.0,1
TCGA-BH-A1FM-11,TCGA-BH-A1FM,BRCA,44.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,1998.0,nan,-16289.0,Dead,nan,nan,1388.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1388.0,nan,1388.0,nan,nan,0.0,1388.0,1
TCGA-BH-A1FN-01,TCGA-BH-A1FN,BRCA,34.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,1997.0,nan,-12525.0,Dead,WITH TUMOR,nan,2192.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2192.0,1.0,2192.0,nan,nan,1.0,2192.0,1
TCGA-BH-A1FN-11,TCGA-BH-A1FN,BRCA,34.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,1997.0,nan,-12525.0,Dead,WITH TUMOR,nan,2192.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2192.0,1.0,2192.0,nan,nan,1.0,2192.0,1
TCGA-BH-A1FR-01,TCGA-BH-A1FR,BRCA,73.0,FEMALE,WHITE,Stage IIIB,nan,"Other, specify",nan,1997.0,nan,-26684.0,Dead,WITH TUMOR,nan,1642.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1642.0,1.0,1642.0,nan,nan,1.0,1642.0,1
TCGA-BH-A1FR-11,TCGA-BH-A1FR,BRCA,73.0,FEMALE,WHITE,Stage IIIB,nan,"Other, specify",nan,1997.0,nan,-26684.0,Dead,WITH TUMOR,nan,1642.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1642.0,1.0,1642.0,nan,nan,1.0,1642.0,1
TCGA-BH-A1FU-01,TCGA-BH-A1FU,BRCA,44.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,1997.0,nan,-16174.0,Dead,WITH TUMOR,nan,1688.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1688.0,1.0,1688.0,nan,nan,1.0,1688.0,1
TCGA-BH-A1FU-11,TCGA-BH-A1FU,BRCA,44.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,1997.0,nan,-16174.0,Dead,WITH TUMOR,nan,1688.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1688.0,1.0,1688.0,nan,nan,1.0,1688.0,1
TCGA-BH-A201-01,TCGA-BH-A201,BRCA,64.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23423.0,Alive,TUMOR FREE,856.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,856.0,0.0,856.0,nan,nan,0.0,856.0,0
TCGA-BH-A202-01,TCGA-BH-A202,BRCA,60.0,FEMALE,WHITE,Stage II,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22052.0,Alive,TUMOR FREE,795.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,795.0,0.0,795.0,nan,nan,0.0,795.0,0
TCGA-BH-A203-01,TCGA-BH-A203,BRCA,78.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,1996.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28609.0,Dead,WITH TUMOR,nan,1174.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1174.0,1.0,1174.0,nan,nan,1.0,1174.0,1
TCGA-BH-A203-11,TCGA-BH-A203,BRCA,78.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,1996.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28609.0,Dead,WITH TUMOR,nan,1174.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1174.0,1.0,1174.0,nan,nan,1.0,1174.0,1
TCGA-BH-A204-01,TCGA-BH-A204,BRCA,80.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,1996.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29529.0,Dead,nan,nan,2534.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2534.0,nan,2534.0,nan,nan,0.0,2534.0,1
TCGA-BH-A204-11,TCGA-BH-A204,BRCA,80.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,1996.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29529.0,Dead,nan,nan,2534.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2534.0,nan,2534.0,nan,nan,0.0,2534.0,1
TCGA-BH-A208-01,TCGA-BH-A208,BRCA,48.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,1995.0,nan,-17715.0,Dead,TUMOR FREE,nan,1759.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1759.0,0.0,1759.0,nan,nan,0.0,1759.0,0
TCGA-BH-A208-11,TCGA-BH-A208,BRCA,48.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,1995.0,nan,-17715.0,Dead,TUMOR FREE,nan,1759.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1759.0,0.0,1759.0,nan,nan,0.0,1759.0,0
TCGA-BH-A209-01,TCGA-BH-A209,BRCA,77.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Medullary Carcinoma,nan,1996.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28403.0,Dead,TUMOR FREE,nan,3959.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,3959.0,0.0,3959.0,nan,nan,0.0,3959.0,0
TCGA-BH-A209-11,TCGA-BH-A209,BRCA,77.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Medullary Carcinoma,nan,1996.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28403.0,Dead,TUMOR FREE,nan,3959.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,3959.0,0.0,3959.0,nan,nan,0.0,3959.0,0
TCGA-BH-A28O-01,TCGA-BH-A28O,BRCA,50.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2010.0,nan,-18501.0,Alive,TUMOR FREE,1120.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1120.0,0.0,1120.0,0.0,1120.0,0.0,1120.0,0
TCGA-BH-A28Q-01,TCGA-BH-A28Q,BRCA,46.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16882.0,Alive,TUMOR FREE,1119.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1119.0,0.0,1119.0,nan,nan,0.0,1119.0,0
TCGA-BH-A2L8-01,TCGA-BH-A2L8,BRCA,45.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16658.0,Alive,TUMOR FREE,612.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,612.0,0.0,612.0,0.0,612.0,0.0,612.0,0
TCGA-BH-A42T-01,TCGA-BH-A42T,BRCA,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27731.0,Dead,TUMOR FREE,nan,320.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,320.0,0.0,320.0,0.0,320.0,0.0,320.0,0
TCGA-BH-A42U-01,TCGA-BH-A42U,BRCA,80.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29330.0,Alive,TUMOR FREE,3364.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3364.0,0.0,3364.0,0.0,3364.0,0.0,3364.0,0
TCGA-BH-A42V-01,TCGA-BH-A42V,BRCA,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Infiltrating Ductal Carcinoma,nan,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15158.0,Alive,TUMOR FREE,635.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,635.0,0.0,635.0,0.0,635.0,0.0,635.0,0
TCGA-BH-A5IZ-01,TCGA-BH-A5IZ,BRCA,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18927.0,Alive,TUMOR FREE,567.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,567.0,0.0,567.0,0.0,567.0,0.0,567.0,0
TCGA-BH-A5J0-01,TCGA-BH-A5J0,BRCA,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23072.0,Alive,TUMOR FREE,715.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,715.0,0.0,715.0,0.0,715.0,0.0,715.0,0
TCGA-BH-A6R8-01,TCGA-BH-A6R8,BRCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2012.0,[Unknown],-16829.0,Alive,TUMOR FREE,293.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,293.0,0.0,293.0,0.0,293.0,0.0,293.0,0
TCGA-BH-A6R9-01,TCGA-BH-A6R9,BRCA,61.0,FEMALE,WHITE,Stage IIA,nan,Metaplastic Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22325.0,Alive,TUMOR FREE,160.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,160.0,0.0,160.0,0.0,160.0,0.0,160.0,0
TCGA-BH-A8FY-01,TCGA-BH-A8FY,BRCA,87.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31932.0,Dead,TUMOR FREE,nan,295.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,295.0,0.0,295.0,0.0,295.0,0.0,295.0,0
TCGA-BH-A8FZ-01,TCGA-BH-A8FZ,BRCA,58.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21343.0,Alive,TUMOR FREE,574.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,574.0,0.0,574.0,0.0,574.0,0.0,574.0,0
TCGA-BH-A8G0-01,TCGA-BH-A8G0,BRCA,54.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Peri (6-12 months since last menstrual period),-19975.0,Alive,TUMOR FREE,662.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,662.0,0.0,662.0,0.0,662.0,0.0,662.0,0
TCGA-BH-AB28-01,TCGA-BH-AB28,BRCA,53.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2013.0,[Unknown],-19570.0,Alive,TUMOR FREE,287.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,287.0,0.0,287.0,0.0,287.0,0.0,287.0,0
TCGA-C8-A12K-01,TCGA-C8-A12K,BRCA,80.0,FEMALE,ASIAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29463.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0
TCGA-C8-A12L-01,TCGA-C8-A12L,BRCA,67.0,FEMALE,ASIAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24710.0,Alive,TUMOR FREE,363.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,363.0,0.0,363.0,0.0,363.0,0.0,363.0,0
TCGA-C8-A12M-01,TCGA-C8-A12M,BRCA,70.0,FEMALE,ASIAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25811.0,Alive,TUMOR FREE,358.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,358.0,0.0,358.0,0.0,358.0,0.0,358.0,0
TCGA-C8-A12N-01,TCGA-C8-A12N,BRCA,58.0,FEMALE,ASIAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21428.0,Alive,TUMOR FREE,358.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,358.0,0.0,358.0,0.0,358.0,0.0,358.0,0
TCGA-C8-A12O-01,TCGA-C8-A12O,BRCA,50.0,FEMALE,ASIAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18506.0,Alive,TUMOR FREE,385.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,0
TCGA-C8-A12P-01,TCGA-C8-A12P,BRCA,55.0,FEMALE,ASIAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20332.0,Alive,TUMOR FREE,358.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,358.0,0.0,358.0,0.0,358.0,0.0,358.0,0
TCGA-C8-A12Q-01,TCGA-C8-A12Q,BRCA,78.0,FEMALE,ASIAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28733.0,Dead,WITH TUMOR,nan,385.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,385.0,1.0,385.0,nan,nan,1.0,385.0,1
TCGA-C8-A12T-01,TCGA-C8-A12T,BRCA,43.0,FEMALE,ASIAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),nan,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0
TCGA-C8-A12U-01,TCGA-C8-A12U,BRCA,46.0,FEMALE,ASIAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17045.0,Alive,TUMOR FREE,385.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,0
TCGA-C8-A12V-01,TCGA-C8-A12V,BRCA,55.0,FEMALE,ASIAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20346.0,Alive,TUMOR FREE,385.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,385.0,0.0,385.0,nan,nan,0.0,385.0,0
TCGA-C8-A12W-01,TCGA-C8-A12W,BRCA,49.0,FEMALE,ASIAN,Stage IIIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18140.0,Alive,TUMOR FREE,385.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,0
TCGA-C8-A12X-01,TCGA-C8-A12X,BRCA,62.0,FEMALE,ASIAN,Stage IIB,nan,Mucinous Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22889.0,Alive,TUMOR FREE,385.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,0
TCGA-C8-A12Y-01,TCGA-C8-A12Y,BRCA,44.0,FEMALE,ASIAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),nan,Alive,TUMOR FREE,1476.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1476.0,0.0,1476.0,0.0,1476.0,0.0,1476.0,0
TCGA-C8-A12Z-01,TCGA-C8-A12Z,BRCA,45.0,FEMALE,ASIAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Peri (6-12 months since last menstrual period),-16508.0,Alive,TUMOR FREE,382.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,382.0,0.0,382.0,0.0,382.0,0.0,382.0,0
TCGA-C8-A130-01,TCGA-C8-A130,BRCA,52.0,FEMALE,ASIAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Peri (6-12 months since last menstrual period),-19117.0,Alive,TUMOR FREE,370.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,370.0,0.0,370.0,0.0,370.0,0.0,370.0,0
TCGA-C8-A131-01,TCGA-C8-A131,BRCA,82.0,FEMALE,ASIAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29966.0,Alive,TUMOR FREE,411.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,411.0,0.0,411.0,0.0,411.0,0.0,411.0,0
TCGA-C8-A132-01,TCGA-C8-A132,BRCA,56.0,FEMALE,ASIAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20471.0,Alive,TUMOR FREE,383.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,0
TCGA-C8-A133-01,TCGA-C8-A133,BRCA,65.0,FEMALE,WHITE,Stage IIIA,nan,"Other, specify",nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23922.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0
TCGA-C8-A134-01,TCGA-C8-A134,BRCA,52.0,FEMALE,ASIAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Peri (6-12 months since last menstrual period),-19010.0,Alive,TUMOR FREE,383.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,0
TCGA-C8-A135-01,TCGA-C8-A135,BRCA,64.0,FEMALE,ASIAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23667.0,Alive,TUMOR FREE,393.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,393.0,0.0,393.0,0.0,393.0,0.0,393.0,0
TCGA-C8-A137-01,TCGA-C8-A137,BRCA,34.0,FEMALE,ASIAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12729.0,Alive,WITH TUMOR,379.0,nan,nan,Locoregional Recurrence,nan,nan,136.0,nan,Negative,nan,0.0,379.0,0.0,379.0,1.0,136.0,1.0,136.0,0
TCGA-C8-A138-01,TCGA-C8-A138,BRCA,54.0,FEMALE,ASIAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20053.0,Alive,TUMOR FREE,380.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,380.0,0.0,380.0,0.0,380.0,0.0,380.0,0
TCGA-C8-A1HE-01,TCGA-C8-A1HE,BRCA,59.0,FEMALE,ASIAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),nan,Alive,TUMOR FREE,375.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,375.0,0.0,375.0,0.0,375.0,0.0,375.0,0
TCGA-C8-A1HF-01,TCGA-C8-A1HF,BRCA,48.0,FEMALE,ASIAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),nan,Alive,TUMOR FREE,332.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,332.0,0.0,332.0,0.0,332.0,0.0,332.0,0
TCGA-C8-A1HG-01,TCGA-C8-A1HG,BRCA,50.0,FEMALE,ASIAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),nan,Alive,TUMOR FREE,345.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,345.0,0.0,345.0,0.0,345.0,0.0,345.0,0
TCGA-C8-A1HI-01,TCGA-C8-A1HI,BRCA,40.0,FEMALE,ASIAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),nan,Alive,TUMOR FREE,343.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,343.0,0.0,343.0,0.0,343.0,0.0,343.0,0
TCGA-C8-A1HJ-01,TCGA-C8-A1HJ,BRCA,53.0,FEMALE,ASIAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Peri (6-12 months since last menstrual period),-19629.0,Alive,TUMOR FREE,5.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,5.0,0.0,5.0,0.0,5.0,0.0,5.0,0
TCGA-C8-A1HK-01,TCGA-C8-A1HK,BRCA,53.0,FEMALE,ASIAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Peri (6-12 months since last menstrual period),nan,Alive,TUMOR FREE,366.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,366.0,0.0,366.0,0.0,366.0,0.0,366.0,0
TCGA-C8-A1HL-01,TCGA-C8-A1HL,BRCA,38.0,FEMALE,ASIAN,Stage IIIA,nan,"Other, specify",nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),nan,Alive,TUMOR FREE,317.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,317.0,0.0,317.0,0.0,317.0,0.0,317.0,0
TCGA-C8-A1HM-01,TCGA-C8-A1HM,BRCA,74.0,FEMALE,ASIAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27063.0,Alive,TUMOR FREE,375.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,375.0,0.0,375.0,0.0,375.0,0.0,375.0,0
TCGA-C8-A1HN-01,TCGA-C8-A1HN,BRCA,56.0,FEMALE,ASIAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20712.0,Alive,TUMOR FREE,394.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,394.0,0.0,394.0,0.0,394.0,0.0,394.0,0
TCGA-C8-A1HO-01,TCGA-C8-A1HO,BRCA,34.0,FEMALE,ASIAN,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12715.0,Alive,TUMOR FREE,375.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,375.0,0.0,375.0,0.0,375.0,0.0,375.0,0
TCGA-C8-A26V-01,TCGA-C8-A26V,BRCA,47.0,FEMALE,ASIAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Peri (6-12 months since last menstrual period),-17468.0,Alive,TUMOR FREE,616.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,616.0,0.0,616.0,0.0,616.0,0.0,616.0,0
TCGA-C8-A26W-01,TCGA-C8-A26W,BRCA,58.0,FEMALE,ASIAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21391.0,Alive,TUMOR FREE,381.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,381.0,0.0,381.0,0.0,381.0,0.0,381.0,0
TCGA-C8-A26X-01,TCGA-C8-A26X,BRCA,58.0,FEMALE,ASIAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21463.0,Alive,TUMOR FREE,376.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,376.0,0.0,376.0,0.0,376.0,0.0,376.0,0
TCGA-C8-A26Y-01,TCGA-C8-A26Y,BRCA,90.0,FEMALE,ASIAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32872.0,Alive,TUMOR FREE,394.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,394.0,0.0,394.0,0.0,394.0,0.0,394.0,0
TCGA-C8-A26Z-01,TCGA-C8-A26Z,BRCA,59.0,FEMALE,ASIAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),nan,Alive,TUMOR FREE,470.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,470.0,0.0,470.0,0.0,470.0,0.0,470.0,0
TCGA-C8-A273-01,TCGA-C8-A273,BRCA,29.0,FEMALE,ASIAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),nan,Alive,TUMOR FREE,513.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,513.0,0.0,513.0,0.0,513.0,0.0,513.0,0
TCGA-C8-A274-01,TCGA-C8-A274,BRCA,63.0,FEMALE,ASIAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23337.0,Alive,TUMOR FREE,508.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,508.0,0.0,508.0,0.0,508.0,0.0,508.0,0
TCGA-C8-A275-01,TCGA-C8-A275,BRCA,56.0,FEMALE,ASIAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20774.0,Alive,TUMOR FREE,1.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,0
TCGA-C8-A278-01,TCGA-C8-A278,BRCA,61.0,FEMALE,ASIAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22598.0,Alive,TUMOR FREE,297.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,297.0,0.0,297.0,0.0,297.0,0.0,297.0,0
TCGA-C8-A27A-01,TCGA-C8-A27A,BRCA,48.0,FEMALE,ASIAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Peri (6-12 months since last menstrual period),-17779.0,Alive,TUMOR FREE,747.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,747.0,0.0,747.0,0.0,747.0,0.0,747.0,0
TCGA-C8-A27B-01,TCGA-C8-A27B,BRCA,48.0,FEMALE,ASIAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Peri (6-12 months since last menstrual period),-17763.0,Alive,TUMOR FREE,439.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,439.0,0.0,439.0,0.0,439.0,0.0,439.0,0
TCGA-C8-A3M7-01,TCGA-C8-A3M7,BRCA,60.0,FEMALE,ASIAN,Stage IIIB,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22096.0,Dead,WITH TUMOR,nan,1034.0,nan,Locoregional Recurrence,nan,nan,1034.0,nan,Negative,nan,1.0,1034.0,1.0,1034.0,1.0,1034.0,1.0,1034.0,1
TCGA-C8-A3M8-01,TCGA-C8-A3M8,BRCA,68.0,FEMALE,ASIAN,Stage IA,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24877.0,Alive,TUMOR FREE,394.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,394.0,0.0,394.0,0.0,394.0,0.0,394.0,0
TCGA-C8-A8HP-01,TCGA-C8-A8HP,BRCA,59.0,FEMALE,ASIAN,Stage IIIA,nan,Metaplastic Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21613.0,Alive,TUMOR FREE,396.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,396.0,0.0,396.0,0.0,396.0,0.0,396.0,0
TCGA-C8-A8HQ-01,TCGA-C8-A8HQ,BRCA,53.0,FEMALE,ASIAN,Stage IIB,nan,Mucinous Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19432.0,Alive,TUMOR FREE,380.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,380.0,0.0,380.0,0.0,380.0,0.0,380.0,0
TCGA-C8-A8HR-01,TCGA-C8-A8HR,BRCA,49.0,FEMALE,ASIAN,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2013.0,Peri (6-12 months since last menstrual period),-17921.0,Alive,TUMOR FREE,408.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,408.0,0.0,408.0,0.0,408.0,0.0,408.0,0
TCGA-C8-A9FZ-01,TCGA-C8-A9FZ,BRCA,49.0,FEMALE,WHITE,Stage IIB,nan,Mixed Histology (please specify),nan,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18038.0,Alive,TUMOR FREE,592.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,592.0,0.0,592.0,0.0,592.0,0.0,592.0,0
TCGA-D8-A13Y-01,TCGA-D8-A13Y,BRCA,52.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19028.0,Alive,TUMOR FREE,1728.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1728.0,0.0,1728.0,0.0,1728.0,0.0,1728.0,0
TCGA-D8-A13Z-01,TCGA-D8-A13Z,BRCA,51.0,FEMALE,WHITE,nan,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18942.0,Alive,TUMOR FREE,635.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,635.0,0.0,635.0,0.0,635.0,0.0,635.0,0
TCGA-D8-A140-01,TCGA-D8-A140,BRCA,62.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22900.0,Alive,TUMOR FREE,403.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,403.0,0.0,403.0,0.0,403.0,0.0,403.0,0
TCGA-D8-A141-01,TCGA-D8-A141,BRCA,40.0,FEMALE,WHITE,nan,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Indeterminate (neither Pre or Postmenopausal),-14626.0,Alive,TUMOR FREE,626.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,626.0,0.0,626.0,0.0,626.0,0.0,626.0,0
TCGA-D8-A142-01,TCGA-D8-A142,BRCA,74.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27313.0,Alive,TUMOR FREE,425.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,425.0,0.0,425.0,0.0,425.0,0.0,425.0,0
TCGA-D8-A143-01,TCGA-D8-A143,BRCA,51.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18984.0,Alive,TUMOR FREE,431.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,431.0,0.0,431.0,0.0,431.0,0.0,431.0,0
TCGA-D8-A145-01,TCGA-D8-A145,BRCA,80.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29280.0,Alive,TUMOR FREE,410.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,410.0,0.0,410.0,0.0,410.0,0.0,410.0,0
TCGA-D8-A146-01,TCGA-D8-A146,BRCA,57.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20861.0,Alive,TUMOR FREE,643.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,643.0,0.0,643.0,0.0,643.0,0.0,643.0,0
TCGA-D8-A147-01,TCGA-D8-A147,BRCA,45.0,FEMALE,WHITE,nan,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Indeterminate (neither Pre or Postmenopausal),-16736.0,Alive,TUMOR FREE,584.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,584.0,0.0,584.0,0.0,584.0,0.0,584.0,0
TCGA-D8-A1J8-01,TCGA-D8-A1J8,BRCA,77.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28444.0,Alive,TUMOR FREE,431.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,431.0,0.0,431.0,0.0,431.0,0.0,431.0,0
TCGA-D8-A1J9-01,TCGA-D8-A1J9,BRCA,48.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17879.0,Alive,TUMOR FREE,532.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,532.0,0.0,532.0,0.0,532.0,0.0,532.0,0
TCGA-D8-A1JA-01,TCGA-D8-A1JA,BRCA,60.0,FEMALE,WHITE,nan,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21918.0,Alive,WITH TUMOR,502.0,nan,nan,Locoregional Disease,nan,nan,431.0,nan,Negative,nan,0.0,502.0,0.0,502.0,1.0,431.0,1.0,431.0,0
TCGA-D8-A1JB-01,TCGA-D8-A1JB,BRCA,54.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19822.0,Alive,TUMOR FREE,1688.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1688.0,0.0,1688.0,0.0,1688.0,0.0,1688.0,0
TCGA-D8-A1JC-01,TCGA-D8-A1JC,BRCA,59.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21898.0,Alive,TUMOR FREE,480.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,480.0,0.0,480.0,0.0,480.0,0.0,480.0,0
TCGA-D8-A1JD-01,TCGA-D8-A1JD,BRCA,41.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15166.0,Alive,TUMOR FREE,552.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,552.0,0.0,552.0,0.0,552.0,0.0,552.0,0
TCGA-D8-A1JE-01,TCGA-D8-A1JE,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22683.0,Alive,TUMOR FREE,575.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,575.0,0.0,575.0,0.0,575.0,0.0,575.0,0
TCGA-D8-A1JF-01,TCGA-D8-A1JF,BRCA,79.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29199.0,Alive,TUMOR FREE,366.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,366.0,0.0,366.0,0.0,366.0,0.0,366.0,0
TCGA-D8-A1JG-01,TCGA-D8-A1JG,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22878.0,Alive,TUMOR FREE,1612.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1612.0,0.0,1612.0,0.0,1612.0,0.0,1612.0,0
TCGA-D8-A1JH-01,TCGA-D8-A1JH,BRCA,56.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20497.0,Alive,TUMOR FREE,426.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,426.0,0.0,426.0,0.0,426.0,0.0,426.0,0
TCGA-D8-A1JI-01,TCGA-D8-A1JI,BRCA,54.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20072.0,Alive,TUMOR FREE,577.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,577.0,0.0,577.0,0.0,577.0,0.0,577.0,0
TCGA-D8-A1JJ-01,TCGA-D8-A1JJ,BRCA,54.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19966.0,Alive,TUMOR FREE,611.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,611.0,0.0,611.0,0.0,611.0,0.0,611.0,0
TCGA-D8-A1JK-01,TCGA-D8-A1JK,BRCA,90.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32872.0,Alive,TUMOR FREE,612.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,612.0,0.0,612.0,0.0,612.0,0.0,612.0,0
TCGA-D8-A1JL-01,TCGA-D8-A1JL,BRCA,72.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26484.0,Alive,TUMOR FREE,611.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,611.0,0.0,611.0,0.0,611.0,0.0,611.0,0
TCGA-D8-A1JM-01,TCGA-D8-A1JM,BRCA,59.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21602.0,Alive,TUMOR FREE,590.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,590.0,0.0,590.0,0.0,590.0,0.0,590.0,0
TCGA-D8-A1JN-01,TCGA-D8-A1JN,BRCA,80.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29331.0,Alive,TUMOR FREE,620.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,620.0,0.0,620.0,0.0,620.0,0.0,620.0,0
TCGA-D8-A1JP-01,TCGA-D8-A1JP,BRCA,73.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26862.0,Alive,TUMOR FREE,639.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,639.0,0.0,639.0,0.0,639.0,0.0,639.0,0
TCGA-D8-A1JS-01,TCGA-D8-A1JS,BRCA,77.0,FEMALE,WHITE,Stage IA,nan,"Other, specify",nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28178.0,Alive,TUMOR FREE,371.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,371.0,0.0,371.0,0.0,371.0,0.0,371.0,0
TCGA-D8-A1JT-01,TCGA-D8-A1JT,BRCA,70.0,FEMALE,WHITE,Stage IIA,nan,"Other, specify",nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25677.0,Alive,TUMOR FREE,405.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,405.0,0.0,405.0,0.0,405.0,0.0,405.0,0
TCGA-D8-A1JU-01,TCGA-D8-A1JU,BRCA,51.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18733.0,Alive,TUMOR FREE,447.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,447.0,0.0,447.0,0.0,447.0,0.0,447.0,0
TCGA-D8-A1X5-01,TCGA-D8-A1X5,BRCA,81.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29734.0,Alive,TUMOR FREE,565.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,565.0,0.0,565.0,0.0,565.0,0.0,565.0,0
TCGA-D8-A1X6-01,TCGA-D8-A1X6,BRCA,80.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29256.0,Alive,TUMOR FREE,541.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,541.0,0.0,541.0,0.0,541.0,0.0,541.0,0
TCGA-D8-A1X7-01,TCGA-D8-A1X7,BRCA,40.0,FEMALE,WHITE,Stage IIA,nan,"Other, specify",nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14858.0,Alive,TUMOR FREE,509.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,509.0,0.0,509.0,0.0,509.0,0.0,509.0,0
TCGA-D8-A1X8-01,TCGA-D8-A1X8,BRCA,62.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22995.0,Alive,TUMOR FREE,783.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,783.0,0.0,783.0,0.0,783.0,0.0,783.0,0
TCGA-D8-A1X9-01,TCGA-D8-A1X9,BRCA,66.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24417.0,Alive,TUMOR FREE,727.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,727.0,0.0,727.0,nan,nan,0.0,727.0,0
TCGA-D8-A1XA-01,TCGA-D8-A1XA,BRCA,64.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23387.0,Alive,TUMOR FREE,839.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,839.0,0.0,839.0,0.0,839.0,0.0,839.0,0
TCGA-D8-A1XB-01,TCGA-D8-A1XB,BRCA,62.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22976.0,Alive,TUMOR FREE,552.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,552.0,0.0,552.0,0.0,552.0,0.0,552.0,0
TCGA-D8-A1XC-01,TCGA-D8-A1XC,BRCA,85.0,FEMALE,WHITE,Stage IIIB,nan,Mucinous Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31220.0,Dead,WITH TUMOR,nan,377.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,377.0,1.0,377.0,nan,nan,1.0,377.0,1
TCGA-D8-A1XD-01,TCGA-D8-A1XD,BRCA,36.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13510.0,Alive,TUMOR FREE,522.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,522.0,0.0,522.0,0.0,522.0,0.0,522.0,0
TCGA-D8-A1XF-01,TCGA-D8-A1XF,BRCA,45.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16787.0,Alive,TUMOR FREE,463.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,463.0,0.0,463.0,nan,nan,0.0,463.0,0
TCGA-D8-A1XG-01,TCGA-D8-A1XG,BRCA,86.0,FEMALE,WHITE,Stage IIIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31748.0,Alive,TUMOR FREE,448.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,448.0,0.0,448.0,0.0,448.0,0.0,448.0,0
TCGA-D8-A1XJ-01,TCGA-D8-A1XJ,BRCA,76.0,FEMALE,WHITE,Stage IIIA,nan,"Other, specify",nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27967.0,Alive,TUMOR FREE,664.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,664.0,0.0,664.0,0.0,664.0,0.0,664.0,0
TCGA-D8-A1XK-01,TCGA-D8-A1XK,BRCA,55.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20092.0,Alive,TUMOR FREE,441.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,441.0,0.0,441.0,0.0,441.0,0.0,441.0,0
TCGA-D8-A1XL-01,TCGA-D8-A1XL,BRCA,34.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12668.0,Alive,TUMOR FREE,606.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,606.0,0.0,606.0,0.0,606.0,0.0,606.0,0
TCGA-D8-A1XM-01,TCGA-D8-A1XM,BRCA,57.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21056.0,Alive,TUMOR FREE,538.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,538.0,0.0,538.0,0.0,538.0,0.0,538.0,0
TCGA-D8-A1XO-01,TCGA-D8-A1XO,BRCA,56.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20606.0,Alive,TUMOR FREE,1682.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1682.0,0.0,1682.0,0.0,1682.0,0.0,1682.0,0
TCGA-D8-A1XQ-01,TCGA-D8-A1XQ,BRCA,69.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25345.0,Alive,TUMOR FREE,499.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,499.0,0.0,499.0,0.0,499.0,0.0,499.0,0
TCGA-D8-A1XR-01,TCGA-D8-A1XR,BRCA,56.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20488.0,Alive,TUMOR FREE,482.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,482.0,0.0,482.0,0.0,482.0,0.0,482.0,0
TCGA-D8-A1XS-01,TCGA-D8-A1XS,BRCA,48.0,MALE,WHITE,Stage IIIC,nan,"Other, specify",nan,2010.0,nan,-17708.0,Alive,TUMOR FREE,496.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,496.0,0.0,496.0,0.0,496.0,0.0,496.0,0
TCGA-D8-A1XT-01,TCGA-D8-A1XT,BRCA,61.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22448.0,Alive,TUMOR FREE,506.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,506.0,0.0,506.0,0.0,506.0,0.0,506.0,0
TCGA-D8-A1XU-01,TCGA-D8-A1XU,BRCA,56.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20715.0,Alive,TUMOR FREE,395.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,395.0,0.0,395.0,0.0,395.0,0.0,395.0,0
TCGA-D8-A1XV-01,TCGA-D8-A1XV,BRCA,84.0,FEMALE,WHITE,Stage IIA,nan,Mucinous Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30830.0,Alive,TUMOR FREE,461.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,461.0,0.0,461.0,0.0,461.0,0.0,461.0,0
TCGA-D8-A1XW-01,TCGA-D8-A1XW,BRCA,53.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19478.0,Alive,TUMOR FREE,1309.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1309.0,0.0,1309.0,0.0,1309.0,0.0,1309.0,0
TCGA-D8-A1XY-01,TCGA-D8-A1XY,BRCA,74.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27106.0,Alive,TUMOR FREE,503.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,503.0,0.0,503.0,nan,nan,0.0,503.0,0
TCGA-D8-A1XZ-01,TCGA-D8-A1XZ,BRCA,81.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29916.0,Alive,TUMOR FREE,466.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,466.0,0.0,466.0,0.0,466.0,0.0,466.0,0
TCGA-D8-A1Y0-01,TCGA-D8-A1Y0,BRCA,65.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24083.0,Alive,TUMOR FREE,472.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,472.0,0.0,472.0,nan,nan,0.0,472.0,0
TCGA-D8-A1Y1-01,TCGA-D8-A1Y1,BRCA,80.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29474.0,Dead,WITH TUMOR,nan,302.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,302.0,1.0,302.0,nan,nan,1.0,302.0,1
TCGA-D8-A1Y2-01,TCGA-D8-A1Y2,BRCA,71.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26021.0,Alive,TUMOR FREE,433.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,433.0,0.0,433.0,0.0,433.0,0.0,433.0,0
TCGA-D8-A1Y3-01,TCGA-D8-A1Y3,BRCA,61.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22317.0,Alive,TUMOR FREE,430.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,430.0,0.0,430.0,0.0,430.0,0.0,430.0,0
TCGA-D8-A27E-01,TCGA-D8-A27E,BRCA,66.0,FEMALE,WHITE,Stage IA,nan,"Other, specify",nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24315.0,Alive,TUMOR FREE,530.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,530.0,0.0,530.0,0.0,530.0,0.0,530.0,0
TCGA-D8-A27F-01,TCGA-D8-A27F,BRCA,40.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14731.0,Alive,TUMOR FREE,488.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,488.0,0.0,488.0,0.0,488.0,0.0,488.0,0
TCGA-D8-A27G-01,TCGA-D8-A27G,BRCA,75.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27521.0,Alive,TUMOR FREE,409.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,409.0,0.0,409.0,0.0,409.0,0.0,409.0,0
TCGA-D8-A27H-01,TCGA-D8-A27H,BRCA,72.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26588.0,Alive,TUMOR FREE,397.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,397.0,0.0,397.0,0.0,397.0,0.0,397.0,0
TCGA-D8-A27I-01,TCGA-D8-A27I,BRCA,58.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21327.0,Alive,TUMOR FREE,439.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,439.0,0.0,439.0,0.0,439.0,0.0,439.0,0
TCGA-D8-A27K-01,TCGA-D8-A27K,BRCA,47.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17426.0,Alive,TUMOR FREE,1461.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1461.0,0.0,1461.0,0.0,1461.0,0.0,1461.0,0
TCGA-D8-A27L-01,TCGA-D8-A27L,BRCA,49.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18025.0,Alive,TUMOR FREE,499.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,499.0,0.0,499.0,0.0,499.0,0.0,499.0,0
TCGA-D8-A27M-01,TCGA-D8-A27M,BRCA,59.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21910.0,Alive,TUMOR FREE,410.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,410.0,0.0,410.0,0.0,410.0,0.0,410.0,0
TCGA-D8-A27N-01,TCGA-D8-A27N,BRCA,36.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13243.0,Alive,TUMOR FREE,519.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,519.0,0.0,519.0,0.0,519.0,0.0,519.0,0
TCGA-D8-A27P-01,TCGA-D8-A27P,BRCA,64.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23576.0,Alive,TUMOR FREE,49.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,49.0,0.0,49.0,0.0,49.0,0.0,49.0,0
TCGA-D8-A27R-01,TCGA-D8-A27R,BRCA,41.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-15122.0,Alive,TUMOR FREE,307.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,307.0,0.0,307.0,0.0,307.0,0.0,307.0,0
TCGA-D8-A27T-01,TCGA-D8-A27T,BRCA,53.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19591.0,Alive,TUMOR FREE,398.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,398.0,0.0,398.0,0.0,398.0,0.0,398.0,0
TCGA-D8-A27V-01,TCGA-D8-A27V,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22958.0,Alive,TUMOR FREE,381.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,381.0,0.0,381.0,0.0,381.0,0.0,381.0,0
TCGA-D8-A27W-01,TCGA-D8-A27W,BRCA,55.0,FEMALE,WHITE,Stage IIIB,nan,Mucinous Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20173.0,Alive,TUMOR FREE,373.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,373.0,0.0,373.0,0.0,373.0,0.0,373.0,0
TCGA-D8-A3Z5-01,TCGA-D8-A3Z5,BRCA,54.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19846.0,Alive,TUMOR FREE,1015.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1015.0,0.0,1015.0,0.0,1015.0,0.0,1015.0,0
TCGA-D8-A3Z6-01,TCGA-D8-A3Z6,BRCA,56.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20629.0,Alive,TUMOR FREE,563.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,563.0,0.0,563.0,0.0,563.0,0.0,563.0,0
TCGA-D8-A4Z1-01,TCGA-D8-A4Z1,BRCA,68.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25097.0,Alive,TUMOR FREE,659.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,659.0,0.0,659.0,0.0,659.0,0.0,659.0,0
TCGA-D8-A73U-01,TCGA-D8-A73U,BRCA,88.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32208.0,Alive,WITH TUMOR,492.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,492.0,0.0,492.0,0.0,492.0,0.0,492.0,0
TCGA-D8-A73W-01,TCGA-D8-A73W,BRCA,79.0,FEMALE,WHITE,Stage IIIA,nan,Mucinous Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29125.0,Dead,WITH TUMOR,nan,385.0,nan,Distant Metastasis,Lung,nan,21.0,nan,Negative,nan,1.0,385.0,1.0,385.0,1.0,21.0,1.0,21.0,1
TCGA-D8-A73X-01,TCGA-D8-A73X,BRCA,53.0,FEMALE,WHITE,Stage IIA,nan,"Other, specify",nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19607.0,Alive,TUMOR FREE,767.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,767.0,0.0,767.0,0.0,767.0,0.0,767.0,0
TCGA-E2-A105-01,TCGA-E2-A105,BRCA,79.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28855.0,Alive,TUMOR FREE,1308.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1308.0,0.0,1308.0,0.0,1308.0,0.0,1308.0,0
TCGA-E2-A106-01,TCGA-E2-A106,BRCA,34.0,FEMALE,ASIAN,Stage IB,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12528.0,Alive,TUMOR FREE,2541.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2541.0,0.0,2541.0,0.0,2541.0,0.0,2541.0,0
TCGA-E2-A107-01,TCGA-E2-A107,BRCA,54.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20065.0,Alive,TUMOR FREE,1047.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1047.0,0.0,1047.0,0.0,1047.0,0.0,1047.0,0
TCGA-E2-A108-01,TCGA-E2-A108,BRCA,64.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23530.0,Alive,WITH TUMOR,837.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,837.0,0.0,837.0,0.0,837.0,0.0,837.0,0
TCGA-E2-A109-01,TCGA-E2-A109,BRCA,64.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23521.0,Alive,TUMOR FREE,1417.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1417.0,0.0,1417.0,0.0,1417.0,0.0,1417.0,0
TCGA-E2-A10A-01,TCGA-E2-A10A,BRCA,41.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15085.0,Alive,WITH TUMOR,1229.0,nan,nan,Distant Metastasis,Bone,nan,75.0,nan,Negative,nan,0.0,1229.0,0.0,1229.0,1.0,75.0,1.0,75.0,0
TCGA-E2-A10B-01,TCGA-E2-A10B,BRCA,67.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24577.0,Alive,TUMOR FREE,1141.0,nan,nan,New Primary Tumor,Lung,nan,195.0,nan,Close,nan,0.0,1141.0,0.0,1141.0,nan,nan,1.0,195.0,0
TCGA-E2-A10C-01,TCGA-E2-A10C,BRCA,54.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19849.0,Alive,TUMOR FREE,1220.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1220.0,0.0,1220.0,0.0,1220.0,0.0,1220.0,0
TCGA-E2-A10E-01,TCGA-E2-A10E,BRCA,64.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23684.0,Alive,TUMOR FREE,865.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,865.0,0.0,865.0,0.0,865.0,0.0,865.0,0
TCGA-E2-A10F-01,TCGA-E2-A10F,BRCA,47.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17257.0,Alive,TUMOR FREE,878.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,878.0,0.0,878.0,0.0,878.0,0.0,878.0,0
TCGA-E2-A14N-01,TCGA-E2-A14N,BRCA,37.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13743.0,Alive,TUMOR FREE,1434.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1434.0,0.0,1434.0,0.0,1434.0,0.0,1434.0,0
TCGA-E2-A14O-01,TCGA-E2-A14O,BRCA,76.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27837.0,Alive,TUMOR FREE,1359.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1359.0,0.0,1359.0,0.0,1359.0,0.0,1359.0,0
TCGA-E2-A14P-01,TCGA-E2-A14P,BRCA,79.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28923.0,Alive,TUMOR FREE,1246.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1246.0,0.0,1246.0,0.0,1246.0,0.0,1246.0,0
TCGA-E2-A14Q-01,TCGA-E2-A14Q,BRCA,50.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18507.0,Alive,TUMOR FREE,1163.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1163.0,0.0,1163.0,0.0,1163.0,0.0,1163.0,0
TCGA-E2-A14R-01,TCGA-E2-A14R,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22686.0,Alive,TUMOR FREE,1174.0,nan,nan,New Primary Tumor,"Other, specify",Endometrial,971.0,nan,Negative,nan,0.0,1174.0,0.0,1174.0,0.0,1174.0,1.0,971.0,0
TCGA-E2-A14S-01,TCGA-E2-A14S,BRCA,65.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23878.0,Alive,TUMOR FREE,1009.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1009.0,0.0,1009.0,0.0,1009.0,0.0,1009.0,0
TCGA-E2-A14T-01,TCGA-E2-A14T,BRCA,52.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19237.0,Alive,TUMOR FREE,2311.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2311.0,0.0,2311.0,0.0,2311.0,0.0,2311.0,0
TCGA-E2-A14U-01,TCGA-E2-A14U,BRCA,74.0,FEMALE,WHITE,Stage I,nan,Infiltrating Lobular Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27389.0,Alive,TUMOR FREE,1318.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1318.0,0.0,1318.0,0.0,1318.0,0.0,1318.0,0
TCGA-E2-A14V-01,TCGA-E2-A14V,BRCA,53.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19643.0,Alive,TUMOR FREE,1042.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1042.0,0.0,1042.0,0.0,1042.0,0.0,1042.0,0
TCGA-E2-A14W-01,TCGA-E2-A14W,BRCA,78.0,MALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,nan,-28664.0,Alive,TUMOR FREE,974.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,974.0,0.0,974.0,0.0,974.0,0.0,974.0,0
TCGA-E2-A14X-01,TCGA-E2-A14X,BRCA,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20105.0,Alive,TUMOR FREE,972.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,972.0,0.0,972.0,0.0,972.0,0.0,972.0,0
TCGA-E2-A14Y-01,TCGA-E2-A14Y,BRCA,35.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13004.0,Alive,TUMOR FREE,2109.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2109.0,0.0,2109.0,0.0,2109.0,0.0,2109.0,0
TCGA-E2-A14Y-11,TCGA-E2-A14Y,BRCA,35.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13004.0,Alive,TUMOR FREE,2109.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2109.0,0.0,2109.0,0.0,2109.0,0.0,2109.0,0
TCGA-E2-A14Z-01,TCGA-E2-A14Z,BRCA,64.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23682.0,Dead,WITH TUMOR,nan,563.0,nan,Distant Metastasis,Bone,nan,188.0,nan,Negative,nan,1.0,563.0,1.0,563.0,1.0,188.0,1.0,188.0,1
TCGA-E2-A150-01,TCGA-E2-A150,BRCA,48.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17580.0,Alive,TUMOR FREE,1935.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1935.0,0.0,1935.0,0.0,1935.0,0.0,1935.0,0
TCGA-E2-A152-01,TCGA-E2-A152,BRCA,56.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20705.0,Alive,TUMOR FREE,2128.0,nan,nan,Distant Metastasis,Liver,nan,54.0,nan,Negative,nan,0.0,2128.0,0.0,2128.0,1.0,54.0,1.0,54.0,0
TCGA-E2-A153-01,TCGA-E2-A153,BRCA,51.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18875.0,Alive,TUMOR FREE,707.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,707.0,0.0,707.0,0.0,707.0,0.0,707.0,0
TCGA-E2-A153-11,TCGA-E2-A153,BRCA,51.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18875.0,Alive,TUMOR FREE,707.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,707.0,0.0,707.0,0.0,707.0,0.0,707.0,0
TCGA-E2-A154-01,TCGA-E2-A154,BRCA,68.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24999.0,Alive,TUMOR FREE,591.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,591.0,0.0,591.0,0.0,591.0,0.0,591.0,0
TCGA-E2-A155-01,TCGA-E2-A155,BRCA,58.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21348.0,Alive,TUMOR FREE,640.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,640.0,0.0,640.0,0.0,640.0,0.0,640.0,0
TCGA-E2-A156-01,TCGA-E2-A156,BRCA,61.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22422.0,Alive,TUMOR FREE,726.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,726.0,0.0,726.0,0.0,726.0,0.0,726.0,0
TCGA-E2-A158-01,TCGA-E2-A158,BRCA,43.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15903.0,Alive,TUMOR FREE,450.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,450.0,0.0,450.0,0.0,450.0,0.0,450.0,0
TCGA-E2-A158-11,TCGA-E2-A158,BRCA,43.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15903.0,Alive,TUMOR FREE,450.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,450.0,0.0,450.0,0.0,450.0,0.0,450.0,0
TCGA-E2-A159-01,TCGA-E2-A159,BRCA,50.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18621.0,Alive,TUMOR FREE,762.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,762.0,0.0,762.0,0.0,762.0,0.0,762.0,0
TCGA-E2-A15A-06,TCGA-E2-A15A,BRCA,45.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16750.0,Alive,TUMOR FREE,710.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,710.0,0.0,710.0,0.0,710.0,0.0,710.0,0
TCGA-E2-A15A-01,TCGA-E2-A15A,BRCA,45.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16750.0,Alive,TUMOR FREE,710.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,710.0,0.0,710.0,0.0,710.0,0.0,710.0,0
TCGA-E2-A15C-01,TCGA-E2-A15C,BRCA,61.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22583.0,Alive,TUMOR FREE,694.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,694.0,0.0,694.0,0.0,694.0,0.0,694.0,0
TCGA-E2-A15D-01,TCGA-E2-A15D,BRCA,47.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17224.0,Alive,TUMOR FREE,526.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,526.0,0.0,526.0,0.0,526.0,0.0,526.0,0
TCGA-E2-A15E-06,TCGA-E2-A15E,BRCA,40.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14894.0,Alive,TUMOR FREE,630.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,630.0,0.0,630.0,0.0,630.0,0.0,630.0,0
TCGA-E2-A15E-01,TCGA-E2-A15E,BRCA,40.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14894.0,Alive,TUMOR FREE,630.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,630.0,0.0,630.0,0.0,630.0,0.0,630.0,0
TCGA-E2-A15F-01,TCGA-E2-A15F,BRCA,64.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23660.0,Alive,TUMOR FREE,658.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,658.0,0.0,658.0,0.0,658.0,0.0,658.0,0
TCGA-E2-A15G-01,TCGA-E2-A15G,BRCA,76.0,FEMALE,WHITE,Stage IIA,nan,Mixed Histology (please specify),nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28013.0,Alive,TUMOR FREE,554.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,554.0,0.0,554.0,0.0,554.0,0.0,554.0,0
TCGA-E2-A15H-01,TCGA-E2-A15H,BRCA,38.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13985.0,Alive,TUMOR FREE,393.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,393.0,0.0,393.0,0.0,393.0,0.0,393.0,0
TCGA-E2-A15I-01,TCGA-E2-A15I,BRCA,44.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16163.0,Alive,TUMOR FREE,1692.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1692.0,0.0,1692.0,0.0,1692.0,0.0,1692.0,0
TCGA-E2-A15I-11,TCGA-E2-A15I,BRCA,44.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16163.0,Alive,TUMOR FREE,1692.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1692.0,0.0,1692.0,0.0,1692.0,0.0,1692.0,0
TCGA-E2-A15J-01,TCGA-E2-A15J,BRCA,51.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18771.0,Alive,TUMOR FREE,1640.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1640.0,0.0,1640.0,0.0,1640.0,0.0,1640.0,0
TCGA-E2-A15K-06,TCGA-E2-A15K,BRCA,58.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21514.0,Alive,TUMOR FREE,275.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,275.0,0.0,275.0,0.0,275.0,0.0,275.0,0
TCGA-E2-A15K-01,TCGA-E2-A15K,BRCA,58.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21514.0,Alive,TUMOR FREE,275.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,275.0,0.0,275.0,0.0,275.0,0.0,275.0,0
TCGA-E2-A15K-11,TCGA-E2-A15K,BRCA,58.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21514.0,Alive,TUMOR FREE,275.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,275.0,0.0,275.0,0.0,275.0,0.0,275.0,0
TCGA-E2-A15L-01,TCGA-E2-A15L,BRCA,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23845.0,Alive,TUMOR FREE,626.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,626.0,0.0,626.0,0.0,626.0,0.0,626.0,0
TCGA-E2-A15L-11,TCGA-E2-A15L,BRCA,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23845.0,Alive,TUMOR FREE,626.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,626.0,0.0,626.0,0.0,626.0,0.0,626.0,0
TCGA-E2-A15M-01,TCGA-E2-A15M,BRCA,66.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24266.0,Dead,TUMOR FREE,nan,336.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,336.0,0.0,336.0,0.0,336.0,0.0,336.0,0
TCGA-E2-A15M-11,TCGA-E2-A15M,BRCA,66.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24266.0,Dead,TUMOR FREE,nan,336.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,336.0,0.0,336.0,0.0,336.0,0.0,336.0,0
TCGA-E2-A15O-01,TCGA-E2-A15O,BRCA,89.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32583.0,Alive,TUMOR FREE,1545.0,nan,nan,Locoregional Recurrence,nan,nan,1210.0,nan,Negative,nan,0.0,1545.0,0.0,1545.0,1.0,1210.0,1.0,1210.0,0
TCGA-E2-A15P-01,TCGA-E2-A15P,BRCA,61.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22524.0,Alive,TUMOR FREE,595.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,595.0,0.0,595.0,0.0,595.0,0.0,595.0,0
TCGA-E2-A15R-01,TCGA-E2-A15R,BRCA,64.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23570.0,Alive,TUMOR FREE,1732.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1732.0,0.0,1732.0,0.0,1732.0,0.0,1732.0,0
TCGA-E2-A15S-01,TCGA-E2-A15S,BRCA,34.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-12671.0,Alive,TUMOR FREE,428.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,428.0,0.0,428.0,0.0,428.0,0.0,428.0,0
TCGA-E2-A15T-01,TCGA-E2-A15T,BRCA,65.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24054.0,Alive,TUMOR FREE,1563.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1563.0,0.0,1563.0,0.0,1563.0,0.0,1563.0,0
TCGA-E2-A1AZ-01,TCGA-E2-A1AZ,BRCA,63.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23230.0,Alive,TUMOR FREE,2329.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2329.0,0.0,2329.0,0.0,2329.0,0.0,2329.0,0
TCGA-E2-A1B0-01,TCGA-E2-A1B0,BRCA,50.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18346.0,Alive,TUMOR FREE,1631.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1631.0,0.0,1631.0,0.0,1631.0,0.0,1631.0,0
TCGA-E2-A1B1-01,TCGA-E2-A1B1,BRCA,45.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16603.0,Alive,TUMOR FREE,2653.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2653.0,0.0,2653.0,0.0,2653.0,0.0,2653.0,0
TCGA-E2-A1B4-01,TCGA-E2-A1B4,BRCA,74.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27241.0,Dead,TUMOR FREE,nan,1004.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,1004.0,0.0,1004.0,0.0,1004.0,0.0,1004.0,0
TCGA-E2-A1B5-01,TCGA-E2-A1B5,BRCA,46.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17039.0,Alive,TUMOR FREE,984.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,984.0,0.0,984.0,0.0,984.0,0.0,984.0,0
TCGA-E2-A1B5-11,TCGA-E2-A1B5,BRCA,46.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17039.0,Alive,TUMOR FREE,984.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,984.0,0.0,984.0,0.0,984.0,0.0,984.0,0
TCGA-E2-A1B6-01,TCGA-E2-A1B6,BRCA,44.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16370.0,Alive,TUMOR FREE,867.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,867.0,0.0,867.0,0.0,867.0,0.0,867.0,0
TCGA-E2-A1BC-01,TCGA-E2-A1BC,BRCA,63.0,FEMALE,nan,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23168.0,Alive,TUMOR FREE,501.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,501.0,0.0,501.0,nan,nan,0.0,501.0,0
TCGA-E2-A1BC-11,TCGA-E2-A1BC,BRCA,63.0,FEMALE,nan,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23168.0,Alive,TUMOR FREE,501.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,501.0,0.0,501.0,nan,nan,0.0,501.0,0
TCGA-E2-A1BD-01,TCGA-E2-A1BD,BRCA,53.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19627.0,Alive,TUMOR FREE,1133.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1133.0,0.0,1133.0,0.0,1133.0,0.0,1133.0,0
TCGA-E2-A1IE-01,TCGA-E2-A1IE,BRCA,61.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22510.0,Alive,WITH TUMOR,2362.0,nan,nan,Distant Metastasis,Liver,nan,1810.0,nan,Negative,nan,0.0,2362.0,0.0,2362.0,1.0,1810.0,1.0,1810.0,0
TCGA-E2-A1IF-01,TCGA-E2-A1IF,BRCA,74.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27341.0,Alive,TUMOR FREE,1138.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1138.0,0.0,1138.0,0.0,1138.0,0.0,1138.0,0
TCGA-E2-A1IF-11,TCGA-E2-A1IF,BRCA,74.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27341.0,Alive,TUMOR FREE,1138.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1138.0,0.0,1138.0,0.0,1138.0,0.0,1138.0,0
TCGA-E2-A1IG-01,TCGA-E2-A1IG,BRCA,45.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16757.0,Alive,TUMOR FREE,2140.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2140.0,0.0,2140.0,0.0,2140.0,0.0,2140.0,0
TCGA-E2-A1IG-11,TCGA-E2-A1IG,BRCA,45.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16757.0,Alive,TUMOR FREE,2140.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2140.0,0.0,2140.0,0.0,2140.0,0.0,2140.0,0
TCGA-E2-A1IH-01,TCGA-E2-A1IH,BRCA,80.0,FEMALE,WHITE,Stage I,nan,Infiltrating Lobular Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29444.0,Alive,TUMOR FREE,1026.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1026.0,0.0,1026.0,0.0,1026.0,0.0,1026.0,0
TCGA-E2-A1II-01,TCGA-E2-A1II,BRCA,51.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18788.0,Alive,TUMOR FREE,1025.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1025.0,0.0,1025.0,0.0,1025.0,0.0,1025.0,0
TCGA-E2-A1II-11,TCGA-E2-A1II,BRCA,51.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18788.0,Alive,TUMOR FREE,1025.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1025.0,0.0,1025.0,0.0,1025.0,0.0,1025.0,0
TCGA-E2-A1IJ-01,TCGA-E2-A1IJ,BRCA,57.0,FEMALE,WHITE,Stage I,nan,Infiltrating Lobular Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20956.0,Alive,TUMOR FREE,865.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,865.0,0.0,865.0,0.0,865.0,0.0,865.0,0
TCGA-E2-A1IK-01,TCGA-E2-A1IK,BRCA,71.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26052.0,Alive,TUMOR FREE,1800.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1800.0,0.0,1800.0,0.0,1800.0,0.0,1800.0,0
TCGA-E2-A1IL-01,TCGA-E2-A1IL,BRCA,78.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28495.0,Alive,TUMOR FREE,118.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,118.0,0.0,118.0,0.0,118.0,0.0,118.0,0
TCGA-E2-A1IN-01,TCGA-E2-A1IN,BRCA,60.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22199.0,Alive,TUMOR FREE,675.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,675.0,0.0,675.0,0.0,675.0,0.0,675.0,0
TCGA-E2-A1IO-01,TCGA-E2-A1IO,BRCA,37.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13671.0,Alive,TUMOR FREE,1855.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1855.0,0.0,1855.0,0.0,1855.0,0.0,1855.0,0
TCGA-E2-A1IO-11,TCGA-E2-A1IO,BRCA,37.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13671.0,Alive,TUMOR FREE,1855.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1855.0,0.0,1855.0,0.0,1855.0,0.0,1855.0,0
TCGA-E2-A1IU-01,TCGA-E2-A1IU,BRCA,60.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22279.0,Alive,TUMOR FREE,337.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,337.0,0.0,337.0,0.0,337.0,0.0,337.0,0
TCGA-E2-A1L6-01,TCGA-E2-A1L6,BRCA,44.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16403.0,Alive,TUMOR FREE,1648.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1648.0,0.0,1648.0,0.0,1648.0,0.0,1648.0,0
TCGA-E2-A1L7-01,TCGA-E2-A1L7,BRCA,40.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14854.0,Alive,TUMOR FREE,1836.0,nan,nan,New Primary Tumor,"Other, specify",left breast,1619.0,nan,Negative,nan,0.0,1836.0,0.0,1836.0,1.0,1619.0,1.0,1619.0,0
TCGA-E2-A1L7-11,TCGA-E2-A1L7,BRCA,40.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14854.0,Alive,TUMOR FREE,1836.0,nan,nan,New Primary Tumor,"Other, specify",left breast,1619.0,nan,Negative,nan,0.0,1836.0,0.0,1836.0,1.0,1619.0,1.0,1619.0,0
TCGA-E2-A1L8-01,TCGA-E2-A1L8,BRCA,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19187.0,Alive,TUMOR FREE,2240.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2240.0,0.0,2240.0,0.0,2240.0,0.0,2240.0,0
TCGA-E2-A1L9-01,TCGA-E2-A1L9,BRCA,40.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14868.0,Alive,TUMOR FREE,598.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,598.0,0.0,598.0,0.0,598.0,0.0,598.0,0
TCGA-E2-A1LA-01,TCGA-E2-A1LA,BRCA,59.0,FEMALE,nan,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21773.0,Alive,TUMOR FREE,748.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,748.0,0.0,748.0,0.0,748.0,0.0,748.0,0
TCGA-E2-A1LB-01,TCGA-E2-A1LB,BRCA,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15283.0,Alive,TUMOR FREE,2306.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2306.0,0.0,2306.0,0.0,2306.0,0.0,2306.0,0
TCGA-E2-A1LB-11,TCGA-E2-A1LB,BRCA,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15283.0,Alive,TUMOR FREE,2306.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2306.0,0.0,2306.0,0.0,2306.0,0.0,2306.0,0
TCGA-E2-A1LE-01,TCGA-E2-A1LE,BRCA,71.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26239.0,Dead,WITH TUMOR,nan,879.0,nan,Distant Metastasis,Lung,nan,361.0,nan,Negative,nan,1.0,879.0,1.0,879.0,1.0,361.0,1.0,361.0,1
TCGA-E2-A1LG-01,TCGA-E2-A1LG,BRCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Peri (6-12 months since last menstrual period),-18492.0,Alive,TUMOR FREE,1523.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1523.0,0.0,1523.0,0.0,1523.0,0.0,1523.0,0
TCGA-E2-A1LH-01,TCGA-E2-A1LH,BRCA,59.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21628.0,Alive,TUMOR FREE,3247.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3247.0,0.0,3247.0,0.0,3247.0,0.0,3247.0,0
TCGA-E2-A1LH-11,TCGA-E2-A1LH,BRCA,59.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21628.0,Alive,TUMOR FREE,3247.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3247.0,0.0,3247.0,0.0,3247.0,0.0,3247.0,0
TCGA-E2-A1LI-01,TCGA-E2-A1LI,BRCA,57.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21064.0,Alive,TUMOR FREE,3121.0,nan,nan,nan,nan,nan,nan,nan,Close,nan,0.0,3121.0,0.0,3121.0,nan,nan,0.0,3121.0,0
TCGA-E2-A1LI-11,TCGA-E2-A1LI,BRCA,57.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21064.0,Alive,TUMOR FREE,3121.0,nan,nan,nan,nan,nan,nan,nan,Close,nan,0.0,3121.0,0.0,3121.0,nan,nan,0.0,3121.0,0
TCGA-E2-A1LK-01,TCGA-E2-A1LK,BRCA,84.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30757.0,Dead,WITH TUMOR,nan,266.0,nan,Locoregional Disease,"Other, specify",Left axilla,155.0,nan,Negative,nan,1.0,266.0,1.0,266.0,1.0,155.0,1.0,155.0,1
TCGA-E2-A1LL-01,TCGA-E2-A1LL,BRCA,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27028.0,Alive,WITH TUMOR,1309.0,nan,nan,Distant Metastasis,Liver,nan,1303.0,nan,Negative,nan,0.0,1309.0,0.0,1309.0,1.0,1303.0,1.0,1303.0,0
TCGA-E2-A1LS-01,TCGA-E2-A1LS,BRCA,46.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16887.0,Alive,TUMOR FREE,1604.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1604.0,0.0,1604.0,0.0,1604.0,0.0,1604.0,0
TCGA-E2-A1LS-11,TCGA-E2-A1LS,BRCA,46.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16887.0,Alive,TUMOR FREE,1604.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1604.0,0.0,1604.0,0.0,1604.0,0.0,1604.0,0
TCGA-E2-A2P5-01,TCGA-E2-A2P5,BRCA,78.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28621.0,Dead,WITH TUMOR,nan,821.0,nan,Distant Metastasis,Bone,nan,597.0,nan,Negative,nan,1.0,821.0,1.0,821.0,1.0,597.0,1.0,597.0,1
TCGA-E2-A2P6-01,TCGA-E2-A2P6,BRCA,77.0,FEMALE,nan,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28411.0,Alive,TUMOR FREE,1051.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1051.0,0.0,1051.0,0.0,1051.0,0.0,1051.0,0
TCGA-E2-A3DX-01,TCGA-E2-A3DX,BRCA,43.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15969.0,Alive,TUMOR FREE,1325.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,1325.0,0.0,1325.0,nan,nan,0.0,1325.0,0
TCGA-E2-A56Z-01,TCGA-E2-A56Z,BRCA,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25282.0,Alive,TUMOR FREE,252.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,252.0,0.0,252.0,0.0,252.0,0.0,252.0,0
TCGA-E2-A570-01,TCGA-E2-A570,BRCA,47.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17456.0,Alive,TUMOR FREE,931.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,931.0,0.0,931.0,0.0,931.0,0.0,931.0,0
TCGA-E2-A572-01,TCGA-E2-A572,BRCA,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26399.0,Alive,TUMOR FREE,1208.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1208.0,0.0,1208.0,0.0,1208.0,0.0,1208.0,0
TCGA-E2-A573-01,TCGA-E2-A573,BRCA,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Peri (6-12 months since last menstrual period),-17689.0,Alive,TUMOR FREE,1062.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1062.0,0.0,1062.0,0.0,1062.0,0.0,1062.0,0
TCGA-E2-A574-01,TCGA-E2-A574,BRCA,44.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16195.0,Alive,TUMOR FREE,1179.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1179.0,0.0,1179.0,0.0,1179.0,0.0,1179.0,0
TCGA-E2-A576-01,TCGA-E2-A576,BRCA,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25350.0,Alive,TUMOR FREE,1043.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1043.0,0.0,1043.0,0.0,1043.0,0.0,1043.0,0
TCGA-E2-A9RU-01,TCGA-E2-A9RU,BRCA,90.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32873.0,Alive,TUMOR FREE,538.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,538.0,0.0,538.0,0.0,538.0,0.0,538.0,0
TCGA-E9-A1N3-01,TCGA-E9-A1N3,BRCA,70.0,FEMALE,WHITE,Stage IIIA,nan,Mixed Histology (please specify),nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25714.0,Alive,TUMOR FREE,1059.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1059.0,0.0,1059.0,0.0,1059.0,0.0,1059.0,0
TCGA-E9-A1N4-01,TCGA-E9-A1N4,BRCA,41.0,FEMALE,WHITE,Stage IIIA,nan,Mixed Histology (please specify),nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15055.0,Alive,TUMOR FREE,1000.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1000.0,0.0,1000.0,0.0,1000.0,0.0,1000.0,0
TCGA-E9-A1N4-11,TCGA-E9-A1N4,BRCA,41.0,FEMALE,WHITE,Stage IIIA,nan,Mixed Histology (please specify),nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15055.0,Alive,TUMOR FREE,1000.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1000.0,0.0,1000.0,0.0,1000.0,0.0,1000.0,0
TCGA-E9-A1N5-01,TCGA-E9-A1N5,BRCA,45.0,FEMALE,WHITE,Stage IIB,nan,Mixed Histology (please specify),nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16736.0,Alive,TUMOR FREE,1120.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1120.0,0.0,1120.0,0.0,1120.0,0.0,1120.0,0
TCGA-E9-A1N5-11,TCGA-E9-A1N5,BRCA,45.0,FEMALE,WHITE,Stage IIB,nan,Mixed Histology (please specify),nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16736.0,Alive,TUMOR FREE,1120.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1120.0,0.0,1120.0,0.0,1120.0,0.0,1120.0,0
TCGA-E9-A1N6-01,TCGA-E9-A1N6,BRCA,52.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19327.0,Dead,WITH TUMOR,nan,678.0,nan,Distant Metastasis,Bone,nan,443.0,nan,Negative,nan,1.0,678.0,1.0,678.0,1.0,443.0,1.0,443.0,1
TCGA-E9-A1N6-11,TCGA-E9-A1N6,BRCA,52.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19327.0,Dead,WITH TUMOR,nan,678.0,nan,Distant Metastasis,Bone,nan,443.0,nan,Negative,nan,1.0,678.0,1.0,678.0,1.0,443.0,1.0,443.0,1
TCGA-E9-A1N8-01,TCGA-E9-A1N8,BRCA,48.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17652.0,Alive,TUMOR FREE,1039.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1039.0,0.0,1039.0,0.0,1039.0,0.0,1039.0,0
TCGA-E9-A1N8-11,TCGA-E9-A1N8,BRCA,48.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17652.0,Alive,TUMOR FREE,1039.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1039.0,0.0,1039.0,0.0,1039.0,0.0,1039.0,0
TCGA-E9-A1N9-01,TCGA-E9-A1N9,BRCA,58.0,FEMALE,WHITE,Stage IIA,nan,Mixed Histology (please specify),nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21228.0,Alive,TUMOR FREE,1101.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1101.0,0.0,1101.0,0.0,1101.0,0.0,1101.0,0
TCGA-E9-A1N9-11,TCGA-E9-A1N9,BRCA,58.0,FEMALE,WHITE,Stage IIA,nan,Mixed Histology (please specify),nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21228.0,Alive,TUMOR FREE,1101.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1101.0,0.0,1101.0,0.0,1101.0,0.0,1101.0,0
TCGA-E9-A1NA-01,TCGA-E9-A1NA,BRCA,58.0,FEMALE,WHITE,Stage IIA,nan,Mixed Histology (please specify),nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21397.0,Alive,TUMOR FREE,1112.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1112.0,0.0,1112.0,0.0,1112.0,0.0,1112.0,0
TCGA-E9-A1NA-11,TCGA-E9-A1NA,BRCA,58.0,FEMALE,WHITE,Stage IIA,nan,Mixed Histology (please specify),nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21397.0,Alive,TUMOR FREE,1112.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1112.0,0.0,1112.0,0.0,1112.0,0.0,1112.0,0
TCGA-E9-A1NC-01,TCGA-E9-A1NC,BRCA,61.0,FEMALE,WHITE,Stage IIB,nan,Mixed Histology (please specify),nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22355.0,Alive,TUMOR FREE,1203.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1203.0,0.0,1203.0,0.0,1203.0,0.0,1203.0,0
TCGA-E9-A1ND-01,TCGA-E9-A1ND,BRCA,75.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27400.0,Alive,TUMOR FREE,1266.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1266.0,0.0,1266.0,0.0,1266.0,0.0,1266.0,0
TCGA-E9-A1ND-11,TCGA-E9-A1ND,BRCA,75.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27400.0,Alive,TUMOR FREE,1266.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1266.0,0.0,1266.0,0.0,1266.0,0.0,1266.0,0
TCGA-E9-A1NE-01,TCGA-E9-A1NE,BRCA,28.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10564.0,Alive,TUMOR FREE,1088.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1088.0,0.0,1088.0,0.0,1088.0,0.0,1088.0,0
TCGA-E9-A1NE-11,TCGA-E9-A1NE,BRCA,28.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10564.0,Alive,TUMOR FREE,1088.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1088.0,0.0,1088.0,0.0,1088.0,0.0,1088.0,0
TCGA-E9-A1NF-01,TCGA-E9-A1NF,BRCA,60.0,FEMALE,WHITE,Stage IIA,nan,Mixed Histology (please specify),nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21981.0,Dead,WITH TUMOR,nan,1072.0,nan,Distant Metastasis,Lung,nan,90.0,nan,Negative,nan,1.0,1072.0,1.0,1072.0,1.0,90.0,1.0,90.0,1
TCGA-E9-A1NF-11,TCGA-E9-A1NF,BRCA,60.0,FEMALE,WHITE,Stage IIA,nan,Mixed Histology (please specify),nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21981.0,Dead,WITH TUMOR,nan,1072.0,nan,Distant Metastasis,Lung,nan,90.0,nan,Negative,nan,1.0,1072.0,1.0,1072.0,1.0,90.0,1.0,90.0,1
TCGA-E9-A1NG-01,TCGA-E9-A1NG,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22896.0,Dead,TUMOR FREE,nan,786.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,786.0,0.0,786.0,0.0,786.0,0.0,786.0,0
TCGA-E9-A1NG-11,TCGA-E9-A1NG,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22896.0,Dead,TUMOR FREE,nan,786.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,786.0,0.0,786.0,0.0,786.0,0.0,786.0,0
TCGA-E9-A1NH-01,TCGA-E9-A1NH,BRCA,71.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26221.0,Alive,TUMOR FREE,576.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,576.0,0.0,576.0,0.0,576.0,0.0,576.0,0
TCGA-E9-A1NI-01,TCGA-E9-A1NI,BRCA,51.0,FEMALE,WHITE,Stage IIA,nan,Mixed Histology (please specify),nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18985.0,Alive,TUMOR FREE,300.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,300.0,0.0,300.0,0.0,300.0,0.0,300.0,0
TCGA-E9-A1QZ-01,TCGA-E9-A1QZ,BRCA,61.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22397.0,Alive,TUMOR FREE,755.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,755.0,0.0,755.0,0.0,755.0,0.0,755.0,0
TCGA-E9-A1R0-01,TCGA-E9-A1R0,BRCA,58.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21394.0,Alive,TUMOR FREE,860.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,860.0,0.0,860.0,nan,nan,0.0,860.0,0
TCGA-E9-A1R2-01,TCGA-E9-A1R2,BRCA,51.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18936.0,Alive,TUMOR FREE,1063.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,1063.0,0.0,1063.0,nan,nan,0.0,1063.0,0
TCGA-E9-A1R3-01,TCGA-E9-A1R3,BRCA,70.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25693.0,Alive,TUMOR FREE,78.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,78.0,0.0,78.0,0.0,78.0,0.0,78.0,0
TCGA-E9-A1R4-01,TCGA-E9-A1R4,BRCA,66.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24181.0,Alive,TUMOR FREE,186.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,186.0,0.0,186.0,0.0,186.0,0.0,186.0,0
TCGA-E9-A1R5-01,TCGA-E9-A1R5,BRCA,63.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23116.0,Alive,TUMOR FREE,92.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,92.0,0.0,92.0,0.0,92.0,0.0,92.0,0
TCGA-E9-A1R6-01,TCGA-E9-A1R6,BRCA,63.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23347.0,Alive,TUMOR FREE,339.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,339.0,0.0,339.0,0.0,339.0,0.0,339.0,0
TCGA-E9-A1R7-01,TCGA-E9-A1R7,BRCA,64.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23397.0,Alive,TUMOR FREE,1467.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1467.0,0.0,1467.0,0.0,1467.0,0.0,1467.0,0
TCGA-E9-A1R7-11,TCGA-E9-A1R7,BRCA,64.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23397.0,Alive,TUMOR FREE,1467.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1467.0,0.0,1467.0,0.0,1467.0,0.0,1467.0,0
TCGA-E9-A1RA-01,TCGA-E9-A1RA,BRCA,48.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17699.0,Alive,TUMOR FREE,1369.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1369.0,0.0,1369.0,0.0,1369.0,0.0,1369.0,0
TCGA-E9-A1RB-01,TCGA-E9-A1RB,BRCA,40.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14755.0,Dead,TUMOR FREE,nan,976.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,976.0,0.0,976.0,0.0,976.0,0.0,976.0,0
TCGA-E9-A1RB-11,TCGA-E9-A1RB,BRCA,40.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14755.0,Dead,TUMOR FREE,nan,976.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,976.0,0.0,976.0,0.0,976.0,0.0,976.0,0
TCGA-E9-A1RC-01,TCGA-E9-A1RC,BRCA,56.0,FEMALE,WHITE,Stage IIIC,nan,Mixed Histology (please specify),nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20795.0,Alive,TUMOR FREE,1224.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1224.0,0.0,1224.0,0.0,1224.0,0.0,1224.0,0
TCGA-E9-A1RC-11,TCGA-E9-A1RC,BRCA,56.0,FEMALE,WHITE,Stage IIIC,nan,Mixed Histology (please specify),nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20795.0,Alive,TUMOR FREE,1224.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1224.0,0.0,1224.0,0.0,1224.0,0.0,1224.0,0
TCGA-E9-A1RD-01,TCGA-E9-A1RD,BRCA,67.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24719.0,Alive,TUMOR FREE,34.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,34.0,0.0,34.0,0.0,34.0,0.0,34.0,0
TCGA-E9-A1RD-11,TCGA-E9-A1RD,BRCA,67.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24719.0,Alive,TUMOR FREE,34.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,34.0,0.0,34.0,0.0,34.0,0.0,34.0,0
TCGA-E9-A1RE-01,TCGA-E9-A1RE,BRCA,74.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27392.0,Alive,TUMOR FREE,1419.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1419.0,0.0,1419.0,0.0,1419.0,0.0,1419.0,0
TCGA-E9-A1RF-01,TCGA-E9-A1RF,BRCA,68.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25119.0,Alive,TUMOR FREE,200.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,200.0,0.0,200.0,0.0,200.0,0.0,200.0,0
TCGA-E9-A1RF-11,TCGA-E9-A1RF,BRCA,68.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25119.0,Alive,TUMOR FREE,200.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,200.0,0.0,200.0,0.0,200.0,0.0,200.0,0
TCGA-E9-A1RG-01,TCGA-E9-A1RG,BRCA,62.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22788.0,Alive,TUMOR FREE,647.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,647.0,0.0,647.0,0.0,647.0,0.0,647.0,0
TCGA-E9-A1RH-01,TCGA-E9-A1RH,BRCA,63.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23224.0,Alive,TUMOR FREE,1417.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1417.0,0.0,1417.0,0.0,1417.0,0.0,1417.0,0
TCGA-E9-A1RH-11,TCGA-E9-A1RH,BRCA,63.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23224.0,Alive,TUMOR FREE,1417.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1417.0,0.0,1417.0,0.0,1417.0,0.0,1417.0,0
TCGA-E9-A1RI-01,TCGA-E9-A1RI,BRCA,43.0,FEMALE,WHITE,Stage IIIA,nan,Mixed Histology (please specify),nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15942.0,Alive,TUMOR FREE,1449.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1449.0,0.0,1449.0,0.0,1449.0,0.0,1449.0,0
TCGA-E9-A1RI-11,TCGA-E9-A1RI,BRCA,43.0,FEMALE,WHITE,Stage IIIA,nan,Mixed Histology (please specify),nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15942.0,Alive,TUMOR FREE,1449.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1449.0,0.0,1449.0,0.0,1449.0,0.0,1449.0,0
TCGA-E9-A226-01,TCGA-E9-A226,BRCA,45.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16511.0,Dead,WITH TUMOR,nan,1048.0,nan,Distant Metastasis,Bone,nan,790.0,nan,Negative,nan,1.0,1048.0,1.0,1048.0,1.0,790.0,1.0,790.0,1
TCGA-E9-A227-01,TCGA-E9-A227,BRCA,42.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15602.0,Alive,TUMOR FREE,975.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,975.0,0.0,975.0,0.0,975.0,0.0,975.0,0
TCGA-E9-A228-01,TCGA-E9-A228,BRCA,58.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21294.0,Alive,TUMOR FREE,1285.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1285.0,0.0,1285.0,0.0,1285.0,0.0,1285.0,0
TCGA-E9-A229-01,TCGA-E9-A229,BRCA,37.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13817.0,Alive,TUMOR FREE,1148.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1148.0,0.0,1148.0,0.0,1148.0,0.0,1148.0,0
TCGA-E9-A22A-01,TCGA-E9-A22A,BRCA,74.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27288.0,Alive,TUMOR FREE,1189.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1189.0,0.0,1189.0,0.0,1189.0,0.0,1189.0,0
TCGA-E9-A22B-01,TCGA-E9-A22B,BRCA,71.0,FEMALE,WHITE,Stage IA,nan,Mixed Histology (please specify),nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26278.0,Alive,TUMOR FREE,1167.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1167.0,0.0,1167.0,0.0,1167.0,0.0,1167.0,0
TCGA-E9-A22D-01,TCGA-E9-A22D,BRCA,38.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14115.0,Alive,TUMOR FREE,1248.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1248.0,0.0,1248.0,0.0,1248.0,0.0,1248.0,0
TCGA-E9-A22E-01,TCGA-E9-A22E,BRCA,56.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20574.0,Alive,TUMOR FREE,1269.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1269.0,0.0,1269.0,0.0,1269.0,0.0,1269.0,0
TCGA-E9-A22G-01,TCGA-E9-A22G,BRCA,47.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17300.0,Alive,TUMOR FREE,1239.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1239.0,0.0,1239.0,0.0,1239.0,0.0,1239.0,0
TCGA-E9-A22H-01,TCGA-E9-A22H,BRCA,42.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15504.0,Alive,TUMOR FREE,1232.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1232.0,0.0,1232.0,0.0,1232.0,0.0,1232.0,0
TCGA-E9-A243-01,TCGA-E9-A243,BRCA,52.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Peri (6-12 months since last menstrual period),-19035.0,Alive,WITH TUMOR,612.0,nan,nan,Distant Metastasis,Bone,nan,305.0,nan,Negative,nan,0.0,612.0,0.0,612.0,1.0,305.0,1.0,305.0,0
TCGA-E9-A244-01,TCGA-E9-A244,BRCA,54.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19778.0,Alive,TUMOR FREE,21.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,21.0,0.0,21.0,0.0,21.0,0.0,21.0,0
TCGA-E9-A245-01,TCGA-E9-A245,BRCA,47.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17363.0,Alive,TUMOR FREE,26.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,26.0,0.0,26.0,0.0,26.0,0.0,26.0,0
TCGA-E9-A247-01,TCGA-E9-A247,BRCA,59.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21562.0,Alive,TUMOR FREE,1186.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1186.0,0.0,1186.0,0.0,1186.0,0.0,1186.0,0
TCGA-E9-A248-01,TCGA-E9-A248,BRCA,51.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Peri (6-12 months since last menstrual period),-18684.0,Alive,TUMOR FREE,59.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,59.0,0.0,59.0,0.0,59.0,0.0,59.0,0
TCGA-E9-A249-01,TCGA-E9-A249,BRCA,45.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16689.0,Alive,TUMOR FREE,217.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,217.0,0.0,217.0,0.0,217.0,0.0,217.0,0
TCGA-E9-A24A-01,TCGA-E9-A24A,BRCA,69.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25370.0,Alive,TUMOR FREE,747.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,747.0,0.0,747.0,0.0,747.0,0.0,747.0,0
TCGA-E9-A295-01,TCGA-E9-A295,BRCA,71.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25957.0,Alive,TUMOR FREE,375.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,375.0,0.0,375.0,0.0,375.0,0.0,375.0,0
TCGA-E9-A2JS-01,TCGA-E9-A2JS,BRCA,72.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26407.0,Dead,WITH TUMOR,nan,904.0,nan,Distant Metastasis,Bone,Liver,524.0,nan,Negative,nan,1.0,904.0,1.0,904.0,1.0,524.0,1.0,524.0,1
TCGA-E9-A2JT-01,TCGA-E9-A2JT,BRCA,63.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23318.0,Alive,TUMOR FREE,288.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,288.0,0.0,288.0,0.0,288.0,0.0,288.0,0
TCGA-E9-A3HO-01,TCGA-E9-A3HO,BRCA,49.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18046.0,Alive,TUMOR FREE,1158.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1158.0,0.0,1158.0,0.0,1158.0,0.0,1158.0,0
TCGA-E9-A3Q9-01,TCGA-E9-A3Q9,BRCA,78.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28715.0,Alive,TUMOR FREE,1001.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1001.0,0.0,1001.0,0.0,1001.0,0.0,1001.0,0
TCGA-E9-A3QA-01,TCGA-E9-A3QA,BRCA,33.0,FEMALE,WHITE,Stage IIA,nan,Medullary Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12142.0,Alive,TUMOR FREE,918.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,918.0,0.0,918.0,0.0,918.0,0.0,918.0,0
TCGA-E9-A3X8-01,TCGA-E9-A3X8,BRCA,48.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17588.0,Alive,TUMOR FREE,926.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,926.0,0.0,926.0,0.0,926.0,0.0,926.0,0
TCGA-E9-A54X-01,TCGA-E9-A54X,BRCA,85.0,FEMALE,WHITE,Stage IA,nan,Mucinous Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31173.0,Alive,TUMOR FREE,727.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,727.0,0.0,727.0,0.0,727.0,0.0,727.0,0
TCGA-E9-A54Y-01,TCGA-E9-A54Y,BRCA,63.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23057.0,Alive,TUMOR FREE,725.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,725.0,0.0,725.0,0.0,725.0,0.0,725.0,0
TCGA-E9-A5FK-01,TCGA-E9-A5FK,BRCA,60.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22199.0,Alive,TUMOR FREE,812.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,812.0,0.0,812.0,0.0,812.0,0.0,812.0,0
TCGA-E9-A5FL-01,TCGA-E9-A5FL,BRCA,65.0,FEMALE,WHITE,Stage IIB,nan,Metaplastic Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24053.0,Alive,TUMOR FREE,24.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,24.0,0.0,24.0,0.0,24.0,0.0,24.0,0
TCGA-E9-A5UO-01,TCGA-E9-A5UO,BRCA,41.0,FEMALE,WHITE,Stage IIA,nan,Mucinous Carcinoma,nan,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15050.0,Alive,TUMOR FREE,785.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,785.0,0.0,785.0,0.0,785.0,0.0,785.0,0
TCGA-E9-A5UP-01,TCGA-E9-A5UP,BRCA,63.0,FEMALE,WHITE,Stage IIA,nan,"Other, specify",nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23371.0,Alive,TUMOR FREE,803.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,803.0,0.0,803.0,0.0,803.0,0.0,803.0,0
TCGA-E9-A6HE-01,TCGA-E9-A6HE,BRCA,45.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16697.0,Alive,TUMOR FREE,847.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,847.0,0.0,847.0,0.0,847.0,0.0,847.0,0
TCGA-EW-A1IW-01,TCGA-EW-A1IW,BRCA,80.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29529.0,Alive,TUMOR FREE,371.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,371.0,0.0,371.0,0.0,371.0,0.0,371.0,0
TCGA-EW-A1IX-01,TCGA-EW-A1IX,BRCA,48.0,FEMALE,ASIAN,Stage IIA,nan,"Other, specify",nan,2008.0,Peri (6-12 months since last menstrual period),-17597.0,Alive,TUMOR FREE,1208.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1208.0,0.0,1208.0,0.0,1208.0,0.0,1208.0,0
TCGA-EW-A1IY-01,TCGA-EW-A1IY,BRCA,38.0,FEMALE,ASIAN,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14122.0,Alive,TUMOR FREE,258.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,258.0,0.0,258.0,0.0,258.0,0.0,258.0,0
TCGA-EW-A1IZ-01,TCGA-EW-A1IZ,BRCA,53.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19706.0,Alive,TUMOR FREE,554.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,554.0,0.0,554.0,0.0,554.0,0.0,554.0,0
TCGA-EW-A1J1-01,TCGA-EW-A1J1,BRCA,38.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14122.0,Alive,TUMOR FREE,575.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,575.0,0.0,575.0,0.0,575.0,0.0,575.0,0
TCGA-EW-A1J2-01,TCGA-EW-A1J2,BRCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Discrepancy],nan,Infiltrating Lobular Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18558.0,Alive,TUMOR FREE,403.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,403.0,0.0,403.0,0.0,403.0,0.0,403.0,0
TCGA-EW-A1J3-01,TCGA-EW-A1J3,BRCA,61.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22332.0,Alive,TUMOR FREE,504.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,504.0,0.0,504.0,0.0,504.0,0.0,504.0,0
TCGA-EW-A1J5-01,TCGA-EW-A1J5,BRCA,59.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21559.0,Alive,TUMOR FREE,477.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,477.0,0.0,477.0,0.0,477.0,0.0,477.0,0
TCGA-EW-A1J6-01,TCGA-EW-A1J6,BRCA,70.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25830.0,Alive,TUMOR FREE,875.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,875.0,0.0,875.0,0.0,875.0,0.0,875.0,0
TCGA-EW-A1OV-01,TCGA-EW-A1OV,BRCA,56.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20764.0,Alive,TUMOR FREE,789.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,789.0,0.0,789.0,0.0,789.0,0.0,789.0,0
TCGA-EW-A1OW-01,TCGA-EW-A1OW,BRCA,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21465.0,Alive,TUMOR FREE,694.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,694.0,0.0,694.0,0.0,694.0,0.0,694.0,0
TCGA-EW-A1OX-01,TCGA-EW-A1OX,BRCA,43.0,FEMALE,WHITE,Stage IIA,nan,Mucinous Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15837.0,Alive,TUMOR FREE,911.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,911.0,0.0,911.0,0.0,911.0,0.0,911.0,0
TCGA-EW-A1OY-01,TCGA-EW-A1OY,BRCA,63.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23266.0,Alive,TUMOR FREE,908.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,908.0,0.0,908.0,0.0,908.0,0.0,908.0,0
TCGA-EW-A1OZ-01,TCGA-EW-A1OZ,BRCA,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20664.0,Alive,TUMOR FREE,1229.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1229.0,0.0,1229.0,0.0,1229.0,0.0,1229.0,0
TCGA-EW-A1P0-01,TCGA-EW-A1P0,BRCA,55.0,FEMALE,WHITE,Stage IIB,nan,"Other, specify",nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20107.0,Alive,TUMOR FREE,1251.0,nan,nan,Distant Metastasis,"Other, specify",mediastinal lymph node,1094.0,nan,Negative,nan,0.0,1251.0,0.0,1251.0,1.0,1094.0,1.0,1094.0,0
TCGA-EW-A1P1-01,TCGA-EW-A1P1,BRCA,68.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24923.0,Alive,TUMOR FREE,1210.0,nan,nan,Distant Metastasis,Lung,nan,1014.0,nan,Negative,nan,0.0,1210.0,0.0,1210.0,1.0,1014.0,1.0,1014.0,0
TCGA-EW-A1P3-01,TCGA-EW-A1P3,BRCA,48.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17637.0,Alive,TUMOR FREE,1611.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1611.0,0.0,1611.0,0.0,1611.0,0.0,1611.0,0
TCGA-EW-A1P4-01,TCGA-EW-A1P4,BRCA,43.0,FEMALE,WHITE,Stage IIA,nan,Medullary Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15989.0,Alive,TUMOR FREE,907.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,907.0,0.0,907.0,0.0,907.0,0.0,907.0,0
TCGA-EW-A1P5-01,TCGA-EW-A1P5,BRCA,77.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28177.0,Alive,TUMOR FREE,703.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,703.0,0.0,703.0,0.0,703.0,0.0,703.0,0
TCGA-EW-A1P6-01,TCGA-EW-A1P6,BRCA,64.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23485.0,Alive,TUMOR FREE,562.0,nan,nan,nan,nan,nan,nan,nan,Close,nan,0.0,562.0,0.0,562.0,nan,nan,0.0,562.0,0
TCGA-EW-A1P7-01,TCGA-EW-A1P7,BRCA,59.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21750.0,Alive,WITH TUMOR,915.0,nan,nan,Distant Metastasis,"Other, specify",mediastinal lymph nodes,729.0,nan,Negative,nan,0.0,915.0,0.0,915.0,1.0,729.0,1.0,729.0,2
TCGA-EW-A1P8-01,TCGA-EW-A1P8,BRCA,58.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21501.0,Dead,WITH TUMOR,nan,239.0,nan,Distant Metastasis,Lung,nan,207.0,nan,Negative,nan,1.0,239.0,1.0,239.0,1.0,207.0,1.0,207.0,1
TCGA-EW-A1PA-01,TCGA-EW-A1PA,BRCA,59.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21837.0,Alive,TUMOR FREE,575.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,575.0,0.0,575.0,0.0,575.0,0.0,575.0,0
TCGA-EW-A1PB-01,TCGA-EW-A1PB,BRCA,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25770.0,Alive,TUMOR FREE,608.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,608.0,0.0,608.0,0.0,608.0,0.0,608.0,0
TCGA-EW-A1PC-01,TCGA-EW-A1PC,BRCA,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24434.0,Alive,TUMOR FREE,187.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,187.0,0.0,187.0,0.0,187.0,0.0,187.0,0
TCGA-EW-A1PD-01,TCGA-EW-A1PD,BRCA,61.0,MALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,nan,-22536.0,Alive,TUMOR FREE,424.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,424.0,0.0,424.0,0.0,424.0,0.0,424.0,0
TCGA-EW-A1PE-01,TCGA-EW-A1PE,BRCA,56.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20694.0,Alive,TUMOR FREE,320.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,320.0,0.0,320.0,0.0,320.0,0.0,320.0,0
TCGA-EW-A1PF-01,TCGA-EW-A1PF,BRCA,50.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18384.0,Alive,TUMOR FREE,439.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,439.0,0.0,439.0,0.0,439.0,0.0,439.0,0
TCGA-EW-A1PG-01,TCGA-EW-A1PG,BRCA,53.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19464.0,Alive,TUMOR FREE,1051.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1051.0,0.0,1051.0,0.0,1051.0,0.0,1051.0,0
TCGA-EW-A1PH-01,TCGA-EW-A1PH,BRCA,52.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19073.0,Alive,TUMOR FREE,607.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,607.0,0.0,607.0,0.0,607.0,0.0,607.0,0
TCGA-EW-A2FR-01,TCGA-EW-A2FR,BRCA,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21628.0,Alive,TUMOR FREE,1673.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1673.0,0.0,1673.0,0.0,1673.0,0.0,1673.0,0
TCGA-EW-A2FS-01,TCGA-EW-A2FS,BRCA,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15302.0,Alive,TUMOR FREE,1604.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1604.0,0.0,1604.0,0.0,1604.0,0.0,1604.0,0
TCGA-EW-A2FV-01,TCGA-EW-A2FV,BRCA,39.0,FEMALE,WHITE,Stage IIIC,nan,"Other, specify",nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14316.0,Alive,TUMOR FREE,788.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,788.0,0.0,788.0,0.0,788.0,0.0,788.0,0
TCGA-EW-A2FW-01,TCGA-EW-A2FW,BRCA,52.0,FEMALE,WHITE,Stage IIA,nan,"Other, specify",nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19085.0,Alive,TUMOR FREE,672.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,672.0,0.0,672.0,0.0,672.0,0.0,672.0,0
TCGA-EW-A3E8-01,TCGA-EW-A3E8,BRCA,60.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2011.0,[Not Evaluated],-21922.0,Alive,TUMOR FREE,1035.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1035.0,0.0,1035.0,0.0,1035.0,0.0,1035.0,0
TCGA-EW-A3U0-01,TCGA-EW-A3U0,BRCA,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22520.0,Alive,TUMOR FREE,532.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,532.0,0.0,532.0,0.0,532.0,0.0,532.0,0
TCGA-EW-A423-01,TCGA-EW-A423,BRCA,75.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27627.0,Alive,TUMOR FREE,533.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,533.0,0.0,533.0,0.0,533.0,0.0,533.0,0
TCGA-EW-A424-01,TCGA-EW-A424,BRCA,51.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2012.0,[Not Evaluated],-18850.0,Alive,TUMOR FREE,715.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,715.0,0.0,715.0,0.0,715.0,0.0,715.0,0
TCGA-EW-A6S9-01,TCGA-EW-A6S9,BRCA,34.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2013.0,nan,-12755.0,Alive,TUMOR FREE,463.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,463.0,0.0,463.0,nan,nan,0.0,463.0,0
TCGA-EW-A6SA-01,TCGA-EW-A6SA,BRCA,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Infiltrating Ductal Carcinoma,nan,2013.0,nan,-21623.0,Alive,TUMOR FREE,510.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,510.0,0.0,510.0,0.0,510.0,0.0,510.0,0
TCGA-EW-A6SB-01,TCGA-EW-A6SB,BRCA,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Infiltrating Ductal Carcinoma,nan,2012.0,nan,-22844.0,Alive,TUMOR FREE,760.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,760.0,0.0,760.0,0.0,760.0,0.0,760.0,0
TCGA-EW-A6SC-01,TCGA-EW-A6SC,BRCA,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2012.0,nan,-21918.0,Alive,TUMOR FREE,952.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,952.0,0.0,952.0,0.0,952.0,0.0,952.0,0
TCGA-EW-A6SD-01,TCGA-EW-A6SD,BRCA,32.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2012.0,nan,-12006.0,Alive,TUMOR FREE,1010.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1010.0,0.0,1010.0,0.0,1010.0,0.0,1010.0,0
TCGA-GI-A2C8-01,TCGA-GI-A2C8,BRCA,63.0,FEMALE,WHITE,Stage IIIB,nan,Infiltrating Ductal Carcinoma,nan,2004.0,nan,-23103.0,Alive,nan,225.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,225.0,0.0,225.0,0.0,225.0,0.0,225.0,0
TCGA-GI-A2C8-11,TCGA-GI-A2C8,BRCA,63.0,FEMALE,WHITE,Stage IIIB,nan,Infiltrating Ductal Carcinoma,nan,2004.0,nan,-23103.0,Alive,nan,225.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,225.0,0.0,225.0,0.0,225.0,0.0,225.0,0
TCGA-GI-A2C9-01,TCGA-GI-A2C9,BRCA,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21534.0,Alive,TUMOR FREE,3342.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3342.0,0.0,3342.0,0.0,3342.0,0.0,3342.0,0
TCGA-GI-A2C9-11,TCGA-GI-A2C9,BRCA,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21534.0,Alive,TUMOR FREE,3342.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3342.0,0.0,3342.0,0.0,3342.0,0.0,3342.0,0
TCGA-GM-A2D9-01,TCGA-GM-A2D9,BRCA,69.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25490.0,Dead,WITH TUMOR,nan,1812.0,nan,Distant Metastasis,Bone,nan,536.0,nan,Negative,nan,1.0,1812.0,1.0,1812.0,1.0,536.0,1.0,536.0,1
TCGA-GM-A2DA-01,TCGA-GM-A2DA,BRCA,46.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,1993.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16854.0,Dead,WITH TUMOR,nan,6593.0,nan,Distant Metastasis,Bone,nan,3014.0,nan,Negative,nan,1.0,6593.0,1.0,6593.0,1.0,3014.0,1.0,3014.0,1
TCGA-GM-A2DB-01,TCGA-GM-A2DB,BRCA,62.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22883.0,Alive,TUMOR FREE,2406.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2406.0,0.0,2406.0,0.0,2406.0,0.0,2406.0,0
TCGA-GM-A2DC-01,TCGA-GM-A2DC,BRCA,57.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21122.0,Alive,TUMOR FREE,2535.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2535.0,0.0,2535.0,0.0,2535.0,0.0,2535.0,0
TCGA-GM-A2DD-01,TCGA-GM-A2DD,BRCA,53.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19415.0,Alive,TUMOR FREE,2282.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2282.0,0.0,2282.0,0.0,2282.0,0.0,2282.0,0
TCGA-GM-A2DF-01,TCGA-GM-A2DF,BRCA,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19614.0,Alive,TUMOR FREE,2155.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2155.0,0.0,2155.0,0.0,2155.0,0.0,2155.0,0
TCGA-GM-A2DH-01,TCGA-GM-A2DH,BRCA,58.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21344.0,Alive,TUMOR FREE,2193.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2193.0,0.0,2193.0,0.0,2193.0,0.0,2193.0,0
TCGA-GM-A2DI-01,TCGA-GM-A2DI,BRCA,52.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19030.0,Alive,TUMOR FREE,2590.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2590.0,0.0,2590.0,0.0,2590.0,0.0,2590.0,0
TCGA-GM-A2DK-01,TCGA-GM-A2DK,BRCA,58.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21198.0,Alive,TUMOR FREE,2645.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2645.0,0.0,2645.0,0.0,2645.0,0.0,2645.0,0
TCGA-GM-A2DL-01,TCGA-GM-A2DL,BRCA,50.0,FEMALE,WHITE,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2003.0,Peri (6-12 months since last menstrual period),-18475.0,Alive,TUMOR FREE,3519.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3519.0,0.0,3519.0,0.0,3519.0,0.0,3519.0,0
TCGA-GM-A2DM-01,TCGA-GM-A2DM,BRCA,57.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21160.0,Alive,TUMOR FREE,3226.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3226.0,0.0,3226.0,0.0,3226.0,0.0,3226.0,0
TCGA-GM-A2DN-01,TCGA-GM-A2DN,BRCA,58.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21288.0,Alive,TUMOR FREE,3091.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3091.0,0.0,3091.0,0.0,3091.0,0.0,3091.0,0
TCGA-GM-A2DO-01,TCGA-GM-A2DO,BRCA,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Infiltrating Lobular Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19842.0,Alive,TUMOR FREE,2596.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2596.0,0.0,2596.0,0.0,2596.0,0.0,2596.0,0
TCGA-GM-A3NW-01,TCGA-GM-A3NW,BRCA,63.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23041.0,Alive,TUMOR FREE,3361.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3361.0,0.0,3361.0,0.0,3361.0,0.0,3361.0,0
TCGA-GM-A3NY-01,TCGA-GM-A3NY,BRCA,72.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26642.0,Alive,TUMOR FREE,1162.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1162.0,0.0,1162.0,0.0,1162.0,0.0,1162.0,0
TCGA-GM-A3XG-01,TCGA-GM-A3XG,BRCA,46.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16948.0,Alive,TUMOR FREE,1330.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1330.0,0.0,1330.0,0.0,1330.0,0.0,1330.0,0
TCGA-GM-A3XL-01,TCGA-GM-A3XL,BRCA,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18171.0,Alive,TUMOR FREE,2108.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2108.0,0.0,2108.0,0.0,2108.0,0.0,2108.0,0
TCGA-GM-A3XN-01,TCGA-GM-A3XN,BRCA,44.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16109.0,Alive,TUMOR FREE,2019.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2019.0,0.0,2019.0,0.0,2019.0,0.0,2019.0,0
TCGA-GM-A4E0-01,TCGA-GM-A4E0,BRCA,67.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24788.0,Alive,TUMOR FREE,2191.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2191.0,0.0,2191.0,0.0,2191.0,0.0,2191.0,0
TCGA-GM-A5PV-01,TCGA-GM-A5PV,BRCA,63.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23215.0,Alive,TUMOR FREE,412.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,412.0,0.0,412.0,0.0,412.0,0.0,412.0,0
TCGA-GM-A5PX-01,TCGA-GM-A5PX,BRCA,65.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23753.0,Alive,TUMOR FREE,551.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,551.0,0.0,551.0,0.0,551.0,0.0,551.0,0
TCGA-HN-A2NL-01,TCGA-HN-A2NL,BRCA,56.0,FEMALE,[Not Evaluated],Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,nan,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20483.0,Alive,TUMOR FREE,79.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,79.0,0.0,79.0,0.0,79.0,0.0,79.0,0
TCGA-HN-A2OB-01,TCGA-HN-A2OB,BRCA,45.0,FEMALE,[Not Evaluated],Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,nan,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16672.0,Dead,WITH TUMOR,nan,1900.0,nan,Distant Metastasis,Bone,nan,1543.0,nan,Negative,nan,1.0,1900.0,1.0,1900.0,1.0,1543.0,1.0,1543.0,1
TCGA-JL-A3YW-01,TCGA-JL-A3YW,BRCA,49.0,FEMALE,ASIAN,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),nan,Alive,nan,360.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,360.0,0.0,360.0,0.0,360.0,0.0,360.0,0
TCGA-JL-A3YX-01,TCGA-JL-A3YX,BRCA,46.0,FEMALE,ASIAN,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),nan,Alive,nan,352.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,352.0,0.0,352.0,0.0,352.0,0.0,352.0,0
TCGA-LD-A66U-01,TCGA-LD-A66U,BRCA,44.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2012.0,[Not Evaluated],-16101.0,Alive,TUMOR FREE,646.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,646.0,0.0,646.0,0.0,646.0,0.0,646.0,0
TCGA-LD-A74U-01,TCGA-LD-A74U,BRCA,79.0,FEMALE,WHITE,Stage IIIC,nan,"Other, specify",nan,2013.0,nan,-28981.0,Alive,WITH TUMOR,402.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,402.0,0.0,402.0,0.0,402.0,0.0,402.0,0
TCGA-LD-A7W5-01,TCGA-LD-A7W5,BRCA,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19169.0,Alive,WITH TUMOR,216.0,nan,nan,nan,nan,nan,nan,nan,Positive,nan,0.0,216.0,0.0,216.0,nan,nan,0.0,216.0,0
TCGA-LD-A7W6-01,TCGA-LD-A7W6,BRCA,54.0,FEMALE,WHITE,Stage IIB,nan,"Other, specify",nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20077.0,Alive,TUMOR FREE,404.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,404.0,0.0,404.0,0.0,404.0,0.0,404.0,0
TCGA-LD-A9QF-01,TCGA-LD-A9QF,BRCA,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26869.0,Alive,TUMOR FREE,323.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,323.0,0.0,323.0,0.0,323.0,0.0,323.0,0
TCGA-LL-A440-01,TCGA-LL-A440,BRCA,61.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22497.0,Alive,TUMOR FREE,759.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,759.0,0.0,759.0,0.0,759.0,0.0,759.0,0
TCGA-LL-A441-01,TCGA-LL-A441,BRCA,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22772.0,Alive,TUMOR FREE,996.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,996.0,0.0,996.0,0.0,996.0,0.0,996.0,0
TCGA-LL-A442-01,TCGA-LL-A442,BRCA,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20495.0,Alive,TUMOR FREE,889.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,889.0,0.0,889.0,0.0,889.0,0.0,889.0,0
TCGA-LL-A50Y-01,TCGA-LL-A50Y,BRCA,84.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30934.0,Alive,TUMOR FREE,762.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,762.0,0.0,762.0,0.0,762.0,0.0,762.0,0
TCGA-LL-A5YL-01,TCGA-LL-A5YL,BRCA,64.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23395.0,Alive,nan,519.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,519.0,0.0,519.0,0.0,519.0,0.0,519.0,0
TCGA-LL-A5YM-01,TCGA-LL-A5YM,BRCA,88.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,nan,Infiltrating Ductal Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32478.0,Alive,WITH TUMOR,466.0,nan,nan,Locoregional Recurrence,"Other, specify",Skin left chest wall,258.0,nan,Negative,nan,0.0,466.0,0.0,466.0,1.0,258.0,1.0,258.0,0
TCGA-LL-A5YN-01,TCGA-LL-A5YN,BRCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16884.0,Alive,TUMOR FREE,447.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,447.0,0.0,447.0,0.0,447.0,0.0,447.0,0
TCGA-LL-A5YO-01,TCGA-LL-A5YO,BRCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18354.0,Alive,TUMOR FREE,440.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,440.0,0.0,440.0,0.0,440.0,0.0,440.0,0
TCGA-LL-A5YP-01,TCGA-LL-A5YP,BRCA,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18041.0,Alive,nan,450.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,450.0,0.0,450.0,0.0,450.0,0.0,450.0,0
TCGA-LL-A6FP-01,TCGA-LL-A6FP,BRCA,90.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32873.0,Alive,TUMOR FREE,677.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,677.0,0.0,677.0,0.0,677.0,0.0,677.0,0
TCGA-LL-A6FQ-01,TCGA-LL-A6FQ,BRCA,77.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28375.0,Alive,nan,80.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,80.0,0.0,80.0,0.0,80.0,0.0,80.0,0
TCGA-LL-A6FR-01,TCGA-LL-A6FR,BRCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18520.0,Alive,TUMOR FREE,489.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,489.0,0.0,489.0,0.0,489.0,0.0,489.0,0
TCGA-LL-A73Y-01,TCGA-LL-A73Y,BRCA,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24647.0,Alive,TUMOR FREE,477.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,477.0,0.0,477.0,0.0,477.0,0.0,477.0,0
TCGA-LL-A73Z-01,TCGA-LL-A73Z,BRCA,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20118.0,Dead,WITH TUMOR,nan,227.0,nan,Distant Metastasis,Brain,nan,192.0,nan,Positive,nan,1.0,227.0,1.0,227.0,nan,nan,1.0,192.0,1
TCGA-LL-A740-01,TCGA-LL-A740,BRCA,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22416.0,Alive,TUMOR FREE,441.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,441.0,0.0,441.0,0.0,441.0,0.0,441.0,0
TCGA-LL-A7SZ-01,TCGA-LL-A7SZ,BRCA,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18161.0,Alive,TUMOR FREE,594.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,594.0,0.0,594.0,0.0,594.0,0.0,594.0,0
TCGA-LL-A7T0-01,TCGA-LL-A7T0,BRCA,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25867.0,Alive,TUMOR FREE,376.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,376.0,0.0,376.0,0.0,376.0,0.0,376.0,0
TCGA-LL-A8F5-01,TCGA-LL-A8F5,BRCA,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22544.0,Alive,TUMOR FREE,596.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,596.0,0.0,596.0,0.0,596.0,0.0,596.0,0
TCGA-LL-A9Q3-01,TCGA-LL-A9Q3,BRCA,69.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25477.0,Alive,TUMOR FREE,532.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,532.0,0.0,532.0,0.0,532.0,0.0,532.0,0
TCGA-LQ-A4E4-01,TCGA-LQ-A4E4,BRCA,73.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26883.0,Alive,WITH TUMOR,849.0,nan,nan,Distant Metastasis,Bone,nan,681.0,nan,Positive,nan,0.0,849.0,0.0,849.0,nan,nan,1.0,681.0,0
TCGA-MS-A51U-01,TCGA-MS-A51U,BRCA,44.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2012.0,nan,-16213.0,Alive,TUMOR FREE,681.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,681.0,0.0,681.0,0.0,681.0,0.0,681.0,0
TCGA-OK-A5Q2-01,TCGA-OK-A5Q2,BRCA,59.0,FEMALE,[Not Evaluated],Stage II,nan,Infiltrating Lobular Carcinoma,nan,2012.0,[Unknown],-21555.0,Alive,nan,64.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,64.0,0.0,64.0,0.0,64.0,0.0,64.0,0
TCGA-OL-A5D6-01,TCGA-OL-A5D6,BRCA,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26052.0,Dead,TUMOR FREE,nan,1104.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,1104.0,0.0,1104.0,0.0,1104.0,0.0,1104.0,0
TCGA-OL-A5D7-01,TCGA-OL-A5D7,BRCA,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25643.0,Alive,TUMOR FREE,1780.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1780.0,0.0,1780.0,0.0,1780.0,0.0,1780.0,0
TCGA-OL-A5D8-01,TCGA-OL-A5D8,BRCA,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14853.0,Alive,TUMOR FREE,973.0,nan,nan,nan,nan,nan,nan,nan,[Unknown],nan,0.0,973.0,0.0,973.0,nan,nan,0.0,973.0,0
TCGA-OL-A5DA-01,TCGA-OL-A5DA,BRCA,61.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22411.0,Alive,TUMOR FREE,1783.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1783.0,0.0,1783.0,0.0,1783.0,0.0,1783.0,0
TCGA-OL-A5RU-01,TCGA-OL-A5RU,BRCA,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23108.0,Alive,TUMOR FREE,1219.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1219.0,0.0,1219.0,0.0,1219.0,0.0,1219.0,0
TCGA-OL-A5RV-01,TCGA-OL-A5RV,BRCA,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15820.0,Alive,TUMOR FREE,1062.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1062.0,0.0,1062.0,0.0,1062.0,0.0,1062.0,0
TCGA-OL-A5RW-01,TCGA-OL-A5RW,BRCA,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14638.0,Alive,TUMOR FREE,1106.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1106.0,0.0,1106.0,0.0,1106.0,0.0,1106.0,0
TCGA-OL-A5RX-01,TCGA-OL-A5RX,BRCA,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18942.0,Alive,TUMOR FREE,878.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,878.0,0.0,878.0,0.0,878.0,0.0,878.0,0
TCGA-OL-A5RY-01,TCGA-OL-A5RY,BRCA,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19216.0,Alive,TUMOR FREE,752.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,752.0,0.0,752.0,0.0,752.0,0.0,752.0,0
TCGA-OL-A5RZ-01,TCGA-OL-A5RZ,BRCA,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21038.0,Alive,TUMOR FREE,679.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,679.0,0.0,679.0,0.0,679.0,0.0,679.0,0
TCGA-OL-A5S0-01,TCGA-OL-A5S0,BRCA,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24139.0,Alive,TUMOR FREE,620.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,620.0,0.0,620.0,0.0,620.0,0.0,620.0,0
TCGA-OL-A66H-01,TCGA-OL-A66H,BRCA,nan,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Mucinous Carcinoma,nan,nan,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),nan,Alive,TUMOR FREE,nan,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,nan,0.0,nan,0.0,nan,0.0,nan,0
TCGA-OL-A66I-01,TCGA-OL-A66I,BRCA,36.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2008.0,[Not Evaluated],-13458.0,Alive,TUMOR FREE,714.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,714.0,0.0,714.0,0.0,714.0,0.0,714.0,0
TCGA-OL-A66J-01,TCGA-OL-A66J,BRCA,80.0,FEMALE,WHITE,Stage I,nan,Infiltrating Lobular Carcinoma,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29345.0,Alive,TUMOR FREE,1996.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1996.0,0.0,1996.0,0.0,1996.0,0.0,1996.0,0
TCGA-OL-A66K-01,TCGA-OL-A66K,BRCA,72.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26299.0,Dead,TUMOR FREE,nan,1275.0,nan,nan,nan,nan,nan,nan,Negative,nan,1.0,1275.0,0.0,1275.0,0.0,1275.0,0.0,1275.0,0
TCGA-OL-A66L-01,TCGA-OL-A66L,BRCA,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26186.0,Alive,TUMOR FREE,1301.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1301.0,0.0,1301.0,0.0,1301.0,0.0,1301.0,0
TCGA-OL-A66N-01,TCGA-OL-A66N,BRCA,59.0,FEMALE,WHITE,Stage IIIC,nan,Infiltrating Lobular Carcinoma,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21608.0,Alive,TUMOR FREE,792.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,792.0,0.0,792.0,0.0,792.0,0.0,792.0,0
TCGA-OL-A66O-01,TCGA-OL-A66O,BRCA,39.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14272.0,Alive,TUMOR FREE,528.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,528.0,0.0,528.0,0.0,528.0,0.0,528.0,0
TCGA-OL-A66P-01,TCGA-OL-A66P,BRCA,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2013.0,nan,-27489.0,Alive,TUMOR FREE,428.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,428.0,0.0,428.0,0.0,428.0,0.0,428.0,0
TCGA-OL-A6VO-01,TCGA-OL-A6VO,BRCA,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2012.0,[Unknown],-15780.0,Alive,TUMOR FREE,858.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,858.0,0.0,858.0,0.0,858.0,0.0,858.0,0
TCGA-OL-A6VQ-01,TCGA-OL-A6VQ,BRCA,49.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18151.0,Alive,TUMOR FREE,600.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,600.0,0.0,600.0,0.0,600.0,0.0,600.0,0
TCGA-OL-A6VR-01,TCGA-OL-A6VR,BRCA,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Infiltrating Ductal Carcinoma,nan,2011.0,[Unknown],-17702.0,Alive,TUMOR FREE,1220.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1220.0,0.0,1220.0,0.0,1220.0,0.0,1220.0,0
TCGA-OL-A97C-01,TCGA-OL-A97C,BRCA,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,"Other, specify",nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24735.0,Alive,TUMOR FREE,271.0,nan,nan,Distant Metastasis,Lung,nan,275.0,nan,nan,nan,0.0,271.0,0.0,271.0,nan,nan,1.0,275.0,0
TCGA-PE-A5DC-01,TCGA-PE-A5DC,BRCA,72.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26514.0,Dead,TUMOR FREE,nan,1430.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1430.0,0.0,1430.0,nan,nan,0.0,1430.0,0
TCGA-PE-A5DD-01,TCGA-PE-A5DD,BRCA,64.0,FEMALE,ASIAN,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23686.0,Alive,TUMOR FREE,1953.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1953.0,0.0,1953.0,0.0,1953.0,0.0,1953.0,0
TCGA-PE-A5DE-01,TCGA-PE-A5DE,BRCA,41.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15216.0,Alive,TUMOR FREE,2645.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2645.0,0.0,2645.0,nan,nan,0.0,2645.0,0
TCGA-PL-A8LV-01,TCGA-PL-A8LV,BRCA,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,nan,Medullary Carcinoma,nan,2013.0,[Unknown],-19746.0,Alive,WITH TUMOR,-7.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-PL-A8LX-01,TCGA-PL-A8LX,BRCA,35.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12840.0,Alive,WITH TUMOR,5.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,5.0,0.0,5.0,nan,nan,0.0,5.0,0
TCGA-PL-A8LY-01,TCGA-PL-A8LY,BRCA,30.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11199.0,Alive,WITH TUMOR,8.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,8.0,0.0,8.0,nan,nan,0.0,8.0,0
TCGA-PL-A8LZ-01,TCGA-PL-A8LZ,BRCA,29.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10869.0,Alive,TUMOR FREE,302.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,302.0,0.0,302.0,nan,nan,0.0,302.0,0
TCGA-S3-A6ZF-01,TCGA-S3-A6ZF,BRCA,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23650.0,Alive,TUMOR FREE,572.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,572.0,0.0,572.0,0.0,572.0,0.0,572.0,0
TCGA-S3-A6ZG-01,TCGA-S3-A6ZG,BRCA,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Mixed Histology (please specify),nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26141.0,Alive,TUMOR FREE,562.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,562.0,0.0,562.0,0.0,562.0,0.0,562.0,0
TCGA-S3-A6ZH-01,TCGA-S3-A6ZH,BRCA,29.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,nan,Infiltrating Ductal Carcinoma,nan,2013.0,[Unknown],-10832.0,Alive,TUMOR FREE,641.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,641.0,0.0,641.0,0.0,641.0,0.0,641.0,0
TCGA-S3-AA0Z-01,TCGA-S3-AA0Z,BRCA,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23314.0,Alive,TUMOR FREE,629.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,629.0,0.0,629.0,0.0,629.0,0.0,629.0,0
TCGA-S3-AA10-01,TCGA-S3-AA10,BRCA,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24075.0,Alive,TUMOR FREE,586.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,586.0,0.0,586.0,0.0,586.0,0.0,586.0,0
TCGA-S3-AA11-01,TCGA-S3-AA11,BRCA,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24813.0,Alive,TUMOR FREE,421.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,421.0,0.0,421.0,0.0,421.0,0.0,421.0,0
TCGA-S3-AA12-01,TCGA-S3-AA12,BRCA,82.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30101.0,Alive,TUMOR FREE,574.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,574.0,0.0,574.0,0.0,574.0,0.0,574.0,0
TCGA-S3-AA14-01,TCGA-S3-AA14,BRCA,47.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17352.0,Alive,TUMOR FREE,529.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,529.0,0.0,529.0,0.0,529.0,0.0,529.0,0
TCGA-S3-AA15-01,TCGA-S3-AA15,BRCA,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18659.0,Alive,TUMOR FREE,525.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,525.0,0.0,525.0,0.0,525.0,0.0,525.0,0
TCGA-S3-AA17-01,TCGA-S3-AA17,BRCA,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23642.0,Alive,TUMOR FREE,424.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,424.0,0.0,424.0,0.0,424.0,0.0,424.0,0
TCGA-UL-AAZ6-01,TCGA-UL-AAZ6,BRCA,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26999.0,Alive,TUMOR FREE,518.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,518.0,0.0,518.0,nan,nan,0.0,518.0,0
TCGA-UU-A93S-01,TCGA-UU-A93S,BRCA,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Infiltrating Ductal Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23278.0,Dead,WITH TUMOR,nan,116.0,nan,nan,nan,nan,nan,nan,Positive,nan,1.0,116.0,1.0,116.0,nan,nan,1.0,116.0,1
TCGA-V7-A7HQ-01,TCGA-V7-A7HQ,BRCA,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Infiltrating Ductal Carcinoma,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27684.0,Alive,TUMOR FREE,2033.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,2033.0,0.0,2033.0,0.0,2033.0,0.0,2033.0,0
TCGA-W8-A86G-01,TCGA-W8-A86G,BRCA,66.0,FEMALE,WHITE,Stage IIA,nan,Infiltrating Lobular Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24125.0,Alive,TUMOR FREE,347.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,347.0,0.0,347.0,0.0,347.0,0.0,347.0,0
TCGA-WT-AB41-01,TCGA-WT-AB41,BRCA,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Infiltrating Ductal Carcinoma,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),nan,Alive,TUMOR FREE,1611.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,1611.0,0.0,1611.0,0.0,1611.0,0.0,1611.0,0
TCGA-WT-AB44-01,TCGA-WT-AB44,BRCA,77.0,FEMALE,WHITE,Stage IA,nan,Infiltrating Lobular Carcinoma,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),nan,Alive,TUMOR FREE,883.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,883.0,0.0,883.0,0.0,883.0,0.0,883.0,0
TCGA-XX-A899-01,TCGA-XX-A899,BRCA,46.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17022.0,Alive,TUMOR FREE,467.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,467.0,0.0,467.0,0.0,467.0,0.0,467.0,0
TCGA-XX-A89A-01,TCGA-XX-A89A,BRCA,68.0,FEMALE,WHITE,Stage IIB,nan,Infiltrating Lobular Carcinoma,nan,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25000.0,Alive,TUMOR FREE,488.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,488.0,0.0,488.0,0.0,488.0,0.0,488.0,0
TCGA-Z7-A8R5-01,TCGA-Z7-A8R5,BRCA,61.0,FEMALE,WHITE,Stage IIIA,nan,Infiltrating Lobular Carcinoma,nan,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22280.0,Alive,WITH TUMOR,3287.0,nan,nan,Locoregional Recurrence,nan,nan,181.0,nan,Positive,nan,0.0,3287.0,0.0,3287.0,nan,nan,1.0,181.0,0
TCGA-Z7-A8R6-01,TCGA-Z7-A8R6,BRCA,46.0,FEMALE,WHITE,Stage I,nan,Infiltrating Lobular Carcinoma,nan,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16955.0,Alive,TUMOR FREE,3256.0,nan,nan,nan,nan,nan,nan,nan,Negative,nan,0.0,3256.0,0.0,3256.0,0.0,3256.0,0.0,3256.0,0
TCGA-2W-A8YY-01,TCGA-2W-A8YY,CESC,51.0,FEMALE,WHITE,nan,Stage IB2,Adenosquamous,G3,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18886.0,Alive,TUMOR FREE,533.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,533.0,0.0,533.0,0.0,533.0,0.0,533.0,0
TCGA-4J-AA1J-01,TCGA-4J-AA1J,CESC,31.0,FEMALE,WHITE,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G3,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11611.0,Alive,TUMOR FREE,542.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,542.0,0.0,542.0,0.0,542.0,0.0,542.0,0
TCGA-BI-A0VR-01,TCGA-BI-A0VR,CESC,53.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19473.0,Alive,TUMOR FREE,1505.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1505.0,0.0,1505.0,nan,nan,0.0,1505.0,0
TCGA-BI-A0VS-01,TCGA-BI-A0VS,CESC,48.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G3,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17839.0,Alive,TUMOR FREE,1735.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1735.0,0.0,1735.0,0.0,1735.0,0.0,1735.0,0
TCGA-BI-A20A-01,TCGA-BI-A20A,CESC,49.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2010.0,nan,-18215.0,Alive,TUMOR FREE,720.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,720.0,0.0,720.0,0.0,720.0,0.0,720.0,0
TCGA-C5-A0TN-01,TCGA-C5-A0TN,CESC,21.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G3,1997.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-7760.0,Dead,WITH TUMOR,nan,348.0,Cervical Cancer,Distant Metastasis,"Other, specify",Pelvis/Liver,62.0,Progressive Disease,nan,nan,1.0,348.0,1.0,348.0,nan,nan,1.0,62.0,1
TCGA-C5-A1BE-01,TCGA-C5-A1BE,CESC,64.0,FEMALE,WHITE,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G2,2000.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23727.0,Dead,WITH TUMOR,nan,2094.0,Cervical Cancer,nan,nan,nan,1674.0,Complete Remission/Response,nan,nan,1.0,2094.0,1.0,2094.0,1.0,1674.0,1.0,1674.0,1
TCGA-C5-A1BF-01,TCGA-C5-A1BF,CESC,46.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G1,1997.0,nan,-16975.0,Dead,WITH TUMOR,nan,570.0,Cervical Cancer,Distant Metastasis,"Other, specify","Lung, Sternum",93.0,Complete Remission/Response,nan,nan,1.0,570.0,1.0,570.0,1.0,93.0,1.0,93.0,1
TCGA-C5-A1BI-01,TCGA-C5-A1BI,CESC,31.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2001.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11564.0,Alive,TUMOR FREE,1112.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1112.0,0.0,1112.0,0.0,1112.0,0.0,1112.0,0
TCGA-C5-A1BJ-01,TCGA-C5-A1BJ,CESC,34.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G2,1997.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12611.0,Alive,TUMOR FREE,4385.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4385.0,0.0,4385.0,0.0,4385.0,0.0,4385.0,0
TCGA-C5-A1BK-01,TCGA-C5-A1BK,CESC,36.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Cervical Squamous Cell Carcinoma,G2,1994.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13297.0,Alive,TUMOR FREE,5385.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,5385.0,0.0,5385.0,0.0,5385.0,0.0,5385.0,0
TCGA-C5-A1BL-01,TCGA-C5-A1BL,CESC,32.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G2,1994.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11723.0,Alive,TUMOR FREE,5271.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,5271.0,0.0,5271.0,0.0,5271.0,0.0,5271.0,0
TCGA-C5-A1BM-01,TCGA-C5-A1BM,CESC,78.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Cervical Squamous Cell Carcinoma,G2,1997.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28815.0,Dead,TUMOR FREE,nan,2520.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2520.0,0.0,2520.0,0.0,2520.0,0.0,2520.0,0
TCGA-C5-A1BN-01,TCGA-C5-A1BN,CESC,26.0,FEMALE,WHITE,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G3,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9783.0,Dead,WITH TUMOR,nan,166.0,Cervical Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,166.0,1.0,166.0,nan,nan,1.0,166.0,1
TCGA-C5-A1BQ-01,TCGA-C5-A1BQ,CESC,65.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24018.0,Dead,TUMOR FREE,nan,604.0,Cervical Cancer,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,604.0,1.0,604.0,nan,nan,0.0,604.0,1
TCGA-C5-A1M5-01,TCGA-C5-A1M5,CESC,53.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G2,1996.0,Indeterminate (neither Pre or Postmenopausal),-19672.0,Dead,WITH TUMOR,nan,2052.0,Cervical Cancer,Distant Metastasis,"Other, specify",Regional recurrence NOS,693.0,Complete Remission/Response,nan,nan,1.0,2052.0,1.0,2052.0,1.0,693.0,1.0,693.0,1
TCGA-C5-A1M6-01,TCGA-C5-A1M6,CESC,55.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G3,1998.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20090.0,Dead,WITH TUMOR,nan,955.0,Cervical Cancer,Distant Metastasis,Lung,nan,316.0,Complete Remission/Response,nan,nan,1.0,955.0,1.0,955.0,1.0,316.0,1.0,316.0,1
TCGA-C5-A1M7-01,TCGA-C5-A1M7,CESC,37.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G2,1999.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13808.0,Alive,TUMOR FREE,1409.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1409.0,0.0,1409.0,0.0,1409.0,0.0,1409.0,0
TCGA-C5-A1M8-01,TCGA-C5-A1M8,CESC,43.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2001.0,Indeterminate (neither Pre or Postmenopausal),-15848.0,Alive,TUMOR FREE,919.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,919.0,0.0,919.0,0.0,919.0,0.0,919.0,0
TCGA-C5-A1M9-01,TCGA-C5-A1M9,CESC,46.0,FEMALE,WHITE,nan,Stage IB1,Endocervical Type of Adenocarcinoma,G3,2002.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17020.0,Dead,WITH TUMOR,nan,1065.0,Cervical Cancer,Distant Metastasis,Lung,nan,555.0,Complete Remission/Response,nan,nan,1.0,1065.0,1.0,1065.0,1.0,555.0,1.0,555.0,1
TCGA-C5-A1ME-01,TCGA-C5-A1ME,CESC,40.0,FEMALE,WHITE,nan,Stage IB1,Endocervical Type of Adenocarcinoma,G1,2003.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14970.0,Alive,TUMOR FREE,1756.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1756.0,0.0,1756.0,0.0,1756.0,0.0,1756.0,0
TCGA-C5-A1MF-01,TCGA-C5-A1MF,CESC,49.0,FEMALE,WHITE,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G2,2004.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17911.0,Alive,TUMOR FREE,1617.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1617.0,0.0,1617.0,0.0,1617.0,0.0,1617.0,0
TCGA-C5-A1MH-01,TCGA-C5-A1MH,CESC,71.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26234.0,Dead,WITH TUMOR,nan,1186.0,Cervical Cancer,Distant Metastasis,Lung,nan,178.0,Complete Remission/Response,nan,nan,1.0,1186.0,1.0,1186.0,1.0,178.0,1.0,178.0,1
TCGA-C5-A1MI-01,TCGA-C5-A1MI,CESC,50.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2004.0,Peri (6-12 months since last menstrual period),-18336.0,Dead,WITH TUMOR,nan,1083.0,Cervical Cancer,Distant Metastasis,"Other, specify",distant recurrence multiple sites,805.0,Complete Remission/Response,nan,nan,1.0,1083.0,1.0,1083.0,1.0,805.0,1.0,805.0,1
TCGA-C5-A1MJ-01,TCGA-C5-A1MJ,CESC,61.0,FEMALE,WHITE,nan,Stage IB1,Endocervical Type of Adenocarcinoma,G2,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22308.0,Dead,TUMOR FREE,nan,14.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,14.0,0.0,14.0,nan,nan,0.0,14.0,1
TCGA-C5-A1MK-01,TCGA-C5-A1MK,CESC,79.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28939.0,Dead,WITH TUMOR,nan,74.0,Cervical Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,74.0,1.0,74.0,nan,nan,1.0,74.0,1
TCGA-C5-A1ML-01,TCGA-C5-A1ML,CESC,49.0,FEMALE,WHITE,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18067.0,Dead,WITH TUMOR,nan,636.0,Cervical Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,636.0,1.0,636.0,nan,nan,1.0,636.0,1
TCGA-C5-A1MN-01,TCGA-C5-A1MN,CESC,42.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15499.0,Dead,TUMOR FREE,nan,1245.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1245.0,0.0,1245.0,0.0,1245.0,0.0,1245.0,0
TCGA-C5-A1MP-01,TCGA-C5-A1MP,CESC,34.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G3,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12692.0,Alive,TUMOR FREE,109.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,109.0,0.0,109.0,0.0,109.0,0.0,109.0,0
TCGA-C5-A1MQ-01,TCGA-C5-A1MQ,CESC,35.0,FEMALE,WHITE,nan,Stage IIA,Cervical Squamous Cell Carcinoma,G2,2009.0,nan,-12836.0,Alive,TUMOR FREE,1031.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1031.0,0.0,1031.0,0.0,1031.0,0.0,1031.0,2
TCGA-C5-A2LS-01,TCGA-C5-A2LS,CESC,37.0,FEMALE,WHITE,nan,Stage IB2,Endocervical Adenocarcinoma of the Usual Type,G1,2005.0,nan,-13857.0,Alive,TUMOR FREE,1345.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1345.0,0.0,1345.0,0.0,1345.0,0.0,1345.0,0
TCGA-C5-A2LT-01,TCGA-C5-A2LT,CESC,38.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G3,2001.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13966.0,Alive,TUMOR FREE,2226.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2226.0,0.0,2226.0,0.0,2226.0,0.0,2226.0,0
TCGA-C5-A2LV-01,TCGA-C5-A2LV,CESC,36.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Cervical Squamous Cell Carcinoma,G3,2003.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13447.0,Alive,TUMOR FREE,2234.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2234.0,0.0,2234.0,0.0,2234.0,0.0,2234.0,0
TCGA-C5-A2LX-01,TCGA-C5-A2LX,CESC,54.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20070.0,Alive,TUMOR FREE,2526.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2526.0,0.0,2526.0,0.0,2526.0,0.0,2526.0,0
TCGA-C5-A2LY-01,TCGA-C5-A2LY,CESC,30.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2002.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11018.0,Alive,TUMOR FREE,2383.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2383.0,0.0,2383.0,0.0,2383.0,0.0,2383.0,0
TCGA-C5-A2LZ-01,TCGA-C5-A2LZ,CESC,65.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G2,1998.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24059.0,Dead,WITH TUMOR,nan,3046.0,Cervical Cancer,Distant Metastasis,nan,nan,2893.0,Complete Remission/Response,nan,nan,1.0,3046.0,1.0,3046.0,1.0,2893.0,1.0,2893.0,2
TCGA-C5-A2M1-01,TCGA-C5-A2M1,CESC,37.0,FEMALE,WHITE,nan,Stage IB1,Endocervical Type of Adenocarcinoma,G2,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13835.0,Alive,TUMOR FREE,1169.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1169.0,0.0,1169.0,0.0,1169.0,0.0,1169.0,0
TCGA-C5-A2M2-01,TCGA-C5-A2M2,CESC,56.0,FEMALE,WHITE,nan,Stage IB2,Endocervical Type of Adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20480.0,Dead,nan,nan,1011.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1011.0,nan,1011.0,nan,nan,0.0,1011.0,1
TCGA-C5-A3HD-01,TCGA-C5-A3HD,CESC,51.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G2,2004.0,nan,-18690.0,Alive,TUMOR FREE,1582.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1582.0,0.0,1582.0,0.0,1582.0,0.0,1582.0,0
TCGA-C5-A3HE-01,TCGA-C5-A3HE,CESC,44.0,FEMALE,WHITE,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G3,2006.0,nan,-16139.0,Alive,nan,548.0,nan,nan,Locoregional Recurrence,Cervix,nan,252.0,nan,nan,nan,0.0,548.0,0.0,548.0,nan,nan,1.0,252.0,2
TCGA-C5-A3HF-01,TCGA-C5-A3HF,CESC,24.0,FEMALE,WHITE,nan,Stage IB2,Mucinous Adenocarcinoma of Endocervical Type,G2,1996.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9115.0,Dead,WITH TUMOR,nan,543.0,Cervical Cancer,Distant Metastasis,"Other, specify",Pelvis,450.0,nan,nan,nan,1.0,543.0,1.0,543.0,nan,nan,1.0,450.0,1
TCGA-C5-A3HL-01,TCGA-C5-A3HL,CESC,76.0,FEMALE,WHITE,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G2,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27963.0,Alive,TUMOR FREE,621.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,621.0,0.0,621.0,0.0,621.0,0.0,621.0,0
TCGA-C5-A7CG-01,TCGA-C5-A7CG,CESC,55.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G2,1997.0,nan,-20242.0,Alive,TUMOR FREE,6408.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,6408.0,0.0,6408.0,nan,nan,0.0,6408.0,0
TCGA-C5-A7CH-01,TCGA-C5-A7CH,CESC,43.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G2,2001.0,nan,-15777.0,Alive,TUMOR FREE,4694.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4694.0,0.0,4694.0,nan,nan,0.0,4694.0,0
TCGA-C5-A7CJ-01,TCGA-C5-A7CJ,CESC,42.0,FEMALE,WHITE,nan,Stage IIA,Cervical Squamous Cell Carcinoma,G2,2002.0,nan,-15652.0,Dead,TUMOR FREE,nan,3097.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,3097.0,0.0,3097.0,nan,nan,0.0,3097.0,1
TCGA-C5-A7CK-01,TCGA-C5-A7CK,CESC,58.0,FEMALE,WHITE,nan,Stage IVA,Cervical Squamous Cell Carcinoma,G2,2001.0,nan,-21520.0,Dead,TUMOR FREE,nan,4086.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,4086.0,0.0,4086.0,nan,nan,0.0,4086.0,1
TCGA-C5-A7CL-01,TCGA-C5-A7CL,CESC,48.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2002.0,nan,-17869.0,Dead,WITH TUMOR,nan,471.0,Cervical Cancer,nan,nan,nan,nan,nan,nan,nan,1.0,471.0,1.0,471.0,nan,nan,1.0,471.0,1
TCGA-C5-A7CM-01,TCGA-C5-A7CM,CESC,35.0,FEMALE,WHITE,nan,Stage IB2,Endocervical Adenocarcinoma of the Usual Type,G2,2012.0,nan,-12853.0,Alive,TUMOR FREE,619.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,619.0,0.0,619.0,0.0,619.0,0.0,619.0,0
TCGA-C5-A7CO-01,TCGA-C5-A7CO,CESC,68.0,FEMALE,WHITE,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G2,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25045.0,Alive,TUMOR FREE,4482.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4482.0,0.0,4482.0,0.0,4482.0,0.0,4482.0,0
TCGA-C5-A7UC-01,TCGA-C5-A7UC,CESC,48.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G3,2002.0,nan,-17765.0,Dead,TUMOR FREE,nan,523.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,523.0,0.0,523.0,nan,nan,0.0,523.0,1
TCGA-C5-A7UE-01,TCGA-C5-A7UE,CESC,45.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2001.0,nan,-16473.0,Alive,TUMOR FREE,4738.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4738.0,0.0,4738.0,0.0,4738.0,0.0,4738.0,0
TCGA-C5-A7UH-01,TCGA-C5-A7UH,CESC,55.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2003.0,nan,-20189.0,Alive,TUMOR FREE,3988.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3988.0,0.0,3988.0,nan,nan,0.0,3988.0,0
TCGA-C5-A7UI-01,TCGA-C5-A7UI,CESC,42.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2004.0,nan,-15349.0,Dead,TUMOR FREE,nan,2888.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2888.0,0.0,2888.0,nan,nan,0.0,2888.0,1
TCGA-C5-A7X3-01,TCGA-C5-A7X3,CESC,70.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G2,1997.0,nan,-25665.0,Dead,TUMOR FREE,nan,284.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,284.0,0.0,284.0,nan,nan,0.0,284.0,1
TCGA-C5-A7X5-01,TCGA-C5-A7X5,CESC,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IVB,Cervical Squamous Cell Carcinoma,G3,2003.0,nan,-26542.0,Dead,WITH TUMOR,nan,414.0,Cervical Cancer,nan,nan,nan,nan,nan,nan,nan,1.0,414.0,1.0,414.0,nan,nan,1.0,414.0,1
TCGA-C5-A7X8-01,TCGA-C5-A7X8,CESC,35.0,FEMALE,WHITE,nan,Stage IB1,Mucinous Adenocarcinoma of Endocervical Type,G2,2003.0,nan,-12977.0,Alive,TUMOR FREE,83.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,83.0,0.0,83.0,nan,nan,0.0,83.0,0
TCGA-C5-A7XC-01,TCGA-C5-A7XC,CESC,26.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2004.0,nan,-9776.0,Alive,TUMOR FREE,1551.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1551.0,0.0,1551.0,nan,nan,0.0,1551.0,0
TCGA-C5-A8XH-01,TCGA-C5-A8XH,CESC,39.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,nan,2007.0,nan,-14444.0,Dead,TUMOR FREE,nan,1394.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1394.0,0.0,1394.0,nan,nan,0.0,1394.0,1
TCGA-C5-A8XI-01,TCGA-C5-A8XI,CESC,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25220.0,Alive,TUMOR FREE,254.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,254.0,0.0,254.0,nan,nan,0.0,254.0,0
TCGA-C5-A8XJ-01,TCGA-C5-A8XJ,CESC,74.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,nan,2002.0,nan,-27087.0,Alive,TUMOR FREE,4467.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4467.0,0.0,4467.0,nan,nan,0.0,4467.0,0
TCGA-C5-A8XK-01,TCGA-C5-A8XK,CESC,30.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Cervical Squamous Cell Carcinoma,G3,2000.0,nan,-11268.0,Alive,TUMOR FREE,3039.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3039.0,0.0,3039.0,nan,nan,0.0,3039.0,0
TCGA-C5-A8YQ-01,TCGA-C5-A8YQ,CESC,79.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28873.0,Dead,WITH TUMOR,nan,715.0,Cervical Cancer,nan,nan,nan,nan,nan,nan,nan,1.0,715.0,1.0,715.0,nan,nan,1.0,715.0,1
TCGA-C5-A8YR-01,TCGA-C5-A8YR,CESC,56.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G3,1994.0,nan,-20672.0,Dead,nan,nan,837.0,nan,Locoregional Recurrence,nan,regional recurrence NOS,272.0,nan,nan,nan,1.0,837.0,nan,837.0,nan,nan,1.0,272.0,1
TCGA-C5-A8YT-01,TCGA-C5-A8YT,CESC,36.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2008.0,nan,-13253.0,Dead,WITH TUMOR,nan,633.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,633.0,1.0,633.0,nan,nan,1.0,633.0,1
TCGA-C5-A8ZZ-01,TCGA-C5-A8ZZ,CESC,41.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G2,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15262.0,Alive,TUMOR FREE,636.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,636.0,0.0,636.0,nan,nan,0.0,636.0,0
TCGA-C5-A901-01,TCGA-C5-A901,CESC,44.0,FEMALE,WHITE,nan,nan,Cervical Squamous Cell Carcinoma,G2,2000.0,nan,-16186.0,Alive,TUMOR FREE,518.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,518.0,0.0,518.0,nan,nan,0.0,518.0,0
TCGA-C5-A902-01,TCGA-C5-A902,CESC,35.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G3,2008.0,nan,-12959.0,Alive,TUMOR FREE,149.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,149.0,0.0,149.0,nan,nan,0.0,149.0,0
TCGA-C5-A905-01,TCGA-C5-A905,CESC,37.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Cervical Squamous Cell Carcinoma,G2,1994.0,nan,-13584.0,Alive,TUMOR FREE,4879.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4879.0,0.0,4879.0,nan,nan,0.0,4879.0,0
TCGA-C5-A907-01,TCGA-C5-A907,CESC,47.0,FEMALE,WHITE,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G2,2013.0,nan,-17304.0,Alive,TUMOR FREE,448.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,448.0,0.0,448.0,nan,nan,0.0,448.0,0
TCGA-DG-A2KH-01,TCGA-DG-A2KH,CESC,25.0,FEMALE,[Not Evaluated],nan,Stage IB1,Adenosquamous,GX,nan,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9209.0,Alive,nan,34.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,34.0,0.0,34.0,nan,nan,0.0,34.0,0
TCGA-DG-A2KJ-01,TCGA-DG-A2KJ,CESC,50.0,FEMALE,[Not Evaluated],nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2006.0,[Unknown],-18453.0,Alive,TUMOR FREE,2893.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2893.0,0.0,2893.0,0.0,2893.0,0.0,2893.0,0
TCGA-DG-A2KK-01,TCGA-DG-A2KK,CESC,51.0,FEMALE,[Not Evaluated],nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18834.0,Alive,TUMOR FREE,2496.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2496.0,0.0,2496.0,0.0,2496.0,0.0,2496.0,0
TCGA-DG-A2KL-01,TCGA-DG-A2KL,CESC,53.0,FEMALE,[Not Evaluated],nan,Stage IIA,Cervical Squamous Cell Carcinoma,G1,nan,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19539.0,Alive,TUMOR FREE,1367.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1367.0,0.0,1367.0,0.0,1367.0,0.0,1367.0,0
TCGA-DG-A2KM-01,TCGA-DG-A2KM,CESC,46.0,FEMALE,[Not Evaluated],nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2008.0,[Unknown],-16808.0,Alive,TUMOR FREE,1946.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1946.0,0.0,1946.0,0.0,1946.0,0.0,1946.0,0
TCGA-DR-A0ZL-01,TCGA-DR-A0ZL,CESC,53.0,FEMALE,ASIAN,nan,Stage IB,Cervical Squamous Cell Carcinoma,G3,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19384.0,Alive,TUMOR FREE,2669.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2669.0,0.0,2669.0,0.0,2669.0,0.0,2669.0,0
TCGA-DR-A0ZM-01,TCGA-DR-A0ZM,CESC,61.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22464.0,Alive,TUMOR FREE,1791.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1791.0,0.0,1791.0,0.0,1791.0,0.0,1791.0,0
TCGA-DS-A0VK-01,TCGA-DS-A0VK,CESC,45.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G3,1996.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16792.0,Dead,WITH TUMOR,nan,1118.0,nan,Distant Metastasis,"Other, specify",Vagina,209.0,Progressive Disease,nan,nan,1.0,1118.0,1.0,1118.0,nan,nan,1.0,209.0,1
TCGA-DS-A0VL-01,TCGA-DS-A0VL,CESC,25.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G2,2001.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9186.0,Alive,TUMOR FREE,81.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,81.0,0.0,81.0,0.0,81.0,0.0,81.0,0
TCGA-DS-A0VM-01,TCGA-DS-A0VM,CESC,51.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G3,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18839.0,Alive,TUMOR FREE,3589.0,nan,nan,Distant Metastasis,Lung,nan,868.0,Complete Remission/Response,nan,nan,0.0,3589.0,0.0,3589.0,1.0,868.0,1.0,868.0,2
TCGA-DS-A0VN-01,TCGA-DS-A0VN,CESC,47.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G2,2002.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17433.0,Alive,TUMOR FREE,3609.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3609.0,0.0,3609.0,0.0,3609.0,0.0,3609.0,0
TCGA-DS-A1O9-01,TCGA-DS-A1O9,CESC,75.0,FEMALE,WHITE,nan,Stage IVA,Cervical Squamous Cell Carcinoma,G3,1999.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27433.0,Dead,WITH TUMOR,266.0,266.0,Cervical Cancer,nan,nan,nan,nan,nan,nan,nan,1.0,266.0,1.0,266.0,nan,nan,1.0,266.0,1
TCGA-DS-A1OA-01,TCGA-DS-A1OA,CESC,77.0,FEMALE,ASIAN,nan,Stage IB,Cervical Squamous Cell Carcinoma,G3,2001.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28160.0,Dead,WITH TUMOR,879.0,879.0,Cervical Cancer,Locoregional Recurrence,nan,nan,379.0,nan,nan,nan,1.0,879.0,1.0,879.0,nan,nan,1.0,379.0,1
TCGA-DS-A1OB-01,TCGA-DS-A1OB,CESC,45.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G2,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16685.0,Dead,WITH TUMOR,nan,861.0,Cervical Cancer,Distant Metastasis,Head & Neck,nan,652.0,Complete Remission/Response,nan,nan,1.0,861.0,1.0,861.0,1.0,652.0,1.0,652.0,1
TCGA-DS-A1OC-01,TCGA-DS-A1OC,CESC,47.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G2,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17357.0,Alive,TUMOR FREE,376.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,376.0,0.0,376.0,0.0,376.0,0.0,376.0,0
TCGA-DS-A1OD-01,TCGA-DS-A1OD,CESC,49.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2003.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17954.0,Alive,TUMOR FREE,3874.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3874.0,0.0,3874.0,0.0,3874.0,0.0,3874.0,0
TCGA-DS-A3LQ-01,TCGA-DS-A3LQ,CESC,46.0,FEMALE,nan,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16861.0,Alive,TUMOR FREE,699.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,699.0,0.0,699.0,0.0,699.0,0.0,699.0,0
TCGA-DS-A5RQ-01,TCGA-DS-A5RQ,CESC,80.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29526.0,Alive,TUMOR FREE,512.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,512.0,0.0,512.0,0.0,512.0,0.0,512.0,0
TCGA-DS-A7WF-01,TCGA-DS-A7WF,CESC,41.0,FEMALE,[Unknown],nan,Stage IB2,Adenosquamous,G3,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15319.0,Dead,WITH TUMOR,nan,492.0,Cervical Cancer,Distant Metastasis,Lung,nan,321.0,Partial Remission/Response,nan,nan,1.0,492.0,1.0,492.0,nan,nan,1.0,321.0,1
TCGA-DS-A7WH-01,TCGA-DS-A7WH,CESC,34.0,FEMALE,WHITE,nan,Stage IB1,Mucinous Adenocarcinoma of Endocervical Type,G2,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12644.0,Alive,TUMOR FREE,533.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,533.0,0.0,533.0,0.0,533.0,0.0,533.0,0
TCGA-DS-A7WI-01,TCGA-DS-A7WI,CESC,43.0,FEMALE,WHITE,nan,Stage IIA2,Cervical Squamous Cell Carcinoma,G2,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15970.0,Dead,WITH TUMOR,nan,252.0,Cervical Cancer,Locoregional Recurrence,"Other, specify",Retroperitoneum,206.0,Complete Remission/Response,nan,nan,1.0,252.0,1.0,252.0,1.0,206.0,1.0,206.0,1
TCGA-EA-A1QS-01,TCGA-EA-A1QS,CESC,46.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16923.0,Alive,TUMOR FREE,1203.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1203.0,0.0,1203.0,0.0,1203.0,0.0,1203.0,0
TCGA-EA-A1QT-01,TCGA-EA-A1QT,CESC,47.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G2,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17475.0,Alive,TUMOR FREE,1243.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1243.0,0.0,1243.0,0.0,1243.0,0.0,1243.0,0
TCGA-EA-A3HQ-01,TCGA-EA-A3HQ,CESC,60.0,FEMALE,WHITE,nan,Stage II,Cervical Squamous Cell Carcinoma,G2,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21966.0,Alive,TUMOR FREE,1136.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1136.0,0.0,1136.0,0.0,1136.0,0.0,1136.0,0
TCGA-EA-A3HR-01,TCGA-EA-A3HR,CESC,57.0,FEMALE,WHITE,nan,Stage II,Cervical Squamous Cell Carcinoma,G2,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20980.0,Alive,TUMOR FREE,940.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,940.0,0.0,940.0,0.0,940.0,0.0,940.0,0
TCGA-EA-A3HS-01,TCGA-EA-A3HS,CESC,35.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G1,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13117.0,Alive,TUMOR FREE,959.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,959.0,0.0,959.0,0.0,959.0,0.0,959.0,0
TCGA-EA-A3HT-01,TCGA-EA-A3HT,CESC,68.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G1,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25138.0,Alive,TUMOR FREE,954.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,954.0,0.0,954.0,0.0,954.0,0.0,954.0,0
TCGA-EA-A3HU-01,TCGA-EA-A3HU,CESC,43.0,FEMALE,WHITE,nan,Stage II,Cervical Squamous Cell Carcinoma,G2,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15909.0,Alive,TUMOR FREE,1013.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1013.0,0.0,1013.0,0.0,1013.0,0.0,1013.0,0
TCGA-EA-A3QD-01,TCGA-EA-A3QD,CESC,59.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21655.0,Alive,TUMOR FREE,397.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,397.0,0.0,397.0,0.0,397.0,0.0,397.0,0
TCGA-EA-A3QE-01,TCGA-EA-A3QE,CESC,45.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G2,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16460.0,Alive,TUMOR FREE,761.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,761.0,0.0,761.0,0.0,761.0,0.0,761.0,0
TCGA-EA-A3Y4-01,TCGA-EA-A3Y4,CESC,40.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14706.0,Alive,TUMOR FREE,1122.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1122.0,0.0,1122.0,0.0,1122.0,0.0,1122.0,0
TCGA-EA-A410-01,TCGA-EA-A410,CESC,51.0,FEMALE,WHITE,nan,Stage IIA2,Cervical Squamous Cell Carcinoma,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18720.0,Alive,TUMOR FREE,803.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,803.0,0.0,803.0,0.0,803.0,0.0,803.0,0
TCGA-EA-A411-01,TCGA-EA-A411,CESC,50.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18561.0,Alive,TUMOR FREE,747.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,747.0,0.0,747.0,0.0,747.0,0.0,747.0,0
TCGA-EA-A439-01,TCGA-EA-A439,CESC,50.0,FEMALE,ASIAN,nan,Stage IIA1,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18529.0,Alive,TUMOR FREE,965.0,nan,nan,Locoregional Recurrence,Cervix,nan,316.0,Complete Remission/Response,nan,nan,0.0,965.0,0.0,965.0,1.0,316.0,1.0,316.0,2
TCGA-EA-A43B-01,TCGA-EA-A43B,CESC,43.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15871.0,Alive,TUMOR FREE,791.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,791.0,0.0,791.0,0.0,791.0,0.0,791.0,0
TCGA-EA-A44S-01,TCGA-EA-A44S,CESC,31.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11621.0,Alive,TUMOR FREE,369.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,369.0,0.0,369.0,nan,nan,0.0,369.0,0
TCGA-EA-A4BA-01,TCGA-EA-A4BA,CESC,49.0,FEMALE,WHITE,nan,Stage IB2,Endocervical Type of Adenocarcinoma,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17995.0,Alive,TUMOR FREE,755.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,755.0,0.0,755.0,0.0,755.0,0.0,755.0,0
TCGA-EA-A50E-01,TCGA-EA-A50E,CESC,45.0,FEMALE,ASIAN,nan,Stage IVA,Cervical Squamous Cell Carcinoma,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16609.0,Dead,WITH TUMOR,nan,227.0,Cervical Cancer,Locoregional Recurrence,Vulva,nan,208.0,Progressive Disease,nan,nan,1.0,227.0,1.0,227.0,nan,nan,1.0,208.0,1
TCGA-EA-A556-01,TCGA-EA-A556,CESC,38.0,FEMALE,WHITE,nan,Stage IB1,Endometrioid Adenocarcinoma of Endocervix,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13988.0,Alive,TUMOR FREE,453.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,453.0,0.0,453.0,0.0,453.0,0.0,453.0,0
TCGA-EA-A5FO-01,TCGA-EA-A5FO,CESC,59.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21561.0,Alive,TUMOR FREE,815.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,815.0,0.0,815.0,0.0,815.0,0.0,815.0,0
TCGA-EA-A5O9-01,TCGA-EA-A5O9,CESC,39.0,FEMALE,WHITE,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14472.0,Alive,TUMOR FREE,788.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,788.0,0.0,788.0,0.0,788.0,0.0,788.0,0
TCGA-EA-A5ZD-01,TCGA-EA-A5ZD,CESC,40.0,FEMALE,ASIAN,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14629.0,Alive,TUMOR FREE,830.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,830.0,0.0,830.0,0.0,830.0,0.0,830.0,0
TCGA-EA-A5ZE-01,TCGA-EA-A5ZE,CESC,54.0,FEMALE,ASIAN,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2012.0,Peri (6-12 months since last menstrual period),-19868.0,Alive,TUMOR FREE,829.0,nan,nan,Distant Metastasis,"Other, specify","Lymph node, inguinal",425.0,Complete Remission/Response,nan,nan,0.0,829.0,0.0,829.0,1.0,425.0,1.0,425.0,2
TCGA-EA-A5ZF-01,TCGA-EA-A5ZF,CESC,56.0,FEMALE,ASIAN,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2012.0,Peri (6-12 months since last menstrual period),-20506.0,Alive,WITH TUMOR,828.0,nan,nan,Locoregional Recurrence,Cervix,nan,440.0,Complete Remission/Response,nan,nan,0.0,828.0,0.0,828.0,1.0,440.0,1.0,440.0,2
TCGA-EA-A6QX-01,TCGA-EA-A6QX,CESC,49.0,FEMALE,ASIAN,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2013.0,Peri (6-12 months since last menstrual period),-18035.0,Alive,TUMOR FREE,730.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,730.0,0.0,730.0,0.0,730.0,0.0,730.0,0
TCGA-EA-A78R-01,TCGA-EA-A78R,CESC,54.0,FEMALE,ASIAN,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2013.0,Peri (6-12 months since last menstrual period),-19942.0,Alive,TUMOR FREE,410.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,410.0,0.0,410.0,0.0,410.0,0.0,410.0,0
TCGA-EA-A97N-01,TCGA-EA-A97N,CESC,38.0,FEMALE,WHITE,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G2,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13984.0,Alive,TUMOR FREE,11.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,11.0,0.0,11.0,0.0,11.0,0.0,11.0,0
TCGA-EK-A2GZ-01,TCGA-EK-A2GZ,CESC,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23599.0,Alive,WITH TUMOR,383.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,383.0,0.0,383.0,nan,nan,0.0,383.0,2
TCGA-EK-A2H0-01,TCGA-EK-A2H0,CESC,24.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G3,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-8918.0,Alive,TUMOR FREE,1847.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1847.0,0.0,1847.0,0.0,1847.0,0.0,1847.0,0
TCGA-EK-A2H1-01,TCGA-EK-A2H1,CESC,20.0,FEMALE,WHITE,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G3,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-7649.0,Alive,TUMOR FREE,799.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,799.0,0.0,799.0,nan,nan,0.0,799.0,0
TCGA-EK-A2IP-01,TCGA-EK-A2IP,CESC,28.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2006.0,nan,-10347.0,Alive,nan,202.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,202.0,0.0,202.0,nan,nan,0.0,202.0,0
TCGA-EK-A2IR-01,TCGA-EK-A2IR,CESC,48.0,FEMALE,WHITE,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G3,1997.0,nan,-17581.0,Alive,TUMOR FREE,3442.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3442.0,0.0,3442.0,0.0,3442.0,0.0,3442.0,0
TCGA-EK-A2PG-01,TCGA-EK-A2PG,CESC,88.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Cervical Squamous Cell Carcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32500.0,Alive,nan,46.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,46.0,0.0,46.0,nan,nan,0.0,46.0,0
TCGA-EK-A2PI-01,TCGA-EK-A2PI,CESC,44.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2009.0,nan,-16324.0,Alive,WITH TUMOR,586.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,586.0,0.0,586.0,nan,nan,0.0,586.0,2
TCGA-EK-A2PK-01,TCGA-EK-A2PK,CESC,43.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2006.0,Indeterminate (neither Pre or Postmenopausal),-15939.0,Alive,TUMOR FREE,12.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,12.0,0.0,12.0,nan,nan,0.0,12.0,0
TCGA-EK-A2PL-01,TCGA-EK-A2PL,CESC,36.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,nan,2008.0,nan,-13384.0,Alive,WITH TUMOR,13.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,13.0,0.0,13.0,nan,nan,0.0,13.0,0
TCGA-EK-A2PM-01,TCGA-EK-A2PM,CESC,81.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29747.0,Alive,WITH TUMOR,18.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,18.0,0.0,18.0,nan,nan,0.0,18.0,0
TCGA-EK-A2R7-01,TCGA-EK-A2R7,CESC,45.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G3,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16487.0,Alive,TUMOR FREE,27.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,27.0,0.0,27.0,nan,nan,0.0,27.0,0
TCGA-EK-A2R8-01,TCGA-EK-A2R8,CESC,48.0,FEMALE,WHITE,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G3,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17692.0,Alive,WITH TUMOR,44.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,44.0,0.0,44.0,nan,nan,0.0,44.0,0
TCGA-EK-A2R9-01,TCGA-EK-A2R9,CESC,58.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2011.0,nan,-21242.0,Alive,WITH TUMOR,4.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4.0,0.0,4.0,nan,nan,0.0,4.0,0
TCGA-EK-A2RA-01,TCGA-EK-A2RA,CESC,74.0,FEMALE,nan,nan,Stage IIA2,Cervical Squamous Cell Carcinoma,G3,2011.0,nan,-27209.0,Alive,WITH TUMOR,1246.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1246.0,0.0,1246.0,nan,nan,0.0,1246.0,0
TCGA-EK-A2RB-01,TCGA-EK-A2RB,CESC,48.0,FEMALE,WHITE,nan,Stage IVB,Cervical Squamous Cell Carcinoma,G3,2011.0,nan,-17752.0,Alive,TUMOR FREE,9.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,9.0,0.0,9.0,nan,nan,0.0,9.0,0
TCGA-EK-A2RC-01,TCGA-EK-A2RC,CESC,33.0,FEMALE,nan,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2009.0,nan,-12353.0,Alive,TUMOR FREE,129.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,129.0,0.0,129.0,nan,nan,0.0,129.0,0
TCGA-EK-A2RD-01,TCGA-EK-A2RD,CESC,47.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17191.0,Alive,TUMOR FREE,2.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2.0,0.0,2.0,nan,nan,0.0,2.0,0
TCGA-EK-A2RE-01,TCGA-EK-A2RE,CESC,26.0,FEMALE,WHITE,nan,Stage IIA,Cervical Squamous Cell Carcinoma,G2,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9743.0,Alive,TUMOR FREE,57.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,57.0,0.0,57.0,nan,nan,0.0,57.0,0
TCGA-EK-A2RJ-01,TCGA-EK-A2RJ,CESC,51.0,FEMALE,WHITE,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G3,2009.0,nan,-18664.0,Alive,TUMOR FREE,53.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,53.0,0.0,53.0,nan,nan,0.0,53.0,0
TCGA-EK-A2RK-01,TCGA-EK-A2RK,CESC,67.0,FEMALE,WHITE,nan,Stage IA2,Cervical Squamous Cell Carcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24541.0,Alive,nan,13.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,13.0,0.0,13.0,nan,nan,0.0,13.0,0
TCGA-EK-A2RL-01,TCGA-EK-A2RL,CESC,32.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Endocervical Type of Adenocarcinoma,G2,2009.0,nan,-12047.0,Dead,WITH TUMOR,nan,1453.0,Cervical Cancer,Locoregional Recurrence,Cervix,nan,1143.0,Progressive Disease,nan,nan,1.0,1453.0,1.0,1453.0,nan,nan,1.0,1143.0,1
TCGA-EK-A2RM-01,TCGA-EK-A2RM,CESC,40.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G3,2009.0,nan,-14842.0,Alive,WITH TUMOR,50.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,50.0,0.0,50.0,nan,nan,0.0,50.0,2
TCGA-EK-A2RN-01,TCGA-EK-A2RN,CESC,45.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16487.0,Alive,WITH TUMOR,71.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,71.0,0.0,71.0,nan,nan,0.0,71.0,2
TCGA-EK-A2RO-01,TCGA-EK-A2RO,CESC,59.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21844.0,Alive,WITH TUMOR,2.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2.0,0.0,2.0,nan,nan,0.0,2.0,0
TCGA-EK-A3GJ-01,TCGA-EK-A3GJ,CESC,51.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2010.0,nan,-18630.0,Alive,[Discrepancy],3.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3.0,0.0,3.0,nan,nan,0.0,3.0,0
TCGA-EK-A3GK-01,TCGA-EK-A3GK,CESC,33.0,FEMALE,WHITE,nan,Stage IB1,Endocervical Type of Adenocarcinoma,G3,2009.0,nan,-12207.0,Alive,TUMOR FREE,15.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,15.0,0.0,15.0,nan,nan,0.0,15.0,0
TCGA-EK-A3GM-01,TCGA-EK-A3GM,CESC,65.0,FEMALE,WHITE,nan,Stage IIA,Endocervical Type of Adenocarcinoma,G2,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23879.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-EK-A3GN-01,TCGA-EK-A3GN,CESC,47.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2005.0,nan,-17425.0,Alive,WITH TUMOR,27.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,27.0,0.0,27.0,nan,nan,0.0,27.0,0
TCGA-EX-A1H5-01,TCGA-EX-A1H5,CESC,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21338.0,Alive,TUMOR FREE,619.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,619.0,0.0,619.0,0.0,619.0,0.0,619.0,0
TCGA-EX-A1H6-01,TCGA-EX-A1H6,CESC,38.0,FEMALE,WHITE,nan,Stage IB1,Endocervical Type of Adenocarcinoma,G1,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14214.0,Alive,TUMOR FREE,241.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,241.0,0.0,241.0,0.0,241.0,0.0,241.0,0
TCGA-EX-A3L1-01,TCGA-EX-A3L1,CESC,32.0,FEMALE,WHITE,nan,Stage IIA1,Cervical Squamous Cell Carcinoma,G3,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11943.0,Alive,TUMOR FREE,463.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,463.0,0.0,463.0,0.0,463.0,0.0,463.0,0
TCGA-EX-A449-01,TCGA-EX-A449,CESC,42.0,FEMALE,WHITE,nan,Stage IVB,Endocervical Type of Adenocarcinoma,G1,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15559.0,Alive,TUMOR FREE,447.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,447.0,0.0,447.0,nan,nan,0.0,447.0,0
TCGA-EX-A69L-01,TCGA-EX-A69L,CESC,41.0,FEMALE,ASIAN,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15121.0,Alive,TUMOR FREE,602.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,602.0,0.0,602.0,0.0,602.0,0.0,602.0,0
TCGA-EX-A69M-01,TCGA-EX-A69M,CESC,62.0,FEMALE,WHITE,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22917.0,Dead,TUMOR FREE,nan,253.0,nan,New Primary Tumor,Lung,nan,77.0,Complete Remission/Response,nan,nan,1.0,253.0,0.0,253.0,0.0,253.0,1.0,77.0,1
TCGA-EX-A8YF-01,TCGA-EX-A8YF,CESC,44.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16258.0,Alive,WITH TUMOR,473.0,nan,nan,Locoregional Recurrence,"Other, specify",Vagina,396.0,Complete Remission/Response,nan,nan,0.0,473.0,0.0,473.0,1.0,396.0,1.0,396.0,2
TCGA-FU-A23K-01,TCGA-FU-A23K,CESC,28.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10551.0,Alive,TUMOR FREE,372.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,372.0,0.0,372.0,0.0,372.0,0.0,372.0,0
TCGA-FU-A23L-01,TCGA-FU-A23L,CESC,60.0,FEMALE,WHITE,nan,Stage IIA1,Cervical Squamous Cell Carcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21962.0,Alive,TUMOR FREE,725.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,725.0,0.0,725.0,0.0,725.0,0.0,725.0,0
TCGA-FU-A2QG-01,TCGA-FU-A2QG,CESC,29.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2011.0,Peri (6-12 months since last menstrual period),-10865.0,Alive,TUMOR FREE,579.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,579.0,0.0,579.0,0.0,579.0,0.0,579.0,0
TCGA-FU-A3EO-01,TCGA-FU-A3EO,CESC,55.0,FEMALE,WHITE,nan,Stage IIB,Endocervical Type of Adenocarcinoma,G2,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20207.0,Alive,TUMOR FREE,490.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,490.0,0.0,490.0,0.0,490.0,0.0,490.0,0
TCGA-FU-A3EO-11,TCGA-FU-A3EO,CESC,55.0,FEMALE,WHITE,nan,Stage IIB,Endocervical Type of Adenocarcinoma,G2,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20207.0,Alive,TUMOR FREE,490.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,490.0,0.0,490.0,0.0,490.0,0.0,490.0,0
TCGA-FU-A3HY-01,TCGA-FU-A3HY,CESC,47.0,FEMALE,WHITE,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G2,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17228.0,Alive,TUMOR FREE,954.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,954.0,0.0,954.0,0.0,954.0,0.0,954.0,0
TCGA-FU-A3HZ-01,TCGA-FU-A3HZ,CESC,64.0,FEMALE,WHITE,nan,Stage IIA2,Cervical Squamous Cell Carcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23565.0,Alive,TUMOR FREE,1103.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1103.0,0.0,1103.0,0.0,1103.0,0.0,1103.0,0
TCGA-FU-A3NI-01,TCGA-FU-A3NI,CESC,45.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16533.0,Dead,TUMOR FREE,nan,638.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,638.0,0.0,638.0,nan,nan,0.0,638.0,1
TCGA-FU-A3TQ-01,TCGA-FU-A3TQ,CESC,55.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20302.0,Alive,TUMOR FREE,795.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,795.0,0.0,795.0,0.0,795.0,0.0,795.0,0
TCGA-FU-A3TX-01,TCGA-FU-A3TX,CESC,78.0,FEMALE,[Not Evaluated],nan,Stage IB2,Cervical Squamous Cell Carcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28825.0,Alive,nan,45.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,45.0,0.0,45.0,nan,nan,0.0,45.0,0
TCGA-FU-A3WB-01,TCGA-FU-A3WB,CESC,43.0,FEMALE,WHITE,nan,Stage IIA2,Cervical Squamous Cell Carcinoma,G2,2012.0,[Unknown],-15833.0,Alive,TUMOR FREE,491.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,491.0,0.0,491.0,0.0,491.0,0.0,491.0,2
TCGA-FU-A3YQ-01,TCGA-FU-A3YQ,CESC,35.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G1,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12816.0,Alive,TUMOR FREE,861.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,861.0,0.0,861.0,0.0,861.0,0.0,861.0,0
TCGA-FU-A40J-01,TCGA-FU-A40J,CESC,38.0,FEMALE,WHITE,nan,Stage IIIB,Endocervical Type of Adenocarcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14182.0,Alive,TUMOR FREE,426.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,426.0,0.0,426.0,0.0,426.0,0.0,426.0,0
TCGA-FU-A57G-01,TCGA-FU-A57G,CESC,49.0,FEMALE,WHITE,nan,Stage IB2,Endocervical Type of Adenocarcinoma,G2,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17905.0,Alive,TUMOR FREE,1078.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1078.0,0.0,1078.0,0.0,1078.0,0.0,1078.0,0
TCGA-FU-A5XV-01,TCGA-FU-A5XV,CESC,32.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11692.0,Alive,TUMOR FREE,321.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,321.0,0.0,321.0,0.0,321.0,0.0,321.0,0
TCGA-FU-A770-01,TCGA-FU-A770,CESC,33.0,FEMALE,WHITE,nan,Stage IIIB,Endocervical Adenocarcinoma of the Usual Type,G2,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12248.0,Alive,TUMOR FREE,34.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,34.0,0.0,34.0,nan,nan,0.0,34.0,0
TCGA-GH-A9DA-01,TCGA-GH-A9DA,CESC,27.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2013.0,[Not Evaluated],-10160.0,Alive,TUMOR FREE,540.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,540.0,0.0,540.0,0.0,540.0,0.0,540.0,0
TCGA-HG-A2PA-01,TCGA-HG-A2PA,CESC,38.0,FEMALE,WHITE,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G2,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14025.0,Dead,WITH TUMOR,nan,773.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,773.0,1.0,773.0,nan,nan,1.0,773.0,1
TCGA-HG-A9SC-01,TCGA-HG-A9SC,CESC,49.0,FEMALE,WHITE,nan,Stage IIB,Adenosquamous,G3,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17963.0,Alive,TUMOR FREE,504.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,504.0,0.0,504.0,0.0,504.0,0.0,504.0,0
TCGA-HM-A3JJ-01,TCGA-HM-A3JJ,CESC,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14736.0,Dead,WITH TUMOR,nan,659.0,Cervical Cancer,Distant Metastasis,nan,nan,385.0,Complete Remission/Response,nan,nan,1.0,659.0,1.0,659.0,1.0,385.0,1.0,385.0,1
TCGA-HM-A3JJ-11,TCGA-HM-A3JJ,CESC,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14736.0,Dead,WITH TUMOR,nan,659.0,Cervical Cancer,Distant Metastasis,nan,nan,385.0,Complete Remission/Response,nan,nan,1.0,659.0,1.0,659.0,1.0,385.0,1.0,385.0,1
TCGA-HM-A3JK-01,TCGA-HM-A3JK,CESC,64.0,FEMALE,WHITE,nan,Stage IIA2,Cervical Squamous Cell Carcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23618.0,Alive,TUMOR FREE,632.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,632.0,0.0,632.0,0.0,632.0,0.0,632.0,0
TCGA-HM-A4S6-01,TCGA-HM-A4S6,CESC,51.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18903.0,Alive,TUMOR FREE,454.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,454.0,0.0,454.0,0.0,454.0,0.0,454.0,0
TCGA-HM-A6W2-06,TCGA-HM-A6W2,CESC,34.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IVB,Adenosquamous,G3,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12775.0,Alive,TUMOR FREE,287.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,287.0,0.0,287.0,nan,nan,0.0,287.0,0
TCGA-HM-A6W2-01,TCGA-HM-A6W2,CESC,34.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IVB,Adenosquamous,G3,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12775.0,Alive,TUMOR FREE,287.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,287.0,0.0,287.0,nan,nan,0.0,287.0,0
TCGA-IR-A3L7-01,TCGA-IR-A3L7,CESC,37.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2000.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13559.0,Alive,TUMOR FREE,4483.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4483.0,0.0,4483.0,0.0,4483.0,0.0,4483.0,0
TCGA-IR-A3LA-01,TCGA-IR-A3LA,CESC,60.0,FEMALE,WHITE,nan,Stage IB1,Endometrioid Adenocarcinoma of Endocervix,G3,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21949.0,Alive,TUMOR FREE,4172.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4172.0,0.0,4172.0,0.0,4172.0,0.0,4172.0,0
TCGA-IR-A3LB-01,TCGA-IR-A3LB,CESC,53.0,FEMALE,WHITE,nan,Stage IB1,Endocervical Type of Adenocarcinoma,G3,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19374.0,Dead,WITH TUMOR,nan,2032.0,nan,Distant Metastasis,Lung,nan,317.0,Complete Remission/Response,nan,nan,1.0,2032.0,1.0,2032.0,1.0,317.0,1.0,317.0,1
TCGA-IR-A3LC-01,TCGA-IR-A3LC,CESC,40.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2003.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14697.0,Alive,TUMOR FREE,3935.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3935.0,0.0,3935.0,0.0,3935.0,0.0,3935.0,0
TCGA-IR-A3LF-01,TCGA-IR-A3LF,CESC,64.0,FEMALE,WHITE,nan,Stage IB1,Endocervical Adenocarcinoma of the Usual Type,G2,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23721.0,Alive,TUMOR FREE,2949.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2949.0,0.0,2949.0,0.0,2949.0,0.0,2949.0,0
TCGA-IR-A3LH-01,TCGA-IR-A3LH,CESC,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIA1,Cervical Squamous Cell Carcinoma,G4,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18118.0,Alive,TUMOR FREE,2394.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2394.0,0.0,2394.0,0.0,2394.0,0.0,2394.0,0
TCGA-IR-A3LI-01,TCGA-IR-A3LI,CESC,48.0,FEMALE,WHITE,nan,Stage IVB,Endocervical Type of Adenocarcinoma,G2,2005.0,Peri (6-12 months since last menstrual period),-17741.0,Alive,TUMOR FREE,2493.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2493.0,0.0,2493.0,nan,nan,0.0,2493.0,2
TCGA-IR-A3LK-01,TCGA-IR-A3LK,CESC,69.0,FEMALE,WHITE,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25440.0,Dead,WITH TUMOR,nan,908.0,Cervical Cancer,Distant Metastasis,"Other, specify","thoracic lymph nodes, liver, abdominal wall",574.0,Complete Remission/Response,nan,nan,1.0,908.0,1.0,908.0,1.0,574.0,1.0,574.0,1
TCGA-IR-A3LL-01,TCGA-IR-A3LL,CESC,60.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22123.0,Alive,TUMOR FREE,1106.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1106.0,0.0,1106.0,0.0,1106.0,0.0,1106.0,0
TCGA-JW-A5VG-01,TCGA-JW-A5VG,CESC,35.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,nan,Stage IIA,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13109.0,Alive,TUMOR FREE,834.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,834.0,0.0,834.0,0.0,834.0,0.0,834.0,0
TCGA-JW-A5VH-01,TCGA-JW-A5VH,CESC,53.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,nan,Stage IVB,Cervical Squamous Cell Carcinoma,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19423.0,Dead,WITH TUMOR,nan,100.0,Cervical Cancer,Distant Metastasis,"Other, specify",Brain,94.0,Progressive Disease,nan,nan,1.0,100.0,1.0,100.0,nan,nan,1.0,94.0,1
TCGA-JW-A5VI-01,TCGA-JW-A5VI,CESC,45.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16444.0,Alive,WITH TUMOR,747.0,nan,nan,Distant Metastasis,Lung,nan,558.0,Complete Remission/Response,nan,nan,0.0,747.0,0.0,747.0,1.0,558.0,1.0,558.0,2
TCGA-JW-A5VJ-01,TCGA-JW-A5VJ,CESC,56.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20714.0,Alive,WITH TUMOR,652.0,nan,nan,Distant Metastasis,Head & Neck,nan,267.0,Progressive Disease,nan,nan,0.0,652.0,0.0,652.0,nan,nan,1.0,267.0,2
TCGA-JW-A5VK-01,TCGA-JW-A5VK,CESC,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15965.0,Alive,TUMOR FREE,623.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,623.0,0.0,623.0,0.0,623.0,0.0,623.0,0
TCGA-JW-A5VL-01,TCGA-JW-A5VL,CESC,37.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,nan,Stage IB2,Cervical Squamous Cell Carcinoma,G1,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13604.0,Alive,TUMOR FREE,474.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,474.0,0.0,474.0,0.0,474.0,0.0,474.0,0
TCGA-JW-A69B-01,TCGA-JW-A69B,CESC,44.0,FEMALE,WHITE,nan,Stage IB2,Endocervical Type of Adenocarcinoma,GX,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16080.0,Alive,TUMOR FREE,863.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,863.0,0.0,863.0,0.0,863.0,0.0,863.0,0
TCGA-JW-A852-01,TCGA-JW-A852,CESC,42.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G2,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15682.0,Dead,WITH TUMOR,nan,252.0,Cervical Cancer,New Primary Tumor,nan,Breast,153.0,Complete Remission/Response,nan,nan,1.0,252.0,1.0,252.0,0.0,252.0,1.0,153.0,1
TCGA-JW-AAVH-01,TCGA-JW-AAVH,CESC,46.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16894.0,Alive,TUMOR FREE,552.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,552.0,0.0,552.0,0.0,552.0,0.0,552.0,0
TCGA-JX-A3PZ-01,TCGA-JX-A3PZ,CESC,25.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G2,1995.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9303.0,Dead,WITH TUMOR,nan,642.0,Cervical Cancer,Locoregional Recurrence,"Other, specify",Pelvis,491.0,Complete Remission/Response,nan,nan,1.0,642.0,1.0,642.0,1.0,491.0,1.0,491.0,1
TCGA-JX-A3Q0-01,TCGA-JX-A3Q0,CESC,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage III,Cervical Squamous Cell Carcinoma,G2,1997.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23313.0,Alive,TUMOR FREE,6375.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,6375.0,0.0,6375.0,0.0,6375.0,0.0,6375.0,0
TCGA-JX-A3Q8-01,TCGA-JX-A3Q8,CESC,40.0,FEMALE,ASIAN,nan,Stage IB1,Endocervical Type of Adenocarcinoma,G3,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14839.0,Alive,TUMOR FREE,1357.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1357.0,0.0,1357.0,0.0,1357.0,0.0,1357.0,0
TCGA-JX-A5QV-01,TCGA-JX-A5QV,CESC,37.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13667.0,Alive,TUMOR FREE,636.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,636.0,0.0,636.0,0.0,636.0,0.0,636.0,0
TCGA-LP-A4AU-01,TCGA-LP-A4AU,CESC,35.0,FEMALE,ASIAN,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13074.0,Alive,TUMOR FREE,343.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,343.0,0.0,343.0,nan,nan,0.0,343.0,0
TCGA-LP-A4AV-01,TCGA-LP-A4AV,CESC,63.0,FEMALE,ASIAN,nan,Stage IB,Cervical Squamous Cell Carcinoma,G2,2011.0,[Not Evaluated],nan,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-LP-A4AW-01,TCGA-LP-A4AW,CESC,52.0,FEMALE,ASIAN,nan,Stage IA,Cervical Squamous Cell Carcinoma,G1,2011.0,Peri (6-12 months since last menstrual period),-19079.0,Alive,TUMOR FREE,27.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,27.0,0.0,27.0,nan,nan,0.0,27.0,0
TCGA-LP-A4AX-01,TCGA-LP-A4AX,CESC,45.0,FEMALE,ASIAN,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2011.0,Peri (6-12 months since last menstrual period),-16544.0,Alive,TUMOR FREE,380.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,380.0,0.0,380.0,0.0,380.0,0.0,380.0,0
TCGA-LP-A5U2-01,TCGA-LP-A5U2,CESC,30.0,FEMALE,ASIAN,nan,Stage IIIB,Endocervical Adenocarcinoma of the Usual Type,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11049.0,Alive,TUMOR FREE,9.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,9.0,0.0,9.0,0.0,9.0,0.0,9.0,0
TCGA-LP-A5U3-01,TCGA-LP-A5U3,CESC,40.0,FEMALE,ASIAN,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14698.0,Alive,TUMOR FREE,25.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,25.0,0.0,25.0,0.0,25.0,0.0,25.0,0
TCGA-LP-A7HU-01,TCGA-LP-A7HU,CESC,53.0,FEMALE,ASIAN,nan,Stage II,Endocervical Type of Adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19595.0,Alive,TUMOR FREE,406.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,406.0,0.0,406.0,0.0,406.0,0.0,406.0,0
TCGA-MA-AA3W-01,TCGA-MA-AA3W,CESC,54.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20066.0,Alive,TUMOR FREE,685.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,685.0,0.0,685.0,0.0,685.0,0.0,685.0,0
TCGA-MA-AA3X-01,TCGA-MA-AA3X,CESC,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18412.0,Alive,TUMOR FREE,617.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,617.0,0.0,617.0,0.0,617.0,0.0,617.0,0
TCGA-MA-AA3Y-01,TCGA-MA-AA3Y,CESC,48.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17795.0,Alive,TUMOR FREE,542.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,542.0,0.0,542.0,0.0,542.0,0.0,542.0,0
TCGA-MA-AA3Z-01,TCGA-MA-AA3Z,CESC,43.0,FEMALE,WHITE,nan,Stage IB2,Cervical Squamous Cell Carcinoma,GX,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15762.0,Alive,TUMOR FREE,595.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,595.0,0.0,595.0,0.0,595.0,0.0,595.0,0
TCGA-MA-AA41-01,TCGA-MA-AA41,CESC,33.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G2,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12398.0,Alive,WITH TUMOR,279.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,279.0,0.0,279.0,nan,nan,0.0,279.0,2
TCGA-MA-AA42-01,TCGA-MA-AA42,CESC,75.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27460.0,Alive,TUMOR FREE,259.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,259.0,0.0,259.0,0.0,259.0,0.0,259.0,0
TCGA-MA-AA43-01,TCGA-MA-AA43,CESC,48.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2013.0,Peri (6-12 months since last menstrual period),-17658.0,Alive,TUMOR FREE,346.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,346.0,0.0,346.0,0.0,346.0,0.0,346.0,0
TCGA-MU-A51Y-01,TCGA-MU-A51Y,CESC,27.0,FEMALE,WHITE,nan,Stage IIA1,Cervical Squamous Cell Carcinoma,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10199.0,Alive,TUMOR FREE,854.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,854.0,0.0,854.0,0.0,854.0,0.0,854.0,0
TCGA-MU-A5YI-01,TCGA-MU-A5YI,CESC,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA1,Cervical Squamous Cell Carcinoma,G2,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21927.0,Alive,WITH TUMOR,1053.0,nan,nan,Distant Metastasis,"Other, specify",Thoracic Spine,630.0,nan,nan,nan,0.0,1053.0,0.0,1053.0,nan,nan,1.0,630.0,2
TCGA-MU-A8JM-01,TCGA-MU-A8JM,CESC,46.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2013.0,[Unknown],-17156.0,Alive,TUMOR FREE,607.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,607.0,0.0,607.0,0.0,607.0,0.0,607.0,0
TCGA-MY-A5BD-01,TCGA-MY-A5BD,CESC,62.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22901.0,Alive,TUMOR FREE,1667.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1667.0,0.0,1667.0,nan,nan,0.0,1667.0,0
TCGA-MY-A5BE-01,TCGA-MY-A5BE,CESC,42.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-15466.0,Alive,TUMOR FREE,1066.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1066.0,0.0,1066.0,0.0,1066.0,0.0,1066.0,0
TCGA-MY-A5BF-01,TCGA-MY-A5BF,CESC,68.0,FEMALE,WHITE,nan,Stage IIA2,Cervical Squamous Cell Carcinoma,G1,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25082.0,Alive,TUMOR FREE,634.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,634.0,0.0,634.0,nan,nan,0.0,634.0,0
TCGA-MY-A5BF-11,TCGA-MY-A5BF,CESC,68.0,FEMALE,WHITE,nan,Stage IIA2,Cervical Squamous Cell Carcinoma,G1,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25082.0,Alive,TUMOR FREE,634.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,634.0,0.0,634.0,nan,nan,0.0,634.0,0
TCGA-MY-A913-01,TCGA-MY-A913,CESC,28.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIA,Cervical Squamous Cell Carcinoma,G3,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-10379.0,Alive,TUMOR FREE,524.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,524.0,0.0,524.0,0.0,524.0,0.0,524.0,0
TCGA-PN-A8MA-01,TCGA-PN-A8MA,CESC,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G3,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15918.0,Alive,WITH TUMOR,90.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,90.0,0.0,90.0,nan,nan,0.0,90.0,2
TCGA-Q1-A5R1-01,TCGA-Q1-A5R1,CESC,32.0,FEMALE,WHITE,nan,Stage IB1,Mucinous Adenocarcinoma of Endocervical Type,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11705.0,Alive,TUMOR FREE,474.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,474.0,0.0,474.0,0.0,474.0,0.0,474.0,0
TCGA-Q1-A5R2-01,TCGA-Q1-A5R2,CESC,64.0,FEMALE,WHITE,nan,nan,Cervical Squamous Cell Carcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23523.0,Alive,TUMOR FREE,499.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,499.0,0.0,499.0,nan,nan,0.0,499.0,0
TCGA-Q1-A5R3-01,TCGA-Q1-A5R3,CESC,56.0,FEMALE,WHITE,nan,nan,Cervical Squamous Cell Carcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20574.0,Alive,TUMOR FREE,485.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,485.0,0.0,485.0,0.0,485.0,0.0,485.0,0
TCGA-Q1-A6DT-01,TCGA-Q1-A6DT,CESC,55.0,FEMALE,WHITE,nan,Stage I,Cervical Squamous Cell Carcinoma,GX,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20286.0,Dead,WITH TUMOR,nan,275.0,Cervical Cancer,nan,nan,nan,nan,nan,nan,nan,1.0,275.0,1.0,275.0,nan,nan,1.0,275.0,1
TCGA-Q1-A6DV-01,TCGA-Q1-A6DV,CESC,36.0,FEMALE,ASIAN,nan,Stage IB1,Mucinous Adenocarcinoma of Endocervical Type,G2,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13166.0,Alive,TUMOR FREE,491.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,491.0,0.0,491.0,0.0,491.0,0.0,491.0,2
TCGA-Q1-A6DW-01,TCGA-Q1-A6DW,CESC,44.0,FEMALE,WHITE,nan,Stage I,Cervical Squamous Cell Carcinoma,GX,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16200.0,Alive,nan,534.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,534.0,0.0,534.0,nan,nan,0.0,534.0,0
TCGA-Q1-A73O-01,TCGA-Q1-A73O,CESC,37.0,FEMALE,[Not Evaluated],nan,Stage IB2,Cervical Squamous Cell Carcinoma,GX,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13601.0,Alive,TUMOR FREE,428.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,428.0,0.0,428.0,0.0,428.0,0.0,428.0,0
TCGA-Q1-A73P-01,TCGA-Q1-A73P,CESC,45.0,FEMALE,WHITE,nan,Stage IB1,Endocervical Type of Adenocarcinoma,G1,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16450.0,Alive,TUMOR FREE,483.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,483.0,0.0,483.0,0.0,483.0,0.0,483.0,0
TCGA-Q1-A73Q-01,TCGA-Q1-A73Q,CESC,46.0,FEMALE,WHITE,nan,Stage I,Cervical Squamous Cell Carcinoma,GX,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16851.0,Alive,WITH TUMOR,284.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,284.0,0.0,284.0,nan,nan,0.0,284.0,2
TCGA-Q1-A73R-01,TCGA-Q1-A73R,CESC,45.0,FEMALE,WHITE,nan,Stage I,Endocervical Type of Adenocarcinoma,GX,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16701.0,Alive,TUMOR FREE,567.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,567.0,0.0,567.0,0.0,567.0,0.0,567.0,0
TCGA-Q1-A73S-01,TCGA-Q1-A73S,CESC,33.0,FEMALE,WHITE,nan,Stage IB1,Adenosquamous,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12229.0,Alive,TUMOR FREE,688.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,688.0,0.0,688.0,0.0,688.0,0.0,688.0,0
TCGA-R2-A69V-01,TCGA-R2-A69V,CESC,42.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G3,2011.0,Peri (6-12 months since last menstrual period),-15479.0,Alive,TUMOR FREE,596.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,596.0,0.0,596.0,0.0,596.0,0.0,596.0,0
TCGA-RA-A741-01,TCGA-RA-A741,CESC,34.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,GX,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12607.0,Alive,TUMOR FREE,444.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,444.0,0.0,444.0,0.0,444.0,0.0,444.0,0
TCGA-UC-A7PD-01,TCGA-UC-A7PD,CESC,21.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G2,1997.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-7855.0,Dead,WITH TUMOR,nan,355.0,Cervical Cancer,Locoregional Recurrence,nan,vaginal cuff,202.0,Complete Remission/Response,nan,nan,1.0,355.0,1.0,355.0,1.0,202.0,1.0,202.0,1
TCGA-UC-A7PF-01,TCGA-UC-A7PF,CESC,44.0,FEMALE,[Not Evaluated],nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,1999.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16412.0,Dead,nan,nan,2859.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2859.0,nan,2859.0,nan,nan,0.0,2859.0,1
TCGA-UC-A7PG-06,TCGA-UC-A7PG,CESC,44.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G1,2003.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16231.0,Dead,WITH TUMOR,nan,370.0,Cervical Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,370.0,1.0,370.0,nan,nan,1.0,370.0,1
TCGA-UC-A7PG-01,TCGA-UC-A7PG,CESC,44.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G1,2003.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16231.0,Dead,WITH TUMOR,nan,370.0,Cervical Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,370.0,1.0,370.0,nan,nan,1.0,370.0,1
TCGA-UC-A7PI-01,TCGA-UC-A7PI,CESC,44.0,FEMALE,WHITE,nan,Stage IB1,Endometrioid Adenocarcinoma of Endocervix,G1,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16427.0,Alive,TUMOR FREE,2114.0,nan,nan,Locoregional Recurrence,"Other, specify",nan,778.0,Complete Remission/Response,nan,nan,0.0,2114.0,0.0,2114.0,1.0,778.0,1.0,778.0,2
TCGA-VS-A8EB-01,TCGA-VS-A8EB,CESC,41.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,GX,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15215.0,Dead,WITH TUMOR,nan,305.0,Cervical Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,305.0,1.0,305.0,nan,nan,1.0,305.0,1
TCGA-VS-A8EC-01,TCGA-VS-A8EC,CESC,55.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2011.0,Peri (6-12 months since last menstrual period),-20286.0,Alive,TUMOR FREE,1415.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1415.0,0.0,1415.0,0.0,1415.0,0.0,1415.0,0
TCGA-VS-A8EG-01,TCGA-VS-A8EG,CESC,36.0,FEMALE,[Unknown],nan,Stage IB1,Cervical Squamous Cell Carcinoma,GX,2011.0,Peri (6-12 months since last menstrual period),-13166.0,Alive,TUMOR FREE,1386.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1386.0,0.0,1386.0,0.0,1386.0,0.0,1386.0,0
TCGA-VS-A8EH-01,TCGA-VS-A8EH,CESC,56.0,FEMALE,[Unknown],nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2012.0,Peri (6-12 months since last menstrual period),-20728.0,Alive,TUMOR FREE,986.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,986.0,0.0,986.0,0.0,986.0,0.0,986.0,0
TCGA-VS-A8EI-01,TCGA-VS-A8EI,CESC,38.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,GX,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14129.0,Alive,TUMOR FREE,729.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,729.0,0.0,729.0,0.0,729.0,0.0,729.0,0
TCGA-VS-A8EJ-01,TCGA-VS-A8EJ,CESC,60.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22000.0,Dead,WITH TUMOR,nan,607.0,Cervical Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,607.0,1.0,607.0,nan,nan,1.0,607.0,1
TCGA-VS-A8EK-01,TCGA-VS-A8EK,CESC,65.0,FEMALE,WHITE,nan,Stage IVA,Cervical Squamous Cell Carcinoma,G2,2008.0,[Not Evaluated],-23817.0,Dead,WITH TUMOR,nan,829.0,Cervical Cancer,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,829.0,1.0,829.0,nan,nan,1.0,829.0,1
TCGA-VS-A8EL-01,TCGA-VS-A8EL,CESC,38.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G3,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14162.0,Alive,TUMOR FREE,1992.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1992.0,0.0,1992.0,0.0,1992.0,0.0,1992.0,0
TCGA-VS-A8Q8-01,TCGA-VS-A8Q8,CESC,26.0,FEMALE,WHITE,nan,Stage IB,Cervical Squamous Cell Carcinoma,G2,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-9571.0,Dead,WITH TUMOR,nan,978.0,Cervical Cancer,Locoregional Recurrence,nan,Pelvis,488.0,Progressive Disease,nan,nan,1.0,978.0,1.0,978.0,nan,nan,1.0,488.0,1
TCGA-VS-A8Q9-01,TCGA-VS-A8Q9,CESC,79.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28881.0,Alive,TUMOR FREE,1630.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1630.0,0.0,1630.0,0.0,1630.0,0.0,1630.0,0
TCGA-VS-A8QA-01,TCGA-VS-A8QA,CESC,44.0,FEMALE,[Unknown],nan,Stage IB1,Cervical Squamous Cell Carcinoma,GX,2011.0,Peri (6-12 months since last menstrual period),-16072.0,Alive,TUMOR FREE,1099.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1099.0,0.0,1099.0,0.0,1099.0,0.0,1099.0,0
TCGA-VS-A8QC-01,TCGA-VS-A8QC,CESC,51.0,FEMALE,WHITE,nan,Stage IVA,Cervical Squamous Cell Carcinoma,G2,2009.0,Peri (6-12 months since last menstrual period),-18743.0,Dead,WITH TUMOR,nan,350.0,Cervical Cancer,Distant Metastasis,nan,Liver,263.0,Progressive Disease,nan,nan,1.0,350.0,1.0,350.0,nan,nan,1.0,263.0,1
TCGA-VS-A8QF-01,TCGA-VS-A8QF,CESC,42.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G2,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15374.0,Alive,TUMOR FREE,1800.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1800.0,0.0,1800.0,0.0,1800.0,0.0,1800.0,0
TCGA-VS-A8QH-01,TCGA-VS-A8QH,CESC,76.0,FEMALE,WHITE,nan,Stage IB1,Mucinous Adenocarcinoma of Endocervical Type,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27909.0,Dead,WITH TUMOR,nan,1210.0,Cervical Cancer,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,1210.0,1.0,1210.0,nan,nan,1.0,1210.0,1
TCGA-VS-A8QM-01,TCGA-VS-A8QM,CESC,47.0,FEMALE,[Unknown],nan,Stage IVB,Cervical Squamous Cell Carcinoma,GX,2009.0,nan,-17168.0,Dead,WITH TUMOR,nan,951.0,Cervical Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,951.0,1.0,951.0,nan,nan,1.0,951.0,1
TCGA-VS-A94W-01,TCGA-VS-A94W,CESC,39.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G2,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14399.0,Alive,TUMOR FREE,1243.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1243.0,0.0,1243.0,0.0,1243.0,0.0,1243.0,0
TCGA-VS-A94X-01,TCGA-VS-A94X,CESC,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G2,2010.0,[Not Evaluated],-14955.0,Dead,WITH TUMOR,nan,506.0,Cervical Cancer,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,506.0,1.0,506.0,nan,nan,1.0,506.0,1
TCGA-VS-A94Y-01,TCGA-VS-A94Y,CESC,47.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,GX,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17465.0,Dead,WITH TUMOR,nan,144.0,Cervical Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,144.0,1.0,144.0,nan,nan,1.0,144.0,1
TCGA-VS-A94Z-01,TCGA-VS-A94Z,CESC,38.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14046.0,Alive,TUMOR FREE,1015.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1015.0,0.0,1015.0,0.0,1015.0,0.0,1015.0,0
TCGA-VS-A950-01,TCGA-VS-A950,CESC,42.0,FEMALE,[Unknown],nan,Stage IIIA,Cervical Squamous Cell Carcinoma,G3,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15365.0,Alive,WITH TUMOR,1221.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,1221.0,0.0,1221.0,nan,nan,0.0,1221.0,0
TCGA-VS-A952-01,TCGA-VS-A952,CESC,66.0,FEMALE,WHITE,nan,Stage IB1,Mucinous Adenocarcinoma of Endocervical Type,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24345.0,Alive,TUMOR FREE,1778.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1778.0,0.0,1778.0,0.0,1778.0,0.0,1778.0,0
TCGA-VS-A953-01,TCGA-VS-A953,CESC,63.0,FEMALE,[Unknown],nan,Stage IVA,Cervical Squamous Cell Carcinoma,GX,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23277.0,Dead,WITH TUMOR,nan,477.0,Cervical Cancer,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,477.0,1.0,477.0,nan,nan,1.0,477.0,1
TCGA-VS-A954-01,TCGA-VS-A954,CESC,67.0,FEMALE,[Unknown],nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24498.0,Alive,TUMOR FREE,1714.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1714.0,0.0,1714.0,0.0,1714.0,0.0,1714.0,0
TCGA-VS-A957-01,TCGA-VS-A957,CESC,64.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23585.0,Alive,TUMOR FREE,1688.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1688.0,0.0,1688.0,0.0,1688.0,0.0,1688.0,0
TCGA-VS-A958-01,TCGA-VS-A958,CESC,46.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G2,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16905.0,Alive,TUMOR FREE,1525.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1525.0,0.0,1525.0,0.0,1525.0,0.0,1525.0,0
TCGA-VS-A959-01,TCGA-VS-A959,CESC,76.0,FEMALE,[Unknown],nan,Stage IIB,Cervical Squamous Cell Carcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27897.0,Alive,TUMOR FREE,1561.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1561.0,0.0,1561.0,0.0,1561.0,0.0,1561.0,0
TCGA-VS-A9U5-01,TCGA-VS-A9U5,CESC,57.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G3,2010.0,Peri (6-12 months since last menstrual period),-21149.0,Alive,TUMOR FREE,1535.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1535.0,0.0,1535.0,0.0,1535.0,0.0,1535.0,0
TCGA-VS-A9U6-01,TCGA-VS-A9U6,CESC,52.0,FEMALE,WHITE,nan,Stage IVB,Cervical Squamous Cell Carcinoma,GX,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19109.0,Alive,WITH TUMOR,1320.0,nan,nan,Distant Metastasis,nan,Diaphragm,711.0,Stable Disease,nan,nan,0.0,1320.0,0.0,1320.0,nan,nan,1.0,711.0,2
TCGA-VS-A9U7-01,TCGA-VS-A9U7,CESC,30.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G3,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11210.0,Alive,TUMOR FREE,1472.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1472.0,0.0,1472.0,0.0,1472.0,0.0,1472.0,0
TCGA-VS-A9UA-01,TCGA-VS-A9UA,CESC,60.0,FEMALE,WHITE,nan,Stage IIIA,Cervical Squamous Cell Carcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22221.0,Alive,TUMOR FREE,867.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,867.0,0.0,867.0,0.0,867.0,0.0,867.0,0
TCGA-VS-A9UB-01,TCGA-VS-A9UB,CESC,54.0,FEMALE,[Unknown],nan,Stage IIB,Cervical Squamous Cell Carcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19737.0,Alive,TUMOR FREE,911.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,911.0,0.0,911.0,0.0,911.0,0.0,911.0,0
TCGA-VS-A9UC-01,TCGA-VS-A9UC,CESC,32.0,FEMALE,[Unknown],nan,Stage IIB,Cervical Squamous Cell Carcinoma,G2,2012.0,Peri (6-12 months since last menstrual period),-11790.0,Alive,WITH TUMOR,825.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,825.0,0.0,825.0,nan,nan,0.0,825.0,2
TCGA-VS-A9UD-01,TCGA-VS-A9UD,CESC,73.0,FEMALE,WHITE,nan,Stage IIIA,Cervical Squamous Cell Carcinoma,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26815.0,Alive,TUMOR FREE,739.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,739.0,0.0,739.0,0.0,739.0,0.0,739.0,0
TCGA-VS-A9UH-01,TCGA-VS-A9UH,CESC,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IVA,Cervical Squamous Cell Carcinoma,GX,2010.0,nan,-19454.0,Alive,TUMOR FREE,1427.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1427.0,0.0,1427.0,nan,nan,0.0,1427.0,0
TCGA-VS-A9UI-01,TCGA-VS-A9UI,CESC,76.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,GX,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27838.0,Dead,TUMOR FREE,nan,1372.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1372.0,0.0,1372.0,0.0,1372.0,0.0,1372.0,0
TCGA-VS-A9UJ-01,TCGA-VS-A9UJ,CESC,55.0,FEMALE,[Unknown],nan,Stage IIB,Cervical Squamous Cell Carcinoma,GX,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20264.0,Dead,WITH TUMOR,nan,52.0,Cervical Cancer,nan,nan,nan,nan,nan,nan,nan,1.0,52.0,1.0,52.0,nan,nan,1.0,52.0,1
TCGA-VS-A9UL-01,TCGA-VS-A9UL,CESC,79.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29033.0,Dead,WITH TUMOR,nan,442.0,Cervical Cancer,Distant Metastasis,nan,Bone,336.0,Progressive Disease,nan,nan,1.0,442.0,1.0,442.0,nan,nan,1.0,336.0,1
TCGA-VS-A9UM-01,TCGA-VS-A9UM,CESC,39.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IVB,Cervical Squamous Cell Carcinoma,G2,2011.0,Peri (6-12 months since last menstrual period),-14255.0,Dead,TUMOR FREE,nan,829.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,829.0,0.0,829.0,nan,nan,0.0,829.0,0
TCGA-VS-A9UO-01,TCGA-VS-A9UO,CESC,43.0,FEMALE,WHITE,nan,Stage IIB,Mucinous Adenocarcinoma of Endocervical Type,G2,2011.0,Peri (6-12 months since last menstrual period),-15813.0,Alive,TUMOR FREE,1456.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1456.0,0.0,1456.0,0.0,1456.0,0.0,1456.0,0
TCGA-VS-A9UP-01,TCGA-VS-A9UP,CESC,43.0,FEMALE,[Unknown],nan,Stage IIA,Mucinous Adenocarcinoma of Endocervical Type,G3,2011.0,Peri (6-12 months since last menstrual period),-15849.0,Alive,WITH TUMOR,1444.0,nan,nan,Distant Metastasis,"Other, specify",Paraortic lymph nodes,352.0,Complete Remission/Response,nan,nan,0.0,1444.0,0.0,1444.0,1.0,352.0,1.0,352.0,2
TCGA-VS-A9UQ-01,TCGA-VS-A9UQ,CESC,32.0,FEMALE,[Unknown],nan,Stage IB,Mucinous Adenocarcinoma of Endocervical Type,G2,2011.0,Peri (6-12 months since last menstrual period),-11853.0,Alive,TUMOR FREE,1263.0,nan,nan,Distant Metastasis,"Other, specify",Ovary,561.0,Complete Remission/Response,nan,nan,0.0,1263.0,0.0,1263.0,1.0,561.0,1.0,561.0,2
TCGA-VS-A9UR-01,TCGA-VS-A9UR,CESC,53.0,FEMALE,WHITE,nan,Stage IIA,Mucinous Adenocarcinoma of Endocervical Type,GX,2013.0,[Unknown],-19688.0,Alive,WITH TUMOR,793.0,nan,nan,Distant Metastasis,"Other, specify",Retroperitoneal,675.0,Complete Remission/Response,nan,nan,0.0,793.0,0.0,793.0,1.0,675.0,1.0,675.0,2
TCGA-VS-A9UT-01,TCGA-VS-A9UT,CESC,72.0,FEMALE,ASIAN,nan,Stage IB,Mucinous Adenocarcinoma of Endocervical Type,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26603.0,Alive,TUMOR FREE,482.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,482.0,0.0,482.0,0.0,482.0,0.0,482.0,0
TCGA-VS-A9UU-01,TCGA-VS-A9UU,CESC,42.0,FEMALE,[Unknown],nan,Stage IIB,Cervical Squamous Cell Carcinoma,G1,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15534.0,Alive,TUMOR FREE,442.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,442.0,0.0,442.0,0.0,442.0,0.0,442.0,0
TCGA-VS-A9UV-01,TCGA-VS-A9UV,CESC,74.0,FEMALE,[Unknown],nan,Stage IVA,Cervical Squamous Cell Carcinoma,GX,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27348.0,Dead,WITH TUMOR,nan,104.0,Cervical Cancer,nan,nan,nan,nan,[Unknown],nan,nan,1.0,104.0,1.0,104.0,nan,nan,1.0,104.0,1
TCGA-VS-A9UY-01,TCGA-VS-A9UY,CESC,29.0,FEMALE,[Unknown],nan,Stage IVB,Cervical Squamous Cell Carcinoma,G2,2012.0,[Unknown],-10707.0,Dead,WITH TUMOR,nan,555.0,Cervical Cancer,Distant Metastasis,Head & Neck,nan,412.0,Progressive Disease,nan,nan,1.0,555.0,1.0,555.0,nan,nan,1.0,412.0,1
TCGA-VS-A9UZ-01,TCGA-VS-A9UZ,CESC,61.0,FEMALE,WHITE,nan,Stage IB1,Mucinous Adenocarcinoma of Endocervical Type,G2,2009.0,Peri (6-12 months since last menstrual period),-22344.0,Alive,TUMOR FREE,2044.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2044.0,0.0,2044.0,0.0,2044.0,0.0,2044.0,2
TCGA-VS-A9V0-01,TCGA-VS-A9V0,CESC,58.0,FEMALE,[Unknown],nan,Stage IB,Mucinous Adenocarcinoma of Endocervical Type,G3,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-21215.0,Alive,WITH TUMOR,573.0,nan,nan,Distant Metastasis,"Other, specify",Retroperitoneal lymph node and pelvic lymph node and lung,475.0,Complete Remission/Response,nan,nan,0.0,573.0,0.0,573.0,1.0,475.0,1.0,475.0,2
TCGA-VS-A9V1-01,TCGA-VS-A9V1,CESC,46.0,FEMALE,WHITE,nan,Stage IVB,Mucinous Adenocarcinoma of Endocervical Type,G2,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17001.0,Dead,WITH TUMOR,nan,157.0,Cervical Cancer,Distant Metastasis,nan,Retroperitoneo,58.0,Progressive Disease,nan,nan,1.0,157.0,1.0,157.0,nan,nan,1.0,58.0,1
TCGA-VS-A9V2-01,TCGA-VS-A9V2,CESC,29.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2013.0,Peri (6-12 months since last menstrual period),-10637.0,Alive,TUMOR FREE,555.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,555.0,0.0,555.0,0.0,555.0,0.0,555.0,0
TCGA-VS-A9V3-01,TCGA-VS-A9V3,CESC,62.0,FEMALE,WHITE,nan,Stage IVB,Cervical Squamous Cell Carcinoma,G3,2013.0,[Not Evaluated],-22990.0,Alive,WITH TUMOR,540.0,nan,nan,Distant Metastasis,"Other, specify",Mediastinal lymph nodes,456.0,Complete Remission/Response,nan,nan,0.0,540.0,0.0,540.0,nan,nan,1.0,456.0,2
TCGA-VS-A9V4-01,TCGA-VS-A9V4,CESC,63.0,FEMALE,WHITE,nan,Stage IVA,Mucinous Adenocarcinoma of Endocervical Type,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23334.0,Dead,WITH TUMOR,nan,132.0,Cervical Cancer,New Primary Tumor,nan,Sigmoid colon,100.0,[Unknown],nan,nan,1.0,132.0,1.0,132.0,nan,nan,1.0,100.0,1
TCGA-VS-A9V5-01,TCGA-VS-A9V5,CESC,50.0,FEMALE,WHITE,nan,Stage IIB,Mucinous Adenocarcinoma of Endocervical Type,G2,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18577.0,Dead,WITH TUMOR,nan,494.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,494.0,1.0,494.0,nan,nan,1.0,494.0,1
TCGA-VS-AA62-01,TCGA-VS-AA62,CESC,51.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G2,2009.0,Peri (6-12 months since last menstrual period),-18792.0,Dead,WITH TUMOR,nan,469.0,Cervical Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,469.0,1.0,469.0,nan,nan,1.0,469.0,1
TCGA-WL-A834-01,TCGA-WL-A834,CESC,57.0,FEMALE,WHITE,nan,nan,Cervical Squamous Cell Carcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),nan,Alive,TUMOR FREE,791.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,791.0,0.0,791.0,nan,nan,0.0,791.0,0
TCGA-XS-A8TJ-01,TCGA-XS-A8TJ,CESC,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15298.0,Alive,TUMOR FREE,890.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,890.0,0.0,890.0,0.0,890.0,0.0,890.0,0
TCGA-ZJ-A8QO-01,TCGA-ZJ-A8QO,CESC,73.0,FEMALE,[Unknown],nan,nan,Cervical Squamous Cell Carcinoma,nan,2007.0,[Unknown],-26723.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-ZJ-A8QQ-01,TCGA-ZJ-A8QQ,CESC,24.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,GX,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-8918.0,Alive,TUMOR FREE,2056.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2056.0,0.0,2056.0,0.0,2056.0,0.0,2056.0,0
TCGA-ZJ-A8QR-01,TCGA-ZJ-A8QR,CESC,38.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,nan,Stage I,Cervical Squamous Cell Carcinoma,GX,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14225.0,Dead,nan,nan,582.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,582.0,nan,582.0,nan,nan,0.0,582.0,1
TCGA-ZJ-AAX4-01,TCGA-ZJ-AAX4,CESC,85.0,FEMALE,WHITE,nan,Stage II,Cervical Squamous Cell Carcinoma,G3,2008.0,[Unknown],-31258.0,Alive,nan,21.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,21.0,0.0,21.0,nan,nan,0.0,21.0,0
TCGA-ZJ-AAX8-01,TCGA-ZJ-AAX8,CESC,58.0,FEMALE,[Unknown],nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2009.0,[Unknown],-21481.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-ZJ-AAXA-01,TCGA-ZJ-AAXA,CESC,64.0,FEMALE,WHITE,nan,Stage IB1,Cervical Squamous Cell Carcinoma,G2,2009.0,[Unknown],-23603.0,Alive,nan,43.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,43.0,0.0,43.0,nan,nan,0.0,43.0,2
TCGA-ZJ-AAXB-01,TCGA-ZJ-AAXB,CESC,42.0,FEMALE,WHITE,nan,Stage IB2,Endocervical Adenocarcinoma of the Usual Type,G3,2009.0,[Unknown],-15492.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-ZJ-AAXD-01,TCGA-ZJ-AAXD,CESC,35.0,FEMALE,[Unknown],nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2010.0,[Unknown],-12968.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-ZJ-AAXF-01,TCGA-ZJ-AAXF,CESC,62.0,FEMALE,[Unknown],nan,Stage IIB,Cervical Squamous Cell Carcinoma,G3,2010.0,[Unknown],-22709.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-ZJ-AAXI-01,TCGA-ZJ-AAXI,CESC,67.0,FEMALE,[Unknown],nan,Stage IIB,Cervical Squamous Cell Carcinoma,G2,2010.0,[Unknown],-24497.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-ZJ-AAXJ-01,TCGA-ZJ-AAXJ,CESC,43.0,FEMALE,[Unknown],nan,Stage IIB,Cervical Squamous Cell Carcinoma,nan,2010.0,[Unknown],-16007.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-ZJ-AAXN-01,TCGA-ZJ-AAXN,CESC,34.0,FEMALE,WHITE,nan,Stage IB2,Cervical Squamous Cell Carcinoma,nan,2010.0,[Unknown],-12701.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-ZJ-AAXT-01,TCGA-ZJ-AAXT,CESC,54.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2009.0,[Unknown],-19847.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-ZJ-AAXU-01,TCGA-ZJ-AAXU,CESC,51.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,G2,2010.0,[Unknown],-18773.0,Alive,nan,5.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,5.0,0.0,5.0,nan,nan,0.0,5.0,2
TCGA-ZJ-AB0H-01,TCGA-ZJ-AB0H,CESC,48.0,FEMALE,[Unknown],nan,Stage IIIB,Cervical Squamous Cell Carcinoma,nan,2006.0,[Unknown],-17869.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-ZJ-AB0I-01,TCGA-ZJ-AB0I,CESC,25.0,FEMALE,WHITE,nan,Stage IIB,Cervical Squamous Cell Carcinoma,nan,2006.0,[Unknown],-9486.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-ZX-AA5X-01,TCGA-ZX-AA5X,CESC,64.0,FEMALE,WHITE,nan,Stage IIIB,Cervical Squamous Cell Carcinoma,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23440.0,Alive,WITH TUMOR,119.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,119.0,0.0,119.0,nan,nan,0.0,119.0,2
TCGA-3X-AAV9-01,TCGA-3X-AAV9,CHOL,72.0,MALE,ASIAN,Stage I,nan,Cholangiocarcinoma; intrahepatic,G2,2010.0,nan,-26349.0,Dead,WITH TUMOR,nan,339.0,nan,Locoregional Recurrence,Liver,nan,216.0,nan,nan,R0,1.0,339.0,1.0,339.0,1.0,216.0,1.0,216.0,1
TCGA-3X-AAVA-01,TCGA-3X-AAVA,CHOL,50.0,FEMALE,WHITE,Stage II,nan,Cholangiocarcinoma; intrahepatic,G2,2012.0,nan,-18303.0,Dead,WITH TUMOR,nan,445.0,nan,Extrahepatic Recurrence,Bone,nan,264.0,nan,nan,R0,1.0,445.0,1.0,445.0,1.0,264.0,1.0,264.0,1
TCGA-3X-AAVB-01,TCGA-3X-AAVB,CHOL,70.0,FEMALE,WHITE,Stage IVB,nan,Cholangiocarcinoma; distal,G1,2012.0,nan,-25819.0,Alive,nan,402.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,402.0,0.0,402.0,nan,nan,0.0,402.0,0
TCGA-3X-AAVC-01,TCGA-3X-AAVC,CHOL,72.0,FEMALE,WHITE,Stage I,nan,Cholangiocarcinoma; hilar/perihilar,G3,2012.0,nan,-26493.0,Alive,TUMOR FREE,709.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,709.0,0.0,709.0,0.0,709.0,0.0,709.0,0
TCGA-3X-AAVE-01,TCGA-3X-AAVE,CHOL,60.0,MALE,ASIAN,Stage II,nan,Cholangiocarcinoma; intrahepatic,G2,2013.0,nan,-21943.0,Alive,TUMOR FREE,650.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,650.0,0.0,650.0,0.0,650.0,0.0,650.0,0
TCGA-4G-AAZO-01,TCGA-4G-AAZO,CHOL,71.0,FEMALE,WHITE,Stage II,nan,Cholangiocarcinoma; intrahepatic,G2,2012.0,nan,-25989.0,Alive,WITH TUMOR,1177.0,nan,nan,Intrahepatic Recurrence,Liver,nan,424.0,nan,nan,R1,0.0,1177.0,0.0,1177.0,nan,nan,1.0,424.0,2
TCGA-4G-AAZT-01,TCGA-4G-AAZT,CHOL,62.0,MALE,WHITE,Stage I,nan,Cholangiocarcinoma; intrahepatic,G2,2013.0,nan,-22777.0,Alive,TUMOR FREE,420.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,420.0,0.0,420.0,0.0,420.0,0.0,420.0,0
TCGA-W5-AA2G-01,TCGA-W5-AA2G,CHOL,62.0,FEMALE,WHITE,Stage I,nan,Cholangiocarcinoma; intrahepatic,G3,2008.0,nan,-22933.0,Alive,TUMOR FREE,1976.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1976.0,0.0,1976.0,0.0,1976.0,0.0,1976.0,0
TCGA-W5-AA2H-01,TCGA-W5-AA2H,CHOL,70.0,FEMALE,WHITE,Stage III,nan,Cholangiocarcinoma; distal,G3,2012.0,nan,-25775.0,Alive,TUMOR FREE,1077.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1077.0,0.0,1077.0,0.0,1077.0,0.0,1077.0,0
TCGA-W5-AA2I-01,TCGA-W5-AA2I,CHOL,66.0,MALE,WHITE,Stage I,nan,Cholangiocarcinoma; intrahepatic,G2,2005.0,nan,-24388.0,Dead,WITH TUMOR,nan,1939.0,nan,New Primary Tumor,"Other, specify",bladder,217.0,nan,nan,R0,1.0,1939.0,1.0,1939.0,0.0,1939.0,1.0,217.0,1
TCGA-W5-AA2I-11,TCGA-W5-AA2I,CHOL,66.0,MALE,WHITE,Stage I,nan,Cholangiocarcinoma; intrahepatic,G2,2005.0,nan,-24388.0,Dead,WITH TUMOR,nan,1939.0,nan,New Primary Tumor,"Other, specify",bladder,217.0,nan,nan,R0,1.0,1939.0,1.0,1939.0,0.0,1939.0,1.0,217.0,1
TCGA-W5-AA2O-01,TCGA-W5-AA2O,CHOL,57.0,MALE,WHITE,Stage I,nan,Cholangiocarcinoma; intrahepatic,G3,2006.0,nan,-21118.0,Dead,WITH TUMOR,nan,640.0,nan,Intrahepatic Recurrence,Liver,nan,215.0,nan,nan,R0,1.0,640.0,1.0,640.0,1.0,215.0,1.0,215.0,1
TCGA-W5-AA2Q-01,TCGA-W5-AA2Q,CHOL,68.0,MALE,WHITE,Stage II,nan,Cholangiocarcinoma; intrahepatic,G2,2006.0,nan,-25069.0,Alive,TUMOR FREE,50.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,50.0,0.0,50.0,0.0,50.0,0.0,50.0,0
TCGA-W5-AA2Q-11,TCGA-W5-AA2Q,CHOL,68.0,MALE,WHITE,Stage II,nan,Cholangiocarcinoma; intrahepatic,G2,2006.0,nan,-25069.0,Alive,TUMOR FREE,50.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,50.0,0.0,50.0,0.0,50.0,0.0,50.0,0
TCGA-W5-AA2R-01,TCGA-W5-AA2R,CHOL,77.0,FEMALE,WHITE,Stage I,nan,Cholangiocarcinoma; intrahepatic,G3,2006.0,nan,-28367.0,Alive,TUMOR FREE,1542.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1542.0,0.0,1542.0,0.0,1542.0,0.0,1542.0,0
TCGA-W5-AA2R-11,TCGA-W5-AA2R,CHOL,77.0,FEMALE,WHITE,Stage I,nan,Cholangiocarcinoma; intrahepatic,G3,2006.0,nan,-28367.0,Alive,TUMOR FREE,1542.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1542.0,0.0,1542.0,0.0,1542.0,0.0,1542.0,0
TCGA-W5-AA2T-01,TCGA-W5-AA2T,CHOL,64.0,FEMALE,WHITE,Stage II,nan,Cholangiocarcinoma; intrahepatic,G3,2008.0,nan,-23560.0,Dead,WITH TUMOR,nan,1220.0,nan,Extrahepatic Recurrence,Bone,nan,295.0,nan,nan,R0,1.0,1220.0,1.0,1220.0,1.0,295.0,1.0,295.0,1
TCGA-W5-AA2U-01,TCGA-W5-AA2U,CHOL,78.0,FEMALE,WHITE,Stage I,nan,Cholangiocarcinoma; intrahepatic,G3,2010.0,nan,-28552.0,Dead,WITH TUMOR,nan,627.0,nan,New Primary Tumor,Lung,nan,95.0,nan,nan,R0,1.0,627.0,1.0,627.0,0.0,627.0,1.0,95.0,1
TCGA-W5-AA2U-11,TCGA-W5-AA2U,CHOL,78.0,FEMALE,WHITE,Stage I,nan,Cholangiocarcinoma; intrahepatic,G3,2010.0,nan,-28552.0,Dead,WITH TUMOR,nan,627.0,nan,New Primary Tumor,Lung,nan,95.0,nan,nan,R0,1.0,627.0,1.0,627.0,0.0,627.0,1.0,95.0,1
TCGA-W5-AA2W-01,TCGA-W5-AA2W,CHOL,31.0,FEMALE,WHITE,Stage IVA,nan,Cholangiocarcinoma; intrahepatic,G3,2010.0,nan,-11438.0,Dead,WITH TUMOR,nan,924.0,nan,Intrahepatic Recurrence,Liver,nan,237.0,nan,nan,R0,1.0,924.0,1.0,924.0,nan,nan,1.0,237.0,1
TCGA-W5-AA2X-01,TCGA-W5-AA2X,CHOL,67.0,MALE,WHITE,Stage IVB,nan,Cholangiocarcinoma; hilar/perihilar,G4,2010.0,nan,-24797.0,Dead,nan,nan,271.0,nan,nan,nan,nan,nan,nan,nan,RX,1.0,271.0,nan,271.0,nan,nan,0.0,271.0,1
TCGA-W5-AA2X-11,TCGA-W5-AA2X,CHOL,67.0,MALE,WHITE,Stage IVB,nan,Cholangiocarcinoma; hilar/perihilar,G4,2010.0,nan,-24797.0,Dead,nan,nan,271.0,nan,nan,nan,nan,nan,nan,nan,RX,1.0,271.0,nan,271.0,nan,nan,0.0,271.0,1
TCGA-W5-AA2Z-01,TCGA-W5-AA2Z,CHOL,29.0,FEMALE,WHITE,Stage II,nan,Cholangiocarcinoma; intrahepatic,G3,2010.0,nan,-10659.0,Alive,WITH TUMOR,1614.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,1614.0,0.0,1614.0,nan,nan,0.0,1614.0,0
TCGA-W5-AA30-01,TCGA-W5-AA30,CHOL,82.0,MALE,WHITE,Stage I,nan,Cholangiocarcinoma; intrahepatic,G3,2010.0,nan,-30039.0,Alive,TUMOR FREE,1153.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1153.0,0.0,1153.0,0.0,1153.0,0.0,1153.0,0
TCGA-W5-AA30-11,TCGA-W5-AA30,CHOL,82.0,MALE,WHITE,Stage I,nan,Cholangiocarcinoma; intrahepatic,G3,2010.0,nan,-30039.0,Alive,TUMOR FREE,1153.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1153.0,0.0,1153.0,0.0,1153.0,0.0,1153.0,0
TCGA-W5-AA31-01,TCGA-W5-AA31,CHOL,71.0,MALE,WHITE,Stage I,nan,Cholangiocarcinoma; intrahepatic,G3,2010.0,nan,-26139.0,Alive,TUMOR FREE,10.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,0
TCGA-W5-AA31-11,TCGA-W5-AA31,CHOL,71.0,MALE,WHITE,Stage I,nan,Cholangiocarcinoma; intrahepatic,G3,2010.0,nan,-26139.0,Alive,TUMOR FREE,10.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,0
TCGA-W5-AA33-01,TCGA-W5-AA33,CHOL,60.0,MALE,WHITE,Stage I,nan,Cholangiocarcinoma; intrahepatic,G3,2011.0,nan,-22090.0,Alive,TUMOR FREE,1449.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1449.0,0.0,1449.0,0.0,1449.0,0.0,1449.0,0
TCGA-W5-AA34-01,TCGA-W5-AA34,CHOL,75.0,FEMALE,WHITE,Stage I,nan,Cholangiocarcinoma; intrahepatic,G2,2012.0,nan,-27535.0,Dead,WITH TUMOR,nan,555.0,nan,Intrahepatic Recurrence,Liver,nan,40.0,nan,nan,R0,1.0,555.0,1.0,555.0,1.0,40.0,1.0,40.0,1
TCGA-W5-AA34-11,TCGA-W5-AA34,CHOL,75.0,FEMALE,WHITE,Stage I,nan,Cholangiocarcinoma; intrahepatic,G2,2012.0,nan,-27535.0,Dead,WITH TUMOR,nan,555.0,nan,Intrahepatic Recurrence,Liver,nan,40.0,nan,nan,R0,1.0,555.0,1.0,555.0,1.0,40.0,1.0,40.0,1
TCGA-W5-AA36-01,TCGA-W5-AA36,CHOL,51.0,FEMALE,WHITE,Stage IV,nan,Cholangiocarcinoma; hilar/perihilar,G3,2008.0,nan,-18882.0,Dead,WITH TUMOR,nan,1402.0,nan,Intrahepatic Recurrence,Liver,nan,362.0,nan,nan,R0,1.0,1402.0,1.0,1402.0,nan,nan,1.0,362.0,1
TCGA-W5-AA38-01,TCGA-W5-AA38,CHOL,55.0,FEMALE,WHITE,Stage I,nan,Cholangiocarcinoma; intrahepatic,G3,2011.0,nan,-20285.0,Alive,TUMOR FREE,1471.0,nan,nan,Locoregional Recurrence,Liver,nan,377.0,nan,nan,R0,0.0,1471.0,0.0,1471.0,1.0,377.0,1.0,377.0,0
TCGA-W5-AA39-01,TCGA-W5-AA39,CHOL,81.0,MALE,WHITE,Stage II,nan,Cholangiocarcinoma; intrahepatic,G4,2010.0,nan,-29594.0,Dead,WITH TUMOR,nan,170.0,nan,nan,nan,nan,nan,nan,nan,RX,1.0,170.0,1.0,170.0,nan,nan,1.0,170.0,1
TCGA-W6-AA0S-01,TCGA-W6-AA0S,CHOL,46.0,FEMALE,WHITE,Stage I,nan,Cholangiocarcinoma; intrahepatic,G2,2013.0,nan,-16951.0,Alive,TUMOR FREE,808.0,nan,nan,Extrahepatic Recurrence,Non-regional / Distant Lymph Nodes,nan,549.0,nan,nan,R0,0.0,808.0,0.0,808.0,1.0,549.0,1.0,549.0,2
TCGA-WD-A7RX-01,TCGA-WD-A7RX,CHOL,71.0,FEMALE,WHITE,Stage II,nan,Cholangiocarcinoma; intrahepatic,G2,2013.0,nan,-26006.0,Dead,TUMOR FREE,nan,21.0,nan,nan,nan,nan,nan,nan,nan,RX,1.0,21.0,0.0,21.0,nan,nan,0.0,21.0,1
TCGA-YR-A95A-01,TCGA-YR-A95A,CHOL,52.0,MALE,WHITE,Stage IV,nan,Cholangiocarcinoma; hilar/perihilar,G2,2009.0,nan,-19292.0,Dead,WITH TUMOR,nan,26.0,nan,New Primary Tumor,"Other, specify",Adrenal gland,17.0,nan,nan,R1,1.0,26.0,1.0,26.0,nan,nan,1.0,17.0,1
TCGA-ZD-A8I3-01,TCGA-ZD-A8I3,CHOL,73.0,FEMALE,ASIAN,Stage II,nan,Cholangiocarcinoma; intrahepatic,G3,2013.0,nan,-26754.0,Dead,WITH TUMOR,nan,169.0,nan,Locoregional Recurrence,Liver,nan,59.0,nan,nan,R0,1.0,169.0,1.0,169.0,1.0,59.0,1.0,59.0,1
TCGA-ZH-A8Y1-01,TCGA-ZH-A8Y1,CHOL,74.0,FEMALE,WHITE,Stage IVA,nan,Cholangiocarcinoma; intrahepatic,G2,2012.0,nan,-27279.0,Dead,WITH TUMOR,nan,385.0,nan,Locoregional Recurrence,nan,nan,49.0,nan,nan,R1,1.0,385.0,1.0,385.0,nan,nan,1.0,49.0,1
TCGA-ZH-A8Y2-01,TCGA-ZH-A8Y2,CHOL,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Cholangiocarcinoma; intrahepatic,G2,2011.0,nan,-21743.0,Dead,WITH TUMOR,nan,701.0,nan,Locoregional Recurrence,nan,nan,198.0,nan,nan,R0,1.0,701.0,1.0,701.0,1.0,198.0,1.0,198.0,1
TCGA-ZH-A8Y4-01,TCGA-ZH-A8Y4,CHOL,58.0,MALE,WHITE,Stage I,nan,Cholangiocarcinoma; intrahepatic,G3,2010.0,nan,-21503.0,Dead,WITH TUMOR,nan,741.0,nan,Locoregional Recurrence,nan,nan,281.0,nan,nan,R1,1.0,741.0,1.0,741.0,nan,nan,1.0,281.0,1
TCGA-ZH-A8Y5-01,TCGA-ZH-A8Y5,CHOL,69.0,MALE,WHITE,Stage IVB,nan,Cholangiocarcinoma; intrahepatic,G3,2012.0,nan,-25268.0,Alive,WITH TUMOR,1229.0,nan,nan,Extrahepatic Recurrence,Lung,nan,242.0,nan,nan,R0,0.0,1229.0,0.0,1229.0,nan,nan,1.0,242.0,0
TCGA-ZH-A8Y6-01,TCGA-ZH-A8Y6,CHOL,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Cholangiocarcinoma; intrahepatic,G2,2013.0,nan,-14976.0,Alive,TUMOR FREE,519.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,519.0,0.0,519.0,0.0,519.0,0.0,519.0,0
TCGA-ZH-A8Y8-01,TCGA-ZH-A8Y8,CHOL,73.0,MALE,WHITE,Stage I,nan,Cholangiocarcinoma; intrahepatic,G2,2013.0,nan,-26744.0,Alive,TUMOR FREE,602.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,602.0,0.0,602.0,0.0,602.0,0.0,602.0,0
TCGA-ZU-A8S4-01,TCGA-ZU-A8S4,CHOL,52.0,MALE,WHITE,Stage I,nan,Cholangiocarcinoma; intrahepatic,G3,2012.0,nan,-19264.0,Dead,WITH TUMOR,nan,98.0,nan,Intrahepatic Recurrence,Liver,nan,72.0,nan,nan,R0,1.0,98.0,1.0,98.0,1.0,72.0,1.0,72.0,1
TCGA-ZU-A8S4-11,TCGA-ZU-A8S4,CHOL,52.0,MALE,WHITE,Stage I,nan,Cholangiocarcinoma; intrahepatic,G3,2012.0,nan,-19264.0,Dead,WITH TUMOR,nan,98.0,nan,Intrahepatic Recurrence,Liver,nan,72.0,nan,nan,R0,1.0,98.0,1.0,98.0,1.0,72.0,1.0,72.0,1
TCGA-3L-AA1B-01,TCGA-3L-AA1B,COAD,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Colon Adenocarcinoma,nan,2013.0,nan,-22379.0,Alive,TUMOR FREE,475.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,475.0,0.0,475.0,0.0,475.0,0.0,475.0,0
TCGA-4N-A93T-01,TCGA-4N-A93T,COAD,67.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,nan,Colon Adenocarcinoma,nan,2013.0,nan,-24523.0,Alive,WITH TUMOR,146.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,146.0,0.0,146.0,nan,nan,0.0,146.0,0
TCGA-4T-AA8H-01,TCGA-4T-AA8H,COAD,42.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Colon Mucinous Adenocarcinoma,nan,2013.0,nan,-15494.0,Alive,TUMOR FREE,385.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,0
TCGA-5M-AAT4-01,TCGA-5M-AAT4,COAD,74.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Colon Adenocarcinoma,nan,2009.0,nan,-27095.0,Dead,WITH TUMOR,nan,49.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,49.0,1.0,49.0,nan,nan,1.0,49.0,1
TCGA-5M-AAT6-01,TCGA-5M-AAT6,COAD,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Colon Adenocarcinoma,nan,2009.0,nan,-14852.0,Dead,WITH TUMOR,nan,290.0,nan,nan,nan,nan,219.0,Progressive Disease,nan,nan,1.0,290.0,1.0,290.0,nan,nan,1.0,219.0,1
TCGA-5M-AATE-01,TCGA-5M-AATE,COAD,76.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2011.0,nan,-27870.0,Alive,WITH TUMOR,1200.0,nan,nan,nan,nan,nan,810.0,Progressive Disease,nan,nan,0.0,1200.0,0.0,1200.0,nan,nan,1.0,810.0,0
TCGA-A6-2670-01,TCGA-A6-2670,COAD,45.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-16512.0,Alive,TUMOR FREE,775.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,775.0,0.0,775.0,nan,nan,0.0,775.0,0
TCGA-A6-2671-01,TCGA-A6-2671,COAD,85.0,MALE,WHITE,Stage IV,nan,Colon Adenocarcinoma,nan,2009.0,nan,-31329.0,Dead,WITH TUMOR,nan,1331.0,nan,nan,nan,nan,535.0,nan,nan,nan,1.0,1331.0,1.0,1331.0,nan,nan,1.0,535.0,1
TCGA-A6-2671-11,TCGA-A6-2671,COAD,85.0,MALE,WHITE,Stage IV,nan,Colon Adenocarcinoma,nan,2009.0,nan,-31329.0,Dead,WITH TUMOR,nan,1331.0,nan,nan,nan,nan,535.0,nan,nan,nan,1.0,1331.0,1.0,1331.0,nan,nan,1.0,535.0,1
TCGA-A6-2672-01,TCGA-A6-2672,COAD,82.0,FEMALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2009.0,nan,-30237.0,Alive,TUMOR FREE,1419.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1419.0,0.0,1419.0,0.0,1419.0,0.0,1419.0,0
TCGA-A6-2672-11,TCGA-A6-2672,COAD,82.0,FEMALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2009.0,nan,-30237.0,Alive,TUMOR FREE,1419.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1419.0,0.0,1419.0,0.0,1419.0,0.0,1419.0,0
TCGA-A6-2674-01,TCGA-A6-2674,COAD,71.0,MALE,WHITE,Stage IV,nan,Colon Mucinous Adenocarcinoma,nan,2009.0,nan,-26292.0,Alive,TUMOR FREE,1331.0,nan,nan,nan,nan,nan,735.0,Complete Remission/Response,nan,nan,0.0,1331.0,0.0,1331.0,nan,nan,1.0,735.0,0
TCGA-A6-2674-11,TCGA-A6-2674,COAD,71.0,MALE,WHITE,Stage IV,nan,Colon Mucinous Adenocarcinoma,nan,2009.0,nan,-26292.0,Alive,TUMOR FREE,1331.0,nan,nan,nan,nan,nan,735.0,Complete Remission/Response,nan,nan,0.0,1331.0,0.0,1331.0,nan,nan,1.0,735.0,0
TCGA-A6-2675-01,TCGA-A6-2675,COAD,78.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-28813.0,Alive,TUMOR FREE,1321.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1321.0,0.0,1321.0,0.0,1321.0,0.0,1321.0,0
TCGA-A6-2675-11,TCGA-A6-2675,COAD,78.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-28813.0,Alive,TUMOR FREE,1321.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1321.0,0.0,1321.0,0.0,1321.0,0.0,1321.0,0
TCGA-A6-2676-01,TCGA-A6-2676,COAD,75.0,FEMALE,WHITE,Stage IIB,nan,Colon Adenocarcinoma,nan,2009.0,nan,-27403.0,Dead,TUMOR FREE,nan,1305.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1305.0,0.0,1305.0,0.0,1305.0,0.0,1305.0,0
TCGA-A6-2676-11,TCGA-A6-2676,COAD,75.0,FEMALE,WHITE,Stage IIB,nan,Colon Adenocarcinoma,nan,2009.0,nan,-27403.0,Dead,TUMOR FREE,nan,1305.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1305.0,0.0,1305.0,0.0,1305.0,0.0,1305.0,0
TCGA-A6-2677-01,TCGA-A6-2677,COAD,68.0,FEMALE,WHITE,Stage IIIC,nan,Colon Adenocarcinoma,nan,2009.0,nan,-25143.0,Dead,TUMOR FREE,nan,740.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,740.0,0.0,740.0,nan,nan,0.0,740.0,1
TCGA-A6-2677-11,TCGA-A6-2677,COAD,68.0,FEMALE,WHITE,Stage IIIC,nan,Colon Adenocarcinoma,nan,2009.0,nan,-25143.0,Dead,TUMOR FREE,nan,740.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,740.0,0.0,740.0,nan,nan,0.0,740.0,1
TCGA-A6-2678-01,TCGA-A6-2678,COAD,43.0,FEMALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2009.0,nan,-16030.0,Alive,TUMOR FREE,1286.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1286.0,0.0,1286.0,0.0,1286.0,0.0,1286.0,0
TCGA-A6-2678-11,TCGA-A6-2678,COAD,43.0,FEMALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2009.0,nan,-16030.0,Alive,TUMOR FREE,1286.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1286.0,0.0,1286.0,0.0,1286.0,0.0,1286.0,0
TCGA-A6-2679-01,TCGA-A6-2679,COAD,73.0,FEMALE,WHITE,Stage IIB,nan,Colon Adenocarcinoma,nan,2009.0,nan,-26820.0,Alive,TUMOR FREE,1366.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1366.0,0.0,1366.0,0.0,1366.0,0.0,1366.0,0
TCGA-A6-2679-11,TCGA-A6-2679,COAD,73.0,FEMALE,WHITE,Stage IIB,nan,Colon Adenocarcinoma,nan,2009.0,nan,-26820.0,Alive,TUMOR FREE,1366.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1366.0,0.0,1366.0,0.0,1366.0,0.0,1366.0,0
TCGA-A6-2680-01,TCGA-A6-2680,COAD,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Colon Adenocarcinoma,nan,2009.0,nan,-26533.0,Alive,TUMOR FREE,1068.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1068.0,0.0,1068.0,0.0,1068.0,0.0,1068.0,0
TCGA-A6-2680-11,TCGA-A6-2680,COAD,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Colon Adenocarcinoma,nan,2009.0,nan,-26533.0,Alive,TUMOR FREE,1068.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1068.0,0.0,1068.0,0.0,1068.0,0.0,1068.0,0
TCGA-A6-2681-01,TCGA-A6-2681,COAD,73.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-26929.0,Alive,TUMOR FREE,1387.0,nan,nan,nan,nan,nan,1150.0,Complete Remission/Response,nan,nan,0.0,1387.0,0.0,1387.0,1.0,1150.0,1.0,1150.0,2
TCGA-A6-2681-11,TCGA-A6-2681,COAD,73.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-26929.0,Alive,TUMOR FREE,1387.0,nan,nan,nan,nan,nan,1150.0,Complete Remission/Response,nan,nan,0.0,1387.0,0.0,1387.0,1.0,1150.0,1.0,1150.0,2
TCGA-A6-2682-01,TCGA-A6-2682,COAD,70.0,MALE,WHITE,Stage IV,nan,Colon Adenocarcinoma,nan,2009.0,nan,-25683.0,Dead,WITH TUMOR,nan,424.0,nan,nan,nan,nan,381.0,nan,nan,nan,1.0,424.0,1.0,424.0,nan,nan,1.0,381.0,1
TCGA-A6-2682-11,TCGA-A6-2682,COAD,70.0,MALE,WHITE,Stage IV,nan,Colon Adenocarcinoma,nan,2009.0,nan,-25683.0,Dead,WITH TUMOR,nan,424.0,nan,nan,nan,nan,381.0,nan,nan,nan,1.0,424.0,1.0,424.0,nan,nan,1.0,381.0,1
TCGA-A6-2683-01,TCGA-A6-2683,COAD,57.0,FEMALE,WHITE,Stage IV,nan,Colon Adenocarcinoma,nan,2009.0,nan,-20871.0,Dead,WITH TUMOR,nan,504.0,nan,nan,nan,nan,300.0,nan,nan,nan,1.0,504.0,1.0,504.0,nan,nan,1.0,300.0,1
TCGA-A6-2683-11,TCGA-A6-2683,COAD,57.0,FEMALE,WHITE,Stage IV,nan,Colon Adenocarcinoma,nan,2009.0,nan,-20871.0,Dead,WITH TUMOR,nan,504.0,nan,nan,nan,nan,300.0,nan,nan,nan,1.0,504.0,1.0,504.0,nan,nan,1.0,300.0,1
TCGA-A6-2684-01,TCGA-A6-2684,COAD,75.0,FEMALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2009.0,nan,-27708.0,Alive,TUMOR FREE,1127.0,nan,nan,Locoregional Disease,nan,nan,976.0,nan,nan,nan,0.0,1127.0,0.0,1127.0,nan,nan,1.0,976.0,0
TCGA-A6-2684-11,TCGA-A6-2684,COAD,75.0,FEMALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2009.0,nan,-27708.0,Alive,TUMOR FREE,1127.0,nan,nan,Locoregional Disease,nan,nan,976.0,nan,nan,nan,0.0,1127.0,0.0,1127.0,nan,nan,1.0,976.0,0
TCGA-A6-2685-01,TCGA-A6-2685,COAD,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-17757.0,Alive,TUMOR FREE,1133.0,nan,nan,Locoregional Disease,nan,nan,948.0,nan,nan,nan,0.0,1133.0,0.0,1133.0,nan,nan,1.0,948.0,0
TCGA-A6-2685-11,TCGA-A6-2685,COAD,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-17757.0,Alive,TUMOR FREE,1133.0,nan,nan,Locoregional Disease,nan,nan,948.0,nan,nan,nan,0.0,1133.0,0.0,1133.0,nan,nan,1.0,948.0,0
TCGA-A6-2686-01,TCGA-A6-2686,COAD,81.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-29623.0,Dead,TUMOR FREE,nan,1126.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1126.0,0.0,1126.0,0.0,1126.0,0.0,1126.0,0
TCGA-A6-2686-11,TCGA-A6-2686,COAD,81.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-29623.0,Dead,TUMOR FREE,nan,1126.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1126.0,0.0,1126.0,0.0,1126.0,0.0,1126.0,0
TCGA-A6-3807-01,TCGA-A6-3807,COAD,53.0,FEMALE,WHITE,Stage IIIC,nan,Colon Adenocarcinoma,nan,2009.0,nan,-19624.0,Alive,TUMOR FREE,1054.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1054.0,0.0,1054.0,nan,nan,0.0,1054.0,0
TCGA-A6-3807-11,TCGA-A6-3807,COAD,53.0,FEMALE,WHITE,Stage IIIC,nan,Colon Adenocarcinoma,nan,2009.0,nan,-19624.0,Alive,TUMOR FREE,1054.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1054.0,0.0,1054.0,nan,nan,0.0,1054.0,0
TCGA-A6-3808-01,TCGA-A6-3808,COAD,73.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-26666.0,Alive,TUMOR FREE,1014.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1014.0,0.0,1014.0,nan,nan,0.0,1014.0,0
TCGA-A6-3808-11,TCGA-A6-3808,COAD,73.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-26666.0,Alive,TUMOR FREE,1014.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1014.0,0.0,1014.0,nan,nan,0.0,1014.0,0
TCGA-A6-3809-01,TCGA-A6-3809,COAD,71.0,FEMALE,WHITE,Stage IIB,nan,Colon Mucinous Adenocarcinoma,nan,2009.0,nan,-26274.0,Alive,TUMOR FREE,996.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,996.0,0.0,996.0,nan,nan,0.0,996.0,0
TCGA-A6-3809-11,TCGA-A6-3809,COAD,71.0,FEMALE,WHITE,Stage IIB,nan,Colon Mucinous Adenocarcinoma,nan,2009.0,nan,-26274.0,Alive,TUMOR FREE,996.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,996.0,0.0,996.0,nan,nan,0.0,996.0,0
TCGA-A6-3810-01,TCGA-A6-3810,COAD,62.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-22999.0,Alive,TUMOR FREE,1111.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1111.0,0.0,1111.0,0.0,1111.0,0.0,1111.0,0
TCGA-A6-3810-11,TCGA-A6-3810,COAD,62.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-22999.0,Alive,TUMOR FREE,1111.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1111.0,0.0,1111.0,0.0,1111.0,0.0,1111.0,0
TCGA-A6-4105-01,TCGA-A6-4105,COAD,79.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-29097.0,Dead,TUMOR FREE,nan,442.0,nan,nan,nan,nan,364.0,nan,nan,nan,1.0,442.0,0.0,442.0,nan,nan,1.0,364.0,1
TCGA-A6-4107-01,TCGA-A6-4107,COAD,57.0,FEMALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2010.0,nan,-21064.0,Alive,TUMOR FREE,987.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,987.0,0.0,987.0,0.0,987.0,0.0,987.0,0
TCGA-A6-4107-11,TCGA-A6-4107,COAD,57.0,FEMALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2010.0,nan,-21064.0,Alive,TUMOR FREE,987.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,987.0,0.0,987.0,0.0,987.0,0.0,987.0,0
TCGA-A6-5656-01,TCGA-A6-5656,COAD,74.0,MALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2010.0,nan,-27184.0,Alive,TUMOR FREE,1001.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1001.0,0.0,1001.0,0.0,1001.0,0.0,1001.0,0
TCGA-A6-5657-01,TCGA-A6-5657,COAD,65.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,nan,Colon Adenocarcinoma,nan,2010.0,nan,-23920.0,Alive,TUMOR FREE,962.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,962.0,0.0,962.0,0.0,962.0,0.0,962.0,0
TCGA-A6-5659-01,TCGA-A6-5659,COAD,82.0,MALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2010.0,nan,-30028.0,Alive,TUMOR FREE,926.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,926.0,0.0,926.0,0.0,926.0,0.0,926.0,0
TCGA-A6-5659-11,TCGA-A6-5659,COAD,82.0,MALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2010.0,nan,-30028.0,Alive,TUMOR FREE,926.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,926.0,0.0,926.0,0.0,926.0,0.0,926.0,0
TCGA-A6-5660-01,TCGA-A6-5660,COAD,73.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,nan,Colon Adenocarcinoma,nan,2010.0,nan,-26803.0,Alive,TUMOR FREE,888.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,888.0,0.0,888.0,0.0,888.0,0.0,888.0,0
TCGA-A6-5661-01,TCGA-A6-5661,COAD,80.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-29446.0,Alive,TUMOR FREE,1020.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1020.0,0.0,1020.0,0.0,1020.0,0.0,1020.0,0
TCGA-A6-5662-01,TCGA-A6-5662,COAD,46.0,MALE,WHITE,Stage IVA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-16873.0,Alive,WITH TUMOR,718.0,nan,nan,nan,nan,nan,495.0,nan,nan,nan,0.0,718.0,0.0,718.0,nan,nan,1.0,495.0,0
TCGA-A6-5662-11,TCGA-A6-5662,COAD,46.0,MALE,WHITE,Stage IVA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-16873.0,Alive,WITH TUMOR,718.0,nan,nan,nan,nan,nan,495.0,nan,nan,nan,0.0,718.0,0.0,718.0,nan,nan,1.0,495.0,0
TCGA-A6-5664-01,TCGA-A6-5664,COAD,80.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,nan,Colon Adenocarcinoma,nan,2010.0,nan,-29426.0,Alive,WITH TUMOR,672.0,nan,nan,nan,nan,nan,183.0,nan,nan,nan,0.0,672.0,0.0,672.0,nan,nan,1.0,183.0,0
TCGA-A6-5665-01,TCGA-A6-5665,COAD,84.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-30915.0,Alive,TUMOR FREE,671.0,nan,nan,nan,nan,nan,529.0,nan,nan,nan,0.0,671.0,0.0,671.0,nan,nan,1.0,529.0,0
TCGA-A6-5665-11,TCGA-A6-5665,COAD,84.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-30915.0,Alive,TUMOR FREE,671.0,nan,nan,nan,nan,nan,529.0,nan,nan,nan,0.0,671.0,0.0,671.0,nan,nan,1.0,529.0,0
TCGA-A6-5666-01,TCGA-A6-5666,COAD,78.0,MALE,WHITE,Stage IIC,nan,Colon Adenocarcinoma,nan,2010.0,nan,-28514.0,Alive,WITH TUMOR,995.0,nan,nan,nan,nan,nan,509.0,Complete Remission/Response,nan,nan,0.0,995.0,0.0,995.0,1.0,509.0,1.0,509.0,2
TCGA-A6-5667-01,TCGA-A6-5667,COAD,40.0,FEMALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2010.0,nan,-14756.0,Alive,TUMOR FREE,887.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,887.0,0.0,887.0,0.0,887.0,0.0,887.0,0
TCGA-A6-5667-11,TCGA-A6-5667,COAD,40.0,FEMALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2010.0,nan,-14756.0,Alive,TUMOR FREE,887.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,887.0,0.0,887.0,0.0,887.0,0.0,887.0,0
TCGA-A6-6137-01,TCGA-A6-6137,COAD,55.0,MALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2010.0,nan,-20095.0,Alive,TUMOR FREE,824.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,824.0,0.0,824.0,0.0,824.0,0.0,824.0,0
TCGA-A6-6138-01,TCGA-A6-6138,COAD,61.0,MALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2010.0,nan,-22523.0,Alive,TUMOR FREE,685.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,685.0,0.0,685.0,nan,nan,0.0,685.0,0
TCGA-A6-6140-01,TCGA-A6-6140,COAD,62.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2011.0,nan,-22835.0,Alive,TUMOR FREE,734.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,734.0,0.0,734.0,0.0,734.0,0.0,734.0,0
TCGA-A6-6141-01,TCGA-A6-6141,COAD,31.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2011.0,nan,-11391.0,Alive,TUMOR FREE,255.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,255.0,0.0,255.0,nan,nan,0.0,255.0,0
TCGA-A6-6142-01,TCGA-A6-6142,COAD,56.0,FEMALE,WHITE,Stage IVA,nan,Colon Adenocarcinoma,nan,2011.0,nan,-20485.0,Alive,WITH TUMOR,763.0,nan,nan,nan,nan,nan,654.0,Complete Remission/Response,nan,nan,0.0,763.0,0.0,763.0,nan,nan,1.0,654.0,2
TCGA-A6-6648-01,TCGA-A6-6648,COAD,56.0,MALE,WHITE,Stage IVA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-20641.0,Alive,WITH TUMOR,766.0,nan,nan,nan,nan,nan,686.0,nan,nan,nan,0.0,766.0,0.0,766.0,nan,nan,1.0,686.0,0
TCGA-A6-6649-01,TCGA-A6-6649,COAD,66.0,MALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2010.0,nan,-24237.0,Alive,TUMOR FREE,735.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,735.0,0.0,735.0,0.0,735.0,0.0,735.0,0
TCGA-A6-6650-01,TCGA-A6-6650,COAD,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-25516.0,Alive,TUMOR FREE,627.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,627.0,0.0,627.0,nan,nan,0.0,627.0,0
TCGA-A6-6651-01,TCGA-A6-6651,COAD,55.0,FEMALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2010.0,nan,-20110.0,Alive,TUMOR FREE,662.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,662.0,0.0,662.0,nan,nan,0.0,662.0,0
TCGA-A6-6652-01,TCGA-A6-6652,COAD,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,nan,Colon Adenocarcinoma,nan,2011.0,nan,-21638.0,Alive,WITH TUMOR,751.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,751.0,0.0,751.0,nan,nan,0.0,751.0,0
TCGA-A6-6653-01,TCGA-A6-6653,COAD,82.0,MALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2011.0,nan,-29996.0,Alive,TUMOR FREE,742.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,742.0,0.0,742.0,0.0,742.0,0.0,742.0,0
TCGA-A6-6654-01,TCGA-A6-6654,COAD,65.0,FEMALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2011.0,nan,-23953.0,Alive,TUMOR FREE,726.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,726.0,0.0,726.0,0.0,726.0,0.0,726.0,0
TCGA-A6-6780-01,TCGA-A6-6780,COAD,74.0,MALE,WHITE,Stage IIA,nan,Colon Mucinous Adenocarcinoma,nan,2011.0,nan,-27250.0,Alive,TUMOR FREE,612.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,612.0,0.0,612.0,0.0,612.0,0.0,612.0,0
TCGA-A6-6781-01,TCGA-A6-6781,COAD,43.0,MALE,WHITE,Stage IIIC,nan,Colon Mucinous Adenocarcinoma,nan,2011.0,nan,-15842.0,Alive,TUMOR FREE,598.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,598.0,0.0,598.0,0.0,598.0,0.0,598.0,0
TCGA-A6-6782-01,TCGA-A6-6782,COAD,82.0,MALE,WHITE,Stage IIB,nan,Colon Adenocarcinoma,nan,2011.0,nan,-30012.0,Alive,TUMOR FREE,617.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,617.0,0.0,617.0,0.0,617.0,0.0,617.0,0
TCGA-A6-A565-01,TCGA-A6-A565,COAD,34.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,nan,Colon Mucinous Adenocarcinoma,nan,2008.0,nan,-12526.0,Dead,WITH TUMOR,nan,494.0,nan,nan,nan,nan,301.0,Progressive Disease,nan,nan,1.0,494.0,1.0,494.0,nan,nan,1.0,301.0,1
TCGA-A6-A566-01,TCGA-A6-A566,COAD,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,nan,Colon Mucinous Adenocarcinoma,nan,2007.0,nan,-20181.0,Dead,WITH TUMOR,nan,758.0,nan,nan,nan,nan,257.0,Progressive Disease,nan,nan,1.0,758.0,1.0,758.0,nan,nan,1.0,257.0,1
TCGA-A6-A567-01,TCGA-A6-A567,COAD,56.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Colon Adenocarcinoma,nan,2007.0,nan,-20493.0,Dead,WITH TUMOR,nan,1881.0,nan,Metastatic,nan,nan,612.0,[Unknown],nan,nan,1.0,1881.0,1.0,1881.0,nan,nan,1.0,612.0,1
TCGA-A6-A56B-01,TCGA-A6-A56B,COAD,57.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,nan,Colon Adenocarcinoma,nan,2008.0,nan,-20903.0,Dead,TUMOR FREE,nan,1711.0,nan,nan,nan,nan,1678.0,Complete Remission/Response,nan,nan,1.0,1711.0,0.0,1711.0,1.0,1678.0,1.0,1678.0,1
TCGA-A6-A5ZU-01,TCGA-A6-A5ZU,COAD,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,nan,Colon Adenocarcinoma,nan,2013.0,nan,-21554.0,Alive,TUMOR FREE,293.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,293.0,0.0,293.0,0.0,293.0,0.0,293.0,0
TCGA-AA-3488-01,TCGA-AA-3488,COAD,58.0,MALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2002.0,nan,-21519.0,Dead,WITH TUMOR,nan,153.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,153.0,1.0,153.0,nan,nan,1.0,153.0,1
TCGA-AA-3488-11,TCGA-AA-3488,COAD,58.0,MALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2002.0,nan,-21519.0,Dead,WITH TUMOR,nan,153.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,153.0,1.0,153.0,nan,nan,1.0,153.0,1
TCGA-AA-3489-01,TCGA-AA-3489,COAD,75.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2002.0,nan,-27606.0,Dead,WITH TUMOR,nan,214.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,214.0,1.0,214.0,nan,nan,1.0,214.0,1
TCGA-AA-3489-11,TCGA-AA-3489,COAD,75.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2002.0,nan,-27606.0,Dead,WITH TUMOR,nan,214.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,214.0,1.0,214.0,nan,nan,1.0,214.0,1
TCGA-AA-3492-01,TCGA-AA-3492,COAD,90.0,FEMALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2002.0,nan,-32871.0,Dead,TUMOR FREE,nan,92.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,92.0,0.0,92.0,nan,nan,0.0,92.0,1
TCGA-AA-3492-11,TCGA-AA-3492,COAD,90.0,FEMALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2002.0,nan,-32871.0,Dead,TUMOR FREE,nan,92.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,92.0,0.0,92.0,nan,nan,0.0,92.0,1
TCGA-AA-3494-01,TCGA-AA-3494,COAD,55.0,MALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2002.0,nan,-20089.0,Alive,WITH TUMOR,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-AA-3494-11,TCGA-AA-3494,COAD,55.0,MALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2002.0,nan,-20089.0,Alive,WITH TUMOR,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-AA-3495-01,TCGA-AA-3495,COAD,79.0,MALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2002.0,nan,-28886.0,Alive,TUMOR FREE,1127.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1127.0,0.0,1127.0,0.0,1127.0,0.0,1127.0,0
TCGA-AA-3495-11,TCGA-AA-3495,COAD,79.0,MALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2002.0,nan,-28886.0,Alive,TUMOR FREE,1127.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1127.0,0.0,1127.0,0.0,1127.0,0.0,1127.0,0
TCGA-AA-3496-01,TCGA-AA-3496,COAD,83.0,FEMALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2002.0,nan,-30438.0,Alive,WITH TUMOR,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-AA-3496-11,TCGA-AA-3496,COAD,83.0,FEMALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2002.0,nan,-30438.0,Alive,WITH TUMOR,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-AA-3502-01,TCGA-AA-3502,COAD,73.0,MALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2003.0,nan,-26724.0,Alive,WITH TUMOR,1065.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1065.0,0.0,1065.0,0.0,1065.0,0.0,1065.0,0
TCGA-AA-3502-11,TCGA-AA-3502,COAD,73.0,MALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2003.0,nan,-26724.0,Alive,WITH TUMOR,1065.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1065.0,0.0,1065.0,0.0,1065.0,0.0,1065.0,0
TCGA-AA-3506-01,TCGA-AA-3506,COAD,77.0,MALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2004.0,nan,-28275.0,Alive,WITH TUMOR,1765.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1765.0,0.0,1765.0,nan,nan,0.0,1765.0,0
TCGA-AA-3506-11,TCGA-AA-3506,COAD,77.0,MALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2004.0,nan,-28275.0,Alive,WITH TUMOR,1765.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1765.0,0.0,1765.0,nan,nan,0.0,1765.0,0
TCGA-AA-3509-01,TCGA-AA-3509,COAD,54.0,FEMALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2005.0,nan,-19786.0,Alive,TUMOR FREE,1915.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1915.0,0.0,1915.0,0.0,1915.0,0.0,1915.0,0
TCGA-AA-3509-11,TCGA-AA-3509,COAD,54.0,FEMALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2005.0,nan,-19786.0,Alive,TUMOR FREE,1915.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1915.0,0.0,1915.0,0.0,1915.0,0.0,1915.0,0
TCGA-AA-3510-01,TCGA-AA-3510,COAD,70.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2005.0,nan,-25902.0,Alive,TUMOR FREE,1946.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1946.0,0.0,1946.0,0.0,1946.0,0.0,1946.0,0
TCGA-AA-3510-11,TCGA-AA-3510,COAD,70.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2005.0,nan,-25902.0,Alive,TUMOR FREE,1946.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1946.0,0.0,1946.0,0.0,1946.0,0.0,1946.0,0
TCGA-AA-3511-01,TCGA-AA-3511,COAD,64.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2005.0,nan,-23407.0,Alive,TUMOR FREE,212.0,nan,nan,nan,nan,nan,59.0,Complete Remission/Response,nan,nan,0.0,212.0,0.0,212.0,1.0,59.0,1.0,59.0,0
TCGA-AA-3511-11,TCGA-AA-3511,COAD,64.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2005.0,nan,-23407.0,Alive,TUMOR FREE,212.0,nan,nan,nan,nan,nan,59.0,Complete Remission/Response,nan,nan,0.0,212.0,0.0,212.0,1.0,59.0,1.0,59.0,0
TCGA-AA-3514-01,TCGA-AA-3514,COAD,81.0,FEMALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2006.0,nan,-29738.0,Alive,TUMOR FREE,31.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-AA-3514-11,TCGA-AA-3514,COAD,81.0,FEMALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2006.0,nan,-29738.0,Alive,TUMOR FREE,31.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-AA-3516-01,TCGA-AA-3516,COAD,74.0,FEMALE,nan,Stage III,nan,Colon Mucinous Adenocarcinoma,nan,2007.0,nan,-27303.0,Dead,WITH TUMOR,nan,396.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,396.0,1.0,396.0,nan,nan,1.0,396.0,1
TCGA-AA-3516-11,TCGA-AA-3516,COAD,74.0,FEMALE,nan,Stage III,nan,Colon Mucinous Adenocarcinoma,nan,2007.0,nan,-27303.0,Dead,WITH TUMOR,nan,396.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,396.0,1.0,396.0,nan,nan,1.0,396.0,1
TCGA-AA-3517-01,TCGA-AA-3517,COAD,60.0,MALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2007.0,nan,-22099.0,Alive,TUMOR FREE,1186.0,nan,nan,nan,nan,nan,821.0,Complete Remission/Response,nan,nan,0.0,1186.0,0.0,1186.0,1.0,821.0,1.0,821.0,0
TCGA-AA-3517-11,TCGA-AA-3517,COAD,60.0,MALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2007.0,nan,-22099.0,Alive,TUMOR FREE,1186.0,nan,nan,nan,nan,nan,821.0,Complete Remission/Response,nan,nan,0.0,1186.0,0.0,1186.0,1.0,821.0,1.0,821.0,0
TCGA-AA-3518-01,TCGA-AA-3518,COAD,81.0,FEMALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2007.0,nan,-29769.0,Alive,WITH TUMOR,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-AA-3518-11,TCGA-AA-3518,COAD,81.0,FEMALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2007.0,nan,-29769.0,Alive,WITH TUMOR,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-AA-3519-01,TCGA-AA-3519,COAD,63.0,MALE,nan,Stage III,nan,Colon Adenocarcinoma,nan,2007.0,nan,-23131.0,Alive,TUMOR FREE,276.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,276.0,0.0,276.0,0.0,276.0,0.0,276.0,0
TCGA-AA-3519-11,TCGA-AA-3519,COAD,63.0,MALE,nan,Stage III,nan,Colon Adenocarcinoma,nan,2007.0,nan,-23131.0,Alive,TUMOR FREE,276.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,276.0,0.0,276.0,0.0,276.0,0.0,276.0,0
TCGA-AA-3520-01,TCGA-AA-3520,COAD,86.0,FEMALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2007.0,nan,-31531.0,Alive,WITH TUMOR,731.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,731.0,0.0,731.0,nan,nan,0.0,731.0,0
TCGA-AA-3520-11,TCGA-AA-3520,COAD,86.0,FEMALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2007.0,nan,-31531.0,Alive,WITH TUMOR,731.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,731.0,0.0,731.0,nan,nan,0.0,731.0,0
TCGA-AA-3521-01,TCGA-AA-3521,COAD,87.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2007.0,nan,-31805.0,Alive,WITH TUMOR,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,nan,0.0,nan,nan,nan,0.0,nan,0
TCGA-AA-3521-11,TCGA-AA-3521,COAD,87.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2007.0,nan,-31805.0,Alive,WITH TUMOR,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,nan,0.0,nan,nan,nan,0.0,nan,0
TCGA-AA-3522-01,TCGA-AA-3522,COAD,67.0,MALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2007.0,nan,-24653.0,Alive,TUMOR FREE,1127.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1127.0,0.0,1127.0,0.0,1127.0,0.0,1127.0,0
TCGA-AA-3522-11,TCGA-AA-3522,COAD,67.0,MALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2007.0,nan,-24653.0,Alive,TUMOR FREE,1127.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1127.0,0.0,1127.0,0.0,1127.0,0.0,1127.0,0
TCGA-AA-3524-01,TCGA-AA-3524,COAD,85.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2007.0,nan,-31197.0,Alive,TUMOR FREE,1096.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1096.0,0.0,1096.0,0.0,1096.0,0.0,1096.0,0
TCGA-AA-3524-11,TCGA-AA-3524,COAD,85.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2007.0,nan,-31197.0,Alive,TUMOR FREE,1096.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1096.0,0.0,1096.0,0.0,1096.0,0.0,1096.0,0
TCGA-AA-3525-01,TCGA-AA-3525,COAD,90.0,MALE,nan,Stage IIIB,nan,Colon Adenocarcinoma,nan,2007.0,nan,-32871.0,Alive,TUMOR FREE,245.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,245.0,0.0,245.0,nan,nan,0.0,245.0,0
TCGA-AA-3525-11,TCGA-AA-3525,COAD,90.0,MALE,nan,Stage IIIB,nan,Colon Adenocarcinoma,nan,2007.0,nan,-32871.0,Alive,TUMOR FREE,245.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,245.0,0.0,245.0,nan,nan,0.0,245.0,0
TCGA-AA-3526-01,TCGA-AA-3526,COAD,57.0,MALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2007.0,nan,-21123.0,Alive,TUMOR FREE,580.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,580.0,0.0,580.0,0.0,580.0,0.0,580.0,0
TCGA-AA-3526-11,TCGA-AA-3526,COAD,57.0,MALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2007.0,nan,-21123.0,Alive,TUMOR FREE,580.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,580.0,0.0,580.0,0.0,580.0,0.0,580.0,0
TCGA-AA-3527-01,TCGA-AA-3527,COAD,90.0,FEMALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2007.0,nan,-32871.0,Alive,WITH TUMOR,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-AA-3527-11,TCGA-AA-3527,COAD,90.0,FEMALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2007.0,nan,-32871.0,Alive,WITH TUMOR,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-AA-3529-01,TCGA-AA-3529,COAD,78.0,FEMALE,nan,Stage IIIC,nan,Colon Adenocarcinoma,nan,2007.0,nan,-28609.0,Dead,WITH TUMOR,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,0.0,1.0,0.0,nan,nan,1.0,0.0,1
TCGA-AA-3529-11,TCGA-AA-3529,COAD,78.0,FEMALE,nan,Stage IIIC,nan,Colon Adenocarcinoma,nan,2007.0,nan,-28609.0,Dead,WITH TUMOR,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,0.0,1.0,0.0,nan,nan,1.0,0.0,1
TCGA-AA-3530-01,TCGA-AA-3530,COAD,80.0,MALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2007.0,nan,-29402.0,Alive,TUMOR FREE,580.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,580.0,0.0,580.0,0.0,580.0,0.0,580.0,0
TCGA-AA-3531-01,TCGA-AA-3531,COAD,75.0,FEMALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2007.0,nan,-27514.0,Alive,TUMOR FREE,1035.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1035.0,0.0,1035.0,0.0,1035.0,0.0,1035.0,0
TCGA-AA-3531-11,TCGA-AA-3531,COAD,75.0,FEMALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2007.0,nan,-27514.0,Alive,TUMOR FREE,1035.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1035.0,0.0,1035.0,0.0,1035.0,0.0,1035.0,0
TCGA-AA-3532-01,TCGA-AA-3532,COAD,63.0,MALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2007.0,nan,-23133.0,Alive,WITH TUMOR,882.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,882.0,0.0,882.0,nan,nan,0.0,882.0,0
TCGA-AA-3532-11,TCGA-AA-3532,COAD,63.0,MALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2007.0,nan,-23133.0,Alive,WITH TUMOR,882.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,882.0,0.0,882.0,nan,nan,0.0,882.0,0
TCGA-AA-3534-01,TCGA-AA-3534,COAD,78.0,FEMALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2007.0,nan,-28489.0,Alive,TUMOR FREE,882.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,882.0,0.0,882.0,0.0,882.0,0.0,882.0,0
TCGA-AA-3534-11,TCGA-AA-3534,COAD,78.0,FEMALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2007.0,nan,-28489.0,Alive,TUMOR FREE,882.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,882.0,0.0,882.0,0.0,882.0,0.0,882.0,0
TCGA-AA-3538-01,TCGA-AA-3538,COAD,54.0,FEMALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2008.0,nan,-19752.0,Alive,TUMOR FREE,791.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,791.0,0.0,791.0,0.0,791.0,0.0,791.0,0
TCGA-AA-3542-01,TCGA-AA-3542,COAD,69.0,MALE,nan,Stage IIIC,nan,Colon Adenocarcinoma,nan,2008.0,nan,-25324.0,Alive,TUMOR FREE,395.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,395.0,0.0,395.0,0.0,395.0,0.0,395.0,0
TCGA-AA-3543-01,TCGA-AA-3543,COAD,84.0,MALE,nan,Stage I,nan,Colon Mucinous Adenocarcinoma,nan,2008.0,nan,-30772.0,Alive,TUMOR FREE,30.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,30.0,0.0,30.0,nan,nan,0.0,30.0,0
TCGA-AA-3544-01,TCGA-AA-3544,COAD,68.0,MALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2008.0,nan,-24959.0,Alive,TUMOR FREE,426.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,426.0,0.0,426.0,0.0,426.0,0.0,426.0,0
TCGA-AA-3548-01,TCGA-AA-3548,COAD,71.0,FEMALE,nan,Stage IIIC,nan,Colon Adenocarcinoma,nan,2008.0,nan,-26175.0,Alive,TUMOR FREE,1034.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1034.0,0.0,1034.0,0.0,1034.0,0.0,1034.0,0
TCGA-AA-3549-01,TCGA-AA-3549,COAD,69.0,MALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2008.0,nan,-25415.0,Alive,TUMOR FREE,639.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,639.0,0.0,639.0,0.0,639.0,0.0,639.0,0
TCGA-AA-3552-01,TCGA-AA-3552,COAD,85.0,MALE,nan,Stage IIIC,nan,Colon Adenocarcinoma,nan,2008.0,nan,-31290.0,Dead,TUMOR FREE,nan,396.0,nan,nan,nan,nan,122.0,Complete Remission/Response,nan,nan,1.0,396.0,0.0,396.0,1.0,122.0,1.0,122.0,1
TCGA-AA-3553-01,TCGA-AA-3553,COAD,61.0,FEMALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2008.0,nan,-22524.0,Alive,TUMOR FREE,730.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,730.0,0.0,730.0,0.0,730.0,0.0,730.0,0
TCGA-AA-3554-01,TCGA-AA-3554,COAD,62.0,FEMALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2008.0,nan,-22799.0,Alive,TUMOR FREE,546.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,546.0,0.0,546.0,0.0,546.0,0.0,546.0,0
TCGA-AA-3555-01,TCGA-AA-3555,COAD,81.0,FEMALE,nan,Stage IIA,nan,Colon Mucinous Adenocarcinoma,nan,2008.0,nan,-29617.0,Alive,TUMOR FREE,911.0,nan,nan,nan,nan,nan,91.0,Complete Remission/Response,nan,nan,0.0,911.0,0.0,911.0,1.0,91.0,1.0,91.0,2
TCGA-AA-3556-01,TCGA-AA-3556,COAD,78.0,MALE,nan,Stage I,nan,nan,nan,2008.0,nan,-28704.0,Alive,WITH TUMOR,700.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,700.0,0.0,700.0,nan,nan,0.0,700.0,0
TCGA-AA-3558-01,TCGA-AA-3558,COAD,70.0,MALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2008.0,nan,-25752.0,Alive,TUMOR FREE,638.0,nan,nan,nan,nan,nan,92.0,Complete Remission/Response,nan,nan,0.0,638.0,0.0,638.0,1.0,92.0,1.0,92.0,0
TCGA-AA-3560-01,TCGA-AA-3560,COAD,72.0,FEMALE,nan,Stage IIIC,nan,Colon Adenocarcinoma,nan,2009.0,nan,-26359.0,Alive,TUMOR FREE,608.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,608.0,0.0,608.0,0.0,608.0,0.0,608.0,0
TCGA-AA-3561-01,TCGA-AA-3561,COAD,72.0,MALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-26420.0,Alive,TUMOR FREE,424.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,424.0,0.0,424.0,0.0,424.0,0.0,424.0,0
TCGA-AA-3562-01,TCGA-AA-3562,COAD,82.0,MALE,nan,Stage IIIC,nan,Colon Adenocarcinoma,nan,2008.0,nan,-30254.0,Alive,WITH TUMOR,608.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,608.0,0.0,608.0,nan,nan,0.0,608.0,0
TCGA-AA-3655-01,TCGA-AA-3655,COAD,68.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2005.0,nan,-24896.0,Alive,TUMOR FREE,1856.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1856.0,0.0,1856.0,0.0,1856.0,0.0,1856.0,0
TCGA-AA-3655-11,TCGA-AA-3655,COAD,68.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2005.0,nan,-24896.0,Alive,TUMOR FREE,1856.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1856.0,0.0,1856.0,0.0,1856.0,0.0,1856.0,0
TCGA-AA-3660-01,TCGA-AA-3660,COAD,51.0,FEMALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2005.0,nan,-18932.0,Alive,TUMOR FREE,2375.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2375.0,0.0,2375.0,0.0,2375.0,0.0,2375.0,0
TCGA-AA-3660-11,TCGA-AA-3660,COAD,51.0,FEMALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2005.0,nan,-18932.0,Alive,TUMOR FREE,2375.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2375.0,0.0,2375.0,0.0,2375.0,0.0,2375.0,0
TCGA-AA-3662-01,TCGA-AA-3662,COAD,80.0,FEMALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2005.0,nan,-29554.0,Alive,WITH TUMOR,184.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,184.0,0.0,184.0,nan,nan,0.0,184.0,0
TCGA-AA-3662-11,TCGA-AA-3662,COAD,80.0,FEMALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2005.0,nan,-29554.0,Alive,WITH TUMOR,184.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,184.0,0.0,184.0,nan,nan,0.0,184.0,0
TCGA-AA-3663-01,TCGA-AA-3663,COAD,42.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2005.0,nan,-15675.0,Alive,TUMOR FREE,212.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,212.0,0.0,212.0,0.0,212.0,0.0,212.0,0
TCGA-AA-3663-11,TCGA-AA-3663,COAD,42.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2005.0,nan,-15675.0,Alive,TUMOR FREE,212.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,212.0,0.0,212.0,0.0,212.0,0.0,212.0,0
TCGA-AA-3664-01,TCGA-AA-3664,COAD,74.0,FEMALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2005.0,nan,-27363.0,Alive,WITH TUMOR,1643.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1643.0,0.0,1643.0,nan,nan,0.0,1643.0,0
TCGA-AA-3666-01,TCGA-AA-3666,COAD,68.0,MALE,nan,Stage III,nan,Colon Adenocarcinoma,nan,2005.0,nan,-25020.0,Dead,WITH TUMOR,nan,61.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,61.0,1.0,61.0,nan,nan,1.0,61.0,1
TCGA-AA-3667-01,TCGA-AA-3667,COAD,36.0,FEMALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2005.0,nan,-13302.0,Alive,TUMOR FREE,426.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,426.0,0.0,426.0,0.0,426.0,0.0,426.0,0
TCGA-AA-3672-01,TCGA-AA-3672,COAD,90.0,FEMALE,nan,Stage III,nan,Colon Adenocarcinoma,nan,2006.0,nan,-32873.0,Alive,TUMOR FREE,28.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,28.0,0.0,28.0,nan,nan,0.0,28.0,0
TCGA-AA-3673-01,TCGA-AA-3673,COAD,53.0,FEMALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2006.0,nan,-19509.0,Alive,TUMOR FREE,1522.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1522.0,0.0,1522.0,0.0,1522.0,0.0,1522.0,0
TCGA-AA-3675-01,TCGA-AA-3675,COAD,84.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2006.0,nan,-30801.0,Alive,TUMOR FREE,1431.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1431.0,0.0,1431.0,0.0,1431.0,0.0,1431.0,0
TCGA-AA-3678-01,TCGA-AA-3678,COAD,60.0,FEMALE,nan,Stage III,nan,Colon Adenocarcinoma,nan,2006.0,nan,-22219.0,Alive,TUMOR FREE,1430.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1430.0,0.0,1430.0,0.0,1430.0,0.0,1430.0,0
TCGA-AA-3679-01,TCGA-AA-3679,COAD,59.0,MALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2006.0,nan,-21611.0,Alive,WITH TUMOR,457.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,457.0,0.0,457.0,nan,nan,0.0,457.0,0
TCGA-AA-3680-01,TCGA-AA-3680,COAD,67.0,FEMALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2006.0,nan,-24655.0,Dead,WITH TUMOR,nan,335.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,335.0,1.0,335.0,nan,nan,1.0,335.0,1
TCGA-AA-3681-01,TCGA-AA-3681,COAD,77.0,FEMALE,nan,Stage III,nan,Colon Adenocarcinoma,nan,2006.0,nan,-28399.0,Alive,TUMOR FREE,182.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,182.0,0.0,182.0,0.0,182.0,0.0,182.0,0
TCGA-AA-3684-01,TCGA-AA-3684,COAD,65.0,FEMALE,nan,Stage IV,nan,Colon Mucinous Adenocarcinoma,nan,2007.0,nan,-23741.0,Alive,WITH TUMOR,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-AA-3685-01,TCGA-AA-3685,COAD,69.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2007.0,nan,-25506.0,Alive,TUMOR FREE,1127.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1127.0,0.0,1127.0,0.0,1127.0,0.0,1127.0,0
TCGA-AA-3688-01,TCGA-AA-3688,COAD,80.0,MALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2007.0,nan,-29220.0,Alive,WITH TUMOR,578.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,578.0,0.0,578.0,nan,nan,0.0,578.0,0
TCGA-AA-3692-01,TCGA-AA-3692,COAD,47.0,FEMALE,nan,Stage IV,nan,Colon Mucinous Adenocarcinoma,nan,2008.0,nan,-17167.0,Dead,WITH TUMOR,nan,1095.0,nan,nan,nan,nan,396.0,Progressive Disease,nan,nan,1.0,1095.0,1.0,1095.0,nan,nan,1.0,396.0,1
TCGA-AA-3693-01,TCGA-AA-3693,COAD,77.0,FEMALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2008.0,nan,-28459.0,Alive,WITH TUMOR,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-AA-3695-01,TCGA-AA-3695,COAD,63.0,FEMALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2009.0,nan,-23164.0,Alive,WITH TUMOR,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-AA-3696-01,TCGA-AA-3696,COAD,75.0,FEMALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2009.0,nan,-27667.0,Dead,WITH TUMOR,nan,153.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,153.0,1.0,153.0,nan,nan,1.0,153.0,1
TCGA-AA-3697-01,TCGA-AA-3697,COAD,77.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2003.0,nan,-28367.0,Alive,WITH TUMOR,2587.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,2587.0,0.0,2587.0,nan,nan,0.0,2587.0,0
TCGA-AA-3697-11,TCGA-AA-3697,COAD,77.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2003.0,nan,-28367.0,Alive,WITH TUMOR,2587.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,2587.0,0.0,2587.0,nan,nan,0.0,2587.0,0
TCGA-AA-3710-01,TCGA-AA-3710,COAD,80.0,FEMALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2008.0,nan,-29465.0,Alive,TUMOR FREE,821.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,821.0,0.0,821.0,0.0,821.0,0.0,821.0,0
TCGA-AA-3712-01,TCGA-AA-3712,COAD,65.0,MALE,nan,Stage III,nan,Colon Adenocarcinoma,nan,2004.0,nan,-23831.0,Alive,WITH TUMOR,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-AA-3712-11,TCGA-AA-3712,COAD,65.0,MALE,nan,Stage III,nan,Colon Adenocarcinoma,nan,2004.0,nan,-23831.0,Alive,WITH TUMOR,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-AA-3713-01,TCGA-AA-3713,COAD,68.0,MALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2005.0,nan,-24927.0,Alive,TUMOR FREE,579.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,579.0,0.0,579.0,nan,nan,0.0,579.0,0
TCGA-AA-3713-11,TCGA-AA-3713,COAD,68.0,MALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2005.0,nan,-24927.0,Alive,TUMOR FREE,579.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,579.0,0.0,579.0,nan,nan,0.0,579.0,0
TCGA-AA-3715-01,TCGA-AA-3715,COAD,77.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2006.0,nan,-28428.0,Dead,WITH TUMOR,nan,579.0,nan,nan,nan,nan,153.0,[Unknown],nan,nan,1.0,579.0,1.0,579.0,nan,nan,1.0,153.0,1
TCGA-AA-3811-01,TCGA-AA-3811,COAD,84.0,FEMALE,nan,Stage III,nan,Colon Adenocarcinoma,nan,2007.0,nan,-30893.0,Dead,WITH TUMOR,nan,306.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,306.0,1.0,306.0,nan,nan,1.0,306.0,1
TCGA-AA-3812-01,TCGA-AA-3812,COAD,82.0,FEMALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2007.0,nan,-29980.0,Alive,TUMOR FREE,1066.0,nan,nan,nan,nan,nan,762.0,Complete Remission/Response,nan,nan,0.0,1066.0,0.0,1066.0,1.0,762.0,1.0,762.0,2
TCGA-AA-3814-01,TCGA-AA-3814,COAD,85.0,FEMALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2007.0,nan,-31380.0,Alive,WITH TUMOR,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-AA-3815-01,TCGA-AA-3815,COAD,65.0,FEMALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2007.0,nan,-23922.0,Alive,TUMOR FREE,1005.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1005.0,0.0,1005.0,0.0,1005.0,0.0,1005.0,0
TCGA-AA-3818-01,TCGA-AA-3818,COAD,78.0,FEMALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2007.0,nan,-28763.0,Dead,WITH TUMOR,nan,30.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,30.0,1.0,30.0,nan,nan,1.0,30.0,1
TCGA-AA-3819-01,TCGA-AA-3819,COAD,41.0,FEMALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2008.0,nan,-15280.0,Alive,TUMOR FREE,761.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,761.0,0.0,761.0,0.0,761.0,0.0,761.0,0
TCGA-AA-3821-01,TCGA-AA-3821,COAD,81.0,FEMALE,nan,Stage I,nan,Colon Mucinous Adenocarcinoma,nan,2008.0,nan,-29706.0,Alive,TUMOR FREE,31.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-AA-3831-01,TCGA-AA-3831,COAD,66.0,MALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2008.0,nan,-24411.0,Alive,TUMOR FREE,547.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,547.0,0.0,547.0,0.0,547.0,0.0,547.0,0
TCGA-AA-3833-01,TCGA-AA-3833,COAD,63.0,FEMALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2008.0,nan,-23011.0,Alive,TUMOR FREE,485.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,485.0,0.0,485.0,0.0,485.0,0.0,485.0,0
TCGA-AA-3837-01,TCGA-AA-3837,COAD,67.0,MALE,nan,Stage IIA,nan,Colon Mucinous Adenocarcinoma,nan,2008.0,nan,-24655.0,Alive,TUMOR FREE,1186.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1186.0,0.0,1186.0,0.0,1186.0,0.0,1186.0,0
TCGA-AA-3841-01,TCGA-AA-3841,COAD,66.0,MALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-24230.0,Alive,TUMOR FREE,1124.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1124.0,0.0,1124.0,0.0,1124.0,0.0,1124.0,0
TCGA-AA-3842-01,TCGA-AA-3842,COAD,51.0,MALE,nan,Stage IIIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-18842.0,Alive,TUMOR FREE,1126.0,nan,nan,nan,nan,nan,396.0,Complete Remission/Response,nan,nan,0.0,1126.0,0.0,1126.0,1.0,396.0,1.0,396.0,2
TCGA-AA-3844-01,TCGA-AA-3844,COAD,78.0,FEMALE,nan,Stage IIIC,nan,Colon Adenocarcinoma,nan,2009.0,nan,-28521.0,Alive,WITH TUMOR,454.0,nan,nan,nan,nan,nan,365.0,Progressive Disease,nan,nan,0.0,454.0,0.0,454.0,nan,nan,1.0,365.0,2
TCGA-AA-3845-01,TCGA-AA-3845,COAD,86.0,FEMALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-31593.0,Dead,WITH TUMOR,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,0.0,1.0,0.0,nan,nan,1.0,0.0,1
TCGA-AA-3846-01,TCGA-AA-3846,COAD,74.0,FEMALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-27057.0,Alive,WITH TUMOR,518.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,518.0,0.0,518.0,nan,nan,0.0,518.0,2
TCGA-AA-3848-01,TCGA-AA-3848,COAD,82.0,FEMALE,nan,Stage IIIC,nan,Colon Adenocarcinoma,nan,2009.0,nan,-30194.0,Dead,WITH TUMOR,nan,306.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,306.0,1.0,306.0,nan,nan,1.0,306.0,1
TCGA-AA-3850-01,TCGA-AA-3850,COAD,74.0,MALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2009.0,nan,-27090.0,Dead,WITH TUMOR,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,0.0,1.0,0.0,nan,nan,1.0,0.0,1
TCGA-AA-3851-01,TCGA-AA-3851,COAD,74.0,MALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-27090.0,Alive,WITH TUMOR,1006.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1006.0,0.0,1006.0,nan,nan,0.0,1006.0,0
TCGA-AA-3852-01,TCGA-AA-3852,COAD,88.0,MALE,nan,Stage IIA,nan,Colon Mucinous Adenocarcinoma,nan,2009.0,nan,-32203.0,Dead,WITH TUMOR,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,0.0,1.0,0.0,nan,nan,1.0,0.0,1
TCGA-AA-3854-01,TCGA-AA-3854,COAD,71.0,FEMALE,nan,Stage I,nan,Colon Mucinous Adenocarcinoma,nan,2009.0,nan,-26022.0,Alive,TUMOR FREE,1096.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1096.0,0.0,1096.0,0.0,1096.0,0.0,1096.0,0
TCGA-AA-3855-01,TCGA-AA-3855,COAD,72.0,MALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2009.0,nan,-26541.0,Alive,WITH TUMOR,975.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,975.0,0.0,975.0,nan,nan,0.0,975.0,0
TCGA-AA-3856-01,TCGA-AA-3856,COAD,59.0,MALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-21670.0,Alive,WITH TUMOR,30.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,30.0,0.0,30.0,nan,nan,0.0,30.0,0
TCGA-AA-3858-01,TCGA-AA-3858,COAD,67.0,MALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2009.0,nan,-24806.0,Alive,TUMOR FREE,945.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,945.0,0.0,945.0,0.0,945.0,0.0,945.0,0
TCGA-AA-3860-01,TCGA-AA-3860,COAD,53.0,FEMALE,nan,Stage IIIB,nan,Colon Adenocarcinoma,nan,2009.0,nan,-19449.0,Alive,TUMOR FREE,945.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,945.0,0.0,945.0,0.0,945.0,0.0,945.0,0
TCGA-AA-3861-01,TCGA-AA-3861,COAD,72.0,MALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-26602.0,Alive,TUMOR FREE,914.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,914.0,0.0,914.0,0.0,914.0,0.0,914.0,0
TCGA-AA-3862-01,TCGA-AA-3862,COAD,82.0,MALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-30163.0,Alive,TUMOR FREE,914.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,914.0,0.0,914.0,0.0,914.0,0.0,914.0,0
TCGA-AA-3864-01,TCGA-AA-3864,COAD,71.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2005.0,nan,-26237.0,Alive,TUMOR FREE,1612.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1612.0,0.0,1612.0,0.0,1612.0,0.0,1612.0,0
TCGA-AA-3866-01,TCGA-AA-3866,COAD,78.0,FEMALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2006.0,nan,-28672.0,Alive,TUMOR FREE,518.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,518.0,0.0,518.0,0.0,518.0,0.0,518.0,0
TCGA-AA-3867-01,TCGA-AA-3867,COAD,74.0,MALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2007.0,nan,-27028.0,Alive,WITH TUMOR,731.0,nan,nan,nan,nan,nan,394.0,[Unknown],nan,nan,0.0,731.0,0.0,731.0,nan,nan,1.0,394.0,0
TCGA-AA-3869-01,TCGA-AA-3869,COAD,76.0,MALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2009.0,nan,-28062.0,Dead,WITH TUMOR,nan,822.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,822.0,1.0,822.0,nan,nan,1.0,822.0,1
TCGA-AA-3870-01,TCGA-AA-3870,COAD,71.0,FEMALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2009.0,nan,-26086.0,Alive,TUMOR FREE,912.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,912.0,0.0,912.0,nan,nan,0.0,912.0,0
TCGA-AA-3872-01,TCGA-AA-3872,COAD,45.0,MALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2009.0,nan,-16651.0,Alive,WITH TUMOR,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-AA-3875-01,TCGA-AA-3875,COAD,78.0,FEMALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2007.0,nan,-28640.0,Alive,WITH TUMOR,549.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,549.0,0.0,549.0,nan,nan,0.0,549.0,0
TCGA-AA-3877-01,TCGA-AA-3877,COAD,83.0,FEMALE,nan,Stage I,nan,Colon Mucinous Adenocarcinoma,nan,2007.0,nan,-30377.0,Alive,TUMOR FREE,943.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,943.0,0.0,943.0,0.0,943.0,0.0,943.0,0
TCGA-AA-3930-01,TCGA-AA-3930,COAD,66.0,MALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2008.0,nan,-24321.0,Dead,WITH TUMOR,nan,61.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,61.0,1.0,61.0,nan,nan,1.0,61.0,1
TCGA-AA-3939-01,TCGA-AA-3939,COAD,83.0,MALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-30439.0,Alive,WITH TUMOR,395.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,395.0,0.0,395.0,nan,nan,0.0,395.0,0
TCGA-AA-3941-01,TCGA-AA-3941,COAD,84.0,FEMALE,nan,Stage IVA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-31015.0,Alive,WITH TUMOR,730.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,730.0,0.0,730.0,nan,nan,0.0,730.0,0
TCGA-AA-3947-01,TCGA-AA-3947,COAD,60.0,FEMALE,nan,Stage IIB,nan,Colon Mucinous Adenocarcinoma,nan,2009.0,nan,-22035.0,Alive,TUMOR FREE,1004.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1004.0,0.0,1004.0,0.0,1004.0,0.0,1004.0,0
TCGA-AA-3949-01,TCGA-AA-3949,COAD,87.0,FEMALE,nan,Stage IIIB,nan,Colon Mucinous Adenocarcinoma,nan,2009.0,nan,-32081.0,Alive,TUMOR FREE,791.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,791.0,0.0,791.0,0.0,791.0,0.0,791.0,0
TCGA-AA-3950-01,TCGA-AA-3950,COAD,79.0,FEMALE,nan,Stage IIA,nan,Colon Mucinous Adenocarcinoma,nan,2010.0,nan,-29130.0,Alive,TUMOR FREE,730.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,730.0,0.0,730.0,0.0,730.0,0.0,730.0,0
TCGA-AA-3952-01,TCGA-AA-3952,COAD,68.0,MALE,nan,Stage IIIC,nan,Colon Adenocarcinoma,nan,2008.0,nan,-24868.0,Dead,WITH TUMOR,nan,61.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,61.0,1.0,61.0,nan,nan,1.0,61.0,1
TCGA-AA-3955-01,TCGA-AA-3955,COAD,38.0,MALE,nan,Stage IIIB,nan,Colon Adenocarcinoma,nan,2010.0,nan,-14186.0,Alive,TUMOR FREE,638.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,638.0,0.0,638.0,0.0,638.0,0.0,638.0,0
TCGA-AA-3956-01,TCGA-AA-3956,COAD,65.0,MALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2007.0,nan,-24045.0,Alive,WITH TUMOR,1035.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1035.0,0.0,1035.0,nan,nan,0.0,1035.0,0
TCGA-AA-3966-01,TCGA-AA-3966,COAD,89.0,FEMALE,nan,Stage IIA,nan,Colon Mucinous Adenocarcinoma,nan,2009.0,nan,-32537.0,Alive,WITH TUMOR,61.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,61.0,0.0,61.0,nan,nan,0.0,61.0,0
TCGA-AA-3968-01,TCGA-AA-3968,COAD,55.0,FEMALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2008.0,nan,-20089.0,Alive,TUMOR FREE,669.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,669.0,0.0,669.0,0.0,669.0,0.0,669.0,0
TCGA-AA-3970-01,TCGA-AA-3970,COAD,65.0,MALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-23741.0,Alive,TUMOR FREE,1096.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1096.0,0.0,1096.0,0.0,1096.0,0.0,1096.0,0
TCGA-AA-3971-01,TCGA-AA-3971,COAD,58.0,MALE,nan,Stage III,nan,Colon Adenocarcinoma,nan,2007.0,nan,-21518.0,Alive,TUMOR FREE,489.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,489.0,0.0,489.0,0.0,489.0,0.0,489.0,0
TCGA-AA-3972-01,TCGA-AA-3972,COAD,72.0,MALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2008.0,nan,-26360.0,Alive,WITH TUMOR,1551.0,nan,nan,nan,nan,nan,1216.0,Progressive Disease,nan,nan,0.0,1551.0,0.0,1551.0,nan,nan,1.0,1216.0,0
TCGA-AA-3973-01,TCGA-AA-3973,COAD,69.0,MALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2007.0,nan,-25536.0,Alive,WITH TUMOR,397.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,397.0,0.0,397.0,nan,nan,0.0,397.0,0
TCGA-AA-3975-01,TCGA-AA-3975,COAD,80.0,MALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2009.0,nan,-29310.0,Alive,TUMOR FREE,1036.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1036.0,0.0,1036.0,0.0,1036.0,0.0,1036.0,0
TCGA-AA-3976-01,TCGA-AA-3976,COAD,70.0,MALE,nan,Stage IIIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-25599.0,Alive,WITH TUMOR,791.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,791.0,0.0,791.0,0.0,791.0,0.0,791.0,0
TCGA-AA-3977-01,TCGA-AA-3977,COAD,65.0,MALE,nan,nan,nan,Colon Adenocarcinoma,nan,2009.0,nan,-23832.0,Alive,TUMOR FREE,761.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,761.0,0.0,761.0,0.0,761.0,0.0,761.0,0
TCGA-AA-3979-01,TCGA-AA-3979,COAD,84.0,MALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-30742.0,Alive,TUMOR FREE,730.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,730.0,0.0,730.0,0.0,730.0,0.0,730.0,0
TCGA-AA-3980-01,TCGA-AA-3980,COAD,89.0,FEMALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2009.0,nan,-32630.0,Alive,TUMOR FREE,822.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,822.0,0.0,822.0,0.0,822.0,0.0,822.0,0
TCGA-AA-3982-01,TCGA-AA-3982,COAD,75.0,MALE,nan,Stage IIIB,nan,Colon Adenocarcinoma,nan,2009.0,nan,-27608.0,Alive,WITH TUMOR,822.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,822.0,0.0,822.0,nan,nan,0.0,822.0,0
TCGA-AA-3984-01,TCGA-AA-3984,COAD,61.0,FEMALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-22585.0,Alive,WITH TUMOR,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-AA-3986-01,TCGA-AA-3986,COAD,73.0,MALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2007.0,nan,-26967.0,Alive,TUMOR FREE,580.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,580.0,0.0,580.0,0.0,580.0,0.0,580.0,0
TCGA-AA-3989-01,TCGA-AA-3989,COAD,84.0,MALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2009.0,nan,-30712.0,Dead,WITH TUMOR,nan,242.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,242.0,1.0,242.0,nan,nan,1.0,242.0,1
TCGA-AA-3994-01,TCGA-AA-3994,COAD,69.0,MALE,nan,Stage IIIB,nan,Colon Mucinous Adenocarcinoma,nan,2008.0,nan,-25323.0,Alive,TUMOR FREE,822.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,822.0,0.0,822.0,0.0,822.0,0.0,822.0,0
TCGA-AA-A004-01,TCGA-AA-A004,COAD,76.0,MALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-27943.0,Alive,TUMOR FREE,424.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,424.0,0.0,424.0,0.0,424.0,0.0,424.0,0
TCGA-AA-A00A-01,TCGA-AA-A00A,COAD,80.0,MALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-29463.0,Alive,WITH TUMOR,1157.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1157.0,0.0,1157.0,nan,nan,0.0,1157.0,0
TCGA-AA-A00D-01,TCGA-AA-A00D,COAD,70.0,MALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2007.0,nan,-25689.0,Alive,TUMOR FREE,578.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,578.0,0.0,578.0,0.0,578.0,0.0,578.0,0
TCGA-AA-A00E-01,TCGA-AA-A00E,COAD,65.0,MALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2007.0,nan,-23741.0,Alive,TUMOR FREE,913.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,913.0,0.0,913.0,0.0,913.0,0.0,913.0,0
TCGA-AA-A00F-01,TCGA-AA-A00F,COAD,66.0,MALE,nan,Stage IIIC,nan,Colon Adenocarcinoma,nan,2007.0,nan,-24379.0,Alive,TUMOR FREE,1035.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,1035.0,0.0,1035.0,nan,nan,0.0,1035.0,0
TCGA-AA-A00J-01,TCGA-AA-A00J,COAD,80.0,MALE,nan,Stage IIIB,nan,Colon Mucinous Adenocarcinoma,nan,2009.0,nan,-29371.0,Alive,TUMOR FREE,549.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,549.0,0.0,549.0,nan,nan,0.0,549.0,0
TCGA-AA-A00K-01,TCGA-AA-A00K,COAD,79.0,MALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-29189.0,Alive,WITH TUMOR,549.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,549.0,0.0,549.0,nan,nan,0.0,549.0,0
TCGA-AA-A00L-01,TCGA-AA-A00L,COAD,66.0,MALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-24319.0,Alive,TUMOR FREE,1157.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1157.0,0.0,1157.0,0.0,1157.0,0.0,1157.0,0
TCGA-AA-A00N-01,TCGA-AA-A00N,COAD,75.0,MALE,nan,Stage IIB,nan,Colon Mucinous Adenocarcinoma,nan,2008.0,nan,-27667.0,Dead,WITH TUMOR,nan,122.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,122.0,1.0,122.0,nan,nan,1.0,122.0,1
TCGA-AA-A00O-01,TCGA-AA-A00O,COAD,83.0,FEMALE,nan,Stage IIIC,nan,Colon Adenocarcinoma,nan,2008.0,nan,-30316.0,Alive,[Discrepancy],822.0,nan,nan,nan,nan,nan,nan,[Discrepancy],nan,nan,0.0,822.0,0.0,822.0,nan,nan,0.0,822.0,0
TCGA-AA-A00Q-01,TCGA-AA-A00Q,COAD,66.0,FEMALE,nan,Stage IIIB,nan,Colon Adenocarcinoma,nan,2008.0,nan,-24199.0,Alive,TUMOR FREE,1278.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1278.0,0.0,1278.0,0.0,1278.0,0.0,1278.0,0
TCGA-AA-A00R-01,TCGA-AA-A00R,COAD,64.0,FEMALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2008.0,nan,-23528.0,Alive,WITH TUMOR,30.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,30.0,0.0,30.0,nan,nan,0.0,30.0,0
TCGA-AA-A00U-01,TCGA-AA-A00U,COAD,50.0,MALE,nan,Stage IIIB,nan,Colon Adenocarcinoma,nan,2009.0,nan,-18263.0,Alive,TUMOR FREE,518.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,518.0,0.0,518.0,0.0,518.0,0.0,518.0,0
TCGA-AA-A00W-01,TCGA-AA-A00W,COAD,80.0,MALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2008.0,nan,-29311.0,Alive,TUMOR FREE,456.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,456.0,0.0,456.0,nan,nan,0.0,456.0,0
TCGA-AA-A00Z-01,TCGA-AA-A00Z,COAD,70.0,MALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2008.0,nan,-25872.0,Alive,TUMOR FREE,669.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,669.0,0.0,669.0,0.0,669.0,0.0,669.0,0
TCGA-AA-A010-01,TCGA-AA-A010,COAD,46.0,FEMALE,nan,Stage IIB,nan,Colon Adenocarcinoma,nan,2008.0,nan,-16922.0,Alive,TUMOR FREE,1064.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1064.0,0.0,1064.0,0.0,1064.0,0.0,1064.0,0
TCGA-AA-A017-01,TCGA-AA-A017,COAD,57.0,FEMALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-21032.0,Alive,TUMOR FREE,457.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,457.0,0.0,457.0,0.0,457.0,0.0,457.0,0
TCGA-AA-A01C-01,TCGA-AA-A01C,COAD,75.0,MALE,nan,Stage IIIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-27729.0,Alive,TUMOR FREE,457.0,nan,nan,nan,nan,nan,nan,[Discrepancy],nan,nan,0.0,457.0,0.0,457.0,nan,nan,0.0,457.0,0
TCGA-AA-A01D-01,TCGA-AA-A01D,COAD,47.0,FEMALE,nan,Stage IIIC,nan,Colon Mucinous Adenocarcinoma,nan,2009.0,nan,-17318.0,Dead,WITH TUMOR,nan,334.0,nan,nan,nan,nan,183.0,Progressive Disease,nan,nan,1.0,334.0,1.0,334.0,nan,nan,1.0,183.0,1
TCGA-AA-A01F-01,TCGA-AA-A01F,COAD,72.0,MALE,nan,Stage IIIB,nan,Colon Adenocarcinoma,nan,2009.0,nan,-26298.0,Alive,WITH TUMOR,974.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,974.0,0.0,974.0,nan,nan,0.0,974.0,0
TCGA-AA-A01G-01,TCGA-AA-A01G,COAD,63.0,MALE,nan,Stage IIA,nan,Colon Mucinous Adenocarcinoma,nan,2009.0,nan,-23133.0,Alive,TUMOR FREE,365.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,365.0,0.0,365.0,0.0,365.0,0.0,365.0,0
TCGA-AA-A01I-01,TCGA-AA-A01I,COAD,76.0,MALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2009.0,nan,-27759.0,Alive,TUMOR FREE,943.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,943.0,0.0,943.0,0.0,943.0,0.0,943.0,0
TCGA-AA-A01K-01,TCGA-AA-A01K,COAD,74.0,FEMALE,nan,Stage IIIC,nan,Colon Adenocarcinoma,nan,2009.0,nan,-27029.0,Alive,TUMOR FREE,943.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,943.0,0.0,943.0,0.0,943.0,0.0,943.0,0
TCGA-AA-A01P-01,TCGA-AA-A01P,COAD,80.0,FEMALE,nan,Stage III,nan,Colon Adenocarcinoma,nan,2003.0,nan,-29554.0,Dead,WITH TUMOR,nan,1158.0,nan,nan,nan,nan,762.0,[Unknown],nan,nan,1.0,1158.0,1.0,1158.0,nan,nan,1.0,762.0,1
TCGA-AA-A01P-11,TCGA-AA-A01P,COAD,80.0,FEMALE,nan,Stage III,nan,Colon Adenocarcinoma,nan,2003.0,nan,-29554.0,Dead,WITH TUMOR,nan,1158.0,nan,nan,nan,nan,762.0,[Unknown],nan,nan,1.0,1158.0,1.0,1158.0,nan,nan,1.0,762.0,1
TCGA-AA-A01Q-01,TCGA-AA-A01Q,COAD,48.0,FEMALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2003.0,nan,-17715.0,Alive,WITH TUMOR,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-AA-A01R-01,TCGA-AA-A01R,COAD,47.0,MALE,nan,Stage III,nan,Colon Mucinous Adenocarcinoma,nan,2004.0,nan,-17289.0,Alive,WITH TUMOR,1065.0,nan,nan,nan,nan,nan,608.0,Partial Remission/Response,nan,nan,0.0,1065.0,0.0,1065.0,nan,nan,1.0,608.0,0
TCGA-AA-A01R-11,TCGA-AA-A01R,COAD,47.0,MALE,nan,Stage III,nan,Colon Mucinous Adenocarcinoma,nan,2004.0,nan,-17289.0,Alive,WITH TUMOR,1065.0,nan,nan,nan,nan,nan,608.0,Partial Remission/Response,nan,nan,0.0,1065.0,0.0,1065.0,nan,nan,1.0,608.0,0
TCGA-AA-A01S-01,TCGA-AA-A01S,COAD,47.0,FEMALE,nan,Stage III,nan,Colon Adenocarcinoma,nan,2004.0,nan,-17257.0,Alive,WITH TUMOR,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-AA-A01S-11,TCGA-AA-A01S,COAD,47.0,FEMALE,nan,Stage III,nan,Colon Adenocarcinoma,nan,2004.0,nan,-17257.0,Alive,WITH TUMOR,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-AA-A01T-01,TCGA-AA-A01T,COAD,63.0,FEMALE,nan,Stage III,nan,Colon Adenocarcinoma,nan,2004.0,nan,-23192.0,Alive,TUMOR FREE,1005.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1005.0,0.0,1005.0,0.0,1005.0,0.0,1005.0,0
TCGA-AA-A01T-11,TCGA-AA-A01T,COAD,63.0,FEMALE,nan,Stage III,nan,Colon Adenocarcinoma,nan,2004.0,nan,-23192.0,Alive,TUMOR FREE,1005.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1005.0,0.0,1005.0,0.0,1005.0,0.0,1005.0,0
TCGA-AA-A01V-01,TCGA-AA-A01V,COAD,59.0,MALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2004.0,nan,-21792.0,Alive,WITH TUMOR,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-AA-A01V-11,TCGA-AA-A01V,COAD,59.0,MALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2004.0,nan,-21792.0,Alive,WITH TUMOR,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-AA-A01X-01,TCGA-AA-A01X,COAD,80.0,FEMALE,nan,Stage III,nan,Colon Adenocarcinoma,nan,2004.0,nan,-29281.0,Alive,WITH TUMOR,791.0,nan,nan,nan,nan,nan,791.0,[Unknown],nan,nan,0.0,791.0,0.0,791.0,nan,nan,1.0,791.0,2
TCGA-AA-A01X-11,TCGA-AA-A01X,COAD,80.0,FEMALE,nan,Stage III,nan,Colon Adenocarcinoma,nan,2004.0,nan,-29281.0,Alive,WITH TUMOR,791.0,nan,nan,nan,nan,nan,791.0,[Unknown],nan,nan,0.0,791.0,0.0,791.0,nan,nan,1.0,791.0,2
TCGA-AA-A01Z-01,TCGA-AA-A01Z,COAD,68.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2004.0,nan,-24990.0,Alive,WITH TUMOR,1126.0,nan,nan,nan,nan,nan,1126.0,Progressive Disease,nan,nan,0.0,1126.0,0.0,1126.0,nan,nan,1.0,1126.0,0
TCGA-AA-A01Z-11,TCGA-AA-A01Z,COAD,68.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2004.0,nan,-24990.0,Alive,WITH TUMOR,1126.0,nan,nan,nan,nan,nan,1126.0,Progressive Disease,nan,nan,0.0,1126.0,0.0,1126.0,nan,nan,1.0,1126.0,0
TCGA-AA-A022-01,TCGA-AA-A022,COAD,88.0,FEMALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2005.0,nan,-32446.0,Alive,WITH TUMOR,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-AA-A022-11,TCGA-AA-A022,COAD,88.0,FEMALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2005.0,nan,-32446.0,Alive,WITH TUMOR,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-AA-A024-01,TCGA-AA-A024,COAD,81.0,MALE,nan,Stage II,nan,Colon Mucinous Adenocarcinoma,nan,2005.0,nan,-29708.0,Dead,TUMOR FREE,nan,1188.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1188.0,0.0,1188.0,0.0,1188.0,0.0,1188.0,0
TCGA-AA-A029-01,TCGA-AA-A029,COAD,67.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2006.0,nan,-24686.0,Alive,TUMOR FREE,1581.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1581.0,0.0,1581.0,0.0,1581.0,0.0,1581.0,0
TCGA-AA-A02E-01,TCGA-AA-A02E,COAD,82.0,FEMALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2007.0,nan,-30256.0,Dead,WITH TUMOR,nan,90.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,90.0,1.0,90.0,nan,nan,1.0,90.0,1
TCGA-AA-A02F-01,TCGA-AA-A02F,COAD,68.0,FEMALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2007.0,nan,-25051.0,Alive,WITH TUMOR,1216.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,1216.0,0.0,1216.0,nan,nan,0.0,1216.0,0
TCGA-AA-A02H-01,TCGA-AA-A02H,COAD,74.0,FEMALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2007.0,nan,-27362.0,Dead,WITH TUMOR,nan,61.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,61.0,1.0,61.0,nan,nan,1.0,61.0,1
TCGA-AA-A02J-01,TCGA-AA-A02J,COAD,70.0,FEMALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2008.0,nan,-25749.0,Dead,WITH TUMOR,nan,153.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,153.0,1.0,153.0,nan,nan,1.0,153.0,1
TCGA-AA-A02K-01,TCGA-AA-A02K,COAD,50.0,MALE,nan,Stage IV,nan,Colon Adenocarcinoma,nan,2009.0,nan,-18506.0,Dead,WITH TUMOR,nan,426.0,nan,nan,nan,nan,306.0,Progressive Disease,nan,nan,1.0,426.0,1.0,426.0,nan,nan,1.0,306.0,1
TCGA-AA-A02O-01,TCGA-AA-A02O,COAD,82.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2005.0,nan,-30288.0,Alive,WITH TUMOR,28.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,28.0,0.0,28.0,nan,nan,0.0,28.0,0
TCGA-AA-A02O-11,TCGA-AA-A02O,COAD,82.0,MALE,nan,Stage II,nan,Colon Adenocarcinoma,nan,2005.0,nan,-30288.0,Alive,WITH TUMOR,28.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,28.0,0.0,28.0,nan,nan,0.0,28.0,0
TCGA-AA-A02R-01,TCGA-AA-A02R,COAD,84.0,FEMALE,nan,Stage IIA,nan,Colon Adenocarcinoma,nan,2006.0,nan,-30834.0,Dead,WITH TUMOR,nan,670.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,670.0,1.0,670.0,nan,nan,1.0,670.0,1
TCGA-AA-A02W-01,TCGA-AA-A02W,COAD,73.0,FEMALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2006.0,nan,-26693.0,Alive,TUMOR FREE,1247.0,nan,nan,nan,nan,nan,1005.0,Complete Remission/Response,nan,nan,0.0,1247.0,0.0,1247.0,1.0,1005.0,1.0,1005.0,2
TCGA-AA-A02Y-01,TCGA-AA-A02Y,COAD,73.0,MALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2007.0,nan,-26724.0,Alive,TUMOR FREE,1216.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1216.0,0.0,1216.0,0.0,1216.0,0.0,1216.0,0
TCGA-AA-A03F-01,TCGA-AA-A03F,COAD,90.0,FEMALE,nan,Stage III,nan,Colon Mucinous Adenocarcinoma,nan,2004.0,nan,-32873.0,Dead,WITH TUMOR,nan,549.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,549.0,1.0,549.0,nan,nan,1.0,549.0,1
TCGA-AA-A03F-11,TCGA-AA-A03F,COAD,90.0,FEMALE,nan,Stage III,nan,Colon Mucinous Adenocarcinoma,nan,2004.0,nan,-32873.0,Dead,WITH TUMOR,nan,549.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,549.0,1.0,549.0,nan,nan,1.0,549.0,1
TCGA-AA-A03J-01,TCGA-AA-A03J,COAD,65.0,FEMALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2004.0,nan,-23986.0,Alive,TUMOR FREE,1246.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1246.0,0.0,1246.0,0.0,1246.0,0.0,1246.0,0
TCGA-AA-A03J-11,TCGA-AA-A03J,COAD,65.0,FEMALE,nan,Stage I,nan,Colon Adenocarcinoma,nan,2004.0,nan,-23986.0,Alive,TUMOR FREE,1246.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1246.0,0.0,1246.0,0.0,1246.0,0.0,1246.0,0
TCGA-AD-5900-01,TCGA-AD-5900,COAD,67.0,MALE,WHITE,Stage I,nan,Colon Mucinous Adenocarcinoma,nan,2010.0,nan,-24776.0,Alive,TUMOR FREE,370.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,370.0,0.0,370.0,0.0,370.0,0.0,370.0,0
TCGA-AD-6548-01,TCGA-AD-6548,COAD,81.0,FEMALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2011.0,nan,-29758.0,Alive,TUMOR FREE,650.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,650.0,0.0,650.0,0.0,650.0,0.0,650.0,0
TCGA-AD-6888-01,TCGA-AD-6888,COAD,73.0,MALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2010.0,nan,-26816.0,Dead,WITH TUMOR,nan,472.0,nan,nan,nan,nan,343.0,Complete Remission/Response,nan,nan,1.0,472.0,1.0,472.0,1.0,343.0,1.0,343.0,1
TCGA-AD-6889-01,TCGA-AD-6889,COAD,76.0,MALE,ASIAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2005.0,nan,nan,Dead,TUMOR FREE,nan,2532.0,nan,nan,nan,nan,1516.0,Complete Remission/Response,nan,nan,1.0,2532.0,0.0,2532.0,1.0,1516.0,1.0,1516.0,0
TCGA-AD-6890-01,TCGA-AD-6890,COAD,65.0,MALE,WHITE,nan,nan,Colon Adenocarcinoma,nan,2010.0,nan,-23769.0,Alive,TUMOR FREE,746.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,746.0,0.0,746.0,0.0,746.0,0.0,746.0,0
TCGA-AD-6895-01,TCGA-AD-6895,COAD,84.0,MALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2011.0,nan,-30879.0,Alive,TUMOR FREE,763.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,763.0,0.0,763.0,0.0,763.0,0.0,763.0,0
TCGA-AD-6899-01,TCGA-AD-6899,COAD,84.0,MALE,WHITE,Stage IIIC,nan,Colon Mucinous Adenocarcinoma,nan,2011.0,nan,-30693.0,Dead,TUMOR FREE,nan,176.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,176.0,0.0,176.0,0.0,176.0,0.0,176.0,0
TCGA-AD-6901-01,TCGA-AD-6901,COAD,78.0,MALE,WHITE,nan,nan,Colon Adenocarcinoma,nan,2011.0,nan,-28579.0,Dead,WITH TUMOR,nan,682.0,nan,Metastatic,nan,nan,468.0,Complete Remission/Response,nan,nan,1.0,682.0,1.0,682.0,1.0,468.0,1.0,468.0,1
TCGA-AD-6963-01,TCGA-AD-6963,COAD,58.0,MALE,WHITE,nan,nan,Colon Adenocarcinoma,nan,2011.0,nan,-21294.0,Alive,TUMOR FREE,834.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,834.0,0.0,834.0,0.0,834.0,0.0,834.0,0
TCGA-AD-6964-01,TCGA-AD-6964,COAD,58.0,MALE,WHITE,nan,nan,Colon Adenocarcinoma,nan,2011.0,nan,-21457.0,Dead,WITH TUMOR,nan,331.0,nan,Metastatic,nan,nan,325.0,Progressive Disease,nan,nan,1.0,331.0,1.0,331.0,nan,nan,1.0,325.0,1
TCGA-AD-6965-01,TCGA-AD-6965,COAD,62.0,MALE,WHITE,Stage IIIC,nan,Colon Adenocarcinoma,nan,2011.0,nan,-22853.0,Alive,WITH TUMOR,805.0,nan,nan,nan,nan,nan,648.0,Complete Remission/Response,nan,nan,0.0,805.0,0.0,805.0,1.0,648.0,1.0,648.0,2
TCGA-AD-A5EJ-01,TCGA-AD-A5EJ,COAD,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2012.0,nan,-27180.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-AD-A5EK-01,TCGA-AD-A5EK,COAD,51.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Colon Adenocarcinoma,nan,2012.0,nan,-18731.0,Alive,TUMOR FREE,500.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,500.0,0.0,500.0,0.0,500.0,0.0,500.0,0
TCGA-AM-5820-01,TCGA-AM-5820,COAD,59.0,FEMALE,WHITE,Stage IVA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-21902.0,Alive,TUMOR FREE,14.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,14.0,0.0,14.0,nan,nan,0.0,14.0,0
TCGA-AM-5821-01,TCGA-AM-5821,COAD,68.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-24903.0,Alive,TUMOR FREE,28.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,28.0,0.0,28.0,nan,nan,0.0,28.0,0
TCGA-AU-3779-01,TCGA-AU-3779,COAD,80.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-29460.0,Alive,TUMOR FREE,441.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,441.0,0.0,441.0,nan,nan,0.0,441.0,0
TCGA-AU-6004-01,TCGA-AU-6004,COAD,69.0,FEMALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2010.0,nan,-25259.0,Alive,TUMOR FREE,824.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,824.0,0.0,824.0,nan,nan,0.0,824.0,0
TCGA-AY-4070-01,TCGA-AY-4070,COAD,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,nan,Colon Adenocarcinoma,nan,2007.0,nan,-18621.0,Dead,WITH TUMOR,nan,496.0,nan,nan,nan,nan,186.0,nan,nan,nan,1.0,496.0,1.0,496.0,nan,nan,1.0,186.0,1
TCGA-AY-4071-01,TCGA-AY-4071,COAD,63.0,FEMALE,WHITE,Stage I,nan,nan,nan,2009.0,nan,-23320.0,Dead,TUMOR FREE,nan,29.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,29.0,0.0,29.0,nan,nan,0.0,29.0,0
TCGA-AY-5543-01,TCGA-AY-5543,COAD,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-23870.0,Alive,TUMOR FREE,1004.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1004.0,0.0,1004.0,nan,nan,0.0,1004.0,0
TCGA-AY-6196-01,TCGA-AY-6196,COAD,47.0,MALE,WHITE,Stage IIIC,nan,Colon Mucinous Adenocarcinoma,nan,2010.0,nan,-17311.0,Alive,TUMOR FREE,6.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,6.0,0.0,6.0,nan,nan,0.0,6.0,0
TCGA-AY-6197-01,TCGA-AY-6197,COAD,60.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-21957.0,Alive,TUMOR FREE,652.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,652.0,0.0,652.0,0.0,652.0,0.0,652.0,0
TCGA-AY-6386-01,TCGA-AY-6386,COAD,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,nan,Colon Adenocarcinoma,nan,2010.0,nan,-24453.0,Alive,TUMOR FREE,542.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,542.0,0.0,542.0,0.0,542.0,0.0,542.0,0
TCGA-AY-A54L-01,TCGA-AY-A54L,COAD,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Colon Adenocarcinoma,nan,2012.0,nan,-27074.0,Alive,WITH TUMOR,525.0,nan,nan,nan,nan,nan,396.0,Complete Remission/Response,nan,nan,0.0,525.0,0.0,525.0,1.0,396.0,1.0,396.0,2
TCGA-AY-A69D-01,TCGA-AY-A69D,COAD,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2012.0,nan,-20299.0,Alive,TUMOR FREE,543.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,543.0,0.0,543.0,0.0,543.0,0.0,543.0,0
TCGA-AY-A71X-01,TCGA-AY-A71X,COAD,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Colon Adenocarcinoma,nan,2013.0,nan,-19904.0,Alive,TUMOR FREE,588.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,588.0,0.0,588.0,0.0,588.0,0.0,588.0,0
TCGA-AY-A8YK-01,TCGA-AY-A8YK,COAD,44.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,nan,Colon Adenocarcinoma,nan,2013.0,nan,-16140.0,Alive,TUMOR FREE,573.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,573.0,0.0,573.0,nan,nan,0.0,573.0,0
TCGA-AZ-4308-01,TCGA-AZ-4308,COAD,47.0,FEMALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2006.0,nan,-17321.0,Alive,TUMOR FREE,3324.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3324.0,0.0,3324.0,0.0,3324.0,0.0,3324.0,0
TCGA-AZ-4313-01,TCGA-AZ-4313,COAD,51.0,FEMALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2007.0,nan,-18765.0,Alive,TUMOR FREE,2310.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2310.0,0.0,2310.0,0.0,2310.0,0.0,2310.0,0
TCGA-AZ-4315-01,TCGA-AZ-4315,COAD,61.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2006.0,nan,-22340.0,Alive,TUMOR FREE,1776.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1776.0,0.0,1776.0,nan,nan,0.0,1776.0,0
TCGA-AZ-4323-01,TCGA-AZ-4323,COAD,37.0,MALE,WHITE,Stage IV,nan,Colon Adenocarcinoma,nan,2002.0,nan,-13755.0,Dead,WITH TUMOR,nan,43.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,43.0,1.0,43.0,nan,nan,1.0,43.0,1
TCGA-AZ-4614-01,TCGA-AZ-4614,COAD,71.0,FEMALE,WHITE,Stage IVA,nan,Colon Adenocarcinoma,nan,2008.0,nan,-26267.0,Dead,WITH TUMOR,nan,172.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,172.0,1.0,172.0,nan,nan,1.0,172.0,1
TCGA-AZ-4615-01,TCGA-AZ-4615,COAD,84.0,MALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2009.0,nan,-30908.0,Alive,WITH TUMOR,1002.0,nan,nan,nan,nan,nan,688.0,nan,nan,nan,0.0,1002.0,0.0,1002.0,nan,nan,1.0,688.0,0
TCGA-AZ-4616-01,TCGA-AZ-4616,COAD,82.0,FEMALE,WHITE,Stage IV,nan,Colon Adenocarcinoma,nan,2009.0,nan,-30043.0,Dead,WITH TUMOR,nan,156.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,156.0,1.0,156.0,nan,nan,1.0,156.0,1
TCGA-AZ-4681-01,TCGA-AZ-4681,COAD,79.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2004.0,nan,-28906.0,Alive,TUMOR FREE,3247.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3247.0,0.0,3247.0,0.0,3247.0,0.0,3247.0,0
TCGA-AZ-4682-01,TCGA-AZ-4682,COAD,61.0,MALE,WHITE,Stage IVA,nan,Colon Adenocarcinoma,nan,2006.0,nan,-22409.0,Dead,WITH TUMOR,nan,680.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,680.0,1.0,680.0,nan,nan,1.0,680.0,1
TCGA-AZ-4684-01,TCGA-AZ-4684,COAD,49.0,MALE,WHITE,Stage IVA,nan,Colon Adenocarcinoma,nan,2006.0,nan,-18252.0,Alive,WITH TUMOR,1977.0,nan,nan,nan,nan,nan,411.0,nan,nan,nan,0.0,1977.0,0.0,1977.0,nan,nan,1.0,411.0,0
TCGA-AZ-5403-01,TCGA-AZ-5403,COAD,43.0,MALE,WHITE,Stage II,nan,Colon Adenocarcinoma,nan,2000.0,nan,-15983.0,Dead,WITH TUMOR,nan,1910.0,nan,nan,nan,nan,304.0,nan,nan,nan,1.0,1910.0,1.0,1910.0,nan,nan,1.0,304.0,1
TCGA-AZ-5407-01,TCGA-AZ-5407,COAD,51.0,FEMALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2007.0,nan,-18820.0,Alive,TUMOR FREE,2683.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2683.0,0.0,2683.0,0.0,2683.0,0.0,2683.0,0
TCGA-AZ-6598-01,TCGA-AZ-6598,COAD,77.0,FEMALE,WHITE,Stage II,nan,Colon Adenocarcinoma,nan,2000.0,nan,-28182.0,Dead,TUMOR FREE,nan,1503.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1503.0,0.0,1503.0,0.0,1503.0,0.0,1503.0,0
TCGA-AZ-6598-11,TCGA-AZ-6598,COAD,77.0,FEMALE,WHITE,Stage II,nan,Colon Adenocarcinoma,nan,2000.0,nan,-28182.0,Dead,TUMOR FREE,nan,1503.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1503.0,0.0,1503.0,0.0,1503.0,0.0,1503.0,0
TCGA-AZ-6599-01,TCGA-AZ-6599,COAD,72.0,MALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2001.0,nan,-26438.0,Dead,TUMOR FREE,nan,206.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,206.0,0.0,206.0,0.0,206.0,0.0,206.0,0
TCGA-AZ-6599-11,TCGA-AZ-6599,COAD,72.0,MALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2001.0,nan,-26438.0,Dead,TUMOR FREE,nan,206.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,206.0,0.0,206.0,0.0,206.0,0.0,206.0,0
TCGA-AZ-6600-01,TCGA-AZ-6600,COAD,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Colon Adenocarcinoma,nan,2001.0,nan,-23581.0,Dead,WITH TUMOR,nan,368.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,368.0,1.0,368.0,nan,nan,1.0,368.0,1
TCGA-AZ-6600-11,TCGA-AZ-6600,COAD,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Colon Adenocarcinoma,nan,2001.0,nan,-23581.0,Dead,WITH TUMOR,nan,368.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,368.0,1.0,368.0,nan,nan,1.0,368.0,1
TCGA-AZ-6601-01,TCGA-AZ-6601,COAD,68.0,MALE,WHITE,Stage II,nan,Colon Adenocarcinoma,nan,2001.0,nan,-25082.0,Dead,WITH TUMOR,nan,3042.0,nan,Locoregional Disease,nan,nan,2270.0,Progressive Disease,nan,nan,1.0,3042.0,1.0,3042.0,nan,nan,1.0,2270.0,1
TCGA-AZ-6601-11,TCGA-AZ-6601,COAD,68.0,MALE,WHITE,Stage II,nan,Colon Adenocarcinoma,nan,2001.0,nan,-25082.0,Dead,WITH TUMOR,nan,3042.0,nan,Locoregional Disease,nan,nan,2270.0,Progressive Disease,nan,nan,1.0,3042.0,1.0,3042.0,nan,nan,1.0,2270.0,1
TCGA-AZ-6603-01,TCGA-AZ-6603,COAD,77.0,FEMALE,WHITE,nan,nan,Colon Adenocarcinoma,nan,2002.0,nan,-28424.0,Dead,TUMOR FREE,nan,899.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,899.0,0.0,899.0,0.0,899.0,0.0,899.0,0
TCGA-AZ-6603-11,TCGA-AZ-6603,COAD,77.0,FEMALE,WHITE,nan,nan,Colon Adenocarcinoma,nan,2002.0,nan,-28424.0,Dead,TUMOR FREE,nan,899.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,899.0,0.0,899.0,0.0,899.0,0.0,899.0,0
TCGA-AZ-6605-01,TCGA-AZ-6605,COAD,77.0,MALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2008.0,nan,-28485.0,Dead,TUMOR FREE,nan,159.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,159.0,0.0,159.0,nan,nan,0.0,159.0,0
TCGA-AZ-6605-11,TCGA-AZ-6605,COAD,77.0,MALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2008.0,nan,-28485.0,Dead,TUMOR FREE,nan,159.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,159.0,0.0,159.0,nan,nan,0.0,159.0,0
TCGA-AZ-6606-01,TCGA-AZ-6606,COAD,81.0,MALE,WHITE,Stage IV,nan,Colon Adenocarcinoma,nan,2009.0,nan,-29704.0,Dead,WITH TUMOR,nan,357.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,357.0,1.0,357.0,nan,nan,1.0,357.0,1
TCGA-AZ-6607-01,TCGA-AZ-6607,COAD,69.0,MALE,WHITE,Stage IV,nan,Colon Adenocarcinoma,nan,2009.0,nan,-25448.0,Dead,WITH TUMOR,nan,97.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,97.0,1.0,97.0,nan,nan,1.0,97.0,1
TCGA-AZ-6608-01,TCGA-AZ-6608,COAD,55.0,FEMALE,WHITE,Stage IIIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-20094.0,Dead,[Discrepancy],nan,59.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,59.0,nan,59.0,nan,nan,0.0,59.0,1
TCGA-CA-5254-01,TCGA-CA-5254,COAD,42.0,FEMALE,ASIAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-15415.0,Alive,TUMOR FREE,386.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,386.0,0.0,386.0,0.0,386.0,0.0,386.0,0
TCGA-CA-5255-01,TCGA-CA-5255,COAD,45.0,MALE,ASIAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-16743.0,Alive,TUMOR FREE,376.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,376.0,0.0,376.0,0.0,376.0,0.0,376.0,0
TCGA-CA-5256-01,TCGA-CA-5256,COAD,54.0,FEMALE,ASIAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-19785.0,Alive,TUMOR FREE,379.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,0
TCGA-CA-5796-01,TCGA-CA-5796,COAD,52.0,FEMALE,ASIAN,Stage IIA,nan,Colon Mucinous Adenocarcinoma,nan,2010.0,nan,-19353.0,Alive,TUMOR FREE,377.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,377.0,0.0,377.0,0.0,377.0,0.0,377.0,0
TCGA-CA-5797-01,TCGA-CA-5797,COAD,56.0,MALE,ASIAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-20662.0,Alive,TUMOR FREE,383.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,0
TCGA-CA-6715-01,TCGA-CA-6715,COAD,63.0,MALE,ASIAN,Stage IIIB,nan,Colon Adenocarcinoma,nan,2010.0,nan,-23075.0,Alive,TUMOR FREE,383.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,0
TCGA-CA-6716-01,TCGA-CA-6716,COAD,65.0,MALE,ASIAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-23943.0,Alive,TUMOR FREE,371.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,371.0,0.0,371.0,0.0,371.0,0.0,371.0,0
TCGA-CA-6717-01,TCGA-CA-6717,COAD,57.0,MALE,ASIAN,Stage IIA,nan,Colon Mucinous Adenocarcinoma,nan,2010.0,nan,-20984.0,Alive,TUMOR FREE,388.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,388.0,0.0,388.0,0.0,388.0,0.0,388.0,0
TCGA-CA-6718-01,TCGA-CA-6718,COAD,46.0,MALE,ASIAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-17109.0,Dead,WITH TUMOR,nan,306.0,nan,nan,nan,nan,207.0,Complete Remission/Response,nan,nan,1.0,306.0,1.0,306.0,1.0,207.0,1.0,207.0,1
TCGA-CA-6719-01,TCGA-CA-6719,COAD,77.0,MALE,ASIAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2011.0,nan,-28343.0,Alive,WITH TUMOR,435.0,nan,nan,nan,nan,nan,354.0,Progressive Disease,nan,nan,0.0,435.0,0.0,435.0,nan,nan,1.0,354.0,0
TCGA-CK-4947-01,TCGA-CK-4947,COAD,46.0,FEMALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2003.0,nan,-16980.0,Alive,WITH TUMOR,534.0,nan,nan,nan,nan,nan,21.0,Stable Disease,nan,nan,0.0,534.0,0.0,534.0,nan,nan,1.0,21.0,2
TCGA-CK-4948-01,TCGA-CK-4948,COAD,45.0,FEMALE,WHITE,Stage III,nan,Colon Adenocarcinoma,nan,2002.0,nan,-16736.0,Alive,TUMOR FREE,4502.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4502.0,0.0,4502.0,0.0,4502.0,0.0,4502.0,0
TCGA-CK-4950-01,TCGA-CK-4950,COAD,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,nan,Colon Mucinous Adenocarcinoma,nan,2008.0,nan,-24944.0,Alive,TUMOR FREE,2599.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2599.0,0.0,2599.0,0.0,2599.0,0.0,2599.0,0
TCGA-CK-4951-01,TCGA-CK-4951,COAD,79.0,FEMALE,WHITE,Stage IIA,nan,Colon Mucinous Adenocarcinoma,nan,2007.0,nan,-28982.0,Dead,TUMOR FREE,nan,2134.0,nan,Locoregional Disease,nan,nan,480.0,nan,nan,nan,1.0,2134.0,0.0,2134.0,nan,nan,1.0,480.0,1
TCGA-CK-4952-01,TCGA-CK-4952,COAD,48.0,FEMALE,WHITE,Stage IIIC,nan,Colon Mucinous Adenocarcinoma,nan,2007.0,nan,-17826.0,Alive,TUMOR FREE,475.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,475.0,0.0,475.0,nan,nan,0.0,475.0,0
TCGA-CK-5912-01,TCGA-CK-5912,COAD,81.0,MALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2006.0,nan,-29938.0,Dead,TUMOR FREE,nan,1493.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1493.0,0.0,1493.0,0.0,1493.0,0.0,1493.0,0
TCGA-CK-5913-01,TCGA-CK-5913,COAD,58.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2008.0,nan,-21399.0,Alive,TUMOR FREE,1561.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1561.0,0.0,1561.0,0.0,1561.0,0.0,1561.0,0
TCGA-CK-5914-01,TCGA-CK-5914,COAD,81.0,MALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2008.0,nan,-29586.0,Alive,TUMOR FREE,669.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,669.0,0.0,669.0,nan,nan,0.0,669.0,0
TCGA-CK-5915-01,TCGA-CK-5915,COAD,63.0,MALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2007.0,nan,-23040.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-CK-5916-01,TCGA-CK-5916,COAD,71.0,FEMALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2003.0,nan,-26024.0,Dead,WITH TUMOR,nan,643.0,nan,nan,nan,nan,292.0,Progressive Disease,nan,nan,1.0,643.0,1.0,643.0,nan,nan,1.0,292.0,1
TCGA-CK-6746-01,TCGA-CK-6746,COAD,84.0,FEMALE,WHITE,Stage IIB,nan,Colon Adenocarcinoma,nan,2009.0,nan,-30957.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-CK-6747-01,TCGA-CK-6747,COAD,87.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2008.0,nan,-32052.0,Alive,TUMOR FREE,2523.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2523.0,0.0,2523.0,0.0,2523.0,0.0,2523.0,0
TCGA-CK-6748-01,TCGA-CK-6748,COAD,45.0,FEMALE,WHITE,Stage IV,nan,Colon Mucinous Adenocarcinoma,nan,2008.0,nan,-16529.0,Alive,WITH TUMOR,61.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,61.0,0.0,61.0,nan,nan,0.0,61.0,0
TCGA-CK-6751-01,TCGA-CK-6751,COAD,88.0,FEMALE,WHITE,Stage I,nan,Colon Mucinous Adenocarcinoma,nan,2002.0,nan,-32354.0,Alive,TUMOR FREE,3780.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3780.0,0.0,3780.0,nan,nan,0.0,3780.0,0
TCGA-CM-4743-01,TCGA-CM-4743,COAD,69.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-25291.0,Alive,TUMOR FREE,701.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,701.0,0.0,701.0,0.0,701.0,0.0,701.0,0
TCGA-CM-4744-01,TCGA-CM-4744,COAD,69.0,MALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2010.0,nan,-25506.0,Alive,TUMOR FREE,609.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,609.0,0.0,609.0,0.0,609.0,0.0,609.0,0
TCGA-CM-4746-01,TCGA-CM-4746,COAD,61.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Colon Adenocarcinoma,nan,2009.0,nan,-22403.0,Alive,TUMOR FREE,1126.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1126.0,0.0,1126.0,0.0,1126.0,0.0,1126.0,0
TCGA-CM-4747-01,TCGA-CM-4747,COAD,47.0,MALE,WHITE,Stage IVA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-17198.0,Alive,[Discrepancy],761.0,nan,nan,nan,nan,nan,nan,[Discrepancy],nan,nan,0.0,761.0,0.0,761.0,nan,nan,0.0,761.0,0
TCGA-CM-4748-01,TCGA-CM-4748,COAD,53.0,MALE,WHITE,Stage IIIB,nan,Colon Mucinous Adenocarcinoma,nan,2010.0,nan,-19509.0,Alive,TUMOR FREE,792.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,792.0,0.0,792.0,0.0,792.0,0.0,792.0,0
TCGA-CM-4750-01,TCGA-CM-4750,COAD,34.0,FEMALE,WHITE,Stage IIIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-12478.0,Alive,TUMOR FREE,244.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,244.0,0.0,244.0,0.0,244.0,0.0,244.0,0
TCGA-CM-4751-01,TCGA-CM-4751,COAD,62.0,MALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2009.0,nan,-22891.0,Alive,TUMOR FREE,822.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,822.0,0.0,822.0,0.0,822.0,0.0,822.0,0
TCGA-CM-4752-01,TCGA-CM-4752,COAD,58.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-21519.0,Alive,TUMOR FREE,396.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,396.0,0.0,396.0,0.0,396.0,0.0,396.0,0
TCGA-CM-5341-01,TCGA-CM-5341,COAD,82.0,FEMALE,WHITE,Stage IIIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-30163.0,Alive,TUMOR FREE,884.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,884.0,0.0,884.0,0.0,884.0,0.0,884.0,0
TCGA-CM-5344-01,TCGA-CM-5344,COAD,39.0,FEMALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2010.0,nan,-14426.0,Alive,TUMOR FREE,670.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,670.0,0.0,670.0,nan,nan,0.0,670.0,0
TCGA-CM-5348-01,TCGA-CM-5348,COAD,72.0,MALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2010.0,nan,-26543.0,Alive,TUMOR FREE,699.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,699.0,0.0,699.0,nan,nan,0.0,699.0,0
TCGA-CM-5349-01,TCGA-CM-5349,COAD,68.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-24867.0,Alive,TUMOR FREE,915.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,915.0,0.0,915.0,nan,nan,0.0,915.0,0
TCGA-CM-5860-01,TCGA-CM-5860,COAD,44.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-16344.0,Alive,TUMOR FREE,974.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,974.0,0.0,974.0,nan,nan,0.0,974.0,0
TCGA-CM-5861-01,TCGA-CM-5861,COAD,63.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-23253.0,Alive,TUMOR FREE,457.0,nan,nan,Locoregional Disease,nan,nan,335.0,nan,nan,nan,0.0,457.0,0.0,457.0,nan,nan,1.0,335.0,0
TCGA-CM-5862-01,TCGA-CM-5862,COAD,80.0,MALE,WHITE,Stage IVA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-29493.0,Dead,WITH TUMOR,nan,153.0,nan,nan,nan,nan,31.0,nan,nan,nan,1.0,153.0,1.0,153.0,nan,nan,1.0,31.0,1
TCGA-CM-5863-01,TCGA-CM-5863,COAD,60.0,FEMALE,WHITE,Stage IIIB,nan,Colon Mucinous Adenocarcinoma,nan,2010.0,nan,-22127.0,Alive,TUMOR FREE,457.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,457.0,0.0,457.0,nan,nan,0.0,457.0,0
TCGA-CM-5864-01,TCGA-CM-5864,COAD,60.0,MALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2010.0,nan,-22219.0,Alive,TUMOR FREE,457.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,457.0,0.0,457.0,nan,nan,0.0,457.0,0
TCGA-CM-5868-01,TCGA-CM-5868,COAD,59.0,FEMALE,WHITE,Stage IVA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-21672.0,Alive,WITH TUMOR,518.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,518.0,0.0,518.0,nan,nan,0.0,518.0,0
TCGA-CM-6161-01,TCGA-CM-6161,COAD,36.0,FEMALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2010.0,nan,-13363.0,Alive,TUMOR FREE,457.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,457.0,0.0,457.0,nan,nan,0.0,457.0,0
TCGA-CM-6162-01,TCGA-CM-6162,COAD,48.0,FEMALE,WHITE,Stage IIIB,nan,Colon Mucinous Adenocarcinoma,nan,2010.0,nan,-17624.0,Alive,TUMOR FREE,365.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,365.0,0.0,365.0,nan,nan,0.0,365.0,0
TCGA-CM-6163-01,TCGA-CM-6163,COAD,74.0,MALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2010.0,nan,-27150.0,Alive,TUMOR FREE,427.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,427.0,0.0,427.0,nan,nan,0.0,427.0,0
TCGA-CM-6164-01,TCGA-CM-6164,COAD,46.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-16802.0,Alive,TUMOR FREE,883.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,883.0,0.0,883.0,nan,nan,0.0,883.0,0
TCGA-CM-6165-01,TCGA-CM-6165,COAD,74.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-27302.0,Alive,TUMOR FREE,488.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,488.0,0.0,488.0,nan,nan,0.0,488.0,0
TCGA-CM-6166-01,TCGA-CM-6166,COAD,48.0,FEMALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2010.0,nan,-17807.0,Alive,TUMOR FREE,669.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,669.0,0.0,669.0,nan,nan,0.0,669.0,0
TCGA-CM-6167-01,TCGA-CM-6167,COAD,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,nan,Colon Adenocarcinoma,nan,2010.0,nan,-21031.0,Alive,TUMOR FREE,456.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,456.0,0.0,456.0,nan,nan,0.0,456.0,0
TCGA-CM-6168-01,TCGA-CM-6168,COAD,84.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-30834.0,Alive,TUMOR FREE,395.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,395.0,0.0,395.0,nan,nan,0.0,395.0,0
TCGA-CM-6169-01,TCGA-CM-6169,COAD,67.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-24564.0,Alive,TUMOR FREE,396.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,396.0,0.0,396.0,nan,nan,0.0,396.0,0
TCGA-CM-6170-01,TCGA-CM-6170,COAD,73.0,FEMALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2010.0,nan,-26663.0,Alive,TUMOR FREE,457.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,457.0,0.0,457.0,nan,nan,0.0,457.0,0
TCGA-CM-6171-01,TCGA-CM-6171,COAD,77.0,FEMALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2010.0,nan,-28307.0,Alive,TUMOR FREE,427.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,427.0,0.0,427.0,nan,nan,0.0,427.0,0
TCGA-CM-6172-01,TCGA-CM-6172,COAD,70.0,FEMALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2010.0,nan,-25902.0,Alive,TUMOR FREE,335.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,335.0,0.0,335.0,nan,nan,0.0,335.0,0
TCGA-CM-6674-01,TCGA-CM-6674,COAD,39.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2011.0,nan,-14368.0,Alive,TUMOR FREE,394.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,394.0,0.0,394.0,nan,nan,0.0,394.0,0
TCGA-CM-6675-01,TCGA-CM-6675,COAD,35.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVB,nan,Colon Adenocarcinoma,nan,2011.0,nan,-12935.0,Alive,WITH TUMOR,397.0,nan,nan,nan,nan,nan,337.0,nan,nan,nan,0.0,397.0,0.0,397.0,nan,nan,1.0,337.0,0
TCGA-CM-6676-01,TCGA-CM-6676,COAD,82.0,MALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2011.0,nan,-30223.0,Alive,TUMOR FREE,337.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,337.0,0.0,337.0,nan,nan,0.0,337.0,0
TCGA-CM-6677-01,TCGA-CM-6677,COAD,75.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2011.0,nan,-27575.0,Alive,TUMOR FREE,337.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,337.0,0.0,337.0,nan,nan,0.0,337.0,0
TCGA-CM-6678-01,TCGA-CM-6678,COAD,63.0,FEMALE,WHITE,Stage IVA,nan,Colon Adenocarcinoma,nan,2011.0,nan,-23070.0,Alive,WITH TUMOR,335.0,nan,nan,Metastatic,nan,nan,0.0,nan,nan,nan,0.0,335.0,0.0,335.0,nan,nan,1.0,0.0,0
TCGA-CM-6679-01,TCGA-CM-6679,COAD,58.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2011.0,nan,-21519.0,Alive,TUMOR FREE,306.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,306.0,0.0,306.0,nan,nan,0.0,306.0,0
TCGA-CM-6680-01,TCGA-CM-6680,COAD,78.0,FEMALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2011.0,nan,-28701.0,Alive,TUMOR FREE,366.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,366.0,0.0,366.0,nan,nan,0.0,366.0,0
TCGA-D5-5537-01,TCGA-D5-5537,COAD,83.0,MALE,WHITE,[Discrepancy],nan,Colon Adenocarcinoma,nan,2010.0,nan,-30505.0,Dead,WITH TUMOR,nan,1381.0,nan,nan,nan,nan,722.0,Complete Remission/Response,nan,nan,1.0,1381.0,1.0,1381.0,1.0,722.0,1.0,722.0,1
TCGA-D5-5538-01,TCGA-D5-5538,COAD,60.0,FEMALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2010.0,nan,-21974.0,Dead,WITH TUMOR,nan,1661.0,nan,nan,nan,nan,1007.0,Progressive Disease,nan,nan,1.0,1661.0,1.0,1661.0,nan,nan,1.0,1007.0,1
TCGA-D5-5539-01,TCGA-D5-5539,COAD,60.0,MALE,WHITE,Stage IIIA,nan,Colon Mucinous Adenocarcinoma,nan,2010.0,nan,-22097.0,Alive,WITH TUMOR,596.0,nan,nan,nan,nan,nan,579.0,nan,nan,nan,0.0,596.0,0.0,596.0,nan,nan,1.0,579.0,0
TCGA-D5-5540-01,TCGA-D5-5540,COAD,73.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-26972.0,Alive,TUMOR FREE,1706.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1706.0,0.0,1706.0,0.0,1706.0,0.0,1706.0,0
TCGA-D5-5541-01,TCGA-D5-5541,COAD,63.0,MALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2010.0,nan,-23109.0,Alive,TUMOR FREE,1701.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1701.0,0.0,1701.0,0.0,1701.0,0.0,1701.0,0
TCGA-D5-6529-01,TCGA-D5-6529,COAD,69.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-25394.0,Alive,WITH TUMOR,614.0,nan,nan,nan,nan,nan,386.0,nan,nan,nan,0.0,614.0,0.0,614.0,nan,nan,1.0,386.0,0
TCGA-D5-6530-01,TCGA-D5-6530,COAD,53.0,MALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2010.0,nan,-19591.0,Alive,TUMOR FREE,621.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,621.0,0.0,621.0,nan,nan,0.0,621.0,0
TCGA-D5-6531-01,TCGA-D5-6531,COAD,75.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-27633.0,Alive,TUMOR FREE,540.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,540.0,0.0,540.0,nan,nan,0.0,540.0,0
TCGA-D5-6532-01,TCGA-D5-6532,COAD,61.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-22344.0,Alive,TUMOR FREE,555.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,555.0,0.0,555.0,nan,nan,0.0,555.0,0
TCGA-D5-6533-01,TCGA-D5-6533,COAD,68.0,FEMALE,WHITE,[Discrepancy],nan,Colon Adenocarcinoma,nan,2010.0,nan,-24971.0,Alive,TUMOR FREE,775.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,775.0,0.0,775.0,0.0,775.0,0.0,775.0,0
TCGA-D5-6534-01,TCGA-D5-6534,COAD,62.0,FEMALE,WHITE,Stage IIA,nan,Colon Mucinous Adenocarcinoma,nan,2010.0,nan,-22778.0,Alive,TUMOR FREE,1316.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1316.0,0.0,1316.0,0.0,1316.0,0.0,1316.0,0
TCGA-D5-6535-01,TCGA-D5-6535,COAD,80.0,FEMALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2010.0,nan,-29278.0,Alive,TUMOR FREE,460.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,460.0,0.0,460.0,nan,nan,0.0,460.0,0
TCGA-D5-6536-01,TCGA-D5-6536,COAD,73.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-26890.0,Alive,WITH TUMOR,543.0,nan,nan,Locoregional Disease,nan,nan,493.0,nan,nan,nan,0.0,543.0,0.0,543.0,nan,nan,1.0,493.0,0
TCGA-D5-6537-01,TCGA-D5-6537,COAD,64.0,MALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2010.0,nan,-23381.0,Dead,WITH TUMOR,nan,146.0,nan,nan,nan,nan,123.0,nan,nan,nan,1.0,146.0,1.0,146.0,nan,nan,1.0,123.0,1
TCGA-D5-6538-01,TCGA-D5-6538,COAD,79.0,FEMALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2010.0,nan,-29194.0,Alive,TUMOR FREE,521.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,521.0,0.0,521.0,nan,nan,0.0,521.0,0
TCGA-D5-6539-01,TCGA-D5-6539,COAD,45.0,FEMALE,WHITE,[Discrepancy],nan,Colon Adenocarcinoma,nan,2010.0,nan,-16703.0,Alive,TUMOR FREE,380.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,380.0,0.0,380.0,nan,nan,0.0,380.0,0
TCGA-D5-6540-01,TCGA-D5-6540,COAD,66.0,MALE,WHITE,Stage I,nan,Colon Mucinous Adenocarcinoma,nan,2010.0,nan,-24282.0,Alive,TUMOR FREE,491.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,491.0,0.0,491.0,nan,nan,0.0,491.0,0
TCGA-D5-6541-01,TCGA-D5-6541,COAD,49.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-18029.0,Alive,TUMOR FREE,474.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,474.0,0.0,474.0,nan,nan,0.0,474.0,0
TCGA-D5-6898-01,TCGA-D5-6898,COAD,51.0,FEMALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2011.0,nan,-18874.0,Alive,TUMOR FREE,229.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,229.0,0.0,229.0,nan,nan,0.0,229.0,0
TCGA-D5-6920-01,TCGA-D5-6920,COAD,77.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2011.0,nan,-28124.0,Alive,TUMOR FREE,377.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,377.0,0.0,377.0,nan,nan,0.0,377.0,0
TCGA-D5-6922-01,TCGA-D5-6922,COAD,76.0,MALE,WHITE,Stage IIIA,nan,Colon Adenocarcinoma,nan,2011.0,nan,-27771.0,Alive,TUMOR FREE,308.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,308.0,0.0,308.0,nan,nan,0.0,308.0,0
TCGA-D5-6923-01,TCGA-D5-6923,COAD,57.0,MALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2011.0,nan,-21118.0,Alive,TUMOR FREE,378.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,378.0,0.0,378.0,nan,nan,0.0,378.0,0
TCGA-D5-6924-01,TCGA-D5-6924,COAD,68.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2011.0,nan,-24964.0,Alive,TUMOR FREE,435.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,435.0,0.0,435.0,nan,nan,0.0,435.0,0
TCGA-D5-6926-01,TCGA-D5-6926,COAD,65.0,MALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2011.0,nan,-23768.0,Alive,TUMOR FREE,275.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,275.0,0.0,275.0,nan,nan,0.0,275.0,0
TCGA-D5-6927-01,TCGA-D5-6927,COAD,34.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2011.0,nan,-12737.0,Alive,TUMOR FREE,287.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,287.0,0.0,287.0,nan,nan,0.0,287.0,0
TCGA-D5-6928-01,TCGA-D5-6928,COAD,80.0,MALE,WHITE,Stage IIA,nan,Colon Mucinous Adenocarcinoma,nan,2011.0,nan,-29411.0,Alive,TUMOR FREE,354.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,354.0,0.0,354.0,nan,nan,0.0,354.0,0
TCGA-D5-6929-01,TCGA-D5-6929,COAD,49.0,FEMALE,WHITE,Stage IV,nan,Colon Adenocarcinoma,nan,2011.0,nan,-17919.0,Alive,TUMOR FREE,408.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,408.0,0.0,408.0,nan,nan,0.0,408.0,0
TCGA-D5-6930-01,TCGA-D5-6930,COAD,67.0,MALE,WHITE,Stage IIA,nan,Colon Mucinous Adenocarcinoma,nan,2011.0,nan,-24764.0,Alive,TUMOR FREE,406.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,406.0,0.0,406.0,nan,nan,0.0,406.0,0
TCGA-D5-6931-01,TCGA-D5-6931,COAD,77.0,MALE,WHITE,Stage IIIC,nan,Colon Adenocarcinoma,nan,2011.0,nan,-28292.0,Alive,TUMOR FREE,365.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,365.0,0.0,365.0,nan,nan,0.0,365.0,0
TCGA-D5-6932-01,TCGA-D5-6932,COAD,69.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2011.0,nan,-25466.0,Alive,TUMOR FREE,346.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,346.0,0.0,346.0,nan,nan,0.0,346.0,0
TCGA-D5-7000-01,TCGA-D5-7000,COAD,79.0,FEMALE,WHITE,Stage I,nan,Colon Mucinous Adenocarcinoma,nan,2011.0,nan,-28913.0,Alive,TUMOR FREE,312.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,312.0,0.0,312.0,nan,nan,0.0,312.0,0
TCGA-DM-A0X9-01,TCGA-DM-A0X9,COAD,71.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2001.0,nan,-26217.0,Alive,nan,3641.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3641.0,0.0,3641.0,nan,nan,0.0,3641.0,0
TCGA-DM-A0XD-01,TCGA-DM-A0XD,COAD,65.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2000.0,nan,-23966.0,Dead,nan,nan,743.0,nan,nan,nan,nan,484.0,nan,nan,nan,1.0,743.0,nan,743.0,nan,nan,1.0,484.0,1
TCGA-DM-A0XF-01,TCGA-DM-A0XF,COAD,68.0,FEMALE,WHITE,Stage IIIC,nan,[Discrepancy],nan,1999.0,nan,-25032.0,Dead,nan,nan,1162.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1162.0,nan,1162.0,nan,nan,0.0,1162.0,1
TCGA-DM-A1D0-01,TCGA-DM-A1D0,COAD,79.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2001.0,nan,-28875.0,Alive,nan,3974.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3974.0,0.0,3974.0,nan,nan,0.0,3974.0,0
TCGA-DM-A1D4-01,TCGA-DM-A1D4,COAD,80.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,1999.0,nan,-29403.0,Dead,nan,2821.0,2821.0,nan,nan,nan,nan,1920.0,nan,nan,nan,1.0,2821.0,nan,2821.0,nan,nan,1.0,1920.0,1
TCGA-DM-A1D6-01,TCGA-DM-A1D6,COAD,88.0,MALE,WHITE,Stage IIA,nan,Colon Mucinous Adenocarcinoma,nan,2000.0,nan,-32302.0,Dead,nan,1518.0,1518.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1518.0,nan,1518.0,nan,nan,0.0,1518.0,1
TCGA-DM-A1D7-01,TCGA-DM-A1D7,COAD,82.0,MALE,WHITE,Stage IIA,nan,[Discrepancy],nan,2000.0,nan,-30142.0,Dead,nan,nan,405.0,nan,nan,nan,nan,80.0,nan,nan,nan,1.0,405.0,nan,405.0,nan,nan,1.0,80.0,1
TCGA-DM-A1D8-01,TCGA-DM-A1D8,COAD,50.0,FEMALE,WHITE,nan,nan,Colon Adenocarcinoma,nan,2000.0,nan,-18311.0,Dead,nan,383.0,383.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,383.0,nan,383.0,nan,nan,0.0,383.0,1
TCGA-DM-A1D9-01,TCGA-DM-A1D9,COAD,67.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2000.0,nan,-24514.0,Alive,nan,4270.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4270.0,0.0,4270.0,nan,nan,0.0,4270.0,0
TCGA-DM-A1DA-01,TCGA-DM-A1DA,COAD,71.0,FEMALE,WHITE,Stage IIIC,nan,Colon Adenocarcinoma,nan,1999.0,nan,-26169.0,Dead,nan,228.0,228.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,228.0,nan,228.0,nan,nan,0.0,228.0,1
TCGA-DM-A1DB-01,TCGA-DM-A1DB,COAD,68.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2000.0,nan,-24888.0,Dead,nan,1348.0,1348.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1348.0,nan,1348.0,nan,nan,0.0,1348.0,1
TCGA-DM-A1HA-01,TCGA-DM-A1HA,COAD,82.0,MALE,WHITE,Stage IIIC,nan,Colon Adenocarcinoma,nan,2000.0,nan,-30272.0,Alive,nan,4000.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4000.0,0.0,4000.0,nan,nan,0.0,4000.0,0
TCGA-DM-A1HB-01,TCGA-DM-A1HB,COAD,75.0,MALE,WHITE,Stage IIIB,nan,[Discrepancy],nan,2000.0,nan,-27708.0,Alive,nan,4126.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4126.0,0.0,4126.0,nan,nan,0.0,4126.0,0
TCGA-DM-A280-01,TCGA-DM-A280,COAD,70.0,FEMALE,WHITE,Stage IIA,nan,Colon Mucinous Adenocarcinoma,nan,1998.0,nan,-25649.0,Dead,nan,236.0,236.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,236.0,nan,236.0,nan,nan,0.0,236.0,1
TCGA-DM-A282-01,TCGA-DM-A282,COAD,60.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2000.0,nan,-22265.0,Alive,nan,4233.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4233.0,0.0,4233.0,nan,nan,0.0,4233.0,0
TCGA-DM-A285-01,TCGA-DM-A285,COAD,71.0,FEMALE,WHITE,Stage IV,nan,Colon Mucinous Adenocarcinoma,nan,2001.0,nan,-26021.0,Dead,nan,nan,179.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,179.0,nan,179.0,nan,nan,0.0,179.0,1
TCGA-DM-A288-01,TCGA-DM-A288,COAD,68.0,MALE,WHITE,Stage IIIC,nan,Colon Mucinous Adenocarcinoma,nan,2001.0,nan,-25084.0,Dead,nan,427.0,427.0,nan,nan,nan,nan,320.0,nan,nan,nan,1.0,427.0,nan,427.0,nan,nan,1.0,320.0,1
TCGA-DM-A28A-01,TCGA-DM-A28A,COAD,78.0,MALE,WHITE,Stage IIIC,nan,Colon Adenocarcinoma,nan,2001.0,nan,-28833.0,Dead,nan,805.0,805.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,805.0,nan,805.0,nan,nan,0.0,805.0,1
TCGA-DM-A28C-01,TCGA-DM-A28C,COAD,74.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2001.0,nan,-27073.0,Dead,nan,2475.0,2475.0,nan,nan,nan,nan,1929.0,nan,nan,nan,1.0,2475.0,nan,2475.0,nan,nan,1.0,1929.0,1
TCGA-DM-A28E-01,TCGA-DM-A28E,COAD,72.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2001.0,nan,-26602.0,Alive,nan,3648.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3648.0,0.0,3648.0,nan,nan,0.0,3648.0,0
TCGA-DM-A28F-01,TCGA-DM-A28F,COAD,73.0,MALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2002.0,nan,-26856.0,Dead,nan,1094.0,1094.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1094.0,nan,1094.0,nan,nan,0.0,1094.0,1
TCGA-DM-A28G-01,TCGA-DM-A28G,COAD,75.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2001.0,nan,-27641.0,Dead,nan,1849.0,1849.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1849.0,nan,1849.0,nan,nan,0.0,1849.0,1
TCGA-DM-A28H-01,TCGA-DM-A28H,COAD,50.0,MALE,WHITE,Stage IIIC,nan,Colon Adenocarcinoma,nan,2002.0,nan,-18325.0,Alive,nan,3561.0,nan,nan,Locoregional Disease,nan,nan,484.0,nan,nan,nan,0.0,3561.0,0.0,3561.0,nan,nan,1.0,484.0,0
TCGA-DM-A28K-01,TCGA-DM-A28K,COAD,75.0,MALE,WHITE,Stage IIA,nan,Colon Mucinous Adenocarcinoma,nan,2003.0,nan,-27428.0,Alive,nan,2988.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2988.0,0.0,2988.0,nan,nan,0.0,2988.0,0
TCGA-DM-A28M-01,TCGA-DM-A28M,COAD,63.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2003.0,nan,-23043.0,Alive,nan,2895.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2895.0,0.0,2895.0,nan,nan,0.0,2895.0,0
TCGA-F4-6459-01,TCGA-F4-6459,COAD,61.0,FEMALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2011.0,nan,-22574.0,Dead,TUMOR FREE,nan,262.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,262.0,0.0,262.0,nan,nan,0.0,262.0,0
TCGA-F4-6460-01,TCGA-F4-6460,COAD,51.0,FEMALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2011.0,nan,-18637.0,Dead,WITH TUMOR,nan,972.0,nan,nan,nan,nan,313.0,Complete Remission/Response,nan,nan,1.0,972.0,1.0,972.0,1.0,313.0,1.0,313.0,1
TCGA-F4-6461-01,TCGA-F4-6461,COAD,41.0,FEMALE,WHITE,Stage IIIC,nan,Colon Adenocarcinoma,nan,2011.0,nan,-15151.0,Dead,WITH TUMOR,nan,338.0,nan,nan,nan,nan,288.0,nan,nan,nan,1.0,338.0,1.0,338.0,nan,nan,1.0,288.0,1
TCGA-F4-6463-01,TCGA-F4-6463,COAD,51.0,MALE,WHITE,Stage IIA,nan,Colon Mucinous Adenocarcinoma,nan,2011.0,nan,-18804.0,Alive,TUMOR FREE,1087.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1087.0,0.0,1087.0,0.0,1087.0,0.0,1087.0,0
TCGA-F4-6569-01,TCGA-F4-6569,COAD,60.0,MALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2011.0,nan,-22203.0,Alive,TUMOR FREE,1087.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1087.0,0.0,1087.0,0.0,1087.0,0.0,1087.0,0
TCGA-F4-6570-01,TCGA-F4-6570,COAD,78.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2011.0,nan,-28772.0,Dead,TUMOR FREE,nan,188.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,188.0,0.0,188.0,nan,nan,0.0,188.0,0
TCGA-F4-6703-01,TCGA-F4-6703,COAD,64.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2011.0,nan,-23644.0,Alive,TUMOR FREE,1456.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1456.0,0.0,1456.0,0.0,1456.0,0.0,1456.0,0
TCGA-F4-6704-01,TCGA-F4-6704,COAD,60.0,MALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage IIIC,nan,Colon Mucinous Adenocarcinoma,nan,2011.0,nan,-21949.0,Alive,TUMOR FREE,47.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,47.0,0.0,47.0,nan,nan,0.0,47.0,0
TCGA-F4-6704-11,TCGA-F4-6704,COAD,60.0,MALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage IIIC,nan,Colon Mucinous Adenocarcinoma,nan,2011.0,nan,-21949.0,Alive,TUMOR FREE,47.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,47.0,0.0,47.0,nan,nan,0.0,47.0,0
TCGA-F4-6805-01,TCGA-F4-6805,COAD,58.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2011.0,nan,-21241.0,Alive,TUMOR FREE,1047.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1047.0,0.0,1047.0,0.0,1047.0,0.0,1047.0,0
TCGA-F4-6806-01,TCGA-F4-6806,COAD,59.0,FEMALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2011.0,nan,-21625.0,Alive,WITH TUMOR,1260.0,nan,nan,Metastatic,nan,nan,336.0,Complete Remission/Response,nan,nan,0.0,1260.0,0.0,1260.0,1.0,336.0,1.0,336.0,2
TCGA-F4-6807-01,TCGA-F4-6807,COAD,51.0,FEMALE,WHITE,Stage IIIC,nan,Colon Adenocarcinoma,nan,2011.0,nan,-18690.0,Alive,TUMOR FREE,1309.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1309.0,0.0,1309.0,0.0,1309.0,0.0,1309.0,0
TCGA-F4-6808-01,TCGA-F4-6808,COAD,54.0,FEMALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2011.0,nan,-19803.0,Alive,TUMOR FREE,1024.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1024.0,0.0,1024.0,0.0,1024.0,0.0,1024.0,0
TCGA-F4-6809-01,TCGA-F4-6809,COAD,52.0,FEMALE,WHITE,Stage IVA,nan,Colon Adenocarcinoma,nan,2011.0,nan,-19039.0,Dead,WITH TUMOR,nan,403.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,403.0,1.0,403.0,nan,nan,1.0,403.0,1
TCGA-F4-6854-01,TCGA-F4-6854,COAD,77.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2011.0,nan,-28272.0,Alive,TUMOR FREE,16.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,16.0,0.0,16.0,0.0,16.0,0.0,16.0,0
TCGA-F4-6855-01,TCGA-F4-6855,COAD,70.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2011.0,nan,-25890.0,Alive,TUMOR FREE,1442.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1442.0,0.0,1442.0,0.0,1442.0,0.0,1442.0,0
TCGA-F4-6856-01,TCGA-F4-6856,COAD,45.0,MALE,WHITE,Stage I,nan,Colon Mucinous Adenocarcinoma,nan,2011.0,nan,-16519.0,Alive,TUMOR FREE,1074.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1074.0,0.0,1074.0,0.0,1074.0,0.0,1074.0,0
TCGA-G4-6293-01,TCGA-G4-6293,COAD,49.0,FEMALE,WHITE,Stage III,nan,Colon Adenocarcinoma,nan,2002.0,nan,-18076.0,Alive,TUMOR FREE,4051.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4051.0,0.0,4051.0,0.0,4051.0,0.0,4051.0,0
TCGA-G4-6294-01,TCGA-G4-6294,COAD,75.0,MALE,WHITE,Stage IV,nan,Colon Adenocarcinoma,nan,2004.0,nan,-27755.0,Dead,WITH TUMOR,nan,858.0,nan,nan,nan,nan,517.0,nan,nan,nan,1.0,858.0,1.0,858.0,nan,nan,1.0,517.0,1
TCGA-G4-6295-01,TCGA-G4-6295,COAD,70.0,FEMALE,WHITE,Stage II,nan,Colon Adenocarcinoma,nan,2004.0,nan,-25758.0,Alive,TUMOR FREE,254.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,254.0,0.0,254.0,nan,nan,0.0,254.0,0
TCGA-G4-6295-11,TCGA-G4-6295,COAD,70.0,FEMALE,WHITE,Stage II,nan,Colon Adenocarcinoma,nan,2004.0,nan,-25758.0,Alive,TUMOR FREE,254.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,254.0,0.0,254.0,nan,nan,0.0,254.0,0
TCGA-G4-6297-01,TCGA-G4-6297,COAD,55.0,FEMALE,WHITE,Stage IV,nan,Colon Adenocarcinoma,nan,2005.0,nan,-20103.0,Alive,WITH TUMOR,2506.0,nan,nan,nan,nan,nan,439.0,nan,nan,nan,0.0,2506.0,0.0,2506.0,nan,nan,1.0,439.0,1
TCGA-G4-6297-11,TCGA-G4-6297,COAD,55.0,FEMALE,WHITE,Stage IV,nan,Colon Adenocarcinoma,nan,2005.0,nan,-20103.0,Alive,WITH TUMOR,2506.0,nan,nan,nan,nan,nan,439.0,nan,nan,nan,0.0,2506.0,0.0,2506.0,nan,nan,1.0,439.0,1
TCGA-G4-6298-01,TCGA-G4-6298,COAD,90.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,nan,Colon Adenocarcinoma,nan,2005.0,nan,-32873.0,Dead,WITH TUMOR,nan,715.0,nan,nan,nan,nan,291.0,nan,nan,nan,1.0,715.0,1.0,715.0,nan,nan,1.0,291.0,1
TCGA-G4-6298-11,TCGA-G4-6298,COAD,90.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,nan,Colon Adenocarcinoma,nan,2005.0,nan,-32873.0,Dead,WITH TUMOR,nan,715.0,nan,nan,nan,nan,291.0,nan,nan,nan,1.0,715.0,1.0,715.0,nan,nan,1.0,291.0,1
TCGA-G4-6299-01,TCGA-G4-6299,COAD,69.0,MALE,WHITE,Stage IIIC,nan,Colon Adenocarcinoma,nan,2005.0,nan,-25318.0,Alive,TUMOR FREE,2268.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2268.0,0.0,2268.0,nan,nan,0.0,2268.0,0
TCGA-G4-6302-01,TCGA-G4-6302,COAD,90.0,FEMALE,WHITE,Stage IIA,nan,Colon Mucinous Adenocarcinoma,nan,2006.0,nan,-32872.0,Dead,TUMOR FREE,nan,2047.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2047.0,0.0,2047.0,nan,nan,0.0,2047.0,1
TCGA-G4-6302-11,TCGA-G4-6302,COAD,90.0,FEMALE,WHITE,Stage IIA,nan,Colon Mucinous Adenocarcinoma,nan,2006.0,nan,-32872.0,Dead,TUMOR FREE,nan,2047.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2047.0,0.0,2047.0,nan,nan,0.0,2047.0,1
TCGA-G4-6303-01,TCGA-G4-6303,COAD,54.0,FEMALE,WHITE,Stage IV,nan,Colon Adenocarcinoma,nan,2006.0,nan,-19800.0,Dead,WITH TUMOR,nan,2003.0,nan,nan,nan,nan,872.0,nan,nan,nan,1.0,2003.0,1.0,2003.0,nan,nan,1.0,872.0,1
TCGA-G4-6304-01,TCGA-G4-6304,COAD,66.0,FEMALE,WHITE,Stage IIB,nan,Colon Adenocarcinoma,nan,2006.0,nan,-24172.0,Alive,TUMOR FREE,1631.0,nan,nan,nan,nan,nan,859.0,nan,nan,nan,0.0,1631.0,0.0,1631.0,nan,nan,1.0,859.0,0
TCGA-G4-6306-01,TCGA-G4-6306,COAD,71.0,MALE,WHITE,[Discrepancy],nan,Colon Adenocarcinoma,nan,2007.0,nan,-26163.0,Alive,TUMOR FREE,1359.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1359.0,0.0,1359.0,nan,nan,0.0,1359.0,0
TCGA-G4-6307-01,TCGA-G4-6307,COAD,37.0,FEMALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2007.0,nan,-13648.0,Alive,TUMOR FREE,1674.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1674.0,0.0,1674.0,nan,nan,0.0,1674.0,0
TCGA-G4-6309-01,TCGA-G4-6309,COAD,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,nan,Colon Adenocarcinoma,nan,2007.0,nan,-14729.0,Alive,TUMOR FREE,2600.0,nan,nan,nan,nan,nan,2176.0,Complete Remission/Response,nan,nan,0.0,2600.0,0.0,2600.0,1.0,2176.0,1.0,2176.0,2
TCGA-G4-6310-01,TCGA-G4-6310,COAD,69.0,MALE,WHITE,Stage IIIB,nan,Colon Adenocarcinoma,nan,2008.0,nan,-25243.0,Alive,TUMOR FREE,1935.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1935.0,0.0,1935.0,0.0,1935.0,0.0,1935.0,0
TCGA-G4-6311-01,TCGA-G4-6311,COAD,80.0,MALE,WHITE,Stage III,nan,Colon Adenocarcinoma,nan,2008.0,nan,-29297.0,Alive,TUMOR FREE,1199.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1199.0,0.0,1199.0,nan,nan,0.0,1199.0,0
TCGA-G4-6311-11,TCGA-G4-6311,COAD,80.0,MALE,WHITE,Stage III,nan,Colon Adenocarcinoma,nan,2008.0,nan,-29297.0,Alive,TUMOR FREE,1199.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1199.0,0.0,1199.0,nan,nan,0.0,1199.0,0
TCGA-G4-6314-01,TCGA-G4-6314,COAD,76.0,FEMALE,WHITE,Stage IV,nan,Colon Adenocarcinoma,nan,2008.0,nan,-27958.0,Alive,WITH TUMOR,1093.0,nan,nan,nan,nan,nan,38.0,nan,nan,nan,0.0,1093.0,0.0,1093.0,nan,nan,1.0,38.0,1
TCGA-G4-6314-11,TCGA-G4-6314,COAD,76.0,FEMALE,WHITE,Stage IV,nan,Colon Adenocarcinoma,nan,2008.0,nan,-27958.0,Alive,WITH TUMOR,1093.0,nan,nan,nan,nan,nan,38.0,nan,nan,nan,0.0,1093.0,0.0,1093.0,nan,nan,1.0,38.0,1
TCGA-G4-6315-01,TCGA-G4-6315,COAD,66.0,MALE,WHITE,Stage IV,nan,Colon Adenocarcinoma,nan,2008.0,nan,-24174.0,Alive,TUMOR FREE,1883.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1883.0,0.0,1883.0,nan,nan,0.0,1883.0,0
TCGA-G4-6317-02,TCGA-G4-6317,COAD,51.0,FEMALE,WHITE,Stage IIIC,nan,Colon Adenocarcinoma,nan,2008.0,nan,-18822.0,Alive,TUMOR FREE,1095.0,nan,nan,Metastatic,nan,nan,592.0,nan,nan,nan,0.0,1095.0,0.0,1095.0,nan,nan,1.0,592.0,0
TCGA-G4-6317-01,TCGA-G4-6317,COAD,51.0,FEMALE,WHITE,Stage IIIC,nan,Colon Adenocarcinoma,nan,2008.0,nan,-18822.0,Alive,TUMOR FREE,1095.0,nan,nan,Metastatic,nan,nan,592.0,nan,nan,nan,0.0,1095.0,0.0,1095.0,nan,nan,1.0,592.0,0
TCGA-G4-6320-01,TCGA-G4-6320,COAD,73.0,MALE,WHITE,Stage III,nan,Colon Adenocarcinoma,nan,2009.0,nan,-26840.0,Alive,TUMOR FREE,804.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,804.0,0.0,804.0,nan,nan,0.0,804.0,0
TCGA-G4-6320-11,TCGA-G4-6320,COAD,73.0,MALE,WHITE,Stage III,nan,Colon Adenocarcinoma,nan,2009.0,nan,-26840.0,Alive,TUMOR FREE,804.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,804.0,0.0,804.0,nan,nan,0.0,804.0,0
TCGA-G4-6321-01,TCGA-G4-6321,COAD,60.0,FEMALE,WHITE,Stage III,nan,Colon Adenocarcinoma,nan,2009.0,nan,-21921.0,Alive,TUMOR FREE,672.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,672.0,0.0,672.0,nan,nan,0.0,672.0,0
TCGA-G4-6322-01,TCGA-G4-6322,COAD,65.0,MALE,WHITE,Stage IIIB,nan,Colon Mucinous Adenocarcinoma,nan,2009.0,nan,-23825.0,Alive,WITH TUMOR,792.0,nan,nan,nan,nan,nan,789.0,nan,nan,nan,0.0,792.0,0.0,792.0,nan,nan,1.0,789.0,2
TCGA-G4-6322-11,TCGA-G4-6322,COAD,65.0,MALE,WHITE,Stage IIIB,nan,Colon Mucinous Adenocarcinoma,nan,2009.0,nan,-23825.0,Alive,WITH TUMOR,792.0,nan,nan,nan,nan,nan,789.0,nan,nan,nan,0.0,792.0,0.0,792.0,nan,nan,1.0,789.0,2
TCGA-G4-6323-01,TCGA-G4-6323,COAD,50.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Colon Adenocarcinoma,nan,2010.0,nan,-18334.0,Alive,TUMOR FREE,419.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,419.0,0.0,419.0,nan,nan,0.0,419.0,0
TCGA-G4-6586-01,TCGA-G4-6586,COAD,73.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2008.0,nan,-27020.0,Alive,TUMOR FREE,1089.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1089.0,0.0,1089.0,nan,nan,0.0,1089.0,0
TCGA-G4-6588-01,TCGA-G4-6588,COAD,58.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2009.0,nan,-21532.0,Alive,TUMOR FREE,796.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,796.0,0.0,796.0,nan,nan,0.0,796.0,0
TCGA-G4-6625-01,TCGA-G4-6625,COAD,77.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2004.0,nan,-28163.0,Alive,TUMOR FREE,2792.0,nan,nan,nan,nan,nan,2564.0,nan,nan,nan,0.0,2792.0,0.0,2792.0,nan,nan,1.0,2564.0,0
TCGA-G4-6625-11,TCGA-G4-6625,COAD,77.0,FEMALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2004.0,nan,-28163.0,Alive,TUMOR FREE,2792.0,nan,nan,nan,nan,nan,2564.0,nan,nan,nan,0.0,2792.0,0.0,2792.0,nan,nan,1.0,2564.0,0
TCGA-G4-6626-01,TCGA-G4-6626,COAD,90.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2006.0,nan,-32871.0,Dead,TUMOR FREE,nan,1422.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1422.0,0.0,1422.0,nan,nan,0.0,1422.0,0
TCGA-G4-6627-01,TCGA-G4-6627,COAD,84.0,MALE,WHITE,Stage IIA,nan,Colon Adenocarcinoma,nan,2007.0,nan,-30697.0,Alive,TUMOR FREE,2275.0,nan,nan,nan,nan,nan,1003.0,Complete Remission/Response,nan,nan,0.0,2275.0,0.0,2275.0,1.0,1003.0,1.0,1003.0,0
TCGA-G4-6628-01,TCGA-G4-6628,COAD,78.0,MALE,WHITE,Stage I,nan,Colon Adenocarcinoma,nan,2006.0,nan,-28772.0,Alive,TUMOR FREE,2424.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2424.0,0.0,2424.0,0.0,2424.0,0.0,2424.0,0
TCGA-NH-A50T-01,TCGA-NH-A50T,COAD,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2012.0,nan,-25089.0,Alive,TUMOR FREE,553.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,553.0,0.0,553.0,0.0,553.0,0.0,553.0,0
TCGA-NH-A50U-01,TCGA-NH-A50U,COAD,42.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,nan,Colon Mucinous Adenocarcinoma,nan,2012.0,nan,-15450.0,Dead,WITH TUMOR,nan,334.0,nan,nan,nan,nan,276.0,Partial Remission/Response,nan,nan,1.0,334.0,1.0,334.0,nan,nan,1.0,276.0,1
TCGA-NH-A50V-01,TCGA-NH-A50V,COAD,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,nan,Colon Adenocarcinoma,nan,2012.0,nan,-25467.0,Alive,TUMOR FREE,588.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,588.0,0.0,588.0,0.0,588.0,0.0,588.0,0
TCGA-NH-A5IV-01,TCGA-NH-A5IV,COAD,90.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2012.0,nan,-32872.0,Alive,TUMOR FREE,588.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,588.0,0.0,588.0,0.0,588.0,0.0,588.0,0
TCGA-NH-A6GA-01,TCGA-NH-A6GA,COAD,58.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,nan,Colon Adenocarcinoma,nan,2013.0,nan,-21313.0,Dead,WITH TUMOR,nan,302.0,nan,nan,nan,nan,6.0,Progressive Disease,nan,nan,1.0,302.0,1.0,302.0,nan,nan,1.0,6.0,1
TCGA-NH-A6GB-01,TCGA-NH-A6GB,COAD,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,nan,Colon Adenocarcinoma,nan,2013.0,nan,-26100.0,Alive,WITH TUMOR,476.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,476.0,0.0,476.0,nan,nan,0.0,476.0,0
TCGA-NH-A6GC-01,TCGA-NH-A6GC,COAD,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVB,nan,Colon Mucinous Adenocarcinoma,nan,2013.0,nan,-24355.0,Alive,nan,389.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,389.0,0.0,389.0,nan,nan,0.0,389.0,0
TCGA-NH-A8F7-06,TCGA-NH-A8F7,COAD,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2013.0,nan,-19535.0,Alive,WITH TUMOR,543.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,543.0,0.0,543.0,nan,nan,0.0,543.0,0
TCGA-NH-A8F7-01,TCGA-NH-A8F7,COAD,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2013.0,nan,-19535.0,Alive,WITH TUMOR,543.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,543.0,0.0,543.0,nan,nan,0.0,543.0,0
TCGA-NH-A8F8-01,TCGA-NH-A8F8,COAD,79.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Colon Adenocarcinoma,nan,2013.0,nan,-29185.0,Dead,WITH TUMOR,nan,511.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,511.0,1.0,511.0,nan,nan,1.0,511.0,1
TCGA-QG-A5YV-01,TCGA-QG-A5YV,COAD,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,nan,Colon Adenocarcinoma,nan,2011.0,nan,-23499.0,Alive,TUMOR FREE,1301.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1301.0,0.0,1301.0,0.0,1301.0,0.0,1301.0,0
TCGA-QG-A5YW-01,TCGA-QG-A5YW,COAD,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,nan,Colon Mucinous Adenocarcinoma,nan,2011.0,nan,-20391.0,Alive,TUMOR FREE,896.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,896.0,0.0,896.0,0.0,896.0,0.0,896.0,0
TCGA-QG-A5YX-01,TCGA-QG-A5YX,COAD,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2011.0,nan,-22617.0,Alive,TUMOR FREE,1003.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1003.0,0.0,1003.0,0.0,1003.0,0.0,1003.0,0
TCGA-QG-A5Z1-01,TCGA-QG-A5Z1,COAD,71.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,nan,Colon Adenocarcinoma,nan,2011.0,nan,-26220.0,Dead,TUMOR FREE,nan,256.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,256.0,0.0,256.0,nan,nan,0.0,256.0,0
TCGA-QG-A5Z2-01,TCGA-QG-A5Z2,COAD,61.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Colon Adenocarcinoma,nan,2012.0,nan,-22367.0,Alive,TUMOR FREE,952.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,952.0,0.0,952.0,0.0,952.0,0.0,952.0,0
TCGA-QL-A97D-01,TCGA-QL-A97D,COAD,84.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Colon Adenocarcinoma,nan,2012.0,nan,-30914.0,Alive,TUMOR FREE,666.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,666.0,0.0,666.0,0.0,666.0,0.0,666.0,0
TCGA-RU-A8FL-01,TCGA-RU-A8FL,COAD,51.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,nan,Colon Adenocarcinoma,nan,2011.0,nan,-18975.0,Alive,WITH TUMOR,1177.0,nan,nan,Metastatic,nan,nan,256.0,Partial Remission/Response,nan,nan,0.0,1177.0,0.0,1177.0,nan,nan,1.0,256.0,0
TCGA-SS-A7HO-01,TCGA-SS-A7HO,COAD,44.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Colon Adenocarcinoma,nan,2010.0,nan,-16416.0,Alive,WITH TUMOR,1829.0,nan,nan,Locoregional Disease,nan,nan,506.0,Complete Remission/Response,nan,nan,0.0,1829.0,0.0,1829.0,1.0,506.0,1.0,506.0,2
TCGA-T9-A92H-01,TCGA-T9-A92H,COAD,82.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Colon Adenocarcinoma,nan,2013.0,nan,-30058.0,Alive,WITH TUMOR,362.0,nan,nan,nan,nan,nan,81.0,Complete Remission/Response,nan,nan,0.0,362.0,0.0,362.0,1.0,81.0,1.0,81.0,2
TCGA-WS-AB45-01,TCGA-WS-AB45,COAD,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Colon Mucinous Adenocarcinoma,nan,2008.0,nan,nan,Alive,TUMOR FREE,2130.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2130.0,0.0,2130.0,0.0,2130.0,0.0,2130.0,0
TCGA-FA-8693-01,TCGA-FA-8693,DLBC,75.0,MALE,WHITE,nan,Stage I,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2012.0,nan,-27468.0,Alive,TUMOR FREE,132.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,132.0,0.0,132.0,0.0,132.0,0.0,132.0,0
TCGA-FA-A4BB-01,TCGA-FA-A4BB,DLBC,67.0,MALE,WHITE,nan,Stage IV,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2012.0,nan,-24590.0,Alive,TUMOR FREE,132.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,132.0,0.0,132.0,nan,nan,0.0,132.0,0
TCGA-FA-A4XK-01,TCGA-FA-A4XK,DLBC,40.0,MALE,ASIAN,nan,Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2012.0,nan,-14723.0,Dead,TUMOR FREE,nan,708.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,708.0,0.0,708.0,0.0,708.0,0.0,708.0,0
TCGA-FA-A6HN-01,TCGA-FA-A6HN,DLBC,73.0,MALE,ASIAN,nan,nan,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2013.0,nan,-27025.0,Dead,TUMOR FREE,nan,58.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,58.0,0.0,58.0,nan,nan,0.0,58.0,0
TCGA-FA-A6HO-01,TCGA-FA-A6HO,DLBC,58.0,FEMALE,ASIAN,nan,nan,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2013.0,nan,-21330.0,Alive,WITH TUMOR,749.0,nan,nan,nan,Paraaortic lymph nodes,nan,739.0,Complete Remission/Response,nan,nan,0.0,749.0,0.0,749.0,1.0,739.0,1.0,739.0,2
TCGA-FA-A7DS-01,TCGA-FA-A7DS,DLBC,54.0,FEMALE,ASIAN,nan,Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2013.0,nan,-20087.0,Alive,TUMOR FREE,719.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,719.0,0.0,719.0,0.0,719.0,0.0,719.0,0
TCGA-FA-A7Q1-01,TCGA-FA-A7Q1,DLBC,61.0,FEMALE,ASIAN,nan,Stage I,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2013.0,nan,-22454.0,Dead,TUMOR FREE,nan,248.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,248.0,0.0,248.0,0.0,248.0,0.0,248.0,0
TCGA-FA-A82F-01,TCGA-FA-A82F,DLBC,48.0,FEMALE,ASIAN,nan,Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2013.0,nan,-17819.0,Alive,TUMOR FREE,427.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,427.0,0.0,427.0,0.0,427.0,0.0,427.0,0
TCGA-FA-A86F-01,TCGA-FA-A86F,DLBC,64.0,FEMALE,WHITE,nan,Stage III,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2013.0,nan,-23641.0,Alive,WITH TUMOR,553.0,nan,nan,nan,"Other, specify","Inguinal, mediastinal, submandibular, hilar",150.0,Partial Remission/Response,nan,nan,0.0,553.0,0.0,553.0,nan,nan,1.0,150.0,2
TCGA-FF-8041-01,TCGA-FF-8041,DLBC,28.0,FEMALE,ASIAN,nan,Stage I,Primary mediastinal (thymic) DLBCL,nan,2010.0,nan,-10466.0,Alive,TUMOR FREE,1081.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1081.0,0.0,1081.0,0.0,1081.0,0.0,1081.0,0
TCGA-FF-8042-01,TCGA-FF-8042,DLBC,57.0,FEMALE,ASIAN,nan,Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2010.0,nan,-21005.0,Alive,TUMOR FREE,946.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,946.0,0.0,946.0,0.0,946.0,0.0,946.0,0
TCGA-FF-8043-01,TCGA-FF-8043,DLBC,70.0,FEMALE,ASIAN,nan,Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2010.0,nan,-25612.0,Alive,TUMOR FREE,965.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,965.0,0.0,965.0,0.0,965.0,0.0,965.0,0
TCGA-FF-8046-01,TCGA-FF-8046,DLBC,51.0,MALE,ASIAN,nan,Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2011.0,nan,-18853.0,Alive,TUMOR FREE,751.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,751.0,0.0,751.0,0.0,751.0,0.0,751.0,0
TCGA-FF-8047-01,TCGA-FF-8047,DLBC,38.0,FEMALE,ASIAN,nan,Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2011.0,nan,-13996.0,Alive,WITH TUMOR,126.0,nan,nan,nan,Leptomeninges,nan,24.0,Progressive Disease,nan,nan,0.0,126.0,0.0,126.0,nan,nan,1.0,24.0,2
TCGA-FF-8061-01,TCGA-FF-8061,DLBC,42.0,MALE,ASIAN,nan,Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2010.0,nan,-15358.0,Alive,TUMOR FREE,832.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,832.0,0.0,832.0,0.0,832.0,0.0,832.0,0
TCGA-FF-8062-01,TCGA-FF-8062,DLBC,60.0,FEMALE,ASIAN,nan,Stage I,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2011.0,nan,-21959.0,Alive,TUMOR FREE,679.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,679.0,0.0,679.0,0.0,679.0,0.0,679.0,0
TCGA-FF-A7CQ-01,TCGA-FF-A7CQ,DLBC,74.0,MALE,ASIAN,nan,Stage IV,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2010.0,nan,-27255.0,Alive,nan,298.0,nan,nan,nan,Brain,nan,255.0,Stable Disease,nan,nan,0.0,298.0,0.0,298.0,nan,nan,1.0,255.0,0
TCGA-FF-A7CR-01,TCGA-FF-A7CR,DLBC,61.0,MALE,ASIAN,nan,Stage IV,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2012.0,nan,-22471.0,Dead,WITH TUMOR,nan,313.0,nan,nan,"Other, specify",Skin (Calf and Chest wall),290.0,Progressive Disease,nan,nan,1.0,313.0,1.0,313.0,nan,nan,1.0,290.0,1
TCGA-FF-A7CW-01,TCGA-FF-A7CW,DLBC,72.0,MALE,ASIAN,nan,Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2012.0,nan,-26520.0,Alive,TUMOR FREE,791.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,791.0,0.0,791.0,0.0,791.0,0.0,791.0,0
TCGA-FF-A7CX-01,TCGA-FF-A7CX,DLBC,46.0,MALE,ASIAN,nan,Stage IV,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2011.0,nan,-16924.0,Alive,TUMOR FREE,385.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,385.0,0.0,385.0,nan,nan,0.0,385.0,0
TCGA-FM-8000-01,TCGA-FM-8000,DLBC,70.0,FEMALE,WHITE,nan,Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2011.0,nan,-25724.0,Alive,TUMOR FREE,972.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,972.0,0.0,972.0,0.0,972.0,0.0,972.0,0
TCGA-G8-6324-01,TCGA-G8-6324,DLBC,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IV,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2006.0,nan,-15750.0,Dead,WITH TUMOR,nan,1252.0,nan,nan,Supraclavicular lymph nodes,nan,338.0,Complete Remission/Response,nan,nan,1.0,1252.0,1.0,1252.0,nan,nan,1.0,338.0,1
TCGA-G8-6325-01,TCGA-G8-6325,DLBC,69.0,MALE,WHITE,nan,Stage IV,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2008.0,nan,-25256.0,Alive,TUMOR FREE,1581.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1581.0,0.0,1581.0,nan,nan,0.0,1581.0,0
TCGA-G8-6326-01,TCGA-G8-6326,DLBC,52.0,MALE,WHITE,nan,Stage IV,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2009.0,nan,-19238.0,Alive,TUMOR FREE,2131.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,2131.0,0.0,2131.0,nan,nan,0.0,2131.0,0
TCGA-G8-6906-01,TCGA-G8-6906,DLBC,58.0,MALE,WHITE,nan,nan,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,1987.0,nan,-21272.0,Dead,TUMOR FREE,nan,6425.0,nan,nan,nan,nan,6383.0,Complete Remission/Response,nan,nan,1.0,6425.0,0.0,6425.0,1.0,6383.0,1.0,6383.0,0
TCGA-G8-6907-01,TCGA-G8-6907,DLBC,57.0,FEMALE,WHITE,nan,Stage IV,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2000.0,nan,-21021.0,Dead,WITH TUMOR,nan,595.0,nan,nan,Ovary,nan,279.0,Stable Disease,nan,nan,1.0,595.0,1.0,595.0,nan,nan,1.0,279.0,1
TCGA-G8-6909-01,TCGA-G8-6909,DLBC,67.0,MALE,WHITE,nan,Stage III,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2002.0,nan,-24661.0,Dead,TUMOR FREE,nan,3553.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,3553.0,0.0,3553.0,0.0,3553.0,0.0,3553.0,0
TCGA-G8-6914-01,TCGA-G8-6914,DLBC,67.0,MALE,WHITE,nan,Stage III,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,1996.0,nan,-24569.0,Alive,TUMOR FREE,5980.0,nan,nan,nan,nan,nan,3669.0,Complete Remission/Response,nan,nan,0.0,5980.0,0.0,5980.0,1.0,3669.0,1.0,3669.0,0
TCGA-GR-7351-01,TCGA-GR-7351,DLBC,56.0,FEMALE,WHITE,nan,Stage I,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2001.0,nan,-20812.0,Alive,TUMOR FREE,4578.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4578.0,0.0,4578.0,0.0,4578.0,0.0,4578.0,0
TCGA-GR-7353-01,TCGA-GR-7353,DLBC,36.0,MALE,WHITE,nan,Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2005.0,nan,-13317.0,Alive,TUMOR FREE,2983.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2983.0,0.0,2983.0,0.0,2983.0,0.0,2983.0,0
TCGA-GR-A4D4-01,TCGA-GR-A4D4,DLBC,57.0,FEMALE,WHITE,nan,Stage IV,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2010.0,nan,-20888.0,Alive,TUMOR FREE,1581.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1581.0,0.0,1581.0,nan,nan,0.0,1581.0,0
TCGA-GR-A4D5-01,TCGA-GR-A4D5,DLBC,46.0,FEMALE,WHITE,nan,Stage IV,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2010.0,nan,-17023.0,Alive,TUMOR FREE,1299.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1299.0,0.0,1299.0,nan,nan,0.0,1299.0,0
TCGA-GR-A4D6-01,TCGA-GR-A4D6,DLBC,54.0,FEMALE,ASIAN,nan,Stage I,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2010.0,nan,-19838.0,Alive,TUMOR FREE,1334.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1334.0,0.0,1334.0,0.0,1334.0,0.0,1334.0,0
TCGA-GR-A4D9-01,TCGA-GR-A4D9,DLBC,66.0,FEMALE,WHITE,nan,Stage IV,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2009.0,nan,-24405.0,Alive,WITH TUMOR,1739.0,nan,nan,nan,Soft Tissue,nan,1218.0,Complete Remission/Response,nan,nan,0.0,1739.0,0.0,1739.0,nan,nan,1.0,1218.0,2
TCGA-GS-A9TQ-01,TCGA-GS-A9TQ,DLBC,69.0,FEMALE,WHITE,nan,Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2012.0,nan,-25292.0,Alive,TUMOR FREE,982.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,982.0,0.0,982.0,0.0,982.0,0.0,982.0,0
TCGA-GS-A9TT-01,TCGA-GS-A9TT,DLBC,70.0,MALE,WHITE,nan,Stage IV,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2011.0,nan,-25794.0,Alive,TUMOR FREE,1163.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1163.0,0.0,1163.0,nan,nan,0.0,1163.0,0
TCGA-GS-A9TU-01,TCGA-GS-A9TU,DLBC,45.0,MALE,WHITE,nan,Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2004.0,nan,-16720.0,Alive,TUMOR FREE,3897.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3897.0,0.0,3897.0,0.0,3897.0,0.0,3897.0,0
TCGA-GS-A9TV-01,TCGA-GS-A9TV,DLBC,40.0,FEMALE,WHITE,nan,Stage II,Primary mediastinal (thymic) DLBCL,nan,2013.0,nan,-14838.0,Alive,TUMOR FREE,730.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,730.0,0.0,730.0,0.0,730.0,0.0,730.0,0
TCGA-GS-A9TW-01,TCGA-GS-A9TW,DLBC,23.0,FEMALE,WHITE,nan,Stage II,Primary mediastinal (thymic) DLBCL,nan,2010.0,nan,-8493.0,Alive,TUMOR FREE,1617.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1617.0,0.0,1617.0,0.0,1617.0,0.0,1617.0,0
TCGA-GS-A9TX-01,TCGA-GS-A9TX,DLBC,37.0,MALE,WHITE,nan,Stage I,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2011.0,nan,-13708.0,Alive,TUMOR FREE,1373.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1373.0,0.0,1373.0,0.0,1373.0,0.0,1373.0,0
TCGA-GS-A9TY-01,TCGA-GS-A9TY,DLBC,82.0,FEMALE,WHITE,nan,Stage I,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2005.0,nan,-30256.0,Alive,WITH TUMOR,3333.0,nan,nan,nan,Pleura/Pleural effusion,nan,3255.0,Complete Remission/Response,nan,nan,0.0,3333.0,0.0,3333.0,1.0,3255.0,1.0,3255.0,2
TCGA-GS-A9TZ-01,TCGA-GS-A9TZ,DLBC,51.0,MALE,WHITE,nan,Stage II,Primary mediastinal (thymic) DLBCL,nan,2012.0,nan,-18691.0,Alive,TUMOR FREE,765.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,765.0,0.0,765.0,nan,nan,0.0,765.0,0
TCGA-GS-A9U3-01,TCGA-GS-A9U3,DLBC,77.0,FEMALE,WHITE,nan,Stage III,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2005.0,nan,-28474.0,Alive,TUMOR FREE,3394.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3394.0,0.0,3394.0,0.0,3394.0,0.0,3394.0,0
TCGA-GS-A9U4-01,TCGA-GS-A9U4,DLBC,27.0,FEMALE,WHITE,nan,Stage II,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2011.0,nan,-10075.0,Dead,WITH TUMOR,nan,391.0,nan,nan,Cervical Lymph Nodes,nan,106.0,Progressive Disease,nan,nan,1.0,391.0,1.0,391.0,nan,nan,1.0,106.0,1
TCGA-RQ-A68N-01,TCGA-RQ-A68N,DLBC,63.0,MALE,WHITE,nan,nan,Primary DLBCL of the CNS,nan,2012.0,nan,-23127.0,Alive,TUMOR FREE,788.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,788.0,0.0,788.0,nan,nan,0.0,788.0,0
TCGA-RQ-A6JB-01,TCGA-RQ-A6JB,DLBC,62.0,FEMALE,WHITE,nan,nan,Primary DLBCL of the CNS,nan,2011.0,nan,-22859.0,Alive,nan,1.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1.0,0.0,1.0,nan,nan,0.0,1.0,0
TCGA-RQ-AAAT-01,TCGA-RQ-AAAT,DLBC,63.0,FEMALE,WHITE,nan,nan,Primary DLBCL of the CNS,nan,2013.0,nan,-23178.0,Alive,TUMOR FREE,17.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,17.0,0.0,17.0,0.0,17.0,0.0,17.0,0
TCGA-VB-A8QN-01,TCGA-VB-A8QN,DLBC,55.0,MALE,WHITE,nan,Stage III,Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal),nan,2013.0,nan,-20270.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-2H-A9GF-01,TCGA-2H-A9GF,ESCA,67.0,MALE,[Unknown],Stage III,nan,"Esophagus Adenocarcinoma, NOS",G3,2001.0,nan,-24487.0,Dead,WITH TUMOR,nan,784.0,nan,Distant Metastasis,Brain,nan,172.0,nan,nan,nan,1.0,784.0,1.0,784.0,nan,nan,1.0,172.0,1
TCGA-2H-A9GG-01,TCGA-2H-A9GG,ESCA,66.0,MALE,[Unknown],Stage III,nan,"Esophagus Adenocarcinoma, NOS",G2,1999.0,nan,-24328.0,Dead,WITH TUMOR,nan,610.0,nan,Distant Metastasis,Brain,nan,504.0,nan,nan,nan,1.0,610.0,1.0,610.0,nan,nan,1.0,504.0,1
TCGA-2H-A9GH-01,TCGA-2H-A9GH,ESCA,44.0,MALE,[Unknown],Stage IIB,nan,"Esophagus Adenocarcinoma, NOS",G2,1998.0,nan,-16197.0,Dead,WITH TUMOR,nan,951.0,nan,Locoregional Recurrence,nan,nan,800.0,nan,nan,nan,1.0,951.0,1.0,951.0,nan,nan,1.0,800.0,1
TCGA-2H-A9GI-01,TCGA-2H-A9GI,ESCA,68.0,MALE,[Unknown],Stage III,nan,"Esophagus Adenocarcinoma, NOS",G2,1999.0,nan,-25097.0,Dead,WITH TUMOR,nan,435.0,nan,Locoregional Recurrence,nan,nan,400.0,nan,nan,nan,1.0,435.0,1.0,435.0,nan,nan,1.0,400.0,1
TCGA-2H-A9GJ-01,TCGA-2H-A9GJ,ESCA,57.0,MALE,[Unknown],Stage I,nan,"Esophagus Adenocarcinoma, NOS",G2,2000.0,nan,-21180.0,Dead,WITH TUMOR,nan,1781.0,nan,Locoregional Recurrence,nan,nan,1261.0,nan,nan,nan,1.0,1781.0,1.0,1781.0,nan,nan,1.0,1261.0,1
TCGA-2H-A9GK-01,TCGA-2H-A9GK,ESCA,43.0,MALE,[Unknown],Stage III,nan,"Esophagus Adenocarcinoma, NOS",G3,2000.0,nan,-16067.0,Dead,WITH TUMOR,nan,232.0,nan,Distant Metastasis,"Other, specify",Lymph node,113.0,nan,nan,nan,1.0,232.0,1.0,232.0,nan,nan,1.0,113.0,1
TCGA-2H-A9GL-01,TCGA-2H-A9GL,ESCA,74.0,MALE,[Unknown],Stage III,nan,"Esophagus Adenocarcinoma, NOS",G3,2000.0,nan,-27115.0,Dead,WITH TUMOR,nan,180.0,nan,Distant Metastasis,nan,nan,109.0,nan,nan,nan,1.0,180.0,1.0,180.0,nan,nan,1.0,109.0,1
TCGA-2H-A9GM-01,TCGA-2H-A9GM,ESCA,53.0,MALE,[Unknown],Stage IIB,nan,"Esophagus Adenocarcinoma, NOS",G2,2000.0,nan,-19484.0,Dead,WITH TUMOR,nan,424.0,nan,Distant Metastasis,"Other, specify",peritoneum,367.0,nan,nan,nan,1.0,424.0,1.0,424.0,nan,nan,1.0,367.0,1
TCGA-2H-A9GN-01,TCGA-2H-A9GN,ESCA,70.0,MALE,[Unknown],Stage III,nan,"Esophagus Adenocarcinoma, NOS",G3,2000.0,nan,-25664.0,Dead,WITH TUMOR,nan,272.0,nan,Distant Metastasis,Brain,nan,242.0,nan,nan,nan,1.0,272.0,1.0,272.0,nan,nan,1.0,242.0,1
TCGA-2H-A9GO-01,TCGA-2H-A9GO,ESCA,58.0,MALE,[Unknown],Stage IVA,nan,"Esophagus Adenocarcinoma, NOS",G3,2000.0,nan,-21486.0,Dead,WITH TUMOR,nan,494.0,nan,Locoregional Recurrence,nan,nan,362.0,nan,nan,nan,1.0,494.0,1.0,494.0,nan,nan,1.0,362.0,1
TCGA-2H-A9GQ-01,TCGA-2H-A9GQ,ESCA,80.0,MALE,[Unknown],Stage III,nan,"Esophagus Adenocarcinoma, NOS",G3,2001.0,nan,-29497.0,Dead,WITH TUMOR,nan,128.0,nan,Locoregional Recurrence,nan,nan,112.0,nan,nan,nan,1.0,128.0,1.0,128.0,nan,nan,1.0,112.0,1
TCGA-2H-A9GR-01,TCGA-2H-A9GR,ESCA,80.0,MALE,[Unknown],Stage IIA,nan,"Esophagus Adenocarcinoma, NOS",G2,1999.0,nan,-29451.0,Dead,WITH TUMOR,nan,987.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,987.0,1.0,987.0,nan,nan,1.0,987.0,1
TCGA-IC-A6RE-01,TCGA-IC-A6RE,ESCA,59.0,MALE,WHITE,Stage IIB,nan,"Esophagus Adenocarcinoma, NOS",G2,2013.0,nan,-21640.0,Alive,WITH TUMOR,234.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,234.0,0.0,234.0,0.0,234.0,0.0,234.0,0
TCGA-IC-A6RE-11,TCGA-IC-A6RE,ESCA,59.0,MALE,WHITE,Stage IIB,nan,"Esophagus Adenocarcinoma, NOS",G2,2013.0,nan,-21640.0,Alive,WITH TUMOR,234.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,234.0,0.0,234.0,0.0,234.0,0.0,234.0,0
TCGA-IC-A6RF-01,TCGA-IC-A6RF,ESCA,69.0,FEMALE,WHITE,Stage IA,Stage IIB,Esophagus Squamous Cell Carcinoma,GX,2013.0,nan,-25417.0,Alive,TUMOR FREE,477.0,nan,nan,Locoregional Recurrence,"Other, specify",regional lymph nodes,293.0,Complete Remission/Response,nan,nan,0.0,477.0,0.0,477.0,1.0,293.0,1.0,293.0,2
TCGA-IC-A6RF-11,TCGA-IC-A6RF,ESCA,69.0,FEMALE,WHITE,Stage IA,Stage IIB,Esophagus Squamous Cell Carcinoma,GX,2013.0,nan,-25417.0,Alive,TUMOR FREE,477.0,nan,nan,Locoregional Recurrence,"Other, specify",regional lymph nodes,293.0,Complete Remission/Response,nan,nan,0.0,477.0,0.0,477.0,1.0,293.0,1.0,293.0,2
TCGA-IG-A3I8-01,TCGA-IG-A3I8,ESCA,51.0,FEMALE,WHITE,Stage IIA,nan,Esophagus Squamous Cell Carcinoma,G2,2011.0,nan,-18786.0,Alive,TUMOR FREE,1012.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1012.0,0.0,1012.0,0.0,1012.0,0.0,1012.0,0
TCGA-IG-A3I8-11,TCGA-IG-A3I8,ESCA,51.0,FEMALE,WHITE,Stage IIA,nan,Esophagus Squamous Cell Carcinoma,G2,2011.0,nan,-18786.0,Alive,TUMOR FREE,1012.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1012.0,0.0,1012.0,0.0,1012.0,0.0,1012.0,0
TCGA-IG-A3QL-01,TCGA-IG-A3QL,ESCA,54.0,MALE,WHITE,Stage IIA,nan,Esophagus Squamous Cell Carcinoma,G2,2011.0,nan,-19755.0,Alive,TUMOR FREE,1071.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1071.0,0.0,1071.0,0.0,1071.0,0.0,1071.0,0
TCGA-IG-A3Y9-01,TCGA-IG-A3Y9,ESCA,72.0,MALE,WHITE,Stage IIIA,nan,Esophagus Squamous Cell Carcinoma,G2,2012.0,nan,-26330.0,Dead,TUMOR FREE,nan,26.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,26.0,0.0,26.0,0.0,26.0,0.0,26.0,0
TCGA-IG-A3YA-01,TCGA-IG-A3YA,ESCA,53.0,MALE,WHITE,Stage IIIA,nan,Esophagus Squamous Cell Carcinoma,G2,2012.0,nan,-19567.0,Alive,TUMOR FREE,632.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,632.0,0.0,632.0,0.0,632.0,0.0,632.0,0
TCGA-IG-A3YB-01,TCGA-IG-A3YB,ESCA,61.0,MALE,WHITE,Stage IIIA,nan,Esophagus Squamous Cell Carcinoma,G2,2012.0,nan,-22316.0,Alive,TUMOR FREE,80.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,80.0,0.0,80.0,0.0,80.0,0.0,80.0,0
TCGA-IG-A3YC-01,TCGA-IG-A3YC,ESCA,62.0,MALE,WHITE,Stage IIIA,nan,Esophagus Squamous Cell Carcinoma,G2,2012.0,nan,-22774.0,Alive,WITH TUMOR,612.0,nan,nan,New Primary Tumor,Lung,nan,542.0,Stable Disease,nan,nan,0.0,612.0,0.0,612.0,nan,nan,1.0,542.0,2
TCGA-IG-A4P3-01,TCGA-IG-A4P3,ESCA,48.0,MALE,WHITE,Stage IIB,nan,Esophagus Squamous Cell Carcinoma,G2,2012.0,nan,-17860.0,Dead,WITH TUMOR,nan,567.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,567.0,1.0,567.0,nan,nan,1.0,567.0,1
TCGA-IG-A4QS-01,TCGA-IG-A4QS,ESCA,71.0,MALE,WHITE,Stage IIIB,nan,"Esophagus Adenocarcinoma, NOS",G3,2012.0,nan,-26273.0,Dead,TUMOR FREE,nan,118.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,118.0,0.0,118.0,0.0,118.0,0.0,118.0,0
TCGA-IG-A4QT-01,TCGA-IG-A4QT,ESCA,56.0,MALE,WHITE,Stage IIA,nan,Esophagus Squamous Cell Carcinoma,G2,2012.0,nan,-20506.0,Dead,TUMOR FREE,nan,283.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,283.0,0.0,283.0,0.0,283.0,0.0,283.0,0
TCGA-IG-A50L-01,TCGA-IG-A50L,ESCA,58.0,MALE,ASIAN,Stage IIIA,Stage IIIA,Esophagus Squamous Cell Carcinoma,G2,2012.0,nan,-21214.0,Alive,TUMOR FREE,16.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,16.0,0.0,16.0,nan,nan,0.0,16.0,0
TCGA-IG-A51D-01,TCGA-IG-A51D,ESCA,63.0,MALE,WHITE,Stage IIB,Stage IV,Esophagus Squamous Cell Carcinoma,G2,2012.0,nan,-23259.0,Alive,TUMOR FREE,518.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,518.0,0.0,518.0,nan,nan,0.0,518.0,0
TCGA-IG-A5B8-01,TCGA-IG-A5B8,ESCA,72.0,MALE,WHITE,Stage IB,nan,Esophagus Squamous Cell Carcinoma,G1,2012.0,nan,-26574.0,Dead,TUMOR FREE,nan,24.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,24.0,0.0,24.0,nan,nan,0.0,24.0,0
TCGA-IG-A5S3-01,TCGA-IG-A5S3,ESCA,69.0,FEMALE,WHITE,Stage IIB,nan,Esophagus Squamous Cell Carcinoma,G2,2012.0,nan,-25414.0,Alive,TUMOR FREE,712.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,712.0,0.0,712.0,0.0,712.0,0.0,712.0,0
TCGA-IG-A625-01,TCGA-IG-A625,ESCA,60.0,MALE,ASIAN,Stage IIIB,nan,Esophagus Squamous Cell Carcinoma,G2,2012.0,nan,-22070.0,Dead,TUMOR FREE,nan,390.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,390.0,0.0,390.0,nan,nan,0.0,390.0,0
TCGA-IG-A6QS-01,TCGA-IG-A6QS,ESCA,54.0,MALE,WHITE,Stage IIB,nan,Esophagus Squamous Cell Carcinoma,G1,2013.0,nan,-19900.0,Dead,TUMOR FREE,nan,303.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,303.0,0.0,303.0,0.0,303.0,0.0,303.0,0
TCGA-IG-A7DP-01,TCGA-IG-A7DP,ESCA,50.0,FEMALE,WHITE,Stage IIIA,nan,"Esophagus Adenocarcinoma, NOS",G2,2013.0,nan,-18364.0,Alive,TUMOR FREE,452.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,452.0,0.0,452.0,0.0,452.0,0.0,452.0,0
TCGA-IG-A8O2-01,TCGA-IG-A8O2,ESCA,62.0,MALE,ASIAN,Stage IIIB,nan,Esophagus Squamous Cell Carcinoma,G3,2013.0,nan,-22869.0,Dead,TUMOR FREE,nan,142.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,142.0,0.0,142.0,0.0,142.0,0.0,142.0,0
TCGA-IG-A97H-01,TCGA-IG-A97H,ESCA,36.0,MALE,ASIAN,Stage IIA,nan,Esophagus Squamous Cell Carcinoma,G3,2013.0,nan,-13166.0,Alive,TUMOR FREE,441.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,441.0,0.0,441.0,0.0,441.0,0.0,441.0,0
TCGA-IG-A97I-01,TCGA-IG-A97I,ESCA,58.0,MALE,WHITE,Stage IIA,nan,Esophagus Squamous Cell Carcinoma,G2,2013.0,nan,-21271.0,Alive,TUMOR FREE,370.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,370.0,0.0,370.0,0.0,370.0,0.0,370.0,0
TCGA-JY-A6F8-01,TCGA-JY-A6F8,ESCA,56.0,MALE,WHITE,Stage I,nan,"Esophagus Adenocarcinoma, NOS",G1,2003.0,nan,-20550.0,Alive,TUMOR FREE,3714.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3714.0,0.0,3714.0,0.0,3714.0,0.0,3714.0,0
TCGA-JY-A6FA-01,TCGA-JY-A6FA,ESCA,51.0,MALE,ASIAN,Stage IIB,nan,Esophagus Squamous Cell Carcinoma,G2,2006.0,nan,-18978.0,Dead,WITH TUMOR,nan,1361.0,nan,Distant Metastasis,Lung,nan,477.0,nan,nan,nan,1.0,1361.0,1.0,1361.0,nan,nan,1.0,477.0,1
TCGA-JY-A6FB-01,TCGA-JY-A6FB,ESCA,77.0,MALE,WHITE,Stage I,nan,"Esophagus Adenocarcinoma, NOS",G2,2007.0,nan,-28269.0,Alive,TUMOR FREE,1837.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1837.0,0.0,1837.0,0.0,1837.0,0.0,1837.0,0
TCGA-JY-A6FD-01,TCGA-JY-A6FD,ESCA,51.0,FEMALE,ASIAN,Stage IIA,nan,Esophagus Squamous Cell Carcinoma,G1,2008.0,nan,-18808.0,Alive,TUMOR FREE,2069.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2069.0,0.0,2069.0,0.0,2069.0,0.0,2069.0,0
TCGA-JY-A6FE-01,TCGA-JY-A6FE,ESCA,49.0,MALE,WHITE,Stage III,nan,Esophagus Squamous Cell Carcinoma,G3,2009.0,nan,-18105.0,Dead,WITH TUMOR,nan,112.0,nan,Distant Metastasis,"Other, specify",Pleural Mets,55.0,nan,nan,nan,1.0,112.0,1.0,112.0,nan,nan,1.0,55.0,1
TCGA-JY-A6FG-01,TCGA-JY-A6FG,ESCA,50.0,MALE,WHITE,Stage III,nan,Esophagus Squamous Cell Carcinoma,G2,2009.0,nan,-18348.0,Dead,TUMOR FREE,nan,1263.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1263.0,0.0,1263.0,nan,nan,0.0,1263.0,0
TCGA-JY-A6FH-01,TCGA-JY-A6FH,ESCA,53.0,MALE,WHITE,Stage IIB,nan,"Esophagus Adenocarcinoma, NOS",G2,2010.0,nan,-19549.0,Alive,TUMOR FREE,1441.0,nan,nan,Distant Metastasis,Lung,nan,749.0,Progressive Disease,nan,nan,0.0,1441.0,0.0,1441.0,nan,nan,1.0,749.0,0
TCGA-JY-A938-01,TCGA-JY-A938,ESCA,75.0,MALE,WHITE,Stage IIB,nan,"Esophagus Adenocarcinoma, NOS",G3,2012.0,nan,-27633.0,Alive,WITH TUMOR,1060.0,nan,nan,Distant Metastasis,"Other, specify",Adrenal Gland,493.0,Complete Remission/Response,nan,nan,0.0,1060.0,0.0,1060.0,1.0,493.0,1.0,493.0,2
TCGA-JY-A939-01,TCGA-JY-A939,ESCA,77.0,MALE,WHITE,Stage IIB,nan,"Esophagus Adenocarcinoma, NOS",G3,2012.0,nan,-28181.0,Alive,WITH TUMOR,660.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,660.0,0.0,660.0,nan,nan,0.0,660.0,0
TCGA-JY-A93C-01,TCGA-JY-A93C,ESCA,47.0,MALE,ASIAN,Stage IIIB,nan,"Esophagus Adenocarcinoma, NOS",G3,2011.0,nan,-17228.0,Alive,WITH TUMOR,705.0,nan,nan,Locoregional Recurrence,nan,nan,652.0,Complete Remission/Response,nan,nan,0.0,705.0,0.0,705.0,1.0,652.0,1.0,652.0,2
TCGA-JY-A93D-01,TCGA-JY-A93D,ESCA,51.0,MALE,WHITE,Stage IIIC,nan,"Esophagus Adenocarcinoma, NOS",G3,2012.0,nan,-18813.0,Dead,WITH TUMOR,nan,960.0,nan,Locoregional Recurrence,"Other, specify",Mediastinal lymph node,732.0,Complete Remission/Response,nan,nan,1.0,960.0,1.0,960.0,1.0,732.0,1.0,732.0,1
TCGA-JY-A93E-01,TCGA-JY-A93E,ESCA,61.0,MALE,WHITE,Stage IIIA,nan,"Esophagus Adenocarcinoma, NOS",G3,2012.0,nan,-22427.0,Alive,WITH TUMOR,767.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,767.0,0.0,767.0,nan,nan,0.0,767.0,0
TCGA-JY-A93F-01,TCGA-JY-A93F,ESCA,58.0,FEMALE,WHITE,Stage IB,nan,Esophagus Squamous Cell Carcinoma,G1,2012.0,nan,-21257.0,Alive,TUMOR FREE,731.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,731.0,0.0,731.0,0.0,731.0,0.0,731.0,0
TCGA-KH-A6WC-01,TCGA-KH-A6WC,ESCA,82.0,MALE,WHITE,Stage IA,Stage IA,Esophagus Squamous Cell Carcinoma,GX,2013.0,nan,-30167.0,Alive,TUMOR FREE,191.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,191.0,0.0,191.0,0.0,191.0,0.0,191.0,0
TCGA-L5-A43C-01,TCGA-L5-A43C,ESCA,81.0,MALE,WHITE,nan,Stage III,"Esophagus Adenocarcinoma, NOS",GX,2009.0,nan,-29753.0,Alive,TUMOR FREE,96.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,96.0,0.0,96.0,nan,nan,0.0,96.0,0
TCGA-L5-A43C-11,TCGA-L5-A43C,ESCA,81.0,MALE,WHITE,nan,Stage III,"Esophagus Adenocarcinoma, NOS",GX,2009.0,nan,-29753.0,Alive,TUMOR FREE,96.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,96.0,0.0,96.0,nan,nan,0.0,96.0,0
TCGA-L5-A43E-01,TCGA-L5-A43E,ESCA,74.0,MALE,WHITE,Stage I,nan,"Esophagus Adenocarcinoma, NOS",GX,2011.0,nan,-27143.0,Alive,TUMOR FREE,920.0,nan,nan,New Primary Tumor,"Other, specify",Right diaphragm-HG spindle cell sarcoma,885.0,Complete Remission/Response,nan,nan,0.0,920.0,0.0,920.0,0.0,920.0,1.0,885.0,0
TCGA-L5-A43H-01,TCGA-L5-A43H,ESCA,75.0,MALE,WHITE,Stage III,nan,Esophagus Squamous Cell Carcinoma,GX,2011.0,nan,-27592.0,Dead,WITH TUMOR,nan,9.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,9.0,1.0,9.0,nan,nan,1.0,9.0,1
TCGA-L5-A43I-01,TCGA-L5-A43I,ESCA,77.0,MALE,WHITE,Stage IIIA,nan,"Esophagus Adenocarcinoma, NOS",GX,2011.0,nan,-28367.0,Dead,TUMOR FREE,nan,556.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,556.0,0.0,556.0,0.0,556.0,0.0,556.0,0
TCGA-L5-A43J-01,TCGA-L5-A43J,ESCA,90.0,MALE,WHITE,Stage IIB,nan,Esophagus Squamous Cell Carcinoma,G3,2011.0,nan,-32872.0,Dead,WITH TUMOR,nan,131.0,nan,Distant Metastasis,Liver,nan,98.0,Progressive Disease,nan,nan,1.0,131.0,1.0,131.0,nan,nan,1.0,98.0,1
TCGA-L5-A43M-01,TCGA-L5-A43M,ESCA,84.0,FEMALE,[Not Evaluated],[Unknown],nan,"Esophagus Adenocarcinoma, NOS",GX,2009.0,nan,-30783.0,Alive,nan,272.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,272.0,0.0,272.0,nan,nan,0.0,272.0,2
TCGA-L5-A4OE-01,TCGA-L5-A4OE,ESCA,81.0,MALE,WHITE,Stage IIIB,nan,"Esophagus Adenocarcinoma, NOS",G2,2011.0,nan,-29591.0,Dead,nan,nan,730.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,730.0,nan,730.0,0.0,730.0,0.0,730.0,0
TCGA-L5-A4OE-11,TCGA-L5-A4OE,ESCA,81.0,MALE,WHITE,Stage IIIB,nan,"Esophagus Adenocarcinoma, NOS",G2,2011.0,nan,-29591.0,Dead,nan,nan,730.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,730.0,nan,730.0,0.0,730.0,0.0,730.0,0
TCGA-L5-A4OF-01,TCGA-L5-A4OF,ESCA,63.0,MALE,WHITE,Stage IIB,nan,"Esophagus Adenocarcinoma, NOS",G3,2012.0,nan,-23194.0,Dead,nan,nan,801.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,801.0,nan,801.0,0.0,801.0,0.0,801.0,0
TCGA-L5-A4OF-11,TCGA-L5-A4OF,ESCA,63.0,MALE,WHITE,Stage IIB,nan,"Esophagus Adenocarcinoma, NOS",G3,2012.0,nan,-23194.0,Dead,nan,nan,801.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,801.0,nan,801.0,0.0,801.0,0.0,801.0,0
TCGA-L5-A4OG-01,TCGA-L5-A4OG,ESCA,79.0,FEMALE,WHITE,Stage I,nan,"Esophagus Adenocarcinoma, NOS",G1,2012.0,nan,-29105.0,Alive,nan,143.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,143.0,0.0,143.0,nan,nan,0.0,143.0,0
TCGA-L5-A4OG-11,TCGA-L5-A4OG,ESCA,79.0,FEMALE,WHITE,Stage I,nan,"Esophagus Adenocarcinoma, NOS",G1,2012.0,nan,-29105.0,Alive,nan,143.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,143.0,0.0,143.0,nan,nan,0.0,143.0,0
TCGA-L5-A4OH-01,TCGA-L5-A4OH,ESCA,71.0,MALE,WHITE,Stage I,nan,"Esophagus Adenocarcinoma, NOS",GX,2012.0,nan,-26180.0,Alive,TUMOR FREE,992.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,992.0,0.0,992.0,0.0,992.0,0.0,992.0,0
TCGA-L5-A4OH-11,TCGA-L5-A4OH,ESCA,71.0,MALE,WHITE,Stage I,nan,"Esophagus Adenocarcinoma, NOS",GX,2012.0,nan,-26180.0,Alive,TUMOR FREE,992.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,992.0,0.0,992.0,0.0,992.0,0.0,992.0,0
TCGA-L5-A4OI-01,TCGA-L5-A4OI,ESCA,79.0,MALE,WHITE,Stage IIIC,nan,"Esophagus Adenocarcinoma, NOS",G2,2012.0,nan,-29190.0,Alive,WITH TUMOR,608.0,nan,nan,Locoregional Recurrence,"Other, specify",Lymph Node,267.0,Stable Disease,nan,nan,0.0,608.0,0.0,608.0,nan,nan,1.0,267.0,2
TCGA-L5-A4OI-11,TCGA-L5-A4OI,ESCA,79.0,MALE,WHITE,Stage IIIC,nan,"Esophagus Adenocarcinoma, NOS",G2,2012.0,nan,-29190.0,Alive,WITH TUMOR,608.0,nan,nan,Locoregional Recurrence,"Other, specify",Lymph Node,267.0,Stable Disease,nan,nan,0.0,608.0,0.0,608.0,nan,nan,1.0,267.0,2
TCGA-L5-A4OJ-01,TCGA-L5-A4OJ,ESCA,70.0,FEMALE,WHITE,Stage I,nan,"Esophagus Adenocarcinoma, NOS",G3,2012.0,nan,-25657.0,Alive,TUMOR FREE,639.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,639.0,0.0,639.0,0.0,639.0,0.0,639.0,0
TCGA-L5-A4OJ-11,TCGA-L5-A4OJ,ESCA,70.0,FEMALE,WHITE,Stage I,nan,"Esophagus Adenocarcinoma, NOS",G3,2012.0,nan,-25657.0,Alive,TUMOR FREE,639.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,639.0,0.0,639.0,0.0,639.0,0.0,639.0,0
TCGA-L5-A4OM-01,TCGA-L5-A4OM,ESCA,54.0,FEMALE,WHITE,Stage IA,nan,Esophagus Squamous Cell Carcinoma,GX,2010.0,nan,-19845.0,Dead,TUMOR FREE,nan,1458.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1458.0,0.0,1458.0,0.0,1458.0,0.0,1458.0,0
TCGA-L5-A4OM-11,TCGA-L5-A4OM,ESCA,54.0,FEMALE,WHITE,Stage IA,nan,Esophagus Squamous Cell Carcinoma,GX,2010.0,nan,-19845.0,Dead,TUMOR FREE,nan,1458.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1458.0,0.0,1458.0,0.0,1458.0,0.0,1458.0,0
TCGA-L5-A4ON-01,TCGA-L5-A4ON,ESCA,65.0,MALE,WHITE,Stage IIB,nan,"Esophagus Adenocarcinoma, NOS",GX,2010.0,nan,-23970.0,Dead,TUMOR FREE,nan,558.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,558.0,0.0,558.0,0.0,558.0,0.0,558.0,0
TCGA-L5-A4ON-11,TCGA-L5-A4ON,ESCA,65.0,MALE,WHITE,Stage IIB,nan,"Esophagus Adenocarcinoma, NOS",GX,2010.0,nan,-23970.0,Dead,TUMOR FREE,nan,558.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,558.0,0.0,558.0,0.0,558.0,0.0,558.0,0
TCGA-L5-A4OO-01,TCGA-L5-A4OO,ESCA,75.0,MALE,WHITE,Stage IIIC,nan,"Esophagus Adenocarcinoma, NOS",G2,2010.0,nan,-27757.0,Alive,nan,101.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,101.0,0.0,101.0,nan,nan,0.0,101.0,0
TCGA-L5-A4OO-11,TCGA-L5-A4OO,ESCA,75.0,MALE,WHITE,Stage IIIC,nan,"Esophagus Adenocarcinoma, NOS",G2,2010.0,nan,-27757.0,Alive,nan,101.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,101.0,0.0,101.0,nan,nan,0.0,101.0,0
TCGA-L5-A4OP-01,TCGA-L5-A4OP,ESCA,67.0,FEMALE,WHITE,Stage IA,nan,"Esophagus Adenocarcinoma, NOS",G2,2010.0,nan,-24829.0,Alive,TUMOR FREE,218.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,218.0,0.0,218.0,nan,nan,0.0,218.0,0
TCGA-L5-A4OP-11,TCGA-L5-A4OP,ESCA,67.0,FEMALE,WHITE,Stage IA,nan,"Esophagus Adenocarcinoma, NOS",G2,2010.0,nan,-24829.0,Alive,TUMOR FREE,218.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,218.0,0.0,218.0,nan,nan,0.0,218.0,0
TCGA-L5-A4OQ-01,TCGA-L5-A4OQ,ESCA,75.0,MALE,WHITE,Stage IIIA,nan,"Esophagus Adenocarcinoma, NOS",GX,2010.0,nan,-27565.0,Dead,WITH TUMOR,nan,42.0,nan,Distant Metastasis,Brain,nan,29.0,nan,nan,nan,1.0,42.0,1.0,42.0,nan,nan,1.0,29.0,1
TCGA-L5-A4OQ-11,TCGA-L5-A4OQ,ESCA,75.0,MALE,WHITE,Stage IIIA,nan,"Esophagus Adenocarcinoma, NOS",GX,2010.0,nan,-27565.0,Dead,WITH TUMOR,nan,42.0,nan,Distant Metastasis,Brain,nan,29.0,nan,nan,nan,1.0,42.0,1.0,42.0,nan,nan,1.0,29.0,1
TCGA-L5-A4OR-01,TCGA-L5-A4OR,ESCA,83.0,MALE,WHITE,Stage IA,nan,"Esophagus Adenocarcinoma, NOS",GX,2010.0,nan,-30417.0,Dead,TUMOR FREE,nan,96.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,96.0,0.0,96.0,0.0,96.0,0.0,96.0,0
TCGA-L5-A4OR-11,TCGA-L5-A4OR,ESCA,83.0,MALE,WHITE,Stage IA,nan,"Esophagus Adenocarcinoma, NOS",GX,2010.0,nan,-30417.0,Dead,TUMOR FREE,nan,96.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,96.0,0.0,96.0,0.0,96.0,0.0,96.0,0
TCGA-L5-A4OS-01,TCGA-L5-A4OS,ESCA,86.0,FEMALE,WHITE,Stage IIB,nan,"Esophagus Adenocarcinoma, NOS",G3,2010.0,nan,-31601.0,Alive,TUMOR FREE,1782.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1782.0,0.0,1782.0,nan,nan,0.0,1782.0,0
TCGA-L5-A4OT-01,TCGA-L5-A4OT,ESCA,77.0,MALE,WHITE,Stage IV,nan,"Esophagus Adenocarcinoma, NOS",GX,2006.0,nan,-28162.0,Dead,WITH TUMOR,nan,149.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,149.0,1.0,149.0,nan,nan,1.0,149.0,1
TCGA-L5-A4OU-01,TCGA-L5-A4OU,ESCA,81.0,MALE,WHITE,Stage IIA,nan,"Esophagus Adenocarcinoma, NOS",GX,2009.0,nan,-29674.0,Alive,TUMOR FREE,882.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,882.0,0.0,882.0,nan,nan,0.0,882.0,0
TCGA-L5-A4OW-01,TCGA-L5-A4OW,ESCA,56.0,FEMALE,[Not Evaluated],Stage IIB,nan,"Esophagus Adenocarcinoma, NOS",GX,2006.0,nan,-20796.0,Dead,TUMOR FREE,nan,217.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,217.0,0.0,217.0,0.0,217.0,0.0,217.0,0
TCGA-L5-A4OX-01,TCGA-L5-A4OX,ESCA,60.0,MALE,WHITE,Stage IIB,nan,"Esophagus Adenocarcinoma, NOS",GX,2006.0,nan,-22015.0,Dead,TUMOR FREE,nan,226.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,226.0,0.0,226.0,0.0,226.0,0.0,226.0,0
TCGA-L5-A88S-01,TCGA-L5-A88S,ESCA,84.0,MALE,WHITE,Stage IB,nan,Esophagus Squamous Cell Carcinoma,GX,2013.0,nan,-30954.0,Alive,TUMOR FREE,471.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,471.0,0.0,471.0,0.0,471.0,0.0,471.0,0
TCGA-L5-A88T-01,TCGA-L5-A88T,ESCA,86.0,MALE,WHITE,Stage IIB,nan,"Esophagus Adenocarcinoma, NOS",GX,2012.0,nan,-31480.0,Alive,TUMOR FREE,694.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,694.0,0.0,694.0,0.0,694.0,0.0,694.0,0
TCGA-L5-A88V-01,TCGA-L5-A88V,ESCA,60.0,MALE,WHITE,Stage III,nan,"Esophagus Adenocarcinoma, NOS",GX,2007.0,nan,-22066.0,Alive,TUMOR FREE,79.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,79.0,0.0,79.0,nan,nan,0.0,79.0,0
TCGA-L5-A88W-01,TCGA-L5-A88W,ESCA,67.0,MALE,WHITE,Stage IIA,nan,Esophagus Squamous Cell Carcinoma,GX,2007.0,nan,-24716.0,Dead,WITH TUMOR,nan,764.0,nan,Distant Metastasis,Liver,nan,315.0,nan,nan,nan,1.0,764.0,1.0,764.0,nan,nan,1.0,315.0,1
TCGA-L5-A88Y-01,TCGA-L5-A88Y,ESCA,76.0,MALE,WHITE,[Unknown],nan,"Esophagus Adenocarcinoma, NOS",GX,2006.0,nan,-28061.0,Alive,nan,11.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,11.0,0.0,11.0,nan,nan,0.0,11.0,0
TCGA-L5-A88Z-01,TCGA-L5-A88Z,ESCA,70.0,FEMALE,WHITE,Stage IIA,nan,Esophagus Squamous Cell Carcinoma,GX,2005.0,nan,-25890.0,Alive,TUMOR FREE,225.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,225.0,0.0,225.0,nan,nan,0.0,225.0,0
TCGA-L5-A891-01,TCGA-L5-A891,ESCA,51.0,MALE,WHITE,[Unknown],nan,"Esophagus Adenocarcinoma, NOS",GX,2005.0,nan,-18925.0,Alive,TUMOR FREE,114.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,114.0,0.0,114.0,nan,nan,0.0,114.0,0
TCGA-L5-A893-01,TCGA-L5-A893,ESCA,71.0,FEMALE,WHITE,Stage I,nan,"Esophagus Adenocarcinoma, NOS",GX,2005.0,nan,-26143.0,Alive,TUMOR FREE,92.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,92.0,0.0,92.0,nan,nan,0.0,92.0,0
TCGA-L5-A8NE-01,TCGA-L5-A8NE,ESCA,77.0,MALE,WHITE,Stage IIB,nan,"Esophagus Adenocarcinoma, NOS",GX,2000.0,nan,-28243.0,Alive,TUMOR FREE,1688.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1688.0,0.0,1688.0,nan,nan,0.0,1688.0,0
TCGA-L5-A8NF-01,TCGA-L5-A8NF,ESCA,57.0,MALE,WHITE,Stage IVA,nan,"Esophagus Adenocarcinoma, NOS",GX,2001.0,nan,-21134.0,Dead,TUMOR FREE,nan,81.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,81.0,0.0,81.0,nan,nan,0.0,81.0,0
TCGA-L5-A8NG-01,TCGA-L5-A8NG,ESCA,77.0,MALE,WHITE,Stage III,nan,"Esophagus Adenocarcinoma, NOS",GX,2001.0,nan,-28219.0,Alive,TUMOR FREE,1094.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1094.0,0.0,1094.0,nan,nan,0.0,1094.0,0
TCGA-L5-A8NH-01,TCGA-L5-A8NH,ESCA,54.0,MALE,WHITE,Stage IV,nan,"Esophagus Adenocarcinoma, NOS",GX,2001.0,nan,-19991.0,Dead,TUMOR FREE,nan,393.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,393.0,0.0,393.0,nan,nan,0.0,393.0,0
TCGA-L5-A8NI-01,TCGA-L5-A8NI,ESCA,79.0,MALE,WHITE,Stage III,nan,"Esophagus Adenocarcinoma, NOS",G3,2004.0,nan,-29135.0,Dead,WITH TUMOR,nan,410.0,nan,Locoregional Recurrence,nan,nan,401.0,nan,nan,nan,1.0,410.0,1.0,410.0,nan,nan,1.0,401.0,1
TCGA-L5-A8NJ-01,TCGA-L5-A8NJ,ESCA,77.0,MALE,WHITE,Stage III,nan,"Esophagus Adenocarcinoma, NOS",GX,2000.0,nan,-28200.0,Alive,WITH TUMOR,501.0,nan,nan,Distant Metastasis,Lung,nan,396.0,[Unknown],nan,nan,0.0,501.0,0.0,501.0,nan,nan,1.0,396.0,2
TCGA-L5-A8NK-01,TCGA-L5-A8NK,ESCA,84.0,FEMALE,WHITE,Stage IIA,nan,Esophagus Squamous Cell Carcinoma,G1,2004.0,nan,-30719.0,Alive,WITH TUMOR,412.0,nan,nan,Locoregional Recurrence,nan,nan,325.0,[Unknown],nan,nan,0.0,412.0,0.0,412.0,nan,nan,1.0,325.0,2
TCGA-L5-A8NL-01,TCGA-L5-A8NL,ESCA,56.0,MALE,WHITE,Stage III,nan,"Esophagus Adenocarcinoma, NOS",GX,2004.0,nan,-20542.0,Alive,TUMOR FREE,402.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,402.0,0.0,402.0,nan,nan,0.0,402.0,0
TCGA-L5-A8NM-01,TCGA-L5-A8NM,ESCA,84.0,FEMALE,WHITE,Stage IIB,nan,"Esophagus Adenocarcinoma, NOS",GX,2004.0,nan,-30936.0,Dead,TUMOR FREE,nan,236.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,236.0,0.0,236.0,nan,nan,0.0,236.0,1
TCGA-L5-A8NN-01,TCGA-L5-A8NN,ESCA,81.0,MALE,WHITE,Stage III,nan,"Esophagus Adenocarcinoma, NOS",GX,2004.0,nan,-29891.0,Alive,nan,167.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,167.0,0.0,167.0,nan,nan,0.0,167.0,0
TCGA-L5-A8NQ-01,TCGA-L5-A8NQ,ESCA,71.0,MALE,WHITE,Stage IIA,nan,Esophagus Squamous Cell Carcinoma,G3,2001.0,nan,-26250.0,Dead,WITH TUMOR,nan,650.0,nan,Locoregional Recurrence,nan,nan,337.0,nan,nan,nan,1.0,650.0,1.0,650.0,nan,nan,1.0,337.0,1
TCGA-L5-A8NR-01,TCGA-L5-A8NR,ESCA,81.0,FEMALE,[Not Evaluated],Stage III,nan,"Esophagus Adenocarcinoma, NOS",GX,2001.0,nan,-29730.0,Alive,WITH TUMOR,265.0,nan,nan,Distant Metastasis,Liver,nan,265.0,[Unknown],nan,nan,0.0,265.0,0.0,265.0,nan,nan,1.0,265.0,2
TCGA-L5-A8NS-01,TCGA-L5-A8NS,ESCA,76.0,MALE,WHITE,Stage IIB,nan,"Esophagus Adenocarcinoma, NOS",GX,2001.0,nan,-27800.0,Alive,WITH TUMOR,408.0,nan,nan,Distant Metastasis,Lung,nan,300.0,[Unknown],nan,nan,0.0,408.0,0.0,408.0,nan,nan,1.0,300.0,2
TCGA-L5-A8NT-01,TCGA-L5-A8NT,ESCA,69.0,MALE,WHITE,Stage IIB,nan,"Esophagus Adenocarcinoma, NOS",GX,2001.0,nan,-25259.0,Alive,WITH TUMOR,825.0,nan,nan,Distant Metastasis,Liver,nan,825.0,[Unknown],nan,nan,0.0,825.0,0.0,825.0,nan,nan,1.0,825.0,2
TCGA-L5-A8NU-01,TCGA-L5-A8NU,ESCA,84.0,MALE,WHITE,Stage IIA,nan,"Esophagus Adenocarcinoma, NOS",G3,2001.0,nan,-30738.0,Dead,TUMOR FREE,nan,2532.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2532.0,0.0,2532.0,nan,nan,0.0,2532.0,0
TCGA-L5-A8NV-01,TCGA-L5-A8NV,ESCA,75.0,MALE,WHITE,Stage IIA,nan,"Esophagus Adenocarcinoma, NOS",G3,2001.0,nan,-27546.0,Dead,WITH TUMOR,nan,1599.0,nan,Locoregional Recurrence,nan,nan,1252.0,nan,nan,nan,1.0,1599.0,1.0,1599.0,nan,nan,1.0,1252.0,1
TCGA-L5-A8NW-01,TCGA-L5-A8NW,ESCA,55.0,MALE,WHITE,[Discrepancy],nan,"Esophagus Adenocarcinoma, NOS",GX,2001.0,nan,-20194.0,Dead,WITH TUMOR,nan,1402.0,nan,Locoregional Recurrence,nan,nan,1147.0,nan,nan,nan,1.0,1402.0,1.0,1402.0,nan,nan,1.0,1147.0,1
TCGA-L7-A56G-01,TCGA-L7-A56G,ESCA,65.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Esophagus Squamous Cell Carcinoma,G3,2012.0,nan,-24106.0,Dead,WITH TUMOR,nan,330.0,nan,Distant Metastasis,Lung,nan,270.0,Stable Disease,nan,nan,1.0,330.0,1.0,330.0,nan,nan,1.0,270.0,1
TCGA-L7-A6VZ-01,TCGA-L7-A6VZ,ESCA,62.0,MALE,WHITE,Stage IIIC,nan,"Esophagus Adenocarcinoma, NOS",G2,2013.0,nan,-22730.0,Alive,TUMOR FREE,315.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,315.0,0.0,315.0,0.0,315.0,0.0,315.0,0
TCGA-LN-A49K-01,TCGA-LN-A49K,ESCA,66.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G2,2010.0,nan,-24379.0,Dead,TUMOR FREE,nan,180.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,180.0,0.0,180.0,0.0,180.0,0.0,180.0,0
TCGA-LN-A49L-01,TCGA-LN-A49L,ESCA,44.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G2,2010.0,nan,-16164.0,Dead,TUMOR FREE,nan,318.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,318.0,0.0,318.0,0.0,318.0,0.0,318.0,0
TCGA-LN-A49M-01,TCGA-LN-A49M,ESCA,62.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G1,2010.0,nan,-22933.0,Alive,TUMOR FREE,385.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,0
TCGA-LN-A49N-01,TCGA-LN-A49N,ESCA,50.0,MALE,ASIAN,Stage IIB,Stage IIB,Esophagus Squamous Cell Carcinoma,G2,2010.0,nan,-18503.0,Alive,TUMOR FREE,378.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,378.0,0.0,378.0,0.0,378.0,0.0,378.0,0
TCGA-LN-A49O-01,TCGA-LN-A49O,ESCA,47.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G3,2011.0,nan,-17237.0,Alive,WITH TUMOR,408.0,nan,nan,Locoregional Recurrence,nan,nan,193.0,Complete Remission/Response,nan,nan,0.0,408.0,0.0,408.0,1.0,193.0,1.0,193.0,2
TCGA-LN-A49P-01,TCGA-LN-A49P,ESCA,71.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G2,2011.0,nan,-26189.0,Alive,WITH TUMOR,375.0,nan,nan,Locoregional Recurrence,nan,nan,320.0,Complete Remission/Response,nan,nan,0.0,375.0,0.0,375.0,1.0,320.0,1.0,320.0,2
TCGA-LN-A49R-01,TCGA-LN-A49R,ESCA,46.0,MALE,ASIAN,Stage III,Stage III,Esophagus Squamous Cell Carcinoma,G3,2011.0,nan,-17109.0,Alive,TUMOR FREE,407.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,407.0,0.0,407.0,0.0,407.0,0.0,407.0,0
TCGA-LN-A49S-01,TCGA-LN-A49S,ESCA,59.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G2,2011.0,nan,-21865.0,Alive,WITH TUMOR,400.0,nan,nan,Locoregional Recurrence,nan,nan,49.0,Complete Remission/Response,nan,nan,0.0,400.0,0.0,400.0,1.0,49.0,1.0,49.0,2
TCGA-LN-A49U-01,TCGA-LN-A49U,ESCA,62.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G1,2011.0,nan,-22969.0,Alive,TUMOR FREE,467.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,467.0,0.0,467.0,0.0,467.0,0.0,467.0,0
TCGA-LN-A49V-01,TCGA-LN-A49V,ESCA,49.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G3,2011.0,nan,-17922.0,Alive,TUMOR FREE,383.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,0
TCGA-LN-A49W-01,TCGA-LN-A49W,ESCA,73.0,MALE,ASIAN,Stage III,Stage III,Esophagus Squamous Cell Carcinoma,G3,2011.0,nan,-26910.0,Alive,TUMOR FREE,403.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,403.0,0.0,403.0,0.0,403.0,0.0,403.0,0
TCGA-LN-A49X-01,TCGA-LN-A49X,ESCA,44.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G2,2011.0,nan,-16154.0,Alive,TUMOR FREE,384.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,384.0,0.0,384.0,0.0,384.0,0.0,384.0,0
TCGA-LN-A49Y-01,TCGA-LN-A49Y,ESCA,77.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G2,2011.0,nan,-28125.0,Alive,WITH TUMOR,379.0,nan,nan,Locoregional Recurrence,nan,nan,90.0,Complete Remission/Response,nan,nan,0.0,379.0,0.0,379.0,1.0,90.0,1.0,90.0,2
TCGA-LN-A4A1-01,TCGA-LN-A4A1,ESCA,60.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G3,2011.0,nan,-21954.0,Alive,WITH TUMOR,383.0,nan,nan,Locoregional Recurrence,nan,nan,205.0,Complete Remission/Response,nan,nan,0.0,383.0,0.0,383.0,1.0,205.0,1.0,205.0,2
TCGA-LN-A4A2-01,TCGA-LN-A4A2,ESCA,57.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G1,2011.0,nan,-21122.0,Alive,TUMOR FREE,380.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,380.0,0.0,380.0,0.0,380.0,0.0,380.0,0
TCGA-LN-A4A3-01,TCGA-LN-A4A3,ESCA,61.0,MALE,ASIAN,Stage III,Stage III,Esophagus Squamous Cell Carcinoma,G2,2011.0,nan,-22313.0,Alive,TUMOR FREE,388.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,388.0,0.0,388.0,0.0,388.0,0.0,388.0,0
TCGA-LN-A4A4-01,TCGA-LN-A4A4,ESCA,36.0,MALE,ASIAN,Stage III,Stage III,Esophagus Squamous Cell Carcinoma,GX,2011.0,nan,-13419.0,Alive,TUMOR FREE,383.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,0
TCGA-LN-A4A5-01,TCGA-LN-A4A5,ESCA,49.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G2,2011.0,nan,-18160.0,Dead,WITH TUMOR,nan,681.0,nan,Locoregional Recurrence,nan,nan,224.0,Complete Remission/Response,nan,nan,1.0,681.0,1.0,681.0,1.0,224.0,1.0,224.0,1
TCGA-LN-A4A6-01,TCGA-LN-A4A6,ESCA,65.0,MALE,ASIAN,Stage II,Stage II,Esophagus Squamous Cell Carcinoma,G2,2012.0,nan,-24011.0,Alive,TUMOR FREE,391.0,nan,nan,Locoregional Recurrence,nan,nan,158.0,Complete Remission/Response,nan,nan,0.0,391.0,0.0,391.0,1.0,158.0,1.0,158.0,2
TCGA-LN-A4A8-01,TCGA-LN-A4A8,ESCA,52.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G2,2012.0,nan,-19046.0,Alive,TUMOR FREE,472.0,nan,nan,Locoregional Recurrence,nan,nan,250.0,Complete Remission/Response,nan,nan,0.0,472.0,0.0,472.0,1.0,250.0,1.0,250.0,2
TCGA-LN-A4A9-01,TCGA-LN-A4A9,ESCA,58.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G1,2012.0,nan,-21217.0,Dead,WITH TUMOR,nan,351.0,nan,Locoregional Recurrence,nan,nan,274.0,Complete Remission/Response,nan,nan,1.0,351.0,1.0,351.0,1.0,274.0,1.0,274.0,1
TCGA-LN-A4MQ-01,TCGA-LN-A4MQ,ESCA,46.0,MALE,ASIAN,Stage III,Stage III,Esophagus Squamous Cell Carcinoma,G3,2010.0,nan,-16990.0,Alive,TUMOR FREE,375.0,nan,nan,Locoregional Recurrence,nan,nan,25.0,Complete Remission/Response,nan,nan,0.0,375.0,0.0,375.0,1.0,25.0,1.0,25.0,2
TCGA-LN-A4MR-01,TCGA-LN-A4MR,ESCA,57.0,MALE,ASIAN,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G2,2012.0,nan,-21142.0,Alive,TUMOR FREE,402.0,nan,nan,Locoregional Recurrence,nan,nan,226.0,Complete Remission/Response,nan,nan,0.0,402.0,0.0,402.0,1.0,226.0,1.0,226.0,2
TCGA-LN-A5U5-01,TCGA-LN-A5U5,ESCA,57.0,MALE,ASIAN,Stage IV,nan,Esophagus Squamous Cell Carcinoma,G2,2012.0,nan,-20993.0,Dead,WITH TUMOR,nan,136.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,136.0,1.0,136.0,nan,nan,1.0,136.0,1
TCGA-LN-A5U6-01,TCGA-LN-A5U6,ESCA,54.0,MALE,ASIAN,Stage IIB,nan,Esophagus Squamous Cell Carcinoma,G2,2012.0,nan,-19840.0,Alive,TUMOR FREE,375.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,375.0,0.0,375.0,0.0,375.0,0.0,375.0,0
TCGA-LN-A5U7-01,TCGA-LN-A5U7,ESCA,46.0,MALE,ASIAN,Stage IIA,nan,Esophagus Squamous Cell Carcinoma,G1,2012.0,nan,-16928.0,Alive,TUMOR FREE,768.0,nan,nan,Locoregional Recurrence,nan,nan,535.0,Complete Remission/Response,nan,nan,0.0,768.0,0.0,768.0,1.0,535.0,1.0,535.0,2
TCGA-LN-A7HV-01,TCGA-LN-A7HV,ESCA,58.0,MALE,ASIAN,Stage IIA,nan,Esophagus Squamous Cell Carcinoma,G1,2012.0,nan,-21462.0,Alive,TUMOR FREE,320.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,320.0,0.0,320.0,0.0,320.0,0.0,320.0,0
TCGA-LN-A7HW-01,TCGA-LN-A7HW,ESCA,59.0,MALE,ASIAN,Stage IIA,nan,Esophagus Squamous Cell Carcinoma,G2,2013.0,nan,-21840.0,Alive,TUMOR FREE,365.0,nan,nan,Locoregional Recurrence,nan,nan,97.0,Complete Remission/Response,nan,nan,0.0,365.0,0.0,365.0,1.0,97.0,1.0,97.0,2
TCGA-LN-A7HX-01,TCGA-LN-A7HX,ESCA,72.0,MALE,ASIAN,Stage IIA,nan,Esophagus Squamous Cell Carcinoma,G2,2013.0,nan,-26517.0,Alive,TUMOR FREE,372.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,372.0,0.0,372.0,0.0,372.0,0.0,372.0,0
TCGA-LN-A7HY-01,TCGA-LN-A7HY,ESCA,50.0,MALE,ASIAN,Stage III,nan,Esophagus Squamous Cell Carcinoma,G2,2013.0,nan,-18296.0,Alive,TUMOR FREE,366.0,nan,nan,Locoregional Recurrence,nan,nan,88.0,Complete Remission/Response,nan,nan,0.0,366.0,0.0,366.0,1.0,88.0,1.0,88.0,2
TCGA-LN-A7HZ-01,TCGA-LN-A7HZ,ESCA,49.0,MALE,ASIAN,Stage IIA,nan,Esophagus Squamous Cell Carcinoma,G2,2013.0,nan,-17931.0,Alive,TUMOR FREE,401.0,nan,nan,Locoregional Recurrence,nan,nan,117.0,Complete Remission/Response,nan,nan,0.0,401.0,0.0,401.0,1.0,117.0,1.0,117.0,2
TCGA-LN-A8HZ-01,TCGA-LN-A8HZ,ESCA,56.0,MALE,ASIAN,Stage IIA,nan,Esophagus Squamous Cell Carcinoma,G3,2013.0,nan,-20510.0,Alive,TUMOR FREE,375.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,375.0,0.0,375.0,0.0,375.0,0.0,375.0,0
TCGA-LN-A8I0-01,TCGA-LN-A8I0,ESCA,52.0,MALE,ASIAN,Stage IIA,nan,Esophagus Squamous Cell Carcinoma,G2,2013.0,nan,-19328.0,Alive,TUMOR FREE,407.0,nan,nan,Locoregional Recurrence,nan,nan,57.0,Complete Remission/Response,nan,nan,0.0,407.0,0.0,407.0,1.0,57.0,1.0,57.0,2
TCGA-LN-A8I1-01,TCGA-LN-A8I1,ESCA,67.0,FEMALE,ASIAN,Stage IIA,nan,Esophagus Squamous Cell Carcinoma,G3,2013.0,nan,-24551.0,Alive,TUMOR FREE,401.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,401.0,0.0,401.0,0.0,401.0,0.0,401.0,0
TCGA-LN-A9FO-01,TCGA-LN-A9FO,ESCA,42.0,MALE,ASIAN,Stage IIA,nan,Esophagus Squamous Cell Carcinoma,G2,2013.0,nan,-15551.0,Alive,TUMOR FREE,4.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4.0,0.0,4.0,nan,nan,0.0,4.0,0
TCGA-LN-A9FP-01,TCGA-LN-A9FP,ESCA,60.0,FEMALE,ASIAN,Stage IIA,nan,Esophagus Squamous Cell Carcinoma,G3,2013.0,nan,-22104.0,Alive,WITH TUMOR,366.0,nan,nan,Locoregional Recurrence,nan,nan,290.0,Complete Remission/Response,nan,nan,0.0,366.0,0.0,366.0,1.0,290.0,1.0,290.0,2
TCGA-LN-A9FQ-01,TCGA-LN-A9FQ,ESCA,62.0,MALE,ASIAN,Stage IIA,nan,Esophagus Squamous Cell Carcinoma,G3,2013.0,nan,-22717.0,Alive,TUMOR FREE,391.0,nan,nan,Locoregional Recurrence,nan,nan,82.0,Complete Remission/Response,nan,nan,0.0,391.0,0.0,391.0,1.0,82.0,1.0,82.0,2
TCGA-LN-A9FR-01,TCGA-LN-A9FR,ESCA,70.0,MALE,ASIAN,Stage IIB,nan,Esophagus Squamous Cell Carcinoma,G2,2013.0,nan,-25657.0,Alive,TUMOR FREE,373.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,373.0,0.0,373.0,0.0,373.0,0.0,373.0,0
TCGA-M9-A5M8-01,TCGA-M9-A5M8,ESCA,58.0,MALE,[Not Evaluated],Stage IIA,nan,"Esophagus Adenocarcinoma, NOS",G2,nan,nan,-21433.0,Alive,TUMOR FREE,1007.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1007.0,0.0,1007.0,0.0,1007.0,0.0,1007.0,0
TCGA-Q9-A6FU-01,TCGA-Q9-A6FU,ESCA,57.0,FEMALE,WHITE,Stage IIIB,nan,Esophagus Squamous Cell Carcinoma,G2,2012.0,nan,-21108.0,Dead,WITH TUMOR,nan,157.0,nan,Distant Metastasis,Liver,nan,99.0,nan,nan,nan,1.0,157.0,1.0,157.0,nan,nan,1.0,99.0,1
TCGA-Q9-A6FW-01,TCGA-Q9-A6FW,ESCA,61.0,MALE,WHITE,Stage IIIB,nan,"Esophagus Adenocarcinoma, NOS",G2,2013.0,nan,-22586.0,Alive,TUMOR FREE,238.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,238.0,0.0,238.0,0.0,238.0,0.0,238.0,0
TCGA-R6-A6DN-01,TCGA-R6-A6DN,ESCA,58.0,MALE,WHITE,nan,Stage IV,"Esophagus Adenocarcinoma, NOS",G3,2011.0,nan,-21259.0,Dead,WITH TUMOR,nan,243.0,nan,Distant Metastasis,"Other, specify",Brain,199.0,Partial Remission/Response,nan,nan,1.0,243.0,1.0,243.0,nan,nan,1.0,199.0,1
TCGA-R6-A6DQ-01,TCGA-R6-A6DQ,ESCA,74.0,FEMALE,WHITE,nan,Stage IIIA,"Esophagus Adenocarcinoma, NOS",G3,2010.0,nan,-27098.0,Dead,WITH TUMOR,nan,231.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,231.0,1.0,231.0,nan,nan,1.0,231.0,1
TCGA-R6-A6KZ-01,TCGA-R6-A6KZ,ESCA,42.0,MALE,WHITE,nan,Stage IV,"Esophagus Adenocarcinoma, NOS",G3,2010.0,nan,-15512.0,Dead,WITH TUMOR,nan,154.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,154.0,1.0,154.0,nan,nan,1.0,154.0,1
TCGA-R6-A6L4-01,TCGA-R6-A6L4,ESCA,27.0,MALE,WHITE,nan,Stage IIIA,"Esophagus Adenocarcinoma, NOS",G2,2012.0,nan,-10222.0,Dead,WITH TUMOR,nan,496.0,nan,Distant Metastasis,Liver,nan,160.0,Progressive Disease,nan,nan,1.0,496.0,1.0,496.0,nan,nan,1.0,160.0,1
TCGA-R6-A6L6-01,TCGA-R6-A6L6,ESCA,68.0,MALE,WHITE,nan,Stage IV,"Esophagus Adenocarcinoma, NOS",G3,2010.0,nan,-25092.0,Dead,WITH TUMOR,nan,214.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,214.0,1.0,214.0,nan,nan,1.0,214.0,1
TCGA-R6-A6XG-01,TCGA-R6-A6XG,ESCA,64.0,MALE,WHITE,nan,Stage IIIA,"Esophagus Adenocarcinoma, NOS",G2,2011.0,nan,-23484.0,Alive,WITH TUMOR,1168.0,nan,nan,Distant Metastasis,"Other, specify",brain,572.0,Complete Remission/Response,nan,nan,0.0,1168.0,0.0,1168.0,1.0,572.0,1.0,572.0,2
TCGA-R6-A6XQ-01,TCGA-R6-A6XQ,ESCA,58.0,MALE,WHITE,nan,Stage IVB,"Esophagus Adenocarcinoma, NOS",G3,2008.0,nan,-21410.0,Dead,WITH TUMOR,nan,193.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,193.0,1.0,193.0,nan,nan,1.0,193.0,1
TCGA-R6-A6Y0-01,TCGA-R6-A6Y0,ESCA,54.0,MALE,WHITE,nan,Stage IVA,"Esophagus Adenocarcinoma, NOS",G2,2005.0,nan,-20045.0,Alive,WITH TUMOR,1641.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1641.0,0.0,1641.0,nan,nan,0.0,1641.0,0
TCGA-R6-A6Y2-01,TCGA-R6-A6Y2,ESCA,71.0,MALE,WHITE,nan,Stage IIB,"Esophagus Adenocarcinoma, NOS",G3,2005.0,nan,-25940.0,Dead,WITH TUMOR,nan,283.0,nan,Distant Metastasis,Bone,nan,102.0,nan,nan,nan,1.0,283.0,1.0,283.0,nan,nan,1.0,102.0,1
TCGA-R6-A8W5-01,TCGA-R6-A8W5,ESCA,60.0,MALE,WHITE,Stage IVA,nan,"Esophagus Adenocarcinoma, NOS",G2,2004.0,nan,-21917.0,Dead,WITH TUMOR,nan,480.0,nan,Distant Metastasis,Liver,nan,336.0,nan,nan,nan,1.0,480.0,1.0,480.0,nan,nan,1.0,336.0,1
TCGA-R6-A8W8-01,TCGA-R6-A8W8,ESCA,72.0,MALE,WHITE,nan,Stage IIIA,"Esophagus Adenocarcinoma, NOS",G2,2012.0,nan,-26535.0,Dead,WITH TUMOR,nan,88.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,88.0,1.0,88.0,nan,nan,1.0,88.0,1
TCGA-R6-A8WC-01,TCGA-R6-A8WC,ESCA,56.0,MALE,WHITE,nan,Stage IIA,"Esophagus Adenocarcinoma, NOS",G2,2013.0,nan,-20812.0,Alive,WITH TUMOR,70.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,70.0,0.0,70.0,nan,nan,0.0,70.0,0
TCGA-R6-A8WG-01,TCGA-R6-A8WG,ESCA,60.0,MALE,WHITE,nan,Stage IIA,"Esophagus Adenocarcinoma, NOS",G3,2013.0,nan,-22093.0,Dead,WITH TUMOR,nan,386.0,nan,Distant Metastasis,"Other, specify",left supraclavicular nodal metastasis,107.0,nan,nan,nan,1.0,386.0,1.0,386.0,nan,nan,1.0,107.0,1
TCGA-RE-A7BO-01,TCGA-RE-A7BO,ESCA,72.0,FEMALE,WHITE,Stage IIB,nan,"Esophagus Adenocarcinoma, NOS",G3,2006.0,nan,-26348.0,Dead,TUMOR FREE,nan,213.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,213.0,0.0,213.0,nan,nan,0.0,213.0,1
TCGA-S8-A6BV-01,TCGA-S8-A6BV,ESCA,76.0,MALE,WHITE,Stage IIIA,Stage IB,"Esophagus Adenocarcinoma, NOS",G2,2012.0,nan,-28111.0,Alive,WITH TUMOR,609.0,nan,nan,Distant Metastasis,Liver,nan,267.0,Progressive Disease,nan,nan,0.0,609.0,0.0,609.0,nan,nan,1.0,267.0,2
TCGA-S8-A6BW-01,TCGA-S8-A6BW,ESCA,51.0,MALE,WHITE,Stage IB,nan,Esophagus Squamous Cell Carcinoma,G1,2012.0,nan,-18944.0,Alive,TUMOR FREE,620.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,620.0,0.0,620.0,0.0,620.0,0.0,620.0,0
TCGA-V5-A7RB-01,TCGA-V5-A7RB,ESCA,59.0,MALE,[Unknown],[Unknown],Stage IIB,"Esophagus Adenocarcinoma, NOS",GX,nan,nan,-21654.0,Dead,TUMOR FREE,nan,161.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,161.0,0.0,161.0,nan,nan,0.0,161.0,0
TCGA-V5-A7RC-06,TCGA-V5-A7RC,ESCA,55.0,MALE,BLACK OR AFRICAN AMERICAN,nan,Stage IV,Esophagus Squamous Cell Carcinoma,GX,nan,nan,-20439.0,Dead,WITH TUMOR,nan,104.0,nan,Distant Metastasis,Liver,nan,88.0,Progressive Disease,nan,nan,1.0,104.0,1.0,104.0,nan,nan,1.0,88.0,1
TCGA-V5-A7RC-01,TCGA-V5-A7RC,ESCA,55.0,MALE,BLACK OR AFRICAN AMERICAN,nan,Stage IV,Esophagus Squamous Cell Carcinoma,GX,nan,nan,-20439.0,Dead,WITH TUMOR,nan,104.0,nan,Distant Metastasis,Liver,nan,88.0,Progressive Disease,nan,nan,1.0,104.0,1.0,104.0,nan,nan,1.0,88.0,1
TCGA-V5-A7RE-01,TCGA-V5-A7RE,ESCA,45.0,MALE,WHITE,Stage IB,Stage IIIA,"Esophagus Adenocarcinoma, NOS",G2,nan,nan,-16643.0,Alive,WITH TUMOR,500.0,nan,nan,Distant Metastasis,"Other, specify",bone,294.0,Partial Remission/Response,nan,nan,0.0,500.0,0.0,500.0,nan,nan,1.0,294.0,2
TCGA-V5-A7RE-11,TCGA-V5-A7RE,ESCA,45.0,MALE,WHITE,Stage IB,Stage IIIA,"Esophagus Adenocarcinoma, NOS",G2,nan,nan,-16643.0,Alive,WITH TUMOR,500.0,nan,nan,Distant Metastasis,"Other, specify",bone,294.0,Partial Remission/Response,nan,nan,0.0,500.0,0.0,500.0,nan,nan,1.0,294.0,2
TCGA-V5-AASV-01,TCGA-V5-AASV,ESCA,67.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Esophagus Squamous Cell Carcinoma,G3,nan,nan,-24559.0,Alive,WITH TUMOR,467.0,nan,nan,Distant Metastasis,Lung,nan,322.0,Partial Remission/Response,nan,nan,0.0,467.0,0.0,467.0,nan,nan,1.0,322.0,2
TCGA-V5-AASW-01,TCGA-V5-AASW,ESCA,72.0,MALE,WHITE,nan,Stage IIIA,"Esophagus Adenocarcinoma, NOS",G3,nan,nan,-26571.0,Alive,WITH TUMOR,282.0,nan,nan,Distant Metastasis,Lung,nan,282.0,[Unknown],nan,nan,0.0,282.0,0.0,282.0,nan,nan,1.0,282.0,2
TCGA-V5-AASX-01,TCGA-V5-AASX,ESCA,74.0,MALE,WHITE,nan,Stage IV,"Esophagus Adenocarcinoma, NOS",G2,nan,nan,-27081.0,Alive,WITH TUMOR,273.0,nan,nan,Distant Metastasis,"Other, specify",bone,273.0,[Unknown],nan,nan,0.0,273.0,0.0,273.0,nan,nan,1.0,273.0,2
TCGA-V5-AASX-11,TCGA-V5-AASX,ESCA,74.0,MALE,WHITE,nan,Stage IV,"Esophagus Adenocarcinoma, NOS",G2,nan,nan,-27081.0,Alive,WITH TUMOR,273.0,nan,nan,Distant Metastasis,"Other, specify",bone,273.0,[Unknown],nan,nan,0.0,273.0,0.0,273.0,nan,nan,1.0,273.0,2
TCGA-VR-A8EO-01,TCGA-VR-A8EO,ESCA,49.0,MALE,WHITE,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G3,2013.0,nan,-18123.0,Alive,TUMOR FREE,785.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,785.0,0.0,785.0,0.0,785.0,0.0,785.0,0
TCGA-VR-A8EP-01,TCGA-VR-A8EP,ESCA,51.0,MALE,WHITE,Stage IIIB,Stage IIB,Esophagus Squamous Cell Carcinoma,G3,2013.0,nan,-18942.0,Alive,TUMOR FREE,824.0,nan,nan,Locoregional Recurrence,nan,nan,242.0,Progressive Disease,nan,nan,0.0,824.0,0.0,824.0,nan,nan,1.0,242.0,0
TCGA-VR-A8EQ-01,TCGA-VR-A8EQ,ESCA,73.0,MALE,WHITE,Stage III,Stage III,"Esophagus Adenocarcinoma, NOS",G2,2009.0,nan,-26912.0,Dead,WITH TUMOR,nan,694.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,694.0,1.0,694.0,nan,nan,1.0,694.0,1
TCGA-VR-A8ER-01,TCGA-VR-A8ER,ESCA,54.0,MALE,[Unknown],Stage III,Stage III,Esophagus Squamous Cell Carcinoma,GX,2009.0,nan,-19951.0,Dead,WITH TUMOR,nan,378.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,378.0,1.0,378.0,nan,nan,1.0,378.0,1
TCGA-VR-A8ET-01,TCGA-VR-A8ET,ESCA,64.0,MALE,WHITE,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G2,2010.0,nan,-23517.0,Dead,TUMOR FREE,nan,47.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,47.0,0.0,47.0,nan,nan,0.0,47.0,0
TCGA-VR-A8EU-01,TCGA-VR-A8EU,ESCA,51.0,MALE,WHITE,Stage IV,Stage IV,Esophagus Squamous Cell Carcinoma,G2,2011.0,nan,-18711.0,Dead,WITH TUMOR,nan,557.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,557.0,1.0,557.0,nan,nan,1.0,557.0,1
TCGA-VR-A8EW-01,TCGA-VR-A8EW,ESCA,57.0,MALE,ASIAN,Stage IIIB,Stage IIIB,Esophagus Squamous Cell Carcinoma,G2,2012.0,nan,-20902.0,Dead,WITH TUMOR,nan,247.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,247.0,1.0,247.0,nan,nan,1.0,247.0,1
TCGA-VR-A8EX-01,TCGA-VR-A8EX,ESCA,63.0,MALE,[Unknown],Stage IVA,Stage IVA,Esophagus Squamous Cell Carcinoma,G2,2009.0,nan,-23226.0,Dead,WITH TUMOR,nan,855.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,855.0,1.0,855.0,nan,nan,1.0,855.0,1
TCGA-VR-A8EY-01,TCGA-VR-A8EY,ESCA,44.0,FEMALE,WHITE,Stage IIA,Stage IIA,Esophagus Squamous Cell Carcinoma,G1,2012.0,nan,-16255.0,Alive,TUMOR FREE,1025.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1025.0,0.0,1025.0,0.0,1025.0,0.0,1025.0,0
TCGA-VR-A8EZ-01,TCGA-VR-A8EZ,ESCA,47.0,MALE,WHITE,Stage IIIC,Stage IIA,Esophagus Squamous Cell Carcinoma,G2,2013.0,nan,-17449.0,Dead,WITH TUMOR,nan,553.0,nan,Distant Metastasis,Bone,nan,379.0,nan,nan,nan,1.0,553.0,1.0,553.0,nan,nan,1.0,379.0,1
TCGA-VR-A8Q7-01,TCGA-VR-A8Q7,ESCA,60.0,MALE,WHITE,Stage IIIA,Stage IIIA,Esophagus Squamous Cell Carcinoma,G3,2010.0,nan,-22149.0,Alive,TUMOR FREE,1590.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1590.0,0.0,1590.0,0.0,1590.0,0.0,1590.0,0
TCGA-VR-AA4D-01,TCGA-VR-AA4D,ESCA,53.0,MALE,WHITE,Stage IIB,Stage IA,"Esophagus Adenocarcinoma, NOS",G2,2010.0,nan,-19714.0,Dead,WITH TUMOR,nan,1405.0,nan,Distant Metastasis,Lung,nan,832.0,Progressive Disease,nan,nan,1.0,1405.0,1.0,1405.0,nan,nan,1.0,832.0,1
TCGA-VR-AA4G-01,TCGA-VR-AA4G,ESCA,51.0,FEMALE,WHITE,Stage IIIA,Stage IIIA,Esophagus Squamous Cell Carcinoma,G2,2013.0,nan,-18909.0,Alive,TUMOR FREE,549.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,549.0,0.0,549.0,0.0,549.0,0.0,549.0,0
TCGA-VR-AA7B-01,TCGA-VR-AA7B,ESCA,65.0,FEMALE,WHITE,Stage IV,Stage IIB,Esophagus Squamous Cell Carcinoma,G2,2011.0,nan,-23915.0,Alive,WITH TUMOR,342.0,nan,nan,Distant Metastasis,Brain,nan,207.0,nan,nan,nan,0.0,342.0,0.0,342.0,nan,nan,1.0,207.0,2
TCGA-VR-AA7D-01,TCGA-VR-AA7D,ESCA,58.0,MALE,[Unknown],Stage IIIC,Stage IIIC,Esophagus Squamous Cell Carcinoma,G2,2012.0,nan,-21468.0,Dead,WITH TUMOR,nan,279.0,nan,Distant Metastasis,"Other, specify",Head and neck lymph node,244.0,nan,nan,nan,1.0,279.0,1.0,279.0,nan,nan,1.0,244.0,1
TCGA-VR-AA7I-01,TCGA-VR-AA7I,ESCA,70.0,MALE,WHITE,Stage III,Stage III,Esophagus Squamous Cell Carcinoma,G1,2010.0,nan,-25855.0,Dead,WITH TUMOR,nan,484.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,484.0,1.0,484.0,nan,nan,1.0,484.0,1
TCGA-X8-AAAR-01,TCGA-X8-AAAR,ESCA,69.0,MALE,WHITE,[Unknown],nan,"Esophagus Adenocarcinoma, NOS",G1,2013.0,nan,-25370.0,Alive,TUMOR FREE,554.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,554.0,0.0,554.0,0.0,554.0,0.0,554.0,0
TCGA-XP-A8T6-01,TCGA-XP-A8T6,ESCA,54.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Esophagus Squamous Cell Carcinoma,G2,2009.0,nan,-19886.0,Dead,TUMOR FREE,nan,763.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,763.0,0.0,763.0,0.0,763.0,0.0,763.0,0
TCGA-XP-A8T7-01,TCGA-XP-A8T7,ESCA,63.0,FEMALE,WHITE,Stage IIA,nan,Esophagus Squamous Cell Carcinoma,G2,2010.0,nan,-23375.0,Alive,TUMOR FREE,1254.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1254.0,0.0,1254.0,0.0,1254.0,0.0,1254.0,0
TCGA-XP-A8T8-01,TCGA-XP-A8T8,ESCA,49.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,Stage IIB,Esophagus Squamous Cell Carcinoma,G1,2011.0,nan,-18048.0,Alive,TUMOR FREE,437.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,437.0,0.0,437.0,0.0,437.0,0.0,437.0,0
TCGA-Z6-A8JD-01,TCGA-Z6-A8JD,ESCA,53.0,MALE,WHITE,Stage IIB,nan,Esophagus Squamous Cell Carcinoma,G2,2013.0,nan,-19523.0,Alive,TUMOR FREE,104.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,104.0,0.0,104.0,0.0,104.0,0.0,104.0,0
TCGA-Z6-A8JE-01,TCGA-Z6-A8JE,ESCA,57.0,MALE,WHITE,Stage IIIA,Stage IIIA,Esophagus Squamous Cell Carcinoma,G3,2013.0,nan,-20855.0,Alive,TUMOR FREE,64.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,64.0,0.0,64.0,0.0,64.0,0.0,64.0,0
TCGA-Z6-A9VB-01,TCGA-Z6-A9VB,ESCA,53.0,MALE,WHITE,Stage IIIA,nan,Esophagus Squamous Cell Carcinoma,G2,2013.0,nan,-19470.0,Alive,TUMOR FREE,40.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,40.0,0.0,40.0,0.0,40.0,0.0,40.0,0
TCGA-Z6-AAPN-01,TCGA-Z6-AAPN,ESCA,57.0,MALE,WHITE,Stage IIA,nan,Esophagus Squamous Cell Carcinoma,G1,2013.0,nan,-20926.0,Alive,TUMOR FREE,81.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,81.0,0.0,81.0,0.0,81.0,0.0,81.0,0
TCGA-ZR-A9CJ-01,TCGA-ZR-A9CJ,ESCA,65.0,MALE,WHITE,Stage IIIC,nan,"Esophagus Adenocarcinoma, NOS",G3,2012.0,nan,-23752.0,Dead,WITH TUMOR,nan,600.0,nan,Distant Metastasis,Liver,nan,163.0,[Unknown],nan,nan,1.0,600.0,1.0,600.0,nan,nan,1.0,163.0,1
TCGA-02-0001-01,TCGA-02-0001,GBM,44.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2002.0,nan,-16179.0,Dead,WITH TUMOR,279.0,358.0,nan,Recurrence,nan,nan,137.0,nan,nan,nan,1.0,358.0,1.0,358.0,nan,nan,1.0,137.0,1
TCGA-02-0003-01,TCGA-02-0003,GBM,50.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-18341.0,Dead,WITH TUMOR,144.0,144.0,nan,Recurrence,nan,nan,40.0,nan,nan,nan,1.0,144.0,1.0,144.0,nan,nan,1.0,40.0,1
TCGA-02-0006-01,TCGA-02-0006,GBM,56.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2002.0,nan,-20516.0,Dead,WITH TUMOR,558.0,558.0,nan,Recurrence,nan,nan,302.0,nan,nan,nan,1.0,558.0,1.0,558.0,nan,nan,1.0,302.0,1
TCGA-02-0007-01,TCGA-02-0007,GBM,40.0,FEMALE,WHITE,nan,nan,Treated primary GBM,nan,2002.0,nan,-14806.0,Dead,WITH TUMOR,705.0,705.0,nan,Progression of Disease,nan,nan,518.0,nan,nan,nan,1.0,705.0,1.0,705.0,nan,nan,1.0,518.0,1
TCGA-02-0009-01,TCGA-02-0009,GBM,61.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-22457.0,Dead,WITH TUMOR,322.0,322.0,nan,Progression of Disease,nan,nan,264.0,nan,nan,nan,1.0,322.0,1.0,322.0,nan,nan,1.0,264.0,1
TCGA-02-0010-01,TCGA-02-0010,GBM,20.0,FEMALE,WHITE,nan,nan,Treated primary GBM,nan,2002.0,nan,-7452.0,Dead,WITH TUMOR,1077.0,1077.0,nan,Progression of Disease,nan,nan,351.0,nan,nan,nan,1.0,1077.0,1.0,1077.0,nan,nan,1.0,351.0,1
TCGA-02-0011-01,TCGA-02-0011,GBM,18.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-6926.0,Dead,WITH TUMOR,630.0,630.0,nan,Progression of Disease,nan,nan,145.0,nan,nan,nan,1.0,630.0,1.0,630.0,nan,nan,1.0,145.0,1
TCGA-02-0014-01,TCGA-02-0014,GBM,25.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1997.0,nan,-9369.0,Dead,WITH TUMOR,2512.0,2512.0,nan,Progression of Disease,nan,nan,2243.0,nan,nan,nan,1.0,2512.0,1.0,2512.0,nan,nan,1.0,2243.0,1
TCGA-02-0015-01,TCGA-02-0015,GBM,50.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2002.0,nan,-18404.0,Dead,WITH TUMOR,627.0,627.0,nan,Recurrence,nan,nan,456.0,nan,nan,nan,1.0,627.0,1.0,627.0,nan,nan,1.0,456.0,1
TCGA-02-0016-01,TCGA-02-0016,GBM,50.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-18271.0,Dead,WITH TUMOR,nan,2648.0,nan,Recurrence,nan,nan,1699.0,nan,nan,nan,1.0,2648.0,1.0,2648.0,nan,nan,1.0,1699.0,1
TCGA-02-0021-01,TCGA-02-0021,GBM,43.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1999.0,nan,-16035.0,Dead,WITH TUMOR,2362.0,2362.0,nan,Progression of Disease,nan,nan,255.0,nan,nan,nan,1.0,2362.0,1.0,2362.0,nan,nan,1.0,255.0,1
TCGA-02-0023-01,TCGA-02-0023,GBM,38.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-14003.0,Dead,WITH TUMOR,612.0,612.0,nan,Progression of Disease,nan,nan,435.0,nan,nan,nan,1.0,612.0,1.0,612.0,nan,nan,1.0,435.0,1
TCGA-02-0024-01,TCGA-02-0024,GBM,35.0,MALE,WHITE,nan,nan,Treated primary GBM,nan,2000.0,nan,-13116.0,Dead,WITH TUMOR,1615.0,1615.0,nan,Recurrence,nan,nan,1401.0,nan,nan,nan,1.0,1615.0,1.0,1615.0,nan,nan,1.0,1401.0,1
TCGA-02-0025-01,TCGA-02-0025,GBM,47.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2002.0,nan,-17402.0,Dead,WITH TUMOR,1300.0,1300.0,nan,Progression of Disease,nan,nan,656.0,nan,nan,nan,1.0,1300.0,1.0,1300.0,nan,nan,1.0,656.0,1
TCGA-02-0026-01,TCGA-02-0026,GBM,27.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-10022.0,Dead,WITH TUMOR,748.0,748.0,nan,Progression of Disease,nan,nan,462.0,nan,nan,nan,1.0,748.0,1.0,748.0,nan,nan,1.0,462.0,1
TCGA-02-0027-01,TCGA-02-0027,GBM,33.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-12369.0,Dead,WITH TUMOR,315.0,370.0,nan,Progression of Disease,nan,nan,257.0,nan,nan,nan,1.0,370.0,1.0,370.0,nan,nan,1.0,257.0,1
TCGA-02-0028-01,TCGA-02-0028,GBM,39.0,MALE,WHITE,nan,nan,Treated primary GBM,nan,1998.0,nan,-14304.0,Dead,WITH TUMOR,2755.0,2755.0,nan,Progression of Disease,nan,nan,1921.0,nan,nan,nan,1.0,2755.0,1.0,2755.0,nan,nan,1.0,1921.0,1
TCGA-02-0033-01,TCGA-02-0033,GBM,54.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-20070.0,Dead,WITH TUMOR,86.0,86.0,nan,Progression of Disease,nan,nan,32.0,nan,nan,nan,1.0,86.0,1.0,86.0,nan,nan,1.0,32.0,1
TCGA-02-0034-01,TCGA-02-0034,GBM,60.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-22166.0,Dead,WITH TUMOR,430.0,430.0,nan,Progression of Disease,nan,nan,386.0,nan,nan,nan,1.0,430.0,1.0,430.0,nan,nan,1.0,386.0,1
TCGA-02-0037-01,TCGA-02-0037,GBM,74.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-27063.0,Dead,WITH TUMOR,110.0,110.0,nan,Progression of Disease,nan,nan,37.0,nan,nan,nan,1.0,110.0,1.0,110.0,nan,nan,1.0,37.0,1
TCGA-02-0038-01,TCGA-02-0038,GBM,48.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-17749.0,Dead,WITH TUMOR,326.0,326.0,nan,Progression of Disease,nan,nan,239.0,nan,nan,nan,1.0,326.0,1.0,326.0,nan,nan,1.0,239.0,1
TCGA-02-0039-01,TCGA-02-0039,GBM,54.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-20065.0,Dead,WITH TUMOR,320.0,320.0,nan,Progression of Disease,nan,nan,102.0,nan,nan,nan,1.0,320.0,1.0,320.0,nan,nan,1.0,102.0,1
TCGA-02-0043-01,TCGA-02-0043,GBM,54.0,FEMALE,WHITE,nan,nan,Treated primary GBM,nan,2004.0,nan,-19882.0,Dead,WITH TUMOR,557.0,557.0,nan,Progression of Disease,nan,nan,282.0,nan,nan,nan,1.0,557.0,1.0,557.0,nan,nan,1.0,282.0,1
TCGA-02-0046-01,TCGA-02-0046,GBM,61.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-22417.0,Dead,WITH TUMOR,209.0,209.0,nan,Progression of Disease,nan,nan,195.0,nan,nan,nan,1.0,209.0,1.0,209.0,nan,nan,1.0,195.0,1
TCGA-02-0047-01,TCGA-02-0047,GBM,78.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-28759.0,Dead,WITH TUMOR,448.0,448.0,nan,Progression of Disease,nan,nan,57.0,nan,nan,nan,1.0,448.0,1.0,448.0,nan,nan,1.0,57.0,1
TCGA-02-0048-01,TCGA-02-0048,GBM,80.0,MALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-29299.0,Dead,nan,98.0,98.0,nan,Progression of Disease,nan,nan,23.0,nan,nan,nan,1.0,98.0,nan,98.0,nan,nan,1.0,23.0,1
TCGA-02-0051-01,TCGA-02-0051,GBM,43.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-15983.0,Dead,WITH TUMOR,459.0,459.0,nan,Progression of Disease,nan,nan,89.0,nan,nan,nan,1.0,459.0,1.0,459.0,nan,nan,1.0,89.0,1
TCGA-02-0052-01,TCGA-02-0052,GBM,49.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-18061.0,Dead,WITH TUMOR,383.0,383.0,nan,Progression of Disease,nan,nan,204.0,nan,nan,nan,1.0,383.0,1.0,383.0,nan,nan,1.0,204.0,1
TCGA-02-0054-01,TCGA-02-0054,GBM,44.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-16224.0,Dead,WITH TUMOR,199.0,199.0,nan,Progression of Disease,nan,nan,72.0,nan,nan,nan,1.0,199.0,1.0,199.0,nan,nan,1.0,72.0,1
TCGA-02-0055-01,TCGA-02-0055,GBM,62.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-22798.0,Dead,WITH TUMOR,76.0,76.0,nan,Progression of Disease,nan,nan,6.0,nan,nan,nan,1.0,76.0,1.0,76.0,nan,nan,1.0,6.0,1
TCGA-02-0057-01,TCGA-02-0057,GBM,66.0,FEMALE,WHITE,nan,nan,Treated primary GBM,nan,2004.0,nan,-24140.0,Dead,WITH TUMOR,604.0,604.0,nan,Progression of Disease,nan,nan,473.0,nan,nan,nan,1.0,604.0,1.0,604.0,nan,nan,1.0,473.0,1
TCGA-02-0058-01,TCGA-02-0058,GBM,28.0,FEMALE,WHITE,nan,nan,Treated primary GBM,nan,2005.0,nan,-10517.0,Dead,WITH TUMOR,254.0,254.0,nan,Progression of Disease,nan,nan,172.0,nan,nan,nan,1.0,254.0,1.0,254.0,nan,nan,1.0,172.0,1
TCGA-02-0059-01,TCGA-02-0059,GBM,68.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-25097.0,Dead,WITH TUMOR,291.0,291.0,nan,Recurrence,nan,nan,21.0,nan,nan,nan,1.0,291.0,1.0,291.0,nan,nan,1.0,21.0,1
TCGA-02-0060-01,TCGA-02-0060,GBM,66.0,FEMALE,ASIAN,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-24151.0,Dead,WITH TUMOR,183.0,183.0,nan,Progression of Disease,nan,nan,183.0,nan,nan,nan,1.0,183.0,1.0,183.0,nan,nan,1.0,183.0,1
TCGA-02-0064-01,TCGA-02-0064,GBM,50.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-18280.0,Dead,WITH TUMOR,600.0,600.0,nan,Recurrence,nan,nan,496.0,nan,nan,nan,1.0,600.0,1.0,600.0,nan,nan,1.0,496.0,1
TCGA-02-0068-01,TCGA-02-0068,GBM,57.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-21160.0,Dead,WITH TUMOR,804.0,804.0,nan,Recurrence,nan,nan,175.0,nan,nan,nan,1.0,804.0,1.0,804.0,nan,nan,1.0,175.0,1
TCGA-02-0069-01,TCGA-02-0069,GBM,31.0,FEMALE,ASIAN,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-11668.0,Alive,WITH TUMOR,873.0,nan,nan,Progression of Disease,nan,nan,873.0,nan,nan,nan,0.0,873.0,0.0,873.0,nan,nan,1.0,873.0,1
TCGA-02-0070-01,TCGA-02-0070,GBM,70.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-25916.0,Alive,WITH TUMOR,762.0,nan,nan,Recurrence,nan,nan,762.0,nan,nan,nan,0.0,762.0,0.0,762.0,nan,nan,1.0,762.0,0
TCGA-02-0071-01,TCGA-02-0071,GBM,53.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-19425.0,Dead,WITH TUMOR,167.0,167.0,nan,Progression of Disease,nan,nan,8.0,nan,nan,nan,1.0,167.0,1.0,167.0,nan,nan,1.0,8.0,1
TCGA-02-0074-01,TCGA-02-0074,GBM,68.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-24906.0,Dead,WITH TUMOR,310.0,310.0,nan,Progression of Disease,nan,nan,154.0,nan,nan,nan,1.0,310.0,1.0,310.0,nan,nan,1.0,154.0,1
TCGA-02-0075-01,TCGA-02-0075,GBM,63.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-23205.0,Dead,WITH TUMOR,634.0,634.0,nan,Progression of Disease,nan,nan,336.0,nan,nan,nan,1.0,634.0,1.0,634.0,nan,nan,1.0,336.0,1
TCGA-02-0079-01,TCGA-02-0079,GBM,57.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-21173.0,Dead,WITH TUMOR,829.0,829.0,nan,Progression of Disease,nan,nan,798.0,nan,nan,nan,1.0,829.0,1.0,829.0,nan,nan,1.0,798.0,1
TCGA-02-0080-01,TCGA-02-0080,GBM,28.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1999.0,nan,-10310.0,Dead,WITH TUMOR,2729.0,2729.0,nan,Progression of Disease,nan,nan,2339.0,nan,nan,nan,1.0,2729.0,1.0,2729.0,nan,nan,1.0,2339.0,1
TCGA-02-0083-01,TCGA-02-0083,GBM,59.0,FEMALE,WHITE,nan,nan,Treated primary GBM,nan,2005.0,nan,-21626.0,Dead,WITH TUMOR,691.0,691.0,nan,Progression of Disease,nan,nan,463.0,nan,nan,nan,1.0,691.0,1.0,691.0,nan,nan,1.0,463.0,1
TCGA-02-0084-01,TCGA-02-0084,GBM,36.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-13263.0,Dead,nan,7.0,384.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,384.0,nan,384.0,nan,nan,0.0,384.0,1
TCGA-02-0085-01,TCGA-02-0085,GBM,63.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-23289.0,Dead,WITH TUMOR,1561.0,1561.0,nan,Progression of Disease,nan,nan,976.0,nan,nan,nan,1.0,1561.0,1.0,1561.0,nan,nan,1.0,976.0,1
TCGA-02-0086-01,TCGA-02-0086,GBM,45.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-16763.0,Dead,WITH TUMOR,268.0,268.0,nan,Progression of Disease,nan,nan,97.0,nan,nan,nan,1.0,268.0,1.0,268.0,nan,nan,1.0,97.0,1
TCGA-02-0087-01,TCGA-02-0087,GBM,27.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-10185.0,Alive,nan,1757.0,nan,nan,Recurrence,nan,nan,1757.0,nan,nan,nan,0.0,1757.0,0.0,1757.0,nan,nan,1.0,1757.0,1
TCGA-02-0089-01,TCGA-02-0089,GBM,52.0,MALE,WHITE,nan,nan,Treated primary GBM,nan,2005.0,nan,-19233.0,Dead,WITH TUMOR,516.0,516.0,nan,Progression of Disease,nan,nan,358.0,nan,nan,nan,1.0,516.0,1.0,516.0,nan,nan,1.0,358.0,1
TCGA-02-0099-01,TCGA-02-0099,GBM,46.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-17080.0,Dead,WITH TUMOR,106.0,106.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,106.0,1.0,106.0,nan,nan,1.0,106.0,1
TCGA-02-0102-01,TCGA-02-0102,GBM,42.0,MALE,WHITE,nan,nan,Treated primary GBM,nan,2004.0,nan,-15660.0,Dead,WITH TUMOR,822.0,822.0,nan,Progression of Disease,nan,nan,450.0,nan,nan,nan,1.0,822.0,1.0,822.0,nan,nan,1.0,450.0,1
TCGA-02-0104-01,TCGA-02-0104,GBM,29.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2001.0,nan,-10699.0,Dead,WITH TUMOR,1977.0,1977.0,nan,Recurrence,nan,nan,1457.0,nan,nan,nan,1.0,1977.0,1.0,1977.0,nan,nan,1.0,1457.0,1
TCGA-02-0106-01,TCGA-02-0106,GBM,54.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-19883.0,Dead,WITH TUMOR,355.0,355.0,nan,Recurrence,nan,nan,196.0,nan,nan,nan,1.0,355.0,1.0,355.0,nan,nan,1.0,196.0,1
TCGA-02-0107-01,TCGA-02-0107,GBM,56.0,MALE,WHITE,nan,nan,Treated primary GBM,nan,2004.0,nan,-20557.0,Dead,WITH TUMOR,537.0,537.0,nan,Recurrence,nan,nan,146.0,nan,nan,nan,1.0,537.0,1.0,537.0,nan,nan,1.0,146.0,1
TCGA-02-0111-01,TCGA-02-0111,GBM,56.0,MALE,ASIAN,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-20813.0,Dead,WITH TUMOR,705.0,705.0,nan,Progression of Disease,nan,nan,74.0,nan,nan,nan,1.0,705.0,1.0,705.0,nan,nan,1.0,74.0,1
TCGA-02-0113-01,TCGA-02-0113,GBM,43.0,FEMALE,WHITE,nan,nan,Treated primary GBM,nan,2001.0,nan,-15836.0,Alive,WITH TUMOR,2818.0,nan,nan,Recurrence,nan,nan,1560.0,nan,nan,nan,0.0,2818.0,0.0,2818.0,nan,nan,1.0,1560.0,1
TCGA-02-0114-01,TCGA-02-0114,GBM,37.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Treated primary GBM,nan,1998.0,nan,-13681.0,Dead,WITH TUMOR,3041.0,3041.0,nan,Recurrence,nan,nan,2296.0,nan,nan,nan,1.0,3041.0,1.0,3041.0,nan,nan,1.0,2296.0,1
TCGA-02-0115-01,TCGA-02-0115,GBM,52.0,MALE,ASIAN,nan,nan,Treated primary GBM,nan,2006.0,nan,-19257.0,Dead,WITH TUMOR,476.0,476.0,nan,Progression of Disease,nan,nan,91.0,nan,nan,nan,1.0,476.0,1.0,476.0,nan,nan,1.0,91.0,1
TCGA-02-0116-01,TCGA-02-0116,GBM,51.0,MALE,WHITE,nan,nan,Treated primary GBM,nan,2003.0,nan,-18657.0,Dead,WITH TUMOR,1489.0,1489.0,nan,Progression of Disease,nan,nan,1231.0,nan,nan,nan,1.0,1489.0,1.0,1489.0,nan,nan,1.0,1231.0,1
TCGA-02-0258-01,TCGA-02-0258,GBM,36.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1989.0,nan,-13269.0,Dead,WITH TUMOR,503.0,503.0,nan,Recurrence,nan,nan,503.0,nan,nan,nan,1.0,503.0,1.0,503.0,nan,nan,1.0,503.0,1
TCGA-02-0260-01,TCGA-02-0260,GBM,54.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1989.0,nan,-19956.0,Dead,WITH TUMOR,515.0,515.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,515.0,1.0,515.0,nan,nan,1.0,515.0,1
TCGA-02-0266-01,TCGA-02-0266,GBM,14.0,MALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,1990.0,nan,-5303.0,Dead,WITH TUMOR,539.0,539.0,nan,Progression of Disease,nan,nan,293.0,nan,nan,nan,1.0,539.0,1.0,539.0,nan,nan,1.0,293.0,1
TCGA-02-0269-01,TCGA-02-0269,GBM,68.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1990.0,nan,-25194.0,Dead,WITH TUMOR,327.0,327.0,nan,Progression of Disease,nan,nan,99.0,nan,nan,nan,1.0,327.0,1.0,327.0,nan,nan,1.0,99.0,1
TCGA-02-0271-01,TCGA-02-0271,GBM,26.0,MALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,1990.0,nan,-9578.0,Dead,nan,440.0,440.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,440.0,nan,440.0,nan,nan,0.0,440.0,1
TCGA-02-0281-01,TCGA-02-0281,GBM,78.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1991.0,nan,-28696.0,Dead,WITH TUMOR,121.0,121.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,121.0,1.0,121.0,nan,nan,1.0,121.0,1
TCGA-02-0285-01,TCGA-02-0285,GBM,50.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1991.0,nan,-18353.0,Dead,WITH TUMOR,422.0,422.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,422.0,1.0,422.0,nan,nan,1.0,422.0,1
TCGA-02-0289-01,TCGA-02-0289,GBM,57.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1992.0,nan,-21031.0,Dead,WITH TUMOR,432.0,432.0,nan,Progression of Disease,nan,nan,245.0,nan,nan,nan,1.0,432.0,1.0,432.0,nan,nan,1.0,245.0,1
TCGA-02-0290-01,TCGA-02-0290,GBM,49.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1992.0,nan,-18066.0,Dead,WITH TUMOR,485.0,485.0,nan,Progression of Disease,nan,nan,374.0,nan,nan,nan,1.0,485.0,1.0,485.0,nan,nan,1.0,374.0,1
TCGA-02-0317-01,TCGA-02-0317,GBM,40.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1994.0,nan,-14636.0,Dead,WITH TUMOR,372.0,372.0,nan,Progression of Disease,nan,nan,238.0,nan,nan,nan,1.0,372.0,1.0,372.0,nan,nan,1.0,238.0,1
TCGA-02-0321-01,TCGA-02-0321,GBM,74.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1995.0,nan,-27125.0,Dead,WITH TUMOR,301.0,301.0,nan,Progression of Disease,nan,nan,73.0,nan,nan,nan,1.0,301.0,1.0,301.0,nan,nan,1.0,73.0,1
TCGA-02-0324-01,TCGA-02-0324,GBM,69.0,FEMALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,1995.0,nan,-25352.0,Dead,WITH TUMOR,235.0,235.0,nan,Progression of Disease,nan,nan,164.0,nan,nan,nan,1.0,235.0,1.0,235.0,nan,nan,1.0,164.0,1
TCGA-02-0325-01,TCGA-02-0325,GBM,61.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1996.0,nan,-22598.0,Dead,WITH TUMOR,323.0,323.0,nan,Progression of Disease,nan,nan,284.0,nan,nan,nan,1.0,323.0,1.0,323.0,nan,nan,1.0,284.0,1
TCGA-02-0326-01,TCGA-02-0326,GBM,82.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1995.0,nan,-30160.0,Dead,WITH TUMOR,5.0,223.0,nan,Progression of Disease,nan,nan,5.0,nan,nan,nan,1.0,223.0,1.0,223.0,nan,nan,1.0,5.0,1
TCGA-02-0330-01,TCGA-02-0330,GBM,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,1995.0,nan,-18654.0,Dead,WITH TUMOR,484.0,484.0,nan,Progression of Disease,nan,nan,120.0,nan,nan,nan,1.0,484.0,1.0,484.0,nan,nan,1.0,120.0,1
TCGA-02-0332-01,TCGA-02-0332,GBM,46.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1995.0,nan,-17021.0,Dead,WITH TUMOR,782.0,782.0,nan,Progression of Disease,nan,nan,438.0,nan,nan,nan,1.0,782.0,1.0,782.0,nan,nan,1.0,438.0,1
TCGA-02-0333-01,TCGA-02-0333,GBM,77.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1996.0,nan,-28449.0,Dead,WITH TUMOR,133.0,133.0,nan,Progression of Disease,nan,nan,4.0,nan,nan,nan,1.0,133.0,1.0,133.0,nan,nan,1.0,4.0,1
TCGA-02-0337-01,TCGA-02-0337,GBM,48.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1996.0,nan,-17643.0,Dead,WITH TUMOR,764.0,764.0,nan,Progression of Disease,nan,nan,691.0,nan,nan,nan,1.0,764.0,1.0,764.0,nan,nan,1.0,691.0,1
TCGA-02-0338-01,TCGA-02-0338,GBM,41.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1996.0,nan,-15231.0,Dead,WITH TUMOR,322.0,322.0,nan,Progression of Disease,nan,nan,168.0,nan,nan,nan,1.0,322.0,1.0,322.0,nan,nan,1.0,168.0,1
TCGA-02-0339-01,TCGA-02-0339,GBM,67.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1995.0,nan,-24524.0,Dead,WITH TUMOR,377.0,377.0,nan,Progression of Disease,nan,nan,148.0,nan,nan,nan,1.0,377.0,1.0,377.0,nan,nan,1.0,148.0,1
TCGA-02-0422-01,TCGA-02-0422,GBM,50.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1996.0,nan,-18368.0,Dead,WITH TUMOR,441.0,441.0,nan,Progression of Disease,nan,nan,125.0,nan,nan,nan,1.0,441.0,1.0,441.0,nan,nan,1.0,125.0,1
TCGA-02-0430-01,TCGA-02-0430,GBM,67.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1997.0,nan,-24641.0,Dead,WITH TUMOR,321.0,321.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,321.0,1.0,321.0,nan,nan,1.0,321.0,1
TCGA-02-0432-01,TCGA-02-0432,GBM,36.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1997.0,nan,-13260.0,Dead,WITH TUMOR,1433.0,1433.0,nan,Progression of Disease,nan,nan,1053.0,nan,nan,nan,1.0,1433.0,1.0,1433.0,nan,nan,1.0,1053.0,1
TCGA-02-0440-01,TCGA-02-0440,GBM,62.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1997.0,nan,-22955.0,Dead,WITH TUMOR,345.0,345.0,nan,Progression of Disease,nan,nan,212.0,nan,nan,nan,1.0,345.0,1.0,345.0,nan,nan,1.0,212.0,1
TCGA-02-0446-01,TCGA-02-0446,GBM,61.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1997.0,nan,-22541.0,Dead,WITH TUMOR,282.0,282.0,nan,Recurrence,nan,nan,15.0,nan,nan,nan,1.0,282.0,1.0,282.0,nan,nan,1.0,15.0,1
TCGA-02-0451-01,TCGA-02-0451,GBM,62.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1998.0,nan,-22662.0,Dead,WITH TUMOR,493.0,493.0,nan,Recurrence,nan,nan,428.0,nan,nan,nan,1.0,493.0,1.0,493.0,nan,nan,1.0,428.0,1
TCGA-02-0456-01,TCGA-02-0456,GBM,67.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1998.0,nan,-24796.0,Dead,WITH TUMOR,102.0,102.0,nan,Recurrence,nan,nan,12.0,nan,nan,nan,1.0,102.0,1.0,102.0,nan,nan,1.0,12.0,1
TCGA-02-2466-01,TCGA-02-2466,GBM,61.0,MALE,WHITE,nan,nan,Treated primary GBM,nan,2007.0,nan,-22457.0,Dead,WITH TUMOR,511.0,511.0,nan,Progression of Disease,nan,nan,128.0,nan,nan,nan,1.0,511.0,1.0,511.0,nan,nan,1.0,128.0,1
TCGA-02-2470-01,TCGA-02-2470,GBM,57.0,MALE,WHITE,nan,nan,Treated primary GBM,nan,2007.0,nan,-21021.0,Dead,WITH TUMOR,393.0,393.0,nan,Progression of Disease,nan,nan,183.0,nan,nan,nan,1.0,393.0,1.0,393.0,nan,nan,1.0,183.0,1
TCGA-02-2483-01,TCGA-02-2483,GBM,43.0,MALE,ASIAN,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-15964.0,Alive,WITH TUMOR,466.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,466.0,0.0,466.0,nan,nan,0.0,466.0,0
TCGA-02-2485-01,TCGA-02-2485,GBM,53.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-19494.0,Alive,WITH TUMOR,470.0,nan,nan,Progression of Disease,nan,nan,186.0,nan,nan,nan,0.0,470.0,0.0,470.0,nan,nan,1.0,186.0,1
TCGA-02-2486-01,TCGA-02-2486,GBM,64.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-23394.0,Dead,WITH TUMOR,nan,618.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,618.0,1.0,618.0,nan,nan,1.0,618.0,1
TCGA-06-0119-01,TCGA-06-0119,GBM,81.0,FEMALE,WHITE,nan,nan,Glioblastoma Multiforme (GBM),nan,2005.0,nan,-29606.0,Dead,WITH TUMOR,nan,82.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,82.0,1.0,82.0,nan,nan,1.0,82.0,1
TCGA-06-0122-01,TCGA-06-0122,GBM,84.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-30968.0,Dead,nan,8.0,187.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,187.0,nan,187.0,nan,nan,0.0,187.0,1
TCGA-06-0124-01,TCGA-06-0124,GBM,67.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1998.0,nan,-24591.0,Dead,WITH TUMOR,123.0,620.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,620.0,1.0,620.0,nan,nan,1.0,620.0,1
TCGA-06-0125-02,TCGA-06-0125,GBM,63.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2001.0,nan,-23343.0,Dead,WITH TUMOR,1439.0,1448.0,nan,Progression of Disease,nan,nan,797.0,nan,nan,nan,1.0,1448.0,1.0,1448.0,nan,nan,1.0,797.0,1
TCGA-06-0125-01,TCGA-06-0125,GBM,63.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2001.0,nan,-23343.0,Dead,WITH TUMOR,1439.0,1448.0,nan,Progression of Disease,nan,nan,797.0,nan,nan,nan,1.0,1448.0,1.0,1448.0,nan,nan,1.0,797.0,1
TCGA-06-0126-01,TCGA-06-0126,GBM,86.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2001.0,nan,-31627.0,Dead,nan,3.0,211.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,211.0,nan,211.0,nan,nan,0.0,211.0,1
TCGA-06-0127-01,TCGA-06-0127,GBM,67.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2002.0,nan,-24502.0,Dead,WITH TUMOR,109.0,121.0,nan,Progression of Disease,nan,nan,91.0,nan,nan,nan,1.0,121.0,1.0,121.0,nan,nan,1.0,91.0,1
TCGA-06-0128-01,TCGA-06-0128,GBM,66.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2000.0,nan,-24217.0,Dead,WITH TUMOR,691.0,691.0,nan,Progression of Disease,nan,nan,190.0,nan,nan,nan,1.0,691.0,1.0,691.0,nan,nan,1.0,190.0,1
TCGA-06-0129-01,TCGA-06-0129,GBM,30.0,MALE,ASIAN,nan,nan,Untreated primary (de novo) GBM,nan,2002.0,nan,-11284.0,Dead,WITH TUMOR,989.0,1024.0,nan,Progression of Disease,nan,nan,148.0,nan,nan,nan,1.0,1024.0,1.0,1024.0,nan,nan,1.0,148.0,1
TCGA-06-0130-01,TCGA-06-0130,GBM,54.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-19812.0,Dead,WITH TUMOR,320.0,394.0,nan,Progression of Disease,nan,nan,244.0,nan,nan,nan,1.0,394.0,1.0,394.0,nan,nan,1.0,244.0,1
TCGA-06-0132-01,TCGA-06-0132,GBM,49.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-18125.0,Dead,WITH TUMOR,570.0,771.0,nan,Progression of Disease,nan,nan,482.0,nan,nan,nan,1.0,771.0,1.0,771.0,nan,nan,1.0,482.0,1
TCGA-06-0133-01,TCGA-06-0133,GBM,64.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-23402.0,Dead,WITH TUMOR,428.0,435.0,nan,Progression of Disease,nan,nan,78.0,nan,nan,nan,1.0,435.0,1.0,435.0,nan,nan,1.0,78.0,1
TCGA-06-0137-01,TCGA-06-0137,GBM,63.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-23273.0,Dead,WITH TUMOR,702.0,812.0,nan,Progression of Disease,nan,nan,487.0,nan,nan,nan,1.0,812.0,1.0,812.0,nan,nan,1.0,487.0,1
TCGA-06-0138-01,TCGA-06-0138,GBM,43.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-15736.0,Dead,WITH TUMOR,674.0,737.0,nan,Progression of Disease,nan,nan,394.0,nan,nan,nan,1.0,737.0,1.0,737.0,nan,nan,1.0,394.0,1
TCGA-06-0139-01,TCGA-06-0139,GBM,40.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-14729.0,Dead,WITH TUMOR,327.0,362.0,nan,Progression of Disease,nan,nan,152.0,nan,nan,nan,1.0,362.0,1.0,362.0,nan,nan,1.0,152.0,1
TCGA-06-0140-01,TCGA-06-0140,GBM,86.0,MALE,WHITE,nan,nan,Glioblastoma Multiforme (GBM),nan,2003.0,nan,-31566.0,Dead,WITH TUMOR,nan,6.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,6.0,1.0,6.0,nan,nan,1.0,6.0,1
TCGA-06-0141-01,TCGA-06-0141,GBM,62.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2000.0,nan,-22926.0,Dead,WITH TUMOR,280.0,313.0,nan,Progression of Disease,nan,nan,145.0,nan,nan,nan,1.0,313.0,1.0,313.0,nan,nan,1.0,145.0,1
TCGA-06-0142-01,TCGA-06-0142,GBM,81.0,MALE,WHITE,nan,nan,Glioblastoma Multiforme (GBM),nan,2002.0,nan,-29642.0,Dead,WITH TUMOR,nan,67.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,67.0,1.0,67.0,nan,nan,1.0,67.0,1
TCGA-06-0143-01,TCGA-06-0143,GBM,58.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-21386.0,Dead,WITH TUMOR,357.0,357.0,nan,Recurrence,nan,nan,265.0,nan,nan,nan,1.0,357.0,1.0,357.0,nan,nan,1.0,265.0,1
TCGA-06-0145-01,TCGA-06-0145,GBM,53.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2002.0,nan,-19661.0,Dead,WITH TUMOR,71.0,71.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,71.0,1.0,71.0,nan,nan,1.0,71.0,1
TCGA-06-0146-01,TCGA-06-0146,GBM,33.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1995.0,nan,-12253.0,Dead,WITH TUMOR,611.0,611.0,nan,Progression of Disease,nan,nan,530.0,nan,nan,nan,1.0,611.0,1.0,611.0,nan,nan,1.0,530.0,1
TCGA-06-0147-01,TCGA-06-0147,GBM,51.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1999.0,nan,-18743.0,Dead,WITH TUMOR,508.0,541.0,nan,Progression of Disease,nan,nan,92.0,nan,nan,nan,1.0,541.0,1.0,541.0,nan,nan,1.0,92.0,1
TCGA-06-0148-01,TCGA-06-0148,GBM,76.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2002.0,nan,-27842.0,Dead,WITH TUMOR,298.0,307.0,nan,Progression of Disease,nan,nan,189.0,nan,nan,nan,1.0,307.0,1.0,307.0,nan,nan,1.0,189.0,1
TCGA-06-0149-01,TCGA-06-0149,GBM,74.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-27315.0,Dead,WITH TUMOR,239.0,262.0,nan,Progression of Disease,nan,nan,204.0,nan,nan,nan,1.0,262.0,1.0,262.0,nan,nan,1.0,204.0,1
TCGA-06-0150-01,TCGA-06-0150,GBM,45.0,MALE,WHITE,nan,nan,Glioblastoma Multiforme (GBM),nan,1995.0,nan,-16442.0,Dead,WITH TUMOR,nan,592.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,592.0,1.0,592.0,nan,nan,1.0,592.0,1
TCGA-06-0151-01,TCGA-06-0151,GBM,32.0,FEMALE,WHITE,nan,nan,Glioblastoma Multiforme (GBM),nan,1995.0,nan,-11956.0,Dead,WITH TUMOR,nan,1417.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1417.0,1.0,1417.0,nan,nan,1.0,1417.0,1
TCGA-06-0152-02,TCGA-06-0152,GBM,68.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1995.0,nan,-24844.0,Dead,WITH TUMOR,359.0,375.0,nan,Progression of Disease,nan,nan,299.0,nan,nan,nan,1.0,375.0,1.0,375.0,nan,nan,1.0,299.0,1
TCGA-06-0152-01,TCGA-06-0152,GBM,68.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1995.0,nan,-24844.0,Dead,WITH TUMOR,359.0,375.0,nan,Progression of Disease,nan,nan,299.0,nan,nan,nan,1.0,375.0,1.0,375.0,nan,nan,1.0,299.0,1
TCGA-06-0154-01,TCGA-06-0154,GBM,54.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1998.0,nan,-20018.0,Dead,WITH TUMOR,389.0,424.0,nan,Progression of Disease,nan,nan,208.0,nan,nan,nan,1.0,424.0,1.0,424.0,nan,nan,1.0,208.0,1
TCGA-06-0155-01,TCGA-06-0155,GBM,61.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1998.0,nan,-22498.0,Dead,WITH TUMOR,263.0,318.0,nan,Progression of Disease,nan,nan,256.0,nan,nan,nan,1.0,318.0,1.0,318.0,nan,nan,1.0,256.0,1
TCGA-06-0156-01,TCGA-06-0156,GBM,57.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1998.0,nan,-20932.0,Dead,WITH TUMOR,164.0,178.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,178.0,1.0,178.0,nan,nan,1.0,178.0,1
TCGA-06-0157-01,TCGA-06-0157,GBM,63.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1998.0,nan,-23128.0,Dead,WITH TUMOR,97.0,97.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,97.0,1.0,97.0,nan,nan,1.0,97.0,1
TCGA-06-0158-01,TCGA-06-0158,GBM,73.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1998.0,nan,-26856.0,Dead,WITH TUMOR,166.0,329.0,nan,Progression of Disease,nan,nan,90.0,nan,nan,nan,1.0,329.0,1.0,329.0,nan,nan,1.0,90.0,1
TCGA-06-0159-01,TCGA-06-0159,GBM,74.0,MALE,WHITE,nan,nan,Glioblastoma Multiforme (GBM),nan,1998.0,nan,-27368.0,Dead,WITH TUMOR,nan,287.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,287.0,1.0,287.0,nan,nan,1.0,287.0,1
TCGA-06-0160-01,TCGA-06-0160,GBM,56.0,FEMALE,WHITE,nan,nan,Glioblastoma Multiforme (GBM),nan,1999.0,nan,-20684.0,Dead,WITH TUMOR,nan,359.0,nan,nan,nan,nan,nan,[Discrepancy],nan,nan,1.0,359.0,1.0,359.0,nan,nan,1.0,359.0,1
TCGA-06-0162-01,TCGA-06-0162,GBM,47.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2000.0,nan,-17272.0,Dead,WITH TUMOR,78.0,104.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,104.0,1.0,104.0,nan,nan,1.0,104.0,1
TCGA-06-0164-01,TCGA-06-0164,GBM,47.0,MALE,ASIAN,nan,nan,Untreated primary (de novo) GBM,nan,2000.0,nan,-17510.0,Dead,WITH TUMOR,1730.0,1731.0,nan,Progression of Disease,nan,nan,1428.0,nan,nan,nan,1.0,1731.0,1.0,1731.0,nan,nan,1.0,1428.0,1
TCGA-06-0165-01,TCGA-06-0165,GBM,52.0,MALE,WHITE,nan,nan,Glioblastoma Multiforme (GBM),nan,2001.0,nan,-19198.0,Dead,WITH TUMOR,nan,324.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,324.0,1.0,324.0,nan,nan,1.0,324.0,1
TCGA-06-0166-01,TCGA-06-0166,GBM,51.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2001.0,nan,-18902.0,Dead,WITH TUMOR,161.0,178.0,nan,Progression of Disease,nan,nan,66.0,nan,nan,nan,1.0,178.0,1.0,178.0,nan,nan,1.0,66.0,1
TCGA-06-0167-01,TCGA-06-0167,GBM,44.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Glioblastoma Multiforme (GBM),nan,2001.0,nan,-16170.0,Dead,WITH TUMOR,nan,347.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,347.0,1.0,347.0,nan,nan,1.0,347.0,1
TCGA-06-0168-01,TCGA-06-0168,GBM,59.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2002.0,nan,-21776.0,Dead,WITH TUMOR,579.0,598.0,nan,Progression of Disease,nan,nan,461.0,nan,nan,nan,1.0,598.0,1.0,598.0,nan,nan,1.0,461.0,1
TCGA-06-0169-01,TCGA-06-0169,GBM,68.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2002.0,nan,-25127.0,Dead,WITH TUMOR,95.0,100.0,nan,Progression of Disease,nan,nan,92.0,nan,nan,nan,1.0,100.0,1.0,100.0,nan,nan,1.0,92.0,1
TCGA-06-0171-02,TCGA-06-0171,GBM,65.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2002.0,nan,-24085.0,Dead,WITH TUMOR,396.0,399.0,nan,Progression of Disease,nan,nan,117.0,nan,nan,nan,1.0,399.0,1.0,399.0,nan,nan,1.0,117.0,1
TCGA-06-0171-01,TCGA-06-0171,GBM,65.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2002.0,nan,-24085.0,Dead,WITH TUMOR,396.0,399.0,nan,Progression of Disease,nan,nan,117.0,nan,nan,nan,1.0,399.0,1.0,399.0,nan,nan,1.0,117.0,1
TCGA-06-0173-01,TCGA-06-0173,GBM,72.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-26549.0,Dead,WITH TUMOR,7.0,136.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,136.0,1.0,136.0,nan,nan,1.0,136.0,1
TCGA-06-0174-01,TCGA-06-0174,GBM,54.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-19824.0,Dead,WITH TUMOR,67.0,98.0,nan,Progression of Disease,nan,nan,47.0,nan,nan,nan,1.0,98.0,1.0,98.0,nan,nan,1.0,47.0,1
TCGA-06-0175-01,TCGA-06-0175,GBM,69.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-25559.0,Dead,WITH TUMOR,83.0,123.0,nan,Progression of Disease,nan,nan,39.0,nan,nan,nan,1.0,123.0,1.0,123.0,nan,nan,1.0,39.0,1
TCGA-06-0176-01,TCGA-06-0176,GBM,34.0,MALE,ASIAN,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-12777.0,Alive,TUMOR FREE,2768.0,nan,nan,Progression of Disease,nan,nan,41.0,nan,nan,nan,0.0,2768.0,0.0,2768.0,nan,nan,1.0,41.0,0
TCGA-06-0177-01,TCGA-06-0177,GBM,64.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-23498.0,Dead,WITH TUMOR,61.0,127.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,127.0,1.0,127.0,nan,nan,1.0,127.0,1
TCGA-06-0178-01,TCGA-06-0178,GBM,38.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-14235.0,Dead,WITH TUMOR,nan,2681.0,nan,Progression of Disease,nan,nan,192.0,nan,nan,nan,1.0,2681.0,1.0,2681.0,nan,nan,1.0,192.0,1
TCGA-06-0179-01,TCGA-06-0179,GBM,64.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-23450.0,Dead,WITH TUMOR,578.0,616.0,nan,Progression of Disease,nan,nan,250.0,nan,nan,nan,1.0,616.0,1.0,616.0,nan,nan,1.0,250.0,1
TCGA-06-0182-01,TCGA-06-0182,GBM,76.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-27964.0,Dead,WITH TUMOR,77.0,111.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,111.0,1.0,111.0,nan,nan,1.0,111.0,1
TCGA-06-0184-01,TCGA-06-0184,GBM,63.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-23317.0,Dead,WITH TUMOR,nan,2126.0,nan,nan,nan,nan,1276.0,nan,nan,nan,1.0,2126.0,1.0,2126.0,nan,nan,1.0,1276.0,1
TCGA-06-0185-01,TCGA-06-0185,GBM,54.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-19923.0,Alive,WITH TUMOR,2246.0,nan,nan,Progression of Disease,nan,nan,711.0,nan,nan,nan,0.0,2246.0,0.0,2246.0,nan,nan,1.0,711.0,1
TCGA-06-0187-01,TCGA-06-0187,GBM,69.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-25318.0,Dead,WITH TUMOR,801.0,828.0,nan,Recurrence,nan,nan,531.0,nan,nan,nan,1.0,828.0,1.0,828.0,nan,nan,1.0,531.0,1
TCGA-06-0188-01,TCGA-06-0188,GBM,71.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-26080.0,Dead,WITH TUMOR,nan,1356.0,nan,nan,nan,nan,310.0,nan,nan,nan,1.0,1356.0,1.0,1356.0,nan,nan,1.0,310.0,1
TCGA-06-0189-01,TCGA-06-0189,GBM,55.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-20297.0,Dead,WITH TUMOR,454.0,469.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,469.0,1.0,469.0,nan,nan,1.0,469.0,1
TCGA-06-0190-02,TCGA-06-0190,GBM,62.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-22835.0,Dead,WITH TUMOR,313.0,317.0,nan,Progression of Disease,nan,nan,88.0,nan,nan,nan,1.0,317.0,1.0,317.0,nan,nan,1.0,88.0,1
TCGA-06-0190-01,TCGA-06-0190,GBM,62.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-22835.0,Dead,WITH TUMOR,313.0,317.0,nan,Progression of Disease,nan,nan,88.0,nan,nan,nan,1.0,317.0,1.0,317.0,nan,nan,1.0,88.0,1
TCGA-06-0192-01,TCGA-06-0192,GBM,58.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-21243.0,Dead,WITH TUMOR,nan,1185.0,nan,Locoregional Disease,nan,nan,648.0,nan,nan,nan,1.0,1185.0,1.0,1185.0,nan,nan,1.0,648.0,1
TCGA-06-0194-01,TCGA-06-0194,GBM,37.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1994.0,nan,-13852.0,Dead,WITH TUMOR,142.0,142.0,nan,Progression of Disease,nan,nan,125.0,nan,nan,nan,1.0,142.0,1.0,142.0,nan,nan,1.0,125.0,1
TCGA-06-0195-01,TCGA-06-0195,GBM,63.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1994.0,nan,-23132.0,Dead,WITH TUMOR,214.0,225.0,nan,Progression of Disease,nan,nan,147.0,nan,nan,nan,1.0,225.0,1.0,225.0,nan,nan,1.0,147.0,1
TCGA-06-0197-01,TCGA-06-0197,GBM,65.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1994.0,nan,-24095.0,Dead,WITH TUMOR,79.0,169.0,nan,Progression of Disease,nan,nan,47.0,nan,nan,nan,1.0,169.0,1.0,169.0,nan,nan,1.0,47.0,1
TCGA-06-0201-01,TCGA-06-0201,GBM,51.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1995.0,nan,-18649.0,Dead,WITH TUMOR,12.0,12.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,12.0,1.0,12.0,nan,nan,1.0,12.0,1
TCGA-06-0206-01,TCGA-06-0206,GBM,40.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1996.0,nan,-14937.0,Dead,WITH TUMOR,197.0,233.0,nan,Recurrence,nan,nan,106.0,nan,nan,nan,1.0,233.0,1.0,233.0,nan,nan,1.0,106.0,1
TCGA-06-0208-01,TCGA-06-0208,GBM,52.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1997.0,nan,-19108.0,Dead,WITH TUMOR,167.0,256.0,nan,Progression of Disease,nan,nan,149.0,nan,nan,nan,1.0,256.0,1.0,256.0,nan,nan,1.0,149.0,1
TCGA-06-0209-01,TCGA-06-0209,GBM,76.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1997.0,nan,-27877.0,Dead,WITH TUMOR,119.0,232.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,232.0,1.0,232.0,nan,nan,1.0,232.0,1
TCGA-06-0210-02,TCGA-06-0210,GBM,72.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1997.0,nan,-26600.0,Dead,WITH TUMOR,151.0,225.0,nan,Progression of Disease,nan,nan,67.0,nan,nan,nan,1.0,225.0,1.0,225.0,nan,nan,1.0,67.0,1
TCGA-06-0210-01,TCGA-06-0210,GBM,72.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1997.0,nan,-26600.0,Dead,WITH TUMOR,151.0,225.0,nan,Progression of Disease,nan,nan,67.0,nan,nan,nan,1.0,225.0,1.0,225.0,nan,nan,1.0,67.0,1
TCGA-06-0211-02,TCGA-06-0211,GBM,47.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1997.0,nan,-17515.0,Dead,WITH TUMOR,360.0,360.0,nan,Progression of Disease,nan,nan,53.0,nan,nan,nan,1.0,360.0,1.0,360.0,nan,nan,1.0,53.0,1
TCGA-06-0211-01,TCGA-06-0211,GBM,47.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1997.0,nan,-17515.0,Dead,WITH TUMOR,360.0,360.0,nan,Progression of Disease,nan,nan,53.0,nan,nan,nan,1.0,360.0,1.0,360.0,nan,nan,1.0,53.0,1
TCGA-06-0213-01,TCGA-06-0213,GBM,55.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1998.0,nan,-20134.0,Dead,WITH TUMOR,6.0,16.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,16.0,1.0,16.0,nan,nan,1.0,16.0,1
TCGA-06-0214-01,TCGA-06-0214,GBM,66.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1998.0,nan,-24187.0,Dead,WITH TUMOR,378.0,457.0,nan,Progression of Disease,nan,nan,48.0,nan,nan,nan,1.0,457.0,1.0,457.0,nan,nan,1.0,48.0,1
TCGA-06-0216-01,TCGA-06-0216,GBM,61.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1999.0,nan,-22524.0,Dead,WITH TUMOR,684.0,735.0,nan,Progression of Disease,nan,nan,175.0,nan,nan,nan,1.0,735.0,1.0,735.0,nan,nan,1.0,175.0,1
TCGA-06-0219-01,TCGA-06-0219,GBM,67.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2000.0,nan,-24488.0,Dead,WITH TUMOR,11.0,22.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,22.0,1.0,22.0,nan,nan,1.0,22.0,1
TCGA-06-0221-02,TCGA-06-0221,GBM,31.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2000.0,nan,-11333.0,Dead,WITH TUMOR,548.0,603.0,nan,Progression of Disease,nan,nan,260.0,nan,nan,nan,1.0,603.0,1.0,603.0,nan,nan,1.0,260.0,1
TCGA-06-0221-01,TCGA-06-0221,GBM,31.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2000.0,nan,-11333.0,Dead,WITH TUMOR,548.0,603.0,nan,Progression of Disease,nan,nan,260.0,nan,nan,nan,1.0,603.0,1.0,603.0,nan,nan,1.0,260.0,1
TCGA-06-0237-01,TCGA-06-0237,GBM,75.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-27735.0,Dead,WITH TUMOR,315.0,415.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,415.0,1.0,415.0,nan,nan,1.0,415.0,1
TCGA-06-0238-01,TCGA-06-0238,GBM,46.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-17037.0,Dead,WITH TUMOR,359.0,405.0,nan,Progression of Disease,nan,nan,311.0,nan,nan,nan,1.0,405.0,1.0,405.0,nan,nan,1.0,311.0,1
TCGA-06-0240-01,TCGA-06-0240,GBM,57.0,MALE,WHITE,nan,nan,Glioblastoma Multiforme (GBM),nan,2007.0,nan,-20937.0,Dead,WITH TUMOR,nan,621.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,621.0,1.0,621.0,nan,nan,1.0,621.0,1
TCGA-06-0241-01,TCGA-06-0241,GBM,65.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-24101.0,Dead,WITH TUMOR,nan,1481.0,nan,Recurrence,nan,nan,196.0,nan,nan,nan,1.0,1481.0,1.0,1481.0,nan,nan,1.0,196.0,1
TCGA-06-0394-01,TCGA-06-0394,GBM,51.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,1992.0,nan,-18913.0,Dead,WITH TUMOR,314.0,329.0,nan,Progression of Disease,nan,nan,87.0,nan,nan,nan,1.0,329.0,1.0,329.0,nan,nan,1.0,87.0,1
TCGA-06-0397-01,TCGA-06-0397,GBM,57.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1993.0,nan,-20845.0,Dead,WITH TUMOR,168.0,274.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,274.0,1.0,274.0,nan,nan,1.0,274.0,1
TCGA-06-0402-01,TCGA-06-0402,GBM,71.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1993.0,nan,-26059.0,Dead,WITH TUMOR,8.0,8.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,8.0,1.0,8.0,nan,nan,1.0,8.0,1
TCGA-06-0409-01,TCGA-06-0409,GBM,43.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,1994.0,nan,-16023.0,Dead,WITH TUMOR,2145.0,2201.0,nan,Progression of Disease,nan,nan,334.0,nan,nan,nan,1.0,2201.0,1.0,2201.0,nan,nan,1.0,334.0,1
TCGA-06-0410-01,TCGA-06-0410,GBM,76.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1995.0,nan,-28084.0,Dead,WITH TUMOR,143.0,143.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,143.0,1.0,143.0,nan,nan,1.0,143.0,1
TCGA-06-0412-01,TCGA-06-0412,GBM,56.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1995.0,nan,-20619.0,Dead,WITH TUMOR,245.0,291.0,nan,Progression of Disease,nan,nan,130.0,nan,nan,nan,1.0,291.0,1.0,291.0,nan,nan,1.0,130.0,1
TCGA-06-0413-01,TCGA-06-0413,GBM,77.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1995.0,nan,-28433.0,Dead,WITH TUMOR,5.0,96.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,96.0,1.0,96.0,nan,nan,1.0,96.0,1
TCGA-06-0414-01,TCGA-06-0414,GBM,63.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1996.0,nan,-23215.0,Dead,TUMOR FREE,1065.0,1068.0,nan,Recurrence,nan,nan,1013.0,nan,nan,nan,1.0,1068.0,0.0,1068.0,nan,nan,1.0,1013.0,1
TCGA-06-0644-01,TCGA-06-0644,GBM,71.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-26247.0,Dead,WITH TUMOR,nan,384.0,nan,Recurrence,nan,nan,85.0,nan,nan,nan,1.0,384.0,1.0,384.0,nan,nan,1.0,85.0,1
TCGA-06-0645-01,TCGA-06-0645,GBM,55.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-20449.0,Dead,WITH TUMOR,98.0,175.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,175.0,1.0,175.0,nan,nan,1.0,175.0,1
TCGA-06-0646-01,TCGA-06-0646,GBM,60.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-22273.0,Dead,WITH TUMOR,136.0,175.0,nan,Progression of Disease,nan,nan,90.0,nan,nan,nan,1.0,175.0,1.0,175.0,nan,nan,1.0,90.0,1
TCGA-06-0648-01,TCGA-06-0648,GBM,77.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-28477.0,Dead,WITH TUMOR,294.0,298.0,nan,Progression of Disease,nan,nan,202.0,nan,nan,nan,1.0,298.0,1.0,298.0,nan,nan,1.0,202.0,1
TCGA-06-0649-01,TCGA-06-0649,GBM,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-26796.0,Dead,WITH TUMOR,62.0,64.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,64.0,1.0,64.0,nan,nan,1.0,64.0,1
TCGA-06-0650-01,TCGA-06-0650,GBM,39.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-14560.0,Dead,WITH TUMOR,717.0,717.0,nan,Progression of Disease,nan,nan,351.0,nan,nan,nan,1.0,717.0,1.0,717.0,nan,nan,1.0,351.0,1
TCGA-06-0686-01,TCGA-06-0686,GBM,53.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-19503.0,Dead,WITH TUMOR,nan,432.0,nan,Progression of Disease,nan,nan,160.0,nan,nan,nan,1.0,432.0,1.0,432.0,nan,nan,1.0,160.0,1
TCGA-06-0743-01,TCGA-06-0743,GBM,69.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-25434.0,Dead,WITH TUMOR,nan,803.0,nan,Progression of Disease,nan,nan,176.0,nan,nan,nan,1.0,803.0,1.0,803.0,nan,nan,1.0,176.0,1
TCGA-06-0744-01,TCGA-06-0744,GBM,66.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-24471.0,Dead,WITH TUMOR,nan,1426.0,nan,nan,nan,nan,1277.0,nan,nan,nan,1.0,1426.0,1.0,1426.0,nan,nan,1.0,1277.0,1
TCGA-06-0745-01,TCGA-06-0745,GBM,59.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-21884.0,Dead,WITH TUMOR,164.0,239.0,nan,Progression of Disease,nan,nan,92.0,nan,nan,nan,1.0,239.0,1.0,239.0,nan,nan,1.0,92.0,1
TCGA-06-0747-01,TCGA-06-0747,GBM,53.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-19657.0,Dead,WITH TUMOR,82.0,82.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,82.0,1.0,82.0,nan,nan,1.0,82.0,1
TCGA-06-0749-01,TCGA-06-0749,GBM,50.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-18571.0,Dead,WITH TUMOR,66.0,82.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,82.0,1.0,82.0,nan,nan,1.0,82.0,1
TCGA-06-0750-01,TCGA-06-0750,GBM,43.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-16018.0,Dead,WITH TUMOR,28.0,28.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,28.0,1.0,28.0,nan,nan,1.0,28.0,1
TCGA-06-0875-01,TCGA-06-0875,GBM,61.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-22312.0,Alive,TUMOR FREE,1322.0,nan,nan,Progression of Disease,nan,nan,279.0,nan,nan,nan,0.0,1322.0,0.0,1322.0,nan,nan,1.0,279.0,1
TCGA-06-0876-01,TCGA-06-0876,GBM,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-26372.0,Alive,WITH TUMOR,1405.0,nan,nan,nan,nan,nan,424.0,nan,nan,nan,0.0,1405.0,0.0,1405.0,nan,nan,1.0,424.0,1
TCGA-06-0877-01,TCGA-06-0877,GBM,78.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-28760.0,Alive,WITH TUMOR,204.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,204.0,0.0,204.0,nan,nan,0.0,204.0,0
TCGA-06-0878-01,TCGA-06-0878,GBM,74.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-27319.0,Alive,WITH TUMOR,218.0,nan,nan,Recurrence,nan,nan,66.0,nan,nan,nan,0.0,218.0,0.0,218.0,nan,nan,1.0,66.0,1
TCGA-06-0879-01,TCGA-06-0879,GBM,52.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-19154.0,Dead,WITH TUMOR,nan,1229.0,nan,Recurrence,nan,nan,699.0,nan,nan,nan,1.0,1229.0,1.0,1229.0,nan,nan,1.0,699.0,1
TCGA-06-0881-01,TCGA-06-0881,GBM,50.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-18278.0,Dead,WITH TUMOR,nan,504.0,nan,Recurrence,nan,nan,141.0,nan,nan,nan,1.0,504.0,1.0,504.0,nan,nan,1.0,141.0,1
TCGA-06-0882-01,TCGA-06-0882,GBM,30.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-11112.0,Dead,WITH TUMOR,nan,632.0,nan,Recurrence,nan,nan,213.0,nan,nan,nan,1.0,632.0,1.0,632.0,nan,nan,1.0,213.0,1
TCGA-06-0939-01,TCGA-06-0939,GBM,79.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-28893.0,Dead,WITH TUMOR,nan,814.0,nan,Progression of Disease,nan,nan,329.0,nan,nan,nan,1.0,814.0,1.0,814.0,nan,nan,1.0,329.0,1
TCGA-06-1084-01,TCGA-06-1084,GBM,54.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-19899.0,Dead,WITH TUMOR,nan,728.0,nan,Progression of Disease,nan,nan,208.0,nan,nan,nan,1.0,728.0,1.0,728.0,nan,nan,1.0,208.0,1
TCGA-06-1086-01,TCGA-06-1086,GBM,42.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-15645.0,Dead,WITH TUMOR,193.0,208.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,208.0,1.0,208.0,nan,nan,1.0,208.0,1
TCGA-06-1087-01,TCGA-06-1087,GBM,75.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-27658.0,Dead,WITH TUMOR,109.0,123.0,nan,Recurrence,nan,nan,109.0,nan,nan,nan,1.0,123.0,1.0,123.0,nan,nan,1.0,109.0,1
TCGA-06-1800-01,TCGA-06-1800,GBM,61.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-22332.0,Dead,WITH TUMOR,815.0,815.0,nan,Recurrence,nan,nan,750.0,nan,nan,nan,1.0,815.0,1.0,815.0,nan,nan,1.0,750.0,1
TCGA-06-1801-01,TCGA-06-1801,GBM,56.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-20538.0,Dead,WITH TUMOR,nan,360.0,nan,Recurrence,nan,nan,232.0,nan,nan,nan,1.0,360.0,1.0,360.0,nan,nan,1.0,232.0,1
TCGA-06-1802-01,TCGA-06-1802,GBM,61.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-22537.0,Dead,WITH TUMOR,nan,466.0,nan,Recurrence,nan,nan,81.0,nan,nan,nan,1.0,466.0,1.0,466.0,nan,nan,1.0,81.0,1
TCGA-06-1804-01,TCGA-06-1804,GBM,81.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-29802.0,Dead,WITH TUMOR,414.0,414.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,414.0,1.0,414.0,nan,nan,1.0,414.0,1
TCGA-06-1805-01,TCGA-06-1805,GBM,28.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-10542.0,Alive,TUMOR FREE,1031.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1031.0,0.0,1031.0,nan,nan,0.0,1031.0,0
TCGA-06-1806-01,TCGA-06-1806,GBM,47.0,MALE,WHITE,nan,nan,Glioblastoma Multiforme (GBM),nan,2009.0,nan,-17296.0,Dead,WITH TUMOR,nan,466.0,nan,Progression of Disease,nan,nan,256.0,Progressive Disease,nan,nan,1.0,466.0,1.0,466.0,nan,nan,1.0,256.0,1
TCGA-06-2557-01,TCGA-06-2557,GBM,76.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-27980.0,Dead,WITH TUMOR,33.0,33.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,33.0,1.0,33.0,nan,nan,1.0,33.0,1
TCGA-06-2558-01,TCGA-06-2558,GBM,75.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-27511.0,Dead,nan,23.0,380.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,380.0,nan,380.0,nan,nan,0.0,380.0,1
TCGA-06-2559-01,TCGA-06-2559,GBM,83.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-30580.0,Dead,WITH TUMOR,150.0,150.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,150.0,1.0,150.0,nan,nan,1.0,150.0,1
TCGA-06-2561-01,TCGA-06-2561,GBM,53.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-19505.0,Dead,WITH TUMOR,nan,537.0,nan,Recurrence,nan,nan,78.0,nan,nan,nan,1.0,537.0,1.0,537.0,nan,nan,1.0,78.0,1
TCGA-06-2562-01,TCGA-06-2562,GBM,81.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-29753.0,Dead,WITH TUMOR,nan,382.0,nan,Progression of Disease,nan,nan,151.0,nan,nan,nan,1.0,382.0,1.0,382.0,nan,nan,1.0,151.0,1
TCGA-06-2563-01,TCGA-06-2563,GBM,72.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-26643.0,Alive,WITH TUMOR,932.0,nan,nan,nan,nan,nan,554.0,nan,nan,nan,0.0,932.0,0.0,932.0,nan,nan,1.0,554.0,1
TCGA-06-2564-01,TCGA-06-2564,GBM,50.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-18435.0,Alive,WITH TUMOR,181.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,181.0,0.0,181.0,nan,nan,0.0,181.0,0
TCGA-06-2565-01,TCGA-06-2565,GBM,59.0,MALE,ASIAN,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-21559.0,Dead,WITH TUMOR,nan,506.0,nan,Progression of Disease,nan,nan,178.0,nan,nan,nan,1.0,506.0,1.0,506.0,nan,nan,1.0,178.0,1
TCGA-06-2566-01,TCGA-06-2566,GBM,23.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-8428.0,Dead,WITH TUMOR,182.0,182.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,182.0,1.0,182.0,nan,nan,1.0,182.0,1
TCGA-06-2567-01,TCGA-06-2567,GBM,65.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-23759.0,Dead,WITH TUMOR,133.0,133.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,133.0,1.0,133.0,nan,nan,1.0,133.0,1
TCGA-06-2569-01,TCGA-06-2569,GBM,24.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-8922.0,Alive,WITH TUMOR,13.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,13.0,0.0,13.0,nan,nan,0.0,13.0,1
TCGA-06-2570-01,TCGA-06-2570,GBM,21.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-7936.0,Alive,TUMOR FREE,958.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,958.0,0.0,958.0,nan,nan,0.0,958.0,0
TCGA-06-5408-01,TCGA-06-5408,GBM,54.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-20063.0,Dead,WITH TUMOR,342.0,357.0,nan,Progression of Disease,nan,nan,158.0,nan,nan,nan,1.0,357.0,1.0,357.0,nan,nan,1.0,158.0,1
TCGA-06-5410-01,TCGA-06-5410,GBM,72.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-26395.0,Dead,WITH TUMOR,108.0,108.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,108.0,1.0,108.0,nan,nan,1.0,108.0,1
TCGA-06-5411-01,TCGA-06-5411,GBM,51.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-18832.0,Dead,WITH TUMOR,254.0,254.0,nan,Progression of Disease,nan,nan,214.0,nan,nan,nan,1.0,254.0,1.0,254.0,nan,nan,1.0,214.0,1
TCGA-06-5412-01,TCGA-06-5412,GBM,78.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-28762.0,Dead,WITH TUMOR,138.0,138.0,nan,Progression of Disease,nan,nan,88.0,nan,nan,nan,1.0,138.0,1.0,138.0,nan,nan,1.0,88.0,1
TCGA-06-5413-01,TCGA-06-5413,GBM,67.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-24477.0,Alive,WITH TUMOR,268.0,nan,nan,Progression of Disease,nan,nan,195.0,nan,nan,nan,0.0,268.0,0.0,268.0,nan,nan,1.0,195.0,1
TCGA-06-5414-01,TCGA-06-5414,GBM,61.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-22527.0,Alive,WITH TUMOR,273.0,nan,nan,Progression of Disease,nan,nan,167.0,nan,nan,nan,0.0,273.0,0.0,273.0,nan,nan,1.0,167.0,1
TCGA-06-5415-01,TCGA-06-5415,GBM,60.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-22213.0,Alive,WITH TUMOR,260.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,260.0,0.0,260.0,nan,nan,0.0,260.0,0
TCGA-06-5416-01,TCGA-06-5416,GBM,23.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-8533.0,Alive,WITH TUMOR,204.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,204.0,0.0,204.0,nan,nan,0.0,204.0,1
TCGA-06-5417-01,TCGA-06-5417,GBM,45.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-16572.0,Alive,WITH TUMOR,155.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,155.0,0.0,155.0,nan,nan,0.0,155.0,1
TCGA-06-5418-01,TCGA-06-5418,GBM,75.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-27584.0,Dead,WITH TUMOR,83.0,83.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,83.0,1.0,83.0,nan,nan,1.0,83.0,1
TCGA-06-5856-01,TCGA-06-5856,GBM,58.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-21232.0,Dead,WITH TUMOR,114.0,114.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,114.0,1.0,114.0,nan,nan,1.0,114.0,1
TCGA-06-5858-01,TCGA-06-5858,GBM,45.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-16662.0,Alive,WITH TUMOR,187.0,nan,nan,Progression of Disease,nan,nan,97.0,nan,nan,nan,0.0,187.0,0.0,187.0,nan,nan,1.0,97.0,1
TCGA-06-5859-01,TCGA-06-5859,GBM,63.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2011.0,nan,-23211.0,Alive,WITH TUMOR,139.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,139.0,0.0,139.0,nan,nan,0.0,139.0,0
TCGA-06-6388-01,TCGA-06-6388,GBM,64.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2011.0,nan,-23519.0,Dead,WITH TUMOR,120.0,159.0,nan,Progression of Disease,nan,nan,85.0,nan,nan,nan,1.0,159.0,1.0,159.0,nan,nan,1.0,85.0,1
TCGA-06-6389-01,TCGA-06-6389,GBM,49.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2011.0,nan,-18248.0,Alive,WITH TUMOR,237.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,237.0,0.0,237.0,nan,nan,0.0,237.0,0
TCGA-06-6390-01,TCGA-06-6390,GBM,58.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2011.0,nan,-21328.0,Dead,WITH TUMOR,164.0,164.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,164.0,1.0,164.0,nan,nan,1.0,164.0,1
TCGA-06-6391-01,TCGA-06-6391,GBM,44.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2011.0,nan,-16206.0,Dead,WITH TUMOR,nan,45.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,45.0,1.0,45.0,nan,nan,1.0,45.0,1
TCGA-06-6693-01,TCGA-06-6693,GBM,64.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1993.0,nan,-23585.0,Dead,WITH TUMOR,15.0,3667.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,3667.0,1.0,3667.0,nan,nan,1.0,3667.0,1
TCGA-06-6694-01,TCGA-06-6694,GBM,76.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1994.0,nan,-27909.0,Dead,WITH TUMOR,224.0,224.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,224.0,1.0,224.0,nan,nan,1.0,224.0,1
TCGA-06-6695-01,TCGA-06-6695,GBM,64.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-23426.0,Alive,WITH TUMOR,253.0,nan,nan,Progression of Disease,nan,nan,133.0,nan,nan,nan,0.0,253.0,0.0,253.0,nan,nan,1.0,133.0,1
TCGA-06-6697-01,TCGA-06-6697,GBM,65.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-23763.0,Alive,WITH TUMOR,391.0,nan,nan,Progression of Disease,nan,nan,306.0,nan,nan,nan,0.0,391.0,0.0,391.0,nan,nan,1.0,306.0,1
TCGA-06-6698-01,TCGA-06-6698,GBM,53.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2011.0,nan,-19591.0,Alive,WITH TUMOR,145.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,145.0,0.0,145.0,nan,nan,0.0,145.0,0
TCGA-06-6699-01,TCGA-06-6699,GBM,58.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2011.0,nan,-21190.0,Alive,WITH TUMOR,47.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,47.0,0.0,47.0,nan,nan,0.0,47.0,0
TCGA-06-6700-01,TCGA-06-6700,GBM,76.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2011.0,nan,-27850.0,Alive,WITH TUMOR,145.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,145.0,0.0,145.0,nan,nan,0.0,145.0,0
TCGA-06-6701-01,TCGA-06-6701,GBM,60.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2011.0,nan,-22051.0,Alive,WITH TUMOR,151.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,151.0,0.0,151.0,nan,nan,0.0,151.0,0
TCGA-06-A5U0-01,TCGA-06-A5U0,GBM,21.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Glioblastoma Multiforme (GBM),nan,2012.0,nan,-7958.0,Alive,WITH TUMOR,815.0,nan,nan,Progression of Disease,nan,nan,100.0,Progressive Disease,nan,nan,0.0,815.0,0.0,815.0,nan,nan,1.0,100.0,1
TCGA-06-A5U1-01,TCGA-06-A5U1,GBM,78.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Glioblastoma Multiforme (GBM),nan,2011.0,nan,-28545.0,Dead,WITH TUMOR,nan,57.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,57.0,1.0,57.0,nan,nan,1.0,57.0,1
TCGA-06-A6S0-01,TCGA-06-A6S0,GBM,79.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Glioblastoma Multiforme (GBM),nan,2011.0,nan,-29037.0,Dead,WITH TUMOR,nan,95.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,95.0,1.0,95.0,nan,nan,1.0,95.0,1
TCGA-06-A6S1-01,TCGA-06-A6S1,GBM,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Glioblastoma Multiforme (GBM),nan,2012.0,nan,-19443.0,Dead,WITH TUMOR,nan,78.0,nan,Progression of Disease,nan,nan,46.0,Progressive Disease,nan,nan,1.0,78.0,1.0,78.0,nan,nan,1.0,46.0,1
TCGA-06-A7TK-01,TCGA-06-A7TK,GBM,64.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Glioblastoma Multiforme (GBM),nan,2013.0,nan,-23674.0,Dead,WITH TUMOR,nan,444.0,nan,Progression of Disease,nan,nan,342.0,Progressive Disease,nan,nan,1.0,444.0,1.0,444.0,nan,nan,1.0,342.0,1
TCGA-06-A7TL-01,TCGA-06-A7TL,GBM,30.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Glioblastoma Multiforme (GBM),nan,2013.0,nan,-11297.0,Alive,WITH TUMOR,539.0,nan,nan,Progression of Disease,nan,nan,188.0,Stable Disease,nan,nan,0.0,539.0,0.0,539.0,nan,nan,1.0,188.0,1
TCGA-08-0244-01,TCGA-08-0244,GBM,62.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2001.0,nan,-22684.0,Dead,WITH TUMOR,690.0,690.0,nan,Recurrence,nan,nan,484.0,nan,nan,nan,1.0,690.0,1.0,690.0,nan,nan,1.0,484.0,1
TCGA-08-0245-01,TCGA-08-0245,GBM,31.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2001.0,nan,-11613.0,Dead,WITH TUMOR,1057.0,1151.0,nan,Progression of Disease,nan,nan,463.0,nan,nan,nan,1.0,1151.0,1.0,1151.0,nan,nan,1.0,463.0,1
TCGA-08-0246-01,TCGA-08-0246,GBM,57.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2001.0,nan,-20974.0,Dead,WITH TUMOR,119.0,127.0,nan,Progression of Disease,nan,nan,103.0,nan,nan,nan,1.0,127.0,1.0,127.0,nan,nan,1.0,103.0,1
TCGA-08-0344-01,TCGA-08-0344,GBM,66.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1992.0,nan,-24253.0,Dead,WITH TUMOR,3310.0,3524.0,nan,Recurrence,nan,nan,1880.0,nan,nan,nan,1.0,3524.0,1.0,3524.0,nan,nan,1.0,1880.0,1
TCGA-08-0345-01,TCGA-08-0345,GBM,71.0,FEMALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,1992.0,nan,-25960.0,Dead,WITH TUMOR,53.0,53.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,53.0,1.0,53.0,nan,nan,1.0,53.0,1
TCGA-08-0346-01,TCGA-08-0346,GBM,69.0,MALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,1993.0,nan,-25409.0,Dead,WITH TUMOR,132.0,256.0,nan,Progression of Disease,nan,nan,75.0,nan,nan,nan,1.0,256.0,1.0,256.0,nan,nan,1.0,75.0,1
TCGA-08-0347-01,TCGA-08-0347,GBM,50.0,MALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,1993.0,nan,-18384.0,Dead,WITH TUMOR,419.0,782.0,nan,Progression of Disease,nan,nan,59.0,nan,nan,nan,1.0,782.0,1.0,782.0,nan,nan,1.0,59.0,1
TCGA-08-0348-01,TCGA-08-0348,GBM,63.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2000.0,nan,-23373.0,Dead,WITH TUMOR,316.0,370.0,nan,Recurrence,nan,nan,198.0,nan,nan,nan,1.0,370.0,1.0,370.0,nan,nan,1.0,198.0,1
TCGA-08-0349-01,TCGA-08-0349,GBM,46.0,MALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,2000.0,nan,-16964.0,Dead,WITH TUMOR,231.0,298.0,nan,Progression of Disease,nan,nan,93.0,nan,nan,nan,1.0,298.0,1.0,298.0,nan,nan,1.0,93.0,1
TCGA-08-0350-01,TCGA-08-0350,GBM,32.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2001.0,nan,-11905.0,Dead,WITH TUMOR,104.0,889.0,nan,Recurrence,nan,nan,439.0,nan,nan,nan,1.0,889.0,1.0,889.0,nan,nan,1.0,439.0,1
TCGA-08-0351-01,TCGA-08-0351,GBM,40.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2001.0,nan,-14838.0,Dead,WITH TUMOR,1637.0,1987.0,nan,Recurrence,nan,nan,1542.0,nan,nan,nan,1.0,1987.0,1.0,1987.0,nan,nan,1.0,1542.0,1
TCGA-08-0352-01,TCGA-08-0352,GBM,79.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-29106.0,Dead,WITH TUMOR,39.0,39.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,39.0,1.0,39.0,nan,nan,1.0,39.0,1
TCGA-08-0353-01,TCGA-08-0353,GBM,58.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-21332.0,Dead,WITH TUMOR,195.0,256.0,nan,Progression of Disease,nan,nan,164.0,nan,nan,nan,1.0,256.0,1.0,256.0,nan,nan,1.0,164.0,1
TCGA-08-0354-01,TCGA-08-0354,GBM,52.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-19199.0,Dead,WITH TUMOR,458.0,546.0,nan,Progression of Disease,nan,nan,253.0,nan,nan,nan,1.0,546.0,1.0,546.0,nan,nan,1.0,253.0,1
TCGA-08-0355-01,TCGA-08-0355,GBM,30.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-11099.0,Dead,WITH TUMOR,685.0,747.0,nan,Recurrence,nan,nan,519.0,nan,nan,nan,1.0,747.0,1.0,747.0,nan,nan,1.0,519.0,1
TCGA-08-0356-01,TCGA-08-0356,GBM,59.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-21900.0,Dead,WITH TUMOR,447.0,946.0,nan,Recurrence,nan,nan,447.0,nan,nan,nan,1.0,946.0,1.0,946.0,nan,nan,1.0,447.0,1
TCGA-08-0357-01,TCGA-08-0357,GBM,49.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-18144.0,Dead,WITH TUMOR,1084.0,1143.0,nan,Recurrence,nan,nan,155.0,nan,nan,nan,1.0,1143.0,1.0,1143.0,nan,nan,1.0,155.0,1
TCGA-08-0358-01,TCGA-08-0358,GBM,50.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-18383.0,Dead,WITH TUMOR,594.0,678.0,nan,Recurrence,nan,nan,264.0,nan,nan,nan,1.0,678.0,1.0,678.0,nan,nan,1.0,264.0,1
TCGA-08-0359-01,TCGA-08-0359,GBM,59.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-21748.0,Dead,WITH TUMOR,29.0,103.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,103.0,1.0,103.0,nan,nan,1.0,103.0,1
TCGA-08-0375-01,TCGA-08-0375,GBM,51.0,FEMALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,1994.0,nan,-18941.0,Dead,WITH TUMOR,279.0,372.0,nan,Recurrence,nan,nan,161.0,nan,nan,nan,1.0,372.0,1.0,372.0,nan,nan,1.0,161.0,1
TCGA-08-0380-01,TCGA-08-0380,GBM,74.0,FEMALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,1997.0,nan,-27277.0,Dead,WITH TUMOR,330.0,454.0,nan,Progression of Disease,nan,nan,151.0,nan,nan,nan,1.0,454.0,1.0,454.0,nan,nan,1.0,151.0,1
TCGA-08-0386-01,TCGA-08-0386,GBM,74.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-27053.0,Dead,WITH TUMOR,478.0,548.0,nan,Recurrence,nan,nan,427.0,nan,nan,nan,1.0,548.0,1.0,548.0,nan,nan,1.0,427.0,1
TCGA-08-0389-01,TCGA-08-0389,GBM,59.0,MALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-21638.0,Dead,WITH TUMOR,97.0,467.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,467.0,1.0,467.0,nan,nan,1.0,467.0,1
TCGA-08-0390-01,TCGA-08-0390,GBM,69.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-25304.0,Dead,WITH TUMOR,322.0,425.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,425.0,1.0,425.0,nan,nan,1.0,425.0,1
TCGA-08-0392-01,TCGA-08-0392,GBM,60.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-22056.0,Dead,WITH TUMOR,9.0,22.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,22.0,1.0,22.0,nan,nan,1.0,22.0,1
TCGA-08-0509-01,TCGA-08-0509,GBM,63.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,1999.0,nan,-23273.0,Dead,WITH TUMOR,17.0,382.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,382.0,1.0,382.0,nan,nan,1.0,382.0,1
TCGA-08-0510-01,TCGA-08-0510,GBM,75.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2000.0,nan,-27675.0,Dead,WITH TUMOR,107.0,130.0,nan,Recurrence,nan,nan,90.0,nan,nan,nan,1.0,130.0,1.0,130.0,nan,nan,1.0,90.0,1
TCGA-08-0512-01,TCGA-08-0512,GBM,48.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2000.0,nan,-17821.0,Dead,WITH TUMOR,358.0,1282.0,nan,Progression of Disease,nan,nan,231.0,nan,nan,nan,1.0,1282.0,1.0,1282.0,nan,nan,1.0,231.0,1
TCGA-08-0514-01,TCGA-08-0514,GBM,69.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2001.0,nan,-25457.0,Dead,WITH TUMOR,259.0,337.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,337.0,1.0,337.0,nan,nan,1.0,337.0,1
TCGA-08-0516-01,TCGA-08-0516,GBM,14.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2001.0,nan,-5309.0,Dead,WITH TUMOR,561.0,596.0,nan,Progression of Disease,nan,nan,40.0,nan,nan,nan,1.0,596.0,1.0,596.0,nan,nan,1.0,40.0,1
TCGA-08-0517-01,TCGA-08-0517,GBM,34.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1996.0,nan,-12771.0,Dead,WITH TUMOR,1770.0,1785.0,nan,Recurrence,nan,nan,1024.0,nan,nan,nan,1.0,1785.0,1.0,1785.0,nan,nan,1.0,1024.0,1
TCGA-08-0518-01,TCGA-08-0518,GBM,60.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2001.0,nan,-21995.0,Dead,WITH TUMOR,39.0,588.0,nan,Progression of Disease,nan,nan,134.0,nan,nan,nan,1.0,588.0,1.0,588.0,nan,nan,1.0,134.0,1
TCGA-08-0520-01,TCGA-08-0520,GBM,70.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2001.0,nan,-25766.0,Dead,WITH TUMOR,327.0,327.0,nan,Recurrence,nan,nan,105.0,nan,nan,nan,1.0,327.0,1.0,327.0,nan,nan,1.0,105.0,1
TCGA-08-0521-01,TCGA-08-0521,GBM,17.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2002.0,nan,-6377.0,Dead,WITH TUMOR,146.0,146.0,nan,Progression of Disease,nan,nan,125.0,nan,nan,nan,1.0,146.0,1.0,146.0,nan,nan,1.0,125.0,1
TCGA-08-0524-01,TCGA-08-0524,GBM,17.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2002.0,nan,-6464.0,Dead,WITH TUMOR,199.0,221.0,nan,Progression of Disease,nan,nan,61.0,nan,nan,nan,1.0,221.0,1.0,221.0,nan,nan,1.0,61.0,1
TCGA-08-0525-01,TCGA-08-0525,GBM,52.0,MALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,2001.0,nan,-19013.0,Dead,WITH TUMOR,486.0,486.0,nan,Progression of Disease,nan,nan,343.0,nan,nan,nan,1.0,486.0,1.0,486.0,nan,nan,1.0,343.0,1
TCGA-08-0529-01,TCGA-08-0529,GBM,56.0,FEMALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-20556.0,Dead,WITH TUMOR,527.0,560.0,nan,Recurrence,nan,nan,328.0,nan,nan,nan,1.0,560.0,1.0,560.0,nan,nan,1.0,328.0,1
TCGA-08-0531-01,TCGA-08-0531,GBM,64.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-23482.0,Dead,WITH TUMOR,168.0,230.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,230.0,1.0,230.0,nan,nan,1.0,230.0,1
TCGA-12-0615-01,TCGA-12-0615,GBM,78.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-28583.0,Dead,WITH TUMOR,426.0,467.0,nan,Progression of Disease,nan,nan,160.0,nan,nan,nan,1.0,467.0,1.0,467.0,nan,nan,1.0,160.0,1
TCGA-12-0616-01,TCGA-12-0616,GBM,36.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-13451.0,Dead,WITH TUMOR,439.0,448.0,nan,Progression of Disease,nan,nan,398.0,nan,nan,nan,1.0,448.0,1.0,448.0,nan,nan,1.0,398.0,1
TCGA-12-0618-01,TCGA-12-0618,GBM,49.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-18071.0,Dead,nan,50.0,395.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,395.0,nan,395.0,nan,nan,0.0,395.0,1
TCGA-12-0619-01,TCGA-12-0619,GBM,60.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-21920.0,Dead,WITH TUMOR,316.0,1062.0,nan,Progression of Disease,nan,nan,203.0,nan,nan,nan,1.0,1062.0,1.0,1062.0,nan,nan,1.0,203.0,1
TCGA-12-0620-01,TCGA-12-0620,GBM,57.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-21069.0,Dead,WITH TUMOR,181.0,318.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,318.0,1.0,318.0,nan,nan,1.0,318.0,1
TCGA-12-0654-01,TCGA-12-0654,GBM,48.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2000.0,nan,-17625.0,Dead,WITH TUMOR,218.0,231.0,nan,Progression of Disease,nan,nan,216.0,nan,nan,nan,1.0,231.0,1.0,231.0,nan,nan,1.0,216.0,1
TCGA-12-0656-01,TCGA-12-0656,GBM,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,1997.0,nan,-17865.0,Dead,WITH TUMOR,2005.0,2883.0,nan,Progression of Disease,nan,nan,1467.0,nan,nan,nan,1.0,2883.0,1.0,2883.0,nan,nan,1.0,1467.0,1
TCGA-12-0657-01,TCGA-12-0657,GBM,69.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1996.0,nan,-25413.0,Dead,WITH TUMOR,3.0,3.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,3.0,1.0,3.0,nan,nan,1.0,3.0,1
TCGA-12-0662-01,TCGA-12-0662,GBM,51.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1998.0,nan,-18717.0,Dead,WITH TUMOR,1161.0,1161.0,nan,Progression of Disease,nan,nan,600.0,nan,nan,nan,1.0,1161.0,1.0,1161.0,nan,nan,1.0,600.0,1
TCGA-12-0670-01,TCGA-12-0670,GBM,60.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2001.0,nan,-22189.0,Dead,nan,790.0,790.0,nan,Progression of Disease,nan,nan,379.0,nan,nan,nan,1.0,790.0,nan,790.0,nan,nan,1.0,379.0,1
TCGA-12-0688-01,TCGA-12-0688,GBM,74.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1998.0,nan,-27085.0,Dead,WITH TUMOR,734.0,811.0,nan,Progression of Disease,nan,nan,228.0,nan,nan,nan,1.0,811.0,1.0,811.0,nan,nan,1.0,228.0,1
TCGA-12-0691-01,TCGA-12-0691,GBM,63.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1999.0,nan,-23019.0,Dead,WITH TUMOR,186.0,369.0,nan,Progression of Disease,nan,nan,98.0,nan,nan,nan,1.0,369.0,1.0,369.0,nan,nan,1.0,98.0,1
TCGA-12-0692-01,TCGA-12-0692,GBM,75.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2000.0,nan,-27519.0,Dead,WITH TUMOR,80.0,111.0,nan,Progression of Disease,nan,nan,35.0,nan,nan,nan,1.0,111.0,1.0,111.0,nan,nan,1.0,35.0,1
TCGA-12-0703-01,TCGA-12-0703,GBM,46.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1996.0,nan,-17125.0,Dead,WITH TUMOR,551.0,620.0,nan,Progression of Disease,nan,nan,208.0,nan,nan,nan,1.0,620.0,1.0,620.0,nan,nan,1.0,208.0,1
TCGA-12-0707-01,TCGA-12-0707,GBM,55.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1997.0,nan,-20136.0,Dead,nan,0.0,864.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,864.0,nan,864.0,nan,nan,0.0,864.0,1
TCGA-12-0769-01,TCGA-12-0769,GBM,52.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2002.0,nan,-19171.0,Dead,WITH TUMOR,378.0,458.0,nan,Progression of Disease,nan,nan,378.0,nan,nan,nan,1.0,458.0,1.0,458.0,nan,nan,1.0,378.0,1
TCGA-12-0772-01,TCGA-12-0772,GBM,46.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-17019.0,Dead,WITH TUMOR,1615.0,1638.0,nan,Progression of Disease,nan,nan,607.0,nan,nan,nan,1.0,1638.0,1.0,1638.0,nan,nan,1.0,607.0,1
TCGA-12-0773-01,TCGA-12-0773,GBM,24.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-8849.0,Dead,WITH TUMOR,1311.0,1315.0,nan,Progression of Disease,nan,nan,725.0,nan,nan,nan,1.0,1315.0,1.0,1315.0,nan,nan,1.0,725.0,1
TCGA-12-0775-01,TCGA-12-0775,GBM,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-27565.0,Dead,WITH TUMOR,167.0,232.0,nan,Progression of Disease,nan,nan,94.0,nan,nan,nan,1.0,232.0,1.0,232.0,nan,nan,1.0,94.0,1
TCGA-12-0776-01,TCGA-12-0776,GBM,52.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-19228.0,Dead,WITH TUMOR,277.0,296.0,nan,Progression of Disease,nan,nan,127.0,nan,nan,nan,1.0,296.0,1.0,296.0,nan,nan,1.0,127.0,1
TCGA-12-0778-01,TCGA-12-0778,GBM,53.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-19460.0,Dead,WITH TUMOR,452.0,454.0,nan,Progression of Disease,nan,nan,232.0,nan,nan,nan,1.0,454.0,1.0,454.0,nan,nan,1.0,232.0,1
TCGA-12-0780-01,TCGA-12-0780,GBM,51.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-18646.0,Dead,WITH TUMOR,434.0,452.0,nan,Progression of Disease,nan,nan,91.0,nan,nan,nan,1.0,452.0,1.0,452.0,nan,nan,1.0,91.0,1
TCGA-12-0818-01,TCGA-12-0818,GBM,45.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1994.0,nan,-16666.0,Dead,nan,2791.0,2791.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2791.0,nan,2791.0,nan,nan,0.0,2791.0,1
TCGA-12-0819-01,TCGA-12-0819,GBM,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,1995.0,nan,-18160.0,Dead,WITH TUMOR,754.0,754.0,nan,Recurrence,nan,nan,428.0,nan,nan,nan,1.0,754.0,1.0,754.0,nan,nan,1.0,428.0,1
TCGA-12-0820-01,TCGA-12-0820,GBM,40.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1997.0,nan,-14878.0,Dead,WITH TUMOR,562.0,562.0,nan,Recurrence,nan,nan,272.0,nan,nan,nan,1.0,562.0,1.0,562.0,nan,nan,1.0,272.0,1
TCGA-12-0821-01,TCGA-12-0821,GBM,62.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1998.0,nan,-22949.0,Dead,WITH TUMOR,323.0,323.0,nan,Recurrence,nan,nan,259.0,nan,nan,nan,1.0,323.0,1.0,323.0,nan,nan,1.0,259.0,1
TCGA-12-0822-01,TCGA-12-0822,GBM,46.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1998.0,nan,-16803.0,Dead,WITH TUMOR,715.0,715.0,nan,Recurrence,nan,nan,91.0,nan,nan,nan,1.0,715.0,1.0,715.0,nan,nan,1.0,91.0,1
TCGA-12-0826-01,TCGA-12-0826,GBM,38.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1999.0,nan,-13887.0,Dead,nan,845.0,845.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,845.0,nan,845.0,nan,nan,0.0,845.0,1
TCGA-12-0827-01,TCGA-12-0827,GBM,38.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1999.0,nan,-14093.0,Dead,WITH TUMOR,1179.0,1179.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1179.0,1.0,1179.0,nan,nan,1.0,1179.0,1
TCGA-12-0828-01,TCGA-12-0828,GBM,57.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2000.0,nan,-20909.0,Dead,WITH TUMOR,272.0,272.0,nan,Progression of Disease,nan,nan,13.0,nan,nan,nan,1.0,272.0,1.0,272.0,nan,nan,1.0,13.0,1
TCGA-12-0829-01,TCGA-12-0829,GBM,75.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-27471.0,Dead,WITH TUMOR,626.0,626.0,nan,Recurrence,nan,nan,473.0,nan,nan,nan,1.0,626.0,1.0,626.0,nan,nan,1.0,473.0,1
TCGA-12-1088-01,TCGA-12-1088,GBM,53.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1989.0,nan,-19667.0,Dead,nan,3881.0,3881.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,3881.0,nan,3881.0,nan,nan,0.0,3881.0,1
TCGA-12-1089-01,TCGA-12-1089,GBM,64.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2000.0,nan,-23419.0,Dead,WITH TUMOR,177.0,177.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,177.0,1.0,177.0,nan,nan,1.0,177.0,1
TCGA-12-1090-01,TCGA-12-1090,GBM,58.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2001.0,nan,-21377.0,Dead,WITH TUMOR,190.0,231.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,231.0,1.0,231.0,nan,nan,1.0,231.0,1
TCGA-12-1091-01,TCGA-12-1091,GBM,10.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2001.0,nan,-3982.0,Dead,WITH TUMOR,929.0,1010.0,nan,Recurrence,nan,nan,56.0,nan,nan,nan,1.0,1010.0,1.0,1010.0,nan,nan,1.0,56.0,1
TCGA-12-1092-01,TCGA-12-1092,GBM,58.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-21411.0,Dead,WITH TUMOR,658.0,661.0,nan,Recurrence,nan,nan,637.0,nan,nan,nan,1.0,661.0,1.0,661.0,nan,nan,1.0,637.0,1
TCGA-12-1093-01,TCGA-12-1093,GBM,66.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-24297.0,Dead,WITH TUMOR,364.0,486.0,nan,Recurrence,nan,nan,322.0,nan,nan,nan,1.0,486.0,1.0,486.0,nan,nan,1.0,322.0,1
TCGA-12-1094-01,TCGA-12-1094,GBM,56.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-20586.0,Dead,WITH TUMOR,346.0,372.0,nan,Recurrence,nan,nan,186.0,nan,nan,nan,1.0,372.0,1.0,372.0,nan,nan,1.0,186.0,1
TCGA-12-1095-01,TCGA-12-1095,GBM,65.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-23775.0,Dead,WITH TUMOR,482.0,482.0,nan,Progression of Disease,nan,nan,96.0,nan,nan,nan,1.0,482.0,1.0,482.0,nan,nan,1.0,96.0,1
TCGA-12-1096-01,TCGA-12-1096,GBM,55.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-20321.0,Dead,WITH TUMOR,nan,277.0,nan,Recurrence,nan,nan,270.0,nan,nan,nan,1.0,277.0,1.0,277.0,nan,nan,1.0,270.0,1
TCGA-12-1097-01,TCGA-12-1097,GBM,61.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-22526.0,Dead,WITH TUMOR,442.0,442.0,nan,Progression of Disease,nan,nan,166.0,nan,nan,nan,1.0,442.0,1.0,442.0,nan,nan,1.0,166.0,1
TCGA-12-1098-01,TCGA-12-1098,GBM,75.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-27726.0,Dead,WITH TUMOR,121.0,121.0,nan,Recurrence,nan,nan,93.0,nan,nan,nan,1.0,121.0,1.0,121.0,nan,nan,1.0,93.0,1
TCGA-12-1099-01,TCGA-12-1099,GBM,68.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-25034.0,Dead,WITH TUMOR,104.0,126.0,nan,Recurrence,nan,nan,62.0,nan,nan,nan,1.0,126.0,1.0,126.0,nan,nan,1.0,62.0,1
TCGA-12-1597-01,TCGA-12-1597,GBM,62.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2002.0,nan,-22865.0,Dead,WITH TUMOR,427.0,675.0,nan,Progression of Disease,nan,nan,180.0,nan,nan,nan,1.0,675.0,1.0,675.0,nan,nan,1.0,180.0,1
TCGA-12-1598-01,TCGA-12-1598,GBM,75.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-27730.0,Dead,WITH TUMOR,287.0,476.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,476.0,1.0,476.0,nan,nan,1.0,476.0,1
TCGA-12-1599-01,TCGA-12-1599,GBM,47.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-17432.0,Dead,WITH TUMOR,769.0,781.0,nan,Progression of Disease,nan,nan,89.0,nan,nan,nan,1.0,781.0,1.0,781.0,nan,nan,1.0,89.0,1
TCGA-12-1600-01,TCGA-12-1600,GBM,86.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-31419.0,Dead,WITH TUMOR,414.0,448.0,nan,Progression of Disease,nan,nan,404.0,nan,nan,nan,1.0,448.0,1.0,448.0,nan,nan,1.0,404.0,1
TCGA-12-1602-01,TCGA-12-1602,GBM,58.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-21492.0,Dead,WITH TUMOR,195.0,206.0,nan,Progression of Disease,nan,nan,140.0,nan,nan,nan,1.0,206.0,1.0,206.0,nan,nan,1.0,140.0,1
TCGA-12-3644-01,TCGA-12-3644,GBM,47.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-17468.0,Dead,WITH TUMOR,1807.0,1818.0,nan,Progression of Disease,nan,nan,1142.0,nan,nan,nan,1.0,1818.0,1.0,1818.0,nan,nan,1.0,1142.0,1
TCGA-12-3646-01,TCGA-12-3646,GBM,59.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-21855.0,Dead,WITH TUMOR,1315.0,1339.0,nan,Progression of Disease,nan,nan,1315.0,nan,nan,nan,1.0,1339.0,1.0,1339.0,nan,nan,1.0,1315.0,1
TCGA-12-3648-01,TCGA-12-3648,GBM,61.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-22463.0,Dead,WITH TUMOR,784.0,819.0,nan,Progression of Disease,nan,nan,86.0,nan,nan,nan,1.0,819.0,1.0,819.0,nan,nan,1.0,86.0,1
TCGA-12-3649-01,TCGA-12-3649,GBM,76.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-27846.0,Dead,WITH TUMOR,351.0,463.0,nan,Progression of Disease,nan,nan,351.0,nan,nan,nan,1.0,463.0,1.0,463.0,nan,nan,1.0,351.0,1
TCGA-12-3650-01,TCGA-12-3650,GBM,46.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-17138.0,Dead,WITH TUMOR,333.0,333.0,nan,Progression of Disease,nan,nan,239.0,nan,nan,nan,1.0,333.0,1.0,333.0,nan,nan,1.0,239.0,1
TCGA-12-3651-01,TCGA-12-3651,GBM,77.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-28277.0,Dead,WITH TUMOR,358.0,386.0,nan,Progression of Disease,nan,nan,358.0,nan,nan,nan,1.0,386.0,1.0,386.0,nan,nan,1.0,358.0,1
TCGA-12-3652-01,TCGA-12-3652,GBM,60.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-21920.0,Dead,WITH TUMOR,1050.0,1062.0,nan,Progression of Disease,nan,nan,203.0,nan,nan,nan,1.0,1062.0,1.0,1062.0,nan,nan,1.0,203.0,1
TCGA-12-3653-01,TCGA-12-3653,GBM,34.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-12529.0,Dead,WITH TUMOR,357.0,442.0,nan,Progression of Disease,nan,nan,224.0,nan,nan,nan,1.0,442.0,1.0,442.0,nan,nan,1.0,224.0,1
TCGA-12-5295-01,TCGA-12-5295,GBM,60.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-22161.0,Dead,WITH TUMOR,399.0,454.0,nan,Progression of Disease,nan,nan,399.0,nan,nan,nan,1.0,454.0,1.0,454.0,nan,nan,1.0,399.0,1
TCGA-12-5299-01,TCGA-12-5299,GBM,56.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-20463.0,Dead,WITH TUMOR,98.0,98.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,98.0,1.0,98.0,nan,nan,1.0,98.0,1
TCGA-12-5301-01,TCGA-12-5301,GBM,59.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-21768.0,Dead,WITH TUMOR,62.0,62.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,62.0,1.0,62.0,nan,nan,1.0,62.0,1
TCGA-14-0736-02,TCGA-14-0736,GBM,49.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,1999.0,nan,-18219.0,Dead,WITH TUMOR,460.0,460.0,nan,Recurrence,nan,nan,128.0,nan,nan,nan,1.0,460.0,1.0,460.0,nan,nan,1.0,128.0,1
TCGA-14-0736-01,TCGA-14-0736,GBM,49.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,1999.0,nan,-18219.0,Dead,WITH TUMOR,460.0,460.0,nan,Recurrence,nan,nan,128.0,nan,nan,nan,1.0,460.0,1.0,460.0,nan,nan,1.0,128.0,1
TCGA-14-0740-01,TCGA-14-0740,GBM,70.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2002.0,nan,-25627.0,Dead,WITH TUMOR,364.0,364.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,364.0,1.0,364.0,nan,nan,1.0,364.0,1
TCGA-14-0781-01,TCGA-14-0781,GBM,49.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-17903.0,Dead,WITH TUMOR,29.0,29.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,29.0,1.0,29.0,nan,nan,1.0,29.0,1
TCGA-14-0783-01,TCGA-14-0783,GBM,36.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2000.0,nan,-13159.0,Dead,WITH TUMOR,189.0,189.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,189.0,1.0,189.0,nan,nan,1.0,189.0,1
TCGA-14-0786-01,TCGA-14-0786,GBM,50.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1998.0,nan,-18592.0,Dead,WITH TUMOR,701.0,701.0,nan,Recurrence,nan,nan,127.0,nan,nan,nan,1.0,701.0,1.0,701.0,nan,nan,1.0,127.0,1
TCGA-14-0787-01,TCGA-14-0787,GBM,69.0,MALE,ASIAN,nan,nan,Untreated primary (de novo) GBM,nan,1999.0,nan,-25326.0,Dead,nan,68.0,68.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,68.0,nan,68.0,nan,nan,0.0,68.0,1
TCGA-14-0789-01,TCGA-14-0789,GBM,54.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-20050.0,Dead,nan,342.0,342.0,nan,Progression of Disease,nan,nan,105.0,nan,nan,nan,1.0,342.0,nan,342.0,nan,nan,1.0,105.0,1
TCGA-14-0790-01,TCGA-14-0790,GBM,64.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-23674.0,Dead,WITH TUMOR,419.0,419.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,419.0,1.0,419.0,nan,nan,1.0,419.0,1
TCGA-14-0812-01,TCGA-14-0812,GBM,65.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-24085.0,Dead,WITH TUMOR,99.0,99.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,99.0,1.0,99.0,nan,nan,1.0,99.0,1
TCGA-14-0813-01,TCGA-14-0813,GBM,78.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-28582.0,Dead,nan,41.0,41.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,41.0,nan,41.0,nan,nan,0.0,41.0,1
TCGA-14-0817-01,TCGA-14-0817,GBM,69.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2002.0,nan,-25425.0,Dead,nan,164.0,164.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,164.0,nan,164.0,nan,nan,0.0,164.0,1
TCGA-14-0862-01,TCGA-14-0862,GBM,60.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2002.0,nan,-22179.0,Dead,WITH TUMOR,88.0,88.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,88.0,1.0,88.0,nan,nan,1.0,88.0,1
TCGA-14-0865-01,TCGA-14-0865,GBM,67.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2002.0,nan,-24797.0,Dead,WITH TUMOR,502.0,502.0,nan,Progression of Disease,nan,nan,215.0,nan,nan,nan,1.0,502.0,1.0,502.0,nan,nan,1.0,215.0,1
TCGA-14-0866-01,TCGA-14-0866,GBM,55.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2002.0,nan,-20179.0,Dead,nan,801.0,801.0,nan,Recurrence,nan,nan,97.0,nan,nan,nan,1.0,801.0,nan,801.0,nan,nan,1.0,97.0,1
TCGA-14-0867-01,TCGA-14-0867,GBM,67.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2002.0,nan,-24815.0,Dead,nan,62.0,62.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,62.0,nan,62.0,nan,nan,0.0,62.0,1
TCGA-14-0871-01,TCGA-14-0871,GBM,74.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1998.0,nan,-27387.0,Dead,nan,880.0,880.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,880.0,nan,880.0,nan,nan,0.0,880.0,1
TCGA-14-1034-02,TCGA-14-1034,GBM,60.0,FEMALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,1999.0,nan,-22029.0,Dead,WITH TUMOR,485.0,485.0,nan,Progression of Disease,nan,nan,282.0,nan,nan,nan,1.0,485.0,1.0,485.0,nan,nan,1.0,282.0,1
TCGA-14-1034-01,TCGA-14-1034,GBM,60.0,FEMALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,1999.0,nan,-22029.0,Dead,WITH TUMOR,485.0,485.0,nan,Progression of Disease,nan,nan,282.0,nan,nan,nan,1.0,485.0,1.0,485.0,nan,nan,1.0,282.0,1
TCGA-14-1037-01,TCGA-14-1037,GBM,66.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2002.0,nan,-24426.0,Dead,WITH TUMOR,587.0,587.0,nan,Recurrence,nan,nan,326.0,nan,nan,nan,1.0,587.0,1.0,587.0,nan,nan,1.0,326.0,1
TCGA-14-1043-01,TCGA-14-1043,GBM,61.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-22392.0,Dead,WITH TUMOR,24.0,24.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,24.0,1.0,24.0,nan,nan,1.0,24.0,1
TCGA-14-1395-01,TCGA-14-1395,GBM,52.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-19237.0,Dead,WITH TUMOR,42.0,42.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,42.0,1.0,42.0,nan,nan,1.0,42.0,1
TCGA-14-1396-01,TCGA-14-1396,GBM,78.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2003.0,nan,-28753.0,Dead,WITH TUMOR,34.0,34.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,34.0,1.0,34.0,nan,nan,1.0,34.0,1
TCGA-14-1401-01,TCGA-14-1401,GBM,54.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-19921.0,Dead,WITH TUMOR,114.0,114.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,114.0,1.0,114.0,nan,nan,1.0,114.0,1
TCGA-14-1402-02,TCGA-14-1402,GBM,58.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-21421.0,Dead,WITH TUMOR,975.0,975.0,nan,Progression of Disease,nan,nan,333.0,nan,nan,nan,1.0,975.0,1.0,975.0,nan,nan,1.0,333.0,1
TCGA-14-1402-01,TCGA-14-1402,GBM,58.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-21421.0,Dead,WITH TUMOR,975.0,975.0,nan,Progression of Disease,nan,nan,333.0,nan,nan,nan,1.0,975.0,1.0,975.0,nan,nan,1.0,333.0,1
TCGA-14-1450-01,TCGA-14-1450,GBM,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-20960.0,Alive,WITH TUMOR,1788.0,nan,nan,Progression of Disease,nan,nan,826.0,nan,nan,nan,0.0,1788.0,0.0,1788.0,nan,nan,1.0,826.0,1
TCGA-14-1451-01,TCGA-14-1451,GBM,39.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-14401.0,Dead,WITH TUMOR,703.0,703.0,nan,Recurrence,nan,nan,19.0,nan,nan,nan,1.0,703.0,1.0,703.0,nan,nan,1.0,19.0,1
TCGA-14-1452-01,TCGA-14-1452,GBM,60.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-22106.0,Dead,WITH TUMOR,216.0,216.0,nan,Recurrence,nan,nan,172.0,nan,nan,nan,1.0,216.0,1.0,216.0,nan,nan,1.0,172.0,1
TCGA-14-1453-01,TCGA-14-1453,GBM,69.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-25297.0,Dead,WITH TUMOR,35.0,35.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,35.0,1.0,35.0,nan,nan,1.0,35.0,1
TCGA-14-1454-01,TCGA-14-1454,GBM,54.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-19887.0,Dead,WITH TUMOR,918.0,918.0,nan,Recurrence,nan,nan,291.0,nan,nan,nan,1.0,918.0,1.0,918.0,nan,nan,1.0,291.0,1
TCGA-14-1455-01,TCGA-14-1455,GBM,61.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-22562.0,Dead,WITH TUMOR,28.0,28.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,28.0,1.0,28.0,nan,nan,1.0,28.0,1
TCGA-14-1456-01,TCGA-14-1456,GBM,23.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-8710.0,Alive,WITH TUMOR,1246.0,nan,nan,Progression of Disease,nan,nan,98.0,nan,nan,nan,0.0,1246.0,0.0,1246.0,nan,nan,1.0,98.0,1
TCGA-14-1458-01,TCGA-14-1458,GBM,54.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-19899.0,Dead,nan,187.0,203.0,nan,Recurrence,nan,nan,81.0,nan,nan,nan,1.0,203.0,nan,203.0,nan,nan,1.0,81.0,1
TCGA-14-1459-01,TCGA-14-1459,GBM,63.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-23231.0,Dead,WITH TUMOR,378.0,378.0,nan,Progression of Disease,nan,nan,275.0,nan,nan,nan,1.0,378.0,1.0,378.0,nan,nan,1.0,275.0,1
TCGA-14-1794-01,TCGA-14-1794,GBM,59.0,MALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-21628.0,Dead,WITH TUMOR,30.0,30.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,30.0,1.0,30.0,nan,nan,1.0,30.0,1
TCGA-14-1795-01,TCGA-14-1795,GBM,66.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-24375.0,Dead,WITH TUMOR,60.0,60.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,60.0,1.0,60.0,nan,nan,1.0,60.0,1
TCGA-14-1821-01,TCGA-14-1821,GBM,31.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-11329.0,Dead,WITH TUMOR,541.0,541.0,nan,Recurrence,nan,nan,331.0,nan,nan,nan,1.0,541.0,1.0,541.0,nan,nan,1.0,331.0,1
TCGA-14-1823-01,TCGA-14-1823,GBM,58.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-21384.0,Dead,WITH TUMOR,543.0,543.0,nan,Recurrence,nan,nan,140.0,nan,nan,nan,1.0,543.0,1.0,543.0,nan,nan,1.0,140.0,1
TCGA-14-1825-01,TCGA-14-1825,GBM,70.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-25684.0,Dead,WITH TUMOR,nan,232.0,nan,Progression of Disease,nan,nan,82.0,nan,nan,nan,1.0,232.0,1.0,232.0,nan,nan,1.0,82.0,1
TCGA-14-1827-01,TCGA-14-1827,GBM,51.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,1998.0,nan,-18828.0,Dead,nan,179.0,179.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,179.0,nan,179.0,nan,nan,0.0,179.0,1
TCGA-14-1829-01,TCGA-14-1829,GBM,57.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-20929.0,Alive,WITH TUMOR,218.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,218.0,0.0,218.0,nan,nan,0.0,218.0,0
TCGA-14-2554-01,TCGA-14-2554,GBM,52.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2002.0,nan,-19090.0,Dead,WITH TUMOR,532.0,532.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,532.0,1.0,532.0,nan,nan,1.0,532.0,1
TCGA-14-2555-01,TCGA-14-2555,GBM,44.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-16259.0,Alive,nan,242.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,242.0,0.0,242.0,nan,nan,0.0,242.0,0
TCGA-14-3476-01,TCGA-14-3476,GBM,74.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-27172.0,Dead,nan,12.0,12.0,nan,Progression of Disease,nan,nan,9.0,nan,nan,nan,1.0,12.0,nan,12.0,nan,nan,1.0,9.0,1
TCGA-14-3477-01,TCGA-14-3477,GBM,38.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-14082.0,Alive,WITH TUMOR,115.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,115.0,0.0,115.0,nan,nan,0.0,115.0,1
TCGA-14-4157-01,TCGA-14-4157,GBM,40.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-14816.0,Alive,nan,104.0,nan,nan,Progression of Disease,nan,nan,96.0,nan,nan,nan,0.0,104.0,0.0,104.0,nan,nan,1.0,96.0,0
TCGA-15-0742-01,TCGA-15-0742,GBM,65.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-24050.0,Dead,nan,nan,419.0,nan,Progression of Disease,nan,nan,232.0,nan,nan,nan,1.0,419.0,nan,419.0,nan,nan,1.0,232.0,1
TCGA-15-1444-01,TCGA-15-1444,GBM,21.0,MALE,WHITE,nan,nan,Glioblastoma Multiforme (GBM),nan,2004.0,nan,-7827.0,Dead,WITH TUMOR,nan,1537.0,nan,Progression of Disease,nan,nan,1550.0,Complete Remission/Response,nan,nan,1.0,1537.0,1.0,1537.0,1.0,1550.0,1.0,1550.0,1
TCGA-15-1446-01,TCGA-15-1446,GBM,55.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-20355.0,Alive,WITH TUMOR,581.0,nan,nan,Recurrence,nan,nan,443.0,nan,nan,nan,0.0,581.0,0.0,581.0,nan,nan,1.0,443.0,1
TCGA-15-1447-01,TCGA-15-1447,GBM,36.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-13326.0,Alive,WITH TUMOR,1618.0,nan,nan,Recurrence,nan,nan,340.0,nan,nan,nan,0.0,1618.0,0.0,1618.0,nan,nan,1.0,340.0,1
TCGA-15-1449-01,TCGA-15-1449,GBM,65.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-23828.0,Dead,WITH TUMOR,nan,404.0,nan,Recurrence,nan,nan,74.0,nan,nan,nan,1.0,404.0,1.0,404.0,nan,nan,1.0,74.0,1
TCGA-16-0846-01,TCGA-16-0846,GBM,85.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-31111.0,Dead,WITH TUMOR,119.0,119.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,119.0,1.0,119.0,nan,nan,1.0,119.0,1
TCGA-16-0848-01,TCGA-16-0848,GBM,57.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-20848.0,Dead,WITH TUMOR,302.0,535.0,nan,Recurrence,nan,nan,129.0,nan,nan,nan,1.0,535.0,1.0,535.0,nan,nan,1.0,129.0,1
TCGA-16-0849-01,TCGA-16-0849,GBM,54.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-19939.0,Alive,nan,793.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,793.0,0.0,793.0,nan,nan,0.0,793.0,0
TCGA-16-0850-01,TCGA-16-0850,GBM,52.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-19281.0,Dead,WITH TUMOR,496.0,498.0,nan,Recurrence,nan,nan,83.0,nan,nan,nan,1.0,498.0,1.0,498.0,nan,nan,1.0,83.0,1
TCGA-16-0861-01,TCGA-16-0861,GBM,65.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-23778.0,nan,nan,131.0,nan,nan,Recurrence,nan,nan,94.0,nan,nan,nan,0.0,131.0,nan,131.0,nan,nan,1.0,94.0,1
TCGA-16-1045-01,TCGA-16-1045,GBM,49.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-18195.0,Dead,WITH TUMOR,883.0,883.0,nan,Recurrence,nan,nan,654.0,nan,nan,nan,1.0,883.0,1.0,883.0,nan,nan,1.0,654.0,1
TCGA-16-1047-01,TCGA-16-1047,GBM,66.0,FEMALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-24301.0,Dead,WITH TUMOR,25.0,139.0,nan,Progression of Disease,nan,nan,25.0,nan,nan,nan,1.0,139.0,1.0,139.0,nan,nan,1.0,25.0,1
TCGA-16-1055-01,TCGA-16-1055,GBM,48.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2004.0,nan,-17840.0,Dead,WITH TUMOR,301.0,313.0,nan,Recurrence,nan,nan,288.0,nan,nan,nan,1.0,313.0,1.0,313.0,nan,nan,1.0,288.0,1
TCGA-16-1056-01,TCGA-16-1056,GBM,55.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-20310.0,Dead,WITH TUMOR,406.0,426.0,nan,Recurrence,nan,nan,239.0,nan,nan,nan,1.0,426.0,1.0,426.0,nan,nan,1.0,239.0,1
TCGA-16-1060-01,TCGA-16-1060,GBM,70.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-25813.0,Dead,WITH TUMOR,111.0,278.0,nan,Progression of Disease,nan,nan,111.0,nan,nan,nan,1.0,278.0,1.0,278.0,nan,nan,1.0,111.0,1
TCGA-16-1062-01,TCGA-16-1062,GBM,57.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-21148.0,Dead,WITH TUMOR,556.0,646.0,nan,Progression of Disease,nan,nan,518.0,nan,nan,nan,1.0,646.0,1.0,646.0,nan,nan,1.0,518.0,1
TCGA-16-1063-01,TCGA-16-1063,GBM,72.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-26313.0,Dead,WITH TUMOR,425.0,425.0,nan,Progression of Disease,nan,nan,369.0,nan,nan,nan,1.0,425.0,1.0,425.0,nan,nan,1.0,369.0,1
TCGA-16-1460-01,TCGA-16-1460,GBM,36.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-13208.0,Alive,nan,195.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,195.0,0.0,195.0,nan,nan,0.0,195.0,1
TCGA-19-0955-01,TCGA-19-0955,GBM,71.0,MALE,ASIAN,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-25974.0,Alive,TUMOR FREE,358.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,358.0,0.0,358.0,nan,nan,0.0,358.0,0
TCGA-19-0957-02,TCGA-19-0957,GBM,48.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-17714.0,Dead,WITH TUMOR,666.0,666.0,nan,Recurrence,nan,nan,50.0,nan,nan,nan,1.0,666.0,1.0,666.0,nan,nan,1.0,50.0,1
TCGA-19-0957-01,TCGA-19-0957,GBM,48.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-17714.0,Dead,WITH TUMOR,666.0,666.0,nan,Recurrence,nan,nan,50.0,nan,nan,nan,1.0,666.0,1.0,666.0,nan,nan,1.0,50.0,1
TCGA-19-0960-01,TCGA-19-0960,GBM,83.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-30364.0,Alive,nan,262.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,262.0,0.0,262.0,nan,nan,0.0,262.0,1
TCGA-19-0962-01,TCGA-19-0962,GBM,77.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-28382.0,Dead,nan,13.0,20.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,20.0,nan,20.0,nan,nan,0.0,20.0,1
TCGA-19-0963-01,TCGA-19-0963,GBM,61.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-22326.0,Dead,WITH TUMOR,434.0,434.0,nan,Recurrence,nan,nan,310.0,nan,nan,nan,1.0,434.0,1.0,434.0,nan,nan,1.0,310.0,1
TCGA-19-0964-01,TCGA-19-0964,GBM,70.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-25800.0,Alive,WITH TUMOR,103.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,103.0,0.0,103.0,nan,nan,0.0,103.0,0
TCGA-19-1385-01,TCGA-19-1385,GBM,69.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-25459.0,Dead,WITH TUMOR,327.0,327.0,nan,Recurrence,nan,nan,177.0,nan,nan,nan,1.0,327.0,1.0,327.0,nan,nan,1.0,177.0,1
TCGA-19-1386-01,TCGA-19-1386,GBM,51.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-18678.0,Dead,WITH TUMOR,276.0,276.0,nan,Recurrence,nan,nan,237.0,nan,nan,nan,1.0,276.0,1.0,276.0,nan,nan,1.0,237.0,1
TCGA-19-1387-01,TCGA-19-1387,GBM,81.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-29892.0,Alive,WITH TUMOR,181.0,nan,nan,Recurrence,nan,nan,79.0,nan,nan,nan,0.0,181.0,0.0,181.0,nan,nan,1.0,79.0,1
TCGA-19-1388-01,TCGA-19-1388,GBM,58.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-21368.0,Dead,WITH TUMOR,394.0,394.0,nan,Progression of Disease,nan,nan,148.0,nan,nan,nan,1.0,394.0,1.0,394.0,nan,nan,1.0,148.0,1
TCGA-19-1389-02,TCGA-19-1389,GBM,51.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-18659.0,Dead,WITH TUMOR,141.0,141.0,nan,Recurrence,nan,nan,81.0,nan,nan,nan,1.0,141.0,1.0,141.0,nan,nan,1.0,81.0,1
TCGA-19-1389-01,TCGA-19-1389,GBM,51.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-18659.0,Dead,WITH TUMOR,141.0,141.0,nan,Recurrence,nan,nan,81.0,nan,nan,nan,1.0,141.0,1.0,141.0,nan,nan,1.0,81.0,1
TCGA-19-1390-01,TCGA-19-1390,GBM,63.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-23063.0,Dead,nan,772.0,772.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,772.0,nan,772.0,nan,nan,0.0,772.0,1
TCGA-19-1392-01,TCGA-19-1392,GBM,72.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-26593.0,Dead,nan,106.0,111.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,111.0,nan,111.0,nan,nan,0.0,111.0,1
TCGA-19-1786-01,TCGA-19-1786,GBM,64.0,FEMALE,ASIAN,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-23568.0,Alive,TUMOR FREE,218.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,218.0,0.0,218.0,nan,nan,0.0,218.0,0
TCGA-19-1787-01,TCGA-19-1787,GBM,48.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-17894.0,Dead,WITH TUMOR,385.0,385.0,nan,Recurrence,nan,nan,308.0,nan,nan,nan,1.0,385.0,1.0,385.0,nan,nan,1.0,308.0,1
TCGA-19-1788-01,TCGA-19-1788,GBM,39.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-14301.0,Dead,nan,112.0,112.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,112.0,nan,112.0,nan,nan,0.0,112.0,1
TCGA-19-1789-01,TCGA-19-1789,GBM,69.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-25282.0,Dead,nan,99.0,99.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,99.0,nan,99.0,nan,nan,0.0,99.0,1
TCGA-19-1790-01,TCGA-19-1790,GBM,56.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-20626.0,Dead,WITH TUMOR,154.0,154.0,nan,Progression of Disease,nan,nan,88.0,nan,nan,nan,1.0,154.0,1.0,154.0,nan,nan,1.0,88.0,1
TCGA-19-1791-01,TCGA-19-1791,GBM,82.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-30065.0,Alive,WITH TUMOR,4.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4.0,0.0,4.0,nan,nan,0.0,4.0,1
TCGA-19-2619-01,TCGA-19-2619,GBM,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-20159.0,Alive,WITH TUMOR,294.0,nan,nan,Progression of Disease,nan,nan,146.0,nan,nan,nan,0.0,294.0,0.0,294.0,nan,nan,1.0,146.0,1
TCGA-19-2620-01,TCGA-19-2620,GBM,70.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-25665.0,Dead,TUMOR FREE,148.0,148.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,148.0,0.0,148.0,nan,nan,0.0,148.0,1
TCGA-19-2621-01,TCGA-19-2621,GBM,83.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-30429.0,Dead,nan,33.0,33.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,33.0,nan,33.0,nan,nan,0.0,33.0,1
TCGA-19-2623-01,TCGA-19-2623,GBM,65.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-23835.0,Alive,TUMOR FREE,229.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,229.0,0.0,229.0,nan,nan,0.0,229.0,0
TCGA-19-2624-01,TCGA-19-2624,GBM,51.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-18891.0,Dead,TUMOR FREE,5.0,5.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,5.0,0.0,5.0,nan,nan,0.0,5.0,1
TCGA-19-2625-01,TCGA-19-2625,GBM,76.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-27930.0,Dead,TUMOR FREE,124.0,124.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,124.0,0.0,124.0,nan,nan,0.0,124.0,1
TCGA-19-2629-01,TCGA-19-2629,GBM,60.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-22257.0,Dead,WITH TUMOR,501.0,737.0,nan,Progression of Disease,nan,nan,145.0,nan,nan,nan,1.0,737.0,1.0,737.0,nan,nan,1.0,145.0,1
TCGA-19-2631-01,TCGA-19-2631,GBM,74.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-27200.0,Dead,TUMOR FREE,213.0,213.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,213.0,0.0,213.0,nan,nan,0.0,213.0,1
TCGA-19-4065-02,TCGA-19-4065,GBM,36.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-13257.0,Alive,WITH TUMOR,214.0,nan,nan,Recurrence,nan,nan,70.0,nan,nan,nan,0.0,214.0,0.0,214.0,nan,nan,1.0,70.0,1
TCGA-19-4065-01,TCGA-19-4065,GBM,36.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-13257.0,Alive,WITH TUMOR,214.0,nan,nan,Recurrence,nan,nan,70.0,nan,nan,nan,0.0,214.0,0.0,214.0,nan,nan,1.0,70.0,1
TCGA-19-4068-01,TCGA-19-4068,GBM,68.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-24945.0,Alive,TUMOR FREE,137.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,137.0,0.0,137.0,nan,nan,0.0,137.0,0
TCGA-19-5947-01,TCGA-19-5947,GBM,47.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-17218.0,Dead,WITH TUMOR,202.0,202.0,nan,Progression of Disease,nan,nan,43.0,nan,nan,nan,1.0,202.0,1.0,202.0,nan,nan,1.0,43.0,1
TCGA-19-5950-01,TCGA-19-5950,GBM,52.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-19244.0,Dead,WITH TUMOR,nan,523.0,nan,Recurrence,nan,nan,294.0,Progressive Disease,nan,nan,1.0,523.0,1.0,523.0,nan,nan,1.0,294.0,1
TCGA-19-5951-01,TCGA-19-5951,GBM,76.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-27995.0,Dead,WITH TUMOR,244.0,244.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,244.0,1.0,244.0,nan,nan,1.0,244.0,1
TCGA-19-5952-01,TCGA-19-5952,GBM,62.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-22841.0,Dead,nan,567.0,575.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,575.0,nan,575.0,nan,nan,0.0,575.0,1
TCGA-19-5953-01,TCGA-19-5953,GBM,58.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-21204.0,Dead,WITH TUMOR,144.0,144.0,nan,Progression of Disease,nan,nan,119.0,nan,nan,nan,1.0,144.0,1.0,144.0,nan,nan,1.0,119.0,1
TCGA-19-5954-01,TCGA-19-5954,GBM,72.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-26355.0,Dead,WITH TUMOR,nan,368.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,368.0,1.0,368.0,nan,nan,1.0,368.0,1
TCGA-19-5955-01,TCGA-19-5955,GBM,83.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-30550.0,Dead,nan,54.0,54.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,54.0,nan,54.0,nan,nan,0.0,54.0,1
TCGA-19-5956-01,TCGA-19-5956,GBM,53.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-19591.0,Dead,WITH TUMOR,nan,684.0,nan,Progression of Disease,nan,nan,647.0,Stable Disease,nan,nan,1.0,684.0,1.0,684.0,nan,nan,1.0,647.0,1
TCGA-19-5958-01,TCGA-19-5958,GBM,56.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-20466.0,Dead,WITH TUMOR,nan,428.0,nan,Recurrence,nan,nan,356.0,Progressive Disease,nan,nan,1.0,428.0,1.0,428.0,nan,nan,1.0,356.0,1
TCGA-19-5959-01,TCGA-19-5959,GBM,77.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-28449.0,Dead,WITH TUMOR,nan,511.0,nan,Recurrence,nan,nan,119.0,Progressive Disease,nan,nan,1.0,511.0,1.0,511.0,nan,nan,1.0,119.0,1
TCGA-19-5960-01,TCGA-19-5960,GBM,56.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-20641.0,Dead,WITH TUMOR,nan,455.0,nan,Recurrence,nan,nan,382.0,Stable Disease,nan,nan,1.0,455.0,1.0,455.0,nan,nan,1.0,382.0,1
TCGA-19-A60I-01,TCGA-19-A60I,GBM,39.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Glioblastoma Multiforme (GBM),nan,2012.0,nan,-14437.0,Alive,WITH TUMOR,541.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,541.0,0.0,541.0,nan,nan,0.0,541.0,0
TCGA-19-A6J4-01,TCGA-19-A6J4,GBM,68.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Glioblastoma Multiforme (GBM),nan,2013.0,nan,-25058.0,Dead,WITH TUMOR,nan,121.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,121.0,1.0,121.0,nan,nan,1.0,121.0,1
TCGA-19-A6J5-01,TCGA-19-A6J5,GBM,40.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Glioblastoma Multiforme (GBM),nan,2012.0,nan,-14970.0,Alive,WITH TUMOR,868.0,nan,nan,Progression of Disease,nan,nan,784.0,Stable Disease,nan,nan,0.0,868.0,0.0,868.0,nan,nan,1.0,784.0,0
TCGA-26-1438-01,TCGA-26-1438,GBM,36.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-13489.0,Alive,WITH TUMOR,305.0,nan,nan,Progression of Disease,nan,nan,158.0,nan,nan,nan,0.0,305.0,0.0,305.0,nan,nan,1.0,158.0,1
TCGA-26-1439-01,TCGA-26-1439,GBM,63.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-23302.0,Dead,WITH TUMOR,nan,422.0,nan,Progression of Disease,nan,nan,284.0,nan,nan,nan,1.0,422.0,1.0,422.0,nan,nan,1.0,284.0,1
TCGA-26-1440-01,TCGA-26-1440,GBM,48.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-17684.0,Alive,WITH TUMOR,296.0,nan,nan,Recurrence,nan,nan,233.0,nan,nan,nan,0.0,296.0,0.0,296.0,nan,nan,1.0,233.0,1
TCGA-26-1442-01,TCGA-26-1442,GBM,43.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-15950.0,Alive,WITH TUMOR,953.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,953.0,0.0,953.0,nan,nan,0.0,953.0,0
TCGA-26-1443-01,TCGA-26-1443,GBM,60.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-21990.0,Alive,WITH TUMOR,217.0,nan,nan,Progression of Disease,nan,nan,217.0,nan,nan,nan,0.0,217.0,0.0,217.0,nan,nan,1.0,217.0,1
TCGA-26-1799-01,TCGA-26-1799,GBM,68.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-25171.0,Dead,WITH TUMOR,285.0,285.0,nan,Recurrence,nan,nan,213.0,nan,nan,nan,1.0,285.0,1.0,285.0,nan,nan,1.0,213.0,1
TCGA-26-5132-01,TCGA-26-5132,GBM,74.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-27196.0,Alive,TUMOR FREE,286.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,286.0,0.0,286.0,nan,nan,0.0,286.0,0
TCGA-26-5133-01,TCGA-26-5133,GBM,59.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-21560.0,Alive,TUMOR FREE,452.0,nan,nan,Progression of Disease,nan,nan,370.0,nan,nan,nan,0.0,452.0,0.0,452.0,nan,nan,1.0,370.0,0
TCGA-26-5134-01,TCGA-26-5134,GBM,74.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-27111.0,Alive,TUMOR FREE,167.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,167.0,0.0,167.0,nan,nan,0.0,167.0,0
TCGA-26-5135-01,TCGA-26-5135,GBM,72.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-26490.0,Dead,nan,nan,270.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,270.0,nan,270.0,nan,nan,0.0,270.0,1
TCGA-26-5136-01,TCGA-26-5136,GBM,78.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-28496.0,Dead,WITH TUMOR,nan,577.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,577.0,1.0,577.0,nan,nan,1.0,577.0,1
TCGA-26-5139-01,TCGA-26-5139,GBM,65.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-23782.0,Alive,WITH TUMOR,48.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,48.0,0.0,48.0,nan,nan,0.0,48.0,1
TCGA-26-6173-01,TCGA-26-6173,GBM,57.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-21093.0,Alive,TUMOR FREE,241.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,241.0,0.0,241.0,nan,nan,0.0,241.0,0
TCGA-26-6174-01,TCGA-26-6174,GBM,65.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2011.0,nan,-23884.0,Alive,nan,71.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,71.0,0.0,71.0,nan,nan,0.0,71.0,0
TCGA-26-A7UX-01,TCGA-26-A7UX,GBM,47.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Glioblastoma Multiforme (GBM),nan,2013.0,nan,-17365.0,Alive,WITH TUMOR,588.0,nan,nan,Recurrence,nan,nan,407.0,Stable Disease,nan,nan,0.0,588.0,0.0,588.0,nan,nan,1.0,407.0,0
TCGA-27-1830-01,TCGA-27-1830,GBM,57.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-21131.0,Dead,WITH TUMOR,146.0,154.0,nan,Recurrence,nan,nan,124.0,nan,nan,nan,1.0,154.0,1.0,154.0,nan,nan,1.0,124.0,1
TCGA-27-1831-01,TCGA-27-1831,GBM,66.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-24447.0,Dead,WITH TUMOR,505.0,505.0,nan,Progression of Disease,nan,nan,144.0,nan,nan,nan,1.0,505.0,1.0,505.0,nan,nan,1.0,144.0,1
TCGA-27-1832-01,TCGA-27-1832,GBM,59.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-21678.0,Dead,WITH TUMOR,0.0,300.0,nan,Progression of Disease,nan,nan,176.0,nan,nan,nan,1.0,300.0,1.0,300.0,nan,nan,1.0,176.0,1
TCGA-27-1833-01,TCGA-27-1833,GBM,67.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-24592.0,Dead,WITH TUMOR,555.0,737.0,nan,Recurrence,nan,nan,469.0,nan,nan,nan,1.0,737.0,1.0,737.0,nan,nan,1.0,469.0,1
TCGA-27-1834-01,TCGA-27-1834,GBM,56.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2006.0,nan,-20568.0,Dead,WITH TUMOR,1008.0,1233.0,nan,Recurrence,nan,nan,335.0,nan,nan,nan,1.0,1233.0,1.0,1233.0,nan,nan,1.0,335.0,1
TCGA-27-1835-01,TCGA-27-1835,GBM,53.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-19444.0,Dead,WITH TUMOR,648.0,648.0,nan,Progression of Disease,nan,nan,157.0,nan,nan,nan,1.0,648.0,1.0,648.0,nan,nan,1.0,157.0,1
TCGA-27-1836-01,TCGA-27-1836,GBM,33.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-12060.0,Dead,WITH TUMOR,nan,914.0,nan,Progression of Disease,nan,nan,172.0,nan,nan,nan,1.0,914.0,1.0,914.0,nan,nan,1.0,172.0,1
TCGA-27-1837-01,TCGA-27-1837,GBM,36.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-13368.0,Dead,WITH TUMOR,427.0,427.0,nan,Progression of Disease,nan,nan,136.0,nan,nan,nan,1.0,427.0,1.0,427.0,nan,nan,1.0,136.0,1
TCGA-27-1838-01,TCGA-27-1838,GBM,59.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-21706.0,Dead,WITH TUMOR,350.0,350.0,nan,Progression of Disease,nan,nan,119.0,nan,nan,nan,1.0,350.0,1.0,350.0,nan,nan,1.0,119.0,1
TCGA-27-2518-01,TCGA-27-2518,GBM,52.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-19130.0,Dead,WITH TUMOR,753.0,753.0,nan,Progression of Disease,nan,nan,539.0,nan,nan,nan,1.0,753.0,1.0,753.0,nan,nan,1.0,539.0,1
TCGA-27-2519-01,TCGA-27-2519,GBM,48.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-17715.0,Dead,WITH TUMOR,nan,550.0,nan,Progression of Disease,nan,nan,256.0,nan,nan,nan,1.0,550.0,1.0,550.0,nan,nan,1.0,256.0,1
TCGA-27-2521-01,TCGA-27-2521,GBM,34.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-12685.0,Dead,WITH TUMOR,nan,510.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,510.0,1.0,510.0,nan,nan,1.0,510.0,1
TCGA-27-2523-01,TCGA-27-2523,GBM,63.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-23034.0,Dead,WITH TUMOR,489.0,489.0,nan,Progression of Disease,nan,nan,402.0,nan,nan,nan,1.0,489.0,1.0,489.0,nan,nan,1.0,402.0,1
TCGA-27-2524-01,TCGA-27-2524,GBM,56.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-20555.0,Dead,WITH TUMOR,231.0,231.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,231.0,1.0,231.0,nan,nan,1.0,231.0,1
TCGA-27-2526-01,TCGA-27-2526,GBM,79.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-28977.0,Dead,WITH TUMOR,87.0,87.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,87.0,1.0,87.0,nan,nan,1.0,87.0,1
TCGA-27-2527-01,TCGA-27-2527,GBM,81.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-29619.0,Dead,WITH TUMOR,438.0,438.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,438.0,1.0,438.0,nan,nan,1.0,438.0,1
TCGA-27-2528-01,TCGA-27-2528,GBM,62.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-22867.0,Dead,WITH TUMOR,480.0,480.0,nan,Progression of Disease,nan,nan,72.0,nan,nan,nan,1.0,480.0,1.0,480.0,nan,nan,1.0,72.0,1
TCGA-28-1745-01,TCGA-28-1745,GBM,76.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-27817.0,Alive,WITH TUMOR,345.0,nan,nan,Progression of Disease,nan,nan,317.0,nan,nan,nan,0.0,345.0,0.0,345.0,nan,nan,1.0,317.0,1
TCGA-28-1746-01,TCGA-28-1746,GBM,77.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-28302.0,Alive,nan,6.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,6.0,0.0,6.0,nan,nan,0.0,6.0,1
TCGA-28-1747-01,TCGA-28-1747,GBM,44.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-16301.0,Dead,nan,77.0,77.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,77.0,nan,77.0,nan,nan,0.0,77.0,1
TCGA-28-1749-01,TCGA-28-1749,GBM,73.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-26765.0,Alive,WITH TUMOR,280.0,nan,nan,Progression of Disease,nan,nan,280.0,nan,nan,nan,0.0,280.0,0.0,280.0,nan,nan,1.0,280.0,1
TCGA-28-1750-01,TCGA-28-1750,GBM,40.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-14817.0,Alive,WITH TUMOR,254.0,nan,nan,Progression of Disease,nan,nan,116.0,nan,nan,nan,0.0,254.0,0.0,254.0,nan,nan,1.0,116.0,1
TCGA-28-1751-01,TCGA-28-1751,GBM,61.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-22291.0,Alive,WITH TUMOR,232.0,nan,nan,Progression of Disease,nan,nan,219.0,nan,nan,nan,0.0,232.0,0.0,232.0,nan,nan,1.0,219.0,1
TCGA-28-1752-01,TCGA-28-1752,GBM,42.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-15565.0,Alive,WITH TUMOR,258.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,258.0,0.0,258.0,nan,nan,0.0,258.0,1
TCGA-28-1753-01,TCGA-28-1753,GBM,53.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-19366.0,Alive,WITH TUMOR,37.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,37.0,0.0,37.0,nan,nan,0.0,37.0,0
TCGA-28-1755-01,TCGA-28-1755,GBM,52.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-19263.0,Dead,WITH TUMOR,47.0,47.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,47.0,1.0,47.0,nan,nan,1.0,47.0,1
TCGA-28-1756-01,TCGA-28-1756,GBM,78.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-28649.0,Alive,TUMOR FREE,86.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,86.0,0.0,86.0,nan,nan,0.0,86.0,0
TCGA-28-1757-01,TCGA-28-1757,GBM,71.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-26189.0,Alive,nan,4.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4.0,0.0,4.0,nan,nan,0.0,4.0,0
TCGA-28-1760-01,TCGA-28-1760,GBM,48.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-17758.0,Alive,WITH TUMOR,143.0,nan,nan,Progression of Disease,nan,nan,105.0,nan,nan,nan,0.0,143.0,0.0,143.0,nan,nan,1.0,105.0,1
TCGA-28-2499-01,TCGA-28-2499,GBM,59.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-21838.0,nan,nan,95.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,95.0,nan,95.0,nan,nan,0.0,95.0,0
TCGA-28-2502-01,TCGA-28-2502,GBM,65.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-23807.0,Alive,nan,20.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,20.0,0.0,20.0,nan,nan,0.0,20.0,0
TCGA-28-2506-01,TCGA-28-2506,GBM,63.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-23292.0,Alive,WITH TUMOR,205.0,nan,nan,Progression of Disease,nan,nan,84.0,nan,nan,nan,0.0,205.0,0.0,205.0,nan,nan,1.0,84.0,1
TCGA-28-2509-01,TCGA-28-2509,GBM,77.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-28240.0,Alive,nan,145.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,145.0,0.0,145.0,nan,nan,0.0,145.0,0
TCGA-28-2512-01,TCGA-28-2512,GBM,37.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-13664.0,Dead,WITH TUMOR,343.0,343.0,nan,Progression of Disease,nan,nan,193.0,nan,nan,nan,1.0,343.0,1.0,343.0,nan,nan,1.0,193.0,1
TCGA-28-2513-01,TCGA-28-2513,GBM,69.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-25421.0,Alive,WITH TUMOR,222.0,nan,nan,Progression of Disease,nan,nan,75.0,nan,nan,nan,0.0,222.0,0.0,222.0,nan,nan,1.0,75.0,1
TCGA-28-2514-01,TCGA-28-2514,GBM,45.0,MALE,ASIAN,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-16737.0,Alive,nan,160.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,160.0,0.0,160.0,nan,nan,0.0,160.0,0
TCGA-28-5204-01,TCGA-28-5204,GBM,72.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-26490.0,Dead,WITH TUMOR,nan,454.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,454.0,1.0,454.0,nan,nan,1.0,454.0,1
TCGA-28-5207-01,TCGA-28-5207,GBM,71.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-25975.0,Dead,WITH TUMOR,275.0,343.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,343.0,1.0,343.0,nan,nan,1.0,343.0,1
TCGA-28-5208-01,TCGA-28-5208,GBM,52.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-19053.0,Dead,WITH TUMOR,nan,544.0,nan,nan,nan,nan,148.0,Progressive Disease,nan,nan,1.0,544.0,1.0,544.0,nan,nan,1.0,148.0,1
TCGA-28-5209-01,TCGA-28-5209,GBM,66.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-24362.0,Alive,nan,442.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,442.0,0.0,442.0,nan,nan,0.0,442.0,0
TCGA-28-5211-01,TCGA-28-5211,GBM,42.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-15507.0,Alive,WITH TUMOR,358.0,nan,nan,nan,nan,nan,225.0,nan,nan,nan,0.0,358.0,0.0,358.0,nan,nan,1.0,225.0,1
TCGA-28-5213-01,TCGA-28-5213,GBM,72.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-26491.0,Alive,WITH TUMOR,951.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,951.0,0.0,951.0,nan,nan,0.0,951.0,0
TCGA-28-5214-01,TCGA-28-5214,GBM,53.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-19520.0,Dead,WITH TUMOR,nan,713.0,nan,Locoregional Disease,nan,nan,247.0,nan,nan,nan,1.0,713.0,1.0,713.0,nan,nan,1.0,247.0,1
TCGA-28-5215-01,TCGA-28-5215,GBM,62.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-22686.0,Dead,WITH TUMOR,237.0,335.0,nan,nan,nan,nan,164.0,nan,nan,nan,1.0,335.0,1.0,335.0,nan,nan,1.0,164.0,1
TCGA-28-5216-01,TCGA-28-5216,GBM,52.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-19239.0,Alive,TUMOR FREE,415.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,415.0,0.0,415.0,nan,nan,0.0,415.0,0
TCGA-28-5218-01,TCGA-28-5218,GBM,63.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-23096.0,Dead,nan,128.0,157.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,157.0,nan,157.0,nan,nan,0.0,157.0,1
TCGA-28-5219-01,TCGA-28-5219,GBM,47.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-17254.0,Alive,TUMOR FREE,690.0,nan,nan,nan,nan,nan,258.0,nan,nan,nan,0.0,690.0,0.0,690.0,nan,nan,1.0,258.0,1
TCGA-28-5220-01,TCGA-28-5220,GBM,67.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-24622.0,Dead,WITH TUMOR,nan,388.0,nan,nan,nan,nan,262.0,nan,nan,nan,1.0,388.0,1.0,388.0,nan,nan,1.0,262.0,1
TCGA-28-6450-01,TCGA-28-6450,GBM,60.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-22177.0,Dead,WITH TUMOR,165.0,165.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,165.0,1.0,165.0,nan,nan,1.0,165.0,1
TCGA-32-1970-01,TCGA-32-1970,GBM,59.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-21613.0,Dead,WITH TUMOR,468.0,468.0,nan,Progression of Disease,nan,nan,408.0,nan,nan,nan,1.0,468.0,1.0,468.0,nan,nan,1.0,408.0,1
TCGA-32-1973-01,TCGA-32-1973,GBM,21.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-7756.0,Dead,WITH TUMOR,641.0,641.0,nan,Progression of Disease,nan,nan,507.0,nan,nan,nan,1.0,641.0,1.0,641.0,nan,nan,1.0,507.0,1
TCGA-32-1976-01,TCGA-32-1976,GBM,65.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-23798.0,Dead,nan,15.0,15.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,15.0,nan,15.0,nan,nan,0.0,15.0,1
TCGA-32-1977-01,TCGA-32-1977,GBM,63.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-23205.0,Alive,WITH TUMOR,3.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3.0,0.0,3.0,nan,nan,0.0,3.0,0
TCGA-32-1978-01,TCGA-32-1978,GBM,57.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-21054.0,Dead,WITH TUMOR,482.0,482.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,482.0,1.0,482.0,nan,nan,1.0,482.0,1
TCGA-32-1979-01,TCGA-32-1979,GBM,69.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-25252.0,Dead,WITH TUMOR,593.0,593.0,nan,Progression of Disease,nan,nan,265.0,nan,nan,nan,1.0,593.0,1.0,593.0,nan,nan,1.0,265.0,1
TCGA-32-1980-01,TCGA-32-1980,GBM,72.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-26467.0,Dead,WITH TUMOR,36.0,36.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,36.0,1.0,36.0,nan,nan,1.0,36.0,1
TCGA-32-1982-01,TCGA-32-1982,GBM,76.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-27764.0,Dead,WITH TUMOR,142.0,142.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,142.0,1.0,142.0,nan,nan,1.0,142.0,1
TCGA-32-1986-01,TCGA-32-1986,GBM,68.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-25061.0,Dead,WITH TUMOR,386.0,386.0,nan,Progression of Disease,nan,nan,233.0,nan,nan,nan,1.0,386.0,1.0,386.0,nan,nan,1.0,233.0,1
TCGA-32-1987-01,TCGA-32-1987,GBM,49.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-18091.0,Dead,WITH TUMOR,452.0,452.0,nan,Recurrence,nan,nan,68.0,nan,nan,nan,1.0,452.0,1.0,452.0,nan,nan,1.0,68.0,1
TCGA-32-1991-01,TCGA-32-1991,GBM,60.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-22021.0,Dead,WITH TUMOR,515.0,515.0,nan,Recurrence,nan,nan,345.0,nan,nan,nan,1.0,515.0,1.0,515.0,nan,nan,1.0,345.0,1
TCGA-32-2491-01,TCGA-32-2491,GBM,63.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-23131.0,Dead,WITH TUMOR,372.0,372.0,nan,Recurrence,nan,nan,70.0,nan,nan,nan,1.0,372.0,1.0,372.0,nan,nan,1.0,70.0,1
TCGA-32-2494-01,TCGA-32-2494,GBM,58.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-21198.0,Dead,WITH TUMOR,632.0,632.0,nan,Progression of Disease,nan,nan,488.0,nan,nan,nan,1.0,632.0,1.0,632.0,nan,nan,1.0,488.0,1
TCGA-32-2495-01,TCGA-32-2495,GBM,59.0,FEMALE,WHITE,nan,nan,Treated primary GBM,nan,2008.0,nan,-21860.0,Dead,WITH TUMOR,457.0,457.0,nan,Recurrence,nan,nan,252.0,nan,nan,nan,1.0,457.0,1.0,457.0,nan,nan,1.0,252.0,1
TCGA-32-2615-01,TCGA-32-2615,GBM,62.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-22916.0,Dead,WITH TUMOR,485.0,485.0,nan,Progression of Disease,nan,nan,131.0,nan,nan,nan,1.0,485.0,1.0,485.0,nan,nan,1.0,131.0,1
TCGA-32-2616-01,TCGA-32-2616,GBM,48.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-17781.0,Dead,WITH TUMOR,224.0,224.0,nan,Progression of Disease,nan,nan,182.0,nan,nan,nan,1.0,224.0,1.0,224.0,nan,nan,1.0,182.0,1
TCGA-32-2632-01,TCGA-32-2632,GBM,80.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-29281.0,Dead,WITH TUMOR,nan,269.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,269.0,1.0,269.0,nan,nan,1.0,269.0,1
TCGA-32-2634-01,TCGA-32-2634,GBM,82.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-29964.0,Alive,TUMOR FREE,693.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,693.0,0.0,693.0,nan,nan,0.0,693.0,0
TCGA-32-2638-01,TCGA-32-2638,GBM,67.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-24658.0,Dead,WITH TUMOR,nan,766.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,766.0,1.0,766.0,nan,nan,1.0,766.0,1
TCGA-32-4208-01,TCGA-32-4208,GBM,25.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-9213.0,Alive,WITH TUMOR,643.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,643.0,0.0,643.0,nan,nan,0.0,643.0,0
TCGA-32-4209-01,TCGA-32-4209,GBM,40.0,MALE,WHITE,nan,nan,Treated primary GBM,nan,2009.0,nan,-14903.0,Dead,WITH TUMOR,nan,618.0,nan,Recurrence,nan,nan,94.0,nan,nan,nan,1.0,618.0,1.0,618.0,nan,nan,1.0,94.0,1
TCGA-32-4210-01,TCGA-32-4210,GBM,73.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-26768.0,Dead,WITH TUMOR,113.0,113.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,113.0,1.0,113.0,nan,nan,1.0,113.0,1
TCGA-32-4211-01,TCGA-32-4211,GBM,56.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-20748.0,Dead,WITH TUMOR,383.0,383.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,383.0,1.0,383.0,nan,nan,1.0,383.0,1
TCGA-32-4213-01,TCGA-32-4213,GBM,47.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-17237.0,Alive,WITH TUMOR,604.0,nan,nan,Recurrence,nan,nan,353.0,nan,nan,nan,0.0,604.0,0.0,604.0,nan,nan,1.0,353.0,1
TCGA-32-4719-01,TCGA-32-4719,GBM,73.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-26691.0,Dead,WITH TUMOR,330.0,330.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,330.0,1.0,330.0,nan,nan,1.0,330.0,1
TCGA-32-5222-01,TCGA-32-5222,GBM,66.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-24134.0,Dead,WITH TUMOR,nan,585.0,nan,Progression of Disease,nan,nan,118.0,nan,nan,nan,1.0,585.0,1.0,585.0,nan,nan,1.0,118.0,1
TCGA-41-2571-01,TCGA-41-2571,GBM,89.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-32612.0,Dead,WITH TUMOR,26.0,26.0,nan,Progression of Disease,nan,nan,26.0,nan,nan,nan,1.0,26.0,1.0,26.0,nan,nan,1.0,26.0,1
TCGA-41-2572-01,TCGA-41-2572,GBM,67.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-24505.0,Dead,WITH TUMOR,406.0,406.0,nan,Progression of Disease,nan,nan,122.0,nan,nan,nan,1.0,406.0,1.0,406.0,nan,nan,1.0,122.0,1
TCGA-41-2573-01,TCGA-41-2573,GBM,59.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-21911.0,Alive,WITH TUMOR,272.0,nan,nan,Progression of Disease,nan,nan,167.0,nan,nan,nan,0.0,272.0,0.0,272.0,nan,nan,1.0,167.0,1
TCGA-41-2575-01,TCGA-41-2575,GBM,75.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-27587.0,Dead,WITH TUMOR,290.0,290.0,nan,Progression of Disease,nan,nan,131.0,nan,nan,nan,1.0,290.0,1.0,290.0,nan,nan,1.0,131.0,1
TCGA-41-3392-01,TCGA-41-3392,GBM,88.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-32351.0,Dead,WITH TUMOR,30.0,30.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,30.0,1.0,30.0,nan,nan,1.0,30.0,1
TCGA-41-3393-01,TCGA-41-3393,GBM,81.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-29904.0,Dead,WITH TUMOR,135.0,135.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,135.0,1.0,135.0,nan,nan,1.0,135.0,1
TCGA-41-3915-01,TCGA-41-3915,GBM,48.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-17880.0,Dead,WITH TUMOR,nan,360.0,nan,Locoregional Disease,nan,nan,288.0,nan,nan,nan,1.0,360.0,1.0,360.0,nan,nan,1.0,288.0,1
TCGA-41-4097-01,TCGA-41-4097,GBM,63.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-23107.0,Dead,WITH TUMOR,6.0,6.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,6.0,1.0,6.0,nan,nan,1.0,6.0,1
TCGA-41-5651-01,TCGA-41-5651,GBM,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-21698.0,Dead,WITH TUMOR,nan,460.0,nan,Progression of Disease,nan,nan,210.0,nan,nan,nan,1.0,460.0,1.0,460.0,nan,nan,1.0,210.0,1
TCGA-41-6646-01,TCGA-41-6646,GBM,73.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2011.0,nan,-26667.0,Dead,WITH TUMOR,nan,379.0,nan,Progression of Disease,nan,nan,200.0,nan,nan,nan,1.0,379.0,1.0,379.0,nan,nan,1.0,200.0,1
TCGA-4W-AA9R-01,TCGA-4W-AA9R,GBM,61.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Glioblastoma Multiforme (GBM),nan,2012.0,nan,-22317.0,Alive,TUMOR FREE,124.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,124.0,0.0,124.0,nan,nan,0.0,124.0,0
TCGA-4W-AA9S-01,TCGA-4W-AA9S,GBM,69.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Glioblastoma Multiforme (GBM),nan,2013.0,nan,-25545.0,Alive,TUMOR FREE,44.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,44.0,0.0,44.0,nan,nan,0.0,44.0,0
TCGA-4W-AA9T-01,TCGA-4W-AA9T,GBM,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Glioblastoma Multiforme (GBM),nan,2012.0,nan,-19801.0,Alive,TUMOR FREE,778.0,nan,nan,nan,nan,nan,749.0,Progressive Disease,nan,nan,0.0,778.0,0.0,778.0,nan,nan,1.0,749.0,0
TCGA-74-6573-01,TCGA-74-6573,GBM,67.0,MALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-24632.0,Dead,WITH TUMOR,nan,105.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,105.0,1.0,105.0,nan,nan,1.0,105.0,1
TCGA-74-6573-11,TCGA-74-6573,GBM,67.0,MALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-24632.0,Dead,WITH TUMOR,nan,105.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,105.0,1.0,105.0,nan,nan,1.0,105.0,1
TCGA-74-6575-01,TCGA-74-6575,GBM,73.0,FEMALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-26827.0,Alive,WITH TUMOR,636.0,nan,nan,nan,nan,nan,93.0,nan,nan,nan,0.0,636.0,0.0,636.0,nan,nan,1.0,93.0,1
TCGA-74-6577-01,TCGA-74-6577,GBM,51.0,MALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-18740.0,Alive,WITH TUMOR,132.0,nan,nan,nan,nan,nan,132.0,nan,nan,nan,0.0,132.0,0.0,132.0,nan,nan,1.0,132.0,1
TCGA-74-6578-01,TCGA-74-6578,GBM,58.0,MALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-21464.0,Alive,WITH TUMOR,436.0,nan,nan,nan,nan,nan,222.0,nan,nan,nan,0.0,436.0,0.0,436.0,nan,nan,1.0,222.0,1
TCGA-74-6581-01,TCGA-74-6581,GBM,77.0,MALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-28263.0,Alive,WITH TUMOR,250.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,250.0,0.0,250.0,nan,nan,0.0,250.0,0
TCGA-74-6584-01,TCGA-74-6584,GBM,55.0,FEMALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-20232.0,Alive,WITH TUMOR,228.0,nan,nan,nan,nan,nan,91.0,nan,nan,nan,0.0,228.0,0.0,228.0,nan,nan,1.0,91.0,1
TCGA-76-4925-01,TCGA-76-4925,GBM,76.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-28011.0,Dead,nan,146.0,146.0,nan,Progression of Disease,nan,nan,88.0,nan,nan,nan,1.0,146.0,nan,146.0,nan,nan,1.0,88.0,1
TCGA-76-4926-01,TCGA-76-4926,GBM,68.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-25085.0,Dead,WITH TUMOR,138.0,138.0,nan,Progression of Disease,nan,nan,34.0,nan,nan,nan,1.0,138.0,1.0,138.0,nan,nan,1.0,34.0,1
TCGA-76-4927-01,TCGA-76-4927,GBM,58.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-21193.0,Dead,WITH TUMOR,535.0,535.0,nan,Progression of Disease,nan,nan,416.0,nan,nan,nan,1.0,535.0,1.0,535.0,nan,nan,1.0,416.0,1
TCGA-76-4928-01,TCGA-76-4928,GBM,85.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-31267.0,Dead,WITH TUMOR,94.0,94.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,94.0,1.0,94.0,nan,nan,1.0,94.0,1
TCGA-76-4929-01,TCGA-76-4929,GBM,76.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-27831.0,Dead,WITH TUMOR,111.0,111.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,111.0,1.0,111.0,nan,nan,1.0,111.0,1
TCGA-76-4931-01,TCGA-76-4931,GBM,70.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2005.0,nan,-25812.0,Dead,WITH TUMOR,279.0,279.0,nan,Progression of Disease,nan,nan,112.0,nan,nan,nan,1.0,279.0,1.0,279.0,nan,nan,1.0,112.0,1
TCGA-76-4932-01,TCGA-76-4932,GBM,50.0,FEMALE,WHITE,nan,nan,Treated primary GBM,nan,2006.0,nan,-18433.0,Dead,WITH TUMOR,1458.0,1458.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1458.0,1.0,1458.0,nan,nan,1.0,1458.0,1
TCGA-76-4934-01,TCGA-76-4934,GBM,66.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-24319.0,Dead,TUMOR FREE,77.0,77.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,77.0,0.0,77.0,nan,nan,0.0,77.0,1
TCGA-76-4935-01,TCGA-76-4935,GBM,52.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-19231.0,Dead,TUMOR FREE,nan,1121.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,1121.0,0.0,1121.0,nan,nan,0.0,1121.0,1
TCGA-76-6191-01,TCGA-76-6191,GBM,57.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-20937.0,Dead,WITH TUMOR,508.0,508.0,nan,Progression of Disease,nan,nan,323.0,nan,nan,nan,1.0,508.0,1.0,508.0,nan,nan,1.0,323.0,1
TCGA-76-6192-01,TCGA-76-6192,GBM,74.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-27322.0,Dead,WITH TUMOR,100.0,100.0,nan,Progression of Disease,nan,nan,76.0,nan,nan,nan,1.0,100.0,1.0,100.0,nan,nan,1.0,76.0,1
TCGA-76-6193-01,TCGA-76-6193,GBM,78.0,MALE,nan,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-28742.0,Dead,nan,82.0,82.0,nan,Progression of Disease,nan,nan,64.0,nan,nan,nan,1.0,82.0,nan,82.0,nan,nan,1.0,64.0,1
TCGA-76-6280-01,TCGA-76-6280,GBM,57.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-20931.0,Dead,WITH TUMOR,346.0,346.0,nan,Progression of Disease,nan,nan,108.0,nan,nan,nan,1.0,346.0,1.0,346.0,nan,nan,1.0,108.0,1
TCGA-76-6282-01,TCGA-76-6282,GBM,63.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2007.0,nan,-23323.0,Dead,WITH TUMOR,519.0,519.0,nan,Progression of Disease,nan,nan,458.0,nan,nan,nan,1.0,519.0,1.0,519.0,nan,nan,1.0,458.0,1
TCGA-76-6283-01,TCGA-76-6283,GBM,71.0,FEMALE,WHITE,nan,nan,Glioblastoma Multiforme (GBM),nan,2007.0,nan,-26002.0,Dead,WITH TUMOR,nan,165.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,165.0,1.0,165.0,nan,nan,1.0,165.0,1
TCGA-76-6285-01,TCGA-76-6285,GBM,64.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2008.0,nan,-23674.0,Dead,WITH TUMOR,254.0,254.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,254.0,1.0,254.0,nan,nan,1.0,254.0,1
TCGA-76-6286-01,TCGA-76-6286,GBM,60.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-22173.0,Dead,WITH TUMOR,638.0,638.0,nan,Progression of Disease,nan,nan,180.0,nan,nan,nan,1.0,638.0,1.0,638.0,nan,nan,1.0,180.0,1
TCGA-76-6656-01,TCGA-76-6656,GBM,66.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-24265.0,Dead,nan,147.0,147.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,147.0,nan,147.0,nan,nan,0.0,147.0,1
TCGA-76-6657-01,TCGA-76-6657,GBM,74.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-27341.0,Dead,WITH TUMOR,153.0,153.0,nan,Progression of Disease,nan,nan,135.0,nan,nan,nan,1.0,153.0,1.0,153.0,nan,nan,1.0,135.0,1
TCGA-76-6660-01,TCGA-76-6660,GBM,73.0,MALE,WHITE,nan,nan,Glioblastoma Multiforme (GBM),nan,2010.0,nan,-26913.0,Dead,WITH TUMOR,nan,114.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,114.0,1.0,114.0,nan,nan,1.0,114.0,1
TCGA-76-6661-01,TCGA-76-6661,GBM,54.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2011.0,nan,-19965.0,Dead,WITH TUMOR,nan,727.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,727.0,1.0,727.0,nan,nan,1.0,727.0,1
TCGA-76-6662-01,TCGA-76-6662,GBM,58.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2011.0,nan,-21511.0,Dead,WITH TUMOR,nan,1048.0,nan,Progression of Disease,nan,nan,205.0,nan,nan,nan,1.0,1048.0,1.0,1048.0,nan,nan,1.0,205.0,1
TCGA-76-6663-01,TCGA-76-6663,GBM,44.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2011.0,nan,-16126.0,Dead,WITH TUMOR,nan,567.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,567.0,1.0,567.0,nan,nan,1.0,567.0,1
TCGA-76-6664-01,TCGA-76-6664,GBM,49.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2011.0,nan,-18054.0,Alive,WITH TUMOR,1101.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1101.0,0.0,1101.0,nan,nan,0.0,1101.0,0
TCGA-81-5910-01,TCGA-81-5910,GBM,64.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2009.0,nan,-23567.0,Dead,WITH TUMOR,nan,49.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,49.0,1.0,49.0,nan,nan,1.0,49.0,1
TCGA-81-5911-01,TCGA-81-5911,GBM,33.0,MALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-12292.0,Alive,WITH TUMOR,539.0,nan,nan,Progression of Disease,nan,nan,277.0,nan,nan,nan,0.0,539.0,0.0,539.0,nan,nan,1.0,277.0,1
TCGA-87-5896-01,TCGA-87-5896,GBM,50.0,FEMALE,WHITE,nan,nan,Untreated primary (de novo) GBM,nan,2010.0,nan,-18391.0,Alive,TUMOR FREE,800.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,800.0,0.0,800.0,0.0,800.0,0.0,800.0,0
TCGA-OX-A56R-01,TCGA-OX-A56R,GBM,68.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Glioblastoma Multiforme (GBM),nan,2012.0,nan,-25178.0,Dead,WITH TUMOR,nan,180.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,180.0,1.0,180.0,nan,nan,1.0,180.0,1
TCGA-RR-A6KA-01,TCGA-RR-A6KA,GBM,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Glioblastoma Multiforme (GBM),nan,2012.0,nan,-26582.0,Dead,WITH TUMOR,nan,191.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,191.0,1.0,191.0,nan,nan,1.0,191.0,1
TCGA-RR-A6KB-01,TCGA-RR-A6KB,GBM,51.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Glioblastoma Multiforme (GBM),nan,2007.0,nan,-18713.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-RR-A6KC-01,TCGA-RR-A6KC,GBM,55.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Glioblastoma Multiforme (GBM),nan,2010.0,nan,-20302.0,Dead,nan,nan,625.0,nan,Recurrence,nan,nan,369.0,Complete Remission/Response,nan,nan,1.0,625.0,nan,625.0,1.0,369.0,1.0,369.0,1
TCGA-4P-AA8J-01,TCGA-4P-AA8J,HNSC,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-24222.0,Alive,TUMOR FREE,102.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,102.0,0.0,102.0,nan,nan,0.0,102.0,0
TCGA-BA-4074-01,TCGA-BA-4074,HNSC,69.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2003.0,nan,-25282.0,Dead,WITH TUMOR,nan,462.0,nan,nan,Distant Metastasis,bone (humerus),396.0,Complete Remission/Response,nan,nan,1.0,462.0,1.0,462.0,nan,nan,1.0,396.0,1
TCGA-BA-4075-01,TCGA-BA-4075,HNSC,49.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2004.0,nan,-17951.0,Dead,WITH TUMOR,nan,283.0,nan,nan,Oral Cavity,nan,236.0,Progressive Disease,nan,nan,1.0,283.0,1.0,283.0,nan,nan,1.0,236.0,1
TCGA-BA-4076-01,TCGA-BA-4076,HNSC,39.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2003.0,nan,-14405.0,Dead,WITH TUMOR,nan,415.0,nan,nan,Larynx,nan,286.0,Complete Remission/Response,nan,nan,1.0,415.0,1.0,415.0,nan,nan,1.0,286.0,1
TCGA-BA-4077-01,TCGA-BA-4077,HNSC,45.0,FEMALE,WHITE,Stage IVA,Stage IVB,Head & Neck Squamous Cell Carcinoma,G2,2003.0,nan,-16536.0,Dead,WITH TUMOR,nan,1134.0,nan,nan,nan,nan,nan,Persistent Disease,nan,nan,1.0,1134.0,1.0,1134.0,nan,nan,1.0,1134.0,1
TCGA-BA-4078-01,TCGA-BA-4078,HNSC,83.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2003.0,nan,-30480.0,Dead,WITH TUMOR,nan,276.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,276.0,1.0,276.0,nan,nan,1.0,276.0,1
TCGA-BA-5149-01,TCGA-BA-5149,HNSC,47.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-17177.0,Dead,WITH TUMOR,nan,806.0,nan,nan,Distant Metastasis,Lung,389.0,Complete Remission/Response,nan,nan,1.0,806.0,1.0,806.0,nan,nan,1.0,389.0,1
TCGA-BA-5151-01,TCGA-BA-5151,HNSC,72.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2010.0,nan,-26569.0,Alive,TUMOR FREE,722.0,nan,nan,nan,nan,nan,517.0,Complete Remission/Response,nan,nan,0.0,722.0,0.0,722.0,nan,nan,1.0,517.0,0
TCGA-BA-5152-01,TCGA-BA-5152,HNSC,56.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-20783.0,Alive,TUMOR FREE,1288.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1288.0,0.0,1288.0,nan,nan,0.0,1288.0,0
TCGA-BA-5153-01,TCGA-BA-5153,HNSC,51.0,MALE,WHITE,nan,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2005.0,nan,-18743.0,Dead,WITH TUMOR,nan,1762.0,nan,nan,Distant Metastasis,bone (hip),1522.0,Complete Remission/Response,nan,nan,1.0,1762.0,1.0,1762.0,1.0,1522.0,1.0,1522.0,1
TCGA-BA-5555-01,TCGA-BA-5555,HNSC,54.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-19956.0,Alive,TUMOR FREE,520.0,nan,nan,nan,Oropharynx,L tonsil,248.0,Complete Remission/Response,nan,nan,0.0,520.0,0.0,520.0,nan,nan,1.0,248.0,2
TCGA-BA-5556-01,TCGA-BA-5556,HNSC,58.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2010.0,nan,-21444.0,Alive,TUMOR FREE,725.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,725.0,0.0,725.0,0.0,725.0,0.0,725.0,0
TCGA-BA-5557-01,TCGA-BA-5557,HNSC,41.0,FEMALE,nan,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-15247.0,Alive,TUMOR FREE,623.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,623.0,0.0,623.0,nan,nan,0.0,623.0,2
TCGA-BA-5558-01,TCGA-BA-5558,HNSC,65.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2006.0,nan,-23984.0,Alive,TUMOR FREE,1995.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1995.0,0.0,1995.0,nan,nan,0.0,1995.0,0
TCGA-BA-5559-01,TCGA-BA-5559,HNSC,71.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2006.0,nan,-26286.0,Dead,WITH TUMOR,nan,2083.0,nan,nan,Oropharynx,nan,1614.0,Complete Remission/Response,nan,nan,1.0,2083.0,1.0,2083.0,nan,nan,1.0,1614.0,1
TCGA-BA-6868-01,TCGA-BA-6868,HNSC,53.0,MALE,BLACK OR AFRICAN AMERICAN,nan,Stage IVB,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-19608.0,Dead,WITH TUMOR,nan,472.0,nan,nan,Distant Metastasis,L neck subdermal mets,344.0,Partial Remission/Response,nan,nan,1.0,472.0,1.0,472.0,nan,nan,1.0,344.0,1
TCGA-BA-6869-01,TCGA-BA-6869,HNSC,62.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-22765.0,Alive,TUMOR FREE,644.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,644.0,0.0,644.0,0.0,644.0,0.0,644.0,0
TCGA-BA-6870-01,TCGA-BA-6870,HNSC,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IVC,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-22222.0,Dead,nan,nan,451.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,451.0,nan,451.0,nan,nan,0.0,451.0,1
TCGA-BA-6871-01,TCGA-BA-6871,HNSC,75.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-27708.0,Dead,WITH TUMOR,nan,108.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,108.0,1.0,108.0,nan,nan,1.0,108.0,1
TCGA-BA-6872-01,TCGA-BA-6872,HNSC,47.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2004.0,nan,-17296.0,Dead,WITH TUMOR,nan,384.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,384.0,1.0,384.0,nan,nan,1.0,384.0,1
TCGA-BA-6873-01,TCGA-BA-6873,HNSC,28.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-10512.0,Alive,WITH TUMOR,122.0,nan,nan,nan,Oral Cavity,L Tongue and bilat. neck LNs,66.0,Progressive Disease,nan,nan,0.0,122.0,0.0,122.0,nan,nan,1.0,66.0,2
TCGA-BA-7269-01,TCGA-BA-7269,HNSC,61.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2010.0,nan,-22609.0,Alive,TUMOR FREE,1273.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1273.0,0.0,1273.0,0.0,1273.0,0.0,1273.0,0
TCGA-BA-A4IF-01,TCGA-BA-A4IF,HNSC,59.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-21635.0,Alive,TUMOR FREE,895.0,nan,nan,New Primary Tumor,nan,LUL Lung,463.0,Complete Remission/Response,nan,nan,0.0,895.0,0.0,895.0,nan,nan,1.0,463.0,0
TCGA-BA-A4IG-01,TCGA-BA-A4IG,HNSC,77.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2011.0,nan,-28402.0,Alive,TUMOR FREE,855.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,855.0,0.0,855.0,nan,nan,0.0,855.0,0
TCGA-BA-A4IH-01,TCGA-BA-A4IH,HNSC,57.0,MALE,WHITE,[Discrepancy],Stage IVA,Head & Neck Squamous Cell Carcinoma Basaloid Type,G3,2012.0,nan,-21094.0,Alive,TUMOR FREE,622.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,622.0,0.0,622.0,nan,nan,0.0,622.0,0
TCGA-BA-A4II-01,TCGA-BA-A4II,HNSC,46.0,MALE,WHITE,Stage II,Stage I,Head & Neck Squamous Cell Carcinoma,G1,2011.0,nan,-17011.0,Alive,WITH TUMOR,918.0,nan,nan,Locoregional Disease,Oral Cavity,L FOM,197.0,Complete Remission/Response,nan,nan,0.0,918.0,0.0,918.0,1.0,197.0,1.0,197.0,2
TCGA-BA-A6D8-01,TCGA-BA-A6D8,HNSC,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-21778.0,Alive,WITH TUMOR,850.0,nan,nan,Distant Metastasis,Oral Cavity,R Floor of Mouth,849.0,Complete Remission/Response,nan,nan,0.0,850.0,0.0,850.0,nan,nan,1.0,849.0,2
TCGA-BA-A6DA-01,TCGA-BA-A6DA,HNSC,41.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-15004.0,Alive,TUMOR FREE,351.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,351.0,0.0,351.0,nan,nan,0.0,351.0,2
TCGA-BA-A6DB-01,TCGA-BA-A6DB,HNSC,24.0,FEMALE,WHITE,Stage I,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2012.0,nan,-8967.0,Alive,WITH TUMOR,216.0,nan,nan,Locoregional Disease,Cervical Lymph Nodes,nan,208.0,Complete Remission/Response,nan,nan,0.0,216.0,0.0,216.0,1.0,208.0,1.0,208.0,2
TCGA-BA-A6DD-01,TCGA-BA-A6DD,HNSC,44.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-16401.0,Dead,WITH TUMOR,nan,173.0,nan,nan,Cervical Lymph Nodes,nan,96.0,Progressive Disease,nan,nan,1.0,173.0,1.0,173.0,nan,nan,1.0,96.0,1
TCGA-BA-A6DE-01,TCGA-BA-A6DE,HNSC,70.0,FEMALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-25874.0,Alive,TUMOR FREE,440.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,440.0,0.0,440.0,0.0,440.0,0.0,440.0,0
TCGA-BA-A6DF-01,TCGA-BA-A6DF,HNSC,80.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-29283.0,Dead,TUMOR FREE,nan,238.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,238.0,0.0,238.0,nan,nan,0.0,238.0,1
TCGA-BA-A6DG-01,TCGA-BA-A6DG,HNSC,49.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-18052.0,Dead,WITH TUMOR,nan,69.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,69.0,1.0,69.0,nan,nan,1.0,69.0,1
TCGA-BA-A6DI-01,TCGA-BA-A6DI,HNSC,62.0,MALE,BLACK OR AFRICAN AMERICAN,nan,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-22857.0,Dead,WITH TUMOR,nan,336.0,nan,nan,Larynx,nan,266.0,Complete Remission/Response,nan,nan,1.0,336.0,1.0,336.0,1.0,266.0,1.0,266.0,1
TCGA-BA-A6DJ-01,TCGA-BA-A6DJ,HNSC,62.0,MALE,ASIAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-22967.0,Dead,WITH TUMOR,nan,407.0,nan,nan,Distant Metastasis,Lungs,240.0,Complete Remission/Response,nan,nan,1.0,407.0,1.0,407.0,nan,nan,1.0,240.0,1
TCGA-BA-A6DL-01,TCGA-BA-A6DL,HNSC,59.0,MALE,WHITE,nan,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-21886.0,Alive,TUMOR FREE,623.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,623.0,0.0,623.0,0.0,623.0,0.0,623.0,0
TCGA-BA-A8YP-01,TCGA-BA-A8YP,HNSC,50.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVB,Stage IVB,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-18355.0,Alive,TUMOR FREE,499.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,499.0,0.0,499.0,nan,nan,0.0,499.0,0
TCGA-BB-4217-01,TCGA-BB-4217,HNSC,68.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2008.0,nan,-25020.0,Alive,WITH TUMOR,187.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,187.0,0.0,187.0,nan,nan,0.0,187.0,0
TCGA-BB-4223-01,TCGA-BB-4223,HNSC,48.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2003.0,nan,-17608.0,Alive,TUMOR FREE,3221.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3221.0,0.0,3221.0,nan,nan,0.0,3221.0,0
TCGA-BB-4224-01,TCGA-BB-4224,HNSC,52.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2004.0,nan,-19119.0,Alive,WITH TUMOR,278.0,nan,nan,nan,Oral Cavity,nan,175.0,Progressive Disease,nan,nan,0.0,278.0,0.0,278.0,nan,nan,1.0,175.0,2
TCGA-BB-4225-01,TCGA-BB-4225,HNSC,73.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2003.0,nan,-26687.0,Alive,WITH TUMOR,146.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,146.0,0.0,146.0,nan,nan,0.0,146.0,0
TCGA-BB-4227-01,TCGA-BB-4227,HNSC,66.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-24322.0,Alive,WITH TUMOR,134.0,nan,nan,Locoregional Recurrence,Hypopharynx,nan,85.0,Stable Disease,nan,nan,0.0,134.0,0.0,134.0,nan,nan,1.0,85.0,2
TCGA-BB-4228-01,TCGA-BB-4228,HNSC,50.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,GX,2010.0,nan,-18536.0,Alive,TUMOR FREE,559.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,559.0,0.0,559.0,0.0,559.0,0.0,559.0,0
TCGA-BB-7861-01,TCGA-BB-7861,HNSC,56.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,nan,2011.0,nan,-20563.0,Alive,TUMOR FREE,682.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,682.0,0.0,682.0,0.0,682.0,0.0,682.0,0
TCGA-BB-7862-01,TCGA-BB-7862,HNSC,67.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2011.0,nan,-24823.0,Alive,TUMOR FREE,1117.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1117.0,0.0,1117.0,nan,nan,0.0,1117.0,0
TCGA-BB-7863-01,TCGA-BB-7863,HNSC,43.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-15899.0,Alive,TUMOR FREE,1025.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1025.0,0.0,1025.0,0.0,1025.0,0.0,1025.0,0
TCGA-BB-7864-01,TCGA-BB-7864,HNSC,61.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-22317.0,Alive,TUMOR FREE,1527.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1527.0,0.0,1527.0,nan,nan,0.0,1527.0,0
TCGA-BB-7866-01,TCGA-BB-7866,HNSC,40.0,MALE,WHITE,nan,Stage III,Head & Neck Squamous Cell Carcinoma,GX,2010.0,nan,-14810.0,Alive,TUMOR FREE,1368.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1368.0,0.0,1368.0,0.0,1368.0,0.0,1368.0,0
TCGA-BB-7870-01,TCGA-BB-7870,HNSC,58.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2009.0,nan,-21443.0,Alive,TUMOR FREE,2016.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2016.0,0.0,2016.0,nan,nan,0.0,2016.0,0
TCGA-BB-7871-01,TCGA-BB-7871,HNSC,64.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-23409.0,Alive,WITH TUMOR,750.0,nan,nan,Distant Metastasis,Distant Metastasis,Pulmonary,428.0,Complete Remission/Response,nan,nan,0.0,750.0,0.0,750.0,nan,nan,1.0,428.0,2
TCGA-BB-7872-01,TCGA-BB-7872,HNSC,63.0,MALE,ASIAN,Stage I,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2011.0,nan,-23185.0,Alive,TUMOR FREE,1168.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1168.0,0.0,1168.0,nan,nan,0.0,1168.0,0
TCGA-BB-8596-01,TCGA-BB-8596,HNSC,69.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2005.0,nan,-25408.0,Alive,TUMOR FREE,2161.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2161.0,0.0,2161.0,nan,nan,0.0,2161.0,0
TCGA-BB-8601-01,TCGA-BB-8601,HNSC,84.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-30721.0,Alive,WITH TUMOR,624.0,nan,nan,Locoregional Disease,Oral Cavity,nan,440.0,Progressive Disease,nan,nan,0.0,624.0,0.0,624.0,nan,nan,1.0,440.0,2
TCGA-BB-A5HU-01,TCGA-BB-A5HU,HNSC,47.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-17502.0,Alive,TUMOR FREE,782.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,782.0,0.0,782.0,nan,nan,0.0,782.0,0
TCGA-BB-A5HY-01,TCGA-BB-A5HY,HNSC,64.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2012.0,nan,-23640.0,Dead,WITH TUMOR,nan,321.0,nan,Distant Metastasis,Distant Metastasis,Cerebellum,230.0,Complete Remission/Response,nan,nan,1.0,321.0,1.0,321.0,nan,nan,1.0,230.0,1
TCGA-BB-A5HZ-01,TCGA-BB-A5HZ,HNSC,65.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-23906.0,Alive,WITH TUMOR,827.0,nan,nan,Distant Metastasis,Distant Metastasis,Adrenal Gland,438.0,Complete Remission/Response,nan,nan,0.0,827.0,0.0,827.0,nan,nan,1.0,438.0,2
TCGA-BB-A6UM-01,TCGA-BB-A6UM,HNSC,52.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,GX,2010.0,nan,-19194.0,Alive,TUMOR FREE,393.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,393.0,0.0,393.0,0.0,393.0,0.0,393.0,0
TCGA-BB-A6UO-01,TCGA-BB-A6UO,HNSC,61.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-22506.0,Dead,WITH TUMOR,nan,268.0,nan,nan,Distant Metastasis,Lung,212.0,Complete Remission/Response,nan,nan,1.0,268.0,1.0,268.0,nan,nan,1.0,212.0,1
TCGA-C9-A47Z-01,TCGA-C9-A47Z,HNSC,72.0,FEMALE,ASIAN,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2011.0,nan,-26592.0,Dead,TUMOR FREE,nan,191.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,191.0,0.0,191.0,0.0,191.0,0.0,191.0,0
TCGA-C9-A480-01,TCGA-C9-A480,HNSC,45.0,FEMALE,ASIAN,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2011.0,nan,-16567.0,Alive,TUMOR FREE,386.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,386.0,0.0,386.0,0.0,386.0,0.0,386.0,0
TCGA-CN-4722-01,TCGA-CN-4722,HNSC,61.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2010.0,nan,-22299.0,Alive,TUMOR FREE,1483.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1483.0,0.0,1483.0,0.0,1483.0,0.0,1483.0,0
TCGA-CN-4723-01,TCGA-CN-4723,HNSC,67.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-24815.0,Alive,TUMOR FREE,1699.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1699.0,0.0,1699.0,nan,nan,0.0,1699.0,0
TCGA-CN-4725-01,TCGA-CN-4725,HNSC,60.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-22171.0,Alive,TUMOR FREE,1157.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1157.0,0.0,1157.0,0.0,1157.0,0.0,1157.0,0
TCGA-CN-4726-01,TCGA-CN-4726,HNSC,68.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-25194.0,Dead,WITH TUMOR,nan,142.0,nan,nan,Distant Metastasis,SKIN NECK,79.0,Progressive Disease,nan,nan,1.0,142.0,1.0,142.0,nan,nan,1.0,79.0,1
TCGA-CN-4727-01,TCGA-CN-4727,HNSC,56.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-20748.0,Alive,TUMOR FREE,1560.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1560.0,0.0,1560.0,nan,nan,0.0,1560.0,0
TCGA-CN-4728-01,TCGA-CN-4728,HNSC,56.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-20660.0,Alive,TUMOR FREE,1724.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1724.0,0.0,1724.0,nan,nan,0.0,1724.0,0
TCGA-CN-4729-01,TCGA-CN-4729,HNSC,73.0,MALE,WHITE,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-26713.0,Alive,TUMOR FREE,392.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,392.0,0.0,392.0,nan,nan,0.0,392.0,0
TCGA-CN-4730-01,TCGA-CN-4730,HNSC,62.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-22828.0,Alive,TUMOR FREE,817.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,817.0,0.0,817.0,nan,nan,0.0,817.0,0
TCGA-CN-4731-01,TCGA-CN-4731,HNSC,63.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2010.0,nan,-23194.0,Dead,WITH TUMOR,nan,998.0,nan,nan,Oral Cavity,nan,243.0,Persistent Disease,nan,nan,1.0,998.0,1.0,998.0,nan,nan,1.0,243.0,1
TCGA-CN-4733-01,TCGA-CN-4733,HNSC,61.0,MALE,WHITE,Stage III,Stage I,Head & Neck Squamous Cell Carcinoma,G3,2010.0,nan,-22561.0,Alive,TUMOR FREE,1586.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1586.0,0.0,1586.0,0.0,1586.0,0.0,1586.0,0
TCGA-CN-4734-01,TCGA-CN-4734,HNSC,70.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-25753.0,Alive,TUMOR FREE,1690.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1690.0,0.0,1690.0,0.0,1690.0,0.0,1690.0,0
TCGA-CN-4735-01,TCGA-CN-4735,HNSC,52.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2010.0,nan,-19107.0,Alive,TUMOR FREE,1737.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1737.0,0.0,1737.0,nan,nan,0.0,1737.0,0
TCGA-CN-4736-01,TCGA-CN-4736,HNSC,70.0,FEMALE,WHITE,nan,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-25683.0,Dead,WITH TUMOR,nan,395.0,nan,nan,Cervical Lymph Nodes,R NECK,209.0,Complete Remission/Response,nan,nan,1.0,395.0,1.0,395.0,1.0,209.0,1.0,209.0,1
TCGA-CN-4737-01,TCGA-CN-4737,HNSC,19.0,MALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-7301.0,Alive,TUMOR FREE,625.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,625.0,0.0,625.0,nan,nan,0.0,625.0,0
TCGA-CN-4738-01,TCGA-CN-4738,HNSC,53.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-19621.0,Dead,nan,nan,436.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,436.0,nan,436.0,nan,nan,0.0,436.0,1
TCGA-CN-4739-01,TCGA-CN-4739,HNSC,71.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-26081.0,Dead,WITH TUMOR,nan,1394.0,nan,Locoregional Recurrence,Oropharynx,"OROPHARYNX, OVERLAPPING",1302.0,Complete Remission/Response,nan,nan,1.0,1394.0,1.0,1394.0,nan,nan,1.0,1302.0,1
TCGA-CN-4740-01,TCGA-CN-4740,HNSC,79.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-29186.0,Dead,WITH TUMOR,nan,839.0,nan,nan,nan,PTERYGOID FOSSA,224.0,Complete Remission/Response,nan,nan,1.0,839.0,1.0,839.0,nan,nan,1.0,224.0,1
TCGA-CN-4741-01,TCGA-CN-4741,HNSC,75.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-27506.0,Alive,TUMOR FREE,2239.0,nan,nan,Locoregional Recurrence,Cervical Lymph Nodes,R NECK,1716.0,Complete Remission/Response,nan,nan,0.0,2239.0,0.0,2239.0,nan,nan,1.0,1716.0,2
TCGA-CN-4742-01,TCGA-CN-4742,HNSC,48.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2008.0,nan,-17793.0,Dead,WITH TUMOR,nan,397.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,397.0,1.0,397.0,nan,nan,1.0,397.0,1
TCGA-CN-5355-01,TCGA-CN-5355,HNSC,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-23670.0,Alive,TUMOR FREE,1278.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1278.0,0.0,1278.0,nan,nan,0.0,1278.0,0
TCGA-CN-5356-01,TCGA-CN-5356,HNSC,56.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-20540.0,Alive,TUMOR FREE,1409.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1409.0,0.0,1409.0,0.0,1409.0,0.0,1409.0,0
TCGA-CN-5358-01,TCGA-CN-5358,HNSC,60.0,MALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-22138.0,Dead,TUMOR FREE,nan,261.0,nan,nan,Cervical Lymph Nodes,nan,145.0,Complete Remission/Response,nan,nan,1.0,261.0,0.0,261.0,1.0,145.0,1.0,145.0,2
TCGA-CN-5359-01,TCGA-CN-5359,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-21858.0,Dead,WITH TUMOR,nan,377.0,nan,nan,Distant Metastasis,"LUNG, BONES, THUMB",356.0,Complete Remission/Response,nan,nan,1.0,377.0,1.0,377.0,nan,nan,1.0,356.0,1
TCGA-CN-5360-01,TCGA-CN-5360,HNSC,68.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-25034.0,Alive,TUMOR FREE,2169.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2169.0,0.0,2169.0,nan,nan,0.0,2169.0,0
TCGA-CN-5361-01,TCGA-CN-5361,HNSC,80.0,MALE,WHITE,Stage IVA,nan,Head & Neck Squamous Cell Carcinoma,G2,2007.0,nan,-29383.0,Dead,TUMOR FREE,nan,2120.0,nan,New Primary Tumor,nan,nan,2062.0,Complete Remission/Response,nan,nan,1.0,2120.0,0.0,2120.0,nan,nan,1.0,2062.0,1
TCGA-CN-5363-01,TCGA-CN-5363,HNSC,48.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVB,Stage IVB,Head & Neck Squamous Cell Carcinoma,G3,2007.0,nan,-17635.0,Dead,WITH TUMOR,nan,253.0,nan,nan,Distant Metastasis,BONE,53.0,Complete Remission/Response,nan,nan,1.0,253.0,1.0,253.0,nan,nan,1.0,53.0,1
TCGA-CN-5364-01,TCGA-CN-5364,HNSC,55.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2006.0,nan,-20362.0,Dead,TUMOR FREE,nan,493.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,493.0,0.0,493.0,nan,nan,0.0,493.0,0
TCGA-CN-5365-01,TCGA-CN-5365,HNSC,38.0,MALE,WHITE,Stage IVB,Stage IVC,Head & Neck Squamous Cell Carcinoma,G2,2006.0,nan,-14190.0,Dead,WITH TUMOR,nan,351.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,351.0,1.0,351.0,nan,nan,1.0,351.0,1
TCGA-CN-5366-01,TCGA-CN-5366,HNSC,51.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2006.0,nan,-18904.0,Dead,WITH TUMOR,nan,360.0,nan,nan,Cervical Lymph Nodes,L NECK,276.0,Complete Remission/Response,nan,nan,1.0,360.0,1.0,360.0,nan,nan,1.0,276.0,1
TCGA-CN-5367-01,TCGA-CN-5367,HNSC,60.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2006.0,nan,-22246.0,Dead,TUMOR FREE,nan,352.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,352.0,0.0,352.0,nan,nan,0.0,352.0,1
TCGA-CN-5369-01,TCGA-CN-5369,HNSC,90.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2006.0,nan,-32871.0,Dead,TUMOR FREE,nan,380.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,380.0,0.0,380.0,nan,nan,0.0,380.0,1
TCGA-CN-5370-01,TCGA-CN-5370,HNSC,78.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2006.0,nan,-28549.0,Dead,WITH TUMOR,nan,259.0,nan,nan,Oral Cavity,nan,123.0,Complete Remission/Response,nan,nan,1.0,259.0,1.0,259.0,1.0,123.0,1.0,123.0,1
TCGA-CN-5373-01,TCGA-CN-5373,HNSC,55.0,FEMALE,WHITE,Stage I,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2010.0,nan,-20143.0,Alive,TUMOR FREE,1584.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1584.0,0.0,1584.0,0.0,1584.0,0.0,1584.0,0
TCGA-CN-5374-01,TCGA-CN-5374,HNSC,56.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2007.0,nan,-20464.0,Dead,TUMOR FREE,nan,1732.0,nan,nan,Distant Metastasis,lung,1369.0,Complete Remission/Response,nan,nan,1.0,1732.0,0.0,1732.0,nan,nan,1.0,1369.0,1
TCGA-CN-6010-01,TCGA-CN-6010,HNSC,53.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-19475.0,Alive,TUMOR FREE,1523.0,nan,nan,New Primary Tumor,nan,nasal cavity,540.0,Complete Remission/Response,nan,nan,0.0,1523.0,0.0,1523.0,nan,nan,1.0,540.0,2
TCGA-CN-6011-01,TCGA-CN-6011,HNSC,57.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2010.0,nan,-21016.0,Alive,TUMOR FREE,933.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,933.0,0.0,933.0,nan,nan,0.0,933.0,0
TCGA-CN-6012-01,TCGA-CN-6012,HNSC,66.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-24286.0,Alive,TUMOR FREE,1460.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1460.0,0.0,1460.0,nan,nan,0.0,1460.0,0
TCGA-CN-6013-01,TCGA-CN-6013,HNSC,56.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2010.0,nan,-20703.0,Dead,WITH TUMOR,nan,727.0,nan,nan,Distant Metastasis,LUNG,323.0,Complete Remission/Response,nan,nan,1.0,727.0,1.0,727.0,nan,nan,1.0,323.0,1
TCGA-CN-6016-01,TCGA-CN-6016,HNSC,64.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-23664.0,Alive,TUMOR FREE,1443.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1443.0,0.0,1443.0,nan,nan,0.0,1443.0,0
TCGA-CN-6017-01,TCGA-CN-6017,HNSC,55.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-20358.0,Dead,TUMOR FREE,nan,853.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,853.0,0.0,853.0,nan,nan,0.0,853.0,0
TCGA-CN-6018-01,TCGA-CN-6018,HNSC,85.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-31242.0,Dead,TUMOR FREE,nan,580.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,580.0,0.0,580.0,nan,nan,0.0,580.0,0
TCGA-CN-6019-01,TCGA-CN-6019,HNSC,61.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-22485.0,Alive,TUMOR FREE,1038.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1038.0,0.0,1038.0,nan,nan,0.0,1038.0,0
TCGA-CN-6020-01,TCGA-CN-6020,HNSC,58.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-21232.0,Dead,TUMOR FREE,nan,205.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,205.0,0.0,205.0,nan,nan,0.0,205.0,0
TCGA-CN-6021-01,TCGA-CN-6021,HNSC,63.0,FEMALE,WHITE,nan,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-23212.0,Dead,WITH TUMOR,nan,276.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,276.0,1.0,276.0,nan,nan,1.0,276.0,1
TCGA-CN-6022-01,TCGA-CN-6022,HNSC,49.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2010.0,nan,-17971.0,Dead,WITH TUMOR,nan,281.0,nan,nan,Cervical Lymph Nodes,nan,101.0,Progressive Disease,nan,nan,1.0,281.0,1.0,281.0,nan,nan,1.0,101.0,1
TCGA-CN-6023-01,TCGA-CN-6023,HNSC,73.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,GX,2010.0,nan,-26769.0,Alive,TUMOR FREE,1584.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1584.0,0.0,1584.0,nan,nan,0.0,1584.0,0
TCGA-CN-6024-01,TCGA-CN-6024,HNSC,66.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-24259.0,Dead,WITH TUMOR,nan,337.0,nan,nan,Cervical Lymph Nodes,nan,156.0,Progressive Disease,nan,nan,1.0,337.0,1.0,337.0,nan,nan,1.0,156.0,1
TCGA-CN-6988-01,TCGA-CN-6988,HNSC,47.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2011.0,nan,-17308.0,Alive,TUMOR FREE,318.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,318.0,0.0,318.0,nan,nan,0.0,318.0,0
TCGA-CN-6989-01,TCGA-CN-6989,HNSC,64.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-23515.0,Dead,WITH TUMOR,nan,980.0,nan,nan,nan,nan,436.0,Complete Remission/Response,nan,nan,1.0,980.0,1.0,980.0,nan,nan,1.0,436.0,1
TCGA-CN-6992-01,TCGA-CN-6992,HNSC,61.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-22598.0,Alive,TUMOR FREE,1066.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1066.0,0.0,1066.0,nan,nan,0.0,1066.0,0
TCGA-CN-6994-01,TCGA-CN-6994,HNSC,67.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-24778.0,Alive,TUMOR FREE,1183.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1183.0,0.0,1183.0,nan,nan,0.0,1183.0,0
TCGA-CN-6995-01,TCGA-CN-6995,HNSC,78.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-28850.0,Dead,TUMOR FREE,nan,112.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,112.0,0.0,112.0,nan,nan,0.0,112.0,0
TCGA-CN-6996-01,TCGA-CN-6996,HNSC,58.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-21447.0,Dead,WITH TUMOR,nan,530.0,nan,nan,Cervical Lymph Nodes,SUPRASTERNAL NOTCH NODE,350.0,Complete Remission/Response,nan,nan,1.0,530.0,1.0,530.0,nan,nan,1.0,350.0,1
TCGA-CN-6997-01,TCGA-CN-6997,HNSC,66.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2011.0,nan,-24298.0,Dead,TUMOR FREE,nan,988.0,nan,nan,Distant Metastasis,LUNG,279.0,Complete Remission/Response,nan,nan,1.0,988.0,0.0,988.0,nan,nan,1.0,279.0,0
TCGA-CN-6998-01,TCGA-CN-6998,HNSC,53.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-19447.0,Dead,WITH TUMOR,nan,357.0,nan,nan,Oropharynx,tonsil,244.0,Progressive Disease,nan,nan,1.0,357.0,1.0,357.0,nan,nan,1.0,244.0,1
TCGA-CN-A497-01,TCGA-CN-A497,HNSC,63.0,MALE,[Unknown],Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-23310.0,Alive,TUMOR FREE,1065.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1065.0,0.0,1065.0,nan,nan,0.0,1065.0,0
TCGA-CN-A498-01,TCGA-CN-A498,HNSC,61.0,FEMALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2011.0,nan,-22330.0,Dead,WITH TUMOR,nan,773.0,nan,Locoregional Recurrence,Oral Cavity,"tongue, r neck nodes",186.0,Complete Remission/Response,nan,nan,1.0,773.0,1.0,773.0,1.0,186.0,1.0,186.0,1
TCGA-CN-A499-01,TCGA-CN-A499,HNSC,60.0,FEMALE,WHITE,Stage II,Stage I,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-21971.0,Alive,TUMOR FREE,717.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,717.0,0.0,717.0,0.0,717.0,0.0,717.0,0
TCGA-CN-A49A-01,TCGA-CN-A49A,HNSC,60.0,MALE,WHITE,Stage IVB,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-21995.0,Dead,WITH TUMOR,nan,526.0,nan,Distant Metastasis,Distant Metastasis,spine,344.0,Complete Remission/Response,nan,nan,1.0,526.0,1.0,526.0,nan,nan,1.0,344.0,1
TCGA-CN-A49B-01,TCGA-CN-A49B,HNSC,71.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2011.0,nan,-26155.0,Alive,TUMOR FREE,904.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,904.0,0.0,904.0,0.0,904.0,0.0,904.0,0
TCGA-CN-A49C-01,TCGA-CN-A49C,HNSC,67.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,GX,2012.0,nan,-24495.0,Alive,TUMOR FREE,645.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,645.0,0.0,645.0,nan,nan,0.0,645.0,0
TCGA-CN-A63T-01,TCGA-CN-A63T,HNSC,60.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2011.0,nan,-22201.0,Alive,TUMOR FREE,225.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,225.0,0.0,225.0,nan,nan,0.0,225.0,0
TCGA-CN-A63U-01,TCGA-CN-A63U,HNSC,50.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2011.0,nan,-18272.0,Alive,TUMOR FREE,964.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,964.0,0.0,964.0,nan,nan,0.0,964.0,0
TCGA-CN-A63V-01,TCGA-CN-A63V,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-21734.0,Alive,TUMOR FREE,679.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,679.0,0.0,679.0,nan,nan,0.0,679.0,0
TCGA-CN-A63W-01,TCGA-CN-A63W,HNSC,48.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-17693.0,Dead,TUMOR FREE,nan,377.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,377.0,0.0,377.0,nan,nan,0.0,377.0,1
TCGA-CN-A63Y-01,TCGA-CN-A63Y,HNSC,46.0,MALE,WHITE,Stage II,Stage I,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-17125.0,Alive,TUMOR FREE,504.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,504.0,0.0,504.0,0.0,504.0,0.0,504.0,0
TCGA-CN-A640-01,TCGA-CN-A640,HNSC,40.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-14758.0,Dead,TUMOR FREE,nan,134.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,134.0,0.0,134.0,nan,nan,0.0,134.0,1
TCGA-CN-A641-01,TCGA-CN-A641,HNSC,47.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-17454.0,Alive,TUMOR FREE,367.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,367.0,0.0,367.0,nan,nan,0.0,367.0,0
TCGA-CN-A642-01,TCGA-CN-A642,HNSC,57.0,MALE,WHITE,Stage IVB,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2012.0,nan,-21011.0,Dead,WITH TUMOR,nan,82.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,82.0,1.0,82.0,nan,nan,1.0,82.0,1
TCGA-CN-A6UY-01,TCGA-CN-A6UY,HNSC,57.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-20967.0,Alive,TUMOR FREE,713.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,713.0,0.0,713.0,nan,nan,0.0,713.0,0
TCGA-CN-A6V1-01,TCGA-CN-A6V1,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,GX,2013.0,nan,-21730.0,Alive,TUMOR FREE,603.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,603.0,0.0,603.0,nan,nan,0.0,603.0,0
TCGA-CN-A6V3-01,TCGA-CN-A6V3,HNSC,61.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2012.0,nan,-22397.0,Alive,TUMOR FREE,742.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,742.0,0.0,742.0,nan,nan,0.0,742.0,0
TCGA-CN-A6V6-01,TCGA-CN-A6V6,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,GX,2013.0,nan,-21811.0,Alive,TUMOR FREE,635.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,635.0,0.0,635.0,nan,nan,0.0,635.0,0
TCGA-CN-A6V7-01,TCGA-CN-A6V7,HNSC,40.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,GX,2013.0,nan,-14895.0,Alive,TUMOR FREE,594.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,594.0,0.0,594.0,nan,nan,0.0,594.0,0
TCGA-CQ-5323-01,TCGA-CQ-5323,HNSC,82.0,MALE,WHITE,Stage I,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2007.0,nan,-30173.0,Alive,TUMOR FREE,1466.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1466.0,0.0,1466.0,0.0,1466.0,0.0,1466.0,0
TCGA-CQ-5324-01,TCGA-CQ-5324,HNSC,59.0,MALE,WHITE,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2007.0,nan,-21803.0,Alive,TUMOR FREE,1593.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1593.0,0.0,1593.0,nan,nan,0.0,1593.0,0
TCGA-CQ-5325-01,TCGA-CQ-5325,HNSC,65.0,MALE,WHITE,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma,G2,2007.0,nan,-23833.0,Dead,WITH TUMOR,nan,654.0,nan,nan,Oral Cavity,nan,204.0,Complete Remission/Response,nan,nan,1.0,654.0,1.0,654.0,1.0,204.0,1.0,204.0,2
TCGA-CQ-5326-01,TCGA-CQ-5326,HNSC,67.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2007.0,nan,-24473.0,Dead,WITH TUMOR,nan,89.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,89.0,1.0,89.0,nan,nan,1.0,89.0,1
TCGA-CQ-5327-01,TCGA-CQ-5327,HNSC,61.0,FEMALE,ASIAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-22307.0,Alive,TUMOR FREE,1660.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1660.0,0.0,1660.0,nan,nan,0.0,1660.0,2
TCGA-CQ-5329-01,TCGA-CQ-5329,HNSC,46.0,FEMALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-17028.0,Alive,TUMOR FREE,2143.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2143.0,0.0,2143.0,0.0,2143.0,0.0,2143.0,0
TCGA-CQ-5330-01,TCGA-CQ-5330,HNSC,69.0,FEMALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2008.0,nan,-25255.0,Alive,TUMOR FREE,1897.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1897.0,0.0,1897.0,nan,nan,0.0,1897.0,0
TCGA-CQ-5331-01,TCGA-CQ-5331,HNSC,73.0,FEMALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-26901.0,Alive,TUMOR FREE,1399.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1399.0,0.0,1399.0,nan,nan,0.0,1399.0,2
TCGA-CQ-5332-01,TCGA-CQ-5332,HNSC,87.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-32032.0,Dead,nan,317.0,317.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,317.0,nan,317.0,nan,nan,0.0,317.0,1
TCGA-CQ-5333-01,TCGA-CQ-5333,HNSC,74.0,MALE,WHITE,Stage II,Stage I,Head & Neck Squamous Cell Carcinoma,G3,2008.0,nan,-27110.0,Dead,WITH TUMOR,nan,341.0,nan,nan,Oropharynx,nan,176.0,Complete Remission/Response,nan,nan,1.0,341.0,1.0,341.0,1.0,176.0,1.0,176.0,1
TCGA-CQ-5334-01,TCGA-CQ-5334,HNSC,87.0,MALE,WHITE,Stage IVA,Stage IVB,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-32024.0,Dead,WITH TUMOR,nan,129.0,nan,nan,Oral Cavity,nan,50.0,Progressive Disease,nan,nan,1.0,129.0,1.0,129.0,nan,nan,1.0,50.0,1
TCGA-CQ-6218-01,TCGA-CQ-6218,HNSC,52.0,FEMALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-19096.0,Alive,TUMOR FREE,1253.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1253.0,0.0,1253.0,nan,nan,0.0,1253.0,2
TCGA-CQ-6219-01,TCGA-CQ-6219,HNSC,50.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2007.0,nan,-18578.0,Dead,WITH TUMOR,nan,479.0,nan,nan,Cervical Lymph Nodes,nan,195.0,Complete Remission/Response,nan,nan,1.0,479.0,1.0,479.0,nan,nan,1.0,195.0,1
TCGA-CQ-6220-01,TCGA-CQ-6220,HNSC,69.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2007.0,nan,-25366.0,Dead,nan,nan,985.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,985.0,nan,985.0,0.0,985.0,0.0,985.0,0
TCGA-CQ-6221-01,TCGA-CQ-6221,HNSC,79.0,MALE,WHITE,nan,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2008.0,nan,-29026.0,Alive,TUMOR FREE,1000.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1000.0,0.0,1000.0,0.0,1000.0,0.0,1000.0,0
TCGA-CQ-6222-01,TCGA-CQ-6222,HNSC,63.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-23326.0,Alive,TUMOR FREE,2016.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2016.0,0.0,2016.0,nan,nan,0.0,2016.0,0
TCGA-CQ-6223-01,TCGA-CQ-6223,HNSC,69.0,MALE,WHITE,Stage II,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-25266.0,Alive,TUMOR FREE,1428.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1428.0,0.0,1428.0,nan,nan,0.0,1428.0,0
TCGA-CQ-6224-01,TCGA-CQ-6224,HNSC,52.0,MALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2009.0,nan,-19051.0,Alive,TUMOR FREE,1721.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1721.0,0.0,1721.0,nan,nan,0.0,1721.0,0
TCGA-CQ-6225-01,TCGA-CQ-6225,HNSC,65.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-23988.0,Dead,nan,nan,403.0,nan,nan,Oral Cavity,nan,180.0,Persistent Disease,nan,nan,1.0,403.0,nan,403.0,nan,nan,1.0,180.0,1
TCGA-CQ-6227-01,TCGA-CQ-6227,HNSC,77.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-28466.0,Dead,WITH TUMOR,nan,129.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,129.0,1.0,129.0,nan,nan,1.0,129.0,1
TCGA-CQ-6228-01,TCGA-CQ-6228,HNSC,71.0,FEMALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-25942.0,Dead,nan,nan,456.0,nan,nan,Distant Metastasis,left axilla,273.0,Complete Remission/Response,nan,nan,1.0,456.0,nan,456.0,nan,nan,1.0,273.0,1
TCGA-CQ-6229-01,TCGA-CQ-6229,HNSC,61.0,MALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-22541.0,Alive,TUMOR FREE,1179.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1179.0,0.0,1179.0,0.0,1179.0,0.0,1179.0,0
TCGA-CQ-7063-01,TCGA-CQ-7063,HNSC,59.0,FEMALE,WHITE,Stage I,nan,Head & Neck Squamous Cell Carcinoma,G1,2008.0,nan,-21723.0,Alive,TUMOR FREE,2133.0,nan,nan,Locoregional Disease,Oral Cavity,left oral tongue,1160.0,Complete Remission/Response,nan,nan,0.0,2133.0,0.0,2133.0,1.0,1160.0,1.0,1160.0,2
TCGA-CQ-7064-01,TCGA-CQ-7064,HNSC,83.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-30640.0,Alive,TUMOR FREE,1973.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1973.0,0.0,1973.0,0.0,1973.0,0.0,1973.0,0
TCGA-CQ-7065-01,TCGA-CQ-7065,HNSC,40.0,MALE,ASIAN,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-14676.0,Alive,TUMOR FREE,1628.0,nan,nan,nan,Oral Cavity,nan,230.0,Complete Remission/Response,nan,nan,0.0,1628.0,0.0,1628.0,1.0,230.0,1.0,230.0,2
TCGA-CQ-7067-01,TCGA-CQ-7067,HNSC,75.0,FEMALE,WHITE,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma,G3,2009.0,nan,-27707.0,Alive,TUMOR FREE,509.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,509.0,0.0,509.0,0.0,509.0,0.0,509.0,0
TCGA-CQ-7068-01,TCGA-CQ-7068,HNSC,80.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-29530.0,Alive,TUMOR FREE,1309.0,nan,nan,New Primary Tumor,Oral Cavity,left buccal mucosa,1148.0,Complete Remission/Response,nan,nan,0.0,1309.0,0.0,1309.0,0.0,1309.0,1.0,1148.0,2
TCGA-CQ-7069-01,TCGA-CQ-7069,HNSC,77.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-28138.0,Alive,TUMOR FREE,1274.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1274.0,0.0,1274.0,0.0,1274.0,0.0,1274.0,0
TCGA-CQ-7071-01,TCGA-CQ-7071,HNSC,76.0,FEMALE,WHITE,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-27928.0,Alive,TUMOR FREE,1311.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1311.0,0.0,1311.0,nan,nan,0.0,1311.0,2
TCGA-CQ-7072-01,TCGA-CQ-7072,HNSC,51.0,MALE,WHITE,Stage II,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2007.0,nan,-18841.0,Alive,TUMOR FREE,2359.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2359.0,0.0,2359.0,nan,nan,0.0,2359.0,0
TCGA-CQ-A4C6-01,TCGA-CQ-A4C6,HNSC,63.0,MALE,ASIAN,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-23205.0,Alive,TUMOR FREE,1353.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1353.0,0.0,1353.0,0.0,1353.0,0.0,1353.0,0
TCGA-CQ-A4C7-01,TCGA-CQ-A4C7,HNSC,88.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2010.0,nan,-32194.0,Dead,nan,nan,353.0,nan,nan,Oral Cavity,left lateral flap margins overlying reconstructed mandible,207.0,Complete Remission/Response,nan,nan,1.0,353.0,nan,353.0,1.0,207.0,1.0,207.0,1
TCGA-CQ-A4C9-01,TCGA-CQ-A4C9,HNSC,56.0,MALE,[Not Evaluated],Stage III,nan,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-20732.0,Alive,WITH TUMOR,707.0,nan,nan,Locoregional Disease,Oral Cavity,nan,287.0,Complete Remission/Response,nan,nan,0.0,707.0,0.0,707.0,1.0,287.0,1.0,287.0,2
TCGA-CQ-A4CA-01,TCGA-CQ-A4CA,HNSC,nan,MALE,[Not Evaluated],Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,nan,Alive,TUMOR FREE,nan,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,nan,0.0,nan,0.0,nan,0.0,nan,0
TCGA-CQ-A4CB-01,TCGA-CQ-A4CB,HNSC,59.0,MALE,[Not Evaluated],Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-21574.0,Alive,TUMOR FREE,893.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,893.0,0.0,893.0,0.0,893.0,0.0,893.0,0
TCGA-CQ-A4CD-01,TCGA-CQ-A4CD,HNSC,69.0,MALE,WHITE,Stage IVA,Stage IVB,Head & Neck Squamous Cell Carcinoma,G3,2011.0,nan,-25497.0,Alive,TUMOR FREE,1022.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1022.0,0.0,1022.0,nan,nan,0.0,1022.0,0
TCGA-CQ-A4CE-01,TCGA-CQ-A4CE,HNSC,76.0,FEMALE,[Not Evaluated],Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-27793.0,Alive,TUMOR FREE,897.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,897.0,0.0,897.0,0.0,897.0,0.0,897.0,0
TCGA-CQ-A4CG-01,TCGA-CQ-A4CG,HNSC,78.0,FEMALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-28637.0,Dead,WITH TUMOR,nan,430.0,nan,nan,Distant Metastasis,new primary in left upper lung lobe with metastasis to brain,350.0,Complete Remission/Response,nan,nan,1.0,430.0,1.0,430.0,1.0,350.0,1.0,350.0,1
TCGA-CQ-A4CH-01,TCGA-CQ-A4CH,HNSC,58.0,MALE,ASIAN,Stage II,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-21455.0,Dead,WITH TUMOR,nan,379.0,nan,nan,nan,trachea,210.0,Complete Remission/Response,nan,nan,1.0,379.0,1.0,379.0,nan,nan,1.0,210.0,1
TCGA-CQ-A4CI-01,TCGA-CQ-A4CI,HNSC,73.0,MALE,WHITE,Stage III,nan,Head & Neck Squamous Cell Carcinoma Basaloid Type,G3,2011.0,nan,-26664.0,Alive,WITH TUMOR,950.0,nan,nan,nan,Distant Metastasis,lung,517.0,Complete Remission/Response,nan,nan,0.0,950.0,0.0,950.0,1.0,517.0,1.0,517.0,2
TCGA-CR-5243-01,TCGA-CR-5243,HNSC,51.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2003.0,nan,-18812.0,Alive,TUMOR FREE,2562.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2562.0,0.0,2562.0,nan,nan,0.0,2562.0,0
TCGA-CR-5247-01,TCGA-CR-5247,HNSC,48.0,MALE,BLACK OR AFRICAN AMERICAN,nan,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2006.0,nan,-17810.0,Alive,TUMOR FREE,358.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,358.0,0.0,358.0,0.0,358.0,0.0,358.0,0
TCGA-CR-5248-01,TCGA-CR-5248,HNSC,53.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2006.0,nan,-19441.0,Alive,WITH TUMOR,1663.0,nan,nan,nan,Cervical Lymph Nodes,nan,936.0,Complete Remission/Response,nan,nan,0.0,1663.0,0.0,1663.0,nan,nan,1.0,936.0,2
TCGA-CR-5249-01,TCGA-CR-5249,HNSC,35.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,GX,2007.0,nan,-13047.0,Alive,TUMOR FREE,1152.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1152.0,0.0,1152.0,0.0,1152.0,0.0,1152.0,0
TCGA-CR-5250-01,TCGA-CR-5250,HNSC,71.0,MALE,WHITE,nan,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2009.0,nan,-26097.0,Alive,TUMOR FREE,799.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,799.0,0.0,799.0,0.0,799.0,0.0,799.0,0
TCGA-CR-6467-01,TCGA-CR-6467,HNSC,59.0,MALE,WHITE,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2006.0,nan,-21689.0,Alive,TUMOR FREE,1777.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1777.0,0.0,1777.0,nan,nan,0.0,1777.0,0
TCGA-CR-6470-01,TCGA-CR-6470,HNSC,38.0,MALE,WHITE,Stage II,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2007.0,nan,-14133.0,Alive,TUMOR FREE,1521.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1521.0,0.0,1521.0,nan,nan,0.0,1521.0,0
TCGA-CR-6471-01,TCGA-CR-6471,HNSC,58.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2007.0,nan,-21315.0,Dead,WITH TUMOR,nan,1202.0,nan,nan,Oropharynx,nan,498.0,Complete Remission/Response,nan,nan,1.0,1202.0,1.0,1202.0,nan,nan,1.0,498.0,1
TCGA-CR-6472-01,TCGA-CR-6472,HNSC,59.0,MALE,WHITE,nan,Stage IVB,Head & Neck Squamous Cell Carcinoma,G3,2008.0,nan,-21654.0,Alive,TUMOR FREE,1050.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1050.0,0.0,1050.0,nan,nan,0.0,1050.0,0
TCGA-CR-6473-01,TCGA-CR-6473,HNSC,68.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2008.0,nan,-24857.0,Alive,TUMOR FREE,1125.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1125.0,0.0,1125.0,nan,nan,0.0,1125.0,0
TCGA-CR-6474-01,TCGA-CR-6474,HNSC,51.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-18840.0,Dead,WITH TUMOR,nan,564.0,nan,nan,Cervical Lymph Nodes,Right neck,220.0,Complete Remission/Response,nan,nan,1.0,564.0,1.0,564.0,nan,nan,1.0,220.0,1
TCGA-CR-6477-01,TCGA-CR-6477,HNSC,56.0,FEMALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-20815.0,Alive,TUMOR FREE,514.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,514.0,0.0,514.0,nan,nan,0.0,514.0,2
TCGA-CR-6478-01,TCGA-CR-6478,HNSC,66.0,FEMALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2010.0,nan,-24244.0,Dead,nan,nan,183.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,183.0,nan,183.0,nan,nan,0.0,183.0,1
TCGA-CR-6480-01,TCGA-CR-6480,HNSC,53.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-19472.0,Alive,TUMOR FREE,362.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,362.0,0.0,362.0,nan,nan,0.0,362.0,0
TCGA-CR-6481-01,TCGA-CR-6481,HNSC,47.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-17203.0,Alive,TUMOR FREE,311.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,311.0,0.0,311.0,nan,nan,0.0,311.0,0
TCGA-CR-6482-01,TCGA-CR-6482,HNSC,62.0,MALE,BLACK OR AFRICAN AMERICAN,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2010.0,nan,-22741.0,Alive,TUMOR FREE,345.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,345.0,0.0,345.0,nan,nan,0.0,345.0,0
TCGA-CR-6484-01,TCGA-CR-6484,HNSC,67.0,FEMALE,ASIAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-24569.0,Alive,TUMOR FREE,354.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,354.0,0.0,354.0,nan,nan,0.0,354.0,2
TCGA-CR-6487-01,TCGA-CR-6487,HNSC,50.0,MALE,WHITE,Stage I,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2010.0,nan,-18331.0,Alive,TUMOR FREE,234.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,234.0,0.0,234.0,0.0,234.0,0.0,234.0,0
TCGA-CR-6488-01,TCGA-CR-6488,HNSC,68.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-25176.0,Alive,TUMOR FREE,379.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,0
TCGA-CR-6491-01,TCGA-CR-6491,HNSC,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-22125.0,Alive,WITH TUMOR,693.0,nan,nan,New Primary Tumor,Distant Metastasis,Lung,499.0,Complete Remission/Response,nan,nan,0.0,693.0,0.0,693.0,nan,nan,1.0,499.0,2
TCGA-CR-6492-01,TCGA-CR-6492,HNSC,78.0,MALE,WHITE,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2010.0,nan,-28600.0,Alive,TUMOR FREE,479.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,479.0,0.0,479.0,nan,nan,0.0,479.0,0
TCGA-CR-6493-01,TCGA-CR-6493,HNSC,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-25432.0,Dead,WITH TUMOR,nan,282.0,nan,Locoregional Recurrence,Oral Cavity,Right gingiva,247.0,Complete Remission/Response,nan,nan,1.0,282.0,1.0,282.0,nan,nan,1.0,247.0,1
TCGA-CR-7364-01,TCGA-CR-7364,HNSC,66.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-24192.0,Alive,TUMOR FREE,1435.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1435.0,0.0,1435.0,0.0,1435.0,0.0,1435.0,0
TCGA-CR-7365-01,TCGA-CR-7365,HNSC,60.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-22101.0,Alive,TUMOR FREE,1191.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1191.0,0.0,1191.0,nan,nan,0.0,1191.0,0
TCGA-CR-7367-01,TCGA-CR-7367,HNSC,52.0,MALE,WHITE,Stage IVA,Stage IVB,Head & Neck Squamous Cell Carcinoma,G1,2008.0,nan,-19116.0,Alive,TUMOR FREE,1440.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1440.0,0.0,1440.0,nan,nan,0.0,1440.0,0
TCGA-CR-7368-01,TCGA-CR-7368,HNSC,54.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-19876.0,Alive,TUMOR FREE,1245.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1245.0,0.0,1245.0,nan,nan,0.0,1245.0,0
TCGA-CR-7369-01,TCGA-CR-7369,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-21897.0,Dead,TUMOR FREE,nan,1090.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1090.0,0.0,1090.0,nan,nan,0.0,1090.0,0
TCGA-CR-7370-01,TCGA-CR-7370,HNSC,72.0,FEMALE,WHITE,nan,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-26468.0,Alive,TUMOR FREE,105.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,105.0,0.0,105.0,0.0,105.0,0.0,105.0,2
TCGA-CR-7371-01,TCGA-CR-7371,HNSC,45.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-16568.0,Dead,nan,nan,94.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,94.0,nan,94.0,nan,nan,0.0,94.0,1
TCGA-CR-7372-01,TCGA-CR-7372,HNSC,45.0,MALE,WHITE,Stage I,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2009.0,nan,-16610.0,Alive,TUMOR FREE,759.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,759.0,0.0,759.0,0.0,759.0,0.0,759.0,0
TCGA-CR-7373-01,TCGA-CR-7373,HNSC,66.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-24448.0,Alive,TUMOR FREE,889.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,889.0,0.0,889.0,nan,nan,0.0,889.0,0
TCGA-CR-7374-01,TCGA-CR-7374,HNSC,67.0,FEMALE,WHITE,nan,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-24558.0,Alive,WITH TUMOR,30.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,30.0,0.0,30.0,nan,nan,0.0,30.0,2
TCGA-CR-7376-01,TCGA-CR-7376,HNSC,83.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-30670.0,Alive,TUMOR FREE,972.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,972.0,0.0,972.0,0.0,972.0,0.0,972.0,0
TCGA-CR-7377-01,TCGA-CR-7377,HNSC,58.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2008.0,nan,-21371.0,Dead,nan,nan,279.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,279.0,nan,279.0,nan,nan,0.0,279.0,1
TCGA-CR-7379-01,TCGA-CR-7379,HNSC,78.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-28763.0,Alive,TUMOR FREE,1036.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1036.0,0.0,1036.0,nan,nan,0.0,1036.0,2
TCGA-CR-7380-01,TCGA-CR-7380,HNSC,58.0,MALE,WHITE,Stage IVB,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-21215.0,Dead,WITH TUMOR,nan,606.0,nan,nan,Distant Metastasis,Lung,561.0,Complete Remission/Response,nan,nan,1.0,606.0,1.0,606.0,nan,nan,1.0,561.0,1
TCGA-CR-7382-01,TCGA-CR-7382,HNSC,49.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-18078.0,Alive,TUMOR FREE,796.0,nan,nan,nan,Oral Cavity,Tongue,614.0,Complete Remission/Response,nan,nan,0.0,796.0,0.0,796.0,nan,nan,1.0,614.0,2
TCGA-CR-7383-01,TCGA-CR-7383,HNSC,79.0,FEMALE,WHITE,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-29122.0,Dead,WITH TUMOR,nan,521.0,nan,nan,Oropharynx,nan,454.0,Complete Remission/Response,nan,nan,1.0,521.0,1.0,521.0,1.0,454.0,1.0,454.0,1
TCGA-CR-7385-01,TCGA-CR-7385,HNSC,42.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-15477.0,Alive,TUMOR FREE,997.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,997.0,0.0,997.0,nan,nan,0.0,997.0,0
TCGA-CR-7386-01,TCGA-CR-7386,HNSC,69.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2008.0,nan,-25238.0,Alive,WITH TUMOR,1430.0,nan,nan,nan,Distant Metastasis,Lung (distant mets or possible new primary),1028.0,Complete Remission/Response,nan,nan,0.0,1430.0,0.0,1430.0,nan,nan,1.0,1028.0,2
TCGA-CR-7388-01,TCGA-CR-7388,HNSC,70.0,FEMALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-25728.0,Dead,WITH TUMOR,nan,823.0,nan,nan,Cervical Lymph Nodes,Right neck,334.0,Complete Remission/Response,nan,nan,1.0,823.0,1.0,823.0,nan,nan,1.0,334.0,1
TCGA-CR-7389-01,TCGA-CR-7389,HNSC,55.0,MALE,BLACK OR AFRICAN AMERICAN,nan,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2007.0,nan,-20169.0,Alive,TUMOR FREE,392.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,392.0,0.0,392.0,0.0,392.0,0.0,392.0,0
TCGA-CR-7390-01,TCGA-CR-7390,HNSC,67.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-24575.0,Alive,TUMOR FREE,1508.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1508.0,0.0,1508.0,nan,nan,0.0,1508.0,0
TCGA-CR-7391-01,TCGA-CR-7391,HNSC,36.0,FEMALE,WHITE,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma,G1,2009.0,nan,-13508.0,Alive,TUMOR FREE,913.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,913.0,0.0,913.0,0.0,913.0,0.0,913.0,0
TCGA-CR-7392-01,TCGA-CR-7392,HNSC,67.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2009.0,nan,-24650.0,Alive,TUMOR FREE,1425.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1425.0,0.0,1425.0,nan,nan,0.0,1425.0,2
TCGA-CR-7393-01,TCGA-CR-7393,HNSC,26.0,MALE,WHITE,Stage III,Stage I,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-9750.0,Alive,TUMOR FREE,993.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,993.0,0.0,993.0,0.0,993.0,0.0,993.0,0
TCGA-CR-7394-01,TCGA-CR-7394,HNSC,70.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-25581.0,Alive,TUMOR FREE,1346.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1346.0,0.0,1346.0,nan,nan,0.0,1346.0,0
TCGA-CR-7395-01,TCGA-CR-7395,HNSC,80.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-29527.0,Alive,TUMOR FREE,930.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,930.0,0.0,930.0,0.0,930.0,0.0,930.0,2
TCGA-CR-7397-01,TCGA-CR-7397,HNSC,44.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-16351.0,Alive,TUMOR FREE,754.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,754.0,0.0,754.0,nan,nan,0.0,754.0,0
TCGA-CR-7398-01,TCGA-CR-7398,HNSC,53.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-19468.0,Alive,TUMOR FREE,156.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,156.0,0.0,156.0,0.0,156.0,0.0,156.0,0
TCGA-CR-7399-01,TCGA-CR-7399,HNSC,60.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2008.0,nan,-22182.0,Alive,TUMOR FREE,181.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,181.0,0.0,181.0,nan,nan,0.0,181.0,0
TCGA-CR-7401-01,TCGA-CR-7401,HNSC,64.0,MALE,WHITE,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-23420.0,Alive,TUMOR FREE,1077.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1077.0,0.0,1077.0,0.0,1077.0,0.0,1077.0,0
TCGA-CR-7402-01,TCGA-CR-7402,HNSC,68.0,MALE,WHITE,nan,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-25138.0,Alive,TUMOR FREE,911.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,911.0,0.0,911.0,0.0,911.0,0.0,911.0,0
TCGA-CR-7404-01,TCGA-CR-7404,HNSC,53.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-19532.0,Alive,WITH TUMOR,1472.0,nan,nan,nan,Oropharynx,nan,234.0,Complete Remission/Response,nan,nan,0.0,1472.0,0.0,1472.0,nan,nan,1.0,234.0,2
TCGA-CV-5430-01,TCGA-CV-5430,HNSC,61.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,1999.0,nan,-22577.0,Alive,TUMOR FREE,4241.0,nan,nan,nan,Distant Metastasis,Lung,783.0,Complete Remission/Response,nan,nan,0.0,4241.0,0.0,4241.0,nan,nan,1.0,783.0,0
TCGA-CV-5430-11,TCGA-CV-5430,HNSC,61.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,1999.0,nan,-22577.0,Alive,TUMOR FREE,4241.0,nan,nan,nan,Distant Metastasis,Lung,783.0,Complete Remission/Response,nan,nan,0.0,4241.0,0.0,4241.0,nan,nan,1.0,783.0,0
TCGA-CV-5431-01,TCGA-CV-5431,HNSC,73.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2000.0,nan,-26953.0,Dead,TUMOR FREE,522.0,522.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,522.0,0.0,522.0,nan,nan,0.0,522.0,0
TCGA-CV-5431-11,TCGA-CV-5431,HNSC,73.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2000.0,nan,-26953.0,Dead,TUMOR FREE,522.0,522.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,522.0,0.0,522.0,nan,nan,0.0,522.0,0
TCGA-CV-5432-01,TCGA-CV-5432,HNSC,68.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2000.0,nan,-25006.0,Alive,TUMOR FREE,3930.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3930.0,0.0,3930.0,nan,nan,0.0,3930.0,0
TCGA-CV-5432-11,TCGA-CV-5432,HNSC,68.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2000.0,nan,-25006.0,Alive,TUMOR FREE,3930.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3930.0,0.0,3930.0,nan,nan,0.0,3930.0,0
TCGA-CV-5434-01,TCGA-CV-5434,HNSC,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2000.0,nan,-22182.0,Dead,TUMOR FREE,3295.0,3314.0,nan,nan,Distant Metastasis,Lung,1859.0,Complete Remission/Response,nan,nan,1.0,3314.0,0.0,3314.0,nan,nan,1.0,1859.0,1
TCGA-CV-5434-11,TCGA-CV-5434,HNSC,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2000.0,nan,-22182.0,Dead,TUMOR FREE,3295.0,3314.0,nan,nan,Distant Metastasis,Lung,1859.0,Complete Remission/Response,nan,nan,1.0,3314.0,0.0,3314.0,nan,nan,1.0,1859.0,1
TCGA-CV-5435-01,TCGA-CV-5435,HNSC,57.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2000.0,nan,-20926.0,Dead,WITH TUMOR,1438.0,2319.0,nan,nan,Distant Metastasis,Lung,284.0,nan,nan,nan,1.0,2319.0,1.0,2319.0,nan,nan,1.0,284.0,1
TCGA-CV-5435-11,TCGA-CV-5435,HNSC,57.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2000.0,nan,-20926.0,Dead,WITH TUMOR,1438.0,2319.0,nan,nan,Distant Metastasis,Lung,284.0,nan,nan,nan,1.0,2319.0,1.0,2319.0,nan,nan,1.0,284.0,1
TCGA-CV-5436-01,TCGA-CV-5436,HNSC,65.0,MALE,nan,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2001.0,nan,-23923.0,Dead,WITH TUMOR,548.0,584.0,nan,nan,nan,nan,nan,Persistent Disease,nan,nan,1.0,584.0,1.0,584.0,nan,nan,1.0,584.0,1
TCGA-CV-5436-11,TCGA-CV-5436,HNSC,65.0,MALE,nan,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2001.0,nan,-23923.0,Dead,WITH TUMOR,548.0,584.0,nan,nan,nan,nan,nan,Persistent Disease,nan,nan,1.0,584.0,1.0,584.0,nan,nan,1.0,584.0,1
TCGA-CV-5439-01,TCGA-CV-5439,HNSC,62.0,MALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2002.0,nan,-22686.0,Dead,WITH TUMOR,546.0,546.0,nan,nan,Oropharynx,nan,211.0,nan,nan,nan,1.0,546.0,1.0,546.0,nan,nan,1.0,211.0,1
TCGA-CV-5439-11,TCGA-CV-5439,HNSC,62.0,MALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2002.0,nan,-22686.0,Dead,WITH TUMOR,546.0,546.0,nan,nan,Oropharynx,nan,211.0,nan,nan,nan,1.0,546.0,1.0,546.0,nan,nan,1.0,211.0,1
TCGA-CV-5440-01,TCGA-CV-5440,HNSC,52.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2002.0,nan,-19197.0,Alive,TUMOR FREE,3270.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3270.0,0.0,3270.0,nan,nan,0.0,3270.0,0
TCGA-CV-5440-11,TCGA-CV-5440,HNSC,52.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2002.0,nan,-19197.0,Alive,TUMOR FREE,3270.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3270.0,0.0,3270.0,nan,nan,0.0,3270.0,0
TCGA-CV-5441-01,TCGA-CV-5441,HNSC,58.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2003.0,nan,-21305.0,Alive,TUMOR FREE,2886.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2886.0,0.0,2886.0,nan,nan,0.0,2886.0,0
TCGA-CV-5441-11,TCGA-CV-5441,HNSC,58.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2003.0,nan,-21305.0,Alive,TUMOR FREE,2886.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2886.0,0.0,2886.0,nan,nan,0.0,2886.0,0
TCGA-CV-5442-01,TCGA-CV-5442,HNSC,76.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2004.0,nan,-28040.0,Alive,TUMOR FREE,2327.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2327.0,0.0,2327.0,nan,nan,0.0,2327.0,0
TCGA-CV-5442-11,TCGA-CV-5442,HNSC,76.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2004.0,nan,-28040.0,Alive,TUMOR FREE,2327.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2327.0,0.0,2327.0,nan,nan,0.0,2327.0,0
TCGA-CV-5443-01,TCGA-CV-5443,HNSC,63.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2004.0,nan,-23287.0,Alive,TUMOR FREE,2784.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2784.0,0.0,2784.0,nan,nan,0.0,2784.0,0
TCGA-CV-5443-11,TCGA-CV-5443,HNSC,63.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2004.0,nan,-23287.0,Alive,TUMOR FREE,2784.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2784.0,0.0,2784.0,nan,nan,0.0,2784.0,0
TCGA-CV-5444-01,TCGA-CV-5444,HNSC,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2004.0,nan,-23650.0,Alive,TUMOR FREE,2437.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2437.0,0.0,2437.0,nan,nan,0.0,2437.0,0
TCGA-CV-5444-11,TCGA-CV-5444,HNSC,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2004.0,nan,-23650.0,Alive,TUMOR FREE,2437.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2437.0,0.0,2437.0,nan,nan,0.0,2437.0,0
TCGA-CV-5966-01,TCGA-CV-5966,HNSC,63.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2005.0,nan,-23119.0,Dead,TUMOR FREE,nan,545.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,545.0,0.0,545.0,nan,nan,0.0,545.0,0
TCGA-CV-5966-11,TCGA-CV-5966,HNSC,63.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2005.0,nan,-23119.0,Dead,TUMOR FREE,nan,545.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,545.0,0.0,545.0,nan,nan,0.0,545.0,0
TCGA-CV-5970-01,TCGA-CV-5970,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-21890.0,Dead,WITH TUMOR,406.0,406.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,406.0,1.0,406.0,nan,nan,1.0,406.0,1
TCGA-CV-5970-11,TCGA-CV-5970,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-21890.0,Dead,WITH TUMOR,406.0,406.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,406.0,1.0,406.0,nan,nan,1.0,406.0,1
TCGA-CV-5971-01,TCGA-CV-5971,HNSC,60.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-22279.0,Alive,TUMOR FREE,701.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,701.0,0.0,701.0,nan,nan,0.0,701.0,0
TCGA-CV-5971-11,TCGA-CV-5971,HNSC,60.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-22279.0,Alive,TUMOR FREE,701.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,701.0,0.0,701.0,nan,nan,0.0,701.0,0
TCGA-CV-5973-01,TCGA-CV-5973,HNSC,62.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2005.0,nan,-22771.0,Alive,TUMOR FREE,2641.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2641.0,0.0,2641.0,0.0,2641.0,0.0,2641.0,0
TCGA-CV-5973-11,TCGA-CV-5973,HNSC,62.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2005.0,nan,-22771.0,Alive,TUMOR FREE,2641.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2641.0,0.0,2641.0,0.0,2641.0,0.0,2641.0,0
TCGA-CV-5976-01,TCGA-CV-5976,HNSC,50.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2006.0,nan,-18267.0,Alive,TUMOR FREE,1478.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1478.0,0.0,1478.0,nan,nan,0.0,1478.0,0
TCGA-CV-5976-11,TCGA-CV-5976,HNSC,50.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2006.0,nan,-18267.0,Alive,TUMOR FREE,1478.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1478.0,0.0,1478.0,nan,nan,0.0,1478.0,0
TCGA-CV-5977-01,TCGA-CV-5977,HNSC,66.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2007.0,nan,-24115.0,Alive,TUMOR FREE,1840.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1840.0,0.0,1840.0,nan,nan,0.0,1840.0,0
TCGA-CV-5977-11,TCGA-CV-5977,HNSC,66.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2007.0,nan,-24115.0,Alive,TUMOR FREE,1840.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1840.0,0.0,1840.0,nan,nan,0.0,1840.0,0
TCGA-CV-5978-01,TCGA-CV-5978,HNSC,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVB,Stage IVB,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-19480.0,Dead,WITH TUMOR,215.0,215.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,215.0,1.0,215.0,nan,nan,1.0,215.0,1
TCGA-CV-5978-11,TCGA-CV-5978,HNSC,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVB,Stage IVB,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-19480.0,Dead,WITH TUMOR,215.0,215.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,215.0,1.0,215.0,nan,nan,1.0,215.0,1
TCGA-CV-5979-01,TCGA-CV-5979,HNSC,26.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2007.0,nan,-9567.0,Alive,TUMOR FREE,1315.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1315.0,0.0,1315.0,nan,nan,0.0,1315.0,0
TCGA-CV-5979-11,TCGA-CV-5979,HNSC,26.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2007.0,nan,-9567.0,Alive,TUMOR FREE,1315.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1315.0,0.0,1315.0,nan,nan,0.0,1315.0,0
TCGA-CV-6003-01,TCGA-CV-6003,HNSC,50.0,FEMALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2007.0,nan,-18600.0,Alive,TUMOR FREE,1665.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1665.0,0.0,1665.0,nan,nan,0.0,1665.0,0
TCGA-CV-6003-11,TCGA-CV-6003,HNSC,50.0,FEMALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2007.0,nan,-18600.0,Alive,TUMOR FREE,1665.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1665.0,0.0,1665.0,nan,nan,0.0,1665.0,0
TCGA-CV-6433-01,TCGA-CV-6433,HNSC,57.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2010.0,nan,-20855.0,Alive,WITH TUMOR,641.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,641.0,0.0,641.0,0.0,641.0,0.0,641.0,0
TCGA-CV-6433-11,TCGA-CV-6433,HNSC,57.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2010.0,nan,-20855.0,Alive,WITH TUMOR,641.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,641.0,0.0,641.0,0.0,641.0,0.0,641.0,0
TCGA-CV-6436-01,TCGA-CV-6436,HNSC,62.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2007.0,nan,-22885.0,Alive,TUMOR FREE,1899.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1899.0,0.0,1899.0,nan,nan,0.0,1899.0,0
TCGA-CV-6436-11,TCGA-CV-6436,HNSC,62.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2007.0,nan,-22885.0,Alive,TUMOR FREE,1899.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1899.0,0.0,1899.0,nan,nan,0.0,1899.0,0
TCGA-CV-6441-01,TCGA-CV-6441,HNSC,60.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2010.0,nan,-22025.0,Dead,WITH TUMOR,nan,292.0,nan,Locoregional Recurrence,Oral Cavity,pharyngeal,95.0,Progressive Disease,nan,nan,1.0,292.0,1.0,292.0,nan,nan,1.0,95.0,1
TCGA-CV-6441-11,TCGA-CV-6441,HNSC,60.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2010.0,nan,-22025.0,Dead,WITH TUMOR,nan,292.0,nan,Locoregional Recurrence,Oral Cavity,pharyngeal,95.0,Progressive Disease,nan,nan,1.0,292.0,1.0,292.0,nan,nan,1.0,95.0,1
TCGA-CV-6933-01,TCGA-CV-6933,HNSC,53.0,MALE,WHITE,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1998.0,nan,-19518.0,Dead,TUMOR FREE,nan,2741.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2741.0,0.0,2741.0,nan,nan,0.0,2741.0,0
TCGA-CV-6933-11,TCGA-CV-6933,HNSC,53.0,MALE,WHITE,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1998.0,nan,-19518.0,Dead,TUMOR FREE,nan,2741.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2741.0,0.0,2741.0,nan,nan,0.0,2741.0,0
TCGA-CV-6934-01,TCGA-CV-6934,HNSC,66.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1998.0,nan,-24180.0,Dead,WITH TUMOR,nan,65.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,65.0,1.0,65.0,nan,nan,1.0,65.0,1
TCGA-CV-6934-11,TCGA-CV-6934,HNSC,66.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1998.0,nan,-24180.0,Dead,WITH TUMOR,nan,65.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,65.0,1.0,65.0,nan,nan,1.0,65.0,1
TCGA-CV-6935-01,TCGA-CV-6935,HNSC,67.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G3,1999.0,nan,-24799.0,Dead,WITH TUMOR,nan,295.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,295.0,1.0,295.0,nan,nan,1.0,295.0,1
TCGA-CV-6935-11,TCGA-CV-6935,HNSC,67.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G3,1999.0,nan,-24799.0,Dead,WITH TUMOR,nan,295.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,295.0,1.0,295.0,nan,nan,1.0,295.0,1
TCGA-CV-6936-01,TCGA-CV-6936,HNSC,68.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2004.0,nan,-25020.0,Dead,WITH TUMOR,nan,166.0,nan,Locoregional Recurrence,Oral Cavity,mandibular,157.0,Progressive Disease,nan,nan,1.0,166.0,1.0,166.0,nan,nan,1.0,157.0,1
TCGA-CV-6936-11,TCGA-CV-6936,HNSC,68.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2004.0,nan,-25020.0,Dead,WITH TUMOR,nan,166.0,nan,Locoregional Recurrence,Oral Cavity,mandibular,157.0,Progressive Disease,nan,nan,1.0,166.0,1.0,166.0,nan,nan,1.0,157.0,1
TCGA-CV-6937-01,TCGA-CV-6937,HNSC,71.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2003.0,nan,-26156.0,Dead,TUMOR FREE,nan,624.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,624.0,0.0,624.0,nan,nan,0.0,624.0,0
TCGA-CV-6938-01,TCGA-CV-6938,HNSC,87.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G1,1996.0,nan,-31825.0,Dead,TUMOR FREE,nan,144.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,144.0,0.0,144.0,nan,nan,0.0,144.0,0
TCGA-CV-6938-11,TCGA-CV-6938,HNSC,87.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G1,1996.0,nan,-31825.0,Dead,TUMOR FREE,nan,144.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,144.0,0.0,144.0,nan,nan,0.0,144.0,0
TCGA-CV-6939-01,TCGA-CV-6939,HNSC,60.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,1994.0,nan,-21947.0,Dead,WITH TUMOR,nan,666.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,666.0,1.0,666.0,nan,nan,1.0,666.0,1
TCGA-CV-6939-11,TCGA-CV-6939,HNSC,60.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,1994.0,nan,-21947.0,Dead,WITH TUMOR,nan,666.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,666.0,1.0,666.0,nan,nan,1.0,666.0,1
TCGA-CV-6940-01,TCGA-CV-6940,HNSC,80.0,FEMALE,WHITE,Stage III,Stage I,Head & Neck Squamous Cell Carcinoma,G2,2002.0,nan,-29382.0,Dead,TUMOR FREE,nan,804.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,804.0,0.0,804.0,0.0,804.0,0.0,804.0,0
TCGA-CV-6941-01,TCGA-CV-6941,HNSC,51.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1999.0,nan,-18812.0,Dead,TUMOR FREE,nan,342.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,342.0,0.0,342.0,0.0,342.0,0.0,342.0,0
TCGA-CV-6942-01,TCGA-CV-6942,HNSC,73.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2000.0,nan,-26941.0,Alive,TUMOR FREE,4282.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4282.0,0.0,4282.0,0.0,4282.0,0.0,4282.0,0
TCGA-CV-6943-01,TCGA-CV-6943,HNSC,74.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1999.0,nan,-27310.0,Dead,WITH TUMOR,nan,602.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,602.0,1.0,602.0,nan,nan,1.0,602.0,1
TCGA-CV-6943-11,TCGA-CV-6943,HNSC,74.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1999.0,nan,-27310.0,Dead,WITH TUMOR,nan,602.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,602.0,1.0,602.0,nan,nan,1.0,602.0,1
TCGA-CV-6945-01,TCGA-CV-6945,HNSC,41.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1993.0,nan,-15158.0,Dead,WITH TUMOR,nan,366.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,366.0,1.0,366.0,nan,nan,1.0,366.0,1
TCGA-CV-6948-01,TCGA-CV-6948,HNSC,79.0,FEMALE,WHITE,Stage IVB,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1994.0,nan,-29153.0,Dead,TUMOR FREE,nan,1289.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1289.0,0.0,1289.0,nan,nan,0.0,1289.0,1
TCGA-CV-6950-01,TCGA-CV-6950,HNSC,64.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1994.0,nan,-23549.0,Dead,WITH TUMOR,nan,459.0,nan,Locoregional Recurrence,Oral Cavity,Tonsil,258.0,Complete Remission/Response,nan,nan,1.0,459.0,1.0,459.0,nan,nan,1.0,258.0,1
TCGA-CV-6951-01,TCGA-CV-6951,HNSC,57.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1996.0,nan,-21166.0,Dead,WITH TUMOR,nan,915.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,915.0,1.0,915.0,nan,nan,1.0,915.0,1
TCGA-CV-6951-11,TCGA-CV-6951,HNSC,57.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1996.0,nan,-21166.0,Dead,WITH TUMOR,nan,915.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,915.0,1.0,915.0,nan,nan,1.0,915.0,1
TCGA-CV-6952-01,TCGA-CV-6952,HNSC,65.0,FEMALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G1,1996.0,nan,-23892.0,Dead,TUMOR FREE,nan,185.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,185.0,0.0,185.0,nan,nan,0.0,185.0,1
TCGA-CV-6952-11,TCGA-CV-6952,HNSC,65.0,FEMALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G1,1996.0,nan,-23892.0,Dead,TUMOR FREE,nan,185.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,185.0,0.0,185.0,nan,nan,0.0,185.0,1
TCGA-CV-6953-01,TCGA-CV-6953,HNSC,80.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G1,1997.0,nan,-29465.0,Dead,WITH TUMOR,nan,1641.0,nan,Locoregional Recurrence,Oral Cavity,oral tongue,1521.0,Complete Remission/Response,nan,nan,1.0,1641.0,1.0,1641.0,1.0,1521.0,1.0,1521.0,1
TCGA-CV-6953-11,TCGA-CV-6953,HNSC,80.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G1,1997.0,nan,-29465.0,Dead,WITH TUMOR,nan,1641.0,nan,Locoregional Recurrence,Oral Cavity,oral tongue,1521.0,Complete Remission/Response,nan,nan,1.0,1641.0,1.0,1641.0,1.0,1521.0,1.0,1521.0,1
TCGA-CV-6954-01,TCGA-CV-6954,HNSC,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1998.0,nan,-21557.0,Dead,TUMOR FREE,nan,2002.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2002.0,0.0,2002.0,nan,nan,0.0,2002.0,0
TCGA-CV-6954-11,TCGA-CV-6954,HNSC,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1998.0,nan,-21557.0,Dead,TUMOR FREE,nan,2002.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2002.0,0.0,2002.0,nan,nan,0.0,2002.0,0
TCGA-CV-6955-01,TCGA-CV-6955,HNSC,74.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2000.0,nan,-27261.0,Dead,WITH TUMOR,nan,334.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,334.0,1.0,334.0,nan,nan,1.0,334.0,1
TCGA-CV-6955-11,TCGA-CV-6955,HNSC,74.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2000.0,nan,-27261.0,Dead,WITH TUMOR,nan,334.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,334.0,1.0,334.0,nan,nan,1.0,334.0,1
TCGA-CV-6956-01,TCGA-CV-6956,HNSC,67.0,MALE,WHITE,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1993.0,nan,-24720.0,Dead,WITH TUMOR,nan,217.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,217.0,1.0,217.0,nan,nan,1.0,217.0,1
TCGA-CV-6956-11,TCGA-CV-6956,HNSC,67.0,MALE,WHITE,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1993.0,nan,-24720.0,Dead,WITH TUMOR,nan,217.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,217.0,1.0,217.0,nan,nan,1.0,217.0,1
TCGA-CV-6959-01,TCGA-CV-6959,HNSC,48.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1999.0,nan,-17679.0,Dead,WITH TUMOR,nan,256.0,nan,Locoregional Recurrence,nan,"Rt. Neck mass, skin",103.0,nan,nan,nan,1.0,256.0,1.0,256.0,nan,nan,1.0,103.0,1
TCGA-CV-6959-11,TCGA-CV-6959,HNSC,48.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1999.0,nan,-17679.0,Dead,WITH TUMOR,nan,256.0,nan,Locoregional Recurrence,nan,"Rt. Neck mass, skin",103.0,nan,nan,nan,1.0,256.0,1.0,256.0,nan,nan,1.0,103.0,1
TCGA-CV-6960-01,TCGA-CV-6960,HNSC,49.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G3,1999.0,nan,-18194.0,Dead,TUMOR FREE,nan,862.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,862.0,0.0,862.0,nan,nan,0.0,862.0,0
TCGA-CV-6960-11,TCGA-CV-6960,HNSC,49.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G3,1999.0,nan,-18194.0,Dead,TUMOR FREE,nan,862.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,862.0,0.0,862.0,nan,nan,0.0,862.0,0
TCGA-CV-6961-01,TCGA-CV-6961,HNSC,61.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G3,1999.0,nan,-22532.0,Dead,WITH TUMOR,nan,76.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,76.0,1.0,76.0,nan,nan,1.0,76.0,1
TCGA-CV-6961-11,TCGA-CV-6961,HNSC,61.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G3,1999.0,nan,-22532.0,Dead,WITH TUMOR,nan,76.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,76.0,1.0,76.0,nan,nan,1.0,76.0,1
TCGA-CV-6962-01,TCGA-CV-6962,HNSC,65.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1999.0,nan,-24103.0,Dead,TUMOR FREE,nan,126.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,126.0,0.0,126.0,nan,nan,0.0,126.0,0
TCGA-CV-6962-11,TCGA-CV-6962,HNSC,65.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1999.0,nan,-24103.0,Dead,TUMOR FREE,nan,126.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,126.0,0.0,126.0,nan,nan,0.0,126.0,0
TCGA-CV-7089-01,TCGA-CV-7089,HNSC,74.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2001.0,nan,-27149.0,Dead,TUMOR FREE,nan,1972.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1972.0,0.0,1972.0,nan,nan,0.0,1972.0,0
TCGA-CV-7089-11,TCGA-CV-7089,HNSC,74.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2001.0,nan,-27149.0,Dead,TUMOR FREE,nan,1972.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1972.0,0.0,1972.0,nan,nan,0.0,1972.0,0
TCGA-CV-7090-01,TCGA-CV-7090,HNSC,39.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2001.0,nan,-14515.0,Alive,TUMOR FREE,5252.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,5252.0,0.0,5252.0,0.0,5252.0,0.0,5252.0,0
TCGA-CV-7091-01,TCGA-CV-7091,HNSC,54.0,MALE,WHITE,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma,G3,2001.0,nan,-19938.0,Alive,TUMOR FREE,3381.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3381.0,0.0,3381.0,nan,nan,0.0,3381.0,0
TCGA-CV-7091-11,TCGA-CV-7091,HNSC,54.0,MALE,WHITE,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma,G3,2001.0,nan,-19938.0,Alive,TUMOR FREE,3381.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3381.0,0.0,3381.0,nan,nan,0.0,3381.0,0
TCGA-CV-7095-01,TCGA-CV-7095,HNSC,87.0,FEMALE,nan,Stage II,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2001.0,nan,-32022.0,Dead,TUMOR FREE,nan,572.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,572.0,0.0,572.0,nan,nan,0.0,572.0,1
TCGA-CV-7097-01,TCGA-CV-7097,HNSC,53.0,MALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2002.0,nan,-19382.0,Dead,WITH TUMOR,nan,385.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,385.0,1.0,385.0,nan,nan,1.0,385.0,1
TCGA-CV-7097-11,TCGA-CV-7097,HNSC,53.0,MALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2002.0,nan,-19382.0,Dead,WITH TUMOR,nan,385.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,385.0,1.0,385.0,nan,nan,1.0,385.0,1
TCGA-CV-7099-01,TCGA-CV-7099,HNSC,85.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2002.0,nan,-31134.0,Dead,TUMOR FREE,nan,243.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,243.0,0.0,243.0,0.0,243.0,0.0,243.0,0
TCGA-CV-7100-01,TCGA-CV-7100,HNSC,66.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2001.0,nan,-24183.0,Dead,WITH TUMOR,nan,274.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,274.0,1.0,274.0,nan,nan,1.0,274.0,1
TCGA-CV-7101-01,TCGA-CV-7101,HNSC,80.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,1999.0,nan,-29550.0,Dead,TUMOR FREE,nan,160.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,160.0,0.0,160.0,nan,nan,0.0,160.0,0
TCGA-CV-7101-11,TCGA-CV-7101,HNSC,80.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,1999.0,nan,-29550.0,Dead,TUMOR FREE,nan,160.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,160.0,0.0,160.0,nan,nan,0.0,160.0,0
TCGA-CV-7102-01,TCGA-CV-7102,HNSC,76.0,FEMALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2000.0,nan,-27805.0,Dead,nan,nan,56.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,56.0,nan,56.0,nan,nan,0.0,56.0,1
TCGA-CV-7103-01,TCGA-CV-7103,HNSC,49.0,MALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2000.0,nan,-18219.0,Dead,WITH TUMOR,nan,1591.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1591.0,1.0,1591.0,nan,nan,1.0,1591.0,1
TCGA-CV-7103-11,TCGA-CV-7103,HNSC,49.0,MALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2000.0,nan,-18219.0,Dead,WITH TUMOR,nan,1591.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1591.0,1.0,1591.0,nan,nan,1.0,1591.0,1
TCGA-CV-7104-01,TCGA-CV-7104,HNSC,61.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2000.0,nan,-22349.0,Dead,TUMOR FREE,nan,393.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,393.0,0.0,393.0,nan,nan,0.0,393.0,1
TCGA-CV-7177-01,TCGA-CV-7177,HNSC,82.0,FEMALE,WHITE,Stage II,Stage I,Head & Neck Squamous Cell Carcinoma,G2,1999.0,nan,-30180.0,Dead,WITH TUMOR,nan,663.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,663.0,1.0,663.0,nan,nan,1.0,663.0,1
TCGA-CV-7177-11,TCGA-CV-7177,HNSC,82.0,FEMALE,WHITE,Stage II,Stage I,Head & Neck Squamous Cell Carcinoma,G2,1999.0,nan,-30180.0,Dead,WITH TUMOR,nan,663.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,663.0,1.0,663.0,nan,nan,1.0,663.0,1
TCGA-CV-7178-01,TCGA-CV-7178,HNSC,64.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2000.0,nan,-23430.0,Dead,WITH TUMOR,nan,2166.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2166.0,1.0,2166.0,nan,nan,1.0,2166.0,1
TCGA-CV-7178-11,TCGA-CV-7178,HNSC,64.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2000.0,nan,-23430.0,Dead,WITH TUMOR,nan,2166.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2166.0,1.0,2166.0,nan,nan,1.0,2166.0,1
TCGA-CV-7180-01,TCGA-CV-7180,HNSC,34.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,1996.0,nan,-12523.0,Dead,WITH TUMOR,nan,327.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,327.0,1.0,327.0,nan,nan,1.0,327.0,1
TCGA-CV-7183-01,TCGA-CV-7183,HNSC,53.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2002.0,nan,-19358.0,Alive,TUMOR FREE,3981.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3981.0,0.0,3981.0,0.0,3981.0,0.0,3981.0,0
TCGA-CV-7183-11,TCGA-CV-7183,HNSC,53.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2002.0,nan,-19358.0,Alive,TUMOR FREE,3981.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3981.0,0.0,3981.0,0.0,3981.0,0.0,3981.0,0
TCGA-CV-7235-01,TCGA-CV-7235,HNSC,67.0,MALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2007.0,nan,-24800.0,Alive,TUMOR FREE,2347.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2347.0,0.0,2347.0,0.0,2347.0,0.0,2347.0,0
TCGA-CV-7235-11,TCGA-CV-7235,HNSC,67.0,MALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2007.0,nan,-24800.0,Alive,TUMOR FREE,2347.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2347.0,0.0,2347.0,0.0,2347.0,0.0,2347.0,0
TCGA-CV-7236-01,TCGA-CV-7236,HNSC,77.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2007.0,nan,-28250.0,Dead,TUMOR FREE,nan,144.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,144.0,0.0,144.0,nan,nan,0.0,144.0,1
TCGA-CV-7238-01,TCGA-CV-7238,HNSC,69.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2007.0,nan,-25471.0,Alive,TUMOR FREE,2727.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2727.0,0.0,2727.0,0.0,2727.0,0.0,2727.0,0
TCGA-CV-7238-11,TCGA-CV-7238,HNSC,69.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2007.0,nan,-25471.0,Alive,TUMOR FREE,2727.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2727.0,0.0,2727.0,0.0,2727.0,0.0,2727.0,0
TCGA-CV-7242-01,TCGA-CV-7242,HNSC,60.0,FEMALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-22136.0,Alive,TUMOR FREE,1095.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1095.0,0.0,1095.0,nan,nan,0.0,1095.0,0
TCGA-CV-7242-11,TCGA-CV-7242,HNSC,60.0,FEMALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-22136.0,Alive,TUMOR FREE,1095.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1095.0,0.0,1095.0,nan,nan,0.0,1095.0,0
TCGA-CV-7243-01,TCGA-CV-7243,HNSC,50.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-18466.0,Alive,TUMOR FREE,954.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,954.0,0.0,954.0,nan,nan,0.0,954.0,0
TCGA-CV-7245-01,TCGA-CV-7245,HNSC,62.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-22646.0,Alive,TUMOR FREE,797.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,797.0,0.0,797.0,nan,nan,0.0,797.0,0
TCGA-CV-7245-11,TCGA-CV-7245,HNSC,62.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-22646.0,Alive,TUMOR FREE,797.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,797.0,0.0,797.0,nan,nan,0.0,797.0,0
TCGA-CV-7247-01,TCGA-CV-7247,HNSC,55.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,1995.0,nan,-20433.0,Dead,WITH TUMOR,nan,577.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,577.0,1.0,577.0,nan,nan,1.0,577.0,1
TCGA-CV-7248-01,TCGA-CV-7248,HNSC,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2001.0,nan,-23082.0,Dead,TUMOR FREE,nan,521.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,521.0,0.0,521.0,nan,nan,0.0,521.0,0
TCGA-CV-7250-01,TCGA-CV-7250,HNSC,64.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2000.0,nan,-23489.0,Dead,TUMOR FREE,nan,2900.0,nan,Distant Metastasis,Distant Metastasis,suprasternal,111.0,Complete Remission/Response,nan,nan,1.0,2900.0,0.0,2900.0,nan,nan,1.0,111.0,1
TCGA-CV-7250-11,TCGA-CV-7250,HNSC,64.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2000.0,nan,-23489.0,Dead,TUMOR FREE,nan,2900.0,nan,Distant Metastasis,Distant Metastasis,suprasternal,111.0,Complete Remission/Response,nan,nan,1.0,2900.0,0.0,2900.0,nan,nan,1.0,111.0,1
TCGA-CV-7252-01,TCGA-CV-7252,HNSC,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1994.0,nan,-22934.0,Dead,WITH TUMOR,nan,151.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,151.0,1.0,151.0,nan,nan,1.0,151.0,1
TCGA-CV-7252-11,TCGA-CV-7252,HNSC,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1994.0,nan,-22934.0,Dead,WITH TUMOR,nan,151.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,151.0,1.0,151.0,nan,nan,1.0,151.0,1
TCGA-CV-7253-01,TCGA-CV-7253,HNSC,58.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G2,1993.0,nan,-21473.0,Dead,WITH TUMOR,nan,361.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,361.0,1.0,361.0,nan,nan,1.0,361.0,1
TCGA-CV-7254-01,TCGA-CV-7254,HNSC,55.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G3,1996.0,nan,-20306.0,Dead,WITH TUMOR,nan,1459.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1459.0,1.0,1459.0,nan,nan,1.0,1459.0,1
TCGA-CV-7255-01,TCGA-CV-7255,HNSC,32.0,FEMALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G2,1995.0,nan,-11931.0,Dead,WITH TUMOR,nan,64.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,64.0,1.0,64.0,nan,nan,1.0,64.0,1
TCGA-CV-7255-11,TCGA-CV-7255,HNSC,32.0,FEMALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G2,1995.0,nan,-11931.0,Dead,WITH TUMOR,nan,64.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,64.0,1.0,64.0,nan,nan,1.0,64.0,1
TCGA-CV-7261-01,TCGA-CV-7261,HNSC,57.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-20992.0,Alive,TUMOR FREE,1512.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1512.0,0.0,1512.0,nan,nan,0.0,1512.0,0
TCGA-CV-7261-11,TCGA-CV-7261,HNSC,57.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-20992.0,Alive,TUMOR FREE,1512.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1512.0,0.0,1512.0,nan,nan,0.0,1512.0,0
TCGA-CV-7263-01,TCGA-CV-7263,HNSC,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G1,1997.0,nan,-23513.0,Dead,WITH TUMOR,nan,560.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,560.0,1.0,560.0,nan,nan,1.0,560.0,1
TCGA-CV-7263-11,TCGA-CV-7263,HNSC,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G1,1997.0,nan,-23513.0,Dead,WITH TUMOR,nan,560.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,560.0,1.0,560.0,nan,nan,1.0,560.0,1
TCGA-CV-7406-01,TCGA-CV-7406,HNSC,49.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,GX,1999.0,nan,-18250.0,Dead,nan,nan,1748.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1748.0,nan,1748.0,nan,nan,0.0,1748.0,1
TCGA-CV-7406-11,TCGA-CV-7406,HNSC,49.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,GX,1999.0,nan,-18250.0,Dead,nan,nan,1748.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1748.0,nan,1748.0,nan,nan,0.0,1748.0,1
TCGA-CV-7407-01,TCGA-CV-7407,HNSC,67.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,1992.0,nan,-24475.0,Dead,nan,nan,1081.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1081.0,nan,1081.0,nan,nan,0.0,1081.0,1
TCGA-CV-7409-01,TCGA-CV-7409,HNSC,43.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVB,Stage IVB,Head & Neck Squamous Cell Carcinoma,G3,1994.0,nan,-15888.0,Dead,nan,nan,543.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,543.0,nan,543.0,nan,nan,0.0,543.0,1
TCGA-CV-7410-01,TCGA-CV-7410,HNSC,61.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,GX,1993.0,nan,-22302.0,Dead,WITH TUMOR,nan,6417.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,6417.0,1.0,6417.0,nan,nan,1.0,6417.0,1
TCGA-CV-7411-01,TCGA-CV-7411,HNSC,64.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,1994.0,nan,-23696.0,Dead,nan,nan,2717.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2717.0,nan,2717.0,nan,nan,0.0,2717.0,1
TCGA-CV-7413-01,TCGA-CV-7413,HNSC,74.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,1995.0,nan,-27231.0,Dead,nan,nan,294.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,294.0,nan,294.0,0.0,294.0,0.0,294.0,2
TCGA-CV-7414-01,TCGA-CV-7414,HNSC,78.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1995.0,nan,-28603.0,Dead,nan,nan,14.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,14.0,nan,14.0,nan,nan,0.0,14.0,1
TCGA-CV-7415-01,TCGA-CV-7415,HNSC,60.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1995.0,nan,-22062.0,Dead,WITH TUMOR,nan,695.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,695.0,1.0,695.0,nan,nan,1.0,695.0,1
TCGA-CV-7416-01,TCGA-CV-7416,HNSC,29.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,GX,1994.0,nan,-10936.0,Dead,nan,nan,763.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,763.0,nan,763.0,nan,nan,0.0,763.0,1
TCGA-CV-7416-11,TCGA-CV-7416,HNSC,29.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,GX,1994.0,nan,-10936.0,Dead,nan,nan,763.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,763.0,nan,763.0,nan,nan,0.0,763.0,1
TCGA-CV-7418-01,TCGA-CV-7418,HNSC,62.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1996.0,nan,-22805.0,Dead,TUMOR FREE,nan,789.0,nan,Locoregional Recurrence,Hypopharynx,nasopharynx,494.0,Complete Remission/Response,nan,nan,1.0,789.0,0.0,789.0,nan,nan,1.0,494.0,1
TCGA-CV-7421-01,TCGA-CV-7421,HNSC,76.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1997.0,nan,-27961.0,Dead,nan,nan,2.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2.0,nan,2.0,nan,nan,0.0,2.0,1
TCGA-CV-7422-01,TCGA-CV-7422,HNSC,60.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,1997.0,nan,-22098.0,Dead,WITH TUMOR,nan,1037.0,nan,Locoregional Recurrence,Larynx,tracheal,733.0,Complete Remission/Response,nan,nan,1.0,1037.0,1.0,1037.0,nan,nan,1.0,733.0,1
TCGA-CV-7423-01,TCGA-CV-7423,HNSC,65.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G1,1997.0,nan,-24071.0,Dead,nan,nan,3059.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,3059.0,nan,3059.0,nan,nan,0.0,3059.0,1
TCGA-CV-7423-11,TCGA-CV-7423,HNSC,65.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G1,1997.0,nan,-24071.0,Dead,nan,nan,3059.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,3059.0,nan,3059.0,nan,nan,0.0,3059.0,1
TCGA-CV-7424-01,TCGA-CV-7424,HNSC,67.0,MALE,ASIAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1997.0,nan,-24775.0,Dead,WITH TUMOR,nan,453.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,453.0,1.0,453.0,nan,nan,1.0,453.0,1
TCGA-CV-7424-11,TCGA-CV-7424,HNSC,67.0,MALE,ASIAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1997.0,nan,-24775.0,Dead,WITH TUMOR,nan,453.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,453.0,1.0,453.0,nan,nan,1.0,453.0,1
TCGA-CV-7425-01,TCGA-CV-7425,HNSC,77.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2000.0,nan,-28368.0,Dead,WITH TUMOR,nan,1718.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1718.0,1.0,1718.0,nan,nan,1.0,1718.0,1
TCGA-CV-7425-11,TCGA-CV-7425,HNSC,77.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2000.0,nan,-28368.0,Dead,WITH TUMOR,nan,1718.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1718.0,1.0,1718.0,nan,nan,1.0,1718.0,1
TCGA-CV-7427-01,TCGA-CV-7427,HNSC,73.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G1,1997.0,nan,-26975.0,Dead,TUMOR FREE,nan,4760.0,nan,Locoregional Recurrence,Oral Cavity,Maxilla,3282.0,Complete Remission/Response,nan,nan,1.0,4760.0,0.0,4760.0,1.0,3282.0,1.0,3282.0,2
TCGA-CV-7428-01,TCGA-CV-7428,HNSC,47.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1998.0,nan,-17429.0,Dead,WITH TUMOR,nan,1671.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1671.0,1.0,1671.0,nan,nan,1.0,1671.0,1
TCGA-CV-7429-01,TCGA-CV-7429,HNSC,55.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G3,1998.0,nan,-20188.0,Dead,WITH TUMOR,nan,107.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,107.0,1.0,107.0,nan,nan,1.0,107.0,1
TCGA-CV-7430-01,TCGA-CV-7430,HNSC,56.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1996.0,nan,-20763.0,Dead,WITH TUMOR,nan,495.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,495.0,1.0,495.0,nan,nan,1.0,495.0,1
TCGA-CV-7432-01,TCGA-CV-7432,HNSC,79.0,MALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G1,1998.0,nan,-28875.0,Dead,WITH TUMOR,nan,2570.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2570.0,1.0,2570.0,nan,nan,1.0,2570.0,1
TCGA-CV-7432-11,TCGA-CV-7432,HNSC,79.0,MALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G1,1998.0,nan,-28875.0,Dead,WITH TUMOR,nan,2570.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2570.0,1.0,2570.0,nan,nan,1.0,2570.0,1
TCGA-CV-7433-01,TCGA-CV-7433,HNSC,49.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,1999.0,nan,-18004.0,Dead,WITH TUMOR,nan,601.0,nan,Distant Metastasis,Distant Metastasis,Lt. Deltoid,445.0,Progressive Disease,nan,nan,1.0,601.0,1.0,601.0,nan,nan,1.0,445.0,1
TCGA-CV-7434-01,TCGA-CV-7434,HNSC,64.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1999.0,nan,-23465.0,Dead,TUMOR FREE,nan,218.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,218.0,0.0,218.0,nan,nan,0.0,218.0,0
TCGA-CV-7434-11,TCGA-CV-7434,HNSC,64.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1999.0,nan,-23465.0,Dead,TUMOR FREE,nan,218.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,218.0,0.0,218.0,nan,nan,0.0,218.0,0
TCGA-CV-7435-01,TCGA-CV-7435,HNSC,57.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,1999.0,nan,-21049.0,Dead,TUMOR FREE,nan,4680.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,4680.0,0.0,4680.0,nan,nan,0.0,4680.0,1
TCGA-CV-7437-01,TCGA-CV-7437,HNSC,77.0,MALE,nan,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,GX,1996.0,nan,-28221.0,Dead,WITH TUMOR,nan,506.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,506.0,1.0,506.0,nan,nan,1.0,506.0,1
TCGA-CV-7437-11,TCGA-CV-7437,HNSC,77.0,MALE,nan,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,GX,1996.0,nan,-28221.0,Dead,WITH TUMOR,nan,506.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,506.0,1.0,506.0,nan,nan,1.0,506.0,1
TCGA-CV-7438-01,TCGA-CV-7438,HNSC,87.0,FEMALE,WHITE,Stage I,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2000.0,nan,-32021.0,Dead,WITH TUMOR,nan,194.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,194.0,1.0,194.0,nan,nan,1.0,194.0,1
TCGA-CV-7438-11,TCGA-CV-7438,HNSC,87.0,FEMALE,WHITE,Stage I,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2000.0,nan,-32021.0,Dead,WITH TUMOR,nan,194.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,194.0,1.0,194.0,nan,nan,1.0,194.0,1
TCGA-CV-7440-01,TCGA-CV-7440,HNSC,38.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,GX,2000.0,nan,-13992.0,Dead,nan,nan,675.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,675.0,nan,675.0,nan,nan,0.0,675.0,1
TCGA-CV-7440-11,TCGA-CV-7440,HNSC,38.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,GX,2000.0,nan,-13992.0,Dead,nan,nan,675.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,675.0,nan,675.0,nan,nan,0.0,675.0,1
TCGA-CV-7446-01,TCGA-CV-7446,HNSC,66.0,MALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G2,1998.0,nan,-24170.0,Dead,WITH TUMOR,nan,1093.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1093.0,1.0,1093.0,nan,nan,1.0,1093.0,1
TCGA-CV-7568-01,TCGA-CV-7568,HNSC,48.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,GX,1995.0,nan,-17670.0,Dead,nan,nan,927.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,927.0,nan,927.0,nan,nan,0.0,927.0,1
TCGA-CV-A45O-01,TCGA-CV-A45O,HNSC,57.0,MALE,WHITE,nan,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1994.0,nan,-20868.0,Alive,TUMOR FREE,851.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,851.0,0.0,851.0,nan,nan,0.0,851.0,0
TCGA-CV-A45P-01,TCGA-CV-A45P,HNSC,82.0,FEMALE,WHITE,Stage I,Stage II,Head & Neck Squamous Cell Carcinoma,G2,1998.0,nan,-30297.0,Alive,WITH TUMOR,639.0,nan,nan,Locoregional Recurrence,Oral Cavity,Floor of mouth,639.0,Complete Remission/Response,nan,nan,0.0,639.0,0.0,639.0,1.0,639.0,1.0,639.0,2
TCGA-CV-A45Q-01,TCGA-CV-A45Q,HNSC,69.0,FEMALE,WHITE,nan,Stage IVC,Head & Neck Squamous Cell Carcinoma,G1,1995.0,nan,-25379.0,Dead,TUMOR FREE,nan,5152.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,5152.0,0.0,5152.0,nan,nan,0.0,5152.0,1
TCGA-CV-A45R-01,TCGA-CV-A45R,HNSC,46.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G1,1997.0,nan,-17125.0,Alive,TUMOR FREE,5480.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,5480.0,0.0,5480.0,0.0,5480.0,0.0,5480.0,0
TCGA-CV-A45T-01,TCGA-CV-A45T,HNSC,64.0,FEMALE,WHITE,[Discrepancy],Stage II,Head & Neck Squamous Cell Carcinoma,G3,1998.0,nan,-23452.0,Dead,TUMOR FREE,nan,4856.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,4856.0,0.0,4856.0,nan,nan,0.0,4856.0,1
TCGA-CV-A45U-01,TCGA-CV-A45U,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,1999.0,nan,-21746.0,Dead,WITH TUMOR,nan,1079.0,nan,nan,Distant Metastasis,pelvis,1064.0,Complete Remission/Response,nan,nan,1.0,1079.0,1.0,1079.0,nan,nan,1.0,1064.0,1
TCGA-CV-A45V-01,TCGA-CV-A45V,HNSC,87.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,1999.0,nan,-31936.0,Dead,nan,nan,32.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,32.0,nan,32.0,nan,nan,0.0,32.0,1
TCGA-CV-A45W-01,TCGA-CV-A45W,HNSC,75.0,MALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G2,1999.0,nan,-27743.0,Dead,TUMOR FREE,nan,1398.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1398.0,0.0,1398.0,nan,nan,0.0,1398.0,0
TCGA-CV-A45X-01,TCGA-CV-A45X,HNSC,47.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2000.0,nan,-17464.0,Dead,TUMOR FREE,nan,198.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,198.0,0.0,198.0,nan,nan,0.0,198.0,0
TCGA-CV-A45Y-01,TCGA-CV-A45Y,HNSC,61.0,MALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2000.0,nan,-22442.0,Dead,TUMOR FREE,nan,2703.0,nan,nan,nan,R. Lung,2318.0,Complete Remission/Response,nan,nan,1.0,2703.0,0.0,2703.0,nan,nan,1.0,2318.0,1
TCGA-CV-A45Z-01,TCGA-CV-A45Z,HNSC,75.0,MALE,WHITE,[Discrepancy],Stage II,Head & Neck Squamous Cell Carcinoma,G3,2000.0,nan,-27397.0,Dead,WITH TUMOR,nan,1466.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1466.0,1.0,1466.0,nan,nan,1.0,1466.0,1
TCGA-CV-A460-01,TCGA-CV-A460,HNSC,72.0,MALE,WHITE,[Discrepancy],Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2001.0,nan,-26539.0,Dead,[Discrepancy],nan,1838.0,nan,New Primary Tumor,nan,mediastinum,1425.0,Complete Remission/Response,nan,nan,1.0,1838.0,nan,1838.0,nan,nan,1.0,1425.0,1
TCGA-CV-A461-01,TCGA-CV-A461,HNSC,65.0,MALE,WHITE,nan,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2004.0,nan,-23955.0,Dead,TUMOR FREE,nan,2064.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2064.0,0.0,2064.0,0.0,2064.0,0.0,2064.0,0
TCGA-CV-A463-01,TCGA-CV-A463,HNSC,82.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2007.0,nan,-30095.0,Dead,TUMOR FREE,nan,23.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,23.0,0.0,23.0,nan,nan,0.0,23.0,1
TCGA-CV-A464-01,TCGA-CV-A464,HNSC,48.0,MALE,WHITE,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-17669.0,Alive,TUMOR FREE,1722.0,nan,nan,Locoregional Disease,nan,pterygoid,28.0,Complete Remission/Response,nan,nan,0.0,1722.0,0.0,1722.0,nan,nan,1.0,28.0,2
TCGA-CV-A465-01,TCGA-CV-A465,HNSC,24.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2008.0,nan,-9015.0,Dead,TUMOR FREE,nan,215.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,215.0,0.0,215.0,0.0,215.0,0.0,215.0,0
TCGA-CV-A468-01,TCGA-CV-A468,HNSC,42.0,MALE,nan,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2001.0,nan,-15372.0,Dead,TUMOR FREE,nan,464.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,464.0,0.0,464.0,nan,nan,0.0,464.0,0
TCGA-CV-A6JD-01,TCGA-CV-A6JD,HNSC,82.0,FEMALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2012.0,nan,-29988.0,Dead,TUMOR FREE,nan,182.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,182.0,0.0,182.0,nan,nan,0.0,182.0,1
TCGA-CV-A6JE-01,TCGA-CV-A6JE,HNSC,78.0,MALE,WHITE,nan,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-28658.0,Alive,TUMOR FREE,1075.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1075.0,0.0,1075.0,0.0,1075.0,0.0,1075.0,0
TCGA-CV-A6JM-01,TCGA-CV-A6JM,HNSC,85.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-31147.0,Dead,TUMOR FREE,nan,194.0,nan,Locoregional Recurrence,Oropharynx,nan,107.0,Complete Remission/Response,nan,nan,1.0,194.0,0.0,194.0,nan,nan,1.0,107.0,0
TCGA-CV-A6JN-01,TCGA-CV-A6JN,HNSC,53.0,MALE,WHITE,nan,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2011.0,nan,-19635.0,Alive,TUMOR FREE,906.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,906.0,0.0,906.0,0.0,906.0,0.0,906.0,0
TCGA-CV-A6JO-01,TCGA-CV-A6JO,HNSC,69.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-25377.0,Dead,WITH TUMOR,nan,197.0,nan,nan,Oral Cavity,submandibular,127.0,Progressive Disease,nan,nan,1.0,197.0,1.0,197.0,nan,nan,1.0,127.0,1
TCGA-CV-A6JT-01,TCGA-CV-A6JT,HNSC,65.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-23806.0,Alive,TUMOR FREE,852.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,852.0,0.0,852.0,0.0,852.0,0.0,852.0,0
TCGA-CV-A6JU-01,TCGA-CV-A6JU,HNSC,61.0,FEMALE,WHITE,Stage IVB,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-22591.0,Alive,TUMOR FREE,110.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,110.0,0.0,110.0,nan,nan,0.0,110.0,0
TCGA-CV-A6JY-01,TCGA-CV-A6JY,HNSC,69.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2011.0,nan,-25321.0,Alive,TUMOR FREE,646.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,646.0,0.0,646.0,nan,nan,0.0,646.0,0
TCGA-CV-A6JZ-01,TCGA-CV-A6JZ,HNSC,68.0,MALE,WHITE,Stage II,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-25182.0,Alive,WITH TUMOR,714.0,nan,nan,Locoregional Recurrence,Oral Cavity,submandibular,393.0,Complete Remission/Response,nan,nan,0.0,714.0,0.0,714.0,nan,nan,1.0,393.0,2
TCGA-CV-A6K0-01,TCGA-CV-A6K0,HNSC,58.0,MALE,WHITE,Stage I,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2011.0,nan,-21488.0,Alive,TUMOR FREE,606.0,nan,nan,nan,Cervical Lymph Nodes,neck,146.0,Complete Remission/Response,nan,nan,0.0,606.0,0.0,606.0,1.0,146.0,1.0,146.0,0
TCGA-CV-A6K1-01,TCGA-CV-A6K1,HNSC,65.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-23848.0,Alive,TUMOR FREE,685.0,nan,nan,New Primary Tumor,Oral Cavity,Tonsil,401.0,Complete Remission/Response,nan,nan,0.0,685.0,0.0,685.0,nan,nan,1.0,401.0,2
TCGA-CV-A6K2-01,TCGA-CV-A6K2,HNSC,79.0,MALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2011.0,nan,-29114.0,Dead,WITH TUMOR,nan,317.0,nan,Locoregional Recurrence,nan,Infratemporal fossa,134.0,Progressive Disease,nan,nan,1.0,317.0,1.0,317.0,nan,nan,1.0,134.0,1
TCGA-CX-7082-01,TCGA-CX-7082,HNSC,82.0,MALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-30174.0,Dead,TUMOR FREE,nan,11.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,11.0,0.0,11.0,nan,nan,0.0,11.0,0
TCGA-CX-7085-01,TCGA-CX-7085,HNSC,77.0,FEMALE,WHITE,Stage I,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-28221.0,Alive,WITH TUMOR,321.0,nan,nan,Locoregional Recurrence,Oropharynx,Submandibular gland,92.0,Complete Remission/Response,nan,nan,0.0,321.0,0.0,321.0,1.0,92.0,1.0,92.0,2
TCGA-CX-7086-01,TCGA-CX-7086,HNSC,53.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-19434.0,Alive,TUMOR FREE,573.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,573.0,0.0,573.0,nan,nan,0.0,573.0,0
TCGA-CX-7219-01,TCGA-CX-7219,HNSC,47.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-17222.0,Alive,TUMOR FREE,1045.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1045.0,0.0,1045.0,nan,nan,0.0,1045.0,0
TCGA-CX-A4AQ-01,TCGA-CX-A4AQ,HNSC,56.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2008.0,nan,-20709.0,Alive,TUMOR FREE,1555.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1555.0,0.0,1555.0,nan,nan,0.0,1555.0,0
TCGA-D6-6515-01,TCGA-D6-6515,HNSC,82.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2010.0,nan,-30099.0,Dead,TUMOR FREE,nan,403.0,nan,nan,Cervical Lymph Nodes,nan,195.0,Complete Remission/Response,nan,nan,1.0,403.0,0.0,403.0,1.0,195.0,1.0,195.0,2
TCGA-D6-6516-01,TCGA-D6-6516,HNSC,69.0,MALE,WHITE,Stage I,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-25242.0,Alive,TUMOR FREE,773.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,773.0,0.0,773.0,0.0,773.0,0.0,773.0,0
TCGA-D6-6517-01,TCGA-D6-6517,HNSC,59.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-21791.0,Alive,WITH TUMOR,292.0,nan,nan,nan,Distant Metastasis,tracheostoma,161.0,Progressive Disease,nan,nan,0.0,292.0,0.0,292.0,nan,nan,1.0,161.0,2
TCGA-D6-6823-01,TCGA-D6-6823,HNSC,50.0,MALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-18611.0,Alive,TUMOR FREE,701.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,701.0,0.0,701.0,0.0,701.0,0.0,701.0,0
TCGA-D6-6824-01,TCGA-D6-6824,HNSC,61.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-22633.0,Alive,TUMOR FREE,77.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,77.0,0.0,77.0,nan,nan,0.0,77.0,0
TCGA-D6-6825-01,TCGA-D6-6825,HNSC,73.0,MALE,WHITE,Stage I,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-26976.0,Alive,TUMOR FREE,491.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,491.0,0.0,491.0,0.0,491.0,0.0,491.0,0
TCGA-D6-6826-01,TCGA-D6-6826,HNSC,64.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-23722.0,Dead,TUMOR FREE,nan,348.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,348.0,0.0,348.0,nan,nan,0.0,348.0,0
TCGA-D6-6827-01,TCGA-D6-6827,HNSC,55.0,FEMALE,WHITE,Stage I,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2011.0,nan,-20175.0,Alive,TUMOR FREE,568.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,568.0,0.0,568.0,0.0,568.0,0.0,568.0,0
TCGA-D6-8568-01,TCGA-D6-8568,HNSC,62.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-22796.0,Alive,TUMOR FREE,759.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,759.0,0.0,759.0,nan,nan,0.0,759.0,0
TCGA-D6-8569-01,TCGA-D6-8569,HNSC,52.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-19212.0,Alive,TUMOR FREE,770.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,770.0,0.0,770.0,nan,nan,0.0,770.0,0
TCGA-D6-A4Z9-01,TCGA-D6-A4Z9,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-21659.0,Alive,TUMOR FREE,539.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,539.0,0.0,539.0,nan,nan,0.0,539.0,0
TCGA-D6-A4ZB-01,TCGA-D6-A4ZB,HNSC,61.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-22455.0,Alive,TUMOR FREE,376.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,376.0,0.0,376.0,0.0,376.0,0.0,376.0,0
TCGA-D6-A6EK-01,TCGA-D6-A6EK,HNSC,67.0,MALE,WHITE,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2012.0,nan,-24558.0,Alive,TUMOR FREE,875.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,875.0,0.0,875.0,nan,nan,0.0,875.0,0
TCGA-D6-A6EM-01,TCGA-D6-A6EM,HNSC,65.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-23865.0,Alive,WITH TUMOR,232.0,nan,nan,nan,Oral Cavity,oral tongue,232.0,Complete Remission/Response,nan,nan,0.0,232.0,0.0,232.0,1.0,232.0,1.0,232.0,2
TCGA-D6-A6EN-01,TCGA-D6-A6EN,HNSC,71.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2013.0,nan,-26294.0,Alive,TUMOR FREE,687.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,687.0,0.0,687.0,0.0,687.0,0.0,687.0,0
TCGA-D6-A6EO-01,TCGA-D6-A6EO,HNSC,44.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-16185.0,Alive,TUMOR FREE,759.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,759.0,0.0,759.0,nan,nan,0.0,759.0,0
TCGA-D6-A6EP-01,TCGA-D6-A6EP,HNSC,62.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2013.0,nan,-22674.0,Alive,TUMOR FREE,424.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,424.0,0.0,424.0,0.0,424.0,0.0,424.0,0
TCGA-D6-A6EQ-01,TCGA-D6-A6EQ,HNSC,57.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2013.0,nan,-20876.0,Alive,TUMOR FREE,368.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,368.0,0.0,368.0,nan,nan,0.0,368.0,0
TCGA-D6-A6ES-01,TCGA-D6-A6ES,HNSC,50.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-18408.0,Alive,TUMOR FREE,389.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,389.0,0.0,389.0,nan,nan,0.0,389.0,0
TCGA-D6-A74Q-01,TCGA-D6-A74Q,HNSC,67.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2013.0,nan,-24702.0,Alive,TUMOR FREE,710.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,710.0,0.0,710.0,nan,nan,0.0,710.0,0
TCGA-DQ-5624-01,TCGA-DQ-5624,HNSC,43.0,FEMALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2007.0,nan,-15867.0,Alive,TUMOR FREE,1778.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1778.0,0.0,1778.0,nan,nan,0.0,1778.0,2
TCGA-DQ-5625-01,TCGA-DQ-5625,HNSC,52.0,FEMALE,WHITE,nan,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-19211.0,Dead,TUMOR FREE,nan,1133.0,nan,nan,Oral Cavity,nan,1058.0,Complete Remission/Response,nan,nan,1.0,1133.0,0.0,1133.0,1.0,1058.0,1.0,1058.0,2
TCGA-DQ-5629-01,TCGA-DQ-5629,HNSC,64.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-23550.0,Dead,TUMOR FREE,nan,941.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,941.0,0.0,941.0,nan,nan,0.0,941.0,0
TCGA-DQ-5630-01,TCGA-DQ-5630,HNSC,73.0,MALE,WHITE,nan,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-26855.0,Alive,TUMOR FREE,1030.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1030.0,0.0,1030.0,0.0,1030.0,0.0,1030.0,0
TCGA-DQ-5631-01,TCGA-DQ-5631,HNSC,52.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2009.0,nan,-19172.0,Dead,WITH TUMOR,548.0,548.0,nan,nan,Distant Metastasis,Lung,447.0,Complete Remission/Response,nan,nan,1.0,548.0,1.0,548.0,nan,nan,1.0,447.0,1
TCGA-DQ-7588-01,TCGA-DQ-7588,HNSC,66.0,MALE,WHITE,nan,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2010.0,nan,-24106.0,Dead,WITH TUMOR,nan,427.0,nan,nan,Oral Cavity,nan,79.0,Persistent Disease,nan,nan,1.0,427.0,1.0,427.0,nan,nan,1.0,79.0,1
TCGA-DQ-7589-01,TCGA-DQ-7589,HNSC,70.0,MALE,WHITE,nan,Stage IVC,Head & Neck Squamous Cell Carcinoma,G4,2010.0,nan,-25606.0,Alive,TUMOR FREE,1409.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1409.0,0.0,1409.0,nan,nan,0.0,1409.0,0
TCGA-DQ-7590-01,TCGA-DQ-7590,HNSC,51.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G4,2010.0,nan,-18718.0,Alive,TUMOR FREE,1413.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1413.0,0.0,1413.0,nan,nan,0.0,1413.0,0
TCGA-DQ-7591-01,TCGA-DQ-7591,HNSC,62.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G4,2011.0,nan,-22798.0,Alive,TUMOR FREE,622.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,622.0,0.0,622.0,nan,nan,0.0,622.0,0
TCGA-DQ-7592-01,TCGA-DQ-7592,HNSC,57.0,MALE,AMERICAN INDIAN OR ALASKA NATIVE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-21041.0,Alive,TUMOR FREE,1143.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1143.0,0.0,1143.0,nan,nan,0.0,1143.0,0
TCGA-DQ-7593-01,TCGA-DQ-7593,HNSC,58.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G4,2011.0,nan,-21439.0,Alive,TUMOR FREE,1224.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1224.0,0.0,1224.0,nan,nan,0.0,1224.0,0
TCGA-DQ-7594-01,TCGA-DQ-7594,HNSC,47.0,MALE,WHITE,nan,Stage IVB,Head & Neck Squamous Cell Carcinoma,G4,2011.0,nan,-17471.0,Alive,TUMOR FREE,1218.0,nan,nan,New Primary Tumor,Oral Cavity,mandibular alveolus,1084.0,Complete Remission/Response,nan,nan,0.0,1218.0,0.0,1218.0,nan,nan,1.0,1084.0,0
TCGA-DQ-7595-01,TCGA-DQ-7595,HNSC,53.0,MALE,WHITE,nan,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2011.0,nan,-19530.0,Alive,TUMOR FREE,1190.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1190.0,0.0,1190.0,0.0,1190.0,0.0,1190.0,0
TCGA-DQ-7596-01,TCGA-DQ-7596,HNSC,48.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G4,2011.0,nan,-17846.0,Alive,TUMOR FREE,1265.0,nan,nan,nan,Cervical Lymph Nodes,nan,137.0,Persistent Disease,nan,nan,0.0,1265.0,0.0,1265.0,nan,nan,1.0,137.0,0
TCGA-F7-7848-01,TCGA-F7-7848,HNSC,47.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-17251.0,Alive,TUMOR FREE,1131.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1131.0,0.0,1131.0,nan,nan,0.0,1131.0,0
TCGA-F7-8298-01,TCGA-F7-8298,HNSC,58.0,MALE,WHITE,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma,G1,2011.0,nan,-21445.0,Alive,TUMOR FREE,995.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,995.0,0.0,995.0,0.0,995.0,0.0,995.0,0
TCGA-F7-8489-01,TCGA-F7-8489,HNSC,48.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2012.0,nan,-17873.0,Alive,TUMOR FREE,658.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,658.0,0.0,658.0,0.0,658.0,0.0,658.0,0
TCGA-F7-A50G-01,TCGA-F7-A50G,HNSC,66.0,MALE,WHITE,Stage III,nan,Head & Neck Squamous Cell Carcinoma,G1,2012.0,nan,-24285.0,Alive,TUMOR FREE,616.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,616.0,0.0,616.0,0.0,616.0,0.0,616.0,0
TCGA-F7-A50I-01,TCGA-F7-A50I,HNSC,72.0,MALE,WHITE,Stage IVA,nan,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-26373.0,Alive,TUMOR FREE,92.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,92.0,0.0,92.0,nan,nan,0.0,92.0,0
TCGA-F7-A50J-01,TCGA-F7-A50J,HNSC,67.0,FEMALE,WHITE,Stage III,nan,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-24758.0,Alive,TUMOR FREE,947.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,947.0,0.0,947.0,0.0,947.0,0.0,947.0,0
TCGA-F7-A61S-01,TCGA-F7-A61S,HNSC,62.0,MALE,WHITE,Stage III,nan,Head & Neck Squamous Cell Carcinoma,G1,2012.0,nan,-22655.0,Alive,TUMOR FREE,576.0,nan,nan,Locoregional Recurrence,Cervical Lymph Nodes,nan,213.0,Complete Remission/Response,nan,nan,0.0,576.0,0.0,576.0,1.0,213.0,1.0,213.0,2
TCGA-F7-A61V-01,TCGA-F7-A61V,HNSC,54.0,MALE,WHITE,Stage II,nan,Head & Neck Squamous Cell Carcinoma,G1,2012.0,nan,-19857.0,Alive,TUMOR FREE,759.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,759.0,0.0,759.0,0.0,759.0,0.0,759.0,0
TCGA-F7-A61W-01,TCGA-F7-A61W,HNSC,51.0,MALE,ASIAN,Stage IVA,nan,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-18879.0,Alive,TUMOR FREE,14.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,14.0,0.0,14.0,nan,nan,0.0,14.0,0
TCGA-F7-A620-01,TCGA-F7-A620,HNSC,47.0,MALE,WHITE,Stage III,nan,Head & Neck Squamous Cell Carcinoma,G1,2012.0,nan,-17475.0,Alive,TUMOR FREE,543.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,543.0,0.0,543.0,0.0,543.0,0.0,543.0,0
TCGA-F7-A622-01,TCGA-F7-A622,HNSC,75.0,MALE,WHITE,Stage III,nan,Head & Neck Squamous Cell Carcinoma,G1,2012.0,nan,-27456.0,Dead,WITH TUMOR,nan,359.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,359.0,1.0,359.0,nan,nan,1.0,359.0,1
TCGA-F7-A623-01,TCGA-F7-A623,HNSC,70.0,MALE,WHITE,Stage IVA,nan,Head & Neck Squamous Cell Carcinoma,G1,2012.0,nan,-25592.0,Alive,TUMOR FREE,616.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,616.0,0.0,616.0,nan,nan,0.0,616.0,0
TCGA-F7-A624-01,TCGA-F7-A624,HNSC,73.0,MALE,WHITE,Stage II,nan,Head & Neck Squamous Cell Carcinoma,G3,2012.0,nan,-26667.0,Alive,TUMOR FREE,378.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,378.0,0.0,378.0,0.0,378.0,0.0,378.0,0
TCGA-H7-7774-01,TCGA-H7-7774,HNSC,75.0,FEMALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-27519.0,Alive,TUMOR FREE,407.0,nan,nan,New Primary Tumor,Oral Cavity,hard palate (right),252.0,Complete Remission/Response,nan,nan,0.0,407.0,0.0,407.0,nan,nan,1.0,252.0,2
TCGA-H7-8501-01,TCGA-H7-8501,HNSC,54.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,GX,2012.0,nan,-19808.0,Alive,TUMOR FREE,461.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,461.0,0.0,461.0,nan,nan,0.0,461.0,0
TCGA-H7-8502-01,TCGA-H7-8502,HNSC,50.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-18286.0,Alive,TUMOR FREE,458.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,458.0,0.0,458.0,nan,nan,0.0,458.0,0
TCGA-H7-A6C4-01,TCGA-H7-A6C4,HNSC,35.0,FEMALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-13137.0,Alive,TUMOR FREE,414.0,nan,nan,Locoregional Recurrence,Distant Metastasis,stoma site,235.0,Complete Remission/Response,nan,nan,0.0,414.0,0.0,414.0,nan,nan,1.0,235.0,2
TCGA-H7-A6C4-11,TCGA-H7-A6C4,HNSC,35.0,FEMALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-13137.0,Alive,TUMOR FREE,414.0,nan,nan,Locoregional Recurrence,Distant Metastasis,stoma site,235.0,Complete Remission/Response,nan,nan,0.0,414.0,0.0,414.0,nan,nan,1.0,235.0,2
TCGA-H7-A6C5-01,TCGA-H7-A6C5,HNSC,65.0,MALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-23808.0,Alive,TUMOR FREE,642.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,642.0,0.0,642.0,0.0,642.0,0.0,642.0,0
TCGA-H7-A6C5-11,TCGA-H7-A6C5,HNSC,65.0,MALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-23808.0,Alive,TUMOR FREE,642.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,642.0,0.0,642.0,0.0,642.0,0.0,642.0,0
TCGA-H7-A76A-01,TCGA-H7-A76A,HNSC,57.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-20946.0,Alive,TUMOR FREE,637.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,637.0,0.0,637.0,nan,nan,0.0,637.0,0
TCGA-HD-7229-01,TCGA-HD-7229,HNSC,60.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2011.0,nan,-22076.0,Alive,WITH TUMOR,1027.0,nan,nan,Locoregional Recurrence,Larynx,nan,162.0,Progressive Disease,nan,nan,0.0,1027.0,0.0,1027.0,nan,nan,1.0,162.0,0
TCGA-HD-7753-01,TCGA-HD-7753,HNSC,62.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-22774.0,Alive,TUMOR FREE,866.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,866.0,0.0,866.0,0.0,866.0,0.0,866.0,0
TCGA-HD-7754-01,TCGA-HD-7754,HNSC,69.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2011.0,nan,-25365.0,Alive,TUMOR FREE,783.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,783.0,0.0,783.0,nan,nan,0.0,783.0,0
TCGA-HD-7831-01,TCGA-HD-7831,HNSC,74.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-27334.0,Alive,WITH TUMOR,667.0,nan,nan,Distant Metastasis,Distant Metastasis,Lung,667.0,Complete Remission/Response,nan,nan,0.0,667.0,0.0,667.0,nan,nan,1.0,667.0,2
TCGA-HD-7832-01,TCGA-HD-7832,HNSC,52.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-19192.0,Alive,TUMOR FREE,836.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,836.0,0.0,836.0,nan,nan,0.0,836.0,0
TCGA-HD-7917-01,TCGA-HD-7917,HNSC,62.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2011.0,nan,-22979.0,Dead,TUMOR FREE,nan,836.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,836.0,0.0,836.0,0.0,836.0,0.0,836.0,0
TCGA-HD-8224-01,TCGA-HD-8224,HNSC,63.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2011.0,nan,-23069.0,Dead,WITH TUMOR,nan,446.0,nan,Distant Metastasis,Distant Metastasis,Lung,171.0,Progressive Disease,nan,nan,1.0,446.0,1.0,446.0,nan,nan,1.0,171.0,1
TCGA-HD-8314-01,TCGA-HD-8314,HNSC,58.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma Basaloid Type,G4,2012.0,nan,-21517.0,Alive,TUMOR FREE,670.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,670.0,0.0,670.0,0.0,670.0,0.0,670.0,0
TCGA-HD-8634-01,TCGA-HD-8634,HNSC,51.0,FEMALE,WHITE,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-18718.0,Dead,TUMOR FREE,nan,385.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,0
TCGA-HD-8635-01,TCGA-HD-8635,HNSC,61.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-22340.0,Alive,TUMOR FREE,695.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,695.0,0.0,695.0,0.0,695.0,0.0,695.0,0
TCGA-HD-8635-11,TCGA-HD-8635,HNSC,61.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-22340.0,Alive,TUMOR FREE,695.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,695.0,0.0,695.0,0.0,695.0,0.0,695.0,0
TCGA-HD-A4C1-01,TCGA-HD-A4C1,HNSC,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2012.0,nan,-15096.0,Alive,nan,11.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,11.0,0.0,11.0,nan,nan,0.0,11.0,0
TCGA-HD-A633-01,TCGA-HD-A633,HNSC,74.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-27057.0,Alive,WITH TUMOR,421.0,nan,nan,Locoregional Recurrence,Oral Cavity,Buccal Space & Infratemporal Fossa,419.0,Complete Remission/Response,nan,nan,0.0,421.0,0.0,421.0,nan,nan,1.0,419.0,2
TCGA-HD-A634-01,TCGA-HD-A634,HNSC,56.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2013.0,nan,-20810.0,Dead,WITH TUMOR,nan,130.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,130.0,1.0,130.0,nan,nan,1.0,130.0,1
TCGA-HD-A6HZ-01,TCGA-HD-A6HZ,HNSC,79.0,FEMALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-29045.0,Alive,TUMOR FREE,111.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,111.0,0.0,111.0,nan,nan,0.0,111.0,0
TCGA-HD-A6HZ-11,TCGA-HD-A6HZ,HNSC,79.0,FEMALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-29045.0,Alive,TUMOR FREE,111.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,111.0,0.0,111.0,nan,nan,0.0,111.0,0
TCGA-HD-A6I0-01,TCGA-HD-A6I0,HNSC,56.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2013.0,nan,-20491.0,Alive,TUMOR FREE,210.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,210.0,0.0,210.0,nan,nan,0.0,210.0,0
TCGA-HD-A6I0-11,TCGA-HD-A6I0,HNSC,56.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2013.0,nan,-20491.0,Alive,TUMOR FREE,210.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,210.0,0.0,210.0,nan,nan,0.0,210.0,0
TCGA-HL-7533-01,TCGA-HL-7533,HNSC,65.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2008.0,nan,-23950.0,Alive,TUMOR FREE,1057.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1057.0,0.0,1057.0,nan,nan,0.0,1057.0,0
TCGA-IQ-7630-01,TCGA-IQ-7630,HNSC,49.0,MALE,WHITE,Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2011.0,nan,-18131.0,Alive,TUMOR FREE,485.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,485.0,0.0,485.0,0.0,485.0,0.0,485.0,0
TCGA-IQ-7631-01,TCGA-IQ-7631,HNSC,60.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2011.0,nan,-22151.0,Alive,TUMOR FREE,1172.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1172.0,0.0,1172.0,0.0,1172.0,0.0,1172.0,0
TCGA-IQ-7632-01,TCGA-IQ-7632,HNSC,68.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2011.0,nan,-24986.0,Alive,TUMOR FREE,441.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,441.0,0.0,441.0,nan,nan,0.0,441.0,0
TCGA-IQ-A61E-01,TCGA-IQ-A61E,HNSC,55.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-20417.0,Alive,TUMOR FREE,1147.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1147.0,0.0,1147.0,0.0,1147.0,0.0,1147.0,0
TCGA-IQ-A61G-01,TCGA-IQ-A61G,HNSC,57.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-21066.0,Alive,WITH TUMOR,360.0,nan,nan,nan,Oral Cavity,nan,249.0,Progressive Disease,nan,nan,0.0,360.0,0.0,360.0,nan,nan,1.0,249.0,2
TCGA-IQ-A61H-01,TCGA-IQ-A61H,HNSC,76.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-27990.0,Alive,TUMOR FREE,1138.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1138.0,0.0,1138.0,0.0,1138.0,0.0,1138.0,0
TCGA-IQ-A61I-01,TCGA-IQ-A61I,HNSC,63.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2012.0,nan,-23035.0,Dead,TUMOR FREE,nan,2.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2.0,0.0,2.0,nan,nan,0.0,2.0,0
TCGA-IQ-A61J-01,TCGA-IQ-A61J,HNSC,54.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2012.0,nan,-19913.0,Alive,TUMOR FREE,1021.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1021.0,0.0,1021.0,nan,nan,0.0,1021.0,0
TCGA-IQ-A61K-01,TCGA-IQ-A61K,HNSC,70.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-25697.0,Dead,TUMOR FREE,nan,161.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,161.0,0.0,161.0,nan,nan,0.0,161.0,1
TCGA-IQ-A61L-01,TCGA-IQ-A61L,HNSC,72.0,FEMALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2012.0,nan,-26506.0,Alive,WITH TUMOR,416.0,nan,nan,Locoregional Recurrence,Oral Cavity,nan,156.0,Progressive Disease,nan,nan,0.0,416.0,0.0,416.0,nan,nan,1.0,156.0,2
TCGA-IQ-A61O-01,TCGA-IQ-A61O,HNSC,43.0,MALE,WHITE,Stage IVA,Stage IVA,"Head & Neck Squamous Cell Carcinoma, Spindle Cell Variant",GX,2012.0,nan,-15920.0,Dead,TUMOR FREE,nan,421.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,421.0,0.0,421.0,nan,nan,0.0,421.0,0
TCGA-IQ-A6SG-01,TCGA-IQ-A6SG,HNSC,61.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-22529.0,Alive,TUMOR FREE,579.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,579.0,0.0,579.0,0.0,579.0,0.0,579.0,0
TCGA-IQ-A6SH-01,TCGA-IQ-A6SH,HNSC,55.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage IVC,Head & Neck Squamous Cell Carcinoma,G1,2013.0,nan,-20109.0,Alive,TUMOR FREE,471.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,471.0,0.0,471.0,nan,nan,0.0,471.0,0
TCGA-KU-A66S-01,TCGA-KU-A66S,HNSC,69.0,FEMALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma Basaloid Type,G2,2012.0,nan,-25454.0,Dead,WITH TUMOR,nan,406.0,nan,Distant Metastasis,Distant Metastasis,Brain Metastasis,389.0,Complete Remission/Response,nan,nan,1.0,406.0,1.0,406.0,1.0,389.0,1.0,389.0,1
TCGA-KU-A66T-01,TCGA-KU-A66T,HNSC,53.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-19405.0,Alive,TUMOR FREE,552.0,nan,nan,Locoregional Recurrence,Oral Cavity,Toungue,552.0,Complete Remission/Response,nan,nan,0.0,552.0,0.0,552.0,nan,nan,1.0,552.0,2
TCGA-KU-A6H7-06,TCGA-KU-A6H7,HNSC,55.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-20314.0,Alive,TUMOR FREE,586.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,586.0,0.0,586.0,nan,nan,0.0,586.0,2
TCGA-KU-A6H7-01,TCGA-KU-A6H7,HNSC,55.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-20314.0,Alive,TUMOR FREE,586.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,586.0,0.0,586.0,nan,nan,0.0,586.0,2
TCGA-KU-A6H8-01,TCGA-KU-A6H8,HNSC,41.0,MALE,WHITE,Stage IVA,Stage I,Head & Neck Squamous Cell Carcinoma,G3,2013.0,nan,-15066.0,Dead,WITH TUMOR,nan,327.0,nan,Locoregional Recurrence,Oral Cavity,Right base of tongue and level 2 a cervical node,110.0,Progressive Disease,nan,nan,1.0,327.0,1.0,327.0,nan,nan,1.0,110.0,1
TCGA-MT-A51W-01,TCGA-MT-A51W,HNSC,52.0,FEMALE,WHITE,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-19098.0,Alive,TUMOR FREE,437.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,437.0,0.0,437.0,0.0,437.0,0.0,437.0,0
TCGA-MT-A51X-01,TCGA-MT-A51X,HNSC,30.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2012.0,nan,-10976.0,Alive,TUMOR FREE,242.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,242.0,0.0,242.0,nan,nan,0.0,242.0,0
TCGA-MT-A67A-01,TCGA-MT-A67A,HNSC,85.0,FEMALE,WHITE,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-31161.0,Alive,TUMOR FREE,914.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,914.0,0.0,914.0,0.0,914.0,0.0,914.0,0
TCGA-MT-A67D-01,TCGA-MT-A67D,HNSC,55.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-20386.0,Alive,nan,56.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,56.0,0.0,56.0,0.0,56.0,0.0,56.0,0
TCGA-MT-A67F-01,TCGA-MT-A67F,HNSC,60.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-22057.0,Alive,TUMOR FREE,384.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,384.0,0.0,384.0,nan,nan,0.0,384.0,2
TCGA-MT-A67G-01,TCGA-MT-A67G,HNSC,53.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-19394.0,Alive,[Discrepancy],190.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,190.0,0.0,190.0,nan,nan,0.0,190.0,2
TCGA-MT-A7BN-01,TCGA-MT-A7BN,HNSC,74.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2013.0,nan,-27162.0,Alive,WITH TUMOR,469.0,nan,nan,Distant Metastasis,Distant Metastasis,lung,179.0,Progressive Disease,nan,nan,0.0,469.0,0.0,469.0,nan,nan,1.0,179.0,2
TCGA-MZ-A5BI-01,TCGA-MZ-A5BI,HNSC,53.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,nan,2008.0,nan,-19500.0,Dead,nan,nan,217.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,217.0,nan,217.0,nan,nan,0.0,217.0,1
TCGA-MZ-A6I9-01,TCGA-MZ-A6I9,HNSC,68.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-24939.0,Dead,WITH TUMOR,nan,489.0,nan,Distant Metastasis,Distant Metastasis,"lung, mediastinal lymph node",246.0,nan,nan,nan,1.0,489.0,1.0,489.0,nan,nan,1.0,246.0,1
TCGA-MZ-A7D7-01,TCGA-MZ-A7D7,HNSC,51.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,nan,2013.0,nan,-18974.0,Alive,WITH TUMOR,547.0,nan,nan,Distant Metastasis,Distant Metastasis,lung,339.0,Complete Remission/Response,nan,nan,0.0,547.0,0.0,547.0,nan,nan,1.0,339.0,2
TCGA-P3-A5Q5-01,TCGA-P3-A5Q5,HNSC,54.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma Basaloid Type,G3,2004.0,nan,-19728.0,Alive,TUMOR FREE,910.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,910.0,0.0,910.0,nan,nan,0.0,910.0,0
TCGA-P3-A5Q6-01,TCGA-P3-A5Q6,HNSC,49.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G3,2005.0,nan,-17917.0,Dead,WITH TUMOR,nan,480.0,nan,nan,Distant Metastasis,Lung,280.0,Complete Remission/Response,nan,nan,1.0,480.0,1.0,480.0,nan,nan,1.0,280.0,1
TCGA-P3-A5QA-01,TCGA-P3-A5QA,HNSC,41.0,MALE,[Unknown],Stage I,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2008.0,nan,-15125.0,Alive,TUMOR FREE,2182.0,nan,nan,Locoregional Disease,Oral Cavity,tongue,1601.0,Complete Remission/Response,nan,nan,0.0,2182.0,0.0,2182.0,1.0,1601.0,1.0,1601.0,2
TCGA-P3-A5QE-01,TCGA-P3-A5QE,HNSC,49.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma Basaloid Type,G2,2009.0,nan,-18002.0,Alive,TUMOR FREE,1559.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1559.0,0.0,1559.0,0.0,1559.0,0.0,1559.0,0
TCGA-P3-A5QF-01,TCGA-P3-A5QF,HNSC,49.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-18035.0,Dead,WITH TUMOR,nan,330.0,nan,nan,Distant Metastasis,Lung,140.0,[Unknown],nan,nan,1.0,330.0,1.0,330.0,nan,nan,1.0,140.0,1
TCGA-P3-A6SW-01,TCGA-P3-A6SW,HNSC,50.0,MALE,WHITE,Stage IVB,Stage IVA,Head & Neck Squamous Cell Carcinoma Basaloid Type,G3,2005.0,nan,-18536.0,Alive,TUMOR FREE,1120.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1120.0,0.0,1120.0,nan,nan,0.0,1120.0,0
TCGA-P3-A6SX-01,TCGA-P3-A6SX,HNSC,67.0,MALE,WHITE,Stage III,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2005.0,nan,-24715.0,Dead,TUMOR FREE,nan,1430.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1430.0,0.0,1430.0,nan,nan,0.0,1430.0,0
TCGA-P3-A6T0-01,TCGA-P3-A6T0,HNSC,47.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2007.0,nan,-17259.0,Alive,TUMOR FREE,578.0,nan,nan,Locoregional Disease,Oral Cavity,nan,365.0,Complete Remission/Response,nan,nan,0.0,578.0,0.0,578.0,nan,nan,1.0,365.0,2
TCGA-P3-A6T2-01,TCGA-P3-A6T2,HNSC,45.0,MALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-16588.0,Alive,TUMOR FREE,2298.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2298.0,0.0,2298.0,nan,nan,0.0,2298.0,0
TCGA-P3-A6T3-01,TCGA-P3-A6T3,HNSC,49.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-18143.0,Dead,WITH TUMOR,nan,577.0,nan,Distant Metastasis,Distant Metastasis,Lung,242.0,Complete Remission/Response,nan,nan,1.0,577.0,1.0,577.0,nan,nan,1.0,242.0,1
TCGA-P3-A6T4-01,TCGA-P3-A6T4,HNSC,54.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-20027.0,Dead,WITH TUMOR,nan,62.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,62.0,1.0,62.0,nan,nan,1.0,62.0,1
TCGA-P3-A6T5-01,TCGA-P3-A6T5,HNSC,79.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-28977.0,Dead,WITH TUMOR,nan,882.0,nan,Locoregional Disease,Oral Cavity,nan,335.0,Complete Remission/Response,nan,nan,1.0,882.0,1.0,882.0,nan,nan,1.0,335.0,1
TCGA-P3-A6T6-01,TCGA-P3-A6T6,HNSC,53.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2009.0,nan,-19694.0,Dead,WITH TUMOR,nan,395.0,nan,Distant Metastasis,Distant Metastasis,lung,273.0,Complete Remission/Response,nan,nan,1.0,395.0,1.0,395.0,nan,nan,1.0,273.0,1
TCGA-P3-A6T7-01,TCGA-P3-A6T7,HNSC,55.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-20301.0,Dead,nan,nan,487.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,487.0,nan,487.0,nan,nan,0.0,487.0,1
TCGA-P3-A6T8-01,TCGA-P3-A6T8,HNSC,54.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2010.0,nan,-19754.0,Alive,TUMOR FREE,400.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,400.0,0.0,400.0,nan,nan,0.0,400.0,0
TCGA-QK-A64Z-01,TCGA-QK-A64Z,HNSC,79.0,FEMALE,WHITE,Stage IVA,Stage II,Head & Neck Squamous Cell Carcinoma,G1,2011.0,nan,-29037.0,Dead,WITH TUMOR,nan,641.0,nan,Locoregional Recurrence,Cervical Lymph Nodes,bilateral,553.0,Progressive Disease,nan,nan,1.0,641.0,1.0,641.0,nan,nan,1.0,553.0,1
TCGA-QK-A652-01,TCGA-QK-A652,HNSC,60.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-22023.0,Alive,TUMOR FREE,645.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,645.0,0.0,645.0,0.0,645.0,0.0,645.0,0
TCGA-QK-A6IF-01,TCGA-QK-A6IF,HNSC,61.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,GX,2013.0,nan,-22463.0,Alive,TUMOR FREE,704.0,nan,nan,Distant Metastasis,Distant Metastasis,pulmonary nodules throughout both lungs,502.0,Complete Remission/Response,nan,nan,0.0,704.0,0.0,704.0,nan,nan,1.0,502.0,0
TCGA-QK-A6IG-01,TCGA-QK-A6IG,HNSC,69.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-25334.0,Dead,WITH TUMOR,nan,222.0,nan,Locoregional Disease,Cervical Lymph Nodes,Left level Ib lymph node,142.0,Progressive Disease,nan,nan,1.0,222.0,1.0,222.0,nan,nan,1.0,142.0,1
TCGA-QK-A6IH-01,TCGA-QK-A6IH,HNSC,65.0,FEMALE,WHITE,Stage IVB,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-23936.0,Alive,WITH TUMOR,653.0,nan,nan,nan,Distant Metastasis,Lung,228.0,Progressive Disease,nan,nan,0.0,653.0,0.0,653.0,nan,nan,1.0,228.0,2
TCGA-QK-A6II-01,TCGA-QK-A6II,HNSC,52.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-19113.0,Dead,WITH TUMOR,nan,284.0,nan,Locoregional Recurrence,Cervical Lymph Nodes,nan,176.0,Progressive Disease,nan,nan,1.0,284.0,1.0,284.0,nan,nan,1.0,176.0,1
TCGA-QK-A6IJ-01,TCGA-QK-A6IJ,HNSC,71.0,MALE,WHITE,Stage III,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2013.0,nan,-25966.0,Alive,TUMOR FREE,387.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,387.0,0.0,387.0,nan,nan,0.0,387.0,0
TCGA-QK-A6V9-01,TCGA-QK-A6V9,HNSC,56.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-20461.0,Alive,TUMOR FREE,833.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,833.0,0.0,833.0,0.0,833.0,0.0,833.0,0
TCGA-QK-A6VB-01,TCGA-QK-A6VB,HNSC,66.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-24144.0,Alive,TUMOR FREE,641.0,nan,nan,New Primary Tumor,nan,Acute myeloid leukemia,613.0,Complete Remission/Response,nan,nan,0.0,641.0,0.0,641.0,nan,nan,1.0,613.0,2
TCGA-QK-A6VC-01,TCGA-QK-A6VC,HNSC,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-22865.0,Alive,TUMOR FREE,600.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,600.0,0.0,600.0,nan,nan,0.0,600.0,2
TCGA-QK-A8Z7-01,TCGA-QK-A8Z7,HNSC,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma Basaloid Type,nan,2013.0,nan,-21711.0,Alive,TUMOR FREE,392.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,392.0,0.0,392.0,nan,nan,0.0,392.0,0
TCGA-QK-A8Z8-01,TCGA-QK-A8Z8,HNSC,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVC,Stage IVC,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-22107.0,Dead,WITH TUMOR,nan,171.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,171.0,1.0,171.0,nan,nan,1.0,171.0,1
TCGA-QK-A8Z9-01,TCGA-QK-A8Z9,HNSC,56.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-20471.0,Dead,WITH TUMOR,nan,449.0,nan,Distant Metastasis,Distant Metastasis,esophagus,205.0,Complete Remission/Response,nan,nan,1.0,449.0,1.0,449.0,nan,nan,1.0,205.0,1
TCGA-QK-A8ZA-01,TCGA-QK-A8ZA,HNSC,60.0,MALE,BLACK OR AFRICAN AMERICAN,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-21979.0,Dead,TUMOR FREE,nan,371.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,371.0,0.0,371.0,nan,nan,0.0,371.0,0
TCGA-QK-A8ZB-01,TCGA-QK-A8ZB,HNSC,68.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-25192.0,Alive,TUMOR FREE,542.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,542.0,0.0,542.0,nan,nan,0.0,542.0,0
TCGA-QK-AA3J-01,TCGA-QK-AA3J,HNSC,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Head & Neck Squamous Cell Carcinoma Basaloid Type,G3,2013.0,nan,-25469.0,Alive,TUMOR FREE,466.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,466.0,0.0,466.0,0.0,466.0,0.0,466.0,0
TCGA-QK-AA3K-01,TCGA-QK-AA3K,HNSC,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-22093.0,Alive,nan,253.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,253.0,0.0,253.0,nan,nan,0.0,253.0,0
TCGA-RS-A6TO-01,TCGA-RS-A6TO,HNSC,82.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-30104.0,Dead,WITH TUMOR,nan,387.0,nan,Locoregional Recurrence,Oral Cavity,L floor of mouth,338.0,Complete Remission/Response,nan,nan,1.0,387.0,1.0,387.0,nan,nan,1.0,338.0,1
TCGA-RS-A6TP-01,TCGA-RS-A6TP,HNSC,58.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2013.0,nan,-21393.0,Alive,TUMOR FREE,516.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,516.0,0.0,516.0,0.0,516.0,0.0,516.0,0
TCGA-T2-A6WX-01,TCGA-T2-A6WX,HNSC,73.0,FEMALE,WHITE,nan,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2010.0,nan,-27005.0,Dead,WITH TUMOR,nan,209.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,209.0,1.0,209.0,nan,nan,1.0,209.0,1
TCGA-T2-A6WZ-01,TCGA-T2-A6WZ,HNSC,53.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-19397.0,Dead,WITH TUMOR,nan,484.0,nan,Distant Metastasis,Distant Metastasis,bilateral pulmonary nodules,229.0,Stable Disease,nan,nan,1.0,484.0,1.0,484.0,nan,nan,1.0,229.0,1
TCGA-T2-A6X0-01,TCGA-T2-A6X0,HNSC,49.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-18114.0,Alive,TUMOR FREE,216.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,216.0,0.0,216.0,nan,nan,0.0,216.0,0
TCGA-T2-A6X2-01,TCGA-T2-A6X2,HNSC,82.0,MALE,WHITE,Stage III,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2011.0,nan,-30013.0,Alive,TUMOR FREE,987.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,987.0,0.0,987.0,0.0,987.0,0.0,987.0,0
TCGA-T3-A92M-01,TCGA-T3-A92M,HNSC,52.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-19247.0,Alive,WITH TUMOR,417.0,nan,nan,Distant Metastasis,Distant Metastasis,(Rt) Lung,417.0,[Unknown],nan,nan,0.0,417.0,0.0,417.0,nan,nan,1.0,417.0,2
TCGA-T3-A92N-01,TCGA-T3-A92N,HNSC,79.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVC,Head & Neck Squamous Cell Carcinoma,G3,2013.0,nan,-28879.0,Dead,WITH TUMOR,nan,95.0,nan,Distant Metastasis,Distant Metastasis,Lung,46.0,Progressive Disease,nan,nan,1.0,95.0,1.0,95.0,nan,nan,1.0,46.0,1
TCGA-TN-A7HI-01,TCGA-TN-A7HI,HNSC,56.0,MALE,WHITE,Stage IVA,Stage I,Head & Neck Squamous Cell Carcinoma,G3,2013.0,nan,-20666.0,Alive,TUMOR FREE,412.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,412.0,0.0,412.0,nan,nan,0.0,412.0,0
TCGA-TN-A7HJ-01,TCGA-TN-A7HJ,HNSC,51.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-18809.0,Alive,TUMOR FREE,403.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,403.0,0.0,403.0,nan,nan,0.0,403.0,0
TCGA-TN-A7HL-01,TCGA-TN-A7HL,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-21731.0,Alive,TUMOR FREE,619.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,619.0,0.0,619.0,nan,nan,0.0,619.0,0
TCGA-UF-A718-01,TCGA-UF-A718,HNSC,62.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-22836.0,Alive,TUMOR FREE,1971.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1971.0,0.0,1971.0,nan,nan,0.0,1971.0,0
TCGA-UF-A719-01,TCGA-UF-A719,HNSC,54.0,MALE,[Unknown],Stage II,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2009.0,nan,-19797.0,Alive,TUMOR FREE,1663.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1663.0,0.0,1663.0,0.0,1663.0,0.0,1663.0,0
TCGA-UF-A71A-06,TCGA-UF-A71A,HNSC,67.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2009.0,nan,-24623.0,Dead,WITH TUMOR,nan,86.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,86.0,1.0,86.0,nan,nan,1.0,86.0,1
TCGA-UF-A71A-01,TCGA-UF-A71A,HNSC,67.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2009.0,nan,-24623.0,Dead,WITH TUMOR,nan,86.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,86.0,1.0,86.0,nan,nan,1.0,86.0,1
TCGA-UF-A71B-01,TCGA-UF-A71B,HNSC,50.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-18404.0,Alive,TUMOR FREE,1506.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1506.0,0.0,1506.0,nan,nan,0.0,1506.0,0
TCGA-UF-A71D-01,TCGA-UF-A71D,HNSC,54.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-19747.0,Alive,TUMOR FREE,1461.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1461.0,0.0,1461.0,nan,nan,0.0,1461.0,2
TCGA-UF-A71E-01,TCGA-UF-A71E,HNSC,63.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma Basaloid Type,G3,2010.0,nan,-23071.0,Dead,TUMOR FREE,nan,1504.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1504.0,0.0,1504.0,nan,nan,0.0,1504.0,0
TCGA-UF-A7J9-01,TCGA-UF-A7J9,HNSC,75.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-27459.0,Alive,TUMOR FREE,1358.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1358.0,0.0,1358.0,nan,nan,0.0,1358.0,0
TCGA-UF-A7JA-01,TCGA-UF-A7JA,HNSC,66.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2008.0,nan,-24121.0,Alive,TUMOR FREE,2265.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2265.0,0.0,2265.0,nan,nan,0.0,2265.0,2
TCGA-UF-A7JC-01,TCGA-UF-A7JC,HNSC,42.0,MALE,WHITE,Stage IVA,Stage III,Head & Neck Squamous Cell Carcinoma,G1,2012.0,nan,-15452.0,Dead,WITH TUMOR,nan,546.0,nan,nan,Oral Cavity,nan,229.0,Complete Remission/Response,nan,nan,1.0,546.0,1.0,546.0,nan,nan,1.0,229.0,1
TCGA-UF-A7JD-01,TCGA-UF-A7JD,HNSC,71.0,MALE,[Unknown],Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2012.0,nan,-26101.0,Dead,TUMOR FREE,nan,739.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,739.0,0.0,739.0,nan,nan,0.0,739.0,0
TCGA-UF-A7JF-01,TCGA-UF-A7JF,HNSC,80.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-29468.0,Alive,TUMOR FREE,1686.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1686.0,0.0,1686.0,nan,nan,0.0,1686.0,0
TCGA-UF-A7JH-01,TCGA-UF-A7JH,HNSC,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2012.0,nan,-21558.0,Alive,TUMOR FREE,896.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,896.0,0.0,896.0,nan,nan,0.0,896.0,0
TCGA-UF-A7JJ-01,TCGA-UF-A7JJ,HNSC,68.0,MALE,[Unknown],Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G1,2013.0,nan,-25201.0,Alive,TUMOR FREE,549.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,549.0,0.0,549.0,nan,nan,0.0,549.0,0
TCGA-UF-A7JK-01,TCGA-UF-A7JK,HNSC,59.0,MALE,[Unknown],Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2010.0,nan,-21696.0,Dead,WITH TUMOR,nan,424.0,nan,nan,Larynx,nan,341.0,Complete Remission/Response,nan,nan,1.0,424.0,1.0,424.0,nan,nan,1.0,341.0,1
TCGA-UF-A7JO-01,TCGA-UF-A7JO,HNSC,79.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2009.0,nan,-28951.0,Dead,WITH TUMOR,nan,631.0,nan,Locoregional Disease,Oral Cavity,Floor of mouth,525.0,Complete Remission/Response,nan,nan,1.0,631.0,1.0,631.0,nan,nan,1.0,525.0,1
TCGA-UF-A7JS-01,TCGA-UF-A7JS,HNSC,59.0,MALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-21676.0,Dead,WITH TUMOR,nan,680.0,nan,Locoregional Recurrence,Cervical Lymph Nodes,nan,519.0,Complete Remission/Response,nan,nan,1.0,680.0,1.0,680.0,nan,nan,1.0,519.0,1
TCGA-UF-A7JT-01,TCGA-UF-A7JT,HNSC,72.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G3,2009.0,nan,-26375.0,Dead,WITH TUMOR,nan,993.0,nan,nan,nan,Cervix,718.0,Complete Remission/Response,nan,nan,1.0,993.0,1.0,993.0,nan,nan,1.0,718.0,1
TCGA-UF-A7JV-01,TCGA-UF-A7JV,HNSC,62.0,FEMALE,WHITE,Stage IVA,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2011.0,nan,-22985.0,Dead,WITH TUMOR,nan,90.0,nan,nan,Oropharynx,Oropharynx and cervical lymph node,55.0,Complete Remission/Response,nan,nan,1.0,90.0,1.0,90.0,nan,nan,1.0,55.0,1
TCGA-UP-A6WW-01,TCGA-UP-A6WW,HNSC,58.0,MALE,WHITE,nan,Stage IVA,Head & Neck Squamous Cell Carcinoma,G2,2013.0,nan,-21427.0,Alive,TUMOR FREE,518.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,518.0,0.0,518.0,nan,nan,0.0,518.0,0
TCGA-WA-A7GZ-01,TCGA-WA-A7GZ,HNSC,58.0,MALE,WHITE,nan,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-21207.0,Dead,TUMOR FREE,nan,625.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,625.0,0.0,625.0,0.0,625.0,0.0,625.0,0
TCGA-WA-A7GZ-11,TCGA-WA-A7GZ,HNSC,58.0,MALE,WHITE,nan,Stage II,Head & Neck Squamous Cell Carcinoma,G2,2012.0,nan,-21207.0,Dead,TUMOR FREE,nan,625.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,625.0,0.0,625.0,0.0,625.0,0.0,625.0,0
TCGA-WA-A7H4-01,TCGA-WA-A7H4,HNSC,69.0,MALE,WHITE,Stage II,Stage II,Head & Neck Squamous Cell Carcinoma,G3,2013.0,nan,-25363.0,Alive,TUMOR FREE,443.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,443.0,0.0,443.0,0.0,443.0,0.0,443.0,0
TCGA-KL-8323-01,TCGA-KL-8323,KICH,57.0,FEMALE,WHITE,Stage III,nan,Kidney Chromophobe,nan,2000.0,nan,-20849.0,Dead,WITH TUMOR,nan,1158.0,nan,nan,nan,nan,758.0,[Unknown],nan,nan,1.0,1158.0,1.0,1158.0,nan,nan,1.0,758.0,1
TCGA-KL-8324-01,TCGA-KL-8324,KICH,67.0,FEMALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2000.0,nan,-24650.0,Alive,TUMOR FREE,4676.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4676.0,0.0,4676.0,nan,nan,0.0,4676.0,0
TCGA-KL-8324-11,TCGA-KL-8324,KICH,67.0,FEMALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2000.0,nan,-24650.0,Alive,TUMOR FREE,4676.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4676.0,0.0,4676.0,nan,nan,0.0,4676.0,0
TCGA-KL-8325-01,TCGA-KL-8325,KICH,56.0,FEMALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2000.0,nan,-20768.0,Dead,TUMOR FREE,nan,725.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,725.0,0.0,725.0,nan,nan,0.0,725.0,1
TCGA-KL-8326-01,TCGA-KL-8326,KICH,69.0,MALE,WHITE,Stage III,nan,Kidney Chromophobe,nan,2001.0,nan,-25267.0,Alive,TUMOR FREE,3322.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,3322.0,0.0,3322.0,nan,nan,0.0,3322.0,0
TCGA-KL-8326-11,TCGA-KL-8326,KICH,69.0,MALE,WHITE,Stage III,nan,Kidney Chromophobe,nan,2001.0,nan,-25267.0,Alive,TUMOR FREE,3322.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,3322.0,0.0,3322.0,nan,nan,0.0,3322.0,0
TCGA-KL-8327-01,TCGA-KL-8327,KICH,46.0,FEMALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2001.0,nan,-17121.0,Alive,TUMOR FREE,4169.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,4169.0,0.0,4169.0,nan,nan,0.0,4169.0,0
TCGA-KL-8328-01,TCGA-KL-8328,KICH,60.0,MALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2003.0,nan,-21976.0,Alive,TUMOR FREE,3127.0,nan,nan,nan,nan,nan,nan,[Not Evaluated],nan,nan,0.0,3127.0,0.0,3127.0,nan,nan,0.0,3127.0,0
TCGA-KL-8329-01,TCGA-KL-8329,KICH,57.0,FEMALE,ASIAN,Stage I,nan,Kidney Chromophobe,nan,2003.0,nan,-20972.0,Alive,TUMOR FREE,2752.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,2752.0,0.0,2752.0,nan,nan,0.0,2752.0,0
TCGA-KL-8329-11,TCGA-KL-8329,KICH,57.0,FEMALE,ASIAN,Stage I,nan,Kidney Chromophobe,nan,2003.0,nan,-20972.0,Alive,TUMOR FREE,2752.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,2752.0,0.0,2752.0,nan,nan,0.0,2752.0,0
TCGA-KL-8330-01,TCGA-KL-8330,KICH,44.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Kidney Chromophobe,nan,2003.0,nan,-16250.0,Alive,TUMOR FREE,3304.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,3304.0,0.0,3304.0,nan,nan,0.0,3304.0,0
TCGA-KL-8331-01,TCGA-KL-8331,KICH,48.0,FEMALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2004.0,nan,-17710.0,Alive,TUMOR FREE,3010.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,3010.0,0.0,3010.0,nan,nan,0.0,3010.0,0
TCGA-KL-8332-01,TCGA-KL-8332,KICH,55.0,MALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2004.0,nan,-20128.0,Alive,TUMOR FREE,2582.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,2582.0,0.0,2582.0,nan,nan,0.0,2582.0,0
TCGA-KL-8332-11,TCGA-KL-8332,KICH,55.0,MALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2004.0,nan,-20128.0,Alive,TUMOR FREE,2582.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,2582.0,0.0,2582.0,nan,nan,0.0,2582.0,0
TCGA-KL-8333-01,TCGA-KL-8333,KICH,69.0,MALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2005.0,nan,-25229.0,Alive,TUMOR FREE,2991.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,2991.0,0.0,2991.0,nan,nan,0.0,2991.0,0
TCGA-KL-8334-01,TCGA-KL-8334,KICH,37.0,FEMALE,WHITE,Stage III,nan,Kidney Chromophobe,nan,2005.0,nan,-13602.0,Alive,TUMOR FREE,2949.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,2949.0,0.0,2949.0,nan,nan,0.0,2949.0,0
TCGA-KL-8335-01,TCGA-KL-8335,KICH,67.0,MALE,WHITE,Stage III,nan,Kidney Chromophobe,nan,2005.0,nan,-24832.0,Alive,TUMOR FREE,2815.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,2815.0,0.0,2815.0,nan,nan,0.0,2815.0,0
TCGA-KL-8336-01,TCGA-KL-8336,KICH,51.0,FEMALE,WHITE,Stage IV,nan,Kidney Chromophobe,nan,2006.0,nan,-18821.0,Dead,WITH TUMOR,nan,920.0,nan,nan,nan,nan,47.0,[Unknown],nan,nan,1.0,920.0,1.0,920.0,nan,nan,1.0,47.0,1
TCGA-KL-8336-11,TCGA-KL-8336,KICH,51.0,FEMALE,WHITE,Stage IV,nan,Kidney Chromophobe,nan,2006.0,nan,-18821.0,Dead,WITH TUMOR,nan,920.0,nan,nan,nan,nan,47.0,[Unknown],nan,nan,1.0,920.0,1.0,920.0,nan,nan,1.0,47.0,1
TCGA-KL-8337-01,TCGA-KL-8337,KICH,26.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Kidney Chromophobe,nan,2006.0,nan,-9819.0,Alive,TUMOR FREE,1364.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1364.0,0.0,1364.0,nan,nan,0.0,1364.0,0
TCGA-KL-8338-01,TCGA-KL-8338,KICH,51.0,MALE,WHITE,Stage III,nan,Kidney Chromophobe,nan,2006.0,nan,-18667.0,Alive,TUMOR FREE,2633.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,2633.0,0.0,2633.0,nan,nan,0.0,2633.0,0
TCGA-KL-8339-01,TCGA-KL-8339,KICH,67.0,MALE,WHITE,Stage IV,nan,Kidney Chromophobe,nan,2006.0,nan,-24545.0,Dead,WITH TUMOR,nan,855.0,nan,nan,nan,nan,64.0,[Not Evaluated],nan,nan,1.0,855.0,1.0,855.0,nan,nan,1.0,64.0,1
TCGA-KL-8339-11,TCGA-KL-8339,KICH,67.0,MALE,WHITE,Stage IV,nan,Kidney Chromophobe,nan,2006.0,nan,-24545.0,Dead,WITH TUMOR,nan,855.0,nan,nan,nan,nan,64.0,[Not Evaluated],nan,nan,1.0,855.0,1.0,855.0,nan,nan,1.0,64.0,1
TCGA-KL-8340-01,TCGA-KL-8340,KICH,34.0,MALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2006.0,nan,-12696.0,Alive,TUMOR FREE,2024.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,2024.0,0.0,2024.0,nan,nan,0.0,2024.0,0
TCGA-KL-8341-01,TCGA-KL-8341,KICH,41.0,MALE,ASIAN,Stage IV,nan,Kidney Chromophobe,nan,2006.0,nan,-15045.0,Dead,WITH TUMOR,nan,754.0,nan,nan,nan,nan,175.0,[Unknown],nan,nan,1.0,754.0,1.0,754.0,nan,nan,1.0,175.0,1
TCGA-KL-8342-01,TCGA-KL-8342,KICH,45.0,FEMALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2006.0,nan,-16550.0,Alive,TUMOR FREE,2248.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,2248.0,0.0,2248.0,nan,nan,0.0,2248.0,0
TCGA-KL-8343-01,TCGA-KL-8343,KICH,72.0,MALE,WHITE,Stage III,nan,Kidney Chromophobe,nan,2007.0,nan,-26562.0,Dead,WITH TUMOR,nan,2172.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,2172.0,1.0,2172.0,nan,nan,1.0,2172.0,1
TCGA-KL-8344-01,TCGA-KL-8344,KICH,51.0,MALE,WHITE,Stage III,nan,Kidney Chromophobe,nan,2007.0,nan,-18742.0,Alive,TUMOR FREE,876.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,876.0,0.0,876.0,nan,nan,0.0,876.0,0
TCGA-KL-8345-01,TCGA-KL-8345,KICH,75.0,MALE,WHITE,Stage III,nan,Kidney Chromophobe,nan,2008.0,nan,-27412.0,Alive,TUMOR FREE,1665.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1665.0,0.0,1665.0,nan,nan,0.0,1665.0,0
TCGA-KL-8346-01,TCGA-KL-8346,KICH,62.0,MALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2008.0,nan,-22651.0,Alive,TUMOR FREE,1897.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1897.0,0.0,1897.0,nan,nan,0.0,1897.0,0
TCGA-KM-8438-01,TCGA-KM-8438,KICH,45.0,FEMALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2000.0,nan,-16683.0,Alive,WITH TUMOR,4622.0,nan,nan,nan,nan,nan,2317.0,Complete Remission/Response,nan,nan,0.0,4622.0,0.0,4622.0,1.0,2317.0,1.0,2317.0,2
TCGA-KM-8439-01,TCGA-KM-8439,KICH,30.0,MALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2011.0,nan,-11266.0,Alive,WITH TUMOR,708.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,708.0,0.0,708.0,nan,nan,0.0,708.0,0
TCGA-KM-8440-01,TCGA-KM-8440,KICH,37.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Kidney Chromophobe,nan,2009.0,nan,-13860.0,Alive,TUMOR FREE,1366.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1366.0,0.0,1366.0,0.0,1366.0,0.0,1366.0,0
TCGA-KM-8441-01,TCGA-KM-8441,KICH,61.0,FEMALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2011.0,nan,-22303.0,Alive,WITH TUMOR,876.0,nan,nan,nan,nan,nan,876.0,Complete Remission/Response,nan,nan,0.0,876.0,0.0,876.0,1.0,876.0,1.0,876.0,2
TCGA-KM-8442-01,TCGA-KM-8442,KICH,38.0,MALE,[Unknown],Stage II,nan,Kidney Chromophobe,nan,2009.0,nan,-14212.0,Alive,TUMOR FREE,1437.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,1437.0,0.0,1437.0,nan,nan,0.0,1437.0,0
TCGA-KM-8443-01,TCGA-KM-8443,KICH,57.0,MALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2009.0,nan,-21183.0,Alive,TUMOR FREE,1520.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1520.0,0.0,1520.0,0.0,1520.0,0.0,1520.0,0
TCGA-KM-8476-01,TCGA-KM-8476,KICH,47.0,MALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2002.0,nan,-17240.0,Alive,TUMOR FREE,3745.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3745.0,0.0,3745.0,0.0,3745.0,0.0,3745.0,0
TCGA-KM-8477-01,TCGA-KM-8477,KICH,56.0,MALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2005.0,nan,-20491.0,Alive,TUMOR FREE,1553.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1553.0,0.0,1553.0,0.0,1553.0,0.0,1553.0,0
TCGA-KM-8639-01,TCGA-KM-8639,KICH,67.0,MALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2005.0,nan,-24640.0,Alive,TUMOR FREE,953.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,953.0,0.0,953.0,0.0,953.0,0.0,953.0,0
TCGA-KN-8418-01,TCGA-KN-8418,KICH,41.0,FEMALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2002.0,nan,-15086.0,Alive,TUMOR FREE,3935.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3935.0,0.0,3935.0,nan,nan,0.0,3935.0,0
TCGA-KN-8419-01,TCGA-KN-8419,KICH,43.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Kidney Chromophobe,nan,2004.0,nan,-15769.0,Alive,TUMOR FREE,714.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,714.0,0.0,714.0,0.0,714.0,0.0,714.0,0
TCGA-KN-8419-11,TCGA-KN-8419,KICH,43.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Kidney Chromophobe,nan,2004.0,nan,-15769.0,Alive,TUMOR FREE,714.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,714.0,0.0,714.0,0.0,714.0,0.0,714.0,0
TCGA-KN-8421-01,TCGA-KN-8421,KICH,47.0,FEMALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2004.0,nan,-17524.0,Alive,TUMOR FREE,2674.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2674.0,0.0,2674.0,nan,nan,0.0,2674.0,0
TCGA-KN-8422-01,TCGA-KN-8422,KICH,28.0,FEMALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2005.0,nan,-10303.0,Alive,TUMOR FREE,775.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,775.0,0.0,775.0,0.0,775.0,0.0,775.0,0
TCGA-KN-8422-11,TCGA-KN-8422,KICH,28.0,FEMALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2005.0,nan,-10303.0,Alive,TUMOR FREE,775.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,775.0,0.0,775.0,0.0,775.0,0.0,775.0,0
TCGA-KN-8423-01,TCGA-KN-8423,KICH,44.0,MALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2005.0,nan,-16335.0,Alive,TUMOR FREE,788.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,788.0,0.0,788.0,0.0,788.0,0.0,788.0,0
TCGA-KN-8423-11,TCGA-KN-8423,KICH,44.0,MALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2005.0,nan,-16335.0,Alive,TUMOR FREE,788.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,788.0,0.0,788.0,0.0,788.0,0.0,788.0,0
TCGA-KN-8424-01,TCGA-KN-8424,KICH,42.0,FEMALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2005.0,nan,-15384.0,Alive,TUMOR FREE,1983.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1983.0,0.0,1983.0,0.0,1983.0,0.0,1983.0,0
TCGA-KN-8424-11,TCGA-KN-8424,KICH,42.0,FEMALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2005.0,nan,-15384.0,Alive,TUMOR FREE,1983.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1983.0,0.0,1983.0,0.0,1983.0,0.0,1983.0,0
TCGA-KN-8425-01,TCGA-KN-8425,KICH,53.0,MALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2005.0,nan,-19692.0,Alive,TUMOR FREE,3179.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3179.0,0.0,3179.0,0.0,3179.0,0.0,3179.0,0
TCGA-KN-8425-11,TCGA-KN-8425,KICH,53.0,MALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2005.0,nan,-19692.0,Alive,TUMOR FREE,3179.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3179.0,0.0,3179.0,0.0,3179.0,0.0,3179.0,0
TCGA-KN-8426-01,TCGA-KN-8426,KICH,50.0,MALE,WHITE,Stage IV,nan,Kidney Chromophobe,nan,2006.0,nan,-18345.0,Alive,WITH TUMOR,108.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,108.0,0.0,108.0,nan,nan,0.0,108.0,0
TCGA-KN-8426-11,TCGA-KN-8426,KICH,50.0,MALE,WHITE,Stage IV,nan,Kidney Chromophobe,nan,2006.0,nan,-18345.0,Alive,WITH TUMOR,108.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,108.0,0.0,108.0,nan,nan,0.0,108.0,0
TCGA-KN-8427-01,TCGA-KN-8427,KICH,54.0,MALE,WHITE,Stage IV,nan,Kidney Chromophobe,nan,2006.0,nan,-19854.0,Alive,TUMOR FREE,30.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,30.0,0.0,30.0,nan,nan,0.0,30.0,0
TCGA-KN-8427-11,TCGA-KN-8427,KICH,54.0,MALE,WHITE,Stage IV,nan,Kidney Chromophobe,nan,2006.0,nan,-19854.0,Alive,TUMOR FREE,30.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,30.0,0.0,30.0,nan,nan,0.0,30.0,0
TCGA-KN-8428-01,TCGA-KN-8428,KICH,71.0,MALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2006.0,nan,-26252.0,Dead,WITH TUMOR,nan,1590.0,nan,nan,nan,nan,478.0,Stable Disease,nan,nan,1.0,1590.0,1.0,1590.0,nan,nan,1.0,478.0,1
TCGA-KN-8428-11,TCGA-KN-8428,KICH,71.0,MALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2006.0,nan,-26252.0,Dead,WITH TUMOR,nan,1590.0,nan,nan,nan,nan,478.0,Stable Disease,nan,nan,1.0,1590.0,1.0,1590.0,nan,nan,1.0,478.0,1
TCGA-KN-8429-01,TCGA-KN-8429,KICH,38.0,FEMALE,WHITE,Stage III,nan,Kidney Chromophobe,nan,2006.0,nan,-13903.0,Alive,TUMOR FREE,2650.0,nan,nan,nan,nan,nan,1989.0,Complete Remission/Response,nan,nan,0.0,2650.0,0.0,2650.0,1.0,1989.0,1.0,1989.0,2
TCGA-KN-8429-11,TCGA-KN-8429,KICH,38.0,FEMALE,WHITE,Stage III,nan,Kidney Chromophobe,nan,2006.0,nan,-13903.0,Alive,TUMOR FREE,2650.0,nan,nan,nan,nan,nan,1989.0,Complete Remission/Response,nan,nan,0.0,2650.0,0.0,2650.0,1.0,1989.0,1.0,1989.0,2
TCGA-KN-8430-01,TCGA-KN-8430,KICH,75.0,MALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2007.0,nan,-27467.0,Dead,WITH TUMOR,nan,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,nan,1.0,nan,nan,nan,1.0,nan,1
TCGA-KN-8430-11,TCGA-KN-8430,KICH,75.0,MALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2007.0,nan,-27467.0,Dead,WITH TUMOR,nan,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,nan,1.0,nan,nan,nan,1.0,nan,1
TCGA-KN-8431-01,TCGA-KN-8431,KICH,35.0,FEMALE,[Not Evaluated],Stage II,nan,Kidney Chromophobe,nan,2007.0,nan,-13043.0,Alive,TUMOR FREE,588.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,588.0,0.0,588.0,nan,nan,0.0,588.0,0
TCGA-KN-8431-11,TCGA-KN-8431,KICH,35.0,FEMALE,[Not Evaluated],Stage II,nan,Kidney Chromophobe,nan,2007.0,nan,-13043.0,Alive,TUMOR FREE,588.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,588.0,0.0,588.0,nan,nan,0.0,588.0,0
TCGA-KN-8432-01,TCGA-KN-8432,KICH,86.0,FEMALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2010.0,nan,-31591.0,Alive,nan,76.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,76.0,0.0,76.0,0.0,76.0,0.0,76.0,0
TCGA-KN-8432-11,TCGA-KN-8432,KICH,86.0,FEMALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2010.0,nan,-31591.0,Alive,nan,76.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,76.0,0.0,76.0,0.0,76.0,0.0,76.0,0
TCGA-KN-8433-01,TCGA-KN-8433,KICH,46.0,FEMALE,WHITE,Stage III,nan,Kidney Chromophobe,nan,2008.0,nan,-17108.0,Alive,TUMOR FREE,341.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,341.0,0.0,341.0,0.0,341.0,0.0,341.0,0
TCGA-KN-8433-11,TCGA-KN-8433,KICH,46.0,FEMALE,WHITE,Stage III,nan,Kidney Chromophobe,nan,2008.0,nan,-17108.0,Alive,TUMOR FREE,341.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,341.0,0.0,341.0,0.0,341.0,0.0,341.0,0
TCGA-KN-8434-01,TCGA-KN-8434,KICH,65.0,FEMALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2009.0,nan,-23934.0,Alive,TUMOR FREE,1797.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1797.0,0.0,1797.0,0.0,1797.0,0.0,1797.0,0
TCGA-KN-8434-11,TCGA-KN-8434,KICH,65.0,FEMALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2009.0,nan,-23934.0,Alive,TUMOR FREE,1797.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1797.0,0.0,1797.0,0.0,1797.0,0.0,1797.0,0
TCGA-KN-8435-01,TCGA-KN-8435,KICH,59.0,MALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2004.0,nan,-21891.0,Alive,TUMOR FREE,3498.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3498.0,0.0,3498.0,0.0,3498.0,0.0,3498.0,0
TCGA-KN-8435-11,TCGA-KN-8435,KICH,59.0,MALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2004.0,nan,-21891.0,Alive,TUMOR FREE,3498.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3498.0,0.0,3498.0,0.0,3498.0,0.0,3498.0,0
TCGA-KN-8436-01,TCGA-KN-8436,KICH,62.0,MALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2009.0,nan,-22997.0,Alive,TUMOR FREE,1288.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1288.0,0.0,1288.0,0.0,1288.0,0.0,1288.0,0
TCGA-KN-8436-11,TCGA-KN-8436,KICH,62.0,MALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2009.0,nan,-22997.0,Alive,TUMOR FREE,1288.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1288.0,0.0,1288.0,0.0,1288.0,0.0,1288.0,0
TCGA-KN-8437-01,TCGA-KN-8437,KICH,42.0,FEMALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2006.0,nan,-15475.0,Alive,TUMOR FREE,3068.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3068.0,0.0,3068.0,0.0,3068.0,0.0,3068.0,0
TCGA-KN-8437-11,TCGA-KN-8437,KICH,42.0,FEMALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2006.0,nan,-15475.0,Alive,TUMOR FREE,3068.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3068.0,0.0,3068.0,0.0,3068.0,0.0,3068.0,0
TCGA-KO-8403-01,TCGA-KO-8403,KICH,49.0,MALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2005.0,nan,-18171.0,Alive,TUMOR FREE,3208.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3208.0,0.0,3208.0,nan,nan,0.0,3208.0,0
TCGA-KO-8403-11,TCGA-KO-8403,KICH,49.0,MALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2005.0,nan,-18171.0,Alive,TUMOR FREE,3208.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3208.0,0.0,3208.0,nan,nan,0.0,3208.0,0
TCGA-KO-8404-01,TCGA-KO-8404,KICH,78.0,MALE,WHITE,Stage IV,nan,Kidney Chromophobe,nan,2005.0,nan,-28705.0,Dead,WITH TUMOR,nan,325.0,nan,nan,nan,nan,148.0,Progressive Disease,nan,nan,1.0,325.0,1.0,325.0,nan,nan,1.0,148.0,1
TCGA-KO-8405-01,TCGA-KO-8405,KICH,29.0,MALE,WHITE,Stage III,nan,Kidney Chromophobe,nan,2005.0,nan,-10671.0,Alive,TUMOR FREE,3056.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3056.0,0.0,3056.0,0.0,3056.0,0.0,3056.0,0
TCGA-KO-8406-01,TCGA-KO-8406,KICH,17.0,FEMALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2005.0,nan,-6556.0,Alive,TUMOR FREE,3145.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3145.0,0.0,3145.0,0.0,3145.0,0.0,3145.0,0
TCGA-KO-8407-01,TCGA-KO-8407,KICH,42.0,MALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2005.0,nan,-15407.0,Alive,TUMOR FREE,2820.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2820.0,0.0,2820.0,0.0,2820.0,0.0,2820.0,0
TCGA-KO-8408-01,TCGA-KO-8408,KICH,47.0,MALE,WHITE,Stage III,nan,Kidney Chromophobe,nan,2004.0,nan,-17299.0,Dead,TUMOR FREE,nan,507.0,nan,nan,nan,nan,46.0,nan,nan,nan,1.0,507.0,0.0,507.0,nan,nan,1.0,46.0,1
TCGA-KO-8409-01,TCGA-KO-8409,KICH,69.0,MALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2004.0,nan,-25419.0,Alive,TUMOR FREE,3180.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3180.0,0.0,3180.0,0.0,3180.0,0.0,3180.0,0
TCGA-KO-8410-01,TCGA-KO-8410,KICH,74.0,FEMALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2004.0,nan,-27084.0,Alive,TUMOR FREE,3136.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3136.0,0.0,3136.0,nan,nan,0.0,3136.0,0
TCGA-KO-8411-01,TCGA-KO-8411,KICH,58.0,MALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2004.0,nan,-21371.0,Alive,TUMOR FREE,3958.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3958.0,0.0,3958.0,0.0,3958.0,0.0,3958.0,0
TCGA-KO-8413-01,TCGA-KO-8413,KICH,46.0,MALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2006.0,nan,-17067.0,Alive,TUMOR FREE,3038.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3038.0,0.0,3038.0,0.0,3038.0,0.0,3038.0,0
TCGA-KO-8414-01,TCGA-KO-8414,KICH,50.0,FEMALE,WHITE,Stage II,nan,Kidney Chromophobe,nan,2006.0,nan,-18502.0,Alive,TUMOR FREE,3212.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3212.0,0.0,3212.0,0.0,3212.0,0.0,3212.0,0
TCGA-KO-8415-01,TCGA-KO-8415,KICH,44.0,FEMALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2007.0,nan,-16395.0,Alive,TUMOR FREE,2939.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2939.0,0.0,2939.0,0.0,2939.0,0.0,2939.0,0
TCGA-KO-8415-11,TCGA-KO-8415,KICH,44.0,FEMALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2007.0,nan,-16395.0,Alive,TUMOR FREE,2939.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2939.0,0.0,2939.0,0.0,2939.0,0.0,2939.0,0
TCGA-KO-8416-01,TCGA-KO-8416,KICH,41.0,MALE,WHITE,Stage III,nan,Kidney Chromophobe,nan,2007.0,nan,-15261.0,Alive,TUMOR FREE,2752.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2752.0,0.0,2752.0,0.0,2752.0,0.0,2752.0,0
TCGA-KO-8417-01,TCGA-KO-8417,KICH,30.0,FEMALE,WHITE,Stage I,nan,Kidney Chromophobe,nan,2007.0,nan,-11139.0,Alive,TUMOR FREE,2815.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2815.0,0.0,2815.0,0.0,2815.0,0.0,2815.0,0
TCGA-3Z-A93Z-01,TCGA-3Z-A93Z,KIRC,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2013.0,nan,-25205.0,Alive,TUMOR FREE,385.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,0
TCGA-6D-AA2E-01,TCGA-6D-AA2E,KIRC,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2013.0,nan,-25043.0,Alive,TUMOR FREE,362.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,362.0,0.0,362.0,nan,nan,0.0,362.0,0
TCGA-A3-3306-01,TCGA-A3-3306,KIRC,67.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-24569.0,Alive,nan,1120.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1120.0,0.0,1120.0,nan,nan,0.0,1120.0,0
TCGA-A3-3306-11,TCGA-A3-3306,KIRC,67.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-24569.0,Alive,nan,1120.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1120.0,0.0,1120.0,nan,nan,0.0,1120.0,0
TCGA-A3-3307-01,TCGA-A3-3307,KIRC,66.0,MALE,nan,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-24315.0,Alive,WITH TUMOR,1436.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1436.0,0.0,1436.0,nan,nan,0.0,1436.0,0
TCGA-A3-3308-01,TCGA-A3-3308,KIRC,77.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-28287.0,Alive,TUMOR FREE,16.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,16.0,0.0,16.0,nan,nan,0.0,16.0,0
TCGA-A3-3308-11,TCGA-A3-3308,KIRC,77.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-28287.0,Alive,TUMOR FREE,16.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,16.0,0.0,16.0,nan,nan,0.0,16.0,0
TCGA-A3-3311-01,TCGA-A3-3311,KIRC,57.0,MALE,nan,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-21183.0,Dead,TUMOR FREE,nan,1191.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1191.0,0.0,1191.0,nan,nan,0.0,1191.0,0
TCGA-A3-3311-11,TCGA-A3-3311,KIRC,57.0,MALE,nan,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-21183.0,Dead,TUMOR FREE,nan,1191.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1191.0,0.0,1191.0,nan,nan,0.0,1191.0,0
TCGA-A3-3313-01,TCGA-A3-3313,KIRC,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-21556.0,Dead,TUMOR FREE,735.0,735.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,735.0,0.0,735.0,nan,nan,0.0,735.0,0
TCGA-A3-3313-11,TCGA-A3-3313,KIRC,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-21556.0,Dead,TUMOR FREE,735.0,735.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,735.0,0.0,735.0,nan,nan,0.0,735.0,0
TCGA-A3-3316-01,TCGA-A3-3316,KIRC,57.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-20931.0,Alive,TUMOR FREE,1493.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1493.0,0.0,1493.0,nan,nan,0.0,1493.0,0
TCGA-A3-3316-11,TCGA-A3-3316,KIRC,57.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-20931.0,Alive,TUMOR FREE,1493.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1493.0,0.0,1493.0,nan,nan,0.0,1493.0,0
TCGA-A3-3317-01,TCGA-A3-3317,KIRC,67.0,MALE,nan,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-24803.0,Alive,TUMOR FREE,1491.0,nan,nan,nan,nan,nan,560.0,nan,nan,nan,0.0,1491.0,0.0,1491.0,nan,nan,1.0,560.0,0
TCGA-A3-3317-11,TCGA-A3-3317,KIRC,67.0,MALE,nan,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-24803.0,Alive,TUMOR FREE,1491.0,nan,nan,nan,nan,nan,560.0,nan,nan,nan,0.0,1491.0,0.0,1491.0,nan,nan,1.0,560.0,0
TCGA-A3-3319-01,TCGA-A3-3319,KIRC,70.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-25699.0,Alive,TUMOR FREE,1130.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1130.0,0.0,1130.0,nan,nan,0.0,1130.0,0
TCGA-A3-3319-11,TCGA-A3-3319,KIRC,70.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-25699.0,Alive,TUMOR FREE,1130.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1130.0,0.0,1130.0,nan,nan,0.0,1130.0,0
TCGA-A3-3320-01,TCGA-A3-3320,KIRC,52.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G1,2005.0,nan,-19138.0,Alive,TUMOR FREE,1508.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1508.0,0.0,1508.0,nan,nan,0.0,1508.0,0
TCGA-A3-3320-11,TCGA-A3-3320,KIRC,52.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G1,2005.0,nan,-19138.0,Alive,TUMOR FREE,1508.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1508.0,0.0,1508.0,nan,nan,0.0,1508.0,0
TCGA-A3-3322-01,TCGA-A3-3322,KIRC,51.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-18754.0,Alive,TUMOR FREE,1478.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1478.0,0.0,1478.0,nan,nan,0.0,1478.0,0
TCGA-A3-3322-11,TCGA-A3-3322,KIRC,51.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-18754.0,Alive,TUMOR FREE,1478.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1478.0,0.0,1478.0,nan,nan,0.0,1478.0,0
TCGA-A3-3323-01,TCGA-A3-3323,KIRC,53.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G1,2006.0,nan,-19456.0,Alive,TUMOR FREE,1106.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1106.0,0.0,1106.0,nan,nan,0.0,1106.0,0
TCGA-A3-3323-11,TCGA-A3-3323,KIRC,53.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G1,2006.0,nan,-19456.0,Alive,TUMOR FREE,1106.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1106.0,0.0,1106.0,nan,nan,0.0,1106.0,0
TCGA-A3-3324-01,TCGA-A3-3324,KIRC,51.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-18843.0,Alive,TUMOR FREE,1186.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1186.0,0.0,1186.0,nan,nan,0.0,1186.0,0
TCGA-A3-3324-11,TCGA-A3-3324,KIRC,51.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-18843.0,Alive,TUMOR FREE,1186.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1186.0,0.0,1186.0,nan,nan,0.0,1186.0,0
TCGA-A3-3325-01,TCGA-A3-3325,KIRC,52.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-19126.0,Dead,TUMOR FREE,nan,1170.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,1170.0,0.0,1170.0,nan,nan,0.0,1170.0,0
TCGA-A3-3325-11,TCGA-A3-3325,KIRC,52.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-19126.0,Dead,TUMOR FREE,nan,1170.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,1170.0,0.0,1170.0,nan,nan,0.0,1170.0,0
TCGA-A3-3326-01,TCGA-A3-3326,KIRC,47.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G1,2006.0,nan,-17285.0,Alive,TUMOR FREE,1137.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1137.0,0.0,1137.0,nan,nan,0.0,1137.0,0
TCGA-A3-3326-11,TCGA-A3-3326,KIRC,47.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G1,2006.0,nan,-17285.0,Alive,TUMOR FREE,1137.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1137.0,0.0,1137.0,nan,nan,0.0,1137.0,0
TCGA-A3-3328-01,TCGA-A3-3328,KIRC,79.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-29168.0,Alive,TUMOR FREE,1385.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1385.0,0.0,1385.0,0.0,1385.0,0.0,1385.0,0
TCGA-A3-3328-11,TCGA-A3-3328,KIRC,79.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-29168.0,Alive,TUMOR FREE,1385.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1385.0,0.0,1385.0,0.0,1385.0,0.0,1385.0,0
TCGA-A3-3329-01,TCGA-A3-3329,KIRC,75.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-27650.0,Alive,TUMOR FREE,1624.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1624.0,0.0,1624.0,0.0,1624.0,0.0,1624.0,0
TCGA-A3-3329-11,TCGA-A3-3329,KIRC,75.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-27650.0,Alive,TUMOR FREE,1624.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1624.0,0.0,1624.0,0.0,1624.0,0.0,1624.0,0
TCGA-A3-3331-01,TCGA-A3-3331,KIRC,86.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-31615.0,Alive,TUMOR FREE,1485.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1485.0,0.0,1485.0,nan,nan,0.0,1485.0,0
TCGA-A3-3331-11,TCGA-A3-3331,KIRC,86.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-31615.0,Alive,TUMOR FREE,1485.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1485.0,0.0,1485.0,nan,nan,0.0,1485.0,0
TCGA-A3-3335-01,TCGA-A3-3335,KIRC,41.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G4,2006.0,nan,-15250.0,Alive,TUMOR FREE,1886.0,nan,nan,nan,nan,nan,1098.0,Complete Remission/Response,nan,nan,0.0,1886.0,0.0,1886.0,1.0,1098.0,1.0,1098.0,2
TCGA-A3-3335-11,TCGA-A3-3335,KIRC,41.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G4,2006.0,nan,-15250.0,Alive,TUMOR FREE,1886.0,nan,nan,nan,nan,nan,1098.0,Complete Remission/Response,nan,nan,0.0,1886.0,0.0,1886.0,1.0,1098.0,1.0,1098.0,2
TCGA-A3-3336-01,TCGA-A3-3336,KIRC,75.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-27538.0,Alive,WITH TUMOR,1043.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1043.0,0.0,1043.0,nan,nan,0.0,1043.0,0
TCGA-A3-3336-11,TCGA-A3-3336,KIRC,75.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-27538.0,Alive,WITH TUMOR,1043.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1043.0,0.0,1043.0,nan,nan,0.0,1043.0,0
TCGA-A3-3343-01,TCGA-A3-3343,KIRC,79.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-28930.0,Alive,TUMOR FREE,945.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,945.0,0.0,945.0,nan,nan,0.0,945.0,0
TCGA-A3-3343-11,TCGA-A3-3343,KIRC,79.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-28930.0,Alive,TUMOR FREE,945.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,945.0,0.0,945.0,nan,nan,0.0,945.0,0
TCGA-A3-3346-01,TCGA-A3-3346,KIRC,68.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-25118.0,Dead,WITH TUMOR,nan,137.0,nan,nan,nan,nan,114.0,Progressive Disease,nan,nan,1.0,137.0,1.0,137.0,nan,nan,1.0,114.0,1
TCGA-A3-3346-11,TCGA-A3-3346,KIRC,68.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-25118.0,Dead,WITH TUMOR,nan,137.0,nan,nan,nan,nan,114.0,Progressive Disease,nan,nan,1.0,137.0,1.0,137.0,nan,nan,1.0,114.0,1
TCGA-A3-3347-01,TCGA-A3-3347,KIRC,76.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-27966.0,Dead,WITH TUMOR,nan,1610.0,nan,nan,nan,nan,610.0,nan,nan,nan,1.0,1610.0,1.0,1610.0,nan,nan,1.0,610.0,1
TCGA-A3-3347-11,TCGA-A3-3347,KIRC,76.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-27966.0,Dead,WITH TUMOR,nan,1610.0,nan,nan,nan,nan,610.0,nan,nan,nan,1.0,1610.0,1.0,1610.0,nan,nan,1.0,610.0,1
TCGA-A3-3349-01,TCGA-A3-3349,KIRC,34.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-12431.0,Alive,TUMOR FREE,1385.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1385.0,0.0,1385.0,nan,nan,0.0,1385.0,0
TCGA-A3-3349-11,TCGA-A3-3349,KIRC,34.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-12431.0,Alive,TUMOR FREE,1385.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1385.0,0.0,1385.0,nan,nan,0.0,1385.0,0
TCGA-A3-3351-01,TCGA-A3-3351,KIRC,42.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-15562.0,Alive,TUMOR FREE,910.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,910.0,0.0,910.0,nan,nan,0.0,910.0,0
TCGA-A3-3351-11,TCGA-A3-3351,KIRC,42.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-15562.0,Alive,TUMOR FREE,910.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,910.0,0.0,910.0,nan,nan,0.0,910.0,0
TCGA-A3-3352-01,TCGA-A3-3352,KIRC,74.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,nan,Dead,TUMOR FREE,nan,561.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,561.0,0.0,561.0,0.0,561.0,0.0,561.0,0
TCGA-A3-3352-11,TCGA-A3-3352,KIRC,74.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,nan,Dead,TUMOR FREE,nan,561.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,561.0,0.0,561.0,0.0,561.0,0.0,561.0,0
TCGA-A3-3357-01,TCGA-A3-3357,KIRC,62.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-22825.0,Alive,TUMOR FREE,2688.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2688.0,0.0,2688.0,0.0,2688.0,0.0,2688.0,0
TCGA-A3-3357-11,TCGA-A3-3357,KIRC,62.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-22825.0,Alive,TUMOR FREE,2688.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2688.0,0.0,2688.0,0.0,2688.0,0.0,2688.0,0
TCGA-A3-3358-01,TCGA-A3-3358,KIRC,57.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-21087.0,Alive,TUMOR FREE,1307.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1307.0,0.0,1307.0,nan,nan,0.0,1307.0,0
TCGA-A3-3358-11,TCGA-A3-3358,KIRC,57.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-21087.0,Alive,TUMOR FREE,1307.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1307.0,0.0,1307.0,nan,nan,0.0,1307.0,0
TCGA-A3-3359-01,TCGA-A3-3359,KIRC,82.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-30269.0,Alive,TUMOR FREE,2504.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2504.0,0.0,2504.0,0.0,2504.0,0.0,2504.0,0
TCGA-A3-3359-11,TCGA-A3-3359,KIRC,82.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-30269.0,Alive,TUMOR FREE,2504.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2504.0,0.0,2504.0,0.0,2504.0,0.0,2504.0,0
TCGA-A3-3362-01,TCGA-A3-3362,KIRC,60.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-21988.0,Alive,TUMOR FREE,1559.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1559.0,0.0,1559.0,nan,nan,0.0,1559.0,0
TCGA-A3-3362-11,TCGA-A3-3362,KIRC,60.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-21988.0,Alive,TUMOR FREE,1559.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1559.0,0.0,1559.0,nan,nan,0.0,1559.0,0
TCGA-A3-3363-01,TCGA-A3-3363,KIRC,50.0,MALE,ASIAN,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-18596.0,Alive,TUMOR FREE,319.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,319.0,0.0,319.0,nan,nan,0.0,319.0,0
TCGA-A3-3363-11,TCGA-A3-3363,KIRC,50.0,MALE,ASIAN,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-18596.0,Alive,TUMOR FREE,319.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,319.0,0.0,319.0,nan,nan,0.0,319.0,0
TCGA-A3-3365-01,TCGA-A3-3365,KIRC,46.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-16915.0,Alive,nan,873.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,873.0,0.0,873.0,nan,nan,0.0,873.0,0
TCGA-A3-3365-11,TCGA-A3-3365,KIRC,46.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-16915.0,Alive,nan,873.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,873.0,0.0,873.0,nan,nan,0.0,873.0,0
TCGA-A3-3367-01,TCGA-A3-3367,KIRC,72.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-26489.0,Alive,TUMOR FREE,2270.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2270.0,0.0,2270.0,0.0,2270.0,0.0,2270.0,0
TCGA-A3-3367-11,TCGA-A3-3367,KIRC,72.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-26489.0,Alive,TUMOR FREE,2270.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2270.0,0.0,2270.0,0.0,2270.0,0.0,2270.0,0
TCGA-A3-3370-01,TCGA-A3-3370,KIRC,48.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-17621.0,Alive,TUMOR FREE,2274.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2274.0,0.0,2274.0,0.0,2274.0,0.0,2274.0,0
TCGA-A3-3370-11,TCGA-A3-3370,KIRC,48.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-17621.0,Alive,TUMOR FREE,2274.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2274.0,0.0,2274.0,0.0,2274.0,0.0,2274.0,0
TCGA-A3-3372-01,TCGA-A3-3372,KIRC,64.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-23528.0,Alive,TUMOR FREE,735.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,735.0,0.0,735.0,nan,nan,0.0,735.0,0
TCGA-A3-3372-11,TCGA-A3-3372,KIRC,64.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-23528.0,Alive,TUMOR FREE,735.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,735.0,0.0,735.0,nan,nan,0.0,735.0,0
TCGA-A3-3373-01,TCGA-A3-3373,KIRC,54.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-19964.0,Alive,TUMOR FREE,1621.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1621.0,0.0,1621.0,0.0,1621.0,0.0,1621.0,0
TCGA-A3-3373-11,TCGA-A3-3373,KIRC,54.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-19964.0,Alive,TUMOR FREE,1621.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1621.0,0.0,1621.0,0.0,1621.0,0.0,1621.0,0
TCGA-A3-3374-01,TCGA-A3-3374,KIRC,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-18890.0,Alive,nan,1314.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1314.0,0.0,1314.0,nan,nan,0.0,1314.0,0
TCGA-A3-3374-11,TCGA-A3-3374,KIRC,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-18890.0,Alive,nan,1314.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1314.0,0.0,1314.0,nan,nan,0.0,1314.0,0
TCGA-A3-3376-01,TCGA-A3-3376,KIRC,51.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-18954.0,Dead,TUMOR FREE,nan,1696.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1696.0,0.0,1696.0,0.0,1696.0,0.0,1696.0,0
TCGA-A3-3376-11,TCGA-A3-3376,KIRC,51.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-18954.0,Dead,TUMOR FREE,nan,1696.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1696.0,0.0,1696.0,0.0,1696.0,0.0,1696.0,0
TCGA-A3-3378-01,TCGA-A3-3378,KIRC,60.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-22090.0,Alive,TUMOR FREE,630.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,630.0,0.0,630.0,nan,nan,0.0,630.0,0
TCGA-A3-3378-11,TCGA-A3-3378,KIRC,60.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-22090.0,Alive,TUMOR FREE,630.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,630.0,0.0,630.0,nan,nan,0.0,630.0,0
TCGA-A3-3380-01,TCGA-A3-3380,KIRC,54.0,MALE,nan,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-19828.0,Alive,TUMOR FREE,567.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,567.0,0.0,567.0,nan,nan,0.0,567.0,0
TCGA-A3-3380-11,TCGA-A3-3380,KIRC,54.0,MALE,nan,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-19828.0,Alive,TUMOR FREE,567.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,567.0,0.0,567.0,nan,nan,0.0,567.0,0
TCGA-A3-3382-01,TCGA-A3-3382,KIRC,69.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-25207.0,Alive,WITH TUMOR,574.0,nan,nan,nan,nan,nan,514.0,nan,nan,nan,0.0,574.0,0.0,574.0,nan,nan,1.0,514.0,0
TCGA-A3-3382-11,TCGA-A3-3382,KIRC,69.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-25207.0,Alive,WITH TUMOR,574.0,nan,nan,nan,nan,nan,514.0,nan,nan,nan,0.0,574.0,0.0,574.0,nan,nan,1.0,514.0,0
TCGA-A3-3383-01,TCGA-A3-3383,KIRC,52.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-19324.0,Alive,nan,861.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,861.0,0.0,861.0,nan,nan,0.0,861.0,0
TCGA-A3-3383-11,TCGA-A3-3383,KIRC,52.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-19324.0,Alive,nan,861.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,861.0,0.0,861.0,nan,nan,0.0,861.0,0
TCGA-A3-3385-01,TCGA-A3-3385,KIRC,46.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-17114.0,Alive,TUMOR FREE,1993.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1993.0,0.0,1993.0,0.0,1993.0,0.0,1993.0,0
TCGA-A3-3385-11,TCGA-A3-3385,KIRC,46.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-17114.0,Alive,TUMOR FREE,1993.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1993.0,0.0,1993.0,0.0,1993.0,0.0,1993.0,0
TCGA-A3-3387-01,TCGA-A3-3387,KIRC,49.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-17920.0,Alive,TUMOR FREE,617.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,617.0,0.0,617.0,nan,nan,0.0,617.0,0
TCGA-A3-3387-11,TCGA-A3-3387,KIRC,49.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-17920.0,Alive,TUMOR FREE,617.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,617.0,0.0,617.0,nan,nan,0.0,617.0,0
TCGA-A3-A6NI-01,TCGA-A3-A6NI,KIRC,47.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2011.0,nan,-17190.0,Alive,TUMOR FREE,1018.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1018.0,0.0,1018.0,0.0,1018.0,0.0,1018.0,0
TCGA-A3-A6NJ-01,TCGA-A3-A6NJ,KIRC,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G1,2012.0,nan,-20918.0,Alive,TUMOR FREE,468.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,468.0,0.0,468.0,0.0,468.0,0.0,468.0,0
TCGA-A3-A6NL-01,TCGA-A3-A6NL,KIRC,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2012.0,nan,-17952.0,Alive,TUMOR FREE,689.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,689.0,0.0,689.0,0.0,689.0,0.0,689.0,0
TCGA-A3-A6NN-01,TCGA-A3-A6NN,KIRC,78.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2012.0,nan,-28689.0,Alive,TUMOR FREE,3.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3.0,0.0,3.0,0.0,3.0,0.0,3.0,0
TCGA-A3-A8CQ-01,TCGA-A3-A8CQ,KIRC,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2011.0,nan,-21572.0,Alive,TUMOR FREE,3.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,3.0,0.0,3.0,nan,nan,0.0,3.0,0
TCGA-A3-A8OU-01,TCGA-A3-A8OU,KIRC,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G1,2011.0,nan,-27377.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0
TCGA-A3-A8OV-01,TCGA-A3-A8OV,KIRC,75.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2011.0,nan,-27526.0,Alive,TUMOR FREE,340.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,340.0,0.0,340.0,0.0,340.0,0.0,340.0,0
TCGA-A3-A8OW-01,TCGA-A3-A8OW,KIRC,37.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2011.0,nan,-13546.0,Alive,TUMOR FREE,323.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,323.0,0.0,323.0,0.0,323.0,0.0,323.0,0
TCGA-A3-A8OX-01,TCGA-A3-A8OX,KIRC,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2012.0,nan,-23998.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0
TCGA-AK-3425-01,TCGA-AK-3425,KIRC,68.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2000.0,nan,-24912.0,Alive,TUMOR FREE,3343.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3343.0,0.0,3343.0,nan,nan,0.0,3343.0,0
TCGA-AK-3426-01,TCGA-AK-3426,KIRC,37.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-13770.0,Dead,WITH TUMOR,nan,885.0,nan,nan,nan,nan,256.0,nan,nan,nan,1.0,885.0,1.0,885.0,nan,nan,1.0,256.0,1
TCGA-AK-3427-01,TCGA-AK-3427,KIRC,65.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,GX,2004.0,nan,-24067.0,Alive,TUMOR FREE,3583.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3583.0,0.0,3583.0,0.0,3583.0,0.0,3583.0,0
TCGA-AK-3428-01,TCGA-AK-3428,KIRC,62.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-22653.0,Alive,TUMOR FREE,3728.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3728.0,0.0,3728.0,0.0,3728.0,0.0,3728.0,0
TCGA-AK-3429-01,TCGA-AK-3429,KIRC,54.0,FEMALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-19849.0,Alive,TUMOR FREE,3328.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3328.0,0.0,3328.0,0.0,3328.0,0.0,3328.0,0
TCGA-AK-3430-01,TCGA-AK-3430,KIRC,61.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-22612.0,Dead,nan,nan,480.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,480.0,nan,480.0,nan,nan,0.0,480.0,1
TCGA-AK-3431-01,TCGA-AK-3431,KIRC,62.0,FEMALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-22852.0,Dead,TUMOR FREE,nan,2241.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2241.0,0.0,2241.0,0.0,2241.0,0.0,2241.0,0
TCGA-AK-3433-01,TCGA-AK-3433,KIRC,48.0,FEMALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,GX,2004.0,nan,-17853.0,Alive,TUMOR FREE,3409.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3409.0,0.0,3409.0,0.0,3409.0,0.0,3409.0,0
TCGA-AK-3434-01,TCGA-AK-3434,KIRC,72.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-26490.0,Alive,WITH TUMOR,2087.0,nan,nan,nan,nan,nan,1640.0,nan,nan,nan,0.0,2087.0,0.0,2087.0,nan,nan,1.0,1640.0,2
TCGA-AK-3436-01,TCGA-AK-3436,KIRC,40.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-14842.0,Alive,TUMOR FREE,3331.0,nan,nan,nan,nan,nan,1189.0,Progressive Disease,nan,nan,0.0,3331.0,0.0,3331.0,nan,nan,1.0,1189.0,0
TCGA-AK-3440-01,TCGA-AK-3440,KIRC,58.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-21337.0,Alive,TUMOR FREE,2865.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2865.0,0.0,2865.0,0.0,2865.0,0.0,2865.0,0
TCGA-AK-3443-01,TCGA-AK-3443,KIRC,45.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,GX,2006.0,nan,-16578.0,Alive,TUMOR FREE,1423.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1423.0,0.0,1423.0,nan,nan,0.0,1423.0,0
TCGA-AK-3444-01,TCGA-AK-3444,KIRC,80.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-29497.0,Alive,TUMOR FREE,1471.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1471.0,0.0,1471.0,nan,nan,0.0,1471.0,0
TCGA-AK-3445-01,TCGA-AK-3445,KIRC,69.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-25494.0,Alive,TUMOR FREE,2392.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2392.0,0.0,2392.0,0.0,2392.0,0.0,2392.0,0
TCGA-AK-3447-01,TCGA-AK-3447,KIRC,83.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-30676.0,Alive,TUMOR FREE,1217.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1217.0,0.0,1217.0,nan,nan,0.0,1217.0,0
TCGA-AK-3450-01,TCGA-AK-3450,KIRC,85.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-31364.0,Alive,TUMOR FREE,1779.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1779.0,0.0,1779.0,nan,nan,0.0,1779.0,0
TCGA-AK-3451-01,TCGA-AK-3451,KIRC,48.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-17859.0,Alive,TUMOR FREE,2868.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2868.0,0.0,2868.0,0.0,2868.0,0.0,2868.0,0
TCGA-AK-3453-01,TCGA-AK-3453,KIRC,58.0,FEMALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-21271.0,Alive,TUMOR FREE,2531.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2531.0,0.0,2531.0,0.0,2531.0,0.0,2531.0,0
TCGA-AK-3454-01,TCGA-AK-3454,KIRC,84.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-30862.0,Alive,TUMOR FREE,874.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,874.0,0.0,874.0,nan,nan,0.0,874.0,0
TCGA-AK-3455-01,TCGA-AK-3455,KIRC,71.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-26221.0,Dead,nan,nan,683.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,683.0,nan,683.0,nan,nan,0.0,683.0,1
TCGA-AK-3456-01,TCGA-AK-3456,KIRC,48.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-17821.0,Alive,nan,1143.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1143.0,0.0,1143.0,nan,nan,0.0,1143.0,0
TCGA-AK-3458-01,TCGA-AK-3458,KIRC,48.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-17557.0,Alive,TUMOR FREE,1168.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1168.0,0.0,1168.0,nan,nan,0.0,1168.0,0
TCGA-AK-3460-01,TCGA-AK-3460,KIRC,58.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-21281.0,Alive,TUMOR FREE,2508.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2508.0,0.0,2508.0,0.0,2508.0,0.0,2508.0,0
TCGA-AK-3461-01,TCGA-AK-3461,KIRC,72.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-26464.0,Alive,TUMOR FREE,2217.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2217.0,0.0,2217.0,0.0,2217.0,0.0,2217.0,0
TCGA-AK-3465-01,TCGA-AK-3465,KIRC,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,GX,2008.0,nan,-26232.0,Alive,TUMOR FREE,369.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,369.0,0.0,369.0,nan,nan,0.0,369.0,0
TCGA-AS-3777-01,TCGA-AS-3777,KIRC,63.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,nan,2009.0,nan,-23039.0,Alive,TUMOR FREE,1238.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1238.0,0.0,1238.0,nan,nan,0.0,1238.0,0
TCGA-AS-3778-01,TCGA-AS-3778,KIRC,35.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G1,2010.0,nan,-12937.0,Alive,TUMOR FREE,43.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,43.0,0.0,43.0,nan,nan,0.0,43.0,0
TCGA-B0-4688-01,TCGA-B0-4688,KIRC,46.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2008.0,nan,-16804.0,Dead,WITH TUMOR,nan,101.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,101.0,1.0,101.0,nan,nan,1.0,101.0,1
TCGA-B0-4688-11,TCGA-B0-4688,KIRC,46.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2008.0,nan,-16804.0,Dead,WITH TUMOR,nan,101.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,101.0,1.0,101.0,nan,nan,1.0,101.0,1
TCGA-B0-4690-01,TCGA-B0-4690,KIRC,65.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2008.0,nan,-23985.0,Dead,WITH TUMOR,nan,43.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,43.0,1.0,43.0,nan,nan,1.0,43.0,1
TCGA-B0-4690-11,TCGA-B0-4690,KIRC,65.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2008.0,nan,-23985.0,Dead,WITH TUMOR,nan,43.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,43.0,1.0,43.0,nan,nan,1.0,43.0,1
TCGA-B0-4691-01,TCGA-B0-4691,KIRC,55.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2009.0,nan,-20176.0,Dead,WITH TUMOR,nan,139.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,139.0,1.0,139.0,nan,nan,1.0,139.0,1
TCGA-B0-4691-11,TCGA-B0-4691,KIRC,55.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2009.0,nan,-20176.0,Dead,WITH TUMOR,nan,139.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,139.0,1.0,139.0,nan,nan,1.0,139.0,1
TCGA-B0-4693-01,TCGA-B0-4693,KIRC,72.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2009.0,nan,-26659.0,Dead,TUMOR FREE,nan,77.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,77.0,0.0,77.0,nan,nan,0.0,77.0,1
TCGA-B0-4693-11,TCGA-B0-4693,KIRC,72.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2009.0,nan,-26659.0,Dead,TUMOR FREE,nan,77.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,77.0,0.0,77.0,nan,nan,0.0,77.0,1
TCGA-B0-4694-01,TCGA-B0-4694,KIRC,72.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2009.0,nan,-26582.0,Dead,TUMOR FREE,nan,106.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,106.0,0.0,106.0,nan,nan,0.0,106.0,0
TCGA-B0-4694-11,TCGA-B0-4694,KIRC,72.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2009.0,nan,-26582.0,Dead,TUMOR FREE,nan,106.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,106.0,0.0,106.0,nan,nan,0.0,106.0,0
TCGA-B0-4696-01,TCGA-B0-4696,KIRC,58.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2001.0,nan,-21317.0,Dead,WITH TUMOR,nan,866.0,nan,nan,nan,nan,794.0,nan,nan,nan,1.0,866.0,1.0,866.0,nan,nan,1.0,794.0,1
TCGA-B0-4696-11,TCGA-B0-4696,KIRC,58.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2001.0,nan,-21317.0,Dead,WITH TUMOR,nan,866.0,nan,nan,nan,nan,794.0,nan,nan,nan,1.0,866.0,1.0,866.0,nan,nan,1.0,794.0,1
TCGA-B0-4697-01,TCGA-B0-4697,KIRC,46.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2003.0,nan,-16844.0,Dead,WITH TUMOR,nan,578.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,578.0,1.0,578.0,nan,nan,1.0,578.0,1
TCGA-B0-4697-11,TCGA-B0-4697,KIRC,46.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2003.0,nan,-16844.0,Dead,WITH TUMOR,nan,578.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,578.0,1.0,578.0,nan,nan,1.0,578.0,1
TCGA-B0-4698-01,TCGA-B0-4698,KIRC,75.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2003.0,nan,-27417.0,Dead,WITH TUMOR,nan,42.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,42.0,1.0,42.0,nan,nan,1.0,42.0,1
TCGA-B0-4698-11,TCGA-B0-4698,KIRC,75.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2003.0,nan,-27417.0,Dead,WITH TUMOR,nan,42.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,42.0,1.0,42.0,nan,nan,1.0,42.0,1
TCGA-B0-4699-01,TCGA-B0-4699,KIRC,74.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-27225.0,Dead,[Discrepancy],nan,110.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,110.0,nan,110.0,nan,nan,0.0,110.0,1
TCGA-B0-4699-11,TCGA-B0-4699,KIRC,74.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-27225.0,Dead,[Discrepancy],nan,110.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,110.0,nan,110.0,nan,nan,0.0,110.0,1
TCGA-B0-4700-01,TCGA-B0-4700,KIRC,60.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-22034.0,Dead,WITH TUMOR,nan,1980.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1980.0,1.0,1980.0,nan,nan,1.0,1980.0,1
TCGA-B0-4700-11,TCGA-B0-4700,KIRC,60.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-22034.0,Dead,WITH TUMOR,nan,1980.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1980.0,1.0,1980.0,nan,nan,1.0,1980.0,1
TCGA-B0-4701-01,TCGA-B0-4701,KIRC,66.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-24232.0,Dead,WITH TUMOR,nan,238.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,238.0,1.0,238.0,nan,nan,1.0,238.0,1
TCGA-B0-4701-11,TCGA-B0-4701,KIRC,66.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-24232.0,Dead,WITH TUMOR,nan,238.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,238.0,1.0,238.0,nan,nan,1.0,238.0,1
TCGA-B0-4703-01,TCGA-B0-4703,KIRC,51.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-18921.0,Dead,WITH TUMOR,nan,182.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,182.0,1.0,182.0,nan,nan,1.0,182.0,1
TCGA-B0-4703-11,TCGA-B0-4703,KIRC,51.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-18921.0,Dead,WITH TUMOR,nan,182.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,182.0,1.0,182.0,nan,nan,1.0,182.0,1
TCGA-B0-4706-01,TCGA-B0-4706,KIRC,61.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-22331.0,Dead,TUMOR FREE,26.0,65.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,65.0,0.0,65.0,nan,nan,0.0,65.0,0
TCGA-B0-4706-11,TCGA-B0-4706,KIRC,61.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-22331.0,Dead,TUMOR FREE,26.0,65.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,65.0,0.0,65.0,nan,nan,0.0,65.0,0
TCGA-B0-4707-01,TCGA-B0-4707,KIRC,63.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2008.0,nan,-23322.0,Dead,WITH TUMOR,nan,600.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,600.0,1.0,600.0,nan,nan,1.0,600.0,1
TCGA-B0-4707-11,TCGA-B0-4707,KIRC,63.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2008.0,nan,-23322.0,Dead,WITH TUMOR,nan,600.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,600.0,1.0,600.0,nan,nan,1.0,600.0,1
TCGA-B0-4710-01,TCGA-B0-4710,KIRC,75.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-27396.0,Alive,TUMOR FREE,1755.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1755.0,0.0,1755.0,0.0,1755.0,0.0,1755.0,0
TCGA-B0-4710-11,TCGA-B0-4710,KIRC,75.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-27396.0,Alive,TUMOR FREE,1755.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1755.0,0.0,1755.0,0.0,1755.0,0.0,1755.0,0
TCGA-B0-4712-01,TCGA-B0-4712,KIRC,76.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-28095.0,Dead,WITH TUMOR,nan,1337.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1337.0,1.0,1337.0,nan,nan,1.0,1337.0,1
TCGA-B0-4712-11,TCGA-B0-4712,KIRC,76.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-28095.0,Dead,WITH TUMOR,nan,1337.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1337.0,1.0,1337.0,nan,nan,1.0,1337.0,1
TCGA-B0-4713-01,TCGA-B0-4713,KIRC,76.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-27899.0,Dead,WITH TUMOR,nan,202.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,202.0,1.0,202.0,nan,nan,1.0,202.0,1
TCGA-B0-4713-11,TCGA-B0-4713,KIRC,76.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-27899.0,Dead,WITH TUMOR,nan,202.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,202.0,1.0,202.0,nan,nan,1.0,202.0,1
TCGA-B0-4714-01,TCGA-B0-4714,KIRC,81.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-29873.0,Dead,WITH TUMOR,nan,99.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,99.0,1.0,99.0,nan,nan,1.0,99.0,1
TCGA-B0-4714-11,TCGA-B0-4714,KIRC,81.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-29873.0,Dead,WITH TUMOR,nan,99.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,99.0,1.0,99.0,nan,nan,1.0,99.0,1
TCGA-B0-4718-01,TCGA-B0-4718,KIRC,57.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-20910.0,Alive,WITH TUMOR,1778.0,nan,nan,nan,nan,nan,768.0,Progressive Disease,nan,nan,0.0,1778.0,0.0,1778.0,nan,nan,1.0,768.0,2
TCGA-B0-4718-11,TCGA-B0-4718,KIRC,57.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-20910.0,Alive,WITH TUMOR,1778.0,nan,nan,nan,nan,nan,768.0,Progressive Disease,nan,nan,0.0,1778.0,0.0,1778.0,nan,nan,1.0,768.0,2
TCGA-B0-4810-01,TCGA-B0-4810,KIRC,47.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2001.0,nan,-17402.0,Dead,WITH TUMOR,nan,478.0,nan,nan,nan,nan,205.0,nan,nan,nan,1.0,478.0,1.0,478.0,nan,nan,1.0,205.0,1
TCGA-B0-4810-11,TCGA-B0-4810,KIRC,47.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2001.0,nan,-17402.0,Dead,WITH TUMOR,nan,478.0,nan,nan,nan,nan,205.0,nan,nan,nan,1.0,478.0,1.0,478.0,nan,nan,1.0,205.0,1
TCGA-B0-4811-01,TCGA-B0-4811,KIRC,48.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2001.0,nan,-17792.0,Dead,WITH TUMOR,nan,1417.0,nan,nan,nan,nan,458.0,nan,nan,nan,1.0,1417.0,1.0,1417.0,nan,nan,1.0,458.0,1
TCGA-B0-4811-11,TCGA-B0-4811,KIRC,48.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2001.0,nan,-17792.0,Dead,WITH TUMOR,nan,1417.0,nan,nan,nan,nan,458.0,nan,nan,nan,1.0,1417.0,1.0,1417.0,nan,nan,1.0,458.0,1
TCGA-B0-4813-01,TCGA-B0-4813,KIRC,68.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2001.0,nan,-25018.0,Dead,TUMOR FREE,18.0,18.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,18.0,0.0,18.0,nan,nan,0.0,18.0,0
TCGA-B0-4813-11,TCGA-B0-4813,KIRC,68.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2001.0,nan,-25018.0,Dead,TUMOR FREE,18.0,18.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,18.0,0.0,18.0,nan,nan,0.0,18.0,0
TCGA-B0-4814-01,TCGA-B0-4814,KIRC,58.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2001.0,nan,-21374.0,Dead,WITH TUMOR,nan,168.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,168.0,1.0,168.0,nan,nan,1.0,168.0,1
TCGA-B0-4814-11,TCGA-B0-4814,KIRC,58.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2001.0,nan,-21374.0,Dead,WITH TUMOR,nan,168.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,168.0,1.0,168.0,nan,nan,1.0,168.0,1
TCGA-B0-4815-01,TCGA-B0-4815,KIRC,65.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2001.0,nan,-23873.0,Dead,WITH TUMOR,nan,1588.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1588.0,1.0,1588.0,nan,nan,1.0,1588.0,1
TCGA-B0-4815-11,TCGA-B0-4815,KIRC,65.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2001.0,nan,-23873.0,Dead,WITH TUMOR,nan,1588.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1588.0,1.0,1588.0,nan,nan,1.0,1588.0,1
TCGA-B0-4816-01,TCGA-B0-4816,KIRC,49.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2002.0,nan,-18133.0,Dead,WITH TUMOR,nan,1371.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1371.0,1.0,1371.0,nan,nan,1.0,1371.0,1
TCGA-B0-4816-11,TCGA-B0-4816,KIRC,49.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2002.0,nan,-18133.0,Dead,WITH TUMOR,nan,1371.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1371.0,1.0,1371.0,nan,nan,1.0,1371.0,1
TCGA-B0-4817-01,TCGA-B0-4817,KIRC,81.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2002.0,nan,-29873.0,Dead,TUMOR FREE,nan,1019.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1019.0,0.0,1019.0,nan,nan,0.0,1019.0,0
TCGA-B0-4817-11,TCGA-B0-4817,KIRC,81.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2002.0,nan,-29873.0,Dead,TUMOR FREE,nan,1019.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1019.0,0.0,1019.0,nan,nan,0.0,1019.0,0
TCGA-B0-4818-01,TCGA-B0-4818,KIRC,68.0,FEMALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2002.0,nan,-24853.0,Dead,WITH TUMOR,nan,510.0,nan,nan,nan,nan,127.0,nan,nan,nan,1.0,510.0,1.0,510.0,nan,nan,1.0,127.0,1
TCGA-B0-4818-11,TCGA-B0-4818,KIRC,68.0,FEMALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2002.0,nan,-24853.0,Dead,WITH TUMOR,nan,510.0,nan,nan,nan,nan,127.0,nan,nan,nan,1.0,510.0,1.0,510.0,nan,nan,1.0,127.0,1
TCGA-B0-4819-01,TCGA-B0-4819,KIRC,60.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2002.0,nan,-22220.0,Dead,TUMOR FREE,183.0,183.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,183.0,0.0,183.0,nan,nan,0.0,183.0,1
TCGA-B0-4819-11,TCGA-B0-4819,KIRC,60.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2002.0,nan,-22220.0,Dead,TUMOR FREE,183.0,183.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,183.0,0.0,183.0,nan,nan,0.0,183.0,1
TCGA-B0-4821-01,TCGA-B0-4821,KIRC,68.0,FEMALE,ASIAN,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2002.0,nan,-25013.0,Dead,WITH TUMOR,nan,1230.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1230.0,1.0,1230.0,nan,nan,1.0,1230.0,1
TCGA-B0-4821-11,TCGA-B0-4821,KIRC,68.0,FEMALE,ASIAN,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2002.0,nan,-25013.0,Dead,WITH TUMOR,nan,1230.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1230.0,1.0,1230.0,nan,nan,1.0,1230.0,1
TCGA-B0-4822-01,TCGA-B0-4822,KIRC,78.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G4,2002.0,nan,-28774.0,Dead,WITH TUMOR,nan,1111.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1111.0,1.0,1111.0,nan,nan,1.0,1111.0,1
TCGA-B0-4822-11,TCGA-B0-4822,KIRC,78.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G4,2002.0,nan,-28774.0,Dead,WITH TUMOR,nan,1111.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1111.0,1.0,1111.0,nan,nan,1.0,1111.0,1
TCGA-B0-4823-01,TCGA-B0-4823,KIRC,88.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-32290.0,Dead,TUMOR FREE,nan,454.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,454.0,0.0,454.0,nan,nan,0.0,454.0,0
TCGA-B0-4823-11,TCGA-B0-4823,KIRC,88.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-32290.0,Dead,TUMOR FREE,nan,454.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,454.0,0.0,454.0,nan,nan,0.0,454.0,0
TCGA-B0-4824-01,TCGA-B0-4824,KIRC,49.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2002.0,nan,-18132.0,Dead,TUMOR FREE,nan,1657.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1657.0,0.0,1657.0,nan,nan,0.0,1657.0,1
TCGA-B0-4824-11,TCGA-B0-4824,KIRC,49.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2002.0,nan,-18132.0,Dead,TUMOR FREE,nan,1657.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1657.0,0.0,1657.0,nan,nan,0.0,1657.0,1
TCGA-B0-4827-01,TCGA-B0-4827,KIRC,77.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2002.0,nan,-28467.0,Dead,WITH TUMOR,nan,885.0,nan,nan,nan,nan,668.0,nan,nan,nan,1.0,885.0,1.0,885.0,nan,nan,1.0,668.0,1
TCGA-B0-4827-11,TCGA-B0-4827,KIRC,77.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2002.0,nan,-28467.0,Dead,WITH TUMOR,nan,885.0,nan,nan,nan,nan,668.0,nan,nan,nan,1.0,885.0,1.0,885.0,nan,nan,1.0,668.0,1
TCGA-B0-4828-01,TCGA-B0-4828,KIRC,79.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-28948.0,Dead,WITH TUMOR,nan,307.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,307.0,1.0,307.0,nan,nan,1.0,307.0,1
TCGA-B0-4828-11,TCGA-B0-4828,KIRC,79.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-28948.0,Dead,WITH TUMOR,nan,307.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,307.0,1.0,307.0,nan,nan,1.0,307.0,1
TCGA-B0-4833-01,TCGA-B0-4833,KIRC,82.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-30190.0,Dead,WITH TUMOR,nan,2386.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2386.0,1.0,2386.0,nan,nan,1.0,2386.0,1
TCGA-B0-4833-11,TCGA-B0-4833,KIRC,82.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-30190.0,Dead,WITH TUMOR,nan,2386.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2386.0,1.0,2386.0,nan,nan,1.0,2386.0,1
TCGA-B0-4834-01,TCGA-B0-4834,KIRC,49.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-18224.0,Dead,TUMOR FREE,nan,2090.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2090.0,0.0,2090.0,nan,nan,0.0,2090.0,0
TCGA-B0-4834-11,TCGA-B0-4834,KIRC,49.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-18224.0,Dead,TUMOR FREE,nan,2090.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2090.0,0.0,2090.0,nan,nan,0.0,2090.0,0
TCGA-B0-4836-01,TCGA-B0-4836,KIRC,61.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-22488.0,Dead,WITH TUMOR,nan,1238.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1238.0,1.0,1238.0,nan,nan,1.0,1238.0,1
TCGA-B0-4836-11,TCGA-B0-4836,KIRC,61.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-22488.0,Dead,WITH TUMOR,nan,1238.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1238.0,1.0,1238.0,nan,nan,1.0,1238.0,1
TCGA-B0-4837-01,TCGA-B0-4837,KIRC,63.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-23129.0,Dead,WITH TUMOR,nan,1378.0,nan,nan,nan,nan,1208.0,nan,nan,nan,1.0,1378.0,1.0,1378.0,nan,nan,1.0,1208.0,1
TCGA-B0-4837-11,TCGA-B0-4837,KIRC,63.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-23129.0,Dead,WITH TUMOR,nan,1378.0,nan,nan,nan,nan,1208.0,nan,nan,nan,1.0,1378.0,1.0,1378.0,nan,nan,1.0,1208.0,1
TCGA-B0-4838-01,TCGA-B0-4838,KIRC,69.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-25268.0,Dead,TUMOR FREE,nan,834.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,834.0,0.0,834.0,nan,nan,0.0,834.0,1
TCGA-B0-4838-11,TCGA-B0-4838,KIRC,69.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-25268.0,Dead,TUMOR FREE,nan,834.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,834.0,0.0,834.0,nan,nan,0.0,834.0,1
TCGA-B0-4839-01,TCGA-B0-4839,KIRC,80.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-29380.0,Dead,TUMOR FREE,nan,1639.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1639.0,0.0,1639.0,nan,nan,0.0,1639.0,1
TCGA-B0-4839-11,TCGA-B0-4839,KIRC,80.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-29380.0,Dead,TUMOR FREE,nan,1639.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1639.0,0.0,1639.0,nan,nan,0.0,1639.0,1
TCGA-B0-4841-01,TCGA-B0-4841,KIRC,63.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-23097.0,Dead,WITH TUMOR,nan,204.0,nan,nan,nan,nan,108.0,nan,nan,nan,1.0,204.0,1.0,204.0,nan,nan,1.0,108.0,1
TCGA-B0-4841-11,TCGA-B0-4841,KIRC,63.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-23097.0,Dead,WITH TUMOR,nan,204.0,nan,nan,nan,nan,108.0,nan,nan,nan,1.0,204.0,1.0,204.0,nan,nan,1.0,108.0,1
TCGA-B0-4842-01,TCGA-B0-4842,KIRC,73.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-27019.0,Dead,WITH TUMOR,nan,1724.0,nan,nan,nan,nan,250.0,nan,nan,nan,1.0,1724.0,1.0,1724.0,nan,nan,1.0,250.0,1
TCGA-B0-4842-11,TCGA-B0-4842,KIRC,73.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-27019.0,Dead,WITH TUMOR,nan,1724.0,nan,nan,nan,nan,250.0,nan,nan,nan,1.0,1724.0,1.0,1724.0,nan,nan,1.0,250.0,1
TCGA-B0-4843-01,TCGA-B0-4843,KIRC,57.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-21088.0,Dead,WITH TUMOR,nan,320.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,320.0,1.0,320.0,nan,nan,1.0,320.0,1
TCGA-B0-4843-11,TCGA-B0-4843,KIRC,57.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-21088.0,Dead,WITH TUMOR,nan,320.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,320.0,1.0,320.0,nan,nan,1.0,320.0,1
TCGA-B0-4844-01,TCGA-B0-4844,KIRC,60.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-22220.0,Dead,WITH TUMOR,nan,313.0,nan,nan,nan,nan,62.0,nan,nan,nan,1.0,313.0,1.0,313.0,nan,nan,1.0,62.0,1
TCGA-B0-4844-11,TCGA-B0-4844,KIRC,60.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-22220.0,Dead,WITH TUMOR,nan,313.0,nan,nan,nan,nan,62.0,nan,nan,nan,1.0,313.0,1.0,313.0,nan,nan,1.0,62.0,1
TCGA-B0-4845-01,TCGA-B0-4845,KIRC,70.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-25582.0,Dead,WITH TUMOR,nan,1986.0,nan,nan,nan,nan,748.0,nan,nan,nan,1.0,1986.0,1.0,1986.0,nan,nan,1.0,748.0,1
TCGA-B0-4845-11,TCGA-B0-4845,KIRC,70.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-25582.0,Dead,WITH TUMOR,nan,1986.0,nan,nan,nan,nan,748.0,nan,nan,nan,1.0,1986.0,1.0,1986.0,nan,nan,1.0,748.0,1
TCGA-B0-4846-01,TCGA-B0-4846,KIRC,52.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-19139.0,Dead,WITH TUMOR,nan,1200.0,nan,nan,nan,nan,163.0,nan,nan,nan,1.0,1200.0,1.0,1200.0,nan,nan,1.0,163.0,1
TCGA-B0-4846-11,TCGA-B0-4846,KIRC,52.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-19139.0,Dead,WITH TUMOR,nan,1200.0,nan,nan,nan,nan,163.0,nan,nan,nan,1.0,1200.0,1.0,1200.0,nan,nan,1.0,163.0,1
TCGA-B0-4847-01,TCGA-B0-4847,KIRC,60.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-22147.0,Dead,[Discrepancy],nan,793.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,793.0,nan,793.0,nan,nan,0.0,793.0,1
TCGA-B0-4847-11,TCGA-B0-4847,KIRC,60.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-22147.0,Dead,[Discrepancy],nan,793.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,793.0,nan,793.0,nan,nan,0.0,793.0,1
TCGA-B0-4848-01,TCGA-B0-4848,KIRC,54.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-19892.0,Dead,WITH TUMOR,nan,883.0,nan,nan,nan,nan,494.0,nan,nan,nan,1.0,883.0,1.0,883.0,nan,nan,1.0,494.0,1
TCGA-B0-4848-11,TCGA-B0-4848,KIRC,54.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-19892.0,Dead,WITH TUMOR,nan,883.0,nan,nan,nan,nan,494.0,nan,nan,nan,1.0,883.0,1.0,883.0,nan,nan,1.0,494.0,1
TCGA-B0-4849-01,TCGA-B0-4849,KIRC,51.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-18843.0,Dead,WITH TUMOR,nan,69.0,nan,nan,nan,nan,4.0,nan,nan,nan,1.0,69.0,1.0,69.0,nan,nan,1.0,4.0,1
TCGA-B0-4849-11,TCGA-B0-4849,KIRC,51.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-18843.0,Dead,WITH TUMOR,nan,69.0,nan,nan,nan,nan,4.0,nan,nan,nan,1.0,69.0,1.0,69.0,nan,nan,1.0,4.0,1
TCGA-B0-4852-01,TCGA-B0-4852,KIRC,78.0,FEMALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-28552.0,Dead,WITH TUMOR,nan,1121.0,nan,nan,nan,nan,860.0,nan,nan,nan,1.0,1121.0,1.0,1121.0,nan,nan,1.0,860.0,1
TCGA-B0-4852-11,TCGA-B0-4852,KIRC,78.0,FEMALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-28552.0,Dead,WITH TUMOR,nan,1121.0,nan,nan,nan,nan,860.0,nan,nan,nan,1.0,1121.0,1.0,1121.0,nan,nan,1.0,860.0,1
TCGA-B0-4945-01,TCGA-B0-4945,KIRC,75.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-27523.0,Dead,TUMOR FREE,nan,2145.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2145.0,0.0,2145.0,nan,nan,0.0,2145.0,1
TCGA-B0-4945-11,TCGA-B0-4945,KIRC,75.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-27523.0,Dead,TUMOR FREE,nan,2145.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2145.0,0.0,2145.0,nan,nan,0.0,2145.0,1
TCGA-B0-5075-01,TCGA-B0-5075,KIRC,77.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-28205.0,Dead,TUMOR FREE,nan,637.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,637.0,0.0,637.0,nan,nan,0.0,637.0,1
TCGA-B0-5075-11,TCGA-B0-5075,KIRC,77.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-28205.0,Dead,TUMOR FREE,nan,637.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,637.0,0.0,637.0,nan,nan,0.0,637.0,1
TCGA-B0-5077-01,TCGA-B0-5077,KIRC,77.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-28405.0,Dead,TUMOR FREE,nan,1317.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1317.0,0.0,1317.0,nan,nan,0.0,1317.0,0
TCGA-B0-5077-11,TCGA-B0-5077,KIRC,77.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-28405.0,Dead,TUMOR FREE,nan,1317.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1317.0,0.0,1317.0,nan,nan,0.0,1317.0,0
TCGA-B0-5080-01,TCGA-B0-5080,KIRC,63.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-23052.0,Dead,WITH TUMOR,nan,342.0,nan,nan,nan,nan,103.0,nan,nan,nan,1.0,342.0,1.0,342.0,nan,nan,1.0,103.0,1
TCGA-B0-5080-11,TCGA-B0-5080,KIRC,63.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-23052.0,Dead,WITH TUMOR,nan,342.0,nan,nan,nan,nan,103.0,nan,nan,nan,1.0,342.0,1.0,342.0,nan,nan,1.0,103.0,1
TCGA-B0-5081-01,TCGA-B0-5081,KIRC,79.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-29219.0,Dead,WITH TUMOR,nan,362.0,nan,nan,nan,nan,213.0,nan,nan,nan,1.0,362.0,1.0,362.0,nan,nan,1.0,213.0,1
TCGA-B0-5081-11,TCGA-B0-5081,KIRC,79.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-29219.0,Dead,WITH TUMOR,nan,362.0,nan,nan,nan,nan,213.0,nan,nan,nan,1.0,362.0,1.0,362.0,nan,nan,1.0,213.0,1
TCGA-B0-5083-01,TCGA-B0-5083,KIRC,63.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-23034.0,Dead,WITH TUMOR,nan,1045.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1045.0,1.0,1045.0,nan,nan,1.0,1045.0,1
TCGA-B0-5083-11,TCGA-B0-5083,KIRC,63.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-23034.0,Dead,WITH TUMOR,nan,1045.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1045.0,1.0,1045.0,nan,nan,1.0,1045.0,1
TCGA-B0-5084-01,TCGA-B0-5084,KIRC,33.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-12219.0,Dead,WITH TUMOR,nan,222.0,nan,nan,nan,nan,65.0,nan,nan,nan,1.0,222.0,1.0,222.0,nan,nan,1.0,65.0,1
TCGA-B0-5084-11,TCGA-B0-5084,KIRC,33.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-12219.0,Dead,WITH TUMOR,nan,222.0,nan,nan,nan,nan,65.0,nan,nan,nan,1.0,222.0,1.0,222.0,nan,nan,1.0,65.0,1
TCGA-B0-5085-01,TCGA-B0-5085,KIRC,76.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-27793.0,Dead,TUMOR FREE,nan,770.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,770.0,0.0,770.0,nan,nan,0.0,770.0,1
TCGA-B0-5085-11,TCGA-B0-5085,KIRC,76.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-27793.0,Dead,TUMOR FREE,nan,770.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,770.0,0.0,770.0,nan,nan,0.0,770.0,1
TCGA-B0-5088-01,TCGA-B0-5088,KIRC,53.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-19677.0,Dead,TUMOR FREE,nan,563.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,563.0,0.0,563.0,nan,nan,0.0,563.0,0
TCGA-B0-5088-11,TCGA-B0-5088,KIRC,53.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-19677.0,Dead,TUMOR FREE,nan,563.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,563.0,0.0,563.0,nan,nan,0.0,563.0,0
TCGA-B0-5092-01,TCGA-B0-5092,KIRC,53.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2008.0,nan,-19611.0,Dead,WITH TUMOR,nan,459.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,459.0,1.0,459.0,nan,nan,1.0,459.0,1
TCGA-B0-5092-11,TCGA-B0-5092,KIRC,53.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2008.0,nan,-19611.0,Dead,WITH TUMOR,nan,459.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,459.0,1.0,459.0,nan,nan,1.0,459.0,1
TCGA-B0-5094-01,TCGA-B0-5094,KIRC,62.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G2,2008.0,nan,-22965.0,Dead,WITH TUMOR,nan,333.0,nan,nan,nan,nan,75.0,nan,nan,nan,1.0,333.0,1.0,333.0,nan,nan,1.0,75.0,1
TCGA-B0-5094-11,TCGA-B0-5094,KIRC,62.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G2,2008.0,nan,-22965.0,Dead,WITH TUMOR,nan,333.0,nan,nan,nan,nan,75.0,nan,nan,nan,1.0,333.0,1.0,333.0,nan,nan,1.0,75.0,1
TCGA-B0-5095-01,TCGA-B0-5095,KIRC,81.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2008.0,nan,-29921.0,Dead,TUMOR FREE,nan,245.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,245.0,0.0,245.0,nan,nan,0.0,245.0,0
TCGA-B0-5095-11,TCGA-B0-5095,KIRC,81.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2008.0,nan,-29921.0,Dead,TUMOR FREE,nan,245.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,245.0,0.0,245.0,nan,nan,0.0,245.0,0
TCGA-B0-5096-01,TCGA-B0-5096,KIRC,72.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,GX,1998.0,nan,-26574.0,Dead,TUMOR FREE,nan,68.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,68.0,0.0,68.0,nan,nan,0.0,68.0,1
TCGA-B0-5096-11,TCGA-B0-5096,KIRC,72.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,GX,1998.0,nan,-26574.0,Dead,TUMOR FREE,nan,68.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,68.0,0.0,68.0,nan,nan,0.0,68.0,1
TCGA-B0-5097-01,TCGA-B0-5097,KIRC,59.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-21852.0,Alive,WITH TUMOR,665.0,nan,nan,nan,nan,nan,359.0,nan,nan,nan,0.0,665.0,0.0,665.0,nan,nan,1.0,359.0,2
TCGA-B0-5097-11,TCGA-B0-5097,KIRC,59.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-21852.0,Alive,WITH TUMOR,665.0,nan,nan,nan,nan,nan,359.0,nan,nan,nan,0.0,665.0,0.0,665.0,nan,nan,1.0,359.0,2
TCGA-B0-5098-01,TCGA-B0-5098,KIRC,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,1998.0,nan,-19620.0,Dead,[Discrepancy],nan,1584.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1584.0,nan,1584.0,nan,nan,0.0,1584.0,1
TCGA-B0-5098-11,TCGA-B0-5098,KIRC,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,1998.0,nan,-19620.0,Dead,[Discrepancy],nan,1584.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1584.0,nan,1584.0,nan,nan,0.0,1584.0,1
TCGA-B0-5099-01,TCGA-B0-5099,KIRC,88.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2002.0,nan,-32364.0,Dead,[Discrepancy],nan,485.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,485.0,nan,485.0,nan,nan,0.0,485.0,1
TCGA-B0-5099-11,TCGA-B0-5099,KIRC,88.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2002.0,nan,-32364.0,Dead,[Discrepancy],nan,485.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,485.0,nan,485.0,nan,nan,0.0,485.0,1
TCGA-B0-5100-01,TCGA-B0-5100,KIRC,72.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,1998.0,nan,-26478.0,Dead,WITH TUMOR,nan,1913.0,nan,nan,nan,nan,1426.0,nan,nan,nan,1.0,1913.0,1.0,1913.0,nan,nan,1.0,1426.0,1
TCGA-B0-5100-11,TCGA-B0-5100,KIRC,72.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,1998.0,nan,-26478.0,Dead,WITH TUMOR,nan,1913.0,nan,nan,nan,nan,1426.0,nan,nan,nan,1.0,1913.0,1.0,1913.0,nan,nan,1.0,1426.0,1
TCGA-B0-5102-01,TCGA-B0-5102,KIRC,74.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,1999.0,nan,-27152.0,Dead,[Discrepancy],nan,2764.0,nan,nan,nan,nan,2734.0,nan,nan,nan,1.0,2764.0,nan,2764.0,nan,nan,1.0,2734.0,1
TCGA-B0-5102-11,TCGA-B0-5102,KIRC,74.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,1999.0,nan,-27152.0,Dead,[Discrepancy],nan,2764.0,nan,nan,nan,nan,2734.0,nan,nan,nan,1.0,2764.0,nan,2764.0,nan,nan,1.0,2734.0,1
TCGA-B0-5104-01,TCGA-B0-5104,KIRC,90.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-32873.0,Dead,TUMOR FREE,nan,2752.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2752.0,0.0,2752.0,nan,nan,0.0,2752.0,1
TCGA-B0-5104-11,TCGA-B0-5104,KIRC,90.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-32873.0,Dead,TUMOR FREE,nan,2752.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2752.0,0.0,2752.0,nan,nan,0.0,2752.0,1
TCGA-B0-5106-01,TCGA-B0-5106,KIRC,64.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-23547.0,Dead,TUMOR FREE,nan,1598.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1598.0,0.0,1598.0,nan,nan,0.0,1598.0,0
TCGA-B0-5106-11,TCGA-B0-5106,KIRC,64.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-23547.0,Dead,TUMOR FREE,nan,1598.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1598.0,0.0,1598.0,nan,nan,0.0,1598.0,0
TCGA-B0-5107-01,TCGA-B0-5107,KIRC,65.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-23929.0,Dead,WITH TUMOR,nan,927.0,nan,nan,nan,nan,549.0,nan,nan,nan,1.0,927.0,1.0,927.0,nan,nan,1.0,549.0,1
TCGA-B0-5107-11,TCGA-B0-5107,KIRC,65.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-23929.0,Dead,WITH TUMOR,nan,927.0,nan,nan,nan,nan,549.0,nan,nan,nan,1.0,927.0,1.0,927.0,nan,nan,1.0,549.0,1
TCGA-B0-5108-01,TCGA-B0-5108,KIRC,54.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2009.0,nan,-19932.0,Alive,TUMOR FREE,1782.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1782.0,0.0,1782.0,0.0,1782.0,0.0,1782.0,0
TCGA-B0-5108-11,TCGA-B0-5108,KIRC,54.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2009.0,nan,-19932.0,Alive,TUMOR FREE,1782.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1782.0,0.0,1782.0,0.0,1782.0,0.0,1782.0,0
TCGA-B0-5109-01,TCGA-B0-5109,KIRC,69.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2009.0,nan,-25428.0,Dead,WITH TUMOR,nan,587.0,nan,nan,nan,nan,70.0,nan,nan,nan,1.0,587.0,1.0,587.0,nan,nan,1.0,70.0,1
TCGA-B0-5109-11,TCGA-B0-5109,KIRC,69.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2009.0,nan,-25428.0,Dead,WITH TUMOR,nan,587.0,nan,nan,nan,nan,70.0,nan,nan,nan,1.0,587.0,1.0,587.0,nan,nan,1.0,70.0,1
TCGA-B0-5110-01,TCGA-B0-5110,KIRC,71.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2009.0,nan,-25976.0,Alive,TUMOR FREE,2009.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2009.0,0.0,2009.0,0.0,2009.0,0.0,2009.0,2
TCGA-B0-5110-11,TCGA-B0-5110,KIRC,71.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2009.0,nan,-25976.0,Alive,TUMOR FREE,2009.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2009.0,0.0,2009.0,0.0,2009.0,0.0,2009.0,2
TCGA-B0-5113-01,TCGA-B0-5113,KIRC,69.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-25369.0,Alive,TUMOR FREE,1175.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1175.0,0.0,1175.0,0.0,1175.0,0.0,1175.0,0
TCGA-B0-5113-11,TCGA-B0-5113,KIRC,69.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-25369.0,Alive,TUMOR FREE,1175.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1175.0,0.0,1175.0,0.0,1175.0,0.0,1175.0,0
TCGA-B0-5115-01,TCGA-B0-5115,KIRC,43.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2009.0,nan,-15935.0,Alive,WITH TUMOR,1604.0,nan,nan,nan,nan,nan,75.0,Progressive Disease,nan,nan,0.0,1604.0,0.0,1604.0,nan,nan,1.0,75.0,2
TCGA-B0-5115-11,TCGA-B0-5115,KIRC,43.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2009.0,nan,-15935.0,Alive,WITH TUMOR,1604.0,nan,nan,nan,nan,nan,75.0,Progressive Disease,nan,nan,0.0,1604.0,0.0,1604.0,nan,nan,1.0,75.0,2
TCGA-B0-5116-01,TCGA-B0-5116,KIRC,52.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-19352.0,Alive,WITH TUMOR,1274.0,nan,nan,nan,nan,nan,1129.0,Complete Remission/Response,nan,nan,0.0,1274.0,0.0,1274.0,1.0,1129.0,1.0,1129.0,2
TCGA-B0-5116-11,TCGA-B0-5116,KIRC,52.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-19352.0,Alive,WITH TUMOR,1274.0,nan,nan,nan,nan,nan,1129.0,Complete Remission/Response,nan,nan,0.0,1274.0,0.0,1274.0,1.0,1129.0,1.0,1129.0,2
TCGA-B0-5117-01,TCGA-B0-5117,KIRC,40.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-14612.0,Alive,TUMOR FREE,1608.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1608.0,0.0,1608.0,0.0,1608.0,0.0,1608.0,0
TCGA-B0-5117-11,TCGA-B0-5117,KIRC,40.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-14612.0,Alive,TUMOR FREE,1608.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1608.0,0.0,1608.0,0.0,1608.0,0.0,1608.0,0
TCGA-B0-5119-01,TCGA-B0-5119,KIRC,61.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-22607.0,Alive,TUMOR FREE,1552.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1552.0,0.0,1552.0,0.0,1552.0,0.0,1552.0,0
TCGA-B0-5119-11,TCGA-B0-5119,KIRC,61.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-22607.0,Alive,TUMOR FREE,1552.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1552.0,0.0,1552.0,0.0,1552.0,0.0,1552.0,0
TCGA-B0-5120-01,TCGA-B0-5120,KIRC,72.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-26559.0,Alive,TUMOR FREE,1169.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1169.0,0.0,1169.0,0.0,1169.0,0.0,1169.0,0
TCGA-B0-5120-11,TCGA-B0-5120,KIRC,72.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-26559.0,Alive,TUMOR FREE,1169.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1169.0,0.0,1169.0,0.0,1169.0,0.0,1169.0,0
TCGA-B0-5121-01,TCGA-B0-5121,KIRC,56.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-20635.0,Alive,TUMOR FREE,1485.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1485.0,0.0,1485.0,0.0,1485.0,0.0,1485.0,0
TCGA-B0-5121-11,TCGA-B0-5121,KIRC,56.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-20635.0,Alive,TUMOR FREE,1485.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1485.0,0.0,1485.0,0.0,1485.0,0.0,1485.0,0
TCGA-B0-5399-01,TCGA-B0-5399,KIRC,46.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-17145.0,Alive,TUMOR FREE,1411.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1411.0,0.0,1411.0,0.0,1411.0,0.0,1411.0,0
TCGA-B0-5400-01,TCGA-B0-5400,KIRC,59.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2008.0,nan,-21819.0,Alive,TUMOR FREE,1733.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1733.0,0.0,1733.0,0.0,1733.0,0.0,1733.0,0
TCGA-B0-5400-11,TCGA-B0-5400,KIRC,59.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2008.0,nan,-21819.0,Alive,TUMOR FREE,1733.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1733.0,0.0,1733.0,0.0,1733.0,0.0,1733.0,0
TCGA-B0-5402-01,TCGA-B0-5402,KIRC,64.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2010.0,nan,-23477.0,Alive,WITH TUMOR,1290.0,nan,nan,nan,nan,nan,444.0,Progressive Disease,nan,nan,0.0,1290.0,0.0,1290.0,nan,nan,1.0,444.0,2
TCGA-B0-5402-11,TCGA-B0-5402,KIRC,64.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2010.0,nan,-23477.0,Alive,WITH TUMOR,1290.0,nan,nan,nan,nan,nan,444.0,Progressive Disease,nan,nan,0.0,1290.0,0.0,1290.0,nan,nan,1.0,444.0,2
TCGA-B0-5690-01,TCGA-B0-5690,KIRC,53.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G1,2004.0,nan,-19685.0,Alive,WITH TUMOR,3392.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,3392.0,0.0,3392.0,nan,nan,0.0,3392.0,2
TCGA-B0-5690-11,TCGA-B0-5690,KIRC,53.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G1,2004.0,nan,-19685.0,Alive,WITH TUMOR,3392.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,3392.0,0.0,3392.0,nan,nan,0.0,3392.0,2
TCGA-B0-5691-01,TCGA-B0-5691,KIRC,66.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2002.0,nan,-24120.0,Alive,WITH TUMOR,3431.0,nan,nan,nan,nan,nan,3250.0,nan,nan,nan,0.0,3431.0,0.0,3431.0,nan,nan,1.0,3250.0,2
TCGA-B0-5691-11,TCGA-B0-5691,KIRC,66.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2002.0,nan,-24120.0,Alive,WITH TUMOR,3431.0,nan,nan,nan,nan,nan,3250.0,nan,nan,nan,0.0,3431.0,0.0,3431.0,nan,nan,1.0,3250.0,2
TCGA-B0-5692-01,TCGA-B0-5692,KIRC,66.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-24140.0,Alive,TUMOR FREE,3944.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3944.0,0.0,3944.0,0.0,3944.0,0.0,3944.0,0
TCGA-B0-5693-01,TCGA-B0-5693,KIRC,47.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-17177.0,Alive,TUMOR FREE,4074.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4074.0,0.0,4074.0,0.0,4074.0,0.0,4074.0,0
TCGA-B0-5694-01,TCGA-B0-5694,KIRC,71.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2008.0,nan,-26060.0,Dead,WITH TUMOR,nan,480.0,nan,nan,nan,nan,288.0,nan,nan,nan,1.0,480.0,1.0,480.0,nan,nan,1.0,288.0,1
TCGA-B0-5694-11,TCGA-B0-5694,KIRC,71.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2008.0,nan,-26060.0,Dead,WITH TUMOR,nan,480.0,nan,nan,nan,nan,288.0,nan,nan,nan,1.0,480.0,1.0,480.0,nan,nan,1.0,288.0,1
TCGA-B0-5695-01,TCGA-B0-5695,KIRC,61.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-22320.0,Alive,TUMOR FREE,2150.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2150.0,0.0,2150.0,0.0,2150.0,0.0,2150.0,0
TCGA-B0-5696-01,TCGA-B0-5696,KIRC,69.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-25552.0,Alive,WITH TUMOR,2609.0,nan,nan,nan,nan,nan,1717.0,Complete Remission/Response,nan,nan,0.0,2609.0,0.0,2609.0,1.0,1717.0,1.0,1717.0,2
TCGA-B0-5696-11,TCGA-B0-5696,KIRC,69.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-25552.0,Alive,WITH TUMOR,2609.0,nan,nan,nan,nan,nan,1717.0,Complete Remission/Response,nan,nan,0.0,2609.0,0.0,2609.0,1.0,1717.0,1.0,1717.0,2
TCGA-B0-5697-01,TCGA-B0-5697,KIRC,50.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-18486.0,Alive,TUMOR FREE,2630.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2630.0,0.0,2630.0,0.0,2630.0,0.0,2630.0,0
TCGA-B0-5697-11,TCGA-B0-5697,KIRC,50.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-18486.0,Alive,TUMOR FREE,2630.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2630.0,0.0,2630.0,0.0,2630.0,0.0,2630.0,0
TCGA-B0-5698-01,TCGA-B0-5698,KIRC,77.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-28438.0,Alive,TUMOR FREE,3631.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3631.0,0.0,3631.0,0.0,3631.0,0.0,3631.0,0
TCGA-B0-5699-01,TCGA-B0-5699,KIRC,53.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-19647.0,Alive,TUMOR FREE,3841.0,nan,nan,nan,nan,nan,94.0,Complete Remission/Response,nan,nan,0.0,3841.0,0.0,3841.0,1.0,94.0,1.0,94.0,2
TCGA-B0-5699-11,TCGA-B0-5699,KIRC,53.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-19647.0,Alive,TUMOR FREE,3841.0,nan,nan,nan,nan,nan,94.0,Complete Remission/Response,nan,nan,0.0,3841.0,0.0,3841.0,1.0,94.0,1.0,94.0,2
TCGA-B0-5700-01,TCGA-B0-5700,KIRC,77.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2009.0,nan,-28184.0,Alive,TUMOR FREE,1790.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1790.0,0.0,1790.0,0.0,1790.0,0.0,1790.0,0
TCGA-B0-5701-01,TCGA-B0-5701,KIRC,65.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-23915.0,Alive,TUMOR FREE,2461.0,nan,nan,nan,nan,nan,224.0,Complete Remission/Response,nan,nan,0.0,2461.0,0.0,2461.0,1.0,224.0,1.0,224.0,2
TCGA-B0-5701-11,TCGA-B0-5701,KIRC,65.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-23915.0,Alive,TUMOR FREE,2461.0,nan,nan,nan,nan,nan,224.0,Complete Remission/Response,nan,nan,0.0,2461.0,0.0,2461.0,1.0,224.0,1.0,224.0,2
TCGA-B0-5702-01,TCGA-B0-5702,KIRC,71.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-26186.0,Alive,TUMOR FREE,2172.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2172.0,0.0,2172.0,0.0,2172.0,0.0,2172.0,0
TCGA-B0-5703-01,TCGA-B0-5703,KIRC,73.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2009.0,nan,-26897.0,Alive,TUMOR FREE,2246.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2246.0,0.0,2246.0,0.0,2246.0,0.0,2246.0,0
TCGA-B0-5703-11,TCGA-B0-5703,KIRC,73.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2009.0,nan,-26897.0,Alive,TUMOR FREE,2246.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2246.0,0.0,2246.0,0.0,2246.0,0.0,2246.0,0
TCGA-B0-5705-01,TCGA-B0-5705,KIRC,65.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-23746.0,Alive,TUMOR FREE,4537.0,nan,nan,nan,nan,nan,842.0,Complete Remission/Response,nan,nan,0.0,4537.0,0.0,4537.0,1.0,842.0,1.0,842.0,2
TCGA-B0-5705-11,TCGA-B0-5705,KIRC,65.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-23746.0,Alive,TUMOR FREE,4537.0,nan,nan,nan,nan,nan,842.0,Complete Remission/Response,nan,nan,0.0,4537.0,0.0,4537.0,1.0,842.0,1.0,842.0,2
TCGA-B0-5706-01,TCGA-B0-5706,KIRC,45.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-16442.0,Alive,TUMOR FREE,3205.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3205.0,0.0,3205.0,0.0,3205.0,0.0,3205.0,0
TCGA-B0-5706-11,TCGA-B0-5706,KIRC,45.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-16442.0,Alive,TUMOR FREE,3205.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3205.0,0.0,3205.0,0.0,3205.0,0.0,3205.0,0
TCGA-B0-5707-01,TCGA-B0-5707,KIRC,39.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-14598.0,Alive,TUMOR FREE,3744.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3744.0,0.0,3744.0,0.0,3744.0,0.0,3744.0,0
TCGA-B0-5709-01,TCGA-B0-5709,KIRC,62.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-22843.0,Alive,TUMOR FREE,3974.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3974.0,0.0,3974.0,0.0,3974.0,0.0,3974.0,0
TCGA-B0-5709-11,TCGA-B0-5709,KIRC,62.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-22843.0,Alive,TUMOR FREE,3974.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3974.0,0.0,3974.0,0.0,3974.0,0.0,3974.0,0
TCGA-B0-5710-01,TCGA-B0-5710,KIRC,57.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2008.0,nan,-21168.0,Alive,WITH TUMOR,2430.0,nan,nan,nan,nan,nan,1441.0,Progressive Disease,nan,nan,0.0,2430.0,0.0,2430.0,nan,nan,1.0,1441.0,2
TCGA-B0-5710-11,TCGA-B0-5710,KIRC,57.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2008.0,nan,-21168.0,Alive,WITH TUMOR,2430.0,nan,nan,nan,nan,nan,1441.0,Progressive Disease,nan,nan,0.0,2430.0,0.0,2430.0,nan,nan,1.0,1441.0,2
TCGA-B0-5711-01,TCGA-B0-5711,KIRC,50.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-18444.0,Alive,WITH TUMOR,3989.0,nan,nan,nan,nan,nan,3766.0,Complete Remission/Response,nan,nan,0.0,3989.0,0.0,3989.0,1.0,3766.0,1.0,3766.0,2
TCGA-B0-5711-11,TCGA-B0-5711,KIRC,50.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-18444.0,Alive,WITH TUMOR,3989.0,nan,nan,nan,nan,nan,3766.0,Complete Remission/Response,nan,nan,0.0,3989.0,0.0,3989.0,1.0,3766.0,1.0,3766.0,2
TCGA-B0-5712-01,TCGA-B0-5712,KIRC,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-24988.0,Alive,WITH TUMOR,2722.0,nan,nan,nan,nan,nan,725.0,nan,nan,nan,0.0,2722.0,0.0,2722.0,nan,nan,1.0,725.0,2
TCGA-B0-5712-11,TCGA-B0-5712,KIRC,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-24988.0,Alive,WITH TUMOR,2722.0,nan,nan,nan,nan,nan,725.0,nan,nan,nan,0.0,2722.0,0.0,2722.0,nan,nan,1.0,725.0,2
TCGA-B0-5713-01,TCGA-B0-5713,KIRC,75.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-27644.0,Alive,TUMOR FREE,2782.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2782.0,0.0,2782.0,0.0,2782.0,0.0,2782.0,0
TCGA-B0-5713-11,TCGA-B0-5713,KIRC,75.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-27644.0,Alive,TUMOR FREE,2782.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2782.0,0.0,2782.0,0.0,2782.0,0.0,2782.0,0
TCGA-B0-5812-01,TCGA-B0-5812,KIRC,53.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-19600.0,Alive,TUMOR FREE,3834.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3834.0,0.0,3834.0,0.0,3834.0,0.0,3834.0,0
TCGA-B2-3923-11,TCGA-B2-3923,KIRC,59.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-21793.0,Alive,TUMOR FREE,992.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,992.0,0.0,992.0,0.0,992.0,0.0,992.0,0
TCGA-B2-3923-01,TCGA-B2-3923,KIRC,59.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-21793.0,Alive,TUMOR FREE,992.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,992.0,0.0,992.0,0.0,992.0,0.0,992.0,0
TCGA-B2-3924-11,TCGA-B2-3924,KIRC,73.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-26846.0,Alive,TUMOR FREE,1092.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1092.0,0.0,1092.0,0.0,1092.0,0.0,1092.0,0
TCGA-B2-3924-01,TCGA-B2-3924,KIRC,73.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-26846.0,Alive,TUMOR FREE,1092.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1092.0,0.0,1092.0,0.0,1092.0,0.0,1092.0,0
TCGA-B2-4098-01,TCGA-B2-4098,KIRC,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-26606.0,Dead,TUMOR FREE,nan,51.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,51.0,0.0,51.0,nan,nan,0.0,51.0,1
TCGA-B2-4098-11,TCGA-B2-4098,KIRC,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-26606.0,Dead,TUMOR FREE,nan,51.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,51.0,0.0,51.0,nan,nan,0.0,51.0,1
TCGA-B2-4099-01,TCGA-B2-4099,KIRC,83.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-30355.0,Alive,TUMOR FREE,972.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,972.0,0.0,972.0,0.0,972.0,0.0,972.0,0
TCGA-B2-4099-11,TCGA-B2-4099,KIRC,83.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-30355.0,Alive,TUMOR FREE,972.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,972.0,0.0,972.0,0.0,972.0,0.0,972.0,0
TCGA-B2-4101-01,TCGA-B2-4101,KIRC,52.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-19059.0,Alive,TUMOR FREE,648.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,648.0,0.0,648.0,0.0,648.0,0.0,648.0,0
TCGA-B2-4102-01,TCGA-B2-4102,KIRC,61.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-22492.0,Alive,TUMOR FREE,952.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,952.0,0.0,952.0,0.0,952.0,0.0,952.0,0
TCGA-B2-4102-11,TCGA-B2-4102,KIRC,61.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-22492.0,Alive,TUMOR FREE,952.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,952.0,0.0,952.0,0.0,952.0,0.0,952.0,0
TCGA-B2-5633-01,TCGA-B2-5633,KIRC,56.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-20493.0,Alive,TUMOR FREE,963.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,963.0,0.0,963.0,0.0,963.0,0.0,963.0,0
TCGA-B2-5635-01,TCGA-B2-5635,KIRC,74.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-27183.0,Alive,TUMOR FREE,755.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,755.0,0.0,755.0,0.0,755.0,0.0,755.0,0
TCGA-B2-5636-01,TCGA-B2-5636,KIRC,79.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-28901.0,Alive,TUMOR FREE,919.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,919.0,0.0,919.0,0.0,919.0,0.0,919.0,0
TCGA-B2-5636-11,TCGA-B2-5636,KIRC,79.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-28901.0,Alive,TUMOR FREE,919.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,919.0,0.0,919.0,0.0,919.0,0.0,919.0,0
TCGA-B2-5639-01,TCGA-B2-5639,KIRC,46.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-17045.0,Dead,WITH TUMOR,nan,1003.0,nan,nan,nan,nan,163.0,Progressive Disease,nan,nan,1.0,1003.0,1.0,1003.0,nan,nan,1.0,163.0,1
TCGA-B2-5641-01,TCGA-B2-5641,KIRC,79.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-28953.0,Alive,TUMOR FREE,656.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,656.0,0.0,656.0,0.0,656.0,0.0,656.0,0
TCGA-B2-5641-11,TCGA-B2-5641,KIRC,79.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-28953.0,Alive,TUMOR FREE,656.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,656.0,0.0,656.0,0.0,656.0,0.0,656.0,0
TCGA-B2-A4SR-01,TCGA-B2-A4SR,KIRC,61.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Kidney Clear Cell Renal Carcinoma,nan,2012.0,nan,-22637.0,Alive,TUMOR FREE,507.0,nan,nan,nan,nan,nan,266.0,Complete Remission/Response,nan,nan,0.0,507.0,0.0,507.0,1.0,266.0,1.0,266.0,0
TCGA-B4-5377-01,TCGA-B4-5377,KIRC,68.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-25115.0,Alive,TUMOR FREE,365.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,365.0,0.0,365.0,nan,nan,0.0,365.0,0
TCGA-B4-5378-01,TCGA-B4-5378,KIRC,62.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-22980.0,Alive,TUMOR FREE,175.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,175.0,0.0,175.0,nan,nan,0.0,175.0,0
TCGA-B4-5832-01,TCGA-B4-5832,KIRC,65.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-23806.0,Alive,TUMOR FREE,155.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,155.0,0.0,155.0,0.0,155.0,0.0,155.0,0
TCGA-B4-5834-01,TCGA-B4-5834,KIRC,59.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G1,2010.0,nan,-21713.0,Alive,TUMOR FREE,38.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,38.0,0.0,38.0,nan,nan,0.0,38.0,0
TCGA-B4-5835-01,TCGA-B4-5835,KIRC,64.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-23408.0,Alive,TUMOR FREE,16.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,16.0,0.0,16.0,nan,nan,0.0,16.0,0
TCGA-B4-5836-01,TCGA-B4-5836,KIRC,61.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-22341.0,Alive,TUMOR FREE,141.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,141.0,0.0,141.0,nan,nan,0.0,141.0,0
TCGA-B4-5838-01,TCGA-B4-5838,KIRC,52.0,MALE,WHITE,[Discrepancy],nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-19242.0,Alive,WITH TUMOR,166.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,166.0,0.0,166.0,nan,nan,0.0,166.0,0
TCGA-B4-5843-01,TCGA-B4-5843,KIRC,45.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-16779.0,Alive,TUMOR FREE,11.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,11.0,0.0,11.0,nan,nan,0.0,11.0,0
TCGA-B4-5844-01,TCGA-B4-5844,KIRC,61.0,FEMALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G1,2010.0,nan,-22409.0,Alive,TUMOR FREE,7.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,7.0,0.0,7.0,nan,nan,0.0,7.0,0
TCGA-B8-4143-01,TCGA-B8-4143,KIRC,66.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2002.0,nan,-24132.0,Dead,WITH TUMOR,nan,709.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,709.0,1.0,709.0,nan,nan,1.0,709.0,1
TCGA-B8-4143-11,TCGA-B8-4143,KIRC,66.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2002.0,nan,-24132.0,Dead,WITH TUMOR,nan,709.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,709.0,1.0,709.0,nan,nan,1.0,709.0,1
TCGA-B8-4146-01,TCGA-B8-4146,KIRC,41.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2009.0,nan,-15063.0,Alive,TUMOR FREE,511.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,511.0,0.0,511.0,0.0,511.0,0.0,511.0,2
TCGA-B8-4148-01,TCGA-B8-4148,KIRC,63.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2009.0,nan,-23062.0,Alive,TUMOR FREE,1520.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1520.0,0.0,1520.0,0.0,1520.0,0.0,1520.0,0
TCGA-B8-4151-01,TCGA-B8-4151,KIRC,51.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2009.0,nan,-18760.0,Alive,TUMOR FREE,1299.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1299.0,0.0,1299.0,0.0,1299.0,0.0,1299.0,2
TCGA-B8-4153-01,TCGA-B8-4153,KIRC,74.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-27031.0,Alive,WITH TUMOR,762.0,nan,nan,nan,nan,nan,223.0,nan,nan,nan,0.0,762.0,0.0,762.0,nan,nan,1.0,223.0,0
TCGA-B8-4154-01,TCGA-B8-4154,KIRC,73.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-26882.0,Alive,TUMOR FREE,1380.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1380.0,0.0,1380.0,0.0,1380.0,0.0,1380.0,0
TCGA-B8-4154-11,TCGA-B8-4154,KIRC,73.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-26882.0,Alive,TUMOR FREE,1380.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1380.0,0.0,1380.0,0.0,1380.0,0.0,1380.0,0
TCGA-B8-4619-01,TCGA-B8-4619,KIRC,58.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-21206.0,Alive,TUMOR FREE,523.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,523.0,0.0,523.0,0.0,523.0,0.0,523.0,0
TCGA-B8-4619-11,TCGA-B8-4619,KIRC,58.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-21206.0,Alive,TUMOR FREE,523.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,523.0,0.0,523.0,0.0,523.0,0.0,523.0,0
TCGA-B8-4620-01,TCGA-B8-4620,KIRC,70.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-25786.0,Alive,WITH TUMOR,777.0,nan,nan,nan,nan,nan,604.0,Complete Remission/Response,nan,nan,0.0,777.0,0.0,777.0,1.0,604.0,1.0,604.0,2
TCGA-B8-4620-11,TCGA-B8-4620,KIRC,70.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-25786.0,Alive,WITH TUMOR,777.0,nan,nan,nan,nan,nan,604.0,Complete Remission/Response,nan,nan,0.0,777.0,0.0,777.0,1.0,604.0,1.0,604.0,2
TCGA-B8-4621-01,TCGA-B8-4621,KIRC,63.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-23176.0,Alive,TUMOR FREE,788.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,788.0,0.0,788.0,0.0,788.0,0.0,788.0,0
TCGA-B8-4622-01,TCGA-B8-4622,KIRC,57.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-21135.0,Alive,WITH TUMOR,1525.0,nan,nan,nan,nan,nan,1227.0,Complete Remission/Response,nan,nan,0.0,1525.0,0.0,1525.0,nan,nan,1.0,1227.0,2
TCGA-B8-4622-11,TCGA-B8-4622,KIRC,57.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-21135.0,Alive,WITH TUMOR,1525.0,nan,nan,nan,nan,nan,1227.0,Complete Remission/Response,nan,nan,0.0,1525.0,0.0,1525.0,nan,nan,1.0,1227.0,2
TCGA-B8-5158-01,TCGA-B8-5158,KIRC,56.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2010.0,nan,-20764.0,Alive,TUMOR FREE,1218.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1218.0,0.0,1218.0,0.0,1218.0,0.0,1218.0,0
TCGA-B8-5159-01,TCGA-B8-5159,KIRC,61.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-22462.0,Alive,TUMOR FREE,722.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,722.0,0.0,722.0,0.0,722.0,0.0,722.0,0
TCGA-B8-5162-01,TCGA-B8-5162,KIRC,62.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-23008.0,Alive,TUMOR FREE,36.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,36.0,0.0,36.0,nan,nan,0.0,36.0,0
TCGA-B8-5163-01,TCGA-B8-5163,KIRC,63.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-23293.0,Alive,TUMOR FREE,822.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,822.0,0.0,822.0,0.0,822.0,0.0,822.0,0
TCGA-B8-5164-01,TCGA-B8-5164,KIRC,65.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-23863.0,Alive,TUMOR FREE,26.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,26.0,0.0,26.0,nan,nan,0.0,26.0,0
TCGA-B8-5165-01,TCGA-B8-5165,KIRC,43.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-15898.0,Alive,TUMOR FREE,737.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,737.0,0.0,737.0,0.0,737.0,0.0,737.0,0
TCGA-B8-5545-01,TCGA-B8-5545,KIRC,42.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-15376.0,Alive,TUMOR FREE,1525.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1525.0,0.0,1525.0,0.0,1525.0,0.0,1525.0,0
TCGA-B8-5546-01,TCGA-B8-5546,KIRC,38.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-14113.0,Alive,TUMOR FREE,505.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,505.0,0.0,505.0,nan,nan,0.0,505.0,0
TCGA-B8-5549-01,TCGA-B8-5549,KIRC,53.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-19561.0,Alive,TUMOR FREE,194.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,194.0,0.0,194.0,0.0,194.0,0.0,194.0,0
TCGA-B8-5549-11,TCGA-B8-5549,KIRC,53.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-19561.0,Alive,TUMOR FREE,194.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,194.0,0.0,194.0,0.0,194.0,0.0,194.0,0
TCGA-B8-5550-01,TCGA-B8-5550,KIRC,71.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-25937.0,Alive,WITH TUMOR,1476.0,nan,nan,nan,nan,nan,694.0,Complete Remission/Response,nan,nan,0.0,1476.0,0.0,1476.0,1.0,694.0,1.0,694.0,2
TCGA-B8-5551-01,TCGA-B8-5551,KIRC,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-23976.0,Alive,TUMOR FREE,16.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,16.0,0.0,16.0,nan,nan,0.0,16.0,0
TCGA-B8-5552-01,TCGA-B8-5552,KIRC,41.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-15219.0,Alive,TUMOR FREE,1046.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1046.0,0.0,1046.0,0.0,1046.0,0.0,1046.0,0
TCGA-B8-5552-11,TCGA-B8-5552,KIRC,41.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-15219.0,Alive,TUMOR FREE,1046.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1046.0,0.0,1046.0,0.0,1046.0,0.0,1046.0,0
TCGA-B8-5553-01,TCGA-B8-5553,KIRC,67.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-24729.0,Alive,TUMOR FREE,435.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,435.0,0.0,435.0,nan,nan,0.0,435.0,0
TCGA-B8-A54D-01,TCGA-B8-A54D,KIRC,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2011.0,nan,-25429.0,Alive,TUMOR FREE,830.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,830.0,0.0,830.0,0.0,830.0,0.0,830.0,0
TCGA-B8-A54E-01,TCGA-B8-A54E,KIRC,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2011.0,nan,-22900.0,Alive,TUMOR FREE,909.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,909.0,0.0,909.0,0.0,909.0,0.0,909.0,0
TCGA-B8-A54F-01,TCGA-B8-A54F,KIRC,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2012.0,nan,-18028.0,Alive,TUMOR FREE,519.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,519.0,0.0,519.0,0.0,519.0,0.0,519.0,0
TCGA-B8-A54G-01,TCGA-B8-A54G,KIRC,50.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2012.0,nan,-18612.0,Alive,TUMOR FREE,53.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,53.0,0.0,53.0,0.0,53.0,0.0,53.0,0
TCGA-B8-A54H-01,TCGA-B8-A54H,KIRC,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2012.0,nan,-25243.0,Alive,TUMOR FREE,256.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,256.0,0.0,256.0,0.0,256.0,0.0,256.0,0
TCGA-B8-A54I-01,TCGA-B8-A54I,KIRC,48.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2012.0,nan,-17722.0,Alive,TUMOR FREE,150.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,150.0,0.0,150.0,0.0,150.0,0.0,150.0,0
TCGA-B8-A54J-01,TCGA-B8-A54J,KIRC,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2012.0,nan,-22071.0,Alive,TUMOR FREE,528.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,528.0,0.0,528.0,0.0,528.0,0.0,528.0,0
TCGA-B8-A54K-01,TCGA-B8-A54K,KIRC,61.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G1,2012.0,nan,-22627.0,Alive,TUMOR FREE,469.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,469.0,0.0,469.0,0.0,469.0,0.0,469.0,0
TCGA-B8-A7U6-01,TCGA-B8-A7U6,KIRC,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2013.0,nan,-19803.0,Alive,TUMOR FREE,495.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,495.0,0.0,495.0,0.0,495.0,0.0,495.0,0
TCGA-B8-A8YJ-01,TCGA-B8-A8YJ,KIRC,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2013.0,nan,-21994.0,Alive,TUMOR FREE,431.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,431.0,0.0,431.0,0.0,431.0,0.0,431.0,0
TCGA-BP-4158-01,TCGA-BP-4158,KIRC,69.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2001.0,nan,-25210.0,Alive,TUMOR FREE,3377.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3377.0,0.0,3377.0,nan,nan,0.0,3377.0,0
TCGA-BP-4158-11,TCGA-BP-4158,KIRC,69.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2001.0,nan,-25210.0,Alive,TUMOR FREE,3377.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3377.0,0.0,3377.0,nan,nan,0.0,3377.0,0
TCGA-BP-4159-01,TCGA-BP-4159,KIRC,70.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-25677.0,Dead,WITH TUMOR,nan,2601.0,nan,nan,nan,nan,2352.0,nan,nan,nan,1.0,2601.0,1.0,2601.0,nan,nan,1.0,2352.0,1
TCGA-BP-4159-11,TCGA-BP-4159,KIRC,70.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-25677.0,Dead,WITH TUMOR,nan,2601.0,nan,nan,nan,nan,2352.0,nan,nan,nan,1.0,2601.0,1.0,2601.0,nan,nan,1.0,2352.0,1
TCGA-BP-4160-01,TCGA-BP-4160,KIRC,67.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-24720.0,Alive,TUMOR FREE,2881.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2881.0,0.0,2881.0,nan,nan,0.0,2881.0,0
TCGA-BP-4160-11,TCGA-BP-4160,KIRC,67.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-24720.0,Alive,TUMOR FREE,2881.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2881.0,0.0,2881.0,nan,nan,0.0,2881.0,0
TCGA-BP-4161-01,TCGA-BP-4161,KIRC,74.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2002.0,nan,-27119.0,Alive,WITH TUMOR,2746.0,nan,nan,nan,nan,nan,2685.0,nan,nan,nan,0.0,2746.0,0.0,2746.0,nan,nan,1.0,2685.0,0
TCGA-BP-4161-11,TCGA-BP-4161,KIRC,74.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2002.0,nan,-27119.0,Alive,WITH TUMOR,2746.0,nan,nan,nan,nan,nan,2685.0,nan,nan,nan,0.0,2746.0,0.0,2746.0,nan,nan,1.0,2685.0,0
TCGA-BP-4162-01,TCGA-BP-4162,KIRC,65.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-23966.0,Alive,TUMOR FREE,3074.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3074.0,0.0,3074.0,nan,nan,0.0,3074.0,0
TCGA-BP-4162-11,TCGA-BP-4162,KIRC,65.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-23966.0,Alive,TUMOR FREE,3074.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3074.0,0.0,3074.0,nan,nan,0.0,3074.0,0
TCGA-BP-4163-01,TCGA-BP-4163,KIRC,60.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2002.0,nan,-21980.0,Alive,TUMOR FREE,2839.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2839.0,0.0,2839.0,nan,nan,0.0,2839.0,0
TCGA-BP-4163-11,TCGA-BP-4163,KIRC,60.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2002.0,nan,-21980.0,Alive,TUMOR FREE,2839.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2839.0,0.0,2839.0,nan,nan,0.0,2839.0,0
TCGA-BP-4164-01,TCGA-BP-4164,KIRC,51.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-18898.0,Dead,TUMOR FREE,nan,992.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,992.0,0.0,992.0,nan,nan,0.0,992.0,1
TCGA-BP-4164-11,TCGA-BP-4164,KIRC,51.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-18898.0,Dead,TUMOR FREE,nan,992.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,992.0,0.0,992.0,nan,nan,0.0,992.0,1
TCGA-BP-4165-01,TCGA-BP-4165,KIRC,64.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G1,2002.0,nan,-23685.0,Alive,WITH TUMOR,3037.0,nan,nan,nan,nan,nan,1049.0,nan,nan,nan,0.0,3037.0,0.0,3037.0,nan,nan,1.0,1049.0,2
TCGA-BP-4165-11,TCGA-BP-4165,KIRC,64.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G1,2002.0,nan,-23685.0,Alive,WITH TUMOR,3037.0,nan,nan,nan,nan,nan,1049.0,nan,nan,nan,0.0,3037.0,0.0,3037.0,nan,nan,1.0,1049.0,2
TCGA-BP-4166-01,TCGA-BP-4166,KIRC,69.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-25300.0,Alive,TUMOR FREE,13.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,13.0,0.0,13.0,nan,nan,0.0,13.0,0
TCGA-BP-4166-11,TCGA-BP-4166,KIRC,69.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-25300.0,Alive,TUMOR FREE,13.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,13.0,0.0,13.0,nan,nan,0.0,13.0,0
TCGA-BP-4167-01,TCGA-BP-4167,KIRC,59.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-21901.0,Alive,TUMOR FREE,2718.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2718.0,0.0,2718.0,nan,nan,0.0,2718.0,0
TCGA-BP-4167-11,TCGA-BP-4167,KIRC,59.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-21901.0,Alive,TUMOR FREE,2718.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2718.0,0.0,2718.0,nan,nan,0.0,2718.0,0
TCGA-BP-4169-01,TCGA-BP-4169,KIRC,76.0,FEMALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-27778.0,Dead,WITH TUMOR,nan,701.0,nan,nan,nan,nan,78.0,nan,nan,nan,1.0,701.0,1.0,701.0,nan,nan,1.0,78.0,1
TCGA-BP-4169-11,TCGA-BP-4169,KIRC,76.0,FEMALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-27778.0,Dead,WITH TUMOR,nan,701.0,nan,nan,nan,nan,78.0,nan,nan,nan,1.0,701.0,1.0,701.0,nan,nan,1.0,78.0,1
TCGA-BP-4170-01,TCGA-BP-4170,KIRC,72.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-26596.0,Dead,TUMOR FREE,nan,2343.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2343.0,0.0,2343.0,nan,nan,0.0,2343.0,1
TCGA-BP-4170-11,TCGA-BP-4170,KIRC,72.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-26596.0,Dead,TUMOR FREE,nan,2343.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2343.0,0.0,2343.0,nan,nan,0.0,2343.0,1
TCGA-BP-4173-01,TCGA-BP-4173,KIRC,47.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-17449.0,Alive,TUMOR FREE,1893.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1893.0,0.0,1893.0,nan,nan,0.0,1893.0,0
TCGA-BP-4173-11,TCGA-BP-4173,KIRC,47.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-17449.0,Alive,TUMOR FREE,1893.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1893.0,0.0,1893.0,nan,nan,0.0,1893.0,0
TCGA-BP-4174-01,TCGA-BP-4174,KIRC,49.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-18054.0,Alive,TUMOR FREE,1879.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1879.0,0.0,1879.0,nan,nan,0.0,1879.0,0
TCGA-BP-4174-11,TCGA-BP-4174,KIRC,49.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-18054.0,Alive,TUMOR FREE,1879.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1879.0,0.0,1879.0,nan,nan,0.0,1879.0,0
TCGA-BP-4176-01,TCGA-BP-4176,KIRC,64.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-23609.0,Alive,TUMOR FREE,1955.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1955.0,0.0,1955.0,nan,nan,0.0,1955.0,0
TCGA-BP-4176-11,TCGA-BP-4176,KIRC,64.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-23609.0,Alive,TUMOR FREE,1955.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1955.0,0.0,1955.0,nan,nan,0.0,1955.0,0
TCGA-BP-4177-01,TCGA-BP-4177,KIRC,65.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-23955.0,Alive,TUMOR FREE,1670.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1670.0,0.0,1670.0,nan,nan,0.0,1670.0,0
TCGA-BP-4177-11,TCGA-BP-4177,KIRC,65.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-23955.0,Alive,TUMOR FREE,1670.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1670.0,0.0,1670.0,nan,nan,0.0,1670.0,0
TCGA-BP-4325-01,TCGA-BP-4325,KIRC,64.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2001.0,nan,-23588.0,Alive,TUMOR FREE,2964.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2964.0,0.0,2964.0,nan,nan,0.0,2964.0,0
TCGA-BP-4325-11,TCGA-BP-4325,KIRC,64.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2001.0,nan,-23588.0,Alive,TUMOR FREE,2964.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2964.0,0.0,2964.0,nan,nan,0.0,2964.0,0
TCGA-BP-4326-01,TCGA-BP-4326,KIRC,53.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-19376.0,Dead,WITH TUMOR,nan,1625.0,nan,nan,nan,nan,958.0,nan,nan,nan,1.0,1625.0,1.0,1625.0,nan,nan,1.0,958.0,1
TCGA-BP-4326-11,TCGA-BP-4326,KIRC,53.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-19376.0,Dead,WITH TUMOR,nan,1625.0,nan,nan,nan,nan,958.0,nan,nan,nan,1.0,1625.0,1.0,1625.0,nan,nan,1.0,958.0,1
TCGA-BP-4327-01,TCGA-BP-4327,KIRC,75.0,FEMALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-27556.0,Dead,TUMOR FREE,nan,109.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,109.0,0.0,109.0,nan,nan,0.0,109.0,1
TCGA-BP-4327-11,TCGA-BP-4327,KIRC,75.0,FEMALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-27556.0,Dead,TUMOR FREE,nan,109.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,109.0,0.0,109.0,nan,nan,0.0,109.0,1
TCGA-BP-4329-01,TCGA-BP-4329,KIRC,75.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-27699.0,Dead,WITH TUMOR,nan,845.0,nan,nan,nan,nan,134.0,nan,nan,nan,1.0,845.0,1.0,845.0,nan,nan,1.0,134.0,1
TCGA-BP-4329-11,TCGA-BP-4329,KIRC,75.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-27699.0,Dead,WITH TUMOR,nan,845.0,nan,nan,nan,nan,134.0,nan,nan,nan,1.0,845.0,1.0,845.0,nan,nan,1.0,134.0,1
TCGA-BP-4330-01,TCGA-BP-4330,KIRC,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-22239.0,Alive,TUMOR FREE,1888.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1888.0,0.0,1888.0,nan,nan,0.0,1888.0,0
TCGA-BP-4330-11,TCGA-BP-4330,KIRC,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-22239.0,Alive,TUMOR FREE,1888.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1888.0,0.0,1888.0,nan,nan,0.0,1888.0,0
TCGA-BP-4331-01,TCGA-BP-4331,KIRC,52.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-19022.0,Dead,TUMOR FREE,nan,2454.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2454.0,0.0,2454.0,nan,nan,0.0,2454.0,0
TCGA-BP-4331-11,TCGA-BP-4331,KIRC,52.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-19022.0,Dead,TUMOR FREE,nan,2454.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2454.0,0.0,2454.0,nan,nan,0.0,2454.0,0
TCGA-BP-4332-01,TCGA-BP-4332,KIRC,36.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-13404.0,Alive,TUMOR FREE,1133.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1133.0,0.0,1133.0,nan,nan,0.0,1133.0,0
TCGA-BP-4332-11,TCGA-BP-4332,KIRC,36.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-13404.0,Alive,TUMOR FREE,1133.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1133.0,0.0,1133.0,nan,nan,0.0,1133.0,0
TCGA-BP-4334-01,TCGA-BP-4334,KIRC,56.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-20609.0,Dead,WITH TUMOR,nan,645.0,nan,nan,nan,nan,442.0,nan,nan,nan,1.0,645.0,1.0,645.0,nan,nan,1.0,442.0,1
TCGA-BP-4334-11,TCGA-BP-4334,KIRC,56.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-20609.0,Dead,WITH TUMOR,nan,645.0,nan,nan,nan,nan,442.0,nan,nan,nan,1.0,645.0,1.0,645.0,nan,nan,1.0,442.0,1
TCGA-BP-4335-01,TCGA-BP-4335,KIRC,65.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-23860.0,Dead,WITH TUMOR,nan,475.0,nan,nan,nan,nan,160.0,nan,nan,nan,1.0,475.0,1.0,475.0,nan,nan,1.0,160.0,1
TCGA-BP-4335-11,TCGA-BP-4335,KIRC,65.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-23860.0,Dead,WITH TUMOR,nan,475.0,nan,nan,nan,nan,160.0,nan,nan,nan,1.0,475.0,1.0,475.0,nan,nan,1.0,160.0,1
TCGA-BP-4337-01,TCGA-BP-4337,KIRC,76.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2003.0,nan,-27906.0,Dead,TUMOR FREE,nan,2.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2.0,0.0,2.0,nan,nan,0.0,2.0,1
TCGA-BP-4337-11,TCGA-BP-4337,KIRC,76.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2003.0,nan,-27906.0,Dead,TUMOR FREE,nan,2.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2.0,0.0,2.0,nan,nan,0.0,2.0,1
TCGA-BP-4338-01,TCGA-BP-4338,KIRC,43.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-15891.0,Alive,WITH TUMOR,2859.0,nan,nan,nan,nan,nan,1757.0,nan,nan,nan,0.0,2859.0,0.0,2859.0,nan,nan,1.0,1757.0,0
TCGA-BP-4338-11,TCGA-BP-4338,KIRC,43.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-15891.0,Alive,WITH TUMOR,2859.0,nan,nan,nan,nan,nan,1757.0,nan,nan,nan,0.0,2859.0,0.0,2859.0,nan,nan,1.0,1757.0,0
TCGA-BP-4340-01,TCGA-BP-4340,KIRC,70.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-25752.0,Dead,TUMOR FREE,nan,562.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,562.0,0.0,562.0,nan,nan,0.0,562.0,1
TCGA-BP-4340-11,TCGA-BP-4340,KIRC,70.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-25752.0,Dead,TUMOR FREE,nan,562.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,562.0,0.0,562.0,nan,nan,0.0,562.0,1
TCGA-BP-4341-01,TCGA-BP-4341,KIRC,67.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-24727.0,Dead,WITH TUMOR,nan,1589.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1589.0,1.0,1589.0,nan,nan,1.0,1589.0,1
TCGA-BP-4341-11,TCGA-BP-4341,KIRC,67.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-24727.0,Dead,WITH TUMOR,nan,1589.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1589.0,1.0,1589.0,nan,nan,1.0,1589.0,1
TCGA-BP-4342-01,TCGA-BP-4342,KIRC,79.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-29032.0,Dead,WITH TUMOR,nan,2256.0,nan,nan,nan,nan,240.0,nan,nan,nan,1.0,2256.0,1.0,2256.0,nan,nan,1.0,240.0,1
TCGA-BP-4342-11,TCGA-BP-4342,KIRC,79.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-29032.0,Dead,WITH TUMOR,nan,2256.0,nan,nan,nan,nan,240.0,nan,nan,nan,1.0,2256.0,1.0,2256.0,nan,nan,1.0,240.0,1
TCGA-BP-4343-01,TCGA-BP-4343,KIRC,64.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-23498.0,Dead,WITH TUMOR,nan,1912.0,nan,nan,nan,nan,330.0,nan,nan,nan,1.0,1912.0,1.0,1912.0,nan,nan,1.0,330.0,1
TCGA-BP-4343-11,TCGA-BP-4343,KIRC,64.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-23498.0,Dead,WITH TUMOR,nan,1912.0,nan,nan,nan,nan,330.0,nan,nan,nan,1.0,1912.0,1.0,1912.0,nan,nan,1.0,330.0,1
TCGA-BP-4344-01,TCGA-BP-4344,KIRC,75.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-27561.0,Alive,TUMOR FREE,1666.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1666.0,0.0,1666.0,nan,nan,0.0,1666.0,0
TCGA-BP-4344-11,TCGA-BP-4344,KIRC,75.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-27561.0,Alive,TUMOR FREE,1666.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1666.0,0.0,1666.0,nan,nan,0.0,1666.0,0
TCGA-BP-4345-01,TCGA-BP-4345,KIRC,62.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-22879.0,Alive,TUMOR FREE,1516.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1516.0,0.0,1516.0,nan,nan,0.0,1516.0,0
TCGA-BP-4345-11,TCGA-BP-4345,KIRC,62.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-22879.0,Alive,TUMOR FREE,1516.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1516.0,0.0,1516.0,nan,nan,0.0,1516.0,0
TCGA-BP-4346-01,TCGA-BP-4346,KIRC,57.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-21057.0,Dead,TUMOR FREE,nan,1493.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1493.0,0.0,1493.0,nan,nan,0.0,1493.0,0
TCGA-BP-4346-11,TCGA-BP-4346,KIRC,57.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-21057.0,Dead,TUMOR FREE,nan,1493.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1493.0,0.0,1493.0,nan,nan,0.0,1493.0,0
TCGA-BP-4347-01,TCGA-BP-4347,KIRC,74.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-27146.0,Alive,TUMOR FREE,1367.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1367.0,0.0,1367.0,nan,nan,0.0,1367.0,0
TCGA-BP-4347-11,TCGA-BP-4347,KIRC,74.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-27146.0,Alive,TUMOR FREE,1367.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1367.0,0.0,1367.0,nan,nan,0.0,1367.0,0
TCGA-BP-4349-01,TCGA-BP-4349,KIRC,68.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-24853.0,Alive,nan,372.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,372.0,0.0,372.0,nan,nan,0.0,372.0,0
TCGA-BP-4349-11,TCGA-BP-4349,KIRC,68.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-24853.0,Alive,nan,372.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,372.0,0.0,372.0,nan,nan,0.0,372.0,0
TCGA-BP-4351-01,TCGA-BP-4351,KIRC,51.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-18662.0,Alive,WITH TUMOR,970.0,nan,nan,nan,nan,nan,873.0,nan,nan,nan,0.0,970.0,0.0,970.0,nan,nan,1.0,873.0,2
TCGA-BP-4351-11,TCGA-BP-4351,KIRC,51.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-18662.0,Alive,WITH TUMOR,970.0,nan,nan,nan,nan,nan,873.0,nan,nan,nan,0.0,970.0,0.0,970.0,nan,nan,1.0,873.0,2
TCGA-BP-4352-01,TCGA-BP-4352,KIRC,74.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-27253.0,Dead,WITH TUMOR,nan,344.0,nan,nan,nan,nan,13.0,nan,nan,nan,1.0,344.0,1.0,344.0,nan,nan,1.0,13.0,1
TCGA-BP-4352-11,TCGA-BP-4352,KIRC,74.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-27253.0,Dead,WITH TUMOR,nan,344.0,nan,nan,nan,nan,13.0,nan,nan,nan,1.0,344.0,1.0,344.0,nan,nan,1.0,13.0,1
TCGA-BP-4353-01,TCGA-BP-4353,KIRC,61.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-22415.0,Dead,TUMOR FREE,nan,375.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,375.0,0.0,375.0,nan,nan,0.0,375.0,0
TCGA-BP-4353-11,TCGA-BP-4353,KIRC,61.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-22415.0,Dead,TUMOR FREE,nan,375.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,375.0,0.0,375.0,nan,nan,0.0,375.0,0
TCGA-BP-4354-01,TCGA-BP-4354,KIRC,40.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2006.0,nan,-14973.0,Dead,WITH TUMOR,nan,1034.0,nan,nan,nan,nan,685.0,nan,nan,nan,1.0,1034.0,1.0,1034.0,nan,nan,1.0,685.0,1
TCGA-BP-4354-11,TCGA-BP-4354,KIRC,40.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2006.0,nan,-14973.0,Dead,WITH TUMOR,nan,1034.0,nan,nan,nan,nan,685.0,nan,nan,nan,1.0,1034.0,1.0,1034.0,nan,nan,1.0,685.0,1
TCGA-BP-4355-01,TCGA-BP-4355,KIRC,59.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2008.0,nan,-21642.0,Dead,nan,nan,953.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,953.0,nan,953.0,nan,nan,0.0,953.0,1
TCGA-BP-4355-11,TCGA-BP-4355,KIRC,59.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2008.0,nan,-21642.0,Dead,nan,nan,953.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,953.0,nan,953.0,nan,nan,0.0,953.0,1
TCGA-BP-4756-01,TCGA-BP-4756,KIRC,62.0,FEMALE,ASIAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-23001.0,Alive,TUMOR FREE,374.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,374.0,0.0,374.0,nan,nan,0.0,374.0,0
TCGA-BP-4756-11,TCGA-BP-4756,KIRC,62.0,FEMALE,ASIAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-23001.0,Alive,TUMOR FREE,374.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,374.0,0.0,374.0,nan,nan,0.0,374.0,0
TCGA-BP-4758-01,TCGA-BP-4758,KIRC,40.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-14824.0,Alive,TUMOR FREE,2208.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2208.0,0.0,2208.0,nan,nan,0.0,2208.0,0
TCGA-BP-4758-11,TCGA-BP-4758,KIRC,40.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-14824.0,Alive,TUMOR FREE,2208.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2208.0,0.0,2208.0,nan,nan,0.0,2208.0,0
TCGA-BP-4759-01,TCGA-BP-4759,KIRC,50.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-18569.0,Alive,TUMOR FREE,2372.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2372.0,0.0,2372.0,nan,nan,0.0,2372.0,0
TCGA-BP-4759-11,TCGA-BP-4759,KIRC,50.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-18569.0,Alive,TUMOR FREE,2372.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2372.0,0.0,2372.0,nan,nan,0.0,2372.0,0
TCGA-BP-4760-01,TCGA-BP-4760,KIRC,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-25268.0,Alive,WITH TUMOR,2361.0,nan,nan,nan,nan,nan,1457.0,nan,nan,nan,0.0,2361.0,0.0,2361.0,nan,nan,1.0,1457.0,2
TCGA-BP-4760-11,TCGA-BP-4760,KIRC,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-25268.0,Alive,WITH TUMOR,2361.0,nan,nan,nan,nan,nan,1457.0,nan,nan,nan,0.0,2361.0,0.0,2361.0,nan,nan,1.0,1457.0,2
TCGA-BP-4761-01,TCGA-BP-4761,KIRC,57.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-21019.0,Alive,TUMOR FREE,182.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,182.0,0.0,182.0,nan,nan,0.0,182.0,0
TCGA-BP-4761-11,TCGA-BP-4761,KIRC,57.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-21019.0,Alive,TUMOR FREE,182.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,182.0,0.0,182.0,nan,nan,0.0,182.0,0
TCGA-BP-4762-01,TCGA-BP-4762,KIRC,42.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-15358.0,Dead,TUMOR FREE,nan,1343.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1343.0,0.0,1343.0,nan,nan,0.0,1343.0,0
TCGA-BP-4762-11,TCGA-BP-4762,KIRC,42.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-15358.0,Dead,TUMOR FREE,nan,1343.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1343.0,0.0,1343.0,nan,nan,0.0,1343.0,0
TCGA-BP-4763-01,TCGA-BP-4763,KIRC,79.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-29150.0,Dead,TUMOR FREE,nan,1270.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1270.0,0.0,1270.0,nan,nan,0.0,1270.0,1
TCGA-BP-4763-11,TCGA-BP-4763,KIRC,79.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-29150.0,Dead,TUMOR FREE,nan,1270.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1270.0,0.0,1270.0,nan,nan,0.0,1270.0,1
TCGA-BP-4765-01,TCGA-BP-4765,KIRC,43.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-15814.0,Alive,TUMOR FREE,2184.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2184.0,0.0,2184.0,nan,nan,0.0,2184.0,0
TCGA-BP-4765-11,TCGA-BP-4765,KIRC,43.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-15814.0,Alive,TUMOR FREE,2184.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2184.0,0.0,2184.0,nan,nan,0.0,2184.0,0
TCGA-BP-4766-01,TCGA-BP-4766,KIRC,43.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-15799.0,Alive,TUMOR FREE,1462.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1462.0,0.0,1462.0,nan,nan,0.0,1462.0,0
TCGA-BP-4766-11,TCGA-BP-4766,KIRC,43.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-15799.0,Alive,TUMOR FREE,1462.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1462.0,0.0,1462.0,nan,nan,0.0,1462.0,0
TCGA-BP-4768-01,TCGA-BP-4768,KIRC,72.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-26474.0,Alive,TUMOR FREE,400.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,400.0,0.0,400.0,nan,nan,0.0,400.0,0
TCGA-BP-4768-11,TCGA-BP-4768,KIRC,72.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-26474.0,Alive,TUMOR FREE,400.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,400.0,0.0,400.0,nan,nan,0.0,400.0,0
TCGA-BP-4769-01,TCGA-BP-4769,KIRC,63.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-23190.0,Alive,TUMOR FREE,1876.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1876.0,0.0,1876.0,nan,nan,0.0,1876.0,0
TCGA-BP-4769-11,TCGA-BP-4769,KIRC,63.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-23190.0,Alive,TUMOR FREE,1876.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1876.0,0.0,1876.0,nan,nan,0.0,1876.0,0
TCGA-BP-4770-01,TCGA-BP-4770,KIRC,73.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-26824.0,Dead,WITH TUMOR,nan,329.0,nan,nan,nan,nan,169.0,nan,nan,nan,1.0,329.0,1.0,329.0,nan,nan,1.0,169.0,1
TCGA-BP-4770-11,TCGA-BP-4770,KIRC,73.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-26824.0,Dead,WITH TUMOR,nan,329.0,nan,nan,nan,nan,169.0,nan,nan,nan,1.0,329.0,1.0,329.0,nan,nan,1.0,169.0,1
TCGA-BP-4771-01,TCGA-BP-4771,KIRC,62.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-22771.0,Dead,WITH TUMOR,nan,162.0,nan,nan,nan,nan,23.0,nan,nan,nan,1.0,162.0,1.0,162.0,nan,nan,1.0,23.0,1
TCGA-BP-4771-11,TCGA-BP-4771,KIRC,62.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-22771.0,Dead,WITH TUMOR,nan,162.0,nan,nan,nan,nan,23.0,nan,nan,nan,1.0,162.0,1.0,162.0,nan,nan,1.0,23.0,1
TCGA-BP-4774-01,TCGA-BP-4774,KIRC,57.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-20827.0,Alive,TUMOR FREE,1885.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1885.0,0.0,1885.0,nan,nan,0.0,1885.0,0
TCGA-BP-4774-11,TCGA-BP-4774,KIRC,57.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-20827.0,Alive,TUMOR FREE,1885.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1885.0,0.0,1885.0,nan,nan,0.0,1885.0,0
TCGA-BP-4775-01,TCGA-BP-4775,KIRC,55.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-20369.0,Alive,[Discrepancy],1843.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1843.0,0.0,1843.0,nan,nan,0.0,1843.0,0
TCGA-BP-4775-11,TCGA-BP-4775,KIRC,55.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-20369.0,Alive,[Discrepancy],1843.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1843.0,0.0,1843.0,nan,nan,0.0,1843.0,0
TCGA-BP-4776-01,TCGA-BP-4776,KIRC,52.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-19143.0,Alive,TUMOR FREE,411.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,411.0,0.0,411.0,nan,nan,0.0,411.0,0
TCGA-BP-4776-11,TCGA-BP-4776,KIRC,52.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-19143.0,Alive,TUMOR FREE,411.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,411.0,0.0,411.0,nan,nan,0.0,411.0,0
TCGA-BP-4777-01,TCGA-BP-4777,KIRC,46.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-17133.0,Alive,TUMOR FREE,1731.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1731.0,0.0,1731.0,nan,nan,0.0,1731.0,0
TCGA-BP-4777-11,TCGA-BP-4777,KIRC,46.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-17133.0,Alive,TUMOR FREE,1731.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1731.0,0.0,1731.0,nan,nan,0.0,1731.0,0
TCGA-BP-4781-01,TCGA-BP-4781,KIRC,78.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-28701.0,Alive,TUMOR FREE,2080.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2080.0,0.0,2080.0,nan,nan,0.0,2080.0,0
TCGA-BP-4781-11,TCGA-BP-4781,KIRC,78.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-28701.0,Alive,TUMOR FREE,2080.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2080.0,0.0,2080.0,nan,nan,0.0,2080.0,0
TCGA-BP-4782-01,TCGA-BP-4782,KIRC,55.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-20102.0,Alive,[Discrepancy],354.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,354.0,0.0,354.0,nan,nan,0.0,354.0,0
TCGA-BP-4782-11,TCGA-BP-4782,KIRC,55.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-20102.0,Alive,[Discrepancy],354.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,354.0,0.0,354.0,nan,nan,0.0,354.0,0
TCGA-BP-4784-01,TCGA-BP-4784,KIRC,67.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-24603.0,Alive,TUMOR FREE,1854.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1854.0,0.0,1854.0,nan,nan,0.0,1854.0,0
TCGA-BP-4784-11,TCGA-BP-4784,KIRC,67.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-24603.0,Alive,TUMOR FREE,1854.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1854.0,0.0,1854.0,nan,nan,0.0,1854.0,0
TCGA-BP-4787-01,TCGA-BP-4787,KIRC,59.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-21697.0,Dead,WITH TUMOR,nan,480.0,nan,nan,nan,nan,259.0,nan,nan,nan,1.0,480.0,1.0,480.0,nan,nan,1.0,259.0,1
TCGA-BP-4787-11,TCGA-BP-4787,KIRC,59.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-21697.0,Dead,WITH TUMOR,nan,480.0,nan,nan,nan,nan,259.0,nan,nan,nan,1.0,480.0,1.0,480.0,nan,nan,1.0,259.0,1
TCGA-BP-4789-01,TCGA-BP-4789,KIRC,48.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-17540.0,Alive,TUMOR FREE,1489.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1489.0,0.0,1489.0,nan,nan,0.0,1489.0,0
TCGA-BP-4789-11,TCGA-BP-4789,KIRC,48.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-17540.0,Alive,TUMOR FREE,1489.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1489.0,0.0,1489.0,nan,nan,0.0,1489.0,0
TCGA-BP-4790-01,TCGA-BP-4790,KIRC,76.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-28076.0,Dead,TUMOR FREE,nan,1111.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1111.0,0.0,1111.0,nan,nan,0.0,1111.0,0
TCGA-BP-4790-11,TCGA-BP-4790,KIRC,76.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-28076.0,Dead,TUMOR FREE,nan,1111.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1111.0,0.0,1111.0,nan,nan,0.0,1111.0,0
TCGA-BP-4795-01,TCGA-BP-4795,KIRC,74.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-27162.0,Alive,TUMOR FREE,620.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,620.0,0.0,620.0,nan,nan,0.0,620.0,0
TCGA-BP-4795-11,TCGA-BP-4795,KIRC,74.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-27162.0,Alive,TUMOR FREE,620.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,620.0,0.0,620.0,nan,nan,0.0,620.0,0
TCGA-BP-4797-01,TCGA-BP-4797,KIRC,34.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-12508.0,Alive,TUMOR FREE,1107.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1107.0,0.0,1107.0,nan,nan,0.0,1107.0,0
TCGA-BP-4797-11,TCGA-BP-4797,KIRC,34.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-12508.0,Alive,TUMOR FREE,1107.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1107.0,0.0,1107.0,nan,nan,0.0,1107.0,0
TCGA-BP-4798-01,TCGA-BP-4798,KIRC,74.0,MALE,WHITE,[Discrepancy],nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-27335.0,Dead,WITH TUMOR,nan,334.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,334.0,1.0,334.0,nan,nan,1.0,334.0,1
TCGA-BP-4798-11,TCGA-BP-4798,KIRC,74.0,MALE,WHITE,[Discrepancy],nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-27335.0,Dead,WITH TUMOR,nan,334.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,334.0,1.0,334.0,nan,nan,1.0,334.0,1
TCGA-BP-4799-01,TCGA-BP-4799,KIRC,70.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-25842.0,Dead,WITH TUMOR,nan,1133.0,nan,nan,nan,nan,352.0,nan,nan,nan,1.0,1133.0,1.0,1133.0,nan,nan,1.0,352.0,1
TCGA-BP-4799-11,TCGA-BP-4799,KIRC,70.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-25842.0,Dead,WITH TUMOR,nan,1133.0,nan,nan,nan,nan,352.0,nan,nan,nan,1.0,1133.0,1.0,1133.0,nan,nan,1.0,352.0,1
TCGA-BP-4801-01,TCGA-BP-4801,KIRC,57.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-20825.0,Alive,TUMOR FREE,1124.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1124.0,0.0,1124.0,nan,nan,0.0,1124.0,0
TCGA-BP-4801-11,TCGA-BP-4801,KIRC,57.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-20825.0,Alive,TUMOR FREE,1124.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1124.0,0.0,1124.0,nan,nan,0.0,1124.0,0
TCGA-BP-4803-01,TCGA-BP-4803,KIRC,79.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2008.0,nan,-28934.0,Alive,TUMOR FREE,204.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,204.0,0.0,204.0,nan,nan,0.0,204.0,0
TCGA-BP-4803-11,TCGA-BP-4803,KIRC,79.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2008.0,nan,-28934.0,Alive,TUMOR FREE,204.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,204.0,0.0,204.0,nan,nan,0.0,204.0,0
TCGA-BP-4804-01,TCGA-BP-4804,KIRC,59.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2008.0,nan,-21727.0,Alive,WITH TUMOR,1459.0,nan,nan,nan,nan,nan,295.0,nan,nan,nan,0.0,1459.0,0.0,1459.0,nan,nan,1.0,295.0,2
TCGA-BP-4804-11,TCGA-BP-4804,KIRC,59.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2008.0,nan,-21727.0,Alive,WITH TUMOR,1459.0,nan,nan,nan,nan,nan,295.0,nan,nan,nan,0.0,1459.0,0.0,1459.0,nan,nan,1.0,295.0,2
TCGA-BP-4807-01,TCGA-BP-4807,KIRC,42.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2008.0,nan,-15360.0,Alive,TUMOR FREE,211.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,211.0,0.0,211.0,nan,nan,0.0,211.0,0
TCGA-BP-4807-11,TCGA-BP-4807,KIRC,42.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2008.0,nan,-15360.0,Alive,TUMOR FREE,211.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,211.0,0.0,211.0,nan,nan,0.0,211.0,0
TCGA-BP-4959-01,TCGA-BP-4959,KIRC,49.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-17968.0,Alive,TUMOR FREE,2660.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2660.0,0.0,2660.0,nan,nan,0.0,2660.0,0
TCGA-BP-4959-11,TCGA-BP-4959,KIRC,49.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-17968.0,Alive,TUMOR FREE,2660.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2660.0,0.0,2660.0,nan,nan,0.0,2660.0,0
TCGA-BP-4960-01,TCGA-BP-4960,KIRC,46.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-17099.0,Alive,TUMOR FREE,2172.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2172.0,0.0,2172.0,nan,nan,0.0,2172.0,0
TCGA-BP-4960-11,TCGA-BP-4960,KIRC,46.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-17099.0,Alive,TUMOR FREE,2172.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2172.0,0.0,2172.0,nan,nan,0.0,2172.0,0
TCGA-BP-4961-01,TCGA-BP-4961,KIRC,47.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-17284.0,Alive,TUMOR FREE,1935.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1935.0,0.0,1935.0,nan,nan,0.0,1935.0,0
TCGA-BP-4961-11,TCGA-BP-4961,KIRC,47.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-17284.0,Alive,TUMOR FREE,1935.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1935.0,0.0,1935.0,nan,nan,0.0,1935.0,0
TCGA-BP-4962-01,TCGA-BP-4962,KIRC,58.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-21255.0,Alive,TUMOR FREE,1785.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1785.0,0.0,1785.0,nan,nan,0.0,1785.0,0
TCGA-BP-4962-11,TCGA-BP-4962,KIRC,58.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-21255.0,Alive,TUMOR FREE,1785.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1785.0,0.0,1785.0,nan,nan,0.0,1785.0,0
TCGA-BP-4963-01,TCGA-BP-4963,KIRC,63.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-23373.0,Alive,TUMOR FREE,1834.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1834.0,0.0,1834.0,nan,nan,0.0,1834.0,0
TCGA-BP-4963-11,TCGA-BP-4963,KIRC,63.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-23373.0,Alive,TUMOR FREE,1834.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1834.0,0.0,1834.0,nan,nan,0.0,1834.0,0
TCGA-BP-4964-01,TCGA-BP-4964,KIRC,54.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-20084.0,Alive,TUMOR FREE,1862.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1862.0,0.0,1862.0,nan,nan,0.0,1862.0,0
TCGA-BP-4964-11,TCGA-BP-4964,KIRC,54.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-20084.0,Alive,TUMOR FREE,1862.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1862.0,0.0,1862.0,nan,nan,0.0,1862.0,0
TCGA-BP-4965-01,TCGA-BP-4965,KIRC,46.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-16992.0,Alive,TUMOR FREE,1871.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1871.0,0.0,1871.0,nan,nan,0.0,1871.0,0
TCGA-BP-4965-11,TCGA-BP-4965,KIRC,46.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-16992.0,Alive,TUMOR FREE,1871.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1871.0,0.0,1871.0,nan,nan,0.0,1871.0,0
TCGA-BP-4967-01,TCGA-BP-4967,KIRC,76.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-27857.0,Alive,TUMOR FREE,205.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,205.0,0.0,205.0,nan,nan,0.0,205.0,0
TCGA-BP-4967-11,TCGA-BP-4967,KIRC,76.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-27857.0,Alive,TUMOR FREE,205.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,205.0,0.0,205.0,nan,nan,0.0,205.0,0
TCGA-BP-4968-01,TCGA-BP-4968,KIRC,40.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-14651.0,Alive,TUMOR FREE,1746.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1746.0,0.0,1746.0,nan,nan,0.0,1746.0,0
TCGA-BP-4968-11,TCGA-BP-4968,KIRC,40.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-14651.0,Alive,TUMOR FREE,1746.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1746.0,0.0,1746.0,nan,nan,0.0,1746.0,0
TCGA-BP-4969-01,TCGA-BP-4969,KIRC,63.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-23216.0,Alive,TUMOR FREE,1794.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1794.0,0.0,1794.0,nan,nan,0.0,1794.0,0
TCGA-BP-4969-11,TCGA-BP-4969,KIRC,63.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-23216.0,Alive,TUMOR FREE,1794.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1794.0,0.0,1794.0,nan,nan,0.0,1794.0,0
TCGA-BP-4970-01,TCGA-BP-4970,KIRC,44.0,MALE,ASIAN,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-16228.0,Alive,TUMOR FREE,433.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,433.0,0.0,433.0,nan,nan,0.0,433.0,0
TCGA-BP-4970-11,TCGA-BP-4970,KIRC,44.0,MALE,ASIAN,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-16228.0,Alive,TUMOR FREE,433.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,433.0,0.0,433.0,nan,nan,0.0,433.0,0
TCGA-BP-4971-01,TCGA-BP-4971,KIRC,40.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-14675.0,Alive,TUMOR FREE,1487.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1487.0,0.0,1487.0,nan,nan,0.0,1487.0,0
TCGA-BP-4971-11,TCGA-BP-4971,KIRC,40.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-14675.0,Alive,TUMOR FREE,1487.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1487.0,0.0,1487.0,nan,nan,0.0,1487.0,0
TCGA-BP-4972-01,TCGA-BP-4972,KIRC,43.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-16038.0,Alive,TUMOR FREE,1502.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1502.0,0.0,1502.0,nan,nan,0.0,1502.0,0
TCGA-BP-4972-11,TCGA-BP-4972,KIRC,43.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-16038.0,Alive,TUMOR FREE,1502.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1502.0,0.0,1502.0,nan,nan,0.0,1502.0,0
TCGA-BP-4973-01,TCGA-BP-4973,KIRC,47.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-17461.0,Alive,TUMOR FREE,1384.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1384.0,0.0,1384.0,nan,nan,0.0,1384.0,0
TCGA-BP-4973-11,TCGA-BP-4973,KIRC,47.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-17461.0,Alive,TUMOR FREE,1384.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1384.0,0.0,1384.0,nan,nan,0.0,1384.0,0
TCGA-BP-4974-01,TCGA-BP-4974,KIRC,58.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2006.0,nan,-21310.0,Dead,WITH TUMOR,nan,211.0,nan,nan,nan,nan,35.0,nan,nan,nan,1.0,211.0,1.0,211.0,nan,nan,1.0,35.0,1
TCGA-BP-4974-11,TCGA-BP-4974,KIRC,58.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2006.0,nan,-21310.0,Dead,WITH TUMOR,nan,211.0,nan,nan,nan,nan,35.0,nan,nan,nan,1.0,211.0,1.0,211.0,nan,nan,1.0,35.0,1
TCGA-BP-4975-01,TCGA-BP-4975,KIRC,40.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-14710.0,Alive,TUMOR FREE,1433.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1433.0,0.0,1433.0,nan,nan,0.0,1433.0,0
TCGA-BP-4975-11,TCGA-BP-4975,KIRC,40.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-14710.0,Alive,TUMOR FREE,1433.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1433.0,0.0,1433.0,nan,nan,0.0,1433.0,0
TCGA-BP-4976-01,TCGA-BP-4976,KIRC,77.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-28380.0,Alive,TUMOR FREE,1632.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1632.0,0.0,1632.0,nan,nan,0.0,1632.0,0
TCGA-BP-4976-11,TCGA-BP-4976,KIRC,77.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-28380.0,Alive,TUMOR FREE,1632.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1632.0,0.0,1632.0,nan,nan,0.0,1632.0,0
TCGA-BP-4977-01,TCGA-BP-4977,KIRC,57.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-20950.0,Alive,TUMOR FREE,454.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,454.0,0.0,454.0,nan,nan,0.0,454.0,0
TCGA-BP-4977-11,TCGA-BP-4977,KIRC,57.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-20950.0,Alive,TUMOR FREE,454.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,454.0,0.0,454.0,nan,nan,0.0,454.0,0
TCGA-BP-4981-01,TCGA-BP-4981,KIRC,75.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-27676.0,Dead,TUMOR FREE,nan,1097.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1097.0,0.0,1097.0,nan,nan,0.0,1097.0,1
TCGA-BP-4981-11,TCGA-BP-4981,KIRC,75.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-27676.0,Dead,TUMOR FREE,nan,1097.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1097.0,0.0,1097.0,nan,nan,0.0,1097.0,1
TCGA-BP-4982-01,TCGA-BP-4982,KIRC,42.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-15451.0,Alive,TUMOR FREE,1014.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1014.0,0.0,1014.0,nan,nan,0.0,1014.0,0
TCGA-BP-4982-11,TCGA-BP-4982,KIRC,42.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-15451.0,Alive,TUMOR FREE,1014.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1014.0,0.0,1014.0,nan,nan,0.0,1014.0,0
TCGA-BP-4983-01,TCGA-BP-4983,KIRC,67.0,FEMALE,ASIAN,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2006.0,nan,-24558.0,Alive,TUMOR FREE,1413.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1413.0,0.0,1413.0,nan,nan,0.0,1413.0,0
TCGA-BP-4983-11,TCGA-BP-4983,KIRC,67.0,FEMALE,ASIAN,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2006.0,nan,-24558.0,Alive,TUMOR FREE,1413.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1413.0,0.0,1413.0,nan,nan,0.0,1413.0,0
TCGA-BP-4985-01,TCGA-BP-4985,KIRC,72.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2006.0,nan,-26611.0,Dead,WITH TUMOR,nan,952.0,nan,nan,nan,nan,205.0,nan,nan,nan,1.0,952.0,1.0,952.0,nan,nan,1.0,205.0,1
TCGA-BP-4985-11,TCGA-BP-4985,KIRC,72.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2006.0,nan,-26611.0,Dead,WITH TUMOR,nan,952.0,nan,nan,nan,nan,205.0,nan,nan,nan,1.0,952.0,1.0,952.0,nan,nan,1.0,205.0,1
TCGA-BP-4986-01,TCGA-BP-4986,KIRC,75.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-27612.0,Alive,TUMOR FREE,785.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,785.0,0.0,785.0,nan,nan,0.0,785.0,0
TCGA-BP-4986-11,TCGA-BP-4986,KIRC,75.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-27612.0,Alive,TUMOR FREE,785.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,785.0,0.0,785.0,nan,nan,0.0,785.0,0
TCGA-BP-4987-01,TCGA-BP-4987,KIRC,41.0,FEMALE,ASIAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-15041.0,Alive,TUMOR FREE,1124.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1124.0,0.0,1124.0,nan,nan,0.0,1124.0,0
TCGA-BP-4987-11,TCGA-BP-4987,KIRC,41.0,FEMALE,ASIAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-15041.0,Alive,TUMOR FREE,1124.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1124.0,0.0,1124.0,nan,nan,0.0,1124.0,0
TCGA-BP-4988-01,TCGA-BP-4988,KIRC,72.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-26576.0,Dead,TUMOR FREE,nan,828.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,828.0,0.0,828.0,nan,nan,0.0,828.0,0
TCGA-BP-4988-11,TCGA-BP-4988,KIRC,72.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-26576.0,Dead,TUMOR FREE,nan,828.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,828.0,0.0,828.0,nan,nan,0.0,828.0,0
TCGA-BP-4989-01,TCGA-BP-4989,KIRC,58.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-21382.0,Alive,TUMOR FREE,118.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,118.0,0.0,118.0,nan,nan,0.0,118.0,0
TCGA-BP-4989-11,TCGA-BP-4989,KIRC,58.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-21382.0,Alive,TUMOR FREE,118.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,118.0,0.0,118.0,nan,nan,0.0,118.0,0
TCGA-BP-4991-01,TCGA-BP-4991,KIRC,54.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-19739.0,Alive,TUMOR FREE,1413.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1413.0,0.0,1413.0,nan,nan,0.0,1413.0,0
TCGA-BP-4991-11,TCGA-BP-4991,KIRC,54.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-19739.0,Alive,TUMOR FREE,1413.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1413.0,0.0,1413.0,nan,nan,0.0,1413.0,0
TCGA-BP-4992-01,TCGA-BP-4992,KIRC,66.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-24438.0,Alive,TUMOR FREE,501.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,501.0,0.0,501.0,nan,nan,0.0,501.0,0
TCGA-BP-4992-11,TCGA-BP-4992,KIRC,66.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-24438.0,Alive,TUMOR FREE,501.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,501.0,0.0,501.0,nan,nan,0.0,501.0,0
TCGA-BP-4993-01,TCGA-BP-4993,KIRC,58.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-21407.0,Alive,TUMOR FREE,177.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,177.0,0.0,177.0,nan,nan,0.0,177.0,0
TCGA-BP-4993-11,TCGA-BP-4993,KIRC,58.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-21407.0,Alive,TUMOR FREE,177.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,177.0,0.0,177.0,nan,nan,0.0,177.0,0
TCGA-BP-4994-01,TCGA-BP-4994,KIRC,54.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-19946.0,Alive,TUMOR FREE,1308.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1308.0,0.0,1308.0,nan,nan,0.0,1308.0,0
TCGA-BP-4994-11,TCGA-BP-4994,KIRC,54.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-19946.0,Alive,TUMOR FREE,1308.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1308.0,0.0,1308.0,nan,nan,0.0,1308.0,0
TCGA-BP-4995-01,TCGA-BP-4995,KIRC,68.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-24850.0,Alive,TUMOR FREE,1371.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1371.0,0.0,1371.0,nan,nan,0.0,1371.0,0
TCGA-BP-4995-11,TCGA-BP-4995,KIRC,68.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-24850.0,Alive,TUMOR FREE,1371.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1371.0,0.0,1371.0,nan,nan,0.0,1371.0,0
TCGA-BP-4998-01,TCGA-BP-4998,KIRC,49.0,MALE,ASIAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-17997.0,Alive,TUMOR FREE,932.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,932.0,0.0,932.0,nan,nan,0.0,932.0,0
TCGA-BP-4998-11,TCGA-BP-4998,KIRC,49.0,MALE,ASIAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-17997.0,Alive,TUMOR FREE,932.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,932.0,0.0,932.0,nan,nan,0.0,932.0,0
TCGA-BP-4999-01,TCGA-BP-4999,KIRC,56.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-20518.0,Alive,TUMOR FREE,1266.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1266.0,0.0,1266.0,nan,nan,0.0,1266.0,0
TCGA-BP-4999-11,TCGA-BP-4999,KIRC,56.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-20518.0,Alive,TUMOR FREE,1266.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1266.0,0.0,1266.0,nan,nan,0.0,1266.0,0
TCGA-BP-5000-01,TCGA-BP-5000,KIRC,40.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-14868.0,Alive,TUMOR FREE,563.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,563.0,0.0,563.0,nan,nan,0.0,563.0,0
TCGA-BP-5000-11,TCGA-BP-5000,KIRC,40.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-14868.0,Alive,TUMOR FREE,563.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,563.0,0.0,563.0,nan,nan,0.0,563.0,0
TCGA-BP-5001-01,TCGA-BP-5001,KIRC,43.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-15858.0,Alive,TUMOR FREE,1177.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1177.0,0.0,1177.0,nan,nan,0.0,1177.0,0
TCGA-BP-5001-11,TCGA-BP-5001,KIRC,43.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-15858.0,Alive,TUMOR FREE,1177.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1177.0,0.0,1177.0,nan,nan,0.0,1177.0,0
TCGA-BP-5004-01,TCGA-BP-5004,KIRC,53.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-19383.0,Alive,TUMOR FREE,1126.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1126.0,0.0,1126.0,nan,nan,0.0,1126.0,0
TCGA-BP-5004-11,TCGA-BP-5004,KIRC,53.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-19383.0,Alive,TUMOR FREE,1126.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1126.0,0.0,1126.0,nan,nan,0.0,1126.0,0
TCGA-BP-5006-01,TCGA-BP-5006,KIRC,61.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-22324.0,Alive,TUMOR FREE,840.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,840.0,0.0,840.0,nan,nan,0.0,840.0,0
TCGA-BP-5006-11,TCGA-BP-5006,KIRC,61.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-22324.0,Alive,TUMOR FREE,840.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,840.0,0.0,840.0,nan,nan,0.0,840.0,0
TCGA-BP-5007-01,TCGA-BP-5007,KIRC,45.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-16793.0,Alive,TUMOR FREE,1140.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1140.0,0.0,1140.0,nan,nan,0.0,1140.0,0
TCGA-BP-5007-11,TCGA-BP-5007,KIRC,45.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-16793.0,Alive,TUMOR FREE,1140.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1140.0,0.0,1140.0,nan,nan,0.0,1140.0,0
TCGA-BP-5008-01,TCGA-BP-5008,KIRC,46.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-17008.0,Alive,TUMOR FREE,1071.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1071.0,0.0,1071.0,nan,nan,0.0,1071.0,0
TCGA-BP-5008-11,TCGA-BP-5008,KIRC,46.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-17008.0,Alive,TUMOR FREE,1071.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1071.0,0.0,1071.0,nan,nan,0.0,1071.0,0
TCGA-BP-5009-01,TCGA-BP-5009,KIRC,52.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-19052.0,Dead,WITH TUMOR,nan,1092.0,nan,nan,nan,nan,324.0,nan,nan,nan,1.0,1092.0,1.0,1092.0,nan,nan,1.0,324.0,1
TCGA-BP-5009-11,TCGA-BP-5009,KIRC,52.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-19052.0,Dead,WITH TUMOR,nan,1092.0,nan,nan,nan,nan,324.0,nan,nan,nan,1.0,1092.0,1.0,1092.0,nan,nan,1.0,324.0,1
TCGA-BP-5010-01,TCGA-BP-5010,KIRC,63.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-23130.0,Dead,WITH TUMOR,nan,878.0,nan,nan,nan,nan,582.0,nan,nan,nan,1.0,878.0,1.0,878.0,nan,nan,1.0,582.0,1
TCGA-BP-5010-11,TCGA-BP-5010,KIRC,63.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-23130.0,Dead,WITH TUMOR,nan,878.0,nan,nan,nan,nan,582.0,nan,nan,nan,1.0,878.0,1.0,878.0,nan,nan,1.0,582.0,1
TCGA-BP-5168-01,TCGA-BP-5168,KIRC,75.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-27692.0,Dead,TUMOR FREE,nan,1463.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1463.0,0.0,1463.0,nan,nan,0.0,1463.0,0
TCGA-BP-5168-11,TCGA-BP-5168,KIRC,75.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2002.0,nan,-27692.0,Dead,TUMOR FREE,nan,1463.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1463.0,0.0,1463.0,nan,nan,0.0,1463.0,0
TCGA-BP-5169-01,TCGA-BP-5169,KIRC,70.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-25615.0,Alive,TUMOR FREE,193.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,193.0,0.0,193.0,nan,nan,0.0,193.0,0
TCGA-BP-5169-11,TCGA-BP-5169,KIRC,70.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-25615.0,Alive,TUMOR FREE,193.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,193.0,0.0,193.0,nan,nan,0.0,193.0,0
TCGA-BP-5170-01,TCGA-BP-5170,KIRC,55.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-20229.0,Alive,TUMOR FREE,2412.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2412.0,0.0,2412.0,nan,nan,0.0,2412.0,0
TCGA-BP-5170-11,TCGA-BP-5170,KIRC,55.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-20229.0,Alive,TUMOR FREE,2412.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2412.0,0.0,2412.0,nan,nan,0.0,2412.0,0
TCGA-BP-5173-01,TCGA-BP-5173,KIRC,75.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-27436.0,Dead,TUMOR FREE,nan,62.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,62.0,0.0,62.0,nan,nan,0.0,62.0,0
TCGA-BP-5173-11,TCGA-BP-5173,KIRC,75.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-27436.0,Dead,TUMOR FREE,nan,62.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,62.0,0.0,62.0,nan,nan,0.0,62.0,0
TCGA-BP-5174-01,TCGA-BP-5174,KIRC,45.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-16693.0,Alive,TUMOR FREE,2257.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2257.0,0.0,2257.0,nan,nan,0.0,2257.0,0
TCGA-BP-5174-11,TCGA-BP-5174,KIRC,45.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-16693.0,Alive,TUMOR FREE,2257.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2257.0,0.0,2257.0,nan,nan,0.0,2257.0,0
TCGA-BP-5175-01,TCGA-BP-5175,KIRC,60.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-21949.0,Alive,TUMOR FREE,932.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,932.0,0.0,932.0,nan,nan,0.0,932.0,0
TCGA-BP-5175-11,TCGA-BP-5175,KIRC,60.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-21949.0,Alive,TUMOR FREE,932.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,932.0,0.0,932.0,nan,nan,0.0,932.0,0
TCGA-BP-5176-01,TCGA-BP-5176,KIRC,78.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-28727.0,Dead,TUMOR FREE,nan,1590.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1590.0,0.0,1590.0,nan,nan,0.0,1590.0,1
TCGA-BP-5176-11,TCGA-BP-5176,KIRC,78.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-28727.0,Dead,TUMOR FREE,nan,1590.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1590.0,0.0,1590.0,nan,nan,0.0,1590.0,1
TCGA-BP-5177-01,TCGA-BP-5177,KIRC,46.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-17147.0,Alive,TUMOR FREE,293.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,293.0,0.0,293.0,nan,nan,0.0,293.0,0
TCGA-BP-5177-11,TCGA-BP-5177,KIRC,46.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-17147.0,Alive,TUMOR FREE,293.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,293.0,0.0,293.0,nan,nan,0.0,293.0,0
TCGA-BP-5178-01,TCGA-BP-5178,KIRC,71.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-26070.0,Dead,WITH TUMOR,nan,1912.0,nan,nan,nan,nan,396.0,nan,nan,nan,1.0,1912.0,1.0,1912.0,nan,nan,1.0,396.0,1
TCGA-BP-5178-11,TCGA-BP-5178,KIRC,71.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-26070.0,Dead,WITH TUMOR,nan,1912.0,nan,nan,nan,nan,396.0,nan,nan,nan,1.0,1912.0,1.0,1912.0,nan,nan,1.0,396.0,1
TCGA-BP-5180-01,TCGA-BP-5180,KIRC,53.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-19413.0,Alive,TUMOR FREE,2263.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2263.0,0.0,2263.0,nan,nan,0.0,2263.0,0
TCGA-BP-5180-11,TCGA-BP-5180,KIRC,53.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-19413.0,Alive,TUMOR FREE,2263.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2263.0,0.0,2263.0,nan,nan,0.0,2263.0,0
TCGA-BP-5181-01,TCGA-BP-5181,KIRC,58.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-21514.0,Alive,TUMOR FREE,1495.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1495.0,0.0,1495.0,nan,nan,0.0,1495.0,0
TCGA-BP-5181-11,TCGA-BP-5181,KIRC,58.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-21514.0,Alive,TUMOR FREE,1495.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1495.0,0.0,1495.0,nan,nan,0.0,1495.0,0
TCGA-BP-5182-01,TCGA-BP-5182,KIRC,56.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-20597.0,Alive,TUMOR FREE,1165.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1165.0,0.0,1165.0,nan,nan,0.0,1165.0,0
TCGA-BP-5182-11,TCGA-BP-5182,KIRC,56.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-20597.0,Alive,TUMOR FREE,1165.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1165.0,0.0,1165.0,nan,nan,0.0,1165.0,0
TCGA-BP-5183-01,TCGA-BP-5183,KIRC,57.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-20881.0,Alive,TUMOR FREE,1291.0,nan,nan,nan,nan,nan,485.0,nan,nan,nan,0.0,1291.0,0.0,1291.0,nan,nan,1.0,485.0,0
TCGA-BP-5183-11,TCGA-BP-5183,KIRC,57.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-20881.0,Alive,TUMOR FREE,1291.0,nan,nan,nan,nan,nan,485.0,nan,nan,nan,0.0,1291.0,0.0,1291.0,nan,nan,1.0,485.0,0
TCGA-BP-5184-01,TCGA-BP-5184,KIRC,54.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-19746.0,Alive,TUMOR FREE,1133.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1133.0,0.0,1133.0,nan,nan,0.0,1133.0,0
TCGA-BP-5184-11,TCGA-BP-5184,KIRC,54.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-19746.0,Alive,TUMOR FREE,1133.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1133.0,0.0,1133.0,nan,nan,0.0,1133.0,0
TCGA-BP-5185-01,TCGA-BP-5185,KIRC,56.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-20470.0,Alive,WITH TUMOR,1132.0,nan,nan,nan,nan,nan,736.0,nan,nan,nan,0.0,1132.0,0.0,1132.0,nan,nan,1.0,736.0,0
TCGA-BP-5185-11,TCGA-BP-5185,KIRC,56.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-20470.0,Alive,WITH TUMOR,1132.0,nan,nan,nan,nan,nan,736.0,nan,nan,nan,0.0,1132.0,0.0,1132.0,nan,nan,1.0,736.0,0
TCGA-BP-5186-01,TCGA-BP-5186,KIRC,50.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-18348.0,Alive,TUMOR FREE,693.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,693.0,0.0,693.0,nan,nan,0.0,693.0,0
TCGA-BP-5186-11,TCGA-BP-5186,KIRC,50.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-18348.0,Alive,TUMOR FREE,693.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,693.0,0.0,693.0,nan,nan,0.0,693.0,0
TCGA-BP-5187-01,TCGA-BP-5187,KIRC,54.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-19999.0,Alive,TUMOR FREE,406.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,406.0,0.0,406.0,nan,nan,0.0,406.0,0
TCGA-BP-5187-11,TCGA-BP-5187,KIRC,54.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-19999.0,Alive,TUMOR FREE,406.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,406.0,0.0,406.0,nan,nan,0.0,406.0,0
TCGA-BP-5189-01,TCGA-BP-5189,KIRC,60.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-22156.0,Dead,WITH TUMOR,nan,822.0,nan,nan,nan,nan,634.0,nan,nan,nan,1.0,822.0,1.0,822.0,nan,nan,1.0,634.0,1
TCGA-BP-5189-11,TCGA-BP-5189,KIRC,60.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-22156.0,Dead,WITH TUMOR,nan,822.0,nan,nan,nan,nan,634.0,nan,nan,nan,1.0,822.0,1.0,822.0,nan,nan,1.0,634.0,1
TCGA-BP-5190-01,TCGA-BP-5190,KIRC,61.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-22285.0,Alive,TUMOR FREE,1011.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1011.0,0.0,1011.0,nan,nan,0.0,1011.0,0
TCGA-BP-5190-11,TCGA-BP-5190,KIRC,61.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-22285.0,Alive,TUMOR FREE,1011.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1011.0,0.0,1011.0,nan,nan,0.0,1011.0,0
TCGA-BP-5191-01,TCGA-BP-5191,KIRC,79.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-29207.0,Alive,TUMOR FREE,967.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,967.0,0.0,967.0,nan,nan,0.0,967.0,0
TCGA-BP-5191-11,TCGA-BP-5191,KIRC,79.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-29207.0,Alive,TUMOR FREE,967.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,967.0,0.0,967.0,nan,nan,0.0,967.0,0
TCGA-BP-5192-01,TCGA-BP-5192,KIRC,59.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-21891.0,Alive,TUMOR FREE,714.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,714.0,0.0,714.0,nan,nan,0.0,714.0,0
TCGA-BP-5192-11,TCGA-BP-5192,KIRC,59.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-21891.0,Alive,TUMOR FREE,714.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,714.0,0.0,714.0,nan,nan,0.0,714.0,0
TCGA-BP-5194-01,TCGA-BP-5194,KIRC,39.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2008.0,nan,-14551.0,Alive,TUMOR FREE,408.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,408.0,0.0,408.0,nan,nan,0.0,408.0,0
TCGA-BP-5194-11,TCGA-BP-5194,KIRC,39.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2008.0,nan,-14551.0,Alive,TUMOR FREE,408.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,408.0,0.0,408.0,nan,nan,0.0,408.0,0
TCGA-BP-5195-01,TCGA-BP-5195,KIRC,75.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2008.0,nan,-27547.0,Alive,TUMOR FREE,749.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,749.0,0.0,749.0,nan,nan,0.0,749.0,0
TCGA-BP-5195-11,TCGA-BP-5195,KIRC,75.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2008.0,nan,-27547.0,Alive,TUMOR FREE,749.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,749.0,0.0,749.0,nan,nan,0.0,749.0,0
TCGA-BP-5196-01,TCGA-BP-5196,KIRC,53.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2008.0,nan,-19719.0,Alive,TUMOR FREE,1018.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1018.0,0.0,1018.0,nan,nan,0.0,1018.0,0
TCGA-BP-5196-11,TCGA-BP-5196,KIRC,53.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2008.0,nan,-19719.0,Alive,TUMOR FREE,1018.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1018.0,0.0,1018.0,nan,nan,0.0,1018.0,0
TCGA-BP-5198-01,TCGA-BP-5198,KIRC,72.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2008.0,nan,-26360.0,Alive,TUMOR FREE,603.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,603.0,0.0,603.0,nan,nan,0.0,603.0,0
TCGA-BP-5198-11,TCGA-BP-5198,KIRC,72.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2008.0,nan,-26360.0,Alive,TUMOR FREE,603.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,603.0,0.0,603.0,nan,nan,0.0,603.0,0
TCGA-BP-5199-01,TCGA-BP-5199,KIRC,58.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G4,2006.0,nan,-21256.0,Alive,TUMOR FREE,1355.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1355.0,0.0,1355.0,nan,nan,0.0,1355.0,0
TCGA-BP-5199-11,TCGA-BP-5199,KIRC,58.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G4,2006.0,nan,-21256.0,Alive,TUMOR FREE,1355.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1355.0,0.0,1355.0,nan,nan,0.0,1355.0,0
TCGA-BP-5200-01,TCGA-BP-5200,KIRC,44.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G4,2008.0,nan,-16197.0,Alive,TUMOR FREE,1063.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1063.0,0.0,1063.0,nan,nan,0.0,1063.0,0
TCGA-BP-5200-11,TCGA-BP-5200,KIRC,44.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G4,2008.0,nan,-16197.0,Alive,TUMOR FREE,1063.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1063.0,0.0,1063.0,nan,nan,0.0,1063.0,0
TCGA-BP-5201-01,TCGA-BP-5201,KIRC,63.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2008.0,nan,-23125.0,Alive,WITH TUMOR,951.0,nan,nan,nan,nan,nan,-19.0,nan,nan,nan,0.0,951.0,0.0,951.0,nan,nan,1.0,nan,0
TCGA-BP-5201-11,TCGA-BP-5201,KIRC,63.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2008.0,nan,-23125.0,Alive,WITH TUMOR,951.0,nan,nan,nan,nan,nan,-19.0,nan,nan,nan,0.0,951.0,0.0,951.0,nan,nan,1.0,nan,0
TCGA-BP-5202-01,TCGA-BP-5202,KIRC,75.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2008.0,nan,-27556.0,Alive,TUMOR FREE,29.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,29.0,0.0,29.0,nan,nan,0.0,29.0,0
TCGA-BP-5202-11,TCGA-BP-5202,KIRC,75.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2008.0,nan,-27556.0,Alive,TUMOR FREE,29.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,29.0,0.0,29.0,nan,nan,0.0,29.0,0
TCGA-CJ-4634-01,TCGA-CJ-4634,KIRC,60.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-22155.0,Alive,TUMOR FREE,3498.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3498.0,0.0,3498.0,0.0,3498.0,0.0,3498.0,0
TCGA-CJ-4634-11,TCGA-CJ-4634,KIRC,60.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-22155.0,Alive,TUMOR FREE,3498.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3498.0,0.0,3498.0,0.0,3498.0,0.0,3498.0,0
TCGA-CJ-4635-01,TCGA-CJ-4635,KIRC,48.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-17620.0,Alive,TUMOR FREE,1416.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1416.0,0.0,1416.0,nan,nan,0.0,1416.0,0
TCGA-CJ-4635-11,TCGA-CJ-4635,KIRC,48.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-17620.0,Alive,TUMOR FREE,1416.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1416.0,0.0,1416.0,nan,nan,0.0,1416.0,0
TCGA-CJ-4636-01,TCGA-CJ-4636,KIRC,51.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-18878.0,Alive,TUMOR FREE,1924.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1924.0,0.0,1924.0,nan,nan,0.0,1924.0,0
TCGA-CJ-4636-11,TCGA-CJ-4636,KIRC,51.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-18878.0,Alive,TUMOR FREE,1924.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1924.0,0.0,1924.0,nan,nan,0.0,1924.0,0
TCGA-CJ-4637-01,TCGA-CJ-4637,KIRC,52.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-19101.0,Dead,WITH TUMOR,nan,2227.0,nan,nan,nan,nan,1821.0,nan,nan,nan,1.0,2227.0,1.0,2227.0,nan,nan,1.0,1821.0,1
TCGA-CJ-4637-11,TCGA-CJ-4637,KIRC,52.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-19101.0,Dead,WITH TUMOR,nan,2227.0,nan,nan,nan,nan,1821.0,nan,nan,nan,1.0,2227.0,1.0,2227.0,nan,nan,1.0,1821.0,1
TCGA-CJ-4638-01,TCGA-CJ-4638,KIRC,46.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-17110.0,Dead,WITH TUMOR,nan,431.0,nan,nan,nan,nan,70.0,nan,nan,nan,1.0,431.0,1.0,431.0,nan,nan,1.0,70.0,1
TCGA-CJ-4638-11,TCGA-CJ-4638,KIRC,46.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-17110.0,Dead,WITH TUMOR,nan,431.0,nan,nan,nan,nan,70.0,nan,nan,nan,1.0,431.0,1.0,431.0,nan,nan,1.0,70.0,1
TCGA-CJ-4639-01,TCGA-CJ-4639,KIRC,49.0,FEMALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-18066.0,Alive,TUMOR FREE,3229.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3229.0,0.0,3229.0,0.0,3229.0,0.0,3229.0,0
TCGA-CJ-4639-11,TCGA-CJ-4639,KIRC,49.0,FEMALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-18066.0,Alive,TUMOR FREE,3229.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3229.0,0.0,3229.0,0.0,3229.0,0.0,3229.0,0
TCGA-CJ-4640-01,TCGA-CJ-4640,KIRC,49.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-18178.0,Alive,TUMOR FREE,3480.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3480.0,0.0,3480.0,0.0,3480.0,0.0,3480.0,0
TCGA-CJ-4640-11,TCGA-CJ-4640,KIRC,49.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-18178.0,Alive,TUMOR FREE,3480.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3480.0,0.0,3480.0,0.0,3480.0,0.0,3480.0,0
TCGA-CJ-4641-01,TCGA-CJ-4641,KIRC,55.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-20410.0,Dead,WITH TUMOR,nan,1661.0,nan,nan,nan,nan,-359.0,nan,nan,nan,1.0,1661.0,1.0,1661.0,nan,nan,1.0,nan,1
TCGA-CJ-4641-11,TCGA-CJ-4641,KIRC,55.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-20410.0,Dead,WITH TUMOR,nan,1661.0,nan,nan,nan,nan,-359.0,nan,nan,nan,1.0,1661.0,1.0,1661.0,nan,nan,1.0,nan,1
TCGA-CJ-4642-01,TCGA-CJ-4642,KIRC,47.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-17367.0,Alive,TUMOR FREE,3205.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3205.0,0.0,3205.0,0.0,3205.0,0.0,3205.0,0
TCGA-CJ-4642-11,TCGA-CJ-4642,KIRC,47.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-17367.0,Alive,TUMOR FREE,3205.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3205.0,0.0,3205.0,0.0,3205.0,0.0,3205.0,0
TCGA-CJ-4643-01,TCGA-CJ-4643,KIRC,67.0,FEMALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-24477.0,Alive,TUMOR FREE,1793.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1793.0,0.0,1793.0,nan,nan,0.0,1793.0,0
TCGA-CJ-4643-11,TCGA-CJ-4643,KIRC,67.0,FEMALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-24477.0,Alive,TUMOR FREE,1793.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1793.0,0.0,1793.0,nan,nan,0.0,1793.0,0
TCGA-CJ-4644-01,TCGA-CJ-4644,KIRC,48.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-17882.0,Dead,WITH TUMOR,nan,336.0,nan,nan,nan,nan,93.0,nan,nan,nan,1.0,336.0,1.0,336.0,nan,nan,1.0,93.0,1
TCGA-CJ-4644-11,TCGA-CJ-4644,KIRC,48.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-17882.0,Dead,WITH TUMOR,nan,336.0,nan,nan,nan,nan,93.0,nan,nan,nan,1.0,336.0,1.0,336.0,nan,nan,1.0,93.0,1
TCGA-CJ-4868-01,TCGA-CJ-4868,KIRC,42.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-15601.0,Dead,WITH TUMOR,646.0,646.0,nan,nan,nan,nan,37.0,nan,nan,nan,1.0,646.0,1.0,646.0,nan,nan,1.0,37.0,1
TCGA-CJ-4868-11,TCGA-CJ-4868,KIRC,42.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-15601.0,Dead,WITH TUMOR,646.0,646.0,nan,nan,nan,nan,37.0,nan,nan,nan,1.0,646.0,1.0,646.0,nan,nan,1.0,37.0,1
TCGA-CJ-4869-01,TCGA-CJ-4869,KIRC,49.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-17923.0,Alive,WITH TUMOR,2554.0,nan,nan,nan,nan,nan,1754.0,nan,nan,nan,0.0,2554.0,0.0,2554.0,nan,nan,1.0,1754.0,2
TCGA-CJ-4869-11,TCGA-CJ-4869,KIRC,49.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-17923.0,Alive,WITH TUMOR,2554.0,nan,nan,nan,nan,nan,1754.0,nan,nan,nan,0.0,2554.0,0.0,2554.0,nan,nan,1.0,1754.0,2
TCGA-CJ-4870-01,TCGA-CJ-4870,KIRC,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-21340.0,Alive,TUMOR FREE,1498.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1498.0,0.0,1498.0,nan,nan,0.0,1498.0,0
TCGA-CJ-4870-11,TCGA-CJ-4870,KIRC,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-21340.0,Alive,TUMOR FREE,1498.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1498.0,0.0,1498.0,nan,nan,0.0,1498.0,0
TCGA-CJ-4871-01,TCGA-CJ-4871,KIRC,63.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-23195.0,Alive,TUMOR FREE,2423.0,nan,nan,nan,nan,nan,169.0,nan,nan,nan,0.0,2423.0,0.0,2423.0,nan,nan,1.0,169.0,0
TCGA-CJ-4871-11,TCGA-CJ-4871,KIRC,63.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-23195.0,Alive,TUMOR FREE,2423.0,nan,nan,nan,nan,nan,169.0,nan,nan,nan,0.0,2423.0,0.0,2423.0,nan,nan,1.0,169.0,0
TCGA-CJ-4872-01,TCGA-CJ-4872,KIRC,51.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-18862.0,Alive,TUMOR FREE,1435.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1435.0,0.0,1435.0,nan,nan,0.0,1435.0,0
TCGA-CJ-4872-11,TCGA-CJ-4872,KIRC,51.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-18862.0,Alive,TUMOR FREE,1435.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1435.0,0.0,1435.0,nan,nan,0.0,1435.0,0
TCGA-CJ-4873-01,TCGA-CJ-4873,KIRC,85.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-31096.0,Alive,TUMOR FREE,2259.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2259.0,0.0,2259.0,nan,nan,0.0,2259.0,0
TCGA-CJ-4873-11,TCGA-CJ-4873,KIRC,85.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-31096.0,Alive,TUMOR FREE,2259.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2259.0,0.0,2259.0,nan,nan,0.0,2259.0,0
TCGA-CJ-4874-01,TCGA-CJ-4874,KIRC,73.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-26761.0,Alive,TUMOR FREE,2283.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2283.0,0.0,2283.0,nan,nan,0.0,2283.0,0
TCGA-CJ-4874-11,TCGA-CJ-4874,KIRC,73.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-26761.0,Alive,TUMOR FREE,2283.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2283.0,0.0,2283.0,nan,nan,0.0,2283.0,0
TCGA-CJ-4875-01,TCGA-CJ-4875,KIRC,67.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-24510.0,Dead,WITH TUMOR,nan,3554.0,nan,nan,nan,nan,531.0,Complete Remission/Response,nan,nan,1.0,3554.0,1.0,3554.0,nan,nan,1.0,531.0,1
TCGA-CJ-4875-11,TCGA-CJ-4875,KIRC,67.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-24510.0,Dead,WITH TUMOR,nan,3554.0,nan,nan,nan,nan,531.0,Complete Remission/Response,nan,nan,1.0,3554.0,1.0,3554.0,nan,nan,1.0,531.0,1
TCGA-CJ-4876-01,TCGA-CJ-4876,KIRC,57.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-20993.0,Alive,TUMOR FREE,1955.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1955.0,0.0,1955.0,nan,nan,0.0,1955.0,0
TCGA-CJ-4876-11,TCGA-CJ-4876,KIRC,57.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-20993.0,Alive,TUMOR FREE,1955.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1955.0,0.0,1955.0,nan,nan,0.0,1955.0,0
TCGA-CJ-4878-01,TCGA-CJ-4878,KIRC,71.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-26224.0,Alive,TUMOR FREE,2186.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2186.0,0.0,2186.0,nan,nan,0.0,2186.0,0
TCGA-CJ-4878-11,TCGA-CJ-4878,KIRC,71.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-26224.0,Alive,TUMOR FREE,2186.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2186.0,0.0,2186.0,nan,nan,0.0,2186.0,0
TCGA-CJ-4881-01,TCGA-CJ-4881,KIRC,41.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-15197.0,Alive,WITH TUMOR,2014.0,nan,nan,nan,nan,nan,1881.0,nan,nan,nan,0.0,2014.0,0.0,2014.0,nan,nan,1.0,1881.0,0
TCGA-CJ-4881-11,TCGA-CJ-4881,KIRC,41.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-15197.0,Alive,WITH TUMOR,2014.0,nan,nan,nan,nan,nan,1881.0,nan,nan,nan,0.0,2014.0,0.0,2014.0,nan,nan,1.0,1881.0,0
TCGA-CJ-4882-01,TCGA-CJ-4882,KIRC,57.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-21074.0,Alive,TUMOR FREE,1883.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1883.0,0.0,1883.0,nan,nan,0.0,1883.0,0
TCGA-CJ-4882-11,TCGA-CJ-4882,KIRC,57.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-21074.0,Alive,TUMOR FREE,1883.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1883.0,0.0,1883.0,nan,nan,0.0,1883.0,0
TCGA-CJ-4884-01,TCGA-CJ-4884,KIRC,72.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-26475.0,Alive,TUMOR FREE,1759.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1759.0,0.0,1759.0,nan,nan,0.0,1759.0,0
TCGA-CJ-4884-11,TCGA-CJ-4884,KIRC,72.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-26475.0,Alive,TUMOR FREE,1759.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1759.0,0.0,1759.0,nan,nan,0.0,1759.0,0
TCGA-CJ-4885-01,TCGA-CJ-4885,KIRC,64.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-23437.0,Alive,TUMOR FREE,3451.0,nan,nan,nan,nan,nan,2041.0,Complete Remission/Response,nan,nan,0.0,3451.0,0.0,3451.0,nan,nan,1.0,2041.0,0
TCGA-CJ-4885-11,TCGA-CJ-4885,KIRC,64.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-23437.0,Alive,TUMOR FREE,3451.0,nan,nan,nan,nan,nan,2041.0,Complete Remission/Response,nan,nan,0.0,3451.0,0.0,3451.0,nan,nan,1.0,2041.0,0
TCGA-CJ-4886-01,TCGA-CJ-4886,KIRC,42.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-15698.0,Alive,TUMOR FREE,1952.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1952.0,0.0,1952.0,nan,nan,0.0,1952.0,0
TCGA-CJ-4886-11,TCGA-CJ-4886,KIRC,42.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-15698.0,Alive,TUMOR FREE,1952.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1952.0,0.0,1952.0,nan,nan,0.0,1952.0,0
TCGA-CJ-4887-01,TCGA-CJ-4887,KIRC,48.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-17611.0,Dead,WITH TUMOR,nan,932.0,nan,nan,nan,nan,322.0,nan,nan,nan,1.0,932.0,1.0,932.0,nan,nan,1.0,322.0,1
TCGA-CJ-4887-11,TCGA-CJ-4887,KIRC,48.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-17611.0,Dead,WITH TUMOR,nan,932.0,nan,nan,nan,nan,322.0,nan,nan,nan,1.0,932.0,1.0,932.0,nan,nan,1.0,322.0,1
TCGA-CJ-4888-01,TCGA-CJ-4888,KIRC,59.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-21701.0,Dead,WITH TUMOR,nan,1567.0,nan,nan,nan,nan,608.0,nan,nan,nan,1.0,1567.0,1.0,1567.0,nan,nan,1.0,608.0,1
TCGA-CJ-4888-11,TCGA-CJ-4888,KIRC,59.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-21701.0,Dead,WITH TUMOR,nan,1567.0,nan,nan,nan,nan,608.0,nan,nan,nan,1.0,1567.0,1.0,1567.0,nan,nan,1.0,608.0,1
TCGA-CJ-4889-01,TCGA-CJ-4889,KIRC,63.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-23051.0,Alive,TUMOR FREE,1946.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1946.0,0.0,1946.0,nan,nan,0.0,1946.0,0
TCGA-CJ-4889-11,TCGA-CJ-4889,KIRC,63.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-23051.0,Alive,TUMOR FREE,1946.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1946.0,0.0,1946.0,nan,nan,0.0,1946.0,0
TCGA-CJ-4890-01,TCGA-CJ-4890,KIRC,72.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-26604.0,Alive,TUMOR FREE,3519.0,nan,nan,nan,nan,nan,70.0,Progressive Disease,nan,nan,0.0,3519.0,0.0,3519.0,nan,nan,1.0,70.0,0
TCGA-CJ-4890-11,TCGA-CJ-4890,KIRC,72.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-26604.0,Alive,TUMOR FREE,3519.0,nan,nan,nan,nan,nan,70.0,Progressive Disease,nan,nan,0.0,3519.0,0.0,3519.0,nan,nan,1.0,70.0,0
TCGA-CJ-4891-01,TCGA-CJ-4891,KIRC,57.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-21059.0,Dead,TUMOR FREE,nan,819.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,819.0,0.0,819.0,nan,nan,0.0,819.0,1
TCGA-CJ-4891-11,TCGA-CJ-4891,KIRC,57.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-21059.0,Dead,TUMOR FREE,nan,819.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,819.0,0.0,819.0,nan,nan,0.0,819.0,1
TCGA-CJ-4892-01,TCGA-CJ-4892,KIRC,65.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-23764.0,Alive,TUMOR FREE,1521.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1521.0,0.0,1521.0,nan,nan,0.0,1521.0,0
TCGA-CJ-4892-11,TCGA-CJ-4892,KIRC,65.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-23764.0,Alive,TUMOR FREE,1521.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1521.0,0.0,1521.0,nan,nan,0.0,1521.0,0
TCGA-CJ-4893-01,TCGA-CJ-4893,KIRC,76.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-27885.0,Alive,TUMOR FREE,750.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,750.0,0.0,750.0,nan,nan,0.0,750.0,0
TCGA-CJ-4893-11,TCGA-CJ-4893,KIRC,76.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-27885.0,Alive,TUMOR FREE,750.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,750.0,0.0,750.0,nan,nan,0.0,750.0,0
TCGA-CJ-4894-01,TCGA-CJ-4894,KIRC,58.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-21524.0,Dead,WITH TUMOR,841.0,841.0,nan,nan,nan,nan,158.0,nan,nan,nan,1.0,841.0,1.0,841.0,nan,nan,1.0,158.0,1
TCGA-CJ-4894-11,TCGA-CJ-4894,KIRC,58.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-21524.0,Dead,WITH TUMOR,841.0,841.0,nan,nan,nan,nan,158.0,nan,nan,nan,1.0,841.0,1.0,841.0,nan,nan,1.0,158.0,1
TCGA-CJ-4895-01,TCGA-CJ-4895,KIRC,62.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-22892.0,Dead,WITH TUMOR,nan,1200.0,nan,nan,nan,nan,61.0,nan,nan,nan,1.0,1200.0,1.0,1200.0,nan,nan,1.0,61.0,1
TCGA-CJ-4895-11,TCGA-CJ-4895,KIRC,62.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-22892.0,Dead,WITH TUMOR,nan,1200.0,nan,nan,nan,nan,61.0,nan,nan,nan,1.0,1200.0,1.0,1200.0,nan,nan,1.0,61.0,1
TCGA-CJ-4897-01,TCGA-CJ-4897,KIRC,79.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-29124.0,Alive,WITH TUMOR,3341.0,nan,nan,nan,nan,nan,1423.0,Complete Remission/Response,nan,nan,0.0,3341.0,0.0,3341.0,1.0,1423.0,1.0,1423.0,2
TCGA-CJ-4897-11,TCGA-CJ-4897,KIRC,79.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-29124.0,Alive,WITH TUMOR,3341.0,nan,nan,nan,nan,nan,1423.0,Complete Remission/Response,nan,nan,0.0,3341.0,0.0,3341.0,1.0,1423.0,1.0,1423.0,2
TCGA-CJ-4899-01,TCGA-CJ-4899,KIRC,42.0,MALE,ASIAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-15637.0,Alive,TUMOR FREE,1528.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1528.0,0.0,1528.0,nan,nan,0.0,1528.0,0
TCGA-CJ-4899-11,TCGA-CJ-4899,KIRC,42.0,MALE,ASIAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-15637.0,Alive,TUMOR FREE,1528.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1528.0,0.0,1528.0,nan,nan,0.0,1528.0,0
TCGA-CJ-4900-01,TCGA-CJ-4900,KIRC,69.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2006.0,nan,-25508.0,Dead,WITH TUMOR,nan,1714.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1714.0,1.0,1714.0,nan,nan,1.0,1714.0,1
TCGA-CJ-4900-11,TCGA-CJ-4900,KIRC,69.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2006.0,nan,-25508.0,Dead,WITH TUMOR,nan,1714.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1714.0,1.0,1714.0,nan,nan,1.0,1714.0,1
TCGA-CJ-4901-01,TCGA-CJ-4901,KIRC,47.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-17396.0,Alive,TUMOR FREE,1450.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1450.0,0.0,1450.0,nan,nan,0.0,1450.0,0
TCGA-CJ-4901-11,TCGA-CJ-4901,KIRC,47.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-17396.0,Alive,TUMOR FREE,1450.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1450.0,0.0,1450.0,nan,nan,0.0,1450.0,0
TCGA-CJ-4902-01,TCGA-CJ-4902,KIRC,61.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-22424.0,Alive,TUMOR FREE,1520.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1520.0,0.0,1520.0,nan,nan,0.0,1520.0,0
TCGA-CJ-4902-11,TCGA-CJ-4902,KIRC,61.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-22424.0,Alive,TUMOR FREE,1520.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1520.0,0.0,1520.0,nan,nan,0.0,1520.0,0
TCGA-CJ-4903-01,TCGA-CJ-4903,KIRC,50.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-18510.0,Alive,TUMOR FREE,1560.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1560.0,0.0,1560.0,nan,nan,0.0,1560.0,0
TCGA-CJ-4903-11,TCGA-CJ-4903,KIRC,50.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-18510.0,Alive,TUMOR FREE,1560.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1560.0,0.0,1560.0,nan,nan,0.0,1560.0,0
TCGA-CJ-4904-01,TCGA-CJ-4904,KIRC,60.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-22036.0,Alive,WITH TUMOR,3302.0,nan,nan,nan,nan,nan,278.0,Stable Disease,nan,nan,0.0,3302.0,0.0,3302.0,nan,nan,1.0,278.0,2
TCGA-CJ-4904-11,TCGA-CJ-4904,KIRC,60.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-22036.0,Alive,WITH TUMOR,3302.0,nan,nan,nan,nan,nan,278.0,Stable Disease,nan,nan,0.0,3302.0,0.0,3302.0,nan,nan,1.0,278.0,2
TCGA-CJ-4905-01,TCGA-CJ-4905,KIRC,62.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-22864.0,Alive,TUMOR FREE,1496.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1496.0,0.0,1496.0,nan,nan,0.0,1496.0,0
TCGA-CJ-4905-11,TCGA-CJ-4905,KIRC,62.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-22864.0,Alive,TUMOR FREE,1496.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1496.0,0.0,1496.0,nan,nan,0.0,1496.0,0
TCGA-CJ-4907-01,TCGA-CJ-4907,KIRC,58.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-21208.0,Alive,TUMOR FREE,1499.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1499.0,0.0,1499.0,nan,nan,0.0,1499.0,0
TCGA-CJ-4907-11,TCGA-CJ-4907,KIRC,58.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-21208.0,Alive,TUMOR FREE,1499.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1499.0,0.0,1499.0,nan,nan,0.0,1499.0,0
TCGA-CJ-4908-01,TCGA-CJ-4908,KIRC,38.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-14226.0,Alive,TUMOR FREE,1531.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1531.0,0.0,1531.0,nan,nan,0.0,1531.0,0
TCGA-CJ-4908-11,TCGA-CJ-4908,KIRC,38.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-14226.0,Alive,TUMOR FREE,1531.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1531.0,0.0,1531.0,nan,nan,0.0,1531.0,0
TCGA-CJ-4912-01,TCGA-CJ-4912,KIRC,61.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-22623.0,Alive,TUMOR FREE,1657.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1657.0,0.0,1657.0,nan,nan,0.0,1657.0,0
TCGA-CJ-4912-11,TCGA-CJ-4912,KIRC,61.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-22623.0,Alive,TUMOR FREE,1657.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1657.0,0.0,1657.0,nan,nan,0.0,1657.0,0
TCGA-CJ-4913-01,TCGA-CJ-4913,KIRC,45.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2006.0,nan,-16757.0,Dead,WITH TUMOR,nan,1173.0,nan,nan,nan,nan,538.0,nan,nan,nan,1.0,1173.0,1.0,1173.0,nan,nan,1.0,538.0,1
TCGA-CJ-4913-11,TCGA-CJ-4913,KIRC,45.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2006.0,nan,-16757.0,Dead,WITH TUMOR,nan,1173.0,nan,nan,nan,nan,538.0,nan,nan,nan,1.0,1173.0,1.0,1173.0,nan,nan,1.0,538.0,1
TCGA-CJ-4916-01,TCGA-CJ-4916,KIRC,69.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-25470.0,Alive,TUMOR FREE,1373.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1373.0,0.0,1373.0,nan,nan,0.0,1373.0,0
TCGA-CJ-4916-11,TCGA-CJ-4916,KIRC,69.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-25470.0,Alive,TUMOR FREE,1373.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1373.0,0.0,1373.0,nan,nan,0.0,1373.0,0
TCGA-CJ-4918-01,TCGA-CJ-4918,KIRC,64.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-23379.0,Dead,WITH TUMOR,nan,93.0,nan,nan,nan,nan,33.0,nan,nan,nan,1.0,93.0,1.0,93.0,nan,nan,1.0,33.0,1
TCGA-CJ-4918-11,TCGA-CJ-4918,KIRC,64.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-23379.0,Dead,WITH TUMOR,nan,93.0,nan,nan,nan,nan,33.0,nan,nan,nan,1.0,93.0,1.0,93.0,nan,nan,1.0,33.0,1
TCGA-CJ-4920-01,TCGA-CJ-4920,KIRC,64.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-23656.0,Dead,TUMOR FREE,nan,139.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,139.0,0.0,139.0,nan,nan,0.0,139.0,1
TCGA-CJ-4920-11,TCGA-CJ-4920,KIRC,64.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-23656.0,Dead,TUMOR FREE,nan,139.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,139.0,0.0,139.0,nan,nan,0.0,139.0,1
TCGA-CJ-4923-01,TCGA-CJ-4923,KIRC,63.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-23353.0,Dead,WITH TUMOR,nan,572.0,nan,nan,nan,nan,25.0,nan,nan,nan,1.0,572.0,1.0,572.0,nan,nan,1.0,25.0,1
TCGA-CJ-4923-11,TCGA-CJ-4923,KIRC,63.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-23353.0,Dead,WITH TUMOR,nan,572.0,nan,nan,nan,nan,25.0,nan,nan,nan,1.0,572.0,1.0,572.0,nan,nan,1.0,25.0,1
TCGA-CJ-5671-01,TCGA-CJ-5671,KIRC,51.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-18954.0,Alive,TUMOR FREE,3987.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3987.0,0.0,3987.0,0.0,3987.0,0.0,3987.0,0
TCGA-CJ-5672-01,TCGA-CJ-5672,KIRC,84.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-30900.0,Dead,TUMOR FREE,nan,2190.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2190.0,0.0,2190.0,nan,nan,0.0,2190.0,0
TCGA-CJ-5672-11,TCGA-CJ-5672,KIRC,84.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-30900.0,Dead,TUMOR FREE,nan,2190.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2190.0,0.0,2190.0,nan,nan,0.0,2190.0,0
TCGA-CJ-5675-01,TCGA-CJ-5675,KIRC,70.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-25617.0,Alive,WITH TUMOR,3936.0,nan,nan,nan,nan,nan,900.0,Complete Remission/Response,nan,nan,0.0,3936.0,0.0,3936.0,1.0,900.0,1.0,900.0,2
TCGA-CJ-5676-01,TCGA-CJ-5676,KIRC,47.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-17170.0,Alive,WITH TUMOR,4067.0,nan,nan,nan,nan,nan,2219.0,Complete Remission/Response,nan,nan,0.0,4067.0,0.0,4067.0,1.0,2219.0,1.0,2219.0,2
TCGA-CJ-5676-11,TCGA-CJ-5676,KIRC,47.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-17170.0,Alive,WITH TUMOR,4067.0,nan,nan,nan,nan,nan,2219.0,Complete Remission/Response,nan,nan,0.0,4067.0,0.0,4067.0,1.0,2219.0,1.0,2219.0,2
TCGA-CJ-5677-01,TCGA-CJ-5677,KIRC,54.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-19849.0,Dead,WITH TUMOR,nan,782.0,nan,nan,nan,nan,288.0,nan,nan,nan,1.0,782.0,1.0,782.0,nan,nan,1.0,288.0,1
TCGA-CJ-5677-11,TCGA-CJ-5677,KIRC,54.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-19849.0,Dead,WITH TUMOR,nan,782.0,nan,nan,nan,nan,288.0,nan,nan,nan,1.0,782.0,1.0,782.0,nan,nan,1.0,288.0,1
TCGA-CJ-5678-01,TCGA-CJ-5678,KIRC,62.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-22944.0,Dead,WITH TUMOR,nan,574.0,nan,nan,nan,nan,399.0,nan,nan,nan,1.0,574.0,1.0,574.0,nan,nan,1.0,399.0,1
TCGA-CJ-5678-11,TCGA-CJ-5678,KIRC,62.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-22944.0,Dead,WITH TUMOR,nan,574.0,nan,nan,nan,nan,399.0,nan,nan,nan,1.0,574.0,1.0,574.0,nan,nan,1.0,399.0,1
TCGA-CJ-5679-01,TCGA-CJ-5679,KIRC,73.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2003.0,nan,-26858.0,Dead,WITH TUMOR,nan,679.0,nan,nan,nan,nan,595.0,nan,nan,nan,1.0,679.0,1.0,679.0,nan,nan,1.0,595.0,1
TCGA-CJ-5679-11,TCGA-CJ-5679,KIRC,73.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2003.0,nan,-26858.0,Dead,WITH TUMOR,nan,679.0,nan,nan,nan,nan,595.0,nan,nan,nan,1.0,679.0,1.0,679.0,nan,nan,1.0,595.0,1
TCGA-CJ-5680-01,TCGA-CJ-5680,KIRC,65.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2003.0,nan,-23778.0,Dead,WITH TUMOR,nan,768.0,nan,nan,nan,nan,153.0,nan,nan,nan,1.0,768.0,1.0,768.0,nan,nan,1.0,153.0,1
TCGA-CJ-5680-11,TCGA-CJ-5680,KIRC,65.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2003.0,nan,-23778.0,Dead,WITH TUMOR,nan,768.0,nan,nan,nan,nan,153.0,nan,nan,nan,1.0,768.0,1.0,768.0,nan,nan,1.0,153.0,1
TCGA-CJ-5681-01,TCGA-CJ-5681,KIRC,44.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-16121.0,Dead,WITH TUMOR,nan,552.0,nan,nan,nan,nan,17.0,nan,nan,nan,1.0,552.0,1.0,552.0,nan,nan,1.0,17.0,1
TCGA-CJ-5681-11,TCGA-CJ-5681,KIRC,44.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-16121.0,Dead,WITH TUMOR,nan,552.0,nan,nan,nan,nan,17.0,nan,nan,nan,1.0,552.0,1.0,552.0,nan,nan,1.0,17.0,1
TCGA-CJ-5682-01,TCGA-CJ-5682,KIRC,60.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-22244.0,Alive,WITH TUMOR,3736.0,nan,nan,nan,nan,nan,55.0,Stable Disease,nan,nan,0.0,3736.0,0.0,3736.0,nan,nan,1.0,55.0,2
TCGA-CJ-5683-01,TCGA-CJ-5683,KIRC,78.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-28745.0,Alive,TUMOR FREE,1889.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1889.0,0.0,1889.0,nan,nan,0.0,1889.0,0
TCGA-CJ-5684-01,TCGA-CJ-5684,KIRC,61.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-22561.0,Alive,TUMOR FREE,2231.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2231.0,0.0,2231.0,nan,nan,0.0,2231.0,0
TCGA-CJ-5686-01,TCGA-CJ-5686,KIRC,59.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-21836.0,Alive,TUMOR FREE,2038.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2038.0,0.0,2038.0,nan,nan,0.0,2038.0,0
TCGA-CJ-5689-01,TCGA-CJ-5689,KIRC,90.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-32872.0,Dead,TUMOR FREE,nan,1620.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1620.0,0.0,1620.0,nan,nan,0.0,1620.0,0
TCGA-CJ-5689-11,TCGA-CJ-5689,KIRC,90.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-32872.0,Dead,TUMOR FREE,nan,1620.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1620.0,0.0,1620.0,nan,nan,0.0,1620.0,0
TCGA-CJ-6027-01,TCGA-CJ-6027,KIRC,77.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G4,2003.0,nan,-28359.0,Dead,TUMOR FREE,nan,3615.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,3615.0,0.0,3615.0,0.0,3615.0,0.0,3615.0,0
TCGA-CJ-6028-01,TCGA-CJ-6028,KIRC,58.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2003.0,nan,-21380.0,Dead,WITH TUMOR,nan,1625.0,nan,nan,nan,nan,137.0,nan,nan,nan,1.0,1625.0,1.0,1625.0,nan,nan,1.0,137.0,1
TCGA-CJ-6030-01,TCGA-CJ-6030,KIRC,65.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-24096.0,Dead,TUMOR FREE,nan,2299.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2299.0,0.0,2299.0,nan,nan,0.0,2299.0,0
TCGA-CJ-6030-11,TCGA-CJ-6030,KIRC,65.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-24096.0,Dead,TUMOR FREE,nan,2299.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2299.0,0.0,2299.0,nan,nan,0.0,2299.0,0
TCGA-CJ-6031-01,TCGA-CJ-6031,KIRC,54.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-19905.0,Alive,TUMOR FREE,1906.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1906.0,0.0,1906.0,nan,nan,0.0,1906.0,0
TCGA-CJ-6032-01,TCGA-CJ-6032,KIRC,63.0,FEMALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-23310.0,Alive,TUMOR FREE,3639.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3639.0,0.0,3639.0,0.0,3639.0,0.0,3639.0,0
TCGA-CJ-6033-01,TCGA-CJ-6033,KIRC,54.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-19919.0,Dead,WITH TUMOR,nan,224.0,nan,nan,nan,nan,144.0,nan,nan,nan,1.0,224.0,1.0,224.0,nan,nan,1.0,144.0,1
TCGA-CJ-6033-11,TCGA-CJ-6033,KIRC,54.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-19919.0,Dead,WITH TUMOR,nan,224.0,nan,nan,nan,nan,144.0,nan,nan,nan,1.0,224.0,1.0,224.0,nan,nan,1.0,144.0,1
TCGA-CW-5580-01,TCGA-CW-5580,KIRC,73.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-26696.0,Dead,nan,nan,1964.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1964.0,nan,1964.0,nan,nan,0.0,1964.0,1
TCGA-CW-5580-11,TCGA-CW-5580,KIRC,73.0,FEMALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-26696.0,Dead,nan,nan,1964.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1964.0,nan,1964.0,nan,nan,0.0,1964.0,1
TCGA-CW-5581-01,TCGA-CW-5581,KIRC,44.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-16195.0,Alive,TUMOR FREE,2799.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2799.0,0.0,2799.0,nan,nan,0.0,2799.0,0
TCGA-CW-5581-11,TCGA-CW-5581,KIRC,44.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-16195.0,Alive,TUMOR FREE,2799.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2799.0,0.0,2799.0,nan,nan,0.0,2799.0,0
TCGA-CW-5583-01,TCGA-CW-5583,KIRC,51.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-18666.0,Alive,TUMOR FREE,2489.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2489.0,0.0,2489.0,nan,nan,0.0,2489.0,0
TCGA-CW-5584-01,TCGA-CW-5584,KIRC,74.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-27352.0,Dead,nan,nan,164.0,nan,nan,nan,nan,102.0,nan,nan,nan,1.0,164.0,nan,164.0,nan,nan,1.0,102.0,1
TCGA-CW-5584-11,TCGA-CW-5584,KIRC,74.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-27352.0,Dead,nan,nan,164.0,nan,nan,nan,nan,102.0,nan,nan,nan,1.0,164.0,nan,164.0,nan,nan,1.0,102.0,1
TCGA-CW-5585-01,TCGA-CW-5585,KIRC,51.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-18898.0,Alive,WITH TUMOR,2609.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2609.0,0.0,2609.0,nan,nan,0.0,2609.0,0
TCGA-CW-5585-11,TCGA-CW-5585,KIRC,51.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-18898.0,Alive,WITH TUMOR,2609.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2609.0,0.0,2609.0,nan,nan,0.0,2609.0,0
TCGA-CW-5587-01,TCGA-CW-5587,KIRC,62.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-22693.0,Alive,TUMOR FREE,2226.0,nan,nan,nan,nan,nan,2003.0,nan,nan,nan,0.0,2226.0,0.0,2226.0,nan,nan,1.0,2003.0,2
TCGA-CW-5587-11,TCGA-CW-5587,KIRC,62.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-22693.0,Alive,TUMOR FREE,2226.0,nan,nan,nan,nan,nan,2003.0,nan,nan,nan,0.0,2226.0,0.0,2226.0,nan,nan,1.0,2003.0,2
TCGA-CW-5588-01,TCGA-CW-5588,KIRC,78.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-28714.0,Alive,nan,2017.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2017.0,0.0,2017.0,nan,nan,0.0,2017.0,0
TCGA-CW-5589-01,TCGA-CW-5589,KIRC,52.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-19312.0,Alive,TUMOR FREE,2378.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2378.0,0.0,2378.0,nan,nan,0.0,2378.0,0
TCGA-CW-5589-11,TCGA-CW-5589,KIRC,52.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-19312.0,Alive,TUMOR FREE,2378.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2378.0,0.0,2378.0,nan,nan,0.0,2378.0,0
TCGA-CW-5590-01,TCGA-CW-5590,KIRC,51.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2004.0,nan,-18905.0,Dead,nan,nan,1075.0,nan,nan,nan,nan,672.0,nan,nan,nan,1.0,1075.0,nan,1075.0,nan,nan,1.0,672.0,1
TCGA-CW-5591-01,TCGA-CW-5591,KIRC,56.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-20712.0,Alive,WITH TUMOR,2271.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2271.0,0.0,2271.0,nan,nan,0.0,2271.0,0
TCGA-CW-5591-11,TCGA-CW-5591,KIRC,56.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G2,2004.0,nan,-20712.0,Alive,WITH TUMOR,2271.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2271.0,0.0,2271.0,nan,nan,0.0,2271.0,0
TCGA-CW-6087-01,TCGA-CW-6087,KIRC,61.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2003.0,nan,-22438.0,Dead,TUMOR FREE,nan,41.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,41.0,0.0,41.0,nan,nan,0.0,41.0,0
TCGA-CW-6087-11,TCGA-CW-6087,KIRC,61.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2003.0,nan,-22438.0,Dead,TUMOR FREE,nan,41.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,41.0,0.0,41.0,nan,nan,0.0,41.0,0
TCGA-CW-6088-01,TCGA-CW-6088,KIRC,60.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-22020.0,Alive,TUMOR FREE,3222.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,3222.0,0.0,3222.0,nan,nan,0.0,3222.0,0
TCGA-CW-6088-11,TCGA-CW-6088,KIRC,60.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2003.0,nan,-22020.0,Alive,TUMOR FREE,3222.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,3222.0,0.0,3222.0,nan,nan,0.0,3222.0,0
TCGA-CW-6090-01,TCGA-CW-6090,KIRC,68.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-24909.0,Alive,TUMOR FREE,2552.0,nan,nan,nan,nan,nan,2780.0,nan,nan,nan,0.0,2552.0,0.0,2552.0,nan,nan,1.0,2780.0,0
TCGA-CW-6090-11,TCGA-CW-6090,KIRC,68.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2003.0,nan,-24909.0,Alive,TUMOR FREE,2552.0,nan,nan,nan,nan,nan,2780.0,nan,nan,nan,0.0,2552.0,0.0,2552.0,nan,nan,1.0,2780.0,0
TCGA-CW-6093-01,TCGA-CW-6093,KIRC,73.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G1,2004.0,nan,-26909.0,Alive,TUMOR FREE,3146.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,3146.0,0.0,3146.0,nan,nan,0.0,3146.0,0
TCGA-CW-6097-01,TCGA-CW-6097,KIRC,32.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2004.0,nan,-11701.0,Dead,WITH TUMOR,nan,571.0,nan,nan,nan,nan,457.0,nan,nan,nan,1.0,571.0,1.0,571.0,nan,nan,1.0,457.0,1
TCGA-CZ-4853-01,TCGA-CZ-4853,KIRC,82.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-30191.0,Alive,TUMOR FREE,774.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,774.0,0.0,774.0,nan,nan,0.0,774.0,0
TCGA-CZ-4853-11,TCGA-CZ-4853,KIRC,82.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-30191.0,Alive,TUMOR FREE,774.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,774.0,0.0,774.0,nan,nan,0.0,774.0,0
TCGA-CZ-4854-01,TCGA-CZ-4854,KIRC,68.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-24876.0,Dead,TUMOR FREE,nan,1404.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1404.0,0.0,1404.0,nan,nan,0.0,1404.0,0
TCGA-CZ-4854-11,TCGA-CZ-4854,KIRC,68.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-24876.0,Dead,TUMOR FREE,nan,1404.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1404.0,0.0,1404.0,nan,nan,0.0,1404.0,0
TCGA-CZ-4856-01,TCGA-CZ-4856,KIRC,62.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-22684.0,Alive,nan,18.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,18.0,0.0,18.0,nan,nan,0.0,18.0,0
TCGA-CZ-4856-11,TCGA-CZ-4856,KIRC,62.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-22684.0,Alive,nan,18.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,18.0,0.0,18.0,nan,nan,0.0,18.0,0
TCGA-CZ-4857-01,TCGA-CZ-4857,KIRC,56.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-20718.0,Dead,WITH TUMOR,nan,1432.0,nan,nan,nan,nan,188.0,nan,nan,nan,1.0,1432.0,1.0,1432.0,nan,nan,1.0,188.0,1
TCGA-CZ-4857-11,TCGA-CZ-4857,KIRC,56.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-20718.0,Dead,WITH TUMOR,nan,1432.0,nan,nan,nan,nan,188.0,nan,nan,nan,1.0,1432.0,1.0,1432.0,nan,nan,1.0,188.0,1
TCGA-CZ-4858-01,TCGA-CZ-4858,KIRC,39.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-14343.0,Dead,WITH TUMOR,nan,2105.0,nan,nan,nan,nan,597.0,nan,nan,nan,1.0,2105.0,1.0,2105.0,nan,nan,1.0,597.0,1
TCGA-CZ-4858-11,TCGA-CZ-4858,KIRC,39.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-14343.0,Dead,WITH TUMOR,nan,2105.0,nan,nan,nan,nan,597.0,nan,nan,nan,1.0,2105.0,1.0,2105.0,nan,nan,1.0,597.0,1
TCGA-CZ-4859-01,TCGA-CZ-4859,KIRC,59.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-21842.0,Alive,TUMOR FREE,1787.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1787.0,0.0,1787.0,nan,nan,0.0,1787.0,0
TCGA-CZ-4859-11,TCGA-CZ-4859,KIRC,59.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-21842.0,Alive,TUMOR FREE,1787.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1787.0,0.0,1787.0,nan,nan,0.0,1787.0,0
TCGA-CZ-4860-01,TCGA-CZ-4860,KIRC,60.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-22115.0,Dead,WITH TUMOR,nan,206.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,206.0,1.0,206.0,nan,nan,1.0,206.0,1
TCGA-CZ-4860-11,TCGA-CZ-4860,KIRC,60.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2005.0,nan,-22115.0,Dead,WITH TUMOR,nan,206.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,206.0,1.0,206.0,nan,nan,1.0,206.0,1
TCGA-CZ-4861-01,TCGA-CZ-4861,KIRC,63.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-23053.0,Dead,WITH TUMOR,nan,446.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,446.0,1.0,446.0,nan,nan,1.0,446.0,1
TCGA-CZ-4861-11,TCGA-CZ-4861,KIRC,63.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-23053.0,Dead,WITH TUMOR,nan,446.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,446.0,1.0,446.0,nan,nan,1.0,446.0,1
TCGA-CZ-4862-01,TCGA-CZ-4862,KIRC,46.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-17077.0,Alive,[Discrepancy],3271.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3271.0,0.0,3271.0,nan,nan,0.0,3271.0,0
TCGA-CZ-4862-11,TCGA-CZ-4862,KIRC,46.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-17077.0,Alive,[Discrepancy],3271.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3271.0,0.0,3271.0,nan,nan,0.0,3271.0,0
TCGA-CZ-4863-01,TCGA-CZ-4863,KIRC,51.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-18730.0,Alive,TUMOR FREE,1928.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1928.0,0.0,1928.0,nan,nan,0.0,1928.0,0
TCGA-CZ-4863-11,TCGA-CZ-4863,KIRC,51.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-18730.0,Alive,TUMOR FREE,1928.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1928.0,0.0,1928.0,nan,nan,0.0,1928.0,0
TCGA-CZ-4864-01,TCGA-CZ-4864,KIRC,86.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2002.0,nan,-31557.0,Dead,TUMOR FREE,2830.0,2830.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2830.0,0.0,2830.0,nan,nan,0.0,2830.0,0
TCGA-CZ-4864-11,TCGA-CZ-4864,KIRC,86.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2002.0,nan,-31557.0,Dead,TUMOR FREE,2830.0,2830.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2830.0,0.0,2830.0,nan,nan,0.0,2830.0,0
TCGA-CZ-4865-01,TCGA-CZ-4865,KIRC,70.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-25709.0,Dead,TUMOR FREE,nan,166.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,166.0,0.0,166.0,nan,nan,0.0,166.0,1
TCGA-CZ-4865-11,TCGA-CZ-4865,KIRC,70.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-25709.0,Dead,TUMOR FREE,nan,166.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,166.0,0.0,166.0,nan,nan,0.0,166.0,1
TCGA-CZ-4866-01,TCGA-CZ-4866,KIRC,79.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-28878.0,Alive,WITH TUMOR,3267.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3267.0,0.0,3267.0,nan,nan,0.0,3267.0,0
TCGA-CZ-4866-11,TCGA-CZ-4866,KIRC,79.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-28878.0,Alive,WITH TUMOR,3267.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3267.0,0.0,3267.0,nan,nan,0.0,3267.0,0
TCGA-CZ-5451-01,TCGA-CZ-5451,KIRC,74.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-27312.0,Alive,TUMOR FREE,1929.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1929.0,0.0,1929.0,nan,nan,0.0,1929.0,0
TCGA-CZ-5451-11,TCGA-CZ-5451,KIRC,74.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-27312.0,Alive,TUMOR FREE,1929.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1929.0,0.0,1929.0,nan,nan,0.0,1929.0,0
TCGA-CZ-5452-01,TCGA-CZ-5452,KIRC,69.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-25486.0,Alive,TUMOR FREE,1789.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1789.0,0.0,1789.0,nan,nan,0.0,1789.0,0
TCGA-CZ-5452-11,TCGA-CZ-5452,KIRC,69.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-25486.0,Alive,TUMOR FREE,1789.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1789.0,0.0,1789.0,nan,nan,0.0,1789.0,0
TCGA-CZ-5453-01,TCGA-CZ-5453,KIRC,67.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-24640.0,Dead,nan,nan,2419.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2419.0,nan,2419.0,nan,nan,0.0,2419.0,1
TCGA-CZ-5453-11,TCGA-CZ-5453,KIRC,67.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-24640.0,Dead,nan,nan,2419.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2419.0,nan,2419.0,nan,nan,0.0,2419.0,1
TCGA-CZ-5454-01,TCGA-CZ-5454,KIRC,63.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-23083.0,Dead,WITH TUMOR,nan,722.0,nan,nan,nan,nan,423.0,nan,nan,nan,1.0,722.0,1.0,722.0,nan,nan,1.0,423.0,1
TCGA-CZ-5454-11,TCGA-CZ-5454,KIRC,63.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-23083.0,Dead,WITH TUMOR,nan,722.0,nan,nan,nan,nan,423.0,nan,nan,nan,1.0,722.0,1.0,722.0,nan,nan,1.0,423.0,1
TCGA-CZ-5455-01,TCGA-CZ-5455,KIRC,63.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2006.0,nan,-23150.0,Dead,WITH TUMOR,nan,561.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,561.0,1.0,561.0,nan,nan,1.0,561.0,1
TCGA-CZ-5455-11,TCGA-CZ-5455,KIRC,63.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2006.0,nan,-23150.0,Dead,WITH TUMOR,nan,561.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,561.0,1.0,561.0,nan,nan,1.0,561.0,1
TCGA-CZ-5456-01,TCGA-CZ-5456,KIRC,57.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-21164.0,Alive,WITH TUMOR,2422.0,nan,nan,nan,nan,nan,951.0,nan,nan,nan,0.0,2422.0,0.0,2422.0,nan,nan,1.0,951.0,0
TCGA-CZ-5456-11,TCGA-CZ-5456,KIRC,57.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-21164.0,Alive,WITH TUMOR,2422.0,nan,nan,nan,nan,nan,951.0,nan,nan,nan,0.0,2422.0,0.0,2422.0,nan,nan,1.0,951.0,0
TCGA-CZ-5457-01,TCGA-CZ-5457,KIRC,62.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2006.0,nan,-22763.0,Alive,WITH TUMOR,2754.0,nan,nan,nan,nan,nan,174.0,nan,nan,nan,0.0,2754.0,0.0,2754.0,nan,nan,1.0,174.0,0
TCGA-CZ-5457-11,TCGA-CZ-5457,KIRC,62.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2006.0,nan,-22763.0,Alive,WITH TUMOR,2754.0,nan,nan,nan,nan,nan,174.0,nan,nan,nan,0.0,2754.0,0.0,2754.0,nan,nan,1.0,174.0,0
TCGA-CZ-5458-01,TCGA-CZ-5458,KIRC,43.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-15790.0,Alive,TUMOR FREE,2789.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2789.0,0.0,2789.0,nan,nan,0.0,2789.0,0
TCGA-CZ-5458-11,TCGA-CZ-5458,KIRC,43.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-15790.0,Alive,TUMOR FREE,2789.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2789.0,0.0,2789.0,nan,nan,0.0,2789.0,0
TCGA-CZ-5459-01,TCGA-CZ-5459,KIRC,63.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-23318.0,Alive,TUMOR FREE,1683.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1683.0,0.0,1683.0,nan,nan,0.0,1683.0,0
TCGA-CZ-5459-11,TCGA-CZ-5459,KIRC,63.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-23318.0,Alive,TUMOR FREE,1683.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1683.0,0.0,1683.0,nan,nan,0.0,1683.0,0
TCGA-CZ-5460-01,TCGA-CZ-5460,KIRC,55.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-20392.0,Alive,WITH TUMOR,2873.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2873.0,0.0,2873.0,nan,nan,0.0,2873.0,0
TCGA-CZ-5460-11,TCGA-CZ-5460,KIRC,55.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-20392.0,Alive,WITH TUMOR,2873.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2873.0,0.0,2873.0,nan,nan,0.0,2873.0,0
TCGA-CZ-5461-01,TCGA-CZ-5461,KIRC,52.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2006.0,nan,-19030.0,Dead,WITH TUMOR,330.0,330.0,nan,nan,nan,nan,48.0,nan,nan,nan,1.0,330.0,1.0,330.0,nan,nan,1.0,48.0,1
TCGA-CZ-5461-11,TCGA-CZ-5461,KIRC,52.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2006.0,nan,-19030.0,Dead,WITH TUMOR,330.0,330.0,nan,nan,nan,nan,48.0,nan,nan,nan,1.0,330.0,1.0,330.0,nan,nan,1.0,48.0,1
TCGA-CZ-5462-01,TCGA-CZ-5462,KIRC,83.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-30659.0,Dead,WITH TUMOR,nan,311.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,311.0,1.0,311.0,nan,nan,1.0,311.0,1
TCGA-CZ-5462-11,TCGA-CZ-5462,KIRC,83.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2007.0,nan,-30659.0,Dead,WITH TUMOR,nan,311.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,311.0,1.0,311.0,nan,nan,1.0,311.0,1
TCGA-CZ-5463-01,TCGA-CZ-5463,KIRC,76.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-27911.0,Alive,nan,662.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,662.0,0.0,662.0,nan,nan,0.0,662.0,0
TCGA-CZ-5463-11,TCGA-CZ-5463,KIRC,76.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-27911.0,Alive,nan,662.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,662.0,0.0,662.0,nan,nan,0.0,662.0,0
TCGA-CZ-5464-01,TCGA-CZ-5464,KIRC,69.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-25463.0,Alive,TUMOR FREE,2128.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2128.0,0.0,2128.0,nan,nan,0.0,2128.0,0
TCGA-CZ-5464-11,TCGA-CZ-5464,KIRC,69.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-25463.0,Alive,TUMOR FREE,2128.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2128.0,0.0,2128.0,nan,nan,0.0,2128.0,0
TCGA-CZ-5465-01,TCGA-CZ-5465,KIRC,76.0,FEMALE,nan,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-27838.0,Dead,TUMOR FREE,nan,2564.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2564.0,0.0,2564.0,nan,nan,0.0,2564.0,1
TCGA-CZ-5465-11,TCGA-CZ-5465,KIRC,76.0,FEMALE,nan,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-27838.0,Dead,TUMOR FREE,nan,2564.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2564.0,0.0,2564.0,nan,nan,0.0,2564.0,1
TCGA-CZ-5466-01,TCGA-CZ-5466,KIRC,67.0,MALE,nan,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-24669.0,Alive,TUMOR FREE,685.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,685.0,0.0,685.0,nan,nan,0.0,685.0,0
TCGA-CZ-5466-11,TCGA-CZ-5466,KIRC,67.0,MALE,nan,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-24669.0,Alive,TUMOR FREE,685.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,685.0,0.0,685.0,nan,nan,0.0,685.0,0
TCGA-CZ-5467-01,TCGA-CZ-5467,KIRC,86.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-31473.0,Dead,WITH TUMOR,nan,73.0,nan,nan,nan,nan,62.0,nan,nan,nan,1.0,73.0,1.0,73.0,nan,nan,1.0,62.0,1
TCGA-CZ-5467-11,TCGA-CZ-5467,KIRC,86.0,FEMALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-31473.0,Dead,WITH TUMOR,nan,73.0,nan,nan,nan,nan,62.0,nan,nan,nan,1.0,73.0,1.0,73.0,nan,nan,1.0,62.0,1
TCGA-CZ-5468-01,TCGA-CZ-5468,KIRC,84.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-30729.0,Dead,WITH TUMOR,59.0,59.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,59.0,1.0,59.0,nan,nan,1.0,59.0,1
TCGA-CZ-5468-11,TCGA-CZ-5468,KIRC,84.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2007.0,nan,-30729.0,Dead,WITH TUMOR,59.0,59.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,59.0,1.0,59.0,nan,nan,1.0,59.0,1
TCGA-CZ-5469-01,TCGA-CZ-5469,KIRC,41.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-15242.0,Dead,WITH TUMOR,nan,946.0,nan,nan,nan,nan,110.0,nan,nan,nan,1.0,946.0,1.0,946.0,nan,nan,1.0,110.0,1
TCGA-CZ-5469-11,TCGA-CZ-5469,KIRC,41.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-15242.0,Dead,WITH TUMOR,nan,946.0,nan,nan,nan,nan,110.0,nan,nan,nan,1.0,946.0,1.0,946.0,nan,nan,1.0,110.0,1
TCGA-CZ-5470-01,TCGA-CZ-5470,KIRC,72.0,FEMALE,nan,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2008.0,nan,-26494.0,Alive,nan,386.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,386.0,0.0,386.0,nan,nan,0.0,386.0,0
TCGA-CZ-5470-11,TCGA-CZ-5470,KIRC,72.0,FEMALE,nan,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G3,2008.0,nan,-26494.0,Alive,nan,386.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,386.0,0.0,386.0,nan,nan,0.0,386.0,0
TCGA-CZ-5982-01,TCGA-CZ-5982,KIRC,59.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-21592.0,Alive,TUMOR FREE,2439.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2439.0,0.0,2439.0,nan,nan,0.0,2439.0,0
TCGA-CZ-5982-11,TCGA-CZ-5982,KIRC,59.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2005.0,nan,-21592.0,Alive,TUMOR FREE,2439.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2439.0,0.0,2439.0,nan,nan,0.0,2439.0,0
TCGA-CZ-5984-01,TCGA-CZ-5984,KIRC,51.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-18775.0,Alive,TUMOR FREE,2067.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2067.0,0.0,2067.0,nan,nan,0.0,2067.0,0
TCGA-CZ-5984-11,TCGA-CZ-5984,KIRC,51.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2005.0,nan,-18775.0,Alive,TUMOR FREE,2067.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2067.0,0.0,2067.0,nan,nan,0.0,2067.0,0
TCGA-CZ-5985-01,TCGA-CZ-5985,KIRC,58.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-21242.0,Alive,TUMOR FREE,1997.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1997.0,0.0,1997.0,nan,nan,0.0,1997.0,0
TCGA-CZ-5985-11,TCGA-CZ-5985,KIRC,58.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-21242.0,Alive,TUMOR FREE,1997.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1997.0,0.0,1997.0,nan,nan,0.0,1997.0,0
TCGA-CZ-5986-01,TCGA-CZ-5986,KIRC,61.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-22456.0,Alive,TUMOR FREE,373.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,373.0,0.0,373.0,nan,nan,0.0,373.0,0
TCGA-CZ-5986-11,TCGA-CZ-5986,KIRC,61.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2006.0,nan,-22456.0,Alive,TUMOR FREE,373.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,373.0,0.0,373.0,nan,nan,0.0,373.0,0
TCGA-CZ-5987-01,TCGA-CZ-5987,KIRC,60.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-21928.0,Dead,WITH TUMOR,nan,445.0,nan,nan,nan,nan,377.0,nan,nan,nan,1.0,445.0,1.0,445.0,nan,nan,1.0,377.0,1
TCGA-CZ-5987-11,TCGA-CZ-5987,KIRC,60.0,MALE,WHITE,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-21928.0,Dead,WITH TUMOR,nan,445.0,nan,nan,nan,nan,377.0,nan,nan,nan,1.0,445.0,1.0,445.0,nan,nan,1.0,377.0,1
TCGA-CZ-5988-01,TCGA-CZ-5988,KIRC,38.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-14131.0,Alive,TUMOR FREE,693.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,693.0,0.0,693.0,nan,nan,0.0,693.0,0
TCGA-CZ-5988-11,TCGA-CZ-5988,KIRC,38.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-14131.0,Alive,TUMOR FREE,693.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,693.0,0.0,693.0,nan,nan,0.0,693.0,0
TCGA-CZ-5989-01,TCGA-CZ-5989,KIRC,60.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-22170.0,Alive,TUMOR FREE,1905.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1905.0,0.0,1905.0,nan,nan,0.0,1905.0,0
TCGA-CZ-5989-11,TCGA-CZ-5989,KIRC,60.0,MALE,WHITE,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2006.0,nan,-22170.0,Alive,TUMOR FREE,1905.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1905.0,0.0,1905.0,nan,nan,0.0,1905.0,0
TCGA-DV-5565-01,TCGA-DV-5565,KIRC,59.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-21642.0,Alive,WITH TUMOR,1329.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1329.0,0.0,1329.0,nan,nan,0.0,1329.0,0
TCGA-DV-5566-01,TCGA-DV-5566,KIRC,67.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-24717.0,Alive,WITH TUMOR,1398.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1398.0,0.0,1398.0,nan,nan,0.0,1398.0,2
TCGA-DV-5567-01,TCGA-DV-5567,KIRC,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2008.0,nan,-14642.0,Alive,WITH TUMOR,2004.0,nan,nan,nan,nan,nan,2004.0,Complete Remission/Response,nan,nan,0.0,2004.0,0.0,2004.0,1.0,2004.0,1.0,2004.0,2
TCGA-DV-5568-01,TCGA-DV-5568,KIRC,26.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2009.0,nan,-9714.0,Alive,WITH TUMOR,370.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,370.0,0.0,370.0,nan,nan,0.0,370.0,0
TCGA-DV-5569-01,TCGA-DV-5569,KIRC,29.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2009.0,nan,-10698.0,Alive,TUMOR FREE,355.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,355.0,0.0,355.0,nan,nan,0.0,355.0,0
TCGA-DV-5573-01,TCGA-DV-5573,KIRC,41.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2008.0,nan,-15264.0,Alive,WITH TUMOR,1130.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1130.0,0.0,1130.0,nan,nan,0.0,1130.0,0
TCGA-DV-5574-01,TCGA-DV-5574,KIRC,37.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2008.0,nan,-13517.0,Alive,WITH TUMOR,2016.0,nan,nan,nan,nan,nan,357.0,Complete Remission/Response,nan,nan,0.0,2016.0,0.0,2016.0,1.0,357.0,1.0,357.0,2
TCGA-DV-5575-01,TCGA-DV-5575,KIRC,52.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-19022.0,Alive,WITH TUMOR,1729.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1729.0,0.0,1729.0,nan,nan,0.0,1729.0,2
TCGA-DV-5576-01,TCGA-DV-5576,KIRC,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2008.0,nan,-20310.0,Dead,WITH TUMOR,nan,727.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,727.0,1.0,727.0,nan,nan,1.0,727.0,1
TCGA-DV-A4VX-01,TCGA-DV-A4VX,KIRC,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2008.0,nan,-21670.0,Dead,WITH TUMOR,nan,1626.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,1626.0,1.0,1626.0,nan,nan,1.0,1626.0,1
TCGA-DV-A4VZ-01,TCGA-DV-A4VZ,KIRC,53.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2007.0,nan,-19560.0,Alive,TUMOR FREE,365.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,365.0,0.0,365.0,0.0,365.0,0.0,365.0,0
TCGA-DV-A4W0-05,TCGA-DV-A4W0,KIRC,55.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2008.0,nan,-20101.0,Alive,WITH TUMOR,2470.0,nan,nan,nan,nan,nan,2008.0,Stable Disease,nan,nan,0.0,2470.0,0.0,2470.0,nan,nan,1.0,2008.0,2
TCGA-DV-A4W0-01,TCGA-DV-A4W0,KIRC,55.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2008.0,nan,-20101.0,Alive,WITH TUMOR,2470.0,nan,nan,nan,nan,nan,2008.0,Stable Disease,nan,nan,0.0,2470.0,0.0,2470.0,nan,nan,1.0,2008.0,2
TCGA-EU-5904-01,TCGA-EU-5904,KIRC,47.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G1,2009.0,nan,-17468.0,Alive,TUMOR FREE,551.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,551.0,0.0,551.0,nan,nan,0.0,551.0,0
TCGA-EU-5905-01,TCGA-EU-5905,KIRC,67.0,FEMALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-24475.0,Alive,TUMOR FREE,119.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,119.0,0.0,119.0,nan,nan,0.0,119.0,0
TCGA-EU-5906-01,TCGA-EU-5906,KIRC,55.0,MALE,WHITE,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2010.0,nan,-20246.0,Alive,TUMOR FREE,206.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,206.0,0.0,206.0,nan,nan,0.0,206.0,0
TCGA-EU-5907-01,TCGA-EU-5907,KIRC,81.0,MALE,WHITE,Stage III,nan,Kidney Clear Cell Renal Carcinoma,G3,2010.0,nan,-29863.0,Alive,TUMOR FREE,127.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,127.0,0.0,127.0,nan,nan,0.0,127.0,0
TCGA-G6-A5PC-01,TCGA-G6-A5PC,KIRC,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G4,2012.0,nan,-20029.0,Dead,WITH TUMOR,nan,242.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,242.0,1.0,242.0,nan,nan,1.0,242.0,1
TCGA-G6-A8L6-01,TCGA-G6-A8L6,KIRC,55.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Kidney Clear Cell Renal Carcinoma,G3,2013.0,nan,-20306.0,Dead,WITH TUMOR,nan,313.0,nan,nan,nan,nan,304.0,Progressive Disease,nan,nan,1.0,313.0,1.0,313.0,nan,nan,1.0,304.0,1
TCGA-G6-A8L7-01,TCGA-G6-A8L7,KIRC,81.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2008.0,nan,-29883.0,Alive,TUMOR FREE,2133.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2133.0,0.0,2133.0,0.0,2133.0,0.0,2133.0,0
TCGA-G6-A8L8-01,TCGA-G6-A8L8,KIRC,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G3,2008.0,nan,-22649.0,Dead,TUMOR FREE,nan,1091.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1091.0,0.0,1091.0,0.0,1091.0,0.0,1091.0,0
TCGA-GK-A6C7-01,TCGA-GK-A6C7,KIRC,76.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,nan,2012.0,nan,-28107.0,Alive,TUMOR FREE,61.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,61.0,0.0,61.0,0.0,61.0,0.0,61.0,0
TCGA-MM-A563-01,TCGA-MM-A563,KIRC,41.0,MALE,BLACK OR AFRICAN AMERICAN,[Discrepancy],nan,Kidney Clear Cell Renal Carcinoma,G2,2012.0,nan,-15037.0,Alive,TUMOR FREE,591.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,591.0,0.0,591.0,0.0,591.0,0.0,591.0,0
TCGA-MM-A564-01,TCGA-MM-A564,KIRC,68.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Kidney Clear Cell Renal Carcinoma,G2,2012.0,nan,-24916.0,Alive,TUMOR FREE,607.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,607.0,0.0,607.0,0.0,607.0,0.0,607.0,0
TCGA-MM-A84U-01,TCGA-MM-A84U,KIRC,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2013.0,nan,-21375.0,Alive,TUMOR FREE,700.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,700.0,0.0,700.0,0.0,700.0,0.0,700.0,0
TCGA-MW-A4EC-01,TCGA-MW-A4EC,KIRC,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G2,2012.0,nan,-26649.0,Alive,TUMOR FREE,498.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,498.0,0.0,498.0,0.0,498.0,0.0,498.0,0
TCGA-T7-A92I-01,TCGA-T7-A92I,KIRC,47.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Clear Cell Renal Carcinoma,G1,2013.0,nan,-17331.0,Alive,TUMOR FREE,356.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,356.0,0.0,356.0,0.0,356.0,0.0,356.0,0
TCGA-2K-A9WE-01,TCGA-2K-A9WE,KIRP,53.0,MALE,WHITE,Stage II,nan,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-19603.0,Alive,TUMOR FREE,214.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,214.0,0.0,214.0,0.0,214.0,0.0,214.0,0
TCGA-2Z-A9J1-01,TCGA-2Z-A9J1,KIRP,71.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,-26244.0,Alive,TUMOR FREE,2298.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2298.0,0.0,2298.0,0.0,2298.0,0.0,2298.0,0
TCGA-2Z-A9J2-01,TCGA-2Z-A9J2,KIRP,71.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,-26134.0,Alive,TUMOR FREE,1795.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1795.0,0.0,1795.0,0.0,1795.0,0.0,1795.0,0
TCGA-2Z-A9J3-01,TCGA-2Z-A9J3,KIRP,67.0,MALE,WHITE,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,-24626.0,Dead,WITH TUMOR,nan,1771.0,nan,nan,nan,nan,790.0,Progressive Disease,nan,nan,1.0,1771.0,1.0,1771.0,nan,nan,1.0,790.0,1
TCGA-2Z-A9J5-01,TCGA-2Z-A9J5,KIRP,80.0,MALE,WHITE,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2006.0,nan,-29275.0,Alive,TUMOR FREE,3050.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,3050.0,0.0,3050.0,nan,nan,0.0,3050.0,0
TCGA-2Z-A9J6-01,TCGA-2Z-A9J6,KIRP,60.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2009.0,nan,-22265.0,Alive,TUMOR FREE,1731.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1731.0,0.0,1731.0,nan,nan,0.0,1731.0,0
TCGA-2Z-A9J7-01,TCGA-2Z-A9J7,KIRP,63.0,MALE,WHITE,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,nan,2007.0,nan,-23230.0,Dead,WITH TUMOR,nan,139.0,nan,nan,nan,nan,96.0,Progressive Disease,nan,nan,1.0,139.0,1.0,139.0,nan,nan,1.0,96.0,1
TCGA-2Z-A9J8-01,TCGA-2Z-A9J8,KIRP,50.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2007.0,nan,-18498.0,Alive,WITH TUMOR,2790.0,nan,nan,nan,nan,nan,506.0,Complete Remission/Response,nan,nan,0.0,2790.0,0.0,2790.0,1.0,506.0,1.0,506.0,2
TCGA-2Z-A9J9-01,TCGA-2Z-A9J9,KIRP,77.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2006.0,nan,-28346.0,Alive,TUMOR FREE,2294.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2294.0,0.0,2294.0,0.0,2294.0,0.0,2294.0,0
TCGA-2Z-A9JD-01,TCGA-2Z-A9JD,KIRP,66.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2009.0,nan,-24370.0,Alive,TUMOR FREE,1060.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1060.0,0.0,1060.0,nan,nan,0.0,1060.0,0
TCGA-2Z-A9JE-01,TCGA-2Z-A9JE,KIRP,59.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-21557.0,Alive,TUMOR FREE,1728.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1728.0,0.0,1728.0,0.0,1728.0,0.0,1728.0,0
TCGA-2Z-A9JG-01,TCGA-2Z-A9JG,KIRP,64.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-23458.0,Alive,TUMOR FREE,1662.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1662.0,0.0,1662.0,0.0,1662.0,0.0,1662.0,0
TCGA-2Z-A9JI-01,TCGA-2Z-A9JI,KIRP,38.0,MALE,WHITE,Stage III,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-14196.0,Alive,TUMOR FREE,1567.0,nan,nan,nan,nan,nan,286.0,Complete Remission/Response,nan,nan,0.0,1567.0,0.0,1567.0,1.0,286.0,1.0,286.0,0
TCGA-2Z-A9JJ-01,TCGA-2Z-A9JJ,KIRP,69.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-25240.0,Alive,TUMOR FREE,1213.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1213.0,0.0,1213.0,0.0,1213.0,0.0,1213.0,0
TCGA-2Z-A9JK-01,TCGA-2Z-A9JK,KIRP,50.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-18540.0,Alive,WITH TUMOR,1186.0,nan,nan,nan,nan,nan,324.0,Stable Disease,nan,nan,0.0,1186.0,0.0,1186.0,nan,nan,1.0,324.0,0
TCGA-2Z-A9JL-01,TCGA-2Z-A9JL,KIRP,47.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-17367.0,Alive,TUMOR FREE,1006.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1006.0,0.0,1006.0,0.0,1006.0,0.0,1006.0,0
TCGA-2Z-A9JM-01,TCGA-2Z-A9JM,KIRP,28.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-10323.0,Alive,TUMOR FREE,934.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,934.0,0.0,934.0,nan,nan,0.0,934.0,0
TCGA-2Z-A9JN-01,TCGA-2Z-A9JN,KIRP,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-18264.0,Alive,TUMOR FREE,740.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,740.0,0.0,740.0,0.0,740.0,0.0,740.0,0
TCGA-2Z-A9JO-01,TCGA-2Z-A9JO,KIRP,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-20466.0,Alive,TUMOR FREE,949.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,949.0,0.0,949.0,0.0,949.0,0.0,949.0,0
TCGA-2Z-A9JP-01,TCGA-2Z-A9JP,KIRP,63.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-23207.0,Alive,TUMOR FREE,893.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,893.0,0.0,893.0,0.0,893.0,0.0,893.0,0
TCGA-2Z-A9JQ-01,TCGA-2Z-A9JQ,KIRP,66.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-24244.0,Alive,WITH TUMOR,778.0,nan,nan,nan,nan,nan,600.0,[Unknown],nan,nan,0.0,778.0,0.0,778.0,nan,nan,1.0,600.0,0
TCGA-2Z-A9JR-01,TCGA-2Z-A9JR,KIRP,57.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-20932.0,Alive,TUMOR FREE,161.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,161.0,0.0,161.0,nan,nan,0.0,161.0,0
TCGA-2Z-A9JS-01,TCGA-2Z-A9JS,KIRP,74.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-27053.0,Dead,TUMOR FREE,nan,492.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,492.0,0.0,492.0,0.0,492.0,0.0,492.0,0
TCGA-2Z-A9JT-01,TCGA-2Z-A9JT,KIRP,71.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-26128.0,Alive,TUMOR FREE,684.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,684.0,0.0,684.0,0.0,684.0,0.0,684.0,0
TCGA-4A-A93W-01,TCGA-4A-A93W,KIRP,66.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-24117.0,Alive,TUMOR FREE,4.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4.0,0.0,4.0,0.0,4.0,0.0,4.0,0
TCGA-4A-A93X-01,TCGA-4A-A93X,KIRP,58.0,MALE,WHITE,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-21348.0,Alive,WITH TUMOR,390.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,390.0,0.0,390.0,nan,nan,0.0,390.0,0
TCGA-4A-A93Y-01,TCGA-4A-A93Y,KIRP,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-23226.0,Alive,TUMOR FREE,352.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,352.0,0.0,352.0,0.0,352.0,0.0,352.0,0
TCGA-5P-A9JU-01,TCGA-5P-A9JU,KIRP,81.0,MALE,WHITE,Stage III,nan,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-29594.0,Alive,TUMOR FREE,373.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,373.0,0.0,373.0,0.0,373.0,0.0,373.0,0
TCGA-5P-A9JV-01,TCGA-5P-A9JV,KIRP,49.0,MALE,WHITE,nan,nan,Kidney Papillary Renal Cell Carcinoma,nan,2005.0,nan,-17973.0,Alive,nan,2043.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2043.0,0.0,2043.0,0.0,2043.0,0.0,2043.0,0
TCGA-5P-A9JW-01,TCGA-5P-A9JW,KIRP,64.0,MALE,WHITE,nan,nan,Kidney Papillary Renal Cell Carcinoma,nan,2006.0,nan,-23570.0,Alive,nan,3241.0,nan,nan,nan,nan,nan,3228.0,Complete Remission/Response,nan,nan,0.0,3241.0,0.0,3241.0,1.0,3228.0,1.0,3228.0,2
TCGA-5P-A9JY-01,TCGA-5P-A9JY,KIRP,79.0,MALE,WHITE,nan,nan,Kidney Papillary Renal Cell Carcinoma,nan,2006.0,nan,-28881.0,Dead,TUMOR FREE,nan,1508.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1508.0,0.0,1508.0,0.0,1508.0,0.0,1508.0,0
TCGA-5P-A9JZ-01,TCGA-5P-A9JZ,KIRP,51.0,FEMALE,WHITE,nan,nan,Kidney Papillary Renal Cell Carcinoma,nan,2006.0,nan,-18885.0,Alive,TUMOR FREE,2744.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2744.0,0.0,2744.0,0.0,2744.0,0.0,2744.0,0
TCGA-5P-A9K0-01,TCGA-5P-A9K0,KIRP,75.0,MALE,WHITE,nan,nan,Kidney Papillary Renal Cell Carcinoma,nan,2007.0,nan,-27434.0,Alive,nan,677.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,677.0,0.0,677.0,nan,nan,0.0,677.0,0
TCGA-5P-A9K2-01,TCGA-5P-A9K2,KIRP,62.0,MALE,WHITE,nan,nan,Kidney Papillary Renal Cell Carcinoma,nan,2007.0,nan,-22964.0,Alive,TUMOR FREE,2392.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2392.0,0.0,2392.0,0.0,2392.0,0.0,2392.0,0
TCGA-5P-A9K3-01,TCGA-5P-A9K3,KIRP,59.0,MALE,WHITE,nan,nan,Kidney Papillary Renal Cell Carcinoma,nan,2007.0,nan,-21829.0,Dead,WITH TUMOR,nan,471.0,nan,nan,nan,nan,17.0,Partial Remission/Response,nan,nan,1.0,471.0,1.0,471.0,nan,nan,1.0,17.0,1
TCGA-5P-A9K4-01,TCGA-5P-A9K4,KIRP,54.0,MALE,WHITE,nan,nan,Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,-19986.0,Alive,TUMOR FREE,2184.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2184.0,0.0,2184.0,0.0,2184.0,0.0,2184.0,0
TCGA-5P-A9K6-01,TCGA-5P-A9K6,KIRP,64.0,MALE,WHITE,nan,nan,Kidney Papillary Renal Cell Carcinoma,nan,2009.0,nan,-23384.0,Alive,nan,1914.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1914.0,0.0,1914.0,0.0,1914.0,0.0,1914.0,0
TCGA-5P-A9K8-01,TCGA-5P-A9K8,KIRP,51.0,FEMALE,WHITE,nan,nan,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-18880.0,Alive,TUMOR FREE,1309.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1309.0,0.0,1309.0,0.0,1309.0,0.0,1309.0,0
TCGA-5P-A9K9-01,TCGA-5P-A9K9,KIRP,59.0,FEMALE,WHITE,nan,nan,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-21600.0,Dead,WITH TUMOR,nan,589.0,nan,nan,nan,nan,548.0,Complete Remission/Response,nan,nan,1.0,589.0,1.0,589.0,1.0,548.0,1.0,548.0,1
TCGA-5P-A9KA-01,TCGA-5P-A9KA,KIRP,61.0,MALE,WHITE,nan,nan,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-22545.0,Alive,TUMOR FREE,395.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,395.0,0.0,395.0,0.0,395.0,0.0,395.0,0
TCGA-5P-A9KC-01,TCGA-5P-A9KC,KIRP,51.0,FEMALE,WHITE,nan,nan,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-18975.0,Alive,TUMOR FREE,377.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,377.0,0.0,377.0,0.0,377.0,0.0,377.0,0
TCGA-5P-A9KE-01,TCGA-5P-A9KE,KIRP,70.0,MALE,WHITE,nan,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-25805.0,Alive,TUMOR FREE,824.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,824.0,0.0,824.0,0.0,824.0,0.0,824.0,0
TCGA-5P-A9KF-01,TCGA-5P-A9KF,KIRP,53.0,MALE,WHITE,nan,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-19631.0,Alive,TUMOR FREE,845.0,nan,nan,nan,nan,nan,728.0,[Unknown],nan,nan,0.0,845.0,0.0,845.0,nan,nan,1.0,728.0,0
TCGA-5P-A9KH-01,TCGA-5P-A9KH,KIRP,77.0,MALE,WHITE,nan,nan,Kidney Papillary Renal Cell Carcinoma,nan,2005.0,nan,-28193.0,Alive,TUMOR FREE,2051.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2051.0,0.0,2051.0,0.0,2051.0,0.0,2051.0,0
TCGA-A4-7286-01,TCGA-A4-7286,KIRP,42.0,MALE,WHITE,nan,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-15631.0,Alive,TUMOR FREE,554.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,554.0,0.0,554.0,0.0,554.0,0.0,554.0,0
TCGA-A4-7287-01,TCGA-A4-7287,KIRP,75.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-27621.0,Dead,WITH TUMOR,nan,597.0,nan,nan,nan,nan,234.0,Complete Remission/Response,nan,nan,1.0,597.0,1.0,597.0,1.0,234.0,1.0,234.0,1
TCGA-A4-7288-01,TCGA-A4-7288,KIRP,71.0,FEMALE,WHITE,nan,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,-26268.0,Alive,TUMOR FREE,1857.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1857.0,0.0,1857.0,0.0,1857.0,0.0,1857.0,0
TCGA-A4-7288-11,TCGA-A4-7288,KIRP,71.0,FEMALE,WHITE,nan,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,-26268.0,Alive,TUMOR FREE,1857.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1857.0,0.0,1857.0,0.0,1857.0,0.0,1857.0,0
TCGA-A4-7583-01,TCGA-A4-7583,KIRP,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-21962.0,Alive,TUMOR FREE,3.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3.0,0.0,3.0,nan,nan,0.0,3.0,0
TCGA-A4-7584-01,TCGA-A4-7584,KIRP,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-21782.0,Alive,TUMOR FREE,650.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,650.0,0.0,650.0,0.0,650.0,0.0,650.0,0
TCGA-A4-7585-01,TCGA-A4-7585,KIRP,67.0,MALE,WHITE,Stage III,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2007.0,nan,-24778.0,Dead,TUMOR FREE,nan,1070.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1070.0,0.0,1070.0,0.0,1070.0,0.0,1070.0,0
TCGA-A4-7585-11,TCGA-A4-7585,KIRP,67.0,MALE,WHITE,Stage III,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2007.0,nan,-24778.0,Dead,TUMOR FREE,nan,1070.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1070.0,0.0,1070.0,0.0,1070.0,0.0,1070.0,0
TCGA-A4-7732-01,TCGA-A4-7732,KIRP,55.0,MALE,BLACK OR AFRICAN AMERICAN,nan,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-20226.0,Alive,TUMOR FREE,582.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,582.0,0.0,582.0,0.0,582.0,0.0,582.0,0
TCGA-A4-7732-11,TCGA-A4-7732,KIRP,55.0,MALE,BLACK OR AFRICAN AMERICAN,nan,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-20226.0,Alive,TUMOR FREE,582.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,582.0,0.0,582.0,0.0,582.0,0.0,582.0,0
TCGA-A4-7734-01,TCGA-A4-7734,KIRP,53.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-19612.0,Alive,TUMOR FREE,27.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,27.0,0.0,27.0,nan,nan,0.0,27.0,0
TCGA-A4-7828-01,TCGA-A4-7828,KIRP,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-27122.0,Alive,TUMOR FREE,238.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,238.0,0.0,238.0,0.0,238.0,0.0,238.0,0
TCGA-A4-7915-01,TCGA-A4-7915,KIRP,35.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-12832.0,Alive,TUMOR FREE,7.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,7.0,0.0,7.0,nan,nan,0.0,7.0,0
TCGA-A4-7996-01,TCGA-A4-7996,KIRP,61.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-22559.0,Alive,TUMOR FREE,506.0,nan,nan,nan,nan,nan,493.0,Complete Remission/Response,nan,nan,0.0,506.0,0.0,506.0,1.0,493.0,1.0,493.0,2
TCGA-A4-7997-01,TCGA-A4-7997,KIRP,67.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-24486.0,Alive,TUMOR FREE,927.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,927.0,0.0,927.0,nan,nan,0.0,927.0,0
TCGA-A4-8098-01,TCGA-A4-8098,KIRP,73.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-26685.0,Alive,TUMOR FREE,896.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,896.0,0.0,896.0,0.0,896.0,0.0,896.0,0
TCGA-A4-8310-01,TCGA-A4-8310,KIRP,58.0,MALE,WHITE,Stage III,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-21312.0,Alive,TUMOR FREE,780.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,780.0,0.0,780.0,0.0,780.0,0.0,780.0,0
TCGA-A4-8311-01,TCGA-A4-8311,KIRP,60.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-22220.0,Alive,TUMOR FREE,729.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,729.0,0.0,729.0,0.0,729.0,0.0,729.0,0
TCGA-A4-8312-01,TCGA-A4-8312,KIRP,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-22231.0,Alive,TUMOR FREE,708.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,708.0,0.0,708.0,0.0,708.0,0.0,708.0,0
TCGA-A4-8515-01,TCGA-A4-8515,KIRP,47.0,MALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-17345.0,Alive,TUMOR FREE,709.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,709.0,0.0,709.0,0.0,709.0,0.0,709.0,0
TCGA-A4-8516-01,TCGA-A4-8516,KIRP,62.0,MALE,WHITE,Stage III,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-22879.0,Alive,nan,23.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,23.0,0.0,23.0,nan,nan,0.0,23.0,0
TCGA-A4-8517-01,TCGA-A4-8517,KIRP,71.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-26090.0,Alive,TUMOR FREE,597.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,597.0,0.0,597.0,0.0,597.0,0.0,597.0,0
TCGA-A4-8518-01,TCGA-A4-8518,KIRP,48.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-17713.0,Alive,TUMOR FREE,600.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,600.0,0.0,600.0,0.0,600.0,0.0,600.0,0
TCGA-A4-8630-01,TCGA-A4-8630,KIRP,59.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-21884.0,Alive,TUMOR FREE,436.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,436.0,0.0,436.0,0.0,436.0,0.0,436.0,0
TCGA-A4-A48D-01,TCGA-A4-A48D,KIRP,84.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-31038.0,Alive,TUMOR FREE,379.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,0
TCGA-A4-A4ZT-01,TCGA-A4-A4ZT,KIRP,71.0,FEMALE,WHITE,Stage I,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-26058.0,Alive,TUMOR FREE,516.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,516.0,0.0,516.0,0.0,516.0,0.0,516.0,0
TCGA-A4-A4ZT-11,TCGA-A4-A4ZT,KIRP,71.0,FEMALE,WHITE,Stage I,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-26058.0,Alive,TUMOR FREE,516.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,516.0,0.0,516.0,0.0,516.0,0.0,516.0,0
TCGA-A4-A57E-01,TCGA-A4-A57E,KIRP,59.0,MALE,WHITE,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-21885.0,Dead,WITH TUMOR,nan,258.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,258.0,1.0,258.0,nan,nan,1.0,258.0,1
TCGA-A4-A57E-11,TCGA-A4-A57E,KIRP,59.0,MALE,WHITE,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-21885.0,Dead,WITH TUMOR,nan,258.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,258.0,1.0,258.0,nan,nan,1.0,258.0,1
TCGA-A4-A5DU-01,TCGA-A4-A5DU,KIRP,45.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-16779.0,Alive,TUMOR FREE,496.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,496.0,0.0,496.0,0.0,496.0,0.0,496.0,0
TCGA-A4-A5XZ-01,TCGA-A4-A5XZ,KIRP,65.0,FEMALE,WHITE,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-24006.0,Alive,TUMOR FREE,479.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,479.0,0.0,479.0,0.0,479.0,0.0,479.0,0
TCGA-A4-A5Y0-01,TCGA-A4-A5Y0,KIRP,61.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-22341.0,Alive,TUMOR FREE,252.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,252.0,0.0,252.0,0.0,252.0,0.0,252.0,0
TCGA-A4-A5Y1-01,TCGA-A4-A5Y1,KIRP,75.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-27541.0,Dead,WITH TUMOR,nan,395.0,nan,nan,nan,nan,296.0,Complete Remission/Response,nan,nan,1.0,395.0,1.0,395.0,1.0,296.0,1.0,296.0,1
TCGA-A4-A5Y1-11,TCGA-A4-A5Y1,KIRP,75.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-27541.0,Dead,WITH TUMOR,nan,395.0,nan,nan,nan,nan,296.0,Complete Remission/Response,nan,nan,1.0,395.0,1.0,395.0,1.0,296.0,1.0,296.0,1
TCGA-A4-A6HP-01,TCGA-A4-A6HP,KIRP,66.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-24447.0,Alive,TUMOR FREE,379.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,0
TCGA-A4-A772-01,TCGA-A4-A772,KIRP,39.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-14278.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-A4-A7UZ-01,TCGA-A4-A7UZ,KIRP,71.0,MALE,WHITE,Stage III,nan,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-26264.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-AL-3466-01,TCGA-AL-3466,KIRP,41.0,MALE,WHITE,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,nan,2004.0,nan,-15181.0,Dead,WITH TUMOR,nan,293.0,nan,nan,nan,nan,138.0,nan,nan,nan,1.0,293.0,1.0,293.0,nan,nan,1.0,138.0,1
TCGA-AL-3467-01,TCGA-AL-3467,KIRP,54.0,FEMALE,WHITE,nan,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2005.0,nan,-19783.0,Alive,TUMOR FREE,2135.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2135.0,0.0,2135.0,0.0,2135.0,0.0,2135.0,0
TCGA-AL-3468-01,TCGA-AL-3468,KIRP,74.0,MALE,WHITE,Stage II,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2005.0,nan,-27205.0,Dead,TUMOR FREE,nan,2331.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2331.0,0.0,2331.0,0.0,2331.0,0.0,2331.0,0
TCGA-AL-3471-01,TCGA-AL-3471,KIRP,74.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2006.0,nan,-27249.0,Dead,TUMOR FREE,nan,1500.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,1500.0,0.0,1500.0,nan,nan,0.0,1500.0,0
TCGA-AL-3472-01,TCGA-AL-3472,KIRP,57.0,MALE,BLACK OR AFRICAN AMERICAN,nan,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,-21166.0,Alive,TUMOR FREE,2029.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2029.0,0.0,2029.0,0.0,2029.0,0.0,2029.0,0
TCGA-AL-3473-01,TCGA-AL-3473,KIRP,55.0,MALE,WHITE,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,-20104.0,Alive,TUMOR FREE,1906.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1906.0,0.0,1906.0,0.0,1906.0,0.0,1906.0,0
TCGA-AL-7173-01,TCGA-AL-7173,KIRP,72.0,FEMALE,WHITE,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,-26326.0,Alive,WITH TUMOR,2060.0,nan,nan,nan,nan,nan,332.0,Progressive Disease,nan,nan,0.0,2060.0,0.0,2060.0,nan,nan,1.0,332.0,1
TCGA-AL-A5DJ-01,TCGA-AL-A5DJ,KIRP,54.0,FEMALE,WHITE,Stage III,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2009.0,nan,-20079.0,Dead,WITH TUMOR,nan,1498.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,1498.0,1.0,1498.0,nan,nan,1.0,1498.0,1
TCGA-AT-A5NU-01,TCGA-AT-A5NU,KIRP,77.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-28137.0,Alive,nan,67.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,67.0,0.0,67.0,nan,nan,0.0,67.0,0
TCGA-B1-5398-01,TCGA-B1-5398,KIRP,73.0,MALE,WHITE,Stage III,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-26820.0,Alive,TUMOR FREE,1251.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1251.0,0.0,1251.0,0.0,1251.0,0.0,1251.0,0
TCGA-B1-7332-01,TCGA-B1-7332,KIRP,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-22277.0,Alive,TUMOR FREE,1141.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1141.0,0.0,1141.0,0.0,1141.0,0.0,1141.0,0
TCGA-B1-A47M-01,TCGA-B1-A47M,KIRP,79.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-29068.0,Alive,WITH TUMOR,659.0,nan,nan,nan,nan,nan,408.0,[Unknown],nan,nan,0.0,659.0,0.0,659.0,nan,nan,1.0,408.0,0
TCGA-B1-A47M-11,TCGA-B1-A47M,KIRP,79.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-29068.0,Alive,WITH TUMOR,659.0,nan,nan,nan,nan,nan,408.0,[Unknown],nan,nan,0.0,659.0,0.0,659.0,nan,nan,1.0,408.0,0
TCGA-B1-A47N-01,TCGA-B1-A47N,KIRP,62.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-22800.0,Alive,TUMOR FREE,1110.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1110.0,0.0,1110.0,0.0,1110.0,0.0,1110.0,0
TCGA-B1-A47O-01,TCGA-B1-A47O,KIRP,54.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-19823.0,Alive,TUMOR FREE,842.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,842.0,0.0,842.0,0.0,842.0,0.0,842.0,0
TCGA-B1-A654-01,TCGA-B1-A654,KIRP,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-15721.0,Alive,TUMOR FREE,616.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,616.0,0.0,616.0,0.0,616.0,0.0,616.0,0
TCGA-B1-A655-01,TCGA-B1-A655,KIRP,77.0,FEMALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-28433.0,Alive,TUMOR FREE,510.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,510.0,0.0,510.0,0.0,510.0,0.0,510.0,0
TCGA-B1-A656-01,TCGA-B1-A656,KIRP,64.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-23702.0,Alive,TUMOR FREE,618.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,618.0,0.0,618.0,0.0,618.0,0.0,618.0,0
TCGA-B1-A657-01,TCGA-B1-A657,KIRP,54.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-19806.0,Alive,TUMOR FREE,641.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,641.0,0.0,641.0,0.0,641.0,0.0,641.0,0
TCGA-B3-3925-01,TCGA-B3-3925,KIRP,52.0,MALE,WHITE,Stage III,nan,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-19224.0,Alive,TUMOR FREE,1029.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1029.0,0.0,1029.0,0.0,1029.0,0.0,1029.0,0
TCGA-B3-3925-11,TCGA-B3-3925,KIRP,52.0,MALE,WHITE,Stage III,nan,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-19224.0,Alive,TUMOR FREE,1029.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1029.0,0.0,1029.0,0.0,1029.0,0.0,1029.0,0
TCGA-B3-3926-01,TCGA-B3-3926,KIRP,59.0,FEMALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-21876.0,Alive,TUMOR FREE,883.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,883.0,0.0,883.0,0.0,883.0,0.0,883.0,0
TCGA-B3-3926-11,TCGA-B3-3926,KIRP,59.0,FEMALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-21876.0,Alive,TUMOR FREE,883.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,883.0,0.0,883.0,0.0,883.0,0.0,883.0,0
TCGA-B3-4103-01,TCGA-B3-4103,KIRP,56.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-20708.0,Alive,TUMOR FREE,930.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,930.0,0.0,930.0,0.0,930.0,0.0,930.0,0
TCGA-B3-4103-11,TCGA-B3-4103,KIRP,56.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-20708.0,Alive,TUMOR FREE,930.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,930.0,0.0,930.0,0.0,930.0,0.0,930.0,0
TCGA-B3-4104-01,TCGA-B3-4104,KIRP,75.0,MALE,WHITE,Stage II,nan,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-27709.0,Alive,TUMOR FREE,1049.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1049.0,0.0,1049.0,nan,nan,0.0,1049.0,0
TCGA-B3-4104-11,TCGA-B3-4104,KIRP,75.0,MALE,WHITE,Stage II,nan,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-27709.0,Alive,TUMOR FREE,1049.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1049.0,0.0,1049.0,nan,nan,0.0,1049.0,0
TCGA-B3-8121-01,TCGA-B3-8121,KIRP,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-17760.0,Alive,TUMOR FREE,379.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,0
TCGA-B3-A6W5-01,TCGA-B3-A6W5,KIRP,43.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-15945.0,Alive,TUMOR FREE,309.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,309.0,0.0,309.0,0.0,309.0,0.0,309.0,0
TCGA-B9-4113-01,TCGA-B9-4113,KIRP,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2002.0,nan,-23613.0,Dead,TUMOR FREE,nan,1536.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1536.0,0.0,1536.0,nan,nan,0.0,1536.0,0
TCGA-B9-4113-11,TCGA-B9-4113,KIRP,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2002.0,nan,-23613.0,Dead,TUMOR FREE,nan,1536.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1536.0,0.0,1536.0,nan,nan,0.0,1536.0,0
TCGA-B9-4114-01,TCGA-B9-4114,KIRP,49.0,MALE,BLACK OR AFRICAN AMERICAN,nan,Stage IV,Kidney Papillary Renal Cell Carcinoma,nan,2009.0,nan,-17989.0,Alive,WITH TUMOR,857.0,nan,nan,nan,nan,nan,637.0,nan,nan,nan,0.0,857.0,0.0,857.0,nan,nan,1.0,637.0,0
TCGA-B9-4115-01,TCGA-B9-4115,KIRP,53.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2009.0,nan,-19571.0,Alive,TUMOR FREE,803.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,803.0,0.0,803.0,nan,nan,0.0,803.0,0
TCGA-B9-4115-11,TCGA-B9-4115,KIRP,53.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2009.0,nan,-19571.0,Alive,TUMOR FREE,803.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,803.0,0.0,803.0,nan,nan,0.0,803.0,0
TCGA-B9-4116-01,TCGA-B9-4116,KIRP,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-27692.0,Alive,TUMOR FREE,627.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,627.0,0.0,627.0,nan,nan,0.0,627.0,0
TCGA-B9-4117-01,TCGA-B9-4117,KIRP,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2009.0,nan,-17622.0,Alive,TUMOR FREE,14.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,14.0,0.0,14.0,nan,nan,0.0,14.0,0
TCGA-B9-4617-01,TCGA-B9-4617,KIRP,41.0,MALE,BLACK OR AFRICAN AMERICAN,nan,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-15053.0,Alive,TUMOR FREE,35.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,35.0,0.0,35.0,nan,nan,0.0,35.0,0
TCGA-B9-5155-01,TCGA-B9-5155,KIRP,71.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-26149.0,Alive,TUMOR FREE,665.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,665.0,0.0,665.0,0.0,665.0,0.0,665.0,0
TCGA-B9-5156-01,TCGA-B9-5156,KIRP,51.0,MALE,WHITE,nan,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-18841.0,Alive,TUMOR FREE,1338.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1338.0,0.0,1338.0,0.0,1338.0,0.0,1338.0,0
TCGA-B9-7268-01,TCGA-B9-7268,KIRP,59.0,MALE,WHITE,Stage II,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-21705.0,Alive,TUMOR FREE,671.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,671.0,0.0,671.0,0.0,671.0,0.0,671.0,0
TCGA-B9-A44B-01,TCGA-B9-A44B,KIRP,70.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-25763.0,Alive,TUMOR FREE,361.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,361.0,0.0,361.0,nan,nan,0.0,361.0,0
TCGA-B9-A5W7-01,TCGA-B9-A5W7,KIRP,47.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-17465.0,Alive,TUMOR FREE,585.0,nan,nan,nan,nan,nan,564.0,Complete Remission/Response,nan,nan,0.0,585.0,0.0,585.0,1.0,564.0,1.0,564.0,0
TCGA-B9-A5W8-01,TCGA-B9-A5W8,KIRP,50.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-18440.0,Alive,TUMOR FREE,524.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,524.0,0.0,524.0,0.0,524.0,0.0,524.0,0
TCGA-B9-A5W9-01,TCGA-B9-A5W9,KIRP,40.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-14668.0,Alive,TUMOR FREE,5.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,5.0,0.0,5.0,0.0,5.0,0.0,5.0,0
TCGA-B9-A69E-01,TCGA-B9-A69E,KIRP,71.0,MALE,WHITE,Stage III,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-26198.0,Alive,TUMOR FREE,452.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,452.0,0.0,452.0,0.0,452.0,0.0,452.0,0
TCGA-B9-A8YH-01,TCGA-B9-A8YH,KIRP,52.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-19051.0,Alive,TUMOR FREE,532.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,532.0,0.0,532.0,0.0,532.0,0.0,532.0,0
TCGA-B9-A8YI-01,TCGA-B9-A8YI,KIRP,79.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-28917.0,Alive,TUMOR FREE,374.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,374.0,0.0,374.0,0.0,374.0,0.0,374.0,0
TCGA-BQ-5875-01,TCGA-BQ-5875,KIRP,66.0,FEMALE,WHITE,Stage III,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2004.0,nan,-24153.0,Alive,TUMOR FREE,2639.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2639.0,0.0,2639.0,nan,nan,0.0,2639.0,0
TCGA-BQ-5875-11,TCGA-BQ-5875,KIRP,66.0,FEMALE,WHITE,Stage III,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2004.0,nan,-24153.0,Alive,TUMOR FREE,2639.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2639.0,0.0,2639.0,nan,nan,0.0,2639.0,0
TCGA-BQ-5876-01,TCGA-BQ-5876,KIRP,75.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2004.0,nan,-27409.0,Alive,TUMOR FREE,586.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,586.0,0.0,586.0,nan,nan,0.0,586.0,0
TCGA-BQ-5876-11,TCGA-BQ-5876,KIRP,75.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2004.0,nan,-27409.0,Alive,TUMOR FREE,586.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,586.0,0.0,586.0,nan,nan,0.0,586.0,0
TCGA-BQ-5877-01,TCGA-BQ-5877,KIRP,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,nan,2004.0,nan,-22095.0,Dead,WITH TUMOR,nan,270.0,nan,nan,nan,nan,127.0,nan,nan,nan,1.0,270.0,1.0,270.0,nan,nan,1.0,127.0,1
TCGA-BQ-5877-11,TCGA-BQ-5877,KIRP,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,nan,2004.0,nan,-22095.0,Dead,WITH TUMOR,nan,270.0,nan,nan,nan,nan,127.0,nan,nan,nan,1.0,270.0,1.0,270.0,nan,nan,1.0,127.0,1
TCGA-BQ-5878-01,TCGA-BQ-5878,KIRP,79.0,FEMALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2005.0,nan,-29010.0,Alive,WITH TUMOR,1938.0,nan,nan,nan,nan,nan,1022.0,nan,nan,nan,0.0,1938.0,0.0,1938.0,nan,nan,1.0,1022.0,1
TCGA-BQ-5878-11,TCGA-BQ-5878,KIRP,79.0,FEMALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2005.0,nan,-29010.0,Alive,WITH TUMOR,1938.0,nan,nan,nan,nan,nan,1022.0,nan,nan,nan,0.0,1938.0,0.0,1938.0,nan,nan,1.0,1022.0,1
TCGA-BQ-5879-01,TCGA-BQ-5879,KIRP,32.0,FEMALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2005.0,nan,-11862.0,Dead,WITH TUMOR,nan,697.0,nan,nan,nan,nan,130.0,nan,nan,nan,1.0,697.0,1.0,697.0,nan,nan,1.0,130.0,1
TCGA-BQ-5879-11,TCGA-BQ-5879,KIRP,32.0,FEMALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2005.0,nan,-11862.0,Dead,WITH TUMOR,nan,697.0,nan,nan,nan,nan,130.0,nan,nan,nan,1.0,697.0,1.0,697.0,nan,nan,1.0,130.0,1
TCGA-BQ-5880-01,TCGA-BQ-5880,KIRP,79.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2006.0,nan,-29053.0,Dead,WITH TUMOR,nan,1314.0,nan,nan,nan,nan,972.0,nan,nan,nan,1.0,1314.0,1.0,1314.0,nan,nan,1.0,972.0,1
TCGA-BQ-5880-11,TCGA-BQ-5880,KIRP,79.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2006.0,nan,-29053.0,Dead,WITH TUMOR,nan,1314.0,nan,nan,nan,nan,972.0,nan,nan,nan,1.0,1314.0,1.0,1314.0,nan,nan,1.0,972.0,1
TCGA-BQ-5881-01,TCGA-BQ-5881,KIRP,69.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2006.0,nan,-25481.0,Alive,TUMOR FREE,1454.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1454.0,0.0,1454.0,nan,nan,0.0,1454.0,0
TCGA-BQ-5881-11,TCGA-BQ-5881,KIRP,69.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2006.0,nan,-25481.0,Alive,TUMOR FREE,1454.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1454.0,0.0,1454.0,nan,nan,0.0,1454.0,0
TCGA-BQ-5882-01,TCGA-BQ-5882,KIRP,54.0,MALE,nan,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2007.0,nan,-20042.0,Dead,WITH TUMOR,nan,658.0,nan,nan,nan,nan,340.0,nan,nan,nan,1.0,658.0,1.0,658.0,nan,nan,1.0,340.0,1
TCGA-BQ-5882-11,TCGA-BQ-5882,KIRP,54.0,MALE,nan,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2007.0,nan,-20042.0,Dead,WITH TUMOR,nan,658.0,nan,nan,nan,nan,340.0,nan,nan,nan,1.0,658.0,1.0,658.0,nan,nan,1.0,340.0,1
TCGA-BQ-5883-01,TCGA-BQ-5883,KIRP,79.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2007.0,nan,-28877.0,Alive,TUMOR FREE,1242.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1242.0,0.0,1242.0,nan,nan,0.0,1242.0,0
TCGA-BQ-5883-11,TCGA-BQ-5883,KIRP,79.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2007.0,nan,-28877.0,Alive,TUMOR FREE,1242.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1242.0,0.0,1242.0,nan,nan,0.0,1242.0,0
TCGA-BQ-5884-01,TCGA-BQ-5884,KIRP,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,-21730.0,Alive,TUMOR FREE,792.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,792.0,0.0,792.0,nan,nan,0.0,792.0,0
TCGA-BQ-5884-11,TCGA-BQ-5884,KIRP,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,-21730.0,Alive,TUMOR FREE,792.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,792.0,0.0,792.0,nan,nan,0.0,792.0,0
TCGA-BQ-5885-01,TCGA-BQ-5885,KIRP,63.0,MALE,WHITE,Stage III,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,-23173.0,Alive,TUMOR FREE,921.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,921.0,0.0,921.0,nan,nan,0.0,921.0,0
TCGA-BQ-5885-11,TCGA-BQ-5885,KIRP,63.0,MALE,WHITE,Stage III,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,-23173.0,Alive,TUMOR FREE,921.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,921.0,0.0,921.0,nan,nan,0.0,921.0,0
TCGA-BQ-5886-01,TCGA-BQ-5886,KIRP,75.0,MALE,WHITE,Stage III,[Discrepancy],Kidney Papillary Renal Cell Carcinoma,nan,2009.0,nan,-27670.0,Alive,TUMOR FREE,792.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,792.0,0.0,792.0,nan,nan,0.0,792.0,0
TCGA-BQ-5886-11,TCGA-BQ-5886,KIRP,75.0,MALE,WHITE,Stage III,[Discrepancy],Kidney Papillary Renal Cell Carcinoma,nan,2009.0,nan,-27670.0,Alive,TUMOR FREE,792.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,792.0,0.0,792.0,nan,nan,0.0,792.0,0
TCGA-BQ-5887-01,TCGA-BQ-5887,KIRP,54.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2009.0,nan,-19747.0,Alive,TUMOR FREE,771.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,771.0,0.0,771.0,nan,nan,0.0,771.0,0
TCGA-BQ-5887-11,TCGA-BQ-5887,KIRP,54.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2009.0,nan,-19747.0,Alive,TUMOR FREE,771.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,771.0,0.0,771.0,nan,nan,0.0,771.0,0
TCGA-BQ-5888-01,TCGA-BQ-5888,KIRP,74.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2009.0,nan,-27346.0,Alive,TUMOR FREE,403.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,403.0,0.0,403.0,nan,nan,0.0,403.0,0
TCGA-BQ-5888-11,TCGA-BQ-5888,KIRP,74.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2009.0,nan,-27346.0,Alive,TUMOR FREE,403.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,403.0,0.0,403.0,nan,nan,0.0,403.0,0
TCGA-BQ-5889-01,TCGA-BQ-5889,KIRP,63.0,MALE,WHITE,Stage IV,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2009.0,nan,-23267.0,Dead,WITH TUMOR,nan,329.0,nan,nan,nan,nan,-35.0,nan,nan,nan,1.0,329.0,1.0,329.0,nan,nan,1.0,nan,1
TCGA-BQ-5889-11,TCGA-BQ-5889,KIRP,63.0,MALE,WHITE,Stage IV,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2009.0,nan,-23267.0,Dead,WITH TUMOR,nan,329.0,nan,nan,nan,nan,-35.0,nan,nan,nan,1.0,329.0,1.0,329.0,nan,nan,1.0,nan,1
TCGA-BQ-5890-01,TCGA-BQ-5890,KIRP,69.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2009.0,nan,-25272.0,Alive,TUMOR FREE,233.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,233.0,0.0,233.0,nan,nan,0.0,233.0,0
TCGA-BQ-5890-11,TCGA-BQ-5890,KIRP,69.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2009.0,nan,-25272.0,Alive,TUMOR FREE,233.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,233.0,0.0,233.0,nan,nan,0.0,233.0,0
TCGA-BQ-5891-01,TCGA-BQ-5891,KIRP,57.0,FEMALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2009.0,nan,-20945.0,Alive,TUMOR FREE,29.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,29.0,0.0,29.0,nan,nan,0.0,29.0,0
TCGA-BQ-5891-11,TCGA-BQ-5891,KIRP,57.0,FEMALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2009.0,nan,-20945.0,Alive,TUMOR FREE,29.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,29.0,0.0,29.0,nan,nan,0.0,29.0,0
TCGA-BQ-5892-01,TCGA-BQ-5892,KIRP,51.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-18785.0,Alive,TUMOR FREE,364.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,364.0,0.0,364.0,nan,nan,0.0,364.0,0
TCGA-BQ-5892-11,TCGA-BQ-5892,KIRP,51.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-18785.0,Alive,TUMOR FREE,364.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,364.0,0.0,364.0,nan,nan,0.0,364.0,0
TCGA-BQ-5893-01,TCGA-BQ-5893,KIRP,61.0,MALE,WHITE,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-22320.0,Dead,WITH TUMOR,nan,241.0,nan,nan,nan,nan,188.0,nan,nan,nan,1.0,241.0,1.0,241.0,nan,nan,1.0,188.0,1
TCGA-BQ-5893-11,TCGA-BQ-5893,KIRP,61.0,MALE,WHITE,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-22320.0,Dead,WITH TUMOR,nan,241.0,nan,nan,nan,nan,188.0,nan,nan,nan,1.0,241.0,1.0,241.0,nan,nan,1.0,188.0,1
TCGA-BQ-5894-01,TCGA-BQ-5894,KIRP,42.0,MALE,nan,Stage IV,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-15510.0,Alive,WITH TUMOR,84.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,84.0,0.0,84.0,nan,nan,0.0,84.0,0
TCGA-BQ-5894-11,TCGA-BQ-5894,KIRP,42.0,MALE,nan,Stage IV,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-15510.0,Alive,WITH TUMOR,84.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,84.0,0.0,84.0,nan,nan,0.0,84.0,0
TCGA-BQ-7044-01,TCGA-BQ-7044,KIRP,73.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2000.0,nan,-26831.0,Alive,TUMOR FREE,3760.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3760.0,0.0,3760.0,nan,nan,0.0,3760.0,0
TCGA-BQ-7044-11,TCGA-BQ-7044,KIRP,73.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2000.0,nan,-26831.0,Alive,TUMOR FREE,3760.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3760.0,0.0,3760.0,nan,nan,0.0,3760.0,0
TCGA-BQ-7045-01,TCGA-BQ-7045,KIRP,78.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2001.0,nan,-28709.0,Dead,TUMOR FREE,nan,1468.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1468.0,0.0,1468.0,nan,nan,0.0,1468.0,0
TCGA-BQ-7045-11,TCGA-BQ-7045,KIRP,78.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2001.0,nan,-28709.0,Dead,TUMOR FREE,nan,1468.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1468.0,0.0,1468.0,nan,nan,0.0,1468.0,0
TCGA-BQ-7046-01,TCGA-BQ-7046,KIRP,61.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2002.0,nan,-22337.0,Alive,TUMOR FREE,2948.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2948.0,0.0,2948.0,nan,nan,0.0,2948.0,0
TCGA-BQ-7046-11,TCGA-BQ-7046,KIRP,61.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2002.0,nan,-22337.0,Alive,TUMOR FREE,2948.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2948.0,0.0,2948.0,nan,nan,0.0,2948.0,0
TCGA-BQ-7048-01,TCGA-BQ-7048,KIRP,64.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2003.0,nan,-23460.0,Alive,WITH TUMOR,2839.0,nan,nan,nan,nan,nan,229.0,nan,nan,nan,0.0,2839.0,0.0,2839.0,nan,nan,1.0,229.0,0
TCGA-BQ-7048-11,TCGA-BQ-7048,KIRP,64.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2003.0,nan,-23460.0,Alive,WITH TUMOR,2839.0,nan,nan,nan,nan,nan,229.0,nan,nan,nan,0.0,2839.0,0.0,2839.0,nan,nan,1.0,229.0,0
TCGA-BQ-7049-01,TCGA-BQ-7049,KIRP,45.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2005.0,nan,-16717.0,Dead,TUMOR FREE,nan,1364.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1364.0,0.0,1364.0,nan,nan,0.0,1364.0,1
TCGA-BQ-7049-11,TCGA-BQ-7049,KIRP,45.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2005.0,nan,-16717.0,Dead,TUMOR FREE,nan,1364.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1364.0,0.0,1364.0,nan,nan,0.0,1364.0,1
TCGA-BQ-7050-01,TCGA-BQ-7050,KIRP,53.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2006.0,nan,-19550.0,Alive,TUMOR FREE,1864.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1864.0,0.0,1864.0,nan,nan,0.0,1864.0,0
TCGA-BQ-7050-11,TCGA-BQ-7050,KIRP,53.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2006.0,nan,-19550.0,Alive,TUMOR FREE,1864.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1864.0,0.0,1864.0,nan,nan,0.0,1864.0,0
TCGA-BQ-7051-01,TCGA-BQ-7051,KIRP,74.0,MALE,WHITE,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2007.0,nan,-27120.0,Alive,TUMOR FREE,1533.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1533.0,0.0,1533.0,nan,nan,0.0,1533.0,0
TCGA-BQ-7051-11,TCGA-BQ-7051,KIRP,74.0,MALE,WHITE,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2007.0,nan,-27120.0,Alive,TUMOR FREE,1533.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1533.0,0.0,1533.0,nan,nan,0.0,1533.0,0
TCGA-BQ-7053-01,TCGA-BQ-7053,KIRP,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2007.0,nan,-20837.0,Alive,TUMOR FREE,1516.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1516.0,0.0,1516.0,nan,nan,0.0,1516.0,0
TCGA-BQ-7053-11,TCGA-BQ-7053,KIRP,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2007.0,nan,-20837.0,Alive,TUMOR FREE,1516.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1516.0,0.0,1516.0,nan,nan,0.0,1516.0,0
TCGA-BQ-7055-01,TCGA-BQ-7055,KIRP,73.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,-26749.0,Alive,TUMOR FREE,799.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,799.0,0.0,799.0,nan,nan,0.0,799.0,0
TCGA-BQ-7055-11,TCGA-BQ-7055,KIRP,73.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,-26749.0,Alive,TUMOR FREE,799.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,799.0,0.0,799.0,nan,nan,0.0,799.0,0
TCGA-BQ-7056-01,TCGA-BQ-7056,KIRP,75.0,FEMALE,WHITE,Stage III,[Discrepancy],Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,-27467.0,Alive,WITH TUMOR,612.0,nan,nan,nan,nan,nan,143.0,nan,nan,nan,0.0,612.0,0.0,612.0,nan,nan,1.0,143.0,1
TCGA-BQ-7056-11,TCGA-BQ-7056,KIRP,75.0,FEMALE,WHITE,Stage III,[Discrepancy],Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,-27467.0,Alive,WITH TUMOR,612.0,nan,nan,nan,nan,nan,143.0,nan,nan,nan,0.0,612.0,0.0,612.0,nan,nan,1.0,143.0,1
TCGA-BQ-7058-01,TCGA-BQ-7058,KIRP,81.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-29856.0,Dead,WITH TUMOR,nan,343.0,nan,nan,nan,nan,50.0,nan,nan,nan,1.0,343.0,1.0,343.0,nan,nan,1.0,50.0,1
TCGA-BQ-7058-11,TCGA-BQ-7058,KIRP,81.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-29856.0,Dead,WITH TUMOR,nan,343.0,nan,nan,nan,nan,50.0,nan,nan,nan,1.0,343.0,1.0,343.0,nan,nan,1.0,50.0,1
TCGA-BQ-7059-01,TCGA-BQ-7059,KIRP,71.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-26136.0,Alive,TUMOR FREE,232.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,232.0,0.0,232.0,nan,nan,0.0,232.0,0
TCGA-BQ-7059-11,TCGA-BQ-7059,KIRP,71.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-26136.0,Alive,TUMOR FREE,232.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,232.0,0.0,232.0,nan,nan,0.0,232.0,0
TCGA-BQ-7060-01,TCGA-BQ-7060,KIRP,53.0,MALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-19479.0,Alive,TUMOR FREE,214.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,214.0,0.0,214.0,nan,nan,0.0,214.0,0
TCGA-BQ-7060-11,TCGA-BQ-7060,KIRP,53.0,MALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-19479.0,Alive,TUMOR FREE,214.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,214.0,0.0,214.0,nan,nan,0.0,214.0,0
TCGA-BQ-7061-01,TCGA-BQ-7061,KIRP,83.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-30662.0,Alive,TUMOR FREE,218.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,218.0,0.0,218.0,nan,nan,0.0,218.0,0
TCGA-BQ-7061-11,TCGA-BQ-7061,KIRP,83.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-30662.0,Alive,TUMOR FREE,218.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,218.0,0.0,218.0,nan,nan,0.0,218.0,0
TCGA-BQ-7062-01,TCGA-BQ-7062,KIRP,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-23559.0,Alive,TUMOR FREE,116.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,116.0,0.0,116.0,nan,nan,0.0,116.0,0
TCGA-BQ-7062-11,TCGA-BQ-7062,KIRP,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-23559.0,Alive,TUMOR FREE,116.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,116.0,0.0,116.0,nan,nan,0.0,116.0,0
TCGA-DW-5560-01,TCGA-DW-5560,KIRP,38.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2009.0,nan,-13964.0,Alive,TUMOR FREE,1486.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1486.0,0.0,1486.0,0.0,1486.0,0.0,1486.0,0
TCGA-DW-5561-01,TCGA-DW-5561,KIRP,51.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,-18744.0,Alive,[Discrepancy],414.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,414.0,0.0,414.0,nan,nan,0.0,414.0,0
TCGA-DW-7834-01,TCGA-DW-7834,KIRP,53.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2001.0,nan,-19660.0,Alive,TUMOR FREE,3950.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3950.0,0.0,3950.0,nan,nan,0.0,3950.0,0
TCGA-DW-7836-01,TCGA-DW-7836,KIRP,55.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,-20269.0,Alive,TUMOR FREE,1093.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1093.0,0.0,1093.0,nan,nan,0.0,1093.0,0
TCGA-DW-7837-01,TCGA-DW-7837,KIRP,43.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2007.0,nan,-15891.0,Alive,WITH TUMOR,1142.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1142.0,0.0,1142.0,nan,nan,0.0,1142.0,0
TCGA-DW-7838-01,TCGA-DW-7838,KIRP,66.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2009.0,nan,-24247.0,Alive,WITH TUMOR,744.0,nan,nan,nan,nan,nan,380.0,nan,nan,nan,0.0,744.0,0.0,744.0,nan,nan,1.0,380.0,0
TCGA-DW-7839-01,TCGA-DW-7839,KIRP,58.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-21347.0,Alive,TUMOR FREE,419.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,419.0,0.0,419.0,nan,nan,0.0,419.0,0
TCGA-DW-7840-01,TCGA-DW-7840,KIRP,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-22141.0,Alive,nan,114.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,114.0,0.0,114.0,nan,nan,0.0,114.0,0
TCGA-DW-7841-01,TCGA-DW-7841,KIRP,61.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-22403.0,Alive,TUMOR FREE,445.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,445.0,0.0,445.0,nan,nan,0.0,445.0,0
TCGA-DW-7842-01,TCGA-DW-7842,KIRP,52.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-19166.0,Alive,WITH TUMOR,92.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,92.0,0.0,92.0,nan,nan,0.0,92.0,0
TCGA-DW-7963-01,TCGA-DW-7963,KIRP,43.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-15967.0,Alive,TUMOR FREE,1240.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1240.0,0.0,1240.0,0.0,1240.0,0.0,1240.0,0
TCGA-DZ-6131-01,TCGA-DZ-6131,KIRP,31.0,MALE,WHITE,Stage III,nan,Kidney Papillary Renal Cell Carcinoma,nan,2003.0,nan,-11487.0,Alive,TUMOR FREE,2429.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2429.0,0.0,2429.0,nan,nan,0.0,2429.0,0
TCGA-DZ-6131-11,TCGA-DZ-6131,KIRP,31.0,MALE,WHITE,Stage III,nan,Kidney Papillary Renal Cell Carcinoma,nan,2003.0,nan,-11487.0,Alive,TUMOR FREE,2429.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2429.0,0.0,2429.0,nan,nan,0.0,2429.0,0
TCGA-DZ-6132-01,TCGA-DZ-6132,KIRP,69.0,MALE,nan,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2003.0,nan,-25417.0,Alive,TUMOR FREE,2460.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2460.0,0.0,2460.0,nan,nan,0.0,2460.0,0
TCGA-DZ-6132-11,TCGA-DZ-6132,KIRP,69.0,MALE,nan,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2003.0,nan,-25417.0,Alive,TUMOR FREE,2460.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2460.0,0.0,2460.0,nan,nan,0.0,2460.0,0
TCGA-DZ-6133-01,TCGA-DZ-6133,KIRP,66.0,FEMALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2004.0,nan,-24311.0,Dead,TUMOR FREE,nan,1557.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1557.0,0.0,1557.0,nan,nan,0.0,1557.0,1
TCGA-DZ-6133-11,TCGA-DZ-6133,KIRP,66.0,FEMALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2004.0,nan,-24311.0,Dead,TUMOR FREE,nan,1557.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1557.0,0.0,1557.0,nan,nan,0.0,1557.0,1
TCGA-DZ-6134-01,TCGA-DZ-6134,KIRP,69.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2005.0,nan,-25529.0,Alive,TUMOR FREE,1856.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1856.0,0.0,1856.0,nan,nan,0.0,1856.0,0
TCGA-DZ-6134-11,TCGA-DZ-6134,KIRP,69.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2005.0,nan,-25529.0,Alive,TUMOR FREE,1856.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1856.0,0.0,1856.0,nan,nan,0.0,1856.0,0
TCGA-DZ-6135-01,TCGA-DZ-6135,KIRP,45.0,MALE,nan,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2006.0,nan,-16468.0,Alive,TUMOR FREE,2269.0,nan,nan,nan,nan,nan,nan,[Discrepancy],nan,nan,0.0,2269.0,0.0,2269.0,nan,nan,0.0,2269.0,0
TCGA-DZ-6135-11,TCGA-DZ-6135,KIRP,45.0,MALE,nan,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2006.0,nan,-16468.0,Alive,TUMOR FREE,2269.0,nan,nan,nan,nan,nan,nan,[Discrepancy],nan,nan,0.0,2269.0,0.0,2269.0,nan,nan,0.0,2269.0,0
TCGA-EV-5901-01,TCGA-EV-5901,KIRP,47.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-17275.0,Alive,TUMOR FREE,1040.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1040.0,0.0,1040.0,nan,nan,0.0,1040.0,0
TCGA-EV-5902-01,TCGA-EV-5902,KIRP,58.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-21344.0,Alive,TUMOR FREE,578.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,578.0,0.0,578.0,nan,nan,0.0,578.0,0
TCGA-EV-5903-01,TCGA-EV-5903,KIRP,57.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-20888.0,Alive,TUMOR FREE,757.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,757.0,0.0,757.0,nan,nan,0.0,757.0,0
TCGA-F9-A4JJ-01,TCGA-F9-A4JJ,KIRP,35.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-12893.0,Dead,WITH TUMOR,nan,325.0,nan,nan,nan,nan,109.0,[Unknown],nan,nan,1.0,325.0,1.0,325.0,nan,nan,1.0,109.0,1
TCGA-F9-A7Q0-01,TCGA-F9-A7Q0,KIRP,37.0,FEMALE,ASIAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-13523.0,Alive,TUMOR FREE,398.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,398.0,0.0,398.0,0.0,398.0,0.0,398.0,0
TCGA-F9-A7VF-01,TCGA-F9-A7VF,KIRP,75.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-27446.0,Alive,TUMOR FREE,73.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,73.0,0.0,73.0,0.0,73.0,0.0,73.0,0
TCGA-F9-A8NY-01,TCGA-F9-A8NY,KIRP,38.0,FEMALE,ASIAN,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-14101.0,Alive,TUMOR FREE,36.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,36.0,0.0,36.0,nan,nan,0.0,36.0,0
TCGA-F9-A97G-01,TCGA-F9-A97G,KIRP,79.0,MALE,ASIAN,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-29156.0,Alive,TUMOR FREE,13.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,13.0,0.0,13.0,0.0,13.0,0.0,13.0,0
TCGA-G7-6789-01,TCGA-G7-6789,KIRP,53.0,FEMALE,WHITE,Stage IV,nan,Kidney Papillary Renal Cell Carcinoma,nan,2004.0,nan,-19593.0,Dead,WITH TUMOR,nan,122.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,122.0,1.0,122.0,nan,nan,1.0,122.0,1
TCGA-G7-6790-01,TCGA-G7-6790,KIRP,57.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2007.0,nan,-21169.0,Alive,TUMOR FREE,1575.0,nan,nan,nan,nan,nan,1558.0,nan,nan,nan,0.0,1575.0,0.0,1575.0,nan,nan,1.0,1558.0,0
TCGA-G7-6792-01,TCGA-G7-6792,KIRP,40.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2007.0,nan,-14664.0,Alive,TUMOR FREE,2765.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2765.0,0.0,2765.0,0.0,2765.0,0.0,2765.0,0
TCGA-G7-6793-01,TCGA-G7-6793,KIRP,60.0,FEMALE,WHITE,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,nan,2007.0,nan,-22215.0,Dead,WITH TUMOR,nan,336.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,336.0,1.0,336.0,nan,nan,1.0,336.0,1
TCGA-G7-6795-01,TCGA-G7-6795,KIRP,56.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,-20478.0,Alive,TUMOR FREE,1194.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1194.0,0.0,1194.0,nan,nan,0.0,1194.0,0
TCGA-G7-6796-01,TCGA-G7-6796,KIRP,58.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,-21252.0,Alive,TUMOR FREE,2173.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2173.0,0.0,2173.0,0.0,2173.0,0.0,2173.0,0
TCGA-G7-6797-01,TCGA-G7-6797,KIRP,46.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-17004.0,Alive,TUMOR FREE,765.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,765.0,0.0,765.0,nan,nan,0.0,765.0,0
TCGA-G7-7501-01,TCGA-G7-7501,KIRP,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-20165.0,Dead,WITH TUMOR,nan,624.0,nan,nan,nan,nan,110.0,Progressive Disease,nan,nan,1.0,624.0,1.0,624.0,nan,nan,1.0,110.0,1
TCGA-G7-7502-01,TCGA-G7-7502,KIRP,83.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-30346.0,Alive,TUMOR FREE,786.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,786.0,0.0,786.0,0.0,786.0,0.0,786.0,0
TCGA-G7-A4TM-01,TCGA-G7-A4TM,KIRP,40.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-14966.0,Alive,TUMOR FREE,768.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,768.0,0.0,768.0,0.0,768.0,0.0,768.0,0
TCGA-G7-A8LB-01,TCGA-G7-A8LB,KIRP,70.0,MALE,WHITE,Stage IV,nan,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-25782.0,Alive,WITH TUMOR,547.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,547.0,0.0,547.0,nan,nan,0.0,547.0,0
TCGA-G7-A8LC-01,TCGA-G7-A8LC,KIRP,61.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-22553.0,Alive,TUMOR FREE,702.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,702.0,0.0,702.0,0.0,702.0,0.0,702.0,0
TCGA-G7-A8LD-01,TCGA-G7-A8LD,KIRP,71.0,MALE,WHITE,Stage III,nan,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-25977.0,Dead,WITH TUMOR,nan,514.0,nan,nan,nan,nan,209.0,Complete Remission/Response,nan,nan,1.0,514.0,1.0,514.0,1.0,209.0,1.0,209.0,1
TCGA-G7-A8LE-01,TCGA-G7-A8LE,KIRP,62.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,-22810.0,Alive,TUMOR FREE,2453.0,nan,nan,nan,nan,nan,1447.0,Complete Remission/Response,nan,nan,0.0,2453.0,0.0,2453.0,1.0,1447.0,1.0,1447.0,0
TCGA-GL-6846-01,TCGA-GL-6846,KIRP,52.0,MALE,WHITE,Stage IV,nan,Kidney Papillary Renal Cell Carcinoma,nan,1996.0,nan,-19012.0,Alive,TUMOR FREE,5925.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,5925.0,0.0,5925.0,nan,nan,0.0,5925.0,0
TCGA-GL-6846-11,TCGA-GL-6846,KIRP,52.0,MALE,WHITE,Stage IV,nan,Kidney Papillary Renal Cell Carcinoma,nan,1996.0,nan,-19012.0,Alive,TUMOR FREE,5925.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,5925.0,0.0,5925.0,nan,nan,0.0,5925.0,0
TCGA-GL-7773-01,TCGA-GL-7773,KIRP,63.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-23239.0,Alive,TUMOR FREE,393.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,393.0,0.0,393.0,0.0,393.0,0.0,393.0,0
TCGA-GL-7966-01,TCGA-GL-7966,KIRP,28.0,FEMALE,WHITE,Stage III,nan,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-10428.0,Alive,WITH TUMOR,112.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,112.0,0.0,112.0,nan,nan,0.0,112.0,0
TCGA-GL-7966-11,TCGA-GL-7966,KIRP,28.0,FEMALE,WHITE,Stage III,nan,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-10428.0,Alive,WITH TUMOR,112.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,112.0,0.0,112.0,nan,nan,0.0,112.0,0
TCGA-GL-8500-01,TCGA-GL-8500,KIRP,63.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-23338.0,Alive,TUMOR FREE,841.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,841.0,0.0,841.0,0.0,841.0,0.0,841.0,0
TCGA-GL-A4EM-01,TCGA-GL-A4EM,KIRP,61.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-22635.0,Alive,TUMOR FREE,32.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,32.0,0.0,32.0,nan,nan,0.0,32.0,0
TCGA-GL-A59R-01,TCGA-GL-A59R,KIRP,79.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-29046.0,Alive,TUMOR FREE,378.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,378.0,0.0,378.0,0.0,378.0,0.0,378.0,0
TCGA-GL-A59R-11,TCGA-GL-A59R,KIRP,79.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-29046.0,Alive,TUMOR FREE,378.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,378.0,0.0,378.0,0.0,378.0,0.0,378.0,0
TCGA-GL-A59T-01,TCGA-GL-A59T,KIRP,46.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-17142.0,Alive,TUMOR FREE,546.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,546.0,0.0,546.0,0.0,546.0,0.0,546.0,0
TCGA-GL-A9DC-01,TCGA-GL-A9DC,KIRP,66.0,FEMALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-24348.0,Alive,TUMOR FREE,392.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,392.0,0.0,392.0,0.0,392.0,0.0,392.0,0
TCGA-GL-A9DD-01,TCGA-GL-A9DD,KIRP,69.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-25483.0,Alive,TUMOR FREE,341.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,341.0,0.0,341.0,0.0,341.0,0.0,341.0,0
TCGA-GL-A9DE-01,TCGA-GL-A9DE,KIRP,74.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-27330.0,Alive,TUMOR FREE,496.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,496.0,0.0,496.0,0.0,496.0,0.0,496.0,0
TCGA-GL-A9DE-11,TCGA-GL-A9DE,KIRP,74.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-27330.0,Alive,TUMOR FREE,496.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,496.0,0.0,496.0,0.0,496.0,0.0,496.0,0
TCGA-HE-7128-01,TCGA-HE-7128,KIRP,nan,MALE,nan,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,nan,Alive,TUMOR FREE,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,nan,0.0,nan,nan,nan,0.0,nan,0
TCGA-HE-7129-01,TCGA-HE-7129,KIRP,nan,MALE,nan,Stage II,nan,Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,nan,Alive,TUMOR FREE,2492.0,nan,nan,nan,nan,nan,2399.0,Complete Remission/Response,nan,nan,0.0,2492.0,0.0,2492.0,1.0,2399.0,1.0,2399.0,0
TCGA-HE-7130-01,TCGA-HE-7130,KIRP,nan,FEMALE,nan,Stage III,nan,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,nan,Alive,TUMOR FREE,1770.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1770.0,0.0,1770.0,0.0,1770.0,0.0,1770.0,0
TCGA-HE-A5NF-01,TCGA-HE-A5NF,KIRP,58.0,MALE,[Not Evaluated],Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,nan,nan,-21524.0,Alive,TUMOR FREE,2582.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2582.0,0.0,2582.0,0.0,2582.0,0.0,2582.0,0
TCGA-HE-A5NH-01,TCGA-HE-A5NH,KIRP,62.0,MALE,[Not Evaluated],Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,nan,nan,-22888.0,Alive,TUMOR FREE,791.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,791.0,0.0,791.0,0.0,791.0,0.0,791.0,0
TCGA-HE-A5NI-01,TCGA-HE-A5NI,KIRP,73.0,MALE,[Not Evaluated],Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,nan,nan,-26985.0,Alive,TUMOR FREE,360.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,360.0,0.0,360.0,0.0,360.0,0.0,360.0,0
TCGA-HE-A5NJ-01,TCGA-HE-A5NJ,KIRP,58.0,MALE,[Not Evaluated],nan,nan,Kidney Papillary Renal Cell Carcinoma,nan,nan,nan,-21485.0,Alive,TUMOR FREE,1726.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1726.0,0.0,1726.0,0.0,1726.0,0.0,1726.0,0
TCGA-HE-A5NK-01,TCGA-HE-A5NK,KIRP,82.0,MALE,[Not Evaluated],nan,nan,Kidney Papillary Renal Cell Carcinoma,nan,nan,nan,-30088.0,Alive,TUMOR FREE,2228.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2228.0,0.0,2228.0,0.0,2228.0,0.0,2228.0,0
TCGA-HE-A5NL-01,TCGA-HE-A5NL,KIRP,51.0,MALE,[Not Evaluated],Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,nan,nan,-18913.0,Alive,TUMOR FREE,767.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,767.0,0.0,767.0,0.0,767.0,0.0,767.0,0
TCGA-IA-A40U-01,TCGA-IA-A40U,KIRP,56.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-20463.0,Alive,TUMOR FREE,511.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,511.0,0.0,511.0,0.0,511.0,0.0,511.0,0
TCGA-IA-A40X-01,TCGA-IA-A40X,KIRP,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-18239.0,Alive,TUMOR FREE,608.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,608.0,0.0,608.0,0.0,608.0,0.0,608.0,0
TCGA-IA-A40Y-01,TCGA-IA-A40Y,KIRP,60.0,FEMALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-21996.0,Alive,TUMOR FREE,62.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,62.0,0.0,62.0,0.0,62.0,0.0,62.0,0
TCGA-IA-A83S-01,TCGA-IA-A83S,KIRP,81.0,MALE,WHITE,[Discrepancy],nan,Kidney Papillary Renal Cell Carcinoma,nan,2003.0,nan,-29677.0,Dead,nan,nan,2609.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,2609.0,nan,2609.0,nan,nan,0.0,2609.0,1
TCGA-IA-A83T-01,TCGA-IA-A83T,KIRP,80.0,MALE,WHITE,[Discrepancy],nan,Kidney Papillary Renal Cell Carcinoma,nan,2005.0,nan,-29430.0,Dead,nan,nan,2684.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,2684.0,nan,2684.0,nan,nan,0.0,2684.0,1
TCGA-IA-A83V-01,TCGA-IA-A83V,KIRP,63.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2002.0,nan,-23238.0,Dead,nan,nan,2941.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,2941.0,nan,2941.0,nan,nan,0.0,2941.0,0
TCGA-IA-A83W-01,TCGA-IA-A83W,KIRP,70.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2003.0,nan,-25678.0,Dead,TUMOR FREE,nan,2043.0,nan,nan,nan,nan,1408.0,Complete Remission/Response,nan,nan,1.0,2043.0,0.0,2043.0,1.0,1408.0,1.0,1408.0,0
TCGA-IZ-8195-01,TCGA-IZ-8195,KIRP,82.0,MALE,WHITE,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-29963.0,Alive,TUMOR FREE,677.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,677.0,0.0,677.0,0.0,677.0,0.0,677.0,0
TCGA-IZ-8196-01,TCGA-IZ-8196,KIRP,50.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-18540.0,Alive,TUMOR FREE,649.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,649.0,0.0,649.0,0.0,649.0,0.0,649.0,0
TCGA-IZ-A6M8-01,TCGA-IZ-A6M8,KIRP,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-25545.0,Alive,TUMOR FREE,497.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,497.0,0.0,497.0,0.0,497.0,0.0,497.0,0
TCGA-IZ-A6M9-01,TCGA-IZ-A6M9,KIRP,63.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-23149.0,Alive,TUMOR FREE,376.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,376.0,0.0,376.0,0.0,376.0,0.0,376.0,0
TCGA-J7-6720-01,TCGA-J7-6720,KIRP,42.0,MALE,ASIAN,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-15620.0,Alive,TUMOR FREE,388.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,388.0,0.0,388.0,0.0,388.0,0.0,388.0,0
TCGA-J7-8537-01,TCGA-J7-8537,KIRP,37.0,FEMALE,ASIAN,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-13628.0,Dead,WITH TUMOR,nan,321.0,nan,nan,nan,nan,220.0,Complete Remission/Response,nan,nan,1.0,321.0,1.0,321.0,1.0,220.0,1.0,220.0,1
TCGA-J7-A8I2-01,TCGA-J7-A8I2,KIRP,75.0,MALE,ASIAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-27431.0,Alive,WITH TUMOR,307.0,nan,nan,nan,nan,nan,268.0,Complete Remission/Response,nan,nan,0.0,307.0,0.0,307.0,1.0,268.0,1.0,268.0,2
TCGA-KV-A6GD-01,TCGA-KV-A6GD,KIRP,85.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-31217.0,Alive,TUMOR FREE,560.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,560.0,0.0,560.0,0.0,560.0,0.0,560.0,0
TCGA-KV-A6GE-01,TCGA-KV-A6GE,KIRP,65.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-23979.0,Alive,TUMOR FREE,885.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,885.0,0.0,885.0,0.0,885.0,0.0,885.0,0
TCGA-KV-A74V-01,TCGA-KV-A74V,KIRP,40.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-14834.0,Alive,TUMOR FREE,347.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,347.0,0.0,347.0,0.0,347.0,0.0,347.0,0
TCGA-MH-A55W-01,TCGA-MH-A55W,KIRP,50.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-18573.0,Alive,TUMOR FREE,1043.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1043.0,0.0,1043.0,0.0,1043.0,0.0,1043.0,0
TCGA-MH-A55Z-01,TCGA-MH-A55Z,KIRP,65.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-24017.0,Alive,TUMOR FREE,845.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,845.0,0.0,845.0,0.0,845.0,0.0,845.0,0
TCGA-MH-A560-01,TCGA-MH-A560,KIRP,62.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-22866.0,Alive,TUMOR FREE,924.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,924.0,0.0,924.0,0.0,924.0,0.0,924.0,0
TCGA-MH-A561-01,TCGA-MH-A561,KIRP,66.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-24271.0,Alive,TUMOR FREE,841.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,841.0,0.0,841.0,0.0,841.0,0.0,841.0,0
TCGA-MH-A562-01,TCGA-MH-A562,KIRP,57.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-20933.0,Alive,TUMOR FREE,616.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,616.0,0.0,616.0,0.0,616.0,0.0,616.0,0
TCGA-MH-A854-01,TCGA-MH-A854,KIRP,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-22804.0,Alive,TUMOR FREE,536.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,536.0,0.0,536.0,0.0,536.0,0.0,536.0,0
TCGA-MH-A855-01,TCGA-MH-A855,KIRP,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-19029.0,Alive,TUMOR FREE,369.0,nan,nan,nan,nan,nan,0.0,Complete Remission/Response,nan,nan,0.0,369.0,0.0,369.0,1.0,0.0,1.0,0.0,2
TCGA-MH-A856-01,TCGA-MH-A856,KIRP,54.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-20006.0,Alive,TUMOR FREE,947.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,947.0,0.0,947.0,0.0,947.0,0.0,947.0,0
TCGA-MH-A857-01,TCGA-MH-A857,KIRP,63.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-23114.0,Alive,TUMOR FREE,890.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,890.0,0.0,890.0,nan,nan,0.0,890.0,0
TCGA-O9-A75Z-01,TCGA-O9-A75Z,KIRP,44.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-16183.0,Alive,nan,471.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,471.0,0.0,471.0,nan,nan,0.0,471.0,0
TCGA-P4-A5E6-01,TCGA-P4-A5E6,KIRP,67.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2004.0,nan,-24615.0,Alive,TUMOR FREE,3035.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3035.0,0.0,3035.0,0.0,3035.0,0.0,3035.0,0
TCGA-P4-A5E7-01,TCGA-P4-A5E7,KIRP,74.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2004.0,nan,-27029.0,Alive,TUMOR FREE,2649.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2649.0,0.0,2649.0,0.0,2649.0,0.0,2649.0,0
TCGA-P4-A5E8-01,TCGA-P4-A5E8,KIRP,57.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2004.0,nan,-21132.0,Dead,WITH TUMOR,nan,1306.0,nan,nan,nan,nan,42.0,nan,nan,nan,1.0,1306.0,1.0,1306.0,nan,nan,1.0,42.0,1
TCGA-P4-A5E8-11,TCGA-P4-A5E8,KIRP,57.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2004.0,nan,-21132.0,Dead,WITH TUMOR,nan,1306.0,nan,nan,nan,nan,42.0,nan,nan,nan,1.0,1306.0,1.0,1306.0,nan,nan,1.0,42.0,1
TCGA-P4-A5EA-01,TCGA-P4-A5EA,KIRP,54.0,FEMALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2007.0,nan,-19748.0,Dead,WITH TUMOR,nan,201.0,nan,nan,nan,nan,44.0,Complete Remission/Response,nan,nan,1.0,201.0,1.0,201.0,1.0,44.0,1.0,44.0,1
TCGA-P4-A5EB-01,TCGA-P4-A5EB,KIRP,83.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2006.0,nan,-30395.0,Alive,TUMOR FREE,3015.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3015.0,0.0,3015.0,0.0,3015.0,0.0,3015.0,0
TCGA-P4-A5ED-01,TCGA-P4-A5ED,KIRP,51.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2005.0,nan,-18698.0,Alive,TUMOR FREE,2816.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2816.0,0.0,2816.0,0.0,2816.0,0.0,2816.0,0
TCGA-P4-A5ED-11,TCGA-P4-A5ED,KIRP,51.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2005.0,nan,-18698.0,Alive,TUMOR FREE,2816.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2816.0,0.0,2816.0,0.0,2816.0,0.0,2816.0,0
TCGA-P4-AAVK-01,TCGA-P4-AAVK,KIRP,74.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-27073.0,Alive,WITH TUMOR,1590.0,nan,nan,nan,nan,nan,232.0,Complete Remission/Response,nan,nan,0.0,1590.0,0.0,1590.0,1.0,232.0,1.0,232.0,2
TCGA-P4-AAVL-01,TCGA-P4-AAVL,KIRP,85.0,MALE,WHITE,Stage III,Stage III,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-31082.0,Dead,WITH TUMOR,nan,487.0,nan,nan,nan,nan,41.0,Complete Remission/Response,nan,nan,1.0,487.0,1.0,487.0,1.0,41.0,1.0,41.0,1
TCGA-P4-AAVM-01,TCGA-P4-AAVM,KIRP,69.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-25280.0,Alive,TUMOR FREE,1539.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1539.0,0.0,1539.0,0.0,1539.0,0.0,1539.0,0
TCGA-P4-AAVO-01,TCGA-P4-AAVO,KIRP,69.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2008.0,nan,-25354.0,Alive,TUMOR FREE,2400.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2400.0,0.0,2400.0,0.0,2400.0,0.0,2400.0,0
TCGA-PJ-A5Z8-01,TCGA-PJ-A5Z8,KIRP,60.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-21968.0,Alive,TUMOR FREE,600.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,600.0,0.0,600.0,0.0,600.0,0.0,600.0,0
TCGA-PJ-A5Z9-01,TCGA-PJ-A5Z9,KIRP,80.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-29365.0,Alive,TUMOR FREE,540.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,540.0,0.0,540.0,0.0,540.0,0.0,540.0,0
TCGA-PJ-A8JU-01,TCGA-PJ-A8JU,KIRP,81.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-29830.0,Alive,TUMOR FREE,380.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,380.0,0.0,380.0,0.0,380.0,0.0,380.0,0
TCGA-Q2-A5QZ-01,TCGA-Q2-A5QZ,KIRP,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-22531.0,Alive,nan,428.0,nan,nan,nan,nan,nan,412.0,Complete Remission/Response,nan,nan,0.0,428.0,0.0,428.0,1.0,412.0,1.0,412.0,2
TCGA-SX-A71R-01,TCGA-SX-A71R,KIRP,51.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-18742.0,Alive,TUMOR FREE,1457.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1457.0,0.0,1457.0,0.0,1457.0,0.0,1457.0,0
TCGA-SX-A71S-01,TCGA-SX-A71S,KIRP,66.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-24211.0,Alive,TUMOR FREE,1504.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1504.0,0.0,1504.0,0.0,1504.0,0.0,1504.0,0
TCGA-SX-A71U-01,TCGA-SX-A71U,KIRP,57.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-21079.0,Alive,TUMOR FREE,1357.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1357.0,0.0,1357.0,0.0,1357.0,0.0,1357.0,0
TCGA-SX-A71V-01,TCGA-SX-A71V,KIRP,80.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-29332.0,Alive,TUMOR FREE,876.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,876.0,0.0,876.0,0.0,876.0,0.0,876.0,0
TCGA-SX-A71W-01,TCGA-SX-A71W,KIRP,66.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-24110.0,Alive,TUMOR FREE,1076.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1076.0,0.0,1076.0,0.0,1076.0,0.0,1076.0,0
TCGA-SX-A7SL-01,TCGA-SX-A7SL,KIRP,74.0,MALE,[Not Evaluated],Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-27063.0,Alive,TUMOR FREE,823.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,823.0,0.0,823.0,0.0,823.0,0.0,823.0,0
TCGA-SX-A7SM-01,TCGA-SX-A7SM,KIRP,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,Stage IV,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-22044.0,Dead,WITH TUMOR,nan,363.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,363.0,1.0,363.0,nan,nan,1.0,363.0,1
TCGA-SX-A7SN-01,TCGA-SX-A7SN,KIRP,52.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-19116.0,Alive,TUMOR FREE,578.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,578.0,0.0,578.0,0.0,578.0,0.0,578.0,0
TCGA-SX-A7SO-01,TCGA-SX-A7SO,KIRP,64.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,-23534.0,Alive,TUMOR FREE,1257.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1257.0,0.0,1257.0,0.0,1257.0,0.0,1257.0,0
TCGA-SX-A7SP-01,TCGA-SX-A7SP,KIRP,66.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-24382.0,Dead,TUMOR FREE,nan,496.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,496.0,0.0,496.0,0.0,496.0,0.0,496.0,0
TCGA-SX-A7SQ-01,TCGA-SX-A7SQ,KIRP,48.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-17696.0,Alive,TUMOR FREE,1266.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1266.0,0.0,1266.0,0.0,1266.0,0.0,1266.0,0
TCGA-SX-A7SR-01,TCGA-SX-A7SR,KIRP,66.0,MALE,WHITE,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-24237.0,Alive,TUMOR FREE,805.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,805.0,0.0,805.0,0.0,805.0,0.0,805.0,0
TCGA-SX-A7SS-01,TCGA-SX-A7SS,KIRP,67.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-24660.0,Alive,TUMOR FREE,1615.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1615.0,0.0,1615.0,0.0,1615.0,0.0,1615.0,0
TCGA-SX-A7SU-01,TCGA-SX-A7SU,KIRP,47.0,MALE,[Not Evaluated],Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2010.0,nan,-17349.0,Alive,TUMOR FREE,1331.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1331.0,0.0,1331.0,0.0,1331.0,0.0,1331.0,0
TCGA-UN-AAZ9-01,TCGA-UN-AAZ9,KIRP,76.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-27851.0,Alive,TUMOR FREE,548.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,548.0,0.0,548.0,0.0,548.0,0.0,548.0,0
TCGA-UZ-A9PJ-01,TCGA-UZ-A9PJ,KIRP,78.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,nan,nan,-28490.0,Dead,nan,nan,797.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,797.0,nan,797.0,0.0,797.0,0.0,797.0,0
TCGA-UZ-A9PK-01,TCGA-UZ-A9PK,KIRP,71.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,nan,nan,-25933.0,Alive,TUMOR FREE,3571.0,nan,nan,nan,nan,nan,3157.0,Complete Remission/Response,nan,nan,0.0,3571.0,0.0,3571.0,1.0,3157.0,1.0,3157.0,0
TCGA-UZ-A9PL-01,TCGA-UZ-A9PL,KIRP,59.0,MALE,WHITE,Stage II,nan,Kidney Papillary Renal Cell Carcinoma,nan,nan,nan,-21550.0,Alive,TUMOR FREE,3152.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3152.0,0.0,3152.0,0.0,3152.0,0.0,3152.0,0
TCGA-UZ-A9PM-01,TCGA-UZ-A9PM,KIRP,62.0,MALE,WHITE,Stage II,nan,Kidney Papillary Renal Cell Carcinoma,nan,nan,nan,-22646.0,Alive,TUMOR FREE,3811.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3811.0,0.0,3811.0,0.0,3811.0,0.0,3811.0,0
TCGA-UZ-A9PN-01,TCGA-UZ-A9PN,KIRP,54.0,MALE,WHITE,Stage III,nan,Kidney Papillary Renal Cell Carcinoma,nan,nan,nan,-19724.0,Dead,WITH TUMOR,nan,1136.0,nan,nan,nan,nan,679.0,Complete Remission/Response,nan,nan,1.0,1136.0,1.0,1136.0,1.0,679.0,1.0,679.0,1
TCGA-UZ-A9PO-01,TCGA-UZ-A9PO,KIRP,80.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,nan,nan,-29220.0,Alive,TUMOR FREE,1911.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1911.0,0.0,1911.0,0.0,1911.0,0.0,1911.0,0
TCGA-UZ-A9PP-01,TCGA-UZ-A9PP,KIRP,60.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,nan,nan,-21915.0,Alive,TUMOR FREE,3010.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3010.0,0.0,3010.0,0.0,3010.0,0.0,3010.0,0
TCGA-UZ-A9PQ-01,TCGA-UZ-A9PQ,KIRP,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Kidney Papillary Renal Cell Carcinoma,nan,nan,nan,-21550.0,Dead,WITH TUMOR,nan,2624.0,nan,nan,nan,nan,2148.0,Complete Remission/Response,nan,nan,1.0,2624.0,1.0,2624.0,1.0,2148.0,1.0,2148.0,1
TCGA-UZ-A9PR-01,TCGA-UZ-A9PR,KIRP,84.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,nan,nan,-30681.0,Alive,TUMOR FREE,2627.0,nan,nan,nan,nan,nan,2494.0,Complete Remission/Response,nan,nan,0.0,2627.0,0.0,2627.0,1.0,2494.0,1.0,2494.0,0
TCGA-UZ-A9PS-05,TCGA-UZ-A9PS,KIRP,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Kidney Papillary Renal Cell Carcinoma,nan,nan,nan,-22646.0,Alive,TUMOR FREE,2167.0,nan,nan,nan,nan,nan,55.0,Complete Remission/Response,nan,nan,0.0,2167.0,0.0,2167.0,1.0,55.0,1.0,55.0,2
TCGA-UZ-A9PS-01,TCGA-UZ-A9PS,KIRP,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Kidney Papillary Renal Cell Carcinoma,nan,nan,nan,-22646.0,Alive,TUMOR FREE,2167.0,nan,nan,nan,nan,nan,55.0,Complete Remission/Response,nan,nan,0.0,2167.0,0.0,2167.0,1.0,55.0,1.0,55.0,2
TCGA-UZ-A9PU-01,TCGA-UZ-A9PU,KIRP,77.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,nan,nan,-28124.0,Dead,TUMOR FREE,nan,933.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,933.0,0.0,933.0,0.0,933.0,0.0,933.0,0
TCGA-UZ-A9PV-01,TCGA-UZ-A9PV,KIRP,65.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,nan,nan,-23741.0,Alive,TUMOR FREE,1444.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1444.0,0.0,1444.0,0.0,1444.0,0.0,1444.0,0
TCGA-UZ-A9PX-01,TCGA-UZ-A9PX,KIRP,73.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,nan,nan,-26663.0,Alive,TUMOR FREE,1981.0,nan,nan,nan,nan,nan,308.0,Complete Remission/Response,nan,nan,0.0,1981.0,0.0,1981.0,1.0,308.0,1.0,308.0,0
TCGA-UZ-A9PZ-01,TCGA-UZ-A9PZ,KIRP,65.0,MALE,WHITE,Stage III,nan,Kidney Papillary Renal Cell Carcinoma,nan,nan,nan,-23741.0,Alive,TUMOR FREE,657.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,657.0,0.0,657.0,0.0,657.0,0.0,657.0,0
TCGA-UZ-A9Q0-01,TCGA-UZ-A9Q0,KIRP,60.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,nan,nan,-21915.0,Alive,TUMOR FREE,3368.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3368.0,0.0,3368.0,0.0,3368.0,0.0,3368.0,0
TCGA-UZ-A9Q1-01,TCGA-UZ-A9Q1,KIRP,88.0,FEMALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,nan,nan,-32142.0,Alive,TUMOR FREE,1562.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1562.0,0.0,1562.0,0.0,1562.0,0.0,1562.0,0
TCGA-V9-A7HT-01,TCGA-V9-A7HT,KIRP,67.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,Stage II,Kidney Papillary Renal Cell Carcinoma,nan,2009.0,nan,-24610.0,Alive,TUMOR FREE,965.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,965.0,0.0,965.0,0.0,965.0,0.0,965.0,0
TCGA-WN-A9G9-01,TCGA-WN-A9G9,KIRP,55.0,MALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,nan,Alive,TUMOR FREE,791.0,nan,nan,nan,nan,nan,791.0,Complete Remission/Response,nan,nan,0.0,791.0,0.0,791.0,1.0,791.0,1.0,791.0,0
TCGA-WN-AB4C-01,TCGA-WN-AB4C,KIRP,60.0,FEMALE,WHITE,Stage I,Stage I,Kidney Papillary Renal Cell Carcinoma,nan,2011.0,nan,nan,Alive,WITH TUMOR,1188.0,nan,nan,nan,nan,nan,1157.0,Complete Remission/Response,nan,nan,0.0,1188.0,0.0,1188.0,1.0,1157.0,1.0,1157.0,2
TCGA-Y8-A894-01,TCGA-Y8-A894,KIRP,57.0,FEMALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-20964.0,Alive,TUMOR FREE,567.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,567.0,0.0,567.0,0.0,567.0,0.0,567.0,0
TCGA-Y8-A895-01,TCGA-Y8-A895,KIRP,74.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-27139.0,Alive,TUMOR FREE,484.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,484.0,0.0,484.0,0.0,484.0,0.0,484.0,0
TCGA-Y8-A896-01,TCGA-Y8-A896,KIRP,62.0,MALE,WHITE,Stage III,nan,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-22750.0,Alive,TUMOR FREE,567.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,567.0,0.0,567.0,0.0,567.0,0.0,567.0,0
TCGA-Y8-A897-01,TCGA-Y8-A897,KIRP,68.0,FEMALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-25047.0,Alive,TUMOR FREE,549.0,nan,nan,nan,nan,nan,450.0,Complete Remission/Response,nan,nan,0.0,549.0,0.0,549.0,1.0,450.0,1.0,450.0,2
TCGA-Y8-A898-01,TCGA-Y8-A898,KIRP,69.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-25344.0,Alive,TUMOR FREE,475.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,475.0,0.0,475.0,0.0,475.0,0.0,475.0,0
TCGA-Y8-A8RY-01,TCGA-Y8-A8RY,KIRP,63.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-23192.0,Alive,TUMOR FREE,769.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,769.0,0.0,769.0,0.0,769.0,0.0,769.0,0
TCGA-Y8-A8RY-11,TCGA-Y8-A8RY,KIRP,63.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2012.0,nan,-23192.0,Alive,TUMOR FREE,769.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,769.0,0.0,769.0,0.0,769.0,0.0,769.0,0
TCGA-Y8-A8RZ-01,TCGA-Y8-A8RZ,KIRP,55.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-20386.0,Alive,TUMOR FREE,205.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,205.0,0.0,205.0,0.0,205.0,0.0,205.0,0
TCGA-Y8-A8S0-01,TCGA-Y8-A8S0,KIRP,58.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-21383.0,Alive,TUMOR FREE,183.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,183.0,0.0,183.0,0.0,183.0,0.0,183.0,0
TCGA-Y8-A8S1-01,TCGA-Y8-A8S1,KIRP,61.0,MALE,WHITE,Stage I,nan,Kidney Papillary Renal Cell Carcinoma,nan,2013.0,nan,-22319.0,Alive,TUMOR FREE,404.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,404.0,0.0,404.0,0.0,404.0,0.0,404.0,0
TCGA-AB-2802-03,TCGA-AB-2802,LAML,50.0,MALE,WHITE,nan,nan,nan,nan,2001.0,nan,-18385.0,Dead,nan,nan,365.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,365.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2803-03,TCGA-AB-2803,LAML,61.0,FEMALE,WHITE,nan,nan,nan,nan,2001.0,nan,-22584.0,Dead,nan,nan,792.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,792.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2804-03,TCGA-AB-2804,LAML,30.0,MALE,WHITE,nan,nan,nan,nan,2001.0,nan,-11203.0,Alive,nan,2557.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2557.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2805-03,TCGA-AB-2805,LAML,77.0,MALE,WHITE,nan,nan,nan,nan,2002.0,nan,-28124.0,Dead,nan,nan,577.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,577.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2806-03,TCGA-AB-2806,LAML,46.0,MALE,WHITE,nan,nan,nan,nan,2002.0,nan,-16892.0,Dead,nan,nan,945.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,945.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2807-03,TCGA-AB-2807,LAML,68.0,FEMALE,WHITE,nan,nan,nan,nan,2002.0,nan,-25143.0,Dead,nan,nan,181.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,181.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2808-03,TCGA-AB-2808,LAML,23.0,MALE,WHITE,nan,nan,nan,nan,2002.0,nan,-8521.0,Alive,nan,2861.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2861.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2809-03,TCGA-AB-2809,LAML,64.0,FEMALE,WHITE,nan,nan,nan,nan,2002.0,nan,-23679.0,Dead,nan,nan,62.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,62.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2810-03,TCGA-AB-2810,LAML,76.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,nan,nan,2002.0,nan,-27971.0,Dead,nan,nan,31.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,31.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2811-03,TCGA-AB-2811,LAML,81.0,MALE,WHITE,nan,nan,nan,nan,2002.0,nan,-29766.0,Dead,nan,nan,243.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,243.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2812-03,TCGA-AB-2812,LAML,25.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,nan,nan,2004.0,nan,-9253.0,Dead,nan,nan,366.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,366.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2813-03,TCGA-AB-2813,LAML,78.0,MALE,WHITE,nan,nan,nan,nan,2005.0,nan,-28581.0,Dead,nan,nan,31.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,31.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2814-03,TCGA-AB-2814,LAML,39.0,FEMALE,WHITE,nan,nan,nan,nan,2003.0,nan,-14427.0,Dead,nan,nan,792.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,792.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2815-03,TCGA-AB-2815,LAML,49.0,MALE,WHITE,nan,nan,nan,nan,2004.0,nan,-17988.0,Dead,nan,nan,822.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,822.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2816-03,TCGA-AB-2816,LAML,57.0,FEMALE,WHITE,nan,nan,nan,nan,2003.0,nan,-20939.0,Dead,nan,nan,245.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,245.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2817-03,TCGA-AB-2817,LAML,64.0,MALE,WHITE,nan,nan,nan,nan,2005.0,nan,-23376.0,Dead,nan,nan,273.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,273.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2818-03,TCGA-AB-2818,LAML,62.0,FEMALE,ASIAN,nan,nan,nan,nan,2002.0,nan,-22707.0,Dead,nan,nan,303.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,303.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2819-03,TCGA-AB-2819,LAML,52.0,FEMALE,WHITE,nan,nan,nan,nan,2003.0,nan,-19054.0,Alive,nan,2496.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2496.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2820-03,TCGA-AB-2820,LAML,76.0,MALE,WHITE,nan,nan,nan,nan,2003.0,nan,-27971.0,Dead,nan,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,0.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2821-03,TCGA-AB-2821,LAML,64.0,MALE,WHITE,nan,nan,nan,nan,2005.0,nan,-23527.0,Dead,nan,nan,822.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,822.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2822-03,TCGA-AB-2822,LAML,65.0,MALE,WHITE,nan,nan,nan,nan,2003.0,nan,-24017.0,Dead,nan,nan,973.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,973.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2823-03,TCGA-AB-2823,LAML,61.0,FEMALE,WHITE,nan,nan,nan,nan,2006.0,nan,-22522.0,Dead,nan,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,0.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2824-03,TCGA-AB-2824,LAML,45.0,MALE,WHITE,nan,nan,nan,nan,2004.0,nan,-16437.0,Dead,nan,nan,30.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,30.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2825-03,TCGA-AB-2825,LAML,31.0,FEMALE,WHITE,nan,nan,nan,nan,2006.0,nan,-11384.0,Dead,nan,nan,212.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,212.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2826-03,TCGA-AB-2826,LAML,64.0,FEMALE,WHITE,nan,nan,nan,nan,2002.0,nan,-23468.0,Dead,nan,nan,731.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,731.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2827-03,TCGA-AB-2827,LAML,33.0,MALE,WHITE,nan,nan,nan,nan,2003.0,nan,-12237.0,Dead,nan,nan,273.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,273.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2828-03,TCGA-AB-2828,LAML,55.0,MALE,WHITE,nan,nan,nan,nan,2003.0,nan,-20393.0,Alive,nan,2284.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2284.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2829-03,TCGA-AB-2829,LAML,50.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,nan,nan,2004.0,nan,-18386.0,Dead,nan,nan,273.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,273.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2830-03,TCGA-AB-2830,LAML,64.0,FEMALE,WHITE,nan,nan,nan,nan,2005.0,nan,-23404.0,Dead,nan,nan,275.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,275.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2831-03,TCGA-AB-2831,LAML,59.0,MALE,WHITE,nan,nan,nan,nan,2004.0,nan,-21550.0,Dead,nan,nan,640.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,640.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2832-03,TCGA-AB-2832,LAML,60.0,FEMALE,WHITE,nan,nan,nan,nan,2005.0,nan,-21915.0,Dead,nan,nan,365.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,365.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2833-03,TCGA-AB-2833,LAML,77.0,MALE,WHITE,nan,nan,nan,nan,2002.0,nan,-28308.0,Dead,nan,nan,456.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,456.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2834-03,TCGA-AB-2834,LAML,33.0,MALE,WHITE,nan,nan,nan,nan,2004.0,nan,-12266.0,Dead,nan,nan,245.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,245.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2835-03,TCGA-AB-2835,LAML,48.0,MALE,WHITE,nan,nan,nan,nan,2005.0,nan,-17624.0,Alive,nan,1673.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1673.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2836-03,TCGA-AB-2836,LAML,35.0,MALE,WHITE,nan,nan,nan,nan,2005.0,nan,-12904.0,Dead,nan,nan,518.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,518.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2837-03,TCGA-AB-2837,LAML,66.0,FEMALE,WHITE,nan,nan,nan,nan,2002.0,nan,-24381.0,Dead,nan,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,0.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2838-03,TCGA-AB-2838,LAML,67.0,MALE,WHITE,nan,nan,nan,nan,2002.0,nan,-24503.0,Dead,nan,nan,365.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,365.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2839-03,TCGA-AB-2839,LAML,51.0,FEMALE,WHITE,nan,nan,nan,nan,2003.0,nan,-18963.0,Dead,nan,nan,486.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,486.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2840-03,TCGA-AB-2840,LAML,74.0,MALE,WHITE,nan,nan,nan,nan,2003.0,nan,-27243.0,Dead,nan,nan,28.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,28.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2841-03,TCGA-AB-2841,LAML,51.0,FEMALE,WHITE,nan,nan,nan,nan,2004.0,nan,-18809.0,Dead,nan,nan,1401.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1401.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2842-03,TCGA-AB-2842,LAML,65.0,MALE,WHITE,nan,nan,nan,nan,2004.0,nan,-23741.0,Dead,nan,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,0.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2843-03,TCGA-AB-2843,LAML,77.0,MALE,WHITE,nan,nan,nan,nan,2004.0,nan,-28275.0,Dead,nan,nan,215.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,215.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2844-03,TCGA-AB-2844,LAML,63.0,MALE,WHITE,nan,nan,nan,nan,2005.0,nan,-23254.0,Dead,nan,nan,122.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,122.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2845-03,TCGA-AB-2845,LAML,37.0,FEMALE,WHITE,nan,nan,nan,nan,2002.0,nan,-13728.0,Dead,nan,nan,304.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,304.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2846-03,TCGA-AB-2846,LAML,57.0,FEMALE,WHITE,nan,nan,nan,nan,2005.0,nan,-20910.0,Dead,nan,nan,1402.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1402.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2847-03,TCGA-AB-2847,LAML,53.0,MALE,WHITE,nan,nan,nan,nan,2004.0,nan,-19481.0,Dead,nan,nan,608.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,608.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2848-03,TCGA-AB-2848,LAML,62.0,MALE,WHITE,nan,nan,nan,nan,2005.0,nan,-22980.0,Dead,nan,nan,455.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,455.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2849-03,TCGA-AB-2849,LAML,39.0,MALE,WHITE,nan,nan,nan,nan,2004.0,nan,-14520.0,Alive,nan,2220.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2220.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2850-03,TCGA-AB-2850,LAML,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,nan,nan,2003.0,nan,-26298.0,Dead,nan,nan,61.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,61.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2851-03,TCGA-AB-2851,LAML,66.0,FEMALE,WHITE,nan,nan,nan,nan,2005.0,nan,-24319.0,Dead,nan,nan,242.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,242.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2853-03,TCGA-AB-2853,LAML,51.0,MALE,WHITE,nan,nan,nan,nan,2003.0,nan,-18720.0,Dead,nan,nan,89.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,89.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2854-03,TCGA-AB-2854,LAML,51.0,FEMALE,WHITE,nan,nan,nan,nan,2003.0,nan,-18809.0,Dead,nan,nan,366.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,366.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2855-03,TCGA-AB-2855,LAML,18.0,MALE,WHITE,nan,nan,nan,nan,2004.0,nan,-6636.0,Dead,nan,nan,212.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,212.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2856-03,TCGA-AB-2856,LAML,63.0,MALE,WHITE,nan,nan,nan,nan,2006.0,nan,-23317.0,Dead,nan,nan,150.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,150.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2857-03,TCGA-AB-2857,LAML,54.0,MALE,WHITE,nan,nan,nan,nan,2005.0,nan,-19905.0,Dead,nan,nan,306.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,306.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2858-03,TCGA-AB-2858,LAML,75.0,FEMALE,WHITE,nan,nan,nan,nan,2004.0,nan,-27547.0,Dead,nan,nan,577.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,577.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2859-03,TCGA-AB-2859,LAML,40.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,nan,nan,2005.0,nan,-14671.0,Dead,nan,nan,304.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,304.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2860-03,TCGA-AB-2860,LAML,60.0,FEMALE,WHITE,nan,nan,nan,nan,2003.0,nan,-22035.0,Dead,nan,nan,427.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,427.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2861-03,TCGA-AB-2861,LAML,76.0,MALE,WHITE,nan,nan,nan,nan,2005.0,nan,-27940.0,Dead,nan,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,0.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2862-03,TCGA-AB-2862,LAML,33.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,nan,nan,2005.0,nan,-12266.0,Alive,nan,1430.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1430.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2863-03,TCGA-AB-2863,LAML,63.0,MALE,WHITE,nan,nan,nan,nan,2003.0,nan,-23132.0,Dead,nan,nan,31.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,31.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2864-03,TCGA-AB-2864,LAML,54.0,FEMALE,WHITE,nan,nan,nan,nan,2005.0,nan,-19724.0,Dead,nan,nan,577.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,577.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2865-03,TCGA-AB-2865,LAML,75.0,MALE,WHITE,nan,nan,nan,nan,2005.0,nan,-27486.0,Dead,nan,nan,61.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,61.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2866-03,TCGA-AB-2866,LAML,67.0,MALE,WHITE,nan,nan,nan,nan,2005.0,nan,-24684.0,Dead,nan,nan,153.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,153.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2867-03,TCGA-AB-2867,LAML,66.0,FEMALE,WHITE,nan,nan,nan,nan,2002.0,nan,-24257.0,Dead,nan,nan,184.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,184.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2868-03,TCGA-AB-2868,LAML,77.0,MALE,WHITE,nan,nan,nan,nan,2002.0,nan,-28216.0,Dead,nan,nan,151.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,151.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2869-03,TCGA-AB-2869,LAML,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,nan,nan,2009.0,nan,-23679.0,Alive,nan,243.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,243.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2870-03,TCGA-AB-2870,LAML,76.0,MALE,WHITE,nan,nan,nan,nan,2007.0,nan,-27787.0,Dead,nan,nan,153.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,153.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2871-03,TCGA-AB-2871,LAML,51.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,nan,nan,2009.0,nan,-18689.0,Alive,nan,153.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,153.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2872-03,TCGA-AB-2872,LAML,42.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,nan,nan,2008.0,nan,-15461.0,Alive,nan,638.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,638.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2873-03,TCGA-AB-2873,LAML,51.0,FEMALE,WHITE,nan,nan,nan,nan,2009.0,nan,-18689.0,Alive,nan,273.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,273.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2874-03,TCGA-AB-2874,LAML,59.0,MALE,WHITE,nan,nan,nan,nan,2009.0,nan,-21764.0,Alive,nan,396.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,396.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2875-03,TCGA-AB-2875,LAML,43.0,MALE,WHITE,nan,nan,nan,nan,2009.0,nan,-16010.0,Alive,nan,212.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,212.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2876-03,TCGA-AB-2876,LAML,45.0,FEMALE,WHITE,nan,nan,nan,nan,2006.0,nan,-16648.0,Alive,nan,1219.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1219.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2877-03,TCGA-AB-2877,LAML,60.0,FEMALE,WHITE,nan,nan,nan,nan,2008.0,nan,-21946.0,Alive,nan,638.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,638.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2878-03,TCGA-AB-2878,LAML,47.0,FEMALE,WHITE,nan,nan,nan,nan,2006.0,nan,-17501.0,Dead,nan,nan,365.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,365.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2879-03,TCGA-AB-2879,LAML,68.0,FEMALE,WHITE,nan,nan,nan,nan,2009.0,nan,-25141.0,Alive,nan,245.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,245.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2880-03,TCGA-AB-2880,LAML,24.0,MALE,WHITE,nan,nan,nan,nan,2009.0,nan,-8827.0,Dead,nan,424.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,1.0,nan,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2881-03,TCGA-AB-2881,LAML,48.0,FEMALE,WHITE,nan,nan,nan,nan,2009.0,nan,-17808.0,Alive,nan,393.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,393.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2882-03,TCGA-AB-2882,LAML,73.0,FEMALE,WHITE,nan,nan,nan,nan,2006.0,nan,-26844.0,Dead,nan,nan,365.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,365.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2883-03,TCGA-AB-2883,LAML,60.0,MALE,WHITE,nan,nan,nan,nan,2008.0,nan,-22067.0,Alive,nan,730.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,730.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2884-03,TCGA-AB-2884,LAML,44.0,FEMALE,WHITE,nan,nan,nan,nan,2008.0,nan,-16285.0,Dead,nan,nan,731.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,731.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2885-03,TCGA-AB-2885,LAML,71.0,MALE,WHITE,nan,nan,nan,nan,2009.0,nan,-26176.0,Dead,nan,nan,214.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,214.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2886-03,TCGA-AB-2886,LAML,26.0,MALE,WHITE,nan,nan,nan,nan,2009.0,nan,-9497.0,Alive,nan,181.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,181.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2887-03,TCGA-AB-2887,LAML,60.0,FEMALE,WHITE,nan,nan,nan,nan,2009.0,nan,-21946.0,Dead,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,1.0,nan,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2888-03,TCGA-AB-2888,LAML,57.0,MALE,WHITE,nan,nan,nan,nan,2009.0,nan,-20879.0,Alive,nan,334.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,334.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2889-03,TCGA-AB-2889,LAML,55.0,MALE,WHITE,nan,nan,nan,nan,2009.0,nan,-20150.0,Alive,nan,304.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,304.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2890-03,TCGA-AB-2890,LAML,69.0,MALE,WHITE,nan,nan,nan,nan,2009.0,nan,-25234.0,Dead,nan,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,0.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2891-03,TCGA-AB-2891,LAML,42.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,nan,nan,2009.0,nan,-15400.0,Dead,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,1.0,nan,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2892-03,TCGA-AB-2892,LAML,42.0,FEMALE,WHITE,nan,nan,nan,nan,2006.0,nan,-15614.0,Alive,nan,943.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,943.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2893-03,TCGA-AB-2893,LAML,45.0,MALE,WHITE,nan,nan,nan,nan,2006.0,nan,-16617.0,Dead,nan,nan,212.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,212.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2894-03,TCGA-AB-2894,LAML,50.0,FEMALE,WHITE,nan,nan,nan,nan,2007.0,nan,-18323.0,Dead,nan,nan,181.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,181.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2895-03,TCGA-AB-2895,LAML,41.0,FEMALE,WHITE,nan,nan,nan,nan,2009.0,nan,-15310.0,Dead,nan,nan,153.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,153.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2896-03,TCGA-AB-2896,LAML,21.0,FEMALE,WHITE,nan,nan,nan,nan,2007.0,nan,-7882.0,Dead,nan,nan,214.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,214.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2897-03,TCGA-AB-2897,LAML,50.0,FEMALE,WHITE,nan,nan,nan,nan,2009.0,nan,-18413.0,Alive,nan,243.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,243.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2898-03,TCGA-AB-2898,LAML,69.0,FEMALE,WHITE,nan,nan,nan,nan,2009.0,nan,-25326.0,Alive,nan,393.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,393.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2899-03,TCGA-AB-2899,LAML,76.0,FEMALE,WHITE,nan,nan,nan,nan,2006.0,nan,-27787.0,Dead,nan,nan,671.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,671.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2900-03,TCGA-AB-2900,LAML,70.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,nan,nan,2009.0,nan,-25627.0,Dead,nan,nan,184.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,184.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2901-03,TCGA-AB-2901,LAML,27.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,nan,nan,2009.0,nan,-10046.0,Alive,nan,59.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,59.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2903-03,TCGA-AB-2903,LAML,76.0,FEMALE,WHITE,nan,nan,nan,nan,2006.0,nan,-27971.0,Dead,nan,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,0.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2904-03,TCGA-AB-2904,LAML,65.0,MALE,WHITE,nan,nan,nan,nan,2008.0,nan,-23833.0,Dead,nan,nan,517.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,517.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2905-03,TCGA-AB-2905,LAML,48.0,MALE,WHITE,nan,nan,nan,nan,2005.0,nan,-17869.0,Alive,nan,1611.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1611.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2906-03,TCGA-AB-2906,LAML,59.0,MALE,WHITE,nan,nan,nan,nan,2008.0,nan,-21581.0,Alive,nan,577.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,577.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2907-03,TCGA-AB-2907,LAML,69.0,MALE,WHITE,nan,nan,nan,nan,2008.0,nan,-25264.0,Dead,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,1.0,nan,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2908-03,TCGA-AB-2908,LAML,81.0,MALE,WHITE,nan,nan,nan,nan,2008.0,nan,-29769.0,Dead,nan,nan,31.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,31.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2909-03,TCGA-AB-2909,LAML,22.0,MALE,ASIAN,nan,nan,nan,nan,2009.0,nan,-8220.0,Alive,nan,30.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,30.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2910-03,TCGA-AB-2910,LAML,61.0,FEMALE,WHITE,nan,nan,nan,nan,2008.0,nan,-22311.0,Dead,nan,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,0.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2911-03,TCGA-AB-2911,LAML,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,nan,nan,2006.0,nan,-18689.0,Alive,nan,1186.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1186.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2912-03,TCGA-AB-2912,LAML,63.0,MALE,WHITE,nan,nan,nan,nan,2007.0,nan,-23345.0,Dead,nan,nan,274.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,274.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2913-03,TCGA-AB-2913,LAML,61.0,MALE,WHITE,nan,nan,nan,nan,2006.0,nan,-22553.0,Alive,nan,1216.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1216.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2914-03,TCGA-AB-2914,LAML,22.0,FEMALE,WHITE,nan,nan,nan,nan,2007.0,nan,-8280.0,Alive,nan,792.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,792.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2915-03,TCGA-AB-2915,LAML,73.0,FEMALE,WHITE,nan,nan,nan,nan,2009.0,nan,-26968.0,Dead,nan,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,0.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2916-03,TCGA-AB-2916,LAML,48.0,FEMALE,WHITE,nan,nan,nan,nan,2007.0,nan,-17866.0,Alive,nan,882.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,882.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2917-03,TCGA-AB-2917,LAML,41.0,FEMALE,WHITE,nan,nan,nan,nan,2006.0,nan,-15128.0,Alive,nan,1216.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1216.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2918-03,TCGA-AB-2918,LAML,47.0,FEMALE,WHITE,nan,nan,nan,nan,2009.0,nan,-17198.0,Dead,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,1.0,nan,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2919-03,TCGA-AB-2919,LAML,54.0,FEMALE,WHITE,nan,nan,nan,nan,2009.0,nan,-19724.0,Alive,nan,61.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,61.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2920-03,TCGA-AB-2920,LAML,44.0,MALE,WHITE,nan,nan,nan,nan,2007.0,nan,-16071.0,Dead,nan,nan,366.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,366.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2921-03,TCGA-AB-2921,LAML,56.0,FEMALE,WHITE,nan,nan,nan,nan,2009.0,nan,-20454.0,Dead,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,1.0,nan,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2922-03,TCGA-AB-2922,LAML,83.0,MALE,WHITE,nan,nan,nan,nan,2008.0,nan,-30438.0,Dead,nan,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,0.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2923-03,TCGA-AB-2923,LAML,78.0,MALE,WHITE,nan,nan,nan,nan,2008.0,nan,-28551.0,Dead,nan,nan,31.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,31.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2924-03,TCGA-AB-2924,LAML,59.0,MALE,WHITE,nan,nan,nan,nan,2009.0,nan,-21825.0,Alive,nan,90.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,90.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2925-03,TCGA-AB-2925,LAML,57.0,MALE,WHITE,nan,nan,nan,nan,2007.0,nan,-20850.0,Dead,nan,nan,243.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,243.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2926-03,TCGA-AB-2926,LAML,57.0,FEMALE,WHITE,nan,nan,nan,nan,2008.0,nan,-20820.0,Dead,nan,nan,457.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,457.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2927-03,TCGA-AB-2927,LAML,88.0,FEMALE,WHITE,nan,nan,nan,nan,2009.0,nan,-32326.0,Dead,nan,nan,90.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,90.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2928-03,TCGA-AB-2928,LAML,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,nan,nan,2010.0,nan,-15890.0,Dead,nan,59.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,1.0,nan,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2929-03,TCGA-AB-2929,LAML,71.0,FEMALE,WHITE,nan,nan,nan,nan,2007.0,nan,-26054.0,Dead,nan,nan,123.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,123.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2930-03,TCGA-AB-2930,LAML,63.0,FEMALE,WHITE,nan,nan,nan,nan,2009.0,nan,-23011.0,Dead,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,1.0,nan,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2931-03,TCGA-AB-2931,LAML,75.0,MALE,WHITE,nan,nan,nan,nan,2007.0,nan,-27485.0,Dead,nan,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,0.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2932-03,TCGA-AB-2932,LAML,62.0,MALE,WHITE,nan,nan,nan,nan,2008.0,nan,-22738.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2933-03,TCGA-AB-2933,LAML,58.0,MALE,WHITE,nan,nan,nan,nan,2007.0,nan,-21396.0,Dead,nan,nan,122.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,122.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2934-03,TCGA-AB-2934,LAML,65.0,MALE,WHITE,nan,nan,nan,nan,2010.0,nan,-23956.0,Alive,nan,28.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,28.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2935-03,TCGA-AB-2935,LAML,66.0,MALE,WHITE,nan,nan,nan,nan,2007.0,nan,-24349.0,Dead,nan,nan,61.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,61.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2936-03,TCGA-AB-2936,LAML,61.0,FEMALE,WHITE,nan,nan,nan,nan,2010.0,nan,-22280.0,Alive,nan,59.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,59.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2937-03,TCGA-AB-2937,LAML,36.0,FEMALE,WHITE,nan,nan,nan,nan,2007.0,nan,-13149.0,Dead,nan,nan,215.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,215.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2938-03,TCGA-AB-2938,LAML,76.0,MALE,WHITE,nan,nan,nan,nan,2005.0,nan,-27881.0,Dead,nan,nan,304.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,304.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2939-03,TCGA-AB-2939,LAML,72.0,MALE,WHITE,nan,nan,nan,nan,2008.0,nan,-26512.0,Alive,nan,455.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,455.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2940-03,TCGA-AB-2940,LAML,35.0,MALE,WHITE,nan,nan,nan,nan,2006.0,nan,-12876.0,Dead,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,1.0,nan,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2941-03,TCGA-AB-2941,LAML,73.0,MALE,WHITE,nan,nan,nan,nan,2006.0,nan,-26998.0,Dead,nan,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,0.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2942-03,TCGA-AB-2942,LAML,67.0,FEMALE,WHITE,nan,nan,nan,nan,2008.0,nan,-24776.0,Alive,nan,641.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,641.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2943-03,TCGA-AB-2943,LAML,70.0,FEMALE,WHITE,nan,nan,nan,nan,2010.0,nan,-25568.0,Dead,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,1.0,nan,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2944-03,TCGA-AB-2944,LAML,48.0,MALE,WHITE,nan,nan,nan,nan,2010.0,nan,-17622.0,Dead,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,1.0,nan,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2945-03,TCGA-AB-2945,LAML,65.0,FEMALE,WHITE,nan,nan,nan,nan,2006.0,nan,-23984.0,Dead,nan,nan,243.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,243.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2946-03,TCGA-AB-2946,LAML,41.0,MALE,WHITE,nan,nan,nan,nan,2010.0,nan,-15156.0,Alive,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,nan,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2947-03,TCGA-AB-2947,LAML,52.0,MALE,WHITE,nan,nan,nan,nan,2009.0,nan,-19146.0,Alive,nan,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2948-03,TCGA-AB-2948,LAML,67.0,MALE,WHITE,nan,nan,nan,nan,2007.0,nan,-24714.0,Dead,nan,nan,580.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,580.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2949-03,TCGA-AB-2949,LAML,58.0,MALE,WHITE,nan,nan,nan,nan,2008.0,nan,-21336.0,Alive,nan,699.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,699.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2950-03,TCGA-AB-2950,LAML,34.0,FEMALE,WHITE,nan,nan,nan,nan,2008.0,nan,-12693.0,Alive,nan,306.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,306.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2952-03,TCGA-AB-2952,LAML,60.0,FEMALE,WHITE,nan,nan,nan,nan,2007.0,nan,-22188.0,Dead,nan,nan,31.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,31.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2954-03,TCGA-AB-2954,LAML,55.0,FEMALE,WHITE,nan,nan,nan,nan,2006.0,nan,-20211.0,Alive,nan,1492.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1492.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2955-03,TCGA-AB-2955,LAML,56.0,FEMALE,WHITE,nan,nan,nan,nan,2007.0,nan,-20484.0,Dead,nan,nan,489.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,489.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2956-03,TCGA-AB-2956,LAML,61.0,MALE,WHITE,nan,nan,nan,nan,2007.0,nan,-22523.0,Dead,nan,nan,183.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,183.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2957-03,TCGA-AB-2957,LAML,31.0,MALE,WHITE,nan,nan,nan,nan,2007.0,nan,-11626.0,Alive,nan,609.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,609.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2959-03,TCGA-AB-2959,LAML,71.0,MALE,WHITE,nan,nan,nan,nan,2007.0,nan,-26114.0,Dead,nan,nan,489.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,489.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2963-03,TCGA-AB-2963,LAML,56.0,MALE,WHITE,nan,nan,nan,nan,2002.0,nan,-20485.0,Dead,nan,nan,1642.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1642.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2964-03,TCGA-AB-2964,LAML,58.0,FEMALE,WHITE,nan,nan,nan,nan,2006.0,nan,-21184.0,Alive,nan,1277.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1277.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2965-03,TCGA-AB-2965,LAML,60.0,MALE,WHITE,nan,nan,nan,nan,2006.0,nan,-22006.0,Dead,nan,nan,335.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,335.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2966-03,TCGA-AB-2966,LAML,57.0,FEMALE,WHITE,nan,nan,nan,nan,2007.0,nan,-20880.0,Dead,nan,nan,854.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,854.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2967-03,TCGA-AB-2967,LAML,58.0,MALE,WHITE,nan,nan,nan,nan,2007.0,nan,-21214.0,Alive,nan,1035.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1035.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2968-03,TCGA-AB-2968,LAML,79.0,MALE,WHITE,nan,nan,nan,nan,2007.0,nan,-28975.0,Dead,nan,nan,458.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,458.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2969-03,TCGA-AB-2969,LAML,55.0,MALE,WHITE,nan,nan,nan,nan,2006.0,nan,-20331.0,Alive,nan,1127.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1127.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2970-03,TCGA-AB-2970,LAML,34.0,FEMALE,WHITE,nan,nan,nan,nan,2007.0,nan,-12569.0,Dead,nan,nan,305.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,305.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2971-03,TCGA-AB-2971,LAML,76.0,FEMALE,WHITE,nan,nan,nan,nan,2007.0,nan,-27790.0,Dead,nan,nan,792.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,792.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2972-03,TCGA-AB-2972,LAML,82.0,FEMALE,WHITE,nan,nan,nan,nan,2007.0,nan,-30134.0,Dead,nan,nan,30.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,30.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2973-03,TCGA-AB-2973,LAML,68.0,FEMALE,WHITE,nan,nan,nan,nan,2007.0,nan,-24837.0,Dead,nan,nan,609.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,609.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2974-03,TCGA-AB-2974,LAML,67.0,FEMALE,WHITE,nan,nan,nan,nan,2007.0,nan,-24715.0,Dead,nan,nan,92.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,92.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2975-03,TCGA-AB-2975,LAML,54.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,nan,nan,2007.0,nan,-20057.0,Dead,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,1.0,nan,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2976-03,TCGA-AB-2976,LAML,53.0,MALE,WHITE,nan,nan,nan,nan,2007.0,nan,-19570.0,Dead,nan,nan,915.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,915.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2977-03,TCGA-AB-2977,LAML,71.0,FEMALE,WHITE,nan,nan,nan,nan,2008.0,nan,-26053.0,Dead,nan,nan,31.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,31.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2978-03,TCGA-AB-2978,LAML,61.0,FEMALE,WHITE,nan,nan,nan,nan,2008.0,nan,-22402.0,Alive,nan,699.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,699.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2979-03,TCGA-AB-2979,LAML,30.0,FEMALE,WHITE,nan,nan,nan,nan,2008.0,nan,-11262.0,Alive,nan,671.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,671.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2980-03,TCGA-AB-2980,LAML,50.0,MALE,WHITE,nan,nan,nan,nan,2008.0,nan,-18506.0,Alive,nan,699.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,699.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2981-03,TCGA-AB-2981,LAML,35.0,FEMALE,WHITE,nan,nan,nan,nan,2008.0,nan,-13027.0,Alive,nan,487.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,487.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2982-03,TCGA-AB-2982,LAML,29.0,FEMALE,nan,nan,nan,nan,nan,2007.0,nan,-10807.0,Alive,nan,150.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,150.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2983-03,TCGA-AB-2983,LAML,45.0,MALE,WHITE,nan,nan,nan,nan,2006.0,nan,-16589.0,Dead,nan,nan,335.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,335.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2984-03,TCGA-AB-2984,LAML,38.0,MALE,WHITE,nan,nan,nan,nan,2006.0,nan,-14123.0,Alive,nan,1157.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1157.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2985-03,TCGA-AB-2985,LAML,81.0,FEMALE,WHITE,nan,nan,nan,nan,2008.0,nan,-29890.0,Dead,nan,nan,273.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,273.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2986-03,TCGA-AB-2986,LAML,31.0,FEMALE,WHITE,nan,nan,nan,nan,2008.0,nan,-11596.0,Dead,nan,nan,212.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,212.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2987-03,TCGA-AB-2987,LAML,75.0,FEMALE,WHITE,nan,nan,nan,nan,2008.0,nan,-27667.0,Dead,nan,nan,184.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,184.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2988-03,TCGA-AB-2988,LAML,67.0,FEMALE,WHITE,nan,nan,nan,nan,2008.0,nan,-24717.0,Dead,nan,nan,30.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,30.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2989-03,TCGA-AB-2989,LAML,29.0,MALE,WHITE,nan,nan,nan,nan,2008.0,nan,-10774.0,Dead,nan,nan,365.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,365.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2990-03,TCGA-AB-2990,LAML,51.0,MALE,WHITE,nan,nan,nan,nan,2008.0,nan,-18962.0,Alive,nan,457.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,457.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2991-03,TCGA-AB-2991,LAML,40.0,FEMALE,WHITE,nan,nan,nan,nan,2004.0,nan,-14885.0,Alive,nan,1826.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1826.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-2992-03,TCGA-AB-2992,LAML,32.0,FEMALE,WHITE,nan,nan,nan,nan,2003.0,nan,-11839.0,Dead,nan,nan,1706.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1706.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2993-03,TCGA-AB-2993,LAML,57.0,FEMALE,WHITE,nan,nan,nan,nan,2004.0,nan,-21124.0,Dead,nan,nan,761.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,761.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2994-03,TCGA-AB-2994,LAML,25.0,MALE,WHITE,nan,nan,nan,nan,2005.0,nan,-9436.0,Alive,nan,1798.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1798.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2995-03,TCGA-AB-2995,LAML,63.0,MALE,WHITE,nan,nan,nan,nan,2005.0,nan,-23164.0,Alive,nan,1551.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1551.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2996-03,TCGA-AB-2996,LAML,74.0,MALE,WHITE,nan,nan,nan,nan,2005.0,nan,-27364.0,Alive,nan,1581.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1581.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-2997-03,TCGA-AB-2997,LAML,25.0,FEMALE,WHITE,nan,nan,nan,nan,2006.0,nan,-9162.0,Dead,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,1.0,nan,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2998-03,TCGA-AB-2998,LAML,68.0,FEMALE,WHITE,nan,nan,nan,nan,2008.0,nan,-24837.0,Dead,nan,nan,31.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,31.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-2999-03,TCGA-AB-2999,LAML,62.0,MALE,WHITE,nan,nan,nan,nan,2004.0,nan,-22980.0,Alive,nan,1735.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1735.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-3000-03,TCGA-AB-3000,LAML,25.0,MALE,WHITE,nan,nan,nan,nan,2006.0,nan,-9251.0,Alive,nan,1249.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1249.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-3001-03,TCGA-AB-3001,LAML,31.0,FEMALE,WHITE,nan,nan,nan,nan,2005.0,nan,-11446.0,Alive,nan,1581.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1581.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-3002-03,TCGA-AB-3002,LAML,68.0,MALE,WHITE,nan,nan,nan,nan,2005.0,nan,-25171.0,Dead,nan,nan,1431.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1431.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-3005-03,TCGA-AB-3005,LAML,45.0,MALE,WHITE,nan,nan,nan,nan,2003.0,nan,-16528.0,Alive,nan,2100.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2100.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-3006-03,TCGA-AB-3006,LAML,61.0,MALE,WHITE,nan,nan,nan,nan,2006.0,nan,-22464.0,Dead,nan,nan,485.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,485.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-3007-03,TCGA-AB-3007,LAML,35.0,MALE,WHITE,nan,nan,nan,nan,2005.0,nan,-13029.0,Alive,nan,1581.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1581.0,0.0,nan,nan,nan,nan,nan,0
TCGA-AB-3008-03,TCGA-AB-3008,LAML,22.0,MALE,WHITE,nan,nan,nan,nan,2005.0,nan,-8159.0,Dead,nan,nan,822.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,822.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-3009-03,TCGA-AB-3009,LAML,23.0,MALE,nan,nan,nan,nan,nan,2005.0,nan,-8676.0,Dead,nan,nan,577.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,577.0,nan,nan,nan,nan,nan,nan,1
TCGA-AB-3011-03,TCGA-AB-3011,LAML,21.0,FEMALE,WHITE,nan,nan,nan,nan,2005.0,nan,-7916.0,Alive,nan,1885.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1885.0,0.0,nan,nan,nan,nan,nan,1
TCGA-AB-3012-03,TCGA-AB-3012,LAML,53.0,MALE,WHITE,nan,nan,nan,nan,2004.0,nan,-19543.0,Alive,nan,1887.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1887.0,0.0,nan,nan,nan,nan,nan,0
TCGA-CS-4938-01,TCGA-CS-4938,LGG,31.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2005.0,nan,-11509.0,Alive,WITH TUMOR,3574.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,3574.0,0.0,3574.0,nan,nan,0.0,3574.0,2
TCGA-CS-4941-01,TCGA-CS-4941,LGG,67.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2005.0,nan,-24578.0,Dead,WITH TUMOR,nan,234.0,nan,nan,nan,nan,9.0,Stable Disease,nan,nan,1.0,234.0,1.0,234.0,nan,nan,1.0,9.0,1
TCGA-CS-4942-01,TCGA-CS-4942,LGG,44.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Astrocytoma,G3,2006.0,nan,-16297.0,Dead,WITH TUMOR,nan,1335.0,nan,nan,nan,nan,1184.0,Progressive Disease,nan,nan,1.0,1335.0,1.0,1335.0,nan,nan,1.0,1184.0,1
TCGA-CS-4943-01,TCGA-CS-4943,LGG,37.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2009.0,nan,-13565.0,Dead,WITH TUMOR,nan,1106.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1106.0,1.0,1106.0,nan,nan,1.0,1106.0,1
TCGA-CS-4944-01,TCGA-CS-4944,LGG,50.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2010.0,nan,-18494.0,Alive,WITH TUMOR,1828.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1828.0,0.0,1828.0,nan,nan,0.0,1828.0,0
TCGA-CS-5390-01,TCGA-CS-5390,LGG,47.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2005.0,nan,-17460.0,Alive,TUMOR FREE,nan,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,nan,0.0,nan,0.0,nan,0.0,nan,0
TCGA-CS-5393-01,TCGA-CS-5393,LGG,39.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2008.0,nan,-14418.0,Alive,TUMOR FREE,1222.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1222.0,0.0,1222.0,0.0,1222.0,0.0,1222.0,0
TCGA-CS-5394-01,TCGA-CS-5394,LGG,40.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2005.0,nan,-14920.0,Alive,nan,8.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,8.0,0.0,8.0,nan,nan,0.0,8.0,0
TCGA-CS-5395-01,TCGA-CS-5395,LGG,43.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Oligodendroglioma,G2,2007.0,nan,-15848.0,Dead,WITH TUMOR,nan,639.0,nan,nan,nan,nan,287.0,Progressive Disease,nan,nan,1.0,639.0,1.0,639.0,nan,nan,1.0,287.0,1
TCGA-CS-5396-01,TCGA-CS-5396,LGG,53.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2010.0,nan,-19399.0,Alive,WITH TUMOR,1631.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,1631.0,0.0,1631.0,nan,nan,0.0,1631.0,2
TCGA-CS-5397-01,TCGA-CS-5397,LGG,54.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2010.0,nan,-19866.0,Dead,WITH TUMOR,nan,194.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,194.0,1.0,194.0,nan,nan,1.0,194.0,1
TCGA-CS-6186-01,TCGA-CS-6186,LGG,58.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2009.0,nan,-21321.0,Dead,WITH TUMOR,nan,538.0,nan,nan,nan,nan,188.0,Progressive Disease,nan,nan,1.0,538.0,1.0,538.0,nan,nan,1.0,188.0,1
TCGA-CS-6188-01,TCGA-CS-6188,LGG,48.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2009.0,nan,-17729.0,Dead,WITH TUMOR,nan,814.0,nan,nan,nan,nan,647.0,Progressive Disease,nan,nan,1.0,814.0,1.0,814.0,nan,nan,1.0,647.0,1
TCGA-CS-6290-01,TCGA-CS-6290,LGG,31.0,MALE,nan,nan,nan,Astrocytoma,G3,2009.0,nan,-11666.0,Dead,nan,nan,1137.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,1137.0,nan,1137.0,nan,nan,0.0,1137.0,1
TCGA-CS-6665-01,TCGA-CS-6665,LGG,51.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2010.0,nan,-18977.0,Alive,WITH TUMOR,1568.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1568.0,0.0,1568.0,nan,nan,0.0,1568.0,2
TCGA-CS-6666-01,TCGA-CS-6666,LGG,22.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2010.0,nan,-8340.0,Alive,TUMOR FREE,1428.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1428.0,0.0,1428.0,nan,nan,0.0,1428.0,0
TCGA-CS-6667-01,TCGA-CS-6667,LGG,39.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2010.0,nan,-14375.0,Alive,WITH TUMOR,1469.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1469.0,0.0,1469.0,nan,nan,0.0,1469.0,2
TCGA-CS-6668-01,TCGA-CS-6668,LGG,57.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2011.0,nan,-20836.0,Alive,WITH TUMOR,1519.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1519.0,0.0,1519.0,nan,nan,0.0,1519.0,2
TCGA-CS-6669-01,TCGA-CS-6669,LGG,26.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2011.0,nan,-9809.0,Alive,WITH TUMOR,1494.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1494.0,0.0,1494.0,nan,nan,0.0,1494.0,2
TCGA-CS-6670-01,TCGA-CS-6670,LGG,43.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2011.0,nan,-16066.0,Alive,WITH TUMOR,1426.0,nan,nan,nan,nan,nan,nan,[Discrepancy],nan,nan,0.0,1426.0,0.0,1426.0,nan,nan,0.0,1426.0,0
TCGA-DB-5270-01,TCGA-DB-5270,LGG,38.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G3,2002.0,nan,-13904.0,Alive,TUMOR FREE,3733.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3733.0,0.0,3733.0,0.0,3733.0,0.0,3733.0,0
TCGA-DB-5273-01,TCGA-DB-5273,LGG,33.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2006.0,nan,-12152.0,Alive,TUMOR FREE,2493.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2493.0,0.0,2493.0,0.0,2493.0,0.0,2493.0,0
TCGA-DB-5274-01,TCGA-DB-5274,LGG,37.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G3,2006.0,nan,-13680.0,Alive,TUMOR FREE,2289.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2289.0,0.0,2289.0,0.0,2289.0,0.0,2289.0,0
TCGA-DB-5275-01,TCGA-DB-5275,LGG,36.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2006.0,nan,-13371.0,Alive,TUMOR FREE,1458.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1458.0,0.0,1458.0,0.0,1458.0,0.0,1458.0,0
TCGA-DB-5276-01,TCGA-DB-5276,LGG,32.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2007.0,nan,-11738.0,Alive,TUMOR FREE,2218.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2218.0,0.0,2218.0,0.0,2218.0,0.0,2218.0,0
TCGA-DB-5277-01,TCGA-DB-5277,LGG,34.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2007.0,nan,-12725.0,Dead,WITH TUMOR,nan,1547.0,nan,nan,nan,nan,1156.0,Complete Remission/Response,nan,nan,1.0,1547.0,1.0,1547.0,1.0,1156.0,1.0,1156.0,1
TCGA-DB-5278-01,TCGA-DB-5278,LGG,17.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2007.0,nan,-6480.0,Alive,WITH TUMOR,2772.0,nan,nan,nan,nan,nan,507.0,Stable Disease,nan,nan,0.0,2772.0,0.0,2772.0,nan,nan,1.0,507.0,2
TCGA-DB-5279-01,TCGA-DB-5279,LGG,59.0,MALE,nan,nan,nan,Oligodendroglioma,G2,2007.0,nan,-21908.0,Alive,TUMOR FREE,1354.0,nan,nan,nan,nan,nan,695.0,Complete Remission/Response,nan,nan,0.0,1354.0,0.0,1354.0,1.0,695.0,1.0,695.0,2
TCGA-DB-5280-01,TCGA-DB-5280,LGG,43.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2007.0,nan,-15836.0,Alive,TUMOR FREE,1112.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1112.0,0.0,1112.0,0.0,1112.0,0.0,1112.0,0
TCGA-DB-5281-01,TCGA-DB-5281,LGG,61.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2006.0,nan,-22342.0,Alive,WITH TUMOR,2381.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,2381.0,0.0,2381.0,nan,nan,0.0,2381.0,0
TCGA-DB-A4X9-01,TCGA-DB-A4X9,LGG,33.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2010.0,nan,-12131.0,Alive,TUMOR FREE,1412.0,nan,nan,nan,nan,nan,501.0,Complete Remission/Response,nan,nan,0.0,1412.0,0.0,1412.0,1.0,501.0,1.0,501.0,2
TCGA-DB-A4XA-01,TCGA-DB-A4XA,LGG,30.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2012.0,nan,-11195.0,Alive,WITH TUMOR,573.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,573.0,0.0,573.0,nan,nan,0.0,573.0,0
TCGA-DB-A4XB-01,TCGA-DB-A4XB,LGG,38.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2011.0,nan,-13990.0,Alive,TUMOR FREE,919.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,919.0,0.0,919.0,nan,nan,0.0,919.0,0
TCGA-DB-A4XC-01,TCGA-DB-A4XC,LGG,26.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2010.0,nan,-9705.0,Alive,TUMOR FREE,1421.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,1421.0,0.0,1421.0,nan,nan,0.0,1421.0,0
TCGA-DB-A4XD-01,TCGA-DB-A4XD,LGG,32.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2010.0,nan,-11741.0,Alive,TUMOR FREE,1210.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1210.0,0.0,1210.0,0.0,1210.0,0.0,1210.0,0
TCGA-DB-A4XE-01,TCGA-DB-A4XE,LGG,27.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G3,2011.0,nan,-10150.0,Alive,TUMOR FREE,1139.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1139.0,0.0,1139.0,0.0,1139.0,0.0,1139.0,0
TCGA-DB-A4XF-01,TCGA-DB-A4XF,LGG,41.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2011.0,nan,-15066.0,Alive,TUMOR FREE,1021.0,nan,nan,nan,nan,nan,468.0,Stable Disease,nan,nan,0.0,1021.0,0.0,1021.0,nan,nan,1.0,468.0,0
TCGA-DB-A4XG-01,TCGA-DB-A4XG,LGG,34.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2006.0,nan,-12550.0,Alive,WITH TUMOR,2219.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,2219.0,0.0,2219.0,nan,nan,0.0,2219.0,0
TCGA-DB-A4XH-01,TCGA-DB-A4XH,LGG,53.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2011.0,nan,-19710.0,Alive,TUMOR FREE,962.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,962.0,0.0,962.0,nan,nan,0.0,962.0,0
TCGA-DB-A64L-01,TCGA-DB-A64L,LGG,67.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2012.0,nan,-24690.0,Alive,WITH TUMOR,736.0,nan,nan,nan,nan,nan,724.0,Complete Remission/Response,nan,nan,0.0,736.0,0.0,736.0,1.0,724.0,1.0,724.0,2
TCGA-DB-A64O-01,TCGA-DB-A64O,LGG,59.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2011.0,nan,-21811.0,Dead,WITH TUMOR,nan,775.0,nan,nan,nan,nan,430.0,Stable Disease,nan,nan,1.0,775.0,1.0,775.0,nan,nan,1.0,430.0,1
TCGA-DB-A64P-01,TCGA-DB-A64P,LGG,40.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2012.0,nan,-14936.0,Alive,TUMOR FREE,916.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,916.0,0.0,916.0,0.0,916.0,0.0,916.0,0
TCGA-DB-A64Q-01,TCGA-DB-A64Q,LGG,31.0,FEMALE,[Unknown],nan,nan,Oligoastrocytoma,G2,2012.0,nan,-11637.0,Alive,TUMOR FREE,182.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,182.0,0.0,182.0,nan,nan,0.0,182.0,0
TCGA-DB-A64R-01,TCGA-DB-A64R,LGG,24.0,FEMALE,[Not Evaluated],nan,nan,Oligodendroglioma,G2,2012.0,nan,-8947.0,Alive,TUMOR FREE,955.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,955.0,0.0,955.0,0.0,955.0,0.0,955.0,0
TCGA-DB-A64S-01,TCGA-DB-A64S,LGG,20.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2012.0,nan,-7389.0,Alive,TUMOR FREE,835.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,835.0,0.0,835.0,0.0,835.0,0.0,835.0,0
TCGA-DB-A64U-01,TCGA-DB-A64U,LGG,38.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2011.0,nan,-14019.0,Alive,TUMOR FREE,846.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,846.0,0.0,846.0,0.0,846.0,0.0,846.0,0
TCGA-DB-A64V-01,TCGA-DB-A64V,LGG,54.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2012.0,nan,-19950.0,Alive,TUMOR FREE,889.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,889.0,0.0,889.0,nan,nan,0.0,889.0,0
TCGA-DB-A64W-01,TCGA-DB-A64W,LGG,65.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G3,2012.0,nan,-23936.0,Dead,TUMOR FREE,nan,438.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,438.0,0.0,438.0,nan,nan,0.0,438.0,1
TCGA-DB-A64X-01,TCGA-DB-A64X,LGG,56.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-20625.0,Alive,TUMOR FREE,563.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,563.0,0.0,563.0,nan,nan,0.0,563.0,0
TCGA-DB-A75K-01,TCGA-DB-A75K,LGG,55.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G3,2013.0,nan,-20241.0,Alive,TUMOR FREE,368.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,368.0,0.0,368.0,0.0,368.0,0.0,368.0,0
TCGA-DB-A75L-01,TCGA-DB-A75L,LGG,36.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2013.0,nan,-13338.0,Alive,TUMOR FREE,342.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,342.0,0.0,342.0,0.0,342.0,0.0,342.0,0
TCGA-DB-A75M-01,TCGA-DB-A75M,LGG,47.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2013.0,nan,-17289.0,Alive,TUMOR FREE,544.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,544.0,0.0,544.0,0.0,544.0,0.0,544.0,0
TCGA-DB-A75O-01,TCGA-DB-A75O,LGG,29.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2010.0,nan,-10812.0,Alive,nan,935.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,935.0,0.0,935.0,nan,nan,0.0,935.0,0
TCGA-DB-A75P-01,TCGA-DB-A75P,LGG,25.0,FEMALE,[Unknown],nan,nan,Astrocytoma,G2,2013.0,nan,-9413.0,Alive,TUMOR FREE,492.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,492.0,0.0,492.0,0.0,492.0,0.0,492.0,0
TCGA-DH-5140-01,TCGA-DH-5140,LGG,38.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G3,2007.0,nan,-13943.0,Dead,WITH TUMOR,nan,607.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,607.0,1.0,607.0,nan,nan,1.0,607.0,1
TCGA-DH-5141-01,TCGA-DH-5141,LGG,32.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2005.0,nan,-11846.0,Alive,nan,968.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,968.0,0.0,968.0,nan,nan,0.0,968.0,0
TCGA-DH-5142-01,TCGA-DH-5142,LGG,29.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2008.0,nan,-10678.0,Alive,WITH TUMOR,1943.0,nan,nan,nan,nan,nan,1627.0,Stable Disease,nan,nan,0.0,1943.0,0.0,1943.0,nan,nan,1.0,1627.0,2
TCGA-DH-5143-01,TCGA-DH-5143,LGG,30.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2009.0,nan,-11291.0,Alive,WITH TUMOR,1401.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1401.0,0.0,1401.0,nan,nan,0.0,1401.0,0
TCGA-DH-5144-01,TCGA-DH-5144,LGG,56.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2009.0,nan,-20558.0,Alive,TUMOR FREE,748.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,748.0,0.0,748.0,0.0,748.0,0.0,748.0,0
TCGA-DH-A669-02,TCGA-DH-A669,LGG,70.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2007.0,nan,-25809.0,Dead,TUMOR FREE,nan,919.0,nan,nan,nan,nan,260.0,Stable Disease,nan,nan,1.0,919.0,0.0,919.0,nan,nan,1.0,260.0,1
TCGA-DH-A669-01,TCGA-DH-A669,LGG,70.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2007.0,nan,-25809.0,Dead,TUMOR FREE,nan,919.0,nan,nan,nan,nan,260.0,Stable Disease,nan,nan,1.0,919.0,0.0,919.0,nan,nan,1.0,260.0,1
TCGA-DH-A66B-01,TCGA-DH-A66B,LGG,52.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2010.0,nan,-19156.0,Alive,WITH TUMOR,1279.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1279.0,0.0,1279.0,nan,nan,0.0,1279.0,0
TCGA-DH-A66D-01,TCGA-DH-A66D,LGG,43.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-15866.0,Alive,WITH TUMOR,846.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,846.0,0.0,846.0,nan,nan,0.0,846.0,2
TCGA-DH-A66F-01,TCGA-DH-A66F,LGG,49.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2012.0,nan,-18193.0,Alive,TUMOR FREE,523.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,523.0,0.0,523.0,0.0,523.0,0.0,523.0,0
TCGA-DH-A66G-01,TCGA-DH-A66G,LGG,49.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2013.0,nan,-18199.0,Alive,WITH TUMOR,523.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,523.0,0.0,523.0,nan,nan,0.0,523.0,2
TCGA-DH-A7UR-01,TCGA-DH-A7UR,LGG,59.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2008.0,nan,-21803.0,Alive,TUMOR FREE,1650.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1650.0,0.0,1650.0,0.0,1650.0,0.0,1650.0,0
TCGA-DH-A7US-01,TCGA-DH-A7US,LGG,50.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2013.0,nan,-18429.0,Alive,WITH TUMOR,706.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,706.0,0.0,706.0,nan,nan,0.0,706.0,0
TCGA-DH-A7UT-01,TCGA-DH-A7UT,LGG,30.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2013.0,nan,-11014.0,Dead,WITH TUMOR,nan,531.0,nan,nan,nan,nan,404.0,Stable Disease,nan,nan,1.0,531.0,1.0,531.0,nan,nan,1.0,404.0,1
TCGA-DH-A7UU-01,TCGA-DH-A7UU,LGG,43.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2013.0,nan,-16037.0,Alive,WITH TUMOR,417.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,417.0,0.0,417.0,nan,nan,0.0,417.0,0
TCGA-DH-A7UV-01,TCGA-DH-A7UV,LGG,49.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2013.0,nan,-18161.0,Alive,WITH TUMOR,566.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,566.0,0.0,566.0,nan,nan,0.0,566.0,0
TCGA-DU-5847-01,TCGA-DU-5847,LGG,34.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2009.0,nan,-12606.0,Alive,WITH TUMOR,548.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,548.0,0.0,548.0,nan,nan,0.0,548.0,2
TCGA-DU-5849-01,TCGA-DU-5849,LGG,48.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2010.0,nan,-17663.0,Alive,TUMOR FREE,443.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,443.0,0.0,443.0,nan,nan,0.0,443.0,0
TCGA-DU-5851-01,TCGA-DU-5851,LGG,40.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G3,2010.0,nan,-14802.0,Alive,WITH TUMOR,531.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,531.0,0.0,531.0,nan,nan,0.0,531.0,2
TCGA-DU-5852-01,TCGA-DU-5852,LGG,61.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G3,2010.0,nan,-22348.0,Dead,WITH TUMOR,nan,205.0,nan,nan,nan,nan,24.0,Progressive Disease,nan,nan,1.0,205.0,1.0,205.0,nan,nan,1.0,24.0,1
TCGA-DU-5853-01,TCGA-DU-5853,LGG,29.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2010.0,nan,-10624.0,Alive,WITH TUMOR,407.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,407.0,0.0,407.0,nan,nan,0.0,407.0,0
TCGA-DU-5854-01,TCGA-DU-5854,LGG,57.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2010.0,nan,-21106.0,Alive,WITH TUMOR,257.0,nan,nan,nan,nan,nan,202.0,Progressive Disease,nan,nan,0.0,257.0,0.0,257.0,nan,nan,1.0,202.0,2
TCGA-DU-5855-01,TCGA-DU-5855,LGG,49.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G3,2010.0,nan,-18234.0,Alive,WITH TUMOR,207.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,207.0,0.0,207.0,nan,nan,0.0,207.0,2
TCGA-DU-5870-02,TCGA-DU-5870,LGG,34.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,1995.0,nan,-12764.0,Alive,WITH TUMOR,5546.0,nan,nan,nan,nan,nan,4347.0,Progressive Disease,nan,nan,0.0,5546.0,0.0,5546.0,nan,nan,1.0,4347.0,2
TCGA-DU-5870-01,TCGA-DU-5870,LGG,34.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,1995.0,nan,-12764.0,Alive,WITH TUMOR,5546.0,nan,nan,nan,nan,nan,4347.0,Progressive Disease,nan,nan,0.0,5546.0,0.0,5546.0,nan,nan,1.0,4347.0,2
TCGA-DU-5871-01,TCGA-DU-5871,LGG,37.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2009.0,nan,-13673.0,Alive,TUMOR FREE,576.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,576.0,0.0,576.0,nan,nan,0.0,576.0,2
TCGA-DU-5872-02,TCGA-DU-5872,LGG,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Oligoastrocytoma,G2,2009.0,nan,-15986.0,Alive,WITH TUMOR,532.0,nan,nan,nan,nan,nan,265.0,Progressive Disease,nan,nan,0.0,532.0,0.0,532.0,nan,nan,1.0,265.0,2
TCGA-DU-5872-01,TCGA-DU-5872,LGG,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Oligoastrocytoma,G2,2009.0,nan,-15986.0,Alive,WITH TUMOR,532.0,nan,nan,nan,nan,nan,265.0,Progressive Disease,nan,nan,0.0,532.0,0.0,532.0,nan,nan,1.0,265.0,2
TCGA-DU-5874-01,TCGA-DU-5874,LGG,62.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2010.0,nan,-22847.0,Alive,TUMOR FREE,461.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,461.0,0.0,461.0,nan,nan,0.0,461.0,0
TCGA-DU-6392-01,TCGA-DU-6392,LGG,35.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,1993.0,nan,-12836.0,Alive,TUMOR FREE,6423.0,nan,nan,nan,nan,nan,950.0,Progressive Disease,nan,nan,0.0,6423.0,0.0,6423.0,nan,nan,1.0,950.0,2
TCGA-DU-6393-01,TCGA-DU-6393,LGG,66.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,1993.0,nan,-24282.0,Dead,nan,nan,1585.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1585.0,nan,1585.0,nan,nan,0.0,1585.0,1
TCGA-DU-6394-01,TCGA-DU-6394,LGG,53.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,1994.0,nan,-19541.0,Dead,WITH TUMOR,nan,682.0,nan,nan,nan,nan,353.0,Progressive Disease,nan,nan,1.0,682.0,1.0,682.0,nan,nan,1.0,353.0,1
TCGA-DU-6395-01,TCGA-DU-6395,LGG,31.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,1994.0,nan,-11584.0,Dead,WITH TUMOR,nan,1491.0,nan,nan,nan,nan,1197.0,Progressive Disease,nan,nan,1.0,1491.0,1.0,1491.0,nan,nan,1.0,1197.0,1
TCGA-DU-6396-01,TCGA-DU-6396,LGG,31.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G3,1996.0,nan,-11427.0,Dead,WITH TUMOR,nan,2286.0,nan,nan,nan,nan,106.0,Progressive Disease,nan,nan,1.0,2286.0,1.0,2286.0,nan,nan,1.0,106.0,1
TCGA-DU-6397-02,TCGA-DU-6397,LGG,45.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,1997.0,nan,-16695.0,Dead,WITH TUMOR,nan,1401.0,nan,nan,nan,nan,837.0,Progressive Disease,nan,nan,1.0,1401.0,1.0,1401.0,nan,nan,1.0,837.0,1
TCGA-DU-6397-01,TCGA-DU-6397,LGG,45.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,1997.0,nan,-16695.0,Dead,WITH TUMOR,nan,1401.0,nan,nan,nan,nan,837.0,Progressive Disease,nan,nan,1.0,1401.0,1.0,1401.0,nan,nan,1.0,837.0,1
TCGA-DU-6399-01,TCGA-DU-6399,LGG,54.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,1998.0,nan,-19906.0,Dead,WITH TUMOR,nan,2000.0,nan,nan,nan,nan,1629.0,Progressive Disease,nan,nan,1.0,2000.0,1.0,2000.0,nan,nan,1.0,1629.0,1
TCGA-DU-6400-01,TCGA-DU-6400,LGG,66.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,1998.0,nan,-24122.0,Dead,WITH TUMOR,nan,37.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,37.0,1.0,37.0,nan,nan,1.0,37.0,1
TCGA-DU-6401-01,TCGA-DU-6401,LGG,31.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,1998.0,nan,-11595.0,Dead,WITH TUMOR,nan,2660.0,nan,nan,nan,nan,1886.0,Progressive Disease,nan,nan,1.0,2660.0,1.0,2660.0,nan,nan,1.0,1886.0,1
TCGA-DU-6402-01,TCGA-DU-6402,LGG,52.0,MALE,WHITE,nan,nan,Astrocytoma,G3,1998.0,nan,-19207.0,Dead,WITH TUMOR,nan,214.0,nan,nan,nan,nan,103.0,Progressive Disease,nan,nan,1.0,214.0,1.0,214.0,nan,nan,1.0,103.0,1
TCGA-DU-6403-01,TCGA-DU-6403,LGG,60.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G3,1999.0,nan,-22031.0,Dead,WITH TUMOR,nan,354.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,354.0,1.0,354.0,nan,nan,1.0,354.0,1
TCGA-DU-6404-02,TCGA-DU-6404,LGG,24.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2000.0,nan,-9021.0,Dead,WITH TUMOR,nan,4068.0,nan,nan,nan,nan,1154.0,Progressive Disease,nan,nan,1.0,4068.0,1.0,4068.0,nan,nan,1.0,1154.0,1
TCGA-DU-6404-01,TCGA-DU-6404,LGG,24.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2000.0,nan,-9021.0,Dead,WITH TUMOR,nan,4068.0,nan,nan,nan,nan,1154.0,Progressive Disease,nan,nan,1.0,4068.0,1.0,4068.0,nan,nan,1.0,1154.0,1
TCGA-DU-6405-01,TCGA-DU-6405,LGG,51.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2000.0,nan,-18686.0,Dead,WITH TUMOR,nan,605.0,nan,nan,nan,nan,486.0,Progressive Disease,nan,nan,1.0,605.0,1.0,605.0,nan,nan,1.0,486.0,1
TCGA-DU-6406-01,TCGA-DU-6406,LGG,59.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G3,2001.0,nan,-21634.0,Dead,nan,nan,512.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,512.0,nan,512.0,nan,nan,0.0,512.0,1
TCGA-DU-6407-02,TCGA-DU-6407,LGG,35.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2001.0,nan,-13021.0,Dead,WITH TUMOR,nan,2875.0,nan,nan,nan,nan,2397.0,Progressive Disease,nan,nan,1.0,2875.0,1.0,2875.0,nan,nan,1.0,2397.0,1
TCGA-DU-6407-01,TCGA-DU-6407,LGG,35.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2001.0,nan,-13021.0,Dead,WITH TUMOR,nan,2875.0,nan,nan,nan,nan,2397.0,Progressive Disease,nan,nan,1.0,2875.0,1.0,2875.0,nan,nan,1.0,2397.0,1
TCGA-DU-6408-01,TCGA-DU-6408,LGG,23.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,1998.0,nan,-8752.0,Dead,nan,nan,3470.0,nan,nan,nan,nan,2097.0,Progressive Disease,nan,nan,1.0,3470.0,nan,3470.0,nan,nan,1.0,2097.0,1
TCGA-DU-6410-01,TCGA-DU-6410,LGG,56.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2010.0,nan,-20567.0,Alive,WITH TUMOR,242.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,242.0,0.0,242.0,nan,nan,0.0,242.0,0
TCGA-DU-6542-01,TCGA-DU-6542,LGG,25.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2011.0,nan,-9380.0,Alive,WITH TUMOR,73.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,73.0,0.0,73.0,nan,nan,0.0,73.0,0
TCGA-DU-7006-01,TCGA-DU-7006,LGG,60.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,1995.0,nan,-21990.0,Dead,WITH TUMOR,nan,349.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,349.0,1.0,349.0,nan,nan,1.0,349.0,1
TCGA-DU-7007-01,TCGA-DU-7007,LGG,33.0,MALE,WHITE,nan,nan,Astrocytoma,G2,1997.0,nan,-12245.0,Dead,nan,nan,1915.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1915.0,nan,1915.0,nan,nan,0.0,1915.0,1
TCGA-DU-7008-01,TCGA-DU-7008,LGG,41.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,1998.0,nan,-15289.0,Alive,TUMOR FREE,4752.0,nan,nan,nan,nan,nan,330.0,Progressive Disease,nan,nan,0.0,4752.0,0.0,4752.0,nan,nan,1.0,330.0,2
TCGA-DU-7009-01,TCGA-DU-7009,LGG,32.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2000.0,nan,-11854.0,Dead,WITH TUMOR,nan,4695.0,nan,nan,nan,nan,2960.0,Progressive Disease,nan,nan,1.0,4695.0,1.0,4695.0,nan,nan,1.0,2960.0,1
TCGA-DU-7010-01,TCGA-DU-7010,LGG,58.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2001.0,nan,-21199.0,Dead,WITH TUMOR,nan,456.0,nan,nan,nan,nan,193.0,Progressive Disease,nan,nan,1.0,456.0,1.0,456.0,nan,nan,1.0,193.0,1
TCGA-DU-7011-01,TCGA-DU-7011,LGG,25.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2000.0,nan,-9322.0,Dead,WITH TUMOR,nan,3200.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,3200.0,1.0,3200.0,nan,nan,1.0,3200.0,1
TCGA-DU-7012-01,TCGA-DU-7012,LGG,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Astrocytoma,G3,2001.0,nan,-27039.0,Dead,WITH TUMOR,nan,199.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,199.0,1.0,199.0,nan,nan,1.0,199.0,1
TCGA-DU-7013-01,TCGA-DU-7013,LGG,59.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2001.0,nan,-21824.0,Dead,WITH TUMOR,nan,269.0,nan,nan,nan,nan,187.0,Progressive Disease,nan,nan,1.0,269.0,1.0,269.0,nan,nan,1.0,187.0,1
TCGA-DU-7014-01,TCGA-DU-7014,LGG,59.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2001.0,nan,-21865.0,Dead,WITH TUMOR,nan,3571.0,nan,nan,nan,nan,3437.0,Progressive Disease,nan,nan,1.0,3571.0,1.0,3571.0,nan,nan,1.0,3437.0,1
TCGA-DU-7015-01,TCGA-DU-7015,LGG,41.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2004.0,nan,-15041.0,Alive,WITH TUMOR,2761.0,nan,nan,nan,nan,nan,591.0,Progressive Disease,nan,nan,0.0,2761.0,0.0,2761.0,nan,nan,1.0,591.0,2
TCGA-DU-7018-01,TCGA-DU-7018,LGG,57.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2006.0,nan,-21019.0,Dead,WITH TUMOR,nan,933.0,nan,nan,nan,nan,338.0,Progressive Disease,nan,nan,1.0,933.0,1.0,933.0,nan,nan,1.0,338.0,1
TCGA-DU-7019-01,TCGA-DU-7019,LGG,39.0,MALE,WHITE,nan,nan,Oligoastrocytoma,[Discrepancy],2009.0,nan,-14279.0,Alive,TUMOR FREE,800.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,800.0,0.0,800.0,nan,nan,0.0,800.0,0
TCGA-DU-7290-01,TCGA-DU-7290,LGG,45.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,1995.0,nan,-16667.0,Dead,WITH TUMOR,nan,315.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,315.0,1.0,315.0,nan,nan,1.0,315.0,1
TCGA-DU-7292-01,TCGA-DU-7292,LGG,69.0,MALE,WHITE,nan,nan,Astrocytoma,G3,1997.0,nan,-25266.0,Dead,WITH TUMOR,nan,242.0,nan,nan,nan,nan,91.0,Progressive Disease,nan,nan,1.0,242.0,1.0,242.0,nan,nan,1.0,91.0,1
TCGA-DU-7294-01,TCGA-DU-7294,LGG,53.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2003.0,nan,-19616.0,Alive,TUMOR FREE,2869.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,2869.0,0.0,2869.0,nan,nan,0.0,2869.0,0
TCGA-DU-7298-01,TCGA-DU-7298,LGG,38.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Astrocytoma,G3,2006.0,nan,-14205.0,Dead,WITH TUMOR,nan,576.0,nan,nan,nan,nan,200.0,Progressive Disease,nan,nan,1.0,576.0,1.0,576.0,nan,nan,1.0,200.0,1
TCGA-DU-7299-01,TCGA-DU-7299,LGG,33.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2006.0,nan,-12266.0,Dead,WITH TUMOR,nan,1339.0,nan,nan,nan,nan,675.0,Progressive Disease,nan,nan,1.0,1339.0,1.0,1339.0,nan,nan,1.0,675.0,1
TCGA-DU-7300-01,TCGA-DU-7300,LGG,53.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2006.0,nan,-19610.0,Dead,WITH TUMOR,nan,1886.0,nan,nan,nan,nan,317.0,Progressive Disease,nan,nan,1.0,1886.0,1.0,1886.0,nan,nan,1.0,317.0,1
TCGA-DU-7301-01,TCGA-DU-7301,LGG,53.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2006.0,nan,-19644.0,Dead,WITH TUMOR,nan,788.0,nan,nan,nan,nan,366.0,Progressive Disease,nan,nan,1.0,788.0,1.0,788.0,nan,nan,1.0,366.0,1
TCGA-DU-7302-01,TCGA-DU-7302,LGG,48.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2006.0,nan,-17656.0,Alive,WITH TUMOR,1834.0,nan,nan,nan,nan,nan,1374.0,Progressive Disease,nan,nan,0.0,1834.0,0.0,1834.0,nan,nan,1.0,1374.0,2
TCGA-DU-7304-02,TCGA-DU-7304,LGG,43.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2008.0,nan,-15931.0,Dead,WITH TUMOR,nan,709.0,nan,nan,nan,nan,309.0,Progressive Disease,nan,nan,1.0,709.0,1.0,709.0,nan,nan,1.0,309.0,1
TCGA-DU-7304-01,TCGA-DU-7304,LGG,43.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2008.0,nan,-15931.0,Dead,WITH TUMOR,nan,709.0,nan,nan,nan,nan,309.0,Progressive Disease,nan,nan,1.0,709.0,1.0,709.0,nan,nan,1.0,309.0,1
TCGA-DU-7306-01,TCGA-DU-7306,LGG,67.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2008.0,nan,-24800.0,Alive,WITH TUMOR,1277.0,nan,nan,nan,nan,nan,1250.0,Progressive Disease,nan,nan,0.0,1277.0,0.0,1277.0,nan,nan,1.0,1250.0,2
TCGA-DU-7309-01,TCGA-DU-7309,LGG,41.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2011.0,nan,-15197.0,Alive,WITH TUMOR,84.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,84.0,0.0,84.0,nan,nan,0.0,84.0,0
TCGA-DU-8158-01,TCGA-DU-8158,LGG,57.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2001.0,nan,-21129.0,Dead,WITH TUMOR,nan,155.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,155.0,1.0,155.0,nan,nan,1.0,155.0,1
TCGA-DU-8161-01,TCGA-DU-8161,LGG,63.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G3,2009.0,nan,-23064.0,Dead,WITH TUMOR,nan,722.0,nan,nan,nan,nan,111.0,Progressive Disease,nan,nan,1.0,722.0,1.0,722.0,nan,nan,1.0,111.0,1
TCGA-DU-8162-01,TCGA-DU-8162,LGG,61.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G3,2011.0,nan,-22596.0,Dead,WITH TUMOR,nan,444.0,nan,nan,nan,nan,402.0,Progressive Disease,nan,nan,1.0,444.0,1.0,444.0,nan,nan,1.0,402.0,1
TCGA-DU-8163-01,TCGA-DU-8163,LGG,29.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2011.0,nan,-10824.0,Alive,WITH TUMOR,629.0,nan,nan,nan,nan,nan,509.0,Progressive Disease,nan,nan,0.0,629.0,0.0,629.0,nan,nan,1.0,509.0,0
TCGA-DU-8164-01,TCGA-DU-8164,LGG,51.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2011.0,nan,-18735.0,Alive,TUMOR FREE,651.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,651.0,0.0,651.0,nan,nan,0.0,651.0,0
TCGA-DU-8165-01,TCGA-DU-8165,LGG,60.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2011.0,nan,-21964.0,Alive,TUMOR FREE,582.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,582.0,0.0,582.0,nan,nan,0.0,582.0,0
TCGA-DU-8166-01,TCGA-DU-8166,LGG,29.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2012.0,nan,-10641.0,Alive,WITH TUMOR,516.0,nan,nan,nan,nan,nan,193.0,Progressive Disease,nan,nan,0.0,516.0,0.0,516.0,nan,nan,1.0,193.0,2
TCGA-DU-8167-01,TCGA-DU-8167,LGG,69.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2012.0,nan,-25262.0,Alive,TUMOR FREE,471.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,471.0,0.0,471.0,nan,nan,0.0,471.0,0
TCGA-DU-8168-01,TCGA-DU-8168,LGG,55.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2012.0,nan,-20136.0,Alive,TUMOR FREE,431.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,431.0,0.0,431.0,nan,nan,0.0,431.0,0
TCGA-DU-A5TP-01,TCGA-DU-A5TP,LGG,33.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-12111.0,Alive,TUMOR FREE,1012.0,nan,nan,nan,nan,nan,203.0,[Discrepancy],nan,nan,0.0,1012.0,0.0,1012.0,nan,nan,1.0,203.0,0
TCGA-DU-A5TR-01,TCGA-DU-A5TR,LGG,51.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2012.0,nan,-18791.0,Alive,TUMOR FREE,908.0,nan,nan,nan,nan,nan,848.0,[Discrepancy],nan,nan,0.0,908.0,0.0,908.0,nan,nan,1.0,848.0,0
TCGA-DU-A5TS-01,TCGA-DU-A5TS,LGG,42.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Oligodendroglioma,G2,2012.0,nan,-15650.0,Alive,TUMOR FREE,964.0,nan,nan,nan,nan,nan,551.0,Stable Disease,nan,nan,0.0,964.0,0.0,964.0,nan,nan,1.0,551.0,0
TCGA-DU-A5TT-01,TCGA-DU-A5TT,LGG,70.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2013.0,nan,-25726.0,Alive,WITH TUMOR,743.0,nan,nan,nan,nan,nan,584.0,[Discrepancy],nan,nan,0.0,743.0,0.0,743.0,nan,nan,1.0,584.0,2
TCGA-DU-A5TU-01,TCGA-DU-A5TU,LGG,62.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2013.0,nan,-22811.0,Alive,WITH TUMOR,796.0,nan,nan,nan,nan,nan,186.0,Progressive Disease,nan,nan,0.0,796.0,0.0,796.0,nan,nan,1.0,186.0,2
TCGA-DU-A5TW-01,TCGA-DU-A5TW,LGG,33.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Astrocytoma,G3,2012.0,nan,-12107.0,Alive,WITH TUMOR,760.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,760.0,0.0,760.0,nan,nan,0.0,760.0,2
TCGA-DU-A5TY-01,TCGA-DU-A5TY,LGG,46.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-16945.0,Dead,WITH TUMOR,nan,1033.0,nan,nan,nan,nan,526.0,[Discrepancy],nan,nan,1.0,1033.0,1.0,1033.0,nan,nan,1.0,526.0,1
TCGA-DU-A6S2-01,TCGA-DU-A6S2,LGG,37.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Oligodendroglioma,G2,2013.0,nan,-13597.0,Alive,TUMOR FREE,777.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,777.0,0.0,777.0,nan,nan,0.0,777.0,0
TCGA-DU-A6S3-01,TCGA-DU-A6S3,LGG,60.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2013.0,nan,-22038.0,Alive,TUMOR FREE,656.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,656.0,0.0,656.0,nan,nan,0.0,656.0,0
TCGA-DU-A6S6-01,TCGA-DU-A6S6,LGG,35.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2007.0,nan,-12809.0,Alive,TUMOR FREE,2893.0,nan,nan,nan,nan,nan,2267.0,[Discrepancy],nan,nan,0.0,2893.0,0.0,2893.0,nan,nan,1.0,2267.0,2
TCGA-DU-A6S7-01,TCGA-DU-A6S7,LGG,27.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2013.0,nan,-10170.0,Alive,TUMOR FREE,638.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,638.0,0.0,638.0,nan,nan,0.0,638.0,0
TCGA-DU-A6S8-01,TCGA-DU-A6S8,LGG,74.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2013.0,nan,-27084.0,Alive,WITH TUMOR,678.0,nan,nan,nan,nan,nan,641.0,Progressive Disease,nan,nan,0.0,678.0,0.0,678.0,nan,nan,1.0,641.0,2
TCGA-DU-A76K-01,TCGA-DU-A76K,LGG,87.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,1999.0,nan,-31776.0,Dead,WITH TUMOR,nan,347.0,nan,nan,nan,nan,203.0,Progressive Disease,nan,nan,1.0,347.0,1.0,347.0,nan,nan,1.0,203.0,1
TCGA-DU-A76L-01,TCGA-DU-A76L,LGG,54.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2000.0,nan,-19823.0,Dead,WITH TUMOR,nan,814.0,nan,nan,nan,nan,410.0,Progressive Disease,nan,nan,1.0,814.0,1.0,814.0,nan,nan,1.0,410.0,1
TCGA-DU-A76O-01,TCGA-DU-A76O,LGG,30.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2013.0,nan,-10960.0,Alive,WITH TUMOR,522.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,522.0,0.0,522.0,nan,nan,0.0,522.0,0
TCGA-DU-A76R-01,TCGA-DU-A76R,LGG,51.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2006.0,nan,-18939.0,Dead,WITH TUMOR,nan,648.0,nan,nan,nan,nan,338.0,Progressive Disease,nan,nan,1.0,648.0,1.0,648.0,nan,nan,1.0,338.0,1
TCGA-DU-A7T6-01,TCGA-DU-A7T6,LGG,73.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2002.0,nan,-26766.0,Dead,WITH TUMOR,nan,547.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,547.0,1.0,547.0,nan,nan,1.0,547.0,1
TCGA-DU-A7T8-01,TCGA-DU-A7T8,LGG,35.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2003.0,nan,-13108.0,Dead,WITH TUMOR,nan,4229.0,nan,nan,nan,nan,3009.0,Stable Disease,nan,nan,1.0,4229.0,1.0,4229.0,nan,nan,1.0,3009.0,1
TCGA-DU-A7TA-01,TCGA-DU-A7TA,LGG,32.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2007.0,nan,-11764.0,Alive,TUMOR FREE,2565.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,2565.0,0.0,2565.0,nan,nan,0.0,2565.0,0
TCGA-DU-A7TB-01,TCGA-DU-A7TB,LGG,56.0,MALE,ASIAN,nan,nan,Oligodendroglioma,G2,2010.0,nan,-20704.0,Alive,TUMOR FREE,1567.0,nan,nan,nan,nan,nan,74.0,Progressive Disease,nan,nan,0.0,1567.0,0.0,1567.0,nan,nan,1.0,74.0,0
TCGA-DU-A7TC-01,TCGA-DU-A7TC,LGG,32.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2011.0,nan,-11884.0,Alive,WITH TUMOR,1137.0,nan,nan,nan,nan,nan,1114.0,[Discrepancy],nan,nan,0.0,1137.0,0.0,1137.0,nan,nan,1.0,1114.0,2
TCGA-DU-A7TD-01,TCGA-DU-A7TD,LGG,52.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2012.0,nan,-19025.0,Dead,WITH TUMOR,nan,228.0,nan,nan,nan,nan,188.0,Progressive Disease,nan,nan,1.0,228.0,1.0,228.0,nan,nan,1.0,188.0,1
TCGA-DU-A7TG-01,TCGA-DU-A7TG,LGG,40.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2008.0,nan,-14671.0,Dead,nan,nan,1351.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,1351.0,nan,1351.0,nan,nan,0.0,1351.0,1
TCGA-DU-A7TI-01,TCGA-DU-A7TI,LGG,32.0,MALE,WHITE,nan,nan,Astrocytoma,G3,1998.0,nan,-11906.0,Dead,WITH TUMOR,nan,1183.0,nan,nan,nan,nan,822.0,Progressive Disease,nan,nan,1.0,1183.0,1.0,1183.0,nan,nan,1.0,822.0,1
TCGA-DU-A7TJ-01,TCGA-DU-A7TJ,LGG,55.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Astrocytoma,G3,2013.0,nan,-20394.0,Alive,WITH TUMOR,17.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,17.0,0.0,17.0,nan,nan,0.0,17.0,0
TCGA-E1-5302-01,TCGA-E1-5302,LGG,41.0,MALE,WHITE,nan,nan,Astrocytoma,G3,1998.0,nan,-15230.0,Dead,WITH TUMOR,nan,1525.0,nan,nan,nan,nan,1242.0,Stable Disease,nan,nan,1.0,1525.0,1.0,1525.0,nan,nan,1.0,1242.0,1
TCGA-E1-5303-01,TCGA-E1-5303,LGG,38.0,MALE,WHITE,nan,nan,Astrocytoma,G3,1998.0,nan,-14212.0,Dead,WITH TUMOR,nan,2052.0,nan,nan,nan,nan,156.0,Progressive Disease,nan,nan,1.0,2052.0,1.0,2052.0,nan,nan,1.0,156.0,1
TCGA-E1-5304-01,TCGA-E1-5304,LGG,42.0,MALE,WHITE,nan,nan,Astrocytoma,G3,1999.0,nan,-15481.0,Dead,WITH TUMOR,nan,1251.0,nan,nan,nan,nan,903.0,Stable Disease,nan,nan,1.0,1251.0,1.0,1251.0,nan,nan,1.0,903.0,1
TCGA-E1-5305-01,TCGA-E1-5305,LGG,34.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2000.0,nan,-12655.0,Dead,WITH TUMOR,nan,2433.0,nan,nan,nan,nan,1604.0,Stable Disease,nan,nan,1.0,2433.0,1.0,2433.0,nan,nan,1.0,1604.0,1
TCGA-E1-5307-01,TCGA-E1-5307,LGG,62.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2000.0,nan,-22837.0,Dead,WITH TUMOR,nan,1762.0,nan,nan,nan,nan,1452.0,Stable Disease,nan,nan,1.0,1762.0,1.0,1762.0,nan,nan,1.0,1452.0,1
TCGA-E1-5311-01,TCGA-E1-5311,LGG,31.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,1994.0,nan,-11332.0,Dead,WITH TUMOR,nan,4084.0,nan,nan,nan,nan,2602.0,Stable Disease,nan,nan,1.0,4084.0,1.0,4084.0,nan,nan,1.0,2602.0,1
TCGA-E1-5318-01,TCGA-E1-5318,LGG,42.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,1997.0,nan,-15372.0,Dead,WITH TUMOR,2379.0,2379.0,nan,nan,nan,nan,362.0,Progressive Disease,nan,nan,1.0,2379.0,1.0,2379.0,nan,nan,1.0,362.0,1
TCGA-E1-5319-01,TCGA-E1-5319,LGG,48.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,1998.0,nan,-17612.0,Dead,WITH TUMOR,nan,2907.0,nan,nan,nan,nan,923.0,Stable Disease,nan,nan,1.0,2907.0,1.0,2907.0,nan,nan,1.0,923.0,1
TCGA-E1-5322-01,TCGA-E1-5322,LGG,38.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,1999.0,nan,-13903.0,Dead,nan,nan,3978.0,nan,nan,nan,nan,1085.0,Stable Disease,nan,nan,1.0,3978.0,nan,3978.0,nan,nan,1.0,1085.0,1
TCGA-E1-A7YD-01,TCGA-E1-A7YD,LGG,57.0,MALE,WHITE,nan,nan,Astrocytoma,G3,1998.0,nan,-21020.0,Dead,WITH TUMOR,nan,435.0,nan,nan,nan,nan,284.0,Stable Disease,nan,nan,1.0,435.0,1.0,435.0,nan,nan,1.0,284.0,1
TCGA-E1-A7YE-01,TCGA-E1-A7YE,LGG,32.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2001.0,nan,-11971.0,Dead,WITH TUMOR,nan,886.0,nan,nan,nan,nan,188.0,Stable Disease,nan,nan,1.0,886.0,1.0,886.0,nan,nan,1.0,188.0,1
TCGA-E1-A7YH-01,TCGA-E1-A7YH,LGG,47.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2005.0,nan,-17465.0,Dead,WITH TUMOR,nan,2835.0,nan,nan,nan,nan,689.0,Stable Disease,nan,nan,1.0,2835.0,1.0,2835.0,nan,nan,1.0,689.0,1
TCGA-E1-A7YI-01,TCGA-E1-A7YI,LGG,33.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2008.0,nan,-12229.0,Dead,WITH TUMOR,nan,111.0,nan,nan,nan,nan,56.0,[Unknown],nan,nan,1.0,111.0,1.0,111.0,nan,nan,1.0,56.0,1
TCGA-E1-A7YJ-01,TCGA-E1-A7YJ,LGG,55.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2008.0,nan,-20180.0,Dead,WITH TUMOR,nan,592.0,nan,nan,nan,nan,516.0,Stable Disease,nan,nan,1.0,592.0,1.0,592.0,nan,nan,1.0,516.0,1
TCGA-E1-A7YK-01,TCGA-E1-A7YK,LGG,52.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2009.0,nan,-19236.0,Dead,nan,nan,378.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,378.0,nan,378.0,nan,nan,0.0,378.0,1
TCGA-E1-A7YL-01,TCGA-E1-A7YL,LGG,46.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2009.0,nan,-16982.0,Dead,WITH TUMOR,nan,492.0,nan,nan,nan,nan,91.0,Progressive Disease,nan,nan,1.0,492.0,1.0,492.0,nan,nan,1.0,91.0,1
TCGA-E1-A7YM-01,TCGA-E1-A7YM,LGG,63.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2010.0,nan,-23263.0,Dead,WITH TUMOR,nan,648.0,nan,nan,nan,nan,88.0,Progressive Disease,nan,nan,1.0,648.0,1.0,648.0,nan,nan,1.0,88.0,1
TCGA-E1-A7YN-01,TCGA-E1-A7YN,LGG,63.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2010.0,nan,-23180.0,Dead,WITH TUMOR,nan,727.0,nan,nan,nan,nan,420.0,Stable Disease,nan,nan,1.0,727.0,1.0,727.0,nan,nan,1.0,420.0,1
TCGA-E1-A7YO-01,TCGA-E1-A7YO,LGG,45.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,1995.0,nan,-16770.0,Dead,WITH TUMOR,nan,2282.0,nan,nan,nan,nan,1977.0,Stable Disease,nan,nan,1.0,2282.0,1.0,2282.0,nan,nan,1.0,1977.0,1
TCGA-E1-A7YQ-01,TCGA-E1-A7YQ,LGG,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Oligodendroglioma,G3,2000.0,nan,-21341.0,Dead,WITH TUMOR,nan,1578.0,nan,nan,nan,nan,580.0,Stable Disease,nan,nan,1.0,1578.0,1.0,1578.0,nan,nan,1.0,580.0,1
TCGA-E1-A7YS-01,TCGA-E1-A7YS,LGG,71.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Oligodendroglioma,G3,2007.0,nan,-26159.0,Dead,WITH TUMOR,nan,466.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,466.0,1.0,466.0,nan,nan,1.0,466.0,1
TCGA-E1-A7YU-01,TCGA-E1-A7YU,LGG,42.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,1996.0,nan,-15345.0,Dead,WITH TUMOR,nan,23.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,23.0,1.0,23.0,nan,nan,1.0,23.0,1
TCGA-E1-A7YV-01,TCGA-E1-A7YV,LGG,26.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G3,2010.0,nan,-9546.0,Dead,WITH TUMOR,nan,987.0,nan,nan,nan,nan,97.0,Progressive Disease,nan,nan,1.0,987.0,1.0,987.0,nan,nan,1.0,97.0,1
TCGA-E1-A7YW-01,TCGA-E1-A7YW,LGG,28.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2002.0,nan,-10571.0,Dead,WITH TUMOR,nan,1120.0,nan,nan,nan,nan,409.0,Progressive Disease,nan,nan,1.0,1120.0,1.0,1120.0,nan,nan,1.0,409.0,1
TCGA-E1-A7YY-01,TCGA-E1-A7YY,LGG,27.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,1998.0,nan,-9867.0,Dead,WITH TUMOR,nan,4445.0,nan,nan,nan,nan,958.0,Stable Disease,nan,nan,1.0,4445.0,1.0,4445.0,nan,nan,1.0,958.0,1
TCGA-E1-A7Z2-01,TCGA-E1-A7Z2,LGG,58.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2012.0,nan,-21341.0,Dead,WITH TUMOR,nan,398.0,nan,nan,nan,nan,213.0,Progressive Disease,nan,nan,1.0,398.0,1.0,398.0,nan,nan,1.0,213.0,1
TCGA-E1-A7Z3-01,TCGA-E1-A7Z3,LGG,31.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Astrocytoma,G2,1992.0,nan,-11330.0,Dead,WITH TUMOR,nan,2235.0,nan,nan,nan,nan,1569.0,Progressive Disease,nan,nan,1.0,2235.0,1.0,2235.0,nan,nan,1.0,1569.0,1
TCGA-E1-A7Z4-01,TCGA-E1-A7Z4,LGG,35.0,MALE,WHITE,nan,nan,Astrocytoma,G2,1999.0,nan,-12849.0,Dead,WITH TUMOR,nan,4412.0,nan,nan,nan,nan,846.0,Progressive Disease,nan,nan,1.0,4412.0,1.0,4412.0,nan,nan,1.0,846.0,1
TCGA-E1-A7Z6-01,TCGA-E1-A7Z6,LGG,41.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2009.0,nan,-14985.0,Dead,WITH TUMOR,nan,984.0,nan,nan,nan,nan,294.0,Progressive Disease,nan,nan,1.0,984.0,1.0,984.0,nan,nan,1.0,294.0,1
TCGA-EZ-7264-01,TCGA-EZ-7264,LGG,47.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2011.0,nan,-17432.0,Alive,WITH TUMOR,1201.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1201.0,0.0,1201.0,nan,nan,0.0,1201.0,2
TCGA-F6-A8O3-01,TCGA-F6-A8O3,LGG,34.0,MALE,ASIAN,nan,nan,Oligodendroglioma,G2,2013.0,nan,-12578.0,Alive,TUMOR FREE,7.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,7.0,0.0,7.0,0.0,7.0,0.0,7.0,0
TCGA-F6-A8O4-01,TCGA-F6-A8O4,LGG,44.0,MALE,ASIAN,nan,nan,Astrocytoma,G2,2013.0,nan,-16202.0,Alive,TUMOR FREE,6.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,6.0,0.0,6.0,0.0,6.0,0.0,6.0,0
TCGA-FG-5962-01,TCGA-FG-5962,LGG,54.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2009.0,nan,-19818.0,Alive,WITH TUMOR,1453.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1453.0,0.0,1453.0,nan,nan,0.0,1453.0,0
TCGA-FG-5963-02,TCGA-FG-5963,LGG,23.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2009.0,nan,-8571.0,Dead,WITH TUMOR,nan,775.0,nan,nan,nan,nan,395.0,Progressive Disease,nan,nan,1.0,775.0,1.0,775.0,nan,nan,1.0,395.0,1
TCGA-FG-5963-01,TCGA-FG-5963,LGG,23.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2009.0,nan,-8571.0,Dead,WITH TUMOR,nan,775.0,nan,nan,nan,nan,395.0,Progressive Disease,nan,nan,1.0,775.0,1.0,775.0,nan,nan,1.0,395.0,1
TCGA-FG-5964-01,TCGA-FG-5964,LGG,62.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2010.0,nan,-22735.0,Alive,WITH TUMOR,1588.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1588.0,0.0,1588.0,nan,nan,0.0,1588.0,0
TCGA-FG-5965-02,TCGA-FG-5965,LGG,39.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2008.0,nan,-14249.0,Dead,WITH TUMOR,nan,1120.0,nan,nan,nan,nan,715.0,Stable Disease,nan,nan,1.0,1120.0,1.0,1120.0,nan,nan,1.0,715.0,1
TCGA-FG-5965-01,TCGA-FG-5965,LGG,39.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2008.0,nan,-14249.0,Dead,WITH TUMOR,nan,1120.0,nan,nan,nan,nan,715.0,Stable Disease,nan,nan,1.0,1120.0,1.0,1120.0,nan,nan,1.0,715.0,1
TCGA-FG-6688-01,TCGA-FG-6688,LGG,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Astrocytoma,G3,2010.0,nan,-21745.0,Alive,WITH TUMOR,571.0,nan,nan,nan,nan,nan,405.0,Progressive Disease,nan,nan,0.0,571.0,0.0,571.0,nan,nan,1.0,405.0,2
TCGA-FG-6689-01,TCGA-FG-6689,LGG,30.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2011.0,nan,-11312.0,Alive,WITH TUMOR,454.0,nan,nan,nan,nan,nan,119.0,Progressive Disease,nan,nan,0.0,454.0,0.0,454.0,nan,nan,1.0,119.0,2
TCGA-FG-6690-01,TCGA-FG-6690,LGG,70.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2011.0,nan,-25667.0,Alive,WITH TUMOR,1294.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1294.0,0.0,1294.0,nan,nan,0.0,1294.0,0
TCGA-FG-6691-01,TCGA-FG-6691,LGG,23.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2011.0,nan,-8403.0,Alive,WITH TUMOR,1257.0,nan,nan,nan,nan,nan,913.0,Complete Remission/Response,nan,nan,0.0,1257.0,0.0,1257.0,1.0,913.0,1.0,913.0,2
TCGA-FG-6692-01,TCGA-FG-6692,LGG,63.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2011.0,nan,-23374.0,Dead,WITH TUMOR,nan,561.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,561.0,1.0,561.0,nan,nan,1.0,561.0,1
TCGA-FG-7634-01,TCGA-FG-7634,LGG,28.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2008.0,nan,-10476.0,Alive,WITH TUMOR,467.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,467.0,0.0,467.0,nan,nan,0.0,467.0,0
TCGA-FG-7636-01,TCGA-FG-7636,LGG,48.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2011.0,nan,-17843.0,Alive,TUMOR FREE,544.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,544.0,0.0,544.0,0.0,544.0,0.0,544.0,0
TCGA-FG-7637-01,TCGA-FG-7637,LGG,49.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2009.0,nan,-18084.0,Alive,WITH TUMOR,1219.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1219.0,0.0,1219.0,nan,nan,0.0,1219.0,2
TCGA-FG-7638-01,TCGA-FG-7638,LGG,31.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2011.0,nan,-11528.0,Alive,WITH TUMOR,686.0,nan,nan,nan,nan,nan,407.0,Stable Disease,nan,nan,0.0,686.0,0.0,686.0,nan,nan,1.0,407.0,2
TCGA-FG-7641-01,TCGA-FG-7641,LGG,31.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2011.0,nan,-11357.0,Alive,TUMOR FREE,627.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,627.0,0.0,627.0,0.0,627.0,0.0,627.0,0
TCGA-FG-7643-01,TCGA-FG-7643,LGG,49.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2011.0,nan,-18206.0,Alive,WITH TUMOR,611.0,nan,nan,nan,nan,nan,254.0,Stable Disease,nan,nan,0.0,611.0,0.0,611.0,nan,nan,1.0,254.0,2
TCGA-FG-8181-01,TCGA-FG-8181,LGG,23.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2012.0,nan,-8642.0,Alive,WITH TUMOR,862.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,862.0,0.0,862.0,nan,nan,0.0,862.0,0
TCGA-FG-8182-01,TCGA-FG-8182,LGG,35.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2012.0,nan,-12972.0,Alive,WITH TUMOR,416.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,416.0,0.0,416.0,nan,nan,0.0,416.0,0
TCGA-FG-8185-01,TCGA-FG-8185,LGG,37.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-13621.0,Alive,TUMOR FREE,433.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,433.0,0.0,433.0,0.0,433.0,0.0,433.0,0
TCGA-FG-8186-01,TCGA-FG-8186,LGG,42.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G3,2011.0,nan,-15431.0,Alive,WITH TUMOR,487.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,487.0,0.0,487.0,nan,nan,0.0,487.0,0
TCGA-FG-8187-01,TCGA-FG-8187,LGG,31.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2011.0,nan,-11684.0,Alive,TUMOR FREE,611.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,611.0,0.0,611.0,0.0,611.0,0.0,611.0,0
TCGA-FG-8188-01,TCGA-FG-8188,LGG,41.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2012.0,nan,-15051.0,Alive,WITH TUMOR,455.0,nan,nan,nan,nan,nan,384.0,Stable Disease,nan,nan,0.0,455.0,0.0,455.0,nan,nan,1.0,384.0,2
TCGA-FG-8189-01,TCGA-FG-8189,LGG,33.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2012.0,nan,-12384.0,Alive,WITH TUMOR,685.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,685.0,0.0,685.0,nan,nan,0.0,685.0,2
TCGA-FG-8191-01,TCGA-FG-8191,LGG,30.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2011.0,nan,-11252.0,Alive,WITH TUMOR,992.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,992.0,0.0,992.0,nan,nan,0.0,992.0,0
TCGA-FG-A4MT-02,TCGA-FG-A4MT,LGG,27.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2010.0,nan,-10082.0,Alive,TUMOR FREE,1164.0,nan,nan,nan,nan,nan,499.0,Complete Remission/Response,nan,nan,0.0,1164.0,0.0,1164.0,1.0,499.0,1.0,499.0,2
TCGA-FG-A4MT-01,TCGA-FG-A4MT,LGG,27.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2010.0,nan,-10082.0,Alive,TUMOR FREE,1164.0,nan,nan,nan,nan,nan,499.0,Complete Remission/Response,nan,nan,0.0,1164.0,0.0,1164.0,1.0,499.0,1.0,499.0,2
TCGA-FG-A4MU-01,TCGA-FG-A4MU,LGG,58.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2012.0,nan,-21450.0,Alive,WITH TUMOR,326.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,326.0,0.0,326.0,nan,nan,0.0,326.0,0
TCGA-FG-A4MW-01,TCGA-FG-A4MW,LGG,63.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2012.0,nan,-23077.0,Dead,WITH TUMOR,nan,559.0,nan,nan,nan,nan,226.0,Stable Disease,nan,nan,1.0,559.0,1.0,559.0,nan,nan,1.0,226.0,1
TCGA-FG-A4MX-01,TCGA-FG-A4MX,LGG,47.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2012.0,nan,-17381.0,Alive,TUMOR FREE,569.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,569.0,0.0,569.0,0.0,569.0,0.0,569.0,0
TCGA-FG-A4MY-01,TCGA-FG-A4MY,LGG,44.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2012.0,nan,-16310.0,Alive,WITH TUMOR,721.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,721.0,0.0,721.0,nan,nan,0.0,721.0,2
TCGA-FG-A60J-01,TCGA-FG-A60J,LGG,47.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2012.0,nan,-17339.0,Alive,TUMOR FREE,449.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,449.0,0.0,449.0,0.0,449.0,0.0,449.0,0
TCGA-FG-A60K-01,TCGA-FG-A60K,LGG,34.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2012.0,nan,-12445.0,Alive,WITH TUMOR,542.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,542.0,0.0,542.0,nan,nan,0.0,542.0,2
TCGA-FG-A60L-01,TCGA-FG-A60L,LGG,34.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2012.0,nan,-12580.0,Alive,TUMOR FREE,655.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,655.0,0.0,655.0,0.0,655.0,0.0,655.0,0
TCGA-FG-A6IZ-01,TCGA-FG-A6IZ,LGG,60.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2013.0,nan,-22275.0,Alive,TUMOR FREE,457.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,457.0,0.0,457.0,0.0,457.0,0.0,457.0,0
TCGA-FG-A6J1-01,TCGA-FG-A6J1,LGG,44.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2013.0,nan,-16106.0,Alive,WITH TUMOR,500.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,500.0,0.0,500.0,nan,nan,0.0,500.0,2
TCGA-FG-A6J3-01,TCGA-FG-A6J3,LGG,52.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-19138.0,Alive,WITH TUMOR,677.0,nan,nan,nan,nan,nan,285.0,Progressive Disease,nan,nan,0.0,677.0,0.0,677.0,nan,nan,1.0,285.0,2
TCGA-FG-A70Y-01,TCGA-FG-A70Y,LGG,20.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2011.0,nan,-7421.0,Alive,WITH TUMOR,868.0,nan,nan,nan,nan,nan,490.0,Complete Remission/Response,nan,nan,0.0,868.0,0.0,868.0,1.0,490.0,1.0,490.0,2
TCGA-FG-A70Z-01,TCGA-FG-A70Z,LGG,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Oligoastrocytoma,G3,2011.0,nan,-19717.0,Alive,WITH TUMOR,328.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,328.0,0.0,328.0,nan,nan,0.0,328.0,0
TCGA-FG-A710-01,TCGA-FG-A710,LGG,50.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2011.0,nan,-18415.0,Alive,WITH TUMOR,1115.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1115.0,0.0,1115.0,nan,nan,0.0,1115.0,2
TCGA-FG-A711-01,TCGA-FG-A711,LGG,33.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2010.0,nan,-12248.0,Dead,WITH TUMOR,nan,1481.0,nan,nan,nan,nan,347.0,Progressive Disease,nan,nan,1.0,1481.0,1.0,1481.0,nan,nan,1.0,347.0,1
TCGA-FG-A713-01,TCGA-FG-A713,LGG,74.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2013.0,nan,-27232.0,Alive,TUMOR FREE,622.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,622.0,0.0,622.0,0.0,622.0,0.0,622.0,0
TCGA-FG-A87N-01,TCGA-FG-A87N,LGG,37.0,FEMALE,ASIAN,nan,nan,Astrocytoma,G3,2013.0,nan,-13606.0,Alive,WITH TUMOR,567.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,567.0,0.0,567.0,nan,nan,0.0,567.0,2
TCGA-FG-A87Q-01,TCGA-FG-A87Q,LGG,61.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2013.0,nan,-22565.0,Alive,TUMOR FREE,174.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,174.0,0.0,174.0,0.0,174.0,0.0,174.0,0
TCGA-FN-7833-01,TCGA-FN-7833,LGG,25.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2011.0,nan,-9228.0,Alive,TUMOR FREE,837.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,837.0,0.0,837.0,0.0,837.0,0.0,837.0,0
TCGA-HT-7467-01,TCGA-HT-7467,LGG,54.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2011.0,nan,-19944.0,Alive,TUMOR FREE,3.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3.0,0.0,3.0,0.0,3.0,0.0,3.0,0
TCGA-HT-7468-01,TCGA-HT-7468,LGG,30.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2011.0,nan,-11209.0,Alive,TUMOR FREE,203.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,203.0,0.0,203.0,nan,nan,0.0,203.0,0
TCGA-HT-7469-01,TCGA-HT-7469,LGG,30.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2011.0,nan,-11097.0,Dead,WITH TUMOR,nan,351.0,nan,nan,nan,nan,92.0,Progressive Disease,nan,nan,1.0,351.0,1.0,351.0,nan,nan,1.0,92.0,1
TCGA-HT-7470-01,TCGA-HT-7470,LGG,37.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2011.0,nan,-13611.0,Dead,TUMOR FREE,nan,1220.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1220.0,0.0,1220.0,0.0,1220.0,0.0,1220.0,0
TCGA-HT-7471-01,TCGA-HT-7471,LGG,37.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2010.0,nan,-13564.0,Alive,TUMOR FREE,4.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4.0,0.0,4.0,nan,nan,0.0,4.0,0
TCGA-HT-7472-01,TCGA-HT-7472,LGG,38.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2010.0,nan,-13968.0,Alive,TUMOR FREE,1.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1.0,0.0,1.0,nan,nan,0.0,1.0,0
TCGA-HT-7473-01,TCGA-HT-7473,LGG,28.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2010.0,nan,-10306.0,Alive,TUMOR FREE,503.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,503.0,0.0,503.0,0.0,503.0,0.0,503.0,0
TCGA-HT-7474-01,TCGA-HT-7474,LGG,52.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2011.0,nan,-19149.0,Alive,TUMOR FREE,114.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,114.0,0.0,114.0,nan,nan,0.0,114.0,0
TCGA-HT-7475-01,TCGA-HT-7475,LGG,67.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2010.0,nan,-24686.0,Alive,TUMOR FREE,530.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,530.0,0.0,530.0,0.0,530.0,0.0,530.0,0
TCGA-HT-7476-01,TCGA-HT-7476,LGG,26.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2011.0,nan,-9614.0,Alive,TUMOR FREE,199.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,199.0,0.0,199.0,nan,nan,0.0,199.0,0
TCGA-HT-7477-01,TCGA-HT-7477,LGG,62.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2011.0,nan,-22948.0,Alive,TUMOR FREE,738.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,738.0,0.0,738.0,0.0,738.0,0.0,738.0,0
TCGA-HT-7478-01,TCGA-HT-7478,LGG,36.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2011.0,nan,-13216.0,Alive,TUMOR FREE,194.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,194.0,0.0,194.0,0.0,194.0,0.0,194.0,0
TCGA-HT-7479-01,TCGA-HT-7479,LGG,44.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2011.0,nan,-16137.0,Alive,TUMOR FREE,1227.0,nan,nan,nan,nan,nan,705.0,Complete Remission/Response,nan,nan,0.0,1227.0,0.0,1227.0,1.0,705.0,1.0,705.0,0
TCGA-HT-7480-01,TCGA-HT-7480,LGG,33.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2005.0,nan,-12291.0,Alive,WITH TUMOR,2287.0,nan,nan,nan,nan,nan,1943.0,Stable Disease,nan,nan,0.0,2287.0,0.0,2287.0,nan,nan,1.0,1943.0,2
TCGA-HT-7481-01,TCGA-HT-7481,LGG,39.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2006.0,nan,-14306.0,Alive,WITH TUMOR,2918.0,nan,nan,nan,nan,nan,880.0,Stable Disease,nan,nan,0.0,2918.0,0.0,2918.0,nan,nan,1.0,880.0,2
TCGA-HT-7482-01,TCGA-HT-7482,LGG,18.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2005.0,nan,-6857.0,Alive,TUMOR FREE,3253.0,nan,nan,nan,nan,nan,374.0,Partial Remission/Response,nan,nan,0.0,3253.0,0.0,3253.0,nan,nan,1.0,374.0,2
TCGA-HT-7483-01,TCGA-HT-7483,LGG,14.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,1998.0,nan,-5267.0,Alive,TUMOR FREE,5255.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,5255.0,0.0,5255.0,0.0,5255.0,0.0,5255.0,0
TCGA-HT-7485-01,TCGA-HT-7485,LGG,42.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2006.0,nan,-15589.0,Alive,TUMOR FREE,122.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,122.0,0.0,122.0,0.0,122.0,0.0,122.0,0
TCGA-HT-7601-01,TCGA-HT-7601,LGG,30.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2008.0,nan,-10989.0,Alive,TUMOR FREE,153.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,153.0,0.0,153.0,nan,nan,0.0,153.0,0
TCGA-HT-7602-01,TCGA-HT-7602,LGG,21.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2008.0,nan,-7946.0,Alive,TUMOR FREE,908.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,908.0,0.0,908.0,nan,nan,0.0,908.0,0
TCGA-HT-7603-01,TCGA-HT-7603,LGG,29.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2008.0,nan,-10883.0,Alive,TUMOR FREE,705.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,705.0,0.0,705.0,0.0,705.0,0.0,705.0,0
TCGA-HT-7604-01,TCGA-HT-7604,LGG,50.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Astrocytoma,G2,2003.0,nan,-18443.0,Alive,TUMOR FREE,3725.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,3725.0,0.0,3725.0,nan,nan,0.0,3725.0,0
TCGA-HT-7605-01,TCGA-HT-7605,LGG,38.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2008.0,nan,-13892.0,Alive,nan,139.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,139.0,0.0,139.0,nan,nan,0.0,139.0,0
TCGA-HT-7606-01,TCGA-HT-7606,LGG,30.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2008.0,nan,-11233.0,Alive,TUMOR FREE,526.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,526.0,0.0,526.0,0.0,526.0,0.0,526.0,0
TCGA-HT-7607-01,TCGA-HT-7607,LGG,61.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2008.0,nan,-22585.0,Dead,WITH TUMOR,nan,96.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,96.0,1.0,96.0,nan,nan,1.0,96.0,1
TCGA-HT-7608-01,TCGA-HT-7608,LGG,61.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Oligoastrocytoma,G2,2007.0,nan,-22302.0,Alive,TUMOR FREE,671.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,671.0,0.0,671.0,nan,nan,0.0,671.0,0
TCGA-HT-7609-01,TCGA-HT-7609,LGG,34.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2007.0,nan,-12607.0,Alive,TUMOR FREE,1399.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1399.0,0.0,1399.0,nan,nan,0.0,1399.0,0
TCGA-HT-7610-01,TCGA-HT-7610,LGG,25.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2007.0,nan,-9447.0,Alive,TUMOR FREE,1706.0,nan,nan,nan,nan,nan,1205.0,Stable Disease,nan,nan,0.0,1706.0,0.0,1706.0,nan,nan,1.0,1205.0,2
TCGA-HT-7611-01,TCGA-HT-7611,LGG,36.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2007.0,nan,-13314.0,Alive,TUMOR FREE,1752.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1752.0,0.0,1752.0,0.0,1752.0,0.0,1752.0,0
TCGA-HT-7616-01,TCGA-HT-7616,LGG,75.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2007.0,nan,-27685.0,Dead,WITH TUMOR,nan,7.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,7.0,1.0,7.0,nan,nan,1.0,7.0,1
TCGA-HT-7620-01,TCGA-HT-7620,LGG,40.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2007.0,nan,-14659.0,Alive,TUMOR FREE,434.0,nan,nan,nan,nan,nan,280.0,Complete Remission/Response,nan,nan,0.0,434.0,0.0,434.0,1.0,280.0,1.0,280.0,2
TCGA-HT-7676-01,TCGA-HT-7676,LGG,26.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2009.0,nan,-9667.0,Alive,TUMOR FREE,5.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,5.0,0.0,5.0,nan,nan,0.0,5.0,0
TCGA-HT-7677-01,TCGA-HT-7677,LGG,53.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2009.0,nan,-19610.0,Alive,[Discrepancy],494.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,494.0,0.0,494.0,nan,nan,0.0,494.0,0
TCGA-HT-7680-01,TCGA-HT-7680,LGG,32.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2010.0,nan,-11970.0,Alive,TUMOR FREE,23.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,23.0,0.0,23.0,nan,nan,0.0,23.0,0
TCGA-HT-7681-01,TCGA-HT-7681,LGG,29.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2009.0,nan,-10790.0,Alive,TUMOR FREE,1359.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1359.0,0.0,1359.0,0.0,1359.0,0.0,1359.0,2
TCGA-HT-7684-01,TCGA-HT-7684,LGG,58.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2008.0,nan,-21352.0,Alive,TUMOR FREE,184.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,184.0,0.0,184.0,0.0,184.0,0.0,184.0,0
TCGA-HT-7686-01,TCGA-HT-7686,LGG,29.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2008.0,nan,-10724.0,Alive,TUMOR FREE,1300.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1300.0,0.0,1300.0,0.0,1300.0,0.0,1300.0,0
TCGA-HT-7687-01,TCGA-HT-7687,LGG,74.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2010.0,nan,-27186.0,Alive,TUMOR FREE,3.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,3.0,0.0,3.0,nan,nan,0.0,3.0,0
TCGA-HT-7688-01,TCGA-HT-7688,LGG,59.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2009.0,nan,-21844.0,Alive,TUMOR FREE,964.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,964.0,0.0,964.0,0.0,964.0,0.0,964.0,0
TCGA-HT-7689-01,TCGA-HT-7689,LGG,58.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2009.0,nan,-21331.0,Alive,TUMOR FREE,455.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,455.0,0.0,455.0,0.0,455.0,0.0,455.0,2
TCGA-HT-7690-01,TCGA-HT-7690,LGG,29.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2009.0,nan,-10673.0,Alive,TUMOR FREE,3.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3.0,0.0,3.0,nan,nan,0.0,3.0,0
TCGA-HT-7691-01,TCGA-HT-7691,LGG,31.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2008.0,nan,-11465.0,Alive,TUMOR FREE,3.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3.0,0.0,3.0,nan,nan,0.0,3.0,0
TCGA-HT-7692-01,TCGA-HT-7692,LGG,43.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2009.0,nan,-15727.0,Alive,TUMOR FREE,90.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,90.0,0.0,90.0,0.0,90.0,0.0,90.0,0
TCGA-HT-7693-01,TCGA-HT-7693,LGG,51.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2008.0,nan,-18956.0,Alive,TUMOR FREE,533.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,533.0,0.0,533.0,nan,nan,0.0,533.0,0
TCGA-HT-7694-01,TCGA-HT-7694,LGG,60.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2008.0,nan,-21930.0,Alive,TUMOR FREE,210.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,210.0,0.0,210.0,0.0,210.0,0.0,210.0,0
TCGA-HT-7695-01,TCGA-HT-7695,LGG,29.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2009.0,nan,-10827.0,Alive,TUMOR FREE,442.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,442.0,0.0,442.0,0.0,442.0,0.0,442.0,2
TCGA-HT-7854-01,TCGA-HT-7854,LGG,62.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2010.0,nan,-22738.0,Alive,TUMOR FREE,1201.0,nan,nan,nan,nan,nan,1147.0,Stable Disease,nan,nan,0.0,1201.0,0.0,1201.0,nan,nan,1.0,1147.0,0
TCGA-HT-7855-01,TCGA-HT-7855,LGG,39.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2008.0,nan,-14496.0,Alive,TUMOR FREE,585.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,585.0,0.0,585.0,0.0,585.0,0.0,585.0,0
TCGA-HT-7856-01,TCGA-HT-7856,LGG,35.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2008.0,nan,-13145.0,Alive,TUMOR FREE,1189.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1189.0,0.0,1189.0,0.0,1189.0,0.0,1189.0,0
TCGA-HT-7857-01,TCGA-HT-7857,LGG,24.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2006.0,nan,-8912.0,Alive,TUMOR FREE,7.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,7.0,0.0,7.0,nan,nan,0.0,7.0,0
TCGA-HT-7858-01,TCGA-HT-7858,LGG,28.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2007.0,nan,-10422.0,Alive,TUMOR FREE,1540.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1540.0,0.0,1540.0,0.0,1540.0,0.0,1540.0,0
TCGA-HT-7860-01,TCGA-HT-7860,LGG,60.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2009.0,nan,-22034.0,Alive,TUMOR FREE,15.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,15.0,0.0,15.0,nan,nan,0.0,15.0,0
TCGA-HT-7873-01,TCGA-HT-7873,LGG,29.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2011.0,nan,-10805.0,Alive,WITH TUMOR,718.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,718.0,0.0,718.0,nan,nan,0.0,718.0,0
TCGA-HT-7874-01,TCGA-HT-7874,LGG,41.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2008.0,nan,-15045.0,Alive,TUMOR FREE,1130.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1130.0,0.0,1130.0,0.0,1130.0,0.0,1130.0,0
TCGA-HT-7875-01,TCGA-HT-7875,LGG,56.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2008.0,nan,-20613.0,Alive,TUMOR FREE,10.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,10.0,0.0,10.0,nan,nan,0.0,10.0,0
TCGA-HT-7877-01,TCGA-HT-7877,LGG,20.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2011.0,nan,-7581.0,Alive,TUMOR FREE,4.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4.0,0.0,4.0,nan,nan,0.0,4.0,0
TCGA-HT-7879-01,TCGA-HT-7879,LGG,31.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2011.0,nan,-11622.0,Alive,TUMOR FREE,112.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,112.0,0.0,112.0,0.0,112.0,0.0,112.0,0
TCGA-HT-7880-01,TCGA-HT-7880,LGG,30.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2011.0,nan,-11043.0,Alive,TUMOR FREE,162.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,162.0,0.0,162.0,nan,nan,0.0,162.0,0
TCGA-HT-7881-01,TCGA-HT-7881,LGG,38.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Oligodendroglioma,G2,2011.0,nan,-14171.0,Alive,TUMOR FREE,1079.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1079.0,0.0,1079.0,0.0,1079.0,0.0,1079.0,0
TCGA-HT-7882-01,TCGA-HT-7882,LGG,66.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2010.0,nan,-24450.0,Dead,WITH TUMOR,nan,113.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,113.0,1.0,113.0,nan,nan,1.0,113.0,1
TCGA-HT-7884-01,TCGA-HT-7884,LGG,44.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2011.0,nan,-16280.0,Alive,[Discrepancy],343.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,343.0,0.0,343.0,nan,nan,0.0,343.0,0
TCGA-HT-7902-01,TCGA-HT-7902,LGG,30.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2009.0,nan,-11118.0,Alive,TUMOR FREE,956.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,956.0,0.0,956.0,nan,nan,0.0,956.0,2
TCGA-HT-8010-01,TCGA-HT-8010,LGG,64.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2011.0,nan,-23680.0,Alive,TUMOR FREE,50.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,50.0,0.0,50.0,nan,nan,0.0,50.0,0
TCGA-HT-8011-01,TCGA-HT-8011,LGG,55.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2009.0,nan,-20175.0,Alive,WITH TUMOR,494.0,nan,nan,nan,nan,nan,278.0,Stable Disease,nan,nan,0.0,494.0,0.0,494.0,nan,nan,1.0,278.0,2
TCGA-HT-8012-01,TCGA-HT-8012,LGG,30.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2010.0,nan,-11295.0,Alive,WITH TUMOR,286.0,nan,nan,nan,nan,nan,133.0,Stable Disease,nan,nan,0.0,286.0,0.0,286.0,nan,nan,1.0,133.0,2
TCGA-HT-8013-01,TCGA-HT-8013,LGG,37.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2005.0,nan,-13753.0,Dead,WITH TUMOR,nan,1933.0,nan,nan,nan,nan,1306.0,Stable Disease,nan,nan,1.0,1933.0,1.0,1933.0,nan,nan,1.0,1306.0,1
TCGA-HT-8015-01,TCGA-HT-8015,LGG,21.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2008.0,nan,-7760.0,Alive,TUMOR FREE,3.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3.0,0.0,3.0,0.0,3.0,0.0,3.0,0
TCGA-HT-8018-01,TCGA-HT-8018,LGG,40.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2010.0,nan,-14910.0,Dead,TUMOR FREE,nan,1152.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,1152.0,0.0,1152.0,nan,nan,0.0,1152.0,1
TCGA-HT-8019-01,TCGA-HT-8019,LGG,34.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2009.0,nan,-12669.0,Alive,TUMOR FREE,1004.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1004.0,0.0,1004.0,0.0,1004.0,0.0,1004.0,0
TCGA-HT-8104-01,TCGA-HT-8104,LGG,51.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2010.0,nan,-18748.0,Alive,TUMOR FREE,372.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,372.0,0.0,372.0,nan,nan,0.0,372.0,0
TCGA-HT-8105-01,TCGA-HT-8105,LGG,54.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2011.0,nan,-20041.0,Alive,TUMOR FREE,190.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,190.0,0.0,190.0,nan,nan,0.0,190.0,0
TCGA-HT-8106-01,TCGA-HT-8106,LGG,53.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2010.0,nan,-19555.0,Alive,TUMOR FREE,3.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,3.0,0.0,3.0,nan,nan,0.0,3.0,0
TCGA-HT-8107-01,TCGA-HT-8107,LGG,62.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2011.0,nan,-22880.0,Alive,TUMOR FREE,14.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,14.0,0.0,14.0,nan,nan,0.0,14.0,0
TCGA-HT-8108-01,TCGA-HT-8108,LGG,26.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2011.0,nan,-9539.0,Alive,TUMOR FREE,76.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,76.0,0.0,76.0,nan,nan,0.0,76.0,0
TCGA-HT-8109-01,TCGA-HT-8109,LGG,64.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2011.0,nan,-23486.0,Alive,TUMOR FREE,169.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,169.0,0.0,169.0,nan,nan,0.0,169.0,0
TCGA-HT-8110-01,TCGA-HT-8110,LGG,57.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2011.0,nan,-21183.0,Alive,TUMOR FREE,419.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,419.0,0.0,419.0,0.0,419.0,0.0,419.0,0
TCGA-HT-8111-01,TCGA-HT-8111,LGG,32.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2011.0,nan,-11810.0,Alive,nan,7.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,7.0,0.0,7.0,nan,nan,0.0,7.0,0
TCGA-HT-8113-01,TCGA-HT-8113,LGG,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Oligodendroglioma,G2,2006.0,nan,-18173.0,Alive,TUMOR FREE,900.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,900.0,0.0,900.0,0.0,900.0,0.0,900.0,0
TCGA-HT-8114-01,TCGA-HT-8114,LGG,36.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2011.0,nan,-13198.0,Alive,TUMOR FREE,1040.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1040.0,0.0,1040.0,0.0,1040.0,0.0,1040.0,0
TCGA-HT-8558-01,TCGA-HT-8558,LGG,29.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2011.0,nan,-10950.0,Alive,TUMOR FREE,418.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,418.0,0.0,418.0,0.0,418.0,0.0,418.0,0
TCGA-HT-8563-01,TCGA-HT-8563,LGG,30.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2011.0,nan,-11305.0,Alive,TUMOR FREE,860.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,860.0,0.0,860.0,0.0,860.0,0.0,860.0,0
TCGA-HT-8564-01,TCGA-HT-8564,LGG,47.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-17499.0,Alive,WITH TUMOR,478.0,nan,nan,nan,nan,nan,120.0,Progressive Disease,nan,nan,0.0,478.0,0.0,478.0,nan,nan,1.0,120.0,2
TCGA-HT-A4DS-01,TCGA-HT-A4DS,LGG,55.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-20296.0,Alive,TUMOR FREE,7.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,7.0,0.0,7.0,nan,nan,0.0,7.0,0
TCGA-HT-A4DV-01,TCGA-HT-A4DV,LGG,51.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2012.0,nan,-18799.0,Alive,TUMOR FREE,792.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,792.0,0.0,792.0,0.0,792.0,0.0,792.0,0
TCGA-HT-A5R5-01,TCGA-HT-A5R5,LGG,33.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2012.0,nan,-12403.0,Alive,TUMOR FREE,4.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4.0,0.0,4.0,0.0,4.0,0.0,4.0,0
TCGA-HT-A5R7-01,TCGA-HT-A5R7,LGG,33.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-12092.0,Alive,TUMOR FREE,615.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,615.0,0.0,615.0,0.0,615.0,0.0,615.0,0
TCGA-HT-A5R9-01,TCGA-HT-A5R9,LGG,48.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2012.0,nan,-17775.0,Alive,nan,2.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2.0,0.0,2.0,nan,nan,0.0,2.0,0
TCGA-HT-A5RA-01,TCGA-HT-A5RA,LGG,65.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-23769.0,Alive,WITH TUMOR,832.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,832.0,0.0,832.0,nan,nan,0.0,832.0,2
TCGA-HT-A5RB-01,TCGA-HT-A5RB,LGG,24.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2011.0,nan,-8820.0,Alive,nan,3.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3.0,0.0,3.0,nan,nan,0.0,3.0,0
TCGA-HT-A5RC-01,TCGA-HT-A5RC,LGG,70.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-25772.0,Dead,WITH TUMOR,nan,162.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,162.0,1.0,162.0,nan,nan,1.0,162.0,1
TCGA-HT-A614-01,TCGA-HT-A614,LGG,47.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2013.0,nan,-17392.0,Alive,WITH TUMOR,82.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,82.0,0.0,82.0,nan,nan,0.0,82.0,0
TCGA-HT-A615-01,TCGA-HT-A615,LGG,38.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2012.0,nan,-13892.0,Alive,TUMOR FREE,515.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,515.0,0.0,515.0,0.0,515.0,0.0,515.0,0
TCGA-HT-A616-01,TCGA-HT-A616,LGG,36.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2013.0,nan,-13222.0,Alive,nan,55.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,55.0,0.0,55.0,nan,nan,0.0,55.0,0
TCGA-HT-A617-01,TCGA-HT-A617,LGG,47.0,MALE,AMERICAN INDIAN OR ALASKA NATIVE,nan,nan,Oligodendroglioma,G2,2010.0,nan,-17331.0,Alive,nan,491.0,nan,nan,nan,nan,nan,395.0,Progressive Disease,nan,nan,0.0,491.0,0.0,491.0,nan,nan,1.0,395.0,2
TCGA-HT-A618-01,TCGA-HT-A618,LGG,37.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2013.0,nan,-13595.0,Alive,TUMOR FREE,512.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,512.0,0.0,512.0,0.0,512.0,0.0,512.0,0
TCGA-HT-A619-01,TCGA-HT-A619,LGG,51.0,FEMALE,ASIAN,nan,nan,Oligodendroglioma,G3,2012.0,nan,-18857.0,Alive,TUMOR FREE,651.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,651.0,0.0,651.0,0.0,651.0,0.0,651.0,0
TCGA-HT-A61A-01,TCGA-HT-A61A,LGG,20.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2013.0,nan,-7664.0,Alive,TUMOR FREE,194.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,194.0,0.0,194.0,0.0,194.0,0.0,194.0,0
TCGA-HT-A61B-01,TCGA-HT-A61B,LGG,22.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-8335.0,Alive,TUMOR FREE,533.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,533.0,0.0,533.0,0.0,533.0,0.0,533.0,0
TCGA-HT-A61C-01,TCGA-HT-A61C,LGG,66.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2013.0,nan,-24276.0,Dead,WITH TUMOR,nan,537.0,nan,nan,nan,nan,476.0,Complete Remission/Response,nan,nan,1.0,537.0,1.0,537.0,1.0,476.0,1.0,476.0,1
TCGA-HT-A74H-01,TCGA-HT-A74H,LGG,62.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2013.0,nan,-22850.0,Alive,nan,74.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,74.0,0.0,74.0,nan,nan,0.0,74.0,0
TCGA-HT-A74J-01,TCGA-HT-A74J,LGG,33.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2013.0,nan,-12393.0,Alive,nan,320.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,320.0,0.0,320.0,nan,nan,0.0,320.0,0
TCGA-HT-A74K-01,TCGA-HT-A74K,LGG,58.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2012.0,nan,-21189.0,Alive,TUMOR FREE,467.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,467.0,0.0,467.0,0.0,467.0,0.0,467.0,0
TCGA-HT-A74L-01,TCGA-HT-A74L,LGG,22.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2013.0,nan,-8240.0,Alive,WITH TUMOR,336.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,336.0,0.0,336.0,nan,nan,0.0,336.0,2
TCGA-HT-A74O-01,TCGA-HT-A74O,LGG,34.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2013.0,nan,-12460.0,Alive,nan,3.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3.0,0.0,3.0,nan,nan,0.0,3.0,0
TCGA-HW-7486-01,TCGA-HW-7486,LGG,37.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2010.0,nan,-13546.0,Alive,TUMOR FREE,1721.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1721.0,0.0,1721.0,nan,nan,0.0,1721.0,0
TCGA-HW-7487-01,TCGA-HW-7487,LGG,39.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2010.0,nan,-14535.0,Alive,WITH TUMOR,1382.0,nan,nan,nan,nan,nan,840.0,Progressive Disease,nan,nan,0.0,1382.0,0.0,1382.0,nan,nan,1.0,840.0,2
TCGA-HW-7489-01,TCGA-HW-7489,LGG,38.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2011.0,nan,-14201.0,Dead,WITH TUMOR,nan,1262.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,1262.0,1.0,1262.0,nan,nan,1.0,1262.0,1
TCGA-HW-7490-01,TCGA-HW-7490,LGG,41.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2011.0,nan,-15092.0,Alive,WITH TUMOR,1387.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,1387.0,0.0,1387.0,nan,nan,0.0,1387.0,0
TCGA-HW-7491-01,TCGA-HW-7491,LGG,35.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2009.0,nan,-12874.0,Alive,WITH TUMOR,2078.0,nan,nan,nan,nan,nan,2197.0,Progressive Disease,nan,nan,0.0,2078.0,0.0,2078.0,nan,nan,1.0,2197.0,2
TCGA-HW-7493-01,TCGA-HW-7493,LGG,40.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2009.0,nan,-14767.0,Alive,WITH TUMOR,2107.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,2107.0,0.0,2107.0,nan,nan,0.0,2107.0,2
TCGA-HW-7495-01,TCGA-HW-7495,LGG,45.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2011.0,nan,-16460.0,Alive,WITH TUMOR,1078.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,1078.0,0.0,1078.0,nan,nan,0.0,1078.0,2
TCGA-HW-8319-01,TCGA-HW-8319,LGG,34.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2011.0,nan,-12557.0,Dead,WITH TUMOR,nan,1209.0,nan,nan,nan,nan,997.0,Partial Remission/Response,nan,nan,1.0,1209.0,1.0,1209.0,nan,nan,1.0,997.0,1
TCGA-HW-8320-01,TCGA-HW-8320,LGG,36.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2011.0,nan,-13503.0,Alive,WITH TUMOR,1217.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1217.0,0.0,1217.0,nan,nan,0.0,1217.0,0
TCGA-HW-8321-01,TCGA-HW-8321,LGG,31.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2011.0,nan,-11474.0,Alive,WITH TUMOR,1294.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1294.0,0.0,1294.0,nan,nan,0.0,1294.0,0
TCGA-HW-8322-01,TCGA-HW-8322,LGG,39.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2012.0,nan,-14548.0,Alive,WITH TUMOR,758.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,758.0,0.0,758.0,nan,nan,0.0,758.0,0
TCGA-HW-A5KJ-01,TCGA-HW-A5KJ,LGG,68.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2012.0,nan,-24966.0,Dead,WITH TUMOR,nan,962.0,nan,nan,nan,nan,615.0,Progressive Disease,nan,nan,1.0,962.0,1.0,962.0,nan,nan,1.0,615.0,1
TCGA-HW-A5KK-01,TCGA-HW-A5KK,LGG,64.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-23484.0,Dead,WITH TUMOR,nan,388.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,388.0,1.0,388.0,nan,nan,1.0,388.0,1
TCGA-HW-A5KL-01,TCGA-HW-A5KL,LGG,42.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2012.0,nan,-15513.0,Alive,WITH TUMOR,878.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,878.0,0.0,878.0,nan,nan,0.0,878.0,2
TCGA-HW-A5KM-01,TCGA-HW-A5KM,LGG,35.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2012.0,nan,-12845.0,Alive,WITH TUMOR,630.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,630.0,0.0,630.0,nan,nan,0.0,630.0,0
TCGA-IK-7675-01,TCGA-IK-7675,LGG,43.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2009.0,nan,-15900.0,Dead,WITH TUMOR,nan,578.0,nan,nan,nan,nan,123.0,Progressive Disease,nan,nan,1.0,578.0,1.0,578.0,nan,nan,1.0,123.0,1
TCGA-IK-8125-01,TCGA-IK-8125,LGG,62.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2009.0,nan,-22745.0,Alive,TUMOR FREE,1301.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1301.0,0.0,1301.0,0.0,1301.0,0.0,1301.0,0
TCGA-KT-A74X-01,TCGA-KT-A74X,LGG,26.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2013.0,nan,-9590.0,Alive,WITH TUMOR,438.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,438.0,0.0,438.0,nan,nan,0.0,438.0,0
TCGA-KT-A7W1-01,TCGA-KT-A7W1,LGG,45.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2013.0,nan,-16560.0,Alive,TUMOR FREE,438.0,nan,nan,nan,nan,nan,84.0,Progressive Disease,nan,nan,0.0,438.0,0.0,438.0,nan,nan,1.0,84.0,2
TCGA-P5-A5ET-01,TCGA-P5-A5ET,LGG,27.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2012.0,nan,-10027.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-P5-A5EU-01,TCGA-P5-A5EU,LGG,35.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-12851.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-P5-A5EV-01,TCGA-P5-A5EV,LGG,39.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2012.0,nan,-14310.0,Alive,WITH TUMOR,7.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,7.0,0.0,7.0,nan,nan,0.0,7.0,0
TCGA-P5-A5EW-01,TCGA-P5-A5EW,LGG,20.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2012.0,nan,-7612.0,Alive,TUMOR FREE,204.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,204.0,0.0,204.0,nan,nan,0.0,204.0,0
TCGA-P5-A5EX-01,TCGA-P5-A5EX,LGG,41.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2012.0,nan,-15091.0,Alive,TUMOR FREE,243.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,243.0,0.0,243.0,nan,nan,0.0,243.0,0
TCGA-P5-A5EY-01,TCGA-P5-A5EY,LGG,21.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2012.0,nan,-7716.0,Alive,nan,72.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,72.0,0.0,72.0,nan,nan,0.0,72.0,0
TCGA-P5-A5EZ-01,TCGA-P5-A5EZ,LGG,39.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-14375.0,Alive,TUMOR FREE,70.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,70.0,0.0,70.0,nan,nan,0.0,70.0,0
TCGA-P5-A5F0-01,TCGA-P5-A5F0,LGG,33.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2012.0,nan,-12157.0,Alive,[Discrepancy],287.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,287.0,0.0,287.0,nan,nan,0.0,287.0,0
TCGA-P5-A5F1-01,TCGA-P5-A5F1,LGG,30.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2012.0,nan,-11070.0,Alive,TUMOR FREE,179.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,179.0,0.0,179.0,nan,nan,0.0,179.0,0
TCGA-P5-A5F2-01,TCGA-P5-A5F2,LGG,36.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2012.0,nan,-13396.0,Alive,WITH TUMOR,242.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,242.0,0.0,242.0,nan,nan,0.0,242.0,2
TCGA-P5-A5F4-01,TCGA-P5-A5F4,LGG,35.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2012.0,nan,-12851.0,Alive,[Discrepancy],231.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,231.0,0.0,231.0,nan,nan,0.0,231.0,0
TCGA-P5-A5F6-01,TCGA-P5-A5F6,LGG,26.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2012.0,nan,-9575.0,Alive,TUMOR FREE,39.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,39.0,0.0,39.0,nan,nan,0.0,39.0,0
TCGA-P5-A72U-01,TCGA-P5-A72U,LGG,71.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2013.0,nan,-26002.0,Alive,TUMOR FREE,7.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,7.0,0.0,7.0,0.0,7.0,0.0,7.0,0
TCGA-P5-A72W-01,TCGA-P5-A72W,LGG,35.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2013.0,nan,-12848.0,Alive,TUMOR FREE,317.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,317.0,0.0,317.0,0.0,317.0,0.0,317.0,0
TCGA-P5-A72X-01,TCGA-P5-A72X,LGG,21.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2013.0,nan,-7913.0,Alive,TUMOR FREE,403.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,403.0,0.0,403.0,0.0,403.0,0.0,403.0,0
TCGA-P5-A72Z-01,TCGA-P5-A72Z,LGG,64.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2013.0,nan,-23482.0,Alive,TUMOR FREE,354.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,354.0,0.0,354.0,0.0,354.0,0.0,354.0,0
TCGA-P5-A730-01,TCGA-P5-A730,LGG,22.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2013.0,nan,-8043.0,Alive,TUMOR FREE,333.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,333.0,0.0,333.0,0.0,333.0,0.0,333.0,0
TCGA-P5-A731-01,TCGA-P5-A731,LGG,59.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2013.0,nan,-21715.0,Alive,TUMOR FREE,274.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,274.0,0.0,274.0,nan,nan,0.0,274.0,0
TCGA-P5-A733-01,TCGA-P5-A733,LGG,52.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2013.0,nan,-19142.0,Alive,TUMOR FREE,414.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,414.0,0.0,414.0,0.0,414.0,0.0,414.0,0
TCGA-P5-A735-01,TCGA-P5-A735,LGG,38.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2013.0,nan,-14152.0,Alive,TUMOR FREE,292.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,292.0,0.0,292.0,0.0,292.0,0.0,292.0,0
TCGA-P5-A736-01,TCGA-P5-A736,LGG,44.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2013.0,nan,-16300.0,Alive,TUMOR FREE,230.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,230.0,0.0,230.0,0.0,230.0,0.0,230.0,0
TCGA-P5-A737-01,TCGA-P5-A737,LGG,47.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2012.0,nan,-17390.0,Alive,TUMOR FREE,372.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,372.0,0.0,372.0,0.0,372.0,0.0,372.0,0
TCGA-P5-A77W-01,TCGA-P5-A77W,LGG,37.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G3,2013.0,nan,-13545.0,Alive,TUMOR FREE,584.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,584.0,0.0,584.0,0.0,584.0,0.0,584.0,0
TCGA-P5-A77X-01,TCGA-P5-A77X,LGG,55.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2013.0,nan,-20128.0,Alive,TUMOR FREE,105.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,105.0,0.0,105.0,0.0,105.0,0.0,105.0,0
TCGA-P5-A780-01,TCGA-P5-A780,LGG,44.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2013.0,nan,-16161.0,Alive,TUMOR FREE,72.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,72.0,0.0,72.0,0.0,72.0,0.0,72.0,0
TCGA-P5-A781-01,TCGA-P5-A781,LGG,34.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2013.0,nan,-12757.0,Alive,TUMOR FREE,134.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,134.0,0.0,134.0,0.0,134.0,0.0,134.0,0
TCGA-QH-A65R-01,TCGA-QH-A65R,LGG,38.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2013.0,nan,-14073.0,Alive,WITH TUMOR,461.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,461.0,0.0,461.0,nan,nan,0.0,461.0,2
TCGA-QH-A65S-01,TCGA-QH-A65S,LGG,32.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2013.0,nan,-11861.0,Alive,[Discrepancy],77.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,77.0,0.0,77.0,nan,nan,0.0,77.0,2
TCGA-QH-A65V-01,TCGA-QH-A65V,LGG,43.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2013.0,nan,-15850.0,Alive,WITH TUMOR,384.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,384.0,0.0,384.0,nan,nan,0.0,384.0,2
TCGA-QH-A65X-01,TCGA-QH-A65X,LGG,28.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G3,2013.0,nan,-10440.0,Alive,TUMOR FREE,482.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,482.0,0.0,482.0,nan,nan,0.0,482.0,0
TCGA-QH-A65Z-01,TCGA-QH-A65Z,LGG,54.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2013.0,nan,-19921.0,Alive,TUMOR FREE,427.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,427.0,0.0,427.0,nan,nan,0.0,427.0,0
TCGA-QH-A6CS-01,TCGA-QH-A6CS,LGG,41.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2013.0,nan,-15092.0,Alive,WITH TUMOR,588.0,nan,nan,nan,nan,nan,498.0,Stable Disease,nan,nan,0.0,588.0,0.0,588.0,nan,nan,1.0,498.0,2
TCGA-QH-A6CU-01,TCGA-QH-A6CU,LGG,52.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2013.0,nan,-19149.0,Alive,TUMOR FREE,451.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,451.0,0.0,451.0,nan,nan,0.0,451.0,0
TCGA-QH-A6CV-01,TCGA-QH-A6CV,LGG,51.0,MALE,ASIAN,nan,nan,Oligoastrocytoma,G3,2013.0,nan,-18955.0,Alive,WITH TUMOR,442.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,442.0,0.0,442.0,nan,nan,0.0,442.0,0
TCGA-QH-A6CW-01,TCGA-QH-A6CW,LGG,43.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2013.0,nan,-15847.0,Alive,TUMOR FREE,414.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,414.0,0.0,414.0,nan,nan,0.0,414.0,0
TCGA-QH-A6CX-01,TCGA-QH-A6CX,LGG,66.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2013.0,nan,-24252.0,Dead,WITH TUMOR,nan,372.0,nan,nan,nan,nan,273.0,Complete Remission/Response,nan,nan,1.0,372.0,1.0,372.0,1.0,273.0,1.0,273.0,1
TCGA-QH-A6CY-01,TCGA-QH-A6CY,LGG,38.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2013.0,nan,-14140.0,Alive,WITH TUMOR,408.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,408.0,0.0,408.0,nan,nan,0.0,408.0,0
TCGA-QH-A6CZ-01,TCGA-QH-A6CZ,LGG,38.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2013.0,nan,-14007.0,Alive,TUMOR FREE,279.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,279.0,0.0,279.0,nan,nan,0.0,279.0,0
TCGA-QH-A6X3-01,TCGA-QH-A6X3,LGG,27.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2013.0,nan,-10184.0,Alive,TUMOR FREE,313.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,313.0,0.0,313.0,0.0,313.0,0.0,313.0,0
TCGA-QH-A6X4-01,TCGA-QH-A6X4,LGG,47.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2013.0,nan,-17258.0,Alive,TUMOR FREE,442.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,442.0,0.0,442.0,0.0,442.0,0.0,442.0,0
TCGA-QH-A6X5-01,TCGA-QH-A6X5,LGG,58.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2013.0,nan,-21239.0,Alive,nan,497.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,497.0,0.0,497.0,nan,nan,0.0,497.0,2
TCGA-QH-A6X8-01,TCGA-QH-A6X8,LGG,56.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2013.0,nan,-20771.0,Alive,WITH TUMOR,509.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,509.0,0.0,509.0,nan,nan,0.0,509.0,2
TCGA-QH-A6X9-01,TCGA-QH-A6X9,LGG,73.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2013.0,nan,-26992.0,Alive,nan,58.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,58.0,0.0,58.0,nan,nan,0.0,58.0,2
TCGA-QH-A6XA-01,TCGA-QH-A6XA,LGG,23.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2013.0,nan,-8508.0,Alive,TUMOR FREE,502.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,502.0,0.0,502.0,0.0,502.0,0.0,502.0,0
TCGA-QH-A6XC-01,TCGA-QH-A6XC,LGG,48.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2013.0,nan,-17692.0,Alive,WITH TUMOR,508.0,nan,nan,nan,nan,nan,438.0,Complete Remission/Response,nan,nan,0.0,508.0,0.0,508.0,1.0,438.0,1.0,438.0,2
TCGA-QH-A86X-01,TCGA-QH-A86X,LGG,33.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2013.0,nan,-12385.0,Alive,TUMOR FREE,337.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,337.0,0.0,337.0,0.0,337.0,0.0,337.0,0
TCGA-QH-A870-01,TCGA-QH-A870,LGG,38.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G3,2013.0,nan,-14082.0,Alive,WITH TUMOR,395.0,nan,nan,nan,nan,nan,335.0,Complete Remission/Response,nan,nan,0.0,395.0,0.0,395.0,1.0,335.0,1.0,335.0,2
TCGA-R8-A6MK-01,TCGA-R8-A6MK,LGG,40.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2005.0,nan,-14716.0,Alive,nan,2702.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,2702.0,0.0,2702.0,nan,nan,0.0,2702.0,0
TCGA-R8-A6ML-01,TCGA-R8-A6ML,LGG,52.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2005.0,nan,-19185.0,Alive,nan,2860.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,2860.0,0.0,2860.0,nan,nan,0.0,2860.0,0
TCGA-R8-A6MO-01,TCGA-R8-A6MO,LGG,53.0,FEMALE,ASIAN,nan,nan,Oligodendroglioma,G2,2009.0,nan,-19432.0,Alive,nan,993.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,993.0,0.0,993.0,nan,nan,0.0,993.0,2
TCGA-R8-A73M-01,TCGA-R8-A73M,LGG,48.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2008.0,nan,-17610.0,Alive,nan,1806.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1806.0,0.0,1806.0,nan,nan,0.0,1806.0,2
TCGA-RY-A83X-01,TCGA-RY-A83X,LGG,46.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2012.0,nan,-16911.0,Alive,TUMOR FREE,939.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,939.0,0.0,939.0,nan,nan,0.0,939.0,0
TCGA-RY-A83Y-01,TCGA-RY-A83Y,LGG,45.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2012.0,nan,-16470.0,Alive,TUMOR FREE,166.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,166.0,0.0,166.0,nan,nan,0.0,166.0,0
TCGA-RY-A83Z-01,TCGA-RY-A83Z,LGG,54.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-19903.0,Alive,WITH TUMOR,301.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,301.0,0.0,301.0,nan,nan,0.0,301.0,2
TCGA-RY-A840-01,TCGA-RY-A840,LGG,47.0,MALE,[Unknown],nan,nan,Oligodendroglioma,G3,2012.0,nan,-17501.0,Alive,WITH TUMOR,854.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,854.0,0.0,854.0,nan,nan,0.0,854.0,0
TCGA-RY-A843-01,TCGA-RY-A843,LGG,30.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-11083.0,Alive,WITH TUMOR,63.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,63.0,0.0,63.0,nan,nan,0.0,63.0,0
TCGA-RY-A845-01,TCGA-RY-A845,LGG,40.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2013.0,nan,-14617.0,Alive,TUMOR FREE,596.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,596.0,0.0,596.0,nan,nan,0.0,596.0,0
TCGA-RY-A847-01,TCGA-RY-A847,LGG,45.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2012.0,nan,-16732.0,Alive,TUMOR FREE,933.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,933.0,0.0,933.0,nan,nan,0.0,933.0,0
TCGA-S9-A6TS-01,TCGA-S9-A6TS,LGG,48.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2006.0,nan,-17857.0,Dead,WITH TUMOR,nan,1891.0,nan,nan,nan,nan,1324.0,Progressive Disease,nan,nan,1.0,1891.0,1.0,1891.0,nan,nan,1.0,1324.0,1
TCGA-S9-A6TU-01,TCGA-S9-A6TU,LGG,38.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2007.0,nan,-14108.0,Alive,WITH TUMOR,2650.0,nan,nan,nan,nan,nan,1475.0,Partial Remission/Response,nan,nan,0.0,2650.0,0.0,2650.0,nan,nan,1.0,1475.0,2
TCGA-S9-A6TV-01,TCGA-S9-A6TV,LGG,50.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2010.0,nan,-18321.0,Alive,TUMOR FREE,571.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,571.0,0.0,571.0,0.0,571.0,0.0,571.0,0
TCGA-S9-A6TW-01,TCGA-S9-A6TW,LGG,40.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2011.0,nan,-14679.0,Alive,TUMOR FREE,1250.0,nan,nan,nan,nan,nan,861.0,Partial Remission/Response,nan,nan,0.0,1250.0,0.0,1250.0,nan,nan,1.0,861.0,0
TCGA-S9-A6TX-01,TCGA-S9-A6TX,LGG,46.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2011.0,nan,-17025.0,Alive,WITH TUMOR,1245.0,nan,nan,nan,nan,nan,856.0,Complete Remission/Response,nan,nan,0.0,1245.0,0.0,1245.0,1.0,856.0,1.0,856.0,2
TCGA-S9-A6TY-01,TCGA-S9-A6TY,LGG,50.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2011.0,nan,-18564.0,Alive,WITH TUMOR,1076.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,1076.0,0.0,1076.0,nan,nan,0.0,1076.0,0
TCGA-S9-A6TZ-01,TCGA-S9-A6TZ,LGG,39.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2011.0,nan,-14592.0,Alive,WITH TUMOR,1120.0,nan,nan,nan,nan,nan,552.0,Partial Remission/Response,nan,nan,0.0,1120.0,0.0,1120.0,nan,nan,1.0,552.0,2
TCGA-S9-A6U0-01,TCGA-S9-A6U0,LGG,46.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-16890.0,Dead,WITH TUMOR,nan,742.0,nan,nan,nan,nan,692.0,Partial Remission/Response,nan,nan,1.0,742.0,1.0,742.0,nan,nan,1.0,692.0,1
TCGA-S9-A6U1-01,TCGA-S9-A6U1,LGG,22.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-8271.0,Alive,TUMOR FREE,785.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,785.0,0.0,785.0,0.0,785.0,0.0,785.0,0
TCGA-S9-A6U2-01,TCGA-S9-A6U2,LGG,48.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2012.0,nan,-17800.0,Alive,WITH TUMOR,908.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,908.0,0.0,908.0,nan,nan,0.0,908.0,2
TCGA-S9-A6U5-01,TCGA-S9-A6U5,LGG,33.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2011.0,nan,-12417.0,Alive,TUMOR FREE,992.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,992.0,0.0,992.0,0.0,992.0,0.0,992.0,0
TCGA-S9-A6U6-01,TCGA-S9-A6U6,LGG,28.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-10253.0,Alive,TUMOR FREE,1069.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1069.0,0.0,1069.0,0.0,1069.0,0.0,1069.0,0
TCGA-S9-A6U8-01,TCGA-S9-A6U8,LGG,24.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2005.0,nan,-9044.0,Dead,WITH TUMOR,nan,2988.0,nan,nan,nan,nan,367.0,Partial Remission/Response,nan,nan,1.0,2988.0,1.0,2988.0,nan,nan,1.0,367.0,1
TCGA-S9-A6U9-01,TCGA-S9-A6U9,LGG,36.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2006.0,nan,-13460.0,Alive,WITH TUMOR,2918.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,2918.0,0.0,2918.0,nan,nan,0.0,2918.0,0
TCGA-S9-A6UA-01,TCGA-S9-A6UA,LGG,66.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2008.0,nan,-24242.0,Dead,WITH TUMOR,nan,178.0,nan,nan,nan,nan,161.0,Progressive Disease,nan,nan,1.0,178.0,1.0,178.0,nan,nan,1.0,161.0,1
TCGA-S9-A6UB-01,TCGA-S9-A6UB,LGG,52.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2005.0,nan,-19223.0,Alive,TUMOR FREE,3761.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3761.0,0.0,3761.0,0.0,3761.0,0.0,3761.0,0
TCGA-S9-A6WD-01,TCGA-S9-A6WD,LGG,58.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2008.0,nan,-21231.0,Alive,WITH TUMOR,2289.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,2289.0,0.0,2289.0,nan,nan,0.0,2289.0,0
TCGA-S9-A6WE-01,TCGA-S9-A6WE,LGG,34.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2004.0,nan,-12488.0,Alive,WITH TUMOR,4113.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,4113.0,0.0,4113.0,nan,nan,0.0,4113.0,0
TCGA-S9-A6WG-01,TCGA-S9-A6WG,LGG,31.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2007.0,nan,-11509.0,Alive,WITH TUMOR,2602.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,2602.0,0.0,2602.0,nan,nan,0.0,2602.0,0
TCGA-S9-A6WH-01,TCGA-S9-A6WH,LGG,73.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2011.0,nan,-26904.0,Alive,WITH TUMOR,1173.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,1173.0,0.0,1173.0,nan,nan,0.0,1173.0,2
TCGA-S9-A6WI-01,TCGA-S9-A6WI,LGG,56.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2006.0,nan,-20609.0,Alive,WITH TUMOR,2585.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,2585.0,0.0,2585.0,nan,nan,0.0,2585.0,2
TCGA-S9-A6WL-01,TCGA-S9-A6WL,LGG,52.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-19234.0,Alive,WITH TUMOR,946.0,nan,nan,nan,nan,nan,240.0,Progressive Disease,nan,nan,0.0,946.0,0.0,946.0,nan,nan,1.0,240.0,2
TCGA-S9-A6WM-01,TCGA-S9-A6WM,LGG,59.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-21761.0,Alive,WITH TUMOR,604.0,nan,nan,nan,nan,nan,505.0,Partial Remission/Response,nan,nan,0.0,604.0,0.0,604.0,nan,nan,1.0,505.0,2
TCGA-S9-A6WN-01,TCGA-S9-A6WN,LGG,38.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2013.0,nan,-13961.0,Alive,WITH TUMOR,805.0,nan,nan,nan,nan,nan,303.0,Progressive Disease,nan,nan,0.0,805.0,0.0,805.0,nan,nan,1.0,303.0,2
TCGA-S9-A6WO-01,TCGA-S9-A6WO,LGG,29.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2013.0,nan,-10933.0,Alive,WITH TUMOR,566.0,nan,nan,nan,nan,nan,187.0,Progressive Disease,nan,nan,0.0,566.0,0.0,566.0,nan,nan,1.0,187.0,2
TCGA-S9-A6WP-01,TCGA-S9-A6WP,LGG,42.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2013.0,nan,-15658.0,Alive,WITH TUMOR,567.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,567.0,0.0,567.0,nan,nan,0.0,567.0,0
TCGA-S9-A6WQ-01,TCGA-S9-A6WQ,LGG,57.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2013.0,nan,-21133.0,Alive,WITH TUMOR,428.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,428.0,0.0,428.0,nan,nan,0.0,428.0,2
TCGA-S9-A7IQ-01,TCGA-S9-A7IQ,LGG,45.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2011.0,nan,-16512.0,Alive,WITH TUMOR,1099.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,1099.0,0.0,1099.0,nan,nan,0.0,1099.0,2
TCGA-S9-A7IS-01,TCGA-S9-A7IS,LGG,33.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2004.0,nan,-12402.0,Dead,WITH TUMOR,nan,241.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,241.0,1.0,241.0,nan,nan,1.0,241.0,1
TCGA-S9-A7IX-01,TCGA-S9-A7IX,LGG,57.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-21095.0,Dead,WITH TUMOR,nan,819.0,nan,nan,nan,nan,350.0,Progressive Disease,nan,nan,1.0,819.0,1.0,819.0,nan,nan,1.0,350.0,1
TCGA-S9-A7IY-01,TCGA-S9-A7IY,LGG,39.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2012.0,nan,-14422.0,Alive,WITH TUMOR,715.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,715.0,0.0,715.0,nan,nan,0.0,715.0,0
TCGA-S9-A7IZ-01,TCGA-S9-A7IZ,LGG,48.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2013.0,nan,-17874.0,Alive,WITH TUMOR,608.0,nan,nan,nan,nan,nan,467.0,Partial Remission/Response,nan,nan,0.0,608.0,0.0,608.0,nan,nan,1.0,467.0,2
TCGA-S9-A7J0-01,TCGA-S9-A7J0,LGG,30.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2013.0,nan,-10989.0,Alive,WITH TUMOR,609.0,nan,nan,nan,nan,nan,390.0,Partial Remission/Response,nan,nan,0.0,609.0,0.0,609.0,nan,nan,1.0,390.0,2
TCGA-S9-A7J1-01,TCGA-S9-A7J1,LGG,43.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2013.0,nan,-15926.0,Alive,WITH TUMOR,249.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,249.0,0.0,249.0,nan,nan,0.0,249.0,0
TCGA-S9-A7J2-01,TCGA-S9-A7J2,LGG,25.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2013.0,nan,-9345.0,Alive,WITH TUMOR,62.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,62.0,0.0,62.0,nan,nan,0.0,62.0,0
TCGA-S9-A7J3-01,TCGA-S9-A7J3,LGG,52.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2013.0,nan,-19056.0,Alive,WITH TUMOR,629.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,629.0,0.0,629.0,nan,nan,0.0,629.0,2
TCGA-S9-A7QW-01,TCGA-S9-A7QW,LGG,54.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2013.0,nan,-19869.0,Alive,WITH TUMOR,458.0,nan,nan,nan,nan,nan,382.0,Complete Remission/Response,nan,nan,0.0,458.0,0.0,458.0,1.0,382.0,1.0,382.0,2
TCGA-S9-A7QX-01,TCGA-S9-A7QX,LGG,36.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2013.0,nan,-13332.0,Alive,WITH TUMOR,564.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,564.0,0.0,564.0,nan,nan,0.0,564.0,2
TCGA-S9-A7QY-01,TCGA-S9-A7QY,LGG,35.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2012.0,nan,-12853.0,Alive,WITH TUMOR,863.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,863.0,0.0,863.0,nan,nan,0.0,863.0,2
TCGA-S9-A7QZ-01,TCGA-S9-A7QZ,LGG,41.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2012.0,nan,-15300.0,Alive,WITH TUMOR,826.0,nan,nan,nan,nan,nan,774.0,Partial Remission/Response,nan,nan,0.0,826.0,0.0,826.0,nan,nan,1.0,774.0,2
TCGA-S9-A7R1-01,TCGA-S9-A7R1,LGG,35.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,1999.0,nan,-12828.0,Dead,WITH TUMOR,nan,5166.0,nan,nan,nan,nan,3637.0,Stable Disease,nan,nan,1.0,5166.0,1.0,5166.0,nan,nan,1.0,3637.0,1
TCGA-S9-A7R2-01,TCGA-S9-A7R2,LGG,69.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2008.0,nan,-25419.0,Dead,WITH TUMOR,nan,316.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,316.0,1.0,316.0,nan,nan,1.0,316.0,1
TCGA-S9-A7R3-01,TCGA-S9-A7R3,LGG,28.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2006.0,nan,-10342.0,Alive,TUMOR FREE,3013.0,nan,nan,nan,nan,nan,970.0,Partial Remission/Response,nan,nan,0.0,3013.0,0.0,3013.0,nan,nan,1.0,970.0,2
TCGA-S9-A7R4-01,TCGA-S9-A7R4,LGG,46.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-17134.0,Alive,WITH TUMOR,914.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,914.0,0.0,914.0,nan,nan,0.0,914.0,0
TCGA-S9-A7R7-01,TCGA-S9-A7R7,LGG,27.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2006.0,nan,-10108.0,Alive,WITH TUMOR,3000.0,nan,nan,nan,nan,nan,144.0,Progressive Disease,nan,nan,0.0,3000.0,0.0,3000.0,nan,nan,1.0,144.0,2
TCGA-S9-A7R8-01,TCGA-S9-A7R8,LGG,44.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2004.0,nan,-16275.0,Dead,WITH TUMOR,nan,961.0,nan,nan,nan,nan,698.0,Progressive Disease,nan,nan,1.0,961.0,1.0,961.0,nan,nan,1.0,698.0,1
TCGA-S9-A89V-01,TCGA-S9-A89V,LGG,70.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-25570.0,Alive,WITH TUMOR,569.0,nan,nan,nan,nan,nan,129.0,Progressive Disease,nan,nan,0.0,569.0,0.0,569.0,nan,nan,1.0,129.0,2
TCGA-S9-A89Z-01,TCGA-S9-A89Z,LGG,40.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2013.0,nan,-14858.0,Alive,WITH TUMOR,623.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,623.0,0.0,623.0,nan,nan,0.0,623.0,0
TCGA-TM-A7C3-01,TCGA-TM-A7C3,LGG,43.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2009.0,nan,-16021.0,Dead,WITH TUMOR,nan,1666.0,nan,nan,nan,nan,713.0,Complete Remission/Response,nan,nan,1.0,1666.0,1.0,1666.0,1.0,713.0,1.0,713.0,1
TCGA-TM-A7C4-01,TCGA-TM-A7C4,LGG,39.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2010.0,nan,-14603.0,Alive,TUMOR FREE,1470.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1470.0,0.0,1470.0,0.0,1470.0,0.0,1470.0,0
TCGA-TM-A7C5-01,TCGA-TM-A7C5,LGG,30.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2010.0,nan,-11286.0,Alive,TUMOR FREE,1500.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1500.0,0.0,1500.0,0.0,1500.0,0.0,1500.0,0
TCGA-TM-A7CA-01,TCGA-TM-A7CA,LGG,44.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2011.0,nan,-16415.0,Alive,TUMOR FREE,1058.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1058.0,0.0,1058.0,0.0,1058.0,0.0,1058.0,0
TCGA-TM-A7CF-02,TCGA-TM-A7CF,LGG,41.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2009.0,nan,-15178.0,Alive,WITH TUMOR,1989.0,nan,nan,nan,nan,nan,924.0,Complete Remission/Response,nan,nan,0.0,1989.0,0.0,1989.0,1.0,924.0,1.0,924.0,2
TCGA-TM-A7CF-01,TCGA-TM-A7CF,LGG,41.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2009.0,nan,-15178.0,Alive,WITH TUMOR,1989.0,nan,nan,nan,nan,nan,924.0,Complete Remission/Response,nan,nan,0.0,1989.0,0.0,1989.0,1.0,924.0,1.0,924.0,2
TCGA-TM-A84B-01,TCGA-TM-A84B,LGG,40.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-14933.0,Dead,WITH TUMOR,nan,758.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,758.0,1.0,758.0,nan,nan,1.0,758.0,1
TCGA-TM-A84C-01,TCGA-TM-A84C,LGG,32.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2012.0,nan,-11849.0,Dead,WITH TUMOR,nan,492.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,492.0,1.0,492.0,nan,nan,1.0,492.0,1
TCGA-TM-A84F-01,TCGA-TM-A84F,LGG,48.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2009.0,nan,-17744.0,Alive,TUMOR FREE,1796.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1796.0,0.0,1796.0,0.0,1796.0,0.0,1796.0,0
TCGA-TM-A84G-01,TCGA-TM-A84G,LGG,54.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2010.0,nan,-20014.0,Alive,TUMOR FREE,1236.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1236.0,0.0,1236.0,0.0,1236.0,0.0,1236.0,0
TCGA-TM-A84H-01,TCGA-TM-A84H,LGG,44.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G3,2012.0,nan,-16277.0,Alive,TUMOR FREE,926.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,926.0,0.0,926.0,0.0,926.0,0.0,926.0,0
TCGA-TM-A84I-01,TCGA-TM-A84I,LGG,30.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-11221.0,Alive,TUMOR FREE,854.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,854.0,0.0,854.0,0.0,854.0,0.0,854.0,0
TCGA-TM-A84J-01,TCGA-TM-A84J,LGG,63.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2012.0,nan,-23091.0,Alive,WITH TUMOR,735.0,nan,nan,nan,nan,nan,454.0,Progressive Disease,nan,nan,0.0,735.0,0.0,735.0,nan,nan,1.0,454.0,0
TCGA-TM-A84L-01,TCGA-TM-A84L,LGG,31.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2010.0,nan,-11498.0,Dead,WITH TUMOR,nan,1242.0,nan,nan,nan,nan,987.0,Complete Remission/Response,nan,nan,1.0,1242.0,1.0,1242.0,1.0,987.0,1.0,987.0,1
TCGA-TM-A84M-01,TCGA-TM-A84M,LGG,40.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2012.0,nan,-14660.0,Alive,TUMOR FREE,754.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,754.0,0.0,754.0,0.0,754.0,0.0,754.0,0
TCGA-TM-A84O-01,TCGA-TM-A84O,LGG,61.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2011.0,nan,-22327.0,Dead,WITH TUMOR,nan,1011.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1011.0,1.0,1011.0,nan,nan,1.0,1011.0,1
TCGA-TM-A84Q-01,TCGA-TM-A84Q,LGG,31.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2012.0,nan,-11668.0,Alive,TUMOR FREE,772.0,nan,nan,nan,nan,nan,455.0,Complete Remission/Response,nan,nan,0.0,772.0,0.0,772.0,1.0,455.0,1.0,455.0,2
TCGA-TM-A84R-01,TCGA-TM-A84R,LGG,46.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2012.0,nan,-16843.0,Alive,TUMOR FREE,566.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,566.0,0.0,566.0,0.0,566.0,0.0,566.0,0
TCGA-TM-A84S-01,TCGA-TM-A84S,LGG,36.0,MALE,WHITE,nan,nan,Oligodendroglioma,G3,2013.0,nan,-13424.0,Alive,TUMOR FREE,454.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,454.0,0.0,454.0,0.0,454.0,0.0,454.0,0
TCGA-TM-A84T-01,TCGA-TM-A84T,LGG,19.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2012.0,nan,-6994.0,Alive,WITH TUMOR,724.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,724.0,0.0,724.0,nan,nan,0.0,724.0,0
TCGA-TQ-A7RF-01,TCGA-TQ-A7RF,LGG,27.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G3,2012.0,nan,-9919.0,Alive,WITH TUMOR,650.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,650.0,0.0,650.0,nan,nan,0.0,650.0,2
TCGA-TQ-A7RG-01,TCGA-TQ-A7RG,LGG,36.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2012.0,nan,-13227.0,Alive,WITH TUMOR,599.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,599.0,0.0,599.0,nan,nan,0.0,599.0,0
TCGA-TQ-A7RH-01,TCGA-TQ-A7RH,LGG,39.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Oligoastrocytoma,G2,2013.0,nan,-14524.0,Alive,WITH TUMOR,486.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,486.0,0.0,486.0,nan,nan,0.0,486.0,0
TCGA-TQ-A7RI-01,TCGA-TQ-A7RI,LGG,37.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2012.0,nan,-13799.0,Alive,TUMOR FREE,62.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,62.0,0.0,62.0,nan,nan,0.0,62.0,0
TCGA-TQ-A7RJ-01,TCGA-TQ-A7RJ,LGG,25.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2011.0,nan,-9209.0,Alive,WITH TUMOR,1229.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1229.0,0.0,1229.0,nan,nan,0.0,1229.0,2
TCGA-TQ-A7RK-02,TCGA-TQ-A7RK,LGG,29.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2010.0,nan,-10742.0,Alive,TUMOR FREE,1341.0,nan,nan,nan,nan,nan,858.0,Complete Remission/Response,nan,nan,0.0,1341.0,0.0,1341.0,1.0,858.0,1.0,858.0,2
TCGA-TQ-A7RK-01,TCGA-TQ-A7RK,LGG,29.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2010.0,nan,-10742.0,Alive,TUMOR FREE,1341.0,nan,nan,nan,nan,nan,858.0,Complete Remission/Response,nan,nan,0.0,1341.0,0.0,1341.0,1.0,858.0,1.0,858.0,2
TCGA-TQ-A7RM-01,TCGA-TQ-A7RM,LGG,41.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G3,2011.0,nan,-15154.0,Alive,WITH TUMOR,1116.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,1116.0,0.0,1116.0,nan,nan,0.0,1116.0,0
TCGA-TQ-A7RN-01,TCGA-TQ-A7RN,LGG,32.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2011.0,nan,-11823.0,Alive,WITH TUMOR,1026.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,1026.0,0.0,1026.0,nan,nan,0.0,1026.0,0
TCGA-TQ-A7RO-01,TCGA-TQ-A7RO,LGG,29.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Oligoastrocytoma,G2,2011.0,nan,-10890.0,Alive,WITH TUMOR,949.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,949.0,0.0,949.0,nan,nan,0.0,949.0,0
TCGA-TQ-A7RP-01,TCGA-TQ-A7RP,LGG,66.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Oligoastrocytoma,G2,2012.0,nan,-24109.0,Alive,WITH TUMOR,914.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,914.0,0.0,914.0,nan,nan,0.0,914.0,0
TCGA-TQ-A7RQ-01,TCGA-TQ-A7RQ,LGG,38.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2012.0,nan,-14187.0,Alive,TUMOR FREE,795.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,795.0,0.0,795.0,0.0,795.0,0.0,795.0,0
TCGA-TQ-A7RR-01,TCGA-TQ-A7RR,LGG,38.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2012.0,nan,-14022.0,Alive,TUMOR FREE,787.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,787.0,0.0,787.0,nan,nan,0.0,787.0,0
TCGA-TQ-A7RS-01,TCGA-TQ-A7RS,LGG,25.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2012.0,nan,-9172.0,Alive,TUMOR FREE,-1.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0
TCGA-TQ-A7RU-01,TCGA-TQ-A7RU,LGG,51.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2011.0,nan,-18990.0,Alive,WITH TUMOR,1032.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,1032.0,0.0,1032.0,nan,nan,0.0,1032.0,0
TCGA-TQ-A7RV-02,TCGA-TQ-A7RV,LGG,27.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2009.0,nan,-10167.0,Alive,WITH TUMOR,1868.0,nan,nan,nan,nan,nan,530.0,Partial Remission/Response,nan,nan,0.0,1868.0,0.0,1868.0,nan,nan,1.0,530.0,2
TCGA-TQ-A7RV-01,TCGA-TQ-A7RV,LGG,27.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2009.0,nan,-10167.0,Alive,WITH TUMOR,1868.0,nan,nan,nan,nan,nan,530.0,Partial Remission/Response,nan,nan,0.0,1868.0,0.0,1868.0,nan,nan,1.0,530.0,2
TCGA-TQ-A7RW-01,TCGA-TQ-A7RW,LGG,32.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2010.0,nan,-11804.0,Dead,WITH TUMOR,nan,821.0,nan,nan,nan,nan,511.0,Progressive Disease,nan,nan,1.0,821.0,1.0,821.0,nan,nan,1.0,511.0,1
TCGA-TQ-A8XE-02,TCGA-TQ-A8XE,LGG,42.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2010.0,nan,-15629.0,Dead,WITH TUMOR,nan,954.0,nan,nan,nan,nan,455.0,Partial Remission/Response,nan,nan,1.0,954.0,1.0,954.0,nan,nan,1.0,455.0,1
TCGA-TQ-A8XE-01,TCGA-TQ-A8XE,LGG,42.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2010.0,nan,-15629.0,Dead,WITH TUMOR,nan,954.0,nan,nan,nan,nan,455.0,Partial Remission/Response,nan,nan,1.0,954.0,1.0,954.0,nan,nan,1.0,455.0,1
TCGA-VM-A8C8-01,TCGA-VM-A8C8,LGG,50.0,FEMALE,WHITE,nan,nan,Oligodendroglioma,G2,2011.0,nan,-18494.0,Alive,nan,1397.0,nan,nan,nan,nan,nan,456.0,[Unknown],nan,nan,0.0,1397.0,0.0,1397.0,nan,nan,1.0,456.0,2
TCGA-VM-A8C9-01,TCGA-VM-A8C9,LGG,37.0,FEMALE,[Not Evaluated],nan,nan,Astrocytoma,G2,2011.0,nan,-13663.0,Alive,TUMOR FREE,1314.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1314.0,0.0,1314.0,0.0,1314.0,0.0,1314.0,0
TCGA-VM-A8CA-01,TCGA-VM-A8CA,LGG,54.0,MALE,[Unknown],nan,nan,Oligodendroglioma,G2,2011.0,nan,-19991.0,Alive,WITH TUMOR,411.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,411.0,0.0,411.0,nan,nan,0.0,411.0,0
TCGA-VM-A8CB-01,TCGA-VM-A8CB,LGG,33.0,MALE,[Unknown],nan,nan,Oligodendroglioma,G3,2011.0,nan,-12340.0,Alive,TUMOR FREE,3.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,3.0,0.0,3.0,nan,nan,0.0,3.0,0
TCGA-VM-A8CD-01,TCGA-VM-A8CD,LGG,58.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2012.0,nan,-21200.0,Dead,WITH TUMOR,nan,240.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,240.0,1.0,240.0,nan,nan,1.0,240.0,1
TCGA-VM-A8CE-01,TCGA-VM-A8CE,LGG,25.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2011.0,nan,-9363.0,Alive,WITH TUMOR,1191.0,nan,nan,nan,nan,nan,815.0,[Unknown],nan,nan,0.0,1191.0,0.0,1191.0,nan,nan,1.0,815.0,2
TCGA-VM-A8CF-01,TCGA-VM-A8CF,LGG,44.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2013.0,nan,-16334.0,Alive,TUMOR FREE,609.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,609.0,0.0,609.0,nan,nan,0.0,609.0,0
TCGA-VM-A8CH-01,TCGA-VM-A8CH,LGG,24.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2013.0,nan,-9005.0,Alive,TUMOR FREE,714.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,714.0,0.0,714.0,0.0,714.0,0.0,714.0,0
TCGA-VV-A829-01,TCGA-VV-A829,LGG,44.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G3,2011.0,nan,-16163.0,Alive,TUMOR FREE,1127.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1127.0,0.0,1127.0,nan,nan,0.0,1127.0,0
TCGA-VV-A86M-01,TCGA-VV-A86M,LGG,36.0,FEMALE,[Not Evaluated],nan,nan,Astrocytoma,G3,2013.0,nan,-13453.0,Alive,TUMOR FREE,487.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,487.0,0.0,487.0,nan,nan,0.0,487.0,0
TCGA-VW-A7QS-01,TCGA-VW-A7QS,LGG,35.0,FEMALE,ASIAN,nan,nan,Oligodendroglioma,G3,2011.0,nan,-12820.0,Alive,WITH TUMOR,706.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,706.0,0.0,706.0,nan,nan,0.0,706.0,0
TCGA-VW-A8FI-01,TCGA-VW-A8FI,LGG,66.0,MALE,WHITE,nan,nan,Astrocytoma,G3,2013.0,nan,-24411.0,Dead,WITH TUMOR,nan,245.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,245.0,1.0,245.0,nan,nan,1.0,245.0,1
TCGA-W9-A837-01,TCGA-W9-A837,LGG,47.0,MALE,WHITE,nan,nan,Oligodendroglioma,G2,2010.0,nan,nan,Alive,WITH TUMOR,1553.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1553.0,0.0,1553.0,nan,nan,0.0,1553.0,0
TCGA-WH-A86K-01,TCGA-WH-A86K,LGG,65.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2013.0,nan,-24055.0,Alive,WITH TUMOR,405.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,405.0,0.0,405.0,nan,nan,0.0,405.0,2
TCGA-WY-A858-01,TCGA-WY-A858,LGG,32.0,FEMALE,WHITE,nan,nan,Astrocytoma,G3,2010.0,nan,-11855.0,Alive,TUMOR FREE,1337.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1337.0,0.0,1337.0,0.0,1337.0,0.0,1337.0,0
TCGA-WY-A859-01,TCGA-WY-A859,LGG,34.0,FEMALE,WHITE,nan,nan,Astrocytoma,G2,2010.0,nan,-12631.0,Alive,WITH TUMOR,1213.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1213.0,0.0,1213.0,nan,nan,0.0,1213.0,2
TCGA-WY-A85A-01,TCGA-WY-A85A,LGG,20.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2010.0,nan,-7380.0,Alive,TUMOR FREE,1320.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,1320.0,0.0,1320.0,nan,nan,0.0,1320.0,0
TCGA-WY-A85B-01,TCGA-WY-A85B,LGG,24.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2010.0,nan,-8817.0,Alive,TUMOR FREE,1393.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1393.0,0.0,1393.0,0.0,1393.0,0.0,1393.0,0
TCGA-WY-A85C-01,TCGA-WY-A85C,LGG,36.0,MALE,WHITE,nan,nan,Astrocytoma,G2,2010.0,nan,-13506.0,Alive,WITH TUMOR,1426.0,nan,nan,nan,nan,nan,809.0,Progressive Disease,nan,nan,0.0,1426.0,0.0,1426.0,nan,nan,1.0,809.0,2
TCGA-WY-A85D-01,TCGA-WY-A85D,LGG,60.0,MALE,WHITE,nan,nan,Oligoastrocytoma,G2,2010.0,nan,-21979.0,Alive,WITH TUMOR,1147.0,nan,nan,nan,nan,nan,887.0,Partial Remission/Response,nan,nan,0.0,1147.0,0.0,1147.0,nan,nan,1.0,887.0,2
TCGA-WY-A85E-01,TCGA-WY-A85E,LGG,48.0,FEMALE,WHITE,nan,nan,Oligoastrocytoma,G2,2011.0,nan,-17878.0,Alive,WITH TUMOR,633.0,nan,nan,nan,nan,nan,532.0,Partial Remission/Response,nan,nan,0.0,633.0,0.0,633.0,nan,nan,1.0,532.0,2
TCGA-2V-A95S-01,TCGA-2V-A95S,LIHC,nan,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G3,nan,nan,nan,Alive,WITH TUMOR,nan,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,nan,0.0,nan,0.0,nan,0.0,nan,0
TCGA-2Y-A9GS-01,TCGA-2Y-A9GS,LIHC,58.0,MALE,WHITE,[Discrepancy],nan,Hepatocellular Carcinoma,G2,2006.0,nan,-21318.0,Dead,WITH TUMOR,nan,724.0,nan,Extrahepatic Recurrence,Lung,nan,102.0,nan,nan,R0,1.0,724.0,1.0,724.0,1.0,102.0,1.0,102.0,1
TCGA-2Y-A9GT-01,TCGA-2Y-A9GT,LIHC,51.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2006.0,nan,-18768.0,Dead,WITH TUMOR,nan,1624.0,nan,Locoregional Recurrence,Liver,nan,1083.0,nan,nan,R0,1.0,1624.0,1.0,1624.0,1.0,1083.0,1.0,1083.0,1
TCGA-2Y-A9GU-01,TCGA-2Y-A9GU,LIHC,55.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2009.0,nan,-20187.0,Alive,TUMOR FREE,1939.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1939.0,0.0,1939.0,0.0,1939.0,0.0,1939.0,0
TCGA-2Y-A9GV-01,TCGA-2Y-A9GV,LIHC,54.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G1,2007.0,nan,-20011.0,Dead,WITH TUMOR,nan,2532.0,nan,New Primary Tumor,"Other, specify",Renal met from prior lung primary,1745.0,nan,nan,R0,1.0,2532.0,1.0,2532.0,0.0,2532.0,1.0,1745.0,1
TCGA-2Y-A9GW-01,TCGA-2Y-A9GW,LIHC,64.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2007.0,nan,-23587.0,Dead,WITH TUMOR,nan,1271.0,nan,Locoregional Recurrence,Liver,nan,1229.0,nan,nan,R0,1.0,1271.0,1.0,1271.0,1.0,1229.0,1.0,1229.0,1
TCGA-2Y-A9GX-01,TCGA-2Y-A9GX,LIHC,68.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2007.0,nan,-24963.0,Alive,WITH TUMOR,2442.0,nan,nan,Locoregional Recurrence,Liver,nan,2133.0,nan,nan,R1,0.0,2442.0,0.0,2442.0,nan,nan,1.0,2133.0,2
TCGA-2Y-A9GY-01,TCGA-2Y-A9GY,LIHC,64.0,FEMALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G3,2007.0,nan,-23435.0,Dead,WITH TUMOR,nan,757.0,nan,Extrahepatic Recurrence,Lung,nan,637.0,nan,nan,R0,1.0,757.0,1.0,757.0,1.0,637.0,1.0,637.0,1
TCGA-2Y-A9GZ-01,TCGA-2Y-A9GZ,LIHC,82.0,FEMALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2007.0,nan,-30082.0,Dead,WITH TUMOR,nan,848.0,nan,Locoregional Recurrence,Liver,nan,719.0,nan,nan,R0,1.0,848.0,1.0,848.0,1.0,719.0,1.0,719.0,1
TCGA-2Y-A9H0-01,TCGA-2Y-A9H0,LIHC,49.0,MALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G1,2004.0,nan,-18109.0,Alive,TUMOR FREE,3675.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,3675.0,0.0,3675.0,0.0,3675.0,0.0,3675.0,0
TCGA-2Y-A9H1-01,TCGA-2Y-A9H1,LIHC,58.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2010.0,nan,-21222.0,Dead,WITH TUMOR,nan,1229.0,nan,Locoregional Recurrence,Liver,nan,321.0,nan,nan,R0,1.0,1229.0,1.0,1229.0,1.0,321.0,1.0,321.0,1
TCGA-2Y-A9H2-01,TCGA-2Y-A9H2,LIHC,64.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G3,2010.0,nan,-23653.0,Alive,TUMOR FREE,1731.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1731.0,0.0,1731.0,0.0,1731.0,0.0,1731.0,0
TCGA-2Y-A9H3-01,TCGA-2Y-A9H3,LIHC,45.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G1,2010.0,nan,-16443.0,Alive,TUMOR FREE,1516.0,nan,nan,Locoregional Recurrence,Liver,nan,22.0,nan,nan,R0,0.0,1516.0,0.0,1516.0,1.0,22.0,1.0,22.0,0
TCGA-2Y-A9H4-01,TCGA-2Y-A9H4,LIHC,68.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Hepatocellular Carcinoma,G2,2010.0,nan,-25096.0,Alive,TUMOR FREE,1452.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1452.0,0.0,1452.0,0.0,1452.0,0.0,1452.0,0
TCGA-2Y-A9H5-01,TCGA-2Y-A9H5,LIHC,59.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G3,2010.0,nan,-21818.0,Dead,WITH TUMOR,nan,555.0,nan,Locoregional Recurrence,Liver,nan,258.0,nan,nan,R0,1.0,555.0,1.0,555.0,1.0,258.0,1.0,258.0,1
TCGA-2Y-A9H6-01,TCGA-2Y-A9H6,LIHC,68.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-24982.0,Alive,nan,357.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,357.0,0.0,357.0,0.0,357.0,0.0,357.0,0
TCGA-2Y-A9H7-01,TCGA-2Y-A9H7,LIHC,81.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-29752.0,Alive,WITH TUMOR,1168.0,nan,nan,Locoregional Recurrence,Liver,nan,1117.0,nan,nan,R0,0.0,1168.0,0.0,1168.0,1.0,1117.0,1.0,1117.0,2
TCGA-2Y-A9H8-01,TCGA-2Y-A9H8,LIHC,85.0,FEMALE,WHITE,[Discrepancy],nan,Hepatocellular Carcinoma,G2,2011.0,nan,-31322.0,Dead,WITH TUMOR,nan,633.0,nan,Extrahepatic Recurrence,"Other, specify",Kidney,398.0,nan,nan,R0,1.0,633.0,1.0,633.0,1.0,398.0,1.0,398.0,1
TCGA-2Y-A9H9-01,TCGA-2Y-A9H9,LIHC,70.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-25670.0,Alive,WITH TUMOR,697.0,nan,nan,Locoregional Recurrence,Liver,nan,59.0,nan,nan,R0,0.0,697.0,0.0,697.0,1.0,59.0,1.0,59.0,2
TCGA-2Y-A9HA-01,TCGA-2Y-A9HA,LIHC,70.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-25892.0,Dead,WITH TUMOR,nan,36.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,36.0,1.0,36.0,nan,nan,1.0,36.0,1
TCGA-2Y-A9HB-01,TCGA-2Y-A9HB,LIHC,66.0,MALE,[Not Evaluated],Stage I,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-24359.0,Alive,TUMOR FREE,260.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,260.0,0.0,260.0,0.0,260.0,0.0,260.0,0
TCGA-3K-AAZ8-01,TCGA-3K-AAZ8,LIHC,65.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,nan,Hepatocellular Carcinoma,G1,2013.0,nan,-24046.0,Alive,WITH TUMOR,396.0,nan,nan,Locoregional Recurrence,Liver,nan,151.0,nan,nan,RX,0.0,396.0,0.0,396.0,nan,nan,1.0,151.0,2
TCGA-4R-AA8I-01,TCGA-4R-AA8I,LIHC,66.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-24279.0,Dead,WITH TUMOR,nan,262.0,nan,Locoregional Recurrence,Liver,nan,158.0,nan,nan,R0,1.0,262.0,1.0,262.0,1.0,158.0,1.0,158.0,1
TCGA-5C-A9VG-01,TCGA-5C-A9VG,LIHC,58.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-21273.0,Alive,TUMOR FREE,328.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,328.0,0.0,328.0,0.0,328.0,0.0,328.0,0
TCGA-5C-A9VH-01,TCGA-5C-A9VH,LIHC,70.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-25608.0,Alive,TUMOR FREE,322.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,322.0,0.0,322.0,0.0,322.0,0.0,322.0,0
TCGA-5C-AAPD-01,TCGA-5C-AAPD,LIHC,61.0,MALE,ASIAN,Stage II,nan,Hepatocholangiocarcinoma (Mixed),G1,2013.0,nan,-22552.0,Alive,TUMOR FREE,20.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,20.0,0.0,20.0,0.0,20.0,0.0,20.0,0
TCGA-5R-AA1C-01,TCGA-5R-AA1C,LIHC,57.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-21073.0,Alive,TUMOR FREE,520.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,520.0,0.0,520.0,0.0,520.0,0.0,520.0,0
TCGA-5R-AA1D-01,TCGA-5R-AA1D,LIHC,17.0,FEMALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-6545.0,Alive,TUMOR FREE,449.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,449.0,0.0,449.0,0.0,449.0,0.0,449.0,0
TCGA-5R-AAAM-01,TCGA-5R-AAAM,LIHC,65.0,FEMALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-24020.0,Dead,TUMOR FREE,nan,46.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,46.0,0.0,46.0,0.0,46.0,0.0,46.0,0
TCGA-BC-4072-01,TCGA-BC-4072,LIHC,74.0,FEMALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2005.0,nan,-27162.0,Dead,WITH TUMOR,nan,1490.0,nan,Extrahepatic Recurrence,Lymph Node(s),nan,475.0,nan,nan,R1,1.0,1490.0,1.0,1490.0,nan,nan,1.0,475.0,1
TCGA-BC-4073-01,TCGA-BC-4073,LIHC,73.0,MALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2009.0,nan,-26795.0,Alive,WITH TUMOR,849.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,849.0,0.0,849.0,nan,nan,0.0,849.0,0
TCGA-BC-A10Q-01,TCGA-BC-A10Q,LIHC,72.0,FEMALE,WHITE,nan,nan,Hepatocellular Carcinoma,nan,1998.0,nan,-26400.0,Dead,WITH TUMOR,nan,1135.0,nan,Intrahepatic Recurrence,nan,nan,340.0,nan,nan,R1,1.0,1135.0,1.0,1135.0,nan,nan,1.0,340.0,1
TCGA-BC-A10Q-11,TCGA-BC-A10Q,LIHC,72.0,FEMALE,WHITE,nan,nan,Hepatocellular Carcinoma,nan,1998.0,nan,-26400.0,Dead,WITH TUMOR,nan,1135.0,nan,Intrahepatic Recurrence,nan,nan,340.0,nan,nan,R1,1.0,1135.0,1.0,1135.0,nan,nan,1.0,340.0,1
TCGA-BC-A10R-01,TCGA-BC-A10R,LIHC,66.0,FEMALE,WHITE,nan,nan,Hepatocellular Carcinoma,G2,1999.0,nan,-24274.0,Dead,WITH TUMOR,nan,308.0,nan,Intrahepatic Recurrence,nan,nan,199.0,nan,nan,R0,1.0,308.0,1.0,308.0,1.0,199.0,1.0,199.0,1
TCGA-BC-A10R-11,TCGA-BC-A10R,LIHC,66.0,FEMALE,WHITE,nan,nan,Hepatocellular Carcinoma,G2,1999.0,nan,-24274.0,Dead,WITH TUMOR,nan,308.0,nan,Intrahepatic Recurrence,nan,nan,199.0,nan,nan,R0,1.0,308.0,1.0,308.0,1.0,199.0,1.0,199.0,1
TCGA-BC-A10S-01,TCGA-BC-A10S,LIHC,81.0,MALE,WHITE,nan,nan,Hepatocellular Carcinoma,G1,1999.0,nan,-29842.0,Dead,WITH TUMOR,nan,1423.0,nan,Intrahepatic Recurrence,nan,nan,1130.0,nan,nan,R0,1.0,1423.0,1.0,1423.0,1.0,1130.0,1.0,1130.0,1
TCGA-BC-A10S-11,TCGA-BC-A10S,LIHC,81.0,MALE,WHITE,nan,nan,Hepatocellular Carcinoma,G1,1999.0,nan,-29842.0,Dead,WITH TUMOR,nan,1423.0,nan,Intrahepatic Recurrence,nan,nan,1130.0,nan,nan,R0,1.0,1423.0,1.0,1423.0,1.0,1130.0,1.0,1130.0,1
TCGA-BC-A10T-01,TCGA-BC-A10T,LIHC,76.0,MALE,WHITE,nan,nan,Hepatocellular Carcinoma,G1,2000.0,nan,-27944.0,Dead,WITH TUMOR,nan,837.0,nan,Extrahepatic Recurrence,Pulmonary,nan,598.0,nan,nan,R1,1.0,837.0,1.0,837.0,nan,nan,1.0,598.0,1
TCGA-BC-A10T-11,TCGA-BC-A10T,LIHC,76.0,MALE,WHITE,nan,nan,Hepatocellular Carcinoma,G1,2000.0,nan,-27944.0,Dead,WITH TUMOR,nan,837.0,nan,Extrahepatic Recurrence,Pulmonary,nan,598.0,nan,nan,R1,1.0,837.0,1.0,837.0,nan,nan,1.0,598.0,1
TCGA-BC-A10U-01,TCGA-BC-A10U,LIHC,69.0,MALE,WHITE,nan,nan,Hepatocellular Carcinoma,G2,2000.0,nan,-25305.0,Dead,WITH TUMOR,nan,837.0,nan,Intrahepatic Recurrence,nan,nan,586.0,nan,nan,R1,1.0,837.0,1.0,837.0,nan,nan,1.0,586.0,1
TCGA-BC-A10U-11,TCGA-BC-A10U,LIHC,69.0,MALE,WHITE,nan,nan,Hepatocellular Carcinoma,G2,2000.0,nan,-25305.0,Dead,WITH TUMOR,nan,837.0,nan,Intrahepatic Recurrence,nan,nan,586.0,nan,nan,R1,1.0,837.0,1.0,837.0,nan,nan,1.0,586.0,1
TCGA-BC-A10W-01,TCGA-BC-A10W,LIHC,50.0,MALE,ASIAN,nan,nan,Hepatocellular Carcinoma,G3,2002.0,nan,-18562.0,Dead,WITH TUMOR,nan,91.0,nan,nan,nan,nan,nan,nan,nan,R1,1.0,91.0,1.0,91.0,nan,nan,1.0,91.0,1
TCGA-BC-A10W-11,TCGA-BC-A10W,LIHC,50.0,MALE,ASIAN,nan,nan,Hepatocellular Carcinoma,G3,2002.0,nan,-18562.0,Dead,WITH TUMOR,nan,91.0,nan,nan,nan,nan,nan,nan,nan,R1,1.0,91.0,1.0,91.0,nan,nan,1.0,91.0,1
TCGA-BC-A10X-01,TCGA-BC-A10X,LIHC,52.0,FEMALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2002.0,nan,-19140.0,Dead,TUMOR FREE,nan,770.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,770.0,0.0,770.0,0.0,770.0,0.0,770.0,0
TCGA-BC-A10X-11,TCGA-BC-A10X,LIHC,52.0,FEMALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2002.0,nan,-19140.0,Dead,TUMOR FREE,nan,770.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,770.0,0.0,770.0,0.0,770.0,0.0,770.0,0
TCGA-BC-A10Y-01,TCGA-BC-A10Y,LIHC,76.0,MALE,WHITE,nan,nan,Hepatocellular Carcinoma,G3,2002.0,nan,-28049.0,Dead,WITH TUMOR,nan,711.0,nan,Intrahepatic Recurrence,nan,nan,400.0,nan,nan,R0,1.0,711.0,1.0,711.0,1.0,400.0,1.0,400.0,1
TCGA-BC-A10Y-11,TCGA-BC-A10Y,LIHC,76.0,MALE,WHITE,nan,nan,Hepatocellular Carcinoma,G3,2002.0,nan,-28049.0,Dead,WITH TUMOR,nan,711.0,nan,Intrahepatic Recurrence,nan,nan,400.0,nan,nan,R0,1.0,711.0,1.0,711.0,1.0,400.0,1.0,400.0,1
TCGA-BC-A10Z-01,TCGA-BC-A10Z,LIHC,62.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2003.0,nan,-22913.0,Dead,TUMOR FREE,nan,34.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,34.0,0.0,34.0,0.0,34.0,0.0,34.0,0
TCGA-BC-A10Z-11,TCGA-BC-A10Z,LIHC,62.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2003.0,nan,-22913.0,Dead,TUMOR FREE,nan,34.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,34.0,0.0,34.0,0.0,34.0,0.0,34.0,0
TCGA-BC-A110-01,TCGA-BC-A110,LIHC,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Hepatocellular Carcinoma,G1,2003.0,nan,-18951.0,Dead,WITH TUMOR,nan,2116.0,nan,Extrahepatic Recurrence,"Other, specify",spleen,2057.0,nan,nan,R0,1.0,2116.0,1.0,2116.0,1.0,2057.0,1.0,2057.0,1
TCGA-BC-A110-11,TCGA-BC-A110,LIHC,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Hepatocellular Carcinoma,G1,2003.0,nan,-18951.0,Dead,WITH TUMOR,nan,2116.0,nan,Extrahepatic Recurrence,"Other, specify",spleen,2057.0,nan,nan,R0,1.0,2116.0,1.0,2116.0,1.0,2057.0,1.0,2057.0,1
TCGA-BC-A112-01,TCGA-BC-A112,LIHC,80.0,MALE,WHITE,nan,nan,Hepatocellular Carcinoma,G2,2009.0,nan,-29511.0,Dead,TUMOR FREE,nan,153.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,153.0,0.0,153.0,0.0,153.0,0.0,153.0,0
TCGA-BC-A112-11,TCGA-BC-A112,LIHC,80.0,MALE,WHITE,nan,nan,Hepatocellular Carcinoma,G2,2009.0,nan,-29511.0,Dead,TUMOR FREE,nan,153.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,153.0,0.0,153.0,0.0,153.0,0.0,153.0,0
TCGA-BC-A216-01,TCGA-BC-A216,LIHC,62.0,FEMALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2008.0,nan,-22968.0,Alive,TUMOR FREE,1351.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1351.0,0.0,1351.0,0.0,1351.0,0.0,1351.0,0
TCGA-BC-A216-11,TCGA-BC-A216,LIHC,62.0,FEMALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2008.0,nan,-22968.0,Alive,TUMOR FREE,1351.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1351.0,0.0,1351.0,0.0,1351.0,0.0,1351.0,0
TCGA-BC-A217-01,TCGA-BC-A217,LIHC,75.0,FEMALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G3,2010.0,nan,-27411.0,Dead,TUMOR FREE,nan,1397.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,1397.0,0.0,1397.0,0.0,1397.0,0.0,1397.0,0
TCGA-BC-A3KF-01,TCGA-BC-A3KF,LIHC,66.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-24328.0,Alive,TUMOR FREE,8.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,8.0,0.0,8.0,0.0,8.0,0.0,8.0,0
TCGA-BC-A3KG-01,TCGA-BC-A3KG,LIHC,68.0,FEMALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G3,2011.0,nan,-25061.0,Alive,WITH TUMOR,680.0,nan,nan,Intrahepatic Recurrence,Liver,nan,209.0,nan,nan,R0,0.0,680.0,0.0,680.0,1.0,209.0,1.0,209.0,2
TCGA-BC-A5W4-01,TCGA-BC-A5W4,LIHC,69.0,MALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2012.0,nan,-25503.0,Dead,TUMOR FREE,nan,547.0,nan,Locoregional Recurrence,nan,nan,384.0,nan,nan,R1,1.0,547.0,0.0,547.0,nan,nan,1.0,384.0,1
TCGA-BC-A69H-01,TCGA-BC-A69H,LIHC,64.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-23380.0,Alive,TUMOR FREE,444.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,444.0,0.0,444.0,0.0,444.0,0.0,444.0,0
TCGA-BC-A69I-01,TCGA-BC-A69I,LIHC,69.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G1,2013.0,nan,-25370.0,Alive,TUMOR FREE,387.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,387.0,0.0,387.0,0.0,387.0,0.0,387.0,0
TCGA-BC-A8YO-01,TCGA-BC-A8YO,LIHC,66.0,FEMALE,WHITE,Stage IIIC,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-24189.0,Alive,WITH TUMOR,562.0,nan,nan,Locoregional Recurrence,Liver,nan,220.0,nan,nan,R0,0.0,562.0,0.0,562.0,1.0,220.0,1.0,220.0,2
TCGA-BD-A2L6-01,TCGA-BD-A2L6,LIHC,69.0,MALE,WHITE,nan,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-25489.0,Alive,WITH TUMOR,1363.0,nan,nan,Intrahepatic Recurrence,Liver,nan,415.0,nan,nan,R0,0.0,1363.0,0.0,1363.0,1.0,415.0,1.0,415.0,2
TCGA-BD-A2L6-11,TCGA-BD-A2L6,LIHC,69.0,MALE,WHITE,nan,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-25489.0,Alive,WITH TUMOR,1363.0,nan,nan,Intrahepatic Recurrence,Liver,nan,415.0,nan,nan,R0,0.0,1363.0,0.0,1363.0,1.0,415.0,1.0,415.0,2
TCGA-BD-A3EP-01,TCGA-BD-A3EP,LIHC,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Hepatocellular Carcinoma,G2,2010.0,nan,-27756.0,Alive,TUMOR FREE,409.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,409.0,0.0,409.0,0.0,409.0,0.0,409.0,0
TCGA-BD-A3EP-11,TCGA-BD-A3EP,LIHC,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Hepatocellular Carcinoma,G2,2010.0,nan,-27756.0,Alive,TUMOR FREE,409.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,409.0,0.0,409.0,0.0,409.0,0.0,409.0,0
TCGA-BD-A3ER-01,TCGA-BD-A3ER,LIHC,62.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-22657.0,Alive,WITH TUMOR,1115.0,nan,nan,Locoregional Recurrence,Liver,nan,226.0,nan,nan,R0,0.0,1115.0,0.0,1115.0,1.0,226.0,1.0,226.0,2
TCGA-BW-A5NO-01,TCGA-BW-A5NO,LIHC,50.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2010.0,nan,-18510.0,Alive,TUMOR FREE,20.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,20.0,0.0,20.0,nan,nan,0.0,20.0,0
TCGA-BW-A5NP-01,TCGA-BW-A5NP,LIHC,26.0,FEMALE,WHITE,Stage IV,nan,Hepatocellular Carcinoma,G3,2010.0,nan,-9809.0,Alive,WITH TUMOR,0.0,nan,nan,Extrahepatic Recurrence,Liver,nan,102.0,nan,nan,RX,0.0,0.0,0.0,0.0,nan,nan,1.0,102.0,0
TCGA-BW-A5NQ-01,TCGA-BW-A5NQ,LIHC,63.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G3,2010.0,nan,-23353.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-CC-5258-01,TCGA-CC-5258,LIHC,48.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G2,2010.0,nan,-17586.0,Dead,TUMOR FREE,nan,129.0,nan,nan,nan,nan,nan,nan,nan,RX,1.0,129.0,0.0,129.0,nan,nan,0.0,129.0,0
TCGA-CC-5259-01,TCGA-CC-5259,LIHC,60.0,FEMALE,ASIAN,Stage IIIC,nan,Hepatocellular Carcinoma,G2,2010.0,nan,-21946.0,Alive,WITH TUMOR,250.0,nan,nan,Locoregional Recurrence,Liver,nan,180.0,nan,nan,R0,0.0,250.0,0.0,250.0,1.0,180.0,1.0,180.0,2
TCGA-CC-5260-01,TCGA-CC-5260,LIHC,61.0,FEMALE,ASIAN,Stage IIIC,nan,Hepatocellular Carcinoma,G1,2010.0,nan,-22345.0,Dead,TUMOR FREE,nan,87.0,nan,nan,nan,nan,nan,nan,nan,RX,1.0,87.0,0.0,87.0,nan,nan,0.0,87.0,1
TCGA-CC-5261-01,TCGA-CC-5261,LIHC,44.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G2,2010.0,nan,-16373.0,Dead,TUMOR FREE,nan,97.0,nan,nan,nan,nan,nan,nan,nan,RX,1.0,97.0,0.0,97.0,nan,nan,0.0,97.0,0
TCGA-CC-5262-01,TCGA-CC-5262,LIHC,67.0,MALE,ASIAN,Stage IIIC,nan,Hepatocellular Carcinoma,G1,2010.0,nan,-24787.0,Dead,TUMOR FREE,nan,103.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,103.0,0.0,103.0,nan,nan,0.0,103.0,0
TCGA-CC-5263-01,TCGA-CC-5263,LIHC,35.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G1,2010.0,nan,-12863.0,Dead,TUMOR FREE,nan,129.0,nan,nan,nan,nan,nan,nan,nan,RX,1.0,129.0,0.0,129.0,nan,nan,0.0,129.0,0
TCGA-CC-5264-01,TCGA-CC-5264,LIHC,71.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2010.0,nan,-25979.0,Dead,TUMOR FREE,nan,102.0,nan,nan,nan,nan,nan,nan,nan,RX,1.0,102.0,0.0,102.0,nan,nan,0.0,102.0,0
TCGA-CC-A123-01,TCGA-CC-A123,LIHC,24.0,FEMALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G1,2010.0,nan,-9107.0,Alive,WITH TUMOR,219.0,nan,nan,New Primary Tumor,Lung,nan,145.0,nan,nan,RX,0.0,219.0,0.0,219.0,nan,nan,1.0,145.0,2
TCGA-CC-A1HT-01,TCGA-CC-A1HT,LIHC,50.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2010.0,nan,-18553.0,Dead,TUMOR FREE,nan,101.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,101.0,0.0,101.0,nan,nan,0.0,101.0,0
TCGA-CC-A3M9-01,TCGA-CC-A3M9,LIHC,45.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2011.0,nan,-16460.0,Dead,WITH TUMOR,nan,300.0,nan,Locoregional Recurrence,nan,nan,219.0,nan,nan,R0,1.0,300.0,1.0,300.0,1.0,219.0,1.0,219.0,1
TCGA-CC-A3MA-01,TCGA-CC-A3MA,LIHC,61.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-22375.0,Dead,WITH TUMOR,nan,303.0,nan,Locoregional Recurrence,nan,nan,261.0,nan,nan,R0,1.0,303.0,1.0,303.0,1.0,261.0,1.0,261.0,1
TCGA-CC-A3MB-01,TCGA-CC-A3MB,LIHC,36.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G1,2011.0,nan,-13255.0,Dead,WITH TUMOR,nan,315.0,nan,New Primary Tumor,Lung,nan,260.0,nan,nan,R0,1.0,315.0,1.0,315.0,0.0,315.0,1.0,260.0,1
TCGA-CC-A3MC-01,TCGA-CC-A3MC,LIHC,54.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-20067.0,Alive,WITH TUMOR,363.0,nan,nan,Locoregional Recurrence,Liver,nan,297.0,nan,nan,R0,0.0,363.0,0.0,363.0,1.0,297.0,1.0,297.0,2
TCGA-CC-A5UC-01,TCGA-CC-A5UC,LIHC,63.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2012.0,nan,-23156.0,Dead,WITH TUMOR,nan,347.0,nan,New Primary Tumor,Lung,nan,312.0,nan,nan,R0,1.0,347.0,1.0,347.0,0.0,347.0,1.0,312.0,1
TCGA-CC-A5UD-01,TCGA-CC-A5UD,LIHC,45.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-16702.0,Dead,WITH TUMOR,nan,304.0,nan,Locoregional Recurrence,nan,nan,182.0,nan,nan,R0,1.0,304.0,1.0,304.0,1.0,182.0,1.0,182.0,1
TCGA-CC-A5UE-01,TCGA-CC-A5UE,LIHC,48.0,MALE,ASIAN,Stage IIIB,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-17805.0,Dead,WITH TUMOR,nan,272.0,nan,Locoregional Recurrence,nan,nan,175.0,nan,nan,R0,1.0,272.0,1.0,272.0,1.0,175.0,1.0,175.0,1
TCGA-CC-A7IE-01,TCGA-CC-A7IE,LIHC,57.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-20985.0,Dead,WITH TUMOR,nan,217.0,nan,New Primary Tumor,Lung,nan,169.0,nan,nan,R0,1.0,217.0,1.0,217.0,0.0,217.0,1.0,169.0,1
TCGA-CC-A7IF-01,TCGA-CC-A7IF,LIHC,59.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G1,2013.0,nan,-21845.0,Dead,WITH TUMOR,nan,649.0,nan,New Primary Tumor,Lung,nan,254.0,nan,nan,R0,1.0,649.0,1.0,649.0,0.0,649.0,1.0,254.0,1
TCGA-CC-A7IG-01,TCGA-CC-A7IG,LIHC,47.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-17453.0,Dead,WITH TUMOR,nan,299.0,nan,Locoregional Recurrence,nan,nan,195.0,nan,nan,R0,1.0,299.0,1.0,299.0,1.0,195.0,1.0,195.0,1
TCGA-CC-A7IH-01,TCGA-CC-A7IH,LIHC,58.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G1,2013.0,nan,-21381.0,Alive,TUMOR FREE,365.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,365.0,0.0,365.0,0.0,365.0,0.0,365.0,0
TCGA-CC-A7II-01,TCGA-CC-A7II,LIHC,54.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-20079.0,Alive,WITH TUMOR,399.0,nan,nan,Locoregional Recurrence,nan,nan,278.0,nan,nan,R0,0.0,399.0,0.0,399.0,1.0,278.0,1.0,278.0,2
TCGA-CC-A7IJ-01,TCGA-CC-A7IJ,LIHC,56.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-20751.0,Alive,TUMOR FREE,382.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,382.0,0.0,382.0,0.0,382.0,0.0,382.0,0
TCGA-CC-A7IK-01,TCGA-CC-A7IK,LIHC,59.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-21552.0,Dead,WITH TUMOR,nan,262.0,nan,Locoregional Recurrence,nan,nan,150.0,nan,nan,R0,1.0,262.0,1.0,262.0,1.0,150.0,1.0,150.0,1
TCGA-CC-A7IL-01,TCGA-CC-A7IL,LIHC,61.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G1,2013.0,nan,-22319.0,Dead,WITH TUMOR,nan,278.0,nan,Locoregional Recurrence,nan,nan,179.0,nan,nan,R0,1.0,278.0,1.0,278.0,1.0,179.0,1.0,179.0,1
TCGA-CC-A8HS-01,TCGA-CC-A8HS,LIHC,18.0,MALE,ASIAN,Stage IIIC,nan,Hepatocellular Carcinoma,G1,2013.0,nan,-6617.0,Dead,WITH TUMOR,nan,300.0,nan,Locoregional Recurrence,nan,nan,201.0,nan,nan,R0,1.0,300.0,1.0,300.0,1.0,201.0,1.0,201.0,1
TCGA-CC-A8HT-01,TCGA-CC-A8HT,LIHC,74.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-27334.0,Dead,WITH TUMOR,nan,140.0,nan,Locoregional Recurrence,nan,nan,83.0,nan,nan,R0,1.0,140.0,1.0,140.0,1.0,83.0,1.0,83.0,1
TCGA-CC-A8HU-01,TCGA-CC-A8HU,LIHC,39.0,FEMALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-14367.0,Dead,WITH TUMOR,nan,344.0,nan,Locoregional Recurrence,nan,nan,301.0,nan,nan,R0,1.0,344.0,1.0,344.0,1.0,301.0,1.0,301.0,1
TCGA-CC-A8HV-01,TCGA-CC-A8HV,LIHC,51.0,FEMALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-18935.0,Dead,WITH TUMOR,nan,279.0,nan,Locoregional Recurrence,nan,nan,149.0,nan,nan,R0,1.0,279.0,1.0,279.0,1.0,149.0,1.0,149.0,1
TCGA-CC-A9FS-01,TCGA-CC-A9FS,LIHC,55.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-20157.0,Alive,WITH TUMOR,211.0,nan,nan,New Primary Tumor,Lung,nan,109.0,nan,nan,R0,0.0,211.0,0.0,211.0,0.0,211.0,1.0,109.0,0
TCGA-CC-A9FU-01,TCGA-CC-A9FU,LIHC,52.0,FEMALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-19326.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0
TCGA-CC-A9FV-01,TCGA-CC-A9FV,LIHC,57.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-21044.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0
TCGA-CC-A9FW-01,TCGA-CC-A9FW,LIHC,68.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-24891.0,Alive,WITH TUMOR,248.0,nan,nan,Locoregional Recurrence,nan,nan,153.0,nan,nan,R0,0.0,248.0,0.0,248.0,1.0,153.0,1.0,153.0,2
TCGA-DD-A113-01,TCGA-DD-A113,LIHC,55.0,FEMALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G3,2006.0,nan,-20188.0,Alive,WITH TUMOR,2425.0,nan,nan,Intrahepatic Recurrence,Liver,nan,1676.0,nan,nan,R0,0.0,2425.0,0.0,2425.0,1.0,1676.0,1.0,1676.0,2
TCGA-DD-A113-11,TCGA-DD-A113,LIHC,55.0,FEMALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G3,2006.0,nan,-20188.0,Alive,WITH TUMOR,2425.0,nan,nan,Intrahepatic Recurrence,Liver,nan,1676.0,nan,nan,R0,0.0,2425.0,0.0,2425.0,1.0,1676.0,1.0,1676.0,2
TCGA-DD-A114-01,TCGA-DD-A114,LIHC,42.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Hepatocellular Carcinoma,G3,2005.0,nan,-15410.0,Dead,TUMOR FREE,nan,1149.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,1149.0,0.0,1149.0,0.0,1149.0,0.0,1149.0,0
TCGA-DD-A114-11,TCGA-DD-A114,LIHC,42.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Hepatocellular Carcinoma,G3,2005.0,nan,-15410.0,Dead,TUMOR FREE,nan,1149.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,1149.0,0.0,1149.0,0.0,1149.0,0.0,1149.0,0
TCGA-DD-A115-01,TCGA-DD-A115,LIHC,53.0,MALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2002.0,nan,-19697.0,Dead,WITH TUMOR,nan,2542.0,nan,Intrahepatic Recurrence,Liver,nan,469.0,nan,nan,R0,1.0,2542.0,1.0,2542.0,1.0,469.0,1.0,469.0,1
TCGA-DD-A115-11,TCGA-DD-A115,LIHC,53.0,MALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2002.0,nan,-19697.0,Dead,WITH TUMOR,nan,2542.0,nan,Intrahepatic Recurrence,Liver,nan,469.0,nan,nan,R0,1.0,2542.0,1.0,2542.0,1.0,469.0,1.0,469.0,1
TCGA-DD-A116-01,TCGA-DD-A116,LIHC,68.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2002.0,nan,-24934.0,Dead,TUMOR FREE,nan,1622.0,nan,Extrahepatic Recurrence,"Other, specify",sternum,828.0,nan,nan,R0,1.0,1622.0,0.0,1622.0,1.0,828.0,1.0,828.0,0
TCGA-DD-A116-11,TCGA-DD-A116,LIHC,68.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2002.0,nan,-24934.0,Dead,TUMOR FREE,nan,1622.0,nan,Extrahepatic Recurrence,"Other, specify",sternum,828.0,nan,nan,R0,1.0,1622.0,0.0,1622.0,1.0,828.0,1.0,828.0,0
TCGA-DD-A118-01,TCGA-DD-A118,LIHC,77.0,FEMALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2003.0,nan,-28406.0,Alive,nan,3437.0,nan,nan,Extrahepatic Recurrence,"Other, specify","lateral to the C-loop of the duodenum, anterior to the right  kidney",658.0,nan,nan,R0,0.0,3437.0,0.0,3437.0,1.0,658.0,1.0,658.0,2
TCGA-DD-A118-11,TCGA-DD-A118,LIHC,77.0,FEMALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2003.0,nan,-28406.0,Alive,nan,3437.0,nan,nan,Extrahepatic Recurrence,"Other, specify","lateral to the C-loop of the duodenum, anterior to the right  kidney",658.0,nan,nan,R0,0.0,3437.0,0.0,3437.0,1.0,658.0,1.0,658.0,2
TCGA-DD-A119-01,TCGA-DD-A119,LIHC,40.0,MALE,ASIAN,Stage IV,nan,Hepatocellular Carcinoma,G3,2003.0,nan,-14613.0,Dead,nan,nan,223.0,nan,nan,nan,nan,nan,nan,nan,R2,1.0,223.0,nan,223.0,nan,nan,0.0,223.0,1
TCGA-DD-A119-11,TCGA-DD-A119,LIHC,40.0,MALE,ASIAN,Stage IV,nan,Hepatocellular Carcinoma,G3,2003.0,nan,-14613.0,Dead,nan,nan,223.0,nan,nan,nan,nan,nan,nan,nan,R2,1.0,223.0,nan,223.0,nan,nan,0.0,223.0,1
TCGA-DD-A11A-01,TCGA-DD-A11A,LIHC,67.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Hepatocellular Carcinoma,G3,2004.0,nan,-24646.0,Alive,nan,79.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,79.0,0.0,79.0,0.0,79.0,0.0,79.0,0
TCGA-DD-A11A-11,TCGA-DD-A11A,LIHC,67.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Hepatocellular Carcinoma,G3,2004.0,nan,-24646.0,Alive,nan,79.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,79.0,0.0,79.0,0.0,79.0,0.0,79.0,0
TCGA-DD-A11B-01,TCGA-DD-A11B,LIHC,73.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2005.0,nan,-26857.0,Dead,TUMOR FREE,nan,14.0,nan,nan,nan,nan,nan,nan,nan,RX,1.0,14.0,0.0,14.0,nan,nan,0.0,14.0,0
TCGA-DD-A11B-11,TCGA-DD-A11B,LIHC,73.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2005.0,nan,-26857.0,Dead,TUMOR FREE,nan,14.0,nan,nan,nan,nan,nan,nan,nan,RX,1.0,14.0,0.0,14.0,nan,nan,0.0,14.0,0
TCGA-DD-A11C-01,TCGA-DD-A11C,LIHC,69.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G3,2006.0,nan,-25403.0,Alive,TUMOR FREE,662.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,662.0,0.0,662.0,nan,nan,0.0,662.0,0
TCGA-DD-A11C-11,TCGA-DD-A11C,LIHC,69.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G3,2006.0,nan,-25403.0,Alive,TUMOR FREE,662.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,662.0,0.0,662.0,nan,nan,0.0,662.0,0
TCGA-DD-A11D-01,TCGA-DD-A11D,LIHC,57.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2006.0,nan,-21003.0,Dead,WITH TUMOR,nan,1560.0,nan,Intrahepatic Recurrence,Liver,nan,498.0,nan,nan,R0,1.0,1560.0,1.0,1560.0,1.0,498.0,1.0,498.0,1
TCGA-DD-A11D-11,TCGA-DD-A11D,LIHC,57.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2006.0,nan,-21003.0,Dead,WITH TUMOR,nan,1560.0,nan,Intrahepatic Recurrence,Liver,nan,498.0,nan,nan,R0,1.0,1560.0,1.0,1560.0,1.0,498.0,1.0,498.0,1
TCGA-DD-A1E9-01,TCGA-DD-A1E9,LIHC,70.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2002.0,nan,-25808.0,Dead,nan,nan,2759.0,nan,Intrahepatic Recurrence,Liver,nan,720.0,nan,nan,R0,1.0,2759.0,nan,2759.0,1.0,720.0,1.0,720.0,1
TCGA-DD-A1E9-11,TCGA-DD-A1E9,LIHC,70.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2002.0,nan,-25808.0,Dead,nan,nan,2759.0,nan,Intrahepatic Recurrence,Liver,nan,720.0,nan,nan,R0,1.0,2759.0,nan,2759.0,1.0,720.0,1.0,720.0,1
TCGA-DD-A1EA-01,TCGA-DD-A1EA,LIHC,68.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G2,2002.0,nan,-24925.0,Alive,WITH TUMOR,2415.0,nan,nan,Locoregional Recurrence,Liver,nan,754.0,nan,nan,R0,0.0,2415.0,0.0,2415.0,1.0,754.0,1.0,754.0,2
TCGA-DD-A1EB-01,TCGA-DD-A1EB,LIHC,72.0,FEMALE,nan,Stage I,nan,Hepatocellular Carcinoma,G2,2001.0,nan,-26471.0,Alive,[Discrepancy],2017.0,nan,nan,Intrahepatic Recurrence,Liver,nan,505.0,nan,nan,R0,0.0,2017.0,0.0,2017.0,1.0,505.0,1.0,505.0,2
TCGA-DD-A1EB-11,TCGA-DD-A1EB,LIHC,72.0,FEMALE,nan,Stage I,nan,Hepatocellular Carcinoma,G2,2001.0,nan,-26471.0,Alive,[Discrepancy],2017.0,nan,nan,Intrahepatic Recurrence,Liver,nan,505.0,nan,nan,R0,0.0,2017.0,0.0,2017.0,1.0,505.0,1.0,505.0,2
TCGA-DD-A1EC-01,TCGA-DD-A1EC,LIHC,20.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G3,2004.0,nan,-7363.0,Alive,nan,602.0,nan,nan,Extrahepatic Recurrence,"Other, specify",peritoneal,299.0,nan,nan,R0,0.0,602.0,0.0,602.0,1.0,299.0,1.0,299.0,2
TCGA-DD-A1EC-11,TCGA-DD-A1EC,LIHC,20.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G3,2004.0,nan,-7363.0,Alive,nan,602.0,nan,nan,Extrahepatic Recurrence,"Other, specify",peritoneal,299.0,nan,nan,R0,0.0,602.0,0.0,602.0,1.0,299.0,1.0,299.0,2
TCGA-DD-A1ED-01,TCGA-DD-A1ED,LIHC,68.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G1,2006.0,nan,-25039.0,Alive,TUMOR FREE,2301.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2301.0,0.0,2301.0,0.0,2301.0,0.0,2301.0,0
TCGA-DD-A1ED-11,TCGA-DD-A1ED,LIHC,68.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G1,2006.0,nan,-25039.0,Alive,TUMOR FREE,2301.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2301.0,0.0,2301.0,0.0,2301.0,0.0,2301.0,0
TCGA-DD-A1EE-01,TCGA-DD-A1EE,LIHC,73.0,MALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2006.0,nan,-26858.0,Dead,WITH TUMOR,nan,349.0,nan,Intrahepatic Recurrence,Liver,nan,44.0,nan,nan,R0,1.0,349.0,1.0,349.0,1.0,44.0,1.0,44.0,1
TCGA-DD-A1EE-11,TCGA-DD-A1EE,LIHC,73.0,MALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2006.0,nan,-26858.0,Dead,WITH TUMOR,nan,349.0,nan,Intrahepatic Recurrence,Liver,nan,44.0,nan,nan,R0,1.0,349.0,1.0,349.0,1.0,44.0,1.0,44.0,1
TCGA-DD-A1EF-01,TCGA-DD-A1EF,LIHC,57.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G3,2007.0,nan,-21165.0,Dead,WITH TUMOR,nan,394.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,394.0,1.0,394.0,nan,nan,1.0,394.0,1
TCGA-DD-A1EF-11,TCGA-DD-A1EF,LIHC,57.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G3,2007.0,nan,-21165.0,Dead,WITH TUMOR,nan,394.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,394.0,1.0,394.0,nan,nan,1.0,394.0,1
TCGA-DD-A1EG-01,TCGA-DD-A1EG,LIHC,76.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G3,2007.0,nan,-28108.0,Dead,WITH TUMOR,nan,1372.0,nan,Intrahepatic Recurrence,Liver,nan,875.0,nan,nan,R0,1.0,1372.0,1.0,1372.0,1.0,875.0,1.0,875.0,1
TCGA-DD-A1EG-11,TCGA-DD-A1EG,LIHC,76.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G3,2007.0,nan,-28108.0,Dead,WITH TUMOR,nan,1372.0,nan,Intrahepatic Recurrence,Liver,nan,875.0,nan,nan,R0,1.0,1372.0,1.0,1372.0,1.0,875.0,1.0,875.0,1
TCGA-DD-A1EH-01,TCGA-DD-A1EH,LIHC,23.0,MALE,WHITE,Stage III,nan,Hepatocellular Carcinoma,G3,2008.0,nan,-8499.0,Alive,WITH TUMOR,1495.0,nan,nan,Intrahepatic Recurrence,Liver,nan,120.0,nan,nan,R0,0.0,1495.0,0.0,1495.0,1.0,120.0,1.0,120.0,2
TCGA-DD-A1EH-11,TCGA-DD-A1EH,LIHC,23.0,MALE,WHITE,Stage III,nan,Hepatocellular Carcinoma,G3,2008.0,nan,-8499.0,Alive,WITH TUMOR,1495.0,nan,nan,Intrahepatic Recurrence,Liver,nan,120.0,nan,nan,R0,0.0,1495.0,0.0,1495.0,1.0,120.0,1.0,120.0,2
TCGA-DD-A1EI-01,TCGA-DD-A1EI,LIHC,46.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2008.0,nan,-17097.0,Alive,TUMOR FREE,183.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,183.0,0.0,183.0,0.0,183.0,0.0,183.0,0
TCGA-DD-A1EI-11,TCGA-DD-A1EI,LIHC,46.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2008.0,nan,-17097.0,Alive,TUMOR FREE,183.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,183.0,0.0,183.0,0.0,183.0,0.0,183.0,0
TCGA-DD-A1EJ-01,TCGA-DD-A1EJ,LIHC,71.0,FEMALE,WHITE,Stage IIIC,nan,Hepatocellular Carcinoma,G2,2008.0,nan,-26009.0,Dead,WITH TUMOR,nan,1005.0,nan,Intrahepatic Recurrence,Liver,nan,263.0,nan,nan,R0,1.0,1005.0,1.0,1005.0,1.0,263.0,1.0,263.0,1
TCGA-DD-A1EJ-11,TCGA-DD-A1EJ,LIHC,71.0,FEMALE,WHITE,Stage IIIC,nan,Hepatocellular Carcinoma,G2,2008.0,nan,-26009.0,Dead,WITH TUMOR,nan,1005.0,nan,Intrahepatic Recurrence,Liver,nan,263.0,nan,nan,R0,1.0,1005.0,1.0,1005.0,1.0,263.0,1.0,263.0,1
TCGA-DD-A1EK-01,TCGA-DD-A1EK,LIHC,64.0,FEMALE,WHITE,Stage IVB,nan,Hepatocellular Carcinoma,G2,2008.0,nan,-23437.0,Dead,WITH TUMOR,nan,558.0,nan,Locoregional Recurrence,Liver,nan,167.0,nan,nan,R0,1.0,558.0,1.0,558.0,nan,nan,1.0,167.0,1
TCGA-DD-A1EL-01,TCGA-DD-A1EL,LIHC,23.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Hepatocellular Carcinoma,G3,2009.0,nan,-8573.0,Dead,WITH TUMOR,nan,415.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,415.0,1.0,415.0,nan,nan,1.0,415.0,1
TCGA-DD-A1EL-11,TCGA-DD-A1EL,LIHC,23.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Hepatocellular Carcinoma,G3,2009.0,nan,-8573.0,Dead,WITH TUMOR,nan,415.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,415.0,1.0,415.0,nan,nan,1.0,415.0,1
TCGA-DD-A39V-01,TCGA-DD-A39V,LIHC,77.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G3,2000.0,nan,-28254.0,Dead,WITH TUMOR,nan,643.0,nan,Extrahepatic Recurrence,"Other, specify",second or third rib posteriorly,455.0,nan,nan,R0,1.0,643.0,1.0,643.0,1.0,455.0,1.0,455.0,1
TCGA-DD-A39V-11,TCGA-DD-A39V,LIHC,77.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G3,2000.0,nan,-28254.0,Dead,WITH TUMOR,nan,643.0,nan,Extrahepatic Recurrence,"Other, specify",second or third rib posteriorly,455.0,nan,nan,R0,1.0,643.0,1.0,643.0,1.0,455.0,1.0,455.0,1
TCGA-DD-A39W-01,TCGA-DD-A39W,LIHC,29.0,FEMALE,WHITE,Stage III,nan,Hepatocellular Carcinoma,G2,1995.0,nan,-10699.0,Dead,nan,nan,827.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,827.0,nan,827.0,0.0,827.0,0.0,827.0,1
TCGA-DD-A39W-11,TCGA-DD-A39W,LIHC,29.0,FEMALE,WHITE,Stage III,nan,Hepatocellular Carcinoma,G2,1995.0,nan,-10699.0,Dead,nan,nan,827.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,827.0,nan,827.0,0.0,827.0,0.0,827.0,1
TCGA-DD-A39X-01,TCGA-DD-A39X,LIHC,78.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,1998.0,nan,-28528.0,Dead,WITH TUMOR,nan,1694.0,nan,Intrahepatic Recurrence,Liver,nan,1032.0,nan,nan,R0,1.0,1694.0,1.0,1694.0,1.0,1032.0,1.0,1032.0,1
TCGA-DD-A39X-11,TCGA-DD-A39X,LIHC,78.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,1998.0,nan,-28528.0,Dead,WITH TUMOR,nan,1694.0,nan,Intrahepatic Recurrence,Liver,nan,1032.0,nan,nan,R0,1.0,1694.0,1.0,1694.0,1.0,1032.0,1.0,1032.0,1
TCGA-DD-A39Y-01,TCGA-DD-A39Y,LIHC,67.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2002.0,nan,-24769.0,Dead,TUMOR FREE,nan,171.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,171.0,0.0,171.0,0.0,171.0,0.0,171.0,0
TCGA-DD-A39Z-01,TCGA-DD-A39Z,LIHC,43.0,FEMALE,nan,Stage II,nan,Hepatocellular Carcinoma,G2,1996.0,nan,-15930.0,Dead,TUMOR FREE,nan,601.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,601.0,0.0,601.0,0.0,601.0,0.0,601.0,0
TCGA-DD-A39Z-11,TCGA-DD-A39Z,LIHC,43.0,FEMALE,nan,Stage II,nan,Hepatocellular Carcinoma,G2,1996.0,nan,-15930.0,Dead,TUMOR FREE,nan,601.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,601.0,0.0,601.0,0.0,601.0,0.0,601.0,0
TCGA-DD-A3A0-01,TCGA-DD-A3A0,LIHC,70.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2001.0,nan,-25889.0,Dead,WITH TUMOR,nan,785.0,nan,New Primary Tumor,nan,nan,359.0,nan,nan,R0,1.0,785.0,1.0,785.0,0.0,785.0,1.0,359.0,1
TCGA-DD-A3A1-01,TCGA-DD-A3A1,LIHC,65.0,MALE,nan,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2001.0,nan,-24046.0,Dead,TUMOR FREE,nan,233.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,233.0,0.0,233.0,0.0,233.0,0.0,233.0,0
TCGA-DD-A3A1-11,TCGA-DD-A3A1,LIHC,65.0,MALE,nan,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2001.0,nan,-24046.0,Dead,TUMOR FREE,nan,233.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,233.0,0.0,233.0,0.0,233.0,0.0,233.0,0
TCGA-DD-A3A2-01,TCGA-DD-A3A2,LIHC,76.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G1,1998.0,nan,-27930.0,Dead,TUMOR FREE,nan,2131.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,2131.0,0.0,2131.0,0.0,2131.0,0.0,2131.0,0
TCGA-DD-A3A2-11,TCGA-DD-A3A2,LIHC,76.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G1,1998.0,nan,-27930.0,Dead,TUMOR FREE,nan,2131.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,2131.0,0.0,2131.0,0.0,2131.0,0.0,2131.0,0
TCGA-DD-A3A3-01,TCGA-DD-A3A3,LIHC,45.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,1999.0,nan,-16708.0,Dead,nan,nan,535.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,535.0,nan,535.0,0.0,535.0,0.0,535.0,0
TCGA-DD-A3A3-11,TCGA-DD-A3A3,LIHC,45.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,1999.0,nan,-16708.0,Dead,nan,nan,535.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,535.0,nan,535.0,0.0,535.0,0.0,535.0,0
TCGA-DD-A3A4-01,TCGA-DD-A3A4,LIHC,37.0,MALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G3,1998.0,nan,-13739.0,Dead,WITH TUMOR,nan,612.0,nan,Intrahepatic Recurrence,Liver,nan,87.0,nan,nan,R0,1.0,612.0,1.0,612.0,1.0,87.0,1.0,87.0,1
TCGA-DD-A3A4-11,TCGA-DD-A3A4,LIHC,37.0,MALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G3,1998.0,nan,-13739.0,Dead,WITH TUMOR,nan,612.0,nan,Intrahepatic Recurrence,Liver,nan,87.0,nan,nan,R0,1.0,612.0,1.0,612.0,1.0,87.0,1.0,87.0,1
TCGA-DD-A3A5-01,TCGA-DD-A3A5,LIHC,66.0,FEMALE,WHITE,Stage III,nan,Hepatocellular Carcinoma,G2,1996.0,nan,-24288.0,Dead,WITH TUMOR,nan,3125.0,nan,Intrahepatic Recurrence,Liver,nan,84.0,nan,nan,R0,1.0,3125.0,1.0,3125.0,1.0,84.0,1.0,84.0,1
TCGA-DD-A3A5-11,TCGA-DD-A3A5,LIHC,66.0,FEMALE,WHITE,Stage III,nan,Hepatocellular Carcinoma,G2,1996.0,nan,-24288.0,Dead,WITH TUMOR,nan,3125.0,nan,Intrahepatic Recurrence,Liver,nan,84.0,nan,nan,R0,1.0,3125.0,1.0,3125.0,1.0,84.0,1.0,84.0,1
TCGA-DD-A3A6-01,TCGA-DD-A3A6,LIHC,72.0,FEMALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,1997.0,nan,-26319.0,Dead,TUMOR FREE,nan,3258.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,3258.0,0.0,3258.0,0.0,3258.0,0.0,3258.0,0
TCGA-DD-A3A6-11,TCGA-DD-A3A6,LIHC,72.0,FEMALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,1997.0,nan,-26319.0,Dead,TUMOR FREE,nan,3258.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,3258.0,0.0,3258.0,0.0,3258.0,0.0,3258.0,0
TCGA-DD-A3A7-01,TCGA-DD-A3A7,LIHC,67.0,MALE,[Unknown],Stage IIIB,nan,Hepatocellular Carcinoma,G3,1998.0,nan,-24599.0,Dead,WITH TUMOR,nan,419.0,nan,Intrahepatic Recurrence,Liver,nan,144.0,nan,nan,R0,1.0,419.0,1.0,419.0,1.0,144.0,1.0,144.0,1
TCGA-DD-A3A8-01,TCGA-DD-A3A8,LIHC,75.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2001.0,nan,-27524.0,Dead,TUMOR FREE,nan,11.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,11.0,0.0,11.0,0.0,11.0,0.0,11.0,0
TCGA-DD-A3A8-11,TCGA-DD-A3A8,LIHC,75.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2001.0,nan,-27524.0,Dead,TUMOR FREE,nan,11.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,11.0,0.0,11.0,0.0,11.0,0.0,11.0,0
TCGA-DD-A3A9-01,TCGA-DD-A3A9,LIHC,64.0,FEMALE,WHITE,Stage IVB,nan,Hepatocellular Carcinoma,G2,2001.0,nan,-23526.0,Dead,WITH TUMOR,nan,931.0,nan,Extrahepatic Recurrence,Lung,nan,289.0,nan,nan,R0,1.0,931.0,1.0,931.0,nan,nan,1.0,289.0,1
TCGA-DD-A4NA-01,TCGA-DD-A4NA,LIHC,67.0,FEMALE,WHITE,Stage IIIC,nan,Hepatocellular Carcinoma,G3,2009.0,nan,-24603.0,Alive,TUMOR FREE,1008.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1008.0,0.0,1008.0,0.0,1008.0,0.0,1008.0,0
TCGA-DD-A4NB-01,TCGA-DD-A4NB,LIHC,25.0,MALE,WHITE,Stage I,nan,Fibrolamellar Carcinoma,G2,2011.0,nan,-9426.0,Alive,TUMOR FREE,989.0,nan,nan,Extrahepatic Recurrence,"Other, specify",retroperitoneal lymph nodes,912.0,nan,nan,R0,0.0,989.0,0.0,989.0,1.0,912.0,1.0,912.0,0
TCGA-DD-A4ND-01,TCGA-DD-A4ND,LIHC,56.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G3,2007.0,nan,-20782.0,Alive,TUMOR FREE,2746.0,nan,nan,New Primary Tumor,"Other, specify",breast cancer,15.0,nan,nan,R0,0.0,2746.0,0.0,2746.0,0.0,2746.0,1.0,15.0,0
TCGA-DD-A4NE-01,TCGA-DD-A4NE,LIHC,75.0,FEMALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2011.0,nan,-27549.0,Dead,WITH TUMOR,nan,660.0,nan,Locoregional Recurrence,Liver,nan,190.0,nan,nan,R0,1.0,660.0,1.0,660.0,1.0,190.0,1.0,190.0,1
TCGA-DD-A4NF-01,TCGA-DD-A4NF,LIHC,72.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-26330.0,Alive,WITH TUMOR,942.0,nan,nan,Extrahepatic Recurrence,Bone,nan,656.0,nan,nan,R0,0.0,942.0,0.0,942.0,1.0,656.0,1.0,656.0,2
TCGA-DD-A4NG-01,TCGA-DD-A4NG,LIHC,77.0,MALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-28234.0,Dead,WITH TUMOR,nan,802.0,nan,Locoregional Recurrence,Liver,nan,430.0,nan,nan,R0,1.0,802.0,1.0,802.0,1.0,430.0,1.0,430.0,1
TCGA-DD-A4NH-01,TCGA-DD-A4NH,LIHC,65.0,FEMALE,WHITE,Stage IIIB,nan,Hepatocellular Carcinoma,G3,2011.0,nan,-23865.0,Alive,WITH TUMOR,917.0,nan,nan,Extrahepatic Recurrence,Lung,nan,161.0,nan,nan,R0,0.0,917.0,0.0,917.0,1.0,161.0,1.0,161.0,2
TCGA-DD-A4NI-01,TCGA-DD-A4NI,LIHC,67.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-24516.0,Alive,TUMOR FREE,816.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,816.0,0.0,816.0,0.0,816.0,0.0,816.0,0
TCGA-DD-A4NJ-01,TCGA-DD-A4NJ,LIHC,54.0,FEMALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-19964.0,Alive,WITH TUMOR,928.0,nan,nan,Intrahepatic Recurrence,Liver,nan,549.0,nan,nan,R0,0.0,928.0,0.0,928.0,1.0,549.0,1.0,549.0,2
TCGA-DD-A4NK-01,TCGA-DD-A4NK,LIHC,80.0,FEMALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2004.0,nan,-29244.0,Dead,WITH TUMOR,nan,1210.0,nan,Intrahepatic Recurrence,Liver,nan,89.0,nan,nan,R0,1.0,1210.0,1.0,1210.0,1.0,89.0,1.0,89.0,1
TCGA-DD-A4NL-01,TCGA-DD-A4NL,LIHC,46.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G1,2007.0,nan,-16874.0,Alive,TUMOR FREE,1711.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1711.0,0.0,1711.0,0.0,1711.0,0.0,1711.0,0
TCGA-DD-A4NN-01,TCGA-DD-A4NN,LIHC,56.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G3,2004.0,nan,-20548.0,Dead,WITH TUMOR,nan,899.0,nan,Extrahepatic Recurrence,Lung,nan,166.0,nan,nan,R0,1.0,899.0,1.0,899.0,1.0,166.0,1.0,166.0,1
TCGA-DD-A4NO-01,TCGA-DD-A4NO,LIHC,65.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G1,2007.0,nan,-24090.0,Alive,WITH TUMOR,2245.0,nan,nan,Locoregional Recurrence,Liver,nan,990.0,nan,nan,R0,0.0,2245.0,0.0,2245.0,1.0,990.0,1.0,990.0,2
TCGA-DD-A4NP-01,TCGA-DD-A4NP,LIHC,32.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G3,2005.0,nan,-11838.0,Alive,TUMOR FREE,3308.0,nan,nan,Intrahepatic Recurrence,Liver,nan,1286.0,nan,nan,R0,0.0,3308.0,0.0,3308.0,1.0,1286.0,1.0,1286.0,0
TCGA-DD-A4NQ-01,TCGA-DD-A4NQ,LIHC,60.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G3,2007.0,nan,-22111.0,Dead,WITH TUMOR,nan,373.0,nan,Intrahepatic Recurrence,Liver,nan,126.0,nan,nan,R0,1.0,373.0,1.0,373.0,1.0,126.0,1.0,126.0,1
TCGA-DD-A4NR-01,TCGA-DD-A4NR,LIHC,85.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G3,2005.0,nan,-31386.0,Dead,TUMOR FREE,nan,9.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,9.0,0.0,9.0,0.0,9.0,0.0,9.0,0
TCGA-DD-A4NS-01,TCGA-DD-A4NS,LIHC,61.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2005.0,nan,-22638.0,Dead,WITH TUMOR,nan,2456.0,nan,Extrahepatic Recurrence,Bone,nan,893.0,nan,nan,R0,1.0,2456.0,1.0,2456.0,1.0,893.0,1.0,893.0,1
TCGA-DD-A4NV-01,TCGA-DD-A4NV,LIHC,61.0,MALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G1,2007.0,nan,-22438.0,Alive,TUMOR FREE,2398.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2398.0,0.0,2398.0,0.0,2398.0,0.0,2398.0,0
TCGA-DD-A73A-01,TCGA-DD-A73A,LIHC,71.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-26136.0,Alive,TUMOR FREE,728.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,728.0,0.0,728.0,0.0,728.0,0.0,728.0,0
TCGA-DD-A73B-01,TCGA-DD-A73B,LIHC,72.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-26390.0,Dead,WITH TUMOR,nan,283.0,nan,Locoregional Recurrence,Liver,nan,240.0,nan,nan,R0,1.0,283.0,1.0,283.0,1.0,240.0,1.0,240.0,1
TCGA-DD-A73C-01,TCGA-DD-A73C,LIHC,65.0,FEMALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G1,2012.0,nan,-23782.0,Alive,WITH TUMOR,701.0,nan,nan,Locoregional Recurrence,Liver,nan,566.0,nan,nan,R0,0.0,701.0,0.0,701.0,1.0,566.0,1.0,566.0,2
TCGA-DD-A73D-01,TCGA-DD-A73D,LIHC,68.0,FEMALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G1,2012.0,nan,-24941.0,Alive,WITH TUMOR,693.0,nan,nan,Intrahepatic Recurrence,Liver,nan,592.0,nan,nan,R0,0.0,693.0,0.0,693.0,1.0,592.0,1.0,592.0,2
TCGA-DD-A73E-01,TCGA-DD-A73E,LIHC,66.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G1,2012.0,nan,-24377.0,Alive,TUMOR FREE,44.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,44.0,0.0,44.0,0.0,44.0,0.0,44.0,0
TCGA-DD-A73F-01,TCGA-DD-A73F,LIHC,77.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G1,2010.0,nan,-28234.0,Alive,TUMOR FREE,1085.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1085.0,0.0,1085.0,0.0,1085.0,0.0,1085.0,0
TCGA-DD-A73G-01,TCGA-DD-A73G,LIHC,73.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G3,2005.0,nan,-26949.0,Alive,TUMOR FREE,3478.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,3478.0,0.0,3478.0,0.0,3478.0,0.0,3478.0,0
TCGA-DD-AA3A-01,TCGA-DD-AA3A,LIHC,81.0,FEMALE,WHITE,Stage I,nan,Hepatocholangiocarcinoma (Mixed),G4,2009.0,nan,-29712.0,Dead,TUMOR FREE,nan,410.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,410.0,0.0,410.0,0.0,410.0,0.0,410.0,0
TCGA-DD-AAC8-01,TCGA-DD-AAC8,LIHC,72.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2008.0,nan,-26322.0,Dead,TUMOR FREE,nan,16.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,16.0,0.0,16.0,0.0,16.0,0.0,16.0,0
TCGA-DD-AAC9-01,TCGA-DD-AAC9,LIHC,51.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2008.0,nan,-18911.0,Alive,TUMOR FREE,347.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,347.0,0.0,347.0,0.0,347.0,0.0,347.0,0
TCGA-DD-AACA-02,TCGA-DD-AACA,LIHC,65.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2008.0,nan,-23973.0,Alive,WITH TUMOR,2301.0,nan,nan,Locoregional Recurrence,Liver,nan,776.0,nan,nan,R0,0.0,2301.0,0.0,2301.0,1.0,776.0,1.0,776.0,2
TCGA-DD-AACA-01,TCGA-DD-AACA,LIHC,65.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2008.0,nan,-23973.0,Alive,WITH TUMOR,2301.0,nan,nan,Locoregional Recurrence,Liver,nan,776.0,nan,nan,R0,0.0,2301.0,0.0,2301.0,1.0,776.0,1.0,776.0,2
TCGA-DD-AACB-01,TCGA-DD-AACB,LIHC,74.0,FEMALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2008.0,nan,-27103.0,Alive,TUMOR FREE,2324.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2324.0,0.0,2324.0,0.0,2324.0,0.0,2324.0,0
TCGA-DD-AACC-01,TCGA-DD-AACC,LIHC,61.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2008.0,nan,-22499.0,Dead,WITH TUMOR,nan,1685.0,nan,Locoregional Recurrence,Liver,nan,537.0,nan,nan,R0,1.0,1685.0,1.0,1685.0,1.0,537.0,1.0,537.0,1
TCGA-DD-AACD-01,TCGA-DD-AACD,LIHC,48.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G4,2008.0,nan,-17828.0,Dead,WITH TUMOR,nan,381.0,nan,Locoregional Recurrence,Lung,nan,151.0,nan,nan,R0,1.0,381.0,1.0,381.0,1.0,151.0,1.0,151.0,1
TCGA-DD-AACE-01,TCGA-DD-AACE,LIHC,62.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2008.0,nan,-22727.0,Alive,TUMOR FREE,2184.0,nan,nan,Intrahepatic Recurrence,Liver,nan,1279.0,nan,nan,R0,0.0,2184.0,0.0,2184.0,1.0,1279.0,1.0,1279.0,0
TCGA-DD-AACF-01,TCGA-DD-AACF,LIHC,68.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2008.0,nan,-25172.0,Dead,WITH TUMOR,nan,365.0,nan,Locoregional Recurrence,Liver,nan,119.0,nan,nan,R0,1.0,365.0,1.0,365.0,1.0,119.0,1.0,119.0,1
TCGA-DD-AACG-01,TCGA-DD-AACG,LIHC,52.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G4,2008.0,nan,-19174.0,Dead,WITH TUMOR,nan,469.0,nan,Intrahepatic Recurrence,Liver,nan,125.0,nan,nan,R0,1.0,469.0,1.0,469.0,1.0,125.0,1.0,125.0,1
TCGA-DD-AACH-01,TCGA-DD-AACH,LIHC,69.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G3,2008.0,nan,-25544.0,Dead,TUMOR FREE,nan,195.0,nan,Intrahepatic Recurrence,Liver,nan,83.0,nan,nan,R0,1.0,195.0,0.0,195.0,1.0,83.0,1.0,83.0,1
TCGA-DD-AACI-01,TCGA-DD-AACI,LIHC,69.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G3,2008.0,nan,-25236.0,Alive,WITH TUMOR,1618.0,nan,nan,Intrahepatic Recurrence,Liver,nan,1432.0,nan,nan,R0,0.0,1618.0,0.0,1618.0,1.0,1432.0,1.0,1432.0,2
TCGA-DD-AACJ-01,TCGA-DD-AACJ,LIHC,75.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G2,2008.0,nan,-27528.0,Alive,WITH TUMOR,2102.0,nan,nan,Locoregional Recurrence,Liver,nan,100.0,nan,nan,R0,0.0,2102.0,0.0,2102.0,1.0,100.0,1.0,100.0,2
TCGA-DD-AACK-01,TCGA-DD-AACK,LIHC,70.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2008.0,nan,-25796.0,Alive,TUMOR FREE,9.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,9.0,0.0,9.0,0.0,9.0,0.0,9.0,0
TCGA-DD-AACL-01,TCGA-DD-AACL,LIHC,66.0,FEMALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2008.0,nan,-24355.0,Dead,nan,nan,107.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,107.0,nan,107.0,0.0,107.0,0.0,107.0,1
TCGA-DD-AACM-01,TCGA-DD-AACM,LIHC,48.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G3,2009.0,nan,-17590.0,Alive,WITH TUMOR,1769.0,nan,nan,Extrahepatic Recurrence,Lung,nan,1097.0,nan,nan,R0,0.0,1769.0,0.0,1769.0,1.0,1097.0,1.0,1097.0,2
TCGA-DD-AACN-01,TCGA-DD-AACN,LIHC,32.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2009.0,nan,-12007.0,Alive,WITH TUMOR,1302.0,nan,nan,Intrahepatic Recurrence,Liver,nan,357.0,nan,nan,R0,0.0,1302.0,0.0,1302.0,1.0,357.0,1.0,357.0,2
TCGA-DD-AACO-01,TCGA-DD-AACO,LIHC,40.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2009.0,nan,-14796.0,Alive,WITH TUMOR,1876.0,nan,nan,Intrahepatic Recurrence,Liver,nan,479.0,nan,nan,R0,0.0,1876.0,0.0,1876.0,1.0,479.0,1.0,479.0,2
TCGA-DD-AACP-01,TCGA-DD-AACP,LIHC,64.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2009.0,nan,-23728.0,Alive,nan,415.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,415.0,0.0,415.0,0.0,415.0,0.0,415.0,0
TCGA-DD-AACQ-01,TCGA-DD-AACQ,LIHC,50.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G3,2009.0,nan,-18429.0,Dead,WITH TUMOR,nan,432.0,nan,Locoregional Recurrence,Liver,nan,105.0,nan,nan,R0,1.0,432.0,1.0,432.0,1.0,105.0,1.0,105.0,1
TCGA-DD-AACS-01,TCGA-DD-AACS,LIHC,39.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2009.0,nan,-14473.0,Alive,TUMOR FREE,1804.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1804.0,0.0,1804.0,0.0,1804.0,0.0,1804.0,0
TCGA-DD-AACT-01,TCGA-DD-AACT,LIHC,69.0,FEMALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2010.0,nan,-25292.0,Alive,TUMOR FREE,1562.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1562.0,0.0,1562.0,0.0,1562.0,0.0,1562.0,0
TCGA-DD-AACU-01,TCGA-DD-AACU,LIHC,59.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2010.0,nan,-21606.0,Alive,TUMOR FREE,1567.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1567.0,0.0,1567.0,0.0,1567.0,0.0,1567.0,0
TCGA-DD-AACV-01,TCGA-DD-AACV,LIHC,53.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2010.0,nan,-19660.0,Alive,WITH TUMOR,1531.0,nan,nan,Intrahepatic Recurrence,Liver,nan,344.0,nan,nan,R0,0.0,1531.0,0.0,1531.0,1.0,344.0,1.0,344.0,2
TCGA-DD-AACW-01,TCGA-DD-AACW,LIHC,43.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2010.0,nan,-15872.0,Alive,TUMOR FREE,1424.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1424.0,0.0,1424.0,0.0,1424.0,0.0,1424.0,0
TCGA-DD-AACX-01,TCGA-DD-AACX,LIHC,66.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G3,2010.0,nan,-24329.0,Alive,WITH TUMOR,170.0,nan,nan,Extrahepatic Recurrence,"Other, specify",lymph node,42.0,nan,nan,R0,0.0,170.0,0.0,170.0,1.0,42.0,1.0,42.0,2
TCGA-DD-AACY-01,TCGA-DD-AACY,LIHC,61.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2010.0,nan,-22332.0,Alive,WITH TUMOR,1450.0,nan,nan,Intrahepatic Recurrence,Liver,nan,776.0,nan,nan,R0,0.0,1450.0,0.0,1450.0,1.0,776.0,1.0,776.0,2
TCGA-DD-AACZ-01,TCGA-DD-AACZ,LIHC,63.0,FEMALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G4,2010.0,nan,-23230.0,Dead,TUMOR FREE,nan,171.0,nan,Locoregional Recurrence,Liver,nan,88.0,nan,nan,R0,1.0,171.0,0.0,171.0,1.0,88.0,1.0,88.0,1
TCGA-DD-AAD0-01,TCGA-DD-AAD0,LIHC,73.0,FEMALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2010.0,nan,-26781.0,Alive,WITH TUMOR,137.0,nan,nan,Intrahepatic Recurrence,Liver,nan,47.0,nan,nan,R0,0.0,137.0,0.0,137.0,1.0,47.0,1.0,47.0,2
TCGA-DD-AAD1-01,TCGA-DD-AAD1,LIHC,51.0,FEMALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G4,2010.0,nan,-18794.0,Alive,WITH TUMOR,564.0,nan,nan,Intrahepatic Recurrence,Liver,nan,127.0,nan,nan,R1,0.0,564.0,0.0,564.0,nan,nan,1.0,127.0,2
TCGA-DD-AAD2-01,TCGA-DD-AAD2,LIHC,66.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2010.0,nan,-24221.0,Alive,TUMOR FREE,658.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,658.0,0.0,658.0,0.0,658.0,0.0,658.0,0
TCGA-DD-AAD3-01,TCGA-DD-AAD3,LIHC,43.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-15706.0,Alive,TUMOR FREE,1295.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1295.0,0.0,1295.0,0.0,1295.0,0.0,1295.0,0
TCGA-DD-AAD5-01,TCGA-DD-AAD5,LIHC,54.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2011.0,nan,-19748.0,Alive,WITH TUMOR,1345.0,nan,nan,Intrahepatic Recurrence,Liver,nan,130.0,nan,nan,R0,0.0,1345.0,0.0,1345.0,1.0,130.0,1.0,130.0,0
TCGA-DD-AAD6-01,TCGA-DD-AAD6,LIHC,66.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2011.0,nan,-24185.0,Alive,TUMOR FREE,672.0,nan,nan,Locoregional Recurrence,Liver,nan,50.0,nan,nan,R0,0.0,672.0,0.0,672.0,1.0,50.0,1.0,50.0,0
TCGA-DD-AAD8-01,TCGA-DD-AAD8,LIHC,73.0,FEMALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-26781.0,Alive,TUMOR FREE,1219.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1219.0,0.0,1219.0,0.0,1219.0,0.0,1219.0,0
TCGA-DD-AADA-01,TCGA-DD-AADA,LIHC,66.0,FEMALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2011.0,nan,-24288.0,Alive,TUMOR FREE,1233.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1233.0,0.0,1233.0,0.0,1233.0,0.0,1233.0,0
TCGA-DD-AADB-01,TCGA-DD-AADB,LIHC,51.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G4,2011.0,nan,-18728.0,Alive,TUMOR FREE,1242.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1242.0,0.0,1242.0,0.0,1242.0,0.0,1242.0,0
TCGA-DD-AADC-01,TCGA-DD-AADC,LIHC,53.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2011.0,nan,-19527.0,Dead,WITH TUMOR,nan,425.0,nan,Intrahepatic Recurrence,Liver,nan,101.0,nan,nan,R0,1.0,425.0,1.0,425.0,1.0,101.0,1.0,101.0,1
TCGA-DD-AADD-01,TCGA-DD-AADD,LIHC,51.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G4,2011.0,nan,-18752.0,Alive,TUMOR FREE,1231.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1231.0,0.0,1231.0,0.0,1231.0,0.0,1231.0,0
TCGA-DD-AADE-01,TCGA-DD-AADE,LIHC,50.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G4,2011.0,nan,-18482.0,Alive,WITH TUMOR,1202.0,nan,nan,Intrahepatic Recurrence,Liver,nan,168.0,nan,nan,R0,0.0,1202.0,0.0,1202.0,1.0,168.0,1.0,168.0,0
TCGA-DD-AADF-01,TCGA-DD-AADF,LIHC,64.0,FEMALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G4,2011.0,nan,-23614.0,Dead,TUMOR FREE,nan,115.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,115.0,0.0,115.0,0.0,115.0,0.0,115.0,0
TCGA-DD-AADG-01,TCGA-DD-AADG,LIHC,70.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2011.0,nan,-25887.0,Alive,TUMOR FREE,1145.0,nan,nan,Intrahepatic Recurrence,Liver,nan,270.0,nan,nan,R0,0.0,1145.0,0.0,1145.0,1.0,270.0,1.0,270.0,0
TCGA-DD-AADI-01,TCGA-DD-AADI,LIHC,43.0,FEMALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2011.0,nan,-15928.0,Alive,TUMOR FREE,1085.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1085.0,0.0,1085.0,0.0,1085.0,0.0,1085.0,0
TCGA-DD-AADJ-01,TCGA-DD-AADJ,LIHC,70.0,FEMALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2011.0,nan,-25863.0,Alive,TUMOR FREE,1066.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1066.0,0.0,1066.0,0.0,1066.0,0.0,1066.0,0
TCGA-DD-AADK-01,TCGA-DD-AADK,LIHC,68.0,FEMALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G3,2011.0,nan,-25046.0,Alive,TUMOR FREE,1049.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1049.0,0.0,1049.0,0.0,1049.0,0.0,1049.0,0
TCGA-DD-AADL-01,TCGA-DD-AADL,LIHC,58.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G4,2012.0,nan,-21512.0,Alive,TUMOR FREE,636.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,636.0,0.0,636.0,0.0,636.0,0.0,636.0,0
TCGA-DD-AADM-01,TCGA-DD-AADM,LIHC,58.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G3,2012.0,nan,-21349.0,Dead,TUMOR FREE,nan,12.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,12.0,0.0,12.0,0.0,12.0,0.0,12.0,0
TCGA-DD-AADN-01,TCGA-DD-AADN,LIHC,59.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G4,2012.0,nan,-21632.0,Alive,TUMOR FREE,898.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,898.0,0.0,898.0,0.0,898.0,0.0,898.0,0
TCGA-DD-AADO-01,TCGA-DD-AADO,LIHC,55.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-20139.0,Alive,TUMOR FREE,453.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,453.0,0.0,453.0,0.0,453.0,0.0,453.0,0
TCGA-DD-AADP-01,TCGA-DD-AADP,LIHC,45.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-16760.0,Alive,TUMOR FREE,458.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,458.0,0.0,458.0,0.0,458.0,0.0,458.0,0
TCGA-DD-AADQ-01,TCGA-DD-AADQ,LIHC,59.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-21756.0,Alive,TUMOR FREE,436.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,436.0,0.0,436.0,0.0,436.0,0.0,436.0,0
TCGA-DD-AADR-01,TCGA-DD-AADR,LIHC,58.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2009.0,nan,-21217.0,Alive,TUMOR FREE,2028.0,nan,nan,Intrahepatic Recurrence,Liver,nan,1700.0,nan,nan,R0,0.0,2028.0,0.0,2028.0,1.0,1700.0,1.0,1700.0,0
TCGA-DD-AADS-01,TCGA-DD-AADS,LIHC,63.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-23227.0,Alive,TUMOR FREE,474.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,474.0,0.0,474.0,0.0,474.0,0.0,474.0,0
TCGA-DD-AADU-01,TCGA-DD-AADU,LIHC,60.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-21940.0,Alive,TUMOR FREE,554.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,554.0,0.0,554.0,0.0,554.0,0.0,554.0,0
TCGA-DD-AADV-01,TCGA-DD-AADV,LIHC,50.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-18300.0,Alive,TUMOR FREE,574.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,574.0,0.0,574.0,0.0,574.0,0.0,574.0,0
TCGA-DD-AADW-01,TCGA-DD-AADW,LIHC,48.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-17781.0,Alive,TUMOR FREE,587.0,nan,nan,Locoregional Recurrence,Liver,nan,386.0,nan,nan,R0,0.0,587.0,0.0,587.0,1.0,386.0,1.0,386.0,0
TCGA-DD-AADY-01,TCGA-DD-AADY,LIHC,55.0,FEMALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-20233.0,Alive,TUMOR FREE,555.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,555.0,0.0,555.0,0.0,555.0,0.0,555.0,0
TCGA-DD-AAE0-01,TCGA-DD-AAE0,LIHC,45.0,FEMALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G4,2013.0,nan,-16732.0,Alive,TUMOR FREE,555.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,555.0,0.0,555.0,0.0,555.0,0.0,555.0,0
TCGA-DD-AAE1-01,TCGA-DD-AAE1,LIHC,52.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-19073.0,Alive,TUMOR FREE,552.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,552.0,0.0,552.0,0.0,552.0,0.0,552.0,0
TCGA-DD-AAE2-01,TCGA-DD-AAE2,LIHC,51.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-18695.0,Alive,TUMOR FREE,638.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,638.0,0.0,638.0,0.0,638.0,0.0,638.0,0
TCGA-DD-AAE3-01,TCGA-DD-AAE3,LIHC,50.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-18271.0,Alive,TUMOR FREE,566.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,566.0,0.0,566.0,0.0,566.0,0.0,566.0,0
TCGA-DD-AAE4-01,TCGA-DD-AAE4,LIHC,49.0,FEMALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G1,2013.0,nan,-18009.0,Alive,WITH TUMOR,608.0,nan,nan,Locoregional Recurrence,Liver,nan,111.0,nan,nan,R0,0.0,608.0,0.0,608.0,1.0,111.0,1.0,111.0,2
TCGA-DD-AAE6-01,TCGA-DD-AAE6,LIHC,59.0,FEMALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-21764.0,Alive,WITH TUMOR,141.0,nan,nan,Intrahepatic Recurrence,Liver,nan,105.0,nan,nan,R0,0.0,141.0,0.0,141.0,1.0,105.0,1.0,105.0,2
TCGA-DD-AAE7-01,TCGA-DD-AAE7,LIHC,72.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-26568.0,Alive,TUMOR FREE,644.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,644.0,0.0,644.0,0.0,644.0,0.0,644.0,0
TCGA-DD-AAE8-01,TCGA-DD-AAE8,LIHC,45.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2012.0,nan,-16549.0,Alive,TUMOR FREE,664.0,nan,nan,Locoregional Recurrence,Liver,nan,28.0,nan,nan,R0,0.0,664.0,0.0,664.0,1.0,28.0,1.0,28.0,0
TCGA-DD-AAE9-01,TCGA-DD-AAE9,LIHC,69.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2012.0,nan,-25451.0,Alive,TUMOR FREE,722.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,722.0,0.0,722.0,0.0,722.0,0.0,722.0,0
TCGA-DD-AAEA-01,TCGA-DD-AAEA,LIHC,65.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2012.0,nan,-24027.0,Alive,TUMOR FREE,575.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,575.0,0.0,575.0,0.0,575.0,0.0,575.0,0
TCGA-DD-AAEB-01,TCGA-DD-AAEB,LIHC,60.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-22121.0,Alive,TUMOR FREE,478.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,478.0,0.0,478.0,0.0,478.0,0.0,478.0,0
TCGA-DD-AAED-01,TCGA-DD-AAED,LIHC,51.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2012.0,nan,-18722.0,Alive,WITH TUMOR,763.0,nan,nan,Intrahepatic Recurrence,Liver,nan,198.0,nan,nan,R0,0.0,763.0,0.0,763.0,1.0,198.0,1.0,198.0,2
TCGA-DD-AAEE-01,TCGA-DD-AAEE,LIHC,55.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G4,2012.0,nan,-20396.0,Alive,WITH TUMOR,810.0,nan,nan,Intrahepatic Recurrence,Liver,nan,224.0,nan,nan,R0,0.0,810.0,0.0,810.0,1.0,224.0,1.0,224.0,2
TCGA-DD-AAEG-01,TCGA-DD-AAEG,LIHC,59.0,FEMALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2012.0,nan,-21853.0,Alive,TUMOR FREE,719.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,719.0,0.0,719.0,0.0,719.0,0.0,719.0,0
TCGA-DD-AAEH-01,TCGA-DD-AAEH,LIHC,73.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-26894.0,Alive,TUMOR FREE,784.0,nan,nan,Extrahepatic Recurrence,Bone,nan,644.0,nan,nan,R0,0.0,784.0,0.0,784.0,1.0,644.0,1.0,644.0,0
TCGA-DD-AAEI-01,TCGA-DD-AAEI,LIHC,72.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2010.0,nan,-26465.0,Alive,WITH TUMOR,1531.0,nan,nan,Extrahepatic Recurrence,Bone,nan,491.0,nan,nan,R0,0.0,1531.0,0.0,1531.0,1.0,491.0,1.0,491.0,2
TCGA-DD-AAEK-01,TCGA-DD-AAEK,LIHC,51.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G3,2010.0,nan,-18757.0,Alive,TUMOR FREE,1067.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1067.0,0.0,1067.0,0.0,1067.0,0.0,1067.0,0
TCGA-DD-AAVP-01,TCGA-DD-AAVP,LIHC,48.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G1,2007.0,nan,-17833.0,Alive,TUMOR FREE,2752.0,nan,nan,Locoregional Recurrence,Liver,nan,903.0,nan,nan,R0,0.0,2752.0,0.0,2752.0,1.0,903.0,1.0,903.0,0
TCGA-DD-AAVQ-01,TCGA-DD-AAVQ,LIHC,38.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2007.0,nan,-13911.0,Alive,TUMOR FREE,2728.0,nan,nan,Locoregional Recurrence,Liver,nan,1509.0,nan,nan,R0,0.0,2728.0,0.0,2728.0,1.0,1509.0,1.0,1509.0,0
TCGA-DD-AAVR-01,TCGA-DD-AAVR,LIHC,44.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2007.0,nan,-16157.0,Alive,TUMOR FREE,2513.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2513.0,0.0,2513.0,0.0,2513.0,0.0,2513.0,0
TCGA-DD-AAVS-01,TCGA-DD-AAVS,LIHC,56.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2007.0,nan,-20586.0,Alive,TUMOR FREE,1823.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1823.0,0.0,1823.0,0.0,1823.0,0.0,1823.0,0
TCGA-DD-AAVU-01,TCGA-DD-AAVU,LIHC,46.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G2,2008.0,nan,-16889.0,Alive,TUMOR FREE,2202.0,nan,nan,Intrahepatic Recurrence,Liver,nan,1630.0,nan,nan,R0,0.0,2202.0,0.0,2202.0,1.0,1630.0,1.0,1630.0,0
TCGA-DD-AAVV-01,TCGA-DD-AAVV,LIHC,56.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G3,2007.0,nan,-20751.0,Alive,TUMOR FREE,2455.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2455.0,0.0,2455.0,0.0,2455.0,0.0,2455.0,0
TCGA-DD-AAVW-01,TCGA-DD-AAVW,LIHC,35.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2008.0,nan,-12986.0,Alive,TUMOR FREE,2317.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2317.0,0.0,2317.0,0.0,2317.0,0.0,2317.0,0
TCGA-DD-AAVX-01,TCGA-DD-AAVX,LIHC,38.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G2,2008.0,nan,-14016.0,Alive,WITH TUMOR,1718.0,nan,nan,Intrahepatic Recurrence,Liver,nan,393.0,nan,nan,R0,0.0,1718.0,0.0,1718.0,1.0,393.0,1.0,393.0,2
TCGA-DD-AAVY-01,TCGA-DD-AAVY,LIHC,56.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2009.0,nan,-20709.0,Alive,TUMOR FREE,1970.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1970.0,0.0,1970.0,0.0,1970.0,0.0,1970.0,0
TCGA-DD-AAVZ-01,TCGA-DD-AAVZ,LIHC,38.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2009.0,nan,-14005.0,Alive,TUMOR FREE,1900.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1900.0,0.0,1900.0,0.0,1900.0,0.0,1900.0,0
TCGA-DD-AAW0-01,TCGA-DD-AAW0,LIHC,54.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2009.0,nan,-19981.0,Alive,TUMOR FREE,2015.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2015.0,0.0,2015.0,0.0,2015.0,0.0,2015.0,0
TCGA-DD-AAW1-01,TCGA-DD-AAW1,LIHC,55.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2009.0,nan,-20288.0,Alive,TUMOR FREE,1989.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1989.0,0.0,1989.0,0.0,1989.0,0.0,1989.0,0
TCGA-DD-AAW2-01,TCGA-DD-AAW2,LIHC,69.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2009.0,nan,-25420.0,Alive,WITH TUMOR,1855.0,nan,nan,Intrahepatic Recurrence,Liver,nan,391.0,nan,nan,R0,0.0,1855.0,0.0,1855.0,1.0,391.0,1.0,391.0,2
TCGA-DD-AAW3-01,TCGA-DD-AAW3,LIHC,69.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2009.0,nan,-25254.0,Alive,TUMOR FREE,1633.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1633.0,0.0,1633.0,0.0,1633.0,0.0,1633.0,0
TCGA-ED-A459-01,TCGA-ED-A459,LIHC,47.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-17402.0,Alive,TUMOR FREE,910.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,910.0,0.0,910.0,0.0,910.0,0.0,910.0,0
TCGA-ED-A4XI-01,TCGA-ED-A4XI,LIHC,58.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G3,2012.0,nan,-21497.0,Alive,TUMOR FREE,819.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,819.0,0.0,819.0,0.0,819.0,0.0,819.0,0
TCGA-ED-A5KG-01,TCGA-ED-A5KG,LIHC,60.0,FEMALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-22258.0,Alive,WITH TUMOR,854.0,nan,nan,New Primary Tumor,"Other, specify",Kidney,110.0,nan,nan,R0,0.0,854.0,0.0,854.0,0.0,854.0,1.0,110.0,2
TCGA-ED-A627-01,TCGA-ED-A627,LIHC,74.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-27303.0,Alive,TUMOR FREE,423.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,423.0,0.0,423.0,0.0,423.0,0.0,423.0,0
TCGA-ED-A66X-01,TCGA-ED-A66X,LIHC,35.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-12947.0,Alive,TUMOR FREE,406.0,nan,nan,Intrahepatic Recurrence,Liver,nan,124.0,nan,nan,R0,0.0,406.0,0.0,406.0,1.0,124.0,1.0,124.0,0
TCGA-ED-A66Y-01,TCGA-ED-A66Y,LIHC,51.0,FEMALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-18797.0,Dead,TUMOR FREE,nan,296.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,296.0,0.0,296.0,0.0,296.0,0.0,296.0,0
TCGA-ED-A7PX-01,TCGA-ED-A7PX,LIHC,48.0,FEMALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-17638.0,Alive,TUMOR FREE,6.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,6.0,0.0,6.0,0.0,6.0,0.0,6.0,0
TCGA-ED-A7PY-01,TCGA-ED-A7PY,LIHC,20.0,FEMALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-7556.0,Alive,TUMOR FREE,390.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,390.0,0.0,390.0,0.0,390.0,0.0,390.0,0
TCGA-ED-A7PZ-01,TCGA-ED-A7PZ,LIHC,61.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-22601.0,Alive,TUMOR FREE,6.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,6.0,0.0,6.0,0.0,6.0,0.0,6.0,0
TCGA-ED-A7XO-01,TCGA-ED-A7XO,LIHC,29.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-10828.0,Alive,WITH TUMOR,427.0,nan,nan,Locoregional Recurrence,Liver,nan,262.0,nan,nan,R0,0.0,427.0,0.0,427.0,1.0,262.0,1.0,262.0,2
TCGA-ED-A7XP-01,TCGA-ED-A7XP,LIHC,53.0,FEMALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-19504.0,Alive,WITH TUMOR,400.0,nan,nan,Locoregional Recurrence,Liver,nan,187.0,nan,nan,R0,0.0,400.0,0.0,400.0,1.0,187.0,1.0,187.0,2
TCGA-ED-A82E-01,TCGA-ED-A82E,LIHC,60.0,FEMALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-22234.0,Alive,TUMOR FREE,408.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,408.0,0.0,408.0,0.0,408.0,0.0,408.0,0
TCGA-ED-A8O5-01,TCGA-ED-A8O5,LIHC,59.0,FEMALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-21648.0,Alive,TUMOR FREE,406.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,406.0,0.0,406.0,0.0,406.0,0.0,406.0,0
TCGA-ED-A8O6-01,TCGA-ED-A8O6,LIHC,50.0,FEMALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-18572.0,Dead,TUMOR FREE,nan,56.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,56.0,0.0,56.0,0.0,56.0,0.0,56.0,0
TCGA-ED-A97K-01,TCGA-ED-A97K,LIHC,54.0,MALE,ASIAN,Stage IIIA,nan,Hepatocholangiocarcinoma (Mixed),G2,2013.0,nan,-20073.0,Alive,TUMOR FREE,6.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,6.0,0.0,6.0,0.0,6.0,0.0,6.0,0
TCGA-EP-A12J-01,TCGA-EP-A12J,LIHC,62.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Hepatocellular Carcinoma,G1,2010.0,nan,-22997.0,Alive,TUMOR FREE,570.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,570.0,0.0,570.0,0.0,570.0,0.0,570.0,0
TCGA-EP-A12J-11,TCGA-EP-A12J,LIHC,62.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Hepatocellular Carcinoma,G1,2010.0,nan,-22997.0,Alive,TUMOR FREE,570.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,570.0,0.0,570.0,0.0,570.0,0.0,570.0,0
TCGA-EP-A26S-01,TCGA-EP-A26S,LIHC,70.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-25677.0,Alive,TUMOR FREE,608.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,608.0,0.0,608.0,nan,nan,0.0,608.0,0
TCGA-EP-A26S-11,TCGA-EP-A26S,LIHC,70.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-25677.0,Alive,TUMOR FREE,608.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,608.0,0.0,608.0,nan,nan,0.0,608.0,0
TCGA-EP-A2KA-01,TCGA-EP-A2KA,LIHC,52.0,FEMALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2011.0,nan,-19214.0,Dead,WITH TUMOR,nan,627.0,nan,Extrahepatic Recurrence,Lung,nan,293.0,nan,nan,R0,1.0,627.0,1.0,627.0,1.0,293.0,1.0,293.0,1
TCGA-EP-A2KB-01,TCGA-EP-A2KB,LIHC,46.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-16835.0,Dead,WITH TUMOR,nan,596.0,nan,Intrahepatic Recurrence,Liver,nan,161.0,nan,nan,R0,1.0,596.0,1.0,596.0,1.0,161.0,1.0,161.0,1
TCGA-EP-A2KC-01,TCGA-EP-A2KC,LIHC,62.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Hepatocellular Carcinoma,G3,2011.0,nan,-22677.0,Dead,TUMOR FREE,nan,19.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,19.0,0.0,19.0,0.0,19.0,0.0,19.0,0
TCGA-EP-A3JL-01,TCGA-EP-A3JL,LIHC,76.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-27886.0,Alive,TUMOR FREE,303.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,303.0,0.0,303.0,nan,nan,0.0,303.0,0
TCGA-EP-A3RK-01,TCGA-EP-A3RK,LIHC,73.0,MALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-26985.0,Alive,WITH TUMOR,363.0,nan,nan,Locoregional Recurrence,Liver,nan,320.0,nan,nan,nan,0.0,363.0,0.0,363.0,nan,nan,1.0,320.0,2
TCGA-EP-A3RK-11,TCGA-EP-A3RK,LIHC,73.0,MALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-26985.0,Alive,WITH TUMOR,363.0,nan,nan,Locoregional Recurrence,Liver,nan,320.0,nan,nan,nan,0.0,363.0,0.0,363.0,nan,nan,1.0,320.0,2
TCGA-ES-A2HS-01,TCGA-ES-A2HS,LIHC,80.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2008.0,nan,-29268.0,Dead,TUMOR FREE,nan,688.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,688.0,0.0,688.0,0.0,688.0,0.0,688.0,0
TCGA-ES-A2HS-11,TCGA-ES-A2HS,LIHC,80.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2008.0,nan,-29268.0,Dead,TUMOR FREE,nan,688.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,688.0,0.0,688.0,0.0,688.0,0.0,688.0,0
TCGA-ES-A2HT-01,TCGA-ES-A2HT,LIHC,54.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Hepatocellular Carcinoma,G2,2007.0,nan,-20023.0,Dead,TUMOR FREE,nan,438.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,438.0,0.0,438.0,0.0,438.0,0.0,438.0,0
TCGA-ES-A2HT-11,TCGA-ES-A2HT,LIHC,54.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Hepatocellular Carcinoma,G2,2007.0,nan,-20023.0,Dead,TUMOR FREE,nan,438.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,438.0,0.0,438.0,0.0,438.0,0.0,438.0,0
TCGA-FV-A23B-01,TCGA-FV-A23B,LIHC,70.0,FEMALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,nan,2005.0,nan,-25788.0,Dead,WITH TUMOR,nan,1852.0,nan,Locoregional Recurrence,Liver,nan,1453.0,nan,nan,R0,1.0,1852.0,1.0,1852.0,1.0,1453.0,1.0,1453.0,1
TCGA-FV-A23B-11,TCGA-FV-A23B,LIHC,70.0,FEMALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,nan,2005.0,nan,-25788.0,Dead,WITH TUMOR,nan,1852.0,nan,Locoregional Recurrence,Liver,nan,1453.0,nan,nan,R0,1.0,1852.0,1.0,1852.0,1.0,1453.0,1.0,1453.0,1
TCGA-FV-A2QQ-01,TCGA-FV-A2QQ,LIHC,80.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-29354.0,Alive,TUMOR FREE,729.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,729.0,0.0,729.0,0.0,729.0,0.0,729.0,0
TCGA-FV-A2QR-01,TCGA-FV-A2QR,LIHC,75.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G1,2006.0,nan,nan,Dead,WITH TUMOR,nan,581.0,nan,Extrahepatic Recurrence,nan,nan,561.0,nan,nan,RX,1.0,581.0,1.0,581.0,nan,nan,1.0,561.0,1
TCGA-FV-A2QR-11,TCGA-FV-A2QR,LIHC,75.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G1,2006.0,nan,nan,Dead,WITH TUMOR,nan,581.0,nan,Extrahepatic Recurrence,nan,nan,561.0,nan,nan,RX,1.0,581.0,1.0,581.0,nan,nan,1.0,561.0,1
TCGA-FV-A3I0-01,TCGA-FV-A3I0,LIHC,76.0,FEMALE,WHITE,Stage II,nan,Hepatocholangiocarcinoma (Mixed),G2,2011.0,nan,-28101.0,Alive,WITH TUMOR,848.0,nan,nan,Intrahepatic Recurrence,Liver,nan,159.0,nan,nan,R0,0.0,848.0,0.0,848.0,1.0,159.0,1.0,159.0,2
TCGA-FV-A3I0-11,TCGA-FV-A3I0,LIHC,76.0,FEMALE,WHITE,Stage II,nan,Hepatocholangiocarcinoma (Mixed),G2,2011.0,nan,-28101.0,Alive,WITH TUMOR,848.0,nan,nan,Intrahepatic Recurrence,Liver,nan,159.0,nan,nan,R0,0.0,848.0,0.0,848.0,1.0,159.0,1.0,159.0,2
TCGA-FV-A3I1-01,TCGA-FV-A3I1,LIHC,81.0,FEMALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2011.0,nan,nan,Dead,TUMOR FREE,nan,247.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,247.0,0.0,247.0,0.0,247.0,0.0,247.0,0
TCGA-FV-A3I1-11,TCGA-FV-A3I1,LIHC,81.0,FEMALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2011.0,nan,nan,Dead,TUMOR FREE,nan,247.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,247.0,0.0,247.0,0.0,247.0,0.0,247.0,0
TCGA-FV-A3R2-01,TCGA-FV-A3R2,LIHC,75.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,nan,2005.0,nan,-27530.0,Dead,TUMOR FREE,nan,194.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,194.0,0.0,194.0,0.0,194.0,0.0,194.0,0
TCGA-FV-A3R2-11,TCGA-FV-A3R2,LIHC,75.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,nan,2005.0,nan,-27530.0,Dead,TUMOR FREE,nan,194.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,194.0,0.0,194.0,0.0,194.0,0.0,194.0,0
TCGA-FV-A3R3-01,TCGA-FV-A3R3,LIHC,38.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-14231.0,Dead,TUMOR FREE,nan,366.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,366.0,0.0,366.0,0.0,366.0,0.0,366.0,0
TCGA-FV-A495-01,TCGA-FV-A495,LIHC,51.0,FEMALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-18740.0,Alive,TUMOR FREE,1.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,0
TCGA-FV-A496-01,TCGA-FV-A496,LIHC,84.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-30950.0,Alive,TUMOR FREE,10.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,10.0,0.0,10.0,0.0,10.0,0.0,10.0,0
TCGA-FV-A4ZP-01,TCGA-FV-A4ZP,LIHC,78.0,MALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2005.0,nan,-28771.0,Dead,TUMOR FREE,nan,2486.0,nan,nan,nan,nan,nan,nan,nan,R1,1.0,2486.0,0.0,2486.0,nan,nan,0.0,2486.0,0
TCGA-FV-A4ZQ-01,TCGA-FV-A4ZQ,LIHC,52.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-19090.0,Alive,TUMOR FREE,12.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,12.0,0.0,12.0,0.0,12.0,0.0,12.0,0
TCGA-G3-A25S-01,TCGA-G3-A25S,LIHC,64.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2009.0,nan,-23571.0,Dead,WITH TUMOR,nan,416.0,nan,Extrahepatic Recurrence,"Other, specify",Bone and Lung,37.0,nan,nan,R1,1.0,416.0,1.0,416.0,nan,nan,1.0,37.0,1
TCGA-G3-A25T-01,TCGA-G3-A25T,LIHC,45.0,FEMALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2007.0,nan,-16461.0,Alive,WITH TUMOR,1553.0,nan,nan,Intrahepatic Recurrence,Liver,nan,452.0,nan,nan,R0,0.0,1553.0,0.0,1553.0,1.0,452.0,1.0,452.0,2
TCGA-G3-A25U-01,TCGA-G3-A25U,LIHC,63.0,FEMALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2007.0,nan,-23207.0,Alive,TUMOR FREE,1636.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1636.0,0.0,1636.0,0.0,1636.0,0.0,1636.0,0
TCGA-G3-A25V-01,TCGA-G3-A25V,LIHC,68.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2010.0,nan,-25144.0,Alive,WITH TUMOR,860.0,nan,nan,Intrahepatic Recurrence,Liver,nan,489.0,nan,nan,R0,0.0,860.0,0.0,860.0,1.0,489.0,1.0,489.0,2
TCGA-G3-A25W-01,TCGA-G3-A25W,LIHC,79.0,FEMALE,WHITE,Stage IIIB,nan,Hepatocellular Carcinoma,G2,2010.0,nan,-29018.0,Alive,TUMOR FREE,935.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,935.0,0.0,935.0,0.0,935.0,0.0,935.0,0
TCGA-G3-A25W-11,TCGA-G3-A25W,LIHC,79.0,FEMALE,WHITE,Stage IIIB,nan,Hepatocellular Carcinoma,G2,2010.0,nan,-29018.0,Alive,TUMOR FREE,935.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,935.0,0.0,935.0,0.0,935.0,0.0,935.0,0
TCGA-G3-A25X-01,TCGA-G3-A25X,LIHC,73.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G3,2007.0,nan,-26988.0,Alive,TUMOR FREE,1779.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1779.0,0.0,1779.0,0.0,1779.0,0.0,1779.0,0
TCGA-G3-A25X-11,TCGA-G3-A25X,LIHC,73.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G3,2007.0,nan,-26988.0,Alive,TUMOR FREE,1779.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1779.0,0.0,1779.0,0.0,1779.0,0.0,1779.0,0
TCGA-G3-A25Y-01,TCGA-G3-A25Y,LIHC,52.0,FEMALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2006.0,nan,-19055.0,Dead,WITH TUMOR,nan,452.0,nan,Locoregional Recurrence,Liver,nan,355.0,nan,nan,R0,1.0,452.0,1.0,452.0,1.0,355.0,1.0,355.0,1
TCGA-G3-A25Z-01,TCGA-G3-A25Z,LIHC,58.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2010.0,nan,-21509.0,Alive,TUMOR FREE,655.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,655.0,0.0,655.0,0.0,655.0,0.0,655.0,0
TCGA-G3-A3CG-01,TCGA-G3-A3CG,LIHC,80.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-29432.0,Alive,WITH TUMOR,673.0,nan,nan,Intrahepatic Recurrence,Liver,nan,329.0,nan,nan,R1,0.0,673.0,0.0,673.0,nan,nan,1.0,329.0,0
TCGA-G3-A3CH-01,TCGA-G3-A3CH,LIHC,53.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2010.0,nan,-19473.0,Alive,WITH TUMOR,780.0,nan,nan,Intrahepatic Recurrence,Liver,nan,116.0,nan,nan,R0,0.0,780.0,0.0,780.0,1.0,116.0,1.0,116.0,2
TCGA-G3-A3CH-11,TCGA-G3-A3CH,LIHC,53.0,MALE,ASIAN,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2010.0,nan,-19473.0,Alive,WITH TUMOR,780.0,nan,nan,Intrahepatic Recurrence,Liver,nan,116.0,nan,nan,R0,0.0,780.0,0.0,780.0,1.0,116.0,1.0,116.0,2
TCGA-G3-A3CI-01,TCGA-G3-A3CI,LIHC,71.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-26224.0,Alive,TUMOR FREE,180.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,180.0,0.0,180.0,0.0,180.0,0.0,180.0,0
TCGA-G3-A3CJ-01,TCGA-G3-A3CJ,LIHC,52.0,MALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage II,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-19305.0,Alive,WITH TUMOR,594.0,nan,nan,Extrahepatic Recurrence,Lung,nan,296.0,nan,nan,R0,0.0,594.0,0.0,594.0,1.0,296.0,1.0,296.0,2
TCGA-G3-A3CK-01,TCGA-G3-A3CK,LIHC,61.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-22462.0,Alive,TUMOR FREE,585.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,585.0,0.0,585.0,0.0,585.0,0.0,585.0,0
TCGA-G3-A5SI-01,TCGA-G3-A5SI,LIHC,44.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-16126.0,Dead,WITH TUMOR,nan,768.0,nan,Intrahepatic Recurrence,Liver,nan,348.0,nan,nan,R0,1.0,768.0,1.0,768.0,1.0,348.0,1.0,348.0,1
TCGA-G3-A5SJ-01,TCGA-G3-A5SJ,LIHC,59.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-21848.0,Alive,TUMOR FREE,698.0,nan,nan,Intrahepatic Recurrence,Liver,nan,308.0,nan,nan,R0,0.0,698.0,0.0,698.0,1.0,308.0,1.0,308.0,0
TCGA-G3-A5SK-01,TCGA-G3-A5SK,LIHC,58.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G1,2012.0,nan,-21320.0,Alive,WITH TUMOR,744.0,nan,nan,Intrahepatic Recurrence,Liver,nan,483.0,nan,nan,R0,0.0,744.0,0.0,744.0,1.0,483.0,1.0,483.0,2
TCGA-G3-A5SL-01,TCGA-G3-A5SL,LIHC,70.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-25671.0,Alive,TUMOR FREE,621.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,621.0,0.0,621.0,0.0,621.0,0.0,621.0,0
TCGA-G3-A5SM-01,TCGA-G3-A5SM,LIHC,58.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G3,2012.0,nan,-21236.0,Alive,TUMOR FREE,520.0,nan,nan,Intrahepatic Recurrence,Liver,nan,252.0,nan,nan,R0,0.0,520.0,0.0,520.0,1.0,252.0,1.0,252.0,0
TCGA-G3-A6UC-01,TCGA-G3-A6UC,LIHC,65.0,MALE,WHITE,Stage IIIB,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-23793.0,Alive,WITH TUMOR,671.0,nan,nan,Intrahepatic Recurrence,Liver,nan,639.0,nan,nan,R0,0.0,671.0,0.0,671.0,1.0,639.0,1.0,639.0,2
TCGA-G3-A7M5-01,TCGA-G3-A7M5,LIHC,76.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-27963.0,Alive,TUMOR FREE,447.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,447.0,0.0,447.0,0.0,447.0,0.0,447.0,0
TCGA-G3-A7M6-01,TCGA-G3-A7M6,LIHC,60.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-22205.0,Alive,WITH TUMOR,632.0,nan,nan,Locoregional Recurrence,Liver,nan,293.0,nan,nan,R0,0.0,632.0,0.0,632.0,1.0,293.0,1.0,293.0,2
TCGA-G3-A7M7-01,TCGA-G3-A7M7,LIHC,65.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G1,2013.0,nan,-24002.0,Alive,TUMOR FREE,361.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,361.0,0.0,361.0,0.0,361.0,0.0,361.0,0
TCGA-G3-A7M8-01,TCGA-G3-A7M8,LIHC,31.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G1,2013.0,nan,-11527.0,Alive,TUMOR FREE,430.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,430.0,0.0,430.0,nan,nan,0.0,430.0,0
TCGA-G3-A7M9-01,TCGA-G3-A7M9,LIHC,70.0,MALE,WHITE,Stage IIIB,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-25588.0,Dead,nan,nan,56.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,56.0,nan,56.0,0.0,56.0,0.0,56.0,0
TCGA-G3-AAUZ-01,TCGA-G3-AAUZ,LIHC,48.0,MALE,[Unknown],Stage I,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-17760.0,Alive,TUMOR FREE,480.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,480.0,0.0,480.0,0.0,480.0,0.0,480.0,0
TCGA-G3-AAV0-01,TCGA-G3-AAV0,LIHC,58.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-21249.0,Alive,TUMOR FREE,476.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,476.0,0.0,476.0,0.0,476.0,0.0,476.0,0
TCGA-G3-AAV1-01,TCGA-G3-AAV1,LIHC,51.0,MALE,ASIAN,Stage IIIC,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-18973.0,Dead,WITH TUMOR,nan,359.0,nan,Locoregional Recurrence,Liver,nan,49.0,nan,nan,R0,1.0,359.0,1.0,359.0,1.0,49.0,1.0,49.0,1
TCGA-G3-AAV2-01,TCGA-G3-AAV2,LIHC,50.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G1,2013.0,nan,-18363.0,Alive,TUMOR FREE,372.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,372.0,0.0,372.0,0.0,372.0,0.0,372.0,0
TCGA-G3-AAV3-01,TCGA-G3-AAV3,LIHC,58.0,FEMALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-21449.0,Alive,TUMOR FREE,412.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,412.0,0.0,412.0,0.0,412.0,0.0,412.0,0
TCGA-G3-AAV4-01,TCGA-G3-AAV4,LIHC,83.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G1,2012.0,nan,-30466.0,Dead,TUMOR FREE,nan,27.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,27.0,0.0,27.0,0.0,27.0,0.0,27.0,0
TCGA-G3-AAV5-01,TCGA-G3-AAV5,LIHC,67.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-24655.0,Alive,WITH TUMOR,354.0,nan,nan,Locoregional Recurrence,Liver,nan,117.0,nan,nan,R0,0.0,354.0,0.0,354.0,1.0,117.0,1.0,117.0,2
TCGA-G3-AAV6-01,TCGA-G3-AAV6,LIHC,53.0,FEMALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-19556.0,Dead,WITH TUMOR,nan,65.0,nan,Intrahepatic Recurrence,Liver,nan,44.0,nan,nan,R0,1.0,65.0,1.0,65.0,1.0,44.0,1.0,44.0,1
TCGA-G3-AAV7-01,TCGA-G3-AAV7,LIHC,38.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-14229.0,Alive,TUMOR FREE,361.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,361.0,0.0,361.0,0.0,361.0,0.0,361.0,0
TCGA-GJ-A3OU-01,TCGA-GJ-A3OU,LIHC,59.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-21671.0,Alive,[Discrepancy],879.0,nan,nan,Intrahepatic Recurrence,Liver,nan,879.0,nan,nan,RX,0.0,879.0,0.0,879.0,nan,nan,1.0,879.0,0
TCGA-GJ-A6C0-01,TCGA-GJ-A6C0,LIHC,75.0,FEMALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-27626.0,Dead,nan,nan,31.0,nan,nan,nan,nan,nan,nan,nan,RX,1.0,31.0,nan,31.0,nan,nan,0.0,31.0,1
TCGA-GJ-A9DB-01,TCGA-GJ-A9DB,LIHC,68.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-25020.0,Dead,nan,nan,67.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,67.0,nan,67.0,0.0,67.0,0.0,67.0,0
TCGA-HP-A5MZ-01,TCGA-HP-A5MZ,LIHC,78.0,MALE,[Not Evaluated],Stage I,nan,Hepatocellular Carcinoma,G2,nan,nan,-22702.0,Dead,TUMOR FREE,nan,91.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,91.0,0.0,91.0,0.0,91.0,0.0,91.0,0
TCGA-HP-A5N0-01,TCGA-HP-A5N0,LIHC,90.0,FEMALE,[Not Evaluated],nan,nan,Hepatocellular Carcinoma,nan,nan,nan,-32120.0,Dead,WITH TUMOR,nan,1147.0,nan,Locoregional Recurrence,Liver,nan,179.0,nan,nan,R0,1.0,1147.0,1.0,1147.0,1.0,179.0,1.0,179.0,1
TCGA-K7-A5RF-01,TCGA-K7-A5RF,LIHC,64.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G1,2012.0,nan,-23557.0,Alive,TUMOR FREE,631.0,nan,nan,Intrahepatic Recurrence,Liver,nan,205.0,nan,nan,R0,0.0,631.0,0.0,631.0,1.0,205.0,1.0,205.0,0
TCGA-K7-A5RG-01,TCGA-K7-A5RG,LIHC,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Hepatocellular Carcinoma,G1,2012.0,nan,-24218.0,Alive,TUMOR FREE,519.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,519.0,0.0,519.0,0.0,519.0,0.0,519.0,0
TCGA-K7-A6G5-01,TCGA-K7-A6G5,LIHC,66.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-24233.0,Alive,TUMOR FREE,512.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,512.0,0.0,512.0,nan,nan,0.0,512.0,0
TCGA-K7-AAU7-01,TCGA-K7-AAU7,LIHC,61.0,MALE,WHITE,Stage II,nan,Hepatocholangiocarcinoma (Mixed),G2,2013.0,nan,-22476.0,Alive,WITH TUMOR,359.0,nan,nan,Intrahepatic Recurrence,Liver,nan,58.0,nan,nan,RX,0.0,359.0,0.0,359.0,nan,nan,1.0,58.0,2
TCGA-KR-A7K0-01,TCGA-KR-A7K0,LIHC,65.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G1,2013.0,nan,-23974.0,Dead,TUMOR FREE,nan,65.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,65.0,0.0,65.0,0.0,65.0,0.0,65.0,0
TCGA-KR-A7K2-01,TCGA-KR-A7K2,LIHC,64.0,MALE,WHITE,Stage I,nan,Hepatocholangiocarcinoma (Mixed),G1,2013.0,nan,-23699.0,Alive,TUMOR FREE,829.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,829.0,0.0,829.0,0.0,829.0,0.0,829.0,0
TCGA-KR-A7K7-01,TCGA-KR-A7K7,LIHC,61.0,FEMALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G1,2012.0,nan,-22587.0,Alive,WITH TUMOR,951.0,nan,nan,Extrahepatic Recurrence,"Other, specify",Adrenal bilateral,239.0,nan,nan,R0,0.0,951.0,0.0,951.0,1.0,239.0,1.0,239.0,2
TCGA-KR-A7K8-01,TCGA-KR-A7K8,LIHC,57.0,MALE,[Unknown],Stage I,nan,Hepatocellular Carcinoma,G1,2012.0,nan,-20914.0,Alive,TUMOR FREE,906.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,906.0,0.0,906.0,0.0,906.0,0.0,906.0,0
TCGA-LG-A6GG-01,TCGA-LG-A6GG,LIHC,79.0,FEMALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-28871.0,Alive,TUMOR FREE,387.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,387.0,0.0,387.0,0.0,387.0,0.0,387.0,0
TCGA-LG-A9QC-01,TCGA-LG-A9QC,LIHC,48.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-17842.0,Alive,TUMOR FREE,425.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,425.0,0.0,425.0,0.0,425.0,0.0,425.0,0
TCGA-LG-A9QD-01,TCGA-LG-A9QD,LIHC,68.0,MALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-24969.0,Alive,WITH TUMOR,366.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,366.0,0.0,366.0,0.0,366.0,0.0,366.0,0
TCGA-MI-A75C-01,TCGA-MI-A75C,LIHC,64.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G3,2012.0,nan,-23441.0,Alive,TUMOR FREE,291.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,291.0,0.0,291.0,0.0,291.0,0.0,291.0,0
TCGA-MI-A75E-01,TCGA-MI-A75E,LIHC,61.0,MALE,WHITE,Stage IIIC,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-22457.0,Alive,TUMOR FREE,507.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,507.0,0.0,507.0,0.0,507.0,0.0,507.0,0
TCGA-MI-A75G-01,TCGA-MI-A75G,LIHC,63.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-23284.0,Alive,TUMOR FREE,698.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,698.0,0.0,698.0,0.0,698.0,0.0,698.0,0
TCGA-MI-A75H-01,TCGA-MI-A75H,LIHC,77.0,MALE,WHITE,nan,nan,Hepatocellular Carcinoma,nan,2012.0,nan,-28371.0,Alive,WITH TUMOR,747.0,nan,nan,Locoregional Recurrence,Liver,nan,301.0,nan,nan,R0,0.0,747.0,0.0,747.0,1.0,301.0,1.0,301.0,0
TCGA-MI-A75I-01,TCGA-MI-A75I,LIHC,61.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Hepatocellular Carcinoma,G1,2011.0,nan,-22341.0,Alive,nan,630.0,nan,nan,nan,Liver,nan,265.0,nan,nan,R0,0.0,630.0,0.0,630.0,1.0,265.0,1.0,265.0,0
TCGA-MR-A520-01,TCGA-MR-A520,LIHC,58.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G1,2012.0,nan,-21398.0,Alive,TUMOR FREE,229.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,229.0,0.0,229.0,nan,nan,0.0,229.0,0
TCGA-MR-A8JO-01,TCGA-MR-A8JO,LIHC,34.0,MALE,WHITE,Stage I,nan,Fibrolamellar Carcinoma,G3,2013.0,nan,-12669.0,Alive,TUMOR FREE,330.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,330.0,0.0,330.0,nan,nan,0.0,330.0,0
TCGA-NI-A4U2-01,TCGA-NI-A4U2,LIHC,71.0,MALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G1,2005.0,nan,-26011.0,Dead,WITH TUMOR,nan,1791.0,nan,Locoregional Recurrence,Liver,nan,106.0,nan,nan,R0,1.0,1791.0,1.0,1791.0,1.0,106.0,1.0,106.0,1
TCGA-NI-A8LF-01,TCGA-NI-A8LF,LIHC,74.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G3,2012.0,nan,-27162.0,Alive,TUMOR FREE,799.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,799.0,0.0,799.0,0.0,799.0,0.0,799.0,0
TCGA-O8-A75V-01,TCGA-O8-A75V,LIHC,54.0,MALE,[Unknown],Stage I,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-19850.0,Alive,TUMOR FREE,538.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,538.0,0.0,538.0,nan,nan,0.0,538.0,0
TCGA-PD-A5DF-01,TCGA-PD-A5DF,LIHC,58.0,FEMALE,WHITE,Stage IIIB,nan,Hepatocellular Carcinoma,G2,2007.0,nan,-21414.0,Dead,WITH TUMOR,nan,639.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,639.0,1.0,639.0,nan,nan,1.0,639.0,1
TCGA-QA-A7B7-01,TCGA-QA-A7B7,LIHC,48.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-17636.0,Alive,WITH TUMOR,94.0,nan,nan,Locoregional Recurrence,Liver,nan,88.0,nan,nan,RX,0.0,94.0,0.0,94.0,nan,nan,1.0,88.0,2
TCGA-RC-A6M3-01,TCGA-RC-A6M3,LIHC,24.0,MALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage II,nan,Hepatocellular Carcinoma,G3,2009.0,nan,-8899.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0
TCGA-RC-A6M4-01,TCGA-RC-A6M4,LIHC,74.0,FEMALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2010.0,nan,-27327.0,Alive,nan,22.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,22.0,0.0,22.0,nan,nan,0.0,22.0,0
TCGA-RC-A6M5-01,TCGA-RC-A6M5,LIHC,20.0,FEMALE,WHITE,Stage IVA,nan,Fibrolamellar Carcinoma,G2,2012.0,nan,-7634.0,Alive,nan,15.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,15.0,0.0,15.0,nan,nan,0.0,15.0,0
TCGA-RC-A6M6-01,TCGA-RC-A6M6,LIHC,75.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G3,2011.0,nan,-27649.0,Alive,nan,9.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,9.0,0.0,9.0,nan,nan,0.0,9.0,0
TCGA-RC-A7S9-01,TCGA-RC-A7S9,LIHC,47.0,FEMALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2012.0,nan,-17403.0,Alive,TUMOR FREE,640.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,640.0,0.0,640.0,0.0,640.0,0.0,640.0,0
TCGA-RC-A7SB-01,TCGA-RC-A7SB,LIHC,53.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-19698.0,Alive,TUMOR FREE,588.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,588.0,0.0,588.0,0.0,588.0,0.0,588.0,0
TCGA-RC-A7SF-01,TCGA-RC-A7SF,LIHC,66.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-24432.0,Alive,WITH TUMOR,579.0,nan,nan,Locoregional Recurrence,Liver,nan,502.0,nan,nan,R0,0.0,579.0,0.0,579.0,1.0,502.0,1.0,502.0,2
TCGA-RC-A7SH-01,TCGA-RC-A7SH,LIHC,42.0,MALE,ASIAN,Stage II,nan,Hepatocellular Carcinoma,G3,2012.0,nan,-15560.0,Alive,WITH TUMOR,468.0,nan,nan,Extrahepatic Recurrence,Lung,nan,91.0,nan,nan,R0,0.0,468.0,0.0,468.0,1.0,91.0,1.0,91.0,2
TCGA-RC-A7SK-01,TCGA-RC-A7SK,LIHC,59.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-21814.0,Alive,TUMOR FREE,472.0,nan,nan,Intrahepatic Recurrence,Liver,nan,312.0,nan,nan,R0,0.0,472.0,0.0,472.0,1.0,312.0,1.0,312.0,0
TCGA-RG-A7D4-01,TCGA-RG-A7D4,LIHC,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-25302.0,Alive,TUMOR FREE,1098.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1098.0,0.0,1098.0,0.0,1098.0,0.0,1098.0,0
TCGA-T1-A6J8-01,TCGA-T1-A6J8,LIHC,68.0,MALE,WHITE,nan,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-24853.0,Alive,TUMOR FREE,23.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,23.0,0.0,23.0,nan,nan,0.0,23.0,0
TCGA-UB-A7MA-01,TCGA-UB-A7MA,LIHC,62.0,FEMALE,WHITE,Stage II,nan,Hepatocholangiocarcinoma (Mixed),G2,2013.0,nan,-22843.0,Alive,WITH TUMOR,848.0,nan,nan,Intrahepatic Recurrence,Liver,nan,221.0,nan,nan,R1,0.0,848.0,0.0,848.0,nan,nan,1.0,221.0,2
TCGA-UB-A7MB-01,TCGA-UB-A7MB,LIHC,24.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-8951.0,Alive,WITH TUMOR,601.0,nan,nan,Intrahepatic Recurrence,Liver,nan,48.0,nan,nan,R0,0.0,601.0,0.0,601.0,1.0,48.0,1.0,48.0,2
TCGA-UB-A7MC-01,TCGA-UB-A7MC,LIHC,59.0,MALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-21733.0,Alive,WITH TUMOR,500.0,nan,nan,Extrahepatic Recurrence,"Other, specify",Adrenal glands,359.0,nan,nan,R0,0.0,500.0,0.0,500.0,1.0,359.0,1.0,359.0,2
TCGA-UB-A7MD-01,TCGA-UB-A7MD,LIHC,67.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Hepatocellular Carcinoma,G3,2013.0,nan,-24717.0,Dead,TUMOR FREE,nan,52.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,52.0,0.0,52.0,0.0,52.0,0.0,52.0,0
TCGA-UB-A7ME-01,TCGA-UB-A7ME,LIHC,51.0,MALE,ASIAN,Stage I,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-18846.0,Alive,TUMOR FREE,486.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,486.0,0.0,486.0,0.0,486.0,0.0,486.0,0
TCGA-UB-A7MF-01,TCGA-UB-A7MF,LIHC,56.0,MALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-20815.0,Dead,WITH TUMOR,nan,214.0,nan,Intrahepatic Recurrence,Liver,nan,133.0,nan,nan,R0,1.0,214.0,1.0,214.0,1.0,133.0,1.0,133.0,1
TCGA-UB-AA0U-01,TCGA-UB-AA0U,LIHC,60.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-21985.0,Alive,TUMOR FREE,327.0,nan,nan,Intrahepatic Recurrence,Liver,nan,106.0,nan,nan,R1,0.0,327.0,0.0,327.0,nan,nan,1.0,106.0,0
TCGA-UB-AA0V-01,TCGA-UB-AA0V,LIHC,69.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G1,2013.0,nan,-25340.0,Alive,TUMOR FREE,314.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,314.0,0.0,314.0,0.0,314.0,0.0,314.0,0
TCGA-WJ-A86L-01,TCGA-WJ-A86L,LIHC,68.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-25018.0,Alive,TUMOR FREE,345.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,345.0,0.0,345.0,0.0,345.0,0.0,345.0,0
TCGA-WQ-A9G7-01,TCGA-WQ-A9G7,LIHC,71.0,FEMALE,WHITE,nan,nan,Hepatocellular Carcinoma,G3,2013.0,nan,nan,Alive,TUMOR FREE,30.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,30.0,0.0,30.0,0.0,30.0,0.0,30.0,0
TCGA-WQ-AB4B-01,TCGA-WQ-AB4B,LIHC,62.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-22769.0,Alive,WITH TUMOR,395.0,nan,nan,Intrahepatic Recurrence,nan,nan,273.0,nan,nan,R0,0.0,395.0,0.0,395.0,1.0,273.0,1.0,273.0,2
TCGA-WX-AA44-01,TCGA-WX-AA44,LIHC,64.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G3,2011.0,nan,-23654.0,Alive,WITH TUMOR,615.0,nan,nan,Intrahepatic Recurrence,Liver,nan,246.0,nan,nan,RX,0.0,615.0,0.0,615.0,nan,nan,1.0,246.0,2
TCGA-WX-AA46-01,TCGA-WX-AA46,LIHC,61.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G1,2012.0,nan,-22639.0,Alive,TUMOR FREE,756.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,756.0,0.0,756.0,0.0,756.0,0.0,756.0,0
TCGA-WX-AA47-01,TCGA-WX-AA47,LIHC,33.0,FEMALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-12056.0,Dead,WITH TUMOR,nan,556.0,nan,Intrahepatic Recurrence,Liver,nan,103.0,nan,nan,R0,1.0,556.0,1.0,556.0,1.0,103.0,1.0,103.0,1
TCGA-XR-A8TC-01,TCGA-XR-A8TC,LIHC,43.0,FEMALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2011.0,nan,-15817.0,Alive,WITH TUMOR,1339.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1339.0,0.0,1339.0,0.0,1339.0,0.0,1339.0,0
TCGA-XR-A8TD-01,TCGA-XR-A8TD,LIHC,49.0,FEMALE,WHITE,Stage IIIB,nan,Hepatocellular Carcinoma,G3,2012.0,nan,-17908.0,Alive,TUMOR FREE,1030.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1030.0,0.0,1030.0,0.0,1030.0,0.0,1030.0,0
TCGA-XR-A8TE-01,TCGA-XR-A8TE,LIHC,16.0,MALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G1,2012.0,nan,-5862.0,Alive,WITH TUMOR,925.0,nan,nan,Intrahepatic Recurrence,Liver,nan,210.0,nan,nan,R0,0.0,925.0,0.0,925.0,1.0,210.0,1.0,210.0,2
TCGA-XR-A8TF-01,TCGA-XR-A8TF,LIHC,74.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G1,2012.0,nan,-27145.0,Dead,TUMOR FREE,nan,693.0,nan,Intrahepatic Recurrence,Liver,nan,231.0,nan,nan,R0,1.0,693.0,0.0,693.0,1.0,231.0,1.0,231.0,0
TCGA-XR-A8TG-01,TCGA-XR-A8TG,LIHC,58.0,MALE,WHITE,Stage I,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-21544.0,Alive,TUMOR FREE,898.0,nan,nan,Intrahepatic Recurrence,Liver,nan,350.0,nan,nan,R0,0.0,898.0,0.0,898.0,1.0,350.0,1.0,350.0,0
TCGA-YA-A8S7-01,TCGA-YA-A8S7,LIHC,68.0,MALE,WHITE,Stage IIIA,nan,Hepatocellular Carcinoma,G3,2012.0,nan,-25188.0,Dead,WITH TUMOR,nan,412.0,nan,Extrahepatic Recurrence,Brain,nan,398.0,nan,nan,R0,1.0,412.0,1.0,412.0,1.0,398.0,1.0,398.0,1
TCGA-ZP-A9CV-01,TCGA-ZP-A9CV,LIHC,59.0,MALE,WHITE,nan,nan,Hepatocellular Carcinoma,G1,2011.0,nan,-21633.0,Dead,WITH TUMOR,nan,1088.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,1088.0,1.0,1088.0,nan,nan,1.0,1088.0,1
TCGA-ZP-A9CY-01,TCGA-ZP-A9CY,LIHC,66.0,FEMALE,WHITE,nan,nan,Hepatocellular Carcinoma,G1,2011.0,nan,-24223.0,Alive,TUMOR FREE,782.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,782.0,0.0,782.0,0.0,782.0,0.0,782.0,0
TCGA-ZP-A9CZ-01,TCGA-ZP-A9CZ,LIHC,72.0,MALE,ASIAN,nan,nan,Hepatocellular Carcinoma,G1,2011.0,nan,-26403.0,Alive,TUMOR FREE,706.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,706.0,0.0,706.0,0.0,706.0,0.0,706.0,0
TCGA-ZP-A9D0-01,TCGA-ZP-A9D0,LIHC,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Hepatocellular Carcinoma,G1,2011.0,nan,-24525.0,Alive,TUMOR FREE,1091.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1091.0,0.0,1091.0,0.0,1091.0,0.0,1091.0,0
TCGA-ZP-A9D1-01,TCGA-ZP-A9D1,LIHC,56.0,FEMALE,WHITE,nan,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-20584.0,Alive,TUMOR FREE,21.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,21.0,0.0,21.0,0.0,21.0,0.0,21.0,0
TCGA-ZP-A9D2-01,TCGA-ZP-A9D2,LIHC,51.0,MALE,WHITE,nan,nan,Hepatocellular Carcinoma,G2,2012.0,nan,-18717.0,Dead,WITH TUMOR,nan,765.0,nan,Intrahepatic Recurrence,Liver,nan,315.0,nan,nan,R0,1.0,765.0,1.0,765.0,1.0,315.0,1.0,315.0,1
TCGA-ZP-A9D4-01,TCGA-ZP-A9D4,LIHC,64.0,FEMALE,WHITE,nan,nan,Hepatocellular Carcinoma,G1,2012.0,nan,-23656.0,Alive,TUMOR FREE,395.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,395.0,0.0,395.0,0.0,395.0,0.0,395.0,0
TCGA-ZS-A9CD-01,TCGA-ZS-A9CD,LIHC,73.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2010.0,nan,-26915.0,Dead,nan,nan,1386.0,nan,Intrahepatic Recurrence,Liver,nan,371.0,nan,nan,R0,1.0,1386.0,nan,1386.0,1.0,371.0,1.0,371.0,1
TCGA-ZS-A9CE-01,TCGA-ZS-A9CE,LIHC,79.0,FEMALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G1,2011.0,nan,-29051.0,Alive,TUMOR FREE,1241.0,nan,nan,New Primary Tumor,"Other, specify",Right Temple,892.0,nan,nan,R0,0.0,1241.0,0.0,1241.0,0.0,1241.0,1.0,892.0,0
TCGA-ZS-A9CF-02,TCGA-ZS-A9CF,LIHC,64.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2008.0,nan,-23510.0,Alive,TUMOR FREE,2412.0,nan,nan,Intrahepatic Recurrence,Liver,nan,636.0,nan,nan,R0,0.0,2412.0,0.0,2412.0,1.0,636.0,1.0,636.0,0
TCGA-ZS-A9CF-01,TCGA-ZS-A9CF,LIHC,64.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2008.0,nan,-23510.0,Alive,TUMOR FREE,2412.0,nan,nan,Intrahepatic Recurrence,Liver,nan,636.0,nan,nan,R0,0.0,2412.0,0.0,2412.0,1.0,636.0,1.0,636.0,0
TCGA-ZS-A9CG-01,TCGA-ZS-A9CG,LIHC,55.0,MALE,WHITE,Stage II,nan,Hepatocellular Carcinoma,G2,2013.0,nan,-20100.0,Alive,TUMOR FREE,341.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,341.0,0.0,341.0,0.0,341.0,0.0,341.0,0
TCGA-05-4244-01,TCGA-05-4244,LUAD,70.0,MALE,nan,Stage IV,nan,Lung Adenocarcinoma,nan,2009.0,nan,-25752.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-05-4249-01,TCGA-05-4249,LUAD,67.0,MALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,2007.0,nan,-24532.0,Alive,TUMOR FREE,1523.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1523.0,0.0,1523.0,nan,nan,0.0,1523.0,0
TCGA-05-4250-01,TCGA-05-4250,LUAD,79.0,FEMALE,nan,Stage IIIA,nan,Lung Adenocarcinoma,nan,2007.0,nan,-29068.0,Dead,nan,nan,121.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,121.0,nan,121.0,nan,nan,0.0,121.0,1
TCGA-05-4382-01,TCGA-05-4382,LUAD,68.0,MALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-24868.0,Alive,TUMOR FREE,607.0,nan,nan,Distant Metastasis,nan,nan,334.0,Complete Remission/Response,nan,nan,0.0,607.0,0.0,607.0,1.0,334.0,1.0,334.0,2
TCGA-05-4384-01,TCGA-05-4384,LUAD,66.0,MALE,nan,Stage IIIA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-24411.0,Alive,WITH TUMOR,426.0,nan,nan,Distant Metastasis,nan,nan,183.0,Progressive Disease,nan,nan,0.0,426.0,0.0,426.0,nan,nan,1.0,183.0,2
TCGA-05-4389-01,TCGA-05-4389,LUAD,70.0,MALE,nan,Stage IA,nan,Lung Adenocarcinoma,nan,2005.0,nan,-25660.0,Alive,TUMOR FREE,1369.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1369.0,0.0,1369.0,nan,nan,0.0,1369.0,0
TCGA-05-4390-01,TCGA-05-4390,LUAD,58.0,FEMALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,2005.0,nan,-21430.0,Alive,TUMOR FREE,1126.0,nan,nan,nan,nan,nan,395.0,Progressive Disease,nan,nan,0.0,1126.0,0.0,1126.0,nan,nan,1.0,395.0,0
TCGA-05-4395-01,TCGA-05-4395,LUAD,76.0,MALE,nan,Stage IIIB,nan,Lung Adenocarcinoma,nan,2006.0,nan,-27971.0,Dead,TUMOR FREE,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-05-4396-01,TCGA-05-4396,LUAD,76.0,MALE,nan,Stage IIIB,nan,Lung Adenocarcinoma,nan,2006.0,nan,-28094.0,Dead,nan,nan,303.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,303.0,nan,303.0,nan,nan,0.0,303.0,1
TCGA-05-4397-01,TCGA-05-4397,LUAD,65.0,MALE,nan,Stage IIB,nan,Lung Adenocarcinoma,nan,2006.0,nan,-23833.0,Dead,nan,nan,731.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,731.0,nan,731.0,nan,nan,0.0,731.0,1
TCGA-05-4398-01,TCGA-05-4398,LUAD,47.0,FEMALE,nan,Stage IIIB,nan,Lung Adenocarcinoma,nan,2006.0,nan,-17471.0,Alive,TUMOR FREE,1431.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1431.0,0.0,1431.0,0.0,1431.0,0.0,1431.0,0
TCGA-05-4402-01,TCGA-05-4402,LUAD,57.0,FEMALE,nan,Stage IV,nan,Lung Adenocarcinoma,nan,2007.0,nan,-20819.0,Dead,TUMOR FREE,nan,244.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,244.0,0.0,244.0,nan,nan,0.0,244.0,1
TCGA-05-4403-01,TCGA-05-4403,LUAD,76.0,MALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,2006.0,nan,-27881.0,Alive,nan,578.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,578.0,0.0,578.0,nan,nan,0.0,578.0,0
TCGA-05-4405-01,TCGA-05-4405,LUAD,74.0,FEMALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,2006.0,nan,-27241.0,Alive,TUMOR FREE,610.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,610.0,0.0,610.0,nan,nan,0.0,610.0,0
TCGA-05-4410-01,TCGA-05-4410,LUAD,62.0,MALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,2007.0,nan,-22888.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-05-4415-01,TCGA-05-4415,LUAD,57.0,MALE,nan,Stage IIIB,nan,Lung Adenocarcinoma,nan,2008.0,nan,-20880.0,Dead,WITH TUMOR,nan,91.0,nan,nan,nan,nan,60.0,Progressive Disease,nan,nan,1.0,91.0,1.0,91.0,nan,nan,1.0,60.0,1
TCGA-05-4417-01,TCGA-05-4417,LUAD,51.0,FEMALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,2008.0,nan,-18780.0,Alive,TUMOR FREE,455.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,455.0,0.0,455.0,nan,nan,0.0,455.0,0
TCGA-05-4418-01,TCGA-05-4418,LUAD,69.0,MALE,nan,Stage IIIA,nan,Lung Adenocarcinoma,nan,2008.0,nan,-25417.0,Dead,nan,nan,274.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,274.0,nan,274.0,nan,nan,0.0,274.0,1
TCGA-05-4420-01,TCGA-05-4420,LUAD,41.0,MALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,2008.0,nan,-15159.0,Alive,TUMOR FREE,912.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,912.0,0.0,912.0,0.0,912.0,0.0,912.0,0
TCGA-05-4422-01,TCGA-05-4422,LUAD,68.0,MALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,2008.0,nan,-24837.0,Alive,nan,365.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,365.0,0.0,365.0,nan,nan,0.0,365.0,0
TCGA-05-4424-01,TCGA-05-4424,LUAD,70.0,MALE,nan,Stage IIB,nan,Lung Adenocarcinoma,nan,2008.0,nan,-25689.0,Alive,WITH TUMOR,913.0,nan,nan,Distant Metastasis,nan,nan,153.0,Progressive Disease,nan,nan,0.0,913.0,0.0,913.0,nan,nan,1.0,153.0,0
TCGA-05-4425-01,TCGA-05-4425,LUAD,70.0,FEMALE,nan,Stage IV,nan,Lung Adenocarcinoma,nan,2008.0,nan,-25902.0,Alive,nan,669.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,669.0,0.0,669.0,nan,nan,0.0,669.0,0
TCGA-05-4426-01,TCGA-05-4426,LUAD,71.0,MALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,2008.0,nan,-26084.0,Alive,TUMOR FREE,791.0,nan,nan,nan,nan,nan,457.0,Complete Remission/Response,nan,nan,0.0,791.0,0.0,791.0,1.0,457.0,1.0,457.0,0
TCGA-05-4427-01,TCGA-05-4427,LUAD,65.0,FEMALE,nan,Stage IIB,nan,Lung Adenocarcinoma,nan,2008.0,nan,-23893.0,Alive,TUMOR FREE,791.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,791.0,0.0,791.0,0.0,791.0,0.0,791.0,0
TCGA-05-4430-01,TCGA-05-4430,LUAD,59.0,FEMALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,2008.0,nan,-21884.0,Alive,TUMOR FREE,761.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,761.0,0.0,761.0,nan,nan,0.0,761.0,0
TCGA-05-4432-01,TCGA-05-4432,LUAD,66.0,MALE,nan,Stage IIB,nan,Lung Adenocarcinoma,nan,2008.0,nan,-24350.0,Alive,TUMOR FREE,761.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,761.0,0.0,761.0,0.0,761.0,0.0,761.0,0
TCGA-05-4433-01,TCGA-05-4433,LUAD,82.0,MALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,2008.0,nan,-30194.0,Alive,TUMOR FREE,730.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,730.0,0.0,730.0,nan,nan,0.0,730.0,0
TCGA-05-4434-01,TCGA-05-4434,LUAD,67.0,FEMALE,nan,Stage IV,nan,Lung Adenocarcinoma,nan,2008.0,nan,-24472.0,Dead,nan,nan,457.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,457.0,nan,457.0,nan,nan,0.0,457.0,1
TCGA-05-5420-01,TCGA-05-5420,LUAD,67.0,MALE,nan,Stage IIIA,nan,Lung Adenocarcinoma,nan,2008.0,nan,-24472.0,Alive,WITH TUMOR,457.0,nan,nan,nan,nan,nan,245.0,Progressive Disease,nan,nan,0.0,457.0,0.0,457.0,nan,nan,1.0,245.0,0
TCGA-05-5420-11,TCGA-05-5420,LUAD,67.0,MALE,nan,Stage IIIA,nan,Lung Adenocarcinoma,nan,2008.0,nan,-24472.0,Alive,WITH TUMOR,457.0,nan,nan,nan,nan,nan,245.0,Progressive Disease,nan,nan,0.0,457.0,0.0,457.0,nan,nan,1.0,245.0,0
TCGA-05-5423-01,TCGA-05-5423,LUAD,65.0,MALE,nan,Stage IIB,nan,Lung Adenocarcinoma,nan,2006.0,nan,-23863.0,Alive,TUMOR FREE,151.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,151.0,0.0,151.0,nan,nan,0.0,151.0,0
TCGA-05-5425-01,TCGA-05-5425,LUAD,68.0,MALE,nan,Stage IIB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-25020.0,Alive,WITH TUMOR,882.0,nan,nan,nan,nan,nan,486.0,nan,nan,nan,0.0,882.0,0.0,882.0,nan,nan,1.0,486.0,0
TCGA-05-5428-01,TCGA-05-5428,LUAD,57.0,MALE,nan,Stage IIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-21061.0,Alive,TUMOR FREE,670.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,670.0,0.0,670.0,0.0,670.0,0.0,670.0,0
TCGA-05-5429-01,TCGA-05-5429,LUAD,60.0,MALE,nan,Stage IIIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-22066.0,Dead,TUMOR FREE,nan,275.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,275.0,0.0,275.0,nan,nan,0.0,275.0,0
TCGA-05-5715-01,TCGA-05-5715,LUAD,69.0,FEMALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,2010.0,nan,-25383.0,Alive,TUMOR FREE,62.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,62.0,0.0,62.0,nan,nan,0.0,62.0,0
TCGA-35-3615-01,TCGA-35-3615,LUAD,57.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2007.0,nan,-21076.0,Alive,TUMOR FREE,14.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,14.0,0.0,14.0,nan,nan,0.0,14.0,0
TCGA-35-4122-01,TCGA-35-4122,LUAD,69.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-25491.0,Alive,TUMOR FREE,225.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,225.0,0.0,225.0,nan,nan,0.0,225.0,0
TCGA-35-4123-01,TCGA-35-4123,LUAD,38.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-14064.0,Alive,TUMOR FREE,182.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,182.0,0.0,182.0,nan,nan,0.0,182.0,0
TCGA-35-5375-01,TCGA-35-5375,LUAD,61.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-22628.0,Alive,TUMOR FREE,264.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,264.0,0.0,264.0,nan,nan,0.0,264.0,0
TCGA-38-4625-01,TCGA-38-4625,LUAD,66.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2002.0,nan,-24241.0,Alive,nan,2973.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2973.0,0.0,2973.0,0.0,2973.0,0.0,2973.0,0
TCGA-38-4625-11,TCGA-38-4625,LUAD,66.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2002.0,nan,-24241.0,Alive,nan,2973.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2973.0,0.0,2973.0,0.0,2973.0,0.0,2973.0,0
TCGA-38-4626-01,TCGA-38-4626,LUAD,57.0,FEMALE,WHITE,[Discrepancy],nan,Lung Adenocarcinoma,nan,2003.0,nan,-20903.0,Alive,TUMOR FREE,3674.0,nan,nan,New Primary Tumor,nan,nan,2518.0,Complete Remission/Response,nan,nan,0.0,3674.0,0.0,3674.0,0.0,3674.0,1.0,2518.0,0
TCGA-38-4626-11,TCGA-38-4626,LUAD,57.0,FEMALE,WHITE,[Discrepancy],nan,Lung Adenocarcinoma,nan,2003.0,nan,-20903.0,Alive,TUMOR FREE,3674.0,nan,nan,New Primary Tumor,nan,nan,2518.0,Complete Remission/Response,nan,nan,0.0,3674.0,0.0,3674.0,0.0,3674.0,1.0,2518.0,0
TCGA-38-4627-01,TCGA-38-4627,LUAD,64.0,FEMALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2003.0,nan,-23510.0,Dead,nan,nan,1147.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1147.0,nan,1147.0,0.0,1147.0,0.0,1147.0,1
TCGA-38-4627-11,TCGA-38-4627,LUAD,64.0,FEMALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2003.0,nan,-23510.0,Dead,nan,nan,1147.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1147.0,nan,1147.0,0.0,1147.0,0.0,1147.0,1
TCGA-38-4628-01,TCGA-38-4628,LUAD,65.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2002.0,nan,-24057.0,Dead,WITH TUMOR,nan,1492.0,nan,nan,nan,nan,1083.0,Complete Remission/Response,nan,nan,1.0,1492.0,1.0,1492.0,1.0,1083.0,1.0,1083.0,1
TCGA-38-4628-11,TCGA-38-4628,LUAD,65.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2002.0,nan,-24057.0,Dead,WITH TUMOR,nan,1492.0,nan,nan,nan,nan,1083.0,Complete Remission/Response,nan,nan,1.0,1492.0,1.0,1492.0,1.0,1083.0,1.0,1083.0,1
TCGA-38-4629-01,TCGA-38-4629,LUAD,68.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2003.0,nan,-25104.0,Dead,WITH TUMOR,nan,864.0,nan,nan,nan,nan,379.0,Complete Remission/Response,nan,nan,1.0,864.0,1.0,864.0,1.0,379.0,1.0,379.0,1
TCGA-38-4629-11,TCGA-38-4629,LUAD,68.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2003.0,nan,-25104.0,Dead,WITH TUMOR,nan,864.0,nan,nan,nan,nan,379.0,Complete Remission/Response,nan,nan,1.0,864.0,1.0,864.0,1.0,379.0,1.0,379.0,1
TCGA-38-4630-01,TCGA-38-4630,LUAD,75.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2000.0,nan,-27667.0,Dead,WITH TUMOR,nan,1073.0,nan,nan,nan,nan,524.0,Complete Remission/Response,nan,nan,1.0,1073.0,1.0,1073.0,1.0,524.0,1.0,524.0,1
TCGA-38-4630-11,TCGA-38-4630,LUAD,75.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2000.0,nan,-27667.0,Dead,WITH TUMOR,nan,1073.0,nan,nan,nan,nan,524.0,Complete Remission/Response,nan,nan,1.0,1073.0,1.0,1073.0,1.0,524.0,1.0,524.0,1
TCGA-38-4631-01,TCGA-38-4631,LUAD,72.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,1997.0,nan,-26538.0,Dead,WITH TUMOR,nan,354.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,354.0,1.0,354.0,nan,nan,1.0,354.0,1
TCGA-38-4631-11,TCGA-38-4631,LUAD,72.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,1997.0,nan,-26538.0,Dead,WITH TUMOR,nan,354.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,354.0,1.0,354.0,nan,nan,1.0,354.0,1
TCGA-38-4632-01,TCGA-38-4632,LUAD,42.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Lung Adenocarcinoma,nan,1998.0,nan,-15418.0,Dead,WITH TUMOR,nan,1357.0,nan,nan,nan,nan,680.0,Complete Remission/Response,nan,nan,1.0,1357.0,1.0,1357.0,nan,nan,1.0,680.0,1
TCGA-38-4632-11,TCGA-38-4632,LUAD,42.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Lung Adenocarcinoma,nan,1998.0,nan,-15418.0,Dead,WITH TUMOR,nan,1357.0,nan,nan,nan,nan,680.0,Complete Remission/Response,nan,nan,1.0,1357.0,1.0,1357.0,nan,nan,1.0,680.0,1
TCGA-38-6178-01,TCGA-38-6178,LUAD,70.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-25593.0,Alive,WITH TUMOR,448.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,448.0,0.0,448.0,nan,nan,0.0,448.0,0
TCGA-38-7271-01,TCGA-38-7271,LUAD,72.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2006.0,nan,-26440.0,Dead,WITH TUMOR,nan,800.0,nan,nan,nan,nan,304.0,Complete Remission/Response,nan,nan,1.0,800.0,1.0,800.0,1.0,304.0,1.0,304.0,1
TCGA-38-A44F-01,TCGA-38-A44F,LUAD,80.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-29534.0,Alive,TUMOR FREE,133.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,133.0,0.0,133.0,0.0,133.0,0.0,133.0,0
TCGA-44-2655-01,TCGA-44-2655,LUAD,65.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-23854.0,Alive,TUMOR FREE,1324.0,nan,nan,New Primary Tumor,nan,nan,1009.0,Complete Remission/Response,nan,nan,0.0,1324.0,0.0,1324.0,0.0,1324.0,1.0,1009.0,2
TCGA-44-2655-11,TCGA-44-2655,LUAD,65.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-23854.0,Alive,TUMOR FREE,1324.0,nan,nan,New Primary Tumor,nan,nan,1009.0,Complete Remission/Response,nan,nan,0.0,1324.0,0.0,1324.0,0.0,1324.0,1.0,1009.0,2
TCGA-44-2656-11,TCGA-44-2656,LUAD,59.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-21766.0,Alive,TUMOR FREE,1429.0,nan,nan,New Primary Tumor,nan,nan,568.0,Complete Remission/Response,nan,nan,0.0,1429.0,0.0,1429.0,0.0,1429.0,1.0,568.0,0
TCGA-44-2656-01,TCGA-44-2656,LUAD,59.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-21766.0,Alive,TUMOR FREE,1429.0,nan,nan,New Primary Tumor,nan,nan,568.0,Complete Remission/Response,nan,nan,0.0,1429.0,0.0,1429.0,0.0,1429.0,1.0,568.0,0
TCGA-44-2657-01,TCGA-44-2657,LUAD,74.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-27298.0,Alive,TUMOR FREE,1351.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1351.0,0.0,1351.0,0.0,1351.0,0.0,1351.0,0
TCGA-44-2657-11,TCGA-44-2657,LUAD,74.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-27298.0,Alive,TUMOR FREE,1351.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1351.0,0.0,1351.0,0.0,1351.0,0.0,1351.0,0
TCGA-44-2659-01,TCGA-44-2659,LUAD,65.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-23808.0,Alive,TUMOR FREE,1367.0,nan,nan,Locoregional Recurrence,nan,nan,1146.0,Complete Remission/Response,nan,nan,0.0,1367.0,0.0,1367.0,1.0,1146.0,1.0,1146.0,2
TCGA-44-2659-11,TCGA-44-2659,LUAD,65.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-23808.0,Alive,TUMOR FREE,1367.0,nan,nan,Locoregional Recurrence,nan,nan,1146.0,Complete Remission/Response,nan,nan,0.0,1367.0,0.0,1367.0,1.0,1146.0,1.0,1146.0,2
TCGA-44-2661-01,TCGA-44-2661,LUAD,69.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-25313.0,Alive,TUMOR FREE,1159.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1159.0,0.0,1159.0,0.0,1159.0,0.0,1159.0,0
TCGA-44-2661-11,TCGA-44-2661,LUAD,69.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-25313.0,Alive,TUMOR FREE,1159.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1159.0,0.0,1159.0,0.0,1159.0,0.0,1159.0,0
TCGA-44-2662-11,TCGA-44-2662,LUAD,65.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-24014.0,Alive,TUMOR FREE,1280.0,nan,nan,nan,nan,nan,245.0,Progressive Disease,nan,nan,0.0,1280.0,0.0,1280.0,nan,nan,1.0,245.0,0
TCGA-44-2662-01,TCGA-44-2662,LUAD,65.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-24014.0,Alive,TUMOR FREE,1280.0,nan,nan,nan,nan,nan,245.0,Progressive Disease,nan,nan,0.0,1280.0,0.0,1280.0,nan,nan,1.0,245.0,0
TCGA-44-2665-11,TCGA-44-2665,LUAD,55.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-20349.0,Alive,TUMOR FREE,1301.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1301.0,0.0,1301.0,nan,nan,0.0,1301.0,0
TCGA-44-2665-01,TCGA-44-2665,LUAD,55.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-20349.0,Alive,TUMOR FREE,1301.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1301.0,0.0,1301.0,nan,nan,0.0,1301.0,0
TCGA-44-2666-01,TCGA-44-2666,LUAD,43.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-15970.0,Dead,WITH TUMOR,97.0,97.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,97.0,1.0,97.0,nan,nan,1.0,97.0,1
TCGA-44-2668-11,TCGA-44-2668,LUAD,51.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-18856.0,Dead,WITH TUMOR,nan,761.0,nan,nan,nan,nan,433.0,Complete Remission/Response,nan,nan,1.0,761.0,1.0,761.0,1.0,433.0,1.0,433.0,1
TCGA-44-2668-01,TCGA-44-2668,LUAD,51.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-18856.0,Dead,WITH TUMOR,nan,761.0,nan,nan,nan,nan,433.0,Complete Remission/Response,nan,nan,1.0,761.0,1.0,761.0,1.0,433.0,1.0,433.0,1
TCGA-44-3396-01,TCGA-44-3396,LUAD,74.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-27073.0,Alive,TUMOR FREE,1130.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1130.0,0.0,1130.0,0.0,1130.0,0.0,1130.0,0
TCGA-44-3396-11,TCGA-44-3396,LUAD,74.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-27073.0,Alive,TUMOR FREE,1130.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1130.0,0.0,1130.0,0.0,1130.0,0.0,1130.0,0
TCGA-44-3398-01,TCGA-44-3398,LUAD,77.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-28392.0,Alive,TUMOR FREE,1163.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1163.0,0.0,1163.0,0.0,1163.0,0.0,1163.0,0
TCGA-44-3398-11,TCGA-44-3398,LUAD,77.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-28392.0,Alive,TUMOR FREE,1163.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1163.0,0.0,1163.0,0.0,1163.0,0.0,1163.0,0
TCGA-44-3917-01,TCGA-44-3917,LUAD,33.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-12179.0,Alive,TUMOR FREE,1183.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1183.0,0.0,1183.0,0.0,1183.0,0.0,1183.0,0
TCGA-44-3918-11,TCGA-44-3918,LUAD,60.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-22236.0,Alive,WITH TUMOR,1036.0,nan,nan,nan,nan,nan,511.0,Complete Remission/Response,nan,nan,0.0,1036.0,0.0,1036.0,1.0,511.0,1.0,511.0,2
TCGA-44-3918-01,TCGA-44-3918,LUAD,60.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-22236.0,Alive,WITH TUMOR,1036.0,nan,nan,nan,nan,nan,511.0,Complete Remission/Response,nan,nan,0.0,1036.0,0.0,1036.0,1.0,511.0,1.0,511.0,2
TCGA-44-3919-01,TCGA-44-3919,LUAD,71.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-26081.0,Dead,WITH TUMOR,nan,1026.0,nan,Locoregional Recurrence,nan,nan,921.0,Complete Remission/Response,nan,nan,1.0,1026.0,1.0,1026.0,1.0,921.0,1.0,921.0,1
TCGA-44-3919-11,TCGA-44-3919,LUAD,71.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-26081.0,Dead,WITH TUMOR,nan,1026.0,nan,Locoregional Recurrence,nan,nan,921.0,Complete Remission/Response,nan,nan,1.0,1026.0,1.0,1026.0,1.0,921.0,1.0,921.0,1
TCGA-44-4112-11,TCGA-44-4112,LUAD,60.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2010.0,nan,-22106.0,Dead,WITH TUMOR,nan,808.0,nan,nan,nan,nan,619.0,Complete Remission/Response,nan,nan,1.0,808.0,1.0,808.0,1.0,619.0,1.0,619.0,1
TCGA-44-4112-01,TCGA-44-4112,LUAD,60.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2010.0,nan,-22106.0,Dead,WITH TUMOR,nan,808.0,nan,nan,nan,nan,619.0,Complete Remission/Response,nan,nan,1.0,808.0,1.0,808.0,1.0,619.0,1.0,619.0,1
TCGA-44-5643-01,TCGA-44-5643,LUAD,53.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-19426.0,Alive,TUMOR FREE,1013.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1013.0,0.0,1013.0,nan,nan,0.0,1013.0,0
TCGA-44-5643-11,TCGA-44-5643,LUAD,53.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-19426.0,Alive,TUMOR FREE,1013.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1013.0,0.0,1013.0,nan,nan,0.0,1013.0,0
TCGA-44-5644-01,TCGA-44-5644,LUAD,51.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2010.0,nan,-18644.0,Alive,TUMOR FREE,863.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,863.0,0.0,863.0,0.0,863.0,0.0,863.0,0
TCGA-44-5645-11,TCGA-44-5645,LUAD,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-22471.0,Alive,TUMOR FREE,852.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,852.0,0.0,852.0,0.0,852.0,0.0,852.0,0
TCGA-44-5645-01,TCGA-44-5645,LUAD,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-22471.0,Alive,TUMOR FREE,852.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,852.0,0.0,852.0,0.0,852.0,0.0,852.0,0
TCGA-44-6144-01,TCGA-44-6144,LUAD,58.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-21283.0,Alive,WITH TUMOR,723.0,nan,nan,nan,nan,nan,399.0,Complete Remission/Response,nan,nan,0.0,723.0,0.0,723.0,1.0,399.0,1.0,399.0,2
TCGA-44-6144-11,TCGA-44-6144,LUAD,58.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-21283.0,Alive,WITH TUMOR,723.0,nan,nan,nan,nan,nan,399.0,Complete Remission/Response,nan,nan,0.0,723.0,0.0,723.0,1.0,399.0,1.0,399.0,2
TCGA-44-6145-01,TCGA-44-6145,LUAD,62.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-22745.0,Alive,TUMOR FREE,595.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,595.0,0.0,595.0,0.0,595.0,0.0,595.0,0
TCGA-44-6145-11,TCGA-44-6145,LUAD,62.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-22745.0,Alive,TUMOR FREE,595.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,595.0,0.0,595.0,0.0,595.0,0.0,595.0,0
TCGA-44-6146-11,TCGA-44-6146,LUAD,64.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2010.0,nan,-23378.0,Alive,TUMOR FREE,728.0,nan,nan,Locoregional Recurrence,nan,nan,631.0,Complete Remission/Response,nan,nan,0.0,728.0,0.0,728.0,1.0,631.0,1.0,631.0,0
TCGA-44-6146-01,TCGA-44-6146,LUAD,64.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2010.0,nan,-23378.0,Alive,TUMOR FREE,728.0,nan,nan,Locoregional Recurrence,nan,nan,631.0,Complete Remission/Response,nan,nan,0.0,728.0,0.0,728.0,1.0,631.0,1.0,631.0,0
TCGA-44-6147-11,TCGA-44-6147,LUAD,67.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-24631.0,Alive,TUMOR FREE,845.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,845.0,0.0,845.0,0.0,845.0,0.0,845.0,0
TCGA-44-6147-01,TCGA-44-6147,LUAD,67.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-24631.0,Alive,TUMOR FREE,845.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,845.0,0.0,845.0,0.0,845.0,0.0,845.0,0
TCGA-44-6148-01,TCGA-44-6148,LUAD,60.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-22138.0,Alive,TUMOR FREE,704.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,704.0,0.0,704.0,0.0,704.0,0.0,704.0,0
TCGA-44-6148-11,TCGA-44-6148,LUAD,60.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-22138.0,Alive,TUMOR FREE,704.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,704.0,0.0,704.0,0.0,704.0,0.0,704.0,0
TCGA-44-6774-01,TCGA-44-6774,LUAD,56.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-20462.0,Alive,TUMOR FREE,658.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,658.0,0.0,658.0,0.0,658.0,0.0,658.0,0
TCGA-44-6775-01,TCGA-44-6775,LUAD,72.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-26415.0,Alive,WITH TUMOR,705.0,nan,nan,Locoregional Recurrence,nan,nan,684.0,Complete Remission/Response,nan,nan,0.0,705.0,0.0,705.0,1.0,684.0,1.0,684.0,2
TCGA-44-6776-01,TCGA-44-6776,LUAD,60.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2005.0,nan,-22150.0,Alive,TUMOR FREE,2616.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2616.0,0.0,2616.0,0.0,2616.0,0.0,2616.0,0
TCGA-44-6776-11,TCGA-44-6776,LUAD,60.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2005.0,nan,-22150.0,Alive,TUMOR FREE,2616.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2616.0,0.0,2616.0,0.0,2616.0,0.0,2616.0,0
TCGA-44-6777-01,TCGA-44-6777,LUAD,85.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2006.0,nan,-31234.0,Dead,TUMOR FREE,nan,987.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,987.0,0.0,987.0,0.0,987.0,0.0,987.0,0
TCGA-44-6777-11,TCGA-44-6777,LUAD,85.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2006.0,nan,-31234.0,Dead,TUMOR FREE,nan,987.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,987.0,0.0,987.0,0.0,987.0,0.0,987.0,0
TCGA-44-6778-01,TCGA-44-6778,LUAD,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Adenocarcinoma,nan,2007.0,nan,-21725.0,Alive,TUMOR FREE,1864.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1864.0,0.0,1864.0,0.0,1864.0,0.0,1864.0,0
TCGA-44-6778-11,TCGA-44-6778,LUAD,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Adenocarcinoma,nan,2007.0,nan,-21725.0,Alive,TUMOR FREE,1864.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1864.0,0.0,1864.0,0.0,1864.0,0.0,1864.0,0
TCGA-44-6779-01,TCGA-44-6779,LUAD,50.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2008.0,nan,-18469.0,Dead,WITH TUMOR,nan,500.0,nan,nan,nan,nan,232.0,Progressive Disease,nan,nan,1.0,500.0,1.0,500.0,nan,nan,1.0,232.0,1
TCGA-44-7659-01,TCGA-44-7659,LUAD,70.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-25730.0,Alive,TUMOR FREE,691.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,691.0,0.0,691.0,0.0,691.0,0.0,691.0,0
TCGA-44-7659-11,TCGA-44-7659,LUAD,70.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-25730.0,Alive,TUMOR FREE,691.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,691.0,0.0,691.0,0.0,691.0,0.0,691.0,0
TCGA-44-7660-01,TCGA-44-7660,LUAD,72.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-26594.0,Alive,WITH TUMOR,592.0,nan,nan,Locoregional Recurrence,nan,nan,253.0,Progressive Disease,nan,nan,0.0,592.0,0.0,592.0,nan,nan,1.0,253.0,0
TCGA-44-7660-11,TCGA-44-7660,LUAD,72.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-26594.0,Alive,WITH TUMOR,592.0,nan,nan,Locoregional Recurrence,nan,nan,253.0,Progressive Disease,nan,nan,0.0,592.0,0.0,592.0,nan,nan,1.0,253.0,0
TCGA-44-7661-01,TCGA-44-7661,LUAD,69.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-25483.0,Dead,WITH TUMOR,nan,557.0,nan,Locoregional Recurrence,nan,nan,335.0,Complete Remission/Response,nan,nan,1.0,557.0,1.0,557.0,1.0,335.0,1.0,335.0,1
TCGA-44-7661-11,TCGA-44-7661,LUAD,69.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-25483.0,Dead,WITH TUMOR,nan,557.0,nan,Locoregional Recurrence,nan,nan,335.0,Complete Remission/Response,nan,nan,1.0,557.0,1.0,557.0,1.0,335.0,1.0,335.0,1
TCGA-44-7662-01,TCGA-44-7662,LUAD,61.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-22543.0,Alive,TUMOR FREE,218.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,218.0,0.0,218.0,0.0,218.0,0.0,218.0,0
TCGA-44-7662-11,TCGA-44-7662,LUAD,61.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-22543.0,Alive,TUMOR FREE,218.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,218.0,0.0,218.0,0.0,218.0,0.0,218.0,0
TCGA-44-7667-01,TCGA-44-7667,LUAD,49.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-18062.0,Alive,TUMOR FREE,1097.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1097.0,0.0,1097.0,0.0,1097.0,0.0,1097.0,0
TCGA-44-7667-11,TCGA-44-7667,LUAD,49.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-18062.0,Alive,TUMOR FREE,1097.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1097.0,0.0,1097.0,0.0,1097.0,0.0,1097.0,0
TCGA-44-7669-01,TCGA-44-7669,LUAD,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-21893.0,Dead,WITH TUMOR,nan,574.0,nan,nan,nan,nan,390.0,Complete Remission/Response,nan,nan,1.0,574.0,1.0,574.0,1.0,390.0,1.0,390.0,1
TCGA-44-7669-11,TCGA-44-7669,LUAD,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-21893.0,Dead,WITH TUMOR,nan,574.0,nan,nan,nan,nan,390.0,Complete Remission/Response,nan,nan,1.0,574.0,1.0,574.0,1.0,390.0,1.0,390.0,1
TCGA-44-7670-01,TCGA-44-7670,LUAD,47.0,FEMALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-17392.0,Alive,TUMOR FREE,882.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,882.0,0.0,882.0,0.0,882.0,0.0,882.0,0
TCGA-44-7670-11,TCGA-44-7670,LUAD,47.0,FEMALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-17392.0,Alive,TUMOR FREE,882.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,882.0,0.0,882.0,0.0,882.0,0.0,882.0,0
TCGA-44-7671-01,TCGA-44-7671,LUAD,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Lung Adenocarcinoma,nan,2010.0,nan,-23538.0,Alive,WITH TUMOR,889.0,nan,nan,Locoregional Recurrence,nan,nan,883.0,Complete Remission/Response,nan,nan,0.0,889.0,0.0,889.0,1.0,883.0,1.0,883.0,2
TCGA-44-7671-11,TCGA-44-7671,LUAD,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Lung Adenocarcinoma,nan,2010.0,nan,-23538.0,Alive,WITH TUMOR,889.0,nan,nan,Locoregional Recurrence,nan,nan,883.0,Complete Remission/Response,nan,nan,0.0,889.0,0.0,889.0,1.0,883.0,1.0,883.0,2
TCGA-44-7672-01,TCGA-44-7672,LUAD,52.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-19200.0,Alive,TUMOR FREE,719.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,719.0,0.0,719.0,0.0,719.0,0.0,719.0,0
TCGA-44-7672-11,TCGA-44-7672,LUAD,52.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-19200.0,Alive,TUMOR FREE,719.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,719.0,0.0,719.0,0.0,719.0,0.0,719.0,0
TCGA-44-8117-01,TCGA-44-8117,LUAD,54.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-19855.0,Alive,TUMOR FREE,385.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,0
TCGA-44-8119-01,TCGA-44-8119,LUAD,73.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-27003.0,Alive,TUMOR FREE,285.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,285.0,0.0,285.0,0.0,285.0,0.0,285.0,0
TCGA-44-8120-01,TCGA-44-8120,LUAD,58.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-21188.0,Alive,TUMOR FREE,260.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,260.0,0.0,260.0,0.0,260.0,0.0,260.0,0
TCGA-44-A479-01,TCGA-44-A479,LUAD,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-27024.0,Alive,TUMOR FREE,486.0,nan,nan,New Primary Tumor,nan,nan,437.0,Complete Remission/Response,nan,nan,0.0,486.0,0.0,486.0,0.0,486.0,1.0,437.0,0
TCGA-44-A47A-01,TCGA-44-A47A,LUAD,78.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-28782.0,Alive,WITH TUMOR,466.0,nan,nan,Distant Metastasis,nan,nan,397.0,Complete Remission/Response,nan,nan,0.0,466.0,0.0,466.0,1.0,397.0,1.0,397.0,2
TCGA-44-A47B-01,TCGA-44-A47B,LUAD,79.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-28869.0,Alive,TUMOR FREE,287.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,287.0,0.0,287.0,0.0,287.0,0.0,287.0,0
TCGA-44-A47F-01,TCGA-44-A47F,LUAD,74.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-27122.0,Alive,TUMOR FREE,337.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,337.0,0.0,337.0,0.0,337.0,0.0,337.0,0
TCGA-44-A47G-01,TCGA-44-A47G,LUAD,73.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-26800.0,Alive,TUMOR FREE,351.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,351.0,0.0,351.0,0.0,351.0,0.0,351.0,0
TCGA-44-A4SS-01,TCGA-44-A4SS,LUAD,73.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-26991.0,Alive,TUMOR FREE,415.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,415.0,0.0,415.0,0.0,415.0,0.0,415.0,0
TCGA-44-A4SU-01,TCGA-44-A4SU,LUAD,67.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-24820.0,Dead,WITH TUMOR,nan,409.0,nan,Locoregional Recurrence,nan,nan,260.0,Complete Remission/Response,nan,nan,1.0,409.0,1.0,409.0,1.0,260.0,1.0,260.0,1
TCGA-49-4486-01,TCGA-49-4486,LUAD,72.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,1992.0,nan,-26415.0,Dead,WITH TUMOR,nan,2318.0,nan,Distant Metastasis,nan,nan,2045.0,Complete Remission/Response,nan,nan,1.0,2318.0,1.0,2318.0,1.0,2045.0,1.0,2045.0,1
TCGA-49-4486-11,TCGA-49-4486,LUAD,72.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,1992.0,nan,-26415.0,Dead,WITH TUMOR,nan,2318.0,nan,Distant Metastasis,nan,nan,2045.0,Complete Remission/Response,nan,nan,1.0,2318.0,1.0,2318.0,1.0,2045.0,1.0,2045.0,1
TCGA-49-4487-01,TCGA-49-4487,LUAD,72.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,1992.0,nan,-26583.0,Dead,WITH TUMOR,nan,855.0,nan,nan,nan,nan,697.0,Complete Remission/Response,nan,nan,1.0,855.0,1.0,855.0,1.0,697.0,1.0,697.0,1
TCGA-49-4488-01,TCGA-49-4488,LUAD,74.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,1992.0,nan,-27332.0,Dead,nan,nan,869.0,nan,nan,nan,nan,634.0,nan,nan,nan,1.0,869.0,nan,869.0,nan,nan,1.0,634.0,1
TCGA-49-4488-11,TCGA-49-4488,LUAD,74.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,1992.0,nan,-27332.0,Dead,nan,nan,869.0,nan,nan,nan,nan,634.0,nan,nan,nan,1.0,869.0,nan,869.0,nan,nan,1.0,634.0,1
TCGA-49-4490-01,TCGA-49-4490,LUAD,45.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,1993.0,nan,-16634.0,Dead,WITH TUMOR,nan,385.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,385.0,1.0,385.0,nan,nan,1.0,385.0,1
TCGA-49-4490-11,TCGA-49-4490,LUAD,45.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,1993.0,nan,-16634.0,Dead,WITH TUMOR,nan,385.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,385.0,1.0,385.0,nan,nan,1.0,385.0,1
TCGA-49-4494-01,TCGA-49-4494,LUAD,77.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,1995.0,nan,-28387.0,Dead,WITH TUMOR,nan,1081.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1081.0,1.0,1081.0,nan,nan,1.0,1081.0,1
TCGA-49-4494-11,TCGA-49-4494,LUAD,77.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,1995.0,nan,-28387.0,Dead,WITH TUMOR,nan,1081.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1081.0,1.0,1081.0,nan,nan,1.0,1081.0,1
TCGA-49-4501-01,TCGA-49-4501,LUAD,67.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,1996.0,nan,-24817.0,Dead,WITH TUMOR,nan,1421.0,nan,nan,nan,nan,545.0,Complete Remission/Response,nan,nan,1.0,1421.0,1.0,1421.0,1.0,545.0,1.0,545.0,1
TCGA-49-4501-11,TCGA-49-4501,LUAD,67.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,1996.0,nan,-24817.0,Dead,WITH TUMOR,nan,1421.0,nan,nan,nan,nan,545.0,Complete Remission/Response,nan,nan,1.0,1421.0,1.0,1421.0,1.0,545.0,1.0,545.0,1
TCGA-49-4505-01,TCGA-49-4505,LUAD,61.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,1996.0,nan,-22628.0,Dead,WITH TUMOR,nan,428.0,nan,Distant Metastasis|New Primary Tumor,nan,nan,417.0,Complete Remission/Response,nan,nan,1.0,428.0,1.0,428.0,1.0,417.0,1.0,417.0,1
TCGA-49-4505-11,TCGA-49-4505,LUAD,61.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,1996.0,nan,-22628.0,Dead,WITH TUMOR,nan,428.0,nan,Distant Metastasis|New Primary Tumor,nan,nan,417.0,Complete Remission/Response,nan,nan,1.0,428.0,1.0,428.0,1.0,417.0,1.0,417.0,1
TCGA-49-4506-01,TCGA-49-4506,LUAD,68.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,1997.0,nan,-25132.0,Dead,[Discrepancy],nan,999.0,nan,Locoregional Recurrence,nan,nan,692.0,Complete Remission/Response,nan,nan,1.0,999.0,nan,999.0,1.0,692.0,1.0,692.0,1
TCGA-49-4506-11,TCGA-49-4506,LUAD,68.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,1997.0,nan,-25132.0,Dead,[Discrepancy],nan,999.0,nan,Locoregional Recurrence,nan,nan,692.0,Complete Remission/Response,nan,nan,1.0,999.0,nan,999.0,1.0,692.0,1.0,692.0,1
TCGA-49-4507-01,TCGA-49-4507,LUAD,73.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,1997.0,nan,-26851.0,Dead,WITH TUMOR,nan,268.0,nan,nan,nan,nan,158.0,Progressive Disease,nan,nan,1.0,268.0,1.0,268.0,nan,nan,1.0,158.0,1
TCGA-49-4507-11,TCGA-49-4507,LUAD,73.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,1997.0,nan,-26851.0,Dead,WITH TUMOR,nan,268.0,nan,nan,nan,nan,158.0,Progressive Disease,nan,nan,1.0,268.0,1.0,268.0,nan,nan,1.0,158.0,1
TCGA-49-4510-01,TCGA-49-4510,LUAD,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Lung Adenocarcinoma,nan,2001.0,nan,-18762.0,Dead,WITH TUMOR,nan,896.0,nan,Distant Metastasis,nan,nan,502.0,Stable Disease,nan,nan,1.0,896.0,1.0,896.0,nan,nan,1.0,502.0,1
TCGA-49-4510-11,TCGA-49-4510,LUAD,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Lung Adenocarcinoma,nan,2001.0,nan,-18762.0,Dead,WITH TUMOR,nan,896.0,nan,Distant Metastasis,nan,nan,502.0,Stable Disease,nan,nan,1.0,896.0,1.0,896.0,nan,nan,1.0,502.0,1
TCGA-49-4512-01,TCGA-49-4512,LUAD,69.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2007.0,nan,-25502.0,Dead,WITH TUMOR,157.0,905.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,905.0,1.0,905.0,nan,nan,1.0,905.0,1
TCGA-49-4512-11,TCGA-49-4512,LUAD,69.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2007.0,nan,-25502.0,Dead,WITH TUMOR,157.0,905.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,905.0,1.0,905.0,nan,nan,1.0,905.0,1
TCGA-49-4514-01,TCGA-49-4514,LUAD,79.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2007.0,nan,-28908.0,Alive,TUMOR FREE,1700.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1700.0,0.0,1700.0,0.0,1700.0,0.0,1700.0,0
TCGA-49-6742-01,TCGA-49-6742,LUAD,70.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-25839.0,Dead,WITH TUMOR,nan,488.0,nan,nan,nan,nan,214.0,Progressive Disease,nan,nan,1.0,488.0,1.0,488.0,nan,nan,1.0,214.0,1
TCGA-49-6742-11,TCGA-49-6742,LUAD,70.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-25839.0,Dead,WITH TUMOR,nan,488.0,nan,nan,nan,nan,214.0,Progressive Disease,nan,nan,1.0,488.0,1.0,488.0,nan,nan,1.0,214.0,1
TCGA-49-6743-01,TCGA-49-6743,LUAD,81.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-29807.0,Alive,TUMOR FREE,1621.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1621.0,0.0,1621.0,0.0,1621.0,0.0,1621.0,0
TCGA-49-6743-11,TCGA-49-6743,LUAD,81.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-29807.0,Alive,TUMOR FREE,1621.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1621.0,0.0,1621.0,0.0,1621.0,0.0,1621.0,0
TCGA-49-6744-01,TCGA-49-6744,LUAD,64.0,FEMALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-23484.0,Alive,TUMOR FREE,1683.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1683.0,0.0,1683.0,0.0,1683.0,0.0,1683.0,0
TCGA-49-6744-11,TCGA-49-6744,LUAD,64.0,FEMALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-23484.0,Alive,TUMOR FREE,1683.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1683.0,0.0,1683.0,0.0,1683.0,0.0,1683.0,0
TCGA-49-6745-01,TCGA-49-6745,LUAD,82.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-30133.0,Alive,TUMOR FREE,522.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,522.0,0.0,522.0,nan,nan,0.0,522.0,0
TCGA-49-6745-11,TCGA-49-6745,LUAD,82.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-30133.0,Alive,TUMOR FREE,522.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,522.0,0.0,522.0,nan,nan,0.0,522.0,0
TCGA-49-6761-01,TCGA-49-6761,LUAD,68.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-24849.0,Alive,TUMOR FREE,354.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,354.0,0.0,354.0,0.0,354.0,0.0,354.0,0
TCGA-49-6761-11,TCGA-49-6761,LUAD,68.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-24849.0,Alive,TUMOR FREE,354.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,354.0,0.0,354.0,0.0,354.0,0.0,354.0,0
TCGA-49-6767-01,TCGA-49-6767,LUAD,46.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2010.0,nan,-17108.0,Alive,TUMOR FREE,677.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,677.0,0.0,677.0,nan,nan,0.0,677.0,0
TCGA-49-AAQV-01,TCGA-49-AAQV,LUAD,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Lung Adenocarcinoma,nan,2012.0,nan,-23370.0,Dead,TUMOR FREE,nan,677.0,nan,Distant Metastasis,nan,nan,509.0,Complete Remission/Response,nan,nan,1.0,677.0,0.0,677.0,1.0,509.0,1.0,509.0,1
TCGA-49-AAR0-01,TCGA-49-AAR0,LUAD,57.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Adenocarcinoma,nan,2002.0,nan,-20932.0,Alive,TUMOR FREE,4765.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4765.0,0.0,4765.0,0.0,4765.0,0.0,4765.0,0
TCGA-49-AAR2-01,TCGA-49-AAR2,LUAD,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-23479.0,Alive,TUMOR FREE,2224.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2224.0,0.0,2224.0,0.0,2224.0,0.0,2224.0,0
TCGA-49-AAR3-01,TCGA-49-AAR3,LUAD,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Lung Adenocarcinoma,nan,2008.0,nan,-25469.0,Alive,[Discrepancy],1893.0,nan,nan,Locoregional Recurrence,nan,nan,1893.0,Complete Remission/Response,nan,nan,0.0,1893.0,0.0,1893.0,1.0,1893.0,1.0,1893.0,2
TCGA-49-AAR4-01,TCGA-49-AAR4,LUAD,51.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Lung Adenocarcinoma,nan,2006.0,nan,-18939.0,Dead,WITH TUMOR,nan,879.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,879.0,1.0,879.0,nan,nan,1.0,879.0,1
TCGA-49-AAR9-01,TCGA-49-AAR9,LUAD,61.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Lung Adenocarcinoma,nan,1999.0,nan,-22510.0,Dead,WITH TUMOR,nan,260.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,260.0,1.0,260.0,nan,nan,1.0,260.0,1
TCGA-49-AARE-01,TCGA-49-AARE,LUAD,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Adenocarcinoma,nan,1999.0,nan,-18893.0,Dead,WITH TUMOR,nan,1229.0,nan,Locoregional Recurrence,nan,nan,388.0,Complete Remission/Response,nan,nan,1.0,1229.0,1.0,1229.0,1.0,388.0,1.0,388.0,1
TCGA-49-AARN-01,TCGA-49-AARN,LUAD,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Adenocarcinoma,nan,2000.0,nan,-20605.0,Dead,nan,nan,1135.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1135.0,nan,1135.0,0.0,1135.0,0.0,1135.0,1
TCGA-49-AARO-01,TCGA-49-AARO,LUAD,39.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Adenocarcinoma,nan,2003.0,nan,-14527.0,Alive,WITH TUMOR,3759.0,nan,nan,Locoregional Recurrence,nan,nan,1144.0,Complete Remission/Response,nan,nan,0.0,3759.0,0.0,3759.0,1.0,1144.0,1.0,1144.0,2
TCGA-49-AARQ-01,TCGA-49-AARQ,LUAD,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Lung Adenocarcinoma,nan,1996.0,nan,-15065.0,Alive,TUMOR FREE,6732.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,6732.0,0.0,6732.0,0.0,6732.0,0.0,6732.0,0
TCGA-49-AARR-01,TCGA-49-AARR,LUAD,68.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Adenocarcinoma,nan,2001.0,nan,-24942.0,Alive,WITH TUMOR,4992.0,nan,nan,New Primary Tumor,nan,nan,1099.0,Complete Remission/Response,nan,nan,0.0,4992.0,0.0,4992.0,1.0,4812.0,1.0,1099.0,2
TCGA-4B-A93V-01,TCGA-4B-A93V,LUAD,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Adenocarcinoma,nan,2013.0,nan,-19035.0,Dead,WITH TUMOR,nan,300.0,nan,Distant Metastasis,nan,nan,251.0,Progressive Disease,nan,nan,1.0,300.0,1.0,300.0,nan,nan,1.0,251.0,1
TCGA-50-5044-01,TCGA-50-5044,LUAD,72.0,FEMALE,WHITE,Stage IIIB,nan,Lung Adenocarcinoma,nan,2002.0,nan,-26567.0,Dead,WITH TUMOR,nan,624.0,nan,Distant Metastasis,nan,nan,483.0,Progressive Disease,nan,nan,1.0,624.0,1.0,624.0,nan,nan,1.0,483.0,1
TCGA-50-5045-01,TCGA-50-5045,LUAD,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,[Discrepancy],nan,Lung Adenocarcinoma,nan,2004.0,nan,-20961.0,Dead,WITH TUMOR,nan,2174.0,nan,Locoregional Recurrence,nan,nan,1433.0,Progressive Disease,nan,nan,1.0,2174.0,1.0,2174.0,nan,nan,1.0,1433.0,1
TCGA-50-5049-01,TCGA-50-5049,LUAD,70.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2006.0,nan,-25577.0,Alive,WITH TUMOR,3094.0,nan,nan,Locoregional Recurrence,nan,nan,1568.0,Progressive Disease,nan,nan,0.0,3094.0,0.0,3094.0,nan,nan,1.0,1568.0,0
TCGA-50-5051-01,TCGA-50-5051,LUAD,42.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2007.0,nan,-15585.0,Dead,WITH TUMOR,nan,478.0,nan,Distant Metastasis,nan,nan,184.0,Progressive Disease,nan,nan,1.0,478.0,1.0,478.0,nan,nan,1.0,184.0,1
TCGA-50-5055-01,TCGA-50-5055,LUAD,79.0,FEMALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2008.0,nan,-28988.0,Dead,WITH TUMOR,nan,1830.0,nan,Locoregional Recurrence|Distant Metastasis,nan,nan,771.0,Stable Disease,nan,nan,1.0,1830.0,1.0,1830.0,nan,nan,1.0,771.0,1
TCGA-50-5066-02,TCGA-50-5066,LUAD,72.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-26385.0,Alive,TUMOR FREE,1442.0,nan,nan,Distant Metastasis,nan,nan,477.0,Complete Remission/Response,nan,nan,0.0,1442.0,0.0,1442.0,1.0,477.0,1.0,477.0,2
TCGA-50-5066-01,TCGA-50-5066,LUAD,72.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-26385.0,Alive,TUMOR FREE,1442.0,nan,nan,Distant Metastasis,nan,nan,477.0,Complete Remission/Response,nan,nan,0.0,1442.0,0.0,1442.0,1.0,477.0,1.0,477.0,2
TCGA-50-5068-01,TCGA-50-5068,LUAD,59.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2003.0,nan,-21728.0,Dead,WITH TUMOR,1499.0,1499.0,nan,Distant Metastasis,nan,nan,686.0,Progressive Disease,nan,nan,1.0,1499.0,1.0,1499.0,nan,nan,1.0,686.0,1
TCGA-50-5072-01,TCGA-50-5072,LUAD,74.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-27036.0,Dead,WITH TUMOR,nan,250.0,nan,Distant Metastasis,nan,nan,213.0,Progressive Disease,nan,nan,1.0,250.0,1.0,250.0,nan,nan,1.0,213.0,1
TCGA-50-5930-01,TCGA-50-5930,LUAD,47.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2001.0,nan,-17238.0,Dead,WITH TUMOR,nan,282.0,nan,Distant Metastasis,nan,nan,177.0,Progressive Disease,nan,nan,1.0,282.0,1.0,282.0,nan,nan,1.0,177.0,1
TCGA-50-5930-11,TCGA-50-5930,LUAD,47.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2001.0,nan,-17238.0,Dead,WITH TUMOR,nan,282.0,nan,Distant Metastasis,nan,nan,177.0,Progressive Disease,nan,nan,1.0,282.0,1.0,282.0,nan,nan,1.0,177.0,1
TCGA-50-5931-01,TCGA-50-5931,LUAD,75.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2001.0,nan,-27733.0,Dead,WITH TUMOR,nan,434.0,nan,Distant Metastasis,nan,nan,425.0,Progressive Disease,nan,nan,1.0,434.0,1.0,434.0,nan,nan,1.0,425.0,1
TCGA-50-5931-11,TCGA-50-5931,LUAD,75.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2001.0,nan,-27733.0,Dead,WITH TUMOR,nan,434.0,nan,Distant Metastasis,nan,nan,425.0,Progressive Disease,nan,nan,1.0,434.0,1.0,434.0,nan,nan,1.0,425.0,1
TCGA-50-5932-01,TCGA-50-5932,LUAD,75.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2001.0,nan,-27454.0,Dead,WITH TUMOR,1091.0,1235.0,nan,Locoregional Recurrence,nan,nan,1090.0,Progressive Disease,nan,nan,1.0,1235.0,1.0,1235.0,nan,nan,1.0,1090.0,1
TCGA-50-5932-11,TCGA-50-5932,LUAD,75.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2001.0,nan,-27454.0,Dead,WITH TUMOR,1091.0,1235.0,nan,Locoregional Recurrence,nan,nan,1090.0,Progressive Disease,nan,nan,1.0,1235.0,1.0,1235.0,nan,nan,1.0,1090.0,1
TCGA-50-5933-01,TCGA-50-5933,LUAD,72.0,MALE,WHITE,Stage IIIB,nan,Lung Adenocarcinoma,nan,2001.0,nan,-26377.0,Dead,TUMOR FREE,2370.0,2393.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2393.0,0.0,2393.0,0.0,2393.0,0.0,2393.0,0
TCGA-50-5933-11,TCGA-50-5933,LUAD,72.0,MALE,WHITE,Stage IIIB,nan,Lung Adenocarcinoma,nan,2001.0,nan,-26377.0,Dead,TUMOR FREE,2370.0,2393.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2393.0,0.0,2393.0,0.0,2393.0,0.0,2393.0,0
TCGA-50-5935-01,TCGA-50-5935,LUAD,86.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2006.0,nan,-31610.0,Dead,TUMOR FREE,653.0,653.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,653.0,0.0,653.0,0.0,653.0,0.0,653.0,0
TCGA-50-5935-11,TCGA-50-5935,LUAD,86.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2006.0,nan,-31610.0,Dead,TUMOR FREE,653.0,653.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,653.0,0.0,653.0,0.0,653.0,0.0,653.0,0
TCGA-50-5936-01,TCGA-50-5936,LUAD,58.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2007.0,nan,-21238.0,Dead,WITH TUMOR,nan,257.0,nan,nan,nan,nan,150.0,Progressive Disease,nan,nan,1.0,257.0,1.0,257.0,nan,nan,1.0,150.0,1
TCGA-50-5936-11,TCGA-50-5936,LUAD,58.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2007.0,nan,-21238.0,Dead,WITH TUMOR,nan,257.0,nan,nan,nan,nan,150.0,Progressive Disease,nan,nan,1.0,257.0,1.0,257.0,nan,nan,1.0,150.0,1
TCGA-50-5939-01,TCGA-50-5939,LUAD,85.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2008.0,nan,-31236.0,Dead,TUMOR FREE,nan,460.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,460.0,0.0,460.0,0.0,460.0,0.0,460.0,0
TCGA-50-5939-11,TCGA-50-5939,LUAD,85.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2008.0,nan,-31236.0,Dead,TUMOR FREE,nan,460.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,460.0,0.0,460.0,0.0,460.0,0.0,460.0,0
TCGA-50-5941-01,TCGA-50-5941,LUAD,55.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-20350.0,Alive,TUMOR FREE,1474.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1474.0,0.0,1474.0,0.0,1474.0,0.0,1474.0,0
TCGA-50-5942-01,TCGA-50-5942,LUAD,67.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-24781.0,Alive,WITH TUMOR,1847.0,nan,nan,Locoregional Recurrence,nan,nan,1378.0,Stable Disease,nan,nan,0.0,1847.0,0.0,1847.0,nan,nan,1.0,1378.0,2
TCGA-50-5944-01,TCGA-50-5944,LUAD,69.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-25440.0,Alive,TUMOR FREE,1750.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1750.0,0.0,1750.0,0.0,1750.0,0.0,1750.0,0
TCGA-50-5946-02,TCGA-50-5946,LUAD,62.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-22852.0,Alive,WITH TUMOR,1617.0,nan,nan,Distant Metastasis,nan,nan,221.0,Progressive Disease,nan,nan,0.0,1617.0,0.0,1617.0,nan,nan,1.0,221.0,0
TCGA-50-5946-01,TCGA-50-5946,LUAD,62.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-22852.0,Alive,WITH TUMOR,1617.0,nan,nan,Distant Metastasis,nan,nan,221.0,Progressive Disease,nan,nan,0.0,1617.0,0.0,1617.0,nan,nan,1.0,221.0,0
TCGA-50-6590-01,TCGA-50-6590,LUAD,72.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2005.0,nan,-26444.0,Dead,TUMOR FREE,nan,1288.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1288.0,0.0,1288.0,0.0,1288.0,0.0,1288.0,0
TCGA-50-6591-01,TCGA-50-6591,LUAD,63.0,FEMALE,WHITE,Stage IV,nan,Lung Adenocarcinoma,nan,2007.0,nan,-23067.0,Dead,WITH TUMOR,nan,119.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,119.0,1.0,119.0,nan,nan,1.0,119.0,1
TCGA-50-6591-11,TCGA-50-6591,LUAD,63.0,FEMALE,WHITE,Stage IV,nan,Lung Adenocarcinoma,nan,2007.0,nan,-23067.0,Dead,WITH TUMOR,nan,119.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,119.0,1.0,119.0,nan,nan,1.0,119.0,1
TCGA-50-6592-01,TCGA-50-6592,LUAD,71.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2007.0,nan,-26191.0,Dead,WITH TUMOR,nan,777.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,777.0,1.0,777.0,nan,nan,1.0,777.0,1
TCGA-50-6592-11,TCGA-50-6592,LUAD,71.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2007.0,nan,-26191.0,Dead,WITH TUMOR,nan,777.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,777.0,1.0,777.0,nan,nan,1.0,777.0,1
TCGA-50-6593-01,TCGA-50-6593,LUAD,49.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2008.0,nan,-18152.0,Dead,WITH TUMOR,nan,336.0,nan,Distant Metastasis,nan,nan,266.0,Progressive Disease,nan,nan,1.0,336.0,1.0,336.0,nan,nan,1.0,266.0,1
TCGA-50-6593-11,TCGA-50-6593,LUAD,49.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2008.0,nan,-18152.0,Dead,WITH TUMOR,nan,336.0,nan,Distant Metastasis,nan,nan,266.0,Progressive Disease,nan,nan,1.0,336.0,1.0,336.0,nan,nan,1.0,266.0,1
TCGA-50-6594-01,TCGA-50-6594,LUAD,79.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-28924.0,Dead,WITH TUMOR,nan,370.0,nan,Distant Metastasis,nan,nan,285.0,Progressive Disease,nan,nan,1.0,370.0,1.0,370.0,nan,nan,1.0,285.0,1
TCGA-50-6594-11,TCGA-50-6594,LUAD,79.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-28924.0,Dead,WITH TUMOR,nan,370.0,nan,Distant Metastasis,nan,nan,285.0,Progressive Disease,nan,nan,1.0,370.0,1.0,370.0,nan,nan,1.0,285.0,1
TCGA-50-6595-01,TCGA-50-6595,LUAD,74.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-27197.0,Dead,WITH TUMOR,nan,189.0,nan,Distant Metastasis,nan,nan,182.0,Progressive Disease,nan,nan,1.0,189.0,1.0,189.0,nan,nan,1.0,182.0,1
TCGA-50-6595-11,TCGA-50-6595,LUAD,74.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-27197.0,Dead,WITH TUMOR,nan,189.0,nan,Distant Metastasis,nan,nan,182.0,Progressive Disease,nan,nan,1.0,189.0,1.0,189.0,nan,nan,1.0,182.0,1
TCGA-50-6597-01,TCGA-50-6597,LUAD,79.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2007.0,nan,-29195.0,Dead,TUMOR FREE,nan,1268.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,1268.0,0.0,1268.0,nan,nan,0.0,1268.0,1
TCGA-50-6673-01,TCGA-50-6673,LUAD,84.0,FEMALE,WHITE,Stage I,nan,Lung Adenocarcinoma,nan,2004.0,nan,-30689.0,Dead,nan,nan,22.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,22.0,nan,22.0,nan,nan,0.0,22.0,1
TCGA-50-7109-01,TCGA-50-7109,LUAD,60.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-21979.0,Dead,WITH TUMOR,nan,308.0,nan,Distant Metastasis,nan,nan,15.0,Progressive Disease,nan,nan,1.0,308.0,1.0,308.0,nan,nan,1.0,15.0,1
TCGA-50-7109-11,TCGA-50-7109,LUAD,60.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-21979.0,Dead,WITH TUMOR,nan,308.0,nan,Distant Metastasis,nan,nan,15.0,Progressive Disease,nan,nan,1.0,308.0,1.0,308.0,nan,nan,1.0,15.0,1
TCGA-50-8457-01,TCGA-50-8457,LUAD,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-23055.0,Alive,TUMOR FREE,1125.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1125.0,0.0,1125.0,0.0,1125.0,0.0,1125.0,0
TCGA-50-8459-01,TCGA-50-8459,LUAD,68.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-24859.0,Alive,WITH TUMOR,1119.0,nan,nan,Locoregional Recurrence,nan,nan,432.0,Progressive Disease,nan,nan,0.0,1119.0,0.0,1119.0,nan,nan,1.0,432.0,0
TCGA-50-8460-01,TCGA-50-8460,LUAD,74.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-27270.0,Alive,TUMOR FREE,829.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,829.0,0.0,829.0,0.0,829.0,0.0,829.0,0
TCGA-53-7624-01,TCGA-53-7624,LUAD,40.0,FEMALE,WHITE,Stage IV,nan,Lung Adenocarcinoma,nan,2008.0,nan,-14794.0,Dead,WITH TUMOR,nan,1043.0,nan,Distant Metastasis,nan,nan,400.0,Progressive Disease,nan,nan,1.0,1043.0,1.0,1043.0,nan,nan,1.0,400.0,1
TCGA-53-7626-01,TCGA-53-7626,LUAD,76.0,FEMALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2008.0,nan,-28024.0,Dead,WITH TUMOR,nan,929.0,nan,Locoregional Recurrence,nan,nan,865.0,Progressive Disease,nan,nan,1.0,929.0,1.0,929.0,nan,nan,1.0,865.0,1
TCGA-53-7813-01,TCGA-53-7813,LUAD,51.0,FEMALE,WHITE,Stage IIIB,nan,Lung Adenocarcinoma,nan,2008.0,nan,-18875.0,Alive,TUMOR FREE,424.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,424.0,0.0,424.0,nan,nan,0.0,424.0,0
TCGA-53-A4EZ-01,TCGA-53-A4EZ,LUAD,63.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-23201.0,Alive,TUMOR FREE,1071.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1071.0,0.0,1071.0,nan,nan,0.0,1071.0,0
TCGA-55-1592-01,TCGA-55-1592,LUAD,65.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2005.0,nan,nan,Dead,WITH TUMOR,nan,701.0,nan,nan,nan,nan,452.0,Complete Remission/Response,nan,nan,1.0,701.0,1.0,701.0,1.0,452.0,1.0,452.0,1
TCGA-55-1592-11,TCGA-55-1592,LUAD,65.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2005.0,nan,nan,Dead,WITH TUMOR,nan,701.0,nan,nan,nan,nan,452.0,Complete Remission/Response,nan,nan,1.0,701.0,1.0,701.0,1.0,452.0,1.0,452.0,1
TCGA-55-1594-01,TCGA-55-1594,LUAD,68.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2005.0,nan,-25008.0,Alive,TUMOR FREE,1178.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1178.0,0.0,1178.0,nan,nan,0.0,1178.0,0
TCGA-55-1594-11,TCGA-55-1594,LUAD,68.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2005.0,nan,-25008.0,Alive,TUMOR FREE,1178.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1178.0,0.0,1178.0,nan,nan,0.0,1178.0,0
TCGA-55-1595-01,TCGA-55-1595,LUAD,74.0,FEMALE,ASIAN,Stage IA,nan,Lung Adenocarcinoma,nan,2004.0,nan,nan,Alive,TUMOR FREE,1479.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1479.0,0.0,1479.0,0.0,1479.0,0.0,1479.0,0
TCGA-55-1595-11,TCGA-55-1595,LUAD,74.0,FEMALE,ASIAN,Stage IA,nan,Lung Adenocarcinoma,nan,2004.0,nan,nan,Alive,TUMOR FREE,1479.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1479.0,0.0,1479.0,0.0,1479.0,0.0,1479.0,0
TCGA-55-1596-01,TCGA-55-1596,LUAD,55.0,MALE,ASIAN,Stage IIB,nan,Lung Adenocarcinoma,nan,2004.0,nan,-20381.0,Alive,TUMOR FREE,2065.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2065.0,0.0,2065.0,0.0,2065.0,0.0,2065.0,0
TCGA-55-1596-11,TCGA-55-1596,LUAD,55.0,MALE,ASIAN,Stage IIB,nan,Lung Adenocarcinoma,nan,2004.0,nan,-20381.0,Alive,TUMOR FREE,2065.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2065.0,0.0,2065.0,0.0,2065.0,0.0,2065.0,0
TCGA-55-5899-01,TCGA-55-5899,LUAD,58.0,MALE,WHITE,[Discrepancy],nan,Lung Adenocarcinoma,nan,2010.0,nan,nan,Alive,TUMOR FREE,930.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,930.0,0.0,930.0,0.0,930.0,0.0,930.0,0
TCGA-55-6543-01,TCGA-55-6543,LUAD,60.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,nan,Alive,TUMOR FREE,435.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,435.0,0.0,435.0,0.0,435.0,0.0,435.0,0
TCGA-55-6642-01,TCGA-55-6642,LUAD,63.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2006.0,nan,-23107.0,Alive,TUMOR FREE,2449.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2449.0,0.0,2449.0,0.0,2449.0,0.0,2449.0,0
TCGA-55-6712-01,TCGA-55-6712,LUAD,71.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,nan,Dead,WITH TUMOR,nan,171.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,171.0,1.0,171.0,nan,nan,1.0,171.0,1
TCGA-55-6968-01,TCGA-55-6968,LUAD,61.0,MALE,WHITE,Stage IV,nan,Lung Adenocarcinoma,nan,2004.0,nan,-22344.0,Dead,WITH TUMOR,nan,1293.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,1293.0,1.0,1293.0,nan,nan,1.0,1293.0,1
TCGA-55-6968-11,TCGA-55-6968,LUAD,61.0,MALE,WHITE,Stage IV,nan,Lung Adenocarcinoma,nan,2004.0,nan,-22344.0,Dead,WITH TUMOR,nan,1293.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,1293.0,1.0,1293.0,nan,nan,1.0,1293.0,1
TCGA-55-6969-01,TCGA-55-6969,LUAD,52.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2004.0,nan,-19270.0,Alive,TUMOR FREE,1239.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1239.0,0.0,1239.0,nan,nan,0.0,1239.0,0
TCGA-55-6969-11,TCGA-55-6969,LUAD,52.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2004.0,nan,-19270.0,Alive,TUMOR FREE,1239.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1239.0,0.0,1239.0,nan,nan,0.0,1239.0,0
TCGA-55-6970-01,TCGA-55-6970,LUAD,67.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2004.0,nan,-24773.0,Dead,WITH TUMOR,nan,464.0,nan,Locoregional Recurrence,nan,nan,457.0,Stable Disease,nan,nan,1.0,464.0,1.0,464.0,nan,nan,1.0,457.0,1
TCGA-55-6970-11,TCGA-55-6970,LUAD,67.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2004.0,nan,-24773.0,Dead,WITH TUMOR,nan,464.0,nan,Locoregional Recurrence,nan,nan,457.0,Stable Disease,nan,nan,1.0,464.0,1.0,464.0,nan,nan,1.0,457.0,1
TCGA-55-6971-01,TCGA-55-6971,LUAD,59.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2010.0,nan,-21734.0,Alive,TUMOR FREE,1400.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1400.0,0.0,1400.0,0.0,1400.0,0.0,1400.0,0
TCGA-55-6971-11,TCGA-55-6971,LUAD,59.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2010.0,nan,-21734.0,Alive,TUMOR FREE,1400.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1400.0,0.0,1400.0,0.0,1400.0,0.0,1400.0,0
TCGA-55-6972-01,TCGA-55-6972,LUAD,72.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2005.0,nan,-26625.0,Dead,TUMOR FREE,nan,1632.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1632.0,0.0,1632.0,0.0,1632.0,0.0,1632.0,0
TCGA-55-6972-11,TCGA-55-6972,LUAD,72.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2005.0,nan,-26625.0,Dead,TUMOR FREE,nan,1632.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1632.0,0.0,1632.0,0.0,1632.0,0.0,1632.0,0
TCGA-55-6975-01,TCGA-55-6975,LUAD,61.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2004.0,nan,nan,Dead,WITH TUMOR,nan,118.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,118.0,1.0,118.0,nan,nan,1.0,118.0,1
TCGA-55-6975-11,TCGA-55-6975,LUAD,61.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2004.0,nan,nan,Dead,WITH TUMOR,nan,118.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,118.0,1.0,118.0,nan,nan,1.0,118.0,1
TCGA-55-6978-01,TCGA-55-6978,LUAD,81.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,nan,Dead,WITH TUMOR,nan,176.0,nan,nan,nan,nan,42.0,Progressive Disease,nan,nan,1.0,176.0,1.0,176.0,nan,nan,1.0,42.0,1
TCGA-55-6978-11,TCGA-55-6978,LUAD,81.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,nan,Dead,WITH TUMOR,nan,176.0,nan,nan,nan,nan,42.0,Progressive Disease,nan,nan,1.0,176.0,1.0,176.0,nan,nan,1.0,42.0,1
TCGA-55-6979-01,TCGA-55-6979,LUAD,59.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2006.0,nan,-21780.0,Dead,WITH TUMOR,nan,237.0,nan,Distant Metastasis,nan,nan,195.0,Progressive Disease,nan,nan,1.0,237.0,1.0,237.0,nan,nan,1.0,195.0,1
TCGA-55-6979-11,TCGA-55-6979,LUAD,59.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2006.0,nan,-21780.0,Dead,WITH TUMOR,nan,237.0,nan,Distant Metastasis,nan,nan,195.0,Progressive Disease,nan,nan,1.0,237.0,1.0,237.0,nan,nan,1.0,195.0,1
TCGA-55-6980-01,TCGA-55-6980,LUAD,56.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2006.0,nan,nan,Alive,TUMOR FREE,2109.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2109.0,0.0,2109.0,0.0,2109.0,0.0,2109.0,0
TCGA-55-6980-11,TCGA-55-6980,LUAD,56.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2006.0,nan,nan,Alive,TUMOR FREE,2109.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2109.0,0.0,2109.0,0.0,2109.0,0.0,2109.0,0
TCGA-55-6981-01,TCGA-55-6981,LUAD,53.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2005.0,nan,-19497.0,Dead,TUMOR FREE,nan,1379.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1379.0,0.0,1379.0,0.0,1379.0,0.0,1379.0,0
TCGA-55-6981-11,TCGA-55-6981,LUAD,53.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2005.0,nan,-19497.0,Dead,TUMOR FREE,nan,1379.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1379.0,0.0,1379.0,0.0,1379.0,0.0,1379.0,0
TCGA-55-6982-01,TCGA-55-6982,LUAD,79.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2004.0,nan,nan,Dead,WITH TUMOR,nan,995.0,nan,Distant Metastasis,nan,nan,183.0,Progressive Disease,nan,nan,1.0,995.0,1.0,995.0,nan,nan,1.0,183.0,1
TCGA-55-6982-11,TCGA-55-6982,LUAD,79.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2004.0,nan,nan,Dead,WITH TUMOR,nan,995.0,nan,Distant Metastasis,nan,nan,183.0,Progressive Disease,nan,nan,1.0,995.0,1.0,995.0,nan,nan,1.0,183.0,1
TCGA-55-6983-01,TCGA-55-6983,LUAD,81.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2005.0,nan,nan,Alive,TUMOR FREE,2823.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2823.0,0.0,2823.0,0.0,2823.0,0.0,2823.0,0
TCGA-55-6983-11,TCGA-55-6983,LUAD,81.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2005.0,nan,nan,Alive,TUMOR FREE,2823.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2823.0,0.0,2823.0,0.0,2823.0,0.0,2823.0,0
TCGA-55-6984-01,TCGA-55-6984,LUAD,71.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2006.0,nan,nan,Dead,WITH TUMOR,nan,760.0,nan,nan,nan,nan,724.0,Complete Remission/Response,nan,nan,1.0,760.0,1.0,760.0,1.0,724.0,1.0,724.0,1
TCGA-55-6984-11,TCGA-55-6984,LUAD,71.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2006.0,nan,nan,Dead,WITH TUMOR,nan,760.0,nan,nan,nan,nan,724.0,Complete Remission/Response,nan,nan,1.0,760.0,1.0,760.0,1.0,724.0,1.0,724.0,1
TCGA-55-6985-01,TCGA-55-6985,LUAD,58.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2004.0,nan,-21381.0,Alive,TUMOR FREE,1233.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1233.0,0.0,1233.0,0.0,1233.0,0.0,1233.0,0
TCGA-55-6985-11,TCGA-55-6985,LUAD,58.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2004.0,nan,-21381.0,Alive,TUMOR FREE,1233.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1233.0,0.0,1233.0,0.0,1233.0,0.0,1233.0,0
TCGA-55-6986-01,TCGA-55-6986,LUAD,74.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2004.0,nan,nan,Alive,TUMOR FREE,3261.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3261.0,0.0,3261.0,0.0,3261.0,0.0,3261.0,0
TCGA-55-6986-11,TCGA-55-6986,LUAD,74.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2004.0,nan,nan,Alive,TUMOR FREE,3261.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3261.0,0.0,3261.0,0.0,3261.0,0.0,3261.0,0
TCGA-55-6987-01,TCGA-55-6987,LUAD,77.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2006.0,nan,-28382.0,Alive,TUMOR FREE,2137.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2137.0,0.0,2137.0,0.0,2137.0,0.0,2137.0,0
TCGA-55-7227-01,TCGA-55-7227,LUAD,77.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-28458.0,Dead,WITH TUMOR,nan,952.0,nan,Locoregional Recurrence,nan,nan,255.0,Complete Remission/Response,nan,nan,1.0,952.0,1.0,952.0,1.0,255.0,1.0,255.0,1
TCGA-55-7281-01,TCGA-55-7281,LUAD,70.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-25870.0,Alive,WITH TUMOR,872.0,nan,nan,Distant Metastasis,nan,nan,339.0,Complete Remission/Response,nan,nan,0.0,872.0,0.0,872.0,1.0,339.0,1.0,339.0,2
TCGA-55-7283-01,TCGA-55-7283,LUAD,76.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-27946.0,Alive,WITH TUMOR,609.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,609.0,0.0,609.0,nan,nan,0.0,609.0,0
TCGA-55-7283-11,TCGA-55-7283,LUAD,76.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-27946.0,Alive,WITH TUMOR,609.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,609.0,0.0,609.0,nan,nan,0.0,609.0,0
TCGA-55-7284-01,TCGA-55-7284,LUAD,74.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-27087.0,Dead,WITH TUMOR,nan,243.0,nan,Distant Metastasis,nan,nan,231.0,Complete Remission/Response,nan,nan,1.0,243.0,1.0,243.0,1.0,231.0,1.0,231.0,1
TCGA-55-7570-01,TCGA-55-7570,LUAD,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-22218.0,Alive,TUMOR FREE,824.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,824.0,0.0,824.0,0.0,824.0,0.0,824.0,0
TCGA-55-7570-11,TCGA-55-7570,LUAD,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-22218.0,Alive,TUMOR FREE,824.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,824.0,0.0,824.0,0.0,824.0,0.0,824.0,0
TCGA-55-7573-01,TCGA-55-7573,LUAD,72.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-26302.0,Alive,TUMOR FREE,487.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,487.0,0.0,487.0,0.0,487.0,0.0,487.0,0
TCGA-55-7574-01,TCGA-55-7574,LUAD,64.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-23703.0,Dead,WITH TUMOR,nan,995.0,nan,Distant Metastasis,nan,nan,478.0,Complete Remission/Response,nan,nan,1.0,995.0,1.0,995.0,1.0,478.0,1.0,478.0,1
TCGA-55-7574-11,TCGA-55-7574,LUAD,64.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-23703.0,Dead,WITH TUMOR,nan,995.0,nan,Distant Metastasis,nan,nan,478.0,Complete Remission/Response,nan,nan,1.0,995.0,1.0,995.0,1.0,478.0,1.0,478.0,1
TCGA-55-7576-01,TCGA-55-7576,LUAD,54.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-19917.0,Alive,TUMOR FREE,670.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,670.0,0.0,670.0,0.0,670.0,0.0,670.0,0
TCGA-55-7576-11,TCGA-55-7576,LUAD,54.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-19917.0,Alive,TUMOR FREE,670.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,670.0,0.0,670.0,0.0,670.0,0.0,670.0,0
TCGA-55-7724-01,TCGA-55-7724,LUAD,76.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-27891.0,Alive,TUMOR FREE,705.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,705.0,0.0,705.0,0.0,705.0,0.0,705.0,0
TCGA-55-7724-11,TCGA-55-7724,LUAD,76.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-27891.0,Alive,TUMOR FREE,705.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,705.0,0.0,705.0,0.0,705.0,0.0,705.0,0
TCGA-55-7725-01,TCGA-55-7725,LUAD,68.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-24848.0,Alive,TUMOR FREE,442.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,442.0,0.0,442.0,0.0,442.0,0.0,442.0,0
TCGA-55-7725-11,TCGA-55-7725,LUAD,68.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-24848.0,Alive,TUMOR FREE,442.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,442.0,0.0,442.0,0.0,442.0,0.0,442.0,0
TCGA-55-7726-01,TCGA-55-7726,LUAD,72.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-26451.0,Alive,TUMOR FREE,652.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,652.0,0.0,652.0,0.0,652.0,0.0,652.0,0
TCGA-55-7726-11,TCGA-55-7726,LUAD,72.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-26451.0,Alive,TUMOR FREE,652.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,652.0,0.0,652.0,0.0,652.0,0.0,652.0,0
TCGA-55-7727-01,TCGA-55-7727,LUAD,70.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-25929.0,Alive,TUMOR FREE,119.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,119.0,0.0,119.0,0.0,119.0,0.0,119.0,0
TCGA-55-7728-01,TCGA-55-7728,LUAD,64.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-23505.0,Alive,TUMOR FREE,704.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,704.0,0.0,704.0,0.0,704.0,0.0,704.0,0
TCGA-55-7815-01,TCGA-55-7815,LUAD,76.0,MALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-28119.0,Alive,WITH TUMOR,773.0,nan,nan,Locoregional Recurrence,nan,nan,466.0,Complete Remission/Response,nan,nan,0.0,773.0,0.0,773.0,1.0,466.0,1.0,466.0,2
TCGA-55-7816-01,TCGA-55-7816,LUAD,49.0,FEMALE,WHITE,Stage IV,nan,Lung Adenocarcinoma,nan,2011.0,nan,-18170.0,Dead,WITH TUMOR,nan,468.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,468.0,1.0,468.0,nan,nan,1.0,468.0,1
TCGA-55-7903-01,TCGA-55-7903,LUAD,64.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-23509.0,Alive,TUMOR FREE,567.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,567.0,0.0,567.0,0.0,567.0,0.0,567.0,0
TCGA-55-7903-11,TCGA-55-7903,LUAD,64.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-23509.0,Alive,TUMOR FREE,567.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,567.0,0.0,567.0,0.0,567.0,0.0,567.0,0
TCGA-55-7907-01,TCGA-55-7907,LUAD,77.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-28201.0,Dead,WITH TUMOR,nan,343.0,nan,Distant Metastasis,nan,nan,294.0,Complete Remission/Response,nan,nan,1.0,343.0,1.0,343.0,1.0,294.0,1.0,294.0,1
TCGA-55-7910-01,TCGA-55-7910,LUAD,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-18289.0,Alive,WITH TUMOR,1040.0,nan,nan,nan,nan,nan,1018.0,Complete Remission/Response,nan,nan,0.0,1040.0,0.0,1040.0,1.0,1018.0,1.0,1018.0,2
TCGA-55-7910-11,TCGA-55-7910,LUAD,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-18289.0,Alive,WITH TUMOR,1040.0,nan,nan,nan,nan,nan,1018.0,Complete Remission/Response,nan,nan,0.0,1040.0,0.0,1040.0,1.0,1018.0,1.0,1018.0,2
TCGA-55-7911-01,TCGA-55-7911,LUAD,70.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-25746.0,Alive,TUMOR FREE,537.0,nan,nan,New Primary Tumor,nan,nan,515.0,Complete Remission/Response,nan,nan,0.0,537.0,0.0,537.0,0.0,537.0,1.0,515.0,0
TCGA-55-7911-11,TCGA-55-7911,LUAD,70.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-25746.0,Alive,TUMOR FREE,537.0,nan,nan,New Primary Tumor,nan,nan,515.0,Complete Remission/Response,nan,nan,0.0,537.0,0.0,537.0,0.0,537.0,1.0,515.0,0
TCGA-55-7913-01,TCGA-55-7913,LUAD,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-22326.0,Dead,WITH TUMOR,nan,561.0,nan,Distant Metastasis,nan,nan,480.0,Complete Remission/Response,nan,nan,1.0,561.0,1.0,561.0,1.0,480.0,1.0,480.0,1
TCGA-55-7914-01,TCGA-55-7914,LUAD,71.0,FEMALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-26105.0,Dead,WITH TUMOR,nan,187.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,187.0,1.0,187.0,nan,nan,1.0,187.0,1
TCGA-55-7914-11,TCGA-55-7914,LUAD,71.0,FEMALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-26105.0,Dead,WITH TUMOR,nan,187.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,187.0,1.0,187.0,nan,nan,1.0,187.0,1
TCGA-55-7994-01,TCGA-55-7994,LUAD,81.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-29858.0,Alive,TUMOR FREE,603.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,603.0,0.0,603.0,0.0,603.0,0.0,603.0,0
TCGA-55-7995-01,TCGA-55-7995,LUAD,73.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-26837.0,Alive,TUMOR FREE,889.0,nan,nan,Locoregional Recurrence,nan,nan,468.0,Complete Remission/Response,nan,nan,0.0,889.0,0.0,889.0,1.0,468.0,1.0,468.0,2
TCGA-55-8085-01,TCGA-55-8085,LUAD,64.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-23596.0,Alive,TUMOR FREE,904.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,904.0,0.0,904.0,0.0,904.0,0.0,904.0,0
TCGA-55-8087-01,TCGA-55-8087,LUAD,59.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-21655.0,Alive,TUMOR FREE,462.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,462.0,0.0,462.0,0.0,462.0,0.0,462.0,0
TCGA-55-8089-01,TCGA-55-8089,LUAD,56.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-20576.0,Dead,TUMOR FREE,nan,702.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,702.0,0.0,702.0,0.0,702.0,0.0,702.0,0
TCGA-55-8090-01,TCGA-55-8090,LUAD,80.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-29235.0,Dead,WITH TUMOR,nan,598.0,nan,Distant Metastasis,nan,nan,548.0,Complete Remission/Response,nan,nan,1.0,598.0,1.0,598.0,1.0,548.0,1.0,548.0,1
TCGA-55-8091-01,TCGA-55-8091,LUAD,74.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-27385.0,Alive,TUMOR FREE,600.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,600.0,0.0,600.0,0.0,600.0,0.0,600.0,0
TCGA-55-8092-01,TCGA-55-8092,LUAD,75.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-27597.0,Dead,WITH TUMOR,nan,154.0,nan,Locoregional Recurrence,nan,nan,127.0,Complete Remission/Response,nan,nan,1.0,154.0,1.0,154.0,1.0,127.0,1.0,127.0,1
TCGA-55-8094-01,TCGA-55-8094,LUAD,51.0,MALE,WHITE,Stage IV,nan,Lung Adenocarcinoma,nan,2012.0,nan,-18903.0,Alive,WITH TUMOR,541.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,541.0,0.0,541.0,nan,nan,0.0,541.0,0
TCGA-55-8096-01,TCGA-55-8096,LUAD,67.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-24684.0,Dead,WITH TUMOR,nan,719.0,nan,Distant Metastasis,nan,nan,566.0,Complete Remission/Response,nan,nan,1.0,719.0,1.0,719.0,1.0,566.0,1.0,566.0,1
TCGA-55-8097-01,TCGA-55-8097,LUAD,60.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-22260.0,Alive,TUMOR FREE,476.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,476.0,0.0,476.0,0.0,476.0,0.0,476.0,0
TCGA-55-8203-01,TCGA-55-8203,LUAD,69.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-25477.0,Alive,TUMOR FREE,547.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,547.0,0.0,547.0,0.0,547.0,0.0,547.0,0
TCGA-55-8204-01,TCGA-55-8204,LUAD,87.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-31818.0,Alive,TUMOR FREE,515.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,515.0,0.0,515.0,0.0,515.0,0.0,515.0,0
TCGA-55-8205-01,TCGA-55-8205,LUAD,76.0,FEMALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-28063.0,Alive,WITH TUMOR,599.0,nan,nan,Distant Metastasis,nan,nan,495.0,Progressive Disease,nan,nan,0.0,599.0,0.0,599.0,nan,nan,1.0,495.0,2
TCGA-55-8206-01,TCGA-55-8206,LUAD,56.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-20690.0,Alive,TUMOR FREE,888.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,888.0,0.0,888.0,0.0,888.0,0.0,888.0,0
TCGA-55-8207-01,TCGA-55-8207,LUAD,73.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-26897.0,Alive,TUMOR FREE,977.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,977.0,0.0,977.0,0.0,977.0,0.0,977.0,0
TCGA-55-8208-01,TCGA-55-8208,LUAD,73.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-26716.0,Alive,WITH TUMOR,674.0,nan,nan,Distant Metastasis,nan,nan,511.0,Complete Remission/Response,nan,nan,0.0,674.0,0.0,674.0,1.0,511.0,1.0,511.0,2
TCGA-55-8299-01,TCGA-55-8299,LUAD,61.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-22626.0,Dead,WITH TUMOR,nan,469.0,nan,Distant Metastasis,nan,nan,274.0,Complete Remission/Response,nan,nan,1.0,469.0,1.0,469.0,1.0,274.0,1.0,274.0,1
TCGA-55-8301-01,TCGA-55-8301,LUAD,58.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-21535.0,Alive,WITH TUMOR,534.0,nan,nan,Locoregional Recurrence,nan,nan,238.0,Complete Remission/Response,nan,nan,0.0,534.0,0.0,534.0,1.0,238.0,1.0,238.0,2
TCGA-55-8302-01,TCGA-55-8302,LUAD,54.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-20011.0,Alive,TUMOR FREE,478.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,478.0,0.0,478.0,0.0,478.0,0.0,478.0,0
TCGA-55-8505-01,TCGA-55-8505,LUAD,62.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-22676.0,Alive,TUMOR FREE,440.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,440.0,0.0,440.0,0.0,440.0,0.0,440.0,0
TCGA-55-8506-01,TCGA-55-8506,LUAD,62.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-22850.0,Alive,nan,11.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,11.0,0.0,11.0,nan,nan,0.0,11.0,0
TCGA-55-8507-01,TCGA-55-8507,LUAD,53.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-19390.0,Alive,TUMOR FREE,418.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,418.0,0.0,418.0,0.0,418.0,0.0,418.0,0
TCGA-55-8508-01,TCGA-55-8508,LUAD,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-22159.0,Alive,TUMOR FREE,617.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,617.0,0.0,617.0,0.0,617.0,0.0,617.0,0
TCGA-55-8510-01,TCGA-55-8510,LUAD,55.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-20410.0,Alive,TUMOR FREE,539.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,539.0,0.0,539.0,0.0,539.0,0.0,539.0,0
TCGA-55-8511-01,TCGA-55-8511,LUAD,73.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-26986.0,Alive,WITH TUMOR,552.0,nan,nan,nan,nan,nan,460.0,Complete Remission/Response,nan,nan,0.0,552.0,0.0,552.0,1.0,460.0,1.0,460.0,2
TCGA-55-8512-01,TCGA-55-8512,LUAD,41.0,MALE,WHITE,Stage IV,nan,Lung Adenocarcinoma,nan,2012.0,nan,-15266.0,Dead,WITH TUMOR,nan,607.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,607.0,1.0,607.0,nan,nan,1.0,607.0,1
TCGA-55-8513-01,TCGA-55-8513,LUAD,77.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-28284.0,Alive,WITH TUMOR,791.0,nan,nan,Distant Metastasis,nan,nan,317.0,Complete Remission/Response,nan,nan,0.0,791.0,0.0,791.0,1.0,317.0,1.0,317.0,2
TCGA-55-8514-01,TCGA-55-8514,LUAD,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-25608.0,Alive,TUMOR FREE,520.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,520.0,0.0,520.0,0.0,520.0,0.0,520.0,0
TCGA-55-8614-01,TCGA-55-8614,LUAD,76.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-27924.0,Alive,TUMOR FREE,536.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,536.0,0.0,536.0,0.0,536.0,0.0,536.0,0
TCGA-55-8615-01,TCGA-55-8615,LUAD,67.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-24786.0,Alive,WITH TUMOR,446.0,nan,nan,Distant Metastasis,nan,nan,224.0,Complete Remission/Response,nan,nan,0.0,446.0,0.0,446.0,1.0,224.0,1.0,224.0,2
TCGA-55-8616-01,TCGA-55-8616,LUAD,58.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-21225.0,Alive,TUMOR FREE,48.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,48.0,0.0,48.0,nan,nan,0.0,48.0,0
TCGA-55-8619-01,TCGA-55-8619,LUAD,72.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-26616.0,Alive,TUMOR FREE,416.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,416.0,0.0,416.0,0.0,416.0,0.0,416.0,0
TCGA-55-8620-01,TCGA-55-8620,LUAD,60.0,MALE,WHITE,Stage IV,nan,Lung Adenocarcinoma,nan,2012.0,nan,-22091.0,Dead,WITH TUMOR,nan,375.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,375.0,1.0,375.0,nan,nan,1.0,375.0,1
TCGA-55-8621-01,TCGA-55-8621,LUAD,75.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-27485.0,Alive,TUMOR FREE,515.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,515.0,0.0,515.0,0.0,515.0,0.0,515.0,0
TCGA-55-A48X-01,TCGA-55-A48X,LUAD,63.0,FEMALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-23341.0,Alive,TUMOR FREE,689.0,nan,nan,New Primary Tumor,nan,nan,615.0,Complete Remission/Response,nan,nan,0.0,689.0,0.0,689.0,0.0,689.0,1.0,615.0,0
TCGA-55-A48Y-01,TCGA-55-A48Y,LUAD,69.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-25384.0,Alive,TUMOR FREE,630.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,630.0,0.0,630.0,0.0,630.0,0.0,630.0,0
TCGA-55-A48Z-01,TCGA-55-A48Z,LUAD,60.0,FEMALE,WHITE,Stage IIIB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-22056.0,Alive,WITH TUMOR,651.0,nan,nan,Distant Metastasis,nan,nan,536.0,Stable Disease,nan,nan,0.0,651.0,0.0,651.0,nan,nan,1.0,536.0,1
TCGA-55-A490-01,TCGA-55-A490,LUAD,78.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-28728.0,Dead,TUMOR FREE,nan,99.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,99.0,0.0,99.0,nan,nan,0.0,99.0,0
TCGA-55-A491-01,TCGA-55-A491,LUAD,81.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-29593.0,Alive,TUMOR FREE,626.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,626.0,0.0,626.0,0.0,626.0,0.0,626.0,0
TCGA-55-A492-01,TCGA-55-A492,LUAD,70.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-25719.0,Alive,TUMOR FREE,596.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,596.0,0.0,596.0,0.0,596.0,0.0,596.0,0
TCGA-55-A493-01,TCGA-55-A493,LUAD,54.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-20027.0,Alive,TUMOR FREE,28.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,28.0,0.0,28.0,nan,nan,0.0,28.0,0
TCGA-55-A494-01,TCGA-55-A494,LUAD,61.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-22540.0,Alive,TUMOR FREE,481.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,481.0,0.0,481.0,0.0,481.0,0.0,481.0,0
TCGA-55-A4DF-01,TCGA-55-A4DF,LUAD,88.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-32432.0,Dead,WITH TUMOR,nan,614.0,nan,Distant Metastasis,nan,nan,515.0,Complete Remission/Response,nan,nan,1.0,614.0,1.0,614.0,1.0,515.0,1.0,515.0,1
TCGA-55-A4DG-01,TCGA-55-A4DG,LUAD,71.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-26044.0,Alive,TUMOR FREE,608.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,608.0,0.0,608.0,0.0,608.0,0.0,608.0,0
TCGA-55-A57B-01,TCGA-55-A57B,LUAD,80.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-29452.0,Alive,TUMOR FREE,546.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,546.0,0.0,546.0,0.0,546.0,0.0,546.0,0
TCGA-62-8394-01,TCGA-62-8394,LUAD,65.0,FEMALE,WHITE,Stage IIIB,nan,Lung Adenocarcinoma,nan,2008.0,nan,-23758.0,Dead,TUMOR FREE,nan,139.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,139.0,0.0,139.0,0.0,139.0,0.0,139.0,0
TCGA-62-8395-01,TCGA-62-8395,LUAD,80.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-29311.0,Alive,WITH TUMOR,1216.0,nan,nan,Locoregional Recurrence,nan,nan,395.0,Complete Remission/Response,nan,nan,0.0,1216.0,0.0,1216.0,1.0,395.0,1.0,395.0,2
TCGA-62-8397-01,TCGA-62-8397,LUAD,70.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2008.0,nan,-25728.0,Alive,TUMOR FREE,1289.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1289.0,0.0,1289.0,0.0,1289.0,0.0,1289.0,0
TCGA-62-8398-01,TCGA-62-8398,LUAD,55.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2007.0,nan,-20197.0,Dead,TUMOR FREE,nan,444.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,444.0,0.0,444.0,0.0,444.0,0.0,444.0,0
TCGA-62-8399-01,TCGA-62-8399,LUAD,62.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2006.0,nan,-22952.0,Alive,TUMOR FREE,2696.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2696.0,0.0,2696.0,0.0,2696.0,0.0,2696.0,0
TCGA-62-8402-01,TCGA-62-8402,LUAD,73.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2008.0,nan,-26934.0,Dead,WITH TUMOR,nan,1498.0,nan,Distant Metastasis,nan,nan,772.0,Complete Remission/Response,nan,nan,1.0,1498.0,1.0,1498.0,1.0,772.0,1.0,772.0,1
TCGA-62-A46O-01,TCGA-62-A46O,LUAD,65.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2006.0,nan,-24050.0,Dead,WITH TUMOR,nan,1454.0,nan,Locoregional Recurrence|Distant Metastasis,nan,nan,943.0,Complete Remission/Response,nan,nan,1.0,1454.0,1.0,1454.0,1.0,943.0,1.0,943.0,1
TCGA-62-A46P-01,TCGA-62-A46P,LUAD,65.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2006.0,nan,-23993.0,Dead,TUMOR FREE,nan,594.0,nan,Distant Metastasis,nan,nan,267.0,Complete Remission/Response,nan,nan,1.0,594.0,0.0,594.0,1.0,267.0,1.0,267.0,2
TCGA-62-A46R-01,TCGA-62-A46R,LUAD,54.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2006.0,nan,-20063.0,Dead,TUMOR FREE,nan,1725.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1725.0,0.0,1725.0,0.0,1725.0,0.0,1725.0,0
TCGA-62-A46S-01,TCGA-62-A46S,LUAD,73.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2007.0,nan,-26825.0,Dead,WITH TUMOR,nan,1653.0,nan,Locoregional Recurrence|Distant Metastasis,nan,nan,527.0,Complete Remission/Response,nan,nan,1.0,1653.0,1.0,1653.0,1.0,527.0,1.0,527.0,1
TCGA-62-A46U-01,TCGA-62-A46U,LUAD,71.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2007.0,nan,-25998.0,Alive,TUMOR FREE,2067.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2067.0,0.0,2067.0,0.0,2067.0,0.0,2067.0,0
TCGA-62-A46V-01,TCGA-62-A46V,LUAD,78.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2007.0,nan,-28495.0,Alive,TUMOR FREE,2199.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2199.0,0.0,2199.0,0.0,2199.0,0.0,2199.0,0
TCGA-62-A46Y-01,TCGA-62-A46Y,LUAD,70.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2008.0,nan,-25905.0,Dead,WITH TUMOR,nan,414.0,nan,Distant Metastasis,nan,nan,314.0,Complete Remission/Response,nan,nan,1.0,414.0,1.0,414.0,1.0,314.0,1.0,314.0,1
TCGA-62-A470-01,TCGA-62-A470,LUAD,84.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-30689.0,Dead,WITH TUMOR,nan,1194.0,nan,Locoregional Recurrence,nan,nan,539.0,Complete Remission/Response,nan,nan,1.0,1194.0,1.0,1194.0,1.0,539.0,1.0,539.0,1
TCGA-62-A471-01,TCGA-62-A471,LUAD,64.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2010.0,nan,-23689.0,Alive,TUMOR FREE,1246.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1246.0,0.0,1246.0,0.0,1246.0,0.0,1246.0,0
TCGA-62-A472-01,TCGA-62-A472,LUAD,70.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-25893.0,Alive,WITH TUMOR,910.0,nan,nan,Locoregional Recurrence,nan,nan,290.0,Complete Remission/Response,nan,nan,0.0,910.0,0.0,910.0,1.0,290.0,1.0,290.0,2
TCGA-64-1676-01,TCGA-64-1676,LUAD,58.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2005.0,nan,-21428.0,Alive,TUMOR FREE,1728.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1728.0,0.0,1728.0,0.0,1728.0,0.0,1728.0,0
TCGA-64-1677-01,TCGA-64-1677,LUAD,77.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2005.0,nan,-28482.0,Dead,nan,nan,628.0,nan,nan,nan,nan,360.0,nan,nan,nan,1.0,628.0,nan,628.0,nan,nan,1.0,360.0,1
TCGA-64-1678-01,TCGA-64-1678,LUAD,70.0,FEMALE,WHITE,[Discrepancy],nan,Lung Adenocarcinoma,nan,2006.0,nan,-25931.0,Alive,TUMOR FREE,1189.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1189.0,0.0,1189.0,0.0,1189.0,0.0,1189.0,0
TCGA-64-1679-01,TCGA-64-1679,LUAD,58.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2007.0,nan,-21310.0,Alive,TUMOR FREE,2488.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2488.0,0.0,2488.0,0.0,2488.0,0.0,2488.0,0
TCGA-64-1680-01,TCGA-64-1680,LUAD,63.0,MALE,WHITE,Stage IV,nan,Lung Adenocarcinoma,nan,2007.0,nan,-23267.0,Alive,TUMOR FREE,1126.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1126.0,0.0,1126.0,nan,nan,0.0,1126.0,0
TCGA-64-1681-01,TCGA-64-1681,LUAD,61.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2008.0,nan,-22525.0,Dead,nan,nan,1167.0,nan,nan,nan,nan,439.0,nan,nan,nan,1.0,1167.0,nan,1167.0,nan,nan,1.0,439.0,1
TCGA-64-5774-01,TCGA-64-5774,LUAD,60.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2004.0,nan,-22059.0,Alive,TUMOR FREE,2676.0,nan,nan,nan,nan,nan,246.0,Complete Remission/Response,nan,nan,0.0,2676.0,0.0,2676.0,1.0,246.0,1.0,246.0,0
TCGA-64-5775-01,TCGA-64-5775,LUAD,71.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2005.0,nan,-26058.0,Dead,WITH TUMOR,nan,62.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,62.0,1.0,62.0,nan,nan,1.0,62.0,1
TCGA-64-5778-01,TCGA-64-5778,LUAD,60.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2008.0,nan,-21927.0,Alive,WITH TUMOR,1305.0,nan,nan,Distant Metastasis,nan,nan,962.0,Complete Remission/Response,nan,nan,0.0,1305.0,0.0,1305.0,1.0,962.0,1.0,962.0,2
TCGA-64-5779-01,TCGA-64-5779,LUAD,61.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-22305.0,Alive,TUMOR FREE,864.0,nan,nan,Distant Metastasis,nan,nan,795.0,Stable Disease,nan,nan,0.0,864.0,0.0,864.0,nan,nan,1.0,795.0,0
TCGA-64-5781-01,TCGA-64-5781,LUAD,55.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2007.0,nan,-20219.0,Alive,TUMOR FREE,1559.0,nan,nan,nan,nan,nan,96.0,Progressive Disease,nan,nan,0.0,1559.0,0.0,1559.0,nan,nan,1.0,96.0,0
TCGA-64-5815-01,TCGA-64-5815,LUAD,74.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-27280.0,Alive,TUMOR FREE,866.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,866.0,0.0,866.0,0.0,866.0,0.0,866.0,0
TCGA-67-3770-01,TCGA-67-3770,LUAD,70.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-25658.0,Alive,TUMOR FREE,610.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,610.0,0.0,610.0,nan,nan,0.0,610.0,0
TCGA-67-3771-01,TCGA-67-3771,LUAD,77.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-28406.0,Alive,TUMOR FREE,610.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,610.0,0.0,610.0,nan,nan,0.0,610.0,0
TCGA-67-3772-01,TCGA-67-3772,LUAD,82.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-29989.0,Alive,TUMOR FREE,573.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,573.0,0.0,573.0,nan,nan,0.0,573.0,0
TCGA-67-3773-01,TCGA-67-3773,LUAD,84.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-30706.0,Alive,TUMOR FREE,427.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,427.0,0.0,427.0,nan,nan,0.0,427.0,0
TCGA-67-3774-01,TCGA-67-3774,LUAD,73.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-26704.0,Alive,TUMOR FREE,385.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,385.0,0.0,385.0,nan,nan,0.0,385.0,0
TCGA-67-4679-01,TCGA-67-4679,LUAD,69.0,MALE,WHITE,[Discrepancy],nan,Lung Adenocarcinoma,nan,2009.0,nan,-25202.0,Alive,TUMOR FREE,448.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,448.0,0.0,448.0,nan,nan,0.0,448.0,0
TCGA-67-6215-01,TCGA-67-6215,LUAD,52.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2010.0,nan,-19310.0,Alive,TUMOR FREE,174.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,174.0,0.0,174.0,0.0,174.0,0.0,174.0,0
TCGA-67-6216-01,TCGA-67-6216,LUAD,57.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-20967.0,Alive,TUMOR FREE,141.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,141.0,0.0,141.0,0.0,141.0,0.0,141.0,0
TCGA-67-6217-01,TCGA-67-6217,LUAD,73.0,FEMALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-26920.0,Alive,WITH TUMOR,422.0,nan,nan,nan,nan,nan,296.0,Progressive Disease,nan,nan,0.0,422.0,0.0,422.0,nan,nan,1.0,296.0,2
TCGA-69-7760-01,TCGA-69-7760,LUAD,73.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-26777.0,Alive,TUMOR FREE,202.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,202.0,0.0,202.0,nan,nan,0.0,202.0,0
TCGA-69-7761-01,TCGA-69-7761,LUAD,84.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-31041.0,Alive,TUMOR FREE,186.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,186.0,0.0,186.0,nan,nan,0.0,186.0,0
TCGA-69-7763-01,TCGA-69-7763,LUAD,69.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-25316.0,Alive,nan,690.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,690.0,0.0,690.0,nan,nan,0.0,690.0,0
TCGA-69-7764-01,TCGA-69-7764,LUAD,75.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-27693.0,Alive,TUMOR FREE,414.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,414.0,0.0,414.0,nan,nan,0.0,414.0,0
TCGA-69-7765-01,TCGA-69-7765,LUAD,56.0,MALE,BLACK OR AFRICAN AMERICAN,[Discrepancy],nan,Lung Adenocarcinoma,nan,2011.0,nan,-20625.0,Alive,nan,165.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,165.0,0.0,165.0,nan,nan,0.0,165.0,0
TCGA-69-7973-01,TCGA-69-7973,LUAD,42.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-15355.0,Alive,TUMOR FREE,230.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,230.0,0.0,230.0,0.0,230.0,0.0,230.0,0
TCGA-69-7974-01,TCGA-69-7974,LUAD,54.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-20021.0,Alive,WITH TUMOR,184.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,184.0,0.0,184.0,nan,nan,0.0,184.0,0
TCGA-69-7978-01,TCGA-69-7978,LUAD,59.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-21785.0,Alive,[Discrepancy],134.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,134.0,0.0,134.0,nan,nan,0.0,134.0,0
TCGA-69-7979-01,TCGA-69-7979,LUAD,71.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-26180.0,Alive,nan,408.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,408.0,0.0,408.0,nan,nan,0.0,408.0,0
TCGA-69-7980-01,TCGA-69-7980,LUAD,70.0,FEMALE,WHITE,Stage I,nan,Lung Adenocarcinoma,nan,2011.0,nan,-25583.0,Alive,TUMOR FREE,411.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,411.0,0.0,411.0,0.0,411.0,0.0,411.0,0
TCGA-69-8253-01,TCGA-69-8253,LUAD,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-21771.0,Alive,TUMOR FREE,426.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,426.0,0.0,426.0,0.0,426.0,0.0,426.0,0
TCGA-69-8254-01,TCGA-69-8254,LUAD,85.0,MALE,WHITE,nan,nan,Lung Adenocarcinoma,nan,2012.0,nan,-31134.0,Alive,TUMOR FREE,409.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,409.0,0.0,409.0,0.0,409.0,0.0,409.0,0
TCGA-69-8255-01,TCGA-69-8255,LUAD,71.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-26289.0,Alive,nan,129.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,129.0,0.0,129.0,nan,nan,0.0,129.0,0
TCGA-69-8453-01,TCGA-69-8453,LUAD,77.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-28413.0,Alive,WITH TUMOR,813.0,nan,nan,Locoregional Recurrence,nan,nan,344.0,Stable Disease,nan,nan,0.0,813.0,0.0,813.0,nan,nan,1.0,344.0,0
TCGA-69-A59K-01,TCGA-69-A59K,LUAD,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-22093.0,Alive,TUMOR FREE,591.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,591.0,0.0,591.0,nan,nan,0.0,591.0,0
TCGA-71-6725-01,TCGA-71-6725,LUAD,48.0,FEMALE,ASIAN,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-17793.0,Alive,WITH TUMOR,256.0,nan,nan,Locoregional Recurrence,nan,nan,164.0,Progressive Disease,nan,nan,0.0,256.0,0.0,256.0,nan,nan,1.0,164.0,2
TCGA-71-8520-01,TCGA-71-8520,LUAD,60.0,FEMALE,ASIAN,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-21921.0,Dead,WITH TUMOR,nan,210.0,nan,Locoregional Recurrence,nan,nan,179.0,Complete Remission/Response,nan,nan,1.0,210.0,1.0,210.0,1.0,179.0,1.0,179.0,1
TCGA-73-4658-01,TCGA-73-4658,LUAD,80.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2004.0,nan,-29508.0,Dead,TUMOR FREE,1600.0,1600.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1600.0,0.0,1600.0,0.0,1600.0,0.0,1600.0,0
TCGA-73-4658-11,TCGA-73-4658,LUAD,80.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2004.0,nan,-29508.0,Dead,TUMOR FREE,1600.0,1600.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1600.0,0.0,1600.0,0.0,1600.0,0.0,1600.0,0
TCGA-73-4659-01,TCGA-73-4659,LUAD,66.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2006.0,nan,-24253.0,Dead,WITH TUMOR,711.0,711.0,nan,nan,nan,nan,35.0,Progressive Disease,nan,nan,1.0,711.0,1.0,711.0,nan,nan,1.0,35.0,1
TCGA-73-4659-11,TCGA-73-4659,LUAD,66.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2006.0,nan,-24253.0,Dead,WITH TUMOR,711.0,711.0,nan,nan,nan,nan,35.0,Progressive Disease,nan,nan,1.0,711.0,1.0,711.0,nan,nan,1.0,35.0,1
TCGA-73-4662-01,TCGA-73-4662,LUAD,65.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2007.0,nan,-23762.0,Alive,TUMOR FREE,2515.0,nan,nan,nan,nan,nan,21.0,Complete Remission/Response,nan,nan,0.0,2515.0,0.0,2515.0,1.0,21.0,1.0,21.0,2
TCGA-73-4662-11,TCGA-73-4662,LUAD,65.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2007.0,nan,-23762.0,Alive,TUMOR FREE,2515.0,nan,nan,nan,nan,nan,21.0,Complete Remission/Response,nan,nan,0.0,2515.0,0.0,2515.0,1.0,21.0,1.0,21.0,2
TCGA-73-4666-01,TCGA-73-4666,LUAD,52.0,FEMALE,WHITE,Stage IV,nan,Lung Adenocarcinoma,nan,2009.0,nan,-19074.0,Alive,TUMOR FREE,800.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,800.0,0.0,800.0,nan,nan,0.0,800.0,0
TCGA-73-4666-11,TCGA-73-4666,LUAD,52.0,FEMALE,WHITE,Stage IV,nan,Lung Adenocarcinoma,nan,2009.0,nan,-19074.0,Alive,TUMOR FREE,800.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,800.0,0.0,800.0,nan,nan,0.0,800.0,0
TCGA-73-4668-01,TCGA-73-4668,LUAD,66.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage IIB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-24255.0,Alive,WITH TUMOR,467.0,nan,nan,nan,nan,nan,236.0,Complete Remission/Response,nan,nan,0.0,467.0,0.0,467.0,1.0,236.0,1.0,236.0,2
TCGA-73-4668-11,TCGA-73-4668,LUAD,66.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage IIB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-24255.0,Alive,WITH TUMOR,467.0,nan,nan,nan,nan,nan,236.0,Complete Remission/Response,nan,nan,0.0,467.0,0.0,467.0,1.0,236.0,1.0,236.0,2
TCGA-73-4670-01,TCGA-73-4670,LUAD,69.0,FEMALE,WHITE,Stage IV,nan,Lung Adenocarcinoma,nan,2010.0,nan,-25526.0,Alive,WITH TUMOR,131.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,131.0,0.0,131.0,nan,nan,0.0,131.0,0
TCGA-73-4670-11,TCGA-73-4670,LUAD,69.0,FEMALE,WHITE,Stage IV,nan,Lung Adenocarcinoma,nan,2010.0,nan,-25526.0,Alive,WITH TUMOR,131.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,131.0,0.0,131.0,nan,nan,0.0,131.0,0
TCGA-73-4675-01,TCGA-73-4675,LUAD,59.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-21614.0,Dead,TUMOR FREE,nan,922.0,nan,Locoregional Recurrence,nan,nan,361.0,Progressive Disease,nan,nan,1.0,922.0,0.0,922.0,nan,nan,1.0,361.0,1
TCGA-73-4675-11,TCGA-73-4675,LUAD,59.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-21614.0,Dead,TUMOR FREE,nan,922.0,nan,Locoregional Recurrence,nan,nan,361.0,Progressive Disease,nan,nan,1.0,922.0,0.0,922.0,nan,nan,1.0,361.0,1
TCGA-73-4676-01,TCGA-73-4676,LUAD,45.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-16746.0,Dead,WITH TUMOR,nan,281.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,281.0,1.0,281.0,nan,nan,1.0,281.0,1
TCGA-73-4676-11,TCGA-73-4676,LUAD,45.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-16746.0,Dead,WITH TUMOR,nan,281.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,281.0,1.0,281.0,nan,nan,1.0,281.0,1
TCGA-73-4677-01,TCGA-73-4677,LUAD,74.0,MALE,WHITE,[Discrepancy],nan,Lung Adenocarcinoma,nan,2010.0,nan,-27381.0,Dead,WITH TUMOR,nan,38.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,38.0,1.0,38.0,nan,nan,1.0,38.0,1
TCGA-73-4677-11,TCGA-73-4677,LUAD,74.0,MALE,WHITE,[Discrepancy],nan,Lung Adenocarcinoma,nan,2010.0,nan,-27381.0,Dead,WITH TUMOR,nan,38.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,38.0,1.0,38.0,nan,nan,1.0,38.0,1
TCGA-73-7498-01,TCGA-73-7498,LUAD,58.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-21527.0,Alive,TUMOR FREE,1189.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1189.0,0.0,1189.0,0.0,1189.0,0.0,1189.0,0
TCGA-73-7499-01,TCGA-73-7499,LUAD,81.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2010.0,nan,-29683.0,Dead,TUMOR FREE,nan,1531.0,nan,Distant Metastasis,nan,nan,1447.0,Complete Remission/Response,nan,nan,1.0,1531.0,0.0,1531.0,1.0,1447.0,1.0,1447.0,1
TCGA-73-A9RS-01,TCGA-73-A9RS,LUAD,41.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Lung Adenocarcinoma,nan,2013.0,nan,-15162.0,Dead,WITH TUMOR,nan,340.0,nan,Locoregional Recurrence,nan,nan,107.0,Progressive Disease,nan,nan,1.0,340.0,1.0,340.0,nan,nan,1.0,107.0,1
TCGA-75-5122-01,TCGA-75-5122,LUAD,nan,MALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,2005.0,nan,nan,Dead,WITH TUMOR,nan,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,nan,1.0,nan,nan,nan,1.0,nan,1
TCGA-75-5125-01,TCGA-75-5125,LUAD,nan,MALE,nan,Stage IIB,nan,Lung Adenocarcinoma,nan,nan,nan,nan,Dead,WITH TUMOR,nan,2027.0,nan,nan,nan,nan,1752.0,Complete Remission/Response,nan,nan,1.0,2027.0,1.0,2027.0,1.0,1752.0,1.0,1752.0,1
TCGA-75-5126-01,TCGA-75-5126,LUAD,nan,FEMALE,nan,Stage IIIA,nan,Lung Adenocarcinoma,nan,2007.0,nan,nan,Alive,WITH TUMOR,nan,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,nan,0.0,nan,nan,nan,0.0,nan,1
TCGA-75-5146-01,TCGA-75-5146,LUAD,nan,MALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,nan,nan,nan,Alive,TUMOR FREE,2368.0,nan,nan,New Primary Tumor,nan,nan,1773.0,Complete Remission/Response,nan,nan,0.0,2368.0,0.0,2368.0,0.0,2368.0,1.0,1773.0,0
TCGA-75-5147-01,TCGA-75-5147,LUAD,nan,FEMALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,nan,nan,nan,Alive,TUMOR FREE,1333.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1333.0,0.0,1333.0,0.0,1333.0,0.0,1333.0,0
TCGA-75-6203-01,TCGA-75-6203,LUAD,nan,FEMALE,nan,Stage IIIA,nan,Lung Adenocarcinoma,nan,2008.0,nan,nan,Alive,TUMOR FREE,nan,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,nan,0.0,nan,0.0,nan,0.0,nan,0
TCGA-75-6205-01,TCGA-75-6205,LUAD,nan,FEMALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,2006.0,nan,nan,Dead,WITH TUMOR,nan,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,nan,1.0,nan,nan,nan,1.0,nan,1
TCGA-75-6206-01,TCGA-75-6206,LUAD,nan,MALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,nan,nan,nan,Alive,TUMOR FREE,2590.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2590.0,0.0,2590.0,0.0,2590.0,0.0,2590.0,0
TCGA-75-6207-01,TCGA-75-6207,LUAD,nan,MALE,nan,Stage IIIA,nan,Lung Adenocarcinoma,nan,2007.0,nan,nan,Dead,nan,nan,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,nan,nan,nan,0.0,nan,0.0,nan,1
TCGA-75-6211-01,TCGA-75-6211,LUAD,nan,FEMALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,2009.0,nan,nan,Dead,WITH TUMOR,nan,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,nan,1.0,nan,nan,nan,1.0,nan,1
TCGA-75-6212-01,TCGA-75-6212,LUAD,nan,FEMALE,nan,Stage IIB,nan,Lung Adenocarcinoma,nan,nan,nan,nan,Dead,WITH TUMOR,nan,1516.0,nan,New Primary Tumor,nan,nan,1340.0,Complete Remission/Response,nan,nan,1.0,1516.0,1.0,1516.0,0.0,1516.0,1.0,1340.0,1
TCGA-75-6214-01,TCGA-75-6214,LUAD,nan,FEMALE,nan,Stage IIIA,nan,Lung Adenocarcinoma,nan,nan,nan,nan,Dead,WITH TUMOR,nan,1115.0,nan,Distant Metastasis,nan,nan,419.0,Complete Remission/Response,nan,nan,1.0,1115.0,1.0,1115.0,1.0,419.0,1.0,419.0,1
TCGA-75-7025-01,TCGA-75-7025,LUAD,nan,MALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,nan,nan,nan,Alive,TUMOR FREE,3305.0,nan,nan,Locoregional Recurrence|Distant Metastasis,nan,nan,1481.0,Complete Remission/Response,nan,nan,0.0,3305.0,0.0,3305.0,1.0,1481.0,1.0,1481.0,0
TCGA-75-7027-01,TCGA-75-7027,LUAD,nan,MALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,nan,nan,nan,Alive,TUMOR FREE,3059.0,nan,nan,Locoregional Recurrence,nan,nan,2949.0,Complete Remission/Response,nan,nan,0.0,3059.0,0.0,3059.0,1.0,2949.0,1.0,2949.0,0
TCGA-75-7030-01,TCGA-75-7030,LUAD,nan,MALE,nan,Stage IIB,nan,Lung Adenocarcinoma,nan,2007.0,nan,nan,Alive,TUMOR FREE,nan,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,nan,0.0,nan,0.0,nan,0.0,nan,0
TCGA-75-7031-01,TCGA-75-7031,LUAD,nan,FEMALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,2008.0,nan,nan,Alive,TUMOR FREE,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,nan,0.0,nan,nan,nan,0.0,nan,1
TCGA-78-7143-01,TCGA-78-7143,LUAD,62.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,1992.0,nan,-22673.0,Dead,[Discrepancy],nan,4961.0,nan,nan,nan,nan,1500.0,nan,nan,nan,1.0,4961.0,nan,4961.0,nan,nan,1.0,1500.0,1
TCGA-78-7145-01,TCGA-78-7145,LUAD,52.0,FEMALE,WHITE,Stage IV,nan,Lung Adenocarcinoma,nan,2000.0,nan,-19080.0,Dead,WITH TUMOR,nan,826.0,nan,nan,nan,nan,422.0,nan,nan,nan,1.0,826.0,1.0,826.0,nan,nan,1.0,422.0,1
TCGA-78-7146-01,TCGA-78-7146,LUAD,71.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,1999.0,nan,-26272.0,Dead,nan,nan,173.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,173.0,nan,173.0,nan,nan,0.0,173.0,1
TCGA-78-7147-01,TCGA-78-7147,LUAD,67.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2001.0,nan,-24809.0,Dead,WITH TUMOR,nan,586.0,nan,nan,nan,nan,578.0,nan,nan,nan,1.0,586.0,1.0,586.0,nan,nan,1.0,578.0,1
TCGA-78-7148-01,TCGA-78-7148,LUAD,71.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2001.0,nan,-25990.0,Dead,nan,nan,626.0,nan,nan,nan,nan,182.0,nan,nan,nan,1.0,626.0,nan,626.0,nan,nan,1.0,182.0,1
TCGA-78-7149-01,TCGA-78-7149,LUAD,71.0,MALE,WHITE,Stage IIIB,nan,Lung Adenocarcinoma,nan,2002.0,nan,-26285.0,Alive,nan,3940.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3940.0,0.0,3940.0,0.0,3940.0,0.0,3940.0,0
TCGA-78-7150-01,TCGA-78-7150,LUAD,59.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2002.0,nan,-21891.0,Dead,WITH TUMOR,nan,666.0,nan,nan,nan,nan,139.0,nan,nan,nan,1.0,666.0,1.0,666.0,nan,nan,1.0,139.0,1
TCGA-78-7152-01,TCGA-78-7152,LUAD,65.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2003.0,nan,-23782.0,Dead,WITH TUMOR,nan,1215.0,nan,nan,nan,nan,1202.0,Complete Remission/Response,nan,nan,1.0,1215.0,1.0,1215.0,1.0,1202.0,1.0,1202.0,1
TCGA-78-7153-01,TCGA-78-7153,LUAD,65.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2003.0,nan,-23922.0,Alive,nan,3635.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3635.0,0.0,3635.0,0.0,3635.0,0.0,3635.0,0
TCGA-78-7154-01,TCGA-78-7154,LUAD,72.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2003.0,nan,-26481.0,Dead,nan,nan,593.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,593.0,nan,593.0,nan,nan,0.0,593.0,1
TCGA-78-7155-01,TCGA-78-7155,LUAD,68.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2005.0,nan,-24863.0,Dead,nan,nan,1171.0,nan,nan,nan,nan,209.0,nan,nan,nan,1.0,1171.0,nan,1171.0,nan,nan,1.0,209.0,1
TCGA-78-7156-01,TCGA-78-7156,LUAD,62.0,MALE,WHITE,Stage IV,nan,Lung Adenocarcinoma,nan,2006.0,nan,-22720.0,Dead,nan,nan,976.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,976.0,nan,976.0,nan,nan,0.0,976.0,1
TCGA-78-7158-01,TCGA-78-7158,LUAD,59.0,FEMALE,WHITE,Stage IIIB,nan,Lung Adenocarcinoma,nan,2007.0,nan,-21742.0,Dead,WITH TUMOR,nan,179.0,nan,nan,nan,nan,132.0,Progressive Disease,nan,nan,1.0,179.0,1.0,179.0,nan,nan,1.0,132.0,1
TCGA-78-7159-01,TCGA-78-7159,LUAD,60.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2008.0,nan,-22261.0,Alive,nan,1974.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1974.0,0.0,1974.0,0.0,1974.0,0.0,1974.0,0
TCGA-78-7160-01,TCGA-78-7160,LUAD,61.0,MALE,WHITE,Stage IV,nan,Lung Adenocarcinoma,nan,2008.0,nan,-22385.0,Dead,nan,nan,697.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,697.0,nan,697.0,nan,nan,0.0,697.0,1
TCGA-78-7161-01,TCGA-78-7161,LUAD,69.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-25294.0,Dead,WITH TUMOR,nan,291.0,nan,nan,nan,nan,162.0,Progressive Disease,nan,nan,1.0,291.0,1.0,291.0,nan,nan,1.0,162.0,1
TCGA-78-7162-01,TCGA-78-7162,LUAD,75.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,1991.0,nan,-27593.0,Dead,nan,nan,3169.0,nan,nan,nan,nan,2218.0,nan,nan,nan,1.0,3169.0,nan,3169.0,nan,nan,1.0,2218.0,1
TCGA-78-7163-01,TCGA-78-7163,LUAD,60.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,1992.0,nan,-22002.0,Alive,TUMOR FREE,7248.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,7248.0,0.0,7248.0,0.0,7248.0,0.0,7248.0,0
TCGA-78-7163-11,TCGA-78-7163,LUAD,60.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,1992.0,nan,-22002.0,Alive,TUMOR FREE,7248.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,7248.0,0.0,7248.0,0.0,7248.0,0.0,7248.0,0
TCGA-78-7166-01,TCGA-78-7166,LUAD,84.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2002.0,nan,-30869.0,Dead,nan,nan,258.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,258.0,nan,258.0,nan,nan,0.0,258.0,1
TCGA-78-7167-01,TCGA-78-7167,LUAD,77.0,MALE,WHITE,Stage IV,nan,Lung Adenocarcinoma,nan,2002.0,nan,-28295.0,Dead,WITH TUMOR,nan,2681.0,nan,nan,nan,nan,726.0,nan,nan,nan,1.0,2681.0,1.0,2681.0,nan,nan,1.0,726.0,1
TCGA-78-7220-01,TCGA-78-7220,LUAD,53.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2000.0,nan,-19480.0,Dead,WITH TUMOR,nan,807.0,nan,nan,nan,nan,531.0,nan,nan,nan,1.0,807.0,1.0,807.0,nan,nan,1.0,531.0,1
TCGA-78-7535-01,TCGA-78-7535,LUAD,45.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2000.0,nan,-16571.0,Dead,WITH TUMOR,nan,949.0,nan,nan,nan,nan,809.0,Stable Disease,nan,nan,1.0,949.0,1.0,949.0,nan,nan,1.0,809.0,1
TCGA-78-7536-01,TCGA-78-7536,LUAD,69.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2001.0,nan,-25558.0,Dead,WITH TUMOR,nan,244.0,nan,nan,nan,nan,231.0,Progressive Disease,nan,nan,1.0,244.0,1.0,244.0,nan,nan,1.0,231.0,1
TCGA-78-7537-01,TCGA-78-7537,LUAD,72.0,MALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,2002.0,nan,-26610.0,Dead,nan,nan,1622.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1622.0,nan,1622.0,nan,nan,0.0,1622.0,1
TCGA-78-7539-01,TCGA-78-7539,LUAD,75.0,FEMALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-27445.0,Alive,nan,791.0,nan,nan,Distant Metastasis,nan,nan,688.0,Complete Remission/Response,nan,nan,0.0,791.0,0.0,791.0,1.0,688.0,1.0,688.0,2
TCGA-78-7540-01,TCGA-78-7540,LUAD,66.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,1999.0,nan,-24440.0,Dead,nan,nan,1197.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1197.0,nan,1197.0,0.0,1197.0,0.0,1197.0,1
TCGA-78-7540-11,TCGA-78-7540,LUAD,66.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,1999.0,nan,-24440.0,Dead,nan,nan,1197.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1197.0,nan,1197.0,0.0,1197.0,0.0,1197.0,1
TCGA-78-7542-01,TCGA-78-7542,LUAD,56.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,1993.0,nan,-20763.0,Dead,nan,nan,321.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,321.0,nan,321.0,nan,nan,0.0,321.0,1
TCGA-78-7633-01,TCGA-78-7633,LUAD,67.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-24713.0,Dead,WITH TUMOR,nan,1528.0,nan,Locoregional Recurrence,nan,nan,1450.0,Complete Remission/Response,nan,nan,1.0,1528.0,1.0,1528.0,1.0,1450.0,1.0,1450.0,1
TCGA-78-8640-01,TCGA-78-8640,LUAD,59.0,MALE,[Not Evaluated],Stage IIA,nan,Lung Adenocarcinoma,nan,1994.0,nan,-21832.0,Alive,TUMOR FREE,7062.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,7062.0,0.0,7062.0,0.0,7062.0,0.0,7062.0,0
TCGA-78-8648-01,TCGA-78-8648,LUAD,58.0,FEMALE,[Not Evaluated],Stage IIB,nan,Lung Adenocarcinoma,nan,2002.0,nan,-21443.0,Dead,nan,nan,1209.0,nan,Locoregional Recurrence,nan,nan,720.0,[Unknown],nan,nan,1.0,1209.0,nan,1209.0,nan,nan,1.0,720.0,1
TCGA-78-8655-01,TCGA-78-8655,LUAD,77.0,FEMALE,[Not Evaluated],Stage IA,nan,Lung Adenocarcinoma,nan,2003.0,nan,-28379.0,Alive,nan,2360.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2360.0,0.0,2360.0,0.0,2360.0,0.0,2360.0,0
TCGA-78-8660-01,TCGA-78-8660,LUAD,69.0,MALE,[Not Evaluated],Stage IIB,nan,Lung Adenocarcinoma,nan,2005.0,nan,-25422.0,Dead,WITH TUMOR,nan,321.0,nan,Distant Metastasis,nan,nan,242.0,[Unknown],nan,nan,1.0,321.0,1.0,321.0,nan,nan,1.0,242.0,1
TCGA-78-8662-01,TCGA-78-8662,LUAD,53.0,FEMALE,[Not Evaluated],Stage IB,nan,Lung Adenocarcinoma,nan,2000.0,nan,-19563.0,Dead,nan,nan,3361.0,nan,Locoregional Recurrence,nan,nan,3044.0,Complete Remission/Response,nan,nan,1.0,3361.0,nan,3361.0,1.0,3044.0,1.0,3044.0,1
TCGA-80-5607-01,TCGA-80-5607,LUAD,nan,FEMALE,nan,Stage IIB,nan,Lung Adenocarcinoma,nan,2007.0,nan,nan,Alive,WITH TUMOR,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,nan,0.0,nan,nan,nan,0.0,nan,1
TCGA-80-5608-01,TCGA-80-5608,LUAD,nan,FEMALE,nan,Stage IA,nan,Lung Adenocarcinoma,nan,nan,nan,nan,Alive,TUMOR FREE,2832.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2832.0,0.0,2832.0,0.0,2832.0,0.0,2832.0,0
TCGA-80-5611-01,TCGA-80-5611,LUAD,nan,MALE,nan,Stage IB,nan,Lung Adenocarcinoma,nan,nan,nan,nan,Alive,TUMOR FREE,2595.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2595.0,0.0,2595.0,0.0,2595.0,0.0,2595.0,0
TCGA-83-5908-01,TCGA-83-5908,LUAD,59.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-21760.0,Alive,TUMOR FREE,824.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,824.0,0.0,824.0,nan,nan,0.0,824.0,0
TCGA-86-6562-01,TCGA-86-6562,LUAD,52.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-19301.0,Dead,WITH TUMOR,nan,376.0,nan,nan,nan,nan,274.0,Progressive Disease,nan,nan,1.0,376.0,1.0,376.0,nan,nan,1.0,274.0,1
TCGA-86-6851-01,TCGA-86-6851,LUAD,73.0,FEMALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-26808.0,Alive,TUMOR FREE,179.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,179.0,0.0,179.0,0.0,179.0,0.0,179.0,0
TCGA-86-7701-01,TCGA-86-7701,LUAD,66.0,MALE,WHITE,Stage IV,nan,Lung Adenocarcinoma,nan,2011.0,nan,-24209.0,Alive,WITH TUMOR,947.0,nan,nan,Distant Metastasis,nan,nan,424.0,Complete Remission/Response,nan,nan,0.0,947.0,0.0,947.0,nan,nan,1.0,424.0,0
TCGA-86-7711-01,TCGA-86-7711,LUAD,70.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-25719.0,Dead,WITH TUMOR,nan,1046.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,1046.0,1.0,1046.0,nan,nan,1.0,1046.0,1
TCGA-86-7711-11,TCGA-86-7711,LUAD,70.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-25719.0,Dead,WITH TUMOR,nan,1046.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,1046.0,1.0,1046.0,nan,nan,1.0,1046.0,1
TCGA-86-7713-01,TCGA-86-7713,LUAD,70.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-25791.0,Alive,TUMOR FREE,1157.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1157.0,0.0,1157.0,0.0,1157.0,0.0,1157.0,0
TCGA-86-7713-11,TCGA-86-7713,LUAD,70.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-25791.0,Alive,TUMOR FREE,1157.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1157.0,0.0,1157.0,0.0,1157.0,0.0,1157.0,0
TCGA-86-7714-01,TCGA-86-7714,LUAD,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-22619.0,Dead,WITH TUMOR,nan,625.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,625.0,1.0,625.0,nan,nan,1.0,625.0,1
TCGA-86-7953-01,TCGA-86-7953,LUAD,69.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-25315.0,Alive,TUMOR FREE,997.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,997.0,0.0,997.0,0.0,997.0,0.0,997.0,0
TCGA-86-7954-01,TCGA-86-7954,LUAD,68.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-25062.0,Alive,TUMOR FREE,605.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,605.0,0.0,605.0,0.0,605.0,0.0,605.0,0
TCGA-86-7955-01,TCGA-86-7955,LUAD,62.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-22772.0,Alive,TUMOR FREE,1072.0,nan,nan,Locoregional Recurrence,nan,nan,820.0,Complete Remission/Response,nan,nan,0.0,1072.0,0.0,1072.0,1.0,820.0,1.0,820.0,0
TCGA-86-8054-01,TCGA-86-8054,LUAD,61.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-22584.0,Alive,TUMOR FREE,1148.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1148.0,0.0,1148.0,0.0,1148.0,0.0,1148.0,0
TCGA-86-8055-01,TCGA-86-8055,LUAD,79.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-29124.0,Dead,TUMOR FREE,nan,124.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,124.0,0.0,124.0,0.0,124.0,0.0,124.0,0
TCGA-86-8056-01,TCGA-86-8056,LUAD,63.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-23369.0,Alive,TUMOR FREE,139.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,139.0,0.0,139.0,0.0,139.0,0.0,139.0,0
TCGA-86-8073-01,TCGA-86-8073,LUAD,58.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-21214.0,Alive,TUMOR FREE,740.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,740.0,0.0,740.0,0.0,740.0,0.0,740.0,0
TCGA-86-8074-01,TCGA-86-8074,LUAD,62.0,FEMALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-22862.0,Alive,TUMOR FREE,24.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,24.0,0.0,24.0,nan,nan,0.0,24.0,0
TCGA-86-8075-01,TCGA-86-8075,LUAD,66.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-24402.0,Dead,TUMOR FREE,nan,694.0,nan,Locoregional Recurrence,nan,nan,199.0,Complete Remission/Response,nan,nan,1.0,694.0,0.0,694.0,1.0,199.0,1.0,199.0,1
TCGA-86-8076-01,TCGA-86-8076,LUAD,42.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-15605.0,Alive,TUMOR FREE,993.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,993.0,0.0,993.0,0.0,993.0,0.0,993.0,0
TCGA-86-8278-01,TCGA-86-8278,LUAD,63.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-23117.0,Alive,WITH TUMOR,944.0,nan,nan,nan,nan,nan,29.0,Complete Remission/Response,nan,nan,0.0,944.0,0.0,944.0,1.0,29.0,1.0,29.0,2
TCGA-86-8279-01,TCGA-86-8279,LUAD,46.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-17032.0,Alive,TUMOR FREE,949.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,949.0,0.0,949.0,0.0,949.0,0.0,949.0,0
TCGA-86-8280-01,TCGA-86-8280,LUAD,54.0,FEMALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-19977.0,Alive,TUMOR FREE,701.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,701.0,0.0,701.0,0.0,701.0,0.0,701.0,0
TCGA-86-8281-01,TCGA-86-8281,LUAD,75.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-27409.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0
TCGA-86-8358-01,TCGA-86-8358,LUAD,44.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-16409.0,Alive,TUMOR FREE,653.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,653.0,0.0,653.0,0.0,653.0,0.0,653.0,0
TCGA-86-8359-01,TCGA-86-8359,LUAD,52.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-19088.0,Dead,TUMOR FREE,nan,444.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,444.0,0.0,444.0,nan,nan,0.0,444.0,0
TCGA-86-8585-01,TCGA-86-8585,LUAD,57.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-20918.0,Alive,TUMOR FREE,353.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,353.0,0.0,353.0,0.0,353.0,0.0,353.0,0
TCGA-86-8668-01,TCGA-86-8668,LUAD,61.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-22383.0,Alive,TUMOR FREE,423.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,423.0,0.0,423.0,0.0,423.0,0.0,423.0,0
TCGA-86-8669-01,TCGA-86-8669,LUAD,64.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-23443.0,Alive,TUMOR FREE,938.0,nan,nan,Distant Metastasis,nan,nan,849.0,Complete Remission/Response,nan,nan,0.0,938.0,0.0,938.0,1.0,849.0,1.0,849.0,0
TCGA-86-8671-01,TCGA-86-8671,LUAD,72.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-26448.0,Alive,TUMOR FREE,839.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,839.0,0.0,839.0,0.0,839.0,0.0,839.0,0
TCGA-86-8672-01,TCGA-86-8672,LUAD,59.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-21682.0,Dead,TUMOR FREE,nan,19.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,19.0,0.0,19.0,0.0,19.0,0.0,19.0,0
TCGA-86-8673-01,TCGA-86-8673,LUAD,61.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-22571.0,Alive,TUMOR FREE,862.0,nan,nan,Locoregional Recurrence,nan,nan,636.0,Complete Remission/Response,nan,nan,0.0,862.0,0.0,862.0,1.0,636.0,1.0,636.0,0
TCGA-86-8674-01,TCGA-86-8674,LUAD,50.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-18479.0,Alive,TUMOR FREE,806.0,nan,nan,Locoregional Recurrence,nan,nan,334.0,Complete Remission/Response,nan,nan,0.0,806.0,0.0,806.0,1.0,334.0,1.0,334.0,0
TCGA-86-A456-01,TCGA-86-A456,LUAD,78.0,FEMALE,ASIAN,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-28533.0,Alive,TUMOR FREE,896.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,896.0,0.0,896.0,0.0,896.0,0.0,896.0,0
TCGA-86-A4D0-01,TCGA-86-A4D0,LUAD,48.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-17607.0,Dead,TUMOR FREE,nan,116.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,116.0,0.0,116.0,0.0,116.0,0.0,116.0,0
TCGA-86-A4JF-01,TCGA-86-A4JF,LUAD,56.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-20491.0,Dead,WITH TUMOR,nan,737.0,nan,Distant Metastasis,nan,nan,436.0,Complete Remission/Response,nan,nan,1.0,737.0,1.0,737.0,1.0,436.0,1.0,436.0,1
TCGA-86-A4P7-01,TCGA-86-A4P7,LUAD,63.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-23330.0,Alive,TUMOR FREE,415.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,415.0,0.0,415.0,0.0,415.0,0.0,415.0,0
TCGA-86-A4P8-01,TCGA-86-A4P8,LUAD,59.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-21738.0,Alive,TUMOR FREE,805.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,805.0,0.0,805.0,0.0,805.0,0.0,805.0,0
TCGA-91-6828-01,TCGA-91-6828,LUAD,70.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-25870.0,Alive,TUMOR FREE,323.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,323.0,0.0,323.0,0.0,323.0,0.0,323.0,0
TCGA-91-6828-11,TCGA-91-6828,LUAD,70.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-25870.0,Alive,TUMOR FREE,323.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,323.0,0.0,323.0,0.0,323.0,0.0,323.0,0
TCGA-91-6829-01,TCGA-91-6829,LUAD,78.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2001.0,nan,-28841.0,Dead,TUMOR FREE,nan,1258.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,1258.0,0.0,1258.0,nan,nan,0.0,1258.0,0
TCGA-91-6829-11,TCGA-91-6829,LUAD,78.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2001.0,nan,-28841.0,Dead,TUMOR FREE,nan,1258.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,1258.0,0.0,1258.0,nan,nan,0.0,1258.0,0
TCGA-91-6830-01,TCGA-91-6830,LUAD,65.0,FEMALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2002.0,nan,-23922.0,Alive,WITH TUMOR,60.0,nan,nan,Distant Metastasis,nan,nan,18.0,[Unknown],nan,nan,0.0,60.0,0.0,60.0,nan,nan,1.0,18.0,2
TCGA-91-6831-01,TCGA-91-6831,LUAD,66.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2001.0,nan,-24436.0,Alive,TUMOR FREE,310.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,310.0,0.0,310.0,0.0,310.0,0.0,310.0,0
TCGA-91-6831-11,TCGA-91-6831,LUAD,66.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2001.0,nan,-24436.0,Alive,TUMOR FREE,310.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,310.0,0.0,310.0,0.0,310.0,0.0,310.0,0
TCGA-91-6835-01,TCGA-91-6835,LUAD,81.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-29887.0,Alive,TUMOR FREE,79.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,79.0,0.0,79.0,0.0,79.0,0.0,79.0,0
TCGA-91-6835-11,TCGA-91-6835,LUAD,81.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-29887.0,Alive,TUMOR FREE,79.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,79.0,0.0,79.0,0.0,79.0,0.0,79.0,0
TCGA-91-6836-01,TCGA-91-6836,LUAD,52.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2010.0,nan,-19216.0,Alive,TUMOR FREE,417.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,417.0,0.0,417.0,0.0,417.0,0.0,417.0,0
TCGA-91-6836-11,TCGA-91-6836,LUAD,52.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2010.0,nan,-19216.0,Alive,TUMOR FREE,417.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,417.0,0.0,417.0,0.0,417.0,0.0,417.0,0
TCGA-91-6840-01,TCGA-91-6840,LUAD,59.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-21854.0,Alive,TUMOR FREE,372.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,372.0,0.0,372.0,0.0,372.0,0.0,372.0,0
TCGA-91-6847-01,TCGA-91-6847,LUAD,62.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2002.0,nan,-22862.0,Alive,WITH TUMOR,842.0,nan,nan,Distant Metastasis,nan,nan,772.0,Progressive Disease,nan,nan,0.0,842.0,0.0,842.0,nan,nan,1.0,772.0,2
TCGA-91-6847-11,TCGA-91-6847,LUAD,62.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2002.0,nan,-22862.0,Alive,WITH TUMOR,842.0,nan,nan,Distant Metastasis,nan,nan,772.0,Progressive Disease,nan,nan,0.0,842.0,0.0,842.0,nan,nan,1.0,772.0,2
TCGA-91-6848-01,TCGA-91-6848,LUAD,59.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-21829.0,Alive,TUMOR FREE,224.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,224.0,0.0,224.0,0.0,224.0,0.0,224.0,0
TCGA-91-6849-01,TCGA-91-6849,LUAD,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-27676.0,Alive,nan,35.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,35.0,0.0,35.0,nan,nan,0.0,35.0,0
TCGA-91-6849-11,TCGA-91-6849,LUAD,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-27676.0,Alive,nan,35.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,35.0,0.0,35.0,nan,nan,0.0,35.0,0
TCGA-91-7771-01,TCGA-91-7771,LUAD,62.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-22926.0,Alive,TUMOR FREE,492.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,492.0,0.0,492.0,0.0,492.0,0.0,492.0,0
TCGA-91-8496-01,TCGA-91-8496,LUAD,63.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-23358.0,Alive,TUMOR FREE,505.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,505.0,0.0,505.0,0.0,505.0,0.0,505.0,0
TCGA-91-8497-01,TCGA-91-8497,LUAD,75.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-27632.0,Dead,TUMOR FREE,nan,434.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,434.0,0.0,434.0,0.0,434.0,0.0,434.0,0
TCGA-91-8499-01,TCGA-91-8499,LUAD,76.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-27853.0,Alive,nan,36.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,36.0,0.0,36.0,nan,nan,0.0,36.0,0
TCGA-91-A4BC-01,TCGA-91-A4BC,LUAD,59.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-21565.0,Alive,nan,44.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,44.0,0.0,44.0,nan,nan,0.0,44.0,0
TCGA-91-A4BD-01,TCGA-91-A4BD,LUAD,78.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-28544.0,Alive,TUMOR FREE,603.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,603.0,0.0,603.0,0.0,603.0,0.0,603.0,0
TCGA-93-7347-01,TCGA-93-7347,LUAD,76.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-27949.0,Alive,TUMOR FREE,683.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,683.0,0.0,683.0,0.0,683.0,0.0,683.0,0
TCGA-93-7348-01,TCGA-93-7348,LUAD,75.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-27456.0,Alive,TUMOR FREE,531.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,531.0,0.0,531.0,0.0,531.0,0.0,531.0,0
TCGA-93-7348-11,TCGA-93-7348,LUAD,75.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-27456.0,Alive,TUMOR FREE,531.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,531.0,0.0,531.0,0.0,531.0,0.0,531.0,0
TCGA-93-8067-01,TCGA-93-8067,LUAD,77.0,MALE,ASIAN,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-28453.0,Alive,TUMOR FREE,186.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,186.0,0.0,186.0,0.0,186.0,0.0,186.0,0
TCGA-93-A4JN-01,TCGA-93-A4JN,LUAD,71.0,MALE,WHITE,Stage IV,nan,Lung Adenocarcinoma,nan,2012.0,nan,-26273.0,Alive,WITH TUMOR,718.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,718.0,0.0,718.0,nan,nan,0.0,718.0,0
TCGA-93-A4JO-01,TCGA-93-A4JO,LUAD,70.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-25898.0,Dead,TUMOR FREE,nan,33.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,33.0,0.0,33.0,nan,nan,0.0,33.0,0
TCGA-93-A4JP-01,TCGA-93-A4JP,LUAD,64.0,MALE,ASIAN,Stage IV,nan,Lung Adenocarcinoma,nan,2012.0,nan,-23620.0,Alive,WITH TUMOR,578.0,nan,nan,Distant Metastasis,nan,nan,497.0,Partial Remission/Response,nan,nan,0.0,578.0,0.0,578.0,nan,nan,1.0,497.0,0
TCGA-93-A4JQ-01,TCGA-93-A4JQ,LUAD,49.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-17951.0,Alive,TUMOR FREE,526.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,526.0,0.0,526.0,0.0,526.0,0.0,526.0,0
TCGA-95-7039-01,TCGA-95-7039,LUAD,54.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-19981.0,Alive,WITH TUMOR,1272.0,nan,nan,Locoregional Recurrence,nan,nan,1258.0,Complete Remission/Response,nan,nan,0.0,1272.0,0.0,1272.0,1.0,1258.0,1.0,1258.0,2
TCGA-95-7043-01,TCGA-95-7043,LUAD,63.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-23165.0,Dead,WITH TUMOR,nan,503.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,503.0,1.0,503.0,nan,nan,1.0,503.0,1
TCGA-95-7562-01,TCGA-95-7562,LUAD,71.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-26000.0,Dead,TUMOR FREE,nan,87.0,nan,nan,nan,nan,nan,[Not Evaluated],nan,nan,1.0,87.0,0.0,87.0,nan,nan,0.0,87.0,0
TCGA-95-7567-01,TCGA-95-7567,LUAD,61.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-22437.0,Alive,TUMOR FREE,568.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,568.0,0.0,568.0,nan,nan,0.0,568.0,0
TCGA-95-7944-01,TCGA-95-7944,LUAD,71.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-26003.0,Alive,TUMOR FREE,377.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,377.0,0.0,377.0,nan,nan,0.0,377.0,0
TCGA-95-7947-01,TCGA-95-7947,LUAD,67.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-24752.0,Alive,TUMOR FREE,477.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,477.0,0.0,477.0,0.0,477.0,0.0,477.0,0
TCGA-95-7948-01,TCGA-95-7948,LUAD,42.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-15363.0,Alive,TUMOR FREE,476.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,476.0,0.0,476.0,0.0,476.0,0.0,476.0,0
TCGA-95-8039-01,TCGA-95-8039,LUAD,72.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-26317.0,Alive,TUMOR FREE,830.0,nan,nan,Locoregional Recurrence,nan,nan,228.0,Complete Remission/Response,nan,nan,0.0,830.0,0.0,830.0,1.0,228.0,1.0,228.0,0
TCGA-95-8494-01,TCGA-95-8494,LUAD,67.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-24773.0,Alive,nan,84.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,84.0,0.0,84.0,0.0,84.0,0.0,84.0,0
TCGA-95-A4VK-01,TCGA-95-A4VK,LUAD,74.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-27040.0,Alive,WITH TUMOR,651.0,nan,nan,Distant Metastasis,nan,nan,496.0,Stable Disease,nan,nan,0.0,651.0,0.0,651.0,nan,nan,1.0,496.0,2
TCGA-95-A4VN-01,TCGA-95-A4VN,LUAD,62.0,FEMALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-22927.0,Alive,TUMOR FREE,553.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,553.0,0.0,553.0,nan,nan,0.0,553.0,0
TCGA-95-A4VP-01,TCGA-95-A4VP,LUAD,66.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-24130.0,Alive,WITH TUMOR,605.0,nan,nan,Distant Metastasis,nan,nan,216.0,Stable Disease,nan,nan,0.0,605.0,0.0,605.0,nan,nan,1.0,216.0,2
TCGA-97-7546-01,TCGA-97-7546,LUAD,76.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2008.0,nan,-27913.0,Alive,WITH TUMOR,1285.0,nan,nan,New Primary Tumor,nan,nan,1255.0,Progressive Disease,nan,nan,0.0,1285.0,0.0,1285.0,nan,nan,1.0,1255.0,1
TCGA-97-7547-01,TCGA-97-7547,LUAD,67.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2007.0,nan,-24737.0,Alive,WITH TUMOR,1965.0,nan,nan,nan,nan,nan,775.0,Progressive Disease,nan,nan,0.0,1965.0,0.0,1965.0,nan,nan,1.0,775.0,2
TCGA-97-7552-01,TCGA-97-7552,LUAD,70.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2007.0,nan,-25578.0,Alive,TUMOR FREE,1932.0,nan,nan,nan,nan,nan,798.0,Stable Disease,nan,nan,0.0,1932.0,0.0,1932.0,nan,nan,1.0,798.0,0
TCGA-97-7553-01,TCGA-97-7553,LUAD,58.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2007.0,nan,-21518.0,Alive,TUMOR FREE,1870.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1870.0,0.0,1870.0,0.0,1870.0,0.0,1870.0,0
TCGA-97-7554-01,TCGA-97-7554,LUAD,83.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-30327.0,Alive,TUMOR FREE,775.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,775.0,0.0,775.0,0.0,775.0,0.0,775.0,0
TCGA-97-7937-01,TCGA-97-7937,LUAD,65.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-23919.0,Alive,TUMOR FREE,564.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,564.0,0.0,564.0,nan,nan,0.0,564.0,0
TCGA-97-7938-01,TCGA-97-7938,LUAD,76.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-27980.0,Dead,TUMOR FREE,nan,18.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,18.0,0.0,18.0,0.0,18.0,0.0,18.0,0
TCGA-97-7941-01,TCGA-97-7941,LUAD,72.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-26298.0,Alive,TUMOR FREE,484.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,484.0,0.0,484.0,0.0,484.0,0.0,484.0,0
TCGA-97-8171-01,TCGA-97-8171,LUAD,81.0,MALE,ASIAN,Stage IV,nan,Lung Adenocarcinoma,nan,2011.0,nan,-29627.0,Alive,WITH TUMOR,568.0,nan,nan,Distant Metastasis,nan,nan,441.0,Progressive Disease,nan,nan,0.0,568.0,0.0,568.0,nan,nan,1.0,441.0,0
TCGA-97-8172-01,TCGA-97-8172,LUAD,75.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-27416.0,Alive,TUMOR FREE,545.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,545.0,0.0,545.0,0.0,545.0,0.0,545.0,0
TCGA-97-8174-01,TCGA-97-8174,LUAD,67.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-24725.0,Dead,nan,nan,164.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,164.0,nan,164.0,nan,nan,0.0,164.0,0
TCGA-97-8175-01,TCGA-97-8175,LUAD,55.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-20206.0,Alive,TUMOR FREE,551.0,nan,nan,Locoregional Recurrence,nan,nan,294.0,Complete Remission/Response,nan,nan,0.0,551.0,0.0,551.0,1.0,294.0,1.0,294.0,2
TCGA-97-8176-01,TCGA-97-8176,LUAD,63.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-23170.0,Dead,TUMOR FREE,nan,468.0,nan,Distant Metastasis,nan,nan,39.0,Stable Disease,nan,nan,1.0,468.0,0.0,468.0,nan,nan,1.0,39.0,0
TCGA-97-8177-01,TCGA-97-8177,LUAD,59.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-21648.0,Alive,TUMOR FREE,499.0,nan,nan,nan,nan,nan,nan,[Not Evaluated],nan,nan,0.0,499.0,0.0,499.0,nan,nan,0.0,499.0,0
TCGA-97-8179-01,TCGA-97-8179,LUAD,72.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-26305.0,Alive,TUMOR FREE,435.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,435.0,0.0,435.0,0.0,435.0,0.0,435.0,0
TCGA-97-8547-01,TCGA-97-8547,LUAD,78.0,FEMALE,[Not Evaluated],Stage IIIA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-28801.0,Alive,TUMOR FREE,657.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,657.0,0.0,657.0,0.0,657.0,0.0,657.0,0
TCGA-97-8552-01,TCGA-97-8552,LUAD,55.0,FEMALE,WHITE,Stage I,nan,Lung Adenocarcinoma,nan,2012.0,nan,-20331.0,Alive,TUMOR FREE,626.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,626.0,0.0,626.0,0.0,626.0,0.0,626.0,0
TCGA-97-A4LX-01,TCGA-97-A4LX,LUAD,81.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-29915.0,Alive,TUMOR FREE,614.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,614.0,0.0,614.0,0.0,614.0,0.0,614.0,0
TCGA-97-A4M0-01,TCGA-97-A4M0,LUAD,60.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2012.0,nan,-22206.0,Alive,TUMOR FREE,652.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,652.0,0.0,652.0,0.0,652.0,0.0,652.0,0
TCGA-97-A4M1-01,TCGA-97-A4M1,LUAD,52.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-19272.0,Alive,TUMOR FREE,601.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,601.0,0.0,601.0,0.0,601.0,0.0,601.0,0
TCGA-97-A4M2-01,TCGA-97-A4M2,LUAD,66.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-24313.0,Alive,TUMOR FREE,624.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,624.0,0.0,624.0,0.0,624.0,0.0,624.0,0
TCGA-97-A4M3-01,TCGA-97-A4M3,LUAD,69.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-25384.0,Alive,TUMOR FREE,540.0,nan,nan,New Primary Tumor,nan,nan,54.0,Complete Remission/Response,nan,nan,0.0,540.0,0.0,540.0,0.0,540.0,1.0,54.0,0
TCGA-97-A4M5-01,TCGA-97-A4M5,LUAD,83.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-30665.0,Alive,TUMOR FREE,634.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,634.0,0.0,634.0,0.0,634.0,0.0,634.0,0
TCGA-97-A4M6-01,TCGA-97-A4M6,LUAD,45.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-16764.0,Alive,TUMOR FREE,568.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,568.0,0.0,568.0,0.0,568.0,0.0,568.0,0
TCGA-97-A4M7-01,TCGA-97-A4M7,LUAD,74.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-27062.0,Alive,TUMOR FREE,629.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,629.0,0.0,629.0,0.0,629.0,0.0,629.0,0
TCGA-99-7458-01,TCGA-99-7458,LUAD,74.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-27359.0,Alive,WITH TUMOR,747.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,747.0,0.0,747.0,nan,nan,0.0,747.0,0
TCGA-99-8025-01,TCGA-99-8025,LUAD,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-26634.0,Alive,TUMOR FREE,1060.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1060.0,0.0,1060.0,0.0,1060.0,0.0,1060.0,0
TCGA-99-8028-01,TCGA-99-8028,LUAD,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-18542.0,Alive,TUMOR FREE,1118.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1118.0,0.0,1118.0,0.0,1118.0,0.0,1118.0,0
TCGA-99-8032-01,TCGA-99-8032,LUAD,61.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-22635.0,Alive,TUMOR FREE,44.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,44.0,0.0,44.0,0.0,44.0,0.0,44.0,0
TCGA-99-8033-01,TCGA-99-8033,LUAD,74.0,FEMALE,WHITE,Stage IV,nan,Lung Adenocarcinoma,nan,2011.0,nan,-27342.0,Dead,WITH TUMOR,nan,656.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,656.0,1.0,656.0,nan,nan,1.0,656.0,1
TCGA-99-AA5R-01,TCGA-99-AA5R,LUAD,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Adenocarcinoma,nan,2013.0,nan,-25778.0,Alive,TUMOR FREE,658.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,658.0,0.0,658.0,0.0,658.0,0.0,658.0,0
TCGA-J2-8192-01,TCGA-J2-8192,LUAD,65.0,FEMALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-23892.0,Alive,TUMOR FREE,739.0,nan,nan,Locoregional Recurrence,nan,nan,482.0,Progressive Disease,nan,nan,0.0,739.0,0.0,739.0,nan,nan,1.0,482.0,0
TCGA-J2-8194-01,TCGA-J2-8194,LUAD,69.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-25441.0,Alive,WITH TUMOR,724.0,nan,nan,Distant Metastasis,nan,nan,470.0,Progressive Disease,nan,nan,0.0,724.0,0.0,724.0,nan,nan,1.0,470.0,2
TCGA-J2-A4AD-01,TCGA-J2-A4AD,LUAD,61.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-22414.0,Dead,WITH TUMOR,nan,550.0,nan,Locoregional Recurrence|Distant Metastasis,nan,nan,524.0,[Unknown],nan,nan,1.0,550.0,1.0,550.0,nan,nan,1.0,524.0,1
TCGA-J2-A4AE-01,TCGA-J2-A4AE,LUAD,77.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-28163.0,Alive,TUMOR FREE,1079.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1079.0,0.0,1079.0,0.0,1079.0,0.0,1079.0,0
TCGA-J2-A4AG-01,TCGA-J2-A4AG,LUAD,66.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-24224.0,Alive,TUMOR FREE,988.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,988.0,0.0,988.0,0.0,988.0,0.0,988.0,0
TCGA-L4-A4E5-01,TCGA-L4-A4E5,LUAD,48.0,FEMALE,WHITE,Stage I,nan,Lung Adenocarcinoma,nan,2012.0,nan,-17680.0,Alive,TUMOR FREE,578.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,578.0,0.0,578.0,0.0,578.0,0.0,578.0,0
TCGA-L4-A4E6-01,TCGA-L4-A4E6,LUAD,67.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-24631.0,Alive,TUMOR FREE,435.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,435.0,0.0,435.0,0.0,435.0,0.0,435.0,0
TCGA-L9-A443-01,TCGA-L9-A443,LUAD,63.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-23062.0,Dead,TUMOR FREE,nan,193.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,193.0,0.0,193.0,0.0,193.0,0.0,193.0,0
TCGA-L9-A444-01,TCGA-L9-A444,LUAD,60.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-22202.0,Alive,TUMOR FREE,307.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,307.0,0.0,307.0,0.0,307.0,0.0,307.0,0
TCGA-L9-A50W-01,TCGA-L9-A50W,LUAD,75.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-27414.0,Dead,WITH TUMOR,nan,442.0,nan,Distant Metastasis,nan,nan,389.0,Complete Remission/Response,nan,nan,1.0,442.0,1.0,442.0,1.0,389.0,1.0,389.0,1
TCGA-L9-A5IP-01,TCGA-L9-A5IP,LUAD,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Lung Adenocarcinoma,nan,2012.0,nan,-14681.0,Dead,WITH TUMOR,nan,58.0,nan,Locoregional Recurrence|Distant Metastasis,nan,nan,49.0,Progressive Disease,nan,nan,1.0,58.0,1.0,58.0,nan,nan,1.0,49.0,1
TCGA-L9-A743-01,TCGA-L9-A743,LUAD,56.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Lung Adenocarcinoma,nan,2013.0,nan,-20780.0,Alive,TUMOR FREE,664.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,664.0,0.0,664.0,0.0,664.0,0.0,664.0,0
TCGA-L9-A7SV-01,TCGA-L9-A7SV,LUAD,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Lung Adenocarcinoma,nan,2013.0,nan,-25298.0,Alive,TUMOR FREE,565.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,565.0,0.0,565.0,0.0,565.0,0.0,565.0,0
TCGA-L9-A8F4-01,TCGA-L9-A8F4,LUAD,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Lung Adenocarcinoma,nan,2013.0,nan,-23617.0,Alive,TUMOR FREE,476.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,476.0,0.0,476.0,nan,nan,0.0,476.0,0
TCGA-MN-A4N1-01,TCGA-MN-A4N1,LUAD,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-21939.0,Alive,TUMOR FREE,827.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,827.0,0.0,827.0,0.0,827.0,0.0,827.0,0
TCGA-MN-A4N4-01,TCGA-MN-A4N4,LUAD,57.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-20888.0,Alive,TUMOR FREE,1175.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1175.0,0.0,1175.0,0.0,1175.0,0.0,1175.0,0
TCGA-MN-A4N5-01,TCGA-MN-A4N5,LUAD,63.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-23257.0,Alive,TUMOR FREE,84.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,84.0,0.0,84.0,0.0,84.0,0.0,84.0,0
TCGA-MP-A4SV-01,TCGA-MP-A4SV,LUAD,67.0,MALE,[Unknown],Stage IB,nan,Lung Adenocarcinoma,nan,2001.0,nan,-24516.0,Dead,nan,nan,2620.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2620.0,nan,2620.0,0.0,2620.0,0.0,2620.0,0
TCGA-MP-A4SW-01,TCGA-MP-A4SW,LUAD,53.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2002.0,nan,-19640.0,Dead,nan,nan,1778.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1778.0,nan,1778.0,0.0,1778.0,0.0,1778.0,0
TCGA-MP-A4SY-01,TCGA-MP-A4SY,LUAD,61.0,MALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2002.0,nan,-22448.0,Dead,TUMOR FREE,nan,1501.0,nan,Locoregional Recurrence,nan,nan,489.0,Complete Remission/Response,nan,nan,1.0,1501.0,0.0,1501.0,1.0,489.0,1.0,489.0,0
TCGA-MP-A4T2-01,TCGA-MP-A4T2,LUAD,71.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2003.0,nan,-26010.0,Dead,WITH TUMOR,nan,1136.0,nan,Distant Metastasis,nan,nan,575.0,Complete Remission/Response,nan,nan,1.0,1136.0,1.0,1136.0,1.0,575.0,1.0,575.0,1
TCGA-MP-A4T4-01,TCGA-MP-A4T4,LUAD,68.0,FEMALE,WHITE,Stage IIB,nan,Lung Adenocarcinoma,nan,2004.0,nan,-25052.0,Dead,nan,nan,2617.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2617.0,nan,2617.0,0.0,2617.0,0.0,2617.0,1
TCGA-MP-A4T6-01,TCGA-MP-A4T6,LUAD,76.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2005.0,nan,-27993.0,Dead,TUMOR FREE,nan,1790.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1790.0,0.0,1790.0,0.0,1790.0,0.0,1790.0,0
TCGA-MP-A4T7-01,TCGA-MP-A4T7,LUAD,75.0,FEMALE,[Unknown],Stage IV,nan,Lung Adenocarcinoma,nan,2005.0,nan,-27603.0,Dead,nan,nan,167.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,167.0,nan,167.0,nan,nan,0.0,167.0,1
TCGA-MP-A4T8-01,TCGA-MP-A4T8,LUAD,68.0,MALE,[Unknown],Stage IIIA,nan,Lung Adenocarcinoma,nan,2006.0,nan,-25069.0,Dead,nan,nan,161.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,161.0,nan,161.0,nan,nan,0.0,161.0,1
TCGA-MP-A4T9-01,TCGA-MP-A4T9,LUAD,54.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2006.0,nan,-19767.0,Dead,WITH TUMOR,nan,1265.0,nan,Locoregional Recurrence|Distant Metastasis,nan,nan,341.0,Complete Remission/Response,nan,nan,1.0,1265.0,1.0,1265.0,1.0,341.0,1.0,341.0,1
TCGA-MP-A4TA-01,TCGA-MP-A4TA,LUAD,75.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2006.0,nan,-27513.0,Dead,WITH TUMOR,nan,950.0,nan,Distant Metastasis,nan,nan,725.0,Complete Remission/Response,nan,nan,1.0,950.0,1.0,950.0,1.0,725.0,1.0,725.0,1
TCGA-MP-A4TC-01,TCGA-MP-A4TC,LUAD,77.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2008.0,nan,-28471.0,Dead,TUMOR FREE,nan,74.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,74.0,0.0,74.0,0.0,74.0,0.0,74.0,0
TCGA-MP-A4TD-01,TCGA-MP-A4TD,LUAD,71.0,MALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2008.0,nan,-25983.0,Dead,nan,nan,307.0,nan,Locoregional Recurrence,nan,nan,226.0,Complete Remission/Response,nan,nan,1.0,307.0,nan,307.0,1.0,226.0,1.0,226.0,1
TCGA-MP-A4TE-01,TCGA-MP-A4TE,LUAD,56.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-20627.0,Dead,WITH TUMOR,nan,896.0,nan,Locoregional Recurrence,nan,nan,226.0,Complete Remission/Response,nan,nan,1.0,896.0,1.0,896.0,1.0,226.0,1.0,226.0,1
TCGA-MP-A4TF-01,TCGA-MP-A4TF,LUAD,58.0,FEMALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-21387.0,Dead,WITH TUMOR,nan,336.0,nan,Distant Metastasis,nan,nan,195.0,Partial Remission/Response,nan,nan,1.0,336.0,1.0,336.0,nan,nan,1.0,195.0,1
TCGA-MP-A4TH-01,TCGA-MP-A4TH,LUAD,70.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2012.0,nan,-25759.0,Alive,TUMOR FREE,741.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,741.0,0.0,741.0,0.0,741.0,0.0,741.0,0
TCGA-MP-A4TI-01,TCGA-MP-A4TI,LUAD,72.0,MALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2010.0,nan,-26565.0,Dead,WITH TUMOR,nan,429.0,nan,Locoregional Recurrence|Distant Metastasis,nan,nan,84.0,[Unknown],nan,nan,1.0,429.0,1.0,429.0,nan,nan,1.0,84.0,1
TCGA-MP-A4TJ-01,TCGA-MP-A4TJ,LUAD,62.0,FEMALE,[Unknown],Stage IA,nan,Lung Adenocarcinoma,nan,2006.0,nan,-22875.0,Dead,nan,nan,339.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,339.0,nan,339.0,0.0,339.0,0.0,339.0,1
TCGA-MP-A4TK-01,TCGA-MP-A4TK,LUAD,56.0,FEMALE,[Unknown],Stage IIB,nan,Lung Adenocarcinoma,nan,2002.0,nan,-20581.0,Dead,WITH TUMOR,nan,582.0,nan,Distant Metastasis,nan,nan,397.0,Complete Remission/Response,nan,nan,1.0,582.0,1.0,582.0,1.0,397.0,1.0,397.0,1
TCGA-MP-A5C7-01,TCGA-MP-A5C7,LUAD,76.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2008.0,nan,-28015.0,Alive,TUMOR FREE,2248.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2248.0,0.0,2248.0,0.0,2248.0,0.0,2248.0,0
TCGA-NJ-A4YF-01,TCGA-NJ-A4YF,LUAD,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Adenocarcinoma,nan,2007.0,nan,-18584.0,Alive,TUMOR FREE,2161.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,2161.0,0.0,2161.0,nan,nan,0.0,2161.0,0
TCGA-NJ-A4YG-01,TCGA-NJ-A4YG,LUAD,65.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2008.0,nan,-23812.0,Alive,TUMOR FREE,2261.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,2261.0,0.0,2261.0,nan,nan,0.0,2261.0,0
TCGA-NJ-A4YI-01,TCGA-NJ-A4YI,LUAD,87.0,FEMALE,WHITE,Stage IIIA,nan,Lung Adenocarcinoma,nan,2009.0,nan,-31867.0,Dead,nan,nan,4.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,4.0,nan,4.0,nan,nan,0.0,4.0,1
TCGA-NJ-A4YP-01,TCGA-NJ-A4YP,LUAD,52.0,MALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2011.0,nan,-19106.0,Alive,TUMOR FREE,50.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,50.0,0.0,50.0,nan,nan,0.0,50.0,0
TCGA-NJ-A4YQ-01,TCGA-NJ-A4YQ,LUAD,69.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-25427.0,Alive,TUMOR FREE,1432.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1432.0,0.0,1432.0,nan,nan,0.0,1432.0,0
TCGA-NJ-A55A-01,TCGA-NJ-A55A,LUAD,76.0,FEMALE,WHITE,Stage IB,nan,Lung Adenocarcinoma,nan,2009.0,nan,-28022.0,Alive,TUMOR FREE,15.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,15.0,0.0,15.0,nan,nan,0.0,15.0,0
TCGA-NJ-A55O-01,TCGA-NJ-A55O,LUAD,56.0,FEMALE,WHITE,Stage IIA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-20628.0,Alive,TUMOR FREE,13.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,13.0,0.0,13.0,nan,nan,0.0,13.0,0
TCGA-NJ-A55R-01,TCGA-NJ-A55R,LUAD,67.0,MALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2011.0,nan,-24738.0,Alive,TUMOR FREE,603.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,603.0,0.0,603.0,nan,nan,0.0,603.0,0
TCGA-NJ-A7XG-01,TCGA-NJ-A7XG,LUAD,49.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Lung Adenocarcinoma,nan,2013.0,nan,-18127.0,Alive,WITH TUMOR,617.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,617.0,0.0,617.0,nan,nan,0.0,617.0,0
TCGA-O1-A52J-01,TCGA-O1-A52J,LUAD,74.0,FEMALE,WHITE,Stage IA,nan,Lung Adenocarcinoma,nan,2007.0,nan,-27223.0,Dead,WITH TUMOR,nan,1798.0,nan,Locoregional Recurrence,nan,nan,898.0,[Unknown],nan,nan,1.0,1798.0,1.0,1798.0,nan,nan,1.0,898.0,1
TCGA-S2-AA1A-01,TCGA-S2-AA1A,LUAD,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Adenocarcinoma,nan,2013.0,nan,-24903.0,Alive,TUMOR FREE,513.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,513.0,0.0,513.0,0.0,513.0,0.0,513.0,0
TCGA-18-3406-01,TCGA-18-3406,LUSC,67.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-24477.0,Dead,WITH TUMOR,nan,371.0,nan,Locoregional Recurrence,nan,nan,357.0,Progressive Disease,nan,nan,1.0,371.0,1.0,371.0,nan,nan,1.0,357.0,1
TCGA-18-3406-11,TCGA-18-3406,LUSC,67.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-24477.0,Dead,WITH TUMOR,nan,371.0,nan,Locoregional Recurrence,nan,nan,357.0,Progressive Disease,nan,nan,1.0,371.0,1.0,371.0,nan,nan,1.0,357.0,1
TCGA-18-3407-01,TCGA-18-3407,LUSC,72.0,MALE,ASIAN,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-26615.0,Dead,TUMOR FREE,nan,136.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,136.0,0.0,136.0,nan,nan,0.0,136.0,0
TCGA-18-3407-11,TCGA-18-3407,LUSC,72.0,MALE,ASIAN,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-26615.0,Dead,TUMOR FREE,nan,136.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,136.0,0.0,136.0,nan,nan,0.0,136.0,0
TCGA-18-3408-01,TCGA-18-3408,LUSC,77.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-28171.0,Dead,WITH TUMOR,nan,2304.0,nan,Locoregional Recurrence,nan,nan,1793.0,[Unknown],nan,nan,1.0,2304.0,1.0,2304.0,nan,nan,1.0,1793.0,1
TCGA-18-3408-11,TCGA-18-3408,LUSC,77.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-28171.0,Dead,WITH TUMOR,nan,2304.0,nan,Locoregional Recurrence,nan,nan,1793.0,[Unknown],nan,nan,1.0,2304.0,1.0,2304.0,nan,nan,1.0,1793.0,1
TCGA-18-3409-01,TCGA-18-3409,LUSC,74.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-27154.0,Alive,TUMOR FREE,3747.0,nan,nan,New Primary Tumor,nan,nan,2291.0,Complete Remission/Response,nan,nan,0.0,3747.0,0.0,3747.0,0.0,3747.0,1.0,2291.0,0
TCGA-18-3409-11,TCGA-18-3409,LUSC,74.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-27154.0,Alive,TUMOR FREE,3747.0,nan,nan,New Primary Tumor,nan,nan,2291.0,Complete Remission/Response,nan,nan,0.0,3747.0,0.0,3747.0,0.0,3747.0,1.0,2291.0,0
TCGA-18-3410-01,TCGA-18-3410,LUSC,81.0,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-29827.0,Dead,TUMOR FREE,nan,146.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,146.0,0.0,146.0,nan,nan,0.0,146.0,0
TCGA-18-3410-11,TCGA-18-3410,LUSC,81.0,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-29827.0,Dead,TUMOR FREE,nan,146.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,146.0,0.0,146.0,nan,nan,0.0,146.0,0
TCGA-18-3411-01,TCGA-18-3411,LUSC,63.0,FEMALE,nan,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-23370.0,Alive,TUMOR FREE,3576.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,3576.0,0.0,3576.0,nan,nan,0.0,3576.0,0
TCGA-18-3411-11,TCGA-18-3411,LUSC,63.0,FEMALE,nan,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-23370.0,Alive,TUMOR FREE,3576.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,3576.0,0.0,3576.0,nan,nan,0.0,3576.0,0
TCGA-18-3412-01,TCGA-18-3412,LUSC,52.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-19025.0,Dead,WITH TUMOR,nan,345.0,nan,Distant Metastasis,nan,nan,273.0,Progressive Disease,nan,nan,1.0,345.0,1.0,345.0,nan,nan,1.0,273.0,1
TCGA-18-3412-11,TCGA-18-3412,LUSC,52.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-19025.0,Dead,WITH TUMOR,nan,345.0,nan,Distant Metastasis,nan,nan,273.0,Progressive Disease,nan,nan,1.0,345.0,1.0,345.0,nan,nan,1.0,273.0,1
TCGA-18-3414-01,TCGA-18-3414,LUSC,73.0,MALE,ASIAN,Stage IV,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-26938.0,Dead,TUMOR FREE,nan,716.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,716.0,0.0,716.0,nan,nan,0.0,716.0,0
TCGA-18-3414-11,TCGA-18-3414,LUSC,73.0,MALE,ASIAN,Stage IV,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-26938.0,Dead,TUMOR FREE,nan,716.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,716.0,0.0,716.0,nan,nan,0.0,716.0,0
TCGA-18-3415-01,TCGA-18-3415,LUSC,77.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-28430.0,Dead,TUMOR FREE,nan,2803.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2803.0,0.0,2803.0,0.0,2803.0,0.0,2803.0,0
TCGA-18-3415-11,TCGA-18-3415,LUSC,77.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-28430.0,Dead,TUMOR FREE,nan,2803.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2803.0,0.0,2803.0,0.0,2803.0,0.0,2803.0,0
TCGA-18-3416-01,TCGA-18-3416,LUSC,83.0,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-30435.0,Dead,WITH TUMOR,nan,973.0,nan,Distant Metastasis,nan,nan,940.0,Complete Remission/Response,nan,nan,1.0,973.0,1.0,973.0,1.0,940.0,1.0,940.0,1
TCGA-18-3416-11,TCGA-18-3416,LUSC,83.0,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-30435.0,Dead,WITH TUMOR,nan,973.0,nan,Distant Metastasis,nan,nan,940.0,Complete Remission/Response,nan,nan,1.0,973.0,1.0,973.0,1.0,940.0,1.0,940.0,1
TCGA-18-3417-01,TCGA-18-3417,LUSC,65.0,MALE,nan,Stage IV,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-24019.0,Dead,TUMOR FREE,nan,1097.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1097.0,0.0,1097.0,nan,nan,0.0,1097.0,0
TCGA-18-3417-11,TCGA-18-3417,LUSC,65.0,MALE,nan,Stage IV,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-24019.0,Dead,TUMOR FREE,nan,1097.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1097.0,0.0,1097.0,nan,nan,0.0,1097.0,0
TCGA-18-3419-01,TCGA-18-3419,LUSC,73.0,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-26813.0,Alive,TUMOR FREE,2811.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2811.0,0.0,2811.0,0.0,2811.0,0.0,2811.0,0
TCGA-18-3419-11,TCGA-18-3419,LUSC,73.0,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-26813.0,Alive,TUMOR FREE,2811.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2811.0,0.0,2811.0,0.0,2811.0,0.0,2811.0,0
TCGA-18-3421-01,TCGA-18-3421,LUSC,65.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-23972.0,Alive,TUMOR FREE,2645.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2645.0,0.0,2645.0,0.0,2645.0,0.0,2645.0,0
TCGA-18-3421-11,TCGA-18-3421,LUSC,65.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-23972.0,Alive,TUMOR FREE,2645.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2645.0,0.0,2645.0,0.0,2645.0,0.0,2645.0,0
TCGA-18-4083-01,TCGA-18-4083,LUSC,63.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-23125.0,Dead,TUMOR FREE,nan,188.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,188.0,0.0,188.0,nan,nan,0.0,188.0,0
TCGA-18-4086-01,TCGA-18-4086,LUSC,64.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-23731.0,Dead,TUMOR FREE,nan,85.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,85.0,0.0,85.0,nan,nan,0.0,85.0,0
TCGA-18-4721-01,TCGA-18-4721,LUSC,74.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-27076.0,Alive,TUMOR FREE,4694.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4694.0,0.0,4694.0,0.0,4694.0,0.0,4694.0,0
TCGA-18-4721-11,TCGA-18-4721,LUSC,74.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-27076.0,Alive,TUMOR FREE,4694.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4694.0,0.0,4694.0,0.0,4694.0,0.0,4694.0,0
TCGA-18-5592-01,TCGA-18-5592,LUSC,57.0,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-21020.0,Alive,TUMOR FREE,1519.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1519.0,0.0,1519.0,nan,nan,0.0,1519.0,0
TCGA-18-5592-11,TCGA-18-5592,LUSC,57.0,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-21020.0,Alive,TUMOR FREE,1519.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1519.0,0.0,1519.0,nan,nan,0.0,1519.0,0
TCGA-18-5595-01,TCGA-18-5595,LUSC,50.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-18611.0,Dead,nan,nan,827.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,827.0,nan,827.0,nan,nan,0.0,827.0,1
TCGA-18-5595-11,TCGA-18-5595,LUSC,50.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-18611.0,Dead,nan,nan,827.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,827.0,nan,827.0,nan,nan,0.0,827.0,1
TCGA-21-1070-01,TCGA-21-1070,LUSC,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2000.0,nan,-22273.0,Alive,TUMOR FREE,3636.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3636.0,0.0,3636.0,nan,nan,0.0,3636.0,0
TCGA-21-1071-01,TCGA-21-1071,LUSC,67.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2001.0,nan,-24515.0,Dead,WITH TUMOR,1426.0,1426.0,nan,nan,nan,nan,993.0,nan,nan,nan,1.0,1426.0,1.0,1426.0,nan,nan,1.0,993.0,1
TCGA-21-1072-01,TCGA-21-1072,LUSC,75.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2001.0,nan,-27397.0,Alive,TUMOR FREE,3016.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3016.0,0.0,3016.0,nan,nan,0.0,3016.0,0
TCGA-21-1075-01,TCGA-21-1075,LUSC,57.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-21093.0,Alive,TUMOR FREE,2134.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2134.0,0.0,2134.0,nan,nan,0.0,2134.0,0
TCGA-21-1076-01,TCGA-21-1076,LUSC,54.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-19863.0,Alive,TUMOR FREE,1852.0,nan,nan,nan,nan,nan,1575.0,nan,nan,nan,0.0,1852.0,0.0,1852.0,nan,nan,1.0,1575.0,0
TCGA-21-1077-01,TCGA-21-1077,LUSC,64.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-23523.0,Dead,WITH TUMOR,1058.0,1058.0,nan,nan,nan,nan,644.0,nan,nan,nan,1.0,1058.0,1.0,1058.0,nan,nan,1.0,644.0,1
TCGA-21-1078-01,TCGA-21-1078,LUSC,77.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-28125.0,Dead,WITH TUMOR,469.0,474.0,nan,nan,nan,nan,257.0,nan,nan,nan,1.0,474.0,1.0,474.0,nan,nan,1.0,257.0,1
TCGA-21-1079-01,TCGA-21-1079,LUSC,71.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,1995.0,nan,-26176.0,Dead,WITH TUMOR,965.0,965.0,nan,nan,nan,nan,317.0,nan,nan,nan,1.0,965.0,1.0,965.0,nan,nan,1.0,317.0,1
TCGA-21-1080-01,TCGA-21-1080,LUSC,66.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,1996.0,nan,-24253.0,Alive,TUMOR FREE,3724.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3724.0,0.0,3724.0,nan,nan,0.0,3724.0,0
TCGA-21-1081-01,TCGA-21-1081,LUSC,69.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,1996.0,nan,-25440.0,Dead,WITH TUMOR,284.0,284.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,284.0,1.0,284.0,nan,nan,1.0,284.0,1
TCGA-21-1082-01,TCGA-21-1082,LUSC,61.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,1997.0,nan,-22492.0,Alive,TUMOR FREE,3644.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3644.0,0.0,3644.0,nan,nan,0.0,3644.0,0
TCGA-21-1083-01,TCGA-21-1083,LUSC,75.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,1997.0,nan,-27708.0,Dead,TUMOR FREE,267.0,1315.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1315.0,0.0,1315.0,nan,nan,0.0,1315.0,0
TCGA-21-5782-01,TCGA-21-5782,LUSC,68.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-24969.0,Dead,nan,962.0,962.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,962.0,nan,962.0,0.0,962.0,0.0,962.0,1
TCGA-21-5783-01,TCGA-21-5783,LUSC,76.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-27904.0,Dead,nan,nan,2680.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2680.0,nan,2680.0,nan,nan,0.0,2680.0,1
TCGA-21-5784-01,TCGA-21-5784,LUSC,80.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-29362.0,Alive,TUMOR FREE,1268.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1268.0,0.0,1268.0,0.0,1268.0,0.0,1268.0,0
TCGA-21-5786-01,TCGA-21-5786,LUSC,64.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-23649.0,Alive,TUMOR FREE,1032.0,nan,nan,Locoregional Recurrence,nan,nan,817.0,Complete Remission/Response,nan,nan,0.0,1032.0,0.0,1032.0,1.0,817.0,1.0,817.0,2
TCGA-21-5787-01,TCGA-21-5787,LUSC,65.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-24071.0,Dead,WITH TUMOR,329.0,329.0,nan,nan,nan,nan,103.0,Progressive Disease,nan,nan,1.0,329.0,1.0,329.0,nan,nan,1.0,103.0,1
TCGA-21-A5DI-01,TCGA-21-A5DI,LUSC,77.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-28374.0,Alive,TUMOR FREE,979.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,979.0,0.0,979.0,0.0,979.0,0.0,979.0,0
TCGA-22-0940-01,TCGA-22-0940,LUSC,71.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2000.0,nan,-26272.0,Dead,WITH TUMOR,608.0,669.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,669.0,1.0,669.0,nan,nan,1.0,669.0,1
TCGA-22-0944-01,TCGA-22-0944,LUSC,61.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2000.0,nan,-22329.0,Dead,TUMOR FREE,223.0,223.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,223.0,0.0,223.0,nan,nan,0.0,223.0,0
TCGA-22-1000-01,TCGA-22-1000,LUSC,76.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2000.0,nan,-27901.0,Dead,WITH TUMOR,nan,454.0,nan,nan,nan,nan,263.0,Complete Remission/Response,nan,nan,1.0,454.0,1.0,454.0,1.0,263.0,1.0,263.0,1
TCGA-22-1002-01,TCGA-22-1002,LUSC,69.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2001.0,nan,-25359.0,Dead,TUMOR FREE,131.0,131.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,131.0,0.0,131.0,nan,nan,0.0,131.0,0
TCGA-22-1005-01,TCGA-22-1005,LUSC,63.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2001.0,nan,-23322.0,Dead,TUMOR FREE,1953.0,1953.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1953.0,0.0,1953.0,0.0,1953.0,0.0,1953.0,0
TCGA-22-1011-01,TCGA-22-1011,LUSC,73.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2001.0,nan,-26732.0,Dead,TUMOR FREE,53.0,53.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,53.0,0.0,53.0,nan,nan,0.0,53.0,0
TCGA-22-1012-01,TCGA-22-1012,LUSC,80.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2001.0,nan,-29273.0,Dead,TUMOR FREE,nan,429.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,429.0,0.0,429.0,0.0,429.0,0.0,429.0,0
TCGA-22-1016-01,TCGA-22-1016,LUSC,65.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2001.0,nan,-24078.0,Dead,TUMOR FREE,802.0,822.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,822.0,0.0,822.0,0.0,822.0,0.0,822.0,0
TCGA-22-1017-01,TCGA-22-1017,LUSC,62.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,1999.0,nan,-22880.0,Dead,WITH TUMOR,nan,1485.0,nan,Locoregional Recurrence|Distant Metastasis,nan,nan,904.0,Complete Remission/Response,nan,nan,1.0,1485.0,1.0,1485.0,1.0,904.0,1.0,904.0,1
TCGA-22-4591-01,TCGA-22-4591,LUSC,80.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2001.0,nan,-29250.0,Dead,WITH TUMOR,623.0,623.0,nan,nan,nan,nan,443.0,Partial Remission/Response,nan,nan,1.0,623.0,1.0,623.0,nan,nan,1.0,443.0,1
TCGA-22-4593-01,TCGA-22-4593,LUSC,77.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-28385.0,Dead,TUMOR FREE,1067.0,1067.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1067.0,0.0,1067.0,nan,nan,0.0,1067.0,0
TCGA-22-4593-11,TCGA-22-4593,LUSC,77.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-28385.0,Dead,TUMOR FREE,1067.0,1067.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1067.0,0.0,1067.0,nan,nan,0.0,1067.0,0
TCGA-22-4594-01,TCGA-22-4594,LUSC,60.0,FEMALE,nan,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-22115.0,Dead,nan,1470.0,1470.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1470.0,nan,1470.0,nan,nan,0.0,1470.0,1
TCGA-22-4595-01,TCGA-22-4595,LUSC,57.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-21146.0,Dead,WITH TUMOR,734.0,734.0,nan,nan,nan,nan,250.0,Complete Remission/Response,nan,nan,1.0,734.0,1.0,734.0,1.0,250.0,1.0,250.0,1
TCGA-22-4596-01,TCGA-22-4596,LUSC,69.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-25448.0,Dead,TUMOR FREE,17.0,17.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,17.0,0.0,17.0,nan,nan,0.0,17.0,1
TCGA-22-4599-01,TCGA-22-4599,LUSC,73.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-26925.0,Dead,nan,1161.0,1161.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1161.0,nan,1161.0,nan,nan,0.0,1161.0,1
TCGA-22-4599-11,TCGA-22-4599,LUSC,73.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-26925.0,Dead,nan,1161.0,1161.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1161.0,nan,1161.0,nan,nan,0.0,1161.0,1
TCGA-22-4601-01,TCGA-22-4601,LUSC,73.0,FEMALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-26937.0,Dead,WITH TUMOR,1057.0,1057.0,nan,nan,nan,nan,525.0,nan,nan,nan,1.0,1057.0,1.0,1057.0,nan,nan,1.0,525.0,1
TCGA-22-4601-11,TCGA-22-4601,LUSC,73.0,FEMALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-26937.0,Dead,WITH TUMOR,1057.0,1057.0,nan,nan,nan,nan,525.0,nan,nan,nan,1.0,1057.0,1.0,1057.0,nan,nan,1.0,525.0,1
TCGA-22-4604-01,TCGA-22-4604,LUSC,73.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-26952.0,Dead,WITH TUMOR,nan,399.0,nan,nan,nan,nan,306.0,nan,nan,nan,1.0,399.0,1.0,399.0,nan,nan,1.0,306.0,1
TCGA-22-4605-01,TCGA-22-4605,LUSC,78.0,FEMALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-28623.0,Dead,TUMOR FREE,nan,974.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,974.0,0.0,974.0,0.0,974.0,0.0,974.0,0
TCGA-22-4607-01,TCGA-22-4607,LUSC,75.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-27601.0,Dead,TUMOR FREE,587.0,587.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,587.0,0.0,587.0,nan,nan,0.0,587.0,0
TCGA-22-4609-01,TCGA-22-4609,LUSC,81.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-29844.0,Dead,TUMOR FREE,nan,291.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,291.0,0.0,291.0,0.0,291.0,0.0,291.0,0
TCGA-22-4609-11,TCGA-22-4609,LUSC,81.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-29844.0,Dead,TUMOR FREE,nan,291.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,291.0,0.0,291.0,0.0,291.0,0.0,291.0,0
TCGA-22-4613-01,TCGA-22-4613,LUSC,73.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-26722.0,Dead,nan,358.0,358.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,358.0,nan,358.0,nan,nan,0.0,358.0,1
TCGA-22-4613-11,TCGA-22-4613,LUSC,73.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-26722.0,Dead,nan,358.0,358.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,358.0,nan,358.0,nan,nan,0.0,358.0,1
TCGA-22-5471-01,TCGA-22-5471,LUSC,75.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-27749.0,Alive,nan,1845.0,nan,nan,nan,nan,nan,229.0,Complete Remission/Response,nan,nan,0.0,1845.0,0.0,1845.0,1.0,229.0,1.0,229.0,2
TCGA-22-5471-11,TCGA-22-5471,LUSC,75.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-27749.0,Alive,nan,1845.0,nan,nan,nan,nan,nan,229.0,Complete Remission/Response,nan,nan,0.0,1845.0,0.0,1845.0,1.0,229.0,1.0,229.0,2
TCGA-22-5472-01,TCGA-22-5472,LUSC,67.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-24482.0,Dead,TUMOR FREE,nan,1975.0,nan,nan,nan,nan,746.0,Complete Remission/Response,nan,nan,1.0,1975.0,0.0,1975.0,1.0,746.0,1.0,746.0,0
TCGA-22-5472-11,TCGA-22-5472,LUSC,67.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-24482.0,Dead,TUMOR FREE,nan,1975.0,nan,nan,nan,nan,746.0,Complete Remission/Response,nan,nan,1.0,1975.0,0.0,1975.0,1.0,746.0,1.0,746.0,0
TCGA-22-5473-01,TCGA-22-5473,LUSC,78.0,MALE,WHITE,[Discrepancy],nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-28826.0,Dead,TUMOR FREE,nan,1933.0,nan,nan,nan,nan,1655.0,Complete Remission/Response,nan,nan,1.0,1933.0,0.0,1933.0,1.0,1655.0,1.0,1655.0,0
TCGA-22-5473-11,TCGA-22-5473,LUSC,78.0,MALE,WHITE,[Discrepancy],nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-28826.0,Dead,TUMOR FREE,nan,1933.0,nan,nan,nan,nan,1655.0,Complete Remission/Response,nan,nan,1.0,1933.0,0.0,1933.0,1.0,1655.0,1.0,1655.0,0
TCGA-22-5474-01,TCGA-22-5474,LUSC,74.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-27271.0,Dead,TUMOR FREE,445.0,445.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,445.0,0.0,445.0,0.0,445.0,0.0,445.0,0
TCGA-22-5474-11,TCGA-22-5474,LUSC,74.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-27271.0,Dead,TUMOR FREE,445.0,445.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,445.0,0.0,445.0,0.0,445.0,0.0,445.0,0
TCGA-22-5477-01,TCGA-22-5477,LUSC,65.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-24055.0,Dead,nan,1346.0,1346.0,nan,nan,nan,nan,511.0,Complete Remission/Response,nan,nan,1.0,1346.0,nan,1346.0,1.0,511.0,1.0,511.0,1
TCGA-22-5477-11,TCGA-22-5477,LUSC,65.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-24055.0,Dead,nan,1346.0,1346.0,nan,nan,nan,nan,511.0,Complete Remission/Response,nan,nan,1.0,1346.0,nan,1346.0,1.0,511.0,1.0,511.0,1
TCGA-22-5478-01,TCGA-22-5478,LUSC,79.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-28978.0,Dead,TUMOR FREE,24.0,24.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,24.0,0.0,24.0,0.0,24.0,0.0,24.0,0
TCGA-22-5478-11,TCGA-22-5478,LUSC,79.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-28978.0,Dead,TUMOR FREE,24.0,24.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,24.0,0.0,24.0,0.0,24.0,0.0,24.0,0
TCGA-22-5479-01,TCGA-22-5479,LUSC,64.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-23563.0,Dead,nan,nan,2625.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,2625.0,nan,2625.0,nan,nan,0.0,2625.0,1
TCGA-22-5480-01,TCGA-22-5480,LUSC,66.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-24245.0,Dead,WITH TUMOR,2170.0,2170.0,nan,nan,nan,nan,1779.0,Complete Remission/Response,nan,nan,1.0,2170.0,1.0,2170.0,1.0,1779.0,1.0,1779.0,1
TCGA-22-5480-11,TCGA-22-5480,LUSC,66.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-24245.0,Dead,WITH TUMOR,2170.0,2170.0,nan,nan,nan,nan,1779.0,Complete Remission/Response,nan,nan,1.0,2170.0,1.0,2170.0,1.0,1779.0,1.0,1779.0,1
TCGA-22-5481-01,TCGA-22-5481,LUSC,72.0,FEMALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-26419.0,Dead,nan,nan,2409.0,nan,nan,nan,nan,346.0,Complete Remission/Response,nan,nan,1.0,2409.0,nan,2409.0,1.0,346.0,1.0,346.0,1
TCGA-22-5481-11,TCGA-22-5481,LUSC,72.0,FEMALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-26419.0,Dead,nan,nan,2409.0,nan,nan,nan,nan,346.0,Complete Remission/Response,nan,nan,1.0,2409.0,nan,2409.0,1.0,346.0,1.0,346.0,1
TCGA-22-5482-01,TCGA-22-5482,LUSC,81.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-29657.0,Dead,TUMOR FREE,357.0,357.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,357.0,0.0,357.0,0.0,357.0,0.0,357.0,0
TCGA-22-5482-11,TCGA-22-5482,LUSC,81.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-29657.0,Dead,TUMOR FREE,357.0,357.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,357.0,0.0,357.0,0.0,357.0,0.0,357.0,0
TCGA-22-5483-01,TCGA-22-5483,LUSC,74.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-27109.0,Dead,WITH TUMOR,573.0,573.0,nan,nan,nan,nan,568.0,Complete Remission/Response,nan,nan,1.0,573.0,1.0,573.0,1.0,568.0,1.0,568.0,1
TCGA-22-5483-11,TCGA-22-5483,LUSC,74.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-27109.0,Dead,WITH TUMOR,573.0,573.0,nan,nan,nan,nan,568.0,Complete Remission/Response,nan,nan,1.0,573.0,1.0,573.0,1.0,568.0,1.0,568.0,1
TCGA-22-5485-01,TCGA-22-5485,LUSC,58.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2001.0,nan,-21488.0,Dead,WITH TUMOR,916.0,916.0,nan,nan,nan,nan,840.0,Complete Remission/Response,nan,nan,1.0,916.0,1.0,916.0,1.0,840.0,1.0,840.0,1
TCGA-22-5485-11,TCGA-22-5485,LUSC,58.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2001.0,nan,-21488.0,Dead,WITH TUMOR,916.0,916.0,nan,nan,nan,nan,840.0,Complete Remission/Response,nan,nan,1.0,916.0,1.0,916.0,1.0,840.0,1.0,840.0,1
TCGA-22-5489-01,TCGA-22-5489,LUSC,64.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-23618.0,Dead,WITH TUMOR,1912.0,1912.0,nan,nan,nan,nan,428.0,Complete Remission/Response,nan,nan,1.0,1912.0,1.0,1912.0,1.0,428.0,1.0,428.0,1
TCGA-22-5489-11,TCGA-22-5489,LUSC,64.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-23618.0,Dead,WITH TUMOR,1912.0,1912.0,nan,nan,nan,nan,428.0,Complete Remission/Response,nan,nan,1.0,1912.0,1.0,1912.0,1.0,428.0,1.0,428.0,1
TCGA-22-5491-01,TCGA-22-5491,LUSC,74.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-27145.0,Dead,nan,1713.0,1713.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1713.0,nan,1713.0,nan,nan,0.0,1713.0,1
TCGA-22-5491-11,TCGA-22-5491,LUSC,74.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-27145.0,Dead,nan,1713.0,1713.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1713.0,nan,1713.0,nan,nan,0.0,1713.0,1
TCGA-22-5492-01,TCGA-22-5492,LUSC,73.0,FEMALE,nan,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-26838.0,Dead,nan,506.0,506.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,506.0,nan,506.0,nan,nan,0.0,506.0,1
TCGA-22-5492-11,TCGA-22-5492,LUSC,73.0,FEMALE,nan,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-26838.0,Dead,nan,506.0,506.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,506.0,nan,506.0,nan,nan,0.0,506.0,1
TCGA-22-A5C4-01,TCGA-22-A5C4,LUSC,70.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-25629.0,Alive,TUMOR FREE,671.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,671.0,0.0,671.0,0.0,671.0,0.0,671.0,0
TCGA-33-4532-01,TCGA-33-4532,LUSC,68.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2001.0,nan,-25169.0,Dead,TUMOR FREE,nan,3924.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,3924.0,0.0,3924.0,0.0,3924.0,0.0,3924.0,0
TCGA-33-4533-01,TCGA-33-4533,LUSC,76.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2001.0,nan,-28001.0,Alive,TUMOR FREE,4068.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4068.0,0.0,4068.0,0.0,4068.0,0.0,4068.0,0
TCGA-33-4538-01,TCGA-33-4538,LUSC,66.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-24174.0,Dead,nan,nan,2979.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2979.0,nan,2979.0,0.0,2979.0,0.0,2979.0,0
TCGA-33-4547-01,TCGA-33-4547,LUSC,68.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-25056.0,Alive,TUMOR FREE,2419.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2419.0,0.0,2419.0,0.0,2419.0,0.0,2419.0,0
TCGA-33-4566-01,TCGA-33-4566,LUSC,40.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,1996.0,nan,-14643.0,Dead,nan,nan,5287.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,5287.0,nan,5287.0,nan,nan,0.0,5287.0,1
TCGA-33-4566-11,TCGA-33-4566,LUSC,40.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,1996.0,nan,-14643.0,Dead,nan,nan,5287.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,5287.0,nan,5287.0,nan,nan,0.0,5287.0,1
TCGA-33-4582-01,TCGA-33-4582,LUSC,55.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2000.0,nan,-20402.0,Dead,WITH TUMOR,nan,3149.0,nan,Locoregional Recurrence,nan,nan,2923.0,Complete Remission/Response,nan,nan,1.0,3149.0,1.0,3149.0,1.0,2923.0,1.0,2923.0,1
TCGA-33-4582-11,TCGA-33-4582,LUSC,55.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2000.0,nan,-20402.0,Dead,WITH TUMOR,nan,3149.0,nan,Locoregional Recurrence,nan,nan,2923.0,Complete Remission/Response,nan,nan,1.0,3149.0,1.0,3149.0,1.0,2923.0,1.0,2923.0,1
TCGA-33-4583-01,TCGA-33-4583,LUSC,73.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,1999.0,nan,-26799.0,Dead,TUMOR FREE,nan,4601.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,4601.0,0.0,4601.0,0.0,4601.0,0.0,4601.0,0
TCGA-33-4583-11,TCGA-33-4583,LUSC,73.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,1999.0,nan,-26799.0,Dead,TUMOR FREE,nan,4601.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,4601.0,0.0,4601.0,0.0,4601.0,0.0,4601.0,0
TCGA-33-4586-01,TCGA-33-4586,LUSC,57.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-21148.0,Dead,nan,nan,428.0,nan,Locoregional Recurrence,nan,nan,169.0,Complete Remission/Response,nan,nan,1.0,428.0,nan,428.0,1.0,169.0,1.0,169.0,1
TCGA-33-4586-11,TCGA-33-4586,LUSC,57.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-21148.0,Dead,nan,nan,428.0,nan,Locoregional Recurrence,nan,nan,169.0,Complete Remission/Response,nan,nan,1.0,428.0,nan,428.0,1.0,169.0,1.0,169.0,1
TCGA-33-4587-01,TCGA-33-4587,LUSC,63.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-23062.0,Dead,WITH TUMOR,nan,1656.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,1656.0,1.0,1656.0,nan,nan,1.0,1656.0,1
TCGA-33-4587-11,TCGA-33-4587,LUSC,63.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-23062.0,Dead,WITH TUMOR,nan,1656.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,1656.0,1.0,1656.0,nan,nan,1.0,1656.0,1
TCGA-33-4589-01,TCGA-33-4589,LUSC,62.0,FEMALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,1992.0,nan,-22754.0,Dead,TUMOR FREE,nan,47.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,47.0,0.0,47.0,0.0,47.0,0.0,47.0,0
TCGA-33-4589-11,TCGA-33-4589,LUSC,62.0,FEMALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,1992.0,nan,-22754.0,Dead,TUMOR FREE,nan,47.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,47.0,0.0,47.0,0.0,47.0,0.0,47.0,0
TCGA-33-6737-01,TCGA-33-6737,LUSC,71.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-26033.0,Dead,WITH TUMOR,nan,601.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,601.0,1.0,601.0,nan,nan,1.0,601.0,1
TCGA-33-6737-11,TCGA-33-6737,LUSC,71.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-26033.0,Dead,WITH TUMOR,nan,601.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,601.0,1.0,601.0,nan,nan,1.0,601.0,1
TCGA-33-6738-01,TCGA-33-6738,LUSC,80.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-29368.0,Alive,TUMOR FREE,1927.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1927.0,0.0,1927.0,0.0,1927.0,0.0,1927.0,0
TCGA-33-A4WN-01,TCGA-33-A4WN,LUSC,60.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-22268.0,Dead,TUMOR FREE,nan,143.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,143.0,0.0,143.0,0.0,143.0,0.0,143.0,0
TCGA-33-A5GW-01,TCGA-33-A5GW,LUSC,67.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-24586.0,Dead,TUMOR FREE,nan,9.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,9.0,0.0,9.0,0.0,9.0,0.0,9.0,0
TCGA-33-AAS8-01,TCGA-33-AAS8,LUSC,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,1998.0,nan,-21675.0,Dead,TUMOR FREE,nan,1114.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1114.0,0.0,1114.0,0.0,1114.0,0.0,1114.0,0
TCGA-33-AASB-01,TCGA-33-AASB,LUSC,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-24183.0,Dead,WITH TUMOR,nan,211.0,nan,Distant Metastasis,nan,nan,30.0,Progressive Disease,nan,nan,1.0,211.0,1.0,211.0,nan,nan,1.0,30.0,1
TCGA-33-AASD-01,TCGA-33-AASD,LUSC,83.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2001.0,nan,-30623.0,Dead,WITH TUMOR,nan,3376.0,nan,Locoregional Recurrence,nan,nan,1912.0,Progressive Disease,nan,nan,1.0,3376.0,1.0,3376.0,nan,nan,1.0,1912.0,1
TCGA-33-AASI-01,TCGA-33-AASI,LUSC,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-23965.0,Dead,WITH TUMOR,nan,1344.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,1344.0,1.0,1344.0,nan,nan,1.0,1344.0,1
TCGA-33-AASJ-01,TCGA-33-AASJ,LUSC,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,1999.0,nan,-22179.0,Dead,WITH TUMOR,nan,3600.0,nan,Locoregional Recurrence,nan,nan,1135.0,Complete Remission/Response,nan,nan,1.0,3600.0,1.0,3600.0,1.0,1135.0,1.0,1135.0,1
TCGA-33-AASL-01,TCGA-33-AASL,LUSC,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2000.0,nan,-20940.0,Dead,WITH TUMOR,nan,826.0,nan,Locoregional Recurrence,nan,nan,149.0,Progressive Disease,nan,nan,1.0,826.0,1.0,826.0,nan,nan,1.0,149.0,1
TCGA-34-2596-01,TCGA-34-2596,LUSC,70.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-25574.0,Dead,TUMOR FREE,80.0,80.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,80.0,0.0,80.0,0.0,80.0,0.0,80.0,0
TCGA-34-2600-01,TCGA-34-2600,LUSC,76.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2000.0,nan,-28072.0,Dead,TUMOR FREE,1874.0,1874.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1874.0,0.0,1874.0,0.0,1874.0,0.0,1874.0,0
TCGA-34-2604-01,TCGA-34-2604,LUSC,81.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,1999.0,nan,-29827.0,Dead,TUMOR FREE,958.0,958.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,958.0,0.0,958.0,0.0,958.0,0.0,958.0,0
TCGA-34-2605-01,TCGA-34-2605,LUSC,76.0,MALE,WHITE,Stage IIIB,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-27833.0,Dead,WITH TUMOR,881.0,881.0,nan,nan,nan,nan,394.0,Complete Remission/Response,nan,nan,1.0,881.0,1.0,881.0,1.0,394.0,1.0,394.0,1
TCGA-34-2608-01,TCGA-34-2608,LUSC,84.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,1999.0,nan,-30958.0,Dead,TUMOR FREE,1000.0,1000.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1000.0,0.0,1000.0,0.0,1000.0,0.0,1000.0,0
TCGA-34-2609-01,TCGA-34-2609,LUSC,81.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-29871.0,Dead,WITH TUMOR,951.0,951.0,nan,nan,nan,nan,387.0,Complete Remission/Response,nan,nan,1.0,951.0,1.0,951.0,1.0,387.0,1.0,387.0,1
TCGA-34-5231-01,TCGA-34-5231,LUSC,72.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-26525.0,Dead,TUMOR FREE,nan,1984.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,1984.0,0.0,1984.0,nan,nan,0.0,1984.0,0
TCGA-34-5232-01,TCGA-34-5232,LUSC,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-27633.0,Alive,TUMOR FREE,2471.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2471.0,0.0,2471.0,0.0,2471.0,0.0,2471.0,0
TCGA-34-5234-01,TCGA-34-5234,LUSC,71.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-26072.0,Alive,TUMOR FREE,2271.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2271.0,0.0,2271.0,0.0,2271.0,0.0,2271.0,0
TCGA-34-5236-01,TCGA-34-5236,LUSC,60.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-21935.0,Dead,WITH TUMOR,nan,276.0,nan,Locoregional Recurrence,nan,nan,113.0,Progressive Disease,nan,nan,1.0,276.0,1.0,276.0,nan,nan,1.0,113.0,1
TCGA-34-5239-01,TCGA-34-5239,LUSC,75.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-27528.0,Alive,WITH TUMOR,1834.0,nan,nan,Distant Metastasis,nan,nan,1530.0,Complete Remission/Response,nan,nan,0.0,1834.0,0.0,1834.0,1.0,1530.0,1.0,1530.0,2
TCGA-34-5240-01,TCGA-34-5240,LUSC,73.0,FEMALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-26735.0,Alive,TUMOR FREE,1541.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1541.0,0.0,1541.0,0.0,1541.0,0.0,1541.0,0
TCGA-34-5241-01,TCGA-34-5241,LUSC,79.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-29098.0,Dead,TUMOR FREE,nan,515.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,515.0,0.0,515.0,nan,nan,0.0,515.0,0
TCGA-34-5927-01,TCGA-34-5927,LUSC,70.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-25857.0,Alive,TUMOR FREE,1361.0,nan,nan,Distant Metastasis,nan,nan,245.0,[Unknown],nan,nan,0.0,1361.0,0.0,1361.0,nan,nan,1.0,245.0,2
TCGA-34-5928-01,TCGA-34-5928,LUSC,83.0,FEMALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-30334.0,Alive,TUMOR FREE,1196.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1196.0,0.0,1196.0,0.0,1196.0,0.0,1196.0,0
TCGA-34-5929-01,TCGA-34-5929,LUSC,78.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-28844.0,Dead,TUMOR FREE,nan,151.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,151.0,0.0,151.0,nan,nan,0.0,151.0,1
TCGA-34-5929-11,TCGA-34-5929,LUSC,78.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-28844.0,Dead,TUMOR FREE,nan,151.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,151.0,0.0,151.0,nan,nan,0.0,151.0,1
TCGA-34-7107-01,TCGA-34-7107,LUSC,70.0,MALE,WHITE,Stage II,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-25677.0,Dead,nan,nan,34.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,34.0,nan,34.0,nan,nan,0.0,34.0,0
TCGA-34-7107-11,TCGA-34-7107,LUSC,70.0,MALE,WHITE,Stage II,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-25677.0,Dead,nan,nan,34.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,34.0,nan,34.0,nan,nan,0.0,34.0,0
TCGA-34-8454-01,TCGA-34-8454,LUSC,62.0,FEMALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-22913.0,Alive,TUMOR FREE,1180.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1180.0,0.0,1180.0,0.0,1180.0,0.0,1180.0,0
TCGA-34-8454-11,TCGA-34-8454,LUSC,62.0,FEMALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-22913.0,Alive,TUMOR FREE,1180.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1180.0,0.0,1180.0,0.0,1180.0,0.0,1180.0,0
TCGA-34-8455-01,TCGA-34-8455,LUSC,67.0,MALE,WHITE,Stage IV,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-24624.0,Dead,WITH TUMOR,nan,123.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,123.0,1.0,123.0,nan,nan,1.0,123.0,1
TCGA-34-8456-01,TCGA-34-8456,LUSC,71.0,FEMALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-26183.0,Alive,TUMOR FREE,804.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,804.0,0.0,804.0,0.0,804.0,0.0,804.0,0
TCGA-34-8456-11,TCGA-34-8456,LUSC,71.0,FEMALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-26183.0,Alive,TUMOR FREE,804.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,804.0,0.0,804.0,0.0,804.0,0.0,804.0,0
TCGA-34-A5IX-01,TCGA-34-A5IX,LUSC,80.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-29391.0,Alive,TUMOR FREE,1031.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1031.0,0.0,1031.0,0.0,1031.0,0.0,1031.0,0
TCGA-37-3783-01,TCGA-37-3783,LUSC,51.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-18728.0,Alive,TUMOR FREE,122.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,122.0,0.0,122.0,nan,nan,0.0,122.0,0
TCGA-37-3789-01,TCGA-37-3789,LUSC,65.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-23782.0,Alive,TUMOR FREE,13.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,13.0,0.0,13.0,nan,nan,0.0,13.0,0
TCGA-37-3792-01,TCGA-37-3792,LUSC,69.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-25502.0,Alive,TUMOR FREE,12.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,12.0,0.0,12.0,nan,nan,0.0,12.0,0
TCGA-37-4129-01,TCGA-37-4129,LUSC,52.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-19154.0,Alive,TUMOR FREE,242.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,242.0,0.0,242.0,0.0,242.0,0.0,242.0,0
TCGA-37-4130-01,TCGA-37-4130,LUSC,56.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-20652.0,Alive,TUMOR FREE,247.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,247.0,0.0,247.0,nan,nan,0.0,247.0,0
TCGA-37-4132-01,TCGA-37-4132,LUSC,61.0,FEMALE,WHITE,Stage IV,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-22520.0,Alive,TUMOR FREE,227.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,227.0,0.0,227.0,nan,nan,0.0,227.0,0
TCGA-37-4133-01,TCGA-37-4133,LUSC,63.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-23083.0,Alive,TUMOR FREE,238.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,238.0,0.0,238.0,nan,nan,0.0,238.0,0
TCGA-37-4135-01,TCGA-37-4135,LUSC,68.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-25041.0,Alive,TUMOR FREE,207.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,207.0,0.0,207.0,nan,nan,0.0,207.0,0
TCGA-37-4141-01,TCGA-37-4141,LUSC,65.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-24048.0,Alive,TUMOR FREE,12.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,12.0,0.0,12.0,nan,nan,0.0,12.0,0
TCGA-37-5819-01,TCGA-37-5819,LUSC,64.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-23726.0,Alive,TUMOR FREE,103.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,103.0,0.0,103.0,nan,nan,0.0,103.0,0
TCGA-37-A5EL-01,TCGA-37-A5EL,LUSC,53.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-19371.0,Dead,WITH TUMOR,nan,1143.0,nan,Distant Metastasis,nan,nan,946.0,[Discrepancy],nan,nan,1.0,1143.0,1.0,1143.0,nan,nan,1.0,946.0,1
TCGA-37-A5EM-01,TCGA-37-A5EM,LUSC,49.0,MALE,WHITE,Stage II,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-18011.0,Alive,TUMOR FREE,867.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,867.0,0.0,867.0,0.0,867.0,0.0,867.0,0
TCGA-37-A5EN-01,TCGA-37-A5EN,LUSC,59.0,MALE,WHITE,Stage IIIB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-21600.0,Alive,TUMOR FREE,660.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,660.0,0.0,660.0,0.0,660.0,0.0,660.0,0
TCGA-39-5011-01,TCGA-39-5011,LUSC,70.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-25788.0,Alive,TUMOR FREE,4053.0,nan,nan,nan,nan,nan,565.0,Complete Remission/Response,nan,nan,0.0,4053.0,0.0,4053.0,1.0,565.0,1.0,565.0,2
TCGA-39-5011-11,TCGA-39-5011,LUSC,70.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-25788.0,Alive,TUMOR FREE,4053.0,nan,nan,nan,nan,nan,565.0,Complete Remission/Response,nan,nan,0.0,4053.0,0.0,4053.0,1.0,565.0,1.0,565.0,2
TCGA-39-5016-01,TCGA-39-5016,LUSC,44.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-16306.0,Alive,TUMOR FREE,3850.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3850.0,0.0,3850.0,0.0,3850.0,0.0,3850.0,0
TCGA-39-5016-11,TCGA-39-5016,LUSC,44.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-16306.0,Alive,TUMOR FREE,3850.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3850.0,0.0,3850.0,0.0,3850.0,0.0,3850.0,0
TCGA-39-5019-01,TCGA-39-5019,LUSC,70.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-25756.0,Alive,TUMOR FREE,3387.0,nan,nan,nan,nan,nan,378.0,Complete Remission/Response,nan,nan,0.0,3387.0,0.0,3387.0,1.0,378.0,1.0,378.0,0
TCGA-39-5019-11,TCGA-39-5019,LUSC,70.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-25756.0,Alive,TUMOR FREE,3387.0,nan,nan,nan,nan,nan,378.0,Complete Remission/Response,nan,nan,0.0,3387.0,0.0,3387.0,1.0,378.0,1.0,378.0,0
TCGA-39-5021-01,TCGA-39-5021,LUSC,70.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-25895.0,Dead,WITH TUMOR,2057.0,2086.0,nan,nan,nan,nan,1875.0,Complete Remission/Response,nan,nan,1.0,2086.0,1.0,2086.0,1.0,1875.0,1.0,1875.0,1
TCGA-39-5021-11,TCGA-39-5021,LUSC,70.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-25895.0,Dead,WITH TUMOR,2057.0,2086.0,nan,nan,nan,nan,1875.0,Complete Remission/Response,nan,nan,1.0,2086.0,1.0,2086.0,1.0,1875.0,1.0,1875.0,1
TCGA-39-5022-01,TCGA-39-5022,LUSC,76.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-27856.0,Dead,TUMOR FREE,nan,1679.0,nan,nan,nan,nan,1448.0,nan,nan,nan,1.0,1679.0,0.0,1679.0,nan,nan,1.0,1448.0,1
TCGA-39-5024-01,TCGA-39-5024,LUSC,65.0,FEMALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-23975.0,Alive,TUMOR FREE,2510.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2510.0,0.0,2510.0,0.0,2510.0,0.0,2510.0,0
TCGA-39-5027-01,TCGA-39-5027,LUSC,73.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-26714.0,Alive,WITH TUMOR,3108.0,nan,nan,New Primary Tumor,nan,nan,3081.0,Complete Remission/Response,nan,nan,0.0,3108.0,0.0,3108.0,0.0,3108.0,1.0,3081.0,0
TCGA-39-5028-01,TCGA-39-5028,LUSC,75.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-27707.0,Dead,nan,52.0,52.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,52.0,nan,52.0,nan,nan,0.0,52.0,1
TCGA-39-5028-11,TCGA-39-5028,LUSC,75.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-27707.0,Dead,nan,52.0,52.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,52.0,nan,52.0,nan,nan,0.0,52.0,1
TCGA-39-5029-01,TCGA-39-5029,LUSC,67.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-24713.0,Dead,WITH TUMOR,nan,740.0,nan,nan,nan,nan,491.0,Stable Disease,nan,nan,1.0,740.0,1.0,740.0,nan,nan,1.0,491.0,1
TCGA-39-5029-11,TCGA-39-5029,LUSC,67.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-24713.0,Dead,WITH TUMOR,nan,740.0,nan,nan,nan,nan,491.0,Stable Disease,nan,nan,1.0,740.0,1.0,740.0,nan,nan,1.0,491.0,1
TCGA-39-5030-01,TCGA-39-5030,LUSC,81.0,FEMALE,ASIAN,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-29893.0,Dead,nan,59.0,59.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,59.0,nan,59.0,0.0,59.0,0.0,59.0,1
TCGA-39-5030-11,TCGA-39-5030,LUSC,81.0,FEMALE,ASIAN,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-29893.0,Dead,nan,59.0,59.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,59.0,nan,59.0,0.0,59.0,0.0,59.0,1
TCGA-39-5031-01,TCGA-39-5031,LUSC,76.0,FEMALE,nan,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-28106.0,Dead,TUMOR FREE,nan,1841.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1841.0,0.0,1841.0,0.0,1841.0,0.0,1841.0,0
TCGA-39-5031-11,TCGA-39-5031,LUSC,76.0,FEMALE,nan,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-28106.0,Dead,TUMOR FREE,nan,1841.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1841.0,0.0,1841.0,0.0,1841.0,0.0,1841.0,0
TCGA-39-5034-01,TCGA-39-5034,LUSC,73.0,FEMALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-26682.0,Dead,nan,1107.0,1107.0,nan,nan,nan,nan,352.0,Complete Remission/Response,nan,nan,1.0,1107.0,nan,1107.0,1.0,352.0,1.0,352.0,1
TCGA-39-5034-11,TCGA-39-5034,LUSC,73.0,FEMALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-26682.0,Dead,nan,1107.0,1107.0,nan,nan,nan,nan,352.0,Complete Remission/Response,nan,nan,1.0,1107.0,nan,1107.0,1.0,352.0,1.0,352.0,1
TCGA-39-5035-01,TCGA-39-5035,LUSC,72.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-26383.0,Alive,TUMOR FREE,2080.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2080.0,0.0,2080.0,0.0,2080.0,0.0,2080.0,0
TCGA-39-5035-11,TCGA-39-5035,LUSC,72.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-26383.0,Alive,TUMOR FREE,2080.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2080.0,0.0,2080.0,0.0,2080.0,0.0,2080.0,0
TCGA-39-5036-01,TCGA-39-5036,LUSC,73.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-26963.0,Alive,TUMOR FREE,2165.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2165.0,0.0,2165.0,0.0,2165.0,0.0,2165.0,0
TCGA-39-5036-11,TCGA-39-5036,LUSC,73.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-26963.0,Alive,TUMOR FREE,2165.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2165.0,0.0,2165.0,0.0,2165.0,0.0,2165.0,0
TCGA-39-5037-01,TCGA-39-5037,LUSC,65.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-23868.0,Alive,TUMOR FREE,1690.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1690.0,0.0,1690.0,0.0,1690.0,0.0,1690.0,0
TCGA-39-5037-11,TCGA-39-5037,LUSC,65.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-23868.0,Alive,TUMOR FREE,1690.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1690.0,0.0,1690.0,0.0,1690.0,0.0,1690.0,0
TCGA-39-5039-01,TCGA-39-5039,LUSC,76.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-27781.0,Dead,TUMOR FREE,544.0,544.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,544.0,0.0,544.0,0.0,544.0,0.0,544.0,0
TCGA-39-5039-11,TCGA-39-5039,LUSC,76.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-27781.0,Dead,TUMOR FREE,544.0,544.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,544.0,0.0,544.0,0.0,544.0,0.0,544.0,0
TCGA-39-5040-01,TCGA-39-5040,LUSC,59.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-21790.0,Dead,WITH TUMOR,nan,519.0,nan,nan,nan,nan,442.0,Stable Disease,nan,nan,1.0,519.0,1.0,519.0,nan,nan,1.0,442.0,1
TCGA-39-5040-11,TCGA-39-5040,LUSC,59.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-21790.0,Dead,WITH TUMOR,nan,519.0,nan,nan,nan,nan,442.0,Stable Disease,nan,nan,1.0,519.0,1.0,519.0,nan,nan,1.0,442.0,1
TCGA-43-2576-01,TCGA-43-2576,LUSC,62.0,FEMALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-22805.0,Alive,TUMOR FREE,1223.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1223.0,0.0,1223.0,0.0,1223.0,0.0,1223.0,0
TCGA-43-2578-01,TCGA-43-2578,LUSC,59.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-21747.0,Dead,TUMOR FREE,nan,684.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,684.0,0.0,684.0,0.0,684.0,0.0,684.0,0
TCGA-43-2581-01,TCGA-43-2581,LUSC,47.0,FEMALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-17447.0,Alive,TUMOR FREE,1176.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1176.0,0.0,1176.0,0.0,1176.0,0.0,1176.0,0
TCGA-43-3394-01,TCGA-43-3394,LUSC,52.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-19310.0,Dead,WITH TUMOR,nan,1190.0,nan,nan,nan,nan,552.0,Complete Remission/Response,nan,nan,1.0,1190.0,1.0,1190.0,1.0,552.0,1.0,552.0,1
TCGA-43-3394-11,TCGA-43-3394,LUSC,52.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-19310.0,Dead,WITH TUMOR,nan,1190.0,nan,nan,nan,nan,552.0,Complete Remission/Response,nan,nan,1.0,1190.0,1.0,1190.0,1.0,552.0,1.0,552.0,1
TCGA-43-3920-01,TCGA-43-3920,LUSC,71.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-26059.0,Alive,TUMOR FREE,1007.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1007.0,0.0,1007.0,0.0,1007.0,0.0,1007.0,0
TCGA-43-3920-11,TCGA-43-3920,LUSC,71.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-26059.0,Alive,TUMOR FREE,1007.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1007.0,0.0,1007.0,0.0,1007.0,0.0,1007.0,0
TCGA-43-5668-01,TCGA-43-5668,LUSC,78.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-28635.0,Dead,WITH TUMOR,nan,559.0,nan,nan,nan,nan,470.0,Complete Remission/Response,nan,nan,1.0,559.0,1.0,559.0,1.0,470.0,1.0,470.0,1
TCGA-43-5668-11,TCGA-43-5668,LUSC,78.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-28635.0,Dead,WITH TUMOR,nan,559.0,nan,nan,nan,nan,470.0,Complete Remission/Response,nan,nan,1.0,559.0,1.0,559.0,1.0,470.0,1.0,470.0,1
TCGA-43-5670-01,TCGA-43-5670,LUSC,70.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-25652.0,Alive,TUMOR FREE,849.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,849.0,0.0,849.0,0.0,849.0,0.0,849.0,0
TCGA-43-5670-11,TCGA-43-5670,LUSC,70.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-25652.0,Alive,TUMOR FREE,849.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,849.0,0.0,849.0,0.0,849.0,0.0,849.0,0
TCGA-43-6143-01,TCGA-43-6143,LUSC,70.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-25820.0,Alive,TUMOR FREE,699.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,699.0,0.0,699.0,0.0,699.0,0.0,699.0,0
TCGA-43-6143-11,TCGA-43-6143,LUSC,70.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-25820.0,Alive,TUMOR FREE,699.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,699.0,0.0,699.0,0.0,699.0,0.0,699.0,0
TCGA-43-6647-01,TCGA-43-6647,LUSC,69.0,FEMALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-25378.0,Alive,TUMOR FREE,757.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,757.0,0.0,757.0,0.0,757.0,0.0,757.0,0
TCGA-43-6647-11,TCGA-43-6647,LUSC,69.0,FEMALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-25378.0,Alive,TUMOR FREE,757.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,757.0,0.0,757.0,0.0,757.0,0.0,757.0,0
TCGA-43-6770-01,TCGA-43-6770,LUSC,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-21683.0,Alive,TUMOR FREE,653.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,653.0,0.0,653.0,0.0,653.0,0.0,653.0,0
TCGA-43-6771-01,TCGA-43-6771,LUSC,85.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-31052.0,Dead,WITH TUMOR,nan,166.0,nan,nan,nan,nan,154.0,Progressive Disease,nan,nan,1.0,166.0,1.0,166.0,nan,nan,1.0,154.0,1
TCGA-43-6771-11,TCGA-43-6771,LUSC,85.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-31052.0,Dead,WITH TUMOR,nan,166.0,nan,nan,nan,nan,154.0,Progressive Disease,nan,nan,1.0,166.0,1.0,166.0,nan,nan,1.0,154.0,1
TCGA-43-6773-01,TCGA-43-6773,LUSC,76.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-28036.0,Dead,TUMOR FREE,nan,116.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,116.0,0.0,116.0,nan,nan,0.0,116.0,0
TCGA-43-6773-11,TCGA-43-6773,LUSC,76.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-28036.0,Dead,TUMOR FREE,nan,116.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,116.0,0.0,116.0,nan,nan,0.0,116.0,0
TCGA-43-7656-01,TCGA-43-7656,LUSC,71.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-25991.0,Alive,TUMOR FREE,596.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,596.0,0.0,596.0,0.0,596.0,0.0,596.0,0
TCGA-43-7657-01,TCGA-43-7657,LUSC,68.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-25042.0,Alive,TUMOR FREE,236.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,236.0,0.0,236.0,0.0,236.0,0.0,236.0,0
TCGA-43-7657-11,TCGA-43-7657,LUSC,68.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-25042.0,Alive,TUMOR FREE,236.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,236.0,0.0,236.0,0.0,236.0,0.0,236.0,0
TCGA-43-7658-01,TCGA-43-7658,LUSC,75.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-27734.0,Dead,WITH TUMOR,nan,2378.0,nan,Distant Metastasis|New Primary Tumor,nan,nan,2305.0,Complete Remission/Response,nan,nan,1.0,2378.0,1.0,2378.0,1.0,2305.0,1.0,2305.0,1
TCGA-43-7658-11,TCGA-43-7658,LUSC,75.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-27734.0,Dead,WITH TUMOR,nan,2378.0,nan,Distant Metastasis|New Primary Tumor,nan,nan,2305.0,Complete Remission/Response,nan,nan,1.0,2378.0,1.0,2378.0,1.0,2305.0,1.0,2305.0,1
TCGA-43-8115-01,TCGA-43-8115,LUSC,72.0,FEMALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-26406.0,Alive,TUMOR FREE,407.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,407.0,0.0,407.0,nan,nan,0.0,407.0,0
TCGA-43-8116-01,TCGA-43-8116,LUSC,73.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-26790.0,Alive,TUMOR FREE,358.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,358.0,0.0,358.0,0.0,358.0,0.0,358.0,0
TCGA-43-8118-01,TCGA-43-8118,LUSC,55.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-20224.0,Dead,nan,nan,89.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,89.0,nan,89.0,nan,nan,0.0,89.0,1
TCGA-43-A474-01,TCGA-43-A474,LUSC,66.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-24286.0,Alive,TUMOR FREE,353.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,353.0,0.0,353.0,0.0,353.0,0.0,353.0,0
TCGA-43-A475-01,TCGA-43-A475,LUSC,67.0,FEMALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-24680.0,Alive,TUMOR FREE,296.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,296.0,0.0,296.0,0.0,296.0,0.0,296.0,0
TCGA-43-A56U-01,TCGA-43-A56U,LUSC,76.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-27847.0,Alive,TUMOR FREE,432.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,432.0,0.0,432.0,0.0,432.0,0.0,432.0,0
TCGA-43-A56V-01,TCGA-43-A56V,LUSC,61.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-22475.0,Alive,WITH TUMOR,366.0,nan,nan,Locoregional Recurrence|Distant Metastasis,nan,nan,355.0,Complete Remission/Response,nan,nan,0.0,366.0,0.0,366.0,1.0,355.0,1.0,355.0,2
TCGA-46-3765-01,TCGA-46-3765,LUSC,59.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-21762.0,Alive,TUMOR FREE,405.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,405.0,0.0,405.0,0.0,405.0,0.0,405.0,0
TCGA-46-3766-01,TCGA-46-3766,LUSC,62.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-22707.0,Alive,TUMOR FREE,370.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,370.0,0.0,370.0,0.0,370.0,0.0,370.0,0
TCGA-46-3767-01,TCGA-46-3767,LUSC,76.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-27912.0,Alive,TUMOR FREE,396.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,396.0,0.0,396.0,0.0,396.0,0.0,396.0,0
TCGA-46-3768-01,TCGA-46-3768,LUSC,58.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-21307.0,Dead,TUMOR FREE,4.0,299.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,299.0,0.0,299.0,0.0,299.0,0.0,299.0,0
TCGA-46-3769-01,TCGA-46-3769,LUSC,57.0,MALE,WHITE,[Discrepancy],nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-20941.0,Alive,TUMOR FREE,135.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,135.0,0.0,135.0,0.0,135.0,0.0,135.0,0
TCGA-46-6025-01,TCGA-46-6025,LUSC,71.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-26168.0,Alive,TUMOR FREE,324.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,324.0,0.0,324.0,0.0,324.0,0.0,324.0,0
TCGA-46-6026-01,TCGA-46-6026,LUSC,81.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-29890.0,Alive,TUMOR FREE,423.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,423.0,0.0,423.0,0.0,423.0,0.0,423.0,0
TCGA-51-4079-01,TCGA-51-4079,LUSC,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-26899.0,Dead,nan,nan,12.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,12.0,nan,12.0,nan,nan,0.0,12.0,1
TCGA-51-4079-11,TCGA-51-4079,LUSC,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-26899.0,Dead,nan,nan,12.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,12.0,nan,12.0,nan,nan,0.0,12.0,1
TCGA-51-4080-01,TCGA-51-4080,LUSC,65.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-24054.0,Dead,TUMOR FREE,nan,12.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,12.0,0.0,12.0,nan,nan,0.0,12.0,0
TCGA-51-4080-11,TCGA-51-4080,LUSC,65.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-24054.0,Dead,TUMOR FREE,nan,12.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,12.0,0.0,12.0,nan,nan,0.0,12.0,0
TCGA-51-4081-01,TCGA-51-4081,LUSC,55.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-20261.0,Alive,TUMOR FREE,911.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,911.0,0.0,911.0,nan,nan,0.0,911.0,0
TCGA-51-4081-11,TCGA-51-4081,LUSC,55.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-20261.0,Alive,TUMOR FREE,911.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,911.0,0.0,911.0,nan,nan,0.0,911.0,0
TCGA-51-6867-01,TCGA-51-6867,LUSC,72.0,FEMALE,WHITE,Stage I,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-26523.0,Dead,WITH TUMOR,nan,1856.0,nan,nan,nan,nan,788.0,Complete Remission/Response,nan,nan,1.0,1856.0,1.0,1856.0,1.0,788.0,1.0,788.0,1
TCGA-52-7622-01,TCGA-52-7622,LUSC,62.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-22807.0,Alive,TUMOR FREE,862.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,862.0,0.0,862.0,0.0,862.0,0.0,862.0,0
TCGA-52-7809-01,TCGA-52-7809,LUSC,74.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-27233.0,Dead,WITH TUMOR,nan,166.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,166.0,1.0,166.0,nan,nan,1.0,166.0,1
TCGA-52-7810-01,TCGA-52-7810,LUSC,60.0,FEMALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-22241.0,Alive,TUMOR FREE,923.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,923.0,0.0,923.0,0.0,923.0,0.0,923.0,0
TCGA-52-7811-01,TCGA-52-7811,LUSC,67.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-24782.0,Dead,WITH TUMOR,nan,266.0,nan,Distant Metastasis,nan,nan,153.0,Progressive Disease,nan,nan,1.0,266.0,1.0,266.0,nan,nan,1.0,153.0,1
TCGA-52-7812-01,TCGA-52-7812,LUSC,68.0,MALE,WHITE,[Discrepancy],nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-24887.0,Dead,WITH TUMOR,nan,835.0,nan,Distant Metastasis,nan,nan,791.0,Progressive Disease,nan,nan,1.0,835.0,1.0,835.0,nan,nan,1.0,791.0,1
TCGA-56-1622-01,TCGA-56-1622,LUSC,58.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-21371.0,Dead,WITH TUMOR,nan,881.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,881.0,1.0,881.0,nan,nan,1.0,881.0,1
TCGA-56-5897-01,TCGA-56-5897,LUSC,74.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-27118.0,Alive,TUMOR FREE,378.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,378.0,0.0,378.0,0.0,378.0,0.0,378.0,0
TCGA-56-5898-01,TCGA-56-5898,LUSC,69.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-25441.0,Alive,TUMOR FREE,555.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,555.0,0.0,555.0,0.0,555.0,0.0,555.0,0
TCGA-56-6545-01,TCGA-56-6545,LUSC,77.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-28400.0,Alive,TUMOR FREE,666.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,666.0,0.0,666.0,0.0,666.0,0.0,666.0,0
TCGA-56-6546-01,TCGA-56-6546,LUSC,67.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-24594.0,Alive,TUMOR FREE,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,nan,0.0,nan,nan,nan,0.0,nan,0
TCGA-56-7221-01,TCGA-56-7221,LUSC,79.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-28873.0,Alive,TUMOR FREE,608.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,608.0,0.0,608.0,0.0,608.0,0.0,608.0,0
TCGA-56-7222-01,TCGA-56-7222,LUSC,60.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-22097.0,Dead,WITH TUMOR,nan,562.0,nan,nan,nan,nan,427.0,Complete Remission/Response,nan,nan,1.0,562.0,1.0,562.0,1.0,427.0,1.0,427.0,1
TCGA-56-7222-11,TCGA-56-7222,LUSC,60.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-22097.0,Dead,WITH TUMOR,nan,562.0,nan,nan,nan,nan,427.0,Complete Remission/Response,nan,nan,1.0,562.0,1.0,562.0,1.0,427.0,1.0,427.0,1
TCGA-56-7223-01,TCGA-56-7223,LUSC,66.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-24288.0,Dead,WITH TUMOR,nan,442.0,nan,Locoregional Recurrence,nan,nan,132.0,Progressive Disease,nan,nan,1.0,442.0,1.0,442.0,nan,nan,1.0,132.0,1
TCGA-56-7579-01,TCGA-56-7579,LUSC,61.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-22632.0,Dead,WITH TUMOR,nan,951.0,nan,Locoregional Recurrence,nan,nan,149.0,Progressive Disease,nan,nan,1.0,951.0,1.0,951.0,nan,nan,1.0,149.0,1
TCGA-56-7579-11,TCGA-56-7579,LUSC,61.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-22632.0,Dead,WITH TUMOR,nan,951.0,nan,Locoregional Recurrence,nan,nan,149.0,Progressive Disease,nan,nan,1.0,951.0,1.0,951.0,nan,nan,1.0,149.0,1
TCGA-56-7580-01,TCGA-56-7580,LUSC,84.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-30740.0,Alive,TUMOR FREE,925.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,925.0,0.0,925.0,0.0,925.0,0.0,925.0,0
TCGA-56-7580-11,TCGA-56-7580,LUSC,84.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-30740.0,Alive,TUMOR FREE,925.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,925.0,0.0,925.0,0.0,925.0,0.0,925.0,0
TCGA-56-7582-01,TCGA-56-7582,LUSC,83.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-30678.0,Alive,TUMOR FREE,601.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,601.0,0.0,601.0,0.0,601.0,0.0,601.0,0
TCGA-56-7582-11,TCGA-56-7582,LUSC,83.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-30678.0,Alive,TUMOR FREE,601.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,601.0,0.0,601.0,0.0,601.0,0.0,601.0,0
TCGA-56-7730-01,TCGA-56-7730,LUSC,73.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-26699.0,Dead,WITH TUMOR,nan,198.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,198.0,1.0,198.0,nan,nan,1.0,198.0,1
TCGA-56-7730-11,TCGA-56-7730,LUSC,73.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-26699.0,Dead,WITH TUMOR,nan,198.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,198.0,1.0,198.0,nan,nan,1.0,198.0,1
TCGA-56-7731-01,TCGA-56-7731,LUSC,66.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-24441.0,Dead,TUMOR FREE,nan,3.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,3.0,0.0,3.0,nan,nan,0.0,3.0,0
TCGA-56-7731-11,TCGA-56-7731,LUSC,66.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-24441.0,Dead,TUMOR FREE,nan,3.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,3.0,0.0,3.0,nan,nan,0.0,3.0,0
TCGA-56-7822-01,TCGA-56-7822,LUSC,75.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-27755.0,Dead,WITH TUMOR,nan,532.0,nan,nan,nan,nan,301.0,[Unknown],nan,nan,1.0,532.0,1.0,532.0,nan,nan,1.0,301.0,1
TCGA-56-7823-01,TCGA-56-7823,LUSC,58.0,FEMALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-21344.0,Alive,TUMOR FREE,1011.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1011.0,0.0,1011.0,0.0,1011.0,0.0,1011.0,0
TCGA-56-7823-11,TCGA-56-7823,LUSC,58.0,FEMALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-21344.0,Alive,TUMOR FREE,1011.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1011.0,0.0,1011.0,0.0,1011.0,0.0,1011.0,0
TCGA-56-8082-01,TCGA-56-8082,LUSC,80.0,FEMALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-29440.0,Alive,TUMOR FREE,455.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,455.0,0.0,455.0,0.0,455.0,0.0,455.0,0
TCGA-56-8082-11,TCGA-56-8082,LUSC,80.0,FEMALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-29440.0,Alive,TUMOR FREE,455.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,455.0,0.0,455.0,0.0,455.0,0.0,455.0,0
TCGA-56-8083-01,TCGA-56-8083,LUSC,56.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-20696.0,Alive,TUMOR FREE,150.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,150.0,0.0,150.0,nan,nan,0.0,150.0,0
TCGA-56-8083-11,TCGA-56-8083,LUSC,56.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-20696.0,Alive,TUMOR FREE,150.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,150.0,0.0,150.0,nan,nan,0.0,150.0,0
TCGA-56-8201-01,TCGA-56-8201,LUSC,74.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-27211.0,Dead,WITH TUMOR,nan,397.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,397.0,1.0,397.0,nan,nan,1.0,397.0,1
TCGA-56-8201-11,TCGA-56-8201,LUSC,74.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-27211.0,Dead,WITH TUMOR,nan,397.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,397.0,1.0,397.0,nan,nan,1.0,397.0,1
TCGA-56-8304-01,TCGA-56-8304,LUSC,73.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-26803.0,Alive,TUMOR FREE,106.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,106.0,0.0,106.0,0.0,106.0,0.0,106.0,0
TCGA-56-8305-01,TCGA-56-8305,LUSC,72.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-26428.0,Alive,TUMOR FREE,105.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,105.0,0.0,105.0,0.0,105.0,0.0,105.0,0
TCGA-56-8307-01,TCGA-56-8307,LUSC,55.0,FEMALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-20411.0,Alive,TUMOR FREE,818.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,818.0,0.0,818.0,0.0,818.0,0.0,818.0,0
TCGA-56-8308-01,TCGA-56-8308,LUSC,79.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-29139.0,Alive,WITH TUMOR,517.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,517.0,0.0,517.0,nan,nan,0.0,517.0,0
TCGA-56-8309-01,TCGA-56-8309,LUSC,66.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-24382.0,Alive,TUMOR FREE,428.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,428.0,0.0,428.0,0.0,428.0,0.0,428.0,0
TCGA-56-8309-11,TCGA-56-8309,LUSC,66.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-24382.0,Alive,TUMOR FREE,428.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,428.0,0.0,428.0,0.0,428.0,0.0,428.0,0
TCGA-56-8503-01,TCGA-56-8503,LUSC,76.0,FEMALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-28095.0,Alive,TUMOR FREE,41.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,41.0,0.0,41.0,nan,nan,0.0,41.0,0
TCGA-56-8504-01,TCGA-56-8504,LUSC,74.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-27210.0,Alive,TUMOR FREE,510.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,510.0,0.0,510.0,0.0,510.0,0.0,510.0,0
TCGA-56-8504-11,TCGA-56-8504,LUSC,74.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-27210.0,Alive,TUMOR FREE,510.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,510.0,0.0,510.0,0.0,510.0,0.0,510.0,0
TCGA-56-8622-01,TCGA-56-8622,LUSC,68.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-24861.0,Alive,TUMOR FREE,55.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,55.0,0.0,55.0,nan,nan,0.0,55.0,0
TCGA-56-8623-01,TCGA-56-8623,LUSC,71.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-26231.0,Dead,TUMOR FREE,nan,692.0,nan,New Primary Tumor,nan,nan,645.0,Complete Remission/Response,nan,nan,1.0,692.0,0.0,692.0,0.0,692.0,1.0,645.0,0
TCGA-56-8623-11,TCGA-56-8623,LUSC,71.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-26231.0,Dead,TUMOR FREE,nan,692.0,nan,New Primary Tumor,nan,nan,645.0,Complete Remission/Response,nan,nan,1.0,692.0,0.0,692.0,0.0,692.0,1.0,645.0,0
TCGA-56-8624-01,TCGA-56-8624,LUSC,84.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-30798.0,Alive,TUMOR FREE,420.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,420.0,0.0,420.0,0.0,420.0,0.0,420.0,0
TCGA-56-8624-11,TCGA-56-8624,LUSC,84.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-30798.0,Alive,TUMOR FREE,420.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,420.0,0.0,420.0,0.0,420.0,0.0,420.0,0
TCGA-56-8625-01,TCGA-56-8625,LUSC,66.0,FEMALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-24188.0,Dead,WITH TUMOR,nan,315.0,nan,Distant Metastasis,nan,nan,272.0,Progressive Disease,nan,nan,1.0,315.0,1.0,315.0,nan,nan,1.0,272.0,1
TCGA-56-8626-01,TCGA-56-8626,LUSC,59.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-21908.0,Dead,TUMOR FREE,nan,302.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,302.0,0.0,302.0,0.0,302.0,0.0,302.0,0
TCGA-56-8628-01,TCGA-56-8628,LUSC,78.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-28805.0,Alive,TUMOR FREE,616.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,616.0,0.0,616.0,0.0,616.0,0.0,616.0,0
TCGA-56-8629-01,TCGA-56-8629,LUSC,63.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-23346.0,Alive,TUMOR FREE,481.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,481.0,0.0,481.0,0.0,481.0,0.0,481.0,0
TCGA-56-8629-11,TCGA-56-8629,LUSC,63.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-23346.0,Alive,TUMOR FREE,481.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,481.0,0.0,481.0,0.0,481.0,0.0,481.0,0
TCGA-56-A49D-01,TCGA-56-A49D,LUSC,67.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-24745.0,Alive,TUMOR FREE,637.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,637.0,0.0,637.0,0.0,637.0,0.0,637.0,0
TCGA-56-A4BW-01,TCGA-56-A4BW,LUSC,55.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-20301.0,Alive,TUMOR FREE,585.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,585.0,0.0,585.0,0.0,585.0,0.0,585.0,0
TCGA-56-A4BX-01,TCGA-56-A4BX,LUSC,70.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-25745.0,Alive,TUMOR FREE,405.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,405.0,0.0,405.0,0.0,405.0,0.0,405.0,0
TCGA-56-A4BY-01,TCGA-56-A4BY,LUSC,66.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-24445.0,Dead,WITH TUMOR,nan,543.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,543.0,1.0,543.0,nan,nan,1.0,543.0,1
TCGA-56-A4ZJ-01,TCGA-56-A4ZJ,LUSC,75.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-27516.0,Alive,TUMOR FREE,640.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,640.0,0.0,640.0,0.0,640.0,0.0,640.0,0
TCGA-56-A4ZK-01,TCGA-56-A4ZK,LUSC,76.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-28039.0,Alive,TUMOR FREE,570.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,570.0,0.0,570.0,0.0,570.0,0.0,570.0,0
TCGA-56-A5DR-01,TCGA-56-A5DR,LUSC,81.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-29828.0,Alive,TUMOR FREE,4.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4.0,0.0,4.0,0.0,4.0,0.0,4.0,0
TCGA-56-A5DS-01,TCGA-56-A5DS,LUSC,72.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-26355.0,Alive,TUMOR FREE,8.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,8.0,0.0,8.0,0.0,8.0,0.0,8.0,0
TCGA-56-A62T-01,TCGA-56-A62T,LUSC,78.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2013.0,nan,-28522.0,Alive,TUMOR FREE,440.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,440.0,0.0,440.0,0.0,440.0,0.0,440.0,0
TCGA-58-8386-01,TCGA-58-8386,LUSC,75.0,MALE,[Not Evaluated],Stage IV,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-27455.0,Dead,TUMOR FREE,nan,1.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1.0,0.0,1.0,nan,nan,0.0,1.0,0
TCGA-58-8386-11,TCGA-58-8386,LUSC,75.0,MALE,[Not Evaluated],Stage IV,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-27455.0,Dead,TUMOR FREE,nan,1.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1.0,0.0,1.0,nan,nan,0.0,1.0,0
TCGA-58-8387-01,TCGA-58-8387,LUSC,60.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-21952.0,Dead,TUMOR FREE,nan,403.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,403.0,0.0,403.0,0.0,403.0,0.0,403.0,0
TCGA-58-8388-01,TCGA-58-8388,LUSC,60.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-21949.0,Dead,TUMOR FREE,nan,412.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,412.0,0.0,412.0,0.0,412.0,0.0,412.0,0
TCGA-58-8390-01,TCGA-58-8390,LUSC,70.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-25827.0,Alive,TUMOR FREE,911.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,911.0,0.0,911.0,0.0,911.0,0.0,911.0,0
TCGA-58-8391-01,TCGA-58-8391,LUSC,57.0,FEMALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-21102.0,Alive,WITH TUMOR,2167.0,nan,nan,Distant Metastasis|New Primary Tumor,nan,nan,2033.0,Complete Remission/Response,nan,nan,0.0,2167.0,0.0,2167.0,1.0,2033.0,1.0,2033.0,2
TCGA-58-8392-01,TCGA-58-8392,LUSC,70.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-25710.0,Dead,WITH TUMOR,nan,501.0,nan,Distant Metastasis,nan,nan,96.0,Complete Remission/Response,nan,nan,1.0,501.0,1.0,501.0,1.0,96.0,1.0,96.0,1
TCGA-58-8393-01,TCGA-58-8393,LUSC,68.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-25132.0,Alive,TUMOR FREE,1058.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1058.0,0.0,1058.0,0.0,1058.0,0.0,1058.0,0
TCGA-58-8393-11,TCGA-58-8393,LUSC,68.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-25132.0,Alive,TUMOR FREE,1058.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1058.0,0.0,1058.0,0.0,1058.0,0.0,1058.0,0
TCGA-58-A46J-01,TCGA-58-A46J,LUSC,64.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-23653.0,Alive,TUMOR FREE,2589.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2589.0,0.0,2589.0,0.0,2589.0,0.0,2589.0,0
TCGA-58-A46K-01,TCGA-58-A46K,LUSC,59.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-21867.0,Dead,WITH TUMOR,nan,1045.0,nan,Locoregional Recurrence|Distant Metastasis,nan,nan,735.0,Complete Remission/Response,nan,nan,1.0,1045.0,1.0,1045.0,1.0,735.0,1.0,735.0,1
TCGA-58-A46L-01,TCGA-58-A46L,LUSC,73.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-26685.0,Alive,TUMOR FREE,1723.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1723.0,0.0,1723.0,0.0,1723.0,0.0,1723.0,0
TCGA-58-A46M-01,TCGA-58-A46M,LUSC,61.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-22592.0,Alive,TUMOR FREE,1072.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1072.0,0.0,1072.0,0.0,1072.0,0.0,1072.0,0
TCGA-58-A46N-01,TCGA-58-A46N,LUSC,52.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-19050.0,Alive,WITH TUMOR,910.0,nan,nan,Locoregional Recurrence,nan,nan,630.0,Complete Remission/Response,nan,nan,0.0,910.0,0.0,910.0,1.0,630.0,1.0,630.0,2
TCGA-60-2695-01,TCGA-60-2695,LUSC,74.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-27211.0,Alive,TUMOR FREE,642.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,642.0,0.0,642.0,0.0,642.0,0.0,642.0,0
TCGA-60-2696-01,TCGA-60-2696,LUSC,76.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-27991.0,Dead,nan,109.0,109.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,109.0,nan,109.0,nan,nan,0.0,109.0,1
TCGA-60-2697-01,TCGA-60-2697,LUSC,41.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,1992.0,nan,-14984.0,Dead,WITH TUMOR,nan,372.0,nan,nan,nan,nan,200.0,Complete Remission/Response,nan,nan,1.0,372.0,1.0,372.0,1.0,200.0,1.0,200.0,1
TCGA-60-2698-01,TCGA-60-2698,LUSC,62.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,1993.0,nan,-22800.0,Dead,WITH TUMOR,nan,311.0,nan,nan,nan,nan,114.0,nan,nan,nan,1.0,311.0,1.0,311.0,nan,nan,1.0,114.0,1
TCGA-60-2703-01,TCGA-60-2703,LUSC,73.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-27003.0,Dead,nan,nan,2945.0,nan,nan,nan,nan,1757.0,Complete Remission/Response,nan,nan,1.0,2945.0,nan,2945.0,1.0,1757.0,1.0,1757.0,1
TCGA-60-2704-01,TCGA-60-2704,LUSC,73.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-26927.0,Dead,WITH TUMOR,nan,1154.0,nan,nan,nan,nan,532.0,nan,nan,nan,1.0,1154.0,1.0,1154.0,nan,nan,1.0,532.0,1
TCGA-60-2706-01,TCGA-60-2706,LUSC,58.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-21477.0,Alive,TUMOR FREE,2820.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2820.0,0.0,2820.0,0.0,2820.0,0.0,2820.0,0
TCGA-60-2707-01,TCGA-60-2707,LUSC,70.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-25758.0,Dead,WITH TUMOR,nan,667.0,nan,nan,nan,nan,579.0,Complete Remission/Response,nan,nan,1.0,667.0,1.0,667.0,1.0,579.0,1.0,579.0,1
TCGA-60-2708-01,TCGA-60-2708,LUSC,64.0,FEMALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-23691.0,Alive,TUMOR FREE,2447.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2447.0,0.0,2447.0,0.0,2447.0,0.0,2447.0,0
TCGA-60-2709-01,TCGA-60-2709,LUSC,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-25453.0,Alive,TUMOR FREE,1505.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1505.0,0.0,1505.0,0.0,1505.0,0.0,1505.0,0
TCGA-60-2709-11,TCGA-60-2709,LUSC,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-25453.0,Alive,TUMOR FREE,1505.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1505.0,0.0,1505.0,0.0,1505.0,0.0,1505.0,0
TCGA-60-2710-01,TCGA-60-2710,LUSC,67.0,FEMALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-24669.0,Alive,TUMOR FREE,2024.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2024.0,0.0,2024.0,0.0,2024.0,0.0,2024.0,0
TCGA-60-2711-01,TCGA-60-2711,LUSC,64.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-23651.0,Alive,TUMOR FREE,1260.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1260.0,0.0,1260.0,0.0,1260.0,0.0,1260.0,0
TCGA-60-2712-01,TCGA-60-2712,LUSC,79.0,FEMALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-29131.0,Dead,nan,274.0,274.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,274.0,nan,274.0,0.0,274.0,0.0,274.0,1
TCGA-60-2713-01,TCGA-60-2713,LUSC,64.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-23630.0,Alive,nan,1731.0,nan,nan,nan,nan,nan,1356.0,Complete Remission/Response,nan,nan,0.0,1731.0,0.0,1731.0,1.0,1356.0,1.0,1356.0,2
TCGA-60-2714-01,TCGA-60-2714,LUSC,66.0,FEMALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-24169.0,Alive,TUMOR FREE,1531.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1531.0,0.0,1531.0,0.0,1531.0,0.0,1531.0,0
TCGA-60-2715-01,TCGA-60-2715,LUSC,51.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-18990.0,Dead,WITH TUMOR,nan,1075.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,1075.0,1.0,1075.0,nan,nan,1.0,1075.0,1
TCGA-60-2716-01,TCGA-60-2716,LUSC,39.0,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-14345.0,Alive,TUMOR FREE,1475.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1475.0,0.0,1475.0,0.0,1475.0,0.0,1475.0,0
TCGA-60-2719-01,TCGA-60-2719,LUSC,83.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-30379.0,Alive,TUMOR FREE,1297.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1297.0,0.0,1297.0,0.0,1297.0,0.0,1297.0,0
TCGA-60-2720-01,TCGA-60-2720,LUSC,60.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-22238.0,Alive,TUMOR FREE,97.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,97.0,0.0,97.0,nan,nan,0.0,97.0,0
TCGA-60-2721-01,TCGA-60-2721,LUSC,73.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-27007.0,Alive,TUMOR FREE,983.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,983.0,0.0,983.0,0.0,983.0,0.0,983.0,0
TCGA-60-2722-01,TCGA-60-2722,LUSC,66.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-24267.0,Alive,TUMOR FREE,908.0,nan,nan,nan,nan,nan,851.0,Complete Remission/Response,nan,nan,0.0,908.0,0.0,908.0,1.0,851.0,1.0,851.0,0
TCGA-60-2723-01,TCGA-60-2723,LUSC,74.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-27225.0,Alive,TUMOR FREE,1092.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1092.0,0.0,1092.0,0.0,1092.0,0.0,1092.0,0
TCGA-60-2724-01,TCGA-60-2724,LUSC,47.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-17462.0,Alive,TUMOR FREE,717.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,717.0,0.0,717.0,nan,nan,0.0,717.0,0
TCGA-60-2725-01,TCGA-60-2725,LUSC,74.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-27073.0,Alive,TUMOR FREE,816.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,816.0,0.0,816.0,0.0,816.0,0.0,816.0,0
TCGA-60-2726-01,TCGA-60-2726,LUSC,56.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-20618.0,Dead,TUMOR FREE,358.0,358.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,358.0,0.0,358.0,0.0,358.0,0.0,358.0,0
TCGA-63-5128-01,TCGA-63-5128,LUSC,nan,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,nan,Dead,WITH TUMOR,nan,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,nan,1.0,nan,nan,nan,1.0,nan,1
TCGA-63-5131-01,TCGA-63-5131,LUSC,nan,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,nan,Dead,TUMOR FREE,nan,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,nan,0.0,nan,0.0,nan,0.0,nan,1
TCGA-63-6202-01,TCGA-63-6202,LUSC,nan,MALE,nan,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,nan,Alive,TUMOR FREE,1602.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1602.0,0.0,1602.0,0.0,1602.0,0.0,1602.0,0
TCGA-63-7020-01,TCGA-63-7020,LUSC,nan,MALE,nan,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,nan,Alive,TUMOR FREE,2133.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2133.0,0.0,2133.0,0.0,2133.0,0.0,2133.0,0
TCGA-63-7021-01,TCGA-63-7021,LUSC,nan,MALE,nan,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,nan,Alive,TUMOR FREE,2142.0,nan,nan,New Primary Tumor,nan,nan,1503.0,Complete Remission/Response,nan,nan,0.0,2142.0,0.0,2142.0,0.0,2142.0,1.0,1503.0,0
TCGA-63-7022-01,TCGA-63-7022,LUSC,nan,FEMALE,nan,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,nan,Alive,TUMOR FREE,2073.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2073.0,0.0,2073.0,0.0,2073.0,0.0,2073.0,0
TCGA-63-7023-01,TCGA-63-7023,LUSC,nan,MALE,nan,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,nan,Alive,TUMOR FREE,1682.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1682.0,0.0,1682.0,0.0,1682.0,0.0,1682.0,0
TCGA-63-A5M9-01,TCGA-63-A5M9,LUSC,nan,FEMALE,[Not Evaluated],Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,nan,nan,nan,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-63-A5MB-01,TCGA-63-A5MB,LUSC,62.0,MALE,[Not Evaluated],Stage IB,nan,Lung Squamous Cell Carcinoma,nan,nan,nan,-22930.0,Alive,TUMOR FREE,3123.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3123.0,0.0,3123.0,0.0,3123.0,0.0,3123.0,0
TCGA-63-A5MG-01,TCGA-63-A5MG,LUSC,68.0,MALE,[Not Evaluated],Stage IB,nan,Lung Squamous Cell Carcinoma,nan,nan,nan,-24957.0,Alive,TUMOR FREE,2148.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2148.0,0.0,2148.0,0.0,2148.0,0.0,2148.0,0
TCGA-63-A5MH-01,TCGA-63-A5MH,LUSC,68.0,MALE,[Not Evaluated],Stage IA,nan,Lung Squamous Cell Carcinoma,nan,nan,nan,-25159.0,Alive,TUMOR FREE,2026.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2026.0,0.0,2026.0,0.0,2026.0,0.0,2026.0,0
TCGA-63-A5MI-01,TCGA-63-A5MI,LUSC,65.0,MALE,[Not Evaluated],Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,nan,nan,-24040.0,Alive,TUMOR FREE,1784.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1784.0,0.0,1784.0,0.0,1784.0,0.0,1784.0,0
TCGA-63-A5MJ-01,TCGA-63-A5MJ,LUSC,54.0,MALE,[Not Evaluated],Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,nan,nan,-20018.0,Alive,TUMOR FREE,1824.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1824.0,0.0,1824.0,0.0,1824.0,0.0,1824.0,0
TCGA-63-A5ML-01,TCGA-63-A5ML,LUSC,68.0,MALE,[Not Evaluated],Stage IB,nan,Lung Squamous Cell Carcinoma,nan,nan,nan,-24947.0,Alive,TUMOR FREE,1386.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1386.0,0.0,1386.0,0.0,1386.0,0.0,1386.0,0
TCGA-63-A5MM-01,TCGA-63-A5MM,LUSC,69.0,FEMALE,[Not Evaluated],Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,nan,nan,-25348.0,Dead,WITH TUMOR,nan,456.0,nan,nan,nan,nan,218.0,Complete Remission/Response,nan,nan,1.0,456.0,1.0,456.0,1.0,218.0,1.0,218.0,1
TCGA-63-A5MN-01,TCGA-63-A5MN,LUSC,78.0,FEMALE,[Not Evaluated],Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,nan,nan,-28677.0,Dead,WITH TUMOR,nan,345.0,nan,nan,nan,nan,320.0,Complete Remission/Response,nan,nan,1.0,345.0,1.0,345.0,1.0,320.0,1.0,320.0,1
TCGA-63-A5MP-01,TCGA-63-A5MP,LUSC,56.0,MALE,[Not Evaluated],Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,nan,nan,-20818.0,Alive,WITH TUMOR,769.0,nan,nan,Locoregional Recurrence,nan,nan,511.0,Complete Remission/Response,nan,nan,0.0,769.0,0.0,769.0,1.0,511.0,1.0,511.0,2
TCGA-63-A5MR-01,TCGA-63-A5MR,LUSC,70.0,FEMALE,[Not Evaluated],Stage IB,nan,Lung Squamous Cell Carcinoma,nan,nan,nan,-25879.0,Alive,TUMOR FREE,2716.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2716.0,0.0,2716.0,0.0,2716.0,0.0,2716.0,0
TCGA-63-A5MS-01,TCGA-63-A5MS,LUSC,78.0,MALE,[Not Evaluated],Stage IB,nan,Lung Squamous Cell Carcinoma,nan,nan,nan,-28827.0,Alive,TUMOR FREE,2381.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2381.0,0.0,2381.0,0.0,2381.0,0.0,2381.0,0
TCGA-63-A5MT-01,TCGA-63-A5MT,LUSC,74.0,MALE,[Not Evaluated],Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,nan,nan,-27263.0,Alive,WITH TUMOR,498.0,nan,nan,Distant Metastasis,nan,nan,427.0,Complete Remission/Response,nan,nan,0.0,498.0,0.0,498.0,1.0,427.0,1.0,427.0,2
TCGA-63-A5MU-01,TCGA-63-A5MU,LUSC,48.0,MALE,[Not Evaluated],Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,nan,nan,-17801.0,Dead,WITH TUMOR,nan,nan,nan,Distant Metastasis,nan,nan,420.0,Complete Remission/Response,nan,nan,1.0,nan,1.0,nan,1.0,420.0,1.0,420.0,1
TCGA-63-A5MV-01,TCGA-63-A5MV,LUSC,69.0,MALE,[Not Evaluated],Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,nan,nan,-25505.0,Alive,TUMOR FREE,1100.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1100.0,0.0,1100.0,0.0,1100.0,0.0,1100.0,0
TCGA-63-A5MW-01,TCGA-63-A5MW,LUSC,76.0,MALE,[Not Evaluated],Stage IB,nan,Lung Squamous Cell Carcinoma,nan,nan,nan,-27892.0,Alive,TUMOR FREE,1639.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1639.0,0.0,1639.0,0.0,1639.0,0.0,1639.0,0
TCGA-63-A5MY-01,TCGA-63-A5MY,LUSC,63.0,MALE,[Not Evaluated],Stage IA,nan,Lung Squamous Cell Carcinoma,nan,nan,nan,-23276.0,Alive,TUMOR FREE,1052.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1052.0,0.0,1052.0,0.0,1052.0,0.0,1052.0,0
TCGA-66-2727-01,TCGA-66-2727,LUSC,55.0,FEMALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-20150.0,Dead,nan,nan,516.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,516.0,nan,516.0,nan,nan,0.0,516.0,1
TCGA-66-2727-11,TCGA-66-2727,LUSC,55.0,FEMALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-20150.0,Dead,nan,nan,516.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,516.0,nan,516.0,nan,nan,0.0,516.0,1
TCGA-66-2734-01,TCGA-66-2734,LUSC,62.0,FEMALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-22919.0,Alive,TUMOR FREE,1311.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1311.0,0.0,1311.0,nan,nan,0.0,1311.0,0
TCGA-66-2734-11,TCGA-66-2734,LUSC,62.0,FEMALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-22919.0,Alive,TUMOR FREE,1311.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1311.0,0.0,1311.0,nan,nan,0.0,1311.0,0
TCGA-66-2737-01,TCGA-66-2737,LUSC,72.0,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-26390.0,Alive,TUMOR FREE,61.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,61.0,0.0,61.0,nan,nan,0.0,61.0,0
TCGA-66-2737-11,TCGA-66-2737,LUSC,72.0,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-26390.0,Alive,TUMOR FREE,61.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,61.0,0.0,61.0,nan,nan,0.0,61.0,0
TCGA-66-2742-01,TCGA-66-2742,LUSC,70.0,MALE,nan,Stage IV,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-25688.0,Alive,TUMOR FREE,641.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,641.0,0.0,641.0,nan,nan,0.0,641.0,0
TCGA-66-2742-11,TCGA-66-2742,LUSC,70.0,MALE,nan,Stage IV,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-25688.0,Alive,TUMOR FREE,641.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,641.0,0.0,641.0,nan,nan,0.0,641.0,0
TCGA-66-2744-01,TCGA-66-2744,LUSC,71.0,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-26084.0,Alive,TUMOR FREE,30.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,30.0,0.0,30.0,nan,nan,0.0,30.0,0
TCGA-66-2744-11,TCGA-66-2744,LUSC,71.0,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-26084.0,Alive,TUMOR FREE,30.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,30.0,0.0,30.0,nan,nan,0.0,30.0,0
TCGA-66-2753-01,TCGA-66-2753,LUSC,69.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-25506.0,Alive,TUMOR FREE,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-66-2753-11,TCGA-66-2753,LUSC,69.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-25506.0,Alive,TUMOR FREE,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-66-2754-01,TCGA-66-2754,LUSC,67.0,MALE,nan,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-24471.0,Alive,TUMOR FREE,61.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,61.0,0.0,61.0,nan,nan,0.0,61.0,0
TCGA-66-2754-11,TCGA-66-2754,LUSC,67.0,MALE,nan,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-24471.0,Alive,TUMOR FREE,61.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,61.0,0.0,61.0,nan,nan,0.0,61.0,0
TCGA-66-2755-01,TCGA-66-2755,LUSC,63.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-23348.0,Alive,TUMOR FREE,28.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,28.0,0.0,28.0,nan,nan,0.0,28.0,0
TCGA-66-2756-01,TCGA-66-2756,LUSC,68.0,MALE,nan,Stage IIIB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-24929.0,Alive,TUMOR FREE,30.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,30.0,0.0,30.0,nan,nan,0.0,30.0,0
TCGA-66-2757-01,TCGA-66-2757,LUSC,65.0,FEMALE,nan,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-24014.0,Dead,WITH TUMOR,nan,1338.0,nan,nan,nan,nan,912.0,nan,nan,nan,1.0,1338.0,1.0,1338.0,nan,nan,1.0,912.0,1
TCGA-66-2758-01,TCGA-66-2758,LUSC,71.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-26209.0,Alive,TUMOR FREE,639.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,639.0,0.0,639.0,0.0,639.0,0.0,639.0,0
TCGA-66-2759-01,TCGA-66-2759,LUSC,66.0,MALE,nan,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-24287.0,Alive,TUMOR FREE,762.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,762.0,0.0,762.0,0.0,762.0,0.0,762.0,0
TCGA-66-2763-01,TCGA-66-2763,LUSC,63.0,FEMALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-23315.0,Alive,TUMOR FREE,30.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,30.0,0.0,30.0,nan,nan,0.0,30.0,0
TCGA-66-2765-01,TCGA-66-2765,LUSC,64.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-23465.0,Alive,TUMOR FREE,61.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,61.0,0.0,61.0,nan,nan,0.0,61.0,0
TCGA-66-2766-01,TCGA-66-2766,LUSC,54.0,MALE,nan,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-19814.0,Alive,TUMOR FREE,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-66-2767-01,TCGA-66-2767,LUSC,62.0,MALE,nan,Stage IIIB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-22888.0,Alive,TUMOR FREE,61.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,61.0,0.0,61.0,nan,nan,0.0,61.0,0
TCGA-66-2768-01,TCGA-66-2768,LUSC,57.0,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-20970.0,Alive,TUMOR FREE,61.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,61.0,0.0,61.0,nan,nan,0.0,61.0,0
TCGA-66-2769-01,TCGA-66-2769,LUSC,75.0,MALE,nan,Stage IIIB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-27515.0,Dead,nan,nan,215.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,215.0,nan,215.0,nan,nan,0.0,215.0,1
TCGA-66-2770-01,TCGA-66-2770,LUSC,79.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-28945.0,Alive,nan,700.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,700.0,0.0,700.0,nan,nan,0.0,700.0,0
TCGA-66-2771-01,TCGA-66-2771,LUSC,60.0,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-22219.0,Alive,TUMOR FREE,578.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,578.0,0.0,578.0,0.0,578.0,0.0,578.0,0
TCGA-66-2771-11,TCGA-66-2771,LUSC,60.0,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-22219.0,Alive,TUMOR FREE,578.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,578.0,0.0,578.0,0.0,578.0,0.0,578.0,0
TCGA-66-2773-01,TCGA-66-2773,LUSC,69.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-25355.0,Dead,TUMOR FREE,nan,92.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,92.0,0.0,92.0,nan,nan,0.0,92.0,0
TCGA-66-2777-01,TCGA-66-2777,LUSC,71.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-26085.0,Alive,TUMOR FREE,61.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,61.0,0.0,61.0,nan,nan,0.0,61.0,0
TCGA-66-2778-01,TCGA-66-2778,LUSC,68.0,FEMALE,nan,Stage IIIB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-25080.0,Alive,TUMOR FREE,578.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,578.0,0.0,578.0,0.0,578.0,0.0,578.0,0
TCGA-66-2780-01,TCGA-66-2780,LUSC,65.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-23955.0,Dead,nan,nan,366.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,366.0,nan,366.0,nan,nan,0.0,366.0,1
TCGA-66-2781-01,TCGA-66-2781,LUSC,67.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-24471.0,Alive,TUMOR FREE,121.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,121.0,0.0,121.0,nan,nan,0.0,121.0,0
TCGA-66-2782-01,TCGA-66-2782,LUSC,71.0,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-26237.0,Dead,WITH TUMOR,nan,365.0,nan,nan,nan,nan,304.0,Progressive Disease,nan,nan,1.0,365.0,1.0,365.0,nan,nan,1.0,304.0,1
TCGA-66-2783-01,TCGA-66-2783,LUSC,67.0,MALE,nan,Stage IIIB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-24686.0,Alive,TUMOR FREE,759.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,759.0,0.0,759.0,0.0,759.0,0.0,759.0,0
TCGA-66-2785-01,TCGA-66-2785,LUSC,65.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-23772.0,Alive,TUMOR FREE,60.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,60.0,0.0,60.0,nan,nan,0.0,60.0,0
TCGA-66-2786-01,TCGA-66-2786,LUSC,68.0,FEMALE,nan,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-25051.0,Alive,TUMOR FREE,790.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,790.0,0.0,790.0,nan,nan,0.0,790.0,0
TCGA-66-2787-01,TCGA-66-2787,LUSC,57.0,MALE,nan,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-21124.0,Alive,TUMOR FREE,1217.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1217.0,0.0,1217.0,nan,nan,0.0,1217.0,0
TCGA-66-2787-11,TCGA-66-2787,LUSC,57.0,MALE,nan,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-21124.0,Alive,TUMOR FREE,1217.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1217.0,0.0,1217.0,nan,nan,0.0,1217.0,0
TCGA-66-2788-01,TCGA-66-2788,LUSC,56.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-20637.0,Alive,TUMOR FREE,699.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,699.0,0.0,699.0,nan,nan,0.0,699.0,0
TCGA-66-2788-11,TCGA-66-2788,LUSC,56.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-20637.0,Alive,TUMOR FREE,699.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,699.0,0.0,699.0,nan,nan,0.0,699.0,0
TCGA-66-2789-01,TCGA-66-2789,LUSC,73.0,MALE,nan,Stage IIIB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-26753.0,Dead,TUMOR FREE,nan,123.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,123.0,0.0,123.0,nan,nan,0.0,123.0,0
TCGA-66-2789-11,TCGA-66-2789,LUSC,73.0,MALE,nan,Stage IIIB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-26753.0,Dead,TUMOR FREE,nan,123.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,123.0,0.0,123.0,nan,nan,0.0,123.0,0
TCGA-66-2790-01,TCGA-66-2790,LUSC,72.0,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-26420.0,Alive,WITH TUMOR,699.0,nan,nan,nan,nan,nan,699.0,Progressive Disease,nan,nan,0.0,699.0,0.0,699.0,nan,nan,1.0,699.0,0
TCGA-66-2790-11,TCGA-66-2790,LUSC,72.0,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-26420.0,Alive,WITH TUMOR,699.0,nan,nan,nan,nan,nan,699.0,Progressive Disease,nan,nan,0.0,699.0,0.0,699.0,nan,nan,1.0,699.0,0
TCGA-66-2791-01,TCGA-66-2791,LUSC,66.0,MALE,nan,Stage IIIB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-24138.0,Dead,nan,nan,153.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,153.0,nan,153.0,nan,nan,0.0,153.0,1
TCGA-66-2791-11,TCGA-66-2791,LUSC,66.0,MALE,nan,Stage IIIB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-24138.0,Dead,nan,nan,153.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,153.0,nan,153.0,nan,nan,0.0,153.0,1
TCGA-66-2792-01,TCGA-66-2792,LUSC,58.0,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-21428.0,Alive,TUMOR FREE,913.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,913.0,0.0,913.0,0.0,913.0,0.0,913.0,0
TCGA-66-2792-11,TCGA-66-2792,LUSC,58.0,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-21428.0,Alive,TUMOR FREE,913.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,913.0,0.0,913.0,0.0,913.0,0.0,913.0,0
TCGA-66-2793-01,TCGA-66-2793,LUSC,68.0,MALE,nan,Stage IIIB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-25111.0,Dead,TUMOR FREE,nan,306.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,306.0,0.0,306.0,nan,nan,0.0,306.0,0
TCGA-66-2794-01,TCGA-66-2794,LUSC,64.0,MALE,nan,Stage IIIB,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-23710.0,Alive,TUMOR FREE,1645.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1645.0,0.0,1645.0,0.0,1645.0,0.0,1645.0,0
TCGA-66-2795-01,TCGA-66-2795,LUSC,68.0,MALE,nan,Stage IIIB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-24897.0,Alive,TUMOR FREE,122.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,122.0,0.0,122.0,nan,nan,0.0,122.0,0
TCGA-66-2795-11,TCGA-66-2795,LUSC,68.0,MALE,nan,Stage IIIB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-24897.0,Alive,TUMOR FREE,122.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,122.0,0.0,122.0,nan,nan,0.0,122.0,0
TCGA-66-2800-01,TCGA-66-2800,LUSC,70.0,MALE,nan,Stage IIIB,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-25810.0,Alive,TUMOR FREE,1492.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1492.0,0.0,1492.0,nan,nan,0.0,1492.0,0
TCGA-68-7755-01,TCGA-68-7755,LUSC,60.0,FEMALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-21936.0,Alive,TUMOR FREE,83.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,83.0,0.0,83.0,nan,nan,0.0,83.0,0
TCGA-68-7756-01,TCGA-68-7756,LUSC,84.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-30763.0,Alive,nan,202.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,202.0,0.0,202.0,nan,nan,0.0,202.0,0
TCGA-68-7757-01,TCGA-68-7757,LUSC,74.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-27272.0,Alive,nan,211.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,211.0,0.0,211.0,nan,nan,0.0,211.0,0
TCGA-68-8250-01,TCGA-68-8250,LUSC,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-24118.0,Alive,TUMOR FREE,244.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,244.0,0.0,244.0,nan,nan,0.0,244.0,0
TCGA-68-8251-01,TCGA-68-8251,LUSC,78.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-28739.0,Alive,TUMOR FREE,406.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,406.0,0.0,406.0,nan,nan,0.0,406.0,0
TCGA-68-A59I-01,TCGA-68-A59I,LUSC,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-26839.0,Alive,WITH TUMOR,492.0,nan,nan,New Primary Tumor,nan,nan,159.0,Stable Disease,nan,nan,0.0,492.0,0.0,492.0,nan,nan,1.0,159.0,2
TCGA-68-A59J-01,TCGA-68-A59J,LUSC,74.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-27031.0,Alive,TUMOR FREE,448.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,448.0,0.0,448.0,0.0,448.0,0.0,448.0,0
TCGA-6A-AB49-01,TCGA-6A-AB49,LUSC,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,nan,Dead,TUMOR FREE,nan,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,nan,0.0,nan,nan,nan,0.0,nan,1
TCGA-70-6722-01,TCGA-70-6722,LUSC,47.0,MALE,ASIAN,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-17328.0,Alive,WITH TUMOR,367.0,nan,nan,Locoregional Recurrence,nan,nan,293.0,Progressive Disease,nan,nan,0.0,367.0,0.0,367.0,nan,nan,1.0,293.0,0
TCGA-70-6723-01,TCGA-70-6723,LUSC,65.0,MALE,ASIAN,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-24035.0,Alive,WITH TUMOR,375.0,nan,nan,Locoregional Recurrence,nan,nan,312.0,Progressive Disease,nan,nan,0.0,375.0,0.0,375.0,nan,nan,1.0,312.0,2
TCGA-77-6842-01,TCGA-77-6842,LUSC,79.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2000.0,nan,-28861.0,Dead,nan,nan,899.0,nan,nan,nan,nan,201.0,nan,nan,nan,1.0,899.0,nan,899.0,nan,nan,1.0,201.0,1
TCGA-77-6843-01,TCGA-77-6843,LUSC,74.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-27291.0,Dead,nan,nan,2224.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2224.0,nan,2224.0,nan,nan,0.0,2224.0,1
TCGA-77-6844-01,TCGA-77-6844,LUSC,74.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-27220.0,Dead,nan,nan,2284.0,nan,nan,nan,nan,1788.0,Complete Remission/Response,nan,nan,1.0,2284.0,nan,2284.0,1.0,1788.0,1.0,1788.0,1
TCGA-77-6845-01,TCGA-77-6845,LUSC,69.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-25321.0,Dead,nan,nan,708.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,708.0,nan,708.0,nan,nan,0.0,708.0,1
TCGA-77-7138-01,TCGA-77-7138,LUSC,67.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,1999.0,nan,-24594.0,Dead,nan,nan,340.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,340.0,nan,340.0,nan,nan,0.0,340.0,1
TCGA-77-7138-11,TCGA-77-7138,LUSC,67.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,1999.0,nan,-24594.0,Dead,nan,nan,340.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,340.0,nan,340.0,nan,nan,0.0,340.0,1
TCGA-77-7139-01,TCGA-77-7139,LUSC,56.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-20632.0,Alive,nan,4261.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4261.0,0.0,4261.0,0.0,4261.0,0.0,4261.0,0
TCGA-77-7140-01,TCGA-77-7140,LUSC,69.0,FEMALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-25303.0,Dead,nan,nan,632.0,nan,nan,nan,nan,250.0,nan,nan,nan,1.0,632.0,nan,632.0,nan,nan,1.0,250.0,1
TCGA-77-7141-01,TCGA-77-7141,LUSC,64.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-23584.0,Alive,nan,15.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,15.0,0.0,15.0,nan,nan,0.0,15.0,0
TCGA-77-7142-01,TCGA-77-7142,LUSC,59.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-21796.0,Alive,TUMOR FREE,2227.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2227.0,0.0,2227.0,nan,nan,0.0,2227.0,0
TCGA-77-7142-11,TCGA-77-7142,LUSC,59.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-21796.0,Alive,TUMOR FREE,2227.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2227.0,0.0,2227.0,nan,nan,0.0,2227.0,0
TCGA-77-7335-01,TCGA-77-7335,LUSC,62.0,FEMALE,WHITE,Stage IIIB,nan,Lung Squamous Cell Carcinoma,nan,1996.0,nan,-22863.0,Dead,nan,nan,2133.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2133.0,nan,2133.0,nan,nan,0.0,2133.0,1
TCGA-77-7335-11,TCGA-77-7335,LUSC,62.0,FEMALE,WHITE,Stage IIIB,nan,Lung Squamous Cell Carcinoma,nan,1996.0,nan,-22863.0,Dead,nan,nan,2133.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2133.0,nan,2133.0,nan,nan,0.0,2133.0,1
TCGA-77-7337-01,TCGA-77-7337,LUSC,65.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2000.0,nan,-24065.0,Dead,nan,nan,3253.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,3253.0,nan,3253.0,nan,nan,0.0,3253.0,1
TCGA-77-7337-11,TCGA-77-7337,LUSC,65.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2000.0,nan,-24065.0,Dead,nan,nan,3253.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,3253.0,nan,3253.0,nan,nan,0.0,3253.0,1
TCGA-77-7338-01,TCGA-77-7338,LUSC,64.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,1995.0,nan,-23480.0,Dead,nan,nan,5.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,5.0,nan,5.0,nan,nan,0.0,5.0,1
TCGA-77-7338-11,TCGA-77-7338,LUSC,64.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,1995.0,nan,-23480.0,Dead,nan,nan,5.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,5.0,nan,5.0,nan,nan,0.0,5.0,1
TCGA-77-7463-01,TCGA-77-7463,LUSC,75.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2001.0,nan,-27520.0,Dead,nan,nan,1423.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1423.0,nan,1423.0,nan,nan,0.0,1423.0,1
TCGA-77-7465-01,TCGA-77-7465,LUSC,58.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-21548.0,Alive,nan,990.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,990.0,0.0,990.0,0.0,990.0,0.0,990.0,0
TCGA-77-8007-01,TCGA-77-8007,LUSC,68.0,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2001.0,nan,-25102.0,Dead,nan,nan,198.0,nan,nan,nan,nan,139.0,nan,nan,nan,1.0,198.0,nan,198.0,nan,nan,1.0,139.0,1
TCGA-77-8007-11,TCGA-77-8007,LUSC,68.0,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2001.0,nan,-25102.0,Dead,nan,nan,198.0,nan,nan,nan,nan,139.0,nan,nan,nan,1.0,198.0,nan,198.0,nan,nan,1.0,139.0,1
TCGA-77-8008-01,TCGA-77-8008,LUSC,68.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2001.0,nan,-24948.0,Dead,nan,nan,2639.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2639.0,nan,2639.0,nan,nan,0.0,2639.0,1
TCGA-77-8008-11,TCGA-77-8008,LUSC,68.0,MALE,nan,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2001.0,nan,-24948.0,Dead,nan,nan,2639.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2639.0,nan,2639.0,nan,nan,0.0,2639.0,1
TCGA-77-8009-01,TCGA-77-8009,LUSC,68.0,MALE,nan,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-25037.0,Dead,nan,nan,1695.0,nan,nan,nan,nan,607.0,Complete Remission/Response,nan,nan,1.0,1695.0,nan,1695.0,1.0,607.0,1.0,607.0,1
TCGA-77-8128-01,TCGA-77-8128,LUSC,60.0,MALE,[Not Evaluated],Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,1999.0,nan,-21986.0,Dead,nan,nan,1150.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1150.0,nan,1150.0,nan,nan,0.0,1150.0,1
TCGA-77-8130-01,TCGA-77-8130,LUSC,69.0,MALE,[Not Evaluated],Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2000.0,nan,-25260.0,Alive,TUMOR FREE,4765.0,nan,nan,New Primary Tumor,nan,nan,4471.0,Complete Remission/Response,nan,nan,0.0,4765.0,0.0,4765.0,0.0,4765.0,1.0,4471.0,0
TCGA-77-8131-01,TCGA-77-8131,LUSC,72.0,MALE,[Not Evaluated],Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2000.0,nan,-26611.0,Dead,nan,nan,383.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,383.0,nan,383.0,nan,nan,0.0,383.0,1
TCGA-77-8133-01,TCGA-77-8133,LUSC,74.0,MALE,[Not Evaluated],Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2001.0,nan,-27139.0,Dead,nan,nan,1640.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1640.0,nan,1640.0,nan,nan,0.0,1640.0,1
TCGA-77-8136-01,TCGA-77-8136,LUSC,74.0,FEMALE,[Not Evaluated],Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-27193.0,Dead,nan,nan,1189.0,nan,Distant Metastasis,nan,nan,301.0,nan,nan,nan,1.0,1189.0,nan,1189.0,nan,nan,1.0,301.0,1
TCGA-77-8138-01,TCGA-77-8138,LUSC,74.0,MALE,[Not Evaluated],Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-27225.0,Dead,WITH TUMOR,nan,539.0,nan,Locoregional Recurrence,nan,nan,289.0,nan,nan,nan,1.0,539.0,1.0,539.0,nan,nan,1.0,289.0,1
TCGA-77-8139-01,TCGA-77-8139,LUSC,72.0,MALE,[Not Evaluated],Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-26464.0,Alive,TUMOR FREE,3166.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3166.0,0.0,3166.0,0.0,3166.0,0.0,3166.0,0
TCGA-77-8140-01,TCGA-77-8140,LUSC,66.0,FEMALE,[Not Evaluated],Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2003.0,nan,-24415.0,Dead,nan,nan,351.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,351.0,nan,351.0,nan,nan,0.0,351.0,1
TCGA-77-8143-01,TCGA-77-8143,LUSC,76.0,MALE,[Not Evaluated],Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-27772.0,Dead,WITH TUMOR,nan,803.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,803.0,1.0,803.0,nan,nan,1.0,803.0,1
TCGA-77-8144-01,TCGA-77-8144,LUSC,70.0,MALE,[Not Evaluated],Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2004.0,nan,-25796.0,Alive,nan,833.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,833.0,0.0,833.0,0.0,833.0,0.0,833.0,0
TCGA-77-8145-01,TCGA-77-8145,LUSC,73.0,MALE,[Not Evaluated],Stage IIIB,nan,Lung Squamous Cell Carcinoma,nan,2000.0,nan,-26707.0,Dead,nan,nan,212.0,nan,Distant Metastasis,nan,nan,136.0,[Unknown],nan,nan,1.0,212.0,nan,212.0,nan,nan,1.0,136.0,1
TCGA-77-8146-01,TCGA-77-8146,LUSC,72.0,MALE,[Not Evaluated],Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-26533.0,Alive,nan,3189.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3189.0,0.0,3189.0,0.0,3189.0,0.0,3189.0,0
TCGA-77-8148-01,TCGA-77-8148,LUSC,68.0,MALE,[Not Evaluated],Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-24918.0,Alive,nan,2023.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2023.0,0.0,2023.0,0.0,2023.0,0.0,2023.0,0
TCGA-77-8150-01,TCGA-77-8150,LUSC,64.0,MALE,[Not Evaluated],Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-23474.0,Dead,WITH TUMOR,nan,1655.0,nan,Locoregional Recurrence,nan,nan,1278.0,nan,nan,nan,1.0,1655.0,1.0,1655.0,nan,nan,1.0,1278.0,1
TCGA-77-8153-01,TCGA-77-8153,LUSC,77.0,FEMALE,[Not Evaluated],Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-28253.0,Alive,TUMOR FREE,1992.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1992.0,0.0,1992.0,0.0,1992.0,0.0,1992.0,0
TCGA-77-8153-11,TCGA-77-8153,LUSC,77.0,FEMALE,[Not Evaluated],Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-28253.0,Alive,TUMOR FREE,1992.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1992.0,0.0,1992.0,0.0,1992.0,0.0,1992.0,0
TCGA-77-8154-01,TCGA-77-8154,LUSC,67.0,MALE,[Not Evaluated],Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-24640.0,Alive,TUMOR FREE,1841.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1841.0,0.0,1841.0,0.0,1841.0,0.0,1841.0,0
TCGA-77-8156-01,TCGA-77-8156,LUSC,60.0,MALE,[Not Evaluated],Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-22198.0,Alive,nan,1106.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1106.0,0.0,1106.0,0.0,1106.0,0.0,1106.0,0
TCGA-77-A5FZ-01,TCGA-77-A5FZ,LUSC,64.0,MALE,[Not Evaluated],Stage IIIB,nan,Lung Squamous Cell Carcinoma,nan,2001.0,nan,-23436.0,Dead,nan,nan,3838.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,3838.0,nan,3838.0,0.0,3838.0,0.0,3838.0,0
TCGA-77-A5G1-01,TCGA-77-A5G1,LUSC,75.0,MALE,[Not Evaluated],Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-27555.0,Alive,nan,4026.0,nan,nan,New Primary Tumor,nan,nan,2197.0,Complete Remission/Response,nan,nan,0.0,4026.0,0.0,4026.0,0.0,4026.0,1.0,2197.0,0
TCGA-77-A5G3-01,TCGA-77-A5G3,LUSC,63.0,MALE,[Not Evaluated],Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2002.0,nan,-23171.0,Alive,TUMOR FREE,4570.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4570.0,0.0,4570.0,0.0,4570.0,0.0,4570.0,0
TCGA-77-A5G6-01,TCGA-77-A5G6,LUSC,66.0,MALE,[Not Evaluated],Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-24215.0,Dead,WITH TUMOR,nan,678.0,nan,Locoregional Recurrence,nan,nan,392.0,Complete Remission/Response,nan,nan,1.0,678.0,1.0,678.0,1.0,392.0,1.0,392.0,1
TCGA-77-A5G7-01,TCGA-77-A5G7,LUSC,63.0,MALE,[Not Evaluated],Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-23090.0,Dead,nan,nan,180.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,180.0,nan,180.0,0.0,180.0,0.0,180.0,0
TCGA-77-A5G8-01,TCGA-77-A5G8,LUSC,70.0,MALE,[Not Evaluated],Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-25921.0,Alive,nan,1884.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1884.0,0.0,1884.0,nan,nan,0.0,1884.0,0
TCGA-77-A5GA-01,TCGA-77-A5GA,LUSC,76.0,MALE,[Not Evaluated],Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-27762.0,Alive,nan,1280.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1280.0,0.0,1280.0,0.0,1280.0,0.0,1280.0,0
TCGA-77-A5GB-01,TCGA-77-A5GB,LUSC,90.0,MALE,[Not Evaluated],Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-32872.0,Dead,nan,nan,937.0,nan,New Primary Tumor,nan,nan,229.0,Complete Remission/Response,nan,nan,1.0,937.0,nan,937.0,0.0,937.0,1.0,229.0,1
TCGA-77-A5GF-01,TCGA-77-A5GF,LUSC,70.0,MALE,[Not Evaluated],Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-25654.0,Dead,WITH TUMOR,nan,840.0,nan,Locoregional Recurrence,nan,nan,722.0,Complete Remission/Response,nan,nan,1.0,840.0,1.0,840.0,1.0,722.0,1.0,722.0,1
TCGA-77-A5GH-01,TCGA-77-A5GH,LUSC,81.0,MALE,[Not Evaluated],Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-29843.0,Alive,nan,1182.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1182.0,0.0,1182.0,0.0,1182.0,0.0,1182.0,0
TCGA-79-5596-01,TCGA-79-5596,LUSC,nan,MALE,nan,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,nan,Alive,TUMOR FREE,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,nan,0.0,nan,nan,nan,0.0,nan,0
TCGA-85-6175-01,TCGA-85-6175,LUSC,63.0,FEMALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-23228.0,Dead,WITH TUMOR,nan,294.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,294.0,1.0,294.0,nan,nan,1.0,294.0,1
TCGA-85-6560-01,TCGA-85-6560,LUSC,59.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-21768.0,Alive,TUMOR FREE,1259.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1259.0,0.0,1259.0,0.0,1259.0,0.0,1259.0,0
TCGA-85-6561-01,TCGA-85-6561,LUSC,66.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-24234.0,Alive,TUMOR FREE,1224.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1224.0,0.0,1224.0,0.0,1224.0,0.0,1224.0,0
TCGA-85-6798-01,TCGA-85-6798,LUSC,57.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-20837.0,Dead,WITH TUMOR,nan,195.0,nan,Distant Metastasis,nan,nan,180.0,Complete Remission/Response,nan,nan,1.0,195.0,1.0,195.0,1.0,180.0,1.0,180.0,1
TCGA-85-7696-01,TCGA-85-7696,LUSC,64.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-23413.0,Alive,TUMOR FREE,1111.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1111.0,0.0,1111.0,0.0,1111.0,0.0,1111.0,0
TCGA-85-7697-01,TCGA-85-7697,LUSC,49.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-17921.0,Alive,TUMOR FREE,1063.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1063.0,0.0,1063.0,0.0,1063.0,0.0,1063.0,0
TCGA-85-7698-01,TCGA-85-7698,LUSC,48.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-17651.0,Alive,TUMOR FREE,952.0,nan,nan,Distant Metastasis,nan,nan,650.0,Complete Remission/Response,nan,nan,0.0,952.0,0.0,952.0,1.0,650.0,1.0,650.0,0
TCGA-85-7699-01,TCGA-85-7699,LUSC,73.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-26965.0,Dead,WITH TUMOR,nan,1001.0,nan,Distant Metastasis,nan,nan,760.0,Complete Remission/Response,nan,nan,1.0,1001.0,1.0,1001.0,1.0,760.0,1.0,760.0,1
TCGA-85-7710-01,TCGA-85-7710,LUSC,59.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-21790.0,Alive,TUMOR FREE,42.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,42.0,0.0,42.0,0.0,42.0,0.0,42.0,0
TCGA-85-7710-11,TCGA-85-7710,LUSC,59.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-21790.0,Alive,TUMOR FREE,42.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,42.0,0.0,42.0,0.0,42.0,0.0,42.0,0
TCGA-85-7843-01,TCGA-85-7843,LUSC,50.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-18353.0,Alive,nan,35.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,35.0,0.0,35.0,nan,nan,0.0,35.0,0
TCGA-85-7844-01,TCGA-85-7844,LUSC,71.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-26141.0,Alive,TUMOR FREE,911.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,911.0,0.0,911.0,0.0,911.0,0.0,911.0,0
TCGA-85-7950-01,TCGA-85-7950,LUSC,46.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-16975.0,Alive,TUMOR FREE,576.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,576.0,0.0,576.0,0.0,576.0,0.0,576.0,0
TCGA-85-8048-01,TCGA-85-8048,LUSC,62.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-22907.0,Alive,TUMOR FREE,765.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,765.0,0.0,765.0,0.0,765.0,0.0,765.0,0
TCGA-85-8049-01,TCGA-85-8049,LUSC,57.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-20995.0,Alive,TUMOR FREE,579.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,579.0,0.0,579.0,0.0,579.0,0.0,579.0,0
TCGA-85-8052-01,TCGA-85-8052,LUSC,53.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-19671.0,Alive,TUMOR FREE,734.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,734.0,0.0,734.0,0.0,734.0,0.0,734.0,0
TCGA-85-8070-01,TCGA-85-8070,LUSC,71.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-26183.0,Alive,TUMOR FREE,960.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,960.0,0.0,960.0,0.0,960.0,0.0,960.0,0
TCGA-85-8071-01,TCGA-85-8071,LUSC,52.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-19158.0,Alive,TUMOR FREE,815.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,815.0,0.0,815.0,0.0,815.0,0.0,815.0,0
TCGA-85-8072-01,TCGA-85-8072,LUSC,60.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-22069.0,Alive,TUMOR FREE,932.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,932.0,0.0,932.0,0.0,932.0,0.0,932.0,0
TCGA-85-8276-01,TCGA-85-8276,LUSC,62.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-22707.0,Alive,WITH TUMOR,1050.0,nan,nan,Distant Metastasis,nan,nan,1048.0,Complete Remission/Response,nan,nan,0.0,1050.0,0.0,1050.0,1.0,1048.0,1.0,1048.0,2
TCGA-85-8277-01,TCGA-85-8277,LUSC,70.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-25793.0,Dead,TUMOR FREE,nan,307.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,307.0,0.0,307.0,0.0,307.0,0.0,307.0,0
TCGA-85-8287-01,TCGA-85-8287,LUSC,72.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-26401.0,Dead,TUMOR FREE,nan,23.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,23.0,0.0,23.0,0.0,23.0,0.0,23.0,0
TCGA-85-8288-01,TCGA-85-8288,LUSC,70.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-25629.0,Dead,TUMOR FREE,nan,402.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,402.0,0.0,402.0,0.0,402.0,0.0,402.0,0
TCGA-85-8350-01,TCGA-85-8350,LUSC,61.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-22526.0,Alive,TUMOR FREE,683.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,683.0,0.0,683.0,0.0,683.0,0.0,683.0,0
TCGA-85-8351-01,TCGA-85-8351,LUSC,72.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-26437.0,Alive,TUMOR FREE,510.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,510.0,0.0,510.0,0.0,510.0,0.0,510.0,0
TCGA-85-8352-01,TCGA-85-8352,LUSC,67.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-24788.0,Dead,WITH TUMOR,nan,161.0,nan,Distant Metastasis,nan,nan,128.0,Complete Remission/Response,nan,nan,1.0,161.0,1.0,161.0,1.0,128.0,1.0,128.0,1
TCGA-85-8353-01,TCGA-85-8353,LUSC,72.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-26549.0,Dead,WITH TUMOR,nan,94.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,94.0,1.0,94.0,nan,nan,1.0,94.0,1
TCGA-85-8354-01,TCGA-85-8354,LUSC,53.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-19692.0,Alive,TUMOR FREE,995.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,995.0,0.0,995.0,0.0,995.0,0.0,995.0,0
TCGA-85-8355-01,TCGA-85-8355,LUSC,63.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-23227.0,Alive,TUMOR FREE,61.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,61.0,0.0,61.0,0.0,61.0,0.0,61.0,0
TCGA-85-8479-01,TCGA-85-8479,LUSC,66.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-24350.0,Alive,TUMOR FREE,468.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,468.0,0.0,468.0,0.0,468.0,0.0,468.0,0
TCGA-85-8481-01,TCGA-85-8481,LUSC,70.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-25782.0,Dead,TUMOR FREE,nan,236.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,236.0,0.0,236.0,nan,nan,0.0,236.0,0
TCGA-85-8580-01,TCGA-85-8580,LUSC,52.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-19301.0,Alive,TUMOR FREE,1113.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1113.0,0.0,1113.0,0.0,1113.0,0.0,1113.0,0
TCGA-85-8582-01,TCGA-85-8582,LUSC,49.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-18168.0,Alive,TUMOR FREE,1160.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1160.0,0.0,1160.0,0.0,1160.0,0.0,1160.0,0
TCGA-85-8584-01,TCGA-85-8584,LUSC,71.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-26081.0,Dead,TUMOR FREE,nan,383.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,0
TCGA-85-8664-01,TCGA-85-8664,LUSC,73.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-26954.0,Dead,WITH TUMOR,nan,550.0,nan,Distant Metastasis,nan,nan,434.0,Complete Remission/Response,nan,nan,1.0,550.0,1.0,550.0,1.0,434.0,1.0,434.0,1
TCGA-85-8666-01,TCGA-85-8666,LUSC,65.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-23906.0,Dead,TUMOR FREE,nan,687.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,687.0,0.0,687.0,0.0,687.0,0.0,687.0,0
TCGA-85-A4CL-01,TCGA-85-A4CL,LUSC,65.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-24005.0,Dead,TUMOR FREE,nan,921.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,921.0,0.0,921.0,0.0,921.0,0.0,921.0,0
TCGA-85-A4CN-01,TCGA-85-A4CN,LUSC,56.0,FEMALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-20490.0,Alive,TUMOR FREE,1038.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1038.0,0.0,1038.0,0.0,1038.0,0.0,1038.0,0
TCGA-85-A4JB-01,TCGA-85-A4JB,LUSC,74.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-27315.0,Alive,TUMOR FREE,942.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,942.0,0.0,942.0,0.0,942.0,0.0,942.0,0
TCGA-85-A4JC-01,TCGA-85-A4JC,LUSC,84.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-30942.0,Dead,WITH TUMOR,nan,604.0,nan,Locoregional Recurrence,nan,nan,548.0,Complete Remission/Response,nan,nan,1.0,604.0,1.0,604.0,1.0,548.0,1.0,548.0,1
TCGA-85-A4PA-01,TCGA-85-A4PA,LUSC,61.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-22614.0,Alive,TUMOR FREE,741.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,741.0,0.0,741.0,0.0,741.0,0.0,741.0,0
TCGA-85-A4QQ-01,TCGA-85-A4QQ,LUSC,68.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-25065.0,Dead,TUMOR FREE,nan,927.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,927.0,0.0,927.0,0.0,927.0,0.0,927.0,0
TCGA-85-A4QR-01,TCGA-85-A4QR,LUSC,67.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-24756.0,Alive,TUMOR FREE,600.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,600.0,0.0,600.0,0.0,600.0,0.0,600.0,0
TCGA-85-A50M-01,TCGA-85-A50M,LUSC,47.0,MALE,ASIAN,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-17429.0,Dead,TUMOR FREE,nan,826.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,826.0,0.0,826.0,0.0,826.0,0.0,826.0,0
TCGA-85-A50Z-01,TCGA-85-A50Z,LUSC,57.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-20941.0,Alive,TUMOR FREE,493.0,nan,nan,New Primary Tumor,nan,nan,462.0,Complete Remission/Response,nan,nan,0.0,493.0,0.0,493.0,0.0,493.0,1.0,462.0,0
TCGA-85-A510-01,TCGA-85-A510,LUSC,74.0,FEMALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-27067.0,Alive,TUMOR FREE,482.0,nan,nan,Distant Metastasis,nan,nan,363.0,Complete Remission/Response,nan,nan,0.0,482.0,0.0,482.0,1.0,363.0,1.0,363.0,2
TCGA-85-A511-01,TCGA-85-A511,LUSC,62.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-22759.0,Dead,WITH TUMOR,nan,455.0,nan,Distant Metastasis,nan,nan,390.0,Complete Remission/Response,nan,nan,1.0,455.0,1.0,455.0,1.0,390.0,1.0,390.0,1
TCGA-85-A512-01,TCGA-85-A512,LUSC,46.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-16811.0,Alive,TUMOR FREE,465.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,465.0,0.0,465.0,0.0,465.0,0.0,465.0,0
TCGA-85-A513-01,TCGA-85-A513,LUSC,60.0,FEMALE,ASIAN,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-21967.0,Alive,TUMOR FREE,910.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,910.0,0.0,910.0,0.0,910.0,0.0,910.0,0
TCGA-85-A53L-01,TCGA-85-A53L,LUSC,63.0,MALE,ASIAN,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-23065.0,Alive,TUMOR FREE,377.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,377.0,0.0,377.0,0.0,377.0,0.0,377.0,0
TCGA-85-A5B5-01,TCGA-85-A5B5,LUSC,58.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-21450.0,Alive,TUMOR FREE,111.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,111.0,0.0,111.0,0.0,111.0,0.0,111.0,0
TCGA-90-6837-01,TCGA-90-6837,LUSC,64.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-23511.0,Alive,TUMOR FREE,758.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,758.0,0.0,758.0,0.0,758.0,0.0,758.0,0
TCGA-90-6837-11,TCGA-90-6837,LUSC,64.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-23511.0,Alive,TUMOR FREE,758.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,758.0,0.0,758.0,0.0,758.0,0.0,758.0,0
TCGA-90-7766-01,TCGA-90-7766,LUSC,66.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-24354.0,Alive,WITH TUMOR,289.0,nan,nan,Locoregional Recurrence,nan,nan,289.0,Progressive Disease,nan,nan,0.0,289.0,0.0,289.0,nan,nan,1.0,289.0,2
TCGA-90-7767-01,TCGA-90-7767,LUSC,56.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-20534.0,Alive,TUMOR FREE,89.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,89.0,0.0,89.0,nan,nan,0.0,89.0,0
TCGA-90-7767-11,TCGA-90-7767,LUSC,56.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-20534.0,Alive,TUMOR FREE,89.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,89.0,0.0,89.0,nan,nan,0.0,89.0,0
TCGA-90-7769-01,TCGA-90-7769,LUSC,55.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-20276.0,Alive,TUMOR FREE,358.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,358.0,0.0,358.0,0.0,358.0,0.0,358.0,0
TCGA-90-7964-01,TCGA-90-7964,LUSC,70.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-25646.0,Alive,TUMOR FREE,428.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,428.0,0.0,428.0,0.0,428.0,0.0,428.0,0
TCGA-90-A4ED-01,TCGA-90-A4ED,LUSC,69.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-25453.0,Alive,TUMOR FREE,615.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,615.0,0.0,615.0,0.0,615.0,0.0,615.0,0
TCGA-90-A4EE-01,TCGA-90-A4EE,LUSC,53.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-19676.0,Alive,TUMOR FREE,688.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,688.0,0.0,688.0,0.0,688.0,0.0,688.0,0
TCGA-90-A59Q-01,TCGA-90-A59Q,LUSC,61.0,FEMALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-22420.0,Dead,WITH TUMOR,nan,322.0,nan,Distant Metastasis,nan,nan,274.0,Complete Remission/Response,nan,nan,1.0,322.0,1.0,322.0,1.0,274.0,1.0,274.0,1
TCGA-92-7340-01,TCGA-92-7340,LUSC,45.0,FEMALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-16447.0,Alive,WITH TUMOR,82.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,82.0,0.0,82.0,nan,nan,0.0,82.0,0
TCGA-92-7340-11,TCGA-92-7340,LUSC,45.0,FEMALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-16447.0,Alive,WITH TUMOR,82.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,82.0,0.0,82.0,nan,nan,0.0,82.0,0
TCGA-92-7341-01,TCGA-92-7341,LUSC,71.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-26134.0,Alive,WITH TUMOR,106.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,106.0,0.0,106.0,nan,nan,0.0,106.0,0
TCGA-92-7341-11,TCGA-92-7341,LUSC,71.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-26134.0,Alive,WITH TUMOR,106.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,106.0,0.0,106.0,nan,nan,0.0,106.0,0
TCGA-92-8063-01,TCGA-92-8063,LUSC,52.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-19193.0,Alive,TUMOR FREE,122.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,122.0,0.0,122.0,0.0,122.0,0.0,122.0,0
TCGA-92-8064-01,TCGA-92-8064,LUSC,58.0,MALE,WHITE,[Discrepancy],nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-21417.0,Alive,TUMOR FREE,160.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,160.0,0.0,160.0,0.0,160.0,0.0,160.0,0
TCGA-92-8065-01,TCGA-92-8065,LUSC,74.0,FEMALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-27049.0,Alive,TUMOR FREE,70.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,70.0,0.0,70.0,0.0,70.0,0.0,70.0,0
TCGA-94-7033-01,TCGA-94-7033,LUSC,73.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-26948.0,Alive,TUMOR FREE,640.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,640.0,0.0,640.0,0.0,640.0,0.0,640.0,0
TCGA-94-7557-01,TCGA-94-7557,LUSC,73.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-26802.0,Dead,TUMOR FREE,nan,5.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,5.0,0.0,5.0,0.0,5.0,0.0,5.0,0
TCGA-94-7943-01,TCGA-94-7943,LUSC,80.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-29282.0,Alive,WITH TUMOR,559.0,nan,nan,Locoregional Recurrence,nan,nan,556.0,Complete Remission/Response,nan,nan,0.0,559.0,0.0,559.0,1.0,556.0,1.0,556.0,2
TCGA-94-8035-01,TCGA-94-8035,LUSC,64.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-23399.0,Alive,TUMOR FREE,122.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,122.0,0.0,122.0,0.0,122.0,0.0,122.0,0
TCGA-94-8490-01,TCGA-94-8490,LUSC,70.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-25588.0,Alive,TUMOR FREE,153.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,153.0,0.0,153.0,nan,nan,0.0,153.0,0
TCGA-94-8491-01,TCGA-94-8491,LUSC,73.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-26698.0,Alive,TUMOR FREE,810.0,nan,nan,Distant Metastasis,nan,nan,641.0,Progressive Disease,nan,nan,0.0,810.0,0.0,810.0,nan,nan,1.0,641.0,0
TCGA-94-A4VJ-01,TCGA-94-A4VJ,LUSC,71.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-25991.0,Alive,TUMOR FREE,430.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,430.0,0.0,430.0,0.0,430.0,0.0,430.0,0
TCGA-94-A5I4-01,TCGA-94-A5I4,LUSC,61.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-22299.0,Alive,WITH TUMOR,491.0,nan,nan,Distant Metastasis,nan,nan,314.0,Complete Remission/Response,nan,nan,0.0,491.0,0.0,491.0,1.0,314.0,1.0,314.0,2
TCGA-94-A5I6-01,TCGA-94-A5I6,LUSC,62.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-22949.0,Alive,WITH TUMOR,538.0,nan,nan,Distant Metastasis,nan,nan,481.0,Progressive Disease,nan,nan,0.0,538.0,0.0,538.0,nan,nan,1.0,481.0,0
TCGA-96-7544-01,TCGA-96-7544,LUSC,83.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-30548.0,Dead,TUMOR FREE,nan,2160.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2160.0,0.0,2160.0,0.0,2160.0,0.0,2160.0,0
TCGA-96-7545-01,TCGA-96-7545,LUSC,73.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-26729.0,Dead,nan,nan,1736.0,nan,Locoregional Recurrence,nan,nan,1693.0,Progressive Disease,nan,nan,1.0,1736.0,nan,1736.0,nan,nan,1.0,1693.0,1
TCGA-96-8169-01,TCGA-96-8169,LUSC,67.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-24674.0,Alive,TUMOR FREE,557.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,557.0,0.0,557.0,0.0,557.0,0.0,557.0,0
TCGA-96-8170-01,TCGA-96-8170,LUSC,75.0,FEMALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-27558.0,Alive,TUMOR FREE,531.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,531.0,0.0,531.0,0.0,531.0,0.0,531.0,0
TCGA-96-A4JK-01,TCGA-96-A4JK,LUSC,65.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-23974.0,Alive,TUMOR FREE,589.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,589.0,0.0,589.0,0.0,589.0,0.0,589.0,0
TCGA-96-A4JL-01,TCGA-96-A4JL,LUSC,78.0,FEMALE,ASIAN,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-28686.0,Alive,TUMOR FREE,842.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,842.0,0.0,842.0,0.0,842.0,0.0,842.0,0
TCGA-98-7454-01,TCGA-98-7454,LUSC,73.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-26827.0,Alive,TUMOR FREE,652.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,652.0,0.0,652.0,0.0,652.0,0.0,652.0,0
TCGA-98-8020-01,TCGA-98-8020,LUSC,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-20509.0,Dead,WITH TUMOR,nan,84.0,nan,Distant Metastasis,nan,nan,11.0,[Unknown],nan,nan,1.0,84.0,1.0,84.0,nan,nan,1.0,11.0,1
TCGA-98-8021-01,TCGA-98-8021,LUSC,75.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-27738.0,Alive,TUMOR FREE,937.0,nan,nan,Locoregional Recurrence,nan,nan,918.0,Complete Remission/Response,nan,nan,0.0,937.0,0.0,937.0,1.0,918.0,1.0,918.0,2
TCGA-98-8022-01,TCGA-98-8022,LUSC,61.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-22487.0,Dead,TUMOR FREE,nan,933.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,933.0,0.0,933.0,0.0,933.0,0.0,933.0,0
TCGA-98-8023-01,TCGA-98-8023,LUSC,70.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-25732.0,Alive,TUMOR FREE,649.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,649.0,0.0,649.0,0.0,649.0,0.0,649.0,0
TCGA-98-A538-01,TCGA-98-A538,LUSC,67.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-24698.0,Alive,TUMOR FREE,826.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,826.0,0.0,826.0,0.0,826.0,0.0,826.0,0
TCGA-98-A539-01,TCGA-98-A539,LUSC,63.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-23098.0,Alive,WITH TUMOR,173.0,nan,nan,Locoregional Recurrence,nan,nan,173.0,nan,nan,nan,0.0,173.0,0.0,173.0,nan,nan,1.0,173.0,0
TCGA-98-A53A-01,TCGA-98-A53A,LUSC,70.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-25662.0,Dead,nan,nan,552.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,552.0,nan,552.0,0.0,552.0,0.0,552.0,0
TCGA-98-A53B-01,TCGA-98-A53B,LUSC,69.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-25390.0,Dead,TUMOR FREE,nan,61.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,61.0,0.0,61.0,0.0,61.0,0.0,61.0,0
TCGA-98-A53C-01,TCGA-98-A53C,LUSC,77.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-28146.0,Alive,TUMOR FREE,822.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,822.0,0.0,822.0,0.0,822.0,0.0,822.0,0
TCGA-98-A53D-01,TCGA-98-A53D,LUSC,68.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-24891.0,Dead,WITH TUMOR,nan,645.0,nan,Locoregional Recurrence,nan,nan,413.0,Complete Remission/Response,nan,nan,1.0,645.0,1.0,645.0,1.0,413.0,1.0,413.0,1
TCGA-98-A53H-01,TCGA-98-A53H,LUSC,76.0,FEMALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-27928.0,Alive,nan,618.0,nan,nan,New Primary Tumor,nan,nan,427.0,Complete Remission/Response,nan,nan,0.0,618.0,0.0,618.0,0.0,618.0,1.0,427.0,2
TCGA-98-A53I-01,TCGA-98-A53I,LUSC,64.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-23502.0,Alive,TUMOR FREE,565.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,565.0,0.0,565.0,0.0,565.0,0.0,565.0,0
TCGA-98-A53J-01,TCGA-98-A53J,LUSC,77.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-28485.0,Alive,TUMOR FREE,630.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,630.0,0.0,630.0,0.0,630.0,0.0,630.0,0
TCGA-J1-A4AH-01,TCGA-J1-A4AH,LUSC,70.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-25893.0,Alive,TUMOR FREE,581.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,581.0,0.0,581.0,0.0,581.0,0.0,581.0,0
TCGA-L3-A4E7-01,TCGA-L3-A4E7,LUSC,71.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-26232.0,Alive,TUMOR FREE,392.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,392.0,0.0,392.0,0.0,392.0,0.0,392.0,0
TCGA-L3-A524-01,TCGA-L3-A524,LUSC,45.0,FEMALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-16765.0,Dead,TUMOR FREE,nan,490.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,490.0,0.0,490.0,0.0,490.0,0.0,490.0,0
TCGA-LA-A446-01,TCGA-LA-A446,LUSC,68.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-25199.0,Alive,TUMOR FREE,401.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,401.0,0.0,401.0,0.0,401.0,0.0,401.0,0
TCGA-LA-A7SW-01,TCGA-LA-A7SW,LUSC,71.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2013.0,nan,-26116.0,Dead,WITH TUMOR,nan,408.0,nan,Locoregional Recurrence,nan,nan,235.0,nan,nan,nan,1.0,408.0,1.0,408.0,nan,nan,1.0,235.0,1
TCGA-MF-A522-01,TCGA-MF-A522,LUSC,54.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-20051.0,Dead,WITH TUMOR,nan,360.0,nan,Distant Metastasis,nan,nan,173.0,Partial Remission/Response,nan,nan,1.0,360.0,1.0,360.0,nan,nan,1.0,173.0,1
TCGA-NC-A5HD-01,TCGA-NC-A5HD,LUSC,79.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-28916.0,Dead,TUMOR FREE,nan,2.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2.0,0.0,2.0,nan,nan,0.0,2.0,0
TCGA-NC-A5HE-01,TCGA-NC-A5HE,LUSC,60.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-22179.0,Alive,TUMOR FREE,2336.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2336.0,0.0,2336.0,0.0,2336.0,0.0,2336.0,0
TCGA-NC-A5HF-01,TCGA-NC-A5HF,LUSC,74.0,MALE,WHITE,Stage IIIB,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-27038.0,Dead,WITH TUMOR,nan,138.0,nan,Distant Metastasis,nan,nan,132.0,Progressive Disease,nan,nan,1.0,138.0,1.0,138.0,nan,nan,1.0,132.0,1
TCGA-NC-A5HG-01,TCGA-NC-A5HG,LUSC,59.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-21608.0,Alive,TUMOR FREE,1963.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1963.0,0.0,1963.0,0.0,1963.0,0.0,1963.0,0
TCGA-NC-A5HH-01,TCGA-NC-A5HH,LUSC,53.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-19485.0,Alive,TUMOR FREE,37.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,37.0,0.0,37.0,0.0,37.0,0.0,37.0,0
TCGA-NC-A5HI-01,TCGA-NC-A5HI,LUSC,68.0,FEMALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-24981.0,Alive,TUMOR FREE,1743.0,nan,nan,New Primary Tumor,nan,nan,70.0,Complete Remission/Response,nan,nan,0.0,1743.0,0.0,1743.0,0.0,1743.0,1.0,70.0,2
TCGA-NC-A5HJ-01,TCGA-NC-A5HJ,LUSC,59.0,MALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2009.0,nan,-21730.0,Dead,WITH TUMOR,nan,418.0,nan,New Primary Tumor,nan,nan,328.0,Complete Remission/Response,nan,nan,1.0,418.0,1.0,418.0,0.0,418.0,1.0,328.0,1
TCGA-NC-A5HK-01,TCGA-NC-A5HK,LUSC,58.0,FEMALE,WHITE,Stage IIB,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-21531.0,Alive,TUMOR FREE,128.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,128.0,0.0,128.0,0.0,128.0,0.0,128.0,0
TCGA-NC-A5HL-01,TCGA-NC-A5HL,LUSC,73.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-26977.0,Dead,TUMOR FREE,nan,88.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,88.0,0.0,88.0,nan,nan,0.0,88.0,0
TCGA-NC-A5HM-01,TCGA-NC-A5HM,LUSC,76.0,MALE,WHITE,Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-27938.0,Alive,TUMOR FREE,1212.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1212.0,0.0,1212.0,0.0,1212.0,0.0,1212.0,0
TCGA-NC-A5HN-01,TCGA-NC-A5HN,LUSC,77.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2010.0,nan,-28151.0,Alive,TUMOR FREE,1499.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1499.0,0.0,1499.0,0.0,1499.0,0.0,1499.0,0
TCGA-NC-A5HO-01,TCGA-NC-A5HO,LUSC,70.0,FEMALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-25694.0,Alive,TUMOR FREE,1336.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1336.0,0.0,1336.0,0.0,1336.0,0.0,1336.0,0
TCGA-NC-A5HP-01,TCGA-NC-A5HP,LUSC,69.0,MALE,WHITE,Stage IV,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-25286.0,Dead,WITH TUMOR,nan,770.0,nan,Distant Metastasis,nan,nan,317.0,Progressive Disease,nan,nan,1.0,770.0,1.0,770.0,nan,nan,1.0,317.0,1
TCGA-NC-A5HQ-01,TCGA-NC-A5HQ,LUSC,70.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-25781.0,Dead,nan,nan,448.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,448.0,nan,448.0,0.0,448.0,0.0,448.0,0
TCGA-NC-A5HR-01,TCGA-NC-A5HR,LUSC,75.0,FEMALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-27629.0,Alive,TUMOR FREE,1244.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1244.0,0.0,1244.0,0.0,1244.0,0.0,1244.0,0
TCGA-NC-A5HT-01,TCGA-NC-A5HT,LUSC,69.0,MALE,WHITE,Stage IIIA,nan,Lung Squamous Cell Carcinoma,nan,2012.0,nan,-25466.0,Alive,WITH TUMOR,804.0,nan,nan,Locoregional Recurrence,nan,nan,203.0,Complete Remission/Response,nan,nan,0.0,804.0,0.0,804.0,1.0,203.0,1.0,203.0,2
TCGA-NK-A5CR-01,TCGA-NK-A5CR,LUSC,77.0,MALE,[Unknown],Stage IB,nan,Lung Squamous Cell Carcinoma,nan,2007.0,nan,-28126.0,Alive,TUMOR FREE,2542.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,2542.0,0.0,2542.0,nan,nan,0.0,2542.0,0
TCGA-NK-A5CT-01,TCGA-NK-A5CT,LUSC,70.0,MALE,WHITE,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2008.0,nan,-25726.0,Alive,WITH TUMOR,1997.0,nan,nan,Locoregional Recurrence,nan,nan,1990.0,Stable Disease,nan,nan,0.0,1997.0,0.0,1997.0,nan,nan,1.0,1990.0,0
TCGA-NK-A5CX-01,TCGA-NK-A5CX,LUSC,73.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-26879.0,Alive,TUMOR FREE,111.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,111.0,0.0,111.0,nan,nan,0.0,111.0,0
TCGA-NK-A5D1-01,TCGA-NK-A5D1,LUSC,57.0,MALE,WHITE,Stage IIA,nan,Lung Squamous Cell Carcinoma,nan,2011.0,nan,-20909.0,Alive,WITH TUMOR,511.0,nan,nan,Distant Metastasis,nan,nan,151.0,Progressive Disease,nan,nan,0.0,511.0,0.0,511.0,nan,nan,1.0,151.0,0
TCGA-NK-A7XE-01,TCGA-NK-A7XE,LUSC,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,nan,Lung Squamous Cell Carcinoma,nan,2013.0,nan,-24319.0,Alive,TUMOR FREE,13.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,13.0,0.0,13.0,nan,nan,0.0,13.0,0
TCGA-O2-A52N-01,TCGA-O2-A52N,LUSC,78.0,MALE,WHITE,Stage I,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-28520.0,Dead,TUMOR FREE,nan,1006.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,1006.0,0.0,1006.0,nan,nan,0.0,1006.0,0
TCGA-O2-A52Q-01,TCGA-O2-A52Q,LUSC,44.0,FEMALE,WHITE,Stage III,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-16429.0,Dead,WITH TUMOR,nan,113.0,nan,Distant Metastasis,nan,nan,87.0,[Unknown],nan,nan,1.0,113.0,1.0,113.0,nan,nan,1.0,87.0,1
TCGA-O2-A52S-01,TCGA-O2-A52S,LUSC,57.0,FEMALE,WHITE,Stage III,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-21182.0,Dead,WITH TUMOR,nan,387.0,nan,Distant Metastasis,nan,nan,246.0,[Unknown],nan,nan,1.0,387.0,1.0,387.0,nan,nan,1.0,246.0,1
TCGA-O2-A52V-01,TCGA-O2-A52V,LUSC,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-27449.0,Dead,TUMOR FREE,nan,1335.0,nan,Distant Metastasis,nan,nan,690.0,[Unknown],nan,nan,1.0,1335.0,0.0,1335.0,nan,nan,1.0,690.0,1
TCGA-O2-A52W-01,TCGA-O2-A52W,LUSC,63.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Lung Squamous Cell Carcinoma,nan,2006.0,nan,-23156.0,Dead,TUMOR FREE,nan,261.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,261.0,0.0,261.0,nan,nan,0.0,261.0,0
TCGA-O2-A5IB-01,TCGA-O2-A5IB,LUSC,71.0,FEMALE,WHITE,Stage III,nan,Lung Squamous Cell Carcinoma,nan,2005.0,nan,-26211.0,Dead,WITH TUMOR,nan,340.0,nan,Distant Metastasis,nan,nan,253.0,[Unknown],nan,nan,1.0,340.0,1.0,340.0,nan,nan,1.0,253.0,1
TCGA-XC-AA0X-01,TCGA-XC-AA0X,LUSC,77.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,Lung Squamous Cell Carcinoma,nan,2013.0,nan,-28211.0,Dead,TUMOR FREE,nan,6.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,6.0,0.0,6.0,nan,nan,0.0,6.0,1
TCGA-3H-AB3K-01,TCGA-3H-AB3K,MESO,64.0,MALE,WHITE,Stage II,nan,Diffuse malignant mesothelioma - NOS,nan,2008.0,nan,-23591.0,Dead,WITH TUMOR,nan,1715.0,nan,Distant Metastasis,Contralateral Pleura,nan,841.0,nan,nan,nan,1.0,1715.0,1.0,1715.0,nan,nan,1.0,841.0,1
TCGA-3H-AB3L-01,TCGA-3H-AB3L,MESO,60.0,MALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2008.0,nan,-21972.0,Dead,WITH TUMOR,nan,361.0,nan,Intrapleural Progression,Ipsilateral Pleura,nan,222.0,nan,nan,nan,1.0,361.0,1.0,361.0,nan,nan,1.0,222.0,1
TCGA-3H-AB3M-01,TCGA-3H-AB3M,MESO,53.0,FEMALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2008.0,nan,-19503.0,Dead,WITH TUMOR,nan,885.0,nan,Distant Metastasis,Lung,nan,107.0,nan,nan,nan,1.0,885.0,1.0,885.0,nan,nan,1.0,107.0,1
TCGA-3H-AB3O-01,TCGA-3H-AB3O,MESO,58.0,MALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2008.0,nan,-21423.0,Dead,WITH TUMOR,nan,1302.0,nan,Intrapleural Progression,Ipsilateral Pleura,nan,627.0,nan,nan,nan,1.0,1302.0,1.0,1302.0,nan,nan,1.0,627.0,1
TCGA-3H-AB3S-01,TCGA-3H-AB3S,MESO,69.0,MALE,WHITE,Stage II,nan,Epithelioid mesothelioma,nan,2009.0,nan,-25471.0,Dead,WITH TUMOR,nan,385.0,nan,Locoregional Recurrence,"Other, specify",Ipsilateral Chest Cavity AND Ipsilateral Lymph Nodes AND Ipsilateral Chest Wall,186.0,nan,nan,[Unknown],1.0,385.0,1.0,385.0,nan,nan,1.0,186.0,1
TCGA-3H-AB3T-01,TCGA-3H-AB3T,MESO,79.0,MALE,WHITE,Stage I,nan,Biphasic mesothelioma,nan,2009.0,nan,-28925.0,Dead,WITH TUMOR,nan,414.0,nan,Intrapleural Progression,"Other, specify",Ipsilateral Chest Cavity AND Ipsilateral Lymph Nodes AND Ipsilateral Chest Wall,312.0,nan,nan,nan,1.0,414.0,1.0,414.0,nan,nan,1.0,312.0,1
TCGA-3H-AB3U-01,TCGA-3H-AB3U,MESO,71.0,MALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2009.0,nan,-26220.0,Dead,WITH TUMOR,nan,826.0,nan,Intrapleural Progression,Ipsilateral Pleura,nan,108.0,nan,nan,[Unknown],1.0,826.0,1.0,826.0,nan,nan,1.0,108.0,1
TCGA-3H-AB3X-01,TCGA-3H-AB3X,MESO,62.0,MALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2010.0,nan,-22702.0,Alive,TUMOR FREE,1490.0,nan,nan,nan,nan,nan,nan,nan,nan,[Unknown],0.0,1490.0,0.0,1490.0,nan,nan,0.0,1490.0,0
TCGA-3U-A98D-01,TCGA-3U-A98D,MESO,80.0,MALE,WHITE,Stage III,nan,Biphasic mesothelioma,nan,2012.0,nan,-29500.0,Dead,nan,nan,142.0,nan,Locoregional Recurrence,Ipsilateral Chest Wall,nan,125.0,nan,nan,nan,1.0,142.0,nan,142.0,nan,nan,1.0,125.0,1
TCGA-3U-A98E-01,TCGA-3U-A98E,MESO,71.0,FEMALE,WHITE,Stage IV,nan,Epithelioid mesothelioma,nan,2010.0,nan,-26264.0,Alive,WITH TUMOR,1916.0,nan,nan,Intrapleural Progression,nan,nan,1257.0,nan,nan,nan,0.0,1916.0,0.0,1916.0,nan,nan,1.0,1257.0,1
TCGA-3U-A98F-01,TCGA-3U-A98F,MESO,73.0,MALE,WHITE,Stage III,nan,Biphasic mesothelioma,nan,2012.0,nan,-26926.0,Dead,WITH TUMOR,nan,536.0,nan,Intrapleural Progression,nan,nan,365.0,nan,nan,nan,1.0,536.0,1.0,536.0,nan,nan,1.0,365.0,1
TCGA-3U-A98G-01,TCGA-3U-A98G,MESO,71.0,MALE,WHITE,Stage IV,nan,Biphasic mesothelioma,nan,2012.0,nan,-26185.0,Dead,WITH TUMOR,nan,630.0,nan,Intrapleural Progression,nan,nan,497.0,nan,nan,R0,1.0,630.0,1.0,630.0,nan,nan,1.0,497.0,1
TCGA-3U-A98H-01,TCGA-3U-A98H,MESO,57.0,MALE,WHITE,Stage IV,nan,Biphasic mesothelioma,nan,2010.0,nan,-21034.0,Dead,WITH TUMOR,nan,1156.0,nan,Intrapleural Progression,nan,nan,798.0,nan,nan,nan,1.0,1156.0,1.0,1156.0,nan,nan,1.0,798.0,1
TCGA-3U-A98I-01,TCGA-3U-A98I,MESO,68.0,MALE,WHITE,Stage IV,nan,Biphasic mesothelioma,nan,2013.0,nan,-25108.0,Dead,WITH TUMOR,nan,860.0,nan,Intrapleural Progression,nan,nan,404.0,nan,nan,nan,1.0,860.0,1.0,860.0,nan,nan,1.0,404.0,1
TCGA-3U-A98J-01,TCGA-3U-A98J,MESO,55.0,MALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2012.0,nan,-20338.0,Dead,WITH TUMOR,nan,741.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,741.0,1.0,741.0,nan,nan,1.0,741.0,1
TCGA-LK-A4NW-01,TCGA-LK-A4NW,MESO,60.0,MALE,WHITE,Stage IV,nan,Diffuse malignant mesothelioma - NOS,nan,2007.0,nan,-21922.0,Dead,WITH TUMOR,nan,546.0,nan,nan,nan,nan,nan,nan,nan,RX,1.0,546.0,1.0,546.0,nan,nan,1.0,546.0,1
TCGA-LK-A4NY-01,TCGA-LK-A4NY,MESO,66.0,FEMALE,WHITE,Stage III,nan,Biphasic mesothelioma,nan,2009.0,nan,-24391.0,Dead,TUMOR FREE,nan,168.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,168.0,0.0,168.0,0.0,168.0,0.0,168.0,0
TCGA-LK-A4NZ-01,TCGA-LK-A4NZ,MESO,75.0,MALE,WHITE,Stage II,nan,Epithelioid mesothelioma,nan,2009.0,nan,-27720.0,Dead,WITH TUMOR,nan,244.0,nan,nan,nan,nan,nan,nan,nan,R2,1.0,244.0,1.0,244.0,nan,nan,1.0,244.0,1
TCGA-LK-A4O0-01,TCGA-LK-A4O0,MESO,81.0,MALE,WHITE,Stage IA,nan,Sarcomatoid mesothelioma,nan,2009.0,nan,-29798.0,Dead,TUMOR FREE,nan,185.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,185.0,0.0,185.0,0.0,185.0,0.0,185.0,0
TCGA-LK-A4O2-01,TCGA-LK-A4O2,MESO,56.0,FEMALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2011.0,nan,-20757.0,Dead,WITH TUMOR,nan,57.0,nan,nan,nan,nan,nan,nan,nan,R2,1.0,57.0,1.0,57.0,nan,nan,1.0,57.0,1
TCGA-LK-A4O4-01,TCGA-LK-A4O4,MESO,69.0,MALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2008.0,nan,-25298.0,Dead,TUMOR FREE,nan,949.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,949.0,0.0,949.0,0.0,949.0,0.0,949.0,0
TCGA-LK-A4O5-01,TCGA-LK-A4O5,MESO,68.0,FEMALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2011.0,nan,-25000.0,Dead,WITH TUMOR,nan,387.0,nan,nan,nan,nan,nan,nan,nan,R1,1.0,387.0,1.0,387.0,nan,nan,1.0,387.0,1
TCGA-LK-A4O6-01,TCGA-LK-A4O6,MESO,66.0,FEMALE,WHITE,Stage III,nan,Biphasic mesothelioma,nan,2012.0,nan,-24449.0,Dead,WITH TUMOR,nan,448.0,nan,nan,nan,nan,nan,nan,nan,RX,1.0,448.0,1.0,448.0,nan,nan,1.0,448.0,1
TCGA-LK-A4O7-01,TCGA-LK-A4O7,MESO,64.0,MALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2012.0,nan,-23606.0,Dead,WITH TUMOR,nan,350.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,350.0,1.0,350.0,nan,nan,1.0,350.0,1
TCGA-MQ-A4KX-01,TCGA-MQ-A4KX,MESO,55.0,MALE,WHITE,Stage I,nan,Epithelioid mesothelioma,nan,2002.0,nan,-20336.0,Dead,nan,nan,2459.0,nan,Distant Metastasis,"Other, specify",IPSILATERAL CHEST,471.0,nan,nan,R0,1.0,2459.0,nan,2459.0,1.0,471.0,1.0,471.0,1
TCGA-MQ-A4LC-01,TCGA-MQ-A4LC,MESO,54.0,MALE,WHITE,Stage II,nan,Epithelioid mesothelioma,nan,2001.0,nan,-19866.0,Dead,TUMOR FREE,nan,2790.0,nan,Locoregional Recurrence,Ipsilateral Chest Cavity,nan,1908.0,nan,nan,R0,1.0,2790.0,0.0,2790.0,1.0,1908.0,1.0,1908.0,0
TCGA-MQ-A4LI-01,TCGA-MQ-A4LI,MESO,60.0,FEMALE,WHITE,Stage II,nan,Epithelioid mesothelioma,nan,1999.0,nan,-21951.0,Dead,WITH TUMOR,nan,572.0,nan,Distant Metastasis,"Other, specify",Chest,416.0,nan,nan,R1,1.0,572.0,1.0,572.0,nan,nan,1.0,416.0,1
TCGA-MQ-A4LJ-01,TCGA-MQ-A4LJ,MESO,53.0,MALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,1999.0,nan,-19437.0,Dead,nan,nan,709.0,nan,Intrapleural Progression,"Other, specify",Ipsilateral chest,409.0,nan,nan,[Unknown],1.0,709.0,nan,709.0,nan,nan,1.0,409.0,1
TCGA-MQ-A4LM-01,TCGA-MQ-A4LM,MESO,67.0,MALE,WHITE,Stage III,nan,Biphasic mesothelioma,nan,2002.0,nan,-24704.0,Dead,nan,nan,158.0,nan,Intrapleural Progression,"Other, specify",CONTRALATERAL EFFUSION,113.0,nan,nan,[Unknown],1.0,158.0,nan,158.0,nan,nan,1.0,113.0,1
TCGA-MQ-A4LP-01,TCGA-MQ-A4LP,MESO,67.0,MALE,WHITE,Stage III,nan,Biphasic mesothelioma,nan,2000.0,nan,-24652.0,Dead,nan,nan,527.0,nan,nan,nan,nan,nan,nan,nan,[Unknown],1.0,527.0,nan,527.0,nan,nan,0.0,527.0,1
TCGA-MQ-A4LV-01,TCGA-MQ-A4LV,MESO,63.0,MALE,WHITE,Stage III,nan,Biphasic mesothelioma,nan,2002.0,nan,-23110.0,Dead,TUMOR FREE,nan,107.0,nan,Intrapleural Progression,Ipsilateral Pleura,nan,99.0,nan,nan,R0,1.0,107.0,0.0,107.0,1.0,99.0,1.0,99.0,0
TCGA-MQ-A6BL-01,TCGA-MQ-A6BL,MESO,78.0,MALE,WHITE,Stage II,nan,Biphasic mesothelioma,nan,2007.0,nan,-28590.0,Dead,nan,nan,333.0,nan,Distant Metastasis,"Other, specify",Bone (Scapula),186.0,nan,nan,[Unknown],1.0,333.0,nan,333.0,nan,nan,1.0,186.0,1
TCGA-MQ-A6BN-01,TCGA-MQ-A6BN,MESO,73.0,FEMALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2007.0,nan,-26790.0,Dead,TUMOR FREE,nan,757.0,nan,Distant Metastasis,"Other, specify",Chest Wall,485.0,nan,nan,R0,1.0,757.0,0.0,757.0,1.0,485.0,1.0,485.0,1
TCGA-MQ-A6BQ-01,TCGA-MQ-A6BQ,MESO,58.0,MALE,WHITE,Stage II,nan,Epithelioid mesothelioma,nan,2009.0,nan,-21236.0,Alive,WITH TUMOR,2359.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,2359.0,0.0,2359.0,nan,nan,0.0,2359.0,0
TCGA-MQ-A6BR-01,TCGA-MQ-A6BR,MESO,55.0,FEMALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2008.0,nan,-20134.0,Alive,WITH TUMOR,2090.0,nan,nan,Distant Metastasis,"Other, specify",Chest Wall,665.0,nan,nan,RX,0.0,2090.0,0.0,2090.0,nan,nan,1.0,665.0,1
TCGA-MQ-A6BS-01,TCGA-MQ-A6BS,MESO,55.0,MALE,WHITE,Stage II,nan,Epithelioid mesothelioma,nan,2012.0,nan,-20384.0,Dead,TUMOR FREE,nan,608.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,608.0,0.0,608.0,0.0,608.0,0.0,608.0,0
TCGA-NQ-A57I-01,TCGA-NQ-A57I,MESO,71.0,MALE,WHITE,Stage IB,nan,Biphasic mesothelioma,nan,2012.0,nan,-26212.0,Dead,WITH TUMOR,nan,20.0,nan,nan,nan,nan,nan,nan,nan,R2,1.0,20.0,1.0,20.0,nan,nan,1.0,20.0,1
TCGA-NQ-A638-01,TCGA-NQ-A638,MESO,66.0,MALE,WHITE,Stage II,nan,Epithelioid mesothelioma,nan,2012.0,nan,-24410.0,Alive,TUMOR FREE,-8.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0
TCGA-SC-A6LM-01,TCGA-SC-A6LM,MESO,64.0,FEMALE,WHITE,Stage IV,nan,Epithelioid mesothelioma,nan,2010.0,nan,-23400.0,Dead,WITH TUMOR,nan,881.0,nan,Locoregional Recurrence,"Other, specify",Ipsilateral Chest Cavity AND Other,363.0,nan,nan,R2,1.0,881.0,1.0,881.0,nan,nan,1.0,363.0,1
TCGA-SC-A6LN-01,TCGA-SC-A6LN,MESO,76.0,MALE,ASIAN,Stage III,nan,Biphasic mesothelioma,nan,2012.0,nan,-27917.0,Dead,TUMOR FREE,nan,414.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,414.0,0.0,414.0,0.0,414.0,0.0,414.0,0
TCGA-SC-A6LP-01,TCGA-SC-A6LP,MESO,58.0,MALE,WHITE,Stage II,nan,Biphasic mesothelioma,nan,2012.0,nan,-21411.0,Dead,WITH TUMOR,nan,78.0,nan,nan,nan,nan,nan,nan,nan,RX,1.0,78.0,1.0,78.0,nan,nan,1.0,78.0,1
TCGA-SC-A6LQ-01,TCGA-SC-A6LQ,MESO,60.0,FEMALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2012.0,nan,-22014.0,Dead,WITH TUMOR,nan,297.0,nan,Distant Metastasis,Abdomen,nan,238.0,nan,nan,R0,1.0,297.0,1.0,297.0,1.0,238.0,1.0,238.0,1
TCGA-SC-A6LR-01,TCGA-SC-A6LR,MESO,73.0,MALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2012.0,nan,-26773.0,Alive,TUMOR FREE,1168.0,nan,nan,nan,nan,nan,nan,nan,nan,R2,0.0,1168.0,0.0,1168.0,nan,nan,0.0,1168.0,0
TCGA-SC-AA5Z-01,TCGA-SC-AA5Z,MESO,54.0,MALE,WHITE,Stage IV,nan,Epithelioid mesothelioma,nan,2013.0,nan,-19746.0,Alive,WITH TUMOR,664.0,nan,nan,nan,nan,nan,nan,nan,nan,R2,0.0,664.0,0.0,664.0,nan,nan,0.0,664.0,0
TCGA-SH-A7BC-01,TCGA-SH-A7BC,MESO,66.0,MALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2011.0,nan,-24459.0,Dead,WITH TUMOR,nan,727.0,nan,Locoregional Recurrence,"Other, specify",Ipsilateral Chest Cavity AND Ipsilateral Lymph Nodes,507.0,nan,nan,R2,1.0,727.0,1.0,727.0,nan,nan,1.0,507.0,1
TCGA-SH-A7BD-01,TCGA-SH-A7BD,MESO,68.0,MALE,WHITE,Stage IV,nan,Epithelioid mesothelioma,nan,2012.0,nan,-25019.0,Dead,WITH TUMOR,nan,459.0,nan,Locoregional Recurrence,"Other, specify",Ipsilateral Chest Cavity AND Ipsilateral Lymph Nodes AND Ipsilateral Chest Wall,200.0,nan,nan,R2,1.0,459.0,1.0,459.0,nan,nan,1.0,200.0,1
TCGA-SH-A7BH-01,TCGA-SH-A7BH,MESO,65.0,FEMALE,WHITE,Stage III,nan,Biphasic mesothelioma,nan,2012.0,nan,-23850.0,Dead,WITH TUMOR,nan,243.0,nan,Locoregional Recurrence,"Other, specify",Ipsilateral Chest Cavity AND Ipsilateral Chest Wall,125.0,nan,nan,R2,1.0,243.0,1.0,243.0,nan,nan,1.0,125.0,1
TCGA-SH-A9CT-01,TCGA-SH-A9CT,MESO,67.0,MALE,WHITE,Stage II,nan,Epithelioid mesothelioma,nan,2013.0,nan,-24528.0,Dead,WITH TUMOR,nan,449.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,449.0,1.0,449.0,nan,nan,1.0,449.0,1
TCGA-SH-A9CU-01,TCGA-SH-A9CU,MESO,60.0,MALE,WHITE,Stage IV,nan,Epithelioid mesothelioma,nan,2013.0,nan,-22135.0,Dead,WITH TUMOR,nan,732.0,nan,nan,nan,nan,nan,nan,nan,RX,1.0,732.0,1.0,732.0,nan,nan,1.0,732.0,1
TCGA-TS-A7OU-01,TCGA-TS-A7OU,MESO,56.0,MALE,WHITE,Stage IV,nan,Epithelioid mesothelioma,nan,2007.0,nan,-20747.0,Dead,nan,nan,1675.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1675.0,nan,1675.0,nan,nan,0.0,1675.0,1
TCGA-TS-A7OY-01,TCGA-TS-A7OY,MESO,62.0,MALE,WHITE,Stage IV,nan,Epithelioid mesothelioma,nan,2009.0,nan,-22720.0,Dead,nan,nan,255.0,nan,nan,nan,nan,nan,nan,nan,[Unknown],1.0,255.0,nan,255.0,nan,nan,0.0,255.0,1
TCGA-TS-A7OZ-01,TCGA-TS-A7OZ,MESO,67.0,MALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2010.0,nan,-24745.0,Dead,nan,nan,844.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,844.0,nan,844.0,nan,nan,0.0,844.0,1
TCGA-TS-A7P0-01,TCGA-TS-A7P0,MESO,42.0,MALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2010.0,nan,-15656.0,Dead,nan,nan,1261.0,nan,Locoregional Recurrence,Ipsilateral Chest Cavity,nan,277.0,nan,nan,[Unknown],1.0,1261.0,nan,1261.0,nan,nan,1.0,277.0,1
TCGA-TS-A7P1-01,TCGA-TS-A7P1,MESO,52.0,MALE,WHITE,Stage I,nan,Epithelioid mesothelioma,nan,2010.0,nan,-19191.0,Dead,nan,nan,563.0,nan,nan,nan,nan,494.0,nan,nan,[Unknown],1.0,563.0,nan,563.0,nan,nan,1.0,494.0,1
TCGA-TS-A7P3-01,TCGA-TS-A7P3,MESO,57.0,MALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2011.0,nan,-20964.0,Dead,nan,nan,689.0,nan,nan,nan,nan,nan,nan,nan,[Unknown],1.0,689.0,nan,689.0,nan,nan,0.0,689.0,0
TCGA-TS-A7P6-01,TCGA-TS-A7P6,MESO,61.0,MALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2011.0,nan,-22338.0,Dead,nan,nan,283.0,nan,nan,nan,nan,nan,nan,nan,[Unknown],1.0,283.0,nan,283.0,nan,nan,0.0,283.0,0
TCGA-TS-A7P7-01,TCGA-TS-A7P7,MESO,62.0,MALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2012.0,nan,-22670.0,Dead,nan,nan,591.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,591.0,nan,591.0,nan,nan,0.0,591.0,1
TCGA-TS-A7P8-01,TCGA-TS-A7P8,MESO,80.0,MALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2012.0,nan,-29464.0,Dead,nan,nan,457.0,nan,nan,"Other, specify",Ipsilateral Chest Cavity,301.0,nan,nan,[Unknown],1.0,457.0,nan,457.0,nan,nan,1.0,301.0,1
TCGA-TS-A7PB-01,TCGA-TS-A7PB,MESO,62.0,MALE,WHITE,Stage III,nan,Biphasic mesothelioma,nan,2011.0,nan,-22822.0,Dead,nan,nan,982.0,nan,nan,nan,nan,nan,nan,nan,[Unknown],1.0,982.0,nan,982.0,nan,nan,0.0,982.0,0
TCGA-TS-A8AF-01,TCGA-TS-A8AF,MESO,69.0,MALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2007.0,nan,-25486.0,Dead,nan,nan,358.0,nan,nan,nan,nan,325.0,nan,nan,[Unknown],1.0,358.0,nan,358.0,nan,nan,1.0,325.0,1
TCGA-TS-A8AI-01,TCGA-TS-A8AI,MESO,58.0,MALE,WHITE,Stage IV,nan,Epithelioid mesothelioma,nan,2009.0,nan,-21323.0,Dead,nan,nan,328.0,nan,nan,nan,nan,nan,nan,nan,[Unknown],1.0,328.0,nan,328.0,nan,nan,0.0,328.0,1
TCGA-TS-A8AS-01,TCGA-TS-A8AS,MESO,77.0,MALE,WHITE,Stage IA,nan,Epithelioid mesothelioma,nan,2011.0,nan,-28273.0,Dead,nan,nan,795.0,nan,nan,nan,nan,nan,nan,nan,[Unknown],1.0,795.0,nan,795.0,nan,nan,0.0,795.0,0
TCGA-TS-A8AV-01,TCGA-TS-A8AV,MESO,55.0,MALE,WHITE,Stage III,nan,Sarcomatoid mesothelioma,nan,2011.0,nan,-20437.0,Dead,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,[Unknown],1.0,nan,nan,nan,nan,nan,0.0,nan,1
TCGA-TS-A8AY-01,TCGA-TS-A8AY,MESO,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Epithelioid mesothelioma,nan,2013.0,nan,-17894.0,Dead,nan,nan,469.0,nan,nan,nan,nan,nan,nan,nan,[Unknown],1.0,469.0,nan,469.0,nan,nan,0.0,469.0,1
TCGA-UD-AABY-01,TCGA-UD-AABY,MESO,50.0,MALE,WHITE,Stage III,nan,Diffuse malignant mesothelioma - NOS,nan,1999.0,nan,-18315.0,Dead,WITH TUMOR,nan,843.0,nan,Intrapleural Progression,Ipsilateral Pleura,nan,47.0,nan,nan,RX,1.0,843.0,1.0,843.0,nan,nan,1.0,47.0,1
TCGA-UD-AABZ-01,TCGA-UD-AABZ,MESO,46.0,MALE,WHITE,Stage II,nan,Epithelioid mesothelioma,nan,2004.0,nan,-16913.0,Dead,WITH TUMOR,nan,197.0,nan,nan,nan,nan,nan,nan,nan,RX,1.0,197.0,1.0,197.0,nan,nan,1.0,197.0,1
TCGA-UD-AAC1-01,TCGA-UD-AAC1,MESO,71.0,FEMALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2005.0,nan,-26057.0,Dead,WITH TUMOR,nan,789.0,nan,Intrapleural Progression,Ipsilateral Pleura,nan,85.0,nan,nan,R2,1.0,789.0,1.0,789.0,nan,nan,1.0,85.0,1
TCGA-UD-AAC4-01,TCGA-UD-AAC4,MESO,65.0,MALE,WHITE,Stage III,nan,Diffuse malignant mesothelioma - NOS,nan,2004.0,nan,-23949.0,Dead,WITH TUMOR,nan,719.0,nan,Intrapleural Progression,Ipsilateral Pleura,nan,267.0,nan,nan,R2,1.0,719.0,1.0,719.0,nan,nan,1.0,267.0,1
TCGA-UD-AAC5-01,TCGA-UD-AAC5,MESO,66.0,MALE,WHITE,Stage I,nan,Epithelioid mesothelioma,nan,2005.0,nan,-24314.0,Dead,WITH TUMOR,nan,253.0,nan,Distant Metastasis,Abdomen,nan,230.0,nan,nan,RX,1.0,253.0,1.0,253.0,nan,nan,1.0,230.0,1
TCGA-UD-AAC6-01,TCGA-UD-AAC6,MESO,67.0,MALE,WHITE,Stage II,nan,Biphasic mesothelioma,nan,2006.0,nan,-24571.0,Dead,WITH TUMOR,nan,456.0,nan,Intrapleural Progression,Ipsilateral Pleura,nan,126.0,nan,nan,R2,1.0,456.0,1.0,456.0,nan,nan,1.0,126.0,1
TCGA-UD-AAC7-01,TCGA-UD-AAC7,MESO,47.0,MALE,WHITE,Stage II,nan,Epithelioid mesothelioma,nan,2008.0,nan,-17299.0,Dead,WITH TUMOR,nan,406.0,nan,Intrapleural Progression,Ipsilateral Pleura,nan,265.0,nan,nan,R2,1.0,406.0,1.0,406.0,nan,nan,1.0,265.0,1
TCGA-UT-A88C-01,TCGA-UT-A88C,MESO,62.0,MALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2012.0,nan,-23002.0,Dead,WITH TUMOR,nan,863.0,nan,Intrapleural Progression,"Other, specify",Mediastinum and Contralateral pleura,479.0,nan,nan,R0,1.0,863.0,1.0,863.0,1.0,479.0,1.0,479.0,1
TCGA-UT-A88D-01,TCGA-UT-A88D,MESO,66.0,MALE,WHITE,Stage II,nan,Epithelioid mesothelioma,nan,2012.0,nan,-24300.0,Dead,TUMOR FREE,nan,823.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,823.0,0.0,823.0,0.0,823.0,0.0,823.0,0
TCGA-UT-A88E-01,TCGA-UT-A88E,MESO,74.0,MALE,WHITE,Stage I,nan,Epithelioid mesothelioma,nan,2012.0,nan,-27347.0,Dead,WITH TUMOR,nan,434.0,nan,Intrapleural Progression,"Other, specify",chest wall musculature invasion,121.0,nan,nan,RX,1.0,434.0,1.0,434.0,nan,nan,1.0,121.0,1
TCGA-UT-A88G-01,TCGA-UT-A88G,MESO,73.0,MALE,WHITE,Stage III,nan,Biphasic mesothelioma,nan,2012.0,nan,-26704.0,Dead,WITH TUMOR,nan,76.0,nan,Intrapleural Progression,"Other, specify",Right Hemithorax,44.0,nan,nan,RX,1.0,76.0,1.0,76.0,nan,nan,1.0,44.0,1
TCGA-UT-A97Y-01,TCGA-UT-A97Y,MESO,81.0,FEMALE,WHITE,Stage I,nan,Epithelioid mesothelioma,nan,2011.0,nan,-29905.0,Dead,WITH TUMOR,nan,144.0,nan,nan,nan,nan,nan,nan,nan,RX,1.0,144.0,1.0,144.0,nan,nan,1.0,144.0,1
TCGA-XT-AASU-01,TCGA-XT-AASU,MESO,60.0,MALE,WHITE,Stage III,nan,Biphasic mesothelioma,nan,2005.0,nan,-22021.0,Dead,WITH TUMOR,nan,142.0,nan,Locoregional Recurrence,Ipsilateral Chest Cavity,nan,133.0,nan,nan,R0,1.0,142.0,1.0,142.0,1.0,133.0,1.0,133.0,1
TCGA-YS-A95B-01,TCGA-YS-A95B,MESO,28.0,FEMALE,WHITE,Stage IV,nan,Epithelioid mesothelioma,nan,2009.0,nan,-10510.0,Dead,WITH TUMOR,nan,39.0,nan,nan,nan,nan,nan,nan,nan,R2,1.0,39.0,1.0,39.0,nan,nan,1.0,39.0,1
TCGA-YS-A95C-01,TCGA-YS-A95C,MESO,54.0,MALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2013.0,nan,-19818.0,Dead,TUMOR FREE,nan,133.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,133.0,0.0,133.0,0.0,133.0,0.0,133.0,0
TCGA-YS-AA4M-01,TCGA-YS-AA4M,MESO,66.0,MALE,WHITE,Stage IV,nan,Diffuse malignant mesothelioma - NOS,nan,2013.0,nan,-24176.0,Dead,WITH TUMOR,nan,84.0,nan,Distant Metastasis,Bone,nan,-131.0,nan,nan,R2,1.0,84.0,1.0,84.0,nan,nan,1.0,nan,1
TCGA-ZN-A9VO-01,TCGA-ZN-A9VO,MESO,36.0,MALE,WHITE,Stage IV,nan,Epithelioid mesothelioma,nan,2011.0,nan,-13243.0,Alive,TUMOR FREE,261.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,261.0,0.0,261.0,nan,nan,0.0,261.0,0
TCGA-ZN-A9VP-01,TCGA-ZN-A9VP,MESO,51.0,MALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2012.0,nan,-18697.0,Alive,TUMOR FREE,228.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,228.0,0.0,228.0,nan,nan,0.0,228.0,0
TCGA-ZN-A9VQ-01,TCGA-ZN-A9VQ,MESO,61.0,MALE,WHITE,Stage I,nan,Biphasic mesothelioma,nan,2012.0,nan,-22443.0,Alive,WITH TUMOR,499.0,nan,nan,Intrapleural Progression,"Other, specify",Right chest wall,313.0,nan,nan,nan,0.0,499.0,0.0,499.0,nan,nan,1.0,313.0,0
TCGA-ZN-A9VS-01,TCGA-ZN-A9VS,MESO,67.0,MALE,WHITE,Stage III,nan,Epithelioid mesothelioma,nan,2011.0,nan,-24490.0,Alive,WITH TUMOR,1228.0,nan,nan,Intrapleural Progression,Ipsilateral Pleura,nan,1025.0,nan,nan,nan,0.0,1228.0,0.0,1228.0,nan,nan,1.0,1025.0,0
TCGA-ZN-A9VU-01,TCGA-ZN-A9VU,MESO,70.0,MALE,WHITE,Stage II,nan,Epithelioid mesothelioma,nan,2012.0,nan,-25714.0,Alive,TUMOR FREE,977.0,nan,nan,Intrapleural Progression,"Other, specify",left chest wall,585.0,nan,nan,nan,0.0,977.0,0.0,977.0,nan,nan,1.0,585.0,0
TCGA-ZN-A9VV-01,TCGA-ZN-A9VV,MESO,68.0,MALE,WHITE,Stage III,nan,Biphasic mesothelioma,nan,2010.0,nan,-25096.0,Alive,WITH TUMOR,1309.0,nan,nan,Intrapleural Progression,Ipsilateral Pleura,nan,676.0,nan,nan,nan,0.0,1309.0,0.0,1309.0,nan,nan,1.0,676.0,0
TCGA-ZN-A9VW-01,TCGA-ZN-A9VW,MESO,61.0,MALE,WHITE,Stage IV,nan,Biphasic mesothelioma,nan,2010.0,nan,-22588.0,Dead,WITH TUMOR,nan,84.0,nan,Intrapleural Progression,"Other, specify",right chest wall,-30.0,nan,nan,nan,1.0,84.0,1.0,84.0,nan,nan,1.0,nan,1
TCGA-04-1331-01,TCGA-04-1331,OV,78.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-28848.0,Dead,WITH TUMOR,1224.0,1336.0,nan,Recurrence,nan,nan,459.0,Complete Remission/Response,nan,nan,1.0,1336.0,1.0,1336.0,1.0,459.0,1.0,459.0,1
TCGA-04-1332-01,TCGA-04-1332,OV,70.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-25786.0,Dead,WITH TUMOR,1247.0,1247.0,nan,Recurrence,nan,nan,393.0,nan,nan,nan,1.0,1247.0,1.0,1247.0,nan,nan,1.0,393.0,1
TCGA-04-1335-01,TCGA-04-1335,OV,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Serous Cystadenocarcinoma,G2,2005.0,nan,-21963.0,Dead,WITH TUMOR,nan,55.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,55.0,1.0,55.0,nan,nan,1.0,55.0,1
TCGA-04-1336-01,TCGA-04-1336,OV,55.0,FEMALE,WHITE,nan,Stage IIIB,Serous Cystadenocarcinoma,G3,2005.0,nan,-20271.0,Alive,TUMOR FREE,1495.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1495.0,0.0,1495.0,0.0,1495.0,0.0,1495.0,0
TCGA-04-1337-01,TCGA-04-1337,OV,78.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2005.0,nan,-28626.0,Dead,WITH TUMOR,nan,61.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,61.0,1.0,61.0,nan,nan,1.0,61.0,1
TCGA-04-1338-01,TCGA-04-1338,OV,78.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-28789.0,Alive,WITH TUMOR,1418.0,nan,nan,Recurrence,nan,nan,380.0,nan,nan,nan,0.0,1418.0,0.0,1418.0,nan,nan,1.0,380.0,2
TCGA-04-1341-01,TCGA-04-1341,OV,85.0,FEMALE,WHITE,nan,nan,Serous Cystadenocarcinoma,G3,2006.0,nan,-31215.0,Alive,nan,33.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,33.0,0.0,33.0,0.0,33.0,0.0,33.0,2
TCGA-04-1342-01,TCGA-04-1342,OV,80.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G2,2006.0,nan,-29501.0,Dead,WITH TUMOR,nan,563.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,563.0,1.0,563.0,nan,nan,1.0,563.0,1
TCGA-04-1343-01,TCGA-04-1343,OV,72.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2002.0,nan,-26428.0,Dead,WITH TUMOR,nan,361.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,361.0,1.0,361.0,nan,nan,1.0,361.0,1
TCGA-04-1346-01,TCGA-04-1346,OV,73.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2003.0,nan,-26865.0,Alive,TUMOR FREE,1993.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1993.0,0.0,1993.0,0.0,1993.0,0.0,1993.0,0
TCGA-04-1347-01,TCGA-04-1347,OV,81.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2004.0,nan,-29695.0,Alive,TUMOR FREE,1919.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1919.0,0.0,1919.0,nan,nan,0.0,1919.0,0
TCGA-04-1348-01,TCGA-04-1348,OV,44.0,FEMALE,WHITE,nan,Stage IIIB,Serous Cystadenocarcinoma,G3,2004.0,nan,-16236.0,Dead,WITH TUMOR,nan,1483.0,nan,Recurrence,nan,nan,575.0,Complete Remission/Response,nan,nan,1.0,1483.0,1.0,1483.0,1.0,575.0,1.0,575.0,1
TCGA-04-1349-01,TCGA-04-1349,OV,69.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2004.0,nan,-25213.0,Dead,WITH TUMOR,nan,656.0,nan,Recurrence,nan,nan,428.0,Complete Remission/Response,nan,nan,1.0,656.0,1.0,656.0,nan,nan,1.0,428.0,1
TCGA-04-1350-01,TCGA-04-1350,OV,46.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-16942.0,Dead,WITH TUMOR,nan,1946.0,nan,Recurrence,nan,nan,111.0,Stable Disease,nan,nan,1.0,1946.0,1.0,1946.0,nan,nan,1.0,111.0,1
TCGA-04-1351-01,TCGA-04-1351,OV,76.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2004.0,nan,-28045.0,Alive,TUMOR FREE,1991.0,nan,nan,Recurrence,nan,nan,1658.0,Complete Remission/Response,nan,nan,0.0,1991.0,0.0,1991.0,1.0,1658.0,1.0,1658.0,2
TCGA-04-1353-01,TCGA-04-1353,OV,64.0,FEMALE,ASIAN,nan,Stage IIIC,Serous Cystadenocarcinoma,nan,2003.0,nan,-23611.0,Alive,nan,16.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,16.0,0.0,16.0,nan,nan,0.0,16.0,0
TCGA-04-1353-11,TCGA-04-1353,OV,64.0,FEMALE,ASIAN,nan,Stage IIIC,Serous Cystadenocarcinoma,nan,2003.0,nan,-23611.0,Alive,nan,16.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,16.0,0.0,16.0,nan,nan,0.0,16.0,0
TCGA-04-1356-01,TCGA-04-1356,OV,62.0,FEMALE,WHITE,nan,Stage IIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-22855.0,Dead,WITH TUMOR,nan,1499.0,nan,Recurrence,nan,nan,156.0,Progressive Disease,nan,nan,1.0,1499.0,1.0,1499.0,nan,nan,1.0,156.0,1
TCGA-04-1357-01,TCGA-04-1357,OV,52.0,FEMALE,nan,nan,Stage IIIB,Serous Cystadenocarcinoma,G3,2005.0,nan,-18999.0,Alive,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,nan,0.0,nan,nan,nan,0.0,nan,1
TCGA-04-1360-01,TCGA-04-1360,OV,65.0,FEMALE,nan,nan,Stage IA,Serous Cystadenocarcinoma,G3,2005.0,nan,-23993.0,Alive,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,nan,0.0,nan,nan,nan,0.0,nan,1
TCGA-04-1361-01,TCGA-04-1361,OV,57.0,FEMALE,WHITE,nan,Stage IIIB,Serous Cystadenocarcinoma,G3,2005.0,nan,-20860.0,Alive,nan,989.0,nan,nan,Recurrence,nan,nan,927.0,Stable Disease,nan,nan,0.0,989.0,0.0,989.0,nan,nan,1.0,927.0,2
TCGA-04-1362-01,TCGA-04-1362,OV,59.0,FEMALE,WHITE,nan,Stage IIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-21745.0,Dead,WITH TUMOR,nan,1348.0,nan,Recurrence,nan,nan,223.0,nan,nan,nan,1.0,1348.0,1.0,1348.0,nan,nan,1.0,223.0,1
TCGA-04-1364-01,TCGA-04-1364,OV,61.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-22294.0,Dead,WITH TUMOR,nan,1024.0,nan,Recurrence,nan,nan,288.0,Progressive Disease,nan,nan,1.0,1024.0,1.0,1024.0,nan,nan,1.0,288.0,1
TCGA-04-1365-01,TCGA-04-1365,OV,87.0,FEMALE,WHITE,nan,Stage IIIB,Serous Cystadenocarcinoma,G3,2003.0,nan,-31925.0,Alive,WITH TUMOR,2329.0,nan,nan,Recurrence,nan,nan,1328.0,Complete Remission/Response,nan,nan,0.0,2329.0,0.0,2329.0,1.0,1328.0,1.0,1328.0,2
TCGA-04-1367-01,TCGA-04-1367,OV,50.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-18577.0,Alive,WITH TUMOR,3145.0,nan,nan,Progression of Disease,nan,nan,2997.0,Complete Remission/Response,nan,nan,0.0,3145.0,0.0,3145.0,1.0,2997.0,1.0,2997.0,2
TCGA-04-1369-01,TCGA-04-1369,OV,53.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2004.0,nan,-19571.0,Dead,WITH TUMOR,nan,642.0,nan,Progression of Disease,nan,nan,315.0,nan,nan,nan,1.0,642.0,1.0,642.0,nan,nan,1.0,315.0,1
TCGA-04-1369-11,TCGA-04-1369,OV,53.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2004.0,nan,-19571.0,Dead,WITH TUMOR,nan,642.0,nan,Progression of Disease,nan,nan,315.0,nan,nan,nan,1.0,642.0,1.0,642.0,nan,nan,1.0,315.0,1
TCGA-04-1371-01,TCGA-04-1371,OV,58.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,nan,-21243.0,Alive,TUMOR FREE,2506.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2506.0,0.0,2506.0,nan,nan,0.0,2506.0,0
TCGA-04-1514-01,TCGA-04-1514,OV,45.0,FEMALE,WHITE,nan,Stage IIIA,Serous Cystadenocarcinoma,G2,2004.0,nan,-16725.0,Dead,TUMOR FREE,nan,1720.0,nan,Recurrence,nan,nan,1221.0,Complete Remission/Response,nan,nan,1.0,1720.0,0.0,1720.0,1.0,1221.0,1.0,1221.0,2
TCGA-04-1516-01,TCGA-04-1516,OV,48.0,FEMALE,WHITE,nan,Stage IA,Serous Cystadenocarcinoma,G3,2006.0,nan,-17768.0,Alive,TUMOR FREE,1265.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1265.0,0.0,1265.0,0.0,1265.0,0.0,1265.0,0
TCGA-04-1516-11,TCGA-04-1516,OV,48.0,FEMALE,WHITE,nan,Stage IA,Serous Cystadenocarcinoma,G3,2006.0,nan,-17768.0,Alive,TUMOR FREE,1265.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1265.0,0.0,1265.0,0.0,1265.0,0.0,1265.0,0
TCGA-04-1517-01,TCGA-04-1517,OV,79.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-29045.0,Dead,WITH TUMOR,nan,608.0,nan,Recurrence,nan,nan,349.0,Complete Remission/Response,nan,nan,1.0,608.0,1.0,608.0,1.0,349.0,1.0,349.0,1
TCGA-04-1519-01,TCGA-04-1519,OV,48.0,FEMALE,nan,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-17671.0,Alive,nan,24.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,24.0,0.0,24.0,nan,nan,0.0,24.0,0
TCGA-04-1525-01,TCGA-04-1525,OV,47.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-17469.0,Dead,WITH TUMOR,1167.0,1167.0,nan,Recurrence,nan,nan,213.0,Complete Remission/Response,nan,nan,1.0,1167.0,1.0,1167.0,1.0,213.0,1.0,213.0,1
TCGA-04-1530-01,TCGA-04-1530,OV,68.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1995.0,nan,-25013.0,Dead,WITH TUMOR,nan,3622.0,nan,Recurrence,nan,nan,350.0,Complete Remission/Response,nan,nan,1.0,3622.0,1.0,3622.0,1.0,350.0,1.0,350.0,1
TCGA-04-1536-01,TCGA-04-1536,OV,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IV,Serous Cystadenocarcinoma,G3,2001.0,nan,-21939.0,Dead,WITH TUMOR,nan,885.0,nan,Recurrence,nan,nan,498.0,nan,nan,nan,1.0,885.0,1.0,885.0,nan,nan,1.0,498.0,1
TCGA-04-1542-01,TCGA-04-1542,OV,52.0,FEMALE,WHITE,nan,Stage IIIB,Serous Cystadenocarcinoma,G2,2001.0,nan,-19263.0,Dead,WITH TUMOR,nan,2561.0,nan,Recurrence,nan,nan,1020.0,Complete Remission/Response,nan,nan,1.0,2561.0,1.0,2561.0,1.0,1020.0,1.0,1020.0,1
TCGA-04-1638-01,TCGA-04-1638,OV,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IV,Serous Cystadenocarcinoma,G3,2002.0,nan,-20987.0,Dead,TUMOR FREE,nan,1686.0,nan,Recurrence,nan,nan,298.0,nan,nan,nan,1.0,1686.0,0.0,1686.0,nan,nan,1.0,298.0,1
TCGA-04-1644-01,TCGA-04-1644,OV,48.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-17725.0,Dead,WITH TUMOR,nan,1487.0,nan,Progression of Disease,nan,nan,634.0,Partial Remission/Response,nan,nan,1.0,1487.0,1.0,1487.0,nan,nan,1.0,634.0,1
TCGA-04-1644-11,TCGA-04-1644,OV,48.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-17725.0,Dead,WITH TUMOR,nan,1487.0,nan,Progression of Disease,nan,nan,634.0,Partial Remission/Response,nan,nan,1.0,1487.0,1.0,1487.0,nan,nan,1.0,634.0,1
TCGA-04-1646-01,TCGA-04-1646,OV,60.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-22207.0,Dead,WITH TUMOR,nan,848.0,nan,Recurrence,nan,nan,508.0,nan,nan,nan,1.0,848.0,1.0,848.0,nan,nan,1.0,508.0,1
TCGA-04-1648-01,TCGA-04-1648,OV,57.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2003.0,nan,-21113.0,Dead,nan,nan,871.0,nan,Recurrence,nan,nan,412.0,nan,nan,nan,1.0,871.0,nan,871.0,nan,nan,1.0,412.0,1
TCGA-04-1649-01,TCGA-04-1649,OV,74.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-27165.0,Alive,nan,1966.0,nan,nan,Recurrence,nan,nan,1672.0,nan,nan,nan,0.0,1966.0,0.0,1966.0,nan,nan,1.0,1672.0,2
TCGA-04-1651-01,TCGA-04-1651,OV,53.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-19628.0,Dead,nan,nan,1102.0,nan,Recurrence,nan,nan,990.0,nan,nan,nan,1.0,1102.0,nan,1102.0,nan,nan,1.0,990.0,1
TCGA-04-1652-01,TCGA-04-1652,OV,76.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2004.0,nan,-28101.0,Dead,WITH TUMOR,nan,969.0,nan,Recurrence,nan,nan,880.0,Complete Remission/Response,nan,nan,1.0,969.0,1.0,969.0,1.0,880.0,1.0,880.0,1
TCGA-04-1654-01,TCGA-04-1654,OV,69.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,1999.0,nan,-25387.0,Dead,nan,nan,1451.0,nan,Recurrence,nan,nan,808.0,nan,nan,nan,1.0,1451.0,nan,1451.0,nan,nan,1.0,808.0,1
TCGA-04-1655-01,TCGA-04-1655,OV,49.0,FEMALE,WHITE,nan,Stage IIIB,Serous Cystadenocarcinoma,G2,1999.0,nan,-17988.0,Dead,nan,nan,1380.0,nan,Recurrence,nan,nan,819.0,nan,nan,nan,1.0,1380.0,nan,1380.0,nan,nan,1.0,819.0,1
TCGA-09-0364-01,TCGA-09-0364,OV,80.0,FEMALE,WHITE,nan,Stage IIC,Serous Cystadenocarcinoma,G3,1998.0,nan,-29262.0,Dead,WITH TUMOR,nan,887.0,nan,Recurrence,nan,nan,395.0,Complete Remission/Response,nan,nan,1.0,887.0,1.0,887.0,1.0,395.0,1.0,395.0,1
TCGA-09-0365-01,TCGA-09-0365,OV,70.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,nan,-25703.0,Dead,WITH TUMOR,nan,288.0,nan,Recurrence,nan,nan,251.0,Complete Remission/Response,nan,nan,1.0,288.0,1.0,288.0,1.0,251.0,1.0,251.0,1
TCGA-09-0366-01,TCGA-09-0366,OV,55.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,nan,-20440.0,Dead,WITH TUMOR,nan,1757.0,nan,Recurrence,nan,nan,190.0,Stable Disease,nan,nan,1.0,1757.0,1.0,1757.0,nan,nan,1.0,190.0,1
TCGA-09-0367-01,TCGA-09-0367,OV,67.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,nan,-24473.0,Dead,WITH TUMOR,nan,547.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,547.0,1.0,547.0,nan,nan,1.0,547.0,1
TCGA-09-0369-01,TCGA-09-0369,OV,56.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-20705.0,Dead,WITH TUMOR,nan,1082.0,nan,Recurrence,nan,nan,274.0,Complete Remission/Response,nan,nan,1.0,1082.0,1.0,1082.0,1.0,274.0,1.0,274.0,1
TCGA-09-1659-01,TCGA-09-1659,OV,51.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1997.0,nan,-18733.0,Dead,WITH TUMOR,nan,304.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,304.0,1.0,304.0,nan,nan,1.0,304.0,1
TCGA-09-1661-01,TCGA-09-1661,OV,75.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2000.0,nan,-27486.0,Dead,WITH TUMOR,nan,1169.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,1169.0,1.0,1169.0,nan,nan,1.0,1169.0,1
TCGA-09-1662-01,TCGA-09-1662,OV,58.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2001.0,nan,-21246.0,Dead,WITH TUMOR,nan,2717.0,nan,Recurrence,nan,nan,1046.0,Complete Remission/Response,nan,nan,1.0,2717.0,1.0,2717.0,nan,nan,1.0,1046.0,1
TCGA-09-1664-01,TCGA-09-1664,OV,37.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G1,2002.0,nan,-13739.0,Dead,nan,nan,2279.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2279.0,nan,2279.0,0.0,2279.0,0.0,2279.0,1
TCGA-09-1665-01,TCGA-09-1665,OV,73.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2002.0,nan,-27010.0,Dead,WITH TUMOR,nan,1266.0,nan,Recurrence,nan,nan,468.0,Complete Remission/Response,nan,nan,1.0,1266.0,1.0,1266.0,1.0,468.0,1.0,468.0,1
TCGA-09-1666-01,TCGA-09-1666,OV,57.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-21066.0,Alive,WITH TUMOR,1752.0,nan,nan,Recurrence,nan,nan,480.0,Complete Remission/Response,nan,nan,0.0,1752.0,0.0,1752.0,1.0,480.0,1.0,480.0,2
TCGA-09-1667-01,TCGA-09-1667,OV,61.0,FEMALE,WHITE,nan,Stage IIC,Serous Cystadenocarcinoma,G2,2004.0,nan,-22306.0,Alive,WITH TUMOR,1882.0,nan,nan,Recurrence,nan,nan,460.0,Complete Remission/Response,nan,nan,0.0,1882.0,0.0,1882.0,1.0,460.0,1.0,460.0,2
TCGA-09-1668-01,TCGA-09-1668,OV,57.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-20972.0,Alive,WITH TUMOR,1684.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1684.0,0.0,1684.0,0.0,1684.0,0.0,1684.0,2
TCGA-09-1669-01,TCGA-09-1669,OV,54.0,FEMALE,WHITE,nan,Stage IIIA,Serous Cystadenocarcinoma,G3,2004.0,nan,-20052.0,Alive,WITH TUMOR,928.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,928.0,0.0,928.0,0.0,928.0,0.0,928.0,2
TCGA-09-1670-01,TCGA-09-1670,OV,57.0,FEMALE,WHITE,nan,Stage IIIA,Serous Cystadenocarcinoma,G3,2005.0,nan,-21147.0,Alive,WITH TUMOR,547.0,nan,nan,Recurrence,nan,nan,547.0,Complete Remission/Response,nan,nan,0.0,547.0,0.0,547.0,1.0,547.0,1.0,547.0,2
TCGA-09-1672-01,TCGA-09-1672,OV,78.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G1,2008.0,nan,-28556.0,Alive,TUMOR FREE,178.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,178.0,0.0,178.0,nan,nan,0.0,178.0,0
TCGA-09-1673-01,TCGA-09-1673,OV,50.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2008.0,nan,-18599.0,Alive,WITH TUMOR,92.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,92.0,0.0,92.0,nan,nan,0.0,92.0,0
TCGA-09-1674-01,TCGA-09-1674,OV,79.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-28878.0,Alive,WITH TUMOR,260.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,260.0,0.0,260.0,0.0,260.0,0.0,260.0,2
TCGA-09-1675-01,TCGA-09-1675,OV,50.0,FEMALE,nan,nan,Stage IC,Serous Cystadenocarcinoma,G2,2001.0,nan,-18596.0,Alive,TUMOR FREE,2967.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2967.0,0.0,2967.0,0.0,2967.0,0.0,2967.0,0
TCGA-09-2043-01,TCGA-09-2043,OV,69.0,FEMALE,WHITE,nan,Stage IC,Serous Cystadenocarcinoma,G3,2009.0,nan,-25480.0,Alive,TUMOR FREE,188.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,188.0,0.0,188.0,0.0,188.0,0.0,188.0,0
TCGA-09-2044-01,TCGA-09-2044,OV,77.0,FEMALE,ASIAN,nan,Stage IIB,Serous Cystadenocarcinoma,G3,2009.0,nan,-28231.0,Alive,TUMOR FREE,186.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,186.0,0.0,186.0,0.0,186.0,0.0,186.0,0
TCGA-09-2045-01,TCGA-09-2045,OV,50.0,FEMALE,ASIAN,nan,Stage IV,Serous Cystadenocarcinoma,G2,1996.0,nan,-18285.0,Dead,WITH TUMOR,nan,1069.0,nan,Recurrence,nan,nan,631.0,Stable Disease,nan,nan,1.0,1069.0,1.0,1069.0,nan,nan,1.0,631.0,1
TCGA-09-2048-01,TCGA-09-2048,OV,63.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,nan,-23043.0,Dead,WITH TUMOR,nan,138.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,138.0,1.0,138.0,nan,nan,1.0,138.0,1
TCGA-09-2049-01,TCGA-09-2049,OV,64.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,nan,-23410.0,Alive,WITH TUMOR,3419.0,nan,nan,Recurrence,nan,nan,953.0,Complete Remission/Response,nan,nan,0.0,3419.0,0.0,3419.0,1.0,953.0,1.0,953.0,2
TCGA-09-2050-01,TCGA-09-2050,OV,65.0,FEMALE,WHITE,nan,Stage IIA,Serous Cystadenocarcinoma,G2,2003.0,nan,-23987.0,Alive,TUMOR FREE,2163.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2163.0,0.0,2163.0,0.0,2163.0,0.0,2163.0,2
TCGA-09-2051-01,TCGA-09-2051,OV,42.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-15650.0,Alive,TUMOR FREE,1919.0,nan,nan,Recurrence,nan,nan,583.0,Complete Remission/Response,nan,nan,0.0,1919.0,0.0,1919.0,1.0,583.0,1.0,583.0,2
TCGA-09-2053-01,TCGA-09-2053,OV,72.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-26433.0,Alive,TUMOR FREE,1209.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1209.0,0.0,1209.0,0.0,1209.0,0.0,1209.0,0
TCGA-09-2054-01,TCGA-09-2054,OV,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-21285.0,Dead,WITH TUMOR,637.0,637.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,637.0,1.0,637.0,nan,nan,1.0,637.0,1
TCGA-09-2055-01,TCGA-09-2055,OV,48.0,FEMALE,WHITE,nan,Stage IC,Serous Cystadenocarcinoma,G3,2007.0,nan,-17545.0,Alive,TUMOR FREE,819.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,819.0,0.0,819.0,0.0,819.0,0.0,819.0,0
TCGA-09-2056-01,TCGA-09-2056,OV,62.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-22864.0,Alive,TUMOR FREE,379.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,0
TCGA-10-0925-01,TCGA-10-0925,OV,58.0,FEMALE,WHITE,nan,Stage IIIB,Serous Cystadenocarcinoma,G1,2000.0,nan,-21498.0,Dead,WITH TUMOR,1652.0,1652.0,nan,Recurrence,nan,nan,558.0,Partial Remission/Response,nan,nan,1.0,1652.0,1.0,1652.0,nan,nan,1.0,558.0,1
TCGA-10-0926-01,TCGA-10-0926,OV,63.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2000.0,nan,-23307.0,Dead,WITH TUMOR,788.0,788.0,nan,Recurrence,nan,nan,287.0,Complete Remission/Response,nan,nan,1.0,788.0,1.0,788.0,1.0,287.0,1.0,287.0,1
TCGA-10-0927-01,TCGA-10-0927,OV,65.0,FEMALE,nan,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2000.0,nan,-23982.0,Dead,WITH TUMOR,2478.0,2490.0,nan,Recurrence,nan,nan,1001.0,Complete Remission/Response,nan,nan,1.0,2490.0,1.0,2490.0,1.0,1001.0,1.0,1001.0,2
TCGA-10-0928-01,TCGA-10-0928,OV,71.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2000.0,nan,-26066.0,Dead,WITH TUMOR,563.0,563.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,563.0,1.0,563.0,nan,nan,1.0,563.0,1
TCGA-10-0930-01,TCGA-10-0930,OV,70.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-25737.0,Dead,WITH TUMOR,1011.0,1040.0,nan,Recurrence,nan,nan,680.0,Complete Remission/Response,nan,nan,1.0,1040.0,1.0,1040.0,1.0,680.0,1.0,680.0,1
TCGA-10-0931-01,TCGA-10-0931,OV,44.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-16262.0,Dead,WITH TUMOR,982.0,1000.0,nan,Recurrence,nan,nan,300.0,Complete Remission/Response,nan,nan,1.0,1000.0,1.0,1000.0,1.0,300.0,1.0,300.0,1
TCGA-10-0933-01,TCGA-10-0933,OV,77.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-28433.0,Dead,WITH TUMOR,356.0,446.0,nan,Recurrence,nan,nan,356.0,Complete Remission/Response,nan,nan,1.0,446.0,1.0,446.0,1.0,356.0,1.0,356.0,1
TCGA-10-0934-01,TCGA-10-0934,OV,50.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-18602.0,Dead,WITH TUMOR,119.0,204.0,nan,Recurrence,nan,nan,111.0,Progressive Disease,nan,nan,1.0,204.0,1.0,204.0,nan,nan,1.0,111.0,1
TCGA-10-0935-01,TCGA-10-0935,OV,68.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-25098.0,Dead,WITH TUMOR,1078.0,1078.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1078.0,1.0,1078.0,nan,nan,1.0,1078.0,1
TCGA-10-0936-01,TCGA-10-0936,OV,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-25454.0,Dead,WITH TUMOR,1089.0,1123.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,1123.0,1.0,1123.0,nan,nan,1.0,1123.0,1
TCGA-10-0937-01,TCGA-10-0937,OV,44.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-16222.0,Dead,WITH TUMOR,460.0,608.0,nan,Recurrence,nan,nan,235.0,Complete Remission/Response,nan,nan,1.0,608.0,1.0,608.0,1.0,235.0,1.0,235.0,1
TCGA-10-0938-01,TCGA-10-0938,OV,80.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-29558.0,Dead,WITH TUMOR,604.0,636.0,nan,Progression of Disease,nan,nan,362.0,Progressive Disease,nan,nan,1.0,636.0,1.0,636.0,nan,nan,1.0,362.0,1
TCGA-13-0714-01,TCGA-13-0714,OV,55.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2000.0,nan,-20109.0,Dead,WITH TUMOR,189.0,189.0,nan,Progression of Disease,nan,nan,110.0,Progressive Disease,nan,nan,1.0,189.0,1.0,189.0,nan,nan,1.0,110.0,1
TCGA-13-0717-01,TCGA-13-0717,OV,54.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2000.0,nan,-20042.0,Dead,WITH TUMOR,748.0,748.0,nan,Recurrence,nan,nan,294.0,Complete Remission/Response,nan,nan,1.0,748.0,1.0,748.0,1.0,294.0,1.0,294.0,1
TCGA-13-0720-01,TCGA-13-0720,OV,48.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,nan,-17799.0,Dead,WITH TUMOR,1355.0,1355.0,nan,Recurrence,nan,nan,292.0,Complete Remission/Response,nan,nan,1.0,1355.0,1.0,1355.0,1.0,292.0,1.0,292.0,1
TCGA-13-0723-01,TCGA-13-0723,OV,63.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-23094.0,Dead,WITH TUMOR,1204.0,1204.0,nan,Progression of Disease,nan,nan,210.0,Progressive Disease,nan,nan,1.0,1204.0,1.0,1204.0,nan,nan,1.0,210.0,1
TCGA-13-0724-01,TCGA-13-0724,OV,72.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2002.0,nan,-26342.0,Dead,WITH TUMOR,83.0,83.0,nan,Progression of Disease,nan,nan,83.0,Progressive Disease,nan,nan,1.0,83.0,1.0,83.0,nan,nan,1.0,83.0,1
TCGA-13-0725-01,TCGA-13-0725,OV,44.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-16086.0,Dead,WITH TUMOR,377.0,377.0,nan,Recurrence,nan,nan,190.0,Complete Remission/Response,nan,nan,1.0,377.0,1.0,377.0,1.0,190.0,1.0,190.0,1
TCGA-13-0726-01,TCGA-13-0726,OV,55.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,GX,2002.0,nan,-20134.0,Dead,WITH TUMOR,946.0,949.0,nan,Recurrence,nan,nan,392.0,Complete Remission/Response,nan,nan,1.0,949.0,1.0,949.0,1.0,392.0,1.0,392.0,1
TCGA-13-0727-01,TCGA-13-0727,OV,71.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-26185.0,Dead,WITH TUMOR,462.0,462.0,nan,Recurrence,nan,nan,253.0,Complete Remission/Response,nan,nan,1.0,462.0,1.0,462.0,1.0,253.0,1.0,253.0,1
TCGA-13-0730-01,TCGA-13-0730,OV,71.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-26086.0,Dead,nan,nan,542.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,542.0,nan,542.0,nan,nan,0.0,542.0,1
TCGA-13-0751-01,TCGA-13-0751,OV,44.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,GX,1999.0,nan,-16304.0,Dead,WITH TUMOR,1678.0,1678.0,nan,Recurrence,nan,nan,653.0,Complete Remission/Response,nan,nan,1.0,1678.0,1.0,1678.0,1.0,653.0,1.0,653.0,1
TCGA-13-0755-01,TCGA-13-0755,OV,75.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2003.0,nan,-27438.0,Dead,WITH TUMOR,76.0,76.0,nan,Progression of Disease,nan,nan,34.0,Progressive Disease,nan,nan,1.0,76.0,1.0,76.0,nan,nan,1.0,34.0,1
TCGA-13-0757-01,TCGA-13-0757,OV,71.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-25999.0,Dead,WITH TUMOR,340.0,340.0,nan,Recurrence,nan,nan,293.0,Complete Remission/Response,nan,nan,1.0,340.0,1.0,340.0,1.0,293.0,1.0,293.0,1
TCGA-13-0758-01,TCGA-13-0758,OV,60.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2005.0,nan,-22088.0,Dead,WITH TUMOR,346.0,346.0,nan,Progression of Disease,nan,nan,212.0,Partial Remission/Response,nan,nan,1.0,346.0,1.0,346.0,nan,nan,1.0,212.0,1
TCGA-13-0760-01,TCGA-13-0760,OV,63.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2006.0,nan,-23036.0,Dead,nan,351.0,351.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,351.0,nan,351.0,nan,nan,0.0,351.0,1
TCGA-13-0761-01,TCGA-13-0761,OV,51.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2006.0,nan,-18697.0,Dead,WITH TUMOR,nan,1156.0,nan,Recurrence,nan,nan,424.0,Complete Remission/Response,nan,nan,1.0,1156.0,1.0,1156.0,nan,nan,1.0,424.0,1
TCGA-13-0762-01,TCGA-13-0762,OV,65.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-23960.0,Alive,WITH TUMOR,3400.0,nan,nan,nan,nan,nan,1003.0,Complete Remission/Response,nan,nan,0.0,3400.0,0.0,3400.0,1.0,1003.0,1.0,1003.0,2
TCGA-13-0764-01,TCGA-13-0764,OV,62.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2006.0,nan,-22965.0,Dead,WITH TUMOR,nan,1881.0,nan,Recurrence,nan,nan,272.0,Partial Remission/Response,nan,nan,1.0,1881.0,1.0,1881.0,nan,nan,1.0,272.0,1
TCGA-13-0765-01,TCGA-13-0765,OV,50.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-18574.0,Dead,WITH TUMOR,nan,1389.0,nan,Recurrence,nan,nan,668.0,Complete Remission/Response,nan,nan,1.0,1389.0,1.0,1389.0,1.0,668.0,1.0,668.0,1
TCGA-13-0766-01,TCGA-13-0766,OV,42.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-15571.0,Dead,WITH TUMOR,nan,1725.0,nan,Recurrence,nan,nan,628.0,Complete Remission/Response,nan,nan,1.0,1725.0,1.0,1725.0,1.0,628.0,1.0,628.0,1
TCGA-13-0768-01,TCGA-13-0768,OV,73.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-26999.0,Dead,WITH TUMOR,nan,1784.0,nan,nan,nan,nan,398.0,Complete Remission/Response,nan,nan,1.0,1784.0,1.0,1784.0,1.0,398.0,1.0,398.0,1
TCGA-13-0791-02,TCGA-13-0791,OV,58.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-21380.0,Dead,WITH TUMOR,nan,1224.0,nan,Recurrence,nan,nan,281.0,Complete Remission/Response,nan,nan,1.0,1224.0,1.0,1224.0,1.0,281.0,1.0,281.0,1
TCGA-13-0791-01,TCGA-13-0791,OV,58.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-21380.0,Dead,WITH TUMOR,nan,1224.0,nan,Recurrence,nan,nan,281.0,Complete Remission/Response,nan,nan,1.0,1224.0,1.0,1224.0,1.0,281.0,1.0,281.0,1
TCGA-13-0792-01,TCGA-13-0792,OV,40.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-14729.0,Alive,WITH TUMOR,3602.0,nan,nan,Recurrence,nan,nan,816.0,Complete Remission/Response,nan,nan,0.0,3602.0,0.0,3602.0,1.0,816.0,1.0,816.0,2
TCGA-13-0793-01,TCGA-13-0793,OV,40.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2006.0,nan,-14708.0,Alive,WITH TUMOR,3263.0,nan,nan,Recurrence,nan,nan,351.0,Complete Remission/Response,nan,nan,0.0,3263.0,0.0,3263.0,nan,nan,1.0,351.0,2
TCGA-13-0794-01,TCGA-13-0794,OV,60.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-21945.0,Dead,WITH TUMOR,nan,1919.0,nan,Recurrence,nan,nan,845.0,Complete Remission/Response,nan,nan,1.0,1919.0,1.0,1919.0,1.0,845.0,1.0,845.0,1
TCGA-13-0795-01,TCGA-13-0795,OV,66.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-24403.0,Dead,WITH TUMOR,nan,619.0,nan,Recurrence,nan,nan,325.0,Complete Remission/Response,nan,nan,1.0,619.0,1.0,619.0,1.0,325.0,1.0,325.0,1
TCGA-13-0797-01,TCGA-13-0797,OV,49.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-18051.0,Alive,WITH TUMOR,2121.0,nan,nan,nan,nan,nan,525.0,Complete Remission/Response,nan,nan,0.0,2121.0,0.0,2121.0,1.0,525.0,1.0,525.0,2
TCGA-13-0799-01,TCGA-13-0799,OV,44.0,FEMALE,ASIAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-16171.0,Alive,TUMOR FREE,2535.0,nan,nan,nan,nan,nan,1262.0,Complete Remission/Response,nan,nan,0.0,2535.0,0.0,2535.0,1.0,1262.0,1.0,1262.0,2
TCGA-13-0800-01,TCGA-13-0800,OV,52.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-19087.0,Alive,TUMOR FREE,2661.0,nan,nan,nan,nan,nan,1396.0,Complete Remission/Response,nan,nan,0.0,2661.0,0.0,2661.0,1.0,1396.0,1.0,1396.0,2
TCGA-13-0801-01,TCGA-13-0801,OV,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-16812.0,Dead,WITH TUMOR,nan,1399.0,nan,nan,nan,nan,345.0,Complete Remission/Response,nan,nan,1.0,1399.0,1.0,1399.0,1.0,345.0,1.0,345.0,1
TCGA-13-0802-01,TCGA-13-0802,OV,79.0,FEMALE,ASIAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-29075.0,Dead,WITH TUMOR,nan,1552.0,nan,nan,nan,nan,510.0,Complete Remission/Response,nan,nan,1.0,1552.0,1.0,1552.0,1.0,510.0,1.0,510.0,1
TCGA-13-0803-01,TCGA-13-0803,OV,81.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,nan,-29685.0,Dead,WITH TUMOR,1334.0,1334.0,nan,Recurrence,nan,nan,337.0,Complete Remission/Response,nan,nan,1.0,1334.0,1.0,1334.0,1.0,337.0,1.0,337.0,1
TCGA-13-0804-01,TCGA-13-0804,OV,73.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-27021.0,Dead,WITH TUMOR,1073.0,1073.0,nan,Recurrence,nan,nan,329.0,Complete Remission/Response,nan,nan,1.0,1073.0,1.0,1073.0,1.0,329.0,1.0,329.0,1
TCGA-13-0805-01,TCGA-13-0805,OV,57.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-21014.0,Dead,WITH TUMOR,1073.0,1074.0,nan,Progression of Disease,nan,nan,177.0,Progressive Disease,nan,nan,1.0,1074.0,1.0,1074.0,nan,nan,1.0,177.0,1
TCGA-13-0807-01,TCGA-13-0807,OV,54.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-19890.0,Dead,nan,414.0,414.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,414.0,nan,414.0,nan,nan,0.0,414.0,1
TCGA-13-0883-01,TCGA-13-0883,OV,61.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-22395.0,Dead,WITH TUMOR,2097.0,2097.0,nan,Recurrence,nan,nan,819.0,Complete Remission/Response,nan,nan,1.0,2097.0,1.0,2097.0,1.0,819.0,1.0,819.0,1
TCGA-13-0884-01,TCGA-13-0884,OV,39.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,nan,-14538.0,Dead,WITH TUMOR,3260.0,3260.0,nan,Recurrence,nan,nan,1251.0,Complete Remission/Response,nan,nan,1.0,3260.0,1.0,3260.0,1.0,1251.0,1.0,1251.0,1
TCGA-13-0885-01,TCGA-13-0885,OV,70.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2000.0,nan,-25763.0,Alive,nan,3388.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3388.0,0.0,3388.0,0.0,3388.0,0.0,3388.0,0
TCGA-13-0886-01,TCGA-13-0886,OV,67.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-24724.0,Alive,TUMOR FREE,4665.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4665.0,0.0,4665.0,0.0,4665.0,0.0,4665.0,0
TCGA-13-0887-01,TCGA-13-0887,OV,42.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-15669.0,Dead,WITH TUMOR,2028.0,2028.0,nan,Recurrence,nan,nan,514.0,Complete Remission/Response,nan,nan,1.0,2028.0,1.0,2028.0,1.0,514.0,1.0,514.0,1
TCGA-13-0888-01,TCGA-13-0888,OV,78.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-28498.0,Dead,TUMOR FREE,nan,2811.0,nan,nan,nan,nan,nan,[Discrepancy],nan,nan,1.0,2811.0,0.0,2811.0,nan,nan,0.0,2811.0,1
TCGA-13-0889-01,TCGA-13-0889,OV,75.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,GX,2003.0,nan,-27674.0,Dead,TUMOR FREE,nan,2894.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2894.0,0.0,2894.0,nan,nan,0.0,2894.0,1
TCGA-13-0890-01,TCGA-13-0890,OV,56.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-20770.0,Alive,TUMOR FREE,4424.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4424.0,0.0,4424.0,0.0,4424.0,0.0,4424.0,0
TCGA-13-0891-01,TCGA-13-0891,OV,73.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2003.0,nan,-26886.0,Dead,WITH TUMOR,nan,3128.0,nan,Recurrence,nan,nan,762.0,Complete Remission/Response,nan,nan,1.0,3128.0,1.0,3128.0,nan,nan,1.0,762.0,1
TCGA-13-0893-01,TCGA-13-0893,OV,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-17573.0,Dead,WITH TUMOR,1319.0,1319.0,nan,Recurrence,nan,nan,461.0,Partial Remission/Response,nan,nan,1.0,1319.0,1.0,1319.0,nan,nan,1.0,461.0,1
TCGA-13-0894-01,TCGA-13-0894,OV,53.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-19466.0,Dead,WITH TUMOR,1509.0,1509.0,nan,Recurrence,nan,nan,565.0,Complete Remission/Response,nan,nan,1.0,1509.0,1.0,1509.0,1.0,565.0,1.0,565.0,1
TCGA-13-0897-01,TCGA-13-0897,OV,54.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-19894.0,Dead,WITH TUMOR,nan,2182.0,nan,Recurrence,nan,nan,554.0,Complete Remission/Response,nan,nan,1.0,2182.0,1.0,2182.0,1.0,554.0,1.0,554.0,1
TCGA-13-0899-01,TCGA-13-0899,OV,60.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-22031.0,Dead,WITH TUMOR,nan,2012.0,nan,Recurrence,nan,nan,547.0,Complete Remission/Response,nan,nan,1.0,2012.0,1.0,2012.0,1.0,547.0,1.0,547.0,1
TCGA-13-0900-01,TCGA-13-0900,OV,59.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-21698.0,Alive,TUMOR FREE,4077.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4077.0,0.0,4077.0,0.0,4077.0,0.0,4077.0,0
TCGA-13-0901-01,TCGA-13-0901,OV,41.0,FEMALE,ASIAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-15333.0,Alive,WITH TUMOR,589.0,nan,nan,Recurrence,nan,nan,390.0,Complete Remission/Response,nan,nan,0.0,589.0,0.0,589.0,1.0,390.0,1.0,390.0,2
TCGA-13-0903-01,TCGA-13-0903,OV,42.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2004.0,nan,-15705.0,Alive,TUMOR FREE,3887.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3887.0,0.0,3887.0,nan,nan,0.0,3887.0,0
TCGA-13-0904-01,TCGA-13-0904,OV,63.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-23278.0,Dead,WITH TUMOR,nan,1532.0,nan,Progression of Disease,nan,nan,330.0,Partial Remission/Response,nan,nan,1.0,1532.0,1.0,1532.0,nan,nan,1.0,330.0,1
TCGA-13-0905-01,TCGA-13-0905,OV,51.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-18757.0,Alive,WITH TUMOR,3746.0,nan,nan,nan,nan,nan,1535.0,Complete Remission/Response,nan,nan,0.0,3746.0,0.0,3746.0,1.0,1535.0,1.0,1535.0,2
TCGA-13-0906-01,TCGA-13-0906,OV,50.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-18383.0,Alive,TUMOR FREE,3619.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3619.0,0.0,3619.0,0.0,3619.0,0.0,3619.0,0
TCGA-13-0908-01,TCGA-13-0908,OV,58.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2005.0,nan,-21422.0,Dead,WITH TUMOR,nan,1843.0,nan,Recurrence,nan,nan,552.0,Complete Remission/Response,nan,nan,1.0,1843.0,1.0,1843.0,nan,nan,1.0,552.0,1
TCGA-13-0910-01,TCGA-13-0910,OV,58.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-21473.0,Alive,WITH TUMOR,3548.0,nan,nan,nan,nan,nan,1212.0,Complete Remission/Response,nan,nan,0.0,3548.0,0.0,3548.0,1.0,1212.0,1.0,1212.0,2
TCGA-13-0911-01,TCGA-13-0911,OV,55.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2005.0,nan,-20276.0,Dead,WITH TUMOR,nan,1355.0,nan,Progression of Disease,nan,nan,279.0,Partial Remission/Response,nan,nan,1.0,1355.0,1.0,1355.0,nan,nan,1.0,279.0,1
TCGA-13-0912-01,TCGA-13-0912,OV,58.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-21427.0,Dead,WITH TUMOR,nan,1145.0,nan,Recurrence,nan,nan,469.0,Complete Remission/Response,nan,nan,1.0,1145.0,1.0,1145.0,1.0,469.0,1.0,469.0,1
TCGA-13-0913-02,TCGA-13-0913,OV,53.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-19573.0,Alive,WITH TUMOR,3325.0,nan,nan,Recurrence,nan,nan,871.0,Complete Remission/Response,nan,nan,0.0,3325.0,0.0,3325.0,1.0,871.0,1.0,871.0,2
TCGA-13-0913-01,TCGA-13-0913,OV,53.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-19573.0,Alive,WITH TUMOR,3325.0,nan,nan,Recurrence,nan,nan,871.0,Complete Remission/Response,nan,nan,0.0,3325.0,0.0,3325.0,1.0,871.0,1.0,871.0,2
TCGA-13-0916-01,TCGA-13-0916,OV,49.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-18189.0,Alive,TUMOR FREE,1785.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1785.0,0.0,1785.0,0.0,1785.0,0.0,1785.0,0
TCGA-13-0919-01,TCGA-13-0919,OV,52.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-19337.0,Alive,TUMOR FREE,2571.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2571.0,0.0,2571.0,0.0,2571.0,0.0,2571.0,0
TCGA-13-0920-01,TCGA-13-0920,OV,65.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-24064.0,Dead,WITH TUMOR,nan,1484.0,nan,Recurrence,nan,nan,297.0,Complete Remission/Response,nan,nan,1.0,1484.0,1.0,1484.0,1.0,297.0,1.0,297.0,1
TCGA-13-0921-01,TCGA-13-0921,OV,72.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-26606.0,Dead,TUMOR FREE,nan,1483.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1483.0,0.0,1483.0,0.0,1483.0,0.0,1483.0,0
TCGA-13-0923-01,TCGA-13-0923,OV,74.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-27081.0,Alive,TUMOR FREE,2547.0,nan,nan,nan,nan,nan,1719.0,Complete Remission/Response,nan,nan,0.0,2547.0,0.0,2547.0,1.0,1719.0,1.0,1719.0,2
TCGA-13-0924-01,TCGA-13-0924,OV,45.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2008.0,nan,-16670.0,Alive,WITH TUMOR,2614.0,nan,nan,nan,nan,nan,962.0,Complete Remission/Response,nan,nan,0.0,2614.0,0.0,2614.0,nan,nan,1.0,962.0,2
TCGA-13-1403-01,TCGA-13-1403,OV,48.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-17697.0,Dead,WITH TUMOR,nan,2345.0,nan,nan,nan,nan,418.0,Complete Remission/Response,nan,nan,1.0,2345.0,1.0,2345.0,1.0,418.0,1.0,418.0,1
TCGA-13-1404-01,TCGA-13-1404,OV,48.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-17784.0,Alive,WITH TUMOR,2469.0,nan,nan,nan,nan,nan,1581.0,Complete Remission/Response,nan,nan,0.0,2469.0,0.0,2469.0,1.0,1581.0,1.0,1581.0,2
TCGA-13-1405-01,TCGA-13-1405,OV,49.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2008.0,nan,-18218.0,Dead,WITH TUMOR,nan,868.0,nan,nan,nan,nan,228.0,Complete Remission/Response,nan,nan,1.0,868.0,1.0,868.0,nan,nan,1.0,228.0,1
TCGA-13-1407-01,TCGA-13-1407,OV,51.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-18896.0,Alive,WITH TUMOR,2534.0,nan,nan,nan,nan,nan,1333.0,Complete Remission/Response,nan,nan,0.0,2534.0,0.0,2534.0,1.0,1333.0,1.0,1333.0,2
TCGA-13-1408-01,TCGA-13-1408,OV,59.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-21635.0,Dead,WITH TUMOR,nan,1680.0,nan,nan,nan,nan,765.0,Partial Remission/Response,nan,nan,1.0,1680.0,1.0,1680.0,nan,nan,1.0,765.0,1
TCGA-13-1409-01,TCGA-13-1409,OV,73.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-26836.0,Dead,WITH TUMOR,nan,1742.0,nan,nan,nan,nan,690.0,nan,nan,nan,1.0,1742.0,1.0,1742.0,nan,nan,1.0,690.0,1
TCGA-13-1410-01,TCGA-13-1410,OV,57.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,GX,2008.0,nan,-20950.0,Alive,WITH TUMOR,2464.0,nan,nan,nan,nan,nan,319.0,Complete Remission/Response,nan,nan,0.0,2464.0,0.0,2464.0,nan,nan,1.0,319.0,2
TCGA-13-1411-01,TCGA-13-1411,OV,81.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-29874.0,Dead,WITH TUMOR,nan,531.0,nan,nan,nan,nan,238.0,Partial Remission/Response,nan,nan,1.0,531.0,1.0,531.0,nan,nan,1.0,238.0,1
TCGA-13-1412-01,TCGA-13-1412,OV,41.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2008.0,nan,-15119.0,Dead,WITH TUMOR,nan,984.0,nan,nan,nan,nan,409.0,Complete Remission/Response,nan,nan,1.0,984.0,1.0,984.0,nan,nan,1.0,409.0,1
TCGA-13-1477-01,TCGA-13-1477,OV,49.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G2,2000.0,nan,-18111.0,Dead,WITH TUMOR,1662.0,1662.0,nan,Progression of Disease,nan,nan,235.0,Progressive Disease,nan,nan,1.0,1662.0,1.0,1662.0,nan,nan,1.0,235.0,1
TCGA-13-1481-01,TCGA-13-1481,OV,76.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2000.0,nan,-27898.0,Dead,TUMOR FREE,2648.0,2648.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2648.0,0.0,2648.0,0.0,2648.0,0.0,2648.0,0
TCGA-13-1482-01,TCGA-13-1482,OV,52.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G2,2000.0,nan,-19178.0,Dead,WITH TUMOR,1877.0,1877.0,nan,Recurrence,nan,nan,602.0,Partial Remission/Response,nan,nan,1.0,1877.0,1.0,1877.0,nan,nan,1.0,602.0,1
TCGA-13-1483-01,TCGA-13-1483,OV,61.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2000.0,nan,-22342.0,Dead,WITH TUMOR,895.0,895.0,nan,Recurrence,nan,nan,297.0,Partial Remission/Response,nan,nan,1.0,895.0,1.0,895.0,nan,nan,1.0,297.0,1
TCGA-13-1484-01,TCGA-13-1484,OV,62.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2000.0,nan,-22698.0,Dead,WITH TUMOR,nan,3785.0,nan,Recurrence,nan,nan,497.0,Complete Remission/Response,nan,nan,1.0,3785.0,1.0,3785.0,1.0,497.0,1.0,497.0,1
TCGA-13-1485-01,TCGA-13-1485,OV,48.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G2,2001.0,nan,-17642.0,Dead,WITH TUMOR,629.0,629.0,nan,Progression of Disease,nan,nan,170.0,Partial Remission/Response,nan,nan,1.0,629.0,1.0,629.0,nan,nan,1.0,170.0,1
TCGA-13-1487-01,TCGA-13-1487,OV,74.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,GX,2002.0,nan,-27176.0,Dead,WITH TUMOR,681.0,681.0,nan,Recurrence,nan,nan,412.0,Complete Remission/Response,nan,nan,1.0,681.0,1.0,681.0,nan,nan,1.0,412.0,1
TCGA-13-1488-01,TCGA-13-1488,OV,59.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2002.0,nan,-21726.0,Dead,WITH TUMOR,2154.0,2154.0,nan,Recurrence,nan,nan,351.0,Complete Remission/Response,nan,nan,1.0,2154.0,1.0,2154.0,nan,nan,1.0,351.0,1
TCGA-13-1489-02,TCGA-13-1489,OV,70.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2002.0,nan,-25768.0,Dead,TUMOR FREE,nan,2553.0,nan,Recurrence,nan,nan,806.0,Complete Remission/Response,nan,nan,1.0,2553.0,0.0,2553.0,1.0,806.0,1.0,806.0,2
TCGA-13-1489-01,TCGA-13-1489,OV,70.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2002.0,nan,-25768.0,Dead,TUMOR FREE,nan,2553.0,nan,Recurrence,nan,nan,806.0,Complete Remission/Response,nan,nan,1.0,2553.0,0.0,2553.0,1.0,806.0,1.0,806.0,2
TCGA-13-1491-01,TCGA-13-1491,OV,55.0,FEMALE,ASIAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-20262.0,Dead,WITH TUMOR,1595.0,1595.0,nan,Recurrence,nan,nan,508.0,Partial Remission/Response,nan,nan,1.0,1595.0,1.0,1595.0,nan,nan,1.0,508.0,1
TCGA-13-1492-01,TCGA-13-1492,OV,66.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-24332.0,Dead,TUMOR FREE,nan,3819.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,3819.0,0.0,3819.0,0.0,3819.0,0.0,3819.0,0
TCGA-13-1494-01,TCGA-13-1494,OV,43.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2004.0,nan,-15993.0,Dead,WITH TUMOR,nan,2856.0,nan,Recurrence,nan,nan,693.0,Complete Remission/Response,nan,nan,1.0,2856.0,1.0,2856.0,nan,nan,1.0,693.0,1
TCGA-13-1495-01,TCGA-13-1495,OV,60.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2004.0,nan,-22046.0,Dead,WITH TUMOR,nan,2749.0,nan,Recurrence,nan,nan,977.0,Complete Remission/Response,nan,nan,1.0,2749.0,1.0,2749.0,1.0,977.0,1.0,977.0,1
TCGA-13-1496-01,TCGA-13-1496,OV,65.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-23993.0,Dead,nan,129.0,129.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,129.0,nan,129.0,nan,nan,0.0,129.0,1
TCGA-13-1497-01,TCGA-13-1497,OV,47.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-17528.0,Alive,TUMOR FREE,3871.0,nan,nan,Recurrence,nan,nan,813.0,Complete Remission/Response,nan,nan,0.0,3871.0,0.0,3871.0,1.0,813.0,1.0,813.0,2
TCGA-13-1498-01,TCGA-13-1498,OV,73.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-26820.0,Dead,WITH TUMOR,nan,2012.0,nan,Progression of Disease,nan,nan,534.0,Partial Remission/Response,nan,nan,1.0,2012.0,1.0,2012.0,nan,nan,1.0,534.0,1
TCGA-13-1499-01,TCGA-13-1499,OV,56.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-20668.0,Alive,WITH TUMOR,3500.0,nan,nan,Recurrence,nan,nan,583.0,Complete Remission/Response,nan,nan,0.0,3500.0,0.0,3500.0,1.0,583.0,1.0,583.0,2
TCGA-13-1500-01,TCGA-13-1500,OV,71.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-26172.0,Dead,WITH TUMOR,425.0,425.0,nan,Recurrence,nan,nan,253.0,Partial Remission/Response,nan,nan,1.0,425.0,1.0,425.0,nan,nan,1.0,253.0,1
TCGA-13-1501-01,TCGA-13-1501,OV,50.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2006.0,nan,-18393.0,Dead,WITH TUMOR,nan,1314.0,nan,Progression of Disease,nan,nan,392.0,Partial Remission/Response,nan,nan,1.0,1314.0,1.0,1314.0,nan,nan,1.0,392.0,1
TCGA-13-1504-01,TCGA-13-1504,OV,68.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-25008.0,Dead,WITH TUMOR,nan,1059.0,nan,nan,nan,nan,548.0,Complete Remission/Response,nan,nan,1.0,1059.0,1.0,1059.0,1.0,548.0,1.0,548.0,1
TCGA-13-1505-01,TCGA-13-1505,OV,63.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-23238.0,Alive,WITH TUMOR,1998.0,nan,nan,nan,nan,nan,1561.0,Complete Remission/Response,nan,nan,0.0,1998.0,0.0,1998.0,1.0,1561.0,1.0,1561.0,2
TCGA-13-1506-01,TCGA-13-1506,OV,45.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-16734.0,Dead,WITH TUMOR,nan,1039.0,nan,nan,nan,nan,666.0,Complete Remission/Response,nan,nan,1.0,1039.0,1.0,1039.0,1.0,666.0,1.0,666.0,1
TCGA-13-1507-01,TCGA-13-1507,OV,77.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-28445.0,Dead,WITH TUMOR,nan,1993.0,nan,nan,nan,nan,324.0,Complete Remission/Response,nan,nan,1.0,1993.0,1.0,1993.0,1.0,324.0,1.0,324.0,1
TCGA-13-1509-01,TCGA-13-1509,OV,64.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2008.0,nan,-23481.0,Alive,WITH TUMOR,2438.0,nan,nan,nan,nan,nan,578.0,Complete Remission/Response,nan,nan,0.0,2438.0,0.0,2438.0,nan,nan,1.0,578.0,2
TCGA-13-1510-01,TCGA-13-1510,OV,62.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-22708.0,Dead,WITH TUMOR,nan,1359.0,nan,nan,nan,nan,1189.0,nan,nan,nan,1.0,1359.0,1.0,1359.0,nan,nan,1.0,1189.0,1
TCGA-13-1511-01,TCGA-13-1511,OV,52.0,FEMALE,ASIAN,nan,Stage IV,Serous Cystadenocarcinoma,G3,2008.0,nan,-19258.0,Dead,WITH TUMOR,nan,1650.0,nan,nan,nan,nan,459.0,Partial Remission/Response,nan,nan,1.0,1650.0,1.0,1650.0,nan,nan,1.0,459.0,1
TCGA-13-1512-01,TCGA-13-1512,OV,49.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-18134.0,Alive,WITH TUMOR,442.0,nan,nan,nan,nan,nan,427.0,nan,nan,nan,0.0,442.0,0.0,442.0,nan,nan,1.0,427.0,1
TCGA-13-1817-02,TCGA-13-1817,OV,56.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,nan,-20771.0,Dead,WITH TUMOR,1024.0,1024.0,nan,Recurrence,nan,nan,541.0,Partial Remission/Response,nan,nan,1.0,1024.0,1.0,1024.0,nan,nan,1.0,541.0,1
TCGA-13-1817-01,TCGA-13-1817,OV,56.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,nan,-20771.0,Dead,WITH TUMOR,1024.0,1024.0,nan,Recurrence,nan,nan,541.0,Partial Remission/Response,nan,nan,1.0,1024.0,1.0,1024.0,nan,nan,1.0,541.0,1
TCGA-13-1819-02,TCGA-13-1819,OV,59.0,FEMALE,WHITE,nan,Stage IIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-21635.0,Dead,WITH TUMOR,nan,2025.0,nan,Recurrence,nan,nan,429.0,Complete Remission/Response,nan,nan,1.0,2025.0,1.0,2025.0,1.0,429.0,1.0,429.0,1
TCGA-13-1819-01,TCGA-13-1819,OV,59.0,FEMALE,WHITE,nan,Stage IIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-21635.0,Dead,WITH TUMOR,nan,2025.0,nan,Recurrence,nan,nan,429.0,Complete Remission/Response,nan,nan,1.0,2025.0,1.0,2025.0,1.0,429.0,1.0,429.0,1
TCGA-13-2057-01,TCGA-13-2057,OV,59.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-21554.0,Alive,WITH TUMOR,2434.0,nan,nan,nan,nan,nan,897.0,Complete Remission/Response,nan,nan,0.0,2434.0,0.0,2434.0,1.0,897.0,1.0,897.0,2
TCGA-13-2059-01,TCGA-13-2059,OV,50.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-18449.0,Alive,WITH TUMOR,2387.0,nan,nan,nan,nan,nan,1005.0,Complete Remission/Response,nan,nan,0.0,2387.0,0.0,2387.0,1.0,1005.0,1.0,1005.0,2
TCGA-13-2060-01,TCGA-13-2060,OV,51.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2009.0,nan,-18635.0,Alive,WITH TUMOR,2369.0,nan,nan,nan,nan,nan,1475.0,Complete Remission/Response,nan,nan,0.0,2369.0,0.0,2369.0,nan,nan,1.0,1475.0,2
TCGA-13-2061-01,TCGA-13-2061,OV,58.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-21543.0,Alive,TUMOR FREE,2339.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2339.0,0.0,2339.0,0.0,2339.0,0.0,2339.0,0
TCGA-13-2065-01,TCGA-13-2065,OV,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-25973.0,Alive,WITH TUMOR,1993.0,nan,nan,nan,nan,nan,946.0,Complete Remission/Response,nan,nan,0.0,1993.0,0.0,1993.0,1.0,946.0,1.0,946.0,2
TCGA-13-2066-01,TCGA-13-2066,OV,49.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2009.0,nan,-18170.0,Dead,WITH TUMOR,nan,2133.0,nan,nan,nan,nan,1028.0,Complete Remission/Response,nan,nan,1.0,2133.0,1.0,2133.0,nan,nan,1.0,1028.0,1
TCGA-13-2071-01,TCGA-13-2071,OV,63.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2009.0,nan,-23367.0,Dead,WITH TUMOR,nan,773.0,nan,nan,nan,nan,322.0,Complete Remission/Response,nan,nan,1.0,773.0,1.0,773.0,nan,nan,1.0,322.0,1
TCGA-13-A5FT-01,TCGA-13-A5FT,OV,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-24743.0,Alive,TUMOR FREE,2143.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2143.0,0.0,2143.0,0.0,2143.0,0.0,2143.0,0
TCGA-13-A5FU-01,TCGA-13-A5FU,OV,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IV,Serous Cystadenocarcinoma,G3,2009.0,nan,-22256.0,Dead,WITH TUMOR,nan,256.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,256.0,1.0,256.0,nan,nan,1.0,256.0,1
TCGA-20-0987-01,TCGA-20-0987,OV,61.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-22287.0,Dead,WITH TUMOR,nan,701.0,nan,Recurrence,nan,nan,442.0,nan,nan,nan,1.0,701.0,1.0,701.0,nan,nan,1.0,442.0,1
TCGA-20-0990-01,TCGA-20-0990,OV,74.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-27170.0,Alive,WITH TUMOR,789.0,nan,nan,Recurrence,nan,nan,871.0,nan,nan,nan,0.0,789.0,0.0,789.0,nan,nan,1.0,871.0,2
TCGA-20-0991-01,TCGA-20-0991,OV,78.0,FEMALE,WHITE,nan,Stage IIB,Serous Cystadenocarcinoma,G3,2006.0,nan,-28694.0,Alive,TUMOR FREE,797.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,797.0,0.0,797.0,0.0,797.0,0.0,797.0,0
TCGA-20-0996-01,TCGA-20-0996,OV,59.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2001.0,nan,-21572.0,Alive,WITH TUMOR,2196.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2196.0,0.0,2196.0,nan,nan,0.0,2196.0,2
TCGA-20-1682-01,TCGA-20-1682,OV,56.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,GX,2007.0,nan,-20583.0,Alive,TUMOR FREE,837.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,837.0,0.0,837.0,0.0,837.0,0.0,837.0,0
TCGA-20-1683-01,TCGA-20-1683,OV,65.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-24006.0,Alive,TUMOR FREE,772.0,nan,nan,Recurrence,nan,nan,618.0,Stable Disease,nan,nan,0.0,772.0,0.0,772.0,nan,nan,1.0,618.0,2
TCGA-20-1684-01,TCGA-20-1684,OV,51.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-18755.0,Alive,TUMOR FREE,581.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,581.0,0.0,581.0,0.0,581.0,0.0,581.0,0
TCGA-20-1685-01,TCGA-20-1685,OV,45.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-16745.0,Alive,TUMOR FREE,508.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,508.0,0.0,508.0,0.0,508.0,0.0,508.0,0
TCGA-20-1686-01,TCGA-20-1686,OV,75.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-27588.0,Alive,TUMOR FREE,89.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,89.0,0.0,89.0,0.0,89.0,0.0,89.0,0
TCGA-20-1687-01,TCGA-20-1687,OV,46.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2008.0,nan,-16961.0,Alive,TUMOR FREE,81.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,81.0,0.0,81.0,nan,nan,0.0,81.0,0
TCGA-23-1021-01,TCGA-23-1021,OV,45.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2004.0,nan,-16484.0,Dead,WITH TUMOR,1446.0,1446.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,1446.0,1.0,1446.0,nan,nan,1.0,1446.0,1
TCGA-23-1022-01,TCGA-23-1022,OV,67.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-24798.0,Dead,WITH TUMOR,nan,1511.0,nan,Recurrence,nan,nan,450.0,Complete Remission/Response,nan,nan,1.0,1511.0,1.0,1511.0,1.0,450.0,1.0,450.0,1
TCGA-23-1023-01,TCGA-23-1023,OV,65.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-23826.0,Alive,WITH TUMOR,1233.0,nan,nan,Recurrence,nan,nan,490.0,Complete Remission/Response,nan,nan,0.0,1233.0,0.0,1233.0,1.0,490.0,1.0,490.0,2
TCGA-23-1024-01,TCGA-23-1024,OV,52.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2007.0,nan,-19052.0,Alive,TUMOR FREE,468.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,468.0,0.0,468.0,nan,nan,0.0,468.0,0
TCGA-23-1026-01,TCGA-23-1026,OV,45.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-16442.0,Alive,WITH TUMOR,816.0,nan,nan,Recurrence,nan,nan,797.0,Complete Remission/Response,nan,nan,0.0,816.0,0.0,816.0,1.0,797.0,1.0,797.0,2
TCGA-23-1027-01,TCGA-23-1027,OV,48.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-17588.0,Dead,nan,966.0,976.0,nan,Recurrence,nan,nan,114.0,Progressive Disease,nan,nan,1.0,976.0,nan,976.0,nan,nan,1.0,114.0,1
TCGA-23-1028-01,TCGA-23-1028,OV,43.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-16018.0,Alive,WITH TUMOR,1503.0,nan,nan,Recurrence,nan,nan,133.0,Complete Remission/Response,nan,nan,0.0,1503.0,0.0,1503.0,1.0,133.0,1.0,133.0,2
TCGA-23-1029-01,TCGA-23-1029,OV,46.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-16889.0,Alive,TUMOR FREE,268.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,268.0,0.0,268.0,0.0,268.0,0.0,268.0,0
TCGA-23-1030-01,TCGA-23-1030,OV,64.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-23416.0,Alive,TUMOR FREE,886.0,nan,nan,Recurrence,nan,nan,544.0,Complete Remission/Response,nan,nan,0.0,886.0,0.0,886.0,1.0,544.0,1.0,544.0,2
TCGA-23-1031-01,TCGA-23-1031,OV,60.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2003.0,nan,-22225.0,Dead,WITH TUMOR,575.0,575.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,575.0,1.0,575.0,nan,nan,1.0,575.0,1
TCGA-23-1032-01,TCGA-23-1032,OV,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IV,Serous Cystadenocarcinoma,G3,2002.0,nan,-26715.0,Dead,WITH TUMOR,68.0,84.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,84.0,1.0,84.0,nan,nan,1.0,84.0,1
TCGA-23-1107-01,TCGA-23-1107,OV,59.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,1999.0,nan,-21561.0,Dead,WITH TUMOR,9.0,9.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,9.0,1.0,9.0,nan,nan,1.0,9.0,1
TCGA-23-1109-01,TCGA-23-1109,OV,62.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,nan,-23002.0,Dead,WITH TUMOR,1562.0,1562.0,nan,Recurrence,nan,nan,987.0,Partial Remission/Response,nan,nan,1.0,1562.0,1.0,1562.0,nan,nan,1.0,987.0,1
TCGA-23-1110-01,TCGA-23-1110,OV,42.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-15383.0,Alive,TUMOR FREE,1658.0,nan,nan,Recurrence,nan,nan,326.0,Complete Remission/Response,nan,nan,0.0,1658.0,0.0,1658.0,1.0,326.0,1.0,326.0,2
TCGA-23-1111-01,TCGA-23-1111,OV,63.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-23171.0,Alive,nan,98.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,98.0,0.0,98.0,nan,nan,0.0,98.0,0
TCGA-23-1113-01,TCGA-23-1113,OV,48.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2002.0,nan,-17791.0,Dead,WITH TUMOR,nan,949.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,949.0,1.0,949.0,nan,nan,1.0,949.0,1
TCGA-23-1114-01,TCGA-23-1114,OV,55.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2000.0,nan,-20409.0,Dead,WITH TUMOR,2089.0,2089.0,nan,Recurrence,nan,nan,634.0,Complete Remission/Response,nan,nan,1.0,2089.0,1.0,2089.0,1.0,634.0,1.0,634.0,1
TCGA-23-1116-01,TCGA-23-1116,OV,83.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-30464.0,Dead,WITH TUMOR,nan,592.0,nan,Recurrence,nan,nan,286.0,Complete Remission/Response,nan,nan,1.0,592.0,1.0,592.0,1.0,286.0,1.0,286.0,1
TCGA-23-1117-01,TCGA-23-1117,OV,42.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1998.0,nan,-15690.0,Dead,WITH TUMOR,nan,1013.0,nan,Recurrence,nan,nan,418.0,Complete Remission/Response,nan,nan,1.0,1013.0,1.0,1013.0,1.0,418.0,1.0,418.0,1
TCGA-23-1118-01,TCGA-23-1118,OV,45.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,nan,-16471.0,Alive,TUMOR FREE,2616.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2616.0,0.0,2616.0,0.0,2616.0,0.0,2616.0,0
TCGA-23-1119-01,TCGA-23-1119,OV,64.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1997.0,nan,-23686.0,Alive,TUMOR FREE,3953.0,nan,nan,Recurrence,nan,nan,3378.0,Complete Remission/Response,nan,nan,0.0,3953.0,0.0,3953.0,1.0,3378.0,1.0,3378.0,2
TCGA-23-1120-01,TCGA-23-1120,OV,60.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-22148.0,Alive,nan,130.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,130.0,0.0,130.0,0.0,130.0,0.0,130.0,0
TCGA-23-1121-01,TCGA-23-1121,OV,51.0,FEMALE,nan,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-18983.0,Alive,nan,194.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,194.0,0.0,194.0,nan,nan,0.0,194.0,0
TCGA-23-1122-01,TCGA-23-1122,OV,53.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1998.0,nan,-19537.0,Dead,WITH TUMOR,nan,1189.0,nan,Recurrence,nan,nan,447.0,Complete Remission/Response,nan,nan,1.0,1189.0,1.0,1189.0,1.0,447.0,1.0,447.0,1
TCGA-23-1123-01,TCGA-23-1123,OV,59.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1998.0,nan,-21552.0,Dead,WITH TUMOR,nan,1018.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,1018.0,1.0,1018.0,nan,nan,1.0,1018.0,1
TCGA-23-1124-01,TCGA-23-1124,OV,62.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,nan,-23005.0,Dead,WITH TUMOR,nan,1768.0,nan,Recurrence,nan,nan,641.0,Complete Remission/Response,nan,nan,1.0,1768.0,1.0,1768.0,1.0,641.0,1.0,641.0,1
TCGA-23-1809-01,TCGA-23-1809,OV,63.0,FEMALE,WHITE,nan,Stage IIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-23111.0,Alive,nan,16.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,16.0,0.0,16.0,nan,nan,0.0,16.0,0
TCGA-23-2072-01,TCGA-23-2072,OV,58.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2000.0,nan,-21523.0,Dead,WITH TUMOR,nan,759.0,nan,Recurrence,nan,nan,476.0,Complete Remission/Response,nan,nan,1.0,759.0,1.0,759.0,nan,nan,1.0,476.0,1
TCGA-23-2077-01,TCGA-23-2077,OV,45.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,nan,-16552.0,Alive,TUMOR FREE,3525.0,nan,nan,Recurrence,nan,nan,1232.0,Complete Remission/Response,nan,nan,0.0,3525.0,0.0,3525.0,1.0,1232.0,1.0,1232.0,2
TCGA-23-2078-01,TCGA-23-2078,OV,66.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,nan,-24223.0,Alive,TUMOR FREE,2661.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2661.0,0.0,2661.0,0.0,2661.0,0.0,2661.0,0
TCGA-23-2079-01,TCGA-23-2079,OV,46.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,nan,-17122.0,Alive,TUMOR FREE,2788.0,nan,nan,Recurrence,nan,nan,283.0,Complete Remission/Response,nan,nan,0.0,2788.0,0.0,2788.0,1.0,283.0,1.0,283.0,2
TCGA-23-2081-01,TCGA-23-2081,OV,49.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2000.0,nan,-18162.0,Dead,WITH TUMOR,nan,2342.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,2342.0,1.0,2342.0,nan,nan,1.0,2342.0,1
TCGA-23-2084-01,TCGA-23-2084,OV,45.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2000.0,nan,-16493.0,Dead,WITH TUMOR,nan,1516.0,nan,Recurrence,nan,nan,619.0,Complete Remission/Response,nan,nan,1.0,1516.0,1.0,1516.0,nan,nan,1.0,619.0,1
TCGA-23-2641-01,TCGA-23-2641,OV,85.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-31232.0,Alive,nan,84.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,84.0,0.0,84.0,nan,nan,0.0,84.0,0
TCGA-23-2643-01,TCGA-23-2643,OV,74.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-27093.0,Alive,TUMOR FREE,143.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,143.0,0.0,143.0,0.0,143.0,0.0,143.0,0
TCGA-23-2645-01,TCGA-23-2645,OV,54.0,FEMALE,ASIAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-19758.0,Alive,nan,137.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,137.0,0.0,137.0,nan,nan,0.0,137.0,0
TCGA-23-2647-01,TCGA-23-2647,OV,49.0,FEMALE,ASIAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-18205.0,Alive,nan,135.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,135.0,0.0,135.0,nan,nan,0.0,135.0,0
TCGA-23-2649-01,TCGA-23-2649,OV,60.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-22210.0,Alive,nan,116.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,116.0,0.0,116.0,nan,nan,0.0,116.0,0
TCGA-24-0966-01,TCGA-24-0966,OV,78.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-28529.0,Alive,WITH TUMOR,232.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,232.0,0.0,232.0,nan,nan,0.0,232.0,2
TCGA-24-0968-01,TCGA-24-0968,OV,59.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-21664.0,Dead,WITH TUMOR,598.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,nan,1.0,nan,nan,nan,1.0,nan,1
TCGA-24-0970-01,TCGA-24-0970,OV,63.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-23276.0,Dead,WITH TUMOR,354.0,354.0,nan,Recurrence,nan,nan,280.0,Partial Remission/Response,nan,nan,1.0,354.0,1.0,354.0,nan,nan,1.0,280.0,1
TCGA-24-0975-01,TCGA-24-0975,OV,58.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-21417.0,Dead,WITH TUMOR,663.0,663.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,663.0,1.0,663.0,nan,nan,1.0,663.0,1
TCGA-24-0979-01,TCGA-24-0979,OV,53.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2003.0,nan,-19595.0,Dead,WITH TUMOR,1264.0,1264.0,nan,Recurrence,nan,nan,428.0,Complete Remission/Response,nan,nan,1.0,1264.0,1.0,1264.0,nan,nan,1.0,428.0,1
TCGA-24-0980-01,TCGA-24-0980,OV,53.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-19579.0,Dead,WITH TUMOR,233.0,233.0,nan,Recurrence,nan,nan,145.0,Progressive Disease,nan,nan,1.0,233.0,1.0,233.0,nan,nan,1.0,145.0,1
TCGA-24-0982-01,TCGA-24-0982,OV,77.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-28201.0,Dead,WITH TUMOR,679.0,679.0,nan,Recurrence,nan,nan,153.0,Complete Remission/Response,nan,nan,1.0,679.0,1.0,679.0,1.0,153.0,1.0,153.0,1
TCGA-24-1103-01,TCGA-24-1103,OV,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,nan,-18583.0,Dead,WITH TUMOR,1646.0,1646.0,nan,Recurrence,nan,nan,678.0,Complete Remission/Response,nan,nan,1.0,1646.0,1.0,1646.0,1.0,678.0,1.0,678.0,1
TCGA-24-1104-01,TCGA-24-1104,OV,56.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2001.0,nan,-20527.0,Dead,WITH TUMOR,1933.0,1933.0,nan,Recurrence,nan,nan,959.0,Complete Remission/Response,nan,nan,1.0,1933.0,1.0,1933.0,nan,nan,1.0,959.0,1
TCGA-24-1105-01,TCGA-24-1105,OV,36.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,nan,-13187.0,Dead,WITH TUMOR,1442.0,1442.0,nan,Recurrence,nan,nan,470.0,Complete Remission/Response,nan,nan,1.0,1442.0,1.0,1442.0,1.0,470.0,1.0,470.0,1
TCGA-24-1413-01,TCGA-24-1413,OV,51.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-18846.0,Alive,TUMOR FREE,192.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,192.0,0.0,192.0,0.0,192.0,0.0,192.0,0
TCGA-24-1416-01,TCGA-24-1416,OV,34.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2008.0,nan,-12772.0,Alive,TUMOR FREE,194.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,194.0,0.0,194.0,nan,nan,0.0,194.0,0
TCGA-24-1417-01,TCGA-24-1417,OV,54.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2008.0,nan,-19775.0,Alive,TUMOR FREE,238.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,238.0,0.0,238.0,nan,nan,0.0,238.0,0
TCGA-24-1418-01,TCGA-24-1418,OV,68.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-24842.0,Alive,TUMOR FREE,243.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,243.0,0.0,243.0,0.0,243.0,0.0,243.0,0
TCGA-24-1419-01,TCGA-24-1419,OV,62.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-22659.0,Alive,TUMOR FREE,239.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,239.0,0.0,239.0,0.0,239.0,0.0,239.0,0
TCGA-24-1422-01,TCGA-24-1422,OV,82.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-30234.0,Dead,nan,23.0,23.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,23.0,nan,23.0,nan,nan,0.0,23.0,1
TCGA-24-1423-01,TCGA-24-1423,OV,61.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-22281.0,Alive,TUMOR FREE,190.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,190.0,0.0,190.0,0.0,190.0,0.0,190.0,0
TCGA-24-1424-01,TCGA-24-1424,OV,67.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-24545.0,Alive,TUMOR FREE,183.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,183.0,0.0,183.0,0.0,183.0,0.0,183.0,0
TCGA-24-1425-01,TCGA-24-1425,OV,45.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-16764.0,Alive,TUMOR FREE,181.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,181.0,0.0,181.0,0.0,181.0,0.0,181.0,0
TCGA-24-1426-01,TCGA-24-1426,OV,43.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-15949.0,Alive,TUMOR FREE,163.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,163.0,0.0,163.0,0.0,163.0,0.0,163.0,0
TCGA-24-1427-01,TCGA-24-1427,OV,58.0,FEMALE,nan,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-21423.0,Alive,WITH TUMOR,147.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,147.0,0.0,147.0,nan,nan,0.0,147.0,2
TCGA-24-1428-01,TCGA-24-1428,OV,50.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-18306.0,Alive,WITH TUMOR,529.0,nan,nan,Recurrence,nan,nan,448.0,Complete Remission/Response,nan,nan,0.0,529.0,0.0,529.0,1.0,448.0,1.0,448.0,2
TCGA-24-1430-01,TCGA-24-1430,OV,68.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2000.0,nan,-24939.0,Dead,WITH TUMOR,863.0,863.0,nan,Recurrence,nan,nan,449.0,Complete Remission/Response,nan,nan,1.0,863.0,1.0,863.0,1.0,449.0,1.0,449.0,1
TCGA-24-1431-01,TCGA-24-1431,OV,67.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,nan,-24758.0,Dead,WITH TUMOR,583.0,567.0,nan,Recurrence,nan,nan,199.0,nan,nan,nan,1.0,567.0,1.0,567.0,nan,nan,1.0,199.0,1
TCGA-24-1434-01,TCGA-24-1434,OV,59.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,nan,-21810.0,Dead,WITH TUMOR,568.0,568.0,nan,Recurrence,nan,nan,337.0,Partial Remission/Response,nan,nan,1.0,568.0,1.0,568.0,nan,nan,1.0,337.0,1
TCGA-24-1435-01,TCGA-24-1435,OV,57.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,nan,-21107.0,Dead,WITH TUMOR,1324.0,1324.0,nan,Recurrence,nan,nan,505.0,Complete Remission/Response,nan,nan,1.0,1324.0,1.0,1324.0,1.0,505.0,1.0,505.0,1
TCGA-24-1436-01,TCGA-24-1436,OV,57.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,nan,-20881.0,Dead,WITH TUMOR,260.0,260.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,260.0,1.0,260.0,nan,nan,1.0,260.0,1
TCGA-24-1463-01,TCGA-24-1463,OV,70.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2000.0,nan,-25734.0,Dead,WITH TUMOR,2218.0,2218.0,nan,Recurrence,nan,nan,971.0,Complete Remission/Response,nan,nan,1.0,2218.0,1.0,2218.0,1.0,971.0,1.0,971.0,1
TCGA-24-1464-01,TCGA-24-1464,OV,70.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1998.0,nan,-25874.0,Dead,WITH TUMOR,379.0,379.0,nan,Recurrence,nan,nan,323.0,nan,nan,nan,1.0,379.0,1.0,379.0,nan,nan,1.0,323.0,1
TCGA-24-1466-01,TCGA-24-1466,OV,74.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1998.0,nan,-27307.0,Dead,WITH TUMOR,1373.0,1373.0,nan,Recurrence,nan,nan,491.0,Complete Remission/Response,nan,nan,1.0,1373.0,1.0,1373.0,1.0,491.0,1.0,491.0,1
TCGA-24-1467-01,TCGA-24-1467,OV,51.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1998.0,nan,-18652.0,Dead,WITH TUMOR,3224.0,3224.0,nan,Recurrence,nan,nan,1253.0,Complete Remission/Response,nan,nan,1.0,3224.0,1.0,3224.0,1.0,1253.0,1.0,1253.0,1
TCGA-24-1469-01,TCGA-24-1469,OV,71.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-25937.0,Alive,TUMOR FREE,277.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,277.0,0.0,277.0,0.0,277.0,0.0,277.0,0
TCGA-24-1470-01,TCGA-24-1470,OV,54.0,FEMALE,WHITE,nan,Stage IIIB,Serous Cystadenocarcinoma,G3,2009.0,nan,-20007.0,Alive,TUMOR FREE,105.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,105.0,0.0,105.0,0.0,105.0,0.0,105.0,0
TCGA-24-1471-01,TCGA-24-1471,OV,60.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-22081.0,Alive,nan,36.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,36.0,0.0,36.0,nan,nan,0.0,36.0,0
TCGA-24-1474-01,TCGA-24-1474,OV,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2000.0,nan,-20902.0,Dead,WITH TUMOR,676.0,676.0,nan,Recurrence,nan,nan,332.0,Partial Remission/Response,nan,nan,1.0,676.0,1.0,676.0,nan,nan,1.0,332.0,1
TCGA-24-1544-01,TCGA-24-1544,OV,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2000.0,nan,-26141.0,Dead,WITH TUMOR,820.0,820.0,nan,Progression of Disease,nan,nan,643.0,Partial Remission/Response,nan,nan,1.0,820.0,1.0,820.0,nan,nan,1.0,643.0,1
TCGA-24-1545-01,TCGA-24-1545,OV,69.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1997.0,nan,-25460.0,Dead,WITH TUMOR,1746.0,1746.0,nan,Recurrence,nan,nan,861.0,Complete Remission/Response,nan,nan,1.0,1746.0,1.0,1746.0,1.0,861.0,1.0,861.0,1
TCGA-24-1546-01,TCGA-24-1546,OV,46.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1997.0,nan,-17130.0,Dead,nan,1955.0,1955.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1955.0,nan,1955.0,nan,nan,0.0,1955.0,1
TCGA-24-1548-01,TCGA-24-1548,OV,57.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1997.0,nan,-20945.0,Dead,WITH TUMOR,493.0,493.0,nan,Recurrence,nan,nan,207.0,Complete Remission/Response,nan,nan,1.0,493.0,1.0,493.0,1.0,207.0,1.0,207.0,1
TCGA-24-1549-01,TCGA-24-1549,OV,58.0,FEMALE,WHITE,nan,Stage IIIB,Serous Cystadenocarcinoma,G3,1997.0,nan,-21432.0,Dead,WITH TUMOR,1721.0,1721.0,nan,Recurrence,nan,nan,1042.0,Complete Remission/Response,nan,nan,1.0,1721.0,1.0,1721.0,1.0,1042.0,1.0,1042.0,1
TCGA-24-1550-01,TCGA-24-1550,OV,49.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1997.0,nan,-18049.0,Dead,WITH TUMOR,1249.0,1249.0,nan,Recurrence,nan,nan,892.0,Complete Remission/Response,nan,nan,1.0,1249.0,1.0,1249.0,1.0,892.0,1.0,892.0,1
TCGA-24-1551-01,TCGA-24-1551,OV,53.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1997.0,nan,-19661.0,Dead,WITH TUMOR,1579.0,1579.0,nan,Recurrence,nan,nan,764.0,Complete Remission/Response,nan,nan,1.0,1579.0,1.0,1579.0,1.0,764.0,1.0,764.0,1
TCGA-24-1552-01,TCGA-24-1552,OV,77.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1997.0,nan,-28129.0,Dead,WITH TUMOR,1259.0,1259.0,nan,Recurrence,nan,nan,403.0,Complete Remission/Response,nan,nan,1.0,1259.0,1.0,1259.0,1.0,403.0,1.0,403.0,1
TCGA-24-1553-01,TCGA-24-1553,OV,53.0,FEMALE,WHITE,nan,Stage IIIB,Serous Cystadenocarcinoma,G3,1997.0,nan,-19393.0,Dead,WITH TUMOR,1767.0,1767.0,nan,Recurrence,nan,nan,553.0,Complete Remission/Response,nan,nan,1.0,1767.0,1.0,1767.0,1.0,553.0,1.0,553.0,1
TCGA-24-1555-01,TCGA-24-1555,OV,50.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1997.0,nan,-18404.0,Dead,WITH TUMOR,2692.0,2692.0,nan,Recurrence,nan,nan,1577.0,Complete Remission/Response,nan,nan,1.0,2692.0,1.0,2692.0,1.0,1577.0,1.0,1577.0,1
TCGA-24-1556-01,TCGA-24-1556,OV,50.0,FEMALE,WHITE,nan,Stage IIB,Serous Cystadenocarcinoma,G3,2000.0,nan,-18517.0,Dead,WITH TUMOR,2148.0,2148.0,nan,Recurrence,nan,nan,539.0,Complete Remission/Response,nan,nan,1.0,2148.0,1.0,2148.0,1.0,539.0,1.0,539.0,1
TCGA-24-1557-01,TCGA-24-1557,OV,49.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2000.0,nan,-17943.0,Dead,WITH TUMOR,1213.0,1213.0,nan,Progression of Disease,nan,nan,447.0,Partial Remission/Response,nan,nan,1.0,1213.0,1.0,1213.0,nan,nan,1.0,447.0,1
TCGA-24-1558-01,TCGA-24-1558,OV,73.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2000.0,nan,-27004.0,Dead,WITH TUMOR,594.0,594.0,nan,Recurrence,nan,nan,273.0,Partial Remission/Response,nan,nan,1.0,594.0,1.0,594.0,nan,nan,1.0,273.0,1
TCGA-24-1560-01,TCGA-24-1560,OV,51.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G4,1999.0,nan,-18671.0,Dead,WITH TUMOR,1341.0,1341.0,nan,Recurrence,nan,nan,143.0,Complete Remission/Response,nan,nan,1.0,1341.0,1.0,1341.0,1.0,143.0,1.0,143.0,1
TCGA-24-1562-01,TCGA-24-1562,OV,67.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,nan,-24747.0,Dead,WITH TUMOR,1384.0,1384.0,nan,Recurrence,nan,nan,229.0,Complete Remission/Response,nan,nan,1.0,1384.0,1.0,1384.0,1.0,229.0,1.0,229.0,1
TCGA-24-1563-01,TCGA-24-1563,OV,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,nan,-24274.0,Dead,WITH TUMOR,1451.0,1451.0,nan,Recurrence,nan,nan,396.0,Complete Remission/Response,nan,nan,1.0,1451.0,1.0,1451.0,1.0,396.0,1.0,396.0,1
TCGA-24-1564-01,TCGA-24-1564,OV,67.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1997.0,nan,-24668.0,Dead,WITH TUMOR,787.0,787.0,nan,Recurrence,nan,nan,221.0,Complete Remission/Response,nan,nan,1.0,787.0,1.0,787.0,1.0,221.0,1.0,221.0,1
TCGA-24-1565-01,TCGA-24-1565,OV,74.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1997.0,nan,-27048.0,Dead,WITH TUMOR,312.0,312.0,nan,Recurrence,nan,nan,145.0,Partial Remission/Response,nan,nan,1.0,312.0,1.0,312.0,nan,nan,1.0,145.0,1
TCGA-24-1567-01,TCGA-24-1567,OV,54.0,FEMALE,WHITE,nan,Stage IIIB,Serous Cystadenocarcinoma,G3,1999.0,nan,-19843.0,Dead,WITH TUMOR,524.0,524.0,nan,Recurrence,nan,nan,319.0,nan,nan,nan,1.0,524.0,1.0,524.0,nan,nan,1.0,319.0,1
TCGA-24-1603-01,TCGA-24-1603,OV,53.0,FEMALE,WHITE,nan,Stage IIIB,Serous Cystadenocarcinoma,G3,1996.0,nan,-19681.0,Dead,WITH TUMOR,2742.0,2742.0,nan,Recurrence,nan,nan,992.0,Complete Remission/Response,nan,nan,1.0,2742.0,1.0,2742.0,1.0,992.0,1.0,992.0,1
TCGA-24-1604-01,TCGA-24-1604,OV,66.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1996.0,nan,-24471.0,Dead,WITH TUMOR,2688.0,2688.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2688.0,1.0,2688.0,nan,nan,1.0,2688.0,1
TCGA-24-1614-01,TCGA-24-1614,OV,57.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,nan,-20993.0,Dead,WITH TUMOR,1470.0,1470.0,nan,Recurrence,nan,nan,644.0,Complete Remission/Response,nan,nan,1.0,1470.0,1.0,1470.0,1.0,644.0,1.0,644.0,1
TCGA-24-1616-01,TCGA-24-1616,OV,56.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,nan,-20785.0,Dead,WITH TUMOR,1163.0,1163.0,nan,Recurrence,nan,nan,405.0,Complete Remission/Response,nan,nan,1.0,1163.0,1.0,1163.0,1.0,405.0,1.0,405.0,1
TCGA-24-1842-01,TCGA-24-1842,OV,49.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-18227.0,Alive,TUMOR FREE,253.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,253.0,0.0,253.0,0.0,253.0,0.0,253.0,0
TCGA-24-1843-01,TCGA-24-1843,OV,66.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-24469.0,Alive,nan,106.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,106.0,0.0,106.0,0.0,106.0,0.0,106.0,2
TCGA-24-1844-01,TCGA-24-1844,OV,64.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-23542.0,Alive,nan,113.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,113.0,0.0,113.0,nan,nan,0.0,113.0,0
TCGA-24-1845-01,TCGA-24-1845,OV,42.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-15599.0,Alive,nan,116.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,116.0,0.0,116.0,nan,nan,0.0,116.0,0
TCGA-24-1846-01,TCGA-24-1846,OV,45.0,FEMALE,nan,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-16534.0,Alive,nan,133.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,133.0,0.0,133.0,nan,nan,0.0,133.0,0
TCGA-24-1847-01,TCGA-24-1847,OV,45.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2009.0,nan,-16529.0,Alive,TUMOR FREE,343.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,343.0,0.0,343.0,nan,nan,0.0,343.0,2
TCGA-24-1849-01,TCGA-24-1849,OV,80.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-29555.0,Alive,TUMOR FREE,176.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,176.0,0.0,176.0,0.0,176.0,0.0,176.0,0
TCGA-24-1850-01,TCGA-24-1850,OV,72.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-26369.0,Alive,TUMOR FREE,168.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,168.0,0.0,168.0,0.0,168.0,0.0,168.0,0
TCGA-24-1852-02,TCGA-24-1852,OV,55.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1997.0,nan,-20390.0,Dead,WITH TUMOR,2201.0,2201.0,nan,Recurrence,nan,nan,1009.0,Complete Remission/Response,nan,nan,1.0,2201.0,1.0,2201.0,1.0,1009.0,1.0,1009.0,1
TCGA-24-1852-01,TCGA-24-1852,OV,55.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1997.0,nan,-20390.0,Dead,WITH TUMOR,2201.0,2201.0,nan,Recurrence,nan,nan,1009.0,Complete Remission/Response,nan,nan,1.0,2201.0,1.0,2201.0,1.0,1009.0,1.0,1009.0,1
TCGA-24-1920-01,TCGA-24-1920,OV,74.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-27042.0,Alive,TUMOR FREE,298.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,298.0,0.0,298.0,0.0,298.0,0.0,298.0,0
TCGA-24-1923-01,TCGA-24-1923,OV,51.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,nan,-18628.0,Dead,WITH TUMOR,690.0,690.0,nan,Recurrence,nan,nan,343.0,Complete Remission/Response,nan,nan,1.0,690.0,1.0,690.0,1.0,343.0,1.0,343.0,1
TCGA-24-1924-01,TCGA-24-1924,OV,65.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,nan,-23801.0,Dead,WITH TUMOR,919.0,919.0,nan,Recurrence,nan,nan,320.0,Complete Remission/Response,nan,nan,1.0,919.0,1.0,919.0,1.0,320.0,1.0,320.0,1
TCGA-24-1927-01,TCGA-24-1927,OV,59.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,nan,-21719.0,Dead,WITH TUMOR,500.0,500.0,nan,Recurrence,nan,nan,290.0,Complete Remission/Response,nan,nan,1.0,500.0,1.0,500.0,1.0,290.0,1.0,290.0,1
TCGA-24-1928-01,TCGA-24-1928,OV,77.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1998.0,nan,-28126.0,Dead,WITH TUMOR,336.0,336.0,nan,Recurrence,nan,nan,70.0,Progressive Disease,nan,nan,1.0,336.0,1.0,336.0,nan,nan,1.0,70.0,1
TCGA-24-1930-01,TCGA-24-1930,OV,53.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1998.0,nan,-19387.0,Dead,WITH TUMOR,2467.0,2467.0,nan,Recurrence,nan,nan,544.0,Complete Remission/Response,nan,nan,1.0,2467.0,1.0,2467.0,1.0,544.0,1.0,544.0,1
TCGA-24-2019-01,TCGA-24-2019,OV,46.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-17009.0,Alive,nan,148.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,148.0,0.0,148.0,nan,nan,0.0,148.0,0
TCGA-24-2020-01,TCGA-24-2020,OV,67.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1994.0,nan,-24682.0,Dead,WITH TUMOR,4624.0,4624.0,nan,Recurrence,nan,nan,723.0,Complete Remission/Response,nan,nan,1.0,4624.0,1.0,4624.0,1.0,723.0,1.0,723.0,1
TCGA-24-2023-01,TCGA-24-2023,OV,54.0,FEMALE,WHITE,nan,Stage IIIA,Serous Cystadenocarcinoma,G3,1994.0,nan,-19901.0,Dead,WITH TUMOR,1364.0,1364.0,nan,Recurrence,nan,nan,1069.0,Complete Remission/Response,nan,nan,1.0,1364.0,1.0,1364.0,1.0,1069.0,1.0,1069.0,1
TCGA-24-2024-01,TCGA-24-2024,OV,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1994.0,nan,-26476.0,Dead,WITH TUMOR,1769.0,1769.0,nan,Recurrence,nan,nan,421.0,Complete Remission/Response,nan,nan,1.0,1769.0,1.0,1769.0,1.0,421.0,1.0,421.0,1
TCGA-24-2026-01,TCGA-24-2026,OV,79.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1995.0,nan,-29050.0,Dead,nan,1059.0,1059.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1059.0,nan,1059.0,nan,nan,0.0,1059.0,1
TCGA-24-2027-01,TCGA-24-2027,OV,51.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,1995.0,nan,-18835.0,Dead,WITH TUMOR,3337.0,3337.0,nan,Recurrence,nan,nan,617.0,Complete Remission/Response,nan,nan,1.0,3337.0,1.0,3337.0,nan,nan,1.0,617.0,1
TCGA-24-2029-01,TCGA-24-2029,OV,75.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1995.0,nan,-27527.0,Dead,WITH TUMOR,439.0,439.0,nan,Recurrence,nan,nan,372.0,Complete Remission/Response,nan,nan,1.0,439.0,1.0,439.0,1.0,372.0,1.0,372.0,1
TCGA-24-2030-01,TCGA-24-2030,OV,87.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1995.0,nan,-31900.0,Dead,WITH TUMOR,1641.0,1701.0,nan,Recurrence,nan,nan,646.0,Complete Remission/Response,nan,nan,1.0,1701.0,1.0,1701.0,1.0,646.0,1.0,646.0,1
TCGA-24-2033-01,TCGA-24-2033,OV,87.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1995.0,nan,-31977.0,Dead,WITH TUMOR,562.0,562.0,nan,Recurrence,nan,nan,351.0,Partial Remission/Response,nan,nan,1.0,562.0,1.0,562.0,nan,nan,1.0,351.0,1
TCGA-24-2035-01,TCGA-24-2035,OV,65.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1996.0,nan,-23855.0,Dead,WITH TUMOR,857.0,857.0,nan,Recurrence,nan,nan,287.0,Partial Remission/Response,nan,nan,1.0,857.0,1.0,857.0,nan,nan,1.0,287.0,1
TCGA-24-2036-01,TCGA-24-2036,OV,50.0,FEMALE,WHITE,nan,Stage IIIA,Serous Cystadenocarcinoma,G3,1996.0,nan,-18582.0,Dead,WITH TUMOR,1947.0,1947.0,nan,Recurrence,nan,nan,914.0,Complete Remission/Response,nan,nan,1.0,1947.0,1.0,1947.0,1.0,914.0,1.0,914.0,1
TCGA-24-2038-01,TCGA-24-2038,OV,68.0,FEMALE,WHITE,nan,Stage IIIA,Serous Cystadenocarcinoma,GB,2000.0,nan,-24957.0,Dead,WITH TUMOR,1354.0,1354.0,nan,Recurrence,nan,nan,1169.0,Complete Remission/Response,nan,nan,1.0,1354.0,1.0,1354.0,1.0,1169.0,1.0,1169.0,1
TCGA-24-2254-01,TCGA-24-2254,OV,66.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-24407.0,Dead,WITH TUMOR,1736.0,1736.0,nan,Recurrence,nan,nan,606.0,Complete Remission/Response,nan,nan,1.0,1736.0,1.0,1736.0,1.0,606.0,1.0,606.0,1
TCGA-24-2260-01,TCGA-24-2260,OV,74.0,FEMALE,WHITE,nan,Stage IIIB,Serous Cystadenocarcinoma,G3,1992.0,nan,-27112.0,Dead,WITH TUMOR,1100.0,1100.0,nan,Recurrence,nan,nan,667.0,Complete Remission/Response,nan,nan,1.0,1100.0,1.0,1100.0,1.0,667.0,1.0,667.0,1
TCGA-24-2261-01,TCGA-24-2261,OV,76.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1992.0,nan,-27897.0,Dead,WITH TUMOR,24.0,24.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,24.0,1.0,24.0,nan,nan,1.0,24.0,1
TCGA-24-2262-01,TCGA-24-2262,OV,57.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1992.0,nan,-20861.0,Dead,WITH TUMOR,11.0,11.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,11.0,1.0,11.0,nan,nan,1.0,11.0,1
TCGA-24-2267-01,TCGA-24-2267,OV,58.0,FEMALE,WHITE,nan,Stage IIB,Serous Cystadenocarcinoma,G3,1993.0,nan,-21293.0,Dead,WITH TUMOR,1446.0,1446.0,nan,Recurrence,nan,nan,512.0,Complete Remission/Response,nan,nan,1.0,1446.0,1.0,1446.0,1.0,512.0,1.0,512.0,1
TCGA-24-2271-01,TCGA-24-2271,OV,55.0,FEMALE,ASIAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,nan,-20399.0,Dead,WITH TUMOR,962.0,962.0,nan,Recurrence,nan,nan,827.0,nan,nan,nan,1.0,962.0,1.0,962.0,nan,nan,1.0,827.0,1
TCGA-24-2280-01,TCGA-24-2280,OV,74.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-27356.0,Alive,WITH TUMOR,2143.0,nan,nan,Recurrence,nan,nan,535.0,Complete Remission/Response,nan,nan,0.0,2143.0,0.0,2143.0,1.0,535.0,1.0,535.0,2
TCGA-24-2281-01,TCGA-24-2281,OV,68.0,FEMALE,WHITE,nan,Stage IIA,Serous Cystadenocarcinoma,G3,2006.0,nan,-25019.0,Alive,TUMOR FREE,1357.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1357.0,0.0,1357.0,0.0,1357.0,0.0,1357.0,0
TCGA-24-2288-01,TCGA-24-2288,OV,70.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,nan,-25831.0,Dead,WITH TUMOR,25.0,25.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,25.0,1.0,25.0,nan,nan,1.0,25.0,1
TCGA-24-2289-01,TCGA-24-2289,OV,68.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,1997.0,nan,-25191.0,Dead,WITH TUMOR,2049.0,2049.0,nan,Recurrence,nan,nan,568.0,Complete Remission/Response,nan,nan,1.0,2049.0,1.0,2049.0,nan,nan,1.0,568.0,1
TCGA-24-2290-01,TCGA-24-2290,OV,56.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1997.0,nan,-20530.0,Dead,WITH TUMOR,1102.0,1102.0,nan,Recurrence,nan,nan,324.0,Complete Remission/Response,nan,nan,1.0,1102.0,1.0,1102.0,1.0,324.0,1.0,324.0,1
TCGA-24-2293-01,TCGA-24-2293,OV,47.0,FEMALE,WHITE,nan,nan,Serous Cystadenocarcinoma,G3,1995.0,nan,-17235.0,Dead,nan,506.0,506.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,506.0,nan,506.0,nan,nan,0.0,506.0,1
TCGA-24-2295-01,TCGA-24-2295,OV,69.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1995.0,nan,-25416.0,Dead,WITH TUMOR,1007.0,1007.0,nan,Recurrence,nan,nan,281.0,Complete Remission/Response,nan,nan,1.0,1007.0,1.0,1007.0,1.0,281.0,1.0,281.0,1
TCGA-24-2297-01,TCGA-24-2297,OV,56.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1993.0,nan,-20487.0,Dead,nan,1699.0,1699.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1699.0,nan,1699.0,0.0,1699.0,0.0,1699.0,1
TCGA-24-2298-01,TCGA-24-2298,OV,55.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1993.0,nan,-20453.0,Dead,WITH TUMOR,1620.0,1620.0,nan,Recurrence,nan,nan,469.0,Complete Remission/Response,nan,nan,1.0,1620.0,1.0,1620.0,1.0,469.0,1.0,469.0,1
TCGA-25-1312-01,TCGA-25-1312,OV,69.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2001.0,nan,-25537.0,Dead,nan,31.0,31.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,31.0,nan,31.0,nan,nan,0.0,31.0,1
TCGA-25-1313-01,TCGA-25-1313,OV,62.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2000.0,nan,-22982.0,Dead,WITH TUMOR,820.0,820.0,nan,Recurrence,nan,nan,394.0,Complete Remission/Response,nan,nan,1.0,820.0,1.0,820.0,nan,nan,1.0,394.0,1
TCGA-25-1314-01,TCGA-25-1314,OV,42.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2000.0,nan,-15462.0,Dead,WITH TUMOR,974.0,1004.0,nan,Progression of Disease,nan,nan,274.0,Partial Remission/Response,nan,nan,1.0,1004.0,1.0,1004.0,nan,nan,1.0,274.0,1
TCGA-25-1315-01,TCGA-25-1315,OV,50.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2000.0,nan,-18263.0,Dead,WITH TUMOR,1553.0,1583.0,nan,Progression of Disease,nan,nan,153.0,Partial Remission/Response,nan,nan,1.0,1583.0,1.0,1583.0,nan,nan,1.0,153.0,1
TCGA-25-1316-01,TCGA-25-1316,OV,55.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2000.0,nan,-20331.0,Dead,WITH TUMOR,1126.0,1279.0,nan,Progression of Disease,nan,nan,276.0,Progressive Disease,nan,nan,1.0,1279.0,1.0,1279.0,nan,nan,1.0,276.0,1
TCGA-25-1317-01,TCGA-25-1317,OV,66.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2000.0,nan,-24199.0,Dead,nan,nan,61.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,61.0,nan,61.0,nan,nan,0.0,61.0,1
TCGA-25-1318-01,TCGA-25-1318,OV,54.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2000.0,nan,-19755.0,Dead,WITH TUMOR,1064.0,1064.0,nan,Recurrence,nan,nan,185.0,Partial Remission/Response,nan,nan,1.0,1064.0,1.0,1064.0,nan,nan,1.0,185.0,1
TCGA-25-1319-01,TCGA-25-1319,OV,73.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2000.0,nan,-26786.0,Dead,nan,1977.0,1977.0,nan,Recurrence,nan,nan,730.0,nan,nan,nan,1.0,1977.0,nan,1977.0,nan,nan,1.0,730.0,1
TCGA-25-1320-01,TCGA-25-1320,OV,65.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,nan,-24018.0,Dead,WITH TUMOR,1124.0,1155.0,nan,Recurrence,nan,nan,424.0,Progressive Disease,nan,nan,1.0,1155.0,1.0,1155.0,nan,nan,1.0,424.0,1
TCGA-25-1321-01,TCGA-25-1321,OV,65.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,nan,-23987.0,Dead,WITH TUMOR,1033.0,1033.0,nan,Recurrence,nan,nan,454.0,Complete Remission/Response,nan,nan,1.0,1033.0,1.0,1033.0,1.0,454.0,1.0,454.0,1
TCGA-25-1322-01,TCGA-25-1322,OV,62.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2001.0,nan,-22646.0,Dead,WITH TUMOR,91.0,91.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,91.0,1.0,91.0,nan,nan,1.0,91.0,1
TCGA-25-1323-01,TCGA-25-1323,OV,72.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,nan,-26602.0,Dead,WITH TUMOR,365.0,395.0,nan,Progression of Disease,nan,nan,365.0,Complete Remission/Response,nan,nan,1.0,395.0,1.0,395.0,1.0,365.0,1.0,365.0,1
TCGA-25-1324-01,TCGA-25-1324,OV,74.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,nan,-27090.0,Dead,nan,1035.0,1035.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1035.0,nan,1035.0,nan,nan,0.0,1035.0,1
TCGA-25-1325-01,TCGA-25-1325,OV,77.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2002.0,nan,-28183.0,Dead,nan,976.0,976.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,976.0,nan,976.0,nan,nan,0.0,976.0,1
TCGA-25-1326-01,TCGA-25-1326,OV,61.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-22339.0,Dead,WITH TUMOR,945.0,1249.0,nan,Recurrence,nan,nan,396.0,Partial Remission/Response,nan,nan,1.0,1249.0,1.0,1249.0,nan,nan,1.0,396.0,1
TCGA-25-1328-01,TCGA-25-1328,OV,38.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,nan,-13911.0,Dead,WITH TUMOR,1979.0,2009.0,nan,Recurrence,nan,nan,244.0,Partial Remission/Response,nan,nan,1.0,2009.0,1.0,2009.0,nan,nan,1.0,244.0,1
TCGA-25-1329-01,TCGA-25-1329,OV,76.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-28093.0,Dead,nan,90.0,457.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,457.0,nan,457.0,nan,nan,0.0,457.0,1
TCGA-25-1623-01,TCGA-25-1623,OV,71.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2006.0,nan,-26060.0,Dead,WITH TUMOR,565.0,565.0,nan,Recurrence,nan,nan,342.0,Complete Remission/Response,nan,nan,1.0,565.0,1.0,565.0,nan,nan,1.0,342.0,1
TCGA-25-1625-01,TCGA-25-1625,OV,66.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-24298.0,Dead,WITH TUMOR,548.0,840.0,nan,Recurrence,nan,nan,526.0,Stable Disease,nan,nan,1.0,840.0,1.0,840.0,nan,nan,1.0,526.0,1
TCGA-25-1626-01,TCGA-25-1626,OV,65.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-23932.0,Dead,WITH TUMOR,481.0,518.0,nan,Recurrence,nan,nan,318.0,Partial Remission/Response,nan,nan,1.0,518.0,1.0,518.0,nan,nan,1.0,318.0,1
TCGA-25-1627-01,TCGA-25-1627,OV,73.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-26784.0,Dead,nan,11.0,394.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,394.0,nan,394.0,nan,nan,0.0,394.0,1
TCGA-25-1628-01,TCGA-25-1628,OV,67.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-24488.0,Dead,WITH TUMOR,627.0,627.0,nan,Recurrence,nan,nan,287.0,Stable Disease,nan,nan,1.0,627.0,1.0,627.0,nan,nan,1.0,287.0,1
TCGA-25-1630-01,TCGA-25-1630,OV,73.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-27006.0,Dead,nan,239.0,1162.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1162.0,nan,1162.0,0.0,1162.0,0.0,1162.0,1
TCGA-25-1631-01,TCGA-25-1631,OV,73.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-26687.0,Dead,TUMOR FREE,9.0,9.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,9.0,0.0,9.0,nan,nan,0.0,9.0,1
TCGA-25-1632-01,TCGA-25-1632,OV,68.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2002.0,nan,-24993.0,Dead,WITH TUMOR,1732.0,1799.0,nan,Recurrence,nan,nan,537.0,Complete Remission/Response,nan,nan,1.0,1799.0,1.0,1799.0,nan,nan,1.0,537.0,1
TCGA-25-1633-01,TCGA-25-1633,OV,64.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-23407.0,Dead,WITH TUMOR,1843.0,1891.0,nan,Recurrence,nan,nan,616.0,Complete Remission/Response,nan,nan,1.0,1891.0,1.0,1891.0,1.0,616.0,1.0,616.0,1
TCGA-25-1634-01,TCGA-25-1634,OV,75.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-27749.0,Dead,WITH TUMOR,1081.0,1091.0,nan,Recurrence,nan,nan,380.0,Complete Remission/Response,nan,nan,1.0,1091.0,1.0,1091.0,1.0,380.0,1.0,380.0,1
TCGA-25-1635-01,TCGA-25-1635,OV,71.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-26200.0,Dead,WITH TUMOR,1558.0,1583.0,nan,Recurrence,nan,nan,614.0,Complete Remission/Response,nan,nan,1.0,1583.0,1.0,1583.0,1.0,614.0,1.0,614.0,1
TCGA-25-1870-01,TCGA-25-1870,OV,59.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1994.0,nan,-21550.0,Dead,WITH TUMOR,455.0,455.0,nan,Recurrence,nan,nan,243.0,Partial Remission/Response,nan,nan,1.0,455.0,1.0,455.0,nan,nan,1.0,243.0,1
TCGA-25-1871-01,TCGA-25-1871,OV,70.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1993.0,nan,-25627.0,Dead,WITH TUMOR,760.0,760.0,nan,Recurrence,nan,nan,230.0,Progressive Disease,nan,nan,1.0,760.0,1.0,760.0,nan,nan,1.0,230.0,1
TCGA-25-1877-01,TCGA-25-1877,OV,81.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1993.0,nan,-29615.0,Dead,WITH TUMOR,549.0,730.0,nan,Recurrence,nan,nan,549.0,Complete Remission/Response,nan,nan,1.0,730.0,1.0,730.0,1.0,549.0,1.0,549.0,1
TCGA-25-1878-01,TCGA-25-1878,OV,60.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1994.0,nan,-22035.0,Dead,WITH TUMOR,2587.0,2587.0,nan,Recurrence,nan,nan,971.0,Complete Remission/Response,nan,nan,1.0,2587.0,1.0,2587.0,1.0,971.0,1.0,971.0,1
TCGA-25-2042-01,TCGA-25-2042,OV,60.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-22127.0,Dead,WITH TUMOR,396.0,396.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,396.0,1.0,396.0,nan,nan,1.0,396.0,1
TCGA-25-2390-01,TCGA-25-2390,OV,80.0,FEMALE,nan,nan,nan,Serous Cystadenocarcinoma,nan,2003.0,nan,-29257.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,nan,1
TCGA-25-2391-01,TCGA-25-2391,OV,57.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-20939.0,Dead,TUMOR FREE,1492.0,1492.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1492.0,0.0,1492.0,0.0,1492.0,0.0,1492.0,0
TCGA-25-2392-01,TCGA-25-2392,OV,75.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2003.0,nan,-27667.0,Dead,nan,31.0,31.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,31.0,nan,31.0,nan,nan,0.0,31.0,1
TCGA-25-2393-01,TCGA-25-2393,OV,81.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-29585.0,Dead,WITH TUMOR,1157.0,1157.0,nan,Recurrence,nan,nan,305.0,Partial Remission/Response,nan,nan,1.0,1157.0,1.0,1157.0,nan,nan,1.0,305.0,1
TCGA-25-2396-01,TCGA-25-2396,OV,71.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-26145.0,Dead,nan,92.0,92.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,92.0,nan,92.0,nan,nan,0.0,92.0,1
TCGA-25-2397-01,TCGA-25-2397,OV,59.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2004.0,nan,-21581.0,Dead,nan,365.0,365.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,365.0,nan,365.0,nan,nan,0.0,365.0,1
TCGA-25-2398-01,TCGA-25-2398,OV,71.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-26267.0,Dead,WITH TUMOR,1369.0,1369.0,nan,Recurrence,nan,nan,577.0,Complete Remission/Response,nan,nan,1.0,1369.0,1.0,1369.0,1.0,577.0,1.0,577.0,1
TCGA-25-2399-01,TCGA-25-2399,OV,80.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-29373.0,Dead,WITH TUMOR,608.0,608.0,nan,Recurrence,nan,nan,243.0,Partial Remission/Response,nan,nan,1.0,608.0,1.0,608.0,nan,nan,1.0,243.0,1
TCGA-25-2400-01,TCGA-25-2400,OV,76.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-27789.0,Dead,WITH TUMOR,1278.0,1278.0,nan,Recurrence,nan,nan,577.0,Complete Remission/Response,nan,nan,1.0,1278.0,1.0,1278.0,1.0,577.0,1.0,577.0,1
TCGA-25-2401-01,TCGA-25-2401,OV,64.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-23711.0,Dead,nan,90.0,90.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,90.0,nan,90.0,nan,nan,0.0,90.0,1
TCGA-25-2404-01,TCGA-25-2404,OV,38.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-14184.0,Dead,WITH TUMOR,883.0,883.0,nan,Recurrence,nan,nan,426.0,Complete Remission/Response,nan,nan,1.0,883.0,1.0,883.0,1.0,426.0,1.0,426.0,1
TCGA-25-2408-01,TCGA-25-2408,OV,37.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G2,2005.0,nan,-13606.0,Dead,WITH TUMOR,943.0,943.0,nan,Recurrence,nan,nan,334.0,Partial Remission/Response,nan,nan,1.0,943.0,1.0,943.0,nan,nan,1.0,334.0,1
TCGA-25-2409-01,TCGA-25-2409,OV,71.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2005.0,nan,-26267.0,Dead,WITH TUMOR,821.0,821.0,nan,Recurrence,nan,nan,304.0,Complete Remission/Response,nan,nan,1.0,821.0,1.0,821.0,nan,nan,1.0,304.0,1
TCGA-29-1688-01,TCGA-29-1688,OV,39.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,1992.0,nan,-14574.0,Dead,WITH TUMOR,2400.0,2400.0,nan,Recurrence,nan,nan,184.0,Stable Disease,nan,nan,1.0,2400.0,1.0,2400.0,nan,nan,1.0,184.0,1
TCGA-29-1690-01,TCGA-29-1690,OV,66.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,1993.0,nan,-24319.0,Dead,WITH TUMOR,1360.0,1448.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1448.0,1.0,1448.0,nan,nan,1.0,1448.0,1
TCGA-29-1691-01,TCGA-29-1691,OV,51.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,1995.0,nan,-18664.0,Dead,WITH TUMOR,1435.0,1470.0,nan,Recurrence,nan,nan,613.0,Complete Remission/Response,nan,nan,1.0,1470.0,1.0,1470.0,1.0,613.0,1.0,613.0,1
TCGA-29-1692-02,TCGA-29-1692,OV,58.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,1997.0,nan,-21193.0,Dead,WITH TUMOR,2872.0,2872.0,nan,Recurrence,nan,nan,544.0,Complete Remission/Response,nan,nan,1.0,2872.0,1.0,2872.0,1.0,544.0,1.0,544.0,1
TCGA-29-1692-01,TCGA-29-1692,OV,58.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,1997.0,nan,-21193.0,Dead,WITH TUMOR,2872.0,2872.0,nan,Recurrence,nan,nan,544.0,Complete Remission/Response,nan,nan,1.0,2872.0,1.0,2872.0,1.0,544.0,1.0,544.0,1
TCGA-29-1693-01,TCGA-29-1693,OV,72.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,nan,-26300.0,Alive,WITH TUMOR,3096.0,nan,nan,Recurrence,nan,nan,694.0,Complete Remission/Response,nan,nan,0.0,3096.0,0.0,3096.0,1.0,694.0,1.0,694.0,2
TCGA-29-1694-01,TCGA-29-1694,OV,45.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,GX,2002.0,nan,-16523.0,Dead,WITH TUMOR,nan,1187.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,1187.0,1.0,1187.0,nan,nan,1.0,1187.0,1
TCGA-29-1695-01,TCGA-29-1695,OV,62.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2003.0,nan,-22895.0,Dead,nan,24.0,1229.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1229.0,nan,1229.0,nan,nan,0.0,1229.0,1
TCGA-29-1696-01,TCGA-29-1696,OV,43.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2003.0,nan,-15818.0,Dead,WITH TUMOR,1025.0,1032.0,nan,Recurrence,nan,nan,342.0,Partial Remission/Response,nan,nan,1.0,1032.0,1.0,1032.0,nan,nan,1.0,342.0,1
TCGA-29-1697-01,TCGA-29-1697,OV,62.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-22933.0,Dead,WITH TUMOR,949.0,949.0,nan,Recurrence,nan,nan,500.0,Complete Remission/Response,nan,nan,1.0,949.0,1.0,949.0,1.0,500.0,1.0,500.0,1
TCGA-29-1698-01,TCGA-29-1698,OV,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-19611.0,Alive,WITH TUMOR,2078.0,nan,nan,Recurrence,nan,nan,181.0,Complete Remission/Response,nan,nan,0.0,2078.0,0.0,2078.0,1.0,181.0,1.0,181.0,2
TCGA-29-1699-01,TCGA-29-1699,OV,57.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-21130.0,Dead,nan,16.0,1106.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1106.0,nan,1106.0,nan,nan,0.0,1106.0,1
TCGA-29-1701-01,TCGA-29-1701,OV,56.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-20737.0,Dead,WITH TUMOR,514.0,515.0,nan,Recurrence,nan,nan,298.0,Partial Remission/Response,nan,nan,1.0,515.0,1.0,515.0,nan,nan,1.0,298.0,1
TCGA-29-1702-01,TCGA-29-1702,OV,84.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-30910.0,Dead,WITH TUMOR,568.0,728.0,nan,Recurrence,nan,nan,286.0,Complete Remission/Response,nan,nan,1.0,728.0,1.0,728.0,1.0,286.0,1.0,286.0,1
TCGA-29-1703-01,TCGA-29-1703,OV,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2005.0,nan,-20622.0,Dead,WITH TUMOR,1815.0,1815.0,nan,Recurrence,nan,nan,324.0,Complete Remission/Response,nan,nan,1.0,1815.0,1.0,1815.0,1.0,324.0,1.0,324.0,1
TCGA-29-1704-02,TCGA-29-1704,OV,61.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-22511.0,Alive,WITH TUMOR,1587.0,nan,nan,Recurrence,nan,nan,568.0,Complete Remission/Response,nan,nan,0.0,1587.0,0.0,1587.0,1.0,568.0,1.0,568.0,2
TCGA-29-1704-01,TCGA-29-1704,OV,61.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-22511.0,Alive,WITH TUMOR,1587.0,nan,nan,Recurrence,nan,nan,568.0,Complete Remission/Response,nan,nan,0.0,1587.0,0.0,1587.0,1.0,568.0,1.0,568.0,2
TCGA-29-1705-02,TCGA-29-1705,OV,47.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2005.0,nan,-17530.0,Dead,WITH TUMOR,555.0,555.0,nan,Recurrence,nan,nan,283.0,Complete Remission/Response,nan,nan,1.0,555.0,1.0,555.0,1.0,283.0,1.0,283.0,1
TCGA-29-1705-01,TCGA-29-1705,OV,47.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2005.0,nan,-17530.0,Dead,WITH TUMOR,555.0,555.0,nan,Recurrence,nan,nan,283.0,Complete Remission/Response,nan,nan,1.0,555.0,1.0,555.0,1.0,283.0,1.0,283.0,1
TCGA-29-1707-02,TCGA-29-1707,OV,41.0,FEMALE,WHITE,nan,Stage IIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-15017.0,Alive,nan,1277.0,nan,nan,Recurrence,nan,nan,1201.0,Complete Remission/Response,nan,nan,0.0,1277.0,0.0,1277.0,1.0,1201.0,1.0,1201.0,2
TCGA-29-1707-01,TCGA-29-1707,OV,41.0,FEMALE,WHITE,nan,Stage IIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-15017.0,Alive,nan,1277.0,nan,nan,Recurrence,nan,nan,1201.0,Complete Remission/Response,nan,nan,0.0,1277.0,0.0,1277.0,1.0,1201.0,1.0,1201.0,2
TCGA-29-1710-02,TCGA-29-1710,OV,54.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2006.0,nan,-19969.0,Dead,WITH TUMOR,889.0,951.0,nan,Recurrence,nan,nan,315.0,Partial Remission/Response,nan,nan,1.0,951.0,1.0,951.0,nan,nan,1.0,315.0,1
TCGA-29-1710-01,TCGA-29-1710,OV,54.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2006.0,nan,-19969.0,Dead,WITH TUMOR,889.0,951.0,nan,Recurrence,nan,nan,315.0,Partial Remission/Response,nan,nan,1.0,951.0,1.0,951.0,nan,nan,1.0,315.0,1
TCGA-29-1711-01,TCGA-29-1711,OV,45.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2006.0,nan,-16485.0,Alive,TUMOR FREE,1053.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1053.0,0.0,1053.0,0.0,1053.0,0.0,1053.0,0
TCGA-29-1761-01,TCGA-29-1761,OV,80.0,FEMALE,ASIAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1998.0,nan,-29337.0,Dead,WITH TUMOR,517.0,528.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,528.0,1.0,528.0,nan,nan,1.0,528.0,1
TCGA-29-1762-01,TCGA-29-1762,OV,59.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G2,1998.0,nan,-21879.0,Dead,WITH TUMOR,2606.0,2634.0,nan,Recurrence,nan,nan,1375.0,Complete Remission/Response,nan,nan,1.0,2634.0,1.0,2634.0,nan,nan,1.0,1375.0,1
TCGA-29-1763-01,TCGA-29-1763,OV,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIC,Serous Cystadenocarcinoma,G2,2004.0,nan,-16021.0,Alive,WITH TUMOR,2032.0,nan,nan,Recurrence,nan,nan,428.0,Complete Remission/Response,nan,nan,0.0,2032.0,0.0,2032.0,1.0,428.0,1.0,428.0,2
TCGA-29-1764-01,TCGA-29-1764,OV,49.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2004.0,nan,-18012.0,Alive,WITH TUMOR,1914.0,nan,nan,Recurrence,nan,nan,792.0,Complete Remission/Response,nan,nan,0.0,1914.0,0.0,1914.0,1.0,792.0,1.0,792.0,2
TCGA-29-1766-01,TCGA-29-1766,OV,74.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2006.0,nan,-27359.0,Dead,WITH TUMOR,1190.0,1199.0,nan,Recurrence,nan,nan,672.0,Progressive Disease,nan,nan,1.0,1199.0,1.0,1199.0,nan,nan,1.0,672.0,1
TCGA-29-1768-01,TCGA-29-1768,OV,50.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2006.0,nan,-18396.0,Dead,WITH TUMOR,950.0,952.0,nan,Recurrence,nan,nan,547.0,Stable Disease,nan,nan,1.0,952.0,1.0,952.0,nan,nan,1.0,547.0,1
TCGA-29-1769-01,TCGA-29-1769,OV,40.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-14754.0,Alive,TUMOR FREE,699.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,699.0,0.0,699.0,0.0,699.0,0.0,699.0,0
TCGA-29-1770-02,TCGA-29-1770,OV,54.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2007.0,nan,-20015.0,Alive,WITH TUMOR,741.0,nan,nan,Recurrence,nan,nan,377.0,Complete Remission/Response,nan,nan,0.0,741.0,0.0,741.0,1.0,377.0,1.0,377.0,2
TCGA-29-1770-01,TCGA-29-1770,OV,54.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2007.0,nan,-20015.0,Alive,WITH TUMOR,741.0,nan,nan,Recurrence,nan,nan,377.0,Complete Remission/Response,nan,nan,0.0,741.0,0.0,741.0,1.0,377.0,1.0,377.0,2
TCGA-29-1771-01,TCGA-29-1771,OV,76.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2007.0,nan,-28093.0,Alive,WITH TUMOR,686.0,nan,nan,Recurrence,nan,nan,595.0,Complete Remission/Response,nan,nan,0.0,686.0,0.0,686.0,1.0,595.0,1.0,595.0,2
TCGA-29-1774-01,TCGA-29-1774,OV,82.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-29991.0,Alive,WITH TUMOR,527.0,nan,nan,Recurrence,nan,nan,234.0,Progressive Disease,nan,nan,0.0,527.0,0.0,527.0,nan,nan,1.0,234.0,2
TCGA-29-1775-01,TCGA-29-1775,OV,51.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2008.0,nan,-18943.0,Alive,WITH TUMOR,376.0,nan,nan,Recurrence,nan,nan,341.0,Complete Remission/Response,nan,nan,0.0,376.0,0.0,376.0,1.0,341.0,1.0,341.0,2
TCGA-29-1776-01,TCGA-29-1776,OV,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-23016.0,Alive,WITH TUMOR,360.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,360.0,0.0,360.0,nan,nan,0.0,360.0,0
TCGA-29-1777-01,TCGA-29-1777,OV,47.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2008.0,nan,-17356.0,Alive,WITH TUMOR,374.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,374.0,0.0,374.0,nan,nan,0.0,374.0,2
TCGA-29-1778-01,TCGA-29-1778,OV,77.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-28147.0,Alive,TUMOR FREE,454.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,454.0,0.0,454.0,0.0,454.0,0.0,454.0,0
TCGA-29-1781-01,TCGA-29-1781,OV,69.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-25404.0,Alive,TUMOR FREE,255.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,255.0,0.0,255.0,0.0,255.0,0.0,255.0,0
TCGA-29-1783-01,TCGA-29-1783,OV,58.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-21284.0,Alive,TUMOR FREE,220.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,220.0,0.0,220.0,nan,nan,0.0,220.0,0
TCGA-29-1784-01,TCGA-29-1784,OV,55.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-20210.0,Alive,TUMOR FREE,163.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,163.0,0.0,163.0,0.0,163.0,0.0,163.0,0
TCGA-29-1785-01,TCGA-29-1785,OV,55.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-20417.0,Dead,nan,1053.0,1104.0,nan,Recurrence,nan,nan,473.0,Complete Remission/Response,nan,nan,1.0,1104.0,nan,1104.0,1.0,473.0,1.0,473.0,1
TCGA-29-2414-02,TCGA-29-2414,OV,75.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,1998.0,nan,-27417.0,Dead,WITH TUMOR,2621.0,2621.0,nan,Recurrence,nan,nan,552.0,Complete Remission/Response,nan,nan,1.0,2621.0,1.0,2621.0,1.0,552.0,1.0,552.0,1
TCGA-29-2414-01,TCGA-29-2414,OV,75.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,1998.0,nan,-27417.0,Dead,WITH TUMOR,2621.0,2621.0,nan,Recurrence,nan,nan,552.0,Complete Remission/Response,nan,nan,1.0,2621.0,1.0,2621.0,1.0,552.0,1.0,552.0,1
TCGA-29-2425-01,TCGA-29-2425,OV,60.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2004.0,nan,-22089.0,Alive,TUMOR FREE,1977.0,nan,nan,Progression of Disease,nan,nan,1577.0,Complete Remission/Response,nan,nan,0.0,1977.0,0.0,1977.0,1.0,1577.0,1.0,1577.0,2
TCGA-29-2427-01,TCGA-29-2427,OV,60.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-21940.0,Alive,WITH TUMOR,1900.0,nan,nan,Recurrence,nan,nan,1582.0,Complete Remission/Response,nan,nan,0.0,1900.0,0.0,1900.0,1.0,1582.0,1.0,1582.0,2
TCGA-29-2428-01,TCGA-29-2428,OV,58.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-21392.0,Alive,TUMOR FREE,1372.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1372.0,0.0,1372.0,0.0,1372.0,0.0,1372.0,0
TCGA-29-2429-01,TCGA-29-2429,OV,79.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-29156.0,Dead,WITH TUMOR,nan,421.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,421.0,1.0,421.0,nan,nan,1.0,421.0,1
TCGA-29-2431-01,TCGA-29-2431,OV,59.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2006.0,nan,-21833.0,Alive,WITH TUMOR,1285.0,nan,nan,Recurrence,nan,nan,960.0,Complete Remission/Response,nan,nan,0.0,1285.0,0.0,1285.0,1.0,960.0,1.0,960.0,2
TCGA-29-2432-01,TCGA-29-2432,OV,61.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-22605.0,Dead,WITH TUMOR,360.0,653.0,nan,Recurrence,nan,nan,174.0,Progressive Disease,nan,nan,1.0,653.0,1.0,653.0,nan,nan,1.0,174.0,1
TCGA-29-2434-01,TCGA-29-2434,OV,52.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-18997.0,Alive,TUMOR FREE,349.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,349.0,0.0,349.0,0.0,349.0,0.0,349.0,0
TCGA-29-2436-01,TCGA-29-2436,OV,36.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2009.0,nan,-13346.0,Alive,TUMOR FREE,297.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,297.0,0.0,297.0,0.0,297.0,0.0,297.0,2
TCGA-29-A5NZ-01,TCGA-29-A5NZ,OV,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2011.0,nan,-24161.0,Dead,WITH TUMOR,nan,1088.0,nan,Recurrence,nan,nan,358.0,Complete Remission/Response,nan,nan,1.0,1088.0,1.0,1088.0,1.0,358.0,1.0,358.0,1
TCGA-30-1714-01,TCGA-30-1714,OV,68.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2001.0,nan,-25032.0,Dead,WITH TUMOR,1158.0,1158.0,nan,Recurrence,nan,nan,241.0,Complete Remission/Response,nan,nan,1.0,1158.0,1.0,1158.0,nan,nan,1.0,241.0,1
TCGA-30-1718-01,TCGA-30-1718,OV,44.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-16400.0,Dead,WITH TUMOR,1579.0,1579.0,nan,Recurrence,nan,nan,896.0,nan,nan,nan,1.0,1579.0,1.0,1579.0,nan,nan,1.0,896.0,1
TCGA-30-1853-01,TCGA-30-1853,OV,58.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2000.0,nan,-21404.0,Dead,WITH TUMOR,1103.0,1103.0,nan,Recurrence,nan,nan,634.0,Complete Remission/Response,nan,nan,1.0,1103.0,1.0,1103.0,1.0,634.0,1.0,634.0,1
TCGA-30-1855-01,TCGA-30-1855,OV,61.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,nan,-22394.0,Dead,WITH TUMOR,75.0,75.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,75.0,1.0,75.0,nan,nan,1.0,75.0,1
TCGA-30-1856-01,TCGA-30-1856,OV,56.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,nan,-20626.0,Dead,WITH TUMOR,477.0,477.0,nan,Recurrence,nan,nan,220.0,Partial Remission/Response,nan,nan,1.0,477.0,1.0,477.0,nan,nan,1.0,220.0,1
TCGA-30-1857-01,TCGA-30-1857,OV,64.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2001.0,nan,-23689.0,Dead,WITH TUMOR,8.0,8.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,8.0,1.0,8.0,nan,nan,1.0,8.0,1
TCGA-30-1859-01,TCGA-30-1859,OV,56.0,FEMALE,WHITE,nan,nan,Serous Cystadenocarcinoma,G3,2002.0,nan,-20498.0,Dead,WITH TUMOR,1463.0,1463.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,1463.0,1.0,1463.0,nan,nan,1.0,1463.0,1
TCGA-30-1860-01,TCGA-30-1860,OV,58.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-21406.0,Dead,WITH TUMOR,1366.0,1366.0,nan,Recurrence,nan,nan,397.0,Complete Remission/Response,nan,nan,1.0,1366.0,1.0,1366.0,1.0,397.0,1.0,397.0,1
TCGA-30-1861-01,TCGA-30-1861,OV,74.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-27103.0,Dead,nan,1058.0,1058.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1058.0,nan,1058.0,nan,nan,0.0,1058.0,1
TCGA-30-1862-01,TCGA-30-1862,OV,65.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G2,2003.0,nan,-23895.0,Dead,WITH TUMOR,186.0,186.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,186.0,1.0,186.0,nan,nan,1.0,186.0,1
TCGA-30-1866-01,TCGA-30-1866,OV,61.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G2,2003.0,nan,-22562.0,Dead,WITH TUMOR,1114.0,1114.0,nan,Recurrence,nan,nan,285.0,Complete Remission/Response,nan,nan,1.0,1114.0,1.0,1114.0,nan,nan,1.0,285.0,1
TCGA-30-1867-01,TCGA-30-1867,OV,46.0,FEMALE,nan,nan,Stage IV,Serous Cystadenocarcinoma,GX,2004.0,nan,-17159.0,Dead,WITH TUMOR,37.0,37.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,37.0,1.0,37.0,nan,nan,1.0,37.0,1
TCGA-30-1869-01,TCGA-30-1869,OV,50.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2004.0,nan,-18398.0,Dead,WITH TUMOR,1563.0,1563.0,nan,Recurrence,nan,nan,767.0,Complete Remission/Response,nan,nan,1.0,1563.0,1.0,1563.0,nan,nan,1.0,767.0,1
TCGA-30-1880-01,TCGA-30-1880,OV,56.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2001.0,nan,-20525.0,Dead,WITH TUMOR,1751.0,1751.0,nan,Recurrence,nan,nan,348.0,Partial Remission/Response,nan,nan,1.0,1751.0,1.0,1751.0,nan,nan,1.0,348.0,1
TCGA-30-1887-01,TCGA-30-1887,OV,67.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2005.0,nan,-24495.0,Dead,WITH TUMOR,738.0,738.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,738.0,1.0,738.0,nan,nan,1.0,738.0,1
TCGA-30-1891-01,TCGA-30-1891,OV,61.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2004.0,nan,-22344.0,Dead,WITH TUMOR,914.0,914.0,nan,Recurrence,nan,nan,181.0,Partial Remission/Response,nan,nan,1.0,914.0,1.0,914.0,nan,nan,1.0,181.0,1
TCGA-30-1892-01,TCGA-30-1892,OV,52.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-19256.0,Dead,WITH TUMOR,1484.0,1484.0,nan,Recurrence,nan,nan,253.0,Complete Remission/Response,nan,nan,1.0,1484.0,1.0,1484.0,1.0,253.0,1.0,253.0,1
TCGA-31-1944-01,TCGA-31-1944,OV,47.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-17207.0,Alive,WITH TUMOR,1386.0,nan,nan,Recurrence,nan,nan,678.0,Complete Remission/Response,nan,nan,0.0,1386.0,0.0,1386.0,1.0,678.0,1.0,678.0,2
TCGA-31-1946-01,TCGA-31-1946,OV,30.0,FEMALE,nan,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-11146.0,Alive,WITH TUMOR,918.0,nan,nan,Recurrence,nan,nan,664.0,nan,nan,nan,0.0,918.0,0.0,918.0,nan,nan,1.0,664.0,2
TCGA-31-1950-01,TCGA-31-1950,OV,76.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2007.0,nan,-28100.0,Alive,WITH TUMOR,571.0,nan,nan,Recurrence,nan,nan,349.0,Partial Remission/Response,nan,nan,0.0,571.0,0.0,571.0,nan,nan,1.0,349.0,2
TCGA-31-1951-01,TCGA-31-1951,OV,58.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-21352.0,Alive,WITH TUMOR,684.0,nan,nan,Recurrence,nan,nan,659.0,nan,nan,nan,0.0,684.0,0.0,684.0,nan,nan,1.0,659.0,2
TCGA-31-1953-01,TCGA-31-1953,OV,52.0,FEMALE,ASIAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-19064.0,Alive,WITH TUMOR,204.0,nan,nan,Recurrence,nan,nan,70.0,Progressive Disease,nan,nan,0.0,204.0,0.0,204.0,nan,nan,1.0,70.0,2
TCGA-31-1955-01,TCGA-31-1955,OV,43.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-15926.0,Alive,WITH TUMOR,1293.0,nan,nan,Recurrence,nan,nan,918.0,nan,nan,nan,0.0,1293.0,0.0,1293.0,nan,nan,1.0,918.0,2
TCGA-31-1956-01,TCGA-31-1956,OV,60.0,FEMALE,WHITE,nan,Stage IIIB,Serous Cystadenocarcinoma,G3,2005.0,nan,-22100.0,Alive,WITH TUMOR,1342.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1342.0,0.0,1342.0,nan,nan,0.0,1342.0,0
TCGA-31-1959-01,TCGA-31-1959,OV,49.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G2,2009.0,nan,-18247.0,Alive,WITH TUMOR,67.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,67.0,0.0,67.0,nan,nan,0.0,67.0,2
TCGA-36-1568-01,TCGA-36-1568,OV,52.0,FEMALE,nan,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-19311.0,Alive,WITH TUMOR,875.0,nan,nan,Recurrence,nan,nan,548.0,Partial Remission/Response,nan,nan,0.0,875.0,0.0,875.0,nan,nan,1.0,548.0,2
TCGA-36-1569-01,TCGA-36-1569,OV,52.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-19151.0,Alive,nan,885.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,885.0,0.0,885.0,nan,nan,0.0,885.0,0
TCGA-36-1570-01,TCGA-36-1570,OV,49.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-17956.0,Alive,WITH TUMOR,655.0,nan,nan,Recurrence,nan,nan,375.0,Partial Remission/Response,nan,nan,0.0,655.0,0.0,655.0,nan,nan,1.0,375.0,2
TCGA-36-1571-01,TCGA-36-1571,OV,53.0,FEMALE,WHITE,nan,Stage IIIB,Serous Cystadenocarcinoma,G3,2007.0,nan,-19608.0,Dead,WITH TUMOR,695.0,695.0,nan,Recurrence,nan,nan,375.0,Complete Remission/Response,nan,nan,1.0,695.0,1.0,695.0,1.0,375.0,1.0,375.0,1
TCGA-36-1574-01,TCGA-36-1574,OV,48.0,FEMALE,ASIAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-17847.0,Alive,WITH TUMOR,686.0,nan,nan,Recurrence,nan,nan,648.0,Complete Remission/Response,nan,nan,0.0,686.0,0.0,686.0,1.0,648.0,1.0,648.0,2
TCGA-36-1575-01,TCGA-36-1575,OV,83.0,FEMALE,nan,nan,Stage IIIB,Serous Cystadenocarcinoma,G3,2006.0,nan,-30592.0,Alive,TUMOR FREE,260.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,260.0,0.0,260.0,nan,nan,0.0,260.0,0
TCGA-36-1576-01,TCGA-36-1576,OV,76.0,FEMALE,nan,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-27778.0,Alive,WITH TUMOR,915.0,nan,nan,Recurrence,nan,nan,817.0,Complete Remission/Response,nan,nan,0.0,915.0,0.0,915.0,1.0,817.0,1.0,817.0,2
TCGA-36-1577-01,TCGA-36-1577,OV,43.0,FEMALE,ASIAN,nan,Stage IIC,Serous Cystadenocarcinoma,G2,2007.0,nan,-15804.0,Alive,TUMOR FREE,783.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,783.0,0.0,783.0,0.0,783.0,0.0,783.0,0
TCGA-36-1578-01,TCGA-36-1578,OV,63.0,FEMALE,ASIAN,nan,Stage IV,Serous Cystadenocarcinoma,G3,2007.0,nan,-23329.0,Alive,WITH TUMOR,847.0,nan,nan,Recurrence,nan,nan,310.0,nan,nan,nan,0.0,847.0,0.0,847.0,nan,nan,1.0,310.0,2
TCGA-36-1580-01,TCGA-36-1580,OV,82.0,FEMALE,nan,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-29992.0,Dead,WITH TUMOR,737.0,737.0,nan,Recurrence,nan,nan,440.0,nan,nan,nan,1.0,737.0,1.0,737.0,nan,nan,1.0,440.0,1
TCGA-36-1581-01,TCGA-36-1581,OV,63.0,FEMALE,WHITE,nan,Stage IIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-23272.0,Alive,WITH TUMOR,751.0,nan,nan,Recurrence,nan,nan,702.0,Complete Remission/Response,nan,nan,0.0,751.0,0.0,751.0,1.0,702.0,1.0,702.0,2
TCGA-36-2529-01,TCGA-36-2529,OV,71.0,FEMALE,nan,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-26092.0,Alive,WITH TUMOR,1066.0,nan,nan,Recurrence,nan,nan,567.0,Complete Remission/Response,nan,nan,0.0,1066.0,0.0,1066.0,1.0,567.0,1.0,567.0,2
TCGA-36-2530-01,TCGA-36-2530,OV,38.0,FEMALE,ASIAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-13885.0,Alive,WITH TUMOR,1004.0,nan,nan,Recurrence,nan,nan,630.0,Complete Remission/Response,nan,nan,0.0,1004.0,0.0,1004.0,1.0,630.0,1.0,630.0,2
TCGA-36-2532-01,TCGA-36-2532,OV,61.0,FEMALE,nan,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-22333.0,Alive,WITH TUMOR,897.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,897.0,0.0,897.0,nan,nan,0.0,897.0,0
TCGA-36-2533-01,TCGA-36-2533,OV,55.0,FEMALE,nan,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-20187.0,nan,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,nan,1
TCGA-36-2534-01,TCGA-36-2534,OV,72.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-26621.0,Alive,WITH TUMOR,907.0,nan,nan,Progression of Disease,nan,nan,383.0,Partial Remission/Response,nan,nan,0.0,907.0,0.0,907.0,nan,nan,1.0,383.0,2
TCGA-36-2537-01,TCGA-36-2537,OV,39.0,FEMALE,nan,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-14595.0,Alive,WITH TUMOR,788.0,nan,nan,Progression of Disease,nan,nan,431.0,Partial Remission/Response,nan,nan,0.0,788.0,0.0,788.0,nan,nan,1.0,431.0,2
TCGA-36-2538-01,TCGA-36-2538,OV,37.0,FEMALE,nan,nan,Stage IIIB,Serous Cystadenocarcinoma,G3,2008.0,nan,-13681.0,Alive,WITH TUMOR,763.0,nan,nan,Recurrence,nan,nan,523.0,Complete Remission/Response,nan,nan,0.0,763.0,0.0,763.0,1.0,523.0,1.0,523.0,2
TCGA-36-2540-01,TCGA-36-2540,OV,26.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G1,2008.0,nan,-9760.0,Alive,WITH TUMOR,724.0,nan,nan,Recurrence,nan,nan,665.0,Complete Remission/Response,nan,nan,0.0,724.0,0.0,724.0,1.0,665.0,1.0,665.0,2
TCGA-36-2542-01,TCGA-36-2542,OV,59.0,FEMALE,ASIAN,nan,Stage IIIB,Serous Cystadenocarcinoma,G3,2008.0,nan,-21902.0,Alive,TUMOR FREE,657.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,657.0,0.0,657.0,0.0,657.0,0.0,657.0,0
TCGA-36-2543-01,TCGA-36-2543,OV,85.0,FEMALE,nan,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-31211.0,Dead,WITH TUMOR,68.0,68.0,nan,Progression of Disease,nan,nan,27.0,Progressive Disease,nan,nan,1.0,68.0,1.0,68.0,nan,nan,1.0,27.0,1
TCGA-36-2544-01,TCGA-36-2544,OV,58.0,FEMALE,nan,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-21384.0,Alive,WITH TUMOR,638.0,nan,nan,Progression of Disease,nan,nan,325.0,Partial Remission/Response,nan,nan,0.0,638.0,0.0,638.0,nan,nan,1.0,325.0,2
TCGA-36-2545-01,TCGA-36-2545,OV,42.0,FEMALE,nan,nan,Stage IIIA,Serous Cystadenocarcinoma,G3,2008.0,nan,-15444.0,Alive,TUMOR FREE,557.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,557.0,0.0,557.0,nan,nan,0.0,557.0,0
TCGA-36-2547-01,TCGA-36-2547,OV,64.0,FEMALE,nan,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-23706.0,Alive,nan,624.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,624.0,0.0,624.0,nan,nan,0.0,624.0,0
TCGA-36-2548-01,TCGA-36-2548,OV,57.0,FEMALE,nan,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-20897.0,Alive,WITH TUMOR,431.0,nan,nan,Recurrence,nan,nan,395.0,nan,nan,nan,0.0,431.0,0.0,431.0,nan,nan,1.0,395.0,1
TCGA-36-2549-01,TCGA-36-2549,OV,54.0,FEMALE,nan,nan,Stage IIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-20076.0,Alive,TUMOR FREE,184.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,184.0,0.0,184.0,nan,nan,0.0,184.0,0
TCGA-36-2551-01,TCGA-36-2551,OV,57.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-21045.0,Alive,WITH TUMOR,492.0,nan,nan,Recurrence,nan,nan,338.0,Complete Remission/Response,nan,nan,0.0,492.0,0.0,492.0,1.0,338.0,1.0,338.0,2
TCGA-36-2552-01,TCGA-36-2552,OV,64.0,FEMALE,nan,nan,Stage IIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-23379.0,Alive,TUMOR FREE,349.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,349.0,0.0,349.0,nan,nan,0.0,349.0,0
TCGA-3P-A9WA-01,TCGA-3P-A9WA,OV,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIB,Serous Cystadenocarcinoma,G3,2013.0,nan,-20211.0,Alive,TUMOR FREE,420.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,420.0,0.0,420.0,0.0,420.0,0.0,420.0,0
TCGA-42-2582-01,TCGA-42-2582,OV,49.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-17961.0,Dead,WITH TUMOR,nan,1447.0,nan,Recurrence,nan,nan,616.0,Stable Disease,nan,nan,1.0,1447.0,1.0,1447.0,nan,nan,1.0,616.0,1
TCGA-42-2587-01,TCGA-42-2587,OV,75.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-27510.0,Alive,TUMOR FREE,722.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,722.0,0.0,722.0,0.0,722.0,0.0,722.0,0
TCGA-42-2588-01,TCGA-42-2588,OV,61.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2009.0,nan,-22377.0,Dead,WITH TUMOR,nan,880.0,nan,Progression of Disease,nan,nan,112.0,Progressive Disease,nan,nan,1.0,880.0,1.0,880.0,nan,nan,1.0,112.0,1
TCGA-42-2589-01,TCGA-42-2589,OV,54.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-19852.0,Alive,WITH TUMOR,1278.0,nan,nan,Recurrence,nan,nan,364.0,Complete Remission/Response,nan,nan,0.0,1278.0,0.0,1278.0,1.0,364.0,1.0,364.0,2
TCGA-42-2590-01,TCGA-42-2590,OV,57.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G2,2009.0,nan,-20965.0,Dead,WITH TUMOR,nan,317.0,nan,Progression of Disease,nan,nan,226.0,Progressive Disease,nan,nan,1.0,317.0,1.0,317.0,nan,nan,1.0,226.0,1
TCGA-42-2591-01,TCGA-42-2591,OV,51.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,GX,2009.0,nan,-18654.0,Alive,TUMOR FREE,1240.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1240.0,0.0,1240.0,0.0,1240.0,0.0,1240.0,0
TCGA-42-2593-01,TCGA-42-2593,OV,67.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-24823.0,Dead,WITH TUMOR,nan,45.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,45.0,1.0,45.0,nan,nan,1.0,45.0,1
TCGA-57-1582-01,TCGA-57-1582,OV,50.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,nan,Dead,WITH TUMOR,731.0,731.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,731.0,1.0,731.0,nan,nan,1.0,731.0,1
TCGA-57-1583-01,TCGA-57-1583,OV,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-21167.0,Dead,WITH TUMOR,346.0,346.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,346.0,1.0,346.0,nan,nan,1.0,346.0,1
TCGA-57-1584-01,TCGA-57-1584,OV,47.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-17263.0,Alive,WITH TUMOR,643.0,nan,nan,Recurrence,nan,nan,530.0,nan,nan,nan,0.0,643.0,0.0,643.0,nan,nan,1.0,530.0,2
TCGA-57-1585-01,TCGA-57-1585,OV,57.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-20862.0,Dead,WITH TUMOR,53.0,53.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,53.0,1.0,53.0,nan,nan,1.0,53.0,1
TCGA-57-1586-01,TCGA-57-1586,OV,66.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-24304.0,Alive,WITH TUMOR,679.0,nan,nan,Recurrence,nan,nan,259.0,nan,nan,nan,0.0,679.0,0.0,679.0,nan,nan,1.0,259.0,2
TCGA-57-1992-01,TCGA-57-1992,OV,62.0,FEMALE,nan,nan,Stage IC,Serous Cystadenocarcinoma,G3,2006.0,nan,nan,Alive,TUMOR FREE,882.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,882.0,0.0,882.0,0.0,882.0,0.0,882.0,0
TCGA-57-1993-01,TCGA-57-1993,OV,56.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-20498.0,Alive,TUMOR FREE,763.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,763.0,0.0,763.0,nan,nan,0.0,763.0,0
TCGA-57-1994-01,TCGA-57-1994,OV,63.0,FEMALE,WHITE,nan,nan,Serous Cystadenocarcinoma,nan,2004.0,nan,-23062.0,Alive,nan,761.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,761.0,0.0,761.0,nan,nan,0.0,761.0,0
TCGA-59-2348-01,TCGA-59-2348,OV,59.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1994.0,nan,nan,Alive,TUMOR FREE,5481.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,5481.0,0.0,5481.0,0.0,5481.0,0.0,5481.0,0
TCGA-59-2349-01,TCGA-59-2349,OV,71.0,FEMALE,nan,nan,Stage IA,Serous Cystadenocarcinoma,G3,1994.0,nan,nan,Dead,nan,nan,2437.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2437.0,nan,2437.0,0.0,2437.0,0.0,2437.0,1
TCGA-59-2350-01,TCGA-59-2350,OV,44.0,FEMALE,nan,nan,Stage IV,Serous Cystadenocarcinoma,G3,1995.0,nan,nan,Dead,WITH TUMOR,nan,679.0,nan,Progression of Disease,nan,nan,211.0,Partial Remission/Response,nan,nan,1.0,679.0,1.0,679.0,nan,nan,1.0,211.0,1
TCGA-59-2351-01,TCGA-59-2351,OV,51.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,nan,nan,Alive,TUMOR FREE,3532.0,nan,nan,Progression of Disease,nan,nan,2139.0,Complete Remission/Response,nan,nan,0.0,3532.0,0.0,3532.0,1.0,2139.0,1.0,2139.0,2
TCGA-59-2352-01,TCGA-59-2352,OV,78.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,nan,Dead,WITH TUMOR,nan,286.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,286.0,1.0,286.0,nan,nan,1.0,286.0,1
TCGA-59-2354-01,TCGA-59-2354,OV,63.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,nan,Dead,WITH TUMOR,nan,1046.0,nan,Progression of Disease,nan,nan,462.0,Stable Disease,nan,nan,1.0,1046.0,1.0,1046.0,nan,nan,1.0,462.0,1
TCGA-59-2355-01,TCGA-59-2355,OV,58.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2006.0,nan,nan,Dead,WITH TUMOR,nan,65.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,65.0,1.0,65.0,nan,nan,1.0,65.0,1
TCGA-59-2363-01,TCGA-59-2363,OV,40.0,FEMALE,ASIAN,nan,Stage IIIA,Serous Cystadenocarcinoma,G3,2007.0,nan,nan,Alive,TUMOR FREE,165.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,165.0,0.0,165.0,0.0,165.0,0.0,165.0,0
TCGA-59-2372-01,TCGA-59-2372,OV,73.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2005.0,nan,nan,Dead,nan,nan,1363.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1363.0,nan,1363.0,nan,nan,0.0,1363.0,1
TCGA-59-A5PD-01,TCGA-59-A5PD,OV,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IC,Serous Cystadenocarcinoma,G3,2011.0,nan,-20263.0,Dead,WITH TUMOR,nan,624.0,nan,Recurrence,nan,nan,145.0,Complete Remission/Response,nan,nan,1.0,624.0,1.0,624.0,1.0,145.0,1.0,145.0,1
TCGA-5X-AA5U-01,TCGA-5X-AA5U,OV,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIC,Serous Cystadenocarcinoma,GX,2013.0,nan,-22438.0,Alive,TUMOR FREE,361.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,361.0,0.0,361.0,0.0,361.0,0.0,361.0,0
TCGA-61-1721-01,TCGA-61-1721,OV,38.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G1,2008.0,nan,-13894.0,Alive,TUMOR FREE,338.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,338.0,0.0,338.0,nan,nan,0.0,338.0,0
TCGA-61-1722-01,TCGA-61-1722,OV,89.0,FEMALE,WHITE,nan,Stage IB,Serous Cystadenocarcinoma,G3,2008.0,nan,-32853.0,Alive,WITH TUMOR,246.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,246.0,0.0,246.0,nan,nan,0.0,246.0,2
TCGA-61-1724-01,TCGA-61-1724,OV,47.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-17168.0,Dead,WITH TUMOR,637.0,637.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,637.0,1.0,637.0,nan,nan,1.0,637.0,1
TCGA-61-1725-01,TCGA-61-1725,OV,40.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-14782.0,Alive,WITH TUMOR,956.0,nan,nan,Recurrence,nan,nan,844.0,Stable Disease,nan,nan,0.0,956.0,0.0,956.0,nan,nan,1.0,844.0,2
TCGA-61-1727-01,TCGA-61-1727,OV,74.0,FEMALE,WHITE,nan,Stage IC,Serous Cystadenocarcinoma,G3,2007.0,nan,-27203.0,Alive,TUMOR FREE,564.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,564.0,0.0,564.0,0.0,564.0,0.0,564.0,0
TCGA-61-1728-01,TCGA-61-1728,OV,59.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2007.0,nan,-21582.0,Alive,TUMOR FREE,848.0,nan,nan,Recurrence,nan,nan,533.0,Complete Remission/Response,nan,nan,0.0,848.0,0.0,848.0,nan,nan,1.0,533.0,2
TCGA-61-1730-01,TCGA-61-1730,OV,78.0,FEMALE,WHITE,nan,Stage IC,Serous Cystadenocarcinoma,G3,2007.0,nan,-28508.0,Dead,WITH TUMOR,132.0,132.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,132.0,1.0,132.0,nan,nan,1.0,132.0,1
TCGA-61-1733-01,TCGA-61-1733,OV,71.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-26180.0,Alive,WITH TUMOR,967.0,nan,nan,Recurrence,nan,nan,175.0,Stable Disease,nan,nan,0.0,967.0,0.0,967.0,nan,nan,1.0,175.0,2
TCGA-61-1734-01,TCGA-61-1734,OV,52.0,FEMALE,WHITE,nan,Stage IC,Serous Cystadenocarcinoma,G3,2006.0,nan,-19026.0,Alive,TUMOR FREE,866.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,866.0,0.0,866.0,0.0,866.0,0.0,866.0,0
TCGA-61-1736-01,TCGA-61-1736,OV,45.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-16613.0,Dead,WITH TUMOR,1484.0,1484.0,nan,Recurrence,nan,nan,764.0,Complete Remission/Response,nan,nan,1.0,1484.0,1.0,1484.0,1.0,764.0,1.0,764.0,1
TCGA-61-1737-01,TCGA-61-1737,OV,42.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2005.0,nan,-15515.0,Alive,TUMOR FREE,1364.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1364.0,0.0,1364.0,nan,nan,0.0,1364.0,0
TCGA-61-1738-01,TCGA-61-1738,OV,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-21965.0,Dead,WITH TUMOR,1089.0,1089.0,nan,Recurrence,nan,nan,276.0,Progressive Disease,nan,nan,1.0,1089.0,1.0,1089.0,nan,nan,1.0,276.0,1
TCGA-61-1740-01,TCGA-61-1740,OV,71.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2005.0,nan,-26169.0,Dead,WITH TUMOR,74.0,74.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,74.0,1.0,74.0,nan,nan,1.0,74.0,1
TCGA-61-1741-01,TCGA-61-1741,OV,76.0,FEMALE,WHITE,nan,Stage IIIB,Serous Cystadenocarcinoma,G3,2004.0,nan,-27762.0,Dead,WITH TUMOR,1024.0,1024.0,nan,Recurrence,nan,nan,488.0,Complete Remission/Response,nan,nan,1.0,1024.0,1.0,1024.0,1.0,488.0,1.0,488.0,1
TCGA-61-1743-01,TCGA-61-1743,OV,53.0,FEMALE,WHITE,nan,Stage IIC,Serous Cystadenocarcinoma,G2,2004.0,nan,-19365.0,Dead,WITH TUMOR,1329.0,1329.0,nan,Recurrence,nan,nan,809.0,Complete Remission/Response,nan,nan,1.0,1329.0,1.0,1329.0,1.0,809.0,1.0,809.0,1
TCGA-61-1895-01,TCGA-61-1895,OV,52.0,FEMALE,WHITE,nan,Stage IIIB,Serous Cystadenocarcinoma,G3,2009.0,nan,-19060.0,Alive,TUMOR FREE,44.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,44.0,0.0,44.0,nan,nan,0.0,44.0,0
TCGA-61-1899-01,TCGA-61-1899,OV,81.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-29692.0,Alive,TUMOR FREE,256.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,256.0,0.0,256.0,0.0,256.0,0.0,256.0,0
TCGA-61-1900-01,TCGA-61-1900,OV,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIB,Serous Cystadenocarcinoma,G3,2008.0,nan,-18963.0,Alive,TUMOR FREE,176.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,176.0,0.0,176.0,nan,nan,0.0,176.0,0
TCGA-61-1901-01,TCGA-61-1901,OV,65.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2008.0,nan,-24042.0,Dead,WITH TUMOR,347.0,347.0,nan,Progression of Disease,nan,nan,329.0,Stable Disease,nan,nan,1.0,347.0,1.0,347.0,nan,nan,1.0,329.0,1
TCGA-61-1903-01,TCGA-61-1903,OV,55.0,FEMALE,WHITE,nan,Stage IB,Serous Cystadenocarcinoma,G3,2007.0,nan,-20381.0,Alive,TUMOR FREE,396.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,396.0,0.0,396.0,0.0,396.0,0.0,396.0,0
TCGA-61-1904-01,TCGA-61-1904,OV,60.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-22009.0,Alive,TUMOR FREE,276.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,276.0,0.0,276.0,0.0,276.0,0.0,276.0,0
TCGA-61-1906-01,TCGA-61-1906,OV,55.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-20378.0,Dead,WITH TUMOR,1038.0,1038.0,nan,Recurrence,nan,nan,236.0,Complete Remission/Response,nan,nan,1.0,1038.0,1.0,1038.0,1.0,236.0,1.0,236.0,1
TCGA-61-1907-01,TCGA-61-1907,OV,63.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-23204.0,Alive,WITH TUMOR,952.0,nan,nan,Recurrence,nan,nan,743.0,Stable Disease,nan,nan,0.0,952.0,0.0,952.0,nan,nan,1.0,743.0,2
TCGA-61-1910-01,TCGA-61-1910,OV,56.0,FEMALE,WHITE,nan,Stage IIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-20779.0,Alive,TUMOR FREE,1127.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1127.0,0.0,1127.0,0.0,1127.0,0.0,1127.0,0
TCGA-61-1911-01,TCGA-61-1911,OV,55.0,FEMALE,WHITE,nan,Stage IIA,Serous Cystadenocarcinoma,G3,2005.0,nan,-20144.0,Alive,WITH TUMOR,1293.0,nan,nan,Recurrence,nan,nan,844.0,Complete Remission/Response,nan,nan,0.0,1293.0,0.0,1293.0,1.0,844.0,1.0,844.0,2
TCGA-61-1913-01,TCGA-61-1913,OV,48.0,FEMALE,WHITE,nan,Stage IIIB,Serous Cystadenocarcinoma,G3,2005.0,nan,-17575.0,Alive,TUMOR FREE,1488.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1488.0,0.0,1488.0,0.0,1488.0,0.0,1488.0,0
TCGA-61-1914-01,TCGA-61-1914,OV,65.0,FEMALE,nan,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-23850.0,Alive,WITH TUMOR,1722.0,nan,nan,Recurrence,nan,nan,1674.0,Complete Remission/Response,nan,nan,0.0,1722.0,0.0,1722.0,1.0,1674.0,1.0,1674.0,2
TCGA-61-1915-01,TCGA-61-1915,OV,50.0,FEMALE,WHITE,nan,Stage IIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-18424.0,Alive,TUMOR FREE,2061.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2061.0,0.0,2061.0,0.0,2061.0,0.0,2061.0,0
TCGA-61-1916-02,TCGA-61-1916,OV,53.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2002.0,nan,-19463.0,Dead,nan,475.0,475.0,nan,Recurrence,nan,nan,326.0,nan,nan,nan,1.0,475.0,nan,475.0,nan,nan,1.0,326.0,1
TCGA-61-1916-01,TCGA-61-1916,OV,53.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2002.0,nan,-19463.0,Dead,nan,475.0,475.0,nan,Recurrence,nan,nan,326.0,nan,nan,nan,1.0,475.0,nan,475.0,nan,nan,1.0,326.0,1
TCGA-61-1917-01,TCGA-61-1917,OV,60.0,FEMALE,WHITE,nan,Stage IIIB,Serous Cystadenocarcinoma,G3,2002.0,nan,-21972.0,Dead,nan,1321.0,1321.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1321.0,nan,1321.0,0.0,1321.0,0.0,1321.0,1
TCGA-61-1918-01,TCGA-61-1918,OV,45.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,2002.0,nan,-16689.0,Dead,WITH TUMOR,479.0,479.0,nan,Recurrence,nan,nan,413.0,Complete Remission/Response,nan,nan,1.0,479.0,1.0,479.0,nan,nan,1.0,413.0,1
TCGA-61-1919-01,TCGA-61-1919,OV,58.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2001.0,nan,-21199.0,Dead,nan,1161.0,1161.0,nan,Recurrence,nan,nan,439.0,Complete Remission/Response,nan,nan,1.0,1161.0,nan,1161.0,1.0,439.0,1.0,439.0,2
TCGA-61-1995-01,TCGA-61-1995,OV,43.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-16016.0,Alive,WITH TUMOR,61.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,61.0,0.0,61.0,nan,nan,0.0,61.0,2
TCGA-61-1998-01,TCGA-61-1998,OV,48.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-17855.0,Alive,WITH TUMOR,168.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,168.0,0.0,168.0,nan,nan,0.0,168.0,2
TCGA-61-2000-01,TCGA-61-2000,OV,67.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-24723.0,Alive,WITH TUMOR,441.0,nan,nan,Recurrence,nan,nan,339.0,Stable Disease,nan,nan,0.0,441.0,0.0,441.0,nan,nan,1.0,339.0,2
TCGA-61-2002-01,TCGA-61-2002,OV,46.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-17115.0,Alive,WITH TUMOR,547.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,547.0,0.0,547.0,nan,nan,0.0,547.0,2
TCGA-61-2003-01,TCGA-61-2003,OV,53.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2008.0,nan,-19605.0,Alive,WITH TUMOR,122.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,122.0,0.0,122.0,nan,nan,0.0,122.0,2
TCGA-61-2008-02,TCGA-61-2008,OV,40.0,FEMALE,ASIAN,nan,Stage IIC,Serous Cystadenocarcinoma,G2,2007.0,nan,-14791.0,Alive,WITH TUMOR,932.0,nan,nan,Recurrence,nan,nan,818.0,Complete Remission/Response,nan,nan,0.0,932.0,0.0,932.0,1.0,818.0,1.0,818.0,2
TCGA-61-2008-01,TCGA-61-2008,OV,40.0,FEMALE,ASIAN,nan,Stage IIC,Serous Cystadenocarcinoma,G2,2007.0,nan,-14791.0,Alive,WITH TUMOR,932.0,nan,nan,Recurrence,nan,nan,818.0,Complete Remission/Response,nan,nan,0.0,932.0,0.0,932.0,1.0,818.0,1.0,818.0,2
TCGA-61-2009-01,TCGA-61-2009,OV,65.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-23772.0,Alive,WITH TUMOR,1212.0,nan,nan,Recurrence,nan,nan,101.0,Complete Remission/Response,nan,nan,0.0,1212.0,0.0,1212.0,1.0,101.0,1.0,101.0,2
TCGA-61-2012-01,TCGA-61-2012,OV,81.0,FEMALE,WHITE,nan,Stage IIC,Serous Cystadenocarcinoma,G2,2006.0,nan,-29830.0,Alive,nan,932.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,932.0,0.0,932.0,nan,nan,0.0,932.0,0
TCGA-61-2016-01,TCGA-61-2016,OV,51.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2006.0,nan,-18788.0,Dead,WITH TUMOR,nan,36.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,36.0,1.0,36.0,nan,nan,1.0,36.0,1
TCGA-61-2017-01,TCGA-61-2017,OV,64.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G1,2005.0,nan,-23509.0,Alive,WITH TUMOR,1398.0,nan,nan,Recurrence,nan,nan,1006.0,Complete Remission/Response,nan,nan,0.0,1398.0,0.0,1398.0,1.0,1006.0,1.0,1006.0,2
TCGA-61-2018-01,TCGA-61-2018,OV,62.0,FEMALE,WHITE,nan,Stage IC,Serous Cystadenocarcinoma,G3,2005.0,nan,-22929.0,Alive,TUMOR FREE,1381.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1381.0,0.0,1381.0,0.0,1381.0,0.0,1381.0,0
TCGA-61-2087-01,TCGA-61-2087,OV,49.0,FEMALE,WHITE,nan,Stage IC,Serous Cystadenocarcinoma,G3,2009.0,nan,-18182.0,Alive,TUMOR FREE,146.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,146.0,0.0,146.0,0.0,146.0,0.0,146.0,0
TCGA-61-2088-01,TCGA-61-2088,OV,51.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2009.0,nan,-18770.0,Alive,TUMOR FREE,145.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,145.0,0.0,145.0,nan,nan,0.0,145.0,0
TCGA-61-2092-01,TCGA-61-2092,OV,57.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2004.0,nan,-21072.0,Alive,TUMOR FREE,1573.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1573.0,0.0,1573.0,0.0,1573.0,0.0,1573.0,0
TCGA-61-2094-01,TCGA-61-2094,OV,63.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2003.0,nan,-23273.0,Alive,TUMOR FREE,2182.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2182.0,0.0,2182.0,0.0,2182.0,0.0,2182.0,0
TCGA-61-2095-02,TCGA-61-2095,OV,54.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2003.0,nan,-19797.0,Dead,WITH TUMOR,nan,1875.0,nan,Recurrence,nan,nan,445.0,Complete Remission/Response,nan,nan,1.0,1875.0,1.0,1875.0,1.0,445.0,1.0,445.0,1
TCGA-61-2095-01,TCGA-61-2095,OV,54.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2003.0,nan,-19797.0,Dead,WITH TUMOR,nan,1875.0,nan,Recurrence,nan,nan,445.0,Complete Remission/Response,nan,nan,1.0,1875.0,1.0,1875.0,1.0,445.0,1.0,445.0,1
TCGA-61-2096-01,TCGA-61-2096,OV,56.0,FEMALE,WHITE,nan,Stage IC,Serous Cystadenocarcinoma,G2,2003.0,nan,-20663.0,Alive,TUMOR FREE,1776.0,nan,nan,Recurrence,nan,nan,421.0,Progressive Disease,nan,nan,0.0,1776.0,0.0,1776.0,nan,nan,1.0,421.0,2
TCGA-61-2097-01,TCGA-61-2097,OV,71.0,FEMALE,WHITE,nan,Stage IIC,Serous Cystadenocarcinoma,G2,2003.0,nan,-25961.0,Alive,TUMOR FREE,1844.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1844.0,0.0,1844.0,0.0,1844.0,0.0,1844.0,0
TCGA-61-2098-01,TCGA-61-2098,OV,62.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,2003.0,nan,-22876.0,Alive,TUMOR FREE,1993.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1993.0,0.0,1993.0,0.0,1993.0,0.0,1993.0,0
TCGA-61-2101-01,TCGA-61-2101,OV,55.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G2,1999.0,nan,-20287.0,Dead,WITH TUMOR,nan,1688.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,1688.0,1.0,1688.0,nan,nan,1.0,1688.0,1
TCGA-61-2102-01,TCGA-61-2102,OV,74.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,nan,-27256.0,Dead,WITH TUMOR,197.0,197.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,197.0,1.0,197.0,nan,nan,1.0,197.0,1
TCGA-61-2104-01,TCGA-61-2104,OV,53.0,FEMALE,WHITE,nan,Stage IIC,Serous Cystadenocarcinoma,G2,2003.0,nan,-19432.0,Alive,nan,2338.0,nan,nan,Recurrence,nan,nan,1680.0,Complete Remission/Response,nan,nan,0.0,2338.0,0.0,2338.0,1.0,1680.0,1.0,1680.0,2
TCGA-61-2109-01,TCGA-61-2109,OV,40.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1999.0,nan,-14900.0,Dead,WITH TUMOR,629.0,629.0,nan,Recurrence,nan,nan,465.0,nan,nan,nan,1.0,629.0,1.0,629.0,nan,nan,1.0,465.0,1
TCGA-61-2110-01,TCGA-61-2110,OV,56.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,nan,1998.0,nan,-20718.0,Dead,WITH TUMOR,1354.0,1354.0,nan,Recurrence,nan,nan,213.0,Progressive Disease,nan,nan,1.0,1354.0,1.0,1354.0,nan,nan,1.0,213.0,1
TCGA-61-2111-01,TCGA-61-2111,OV,61.0,FEMALE,WHITE,nan,Stage IV,Serous Cystadenocarcinoma,G3,1998.0,nan,-22517.0,Alive,WITH TUMOR,3825.0,nan,nan,Recurrence,nan,nan,2205.0,Complete Remission/Response,nan,nan,0.0,3825.0,0.0,3825.0,nan,nan,1.0,2205.0,2
TCGA-61-2113-01,TCGA-61-2113,OV,53.0,FEMALE,WHITE,nan,Stage IIC,Serous Cystadenocarcinoma,G3,1999.0,nan,-19722.0,Dead,nan,676.0,676.0,nan,Recurrence,nan,nan,291.0,nan,nan,nan,1.0,676.0,nan,676.0,nan,nan,1.0,291.0,1
TCGA-61-2610-02,TCGA-61-2610,OV,61.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1998.0,nan,-22481.0,Dead,WITH TUMOR,1579.0,1579.0,nan,Recurrence,nan,nan,524.0,Stable Disease,nan,nan,1.0,1579.0,1.0,1579.0,nan,nan,1.0,524.0,1
TCGA-61-2611-02,TCGA-61-2611,OV,40.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2008.0,nan,-14782.0,Dead,WITH TUMOR,483.0,483.0,nan,Recurrence,nan,nan,383.0,Complete Remission/Response,nan,nan,1.0,483.0,1.0,483.0,1.0,383.0,1.0,383.0,1
TCGA-61-2612-01,TCGA-61-2612,OV,63.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2002.0,nan,-23074.0,Dead,WITH TUMOR,193.0,193.0,nan,Recurrence,nan,nan,179.0,Stable Disease,nan,nan,1.0,193.0,1.0,193.0,nan,nan,1.0,179.0,1
TCGA-61-2613-01,TCGA-61-2613,OV,73.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,1998.0,nan,-26779.0,Dead,WITH TUMOR,945.0,945.0,nan,Recurrence,nan,nan,358.0,Stable Disease,nan,nan,1.0,945.0,1.0,945.0,nan,nan,1.0,358.0,1
TCGA-61-2614-01,TCGA-61-2614,OV,71.0,FEMALE,WHITE,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2007.0,nan,-26142.0,Dead,WITH TUMOR,262.0,262.0,nan,Recurrence,nan,nan,38.0,Stable Disease,nan,nan,1.0,262.0,1.0,262.0,nan,nan,1.0,38.0,1
TCGA-OY-A56P-01,TCGA-OY-A56P,OV,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIB,Serous Cystadenocarcinoma,G3,2010.0,nan,-17580.0,Alive,WITH TUMOR,1207.0,nan,nan,Recurrence,nan,nan,794.0,Complete Remission/Response,nan,nan,0.0,1207.0,0.0,1207.0,1.0,794.0,1.0,794.0,2
TCGA-OY-A56Q-01,TCGA-OY-A56Q,OV,78.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIA,Serous Cystadenocarcinoma,G3,2012.0,nan,-28623.0,Alive,TUMOR FREE,576.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,576.0,0.0,576.0,0.0,576.0,0.0,576.0,0
TCGA-VG-A8LO-01,TCGA-VG-A8LO,OV,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IV,Serous Cystadenocarcinoma,GB,2013.0,nan,-20274.0,Dead,WITH TUMOR,nan,24.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,24.0,1.0,24.0,nan,nan,1.0,24.0,1
TCGA-WR-A838-01,TCGA-WR-A838,OV,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous Cystadenocarcinoma,G3,2013.0,nan,-26418.0,Dead,WITH TUMOR,nan,304.0,nan,Progression of Disease,nan,nan,245.0,Progressive Disease,nan,nan,1.0,304.0,1.0,304.0,nan,nan,1.0,245.0,1
TCGA-2J-AAB1-01,TCGA-2J-AAB1,PAAD,65.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma-Other Subtype,G3,2012.0,nan,-23962.0,Dead,TUMOR FREE,nan,66.0,Pancreatic Cancer,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,66.0,1.0,66.0,0.0,66.0,0.0,66.0,0
TCGA-2J-AAB4-01,TCGA-2J-AAB4,PAAD,48.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma-Other Subtype,G2,2012.0,nan,-17794.0,Alive,TUMOR FREE,729.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,729.0,0.0,729.0,0.0,729.0,0.0,729.0,0
TCGA-2J-AAB6-01,TCGA-2J-AAB6,PAAD,75.0,MALE,WHITE,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-27600.0,Dead,WITH TUMOR,nan,293.0,Pancreatic Cancer,Distant Metastasis,Liver,nan,169.0,Progressive Disease,nan,nan,1.0,293.0,1.0,293.0,nan,nan,1.0,169.0,1
TCGA-2J-AAB8-01,TCGA-2J-AAB8,PAAD,71.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2012.0,nan,-26028.0,Alive,TUMOR FREE,80.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,80.0,0.0,80.0,nan,nan,0.0,80.0,0
TCGA-2J-AAB9-01,TCGA-2J-AAB9,PAAD,70.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G1,2012.0,nan,-25920.0,Dead,WITH TUMOR,nan,627.0,Pancreatic Cancer,Distant Metastasis,Liver,nan,521.0,Complete Remission/Response,nan,nan,1.0,627.0,1.0,627.0,1.0,521.0,1.0,521.0,1
TCGA-2J-AABA-01,TCGA-2J-AABA,PAAD,55.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-20133.0,Dead,WITH TUMOR,nan,607.0,Pancreatic Cancer,Distant Metastasis,"Other, specify",subcut nodule,160.0,Progressive Disease,nan,nan,1.0,607.0,1.0,607.0,nan,nan,1.0,160.0,1
TCGA-2J-AABE-01,TCGA-2J-AABE,PAAD,73.0,MALE,WHITE,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-26943.0,Alive,TUMOR FREE,676.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,676.0,0.0,676.0,0.0,676.0,0.0,676.0,0
TCGA-2J-AABF-01,TCGA-2J-AABF,PAAD,73.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2012.0,nan,-26936.0,Dead,WITH TUMOR,nan,691.0,Pancreatic Cancer,Distant Metastasis,"Other, specify",Liver/lung,443.0,Progressive Disease,nan,nan,1.0,691.0,1.0,691.0,nan,nan,1.0,443.0,1
TCGA-2J-AABH-01,TCGA-2J-AABH,PAAD,61.0,MALE,WHITE,Stage IIA,nan,Pancreas-Adenocarcinoma-Other Subtype,G3,2011.0,nan,-22425.0,Alive,WITH TUMOR,1287.0,nan,nan,Distant Metastasis,"Other, specify",perigastric mass,1287.0,Complete Remission/Response,nan,nan,0.0,1287.0,0.0,1287.0,1.0,1287.0,1.0,1287.0,2
TCGA-2J-AABI-01,TCGA-2J-AABI,PAAD,55.0,FEMALE,WHITE,Stage IIA,nan,Pancreas-Adenocarcinoma-Other Subtype,G3,2011.0,nan,-20316.0,Alive,WITH TUMOR,969.0,nan,nan,Distant Metastasis,Liver,nan,728.0,Progressive Disease,nan,nan,0.0,969.0,0.0,969.0,nan,nan,1.0,728.0,2
TCGA-2J-AABK-01,TCGA-2J-AABK,PAAD,71.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-26188.0,Alive,TUMOR FREE,484.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,484.0,0.0,484.0,0.0,484.0,0.0,484.0,0
TCGA-2J-AABO-01,TCGA-2J-AABO,PAAD,43.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,nan,-15869.0,Alive,WITH TUMOR,440.0,nan,nan,Distant Metastasis,Liver,nan,439.0,Progressive Disease,nan,nan,0.0,440.0,0.0,440.0,nan,nan,1.0,439.0,2
TCGA-2J-AABP-01,TCGA-2J-AABP,PAAD,58.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Undifferentiated Carcinoma,G4,2013.0,nan,-21484.0,Alive,TUMOR FREE,463.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,463.0,0.0,463.0,0.0,463.0,0.0,463.0,0
TCGA-2J-AABR-01,TCGA-2J-AABR,PAAD,60.0,FEMALE,WHITE,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2013.0,nan,-22131.0,Alive,WITH TUMOR,438.0,nan,nan,Distant Metastasis,Liver,nan,327.0,Progressive Disease,nan,nan,0.0,438.0,0.0,438.0,nan,nan,1.0,327.0,2
TCGA-2J-AABT-01,TCGA-2J-AABT,PAAD,72.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-26379.0,Alive,nan,319.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,319.0,0.0,319.0,nan,nan,0.0,319.0,2
TCGA-2J-AABU-01,TCGA-2J-AABU,PAAD,56.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2012.0,nan,-20641.0,Dead,WITH TUMOR,nan,277.0,Pancreatic Cancer,Distant Metastasis,Liver,nan,154.0,Progressive Disease,nan,nan,1.0,277.0,1.0,277.0,nan,nan,1.0,154.0,1
TCGA-2J-AABV-01,TCGA-2J-AABV,PAAD,74.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G4,2012.0,nan,-27082.0,Dead,WITH TUMOR,nan,652.0,Pancreatic Cancer,Distant Metastasis,Liver,nan,126.0,Progressive Disease,nan,nan,1.0,652.0,1.0,652.0,nan,nan,1.0,126.0,1
TCGA-2L-AAQA-01,TCGA-2L-AAQA,PAAD,76.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2010.0,nan,-28074.0,Dead,WITH TUMOR,nan,143.0,Pancreatic Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,143.0,1.0,143.0,nan,nan,1.0,143.0,1
TCGA-2L-AAQE-01,TCGA-2L-AAQE,PAAD,56.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,nan,-20618.0,Dead,WITH TUMOR,nan,684.0,Pancreatic Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,684.0,1.0,684.0,nan,nan,1.0,684.0,1
TCGA-2L-AAQI-01,TCGA-2L-AAQI,PAAD,66.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,nan,-24381.0,Dead,WITH TUMOR,nan,103.0,Pancreatic Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,103.0,1.0,103.0,nan,nan,1.0,103.0,1
TCGA-2L-AAQJ-01,TCGA-2L-AAQJ,PAAD,49.0,FEMALE,WHITE,Stage III,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2010.0,nan,-18103.0,Dead,WITH TUMOR,nan,394.0,Pancreatic Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,394.0,1.0,394.0,nan,nan,1.0,394.0,1
TCGA-2L-AAQL-01,TCGA-2L-AAQL,PAAD,82.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,nan,-30092.0,Dead,WITH TUMOR,nan,292.0,Pancreatic Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,292.0,1.0,292.0,nan,nan,1.0,292.0,1
TCGA-2L-AAQM-01,TCGA-2L-AAQM,PAAD,52.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma-Other Subtype,G1,2010.0,nan,-19315.0,Alive,TUMOR FREE,1383.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1383.0,0.0,1383.0,nan,nan,0.0,1383.0,0
TCGA-3A-A9I5-01,TCGA-3A-A9I5,PAAD,57.0,MALE,WHITE,[Discrepancy],nan,Pancreas-Adenocarcinoma Ductal Type,G1,2009.0,nan,-21175.0,Alive,TUMOR FREE,1794.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1794.0,0.0,1794.0,0.0,1794.0,0.0,1794.0,0
TCGA-3A-A9I7-01,TCGA-3A-A9I7,PAAD,45.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2010.0,nan,-16766.0,Alive,WITH TUMOR,1323.0,nan,nan,Locoregional Recurrence,Peritoneal Surfaces,nan,1309.0,[Unknown],nan,nan,0.0,1323.0,0.0,1323.0,nan,nan,1.0,1309.0,2
TCGA-3A-A9I9-01,TCGA-3A-A9I9,PAAD,67.0,MALE,WHITE,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,nan,-24731.0,Dead,WITH TUMOR,nan,634.0,Pancreatic Cancer,Locoregional Recurrence,Liver,nan,513.0,Stable Disease,nan,nan,1.0,634.0,1.0,634.0,nan,nan,1.0,513.0,1
TCGA-3A-A9IB-01,TCGA-3A-A9IB,PAAD,69.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,nan,-25312.0,Dead,nan,nan,224.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,224.0,nan,224.0,nan,nan,0.0,224.0,1
TCGA-3A-A9IC-01,TCGA-3A-A9IC,PAAD,61.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,nan,-22400.0,Dead,WITH TUMOR,nan,738.0,Pancreatic Cancer,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,738.0,1.0,738.0,nan,nan,1.0,738.0,1
TCGA-3A-A9IH-01,TCGA-3A-A9IH,PAAD,66.0,FEMALE,WHITE,Stage IA,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-24174.0,Alive,WITH TUMOR,1021.0,nan,nan,Distant Metastasis,Lung,nan,763.0,Stable Disease,nan,nan,0.0,1021.0,0.0,1021.0,nan,nan,1.0,763.0,2
TCGA-3A-A9IJ-01,TCGA-3A-A9IJ,PAAD,65.0,MALE,WHITE,Stage IB,nan,Pancreas-Adenocarcinoma-Other Subtype,G1,2009.0,nan,-23791.0,Alive,TUMOR FREE,1854.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1854.0,0.0,1854.0,0.0,1854.0,0.0,1854.0,0
TCGA-3A-A9IL-01,TCGA-3A-A9IL,PAAD,39.0,FEMALE,WHITE,Stage I,nan,Pancreas-Adenocarcinoma-Other Subtype,G1,2007.0,nan,-14599.0,Alive,TUMOR FREE,2741.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,2741.0,0.0,2741.0,nan,nan,0.0,2741.0,0
TCGA-3A-A9IN-01,TCGA-3A-A9IN,PAAD,62.0,FEMALE,WHITE,Stage IB,nan,Pancreas-Adenocarcinoma-Other Subtype,G2,2008.0,nan,-22799.0,Alive,TUMOR FREE,2084.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2084.0,0.0,2084.0,0.0,2084.0,0.0,2084.0,0
TCGA-3A-A9IO-01,TCGA-3A-A9IO,PAAD,55.0,MALE,WHITE,nan,nan,Pancreas-Adenocarcinoma-Other Subtype,G1,2009.0,nan,-20451.0,Alive,TUMOR FREE,1942.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1942.0,0.0,1942.0,nan,nan,0.0,1942.0,0
TCGA-3A-A9IR-01,TCGA-3A-A9IR,PAAD,64.0,FEMALE,WHITE,Stage IB,nan,Pancreas-Adenocarcinoma-Other Subtype,G1,2010.0,nan,-23406.0,Alive,TUMOR FREE,1542.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1542.0,0.0,1542.0,0.0,1542.0,0.0,1542.0,0
TCGA-3A-A9IS-01,TCGA-3A-A9IS,PAAD,67.0,MALE,WHITE,Stage IB,nan,Pancreas-Adenocarcinoma-Other Subtype,G1,2010.0,nan,-24621.0,Alive,TUMOR FREE,998.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,998.0,0.0,998.0,0.0,998.0,0.0,998.0,0
TCGA-3A-A9IU-01,TCGA-3A-A9IU,PAAD,65.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,nan,-23998.0,Dead,WITH TUMOR,nan,458.0,Pancreatic Cancer,Distant Metastasis,Liver,nan,371.0,[Unknown],nan,nan,1.0,458.0,1.0,458.0,nan,nan,1.0,371.0,1
TCGA-3A-A9IV-01,TCGA-3A-A9IV,PAAD,59.0,FEMALE,WHITE,Stage IB,nan,Pancreas-Adenocarcinoma-Other Subtype,G1,2011.0,nan,-21732.0,Alive,TUMOR FREE,1103.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1103.0,0.0,1103.0,0.0,1103.0,0.0,1103.0,0
TCGA-3A-A9IX-01,TCGA-3A-A9IX,PAAD,40.0,MALE,WHITE,Stage IA,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-14729.0,Alive,TUMOR FREE,1037.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1037.0,0.0,1037.0,0.0,1037.0,0.0,1037.0,0
TCGA-3A-A9IZ-01,TCGA-3A-A9IZ,PAAD,47.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-17294.0,Dead,WITH TUMOR,nan,308.0,Pancreatic Cancer,Locoregional Recurrence,Tumor Bed,nan,109.0,Progressive Disease,nan,nan,1.0,308.0,1.0,308.0,nan,nan,1.0,109.0,1
TCGA-3A-A9J0-01,TCGA-3A-A9J0,PAAD,75.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-27453.0,Alive,WITH TUMOR,743.0,nan,nan,Distant Metastasis,Lung,nan,363.0,Progressive Disease,nan,nan,0.0,743.0,0.0,743.0,nan,nan,1.0,363.0,2
TCGA-3E-AAAY-01,TCGA-3E-AAAY,PAAD,67.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2008.0,nan,-24760.0,Alive,[Discrepancy],2285.0,nan,nan,Distant Metastasis,Lung,nan,987.0,Complete Remission/Response,nan,nan,0.0,2285.0,0.0,2285.0,1.0,987.0,1.0,987.0,2
TCGA-3E-AAAZ-01,TCGA-3E-AAAZ,PAAD,71.0,MALE,WHITE,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2008.0,nan,-26234.0,Dead,WITH TUMOR,nan,2182.0,"Other, specify",New Primary Tumor,Lung,nan,1600.0,[Unknown],nan,nan,1.0,2182.0,0.0,2182.0,nan,nan,1.0,1600.0,1
TCGA-F2-6879-01,TCGA-F2-6879,PAAD,57.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma-Other Subtype,G2,2009.0,nan,-20984.0,Dead,WITH TUMOR,nan,334.0,nan,Distant Metastasis,nan,nan,183.0,Complete Remission/Response,nan,nan,1.0,334.0,1.0,334.0,1.0,183.0,1.0,183.0,2
TCGA-F2-6880-01,TCGA-F2-6880,PAAD,70.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G1,2009.0,nan,-25809.0,Alive,TUMOR FREE,295.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,295.0,0.0,295.0,0.0,295.0,0.0,295.0,0
TCGA-F2-7273-01,TCGA-F2-7273,PAAD,54.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,nan,-20071.0,Dead,WITH TUMOR,nan,592.0,Pancreatic Cancer,Distant Metastasis,Liver,nan,256.0,Progressive Disease,nan,nan,1.0,592.0,1.0,592.0,nan,nan,1.0,256.0,1
TCGA-F2-7276-01,TCGA-F2-7276,PAAD,64.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G1,2011.0,nan,-23713.0,Dead,WITH TUMOR,nan,216.0,Pancreatic Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,216.0,1.0,216.0,nan,nan,1.0,216.0,1
TCGA-F2-A44G-01,TCGA-F2-A44G,PAAD,79.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-29150.0,Dead,WITH TUMOR,nan,233.0,Pancreatic Cancer,Locoregional Recurrence,"Other, specify",malignant ascites,214.0,Complete Remission/Response,nan,nan,1.0,233.0,1.0,233.0,1.0,214.0,1.0,214.0,1
TCGA-F2-A44H-01,TCGA-F2-A44H,PAAD,65.0,MALE,WHITE,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-24007.0,Alive,TUMOR FREE,586.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,586.0,0.0,586.0,0.0,586.0,0.0,586.0,0
TCGA-F2-A7TX-01,TCGA-F2-A7TX,PAAD,77.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2013.0,nan,-28239.0,Dead,WITH TUMOR,nan,95.0,Pancreatic Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,95.0,1.0,95.0,nan,nan,1.0,95.0,1
TCGA-F2-A8YN-01,TCGA-F2-A8YN,PAAD,76.0,MALE,WHITE,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,nan,-28047.0,Alive,WITH TUMOR,517.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,517.0,0.0,517.0,nan,nan,0.0,517.0,0
TCGA-FB-A4P5-01,TCGA-FB-A4P5,PAAD,69.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-25412.0,Dead,WITH TUMOR,nan,179.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,179.0,1.0,179.0,nan,nan,1.0,179.0,1
TCGA-FB-A4P6-01,TCGA-FB-A4P6,PAAD,54.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G1,2012.0,nan,-19904.0,Alive,TUMOR FREE,767.0,nan,nan,Locoregional Recurrence,nan,nan,620.0,Complete Remission/Response,nan,nan,0.0,767.0,0.0,767.0,1.0,620.0,1.0,620.0,2
TCGA-FB-A545-01,TCGA-FB-A545,PAAD,72.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-26635.0,Dead,TUMOR FREE,nan,732.0,Pancreatic Cancer,Distant Metastasis,Liver,nan,378.0,Complete Remission/Response,nan,nan,1.0,732.0,1.0,732.0,1.0,378.0,1.0,378.0,1
TCGA-FB-A5VM-01,TCGA-FB-A5VM,PAAD,74.0,MALE,WHITE,Stage IB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2012.0,nan,-27362.0,Dead,WITH TUMOR,nan,498.0,Pancreatic Cancer,Distant Metastasis,Liver,nan,177.0,Progressive Disease,nan,nan,1.0,498.0,1.0,498.0,nan,nan,1.0,177.0,1
TCGA-FB-A78T-01,TCGA-FB-A78T,PAAD,71.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,nan,-26179.0,Dead,nan,nan,375.0,Pancreatic Cancer,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,375.0,1.0,375.0,0.0,375.0,0.0,375.0,1
TCGA-FB-A7DR-01,TCGA-FB-A7DR,PAAD,48.0,MALE,ASIAN,Stage IIA,nan,Pancreas-Colloid (mucinous non-cystic) Carcinoma,G2,2012.0,nan,-17649.0,Dead,TUMOR FREE,nan,353.0,Pancreatic Cancer,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,353.0,1.0,353.0,0.0,353.0,0.0,353.0,0
TCGA-FB-AAPP-01,TCGA-FB-AAPP,PAAD,71.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2009.0,nan,-26239.0,Dead,WITH TUMOR,nan,485.0,Pancreatic Cancer,Distant Metastasis,Lung,nan,150.0,Progressive Disease,nan,nan,1.0,485.0,1.0,485.0,nan,nan,1.0,150.0,1
TCGA-FB-AAPQ-01,TCGA-FB-AAPQ,PAAD,65.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2008.0,nan,-24078.0,Dead,nan,nan,1130.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,1130.0,nan,1130.0,nan,nan,0.0,1130.0,1
TCGA-FB-AAPS-01,TCGA-FB-AAPS,PAAD,62.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2008.0,nan,-22981.0,Alive,nan,228.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,228.0,0.0,228.0,nan,nan,0.0,228.0,2
TCGA-FB-AAPU-01,TCGA-FB-AAPU,PAAD,41.0,FEMALE,ASIAN,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2008.0,nan,-15129.0,Dead,WITH TUMOR,nan,381.0,Pancreatic Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,381.0,1.0,381.0,nan,nan,1.0,381.0,1
TCGA-FB-AAPY-01,TCGA-FB-AAPY,PAAD,71.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2007.0,nan,-26085.0,Dead,TUMOR FREE,nan,1059.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1059.0,0.0,1059.0,0.0,1059.0,0.0,1059.0,0
TCGA-FB-AAPZ-01,TCGA-FB-AAPZ,PAAD,54.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2008.0,nan,-19847.0,Alive,TUMOR FREE,716.0,nan,nan,Distant Metastasis,"Other, specify",Adrenal and right buttock,716.0,Complete Remission/Response,nan,nan,0.0,716.0,0.0,716.0,1.0,716.0,1.0,716.0,2
TCGA-FB-AAQ0-01,TCGA-FB-AAQ0,PAAD,68.0,MALE,WHITE,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,nan,-24988.0,Dead,TUMOR FREE,nan,473.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,473.0,0.0,473.0,0.0,473.0,0.0,473.0,0
TCGA-FB-AAQ1-01,TCGA-FB-AAQ1,PAAD,49.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,nan,-18172.0,Dead,WITH TUMOR,nan,123.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,123.0,1.0,123.0,nan,nan,1.0,123.0,1
TCGA-FB-AAQ2-01,TCGA-FB-AAQ2,PAAD,81.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,nan,-29585.0,Dead,WITH TUMOR,nan,153.0,nan,Distant Metastasis,Liver,nan,92.0,Partial Remission/Response,nan,nan,1.0,153.0,1.0,153.0,nan,nan,1.0,92.0,1
TCGA-FB-AAQ3-01,TCGA-FB-AAQ3,PAAD,65.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2010.0,nan,-23953.0,Dead,TUMOR FREE,nan,31.0,Surgical Complications,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,31.0,0.0,31.0,0.0,31.0,0.0,31.0,2
TCGA-FB-AAQ6-01,TCGA-FB-AAQ6,PAAD,85.0,MALE,WHITE,Stage IA,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,nan,-31319.0,Dead,WITH TUMOR,nan,244.0,Pancreatic Cancer,Locoregional Recurrence,Peritoneal Surfaces,nan,213.0,Progressive Disease,nan,nan,1.0,244.0,1.0,244.0,nan,nan,1.0,213.0,1
TCGA-FZ-5919-01,TCGA-FZ-5919,PAAD,59.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2007.0,nan,-21611.0,Dead,WITH TUMOR,nan,741.0,Pancreatic Cancer,Distant Metastasis,Liver,nan,55.0,Progressive Disease,nan,nan,1.0,741.0,1.0,741.0,nan,nan,1.0,55.0,1
TCGA-FZ-5919-11,TCGA-FZ-5919,PAAD,59.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2007.0,nan,-21611.0,Dead,WITH TUMOR,nan,741.0,Pancreatic Cancer,Distant Metastasis,Liver,nan,55.0,Progressive Disease,nan,nan,1.0,741.0,1.0,741.0,nan,nan,1.0,55.0,1
TCGA-FZ-5920-01,TCGA-FZ-5920,PAAD,52.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2007.0,nan,-19287.0,Dead,nan,nan,61.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,61.0,nan,61.0,nan,nan,0.0,61.0,1
TCGA-FZ-5920-11,TCGA-FZ-5920,PAAD,52.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2007.0,nan,-19287.0,Dead,nan,nan,61.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,61.0,nan,61.0,nan,nan,0.0,61.0,1
TCGA-FZ-5921-01,TCGA-FZ-5921,PAAD,85.0,FEMALE,[Unknown],Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,GX,2007.0,nan,-31074.0,Dead,WITH TUMOR,nan,155.0,nan,Locoregional Recurrence,Peritoneal Surfaces,nan,103.0,Progressive Disease,nan,nan,1.0,155.0,1.0,155.0,nan,nan,1.0,103.0,1
TCGA-FZ-5922-01,TCGA-FZ-5922,PAAD,81.0,MALE,WHITE,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2007.0,nan,-29633.0,Dead,WITH TUMOR,nan,1101.0,Pancreatic Cancer,Distant Metastasis,Peritoneal Surfaces,nan,740.0,Progressive Disease,nan,nan,1.0,1101.0,1.0,1101.0,nan,nan,1.0,740.0,1
TCGA-FZ-5922-11,TCGA-FZ-5922,PAAD,81.0,MALE,WHITE,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2007.0,nan,-29633.0,Dead,WITH TUMOR,nan,1101.0,Pancreatic Cancer,Distant Metastasis,Peritoneal Surfaces,nan,740.0,Progressive Disease,nan,nan,1.0,1101.0,1.0,1101.0,nan,nan,1.0,740.0,1
TCGA-FZ-5923-01,TCGA-FZ-5923,PAAD,71.0,MALE,WHITE,Stage IV,nan,Pancreas-Adenocarcinoma Ductal Type,G1,2008.0,nan,-26216.0,Dead,WITH TUMOR,nan,619.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,619.0,1.0,619.0,nan,nan,1.0,619.0,1
TCGA-FZ-5923-11,TCGA-FZ-5923,PAAD,71.0,MALE,WHITE,Stage IV,nan,Pancreas-Adenocarcinoma Ductal Type,G1,2008.0,nan,-26216.0,Dead,WITH TUMOR,nan,619.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,619.0,1.0,619.0,nan,nan,1.0,619.0,1
TCGA-FZ-5924-01,TCGA-FZ-5924,PAAD,83.0,MALE,WHITE,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2008.0,nan,-30571.0,Dead,WITH TUMOR,nan,480.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,480.0,1.0,480.0,nan,nan,1.0,480.0,1
TCGA-FZ-5924-11,TCGA-FZ-5924,PAAD,83.0,MALE,WHITE,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2008.0,nan,-30571.0,Dead,WITH TUMOR,nan,480.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,480.0,1.0,480.0,nan,nan,1.0,480.0,1
TCGA-FZ-5926-01,TCGA-FZ-5926,PAAD,73.0,FEMALE,WHITE,Stage III,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2001.0,nan,-26881.0,Dead,WITH TUMOR,nan,541.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,541.0,1.0,541.0,nan,nan,1.0,541.0,1
TCGA-FZ-5926-11,TCGA-FZ-5926,PAAD,73.0,FEMALE,WHITE,Stage III,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2001.0,nan,-26881.0,Dead,WITH TUMOR,nan,541.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,541.0,1.0,541.0,nan,nan,1.0,541.0,1
TCGA-H6-8124-01,TCGA-H6-8124,PAAD,56.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,nan,-20741.0,Alive,WITH TUMOR,392.0,nan,nan,Distant Metastasis,Liver,nan,259.0,Complete Remission/Response,nan,nan,0.0,392.0,0.0,392.0,1.0,259.0,1.0,259.0,2
TCGA-H6-8124-11,TCGA-H6-8124,PAAD,56.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,nan,-20741.0,Alive,WITH TUMOR,392.0,nan,nan,Distant Metastasis,Liver,nan,259.0,Complete Remission/Response,nan,nan,0.0,392.0,0.0,392.0,1.0,259.0,1.0,259.0,2
TCGA-H6-A45N-01,TCGA-H6-A45N,PAAD,88.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma-Other Subtype,G3,2012.0,nan,-32475.0,Dead,WITH TUMOR,nan,421.0,Pancreatic Cancer,Locoregional Recurrence,Tumor Bed,nan,363.0,Progressive Disease,nan,nan,1.0,421.0,1.0,421.0,nan,nan,1.0,363.0,1
TCGA-H6-A45N-11,TCGA-H6-A45N,PAAD,88.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma-Other Subtype,G3,2012.0,nan,-32475.0,Dead,WITH TUMOR,nan,421.0,Pancreatic Cancer,Locoregional Recurrence,Tumor Bed,nan,363.0,Progressive Disease,nan,nan,1.0,421.0,1.0,421.0,nan,nan,1.0,363.0,1
TCGA-H8-A6C1-01,TCGA-H8-A6C1,PAAD,53.0,MALE,WHITE,Stage IIA,nan,Pancreas-Adenocarcinoma-Other Subtype,G2,2012.0,nan,-19677.0,Alive,WITH TUMOR,671.0,nan,nan,Distant Metastasis,Liver,nan,455.0,[Discrepancy],nan,nan,0.0,671.0,0.0,671.0,nan,nan,1.0,455.0,2
TCGA-HV-A5A3-01,TCGA-HV-A5A3,PAAD,50.0,MALE,ASIAN,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-18475.0,Dead,TUMOR FREE,nan,128.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,128.0,0.0,128.0,0.0,128.0,0.0,128.0,0
TCGA-HV-A5A3-11,TCGA-HV-A5A3,PAAD,50.0,MALE,ASIAN,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-18475.0,Dead,TUMOR FREE,nan,128.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,128.0,0.0,128.0,0.0,128.0,0.0,128.0,0
TCGA-HV-A5A4-01,TCGA-HV-A5A4,PAAD,72.0,FEMALE,ASIAN,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-26311.0,Alive,nan,232.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,232.0,0.0,232.0,0.0,232.0,0.0,232.0,2
TCGA-HV-A5A5-01,TCGA-HV-A5A5,PAAD,61.0,FEMALE,ASIAN,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-22329.0,Alive,nan,289.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,289.0,0.0,289.0,0.0,289.0,0.0,289.0,2
TCGA-HV-A5A6-01,TCGA-HV-A5A6,PAAD,65.0,FEMALE,ASIAN,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G1,2001.0,nan,-24025.0,Dead,WITH TUMOR,nan,2036.0,Other malignancy,Distant Metastasis,Lung,nan,1511.0,Complete Remission/Response,nan,nan,1.0,2036.0,0.0,2036.0,1.0,1511.0,1.0,1511.0,2
TCGA-HV-A7OL-01,TCGA-HV-A7OL,PAAD,70.0,MALE,ASIAN,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-25768.0,Alive,nan,252.0,nan,nan,Distant Metastasis,Non-regional / Distant Lymph Nodes,nan,123.0,Stable Disease,nan,nan,0.0,252.0,0.0,252.0,nan,nan,1.0,123.0,2
TCGA-HV-A7OP-01,TCGA-HV-A7OP,PAAD,72.0,MALE,ASIAN,Stage IIB,nan,Pancreas-Adenocarcinoma-Other Subtype,GX,2012.0,nan,-26322.0,Alive,nan,978.0,nan,nan,Distant Metastasis,Liver,nan,342.0,[Discrepancy],nan,nan,0.0,978.0,0.0,978.0,nan,nan,1.0,342.0,0
TCGA-HV-AA8V-01,TCGA-HV-AA8V,PAAD,50.0,MALE,ASIAN,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2012.0,nan,-18357.0,Alive,nan,920.0,nan,nan,Distant Metastasis,"Other, specify",bone,526.0,[Discrepancy],nan,nan,0.0,920.0,0.0,920.0,nan,nan,1.0,526.0,0
TCGA-HV-AA8X-01,TCGA-HV-AA8X,PAAD,75.0,FEMALE,ASIAN,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,nan,-27662.0,Dead,WITH TUMOR,nan,532.0,nan,Distant Metastasis,"Other, specify",Omentum,375.0,[Discrepancy],nan,nan,1.0,532.0,1.0,532.0,nan,nan,1.0,375.0,1
TCGA-HZ-7289-01,TCGA-HZ-7289,PAAD,77.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma-Other Subtype,G1,2010.0,nan,-28174.0,Dead,WITH TUMOR,nan,661.0,Pancreatic Cancer,Distant Metastasis,Liver,nan,228.0,[Unknown],nan,nan,1.0,661.0,1.0,661.0,nan,nan,1.0,228.0,1
TCGA-HZ-7918-01,TCGA-HZ-7918,PAAD,72.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,nan,-26573.0,Alive,WITH TUMOR,969.0,nan,nan,Distant Metastasis,Liver,nan,542.0,Complete Remission/Response,nan,nan,0.0,969.0,0.0,969.0,1.0,542.0,1.0,542.0,2
TCGA-HZ-7919-01,TCGA-HZ-7919,PAAD,52.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,nan,-19064.0,Dead,WITH TUMOR,nan,593.0,Pancreatic Cancer,nan,nan,nan,nan,[Unknown],nan,nan,1.0,593.0,1.0,593.0,nan,nan,1.0,593.0,1
TCGA-HZ-7920-01,TCGA-HZ-7920,PAAD,71.0,MALE,WHITE,Stage IB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,nan,-26167.0,Dead,TUMOR FREE,nan,236.0,"Other, non-malignant disease",nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,236.0,0.0,236.0,0.0,236.0,0.0,236.0,0
TCGA-HZ-7922-01,TCGA-HZ-7922,PAAD,61.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G1,2011.0,nan,-22413.0,Alive,nan,4.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4.0,0.0,4.0,nan,nan,0.0,4.0,0
TCGA-HZ-7923-01,TCGA-HZ-7923,PAAD,65.0,MALE,WHITE,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,nan,-23760.0,Alive,TUMOR FREE,314.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,314.0,0.0,314.0,0.0,314.0,0.0,314.0,0
TCGA-HZ-7924-01,TCGA-HZ-7924,PAAD,60.0,FEMALE,WHITE,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,nan,-22090.0,Alive,WITH TUMOR,840.0,nan,nan,Distant Metastasis,nan,Liver,831.0,Complete Remission/Response,nan,nan,0.0,840.0,0.0,840.0,1.0,831.0,1.0,831.0,2
TCGA-HZ-7925-01,TCGA-HZ-7925,PAAD,66.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,nan,-24150.0,Dead,WITH TUMOR,nan,614.0,Pancreatic Cancer,Locoregional Recurrence,"Other, specify",Regional LNs,364.0,Complete Remission/Response,nan,nan,1.0,614.0,1.0,614.0,1.0,364.0,1.0,364.0,1
TCGA-HZ-7926-01,TCGA-HZ-7926,PAAD,57.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G1,2011.0,nan,-21024.0,Dead,WITH TUMOR,nan,518.0,Pancreatic Cancer,Distant Metastasis,Lung,nan,340.0,Progressive Disease,nan,nan,1.0,518.0,1.0,518.0,nan,nan,1.0,340.0,1
TCGA-HZ-8001-01,TCGA-HZ-8001,PAAD,69.0,MALE,WHITE,Stage III,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,nan,-25227.0,Alive,TUMOR FREE,706.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,706.0,0.0,706.0,0.0,706.0,0.0,706.0,0
TCGA-HZ-8002-01,TCGA-HZ-8002,PAAD,61.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,nan,-22433.0,Dead,WITH TUMOR,nan,366.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,366.0,1.0,366.0,nan,nan,1.0,366.0,1
TCGA-HZ-8003-01,TCGA-HZ-8003,PAAD,65.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,nan,-23868.0,Dead,WITH TUMOR,nan,596.0,Pancreatic Cancer,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,596.0,1.0,596.0,nan,nan,1.0,596.0,1
TCGA-HZ-8005-01,TCGA-HZ-8005,PAAD,81.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2012.0,nan,-29674.0,Dead,WITH TUMOR,nan,120.0,Pancreatic Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,120.0,1.0,120.0,nan,nan,1.0,120.0,1
TCGA-HZ-8315-01,TCGA-HZ-8315,PAAD,54.0,FEMALE,WHITE,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-19839.0,Dead,WITH TUMOR,nan,299.0,Pancreatic Cancer,nan,nan,nan,nan,[Unknown],nan,nan,1.0,299.0,1.0,299.0,nan,nan,1.0,299.0,1
TCGA-HZ-8317-01,TCGA-HZ-8317,PAAD,69.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G1,2012.0,nan,-25214.0,Dead,WITH TUMOR,nan,378.0,Pancreatic Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,378.0,1.0,378.0,nan,nan,1.0,378.0,1
TCGA-HZ-8519-01,TCGA-HZ-8519,PAAD,73.0,MALE,WHITE,Stage IA,nan,Pancreas-Adenocarcinoma-Other Subtype,G3,2012.0,nan,-26947.0,Alive,TUMOR FREE,454.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,454.0,0.0,454.0,0.0,454.0,0.0,454.0,0
TCGA-HZ-8636-01,TCGA-HZ-8636,PAAD,58.0,FEMALE,WHITE,Stage IV,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2012.0,nan,-21501.0,Dead,WITH TUMOR,nan,545.0,Pancreatic Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,545.0,1.0,545.0,nan,nan,1.0,545.0,1
TCGA-HZ-8637-01,TCGA-HZ-8637,PAAD,76.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2012.0,nan,-27929.0,Dead,TUMOR FREE,nan,517.0,"Other, non-malignant disease",nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,517.0,0.0,517.0,0.0,517.0,0.0,517.0,0
TCGA-HZ-8638-01,TCGA-HZ-8638,PAAD,84.0,FEMALE,WHITE,Stage IA,nan,Pancreas-Colloid (mucinous non-cystic) Carcinoma,GX,2012.0,nan,-30821.0,Dead,TUMOR FREE,nan,151.0,Surgical Complications,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,151.0,0.0,151.0,0.0,151.0,0.0,151.0,0
TCGA-HZ-A49G-01,TCGA-HZ-A49G,PAAD,58.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-21491.0,Alive,WITH TUMOR,660.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,660.0,0.0,660.0,nan,nan,0.0,660.0,2
TCGA-HZ-A49H-01,TCGA-HZ-A49H,PAAD,68.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-24891.0,Alive,TUMOR FREE,491.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,491.0,0.0,491.0,0.0,491.0,0.0,491.0,2
TCGA-HZ-A49I-01,TCGA-HZ-A49I,PAAD,77.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-28454.0,Dead,WITH TUMOR,nan,308.0,Pancreatic Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,308.0,1.0,308.0,nan,nan,1.0,308.0,1
TCGA-HZ-A4BH-01,TCGA-HZ-A4BH,PAAD,75.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,nan,-27637.0,Alive,WITH TUMOR,194.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,194.0,0.0,194.0,nan,nan,0.0,194.0,0
TCGA-HZ-A4BK-01,TCGA-HZ-A4BK,PAAD,72.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma-Other Subtype,G3,2012.0,nan,-26503.0,Alive,WITH TUMOR,657.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,657.0,0.0,657.0,nan,nan,0.0,657.0,0
TCGA-HZ-A77O-01,TCGA-HZ-A77O,PAAD,77.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,nan,-28434.0,Dead,WITH TUMOR,nan,160.0,Pancreatic Cancer,Locoregional Recurrence,Peritoneal Surfaces,nan,98.0,Complete Remission/Response,nan,nan,1.0,160.0,1.0,160.0,1.0,98.0,1.0,98.0,1
TCGA-HZ-A77P-01,TCGA-HZ-A77P,PAAD,77.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma-Other Subtype,G1,2013.0,nan,-28403.0,Alive,TUMOR FREE,330.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,330.0,0.0,330.0,0.0,330.0,0.0,330.0,0
TCGA-HZ-A77Q-01,TCGA-HZ-A77Q,PAAD,55.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma-Other Subtype,G2,2013.0,nan,-20366.0,Alive,TUMOR FREE,33.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,33.0,0.0,33.0,nan,nan,0.0,33.0,0
TCGA-HZ-A8P0-01,TCGA-HZ-A8P0,PAAD,76.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G1,2013.0,nan,-27850.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-HZ-A8P1-01,TCGA-HZ-A8P1,PAAD,81.0,MALE,WHITE,Stage IB,nan,Pancreas-Adenocarcinoma Ductal Type,G1,2013.0,nan,-29631.0,Alive,TUMOR FREE,7.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,7.0,0.0,7.0,nan,nan,0.0,7.0,0
TCGA-HZ-A9TJ-06,TCGA-HZ-A9TJ,PAAD,70.0,MALE,WHITE,Stage IV,nan,Pancreas-Adenocarcinoma-Other Subtype,G2,2013.0,nan,-25849.0,Alive,WITH TUMOR,603.0,nan,nan,Distant Metastasis,Peritoneal Surfaces,nan,555.0,[Unknown],nan,nan,0.0,603.0,0.0,603.0,nan,nan,1.0,555.0,2
TCGA-HZ-A9TJ-01,TCGA-HZ-A9TJ,PAAD,70.0,MALE,WHITE,Stage IV,nan,Pancreas-Adenocarcinoma-Other Subtype,G2,2013.0,nan,-25849.0,Alive,WITH TUMOR,603.0,nan,nan,Distant Metastasis,Peritoneal Surfaces,nan,555.0,[Unknown],nan,nan,0.0,603.0,0.0,603.0,nan,nan,1.0,555.0,2
TCGA-IB-7644-01,TCGA-IB-7644,PAAD,65.0,FEMALE,WHITE,Stage IV,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,nan,-24043.0,Dead,WITH TUMOR,nan,394.0,Pancreatic Cancer,Distant Metastasis,"Other, specify","Omentum, Peritoneal surface, Non regional Lymph nodes",306.0,Progressive Disease,nan,nan,1.0,394.0,1.0,394.0,nan,nan,1.0,306.0,1
TCGA-IB-7645-01,TCGA-IB-7645,PAAD,44.0,FEMALE,[Unknown],Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G1,2007.0,nan,-16126.0,Dead,WITH TUMOR,nan,1502.0,Pancreatic Cancer,Distant Metastasis,Liver,nan,984.0,Progressive Disease,nan,nan,1.0,1502.0,1.0,1502.0,nan,nan,1.0,984.0,1
TCGA-IB-7646-01,TCGA-IB-7646,PAAD,60.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2007.0,nan,-22148.0,Dead,WITH TUMOR,nan,145.0,Pancreatic Cancer,Locoregional Recurrence,Liver,nan,132.0,Progressive Disease,nan,nan,1.0,145.0,1.0,145.0,nan,nan,1.0,132.0,1
TCGA-IB-7647-01,TCGA-IB-7647,PAAD,41.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2008.0,nan,-15188.0,Dead,WITH TUMOR,nan,666.0,Pancreatic Cancer,Distant Metastasis,Liver,nan,390.0,Progressive Disease,nan,nan,1.0,666.0,1.0,666.0,nan,nan,1.0,390.0,1
TCGA-IB-7649-01,TCGA-IB-7649,PAAD,73.0,FEMALE,[Unknown],Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2007.0,nan,-26773.0,Dead,nan,nan,467.0,nan,Distant Metastasis,Liver,nan,282.0,Partial Remission/Response,nan,nan,1.0,467.0,nan,467.0,nan,nan,1.0,282.0,1
TCGA-IB-7651-01,TCGA-IB-7651,PAAD,64.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2009.0,nan,-23580.0,Dead,WITH TUMOR,nan,603.0,Pancreatic Cancer,Locoregional Recurrence,nan,nan,492.0,Complete Remission/Response,nan,nan,1.0,603.0,1.0,603.0,1.0,492.0,1.0,492.0,2
TCGA-IB-7652-01,TCGA-IB-7652,PAAD,49.0,FEMALE,ASIAN,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,nan,-18129.0,Alive,TUMOR FREE,1116.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1116.0,0.0,1116.0,0.0,1116.0,0.0,1116.0,0
TCGA-IB-7654-01,TCGA-IB-7654,PAAD,80.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2008.0,nan,-29292.0,Dead,WITH TUMOR,nan,476.0,Other malignancy,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,476.0,0.0,476.0,nan,nan,1.0,476.0,1
TCGA-IB-7885-01,TCGA-IB-7885,PAAD,78.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2010.0,nan,-28554.0,Alive,TUMOR FREE,1257.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1257.0,0.0,1257.0,0.0,1257.0,0.0,1257.0,0
TCGA-IB-7886-01,TCGA-IB-7886,PAAD,80.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2010.0,nan,-29319.0,Dead,TUMOR FREE,nan,123.0,"Other, non-malignant disease",nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,123.0,0.0,123.0,0.0,123.0,0.0,123.0,0
TCGA-IB-7887-01,TCGA-IB-7887,PAAD,62.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2009.0,nan,-22990.0,Dead,nan,nan,110.0,Pancreatic Cancer,nan,nan,nan,nan,[Unknown],nan,nan,1.0,110.0,1.0,110.0,nan,nan,0.0,110.0,1
TCGA-IB-7888-01,TCGA-IB-7888,PAAD,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2008.0,nan,-24117.0,Dead,WITH TUMOR,nan,1332.0,Pancreatic Cancer,Distant Metastasis,"Other, specify",Retroperitoneum,427.0,Stable Disease,nan,nan,1.0,1332.0,1.0,1332.0,nan,nan,1.0,427.0,1
TCGA-IB-7889-01,TCGA-IB-7889,PAAD,85.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G1,2011.0,nan,-31393.0,Dead,WITH TUMOR,nan,481.0,Pancreatic Cancer,Locoregional Recurrence,nan,nan,352.0,Progressive Disease,nan,nan,1.0,481.0,1.0,481.0,nan,nan,1.0,352.0,1
TCGA-IB-7890-01,TCGA-IB-7890,PAAD,73.0,MALE,[Unknown],Stage IB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2008.0,nan,-26747.0,Dead,WITH TUMOR,nan,598.0,Pancreatic Cancer,Distant Metastasis,Liver,nan,519.0,Progressive Disease,nan,nan,1.0,598.0,1.0,598.0,nan,nan,1.0,519.0,1
TCGA-IB-7891-01,TCGA-IB-7891,PAAD,49.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G1,2011.0,nan,-18202.0,Dead,WITH TUMOR,nan,913.0,Pancreatic Cancer,Distant Metastasis,"Other, specify",Lung and Liver,525.0,Complete Remission/Response,nan,nan,1.0,913.0,1.0,913.0,1.0,525.0,1.0,525.0,1
TCGA-IB-7893-01,TCGA-IB-7893,PAAD,64.0,MALE,WHITE,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2009.0,nan,-23703.0,Dead,WITH TUMOR,nan,117.0,Pancreatic Cancer,Distant Metastasis,Peritoneal Surfaces,nan,80.0,Progressive Disease,nan,nan,1.0,117.0,1.0,117.0,nan,nan,1.0,80.0,1
TCGA-IB-7897-01,TCGA-IB-7897,PAAD,53.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2008.0,nan,-19718.0,Dead,WITH TUMOR,nan,486.0,Pancreatic Cancer,Locoregional Recurrence|Distant Metastasis,Liver,nan,397.0,Progressive Disease,nan,nan,1.0,486.0,1.0,486.0,nan,nan,1.0,397.0,1
TCGA-IB-8126-01,TCGA-IB-8126,PAAD,79.0,FEMALE,WHITE,Stage III,nan,Pancreas-Adenocarcinoma Ductal Type,G1,2011.0,nan,-29213.0,Alive,WITH TUMOR,462.0,nan,nan,Distant Metastasis,Lung,nan,83.0,Partial Remission/Response,nan,nan,0.0,462.0,0.0,462.0,nan,nan,1.0,83.0,2
TCGA-IB-8127-01,TCGA-IB-8127,PAAD,59.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,nan,-21676.0,Alive,WITH TUMOR,522.0,nan,nan,Locoregional Recurrence|Distant Metastasis,"Other, specify",Tumor Bed and Liver,486.0,Complete Remission/Response,nan,nan,0.0,522.0,0.0,522.0,1.0,486.0,1.0,486.0,2
TCGA-IB-A5SO-01,TCGA-IB-A5SO,PAAD,71.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-26129.0,Dead,WITH TUMOR,nan,365.0,Pancreatic Cancer,Locoregional Recurrence,Peritoneal Surfaces,nan,276.0,Progressive Disease,nan,nan,1.0,365.0,1.0,365.0,nan,nan,1.0,276.0,1
TCGA-IB-A5SP-01,TCGA-IB-A5SP,PAAD,77.0,MALE,WHITE,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2011.0,nan,-28317.0,Alive,WITH TUMOR,482.0,nan,nan,Locoregional Recurrence,"Other, specify",Superior Mesenteric Artery,300.0,[Unknown],nan,nan,0.0,482.0,0.0,482.0,nan,nan,1.0,300.0,2
TCGA-IB-A5SQ-01,TCGA-IB-A5SQ,PAAD,56.0,FEMALE,WHITE,Stage IB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-20760.0,Dead,WITH TUMOR,nan,219.0,nan,Distant Metastasis,Lung,nan,197.0,Complete Remission/Response,nan,nan,1.0,219.0,1.0,219.0,1.0,197.0,1.0,197.0,1
TCGA-IB-A5SS-01,TCGA-IB-A5SS,PAAD,64.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,nan,-23431.0,Dead,WITH TUMOR,nan,460.0,Pancreatic Cancer,Distant Metastasis,Liver,nan,66.0,Complete Remission/Response,nan,nan,1.0,460.0,1.0,460.0,1.0,66.0,1.0,66.0,1
TCGA-IB-A5ST-01,TCGA-IB-A5ST,PAAD,64.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-23672.0,Alive,TUMOR FREE,635.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,635.0,0.0,635.0,0.0,635.0,0.0,635.0,0
TCGA-IB-A6UF-01,TCGA-IB-A6UF,PAAD,63.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-23152.0,Alive,WITH TUMOR,666.0,nan,nan,Distant Metastasis,Liver,nan,593.0,Partial Remission/Response,nan,nan,0.0,666.0,0.0,666.0,nan,nan,1.0,593.0,2
TCGA-IB-A6UG-01,TCGA-IB-A6UG,PAAD,65.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2012.0,nan,-23751.0,Dead,WITH TUMOR,nan,41.0,"Other, non-malignant disease",nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,41.0,0.0,41.0,nan,nan,1.0,41.0,1
TCGA-IB-A7LX-01,TCGA-IB-A7LX,PAAD,57.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-20898.0,Dead,WITH TUMOR,nan,250.0,Pancreatic Cancer,Distant Metastasis,Liver,nan,7.0,Progressive Disease,nan,nan,1.0,250.0,1.0,250.0,nan,nan,1.0,7.0,1
TCGA-IB-A7M4-01,TCGA-IB-A7M4,PAAD,81.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2013.0,nan,-29792.0,Alive,TUMOR FREE,483.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,483.0,0.0,483.0,0.0,483.0,0.0,483.0,0
TCGA-IB-AAUM-01,TCGA-IB-AAUM,PAAD,76.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2013.0,nan,-28013.0,Alive,WITH TUMOR,8.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,8.0,0.0,8.0,nan,nan,0.0,8.0,0
TCGA-IB-AAUN-01,TCGA-IB-AAUN,PAAD,74.0,FEMALE,WHITE,Stage IB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,nan,-27128.0,Dead,nan,nan,144.0,nan,Locoregional Recurrence,"Other, specify",nan,131.0,Complete Remission/Response,nan,nan,1.0,144.0,nan,144.0,1.0,131.0,1.0,131.0,2
TCGA-IB-AAUO-01,TCGA-IB-AAUO,PAAD,64.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2013.0,nan,-23622.0,Dead,WITH TUMOR,nan,239.0,nan,Distant Metastasis,Liver,nan,74.0,Partial Remission/Response,nan,nan,1.0,239.0,1.0,239.0,nan,nan,1.0,74.0,1
TCGA-IB-AAUP-01,TCGA-IB-AAUP,PAAD,68.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,nan,-24864.0,Alive,TUMOR FREE,431.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,431.0,0.0,431.0,0.0,431.0,0.0,431.0,0
TCGA-IB-AAUQ-01,TCGA-IB-AAUQ,PAAD,50.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,nan,-18315.0,Dead,WITH TUMOR,nan,183.0,Pancreatic Cancer,Distant Metastasis,Non-regional / Distant Lymph Nodes,nan,107.0,Partial Remission/Response,nan,nan,1.0,183.0,1.0,183.0,nan,nan,1.0,107.0,1
TCGA-IB-AAUR-01,TCGA-IB-AAUR,PAAD,67.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G1,2013.0,nan,-24576.0,Alive,WITH TUMOR,338.0,nan,nan,Locoregional Recurrence,Tumor Bed,nan,318.0,Partial Remission/Response,nan,nan,0.0,338.0,0.0,338.0,nan,nan,1.0,318.0,2
TCGA-IB-AAUS-01,TCGA-IB-AAUS,PAAD,84.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,nan,-30684.0,Alive,WITH TUMOR,225.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,225.0,0.0,225.0,nan,nan,0.0,225.0,2
TCGA-IB-AAUT-01,TCGA-IB-AAUT,PAAD,65.0,MALE,WHITE,Stage IIB,nan,Pancreas-Colloid (mucinous non-cystic) Carcinoma,G1,2013.0,nan,-23801.0,Alive,TUMOR FREE,287.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,287.0,0.0,287.0,0.0,287.0,0.0,287.0,0
TCGA-IB-AAUU-01,TCGA-IB-AAUU,PAAD,35.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2013.0,nan,-13127.0,Alive,TUMOR FREE,245.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,245.0,0.0,245.0,0.0,245.0,0.0,245.0,0
TCGA-IB-AAUV-01,TCGA-IB-AAUV,PAAD,49.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,nan,-18059.0,Alive,TUMOR FREE,404.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,404.0,0.0,404.0,0.0,404.0,0.0,404.0,0
TCGA-IB-AAUW-01,TCGA-IB-AAUW,PAAD,63.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2013.0,nan,-23306.0,Dead,WITH TUMOR,nan,230.0,nan,Locoregional Recurrence,Tumor Bed,nan,185.0,Complete Remission/Response,nan,nan,1.0,230.0,1.0,230.0,1.0,185.0,1.0,185.0,1
TCGA-L1-A7W4-01,TCGA-L1-A7W4,PAAD,48.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2013.0,nan,-17821.0,Dead,WITH TUMOR,nan,278.0,Pancreatic Cancer,Distant Metastasis,Liver,nan,129.0,Progressive Disease,nan,nan,1.0,278.0,1.0,278.0,nan,nan,1.0,129.0,1
TCGA-LB-A7SX-01,TCGA-LB-A7SX,PAAD,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,nan,-27295.0,Dead,nan,nan,393.0,"Other, non-malignant disease",nan,nan,nan,nan,Stable Disease,nan,nan,1.0,393.0,0.0,393.0,nan,nan,0.0,393.0,1
TCGA-LB-A8F3-01,TCGA-LB-A8F3,PAAD,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G1,2013.0,nan,-23624.0,Alive,TUMOR FREE,379.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,379.0,0.0,379.0,nan,nan,0.0,379.0,0
TCGA-LB-A9Q5-01,TCGA-LB-A9Q5,PAAD,63.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2013.0,nan,-23218.0,Dead,WITH TUMOR,nan,313.0,Pancreatic Cancer,Locoregional Recurrence,"Other, specify",omentum,290.0,[Unknown],nan,nan,1.0,313.0,1.0,313.0,nan,nan,1.0,290.0,1
TCGA-M8-A5N4-01,TCGA-M8-A5N4,PAAD,48.0,FEMALE,[Not Evaluated],Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G2,nan,nan,-17628.0,Alive,WITH TUMOR,584.0,nan,nan,Locoregional Recurrence,"Other, specify",retroperitoneal recurrence around the supramesenteric artery and vein and some para aortic nodes,416.0,Partial Remission/Response,nan,nan,0.0,584.0,0.0,584.0,nan,nan,1.0,416.0,2
TCGA-OE-A75W-01,TCGA-OE-A75W,PAAD,75.0,MALE,WHITE,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G1,2013.0,nan,-27684.0,Dead,nan,nan,267.0,nan,Distant Metastasis,Liver,nan,146.0,Progressive Disease,nan,nan,1.0,267.0,nan,267.0,nan,nan,1.0,146.0,1
TCGA-PZ-A5RE-01,TCGA-PZ-A5RE,PAAD,44.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2012.0,nan,-16255.0,Dead,WITH TUMOR,nan,470.0,Pancreatic Cancer,Distant Metastasis,Liver,nan,393.0,[Unknown],nan,nan,1.0,470.0,1.0,470.0,nan,nan,1.0,393.0,1
TCGA-Q3-A5QY-01,TCGA-Q3-A5QY,PAAD,58.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-21277.0,Alive,nan,416.0,nan,nan,nan,nan,nan,nan,[Discrepancy],nan,nan,0.0,416.0,0.0,416.0,nan,nan,0.0,416.0,0
TCGA-Q3-AA2A-01,TCGA-Q3-AA2A,PAAD,64.0,FEMALE,WHITE,Stage IB,nan,Pancreas-Adenocarcinoma Ductal Type,G1,2013.0,nan,-23685.0,Alive,TUMOR FREE,95.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,95.0,0.0,95.0,nan,nan,0.0,95.0,0
TCGA-RB-A7B8-01,TCGA-RB-A7B8,PAAD,81.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma-Other Subtype,G2,2013.0,nan,-29585.0,Dead,TUMOR FREE,nan,466.0,Pancreatic Cancer,Locoregional Recurrence,nan,nan,449.0,Complete Remission/Response,nan,nan,1.0,466.0,1.0,466.0,1.0,449.0,1.0,449.0,1
TCGA-RB-AA9M-01,TCGA-RB-AA9M,PAAD,43.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2013.0,nan,-15807.0,Alive,WITH TUMOR,286.0,nan,nan,Distant Metastasis,Liver,nan,258.0,Progressive Disease,nan,nan,0.0,286.0,0.0,286.0,nan,nan,1.0,258.0,2
TCGA-RL-AAAS-01,TCGA-RL-AAAS,PAAD,60.0,FEMALE,WHITE,Stage IB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,nan,-22126.0,Alive,TUMOR FREE,9.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,9.0,0.0,9.0,0.0,9.0,0.0,9.0,0
TCGA-S4-A8RM-01,TCGA-S4-A8RM,PAAD,67.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2013.0,nan,-24589.0,Alive,TUMOR FREE,737.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,737.0,0.0,737.0,0.0,737.0,0.0,737.0,0
TCGA-S4-A8RO-01,TCGA-S4-A8RO,PAAD,75.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,nan,-27645.0,Alive,WITH TUMOR,525.0,nan,nan,Distant Metastasis,Lung,nan,291.0,Complete Remission/Response,nan,nan,0.0,525.0,0.0,525.0,1.0,291.0,1.0,291.0,2
TCGA-S4-A8RP-01,TCGA-S4-A8RP,PAAD,77.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2010.0,nan,-28353.0,Dead,nan,nan,702.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,702.0,nan,702.0,nan,nan,0.0,702.0,1
TCGA-US-A774-01,TCGA-US-A774,PAAD,76.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2011.0,nan,-27957.0,Dead,WITH TUMOR,nan,695.0,Pancreatic Cancer,Distant Metastasis,Liver,nan,366.0,Progressive Disease,nan,nan,1.0,695.0,1.0,695.0,nan,nan,1.0,366.0,1
TCGA-US-A776-01,TCGA-US-A776,PAAD,61.0,MALE,WHITE,Stage IIA,nan,Pancreas-Colloid (mucinous non-cystic) Carcinoma,G2,2011.0,nan,-22283.0,Alive,TUMOR FREE,1216.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1216.0,0.0,1216.0,0.0,1216.0,0.0,1216.0,0
TCGA-US-A779-01,TCGA-US-A779,PAAD,54.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G1,2011.0,nan,-20051.0,Dead,WITH TUMOR,nan,511.0,Pancreatic Cancer,nan,nan,nan,nan,nan,nan,nan,1.0,511.0,1.0,511.0,nan,nan,1.0,511.0,1
TCGA-US-A77E-01,TCGA-US-A77E,PAAD,73.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma-Other Subtype,G3,2012.0,nan,-26745.0,Dead,WITH TUMOR,nan,430.0,Pancreatic Cancer,Distant Metastasis,Liver,nan,166.0,nan,nan,nan,1.0,430.0,1.0,430.0,nan,nan,1.0,166.0,1
TCGA-US-A77G-01,TCGA-US-A77G,PAAD,64.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2010.0,nan,-23443.0,Dead,TUMOR FREE,nan,12.0,Surgical Complications,nan,nan,nan,nan,nan,nan,nan,1.0,12.0,0.0,12.0,nan,nan,0.0,12.0,0
TCGA-US-A77J-01,TCGA-US-A77J,PAAD,81.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2010.0,nan,-29904.0,Dead,WITH TUMOR,nan,568.0,Pancreatic Cancer,nan,nan,nan,nan,nan,nan,nan,1.0,568.0,1.0,568.0,nan,nan,1.0,568.0,1
TCGA-XD-AAUG-01,TCGA-XD-AAUG,PAAD,66.0,FEMALE,WHITE,Stage IV,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,nan,-24291.0,Alive,TUMOR FREE,420.0,nan,nan,nan,nan,nan,nan,[Discrepancy],nan,nan,0.0,420.0,0.0,420.0,nan,nan,0.0,420.0,0
TCGA-XD-AAUH-01,TCGA-XD-AAUH,PAAD,57.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,nan,-20858.0,Alive,nan,395.0,nan,nan,New Primary Tumor,"Other, specify",Left shoulder,87.0,[Unknown],nan,nan,0.0,395.0,0.0,395.0,nan,nan,1.0,87.0,2
TCGA-XD-AAUI-01,TCGA-XD-AAUI,PAAD,50.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,nan,-18607.0,Dead,WITH TUMOR,nan,366.0,Pancreatic Cancer,Distant Metastasis,Liver,nan,175.0,Progressive Disease,nan,nan,1.0,366.0,1.0,366.0,nan,nan,1.0,175.0,1
TCGA-XD-AAUL-01,TCGA-XD-AAUL,PAAD,56.0,MALE,WHITE,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,nan,-20607.0,Alive,TUMOR FREE,498.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,498.0,0.0,498.0,0.0,498.0,0.0,498.0,0
TCGA-XN-A8T3-01,TCGA-XN-A8T3,PAAD,67.0,MALE,WHITE,Stage IB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2012.0,nan,-24810.0,Alive,WITH TUMOR,951.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,951.0,0.0,951.0,nan,nan,0.0,951.0,0
TCGA-XN-A8T5-01,TCGA-XN-A8T5,PAAD,53.0,FEMALE,WHITE,Stage IB,nan,Pancreas-Adenocarcinoma-Other Subtype,G2,2012.0,nan,-19707.0,Alive,WITH TUMOR,720.0,nan,nan,Distant Metastasis,Liver,nan,242.0,Progressive Disease,nan,nan,0.0,720.0,0.0,720.0,nan,nan,1.0,242.0,2
TCGA-YB-A89D-01,TCGA-YB-A89D,PAAD,59.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,nan,-21792.0,Alive,TUMOR FREE,350.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,350.0,0.0,350.0,0.0,350.0,0.0,350.0,0
TCGA-YB-A89D-11,TCGA-YB-A89D,PAAD,59.0,MALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G2,2013.0,nan,-21792.0,Alive,TUMOR FREE,350.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,350.0,0.0,350.0,0.0,350.0,0.0,350.0,0
TCGA-YH-A8SY-01,TCGA-YH-A8SY,PAAD,73.0,FEMALE,WHITE,[Discrepancy],nan,[Discrepancy],G2,2011.0,nan,-26859.0,Alive,nan,388.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,388.0,0.0,388.0,nan,nan,0.0,388.0,0
TCGA-YY-A8LH-01,TCGA-YY-A8LH,PAAD,61.0,FEMALE,WHITE,Stage IIB,nan,Pancreas-Adenocarcinoma Ductal Type,G3,2009.0,nan,-22376.0,Alive,TUMOR FREE,2016.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2016.0,0.0,2016.0,0.0,2016.0,0.0,2016.0,0
TCGA-Z5-AAPL-01,TCGA-Z5-AAPL,PAAD,74.0,FEMALE,WHITE,Stage IIA,nan,Pancreas-Adenocarcinoma Ductal Type,G1,2013.0,nan,-27152.0,Alive,TUMOR FREE,467.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,467.0,0.0,467.0,0.0,467.0,0.0,467.0,0
TCGA-P7-A5NX-01,TCGA-P7-A5NX,PCPG,78.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-28497.0,Alive,TUMOR FREE,818.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,818.0,0.0,818.0,0.0,818.0,0.0,818.0,0
TCGA-P7-A5NY-05,TCGA-P7-A5NY,PCPG,21.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-7834.0,Alive,TUMOR FREE,957.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,957.0,0.0,957.0,0.0,957.0,0.0,957.0,0
TCGA-P7-A5NY-01,TCGA-P7-A5NY,PCPG,21.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-7834.0,Alive,TUMOR FREE,957.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,957.0,0.0,957.0,0.0,957.0,0.0,957.0,0
TCGA-P8-A5KC-01,TCGA-P8-A5KC,PCPG,48.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-17790.0,Alive,TUMOR FREE,883.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,883.0,0.0,883.0,0.0,883.0,0.0,883.0,0
TCGA-P8-A5KC-11,TCGA-P8-A5KC,PCPG,48.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-17790.0,Alive,TUMOR FREE,883.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,883.0,0.0,883.0,0.0,883.0,0.0,883.0,0
TCGA-P8-A5KD-01,TCGA-P8-A5KD,PCPG,35.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-12954.0,Alive,TUMOR FREE,123.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,123.0,0.0,123.0,nan,nan,0.0,123.0,0
TCGA-P8-A5KD-11,TCGA-P8-A5KD,PCPG,35.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-12954.0,Alive,TUMOR FREE,123.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,123.0,0.0,123.0,nan,nan,0.0,123.0,0
TCGA-P8-A6RX-01,TCGA-P8-A6RX,PCPG,65.0,MALE,WHITE,nan,nan,Paraganglioma,nan,2013.0,nan,-23825.0,Alive,TUMOR FREE,540.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,540.0,0.0,540.0,nan,nan,0.0,540.0,0
TCGA-P8-A6RY-01,TCGA-P8-A6RY,PCPG,55.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-20109.0,Alive,TUMOR FREE,179.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,179.0,0.0,179.0,nan,nan,0.0,179.0,0
TCGA-PR-A5PF-01,TCGA-PR-A5PF,PCPG,62.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-22987.0,Alive,TUMOR FREE,546.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,546.0,0.0,546.0,0.0,546.0,0.0,546.0,0
TCGA-PR-A5PG-01,TCGA-PR-A5PG,PCPG,42.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2007.0,nan,-15577.0,Alive,WITH TUMOR,2485.0,nan,nan,Distant Metastasis,Bone,nan,2278.0,Complete Remission/Response,nan,nan,0.0,2485.0,0.0,2485.0,1.0,2278.0,1.0,2278.0,2
TCGA-PR-A5PH-01,TCGA-PR-A5PH,PCPG,47.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2007.0,nan,-17347.0,Alive,TUMOR FREE,854.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,854.0,0.0,854.0,0.0,854.0,0.0,854.0,0
TCGA-QR-A6GO-01,TCGA-QR-A6GO,PCPG,43.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2009.0,nan,-15799.0,Alive,TUMOR FREE,1065.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1065.0,0.0,1065.0,0.0,1065.0,0.0,1065.0,0
TCGA-QR-A6GR-01,TCGA-QR-A6GR,PCPG,30.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2009.0,nan,-11089.0,Alive,TUMOR FREE,703.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,703.0,0.0,703.0,0.0,703.0,0.0,703.0,0
TCGA-QR-A6GS-01,TCGA-QR-A6GS,PCPG,51.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2007.0,nan,-18798.0,Alive,TUMOR FREE,38.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,38.0,0.0,38.0,0.0,38.0,0.0,38.0,0
TCGA-QR-A6GT-01,TCGA-QR-A6GT,PCPG,63.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2002.0,nan,-23208.0,Alive,WITH TUMOR,4185.0,nan,nan,Distant Metastasis,Liver,nan,1476.0,Progressive Disease,nan,nan,0.0,4185.0,0.0,4185.0,nan,nan,1.0,1476.0,2
TCGA-QR-A6GU-01,TCGA-QR-A6GU,PCPG,31.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2008.0,nan,-11592.0,Alive,TUMOR FREE,1791.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1791.0,0.0,1791.0,0.0,1791.0,0.0,1791.0,0
TCGA-QR-A6GW-01,TCGA-QR-A6GW,PCPG,53.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2009.0,nan,-19639.0,Alive,TUMOR FREE,491.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,491.0,0.0,491.0,0.0,491.0,0.0,491.0,2
TCGA-QR-A6GX-01,TCGA-QR-A6GX,PCPG,28.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Pheochromocytoma,nan,2011.0,nan,-10548.0,Alive,TUMOR FREE,579.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,579.0,0.0,579.0,0.0,579.0,0.0,579.0,0
TCGA-QR-A6GY-01,TCGA-QR-A6GY,PCPG,37.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2006.0,nan,-13612.0,Alive,TUMOR FREE,32.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,32.0,0.0,32.0,0.0,32.0,0.0,32.0,0
TCGA-QR-A6GZ-05,TCGA-QR-A6GZ,PCPG,31.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2009.0,nan,-11573.0,Alive,TUMOR FREE,928.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,928.0,0.0,928.0,0.0,928.0,0.0,928.0,0
TCGA-QR-A6GZ-01,TCGA-QR-A6GZ,PCPG,31.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2009.0,nan,-11573.0,Alive,TUMOR FREE,928.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,928.0,0.0,928.0,0.0,928.0,0.0,928.0,0
TCGA-QR-A6H0-01,TCGA-QR-A6H0,PCPG,53.0,MALE,WHITE,nan,nan,Paraganglioma; Extra-adrenal Pheochromocytoma,nan,2012.0,nan,-19372.0,Alive,TUMOR FREE,280.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,280.0,0.0,280.0,0.0,280.0,0.0,280.0,0
TCGA-QR-A6H1-01,TCGA-QR-A6H1,PCPG,55.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2009.0,nan,-20295.0,Alive,TUMOR FREE,431.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,431.0,0.0,431.0,0.0,431.0,0.0,431.0,0
TCGA-QR-A6H2-01,TCGA-QR-A6H2,PCPG,33.0,MALE,ASIAN,nan,nan,Pheochromocytoma,nan,2003.0,nan,-12281.0,Alive,TUMOR FREE,302.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,302.0,0.0,302.0,0.0,302.0,0.0,302.0,0
TCGA-QR-A6H3-01,TCGA-QR-A6H3,PCPG,41.0,MALE,WHITE,nan,nan,Paraganglioma,nan,2013.0,nan,-15106.0,Alive,TUMOR FREE,434.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,434.0,0.0,434.0,0.0,434.0,0.0,434.0,0
TCGA-QR-A6H4-01,TCGA-QR-A6H4,PCPG,56.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2007.0,nan,-20492.0,Alive,TUMOR FREE,2661.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2661.0,0.0,2661.0,0.0,2661.0,0.0,2661.0,0
TCGA-QR-A6H5-01,TCGA-QR-A6H5,PCPG,30.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Pheochromocytoma,nan,2008.0,nan,-10987.0,Alive,TUMOR FREE,959.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,959.0,0.0,959.0,0.0,959.0,0.0,959.0,0
TCGA-QR-A6H6-01,TCGA-QR-A6H6,PCPG,27.0,MALE,WHITE,nan,nan,Paraganglioma,nan,2012.0,nan,-10180.0,Alive,TUMOR FREE,474.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,474.0,0.0,474.0,0.0,474.0,0.0,474.0,0
TCGA-QR-A6ZZ-01,TCGA-QR-A6ZZ,PCPG,30.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2013.0,nan,-11075.0,Alive,TUMOR FREE,48.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,48.0,0.0,48.0,0.0,48.0,0.0,48.0,0
TCGA-QR-A700-01,TCGA-QR-A700,PCPG,67.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-24734.0,Alive,WITH TUMOR,978.0,nan,nan,Distant Metastasis,Lung,nan,606.0,Progressive Disease,nan,nan,0.0,978.0,0.0,978.0,nan,nan,1.0,606.0,0
TCGA-QR-A702-01,TCGA-QR-A702,PCPG,75.0,FEMALE,WHITE,nan,nan,Paraganglioma,nan,2010.0,nan,-27395.0,Alive,TUMOR FREE,39.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,39.0,0.0,39.0,0.0,39.0,0.0,39.0,0
TCGA-QR-A703-01,TCGA-QR-A703,PCPG,23.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2008.0,nan,-8421.0,Alive,TUMOR FREE,1167.0,nan,nan,New Primary Tumor,"Other, specify",Left Adrenal Pheochromocytoma,0.0,Complete Remission/Response,nan,nan,0.0,1167.0,0.0,1167.0,0.0,1167.0,1.0,0.0,0
TCGA-QR-A705-01,TCGA-QR-A705,PCPG,63.0,FEMALE,WHITE,nan,nan,Paraganglioma; Extra-adrenal Pheochromocytoma,nan,2010.0,nan,-23086.0,Alive,TUMOR FREE,317.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,317.0,0.0,317.0,0.0,317.0,0.0,317.0,0
TCGA-QR-A706-01,TCGA-QR-A706,PCPG,50.0,FEMALE,WHITE,nan,nan,Paraganglioma,nan,2012.0,nan,-18585.0,Alive,TUMOR FREE,125.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,125.0,0.0,125.0,0.0,125.0,0.0,125.0,0
TCGA-QR-A707-01,TCGA-QR-A707,PCPG,43.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2010.0,nan,-15870.0,Alive,TUMOR FREE,398.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,398.0,0.0,398.0,0.0,398.0,0.0,398.0,0
TCGA-QR-A708-01,TCGA-QR-A708,PCPG,44.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-16170.0,Alive,TUMOR FREE,35.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,35.0,0.0,35.0,0.0,35.0,0.0,35.0,0
TCGA-QR-A70A-01,TCGA-QR-A70A,PCPG,54.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2006.0,nan,-19755.0,Alive,TUMOR FREE,2119.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2119.0,0.0,2119.0,0.0,2119.0,0.0,2119.0,0
TCGA-QR-A70C-01,TCGA-QR-A70C,PCPG,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Pheochromocytoma,nan,2004.0,nan,-18628.0,Alive,TUMOR FREE,3534.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3534.0,0.0,3534.0,0.0,3534.0,0.0,3534.0,0
TCGA-QR-A70D-01,TCGA-QR-A70D,PCPG,39.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Paraganglioma,nan,2012.0,nan,-14412.0,Alive,TUMOR FREE,7.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,7.0,0.0,7.0,0.0,7.0,0.0,7.0,0
TCGA-QR-A70E-01,TCGA-QR-A70E,PCPG,31.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-11400.0,Alive,TUMOR FREE,192.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,192.0,0.0,192.0,0.0,192.0,0.0,192.0,0
TCGA-QR-A70G-01,TCGA-QR-A70G,PCPG,54.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Pheochromocytoma,nan,2011.0,nan,-19914.0,Alive,TUMOR FREE,71.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,71.0,0.0,71.0,0.0,71.0,0.0,71.0,0
TCGA-QR-A70H-01,TCGA-QR-A70H,PCPG,36.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2007.0,nan,-13314.0,Alive,TUMOR FREE,816.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,816.0,0.0,816.0,0.0,816.0,0.0,816.0,0
TCGA-QR-A70I-01,TCGA-QR-A70I,PCPG,24.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Paraganglioma,nan,2010.0,nan,-9070.0,Alive,TUMOR FREE,910.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,910.0,0.0,910.0,0.0,910.0,0.0,910.0,0
TCGA-QR-A70J-01,TCGA-QR-A70J,PCPG,42.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-15420.0,Alive,TUMOR FREE,399.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,399.0,0.0,399.0,0.0,399.0,0.0,399.0,0
TCGA-QR-A70K-01,TCGA-QR-A70K,PCPG,61.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-22519.0,Alive,TUMOR FREE,274.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,274.0,0.0,274.0,0.0,274.0,0.0,274.0,0
TCGA-QR-A70M-01,TCGA-QR-A70M,PCPG,38.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2010.0,nan,-14091.0,Alive,TUMOR FREE,1034.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1034.0,0.0,1034.0,0.0,1034.0,0.0,1034.0,0
TCGA-QR-A70N-01,TCGA-QR-A70N,PCPG,32.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Pheochromocytoma,nan,2008.0,nan,-11781.0,Alive,TUMOR FREE,43.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,43.0,0.0,43.0,0.0,43.0,0.0,43.0,0
TCGA-QR-A70O-01,TCGA-QR-A70O,PCPG,35.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2013.0,nan,-13076.0,Alive,TUMOR FREE,111.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,111.0,0.0,111.0,0.0,111.0,0.0,111.0,0
TCGA-QR-A70P-01,TCGA-QR-A70P,PCPG,45.0,FEMALE,WHITE,nan,nan,Paraganglioma,nan,2004.0,nan,-16655.0,Dead,WITH TUMOR,nan,3563.0,nan,Locoregional Disease,"Other, specify",L jugular area,648.0,Progressive Disease,nan,nan,1.0,3563.0,1.0,3563.0,nan,nan,1.0,648.0,1
TCGA-QR-A70Q-01,TCGA-QR-A70Q,PCPG,33.0,MALE,WHITE,nan,nan,Paraganglioma; Extra-adrenal Pheochromocytoma,nan,2012.0,nan,-12394.0,Alive,TUMOR FREE,140.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,140.0,0.0,140.0,0.0,140.0,0.0,140.0,0
TCGA-QR-A70R-01,TCGA-QR-A70R,PCPG,43.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-15917.0,Alive,TUMOR FREE,432.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,432.0,0.0,432.0,0.0,432.0,0.0,432.0,0
TCGA-QR-A70T-01,TCGA-QR-A70T,PCPG,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Paraganglioma,nan,2011.0,nan,-14780.0,Alive,TUMOR FREE,267.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,267.0,0.0,267.0,0.0,267.0,0.0,267.0,0
TCGA-QR-A70U-01,TCGA-QR-A70U,PCPG,46.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2009.0,nan,-17062.0,Alive,TUMOR FREE,1473.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1473.0,0.0,1473.0,0.0,1473.0,0.0,1473.0,0
TCGA-QR-A70V-01,TCGA-QR-A70V,PCPG,66.0,FEMALE,[Unknown],nan,nan,Pheochromocytoma,nan,2012.0,nan,-24437.0,Alive,TUMOR FREE,2.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2.0,0.0,2.0,0.0,2.0,0.0,2.0,0
TCGA-QR-A70W-01,TCGA-QR-A70W,PCPG,40.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2009.0,nan,-14613.0,Alive,TUMOR FREE,1271.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1271.0,0.0,1271.0,0.0,1271.0,0.0,1271.0,0
TCGA-QR-A70X-01,TCGA-QR-A70X,PCPG,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Pheochromocytoma,nan,2012.0,nan,-16828.0,Alive,TUMOR FREE,183.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,183.0,0.0,183.0,0.0,183.0,0.0,183.0,0
TCGA-QR-A7IN-01,TCGA-QR-A7IN,PCPG,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Pheochromocytoma,nan,2011.0,nan,-19237.0,Alive,TUMOR FREE,377.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,377.0,0.0,377.0,0.0,377.0,0.0,377.0,0
TCGA-QR-A7IP-01,TCGA-QR-A7IP,PCPG,30.0,MALE,WHITE,nan,nan,Paraganglioma,nan,2012.0,nan,-11051.0,Alive,TUMOR FREE,546.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,546.0,0.0,546.0,0.0,546.0,0.0,546.0,0
TCGA-QT-A5XJ-01,TCGA-QT-A5XJ,PCPG,42.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Pheochromocytoma,nan,2011.0,nan,-15535.0,Alive,WITH TUMOR,1102.0,nan,nan,Distant Metastasis,"Other, specify",Bilateral Breasts SubQ Tissue,77.0,Progressive Disease,nan,nan,0.0,1102.0,0.0,1102.0,nan,nan,1.0,77.0,2
TCGA-QT-A5XK-01,TCGA-QT-A5XK,PCPG,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Pheochromocytoma,nan,2011.0,nan,-20724.0,Alive,TUMOR FREE,211.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,211.0,0.0,211.0,0.0,211.0,0.0,211.0,0
TCGA-QT-A5XL-01,TCGA-QT-A5XL,PCPG,27.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2010.0,nan,-10028.0,Alive,TUMOR FREE,55.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,55.0,0.0,55.0,0.0,55.0,0.0,55.0,0
TCGA-QT-A5XM-01,TCGA-QT-A5XM,PCPG,43.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-15915.0,Alive,TUMOR FREE,22.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,22.0,0.0,22.0,0.0,22.0,0.0,22.0,0
TCGA-QT-A5XN-01,TCGA-QT-A5XN,PCPG,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Pheochromocytoma,nan,2010.0,nan,-18812.0,Alive,TUMOR FREE,766.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,766.0,0.0,766.0,0.0,766.0,0.0,766.0,0
TCGA-QT-A5XO-01,TCGA-QT-A5XO,PCPG,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Pheochromocytoma,nan,2012.0,nan,-23154.0,Alive,TUMOR FREE,70.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,70.0,0.0,70.0,0.0,70.0,0.0,70.0,0
TCGA-QT-A5XP-01,TCGA-QT-A5XP,PCPG,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Pheochromocytoma,nan,2012.0,nan,-21072.0,Alive,TUMOR FREE,134.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,134.0,0.0,134.0,0.0,134.0,0.0,134.0,0
TCGA-QT-A69Q-01,TCGA-QT-A69Q,PCPG,40.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-14866.0,Alive,TUMOR FREE,24.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,24.0,0.0,24.0,0.0,24.0,0.0,24.0,0
TCGA-QT-A7U0-01,TCGA-QT-A7U0,PCPG,56.0,MALE,WHITE,nan,nan,Paraganglioma; Extra-adrenal Pheochromocytoma,nan,2013.0,nan,-20538.0,Alive,TUMOR FREE,398.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,398.0,0.0,398.0,0.0,398.0,0.0,398.0,0
TCGA-RM-A68T-01,TCGA-RM-A68T,PCPG,46.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Paraganglioma,nan,2007.0,nan,-17065.0,Alive,TUMOR FREE,2372.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2372.0,0.0,2372.0,0.0,2372.0,0.0,2372.0,0
TCGA-RM-A68W-01,TCGA-RM-A68W,PCPG,41.0,FEMALE,WHITE,nan,nan,Paraganglioma; Extra-adrenal Pheochromocytoma,nan,2010.0,nan,-15273.0,Alive,TUMOR FREE,28.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,28.0,0.0,28.0,0.0,28.0,0.0,28.0,0
TCGA-RT-A6Y9-01,TCGA-RT-A6Y9,PCPG,50.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2005.0,nan,-18594.0,Alive,TUMOR FREE,3293.0,nan,nan,New Primary Tumor,"Other, specify",left thigh,3282.0,Complete Remission/Response,nan,nan,0.0,3293.0,0.0,3293.0,0.0,3293.0,1.0,3282.0,0
TCGA-RT-A6YA-01,TCGA-RT-A6YA,PCPG,71.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2009.0,nan,-26095.0,Alive,TUMOR FREE,1540.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1540.0,0.0,1540.0,0.0,1540.0,0.0,1540.0,0
TCGA-RT-A6YC-01,TCGA-RT-A6YC,PCPG,31.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2013.0,nan,-11572.0,Alive,TUMOR FREE,246.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,246.0,0.0,246.0,0.0,246.0,0.0,246.0,0
TCGA-RW-A67V-01,TCGA-RW-A67V,PCPG,44.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2004.0,nan,-16139.0,Alive,TUMOR FREE,2643.0,nan,nan,Locoregional Disease,"Other, specify",Left adrenal,551.0,Progressive Disease,nan,nan,0.0,2643.0,0.0,2643.0,nan,nan,1.0,551.0,0
TCGA-RW-A67W-01,TCGA-RW-A67W,PCPG,46.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2010.0,nan,-16983.0,Alive,TUMOR FREE,604.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,604.0,0.0,604.0,0.0,604.0,0.0,604.0,0
TCGA-RW-A67X-01,TCGA-RW-A67X,PCPG,47.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2003.0,nan,-17307.0,Alive,TUMOR FREE,89.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,89.0,0.0,89.0,0.0,89.0,0.0,89.0,0
TCGA-RW-A67Y-01,TCGA-RW-A67Y,PCPG,43.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-15729.0,Alive,TUMOR FREE,216.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,216.0,0.0,216.0,0.0,216.0,0.0,216.0,0
TCGA-RW-A680-01,TCGA-RW-A680,PCPG,57.0,FEMALE,WHITE,nan,nan,Paraganglioma; Extra-adrenal Pheochromocytoma,nan,2011.0,nan,-21010.0,Alive,TUMOR FREE,1449.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1449.0,0.0,1449.0,0.0,1449.0,0.0,1449.0,0
TCGA-RW-A681-01,TCGA-RW-A681,PCPG,56.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-20812.0,Alive,TUMOR FREE,1141.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1141.0,0.0,1141.0,0.0,1141.0,0.0,1141.0,0
TCGA-RW-A684-01,TCGA-RW-A684,PCPG,64.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-23440.0,Alive,TUMOR FREE,32.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,32.0,0.0,32.0,0.0,32.0,0.0,32.0,0
TCGA-RW-A685-01,TCGA-RW-A685,PCPG,70.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-25790.0,Alive,TUMOR FREE,26.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,26.0,0.0,26.0,0.0,26.0,0.0,26.0,0
TCGA-RW-A686-06,TCGA-RW-A686,PCPG,62.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-22718.0,Alive,TUMOR FREE,587.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,587.0,0.0,587.0,0.0,587.0,0.0,587.0,0
TCGA-RW-A686-01,TCGA-RW-A686,PCPG,62.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-22718.0,Alive,TUMOR FREE,587.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,587.0,0.0,587.0,0.0,587.0,0.0,587.0,0
TCGA-RW-A688-01,TCGA-RW-A688,PCPG,69.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2013.0,nan,-25216.0,Alive,TUMOR FREE,37.0,nan,nan,New Primary Tumor,Lung,nan,27.0,Complete Remission/Response,nan,nan,0.0,37.0,0.0,37.0,0.0,37.0,1.0,27.0,0
TCGA-RW-A689-01,TCGA-RW-A689,PCPG,58.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-21402.0,Alive,TUMOR FREE,828.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,828.0,0.0,828.0,0.0,828.0,0.0,828.0,0
TCGA-RW-A68A-01,TCGA-RW-A68A,PCPG,19.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-7248.0,Alive,TUMOR FREE,762.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,762.0,0.0,762.0,0.0,762.0,0.0,762.0,0
TCGA-RW-A68B-01,TCGA-RW-A68B,PCPG,31.0,MALE,[Not Evaluated],nan,nan,Pheochromocytoma,nan,2013.0,nan,-11557.0,Alive,TUMOR FREE,727.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,727.0,0.0,727.0,0.0,727.0,0.0,727.0,0
TCGA-RW-A68C-01,TCGA-RW-A68C,PCPG,43.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2013.0,nan,-15962.0,Alive,TUMOR FREE,191.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,191.0,0.0,191.0,0.0,191.0,0.0,191.0,0
TCGA-RW-A68D-01,TCGA-RW-A68D,PCPG,31.0,FEMALE,ASIAN,nan,nan,Pheochromocytoma,nan,2006.0,nan,-11438.0,Alive,TUMOR FREE,2214.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2214.0,0.0,2214.0,0.0,2214.0,0.0,2214.0,0
TCGA-RW-A68F-01,TCGA-RW-A68F,PCPG,51.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2010.0,nan,-18974.0,Alive,TUMOR FREE,1354.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1354.0,0.0,1354.0,0.0,1354.0,0.0,1354.0,0
TCGA-RW-A68G-01,TCGA-RW-A68G,PCPG,49.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-17959.0,Alive,TUMOR FREE,1274.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1274.0,0.0,1274.0,0.0,1274.0,0.0,1274.0,0
TCGA-RW-A7CZ-01,TCGA-RW-A7CZ,PCPG,72.0,FEMALE,WHITE,nan,nan,Paraganglioma; Extra-adrenal Pheochromocytoma,nan,2013.0,nan,-26657.0,Alive,TUMOR FREE,422.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,422.0,0.0,422.0,0.0,422.0,0.0,422.0,0
TCGA-RW-A7D0-01,TCGA-RW-A7D0,PCPG,47.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2013.0,nan,-17422.0,Alive,TUMOR FREE,352.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,352.0,0.0,352.0,0.0,352.0,0.0,352.0,0
TCGA-RW-A8AZ-01,TCGA-RW-A8AZ,PCPG,66.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2013.0,nan,-24268.0,Dead,TUMOR FREE,nan,88.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,88.0,0.0,88.0,nan,nan,0.0,88.0,0
TCGA-RX-A8JQ-01,TCGA-RX-A8JQ,PCPG,44.0,MALE,WHITE,nan,nan,Paraganglioma,nan,2013.0,nan,-16182.0,Alive,TUMOR FREE,611.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,611.0,0.0,611.0,0.0,611.0,0.0,611.0,0
TCGA-S7-A7WL-01,TCGA-S7-A7WL,PCPG,59.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-21643.0,Alive,TUMOR FREE,961.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,961.0,0.0,961.0,0.0,961.0,0.0,961.0,0
TCGA-S7-A7WM-01,TCGA-S7-A7WM,PCPG,76.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-27984.0,Alive,TUMOR FREE,1112.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1112.0,0.0,1112.0,0.0,1112.0,0.0,1112.0,0
TCGA-S7-A7WN-01,TCGA-S7-A7WN,PCPG,40.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-14611.0,Alive,TUMOR FREE,1133.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1133.0,0.0,1133.0,0.0,1133.0,0.0,1133.0,0
TCGA-S7-A7WO-01,TCGA-S7-A7WO,PCPG,76.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-28114.0,Alive,TUMOR FREE,1080.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1080.0,0.0,1080.0,0.0,1080.0,0.0,1080.0,0
TCGA-S7-A7WP-01,TCGA-S7-A7WP,PCPG,25.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-9241.0,Alive,TUMOR FREE,944.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,944.0,0.0,944.0,0.0,944.0,0.0,944.0,0
TCGA-S7-A7WQ-01,TCGA-S7-A7WQ,PCPG,19.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-7269.0,Alive,TUMOR FREE,820.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,820.0,0.0,820.0,0.0,820.0,0.0,820.0,0
TCGA-S7-A7WR-01,TCGA-S7-A7WR,PCPG,32.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-12011.0,Alive,TUMOR FREE,1238.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1238.0,0.0,1238.0,0.0,1238.0,0.0,1238.0,0
TCGA-S7-A7WT-01,TCGA-S7-A7WT,PCPG,74.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-27311.0,Alive,TUMOR FREE,1301.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1301.0,0.0,1301.0,0.0,1301.0,0.0,1301.0,0
TCGA-S7-A7WU-01,TCGA-S7-A7WU,PCPG,63.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-23187.0,Alive,TUMOR FREE,928.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,928.0,0.0,928.0,0.0,928.0,0.0,928.0,0
TCGA-S7-A7WV-01,TCGA-S7-A7WV,PCPG,35.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-12893.0,Alive,TUMOR FREE,849.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,849.0,0.0,849.0,0.0,849.0,0.0,849.0,0
TCGA-S7-A7WW-01,TCGA-S7-A7WW,PCPG,34.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2013.0,nan,-12729.0,Alive,TUMOR FREE,706.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,706.0,0.0,706.0,0.0,706.0,0.0,706.0,0
TCGA-S7-A7WX-01,TCGA-S7-A7WX,PCPG,52.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-19190.0,Alive,TUMOR FREE,770.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,770.0,0.0,770.0,0.0,770.0,0.0,770.0,0
TCGA-S7-A7X0-01,TCGA-S7-A7X0,PCPG,75.0,FEMALE,WHITE,nan,nan,Paraganglioma; Extra-adrenal Pheochromocytoma,nan,2013.0,nan,-27729.0,Alive,TUMOR FREE,546.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,546.0,0.0,546.0,0.0,546.0,0.0,546.0,0
TCGA-S7-A7X1-01,TCGA-S7-A7X1,PCPG,23.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2013.0,nan,-8426.0,Alive,TUMOR FREE,576.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,576.0,0.0,576.0,0.0,576.0,0.0,576.0,0
TCGA-S7-A7X2-01,TCGA-S7-A7X2,PCPG,57.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-21054.0,Alive,TUMOR FREE,736.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,736.0,0.0,736.0,0.0,736.0,0.0,736.0,0
TCGA-SA-A6C2-01,TCGA-SA-A6C2,PCPG,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Paraganglioma; Extra-adrenal Pheochromocytoma,nan,2012.0,nan,-16805.0,Alive,TUMOR FREE,296.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,296.0,0.0,296.0,0.0,296.0,0.0,296.0,0
TCGA-SP-A6QC-01,TCGA-SP-A6QC,PCPG,46.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2004.0,nan,-16891.0,Alive,TUMOR FREE,3491.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3491.0,0.0,3491.0,0.0,3491.0,0.0,3491.0,0
TCGA-SP-A6QD-01,TCGA-SP-A6QD,PCPG,26.0,MALE,[Not Evaluated],nan,nan,Pheochromocytoma,nan,2004.0,nan,-9829.0,Alive,TUMOR FREE,3323.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3323.0,0.0,3323.0,0.0,3323.0,0.0,3323.0,0
TCGA-SP-A6QF-01,TCGA-SP-A6QF,PCPG,48.0,MALE,ASIAN,nan,nan,Pheochromocytoma,nan,2007.0,nan,-17795.0,Alive,TUMOR FREE,2513.0,nan,nan,New Primary Tumor,"Other, specify",Thyroid,588.0,Complete Remission/Response,nan,nan,0.0,2513.0,0.0,2513.0,0.0,2513.0,1.0,588.0,0
TCGA-SP-A6QG-01,TCGA-SP-A6QG,PCPG,35.0,FEMALE,WHITE,nan,nan,Paraganglioma,nan,2008.0,nan,-12874.0,Alive,TUMOR FREE,2417.0,nan,nan,New Primary Tumor,"Other, specify","Breast, left",626.0,Complete Remission/Response,nan,nan,0.0,2417.0,0.0,2417.0,0.0,2417.0,1.0,626.0,0
TCGA-SP-A6QH-01,TCGA-SP-A6QH,PCPG,35.0,FEMALE,ASIAN,nan,nan,Pheochromocytoma,nan,2008.0,nan,-12876.0,Alive,TUMOR FREE,2203.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2203.0,0.0,2203.0,0.0,2203.0,0.0,2203.0,0
TCGA-SP-A6QI-01,TCGA-SP-A6QI,PCPG,47.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2005.0,nan,-17167.0,Alive,TUMOR FREE,3347.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3347.0,0.0,3347.0,0.0,3347.0,0.0,3347.0,0
TCGA-SP-A6QJ-01,TCGA-SP-A6QJ,PCPG,64.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-23406.0,Alive,TUMOR FREE,472.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,472.0,0.0,472.0,0.0,472.0,0.0,472.0,0
TCGA-SP-A6QK-01,TCGA-SP-A6QK,PCPG,46.0,FEMALE,ASIAN,nan,nan,Pheochromocytoma,nan,2005.0,nan,-16923.0,Alive,TUMOR FREE,3384.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3384.0,0.0,3384.0,0.0,3384.0,0.0,3384.0,0
TCGA-SQ-A6I4-01,TCGA-SQ-A6I4,PCPG,53.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-19399.0,Alive,TUMOR FREE,43.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,43.0,0.0,43.0,nan,nan,0.0,43.0,0
TCGA-SQ-A6I4-11,TCGA-SQ-A6I4,PCPG,53.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-19399.0,Alive,TUMOR FREE,43.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,43.0,0.0,43.0,nan,nan,0.0,43.0,0
TCGA-SQ-A6I6-01,TCGA-SQ-A6I6,PCPG,39.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-14451.0,Alive,TUMOR FREE,3.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,3.0,0.0,3.0,nan,nan,0.0,3.0,0
TCGA-SR-A6MP-01,TCGA-SR-A6MP,PCPG,30.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2009.0,nan,-11050.0,Alive,TUMOR FREE,1558.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1558.0,0.0,1558.0,0.0,1558.0,0.0,1558.0,0
TCGA-SR-A6MQ-01,TCGA-SR-A6MQ,PCPG,61.0,FEMALE,ASIAN,nan,nan,Paraganglioma,nan,2008.0,nan,-22621.0,Alive,TUMOR FREE,2087.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2087.0,0.0,2087.0,0.0,2087.0,0.0,2087.0,0
TCGA-SR-A6MR-01,TCGA-SR-A6MR,PCPG,41.0,MALE,WHITE,nan,nan,Paraganglioma,nan,2007.0,nan,-14991.0,Alive,WITH TUMOR,2409.0,nan,nan,New Primary Tumor,Retroperitoneum,nan,928.0,Stable Disease,nan,nan,0.0,2409.0,0.0,2409.0,nan,nan,1.0,928.0,0
TCGA-SR-A6MS-01,TCGA-SR-A6MS,PCPG,35.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2007.0,nan,-12979.0,Alive,TUMOR FREE,2492.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2492.0,0.0,2492.0,0.0,2492.0,0.0,2492.0,0
TCGA-SR-A6MT-01,TCGA-SR-A6MT,PCPG,57.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2004.0,nan,-20944.0,Alive,TUMOR FREE,3247.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3247.0,0.0,3247.0,0.0,3247.0,0.0,3247.0,0
TCGA-SR-A6MU-01,TCGA-SR-A6MU,PCPG,49.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2004.0,nan,-18073.0,Alive,TUMOR FREE,3362.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3362.0,0.0,3362.0,0.0,3362.0,0.0,3362.0,0
TCGA-SR-A6MV-01,TCGA-SR-A6MV,PCPG,35.0,FEMALE,WHITE,nan,nan,Paraganglioma,nan,2004.0,nan,-13074.0,Alive,WITH TUMOR,3682.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,3682.0,0.0,3682.0,nan,nan,0.0,3682.0,0
TCGA-SR-A6MX-06,TCGA-SR-A6MX,PCPG,55.0,MALE,WHITE,nan,nan,Paraganglioma,nan,2013.0,nan,-20186.0,Dead,WITH TUMOR,nan,95.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,95.0,1.0,95.0,nan,nan,1.0,95.0,1
TCGA-SR-A6MX-05,TCGA-SR-A6MX,PCPG,55.0,MALE,WHITE,nan,nan,Paraganglioma,nan,2013.0,nan,-20186.0,Dead,WITH TUMOR,nan,95.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,95.0,1.0,95.0,nan,nan,1.0,95.0,1
TCGA-SR-A6MX-01,TCGA-SR-A6MX,PCPG,55.0,MALE,WHITE,nan,nan,Paraganglioma,nan,2013.0,nan,-20186.0,Dead,WITH TUMOR,nan,95.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,95.0,1.0,95.0,nan,nan,1.0,95.0,1
TCGA-SR-A6MY-01,TCGA-SR-A6MY,PCPG,54.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-19892.0,Alive,TUMOR FREE,750.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,750.0,0.0,750.0,0.0,750.0,0.0,750.0,0
TCGA-SR-A6MZ-01,TCGA-SR-A6MZ,PCPG,46.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-16802.0,Alive,TUMOR FREE,797.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,797.0,0.0,797.0,0.0,797.0,0.0,797.0,0
TCGA-SR-A6N0-01,TCGA-SR-A6N0,PCPG,45.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2010.0,nan,-16489.0,Alive,TUMOR FREE,1509.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1509.0,0.0,1509.0,0.0,1509.0,0.0,1509.0,0
TCGA-TT-A6YJ-01,TCGA-TT-A6YJ,PCPG,45.0,FEMALE,[Unknown],nan,nan,Pheochromocytoma,nan,2011.0,nan,-16475.0,Alive,TUMOR FREE,132.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,132.0,0.0,132.0,0.0,132.0,0.0,132.0,0
TCGA-TT-A6YK-01,TCGA-TT-A6YK,PCPG,61.0,MALE,WHITE,nan,nan,Paraganglioma; Extra-adrenal Pheochromocytoma,nan,2011.0,nan,-22500.0,Alive,TUMOR FREE,1136.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1136.0,0.0,1136.0,0.0,1136.0,0.0,1136.0,0
TCGA-TT-A6YN-01,TCGA-TT-A6YN,PCPG,37.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-13605.0,Alive,TUMOR FREE,606.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,606.0,0.0,606.0,0.0,606.0,0.0,606.0,0
TCGA-TT-A6YO-01,TCGA-TT-A6YO,PCPG,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Pheochromocytoma,nan,2013.0,nan,-23554.0,Alive,TUMOR FREE,405.0,nan,nan,Biochemical evidence of disease,nan,nan,377.0,Complete Remission/Response,nan,nan,0.0,405.0,0.0,405.0,1.0,377.0,1.0,377.0,2
TCGA-TT-A6YP-01,TCGA-TT-A6YP,PCPG,19.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-7240.0,Alive,TUMOR FREE,1292.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1292.0,0.0,1292.0,0.0,1292.0,0.0,1292.0,0
TCGA-W2-A7H5-01,TCGA-W2-A7H5,PCPG,25.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2013.0,nan,-9363.0,Alive,TUMOR FREE,611.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,611.0,0.0,611.0,0.0,611.0,0.0,611.0,0
TCGA-W2-A7H7-01,TCGA-W2-A7H7,PCPG,59.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-21711.0,Alive,TUMOR FREE,522.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,522.0,0.0,522.0,0.0,522.0,0.0,522.0,0
TCGA-W2-A7HA-01,TCGA-W2-A7HA,PCPG,63.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-23059.0,Alive,TUMOR FREE,36.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,36.0,0.0,36.0,0.0,36.0,0.0,36.0,0
TCGA-W2-A7HB-01,TCGA-W2-A7HB,PCPG,24.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-8979.0,Alive,TUMOR FREE,604.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,604.0,0.0,604.0,0.0,604.0,0.0,604.0,0
TCGA-W2-A7HC-01,TCGA-W2-A7HC,PCPG,67.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2013.0,nan,-24834.0,Alive,TUMOR FREE,439.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,439.0,0.0,439.0,0.0,439.0,0.0,439.0,0
TCGA-W2-A7HD-01,TCGA-W2-A7HD,PCPG,76.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2013.0,nan,-27962.0,Alive,TUMOR FREE,561.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,561.0,0.0,561.0,0.0,561.0,0.0,561.0,0
TCGA-W2-A7HE-01,TCGA-W2-A7HE,PCPG,80.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2013.0,nan,-29241.0,Alive,TUMOR FREE,505.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,505.0,0.0,505.0,0.0,505.0,0.0,505.0,0
TCGA-W2-A7HF-01,TCGA-W2-A7HF,PCPG,28.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Pheochromocytoma,nan,2013.0,nan,-10436.0,Alive,TUMOR FREE,538.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,538.0,0.0,538.0,0.0,538.0,0.0,538.0,0
TCGA-W2-A7HH-01,TCGA-W2-A7HH,PCPG,69.0,FEMALE,WHITE,nan,nan,Paraganglioma,nan,2012.0,nan,-25291.0,Alive,TUMOR FREE,779.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,779.0,0.0,779.0,0.0,779.0,0.0,779.0,0
TCGA-W2-A7UY-01,TCGA-W2-A7UY,PCPG,44.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2013.0,nan,-16335.0,Alive,TUMOR FREE,450.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,450.0,0.0,450.0,nan,nan,0.0,450.0,0
TCGA-WB-A80K-01,TCGA-WB-A80K,PCPG,49.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-18033.0,Alive,TUMOR FREE,1255.0,nan,nan,Distant Metastasis,Lymph Node(s),nan,772.0,Complete Remission/Response,nan,nan,0.0,1255.0,0.0,1255.0,1.0,772.0,1.0,772.0,0
TCGA-WB-A80L-01,TCGA-WB-A80L,PCPG,30.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-10980.0,Alive,TUMOR FREE,1042.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1042.0,0.0,1042.0,0.0,1042.0,0.0,1042.0,0
TCGA-WB-A80M-01,TCGA-WB-A80M,PCPG,63.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-23163.0,Alive,TUMOR FREE,136.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,136.0,0.0,136.0,0.0,136.0,0.0,136.0,0
TCGA-WB-A80N-01,TCGA-WB-A80N,PCPG,54.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-19980.0,Alive,TUMOR FREE,144.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,144.0,0.0,144.0,0.0,144.0,0.0,144.0,0
TCGA-WB-A80O-01,TCGA-WB-A80O,PCPG,83.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2013.0,nan,-30555.0,Alive,TUMOR FREE,776.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,776.0,0.0,776.0,0.0,776.0,0.0,776.0,0
TCGA-WB-A80P-01,TCGA-WB-A80P,PCPG,20.0,MALE,WHITE,nan,nan,Paraganglioma; Extra-adrenal Pheochromocytoma,nan,1988.0,nan,-7608.0,Alive,WITH TUMOR,9634.0,nan,nan,Distant Metastasis,Bone,nan,6866.0,Progressive Disease,nan,nan,0.0,9634.0,0.0,9634.0,nan,nan,1.0,6866.0,0
TCGA-WB-A80Q-01,TCGA-WB-A80Q,PCPG,64.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2003.0,nan,-23653.0,Alive,TUMOR FREE,3880.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3880.0,0.0,3880.0,0.0,3880.0,0.0,3880.0,0
TCGA-WB-A80V-01,TCGA-WB-A80V,PCPG,63.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-23254.0,Alive,TUMOR FREE,887.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,887.0,0.0,887.0,0.0,887.0,0.0,887.0,0
TCGA-WB-A80Y-01,TCGA-WB-A80Y,PCPG,59.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-21902.0,Dead,TUMOR FREE,nan,596.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,596.0,0.0,596.0,0.0,596.0,0.0,596.0,0
TCGA-WB-A814-01,TCGA-WB-A814,PCPG,35.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Paraganglioma; Extra-adrenal Pheochromocytoma,nan,2008.0,nan,-12936.0,Alive,TUMOR FREE,2252.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2252.0,0.0,2252.0,0.0,2252.0,0.0,2252.0,0
TCGA-WB-A815-01,TCGA-WB-A815,PCPG,68.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2010.0,nan,-24859.0,Alive,TUMOR FREE,1630.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1630.0,0.0,1630.0,0.0,1630.0,0.0,1630.0,0
TCGA-WB-A816-01,TCGA-WB-A816,PCPG,42.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2010.0,nan,-15400.0,Alive,TUMOR FREE,1254.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1254.0,0.0,1254.0,0.0,1254.0,0.0,1254.0,0
TCGA-WB-A817-01,TCGA-WB-A817,PCPG,27.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-9981.0,Alive,TUMOR FREE,1310.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1310.0,0.0,1310.0,0.0,1310.0,0.0,1310.0,0
TCGA-WB-A818-01,TCGA-WB-A818,PCPG,37.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-13596.0,Alive,TUMOR FREE,1288.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1288.0,0.0,1288.0,0.0,1288.0,0.0,1288.0,0
TCGA-WB-A819-01,TCGA-WB-A819,PCPG,36.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-13233.0,Alive,TUMOR FREE,1031.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1031.0,0.0,1031.0,0.0,1031.0,0.0,1031.0,0
TCGA-WB-A81A-01,TCGA-WB-A81A,PCPG,65.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-23966.0,Alive,TUMOR FREE,735.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,735.0,0.0,735.0,0.0,735.0,0.0,735.0,0
TCGA-WB-A81D-01,TCGA-WB-A81D,PCPG,82.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-30101.0,Alive,TUMOR FREE,1090.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1090.0,0.0,1090.0,0.0,1090.0,0.0,1090.0,0
TCGA-WB-A81E-01,TCGA-WB-A81E,PCPG,47.0,FEMALE,WHITE,nan,nan,Paraganglioma; Extra-adrenal Pheochromocytoma,nan,2011.0,nan,-17407.0,Alive,WITH TUMOR,1476.0,nan,nan,Locoregional Disease,Lymph Node(s),nan,887.0,Complete Remission/Response,nan,nan,0.0,1476.0,0.0,1476.0,1.0,887.0,1.0,887.0,2
TCGA-WB-A81F-01,TCGA-WB-A81F,PCPG,40.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2009.0,nan,-14933.0,Alive,TUMOR FREE,1737.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1737.0,0.0,1737.0,0.0,1737.0,0.0,1737.0,0
TCGA-WB-A81G-01,TCGA-WB-A81G,PCPG,25.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-9248.0,Alive,TUMOR FREE,1179.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1179.0,0.0,1179.0,0.0,1179.0,0.0,1179.0,0
TCGA-WB-A81H-01,TCGA-WB-A81H,PCPG,44.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2009.0,nan,-16425.0,Alive,TUMOR FREE,1946.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1946.0,0.0,1946.0,0.0,1946.0,0.0,1946.0,0
TCGA-WB-A81I-01,TCGA-WB-A81I,PCPG,64.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-23566.0,Alive,TUMOR FREE,679.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,679.0,0.0,679.0,0.0,679.0,0.0,679.0,0
TCGA-WB-A81J-01,TCGA-WB-A81J,PCPG,40.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-14665.0,Alive,TUMOR FREE,741.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,741.0,0.0,741.0,0.0,741.0,0.0,741.0,0
TCGA-WB-A81K-01,TCGA-WB-A81K,PCPG,45.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2010.0,nan,-16483.0,Alive,TUMOR FREE,1218.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1218.0,0.0,1218.0,0.0,1218.0,0.0,1218.0,0
TCGA-WB-A81M-01,TCGA-WB-A81M,PCPG,42.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2010.0,nan,-15505.0,Alive,TUMOR FREE,1394.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1394.0,0.0,1394.0,0.0,1394.0,0.0,1394.0,0
TCGA-WB-A81N-01,TCGA-WB-A81N,PCPG,28.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2010.0,nan,-10283.0,Alive,TUMOR FREE,1887.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1887.0,0.0,1887.0,0.0,1887.0,0.0,1887.0,0
TCGA-WB-A81P-01,TCGA-WB-A81P,PCPG,73.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2011.0,nan,-26867.0,Alive,TUMOR FREE,395.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,395.0,0.0,395.0,0.0,395.0,0.0,395.0,0
TCGA-WB-A81Q-01,TCGA-WB-A81Q,PCPG,44.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,1997.0,nan,-16422.0,Dead,WITH TUMOR,nan,755.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,755.0,1.0,755.0,nan,nan,1.0,755.0,1
TCGA-WB-A81R-01,TCGA-WB-A81R,PCPG,55.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-20438.0,Alive,TUMOR FREE,49.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,49.0,0.0,49.0,0.0,49.0,0.0,49.0,0
TCGA-WB-A81S-01,TCGA-WB-A81S,PCPG,59.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2012.0,nan,-21587.0,Alive,TUMOR FREE,723.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,723.0,0.0,723.0,0.0,723.0,0.0,723.0,0
TCGA-WB-A81T-01,TCGA-WB-A81T,PCPG,45.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2013.0,nan,-16506.0,Alive,TUMOR FREE,776.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,776.0,0.0,776.0,0.0,776.0,0.0,776.0,0
TCGA-WB-A81V-01,TCGA-WB-A81V,PCPG,57.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2006.0,nan,-21106.0,Alive,TUMOR FREE,2161.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2161.0,0.0,2161.0,0.0,2161.0,0.0,2161.0,0
TCGA-WB-A81W-01,TCGA-WB-A81W,PCPG,41.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2007.0,nan,-15001.0,Alive,TUMOR FREE,2379.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2379.0,0.0,2379.0,0.0,2379.0,0.0,2379.0,0
TCGA-WB-A820-01,TCGA-WB-A820,PCPG,40.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2004.0,nan,-14949.0,Dead,WITH TUMOR,nan,309.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,309.0,1.0,309.0,nan,nan,1.0,309.0,1
TCGA-WB-A821-01,TCGA-WB-A821,PCPG,73.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2006.0,nan,-26805.0,Alive,TUMOR FREE,2832.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2832.0,0.0,2832.0,0.0,2832.0,0.0,2832.0,0
TCGA-WB-A822-01,TCGA-WB-A822,PCPG,23.0,MALE,WHITE,nan,nan,Pheochromocytoma,nan,2006.0,nan,-8708.0,Alive,WITH TUMOR,3138.0,nan,nan,Distant Metastasis,Bone,nan,69.0,Progressive Disease,nan,nan,0.0,3138.0,0.0,3138.0,nan,nan,1.0,69.0,0
TCGA-XG-A823-01,TCGA-XG-A823,PCPG,25.0,FEMALE,WHITE,nan,nan,Pheochromocytoma,nan,2013.0,nan,-9149.0,Alive,TUMOR FREE,614.0,nan,nan,New Primary Tumor,"Other, specify",Carotid Body,190.0,Complete Remission/Response,nan,nan,0.0,614.0,0.0,614.0,0.0,614.0,1.0,190.0,0
TCGA-2A-A8VL-01,TCGA-2A-A8VL,PRAD,51.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-18658.0,Alive,TUMOR FREE,621.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,621.0,0.0,621.0,nan,nan,0.0,621.0,0
TCGA-2A-A8VO-01,TCGA-2A-A8VO,PRAD,57.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-20958.0,Alive,TUMOR FREE,1701.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1701.0,0.0,1701.0,nan,nan,0.0,1701.0,0
TCGA-2A-A8VT-01,TCGA-2A-A8VT,PRAD,47.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-17365.0,Alive,[Discrepancy],1373.0,nan,nan,nan,nan,nan,nan,[Discrepancy],nan,nan,0.0,1373.0,0.0,1373.0,nan,nan,0.0,1373.0,0
TCGA-2A-A8VV-01,TCGA-2A-A8VV,PRAD,52.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-19065.0,Alive,TUMOR FREE,671.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,671.0,0.0,671.0,nan,nan,0.0,671.0,0
TCGA-2A-A8VX-01,TCGA-2A-A8VX,PRAD,70.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-25904.0,Alive,TUMOR FREE,1378.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1378.0,0.0,1378.0,nan,nan,0.0,1378.0,0
TCGA-2A-A8W1-01,TCGA-2A-A8W1,PRAD,54.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-19964.0,Alive,nan,112.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,112.0,0.0,112.0,nan,nan,0.0,112.0,0
TCGA-2A-A8W3-01,TCGA-2A-A8W3,PRAD,69.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-25557.0,Alive,[Discrepancy],863.0,nan,nan,Biochemical evidence of disease,nan,nan,198.0,nan,nan,nan,0.0,863.0,0.0,863.0,nan,nan,1.0,198.0,0
TCGA-2A-AAYF-01,TCGA-2A-AAYF,PRAD,57.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-20866.0,Alive,TUMOR FREE,1364.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1364.0,0.0,1364.0,0.0,1364.0,0.0,1364.0,0
TCGA-2A-AAYO-01,TCGA-2A-AAYO,PRAD,57.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-21183.0,Alive,TUMOR FREE,1272.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1272.0,0.0,1272.0,0.0,1272.0,0.0,1272.0,0
TCGA-2A-AAYU-01,TCGA-2A-AAYU,PRAD,56.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-20582.0,Alive,TUMOR FREE,615.0,nan,nan,nan,nan,nan,nan,[Discrepancy],nan,nan,0.0,615.0,0.0,615.0,nan,nan,0.0,615.0,0
TCGA-4L-AA1F-01,TCGA-4L-AA1F,PRAD,64.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-23665.0,Alive,TUMOR FREE,350.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,350.0,0.0,350.0,0.0,350.0,0.0,350.0,0
TCGA-CH-5737-01,TCGA-CH-5737,PRAD,73.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-26753.0,Alive,TUMOR FREE,91.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,91.0,0.0,91.0,nan,nan,0.0,91.0,0
TCGA-CH-5738-01,TCGA-CH-5738,PRAD,72.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2006.0,nan,-26329.0,Alive,TUMOR FREE,212.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,212.0,0.0,212.0,0.0,212.0,0.0,212.0,0
TCGA-CH-5739-01,TCGA-CH-5739,PRAD,65.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2006.0,nan,-23953.0,Alive,TUMOR FREE,671.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,671.0,0.0,671.0,0.0,671.0,0.0,671.0,0
TCGA-CH-5740-01,TCGA-CH-5740,PRAD,57.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-20880.0,Alive,TUMOR FREE,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-CH-5741-01,TCGA-CH-5741,PRAD,56.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-20759.0,Alive,TUMOR FREE,395.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,395.0,0.0,395.0,0.0,395.0,0.0,395.0,0
TCGA-CH-5743-01,TCGA-CH-5743,PRAD,66.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-24321.0,Alive,TUMOR FREE,425.0,nan,nan,New Primary Tumor,nan,nan,425.0,Complete Remission/Response,nan,nan,0.0,425.0,0.0,425.0,0.0,425.0,1.0,425.0,0
TCGA-CH-5744-01,TCGA-CH-5744,PRAD,64.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-23621.0,Alive,TUMOR FREE,60.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,60.0,0.0,60.0,nan,nan,0.0,60.0,0
TCGA-CH-5745-01,TCGA-CH-5745,PRAD,68.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-24837.0,Alive,TUMOR FREE,91.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,91.0,0.0,91.0,nan,nan,0.0,91.0,0
TCGA-CH-5746-01,TCGA-CH-5746,PRAD,57.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-20941.0,Alive,TUMOR FREE,731.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,731.0,0.0,731.0,0.0,731.0,0.0,731.0,0
TCGA-CH-5748-01,TCGA-CH-5748,PRAD,64.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-23649.0,Alive,WITH TUMOR,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-CH-5750-01,TCGA-CH-5750,PRAD,72.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-26389.0,Alive,TUMOR FREE,396.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,396.0,0.0,396.0,0.0,396.0,0.0,396.0,0
TCGA-CH-5751-01,TCGA-CH-5751,PRAD,68.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2006.0,nan,-24957.0,Alive,WITH TUMOR,1065.0,nan,nan,Distant Metastasis,Bone,nan,365.0,Complete Remission/Response,nan,nan,0.0,1065.0,0.0,1065.0,1.0,365.0,1.0,365.0,2
TCGA-CH-5752-01,TCGA-CH-5752,PRAD,66.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2006.0,nan,-24290.0,Alive,TUMOR FREE,943.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,943.0,0.0,943.0,0.0,943.0,0.0,943.0,0
TCGA-CH-5753-01,TCGA-CH-5753,PRAD,70.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-25780.0,Alive,TUMOR FREE,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-CH-5754-01,TCGA-CH-5754,PRAD,65.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-23803.0,Alive,WITH TUMOR,62.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,62.0,0.0,62.0,nan,nan,0.0,62.0,0
TCGA-CH-5761-01,TCGA-CH-5761,PRAD,61.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-22433.0,Alive,TUMOR FREE,28.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,28.0,0.0,28.0,nan,nan,0.0,28.0,0
TCGA-CH-5761-11,TCGA-CH-5761,PRAD,61.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-22433.0,Alive,TUMOR FREE,28.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,28.0,0.0,28.0,nan,nan,0.0,28.0,0
TCGA-CH-5762-01,TCGA-CH-5762,PRAD,60.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2005.0,nan,-22068.0,Alive,[Discrepancy],1339.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1339.0,0.0,1339.0,0.0,1339.0,0.0,1339.0,0
TCGA-CH-5762-11,TCGA-CH-5762,PRAD,60.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2005.0,nan,-22068.0,Alive,[Discrepancy],1339.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1339.0,0.0,1339.0,0.0,1339.0,0.0,1339.0,0
TCGA-CH-5763-01,TCGA-CH-5763,PRAD,66.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-24380.0,Alive,TUMOR FREE,365.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,365.0,0.0,365.0,0.0,365.0,0.0,365.0,0
TCGA-CH-5763-11,TCGA-CH-5763,PRAD,66.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-24380.0,Alive,TUMOR FREE,365.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,365.0,0.0,365.0,0.0,365.0,0.0,365.0,0
TCGA-CH-5764-01,TCGA-CH-5764,PRAD,66.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-24257.0,Alive,TUMOR FREE,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-CH-5764-11,TCGA-CH-5764,PRAD,66.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-24257.0,Alive,TUMOR FREE,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-CH-5765-01,TCGA-CH-5765,PRAD,55.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-20364.0,Alive,TUMOR FREE,700.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,700.0,0.0,700.0,0.0,700.0,0.0,700.0,0
TCGA-CH-5765-11,TCGA-CH-5765,PRAD,55.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-20364.0,Alive,TUMOR FREE,700.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,700.0,0.0,700.0,0.0,700.0,0.0,700.0,0
TCGA-CH-5766-01,TCGA-CH-5766,PRAD,55.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-20392.0,Alive,TUMOR FREE,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-CH-5766-11,TCGA-CH-5766,PRAD,55.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-20392.0,Alive,TUMOR FREE,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-CH-5767-01,TCGA-CH-5767,PRAD,66.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-24287.0,Alive,TUMOR FREE,458.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,458.0,0.0,458.0,0.0,458.0,0.0,458.0,0
TCGA-CH-5767-11,TCGA-CH-5767,PRAD,66.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-24287.0,Alive,TUMOR FREE,458.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,458.0,0.0,458.0,0.0,458.0,0.0,458.0,0
TCGA-CH-5768-01,TCGA-CH-5768,PRAD,72.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-26480.0,Alive,TUMOR FREE,731.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,731.0,0.0,731.0,0.0,731.0,0.0,731.0,0
TCGA-CH-5768-11,TCGA-CH-5768,PRAD,72.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-26480.0,Alive,TUMOR FREE,731.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,731.0,0.0,731.0,0.0,731.0,0.0,731.0,0
TCGA-CH-5769-01,TCGA-CH-5769,PRAD,48.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-17807.0,Alive,WITH TUMOR,62.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,62.0,0.0,62.0,nan,nan,0.0,62.0,0
TCGA-CH-5769-11,TCGA-CH-5769,PRAD,48.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-17807.0,Alive,WITH TUMOR,62.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,62.0,0.0,62.0,nan,nan,0.0,62.0,0
TCGA-CH-5771-01,TCGA-CH-5771,PRAD,63.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-23101.0,Alive,TUMOR FREE,396.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,396.0,0.0,396.0,0.0,396.0,0.0,396.0,0
TCGA-CH-5771-11,TCGA-CH-5771,PRAD,63.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-23101.0,Alive,TUMOR FREE,396.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,396.0,0.0,396.0,0.0,396.0,0.0,396.0,0
TCGA-CH-5772-01,TCGA-CH-5772,PRAD,63.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-23194.0,Alive,TUMOR FREE,486.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,486.0,0.0,486.0,0.0,486.0,0.0,486.0,0
TCGA-CH-5772-11,TCGA-CH-5772,PRAD,63.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-23194.0,Alive,TUMOR FREE,486.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,486.0,0.0,486.0,0.0,486.0,0.0,486.0,0
TCGA-CH-5788-01,TCGA-CH-5788,PRAD,69.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-25233.0,Alive,WITH TUMOR,821.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,821.0,0.0,821.0,nan,nan,0.0,821.0,0
TCGA-CH-5789-01,TCGA-CH-5789,PRAD,61.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2006.0,nan,-22494.0,Alive,TUMOR FREE,304.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,304.0,0.0,304.0,0.0,304.0,0.0,304.0,0
TCGA-CH-5790-01,TCGA-CH-5790,PRAD,64.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2006.0,nan,-23529.0,Alive,TUMOR FREE,974.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,974.0,0.0,974.0,0.0,974.0,0.0,974.0,0
TCGA-CH-5791-01,TCGA-CH-5791,PRAD,72.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2006.0,nan,-26390.0,Alive,nan,1004.0,nan,nan,New Primary Tumor,nan,nan,396.0,Complete Remission/Response,nan,nan,0.0,1004.0,0.0,1004.0,0.0,1004.0,1.0,396.0,0
TCGA-CH-5792-01,TCGA-CH-5792,PRAD,57.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-21002.0,Alive,WITH TUMOR,91.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,91.0,0.0,91.0,nan,nan,0.0,91.0,0
TCGA-CH-5794-01,TCGA-CH-5794,PRAD,65.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2006.0,nan,-23924.0,Alive,TUMOR FREE,882.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,882.0,0.0,882.0,0.0,882.0,0.0,882.0,0
TCGA-EJ-5494-01,TCGA-EJ-5494,PRAD,50.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-18596.0,Alive,TUMOR FREE,1477.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1477.0,0.0,1477.0,0.0,1477.0,0.0,1477.0,0
TCGA-EJ-5495-01,TCGA-EJ-5495,PRAD,68.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-24904.0,Alive,TUMOR FREE,1760.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1760.0,0.0,1760.0,0.0,1760.0,0.0,1760.0,0
TCGA-EJ-5496-01,TCGA-EJ-5496,PRAD,59.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-21897.0,Alive,TUMOR FREE,595.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,595.0,0.0,595.0,0.0,595.0,0.0,595.0,0
TCGA-EJ-5497-01,TCGA-EJ-5497,PRAD,47.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-17523.0,Alive,TUMOR FREE,405.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,405.0,0.0,405.0,0.0,405.0,0.0,405.0,0
TCGA-EJ-5498-01,TCGA-EJ-5498,PRAD,56.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-20472.0,Alive,TUMOR FREE,1720.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1720.0,0.0,1720.0,0.0,1720.0,0.0,1720.0,0
TCGA-EJ-5499-01,TCGA-EJ-5499,PRAD,61.0,MALE,ASIAN,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-22286.0,Alive,TUMOR FREE,1415.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1415.0,0.0,1415.0,0.0,1415.0,0.0,1415.0,0
TCGA-EJ-5501-01,TCGA-EJ-5501,PRAD,55.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-20409.0,Alive,TUMOR FREE,1365.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1365.0,0.0,1365.0,0.0,1365.0,0.0,1365.0,0
TCGA-EJ-5502-01,TCGA-EJ-5502,PRAD,50.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-18447.0,Alive,TUMOR FREE,1171.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1171.0,0.0,1171.0,0.0,1171.0,0.0,1171.0,0
TCGA-EJ-5503-01,TCGA-EJ-5503,PRAD,50.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-18395.0,Alive,TUMOR FREE,1391.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1391.0,0.0,1391.0,0.0,1391.0,0.0,1391.0,0
TCGA-EJ-5504-01,TCGA-EJ-5504,PRAD,65.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-24072.0,Alive,WITH TUMOR,1427.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,1427.0,0.0,1427.0,nan,nan,0.0,1427.0,0
TCGA-EJ-5505-01,TCGA-EJ-5505,PRAD,57.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-21164.0,Alive,TUMOR FREE,922.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,922.0,0.0,922.0,0.0,922.0,0.0,922.0,0
TCGA-EJ-5506-01,TCGA-EJ-5506,PRAD,67.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-24617.0,Alive,TUMOR FREE,1381.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1381.0,0.0,1381.0,0.0,1381.0,0.0,1381.0,0
TCGA-EJ-5507-01,TCGA-EJ-5507,PRAD,54.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-19759.0,Alive,TUMOR FREE,1457.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1457.0,0.0,1457.0,0.0,1457.0,0.0,1457.0,0
TCGA-EJ-5508-01,TCGA-EJ-5508,PRAD,65.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-23758.0,Alive,TUMOR FREE,1965.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1965.0,0.0,1965.0,0.0,1965.0,0.0,1965.0,0
TCGA-EJ-5509-01,TCGA-EJ-5509,PRAD,63.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-23368.0,Alive,TUMOR FREE,1464.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1464.0,0.0,1464.0,0.0,1464.0,0.0,1464.0,0
TCGA-EJ-5510-01,TCGA-EJ-5510,PRAD,48.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-17895.0,Alive,TUMOR FREE,1887.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1887.0,0.0,1887.0,0.0,1887.0,0.0,1887.0,0
TCGA-EJ-5511-01,TCGA-EJ-5511,PRAD,55.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-20409.0,Alive,TUMOR FREE,1476.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1476.0,0.0,1476.0,0.0,1476.0,0.0,1476.0,0
TCGA-EJ-5512-01,TCGA-EJ-5512,PRAD,46.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-17127.0,Alive,TUMOR FREE,1733.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1733.0,0.0,1733.0,0.0,1733.0,0.0,1733.0,0
TCGA-EJ-5514-01,TCGA-EJ-5514,PRAD,66.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-24165.0,Alive,TUMOR FREE,1829.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1829.0,0.0,1829.0,0.0,1829.0,0.0,1829.0,0
TCGA-EJ-5515-01,TCGA-EJ-5515,PRAD,60.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-22097.0,Alive,TUMOR FREE,1832.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1832.0,0.0,1832.0,0.0,1832.0,0.0,1832.0,0
TCGA-EJ-5516-01,TCGA-EJ-5516,PRAD,49.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-17980.0,Alive,TUMOR FREE,1889.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1889.0,0.0,1889.0,0.0,1889.0,0.0,1889.0,0
TCGA-EJ-5517-01,TCGA-EJ-5517,PRAD,55.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-20422.0,Alive,TUMOR FREE,1889.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1889.0,0.0,1889.0,0.0,1889.0,0.0,1889.0,0
TCGA-EJ-5518-01,TCGA-EJ-5518,PRAD,66.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-24313.0,Alive,WITH TUMOR,2118.0,nan,nan,Distant Metastasis,Bone,nan,2104.0,Progressive Disease,nan,nan,0.0,2118.0,0.0,2118.0,nan,nan,1.0,2104.0,0
TCGA-EJ-5519-01,TCGA-EJ-5519,PRAD,64.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-23669.0,Alive,TUMOR FREE,1962.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1962.0,0.0,1962.0,0.0,1962.0,0.0,1962.0,0
TCGA-EJ-5521-01,TCGA-EJ-5521,PRAD,63.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-23304.0,Alive,TUMOR FREE,2279.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2279.0,0.0,2279.0,0.0,2279.0,0.0,2279.0,0
TCGA-EJ-5522-01,TCGA-EJ-5522,PRAD,51.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-18802.0,Alive,TUMOR FREE,2079.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2079.0,0.0,2079.0,0.0,2079.0,0.0,2079.0,0
TCGA-EJ-5524-01,TCGA-EJ-5524,PRAD,57.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-20854.0,Alive,WITH TUMOR,1882.0,nan,nan,Locoregional Recurrence,nan,nan,265.0,Progressive Disease,nan,nan,0.0,1882.0,0.0,1882.0,nan,nan,1.0,265.0,2
TCGA-EJ-5525-01,TCGA-EJ-5525,PRAD,67.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-24535.0,Alive,WITH TUMOR,1115.0,nan,nan,Distant Metastasis,Bone,nan,546.0,Progressive Disease,nan,nan,0.0,1115.0,0.0,1115.0,nan,nan,1.0,546.0,2
TCGA-EJ-5526-01,TCGA-EJ-5526,PRAD,56.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-20558.0,Alive,WITH TUMOR,1909.0,nan,nan,Locoregional Recurrence,nan,nan,537.0,Progressive Disease,nan,nan,0.0,1909.0,0.0,1909.0,nan,nan,1.0,537.0,2
TCGA-EJ-5527-01,TCGA-EJ-5527,PRAD,69.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-25234.0,Alive,TUMOR FREE,1778.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1778.0,0.0,1778.0,0.0,1778.0,0.0,1778.0,0
TCGA-EJ-5530-01,TCGA-EJ-5530,PRAD,61.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-22316.0,Alive,TUMOR FREE,1832.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1832.0,0.0,1832.0,0.0,1832.0,0.0,1832.0,0
TCGA-EJ-5531-01,TCGA-EJ-5531,PRAD,62.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-22760.0,Alive,TUMOR FREE,1273.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1273.0,0.0,1273.0,0.0,1273.0,0.0,1273.0,0
TCGA-EJ-5532-01,TCGA-EJ-5532,PRAD,57.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-21110.0,Alive,TUMOR FREE,1828.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1828.0,0.0,1828.0,0.0,1828.0,0.0,1828.0,0
TCGA-EJ-5542-01,TCGA-EJ-5542,PRAD,60.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-21942.0,Alive,TUMOR FREE,1513.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1513.0,0.0,1513.0,0.0,1513.0,0.0,1513.0,0
TCGA-EJ-7115-01,TCGA-EJ-7115,PRAD,65.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2006.0,nan,-23986.0,Alive,TUMOR FREE,2687.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2687.0,0.0,2687.0,0.0,2687.0,0.0,2687.0,0
TCGA-EJ-7115-11,TCGA-EJ-7115,PRAD,65.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2006.0,nan,-23986.0,Alive,TUMOR FREE,2687.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2687.0,0.0,2687.0,0.0,2687.0,0.0,2687.0,0
TCGA-EJ-7123-01,TCGA-EJ-7123,PRAD,59.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-21741.0,Alive,TUMOR FREE,2572.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2572.0,0.0,2572.0,0.0,2572.0,0.0,2572.0,0
TCGA-EJ-7123-11,TCGA-EJ-7123,PRAD,59.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-21741.0,Alive,TUMOR FREE,2572.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2572.0,0.0,2572.0,0.0,2572.0,0.0,2572.0,0
TCGA-EJ-7125-01,TCGA-EJ-7125,PRAD,44.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2005.0,nan,-16425.0,Alive,TUMOR FREE,2850.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2850.0,0.0,2850.0,0.0,2850.0,0.0,2850.0,0
TCGA-EJ-7125-11,TCGA-EJ-7125,PRAD,44.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2005.0,nan,-16425.0,Alive,TUMOR FREE,2850.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2850.0,0.0,2850.0,0.0,2850.0,0.0,2850.0,0
TCGA-EJ-7218-01,TCGA-EJ-7218,PRAD,71.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2006.0,nan,-26181.0,Alive,TUMOR FREE,2542.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2542.0,0.0,2542.0,0.0,2542.0,0.0,2542.0,0
TCGA-EJ-7312-01,TCGA-EJ-7312,PRAD,58.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-21292.0,Alive,TUMOR FREE,1099.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1099.0,0.0,1099.0,0.0,1099.0,0.0,1099.0,0
TCGA-EJ-7314-01,TCGA-EJ-7314,PRAD,62.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-22766.0,Alive,TUMOR FREE,1150.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1150.0,0.0,1150.0,0.0,1150.0,0.0,1150.0,0
TCGA-EJ-7314-11,TCGA-EJ-7314,PRAD,62.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-22766.0,Alive,TUMOR FREE,1150.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1150.0,0.0,1150.0,0.0,1150.0,0.0,1150.0,0
TCGA-EJ-7315-01,TCGA-EJ-7315,PRAD,68.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-25154.0,Alive,TUMOR FREE,1008.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1008.0,0.0,1008.0,0.0,1008.0,0.0,1008.0,0
TCGA-EJ-7315-11,TCGA-EJ-7315,PRAD,68.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-25154.0,Alive,TUMOR FREE,1008.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1008.0,0.0,1008.0,0.0,1008.0,0.0,1008.0,0
TCGA-EJ-7317-01,TCGA-EJ-7317,PRAD,71.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-26064.0,Alive,TUMOR FREE,771.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,771.0,0.0,771.0,0.0,771.0,0.0,771.0,0
TCGA-EJ-7317-11,TCGA-EJ-7317,PRAD,71.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-26064.0,Alive,TUMOR FREE,771.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,771.0,0.0,771.0,0.0,771.0,0.0,771.0,0
TCGA-EJ-7318-01,TCGA-EJ-7318,PRAD,51.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-18686.0,Alive,TUMOR FREE,1029.0,nan,nan,Locoregional Recurrence,nan,nan,380.0,Partial Remission/Response,nan,nan,0.0,1029.0,0.0,1029.0,nan,nan,1.0,380.0,0
TCGA-EJ-7321-01,TCGA-EJ-7321,PRAD,57.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-21108.0,Alive,TUMOR FREE,824.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,824.0,0.0,824.0,0.0,824.0,0.0,824.0,0
TCGA-EJ-7321-11,TCGA-EJ-7321,PRAD,57.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-21108.0,Alive,TUMOR FREE,824.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,824.0,0.0,824.0,0.0,824.0,0.0,824.0,0
TCGA-EJ-7325-01,TCGA-EJ-7325,PRAD,63.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-23029.0,Alive,TUMOR FREE,1070.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1070.0,0.0,1070.0,0.0,1070.0,0.0,1070.0,0
TCGA-EJ-7327-01,TCGA-EJ-7327,PRAD,61.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-22475.0,Alive,TUMOR FREE,923.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,923.0,0.0,923.0,0.0,923.0,0.0,923.0,0
TCGA-EJ-7327-11,TCGA-EJ-7327,PRAD,61.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-22475.0,Alive,TUMOR FREE,923.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,923.0,0.0,923.0,0.0,923.0,0.0,923.0,0
TCGA-EJ-7328-01,TCGA-EJ-7328,PRAD,70.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-25756.0,Alive,TUMOR FREE,842.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,842.0,0.0,842.0,0.0,842.0,0.0,842.0,0
TCGA-EJ-7328-11,TCGA-EJ-7328,PRAD,70.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-25756.0,Alive,TUMOR FREE,842.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,842.0,0.0,842.0,0.0,842.0,0.0,842.0,0
TCGA-EJ-7330-01,TCGA-EJ-7330,PRAD,68.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-25050.0,Alive,TUMOR FREE,191.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,191.0,0.0,191.0,nan,nan,0.0,191.0,0
TCGA-EJ-7330-11,TCGA-EJ-7330,PRAD,68.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-25050.0,Alive,TUMOR FREE,191.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,191.0,0.0,191.0,nan,nan,0.0,191.0,0
TCGA-EJ-7331-01,TCGA-EJ-7331,PRAD,64.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-23458.0,Alive,TUMOR FREE,742.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,742.0,0.0,742.0,0.0,742.0,0.0,742.0,0
TCGA-EJ-7331-11,TCGA-EJ-7331,PRAD,64.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-23458.0,Alive,TUMOR FREE,742.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,742.0,0.0,742.0,0.0,742.0,0.0,742.0,0
TCGA-EJ-7781-01,TCGA-EJ-7781,PRAD,65.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-23937.0,Alive,TUMOR FREE,1073.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1073.0,0.0,1073.0,0.0,1073.0,0.0,1073.0,0
TCGA-EJ-7781-11,TCGA-EJ-7781,PRAD,65.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-23937.0,Alive,TUMOR FREE,1073.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1073.0,0.0,1073.0,0.0,1073.0,0.0,1073.0,0
TCGA-EJ-7782-01,TCGA-EJ-7782,PRAD,71.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-25965.0,Alive,TUMOR FREE,1167.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1167.0,0.0,1167.0,0.0,1167.0,0.0,1167.0,0
TCGA-EJ-7782-11,TCGA-EJ-7782,PRAD,71.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-25965.0,Alive,TUMOR FREE,1167.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1167.0,0.0,1167.0,0.0,1167.0,0.0,1167.0,0
TCGA-EJ-7783-01,TCGA-EJ-7783,PRAD,70.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-25600.0,Alive,TUMOR FREE,787.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,787.0,0.0,787.0,0.0,787.0,0.0,787.0,0
TCGA-EJ-7783-11,TCGA-EJ-7783,PRAD,70.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-25600.0,Alive,TUMOR FREE,787.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,787.0,0.0,787.0,0.0,787.0,0.0,787.0,0
TCGA-EJ-7784-01,TCGA-EJ-7784,PRAD,63.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-23183.0,Alive,TUMOR FREE,781.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,781.0,0.0,781.0,0.0,781.0,0.0,781.0,0
TCGA-EJ-7784-11,TCGA-EJ-7784,PRAD,63.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-23183.0,Alive,TUMOR FREE,781.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,781.0,0.0,781.0,0.0,781.0,0.0,781.0,0
TCGA-EJ-7785-01,TCGA-EJ-7785,PRAD,54.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-19939.0,Alive,TUMOR FREE,1177.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1177.0,0.0,1177.0,0.0,1177.0,0.0,1177.0,0
TCGA-EJ-7785-11,TCGA-EJ-7785,PRAD,54.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-19939.0,Alive,TUMOR FREE,1177.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1177.0,0.0,1177.0,0.0,1177.0,0.0,1177.0,0
TCGA-EJ-7786-01,TCGA-EJ-7786,PRAD,62.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-22793.0,Alive,TUMOR FREE,1096.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1096.0,0.0,1096.0,0.0,1096.0,0.0,1096.0,0
TCGA-EJ-7786-11,TCGA-EJ-7786,PRAD,62.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-22793.0,Alive,TUMOR FREE,1096.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1096.0,0.0,1096.0,0.0,1096.0,0.0,1096.0,0
TCGA-EJ-7788-01,TCGA-EJ-7788,PRAD,53.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-19623.0,Alive,TUMOR FREE,859.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,859.0,0.0,859.0,0.0,859.0,0.0,859.0,0
TCGA-EJ-7789-01,TCGA-EJ-7789,PRAD,66.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-24107.0,Alive,TUMOR FREE,1105.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1105.0,0.0,1105.0,0.0,1105.0,0.0,1105.0,0
TCGA-EJ-7789-11,TCGA-EJ-7789,PRAD,66.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-24107.0,Alive,TUMOR FREE,1105.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1105.0,0.0,1105.0,0.0,1105.0,0.0,1105.0,0
TCGA-EJ-7791-01,TCGA-EJ-7791,PRAD,67.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-24621.0,Alive,TUMOR FREE,1118.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1118.0,0.0,1118.0,0.0,1118.0,0.0,1118.0,0
TCGA-EJ-7792-01,TCGA-EJ-7792,PRAD,53.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-19454.0,Alive,TUMOR FREE,1396.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1396.0,0.0,1396.0,0.0,1396.0,0.0,1396.0,0
TCGA-EJ-7792-11,TCGA-EJ-7792,PRAD,53.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-19454.0,Alive,TUMOR FREE,1396.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1396.0,0.0,1396.0,0.0,1396.0,0.0,1396.0,0
TCGA-EJ-7793-01,TCGA-EJ-7793,PRAD,49.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-17982.0,Alive,TUMOR FREE,114.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,114.0,0.0,114.0,0.0,114.0,0.0,114.0,0
TCGA-EJ-7793-11,TCGA-EJ-7793,PRAD,49.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-17982.0,Alive,TUMOR FREE,114.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,114.0,0.0,114.0,0.0,114.0,0.0,114.0,0
TCGA-EJ-7794-01,TCGA-EJ-7794,PRAD,67.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-24478.0,Alive,TUMOR FREE,1306.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1306.0,0.0,1306.0,0.0,1306.0,0.0,1306.0,0
TCGA-EJ-7794-11,TCGA-EJ-7794,PRAD,67.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-24478.0,Alive,TUMOR FREE,1306.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1306.0,0.0,1306.0,0.0,1306.0,0.0,1306.0,0
TCGA-EJ-7797-01,TCGA-EJ-7797,PRAD,53.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-19616.0,Alive,TUMOR FREE,983.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,983.0,0.0,983.0,0.0,983.0,0.0,983.0,0
TCGA-EJ-7797-11,TCGA-EJ-7797,PRAD,53.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-19616.0,Alive,TUMOR FREE,983.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,983.0,0.0,983.0,0.0,983.0,0.0,983.0,0
TCGA-EJ-8468-01,TCGA-EJ-8468,PRAD,63.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-23371.0,Alive,TUMOR FREE,2347.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2347.0,0.0,2347.0,0.0,2347.0,0.0,2347.0,0
TCGA-EJ-8469-01,TCGA-EJ-8469,PRAD,46.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-17014.0,Alive,WITH TUMOR,2324.0,nan,nan,Locoregional Recurrence,nan,nan,1925.0,Partial Remission/Response,nan,nan,0.0,2324.0,0.0,2324.0,nan,nan,1.0,1925.0,0
TCGA-EJ-8470-01,TCGA-EJ-8470,PRAD,58.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-21209.0,Alive,TUMOR FREE,1159.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1159.0,0.0,1159.0,0.0,1159.0,0.0,1159.0,0
TCGA-EJ-8472-01,TCGA-EJ-8472,PRAD,63.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-23104.0,Alive,TUMOR FREE,756.0,nan,nan,Biochemical evidence of disease,nan,nan,196.0,Partial Remission/Response,nan,nan,0.0,756.0,0.0,756.0,nan,nan,1.0,196.0,0
TCGA-EJ-8474-01,TCGA-EJ-8474,PRAD,69.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-25561.0,Alive,TUMOR FREE,766.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,766.0,0.0,766.0,0.0,766.0,0.0,766.0,0
TCGA-EJ-A46B-01,TCGA-EJ-A46B,PRAD,66.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-24305.0,Alive,TUMOR FREE,657.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,657.0,0.0,657.0,0.0,657.0,0.0,657.0,0
TCGA-EJ-A46D-01,TCGA-EJ-A46D,PRAD,53.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-19466.0,Alive,TUMOR FREE,626.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,626.0,0.0,626.0,0.0,626.0,0.0,626.0,0
TCGA-EJ-A46E-01,TCGA-EJ-A46E,PRAD,57.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-21054.0,Alive,TUMOR FREE,524.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,524.0,0.0,524.0,0.0,524.0,0.0,524.0,0
TCGA-EJ-A46F-01,TCGA-EJ-A46F,PRAD,57.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-21160.0,Alive,TUMOR FREE,783.0,nan,nan,Biochemical evidence of disease,nan,nan,215.0,Partial Remission/Response,nan,nan,0.0,783.0,0.0,783.0,nan,nan,1.0,215.0,0
TCGA-EJ-A46G-01,TCGA-EJ-A46G,PRAD,71.0,MALE,nan,nan,nan,"Prostate Adenocarcinoma, Other Subtype",nan,2012.0,nan,-26219.0,Alive,TUMOR FREE,668.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,668.0,0.0,668.0,0.0,668.0,0.0,668.0,0
TCGA-EJ-A46H-01,TCGA-EJ-A46H,PRAD,60.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-22059.0,Alive,TUMOR FREE,724.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,724.0,0.0,724.0,0.0,724.0,0.0,724.0,0
TCGA-EJ-A46I-01,TCGA-EJ-A46I,PRAD,57.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-21046.0,Alive,TUMOR FREE,668.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,668.0,0.0,668.0,0.0,668.0,0.0,668.0,0
TCGA-EJ-A65B-01,TCGA-EJ-A65B,PRAD,55.0,MALE,nan,nan,nan,"Prostate Adenocarcinoma, Other Subtype",nan,2012.0,nan,-20204.0,Alive,TUMOR FREE,710.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,710.0,0.0,710.0,0.0,710.0,0.0,710.0,0
TCGA-EJ-A65D-01,TCGA-EJ-A65D,PRAD,66.0,MALE,nan,nan,nan,"Prostate Adenocarcinoma, Other Subtype",nan,2012.0,nan,-24297.0,Alive,TUMOR FREE,393.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,393.0,0.0,393.0,0.0,393.0,0.0,393.0,0
TCGA-EJ-A65E-01,TCGA-EJ-A65E,PRAD,67.0,MALE,nan,nan,nan,"Prostate Adenocarcinoma, Other Subtype",nan,2012.0,nan,-24558.0,Alive,TUMOR FREE,417.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,417.0,0.0,417.0,0.0,417.0,0.0,417.0,0
TCGA-EJ-A65F-01,TCGA-EJ-A65F,PRAD,59.0,MALE,nan,nan,nan,"Prostate Adenocarcinoma, Other Subtype",nan,2012.0,nan,-21681.0,Alive,[Discrepancy],560.0,nan,nan,Biochemical evidence of disease,nan,nan,75.0,Progressive Disease,nan,nan,0.0,560.0,0.0,560.0,nan,nan,1.0,75.0,0
TCGA-EJ-A65G-01,TCGA-EJ-A65G,PRAD,57.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-20821.0,Alive,TUMOR FREE,666.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,666.0,0.0,666.0,0.0,666.0,0.0,666.0,0
TCGA-EJ-A65J-01,TCGA-EJ-A65J,PRAD,62.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-22904.0,Alive,TUMOR FREE,451.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,451.0,0.0,451.0,0.0,451.0,0.0,451.0,0
TCGA-EJ-A65M-01,TCGA-EJ-A65M,PRAD,65.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-23767.0,Alive,TUMOR FREE,230.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,230.0,0.0,230.0,0.0,230.0,0.0,230.0,0
TCGA-EJ-A6RA-01,TCGA-EJ-A6RA,PRAD,70.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-25679.0,Alive,TUMOR FREE,353.0,nan,nan,Locoregional Recurrence,nan,nan,353.0,Partial Remission/Response,nan,nan,0.0,353.0,0.0,353.0,nan,nan,1.0,353.0,0
TCGA-EJ-A6RC-01,TCGA-EJ-A6RC,PRAD,64.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-23598.0,Alive,TUMOR FREE,873.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,873.0,0.0,873.0,0.0,873.0,0.0,873.0,0
TCGA-EJ-A7NF-01,TCGA-EJ-A7NF,PRAD,56.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-20587.0,Alive,TUMOR FREE,250.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,250.0,0.0,250.0,0.0,250.0,0.0,250.0,0
TCGA-EJ-A7NG-01,TCGA-EJ-A7NG,PRAD,64.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-23458.0,Alive,TUMOR FREE,432.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,432.0,0.0,432.0,0.0,432.0,0.0,432.0,0
TCGA-EJ-A7NH-01,TCGA-EJ-A7NH,PRAD,56.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-20734.0,Alive,TUMOR FREE,474.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,474.0,0.0,474.0,0.0,474.0,0.0,474.0,0
TCGA-EJ-A7NJ-01,TCGA-EJ-A7NJ,PRAD,59.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-21748.0,Alive,TUMOR FREE,197.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,197.0,0.0,197.0,0.0,197.0,0.0,197.0,0
TCGA-EJ-A7NK-01,TCGA-EJ-A7NK,PRAD,58.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-21530.0,Alive,TUMOR FREE,476.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,476.0,0.0,476.0,0.0,476.0,0.0,476.0,0
TCGA-EJ-A7NM-01,TCGA-EJ-A7NM,PRAD,64.0,MALE,nan,nan,nan,"Prostate Adenocarcinoma, Other Subtype",nan,2013.0,nan,-23603.0,Alive,TUMOR FREE,128.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,128.0,0.0,128.0,0.0,128.0,0.0,128.0,0
TCGA-EJ-A7NN-01,TCGA-EJ-A7NN,PRAD,61.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-22499.0,Alive,TUMOR FREE,197.0,nan,nan,Biochemical evidence of disease,nan,nan,197.0,Complete Remission/Response,nan,nan,0.0,197.0,0.0,197.0,1.0,197.0,1.0,197.0,0
TCGA-EJ-A8FN-01,TCGA-EJ-A8FN,PRAD,58.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-21506.0,Alive,TUMOR FREE,329.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,329.0,0.0,329.0,0.0,329.0,0.0,329.0,0
TCGA-EJ-A8FO-01,TCGA-EJ-A8FO,PRAD,51.0,MALE,nan,nan,nan,"Prostate Adenocarcinoma, Other Subtype",nan,2013.0,nan,-18875.0,Alive,TUMOR FREE,282.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,282.0,0.0,282.0,0.0,282.0,0.0,282.0,0
TCGA-EJ-A8FO-11,TCGA-EJ-A8FO,PRAD,51.0,MALE,nan,nan,nan,"Prostate Adenocarcinoma, Other Subtype",nan,2013.0,nan,-18875.0,Alive,TUMOR FREE,282.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,282.0,0.0,282.0,0.0,282.0,0.0,282.0,0
TCGA-EJ-A8FP-01,TCGA-EJ-A8FP,PRAD,59.0,MALE,nan,nan,nan,"Prostate Adenocarcinoma, Other Subtype",nan,2013.0,nan,-21769.0,Alive,TUMOR FREE,299.0,nan,nan,Biochemical evidence of disease,nan,nan,117.0,Complete Remission/Response,nan,nan,0.0,299.0,0.0,299.0,1.0,117.0,1.0,117.0,0
TCGA-EJ-A8FS-01,TCGA-EJ-A8FS,PRAD,66.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-24380.0,Alive,TUMOR FREE,266.0,nan,nan,Biochemical evidence of disease,nan,nan,216.0,Complete Remission/Response,nan,nan,0.0,266.0,0.0,266.0,1.0,216.0,1.0,216.0,0
TCGA-EJ-A8FU-01,TCGA-EJ-A8FU,PRAD,64.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-23472.0,Alive,TUMOR FREE,138.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,138.0,0.0,138.0,0.0,138.0,0.0,138.0,0
TCGA-EJ-AB20-01,TCGA-EJ-AB20,PRAD,61.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-22626.0,Alive,TUMOR FREE,131.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,131.0,0.0,131.0,0.0,131.0,0.0,131.0,0
TCGA-EJ-AB27-01,TCGA-EJ-AB27,PRAD,51.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-18648.0,Alive,TUMOR FREE,145.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,145.0,0.0,145.0,0.0,145.0,0.0,145.0,0
TCGA-FC-7708-01,TCGA-FC-7708,PRAD,52.0,MALE,ASIAN,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-19144.0,Alive,TUMOR FREE,864.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,864.0,0.0,864.0,0.0,864.0,0.0,864.0,0
TCGA-FC-7961-01,TCGA-FC-7961,PRAD,62.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-22888.0,Alive,TUMOR FREE,469.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,469.0,0.0,469.0,0.0,469.0,0.0,469.0,0
TCGA-FC-A4JI-01,TCGA-FC-A4JI,PRAD,70.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-25931.0,Alive,TUMOR FREE,877.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,877.0,0.0,877.0,0.0,877.0,0.0,877.0,0
TCGA-FC-A5OB-01,TCGA-FC-A5OB,PRAD,53.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-19413.0,Alive,WITH TUMOR,680.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,680.0,0.0,680.0,nan,nan,0.0,680.0,0
TCGA-FC-A66V-01,TCGA-FC-A66V,PRAD,74.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-27282.0,Alive,TUMOR FREE,524.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,524.0,0.0,524.0,0.0,524.0,0.0,524.0,0
TCGA-FC-A6HD-01,TCGA-FC-A6HD,PRAD,77.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-28197.0,Alive,TUMOR FREE,789.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,789.0,0.0,789.0,0.0,789.0,0.0,789.0,0
TCGA-FC-A8O0-01,TCGA-FC-A8O0,PRAD,68.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-25115.0,Alive,TUMOR FREE,616.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,616.0,0.0,616.0,0.0,616.0,0.0,616.0,0
TCGA-G9-6329-01,TCGA-G9-6329,PRAD,67.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-24797.0,Alive,TUMOR FREE,1266.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1266.0,0.0,1266.0,0.0,1266.0,0.0,1266.0,0
TCGA-G9-6332-01,TCGA-G9-6332,PRAD,55.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2005.0,nan,-20166.0,Alive,WITH TUMOR,2657.0,nan,nan,Biochemical evidence of disease,nan,nan,1180.0,Complete Remission/Response,nan,nan,0.0,2657.0,0.0,2657.0,1.0,1180.0,1.0,1180.0,2
TCGA-G9-6332-11,TCGA-G9-6332,PRAD,55.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2005.0,nan,-20166.0,Alive,WITH TUMOR,2657.0,nan,nan,Biochemical evidence of disease,nan,nan,1180.0,Complete Remission/Response,nan,nan,0.0,2657.0,0.0,2657.0,1.0,1180.0,1.0,1180.0,2
TCGA-G9-6333-01,TCGA-G9-6333,PRAD,66.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2006.0,nan,-24249.0,Alive,TUMOR FREE,2465.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2465.0,0.0,2465.0,0.0,2465.0,0.0,2465.0,0
TCGA-G9-6333-11,TCGA-G9-6333,PRAD,66.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2006.0,nan,-24249.0,Alive,TUMOR FREE,2465.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2465.0,0.0,2465.0,0.0,2465.0,0.0,2465.0,0
TCGA-G9-6336-01,TCGA-G9-6336,PRAD,57.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-20851.0,Alive,TUMOR FREE,2068.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2068.0,0.0,2068.0,0.0,2068.0,0.0,2068.0,0
TCGA-G9-6338-01,TCGA-G9-6338,PRAD,61.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-22360.0,Alive,TUMOR FREE,2028.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2028.0,0.0,2028.0,0.0,2028.0,0.0,2028.0,0
TCGA-G9-6339-01,TCGA-G9-6339,PRAD,58.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-21305.0,Alive,TUMOR FREE,2551.0,nan,nan,Biochemical evidence of disease,nan,nan,1634.0,Complete Remission/Response,nan,nan,0.0,2551.0,0.0,2551.0,1.0,1634.0,1.0,1634.0,0
TCGA-G9-6342-01,TCGA-G9-6342,PRAD,61.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-22472.0,Alive,TUMOR FREE,1696.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1696.0,0.0,1696.0,0.0,1696.0,0.0,1696.0,0
TCGA-G9-6342-11,TCGA-G9-6342,PRAD,61.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-22472.0,Alive,TUMOR FREE,1696.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1696.0,0.0,1696.0,0.0,1696.0,0.0,1696.0,0
TCGA-G9-6343-01,TCGA-G9-6343,PRAD,62.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-22843.0,Alive,TUMOR FREE,2450.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2450.0,0.0,2450.0,0.0,2450.0,0.0,2450.0,0
TCGA-G9-6347-01,TCGA-G9-6347,PRAD,59.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-21721.0,Alive,TUMOR FREE,2089.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2089.0,0.0,2089.0,0.0,2089.0,0.0,2089.0,0
TCGA-G9-6348-01,TCGA-G9-6348,PRAD,68.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-24936.0,Alive,TUMOR FREE,1515.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1515.0,0.0,1515.0,0.0,1515.0,0.0,1515.0,0
TCGA-G9-6348-11,TCGA-G9-6348,PRAD,68.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-24936.0,Alive,TUMOR FREE,1515.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1515.0,0.0,1515.0,0.0,1515.0,0.0,1515.0,0
TCGA-G9-6351-01,TCGA-G9-6351,PRAD,51.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-18723.0,Alive,TUMOR FREE,2048.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2048.0,0.0,2048.0,0.0,2048.0,0.0,2048.0,0
TCGA-G9-6351-11,TCGA-G9-6351,PRAD,51.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-18723.0,Alive,TUMOR FREE,2048.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2048.0,0.0,2048.0,0.0,2048.0,0.0,2048.0,0
TCGA-G9-6353-01,TCGA-G9-6353,PRAD,58.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-21221.0,Alive,TUMOR FREE,1542.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1542.0,0.0,1542.0,0.0,1542.0,0.0,1542.0,0
TCGA-G9-6353-11,TCGA-G9-6353,PRAD,58.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-21221.0,Alive,TUMOR FREE,1542.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1542.0,0.0,1542.0,0.0,1542.0,0.0,1542.0,0
TCGA-G9-6354-01,TCGA-G9-6354,PRAD,55.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-20403.0,Alive,TUMOR FREE,2066.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2066.0,0.0,2066.0,0.0,2066.0,0.0,2066.0,0
TCGA-G9-6356-01,TCGA-G9-6356,PRAD,60.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-22010.0,Alive,TUMOR FREE,1434.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1434.0,0.0,1434.0,0.0,1434.0,0.0,1434.0,0
TCGA-G9-6356-11,TCGA-G9-6356,PRAD,60.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-22010.0,Alive,TUMOR FREE,1434.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1434.0,0.0,1434.0,0.0,1434.0,0.0,1434.0,0
TCGA-G9-6361-01,TCGA-G9-6361,PRAD,61.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-22565.0,Alive,TUMOR FREE,1415.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1415.0,0.0,1415.0,0.0,1415.0,0.0,1415.0,0
TCGA-G9-6362-01,TCGA-G9-6362,PRAD,57.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-21149.0,Alive,WITH TUMOR,1443.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,1443.0,0.0,1443.0,nan,nan,0.0,1443.0,0
TCGA-G9-6362-11,TCGA-G9-6362,PRAD,57.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-21149.0,Alive,WITH TUMOR,1443.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,1443.0,0.0,1443.0,nan,nan,0.0,1443.0,0
TCGA-G9-6363-01,TCGA-G9-6363,PRAD,64.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-23480.0,Alive,TUMOR FREE,1378.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1378.0,0.0,1378.0,0.0,1378.0,0.0,1378.0,0
TCGA-G9-6363-11,TCGA-G9-6363,PRAD,64.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-23480.0,Alive,TUMOR FREE,1378.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1378.0,0.0,1378.0,0.0,1378.0,0.0,1378.0,0
TCGA-G9-6364-01,TCGA-G9-6364,PRAD,72.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-26603.0,Alive,TUMOR FREE,1198.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1198.0,0.0,1198.0,0.0,1198.0,0.0,1198.0,0
TCGA-G9-6364-11,TCGA-G9-6364,PRAD,72.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-26603.0,Alive,TUMOR FREE,1198.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1198.0,0.0,1198.0,0.0,1198.0,0.0,1198.0,0
TCGA-G9-6365-01,TCGA-G9-6365,PRAD,71.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-26207.0,Alive,TUMOR FREE,1363.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1363.0,0.0,1363.0,0.0,1363.0,0.0,1363.0,0
TCGA-G9-6365-11,TCGA-G9-6365,PRAD,71.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-26207.0,Alive,TUMOR FREE,1363.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1363.0,0.0,1363.0,0.0,1363.0,0.0,1363.0,0
TCGA-G9-6366-01,TCGA-G9-6366,PRAD,61.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-22428.0,Alive,nan,1947.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1947.0,0.0,1947.0,0.0,1947.0,0.0,1947.0,0
TCGA-G9-6367-01,TCGA-G9-6367,PRAD,60.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-22176.0,Alive,WITH TUMOR,1222.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,1222.0,0.0,1222.0,nan,nan,0.0,1222.0,0
TCGA-G9-6367-11,TCGA-G9-6367,PRAD,60.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-22176.0,Alive,WITH TUMOR,1222.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,1222.0,0.0,1222.0,nan,nan,0.0,1222.0,0
TCGA-G9-6369-01,TCGA-G9-6369,PRAD,55.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-20238.0,Alive,TUMOR FREE,1215.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1215.0,0.0,1215.0,0.0,1215.0,0.0,1215.0,0
TCGA-G9-6370-01,TCGA-G9-6370,PRAD,52.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-19149.0,Alive,TUMOR FREE,1156.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1156.0,0.0,1156.0,0.0,1156.0,0.0,1156.0,0
TCGA-G9-6371-01,TCGA-G9-6371,PRAD,58.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-21365.0,Alive,TUMOR FREE,1226.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1226.0,0.0,1226.0,0.0,1226.0,0.0,1226.0,0
TCGA-G9-6373-01,TCGA-G9-6373,PRAD,68.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-24887.0,Alive,TUMOR FREE,811.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,811.0,0.0,811.0,0.0,811.0,0.0,811.0,0
TCGA-G9-6373-11,TCGA-G9-6373,PRAD,68.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-24887.0,Alive,TUMOR FREE,811.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,811.0,0.0,811.0,0.0,811.0,0.0,811.0,0
TCGA-G9-6377-01,TCGA-G9-6377,PRAD,61.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-22419.0,Alive,TUMOR FREE,958.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,958.0,0.0,958.0,0.0,958.0,0.0,958.0,0
TCGA-G9-6378-01,TCGA-G9-6378,PRAD,54.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-19879.0,Alive,TUMOR FREE,1155.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1155.0,0.0,1155.0,0.0,1155.0,0.0,1155.0,0
TCGA-G9-6379-01,TCGA-G9-6379,PRAD,68.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-25126.0,Alive,TUMOR FREE,1778.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1778.0,0.0,1778.0,0.0,1778.0,0.0,1778.0,0
TCGA-G9-6384-01,TCGA-G9-6384,PRAD,53.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-19620.0,Alive,TUMOR FREE,765.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,765.0,0.0,765.0,0.0,765.0,0.0,765.0,0
TCGA-G9-6384-11,TCGA-G9-6384,PRAD,53.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-19620.0,Alive,TUMOR FREE,765.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,765.0,0.0,765.0,0.0,765.0,0.0,765.0,0
TCGA-G9-6385-01,TCGA-G9-6385,PRAD,66.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-24399.0,Alive,TUMOR FREE,830.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,830.0,0.0,830.0,0.0,830.0,0.0,830.0,0
TCGA-G9-6385-11,TCGA-G9-6385,PRAD,66.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-24399.0,Alive,TUMOR FREE,830.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,830.0,0.0,830.0,0.0,830.0,0.0,830.0,0
TCGA-G9-6494-01,TCGA-G9-6494,PRAD,66.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-24381.0,Alive,WITH TUMOR,1771.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,1771.0,0.0,1771.0,nan,nan,0.0,1771.0,0
TCGA-G9-6494-11,TCGA-G9-6494,PRAD,66.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-24381.0,Alive,WITH TUMOR,1771.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,1771.0,0.0,1771.0,nan,nan,0.0,1771.0,0
TCGA-G9-6496-01,TCGA-G9-6496,PRAD,61.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-22602.0,Alive,TUMOR FREE,1726.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1726.0,0.0,1726.0,0.0,1726.0,0.0,1726.0,0
TCGA-G9-6496-11,TCGA-G9-6496,PRAD,61.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-22602.0,Alive,TUMOR FREE,1726.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1726.0,0.0,1726.0,0.0,1726.0,0.0,1726.0,0
TCGA-G9-6498-01,TCGA-G9-6498,PRAD,53.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-19568.0,Alive,TUMOR FREE,1952.0,nan,nan,Biochemical evidence of disease,nan,nan,1342.0,Complete Remission/Response,nan,nan,0.0,1952.0,0.0,1952.0,1.0,1342.0,1.0,1342.0,0
TCGA-G9-6499-01,TCGA-G9-6499,PRAD,66.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-24388.0,Alive,TUMOR FREE,1543.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1543.0,0.0,1543.0,0.0,1543.0,0.0,1543.0,0
TCGA-G9-6499-11,TCGA-G9-6499,PRAD,66.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-24388.0,Alive,TUMOR FREE,1543.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1543.0,0.0,1543.0,0.0,1543.0,0.0,1543.0,0
TCGA-G9-7509-01,TCGA-G9-7509,PRAD,48.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-17538.0,Alive,TUMOR FREE,1610.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1610.0,0.0,1610.0,0.0,1610.0,0.0,1610.0,0
TCGA-G9-7510-01,TCGA-G9-7510,PRAD,66.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-24187.0,Alive,TUMOR FREE,1185.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1185.0,0.0,1185.0,0.0,1185.0,0.0,1185.0,0
TCGA-G9-7519-01,TCGA-G9-7519,PRAD,58.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-21276.0,Alive,TUMOR FREE,849.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,849.0,0.0,849.0,0.0,849.0,0.0,849.0,0
TCGA-G9-7521-01,TCGA-G9-7521,PRAD,52.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-19216.0,Alive,[Discrepancy],942.0,nan,nan,nan,nan,nan,nan,[Discrepancy],nan,nan,0.0,942.0,0.0,942.0,nan,nan,0.0,942.0,0
TCGA-G9-7522-01,TCGA-G9-7522,PRAD,49.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-18033.0,Alive,TUMOR FREE,1078.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1078.0,0.0,1078.0,0.0,1078.0,0.0,1078.0,0
TCGA-G9-7523-01,TCGA-G9-7523,PRAD,44.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-16269.0,Alive,TUMOR FREE,857.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,857.0,0.0,857.0,0.0,857.0,0.0,857.0,0
TCGA-G9-7525-01,TCGA-G9-7525,PRAD,64.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-23481.0,Alive,TUMOR FREE,994.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,994.0,0.0,994.0,0.0,994.0,0.0,994.0,0
TCGA-G9-A9S0-01,TCGA-G9-A9S0,PRAD,53.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-19530.0,Dead,WITH TUMOR,nan,791.0,Prostate Cancer,Distant Metastasis,Bone,nan,423.0,Progressive Disease,nan,nan,1.0,791.0,1.0,791.0,nan,nan,1.0,423.0,1
TCGA-G9-A9S4-01,TCGA-G9-A9S4,PRAD,62.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-22684.0,Alive,TUMOR FREE,906.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,906.0,0.0,906.0,0.0,906.0,0.0,906.0,0
TCGA-G9-A9S7-01,TCGA-G9-A9S7,PRAD,55.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-20213.0,Alive,WITH TUMOR,728.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,728.0,0.0,728.0,nan,nan,0.0,728.0,0
TCGA-H9-7775-01,TCGA-H9-7775,PRAD,68.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-24898.0,Alive,TUMOR FREE,185.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,185.0,0.0,185.0,0.0,185.0,0.0,185.0,0
TCGA-H9-A6BX-01,TCGA-H9-A6BX,PRAD,60.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-22039.0,Alive,TUMOR FREE,941.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,941.0,0.0,941.0,0.0,941.0,0.0,941.0,0
TCGA-H9-A6BY-01,TCGA-H9-A6BY,PRAD,63.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-23297.0,Alive,nan,112.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,112.0,0.0,112.0,nan,nan,0.0,112.0,0
TCGA-HC-7075-01,TCGA-HC-7075,PRAD,63.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,nan,Alive,TUMOR FREE,601.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,601.0,0.0,601.0,0.0,601.0,0.0,601.0,0
TCGA-HC-7077-01,TCGA-HC-7077,PRAD,64.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2006.0,nan,-23636.0,Alive,TUMOR FREE,2115.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2115.0,0.0,2115.0,0.0,2115.0,0.0,2115.0,0
TCGA-HC-7078-01,TCGA-HC-7078,PRAD,69.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-25402.0,Alive,TUMOR FREE,1985.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1985.0,0.0,1985.0,0.0,1985.0,0.0,1985.0,0
TCGA-HC-7079-01,TCGA-HC-7079,PRAD,51.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-18734.0,Alive,WITH TUMOR,1184.0,nan,nan,Biochemical evidence of disease,nan,nan,380.0,Partial Remission/Response,nan,nan,0.0,1184.0,0.0,1184.0,nan,nan,1.0,380.0,0
TCGA-HC-7080-01,TCGA-HC-7080,PRAD,66.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-24243.0,Alive,TUMOR FREE,1106.0,nan,nan,New Primary Tumor,nan,nan,894.0,Complete Remission/Response,nan,nan,0.0,1106.0,0.0,1106.0,0.0,1106.0,1.0,894.0,0
TCGA-HC-7081-01,TCGA-HC-7081,PRAD,62.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,nan,Alive,WITH TUMOR,1136.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,1136.0,0.0,1136.0,nan,nan,0.0,1136.0,0
TCGA-HC-7209-01,TCGA-HC-7209,PRAD,60.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-22129.0,Alive,TUMOR FREE,440.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,440.0,0.0,440.0,0.0,440.0,0.0,440.0,0
TCGA-HC-7210-01,TCGA-HC-7210,PRAD,74.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-27343.0,Alive,TUMOR FREE,868.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,868.0,0.0,868.0,0.0,868.0,0.0,868.0,0
TCGA-HC-7211-01,TCGA-HC-7211,PRAD,62.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-22768.0,Alive,TUMOR FREE,1221.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1221.0,0.0,1221.0,0.0,1221.0,0.0,1221.0,0
TCGA-HC-7211-11,TCGA-HC-7211,PRAD,62.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-22768.0,Alive,TUMOR FREE,1221.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1221.0,0.0,1221.0,0.0,1221.0,0.0,1221.0,0
TCGA-HC-7212-01,TCGA-HC-7212,PRAD,56.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-20576.0,Alive,TUMOR FREE,870.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,870.0,0.0,870.0,0.0,870.0,0.0,870.0,0
TCGA-HC-7213-01,TCGA-HC-7213,PRAD,53.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-19699.0,Alive,TUMOR FREE,1219.0,nan,nan,Biochemical evidence of disease,nan,nan,170.0,Partial Remission/Response,nan,nan,0.0,1219.0,0.0,1219.0,nan,nan,1.0,170.0,0
TCGA-HC-7230-01,TCGA-HC-7230,PRAD,50.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-18577.0,Alive,TUMOR FREE,1001.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1001.0,0.0,1001.0,0.0,1001.0,0.0,1001.0,0
TCGA-HC-7231-01,TCGA-HC-7231,PRAD,66.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-24278.0,Alive,TUMOR FREE,939.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,939.0,0.0,939.0,0.0,939.0,0.0,939.0,0
TCGA-HC-7232-01,TCGA-HC-7232,PRAD,66.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-24324.0,Alive,WITH TUMOR,1161.0,nan,nan,Biochemical evidence of disease,nan,nan,766.0,Complete Remission/Response,nan,nan,0.0,1161.0,0.0,1161.0,1.0,766.0,1.0,766.0,2
TCGA-HC-7233-01,TCGA-HC-7233,PRAD,73.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,nan,Alive,TUMOR FREE,1355.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1355.0,0.0,1355.0,0.0,1355.0,0.0,1355.0,0
TCGA-HC-7736-01,TCGA-HC-7736,PRAD,59.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-21703.0,Alive,TUMOR FREE,1103.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1103.0,0.0,1103.0,0.0,1103.0,0.0,1103.0,0
TCGA-HC-7737-01,TCGA-HC-7737,PRAD,55.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-20122.0,Alive,TUMOR FREE,1090.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1090.0,0.0,1090.0,0.0,1090.0,0.0,1090.0,0
TCGA-HC-7737-11,TCGA-HC-7737,PRAD,55.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-20122.0,Alive,TUMOR FREE,1090.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1090.0,0.0,1090.0,0.0,1090.0,0.0,1090.0,0
TCGA-HC-7738-01,TCGA-HC-7738,PRAD,58.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-21195.0,Alive,WITH TUMOR,964.0,nan,nan,Biochemical evidence of disease,"Other, specify",biochemical recurrence only,420.0,Partial Remission/Response,nan,nan,0.0,964.0,0.0,964.0,nan,nan,1.0,420.0,0
TCGA-HC-7738-11,TCGA-HC-7738,PRAD,58.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-21195.0,Alive,WITH TUMOR,964.0,nan,nan,Biochemical evidence of disease,"Other, specify",biochemical recurrence only,420.0,Partial Remission/Response,nan,nan,0.0,964.0,0.0,964.0,nan,nan,1.0,420.0,0
TCGA-HC-7740-01,TCGA-HC-7740,PRAD,59.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-21883.0,Alive,TUMOR FREE,717.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,717.0,0.0,717.0,0.0,717.0,0.0,717.0,0
TCGA-HC-7740-11,TCGA-HC-7740,PRAD,59.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-21883.0,Alive,TUMOR FREE,717.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,717.0,0.0,717.0,0.0,717.0,0.0,717.0,0
TCGA-HC-7742-01,TCGA-HC-7742,PRAD,58.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-21323.0,Alive,WITH TUMOR,938.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,938.0,0.0,938.0,nan,nan,0.0,938.0,0
TCGA-HC-7742-11,TCGA-HC-7742,PRAD,58.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-21323.0,Alive,WITH TUMOR,938.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,938.0,0.0,938.0,nan,nan,0.0,938.0,0
TCGA-HC-7744-01,TCGA-HC-7744,PRAD,46.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-17065.0,Alive,TUMOR FREE,531.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,531.0,0.0,531.0,0.0,531.0,0.0,531.0,0
TCGA-HC-7745-01,TCGA-HC-7745,PRAD,65.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-24078.0,Alive,TUMOR FREE,721.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,721.0,0.0,721.0,0.0,721.0,0.0,721.0,0
TCGA-HC-7745-11,TCGA-HC-7745,PRAD,65.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-24078.0,Alive,TUMOR FREE,721.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,721.0,0.0,721.0,0.0,721.0,0.0,721.0,0
TCGA-HC-7747-01,TCGA-HC-7747,PRAD,52.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-19188.0,Alive,TUMOR FREE,748.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,748.0,0.0,748.0,0.0,748.0,0.0,748.0,0
TCGA-HC-7747-11,TCGA-HC-7747,PRAD,52.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-19188.0,Alive,TUMOR FREE,748.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,748.0,0.0,748.0,0.0,748.0,0.0,748.0,0
TCGA-HC-7748-01,TCGA-HC-7748,PRAD,60.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-22072.0,Alive,TUMOR FREE,792.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,792.0,0.0,792.0,0.0,792.0,0.0,792.0,0
TCGA-HC-7749-01,TCGA-HC-7749,PRAD,70.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-25688.0,Alive,TUMOR FREE,724.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,724.0,0.0,724.0,0.0,724.0,0.0,724.0,0
TCGA-HC-7750-01,TCGA-HC-7750,PRAD,50.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-18580.0,Alive,TUMOR FREE,522.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,522.0,0.0,522.0,0.0,522.0,0.0,522.0,0
TCGA-HC-7752-01,TCGA-HC-7752,PRAD,61.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-22366.0,Alive,TUMOR FREE,782.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,782.0,0.0,782.0,0.0,782.0,0.0,782.0,0
TCGA-HC-7752-11,TCGA-HC-7752,PRAD,61.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-22366.0,Alive,TUMOR FREE,782.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,782.0,0.0,782.0,0.0,782.0,0.0,782.0,0
TCGA-HC-7817-01,TCGA-HC-7817,PRAD,52.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-19207.0,Alive,TUMOR FREE,928.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,928.0,0.0,928.0,0.0,928.0,0.0,928.0,0
TCGA-HC-7818-01,TCGA-HC-7818,PRAD,66.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-24391.0,Alive,TUMOR FREE,938.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,938.0,0.0,938.0,0.0,938.0,0.0,938.0,0
TCGA-HC-7819-01,TCGA-HC-7819,PRAD,53.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-19663.0,Alive,TUMOR FREE,543.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,543.0,0.0,543.0,0.0,543.0,0.0,543.0,0
TCGA-HC-7819-11,TCGA-HC-7819,PRAD,53.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-19663.0,Alive,TUMOR FREE,543.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,543.0,0.0,543.0,0.0,543.0,0.0,543.0,0
TCGA-HC-7820-01,TCGA-HC-7820,PRAD,72.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-26576.0,Alive,TUMOR FREE,747.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,747.0,0.0,747.0,0.0,747.0,0.0,747.0,0
TCGA-HC-7820-11,TCGA-HC-7820,PRAD,72.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-26576.0,Alive,TUMOR FREE,747.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,747.0,0.0,747.0,0.0,747.0,0.0,747.0,0
TCGA-HC-7821-01,TCGA-HC-7821,PRAD,54.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-19894.0,Alive,WITH TUMOR,956.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,956.0,0.0,956.0,0.0,956.0,0.0,956.0,0
TCGA-HC-8213-01,TCGA-HC-8213,PRAD,48.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-17673.0,Alive,TUMOR FREE,589.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,589.0,0.0,589.0,0.0,589.0,0.0,589.0,0
TCGA-HC-8216-01,TCGA-HC-8216,PRAD,58.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-21428.0,Alive,TUMOR FREE,682.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,682.0,0.0,682.0,0.0,682.0,0.0,682.0,0
TCGA-HC-8256-01,TCGA-HC-8256,PRAD,53.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-19598.0,Alive,TUMOR FREE,860.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,860.0,0.0,860.0,0.0,860.0,0.0,860.0,0
TCGA-HC-8257-01,TCGA-HC-8257,PRAD,70.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-25629.0,Alive,TUMOR FREE,726.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,726.0,0.0,726.0,0.0,726.0,0.0,726.0,0
TCGA-HC-8258-01,TCGA-HC-8258,PRAD,56.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-20703.0,Alive,TUMOR FREE,847.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,847.0,0.0,847.0,0.0,847.0,0.0,847.0,0
TCGA-HC-8258-11,TCGA-HC-8258,PRAD,56.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-20703.0,Alive,TUMOR FREE,847.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,847.0,0.0,847.0,0.0,847.0,0.0,847.0,0
TCGA-HC-8259-01,TCGA-HC-8259,PRAD,50.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-18309.0,Alive,TUMOR FREE,924.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,924.0,0.0,924.0,0.0,924.0,0.0,924.0,0
TCGA-HC-8259-11,TCGA-HC-8259,PRAD,50.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-18309.0,Alive,TUMOR FREE,924.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,924.0,0.0,924.0,0.0,924.0,0.0,924.0,0
TCGA-HC-8260-01,TCGA-HC-8260,PRAD,43.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-15884.0,Alive,TUMOR FREE,686.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,686.0,0.0,686.0,0.0,686.0,0.0,686.0,0
TCGA-HC-8260-11,TCGA-HC-8260,PRAD,43.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-15884.0,Alive,TUMOR FREE,686.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,686.0,0.0,686.0,0.0,686.0,0.0,686.0,0
TCGA-HC-8261-01,TCGA-HC-8261,PRAD,48.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-17874.0,Alive,TUMOR FREE,546.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,546.0,0.0,546.0,0.0,546.0,0.0,546.0,0
TCGA-HC-8262-01,TCGA-HC-8262,PRAD,57.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-20946.0,Alive,TUMOR FREE,679.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,679.0,0.0,679.0,0.0,679.0,0.0,679.0,0
TCGA-HC-8262-11,TCGA-HC-8262,PRAD,57.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-20946.0,Alive,TUMOR FREE,679.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,679.0,0.0,679.0,0.0,679.0,0.0,679.0,0
TCGA-HC-8264-01,TCGA-HC-8264,PRAD,60.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-22177.0,Alive,WITH TUMOR,48.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,48.0,0.0,48.0,nan,nan,0.0,48.0,0
TCGA-HC-8265-01,TCGA-HC-8265,PRAD,66.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-24382.0,Alive,TUMOR FREE,483.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,483.0,0.0,483.0,0.0,483.0,0.0,483.0,0
TCGA-HC-8266-01,TCGA-HC-8266,PRAD,55.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-20280.0,Alive,WITH TUMOR,473.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,473.0,0.0,473.0,nan,nan,0.0,473.0,0
TCGA-HC-A48F-01,TCGA-HC-A48F,PRAD,47.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-17434.0,Alive,TUMOR FREE,680.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,680.0,0.0,680.0,0.0,680.0,0.0,680.0,0
TCGA-HC-A4ZV-01,TCGA-HC-A4ZV,PRAD,56.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-20634.0,Alive,WITH TUMOR,23.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,23.0,0.0,23.0,nan,nan,0.0,23.0,0
TCGA-HC-A631-01,TCGA-HC-A631,PRAD,67.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-24749.0,Alive,WITH TUMOR,54.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,54.0,0.0,54.0,nan,nan,0.0,54.0,0
TCGA-HC-A632-01,TCGA-HC-A632,PRAD,68.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-24916.0,Alive,TUMOR FREE,61.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,61.0,0.0,61.0,nan,nan,0.0,61.0,0
TCGA-HC-A6AL-01,TCGA-HC-A6AL,PRAD,64.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-23618.0,Alive,TUMOR FREE,67.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,67.0,0.0,67.0,nan,nan,0.0,67.0,0
TCGA-HC-A6AN-01,TCGA-HC-A6AN,PRAD,67.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-24697.0,Alive,WITH TUMOR,49.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,49.0,0.0,49.0,nan,nan,0.0,49.0,0
TCGA-HC-A6AO-01,TCGA-HC-A6AO,PRAD,52.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-19298.0,Alive,TUMOR FREE,530.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,530.0,0.0,530.0,0.0,530.0,0.0,530.0,0
TCGA-HC-A6AP-01,TCGA-HC-A6AP,PRAD,61.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-22318.0,Alive,nan,71.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,71.0,0.0,71.0,nan,nan,0.0,71.0,0
TCGA-HC-A6AQ-01,TCGA-HC-A6AQ,PRAD,60.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-22208.0,Alive,TUMOR FREE,106.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,106.0,0.0,106.0,nan,nan,0.0,106.0,0
TCGA-HC-A6AS-01,TCGA-HC-A6AS,PRAD,70.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-25661.0,Alive,TUMOR FREE,44.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,44.0,0.0,44.0,nan,nan,0.0,44.0,0
TCGA-HC-A6HX-01,TCGA-HC-A6HX,PRAD,55.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-20263.0,Alive,TUMOR FREE,38.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,38.0,0.0,38.0,nan,nan,0.0,38.0,0
TCGA-HC-A6HY-01,TCGA-HC-A6HY,PRAD,51.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-18779.0,Alive,TUMOR FREE,134.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,134.0,0.0,134.0,nan,nan,0.0,134.0,0
TCGA-HC-A76W-01,TCGA-HC-A76W,PRAD,73.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-26755.0,Alive,WITH TUMOR,213.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,213.0,0.0,213.0,nan,nan,0.0,213.0,0
TCGA-HC-A76X-01,TCGA-HC-A76X,PRAD,62.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-22756.0,Alive,TUMOR FREE,150.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,150.0,0.0,150.0,nan,nan,0.0,150.0,0
TCGA-HC-A8CY-01,TCGA-HC-A8CY,PRAD,63.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-23154.0,Alive,WITH TUMOR,290.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,290.0,0.0,290.0,nan,nan,0.0,290.0,0
TCGA-HC-A8D0-01,TCGA-HC-A8D0,PRAD,61.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-22465.0,Alive,TUMOR FREE,775.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,775.0,0.0,775.0,0.0,775.0,0.0,775.0,0
TCGA-HC-A8D1-01,TCGA-HC-A8D1,PRAD,68.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-25137.0,Alive,TUMOR FREE,573.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,573.0,0.0,573.0,0.0,573.0,0.0,573.0,0
TCGA-HC-A9TE-01,TCGA-HC-A9TE,PRAD,64.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-23543.0,Alive,WITH TUMOR,587.0,nan,nan,Biochemical evidence of disease,"Other, specify",Biochemical,216.0,Partial Remission/Response,nan,nan,0.0,587.0,0.0,587.0,nan,nan,1.0,216.0,0
TCGA-HC-A9TH-01,TCGA-HC-A9TH,PRAD,58.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-21460.0,Alive,WITH TUMOR,844.0,nan,nan,Biochemical evidence of disease,"Other, specify",Biochemical,351.0,Partial Remission/Response,nan,nan,0.0,844.0,0.0,844.0,nan,nan,1.0,351.0,0
TCGA-HI-7168-01,TCGA-HI-7168,PRAD,62.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2005.0,nan,-22881.0,Alive,WITH TUMOR,3323.0,nan,nan,Biochemical evidence of disease,Bone,nan,2505.0,Stable Disease,nan,nan,0.0,3323.0,0.0,3323.0,nan,nan,1.0,2505.0,0
TCGA-HI-7169-01,TCGA-HI-7169,PRAD,55.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2006.0,nan,-20133.0,Alive,TUMOR FREE,2684.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2684.0,0.0,2684.0,0.0,2684.0,0.0,2684.0,0
TCGA-HI-7170-01,TCGA-HI-7170,PRAD,58.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2006.0,nan,-21199.0,Alive,TUMOR FREE,2522.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2522.0,0.0,2522.0,0.0,2522.0,0.0,2522.0,0
TCGA-HI-7171-01,TCGA-HI-7171,PRAD,56.0,MALE,WHITE,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-20776.0,Dead,WITH TUMOR,nan,1329.0,[Unknown],nan,nan,nan,nan,Stable Disease,nan,nan,1.0,1329.0,1.0,1329.0,nan,nan,1.0,1329.0,1
TCGA-J4-8198-01,TCGA-J4-8198,PRAD,49.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-17935.0,Alive,TUMOR FREE,614.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,614.0,0.0,614.0,0.0,614.0,0.0,614.0,0
TCGA-J4-8200-01,TCGA-J4-8200,PRAD,47.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-17167.0,Alive,TUMOR FREE,1218.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1218.0,0.0,1218.0,0.0,1218.0,0.0,1218.0,0
TCGA-J4-A67K-01,TCGA-J4-A67K,PRAD,68.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-24908.0,Alive,TUMOR FREE,1004.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1004.0,0.0,1004.0,0.0,1004.0,0.0,1004.0,0
TCGA-J4-A67L-01,TCGA-J4-A67L,PRAD,54.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-20034.0,Alive,TUMOR FREE,770.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,770.0,0.0,770.0,0.0,770.0,0.0,770.0,0
TCGA-J4-A67M-01,TCGA-J4-A67M,PRAD,55.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-20211.0,Alive,TUMOR FREE,941.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,941.0,0.0,941.0,0.0,941.0,0.0,941.0,0
TCGA-J4-A67N-01,TCGA-J4-A67N,PRAD,61.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-22420.0,Alive,WITH TUMOR,937.0,nan,nan,Biochemical evidence of disease,nan,nan,442.0,Partial Remission/Response,nan,nan,0.0,937.0,0.0,937.0,nan,nan,1.0,442.0,0
TCGA-J4-A67O-01,TCGA-J4-A67O,PRAD,59.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-21714.0,Alive,TUMOR FREE,839.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,839.0,0.0,839.0,0.0,839.0,0.0,839.0,0
TCGA-J4-A67Q-01,TCGA-J4-A67Q,PRAD,77.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-28447.0,Alive,TUMOR FREE,975.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,975.0,0.0,975.0,0.0,975.0,0.0,975.0,0
TCGA-J4-A67R-01,TCGA-J4-A67R,PRAD,65.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-23807.0,Alive,TUMOR FREE,910.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,910.0,0.0,910.0,0.0,910.0,0.0,910.0,0
TCGA-J4-A67S-01,TCGA-J4-A67S,PRAD,63.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-23332.0,Alive,WITH TUMOR,833.0,nan,nan,Biochemical evidence of disease,nan,nan,708.0,Complete Remission/Response,nan,nan,0.0,833.0,0.0,833.0,1.0,708.0,1.0,708.0,2
TCGA-J4-A67T-01,TCGA-J4-A67T,PRAD,63.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-23211.0,Alive,TUMOR FREE,183.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,183.0,0.0,183.0,0.0,183.0,0.0,183.0,0
TCGA-J4-A6G1-01,TCGA-J4-A6G1,PRAD,68.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-24945.0,Alive,TUMOR FREE,769.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,769.0,0.0,769.0,0.0,769.0,0.0,769.0,0
TCGA-J4-A6G3-01,TCGA-J4-A6G3,PRAD,57.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-20836.0,Alive,WITH TUMOR,849.0,nan,nan,Biochemical evidence of disease,nan,nan,618.0,Partial Remission/Response,nan,nan,0.0,849.0,0.0,849.0,nan,nan,1.0,618.0,0
TCGA-J4-A6M7-01,TCGA-J4-A6M7,PRAD,53.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-19640.0,Alive,TUMOR FREE,512.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,512.0,0.0,512.0,0.0,512.0,0.0,512.0,0
TCGA-J4-A83I-01,TCGA-J4-A83I,PRAD,63.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-23240.0,Alive,TUMOR FREE,685.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,685.0,0.0,685.0,0.0,685.0,0.0,685.0,0
TCGA-J4-A83J-01,TCGA-J4-A83J,PRAD,68.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-24960.0,Alive,TUMOR FREE,696.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,696.0,0.0,696.0,0.0,696.0,0.0,696.0,0
TCGA-J4-A83J-11,TCGA-J4-A83J,PRAD,68.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-24960.0,Alive,TUMOR FREE,696.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,696.0,0.0,696.0,0.0,696.0,0.0,696.0,0
TCGA-J4-A83K-01,TCGA-J4-A83K,PRAD,52.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-19299.0,Alive,TUMOR FREE,328.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,328.0,0.0,328.0,0.0,328.0,0.0,328.0,0
TCGA-J4-A83L-01,TCGA-J4-A83L,PRAD,61.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-22338.0,Alive,TUMOR FREE,720.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,720.0,0.0,720.0,0.0,720.0,0.0,720.0,0
TCGA-J4-A83M-01,TCGA-J4-A83M,PRAD,64.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-23624.0,Alive,nan,543.0,nan,nan,Biochemical evidence of disease,nan,nan,521.0,Complete Remission/Response,nan,nan,0.0,543.0,0.0,543.0,1.0,521.0,1.0,521.0,2
TCGA-J4-A83N-01,TCGA-J4-A83N,PRAD,57.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-20841.0,Alive,TUMOR FREE,992.0,nan,nan,New Primary Tumor,nan,nan,433.0,Complete Remission/Response,nan,nan,0.0,992.0,0.0,992.0,0.0,992.0,1.0,433.0,0
TCGA-J4-AATV-01,TCGA-J4-AATV,PRAD,71.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-25943.0,Alive,WITH TUMOR,553.0,nan,nan,nan,nan,nan,nan,[Discrepancy],nan,nan,0.0,553.0,0.0,553.0,nan,nan,0.0,553.0,0
TCGA-J4-AATZ-01,TCGA-J4-AATZ,PRAD,66.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-24226.0,Alive,WITH TUMOR,412.0,nan,nan,Biochemical evidence of disease,nan,nan,79.0,Complete Remission/Response,nan,nan,0.0,412.0,0.0,412.0,1.0,79.0,1.0,79.0,2
TCGA-J4-AAU2-01,TCGA-J4-AAU2,PRAD,59.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-21656.0,Alive,TUMOR FREE,825.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,825.0,0.0,825.0,0.0,825.0,0.0,825.0,0
TCGA-J9-A52B-01,TCGA-J9-A52B,PRAD,62.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-22849.0,Alive,nan,422.0,nan,nan,Biochemical evidence of disease,nan,nan,57.0,Complete Remission/Response,nan,nan,0.0,422.0,0.0,422.0,1.0,57.0,1.0,57.0,2
TCGA-J9-A52C-01,TCGA-J9-A52C,PRAD,57.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-20966.0,Alive,nan,178.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,178.0,0.0,178.0,nan,nan,0.0,178.0,0
TCGA-J9-A52D-01,TCGA-J9-A52D,PRAD,71.0,MALE,nan,nan,nan,"Prostate Adenocarcinoma, Other Subtype",nan,2012.0,nan,-26023.0,Alive,TUMOR FREE,212.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,212.0,0.0,212.0,nan,nan,0.0,212.0,0
TCGA-J9-A52E-01,TCGA-J9-A52E,PRAD,65.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-23741.0,Alive,TUMOR FREE,323.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,323.0,0.0,323.0,nan,nan,0.0,323.0,0
TCGA-J9-A8CK-01,TCGA-J9-A8CK,PRAD,66.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-24285.0,Alive,TUMOR FREE,321.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,321.0,0.0,321.0,nan,nan,0.0,321.0,0
TCGA-J9-A8CL-01,TCGA-J9-A8CL,PRAD,66.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-24145.0,Alive,WITH TUMOR,405.0,nan,nan,Biochemical evidence of disease,nan,nan,132.0,[Unknown],nan,nan,0.0,405.0,0.0,405.0,nan,nan,1.0,132.0,0
TCGA-J9-A8CM-01,TCGA-J9-A8CM,PRAD,66.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-24118.0,Alive,WITH TUMOR,463.0,nan,nan,Biochemical evidence of disease,nan,nan,344.0,Partial Remission/Response,nan,nan,0.0,463.0,0.0,463.0,nan,nan,1.0,344.0,0
TCGA-J9-A8CN-01,TCGA-J9-A8CN,PRAD,53.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-19662.0,Alive,TUMOR FREE,1237.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1237.0,0.0,1237.0,0.0,1237.0,0.0,1237.0,0
TCGA-J9-A8CP-01,TCGA-J9-A8CP,PRAD,66.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-24299.0,Alive,TUMOR FREE,386.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,386.0,0.0,386.0,0.0,386.0,0.0,386.0,0
TCGA-KC-A4BL-01,TCGA-KC-A4BL,PRAD,65.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2006.0,nan,-24081.0,Alive,WITH TUMOR,934.0,nan,nan,Biochemical evidence of disease,nan,nan,193.0,Partial Remission/Response,nan,nan,0.0,934.0,0.0,934.0,nan,nan,1.0,193.0,2
TCGA-KC-A4BN-01,TCGA-KC-A4BN,PRAD,55.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-20392.0,Alive,TUMOR FREE,1815.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1815.0,0.0,1815.0,0.0,1815.0,0.0,1815.0,0
TCGA-KC-A4BO-01,TCGA-KC-A4BO,PRAD,55.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-20368.0,Alive,TUMOR FREE,607.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,607.0,0.0,607.0,0.0,607.0,0.0,607.0,0
TCGA-KC-A4BR-01,TCGA-KC-A4BR,PRAD,75.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-27741.0,Alive,WITH TUMOR,1349.0,nan,nan,Biochemical evidence of disease,nan,nan,1022.0,Complete Remission/Response,nan,nan,0.0,1349.0,0.0,1349.0,1.0,1022.0,1.0,1022.0,2
TCGA-KC-A4BV-01,TCGA-KC-A4BV,PRAD,66.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-24138.0,Alive,WITH TUMOR,1328.0,nan,nan,Biochemical evidence of disease,nan,nan,1328.0,Complete Remission/Response,nan,nan,0.0,1328.0,0.0,1328.0,1.0,1328.0,1.0,1328.0,2
TCGA-KC-A7F3-01,TCGA-KC-A7F3,PRAD,67.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-24676.0,Alive,TUMOR FREE,665.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,665.0,0.0,665.0,0.0,665.0,0.0,665.0,0
TCGA-KC-A7F5-01,TCGA-KC-A7F5,PRAD,54.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-20015.0,Alive,TUMOR FREE,91.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,91.0,0.0,91.0,0.0,91.0,0.0,91.0,0
TCGA-KC-A7F6-01,TCGA-KC-A7F6,PRAD,63.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-23367.0,Alive,TUMOR FREE,263.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,263.0,0.0,263.0,0.0,263.0,0.0,263.0,0
TCGA-KC-A7FA-01,TCGA-KC-A7FA,PRAD,63.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-23208.0,Alive,TUMOR FREE,598.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,598.0,0.0,598.0,0.0,598.0,0.0,598.0,0
TCGA-KC-A7FD-01,TCGA-KC-A7FD,PRAD,62.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-22745.0,Alive,TUMOR FREE,270.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,270.0,0.0,270.0,0.0,270.0,0.0,270.0,0
TCGA-KC-A7FE-01,TCGA-KC-A7FE,PRAD,62.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-22718.0,Alive,TUMOR FREE,352.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,352.0,0.0,352.0,0.0,352.0,0.0,352.0,0
TCGA-KK-A59V-01,TCGA-KK-A59V,PRAD,64.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2005.0,nan,-23483.0,Alive,TUMOR FREE,3440.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3440.0,0.0,3440.0,0.0,3440.0,0.0,3440.0,0
TCGA-KK-A59X-01,TCGA-KK-A59X,PRAD,55.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-20416.0,Alive,WITH TUMOR,2535.0,nan,nan,Locoregional Recurrence,"Other, specify",Bladder,2233.0,[Unknown],nan,nan,0.0,2535.0,0.0,2535.0,nan,nan,1.0,2233.0,0
TCGA-KK-A59Y-01,TCGA-KK-A59Y,PRAD,56.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-20768.0,Alive,TUMOR FREE,1968.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1968.0,0.0,1968.0,0.0,1968.0,0.0,1968.0,0
TCGA-KK-A59Z-01,TCGA-KK-A59Z,PRAD,66.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-24306.0,Alive,TUMOR FREE,2628.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2628.0,0.0,2628.0,nan,nan,0.0,2628.0,0
TCGA-KK-A5A1-01,TCGA-KK-A5A1,PRAD,72.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2003.0,nan,-26415.0,Dead,nan,nan,2469.0,nan,Locoregional Recurrence,nan,nan,203.0,Partial Remission/Response,nan,nan,1.0,2469.0,nan,2469.0,nan,nan,1.0,203.0,1
TCGA-KK-A6DY-01,TCGA-KK-A6DY,PRAD,50.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2002.0,nan,-18420.0,Alive,WITH TUMOR,4295.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4295.0,0.0,4295.0,nan,nan,0.0,4295.0,0
TCGA-KK-A6E0-01,TCGA-KK-A6E0,PRAD,59.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-21700.0,Alive,TUMOR FREE,1483.0,nan,nan,Biochemical evidence of disease,nan,nan,941.0,Complete Remission/Response,nan,nan,0.0,1483.0,0.0,1483.0,1.0,941.0,1.0,941.0,0
TCGA-KK-A6E1-01,TCGA-KK-A6E1,PRAD,57.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-21063.0,Alive,TUMOR FREE,2198.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2198.0,0.0,2198.0,0.0,2198.0,0.0,2198.0,0
TCGA-KK-A6E2-01,TCGA-KK-A6E2,PRAD,54.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2000.0,nan,-19974.0,Alive,TUMOR FREE,5024.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,5024.0,0.0,5024.0,0.0,5024.0,0.0,5024.0,0
TCGA-KK-A6E3-01,TCGA-KK-A6E3,PRAD,56.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2004.0,nan,-20547.0,Alive,TUMOR FREE,2056.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2056.0,0.0,2056.0,nan,nan,0.0,2056.0,0
TCGA-KK-A6E4-01,TCGA-KK-A6E4,PRAD,69.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2004.0,nan,-25338.0,Dead,TUMOR FREE,nan,3502.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,3502.0,0.0,3502.0,0.0,3502.0,0.0,3502.0,0
TCGA-KK-A6E5-01,TCGA-KK-A6E5,PRAD,63.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-23144.0,Alive,TUMOR FREE,2073.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2073.0,0.0,2073.0,0.0,2073.0,0.0,2073.0,0
TCGA-KK-A6E6-01,TCGA-KK-A6E6,PRAD,69.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2002.0,nan,-25320.0,Alive,TUMOR FREE,3447.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3447.0,0.0,3447.0,nan,nan,0.0,3447.0,0
TCGA-KK-A6E7-01,TCGA-KK-A6E7,PRAD,46.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-17074.0,Alive,WITH TUMOR,2760.0,nan,nan,Biochemical evidence of disease,nan,nan,925.0,Partial Remission/Response,nan,nan,0.0,2760.0,0.0,2760.0,nan,nan,1.0,925.0,0
TCGA-KK-A6E8-01,TCGA-KK-A6E8,PRAD,68.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-25026.0,Alive,TUMOR FREE,1770.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1770.0,0.0,1770.0,nan,nan,0.0,1770.0,0
TCGA-KK-A7AP-01,TCGA-KK-A7AP,PRAD,55.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-20403.0,Alive,nan,196.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,196.0,0.0,196.0,nan,nan,0.0,196.0,0
TCGA-KK-A7AQ-01,TCGA-KK-A7AQ,PRAD,62.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-22731.0,Alive,TUMOR FREE,1610.0,nan,nan,Biochemical evidence of disease,nan,nan,1217.0,Complete Remission/Response,nan,nan,0.0,1610.0,0.0,1610.0,1.0,1217.0,1.0,1217.0,0
TCGA-KK-A7AU-01,TCGA-KK-A7AU,PRAD,63.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-23118.0,Alive,TUMOR FREE,1775.0,nan,nan,Biochemical evidence of disease,nan,nan,207.0,Progressive Disease,nan,nan,0.0,1775.0,0.0,1775.0,nan,nan,1.0,207.0,0
TCGA-KK-A7AV-01,TCGA-KK-A7AV,PRAD,58.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-21192.0,Alive,TUMOR FREE,822.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,822.0,0.0,822.0,0.0,822.0,0.0,822.0,0
TCGA-KK-A7AW-01,TCGA-KK-A7AW,PRAD,57.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-20869.0,Alive,TUMOR FREE,1054.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1054.0,0.0,1054.0,nan,nan,0.0,1054.0,0
TCGA-KK-A7AY-01,TCGA-KK-A7AY,PRAD,60.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-22220.0,Alive,TUMOR FREE,1754.0,nan,nan,Biochemical evidence of disease,nan,nan,1124.0,Complete Remission/Response,nan,nan,0.0,1754.0,0.0,1754.0,1.0,1124.0,1.0,1124.0,0
TCGA-KK-A7AZ-01,TCGA-KK-A7AZ,PRAD,56.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-20507.0,Alive,nan,1519.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1519.0,0.0,1519.0,nan,nan,0.0,1519.0,0
TCGA-KK-A7B0-01,TCGA-KK-A7B0,PRAD,67.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-24756.0,Alive,TUMOR FREE,1329.0,nan,nan,Biochemical evidence of disease,nan,nan,606.0,Stable Disease,nan,nan,0.0,1329.0,0.0,1329.0,nan,nan,1.0,606.0,0
TCGA-KK-A7B1-01,TCGA-KK-A7B1,PRAD,65.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-23803.0,Alive,nan,1063.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1063.0,0.0,1063.0,0.0,1063.0,0.0,1063.0,0
TCGA-KK-A7B2-01,TCGA-KK-A7B2,PRAD,68.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-24845.0,Alive,WITH TUMOR,1099.0,nan,nan,Biochemical evidence of disease,nan,nan,692.0,Stable Disease,nan,nan,0.0,1099.0,0.0,1099.0,nan,nan,1.0,692.0,0
TCGA-KK-A7B3-01,TCGA-KK-A7B3,PRAD,62.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-22830.0,Alive,TUMOR FREE,899.0,nan,nan,Biochemical evidence of disease,nan,nan,294.0,Complete Remission/Response,nan,nan,0.0,899.0,0.0,899.0,1.0,294.0,1.0,294.0,2
TCGA-KK-A7B4-01,TCGA-KK-A7B4,PRAD,64.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-23644.0,Alive,WITH TUMOR,987.0,nan,nan,Biochemical evidence of disease,nan,nan,637.0,Stable Disease,nan,nan,0.0,987.0,0.0,987.0,nan,nan,1.0,637.0,0
TCGA-KK-A8I4-01,TCGA-KK-A8I4,PRAD,64.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-23706.0,Alive,WITH TUMOR,2259.0,nan,nan,Distant Metastasis,Bone,nan,1162.0,Progressive Disease,nan,nan,0.0,2259.0,0.0,2259.0,nan,nan,1.0,1162.0,0
TCGA-KK-A8I5-01,TCGA-KK-A8I5,PRAD,55.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2006.0,nan,-20337.0,Alive,TUMOR FREE,3096.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3096.0,0.0,3096.0,0.0,3096.0,0.0,3096.0,0
TCGA-KK-A8I6-01,TCGA-KK-A8I6,PRAD,58.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-21499.0,Alive,TUMOR FREE,668.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,668.0,0.0,668.0,0.0,668.0,0.0,668.0,0
TCGA-KK-A8I7-01,TCGA-KK-A8I7,PRAD,55.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-20256.0,Alive,TUMOR FREE,2002.0,nan,nan,Biochemical evidence of disease,nan,nan,1088.0,Progressive Disease,nan,nan,0.0,2002.0,0.0,2002.0,nan,nan,1.0,1088.0,0
TCGA-KK-A8I8-01,TCGA-KK-A8I8,PRAD,69.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-25546.0,Alive,TUMOR FREE,967.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,967.0,0.0,967.0,0.0,967.0,0.0,967.0,0
TCGA-KK-A8I9-01,TCGA-KK-A8I9,PRAD,61.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-22295.0,Alive,WITH TUMOR,1001.0,nan,nan,Biochemical evidence of disease,nan,nan,940.0,Complete Remission/Response,nan,nan,0.0,1001.0,0.0,1001.0,1.0,940.0,1.0,940.0,2
TCGA-KK-A8IA-01,TCGA-KK-A8IA,PRAD,69.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-25284.0,Alive,nan,1931.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1931.0,0.0,1931.0,nan,nan,0.0,1931.0,0
TCGA-KK-A8IB-01,TCGA-KK-A8IB,PRAD,65.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-24041.0,Alive,nan,83.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,83.0,0.0,83.0,nan,nan,0.0,83.0,0
TCGA-KK-A8IC-01,TCGA-KK-A8IC,PRAD,54.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-19902.0,Alive,WITH TUMOR,2051.0,nan,nan,Biochemical evidence of disease,nan,nan,1060.0,Progressive Disease,nan,nan,0.0,2051.0,0.0,2051.0,nan,nan,1.0,1060.0,0
TCGA-KK-A8ID-01,TCGA-KK-A8ID,PRAD,70.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-25851.0,Alive,TUMOR FREE,2107.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2107.0,0.0,2107.0,0.0,2107.0,0.0,2107.0,0
TCGA-KK-A8IF-01,TCGA-KK-A8IF,PRAD,57.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-20888.0,Alive,WITH TUMOR,804.0,nan,nan,Biochemical evidence of disease,nan,nan,648.0,[Unknown],nan,nan,0.0,804.0,0.0,804.0,nan,nan,1.0,648.0,0
TCGA-KK-A8IG-01,TCGA-KK-A8IG,PRAD,55.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-20266.0,Alive,TUMOR FREE,2505.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2505.0,0.0,2505.0,0.0,2505.0,0.0,2505.0,0
TCGA-KK-A8IH-01,TCGA-KK-A8IH,PRAD,50.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-18560.0,Alive,TUMOR FREE,2013.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2013.0,0.0,2013.0,0.0,2013.0,0.0,2013.0,0
TCGA-KK-A8II-01,TCGA-KK-A8II,PRAD,61.0,MALE,nan,nan,nan,"Prostate Adenocarcinoma, Other Subtype",nan,2004.0,nan,-22460.0,Dead,WITH TUMOR,nan,3467.0,[Unknown],Biochemical evidence of disease,nan,nan,626.0,Progressive Disease,nan,nan,1.0,3467.0,1.0,3467.0,nan,nan,1.0,626.0,1
TCGA-KK-A8IJ-01,TCGA-KK-A8IJ,PRAD,59.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-21793.0,Alive,nan,1559.0,nan,nan,New Primary Tumor,"Other, specify",Melanoma in situ of the right midback,307.0,[Unknown],nan,nan,0.0,1559.0,0.0,1559.0,nan,nan,1.0,307.0,0
TCGA-KK-A8IK-01,TCGA-KK-A8IK,PRAD,56.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-20594.0,Alive,TUMOR FREE,2052.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2052.0,0.0,2052.0,0.0,2052.0,0.0,2052.0,0
TCGA-KK-A8IL-01,TCGA-KK-A8IL,PRAD,65.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-23849.0,Dead,nan,nan,628.0,[Unknown],nan,nan,nan,nan,[Unknown],nan,nan,1.0,628.0,nan,628.0,nan,nan,0.0,628.0,1
TCGA-KK-A8IM-01,TCGA-KK-A8IM,PRAD,55.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-20425.0,Alive,TUMOR FREE,1915.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1915.0,0.0,1915.0,0.0,1915.0,0.0,1915.0,0
TCGA-M7-A71Y-01,TCGA-M7-A71Y,PRAD,55.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-20357.0,Alive,TUMOR FREE,493.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,493.0,0.0,493.0,0.0,493.0,0.0,493.0,0
TCGA-M7-A71Z-01,TCGA-M7-A71Z,PRAD,62.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-22785.0,Alive,TUMOR FREE,643.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,643.0,0.0,643.0,0.0,643.0,0.0,643.0,0
TCGA-M7-A720-01,TCGA-M7-A720,PRAD,53.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-19642.0,Alive,TUMOR FREE,384.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,384.0,0.0,384.0,0.0,384.0,0.0,384.0,0
TCGA-M7-A721-01,TCGA-M7-A721,PRAD,70.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-25585.0,Alive,TUMOR FREE,400.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,400.0,0.0,400.0,0.0,400.0,0.0,400.0,0
TCGA-M7-A722-01,TCGA-M7-A722,PRAD,65.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-23880.0,Alive,TUMOR FREE,1060.0,nan,nan,Biochemical evidence of disease,nan,nan,559.0,Partial Remission/Response,nan,nan,0.0,1060.0,0.0,1060.0,nan,nan,1.0,559.0,0
TCGA-M7-A723-01,TCGA-M7-A723,PRAD,54.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-20064.0,Alive,TUMOR FREE,763.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,763.0,0.0,763.0,0.0,763.0,0.0,763.0,0
TCGA-M7-A724-01,TCGA-M7-A724,PRAD,64.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-23595.0,Alive,WITH TUMOR,889.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,889.0,0.0,889.0,nan,nan,0.0,889.0,0
TCGA-M7-A725-01,TCGA-M7-A725,PRAD,56.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-20474.0,Alive,TUMOR FREE,573.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,573.0,0.0,573.0,0.0,573.0,0.0,573.0,0
TCGA-MG-AAMC-01,TCGA-MG-AAMC,PRAD,59.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-21846.0,Alive,TUMOR FREE,173.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,173.0,0.0,173.0,0.0,173.0,0.0,173.0,0
TCGA-QU-A6IL-01,TCGA-QU-A6IL,PRAD,64.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2002.0,nan,-23710.0,Alive,TUMOR FREE,97.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,97.0,0.0,97.0,0.0,97.0,0.0,97.0,0
TCGA-QU-A6IM-01,TCGA-QU-A6IM,PRAD,59.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2003.0,nan,-21792.0,Alive,TUMOR FREE,1247.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1247.0,0.0,1247.0,0.0,1247.0,0.0,1247.0,0
TCGA-QU-A6IN-01,TCGA-QU-A6IN,PRAD,61.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2003.0,nan,-22286.0,Alive,TUMOR FREE,4264.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4264.0,0.0,4264.0,0.0,4264.0,0.0,4264.0,0
TCGA-QU-A6IO-01,TCGA-QU-A6IO,PRAD,53.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2003.0,nan,-19564.0,Alive,TUMOR FREE,3716.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3716.0,0.0,3716.0,0.0,3716.0,0.0,3716.0,0
TCGA-QU-A6IP-01,TCGA-QU-A6IP,PRAD,66.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2004.0,nan,-24212.0,Alive,TUMOR FREE,2620.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2620.0,0.0,2620.0,0.0,2620.0,0.0,2620.0,0
TCGA-SU-A7E7-01,TCGA-SU-A7E7,PRAD,60.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-22185.0,Alive,TUMOR FREE,551.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,551.0,0.0,551.0,0.0,551.0,0.0,551.0,0
TCGA-TK-A8OK-01,TCGA-TK-A8OK,PRAD,73.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-26976.0,Alive,TUMOR FREE,27.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,27.0,0.0,27.0,nan,nan,0.0,27.0,0
TCGA-TP-A8TT-01,TCGA-TP-A8TT,PRAD,64.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-23476.0,Alive,nan,526.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,526.0,0.0,526.0,nan,nan,0.0,526.0,0
TCGA-TP-A8TV-01,TCGA-TP-A8TV,PRAD,62.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-22872.0,Alive,TUMOR FREE,610.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,610.0,0.0,610.0,0.0,610.0,0.0,610.0,0
TCGA-V1-A8MF-01,TCGA-V1-A8MF,PRAD,65.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-24090.0,Alive,nan,1449.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1449.0,0.0,1449.0,0.0,1449.0,0.0,1449.0,0
TCGA-V1-A8MG-01,TCGA-V1-A8MG,PRAD,53.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-19710.0,Alive,nan,857.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,857.0,0.0,857.0,0.0,857.0,0.0,857.0,0
TCGA-V1-A8MJ-01,TCGA-V1-A8MJ,PRAD,58.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-21535.0,Alive,nan,1791.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,1791.0,0.0,1791.0,nan,nan,0.0,1791.0,0
TCGA-V1-A8MK-01,TCGA-V1-A8MK,PRAD,41.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-15330.0,Alive,nan,508.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,508.0,0.0,508.0,0.0,508.0,0.0,508.0,0
TCGA-V1-A8ML-01,TCGA-V1-A8ML,PRAD,63.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-23360.0,Alive,nan,448.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,448.0,0.0,448.0,0.0,448.0,0.0,448.0,0
TCGA-V1-A8MM-01,TCGA-V1-A8MM,PRAD,60.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-22265.0,Alive,nan,1195.0,nan,nan,Biochemical evidence of disease,nan,nan,990.0,Complete Remission/Response,nan,nan,0.0,1195.0,0.0,1195.0,1.0,990.0,1.0,990.0,2
TCGA-V1-A8MU-01,TCGA-V1-A8MU,PRAD,56.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-20805.0,Alive,nan,1876.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,1876.0,0.0,1876.0,nan,nan,0.0,1876.0,0
TCGA-V1-A8WL-01,TCGA-V1-A8WL,PRAD,64.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-23725.0,Alive,nan,1948.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1948.0,0.0,1948.0,0.0,1948.0,0.0,1948.0,0
TCGA-V1-A8WN-01,TCGA-V1-A8WN,PRAD,47.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-17520.0,Alive,nan,924.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,924.0,0.0,924.0,0.0,924.0,0.0,924.0,0
TCGA-V1-A8WS-01,TCGA-V1-A8WS,PRAD,56.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-20805.0,Alive,nan,474.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,474.0,0.0,474.0,nan,nan,0.0,474.0,0
TCGA-V1-A8WV-01,TCGA-V1-A8WV,PRAD,52.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-19345.0,Alive,nan,686.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,686.0,0.0,686.0,0.0,686.0,0.0,686.0,0
TCGA-V1-A8WW-01,TCGA-V1-A8WW,PRAD,59.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-21900.0,Alive,nan,1078.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1078.0,0.0,1078.0,0.0,1078.0,0.0,1078.0,0
TCGA-V1-A8X3-01,TCGA-V1-A8X3,PRAD,51.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-18980.0,Alive,nan,202.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,202.0,0.0,202.0,0.0,202.0,0.0,202.0,0
TCGA-V1-A9O5-06,TCGA-V1-A9O5,PRAD,64.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-23725.0,Alive,nan,1932.0,nan,nan,Biochemical evidence of disease,nan,nan,124.0,Complete Remission/Response,nan,nan,0.0,1932.0,0.0,1932.0,1.0,124.0,1.0,124.0,2
TCGA-V1-A9O5-01,TCGA-V1-A9O5,PRAD,64.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-23725.0,Alive,nan,1932.0,nan,nan,Biochemical evidence of disease,nan,nan,124.0,Complete Remission/Response,nan,nan,0.0,1932.0,0.0,1932.0,1.0,124.0,1.0,124.0,2
TCGA-V1-A9O7-01,TCGA-V1-A9O7,PRAD,60.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-22265.0,Alive,nan,2499.0,nan,nan,Biochemical evidence of disease,nan,nan,819.0,Progressive Disease,nan,nan,0.0,2499.0,0.0,2499.0,nan,nan,1.0,819.0,0
TCGA-V1-A9O9-01,TCGA-V1-A9O9,PRAD,56.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-20805.0,Alive,nan,2870.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2870.0,0.0,2870.0,0.0,2870.0,0.0,2870.0,0
TCGA-V1-A9OA-01,TCGA-V1-A9OA,PRAD,61.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-22630.0,Alive,nan,636.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,636.0,0.0,636.0,0.0,636.0,0.0,636.0,0
TCGA-V1-A9OF-01,TCGA-V1-A9OF,PRAD,49.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-18250.0,Alive,nan,1184.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1184.0,0.0,1184.0,0.0,1184.0,0.0,1184.0,0
TCGA-V1-A9OH-01,TCGA-V1-A9OH,PRAD,63.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-23360.0,Alive,nan,2403.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2403.0,0.0,2403.0,0.0,2403.0,0.0,2403.0,0
TCGA-V1-A9OL-01,TCGA-V1-A9OL,PRAD,65.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-24090.0,Alive,nan,1913.0,nan,nan,Biochemical evidence of disease,nan,nan,105.0,Complete Remission/Response,nan,nan,0.0,1913.0,0.0,1913.0,1.0,105.0,1.0,105.0,2
TCGA-V1-A9OQ-01,TCGA-V1-A9OQ,PRAD,67.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-24820.0,Alive,nan,371.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,371.0,0.0,371.0,0.0,371.0,0.0,371.0,0
TCGA-V1-A9OT-01,TCGA-V1-A9OT,PRAD,61.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-22630.0,Alive,nan,476.0,nan,nan,Biochemical evidence of disease,nan,nan,292.0,Progressive Disease,nan,nan,0.0,476.0,0.0,476.0,nan,nan,1.0,292.0,0
TCGA-V1-A9OX-01,TCGA-V1-A9OX,PRAD,56.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-20805.0,Alive,nan,1134.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,1134.0,0.0,1134.0,nan,nan,0.0,1134.0,0
TCGA-V1-A9OY-01,TCGA-V1-A9OY,PRAD,57.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-21170.0,Alive,nan,1067.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1067.0,0.0,1067.0,0.0,1067.0,0.0,1067.0,0
TCGA-V1-A9Z7-01,TCGA-V1-A9Z7,PRAD,54.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-20075.0,Alive,nan,874.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,874.0,0.0,874.0,0.0,874.0,0.0,874.0,0
TCGA-V1-A9Z8-01,TCGA-V1-A9Z8,PRAD,59.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-21900.0,Alive,TUMOR FREE,827.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,827.0,0.0,827.0,0.0,827.0,0.0,827.0,0
TCGA-V1-A9Z9-01,TCGA-V1-A9Z9,PRAD,63.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-23360.0,Alive,TUMOR FREE,540.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,540.0,0.0,540.0,0.0,540.0,0.0,540.0,0
TCGA-V1-A9ZG-01,TCGA-V1-A9ZG,PRAD,64.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-23725.0,Alive,TUMOR FREE,1517.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1517.0,0.0,1517.0,0.0,1517.0,0.0,1517.0,0
TCGA-V1-A9ZI-01,TCGA-V1-A9ZI,PRAD,68.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-25185.0,Alive,nan,1640.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,1640.0,0.0,1640.0,nan,nan,0.0,1640.0,0
TCGA-V1-A9ZK-01,TCGA-V1-A9ZK,PRAD,68.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-25185.0,Alive,TUMOR FREE,1383.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1383.0,0.0,1383.0,0.0,1383.0,0.0,1383.0,0
TCGA-V1-A9ZR-01,TCGA-V1-A9ZR,PRAD,68.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,nan,nan,-25185.0,Alive,TUMOR FREE,1361.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1361.0,0.0,1361.0,0.0,1361.0,0.0,1361.0,0
TCGA-VN-A88I-01,TCGA-VN-A88I,PRAD,59.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-21576.0,Alive,WITH TUMOR,269.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,269.0,0.0,269.0,nan,nan,0.0,269.0,0
TCGA-VN-A88K-01,TCGA-VN-A88K,PRAD,58.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-21524.0,Alive,nan,776.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,776.0,0.0,776.0,0.0,776.0,0.0,776.0,0
TCGA-VN-A88L-01,TCGA-VN-A88L,PRAD,54.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-20026.0,Alive,TUMOR FREE,746.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,746.0,0.0,746.0,0.0,746.0,0.0,746.0,0
TCGA-VN-A88M-01,TCGA-VN-A88M,PRAD,55.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-20157.0,Alive,TUMOR FREE,189.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,189.0,0.0,189.0,0.0,189.0,0.0,189.0,0
TCGA-VN-A88N-01,TCGA-VN-A88N,PRAD,62.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-22695.0,Alive,TUMOR FREE,766.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,766.0,0.0,766.0,0.0,766.0,0.0,766.0,0
TCGA-VN-A88O-01,TCGA-VN-A88O,PRAD,49.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-17945.0,Alive,TUMOR FREE,481.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,481.0,0.0,481.0,0.0,481.0,0.0,481.0,0
TCGA-VN-A88P-01,TCGA-VN-A88P,PRAD,60.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-21916.0,Alive,TUMOR FREE,1260.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1260.0,0.0,1260.0,0.0,1260.0,0.0,1260.0,0
TCGA-VN-A88Q-01,TCGA-VN-A88Q,PRAD,60.0,MALE,nan,nan,nan,"Prostate Adenocarcinoma, Other Subtype",nan,2010.0,nan,-22087.0,Alive,TUMOR FREE,1366.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1366.0,0.0,1366.0,0.0,1366.0,0.0,1366.0,0
TCGA-VN-A88R-01,TCGA-VN-A88R,PRAD,53.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-19513.0,Alive,nan,784.0,nan,nan,Biochemical evidence of disease,nan,nan,512.0,Partial Remission/Response,nan,nan,0.0,784.0,0.0,784.0,nan,nan,1.0,512.0,0
TCGA-VN-A943-01,TCGA-VN-A943,PRAD,71.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-26162.0,Alive,TUMOR FREE,496.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,496.0,0.0,496.0,0.0,496.0,0.0,496.0,0
TCGA-VP-A872-01,TCGA-VP-A872,PRAD,60.0,MALE,nan,nan,nan,"Prostate Adenocarcinoma, Other Subtype",nan,2005.0,nan,-22098.0,Alive,TUMOR FREE,3631.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3631.0,0.0,3631.0,0.0,3631.0,0.0,3631.0,0
TCGA-VP-A875-01,TCGA-VP-A875,PRAD,67.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2005.0,nan,-24742.0,Alive,TUMOR FREE,2309.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2309.0,0.0,2309.0,0.0,2309.0,0.0,2309.0,0
TCGA-VP-A876-01,TCGA-VP-A876,PRAD,46.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2005.0,nan,-16934.0,Alive,TUMOR FREE,3333.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3333.0,0.0,3333.0,0.0,3333.0,0.0,3333.0,0
TCGA-VP-A878-01,TCGA-VP-A878,PRAD,58.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2006.0,nan,-21402.0,Alive,WITH TUMOR,3130.0,nan,nan,Biochemical evidence of disease,nan,nan,98.0,Partial Remission/Response,nan,nan,0.0,3130.0,0.0,3130.0,nan,nan,1.0,98.0,0
TCGA-VP-A879-01,TCGA-VP-A879,PRAD,70.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2006.0,nan,-25799.0,Dead,TUMOR FREE,nan,728.0,[Unknown],nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,728.0,0.0,728.0,0.0,728.0,0.0,728.0,0
TCGA-VP-A87B-01,TCGA-VP-A87B,PRAD,63.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-23271.0,Alive,WITH TUMOR,2722.0,nan,nan,New Primary Tumor,Lung,nan,2473.0,Complete Remission/Response,nan,nan,0.0,2722.0,0.0,2722.0,0.0,2722.0,1.0,2473.0,0
TCGA-VP-A87C-01,TCGA-VP-A87C,PRAD,67.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-24608.0,Alive,TUMOR FREE,1690.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1690.0,0.0,1690.0,0.0,1690.0,0.0,1690.0,0
TCGA-VP-A87D-01,TCGA-VP-A87D,PRAD,54.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,-19818.0,Alive,TUMOR FREE,1853.0,nan,nan,Biochemical evidence of disease,nan,nan,1194.0,Complete Remission/Response,nan,nan,0.0,1853.0,0.0,1853.0,1.0,1194.0,1.0,1194.0,0
TCGA-VP-A87E-01,TCGA-VP-A87E,PRAD,59.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-21811.0,Alive,TUMOR FREE,2037.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2037.0,0.0,2037.0,0.0,2037.0,0.0,2037.0,0
TCGA-VP-A87H-01,TCGA-VP-A87H,PRAD,76.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-28060.0,Alive,TUMOR FREE,663.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,663.0,0.0,663.0,0.0,663.0,0.0,663.0,0
TCGA-VP-A87J-01,TCGA-VP-A87J,PRAD,56.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-20792.0,Alive,TUMOR FREE,1774.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1774.0,0.0,1774.0,0.0,1774.0,0.0,1774.0,0
TCGA-VP-A87K-01,TCGA-VP-A87K,PRAD,63.0,MALE,nan,nan,nan,"Prostate Adenocarcinoma, Other Subtype",nan,2010.0,nan,-23030.0,Alive,TUMOR FREE,1306.0,nan,nan,Biochemical evidence of disease,nan,nan,533.0,Complete Remission/Response,nan,nan,0.0,1306.0,0.0,1306.0,1.0,533.0,1.0,533.0,0
TCGA-VP-AA1N-01,TCGA-VP-AA1N,PRAD,70.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-25781.0,Alive,TUMOR FREE,1365.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1365.0,0.0,1365.0,0.0,1365.0,0.0,1365.0,0
TCGA-WW-A8ZI-01,TCGA-WW-A8ZI,PRAD,70.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-25593.0,Alive,TUMOR FREE,449.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,449.0,0.0,449.0,0.0,449.0,0.0,449.0,0
TCGA-X4-A8KQ-01,TCGA-X4-A8KQ,PRAD,65.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-23999.0,Alive,WITH TUMOR,1383.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,1383.0,0.0,1383.0,nan,nan,0.0,1383.0,0
TCGA-X4-A8KS-01,TCGA-X4-A8KS,PRAD,61.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-22571.0,Alive,TUMOR FREE,979.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,979.0,0.0,979.0,nan,nan,0.0,979.0,0
TCGA-XA-A8JR-01,TCGA-XA-A8JR,PRAD,68.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-25090.0,Alive,TUMOR FREE,376.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,376.0,0.0,376.0,0.0,376.0,0.0,376.0,0
TCGA-XJ-A83F-01,TCGA-XJ-A83F,PRAD,67.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,nan,Alive,TUMOR FREE,1127.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1127.0,0.0,1127.0,0.0,1127.0,0.0,1127.0,0
TCGA-XJ-A83G-01,TCGA-XJ-A83G,PRAD,51.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,nan,Alive,TUMOR FREE,1461.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1461.0,0.0,1461.0,0.0,1461.0,0.0,1461.0,0
TCGA-XJ-A83H-01,TCGA-XJ-A83H,PRAD,57.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,nan,Alive,nan,1280.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,1280.0,0.0,1280.0,nan,nan,0.0,1280.0,0
TCGA-XJ-A9DI-01,TCGA-XJ-A9DI,PRAD,62.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,nan,Alive,TUMOR FREE,1461.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1461.0,0.0,1461.0,0.0,1461.0,0.0,1461.0,0
TCGA-XJ-A9DK-01,TCGA-XJ-A9DK,PRAD,63.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,nan,Alive,TUMOR FREE,275.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,275.0,0.0,275.0,0.0,275.0,0.0,275.0,0
TCGA-XJ-A9DQ-01,TCGA-XJ-A9DQ,PRAD,48.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2007.0,nan,nan,Alive,nan,91.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,91.0,0.0,91.0,nan,nan,0.0,91.0,0
TCGA-XJ-A9DX-01,TCGA-XJ-A9DX,PRAD,51.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,nan,Alive,TUMOR FREE,973.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,973.0,0.0,973.0,nan,nan,0.0,973.0,0
TCGA-XK-AAIR-01,TCGA-XK-AAIR,PRAD,75.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-27703.0,Alive,TUMOR FREE,972.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,972.0,0.0,972.0,0.0,972.0,0.0,972.0,0
TCGA-XK-AAIV-01,TCGA-XK-AAIV,PRAD,63.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-23325.0,Alive,TUMOR FREE,1133.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1133.0,0.0,1133.0,0.0,1133.0,0.0,1133.0,0
TCGA-XK-AAIW-01,TCGA-XK-AAIW,PRAD,78.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-28721.0,Alive,TUMOR FREE,1218.0,nan,nan,New Primary Tumor,nan,nan,427.0,Complete Remission/Response,nan,nan,0.0,1218.0,0.0,1218.0,0.0,1218.0,1.0,427.0,0
TCGA-XK-AAJ3-01,TCGA-XK-AAJ3,PRAD,56.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-20604.0,Alive,TUMOR FREE,1262.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1262.0,0.0,1262.0,0.0,1262.0,0.0,1262.0,0
TCGA-XK-AAJA-01,TCGA-XK-AAJA,PRAD,62.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-22771.0,Alive,nan,930.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,930.0,0.0,930.0,0.0,930.0,0.0,930.0,0
TCGA-XK-AAJP-01,TCGA-XK-AAJP,PRAD,66.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-24320.0,Alive,TUMOR FREE,1259.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1259.0,0.0,1259.0,0.0,1259.0,0.0,1259.0,0
TCGA-XK-AAJR-01,TCGA-XK-AAJR,PRAD,61.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-22643.0,Alive,TUMOR FREE,1124.0,nan,nan,Biochemical evidence of disease,nan,nan,131.0,Complete Remission/Response,nan,nan,0.0,1124.0,0.0,1124.0,1.0,131.0,1.0,131.0,0
TCGA-XK-AAJT-01,TCGA-XK-AAJT,PRAD,75.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-27428.0,Alive,TUMOR FREE,1434.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,1434.0,0.0,1434.0,nan,nan,0.0,1434.0,0
TCGA-XK-AAJU-01,TCGA-XK-AAJU,PRAD,65.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-23958.0,Alive,TUMOR FREE,1576.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1576.0,0.0,1576.0,0.0,1576.0,0.0,1576.0,0
TCGA-XK-AAK1-01,TCGA-XK-AAK1,PRAD,62.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-22965.0,Alive,TUMOR FREE,979.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,979.0,0.0,979.0,0.0,979.0,0.0,979.0,0
TCGA-XQ-A8TA-01,TCGA-XQ-A8TA,PRAD,59.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-21889.0,Dead,WITH TUMOR,nan,146.0,Prostate Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,146.0,1.0,146.0,nan,nan,1.0,146.0,1
TCGA-XQ-A8TB-01,TCGA-XQ-A8TB,PRAD,67.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-24623.0,Alive,TUMOR FREE,770.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,770.0,0.0,770.0,0.0,770.0,0.0,770.0,0
TCGA-Y6-A8TL-01,TCGA-Y6-A8TL,PRAD,65.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-23776.0,Alive,TUMOR FREE,992.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,992.0,0.0,992.0,nan,nan,0.0,992.0,0
TCGA-Y6-A9XI-01,TCGA-Y6-A9XI,PRAD,72.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-26471.0,Alive,TUMOR FREE,526.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,526.0,0.0,526.0,0.0,526.0,0.0,526.0,0
TCGA-YJ-A8SW-01,TCGA-YJ-A8SW,PRAD,67.0,MALE,nan,nan,nan,"Prostate Adenocarcinoma, Other Subtype",nan,2008.0,nan,nan,Alive,nan,148.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,148.0,0.0,148.0,nan,nan,0.0,148.0,0
TCGA-YL-A8HJ-01,TCGA-YL-A8HJ,PRAD,58.0,MALE,nan,nan,nan,"Prostate Adenocarcinoma, Other Subtype",nan,2009.0,nan,-21416.0,Alive,TUMOR FREE,1611.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1611.0,0.0,1611.0,0.0,1611.0,0.0,1611.0,0
TCGA-YL-A8HK-01,TCGA-YL-A8HK,PRAD,59.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-21850.0,Alive,WITH TUMOR,1491.0,nan,nan,Biochemical evidence of disease,nan,nan,1376.0,Complete Remission/Response,nan,nan,0.0,1491.0,0.0,1491.0,1.0,1376.0,1.0,1376.0,2
TCGA-YL-A8HL-01,TCGA-YL-A8HL,PRAD,58.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-21249.0,Alive,nan,1565.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1565.0,0.0,1565.0,nan,nan,0.0,1565.0,0
TCGA-YL-A8HM-01,TCGA-YL-A8HM,PRAD,66.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-24121.0,Alive,WITH TUMOR,1482.0,nan,nan,Biochemical evidence of disease,nan,nan,1473.0,Complete Remission/Response,nan,nan,0.0,1482.0,0.0,1482.0,1.0,1473.0,1.0,1473.0,2
TCGA-YL-A8HO-01,TCGA-YL-A8HO,PRAD,67.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-24509.0,Alive,WITH TUMOR,2304.0,nan,nan,Biochemical evidence of disease,nan,nan,1068.0,Stable Disease,nan,nan,0.0,2304.0,0.0,2304.0,nan,nan,1.0,1068.0,0
TCGA-YL-A8S8-01,TCGA-YL-A8S8,PRAD,68.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-25119.0,Alive,WITH TUMOR,1890.0,nan,nan,Biochemical evidence of disease,nan,nan,679.0,Stable Disease,nan,nan,0.0,1890.0,0.0,1890.0,nan,nan,1.0,679.0,0
TCGA-YL-A8S9-01,TCGA-YL-A8S9,PRAD,63.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-23204.0,Alive,nan,1842.0,nan,nan,Locoregional Recurrence,nan,nan,1006.0,Stable Disease,nan,nan,0.0,1842.0,0.0,1842.0,nan,nan,1.0,1006.0,0
TCGA-YL-A8SA-01,TCGA-YL-A8SA,PRAD,69.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-25340.0,Alive,nan,512.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,512.0,0.0,512.0,nan,nan,0.0,512.0,0
TCGA-YL-A8SB-01,TCGA-YL-A8SB,PRAD,62.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-22991.0,Alive,WITH TUMOR,1719.0,nan,nan,Biochemical evidence of disease,nan,nan,1384.0,Stable Disease,nan,nan,0.0,1719.0,0.0,1719.0,nan,nan,1.0,1384.0,0
TCGA-YL-A8SC-01,TCGA-YL-A8SC,PRAD,66.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-24206.0,Alive,WITH TUMOR,1261.0,nan,nan,Biochemical evidence of disease,nan,nan,152.0,Partial Remission/Response,nan,nan,0.0,1261.0,0.0,1261.0,nan,nan,1.0,152.0,0
TCGA-YL-A8SF-01,TCGA-YL-A8SF,PRAD,62.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-22844.0,Alive,nan,1373.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1373.0,0.0,1373.0,nan,nan,0.0,1373.0,0
TCGA-YL-A8SH-01,TCGA-YL-A8SH,PRAD,69.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-25395.0,Dead,TUMOR FREE,nan,875.0,"Other, non-malignant disease",nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,875.0,0.0,875.0,0.0,875.0,0.0,875.0,0
TCGA-YL-A8SI-01,TCGA-YL-A8SI,PRAD,69.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-25292.0,Alive,TUMOR FREE,1614.0,nan,nan,Biochemical evidence of disease,nan,nan,1423.0,Complete Remission/Response,nan,nan,0.0,1614.0,0.0,1614.0,1.0,1423.0,1.0,1423.0,0
TCGA-YL-A8SJ-01,TCGA-YL-A8SJ,PRAD,60.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-21916.0,Alive,WITH TUMOR,1395.0,nan,nan,Biochemical evidence of disease,nan,nan,752.0,Complete Remission/Response,nan,nan,0.0,1395.0,0.0,1395.0,1.0,752.0,1.0,752.0,2
TCGA-YL-A8SK-01,TCGA-YL-A8SK,PRAD,67.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-24759.0,Alive,nan,1408.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1408.0,0.0,1408.0,nan,nan,0.0,1408.0,0
TCGA-YL-A8SL-01,TCGA-YL-A8SL,PRAD,74.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-27033.0,Alive,TUMOR FREE,987.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,987.0,0.0,987.0,0.0,987.0,0.0,987.0,0
TCGA-YL-A8SO-01,TCGA-YL-A8SO,PRAD,64.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2004.0,nan,-23584.0,Alive,nan,3479.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,3479.0,0.0,3479.0,nan,nan,0.0,3479.0,0
TCGA-YL-A8SP-01,TCGA-YL-A8SP,PRAD,58.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-21455.0,Alive,WITH TUMOR,2366.0,nan,nan,Biochemical evidence of disease,nan,nan,2036.0,Stable Disease,nan,nan,0.0,2366.0,0.0,2366.0,nan,nan,1.0,2036.0,0
TCGA-YL-A8SQ-01,TCGA-YL-A8SQ,PRAD,61.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-22482.0,Alive,WITH TUMOR,2083.0,nan,nan,Biochemical evidence of disease,nan,nan,329.0,Stable Disease,nan,nan,0.0,2083.0,0.0,2083.0,nan,nan,1.0,329.0,0
TCGA-YL-A8SR-01,TCGA-YL-A8SR,PRAD,64.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-23488.0,Alive,nan,273.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,273.0,0.0,273.0,nan,nan,0.0,273.0,0
TCGA-YL-A9WH-01,TCGA-YL-A9WH,PRAD,67.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-24755.0,Alive,nan,427.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,427.0,0.0,427.0,nan,nan,0.0,427.0,0
TCGA-YL-A9WI-01,TCGA-YL-A9WI,PRAD,63.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-23184.0,Alive,TUMOR FREE,1623.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1623.0,0.0,1623.0,nan,nan,0.0,1623.0,0
TCGA-YL-A9WJ-01,TCGA-YL-A9WJ,PRAD,47.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-17322.0,Dead,WITH TUMOR,nan,1855.0,Prostate Cancer,Distant Metastasis,"Other, specify",Neck,1476.0,Progressive Disease,nan,nan,1.0,1855.0,1.0,1855.0,nan,nan,1.0,1476.0,1
TCGA-YL-A9WK-01,TCGA-YL-A9WK,PRAD,63.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2008.0,nan,-23272.0,Alive,WITH TUMOR,2136.0,nan,nan,Biochemical evidence of disease,nan,nan,1009.0,Stable Disease,nan,nan,0.0,2136.0,0.0,2136.0,nan,nan,1.0,1009.0,0
TCGA-YL-A9WL-01,TCGA-YL-A9WL,PRAD,59.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-21626.0,Alive,WITH TUMOR,740.0,nan,nan,Biochemical evidence of disease,nan,nan,740.0,Complete Remission/Response,nan,nan,0.0,740.0,0.0,740.0,1.0,740.0,1.0,740.0,2
TCGA-YL-A9WX-01,TCGA-YL-A9WX,PRAD,68.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2009.0,nan,-25008.0,Alive,WITH TUMOR,1518.0,nan,nan,Biochemical evidence of disease,nan,nan,1506.0,Stable Disease,nan,nan,0.0,1518.0,0.0,1518.0,nan,nan,1.0,1506.0,2
TCGA-YL-A9WY-01,TCGA-YL-A9WY,PRAD,57.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-21164.0,Alive,WITH TUMOR,1098.0,nan,nan,Biochemical evidence of disease,nan,nan,765.0,Stable Disease,nan,nan,0.0,1098.0,0.0,1098.0,nan,nan,1.0,765.0,0
TCGA-ZG-A8QW-01,TCGA-ZG-A8QW,PRAD,72.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-26632.0,Alive,TUMOR FREE,94.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,94.0,0.0,94.0,nan,nan,0.0,94.0,0
TCGA-ZG-A8QX-01,TCGA-ZG-A8QX,PRAD,56.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-20683.0,Alive,TUMOR FREE,442.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,442.0,0.0,442.0,nan,nan,0.0,442.0,0
TCGA-ZG-A8QY-01,TCGA-ZG-A8QY,PRAD,67.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-24731.0,Alive,WITH TUMOR,404.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,404.0,0.0,404.0,nan,nan,0.0,404.0,0
TCGA-ZG-A8QZ-01,TCGA-ZG-A8QZ,PRAD,65.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-23980.0,Alive,TUMOR FREE,308.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,308.0,0.0,308.0,nan,nan,0.0,308.0,0
TCGA-ZG-A9KY-01,TCGA-ZG-A9KY,PRAD,73.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-27000.0,Alive,nan,130.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,130.0,0.0,130.0,nan,nan,0.0,130.0,0
TCGA-ZG-A9L0-01,TCGA-ZG-A9L0,PRAD,71.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-26055.0,Alive,TUMOR FREE,355.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,355.0,0.0,355.0,nan,nan,0.0,355.0,0
TCGA-ZG-A9L1-01,TCGA-ZG-A9L1,PRAD,66.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2010.0,nan,-24214.0,Alive,WITH TUMOR,1302.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,1302.0,0.0,1302.0,nan,nan,0.0,1302.0,0
TCGA-ZG-A9L2-01,TCGA-ZG-A9L2,PRAD,70.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-25573.0,Alive,WITH TUMOR,1154.0,nan,nan,Biochemical evidence of disease,nan,nan,180.0,Stable Disease,nan,nan,0.0,1154.0,0.0,1154.0,nan,nan,1.0,180.0,0
TCGA-ZG-A9L4-01,TCGA-ZG-A9L4,PRAD,61.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-22388.0,Alive,nan,1108.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1108.0,0.0,1108.0,nan,nan,0.0,1108.0,0
TCGA-ZG-A9L5-01,TCGA-ZG-A9L5,PRAD,58.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-21293.0,Alive,WITH TUMOR,908.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,908.0,0.0,908.0,nan,nan,0.0,908.0,0
TCGA-ZG-A9L6-01,TCGA-ZG-A9L6,PRAD,64.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-23681.0,Alive,WITH TUMOR,687.0,nan,nan,Biochemical evidence of disease,nan,nan,664.0,Partial Remission/Response,nan,nan,0.0,687.0,0.0,687.0,nan,nan,1.0,664.0,0
TCGA-ZG-A9L9-01,TCGA-ZG-A9L9,PRAD,60.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-22108.0,Alive,WITH TUMOR,617.0,nan,nan,Biochemical evidence of disease,nan,nan,51.0,Progressive Disease,nan,nan,0.0,617.0,0.0,617.0,nan,nan,1.0,51.0,0
TCGA-ZG-A9LB-01,TCGA-ZG-A9LB,PRAD,72.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-26447.0,Alive,WITH TUMOR,583.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,583.0,0.0,583.0,nan,nan,0.0,583.0,0
TCGA-ZG-A9LM-01,TCGA-ZG-A9LM,PRAD,72.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-26377.0,Alive,TUMOR FREE,378.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,378.0,0.0,378.0,0.0,378.0,0.0,378.0,0
TCGA-ZG-A9LN-01,TCGA-ZG-A9LN,PRAD,57.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-21050.0,Alive,WITH TUMOR,115.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,115.0,0.0,115.0,nan,nan,0.0,115.0,0
TCGA-ZG-A9LS-01,TCGA-ZG-A9LS,PRAD,64.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-23540.0,Alive,TUMOR FREE,516.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,516.0,0.0,516.0,0.0,516.0,0.0,516.0,0
TCGA-ZG-A9LU-01,TCGA-ZG-A9LU,PRAD,67.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-24742.0,Alive,WITH TUMOR,579.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,579.0,0.0,579.0,nan,nan,0.0,579.0,0
TCGA-ZG-A9LY-01,TCGA-ZG-A9LY,PRAD,60.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-21942.0,Alive,TUMOR FREE,370.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,370.0,0.0,370.0,0.0,370.0,0.0,370.0,0
TCGA-ZG-A9LZ-01,TCGA-ZG-A9LZ,PRAD,66.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2011.0,nan,-24132.0,Alive,WITH TUMOR,692.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,692.0,0.0,692.0,nan,nan,0.0,692.0,0
TCGA-ZG-A9M4-01,TCGA-ZG-A9M4,PRAD,65.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-24030.0,Alive,WITH TUMOR,547.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,547.0,0.0,547.0,nan,nan,0.0,547.0,0
TCGA-ZG-A9MC-01,TCGA-ZG-A9MC,PRAD,69.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2012.0,nan,-25477.0,Alive,WITH TUMOR,455.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,455.0,0.0,455.0,nan,nan,0.0,455.0,0
TCGA-ZG-A9N3-01,TCGA-ZG-A9N3,PRAD,73.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-26902.0,Alive,WITH TUMOR,349.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,349.0,0.0,349.0,nan,nan,0.0,349.0,0
TCGA-ZG-A9ND-01,TCGA-ZG-A9ND,PRAD,55.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-20428.0,Alive,TUMOR FREE,410.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,410.0,0.0,410.0,0.0,410.0,0.0,410.0,0
TCGA-ZG-A9NI-01,TCGA-ZG-A9NI,PRAD,73.0,MALE,nan,nan,nan,Prostate Adenocarcinoma Acinar Type,nan,2013.0,nan,-26697.0,Alive,TUMOR FREE,132.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,132.0,0.0,132.0,0.0,132.0,0.0,132.0,0
TCGA-AF-2687-01,TCGA-AF-2687,READ,57.0,MALE,WHITE,Stage IIIC,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-21098.0,Alive,TUMOR FREE,1427.0,nan,nan,nan,nan,nan,1267.0,Complete Remission/Response,nan,nan,0.0,1427.0,0.0,1427.0,1.0,1267.0,1.0,1267.0,2
TCGA-AF-2689-01,TCGA-AF-2689,READ,41.0,FEMALE,WHITE,Stage IV,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-15082.0,Dead,WITH TUMOR,nan,1201.0,nan,nan,nan,nan,301.0,nan,nan,nan,1.0,1201.0,1.0,1201.0,nan,nan,1.0,301.0,1
TCGA-AF-2689-11,TCGA-AF-2689,READ,41.0,FEMALE,WHITE,Stage IV,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-15082.0,Dead,WITH TUMOR,nan,1201.0,nan,nan,nan,nan,301.0,nan,nan,nan,1.0,1201.0,1.0,1201.0,nan,nan,1.0,301.0,1
TCGA-AF-2690-01,TCGA-AF-2690,READ,76.0,FEMALE,WHITE,Stage IIIC,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-28119.0,Dead,TUMOR FREE,nan,524.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,524.0,0.0,524.0,nan,nan,0.0,524.0,1
TCGA-AF-2691-01,TCGA-AF-2691,READ,48.0,FEMALE,WHITE,Stage I,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-17759.0,Alive,TUMOR FREE,1309.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1309.0,0.0,1309.0,0.0,1309.0,0.0,1309.0,0
TCGA-AF-2691-11,TCGA-AF-2691,READ,48.0,FEMALE,WHITE,Stage I,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-17759.0,Alive,TUMOR FREE,1309.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1309.0,0.0,1309.0,0.0,1309.0,0.0,1309.0,0
TCGA-AF-2692-01,TCGA-AF-2692,READ,54.0,FEMALE,WHITE,Stage IIA,nan,nan,nan,2009.0,nan,-19830.0,Alive,WITH TUMOR,412.0,nan,nan,Metastatic,nan,nan,327.0,nan,nan,nan,0.0,412.0,0.0,412.0,nan,nan,1.0,327.0,2
TCGA-AF-2692-11,TCGA-AF-2692,READ,54.0,FEMALE,WHITE,Stage IIA,nan,nan,nan,2009.0,nan,-19830.0,Alive,WITH TUMOR,412.0,nan,nan,Metastatic,nan,nan,327.0,nan,nan,nan,0.0,412.0,0.0,412.0,nan,nan,1.0,327.0,2
TCGA-AF-2693-01,TCGA-AF-2693,READ,75.0,MALE,WHITE,Stage I,nan,nan,nan,2009.0,nan,-27443.0,Alive,TUMOR FREE,1155.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1155.0,0.0,1155.0,nan,nan,0.0,1155.0,0
TCGA-AF-3400-01,TCGA-AF-3400,READ,54.0,MALE,WHITE,Stage IIA,nan,Rectal Mucinous Adenocarcinoma,nan,2009.0,nan,-19826.0,Alive,TUMOR FREE,1049.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1049.0,0.0,1049.0,nan,nan,0.0,1049.0,0
TCGA-AF-3400-11,TCGA-AF-3400,READ,54.0,MALE,WHITE,Stage IIA,nan,Rectal Mucinous Adenocarcinoma,nan,2009.0,nan,-19826.0,Alive,TUMOR FREE,1049.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1049.0,0.0,1049.0,nan,nan,0.0,1049.0,0
TCGA-AF-3911-01,TCGA-AF-3911,READ,48.0,MALE,WHITE,Stage IIIC,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-17609.0,Alive,WITH TUMOR,1148.0,nan,nan,nan,nan,nan,695.0,Complete Remission/Response,nan,nan,0.0,1148.0,0.0,1148.0,1.0,695.0,1.0,695.0,2
TCGA-AF-3913-01,TCGA-AF-3913,READ,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-21970.0,Dead,WITH TUMOR,nan,316.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,316.0,1.0,316.0,nan,nan,1.0,316.0,1
TCGA-AF-3913-11,TCGA-AF-3913,READ,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-21970.0,Dead,WITH TUMOR,nan,316.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,316.0,1.0,316.0,nan,nan,1.0,316.0,1
TCGA-AF-4110-01,TCGA-AF-4110,READ,77.0,MALE,WHITE,Stage IVA,nan,nan,nan,2010.0,nan,-28289.0,Alive,TUMOR FREE,912.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,912.0,0.0,912.0,nan,nan,0.0,912.0,0
TCGA-AF-5654-01,TCGA-AF-5654,READ,73.0,FEMALE,WHITE,Stage I,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-26738.0,Dead,TUMOR FREE,nan,512.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,512.0,0.0,512.0,nan,nan,0.0,512.0,1
TCGA-AF-5654-11,TCGA-AF-5654,READ,73.0,FEMALE,WHITE,Stage I,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-26738.0,Dead,TUMOR FREE,nan,512.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,512.0,0.0,512.0,nan,nan,0.0,512.0,1
TCGA-AF-6136-01,TCGA-AF-6136,READ,72.0,FEMALE,WHITE,Stage IIIB,nan,Rectal Adenocarcinoma,nan,2011.0,nan,-26490.0,Alive,WITH TUMOR,741.0,nan,nan,nan,nan,nan,199.0,Progressive Disease,nan,nan,0.0,741.0,0.0,741.0,nan,nan,1.0,199.0,2
TCGA-AF-6655-01,TCGA-AF-6655,READ,66.0,MALE,WHITE,Stage IIIA,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-24417.0,Alive,TUMOR FREE,609.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,609.0,0.0,609.0,0.0,609.0,0.0,609.0,0
TCGA-AF-6672-01,TCGA-AF-6672,READ,43.0,MALE,WHITE,Stage IV,nan,Rectal Adenocarcinoma,nan,2011.0,nan,-15965.0,Alive,WITH TUMOR,748.0,nan,nan,Metastatic,nan,nan,279.0,Progressive Disease,nan,nan,0.0,748.0,0.0,748.0,nan,nan,1.0,279.0,0
TCGA-AF-A56K-01,TCGA-AF-A56K,READ,56.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Rectal Adenocarcinoma,nan,2006.0,nan,-20527.0,Alive,TUMOR FREE,2635.0,nan,nan,Locoregional Disease,nan,nan,1217.0,Complete Remission/Response,nan,nan,0.0,2635.0,0.0,2635.0,1.0,1217.0,1.0,1217.0,0
TCGA-AF-A56L-01,TCGA-AF-A56L,READ,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,nan,Rectal Adenocarcinoma,nan,2008.0,nan,-17734.0,Alive,TUMOR FREE,2007.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2007.0,0.0,2007.0,0.0,2007.0,0.0,2007.0,0
TCGA-AF-A56N-01,TCGA-AF-A56N,READ,47.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,Rectal Adenocarcinoma,nan,2012.0,nan,-17480.0,Alive,TUMOR FREE,360.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,360.0,0.0,360.0,0.0,360.0,0.0,360.0,0
TCGA-AG-3574-01,TCGA-AG-3574,READ,89.0,FEMALE,nan,Stage II,nan,Rectal Adenocarcinoma,nan,2005.0,nan,-32781.0,Dead,WITH TUMOR,nan,1096.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1096.0,1.0,1096.0,nan,nan,1.0,1096.0,1
TCGA-AG-3575-01,TCGA-AG-3575,READ,51.0,MALE,nan,Stage II,nan,Rectal Adenocarcinoma,nan,2006.0,nan,-18932.0,Alive,TUMOR FREE,365.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,365.0,0.0,365.0,nan,nan,0.0,365.0,0
TCGA-AG-3578-01,TCGA-AG-3578,READ,76.0,FEMALE,nan,Stage IIA,nan,Rectal Mucinous Adenocarcinoma,nan,2007.0,nan,-27851.0,Alive,TUMOR FREE,974.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,974.0,0.0,974.0,nan,nan,0.0,974.0,0
TCGA-AG-3580-01,TCGA-AG-3580,READ,67.0,MALE,nan,Stage I,nan,Rectal Adenocarcinoma,nan,2007.0,nan,-24775.0,Alive,TUMOR FREE,244.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,244.0,0.0,244.0,nan,nan,0.0,244.0,0
TCGA-AG-3581-01,TCGA-AG-3581,READ,63.0,MALE,nan,Stage I,nan,Rectal Adenocarcinoma,nan,2007.0,nan,-23345.0,Alive,TUMOR FREE,215.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,215.0,0.0,215.0,nan,nan,0.0,215.0,0
TCGA-AG-3582-01,TCGA-AG-3582,READ,75.0,MALE,nan,Stage IV,nan,Rectal Adenocarcinoma,nan,2007.0,nan,-27636.0,Dead,WITH TUMOR,nan,1096.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1096.0,1.0,1096.0,nan,nan,1.0,1096.0,1
TCGA-AG-3583-01,TCGA-AG-3583,READ,66.0,MALE,nan,Stage IV,nan,Rectal Mucinous Adenocarcinoma,nan,2008.0,nan,-24107.0,Dead,WITH TUMOR,nan,610.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,610.0,1.0,610.0,nan,nan,1.0,610.0,1
TCGA-AG-3584-01,TCGA-AG-3584,READ,60.0,MALE,nan,Stage IV,nan,Rectal Adenocarcinoma,nan,2008.0,nan,-22189.0,Dead,WITH TUMOR,nan,730.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,730.0,1.0,730.0,nan,nan,1.0,730.0,1
TCGA-AG-3586-01,TCGA-AG-3586,READ,72.0,FEMALE,nan,Stage III,nan,nan,nan,2006.0,nan,-26542.0,Alive,WITH TUMOR,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-AG-3587-01,TCGA-AG-3587,READ,65.0,MALE,nan,Stage I,nan,Rectal Adenocarcinoma,nan,2007.0,nan,-24075.0,Alive,TUMOR FREE,1400.0,nan,nan,nan,nan,nan,1216.0,[Unknown],nan,nan,0.0,1400.0,0.0,1400.0,nan,nan,1.0,1216.0,0
TCGA-AG-3591-01,TCGA-AG-3591,READ,66.0,FEMALE,nan,Stage IIA,nan,Rectal Adenocarcinoma,nan,2007.0,nan,-24167.0,Alive,TUMOR FREE,1035.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1035.0,0.0,1035.0,0.0,1035.0,0.0,1035.0,0
TCGA-AG-3592-01,TCGA-AG-3592,READ,68.0,MALE,nan,Stage IIA,nan,Rectal Adenocarcinoma,nan,2007.0,nan,-25141.0,Alive,TUMOR FREE,1035.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1035.0,0.0,1035.0,nan,nan,0.0,1035.0,0
TCGA-AG-3593-01,TCGA-AG-3593,READ,72.0,FEMALE,nan,Stage IIA,nan,Rectal Adenocarcinoma,nan,2007.0,nan,-26480.0,Alive,TUMOR FREE,1035.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1035.0,0.0,1035.0,0.0,1035.0,0.0,1035.0,0
TCGA-AG-3594-01,TCGA-AG-3594,READ,77.0,MALE,nan,Stage IIA,nan,Rectal Mucinous Adenocarcinoma,nan,2007.0,nan,-28277.0,Dead,WITH TUMOR,nan,61.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,61.0,1.0,61.0,nan,nan,1.0,61.0,1
TCGA-AG-3598-01,TCGA-AG-3598,READ,69.0,MALE,nan,Stage IIA,nan,Rectal Adenocarcinoma,nan,2007.0,nan,-25324.0,Alive,TUMOR FREE,1522.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1522.0,0.0,1522.0,nan,nan,0.0,1522.0,0
TCGA-AG-3599-01,TCGA-AG-3599,READ,70.0,MALE,nan,Stage I,nan,nan,nan,2007.0,nan,-25749.0,Alive,TUMOR FREE,366.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,366.0,0.0,366.0,nan,nan,0.0,366.0,0
TCGA-AG-3600-01,TCGA-AG-3600,READ,62.0,MALE,nan,Stage IIIC,nan,Rectal Adenocarcinoma,nan,2007.0,nan,-22767.0,Alive,TUMOR FREE,184.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,184.0,0.0,184.0,0.0,184.0,0.0,184.0,0
TCGA-AG-3601-01,TCGA-AG-3601,READ,68.0,MALE,nan,Stage IIIB,nan,Rectal Adenocarcinoma,nan,2007.0,nan,-24837.0,Alive,WITH TUMOR,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-AG-3602-01,TCGA-AG-3602,READ,66.0,FEMALE,nan,Stage IIIC,nan,Rectal Adenocarcinoma,nan,2007.0,nan,-24350.0,Alive,WITH TUMOR,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-AG-3605-01,TCGA-AG-3605,READ,85.0,FEMALE,nan,Stage IV,nan,Rectal Adenocarcinoma,nan,2008.0,nan,-31078.0,Alive,WITH TUMOR,30.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,30.0,0.0,30.0,nan,nan,0.0,30.0,0
TCGA-AG-3608-01,TCGA-AG-3608,READ,79.0,FEMALE,nan,Stage IIA,nan,Rectal Adenocarcinoma,nan,2008.0,nan,-29008.0,Alive,TUMOR FREE,485.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,485.0,0.0,485.0,nan,nan,0.0,485.0,0
TCGA-AG-3609-01,TCGA-AG-3609,READ,65.0,FEMALE,nan,Stage IIIC,nan,Rectal Adenocarcinoma,nan,2008.0,nan,-23925.0,Alive,TUMOR FREE,608.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,608.0,0.0,608.0,0.0,608.0,0.0,608.0,0
TCGA-AG-3611-01,TCGA-AG-3611,READ,72.0,MALE,nan,Stage IIA,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-26420.0,Alive,TUMOR FREE,424.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,424.0,0.0,424.0,0.0,424.0,0.0,424.0,0
TCGA-AG-3612-01,TCGA-AG-3612,READ,55.0,FEMALE,nan,Stage IIIB,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-20242.0,Alive,TUMOR FREE,608.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,608.0,0.0,608.0,0.0,608.0,0.0,608.0,0
TCGA-AG-3725-01,TCGA-AG-3725,READ,90.0,FEMALE,nan,Stage III,nan,Rectal Adenocarcinoma,nan,2005.0,nan,-32872.0,Alive,TUMOR FREE,638.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,638.0,0.0,638.0,nan,nan,0.0,638.0,0
TCGA-AG-3725-11,TCGA-AG-3725,READ,90.0,FEMALE,nan,Stage III,nan,Rectal Adenocarcinoma,nan,2005.0,nan,-32872.0,Alive,TUMOR FREE,638.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,638.0,0.0,638.0,nan,nan,0.0,638.0,0
TCGA-AG-3726-01,TCGA-AG-3726,READ,63.0,FEMALE,nan,Stage I,nan,Rectal Adenocarcinoma,nan,2006.0,nan,-23345.0,Alive,TUMOR FREE,243.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,243.0,0.0,243.0,nan,nan,0.0,243.0,0
TCGA-AG-3727-01,TCGA-AG-3727,READ,78.0,FEMALE,nan,Stage III,nan,Rectal Adenocarcinoma,nan,2006.0,nan,-28641.0,Alive,WITH TUMOR,30.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,30.0,0.0,30.0,nan,nan,0.0,30.0,0
TCGA-AG-3728-01,TCGA-AG-3728,READ,73.0,MALE,nan,Stage IIIB,nan,Rectal Adenocarcinoma,nan,2006.0,nan,-26906.0,Alive,WITH TUMOR,912.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,912.0,0.0,912.0,0.0,912.0,0.0,912.0,0
TCGA-AG-3731-01,TCGA-AG-3731,READ,65.0,MALE,nan,Stage IV,nan,Rectal Adenocarcinoma,nan,2004.0,nan,-23923.0,Alive,TUMOR FREE,1126.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1126.0,0.0,1126.0,nan,nan,0.0,1126.0,0
TCGA-AG-3731-11,TCGA-AG-3731,READ,65.0,MALE,nan,Stage IV,nan,Rectal Adenocarcinoma,nan,2004.0,nan,-23923.0,Alive,TUMOR FREE,1126.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1126.0,0.0,1126.0,nan,nan,0.0,1126.0,0
TCGA-AG-3732-01,TCGA-AG-3732,READ,78.0,FEMALE,nan,Stage I,nan,Rectal Adenocarcinoma,nan,2005.0,nan,-28521.0,Alive,TUMOR FREE,1003.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1003.0,0.0,1003.0,0.0,1003.0,0.0,1003.0,0
TCGA-AG-3732-11,TCGA-AG-3732,READ,78.0,FEMALE,nan,Stage I,nan,Rectal Adenocarcinoma,nan,2005.0,nan,-28521.0,Alive,TUMOR FREE,1003.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1003.0,0.0,1003.0,0.0,1003.0,0.0,1003.0,0
TCGA-AG-3742-01,TCGA-AG-3742,READ,85.0,FEMALE,nan,Stage I,nan,Rectal Adenocarcinoma,nan,2004.0,nan,-31078.0,Alive,WITH TUMOR,30.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,30.0,0.0,30.0,nan,nan,0.0,30.0,0
TCGA-AG-3742-11,TCGA-AG-3742,READ,85.0,FEMALE,nan,Stage I,nan,Rectal Adenocarcinoma,nan,2004.0,nan,-31078.0,Alive,WITH TUMOR,30.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,30.0,0.0,30.0,nan,nan,0.0,30.0,0
TCGA-AG-3878-01,TCGA-AG-3878,READ,64.0,MALE,nan,Stage I,nan,Rectal Adenocarcinoma,nan,2007.0,nan,-23527.0,Alive,WITH TUMOR,30.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,30.0,0.0,30.0,nan,nan,0.0,30.0,0
TCGA-AG-3881-01,TCGA-AG-3881,READ,83.0,FEMALE,nan,Stage IIA,nan,nan,nan,2008.0,nan,-30467.0,Alive,TUMOR FREE,579.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,579.0,0.0,579.0,nan,nan,0.0,579.0,0
TCGA-AG-3882-01,TCGA-AG-3882,READ,66.0,FEMALE,nan,Stage I,nan,Rectal Adenocarcinoma,nan,2008.0,nan,-24198.0,Alive,TUMOR FREE,608.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,608.0,0.0,608.0,nan,nan,0.0,608.0,0
TCGA-AG-3883-01,TCGA-AG-3883,READ,69.0,MALE,nan,Stage I,nan,Rectal Adenocarcinoma,nan,2008.0,nan,-25415.0,Alive,WITH TUMOR,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-AG-3885-01,TCGA-AG-3885,READ,71.0,FEMALE,nan,Stage IIIB,nan,Rectal Adenocarcinoma,nan,2008.0,nan,-26145.0,Alive,TUMOR FREE,546.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,546.0,0.0,546.0,0.0,546.0,0.0,546.0,0
TCGA-AG-3887-01,TCGA-AG-3887,READ,68.0,MALE,nan,Stage IIA,nan,Rectal Mucinous Adenocarcinoma,nan,2009.0,nan,-24960.0,Alive,WITH TUMOR,1124.0,nan,nan,nan,nan,nan,1064.0,nan,nan,nan,0.0,1124.0,0.0,1124.0,nan,nan,1.0,1064.0,0
TCGA-AG-3890-01,TCGA-AG-3890,READ,62.0,MALE,nan,Stage I,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-22950.0,Alive,TUMOR FREE,518.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,518.0,0.0,518.0,nan,nan,0.0,518.0,0
TCGA-AG-3892-01,TCGA-AG-3892,READ,57.0,FEMALE,nan,Stage I,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-20880.0,Alive,TUMOR FREE,396.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,396.0,0.0,396.0,0.0,396.0,0.0,396.0,0
TCGA-AG-3893-01,TCGA-AG-3893,READ,74.0,MALE,nan,Stage IIIB,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-27272.0,Alive,TUMOR FREE,1065.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1065.0,0.0,1065.0,0.0,1065.0,0.0,1065.0,0
TCGA-AG-3894-01,TCGA-AG-3894,READ,65.0,MALE,nan,Stage IIA,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-23954.0,Alive,TUMOR FREE,426.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,426.0,0.0,426.0,0.0,426.0,0.0,426.0,0
TCGA-AG-3896-01,TCGA-AG-3896,READ,85.0,FEMALE,nan,Stage I,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-31046.0,Alive,WITH TUMOR,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-AG-3898-01,TCGA-AG-3898,READ,61.0,MALE,nan,Stage IIA,nan,Rectal Adenocarcinoma,nan,2006.0,nan,-22492.0,Alive,WITH TUMOR,1461.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1461.0,0.0,1461.0,nan,nan,0.0,1461.0,0
TCGA-AG-3901-01,TCGA-AG-3901,READ,67.0,FEMALE,nan,Stage IIIB,nan,Rectal Mucinous Adenocarcinoma,nan,2007.0,nan,-24502.0,Alive,WITH TUMOR,761.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,761.0,0.0,761.0,nan,nan,0.0,761.0,0
TCGA-AG-3902-01,TCGA-AG-3902,READ,61.0,MALE,nan,Stage IIA,nan,Rectal Adenocarcinoma,nan,2007.0,nan,-22492.0,Alive,TUMOR FREE,974.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,974.0,0.0,974.0,nan,nan,0.0,974.0,0
TCGA-AG-3909-01,TCGA-AG-3909,READ,69.0,FEMALE,nan,Stage IIIB,nan,Rectal Adenocarcinoma,nan,2008.0,nan,-25537.0,Alive,TUMOR FREE,608.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,608.0,0.0,608.0,0.0,608.0,0.0,608.0,0
TCGA-AG-3999-01,TCGA-AG-3999,READ,61.0,FEMALE,nan,Stage IIIC,nan,Rectal Adenocarcinoma,nan,2008.0,nan,-22311.0,Alive,TUMOR FREE,853.0,nan,nan,nan,nan,nan,791.0,Progressive Disease,nan,nan,0.0,853.0,0.0,853.0,nan,nan,1.0,791.0,0
TCGA-AG-4001-01,TCGA-AG-4001,READ,74.0,FEMALE,nan,Stage IIA,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-27302.0,Alive,TUMOR FREE,1096.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1096.0,0.0,1096.0,nan,nan,0.0,1096.0,0
TCGA-AG-4005-01,TCGA-AG-4005,READ,64.0,MALE,nan,Stage IV,nan,Rectal Adenocarcinoma,nan,2007.0,nan,-23407.0,Alive,TUMOR FREE,427.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,427.0,0.0,427.0,nan,nan,0.0,427.0,0
TCGA-AG-4007-01,TCGA-AG-4007,READ,87.0,MALE,nan,Stage IV,nan,Rectal Adenocarcinoma,nan,2007.0,nan,-31776.0,Alive,WITH TUMOR,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-AG-4008-01,TCGA-AG-4008,READ,63.0,MALE,nan,Stage IIA,nan,Rectal Adenocarcinoma,nan,2008.0,nan,-23192.0,Alive,TUMOR FREE,518.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,518.0,0.0,518.0,0.0,518.0,0.0,518.0,0
TCGA-AG-4015-01,TCGA-AG-4015,READ,85.0,FEMALE,nan,Stage IIA,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-31291.0,Alive,WITH TUMOR,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-AG-4021-01,TCGA-AG-4021,READ,84.0,FEMALE,nan,Stage IV,nan,Rectal Adenocarcinoma,nan,2005.0,nan,-31015.0,Dead,WITH TUMOR,nan,121.0,nan,nan,nan,nan,0.0,nan,nan,nan,1.0,121.0,1.0,121.0,nan,nan,1.0,0.0,1
TCGA-AG-4022-01,TCGA-AG-4022,READ,59.0,FEMALE,nan,Stage II,nan,Rectal Adenocarcinoma,nan,2006.0,nan,-21823.0,Alive,TUMOR FREE,1400.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1400.0,0.0,1400.0,0.0,1400.0,0.0,1400.0,0
TCGA-AG-A002-01,TCGA-AG-A002,READ,35.0,MALE,nan,Stage I,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-13090.0,Alive,TUMOR FREE,638.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,638.0,0.0,638.0,0.0,638.0,0.0,638.0,0
TCGA-AG-A008-01,TCGA-AG-A008,READ,50.0,FEMALE,nan,Stage I,nan,Rectal Mucinous Adenocarcinoma,nan,2009.0,nan,-18416.0,Alive,TUMOR FREE,424.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,424.0,0.0,424.0,0.0,424.0,0.0,424.0,0
TCGA-AG-A00C-01,TCGA-AG-A00C,READ,49.0,FEMALE,nan,Stage IIIB,nan,Rectal Adenocarcinoma,nan,2007.0,nan,-18201.0,Alive,TUMOR FREE,183.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,183.0,0.0,183.0,0.0,183.0,0.0,183.0,0
TCGA-AG-A00H-01,TCGA-AG-A00H,READ,75.0,MALE,nan,Stage IIA,nan,Rectal Adenocarcinoma,nan,2008.0,nan,-27485.0,Alive,WITH TUMOR,790.0,nan,nan,nan,nan,nan,790.0,Progressive Disease,nan,nan,0.0,790.0,0.0,790.0,nan,nan,1.0,790.0,0
TCGA-AG-A00Y-01,TCGA-AG-A00Y,READ,68.0,MALE,nan,Stage IIA,nan,Rectal Adenocarcinoma,nan,2008.0,nan,-24837.0,Alive,TUMOR FREE,700.0,nan,nan,nan,nan,nan,123.0,Complete Remission/Response,nan,nan,0.0,700.0,0.0,700.0,1.0,123.0,1.0,123.0,0
TCGA-AG-A011-01,TCGA-AG-A011,READ,80.0,MALE,nan,Stage IIA,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-29463.0,Alive,TUMOR FREE,1126.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1126.0,0.0,1126.0,nan,nan,0.0,1126.0,0
TCGA-AG-A014-01,TCGA-AG-A014,READ,86.0,MALE,nan,Stage I,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-31718.0,Alive,WITH TUMOR,485.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,485.0,0.0,485.0,nan,nan,0.0,485.0,0
TCGA-AG-A015-01,TCGA-AG-A015,READ,64.0,FEMALE,nan,Stage I,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-23496.0,Alive,TUMOR FREE,1096.0,nan,nan,nan,nan,nan,518.0,nan,nan,nan,0.0,1096.0,0.0,1096.0,nan,nan,1.0,518.0,0
TCGA-AG-A016-01,TCGA-AG-A016,READ,55.0,MALE,nan,Stage IV,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-20178.0,Alive,WITH TUMOR,276.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,276.0,0.0,276.0,nan,nan,0.0,276.0,0
TCGA-AG-A01J-01,TCGA-AG-A01J,READ,59.0,FEMALE,nan,Stage IIA,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-21581.0,Alive,WITH TUMOR,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-AG-A01L-01,TCGA-AG-A01L,READ,58.0,MALE,nan,Stage IIIB,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-21369.0,Alive,WITH TUMOR,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-AG-A01N-01,TCGA-AG-A01N,READ,68.0,FEMALE,nan,Stage IV,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-25049.0,Alive,WITH TUMOR,943.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,943.0,0.0,943.0,nan,nan,0.0,943.0,2
TCGA-AG-A01W-01,TCGA-AG-A01W,READ,67.0,FEMALE,nan,Stage II,nan,Rectal Adenocarcinoma,nan,2004.0,nan,-24745.0,Alive,WITH TUMOR,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-AG-A01W-11,TCGA-AG-A01W,READ,67.0,FEMALE,nan,Stage II,nan,Rectal Adenocarcinoma,nan,2004.0,nan,-24745.0,Alive,WITH TUMOR,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-AG-A01Y-01,TCGA-AG-A01Y,READ,49.0,FEMALE,nan,Stage II,nan,Rectal Adenocarcinoma,nan,2004.0,nan,-18112.0,Alive,WITH TUMOR,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-AG-A01Y-11,TCGA-AG-A01Y,READ,49.0,FEMALE,nan,Stage II,nan,Rectal Adenocarcinoma,nan,2004.0,nan,-18112.0,Alive,WITH TUMOR,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-AG-A020-01,TCGA-AG-A020,READ,57.0,FEMALE,nan,Stage III,nan,Rectal Mucinous Adenocarcinoma,nan,2005.0,nan,-20851.0,Alive,WITH TUMOR,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-AG-A020-11,TCGA-AG-A020,READ,57.0,FEMALE,nan,Stage III,nan,Rectal Mucinous Adenocarcinoma,nan,2005.0,nan,-20851.0,Alive,WITH TUMOR,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-AG-A023-01,TCGA-AG-A023,READ,62.0,FEMALE,nan,Stage IV,nan,Rectal Adenocarcinoma,nan,2005.0,nan,-22830.0,Dead,WITH TUMOR,nan,1581.0,nan,nan,nan,nan,822.0,nan,nan,nan,1.0,1581.0,1.0,1581.0,nan,nan,1.0,822.0,1
TCGA-AG-A025-01,TCGA-AG-A025,READ,62.0,FEMALE,nan,Stage I,nan,Rectal Adenocarcinoma,nan,2006.0,nan,-22952.0,Alive,WITH TUMOR,1520.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1520.0,0.0,1520.0,nan,nan,0.0,1520.0,0
TCGA-AG-A026-01,TCGA-AG-A026,READ,66.0,MALE,nan,Stage II,nan,Rectal Adenocarcinoma,nan,2006.0,nan,-24413.0,Dead,WITH TUMOR,nan,59.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,59.0,1.0,59.0,nan,nan,1.0,59.0,1
TCGA-AG-A02G-01,TCGA-AG-A02G,READ,66.0,MALE,nan,Stage IV,nan,Rectal Adenocarcinoma,nan,2007.0,nan,-24259.0,Dead,WITH TUMOR,nan,1185.0,nan,nan,nan,nan,578.0,Partial Remission/Response,nan,nan,1.0,1185.0,1.0,1185.0,nan,nan,1.0,578.0,1
TCGA-AG-A02N-01,TCGA-AG-A02N,READ,67.0,MALE,nan,Stage II,nan,Rectal Adenocarcinoma,nan,2005.0,nan,-24687.0,Alive,WITH TUMOR,1885.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1885.0,0.0,1885.0,nan,nan,0.0,1885.0,0
TCGA-AG-A02N-11,TCGA-AG-A02N,READ,67.0,MALE,nan,Stage II,nan,Rectal Adenocarcinoma,nan,2005.0,nan,-24687.0,Alive,WITH TUMOR,1885.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1885.0,0.0,1885.0,nan,nan,0.0,1885.0,0
TCGA-AG-A02X-01,TCGA-AG-A02X,READ,77.0,MALE,nan,Stage I,nan,Rectal Adenocarcinoma,nan,2007.0,nan,-28399.0,Alive,WITH TUMOR,1247.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1247.0,0.0,1247.0,nan,nan,0.0,1247.0,0
TCGA-AG-A032-01,TCGA-AG-A032,READ,68.0,MALE,nan,Stage IIIB,nan,Rectal Adenocarcinoma,nan,2007.0,nan,-24865.0,Alive,WITH TUMOR,1157.0,nan,nan,nan,nan,nan,792.0,Partial Remission/Response,nan,nan,0.0,1157.0,0.0,1157.0,nan,nan,1.0,792.0,0
TCGA-AG-A036-01,TCGA-AG-A036,READ,71.0,MALE,nan,Stage III,nan,Rectal Adenocarcinoma,nan,2002.0,nan,-26206.0,Alive,TUMOR FREE,3562.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3562.0,0.0,3562.0,0.0,3562.0,0.0,3562.0,0
TCGA-AG-A036-11,TCGA-AG-A036,READ,71.0,MALE,nan,Stage III,nan,Rectal Adenocarcinoma,nan,2002.0,nan,-26206.0,Alive,TUMOR FREE,3562.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3562.0,0.0,3562.0,0.0,3562.0,0.0,3562.0,0
TCGA-AH-6544-01,TCGA-AH-6544,READ,60.0,MALE,WHITE,nan,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-21977.0,Alive,WITH TUMOR,1173.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1173.0,0.0,1173.0,nan,nan,0.0,1173.0,0
TCGA-AH-6547-01,TCGA-AH-6547,READ,79.0,FEMALE,WHITE,nan,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-29030.0,Dead,TUMOR FREE,nan,76.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,76.0,0.0,76.0,0.0,76.0,0.0,76.0,0
TCGA-AH-6549-01,TCGA-AH-6549,READ,66.0,MALE,WHITE,nan,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-24337.0,Alive,TUMOR FREE,532.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,532.0,0.0,532.0,0.0,532.0,0.0,532.0,0
TCGA-AH-6643-01,TCGA-AH-6643,READ,50.0,MALE,WHITE,Stage IIIC,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-18273.0,Dead,WITH TUMOR,nan,1314.0,nan,nan,nan,nan,1026.0,Complete Remission/Response,nan,nan,1.0,1314.0,1.0,1314.0,1.0,1026.0,1.0,1026.0,1
TCGA-AH-6643-11,TCGA-AH-6643,READ,50.0,MALE,WHITE,Stage IIIC,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-18273.0,Dead,WITH TUMOR,nan,1314.0,nan,nan,nan,nan,1026.0,Complete Remission/Response,nan,nan,1.0,1314.0,1.0,1314.0,1.0,1026.0,1.0,1026.0,1
TCGA-AH-6644-01,TCGA-AH-6644,READ,73.0,MALE,WHITE,nan,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-26892.0,Alive,TUMOR FREE,838.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,838.0,0.0,838.0,0.0,838.0,0.0,838.0,0
TCGA-AH-6897-01,TCGA-AH-6897,READ,48.0,MALE,WHITE,Stage I,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-17536.0,Alive,TUMOR FREE,804.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,804.0,0.0,804.0,0.0,804.0,0.0,804.0,0
TCGA-AH-6903-01,TCGA-AH-6903,READ,46.0,MALE,WHITE,Stage IIIB,nan,Rectal Mucinous Adenocarcinoma,nan,2010.0,nan,-17030.0,Alive,TUMOR FREE,592.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,592.0,0.0,592.0,0.0,592.0,0.0,592.0,0
TCGA-BM-6198-01,TCGA-BM-6198,READ,73.0,MALE,WHITE,Stage IIIB,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-26837.0,Alive,TUMOR FREE,646.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,646.0,0.0,646.0,0.0,646.0,0.0,646.0,0
TCGA-CI-6619-01,TCGA-CI-6619,READ,41.0,MALE,WHITE,Stage IV,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-15322.0,Alive,nan,184.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,184.0,0.0,184.0,nan,nan,0.0,184.0,0
TCGA-CI-6620-01,TCGA-CI-6620,READ,41.0,FEMALE,WHITE,Stage IVA,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-15322.0,Alive,WITH TUMOR,1009.0,nan,nan,nan,nan,nan,90.0,Progressive Disease,nan,nan,0.0,1009.0,0.0,1009.0,nan,nan,1.0,90.0,2
TCGA-CI-6621-01,TCGA-CI-6621,READ,63.0,MALE,WHITE,Stage IIIB,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-23240.0,Alive,nan,419.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,419.0,0.0,419.0,nan,nan,0.0,419.0,0
TCGA-CI-6622-01,TCGA-CI-6622,READ,74.0,MALE,WHITE,Stage IIB,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-27336.0,Alive,TUMOR FREE,1362.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1362.0,0.0,1362.0,nan,nan,0.0,1362.0,0
TCGA-CI-6623-01,TCGA-CI-6623,READ,44.0,MALE,WHITE,Stage I,nan,Rectal Adenocarcinoma,nan,2011.0,nan,-16177.0,Alive,TUMOR FREE,1443.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1443.0,0.0,1443.0,nan,nan,0.0,1443.0,0
TCGA-CI-6624-01,TCGA-CI-6624,READ,53.0,FEMALE,WHITE,Stage I,nan,Rectal Adenocarcinoma,nan,2011.0,nan,-19419.0,Alive,nan,1466.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,1466.0,0.0,1466.0,nan,nan,0.0,1466.0,0
TCGA-CL-4957-01,TCGA-CL-4957,READ,79.0,FEMALE,nan,[Discrepancy],nan,Rectal Adenocarcinoma,nan,2008.0,nan,-29081.0,Alive,nan,425.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,425.0,0.0,425.0,0.0,425.0,0.0,425.0,0
TCGA-CL-5917-01,TCGA-CL-5917,READ,71.0,FEMALE,WHITE,Stage IIIC,nan,Rectal Adenocarcinoma,nan,2006.0,nan,-26084.0,Alive,TUMOR FREE,2376.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2376.0,0.0,2376.0,0.0,2376.0,0.0,2376.0,0
TCGA-CL-5918-01,TCGA-CL-5918,READ,90.0,FEMALE,WHITE,Stage IIA,nan,Rectal Adenocarcinoma,nan,2008.0,nan,-32873.0,Alive,TUMOR FREE,218.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,218.0,0.0,218.0,0.0,218.0,0.0,218.0,0
TCGA-DC-4745-01,TCGA-DC-4745,READ,49.0,FEMALE,WHITE,Stage IIIB,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-17958.0,Alive,TUMOR FREE,639.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,639.0,0.0,639.0,0.0,639.0,0.0,639.0,0
TCGA-DC-4749-01,TCGA-DC-4749,READ,57.0,MALE,WHITE,Stage I,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-21092.0,Alive,TUMOR FREE,762.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,762.0,0.0,762.0,0.0,762.0,0.0,762.0,0
TCGA-DC-5337-01,TCGA-DC-5337,READ,69.0,MALE,WHITE,Stage I,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-25202.0,Alive,TUMOR FREE,792.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,792.0,0.0,792.0,nan,nan,0.0,792.0,0
TCGA-DC-5869-01,TCGA-DC-5869,READ,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-22676.0,Alive,TUMOR FREE,943.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,943.0,0.0,943.0,nan,nan,0.0,943.0,0
TCGA-DC-6154-01,TCGA-DC-6154,READ,57.0,FEMALE,WHITE,Stage IVA,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-21093.0,Alive,TUMOR FREE,365.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,365.0,0.0,365.0,nan,nan,0.0,365.0,0
TCGA-DC-6155-01,TCGA-DC-6155,READ,31.0,FEMALE,WHITE,Stage IIIA,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-11381.0,Alive,TUMOR FREE,425.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,425.0,0.0,425.0,nan,nan,0.0,425.0,0
TCGA-DC-6156-01,TCGA-DC-6156,READ,62.0,MALE,WHITE,Stage IVA,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-22706.0,Alive,WITH TUMOR,943.0,nan,nan,nan,nan,nan,30.0,nan,nan,nan,0.0,943.0,0.0,943.0,nan,nan,1.0,30.0,0
TCGA-DC-6157-01,TCGA-DC-6157,READ,48.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-17807.0,Alive,TUMOR FREE,1581.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1581.0,0.0,1581.0,nan,nan,0.0,1581.0,0
TCGA-DC-6158-01,TCGA-DC-6158,READ,70.0,MALE,WHITE,Stage I,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-25842.0,Dead,TUMOR FREE,nan,334.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,334.0,0.0,334.0,nan,nan,0.0,334.0,0
TCGA-DC-6160-01,TCGA-DC-6160,READ,68.0,MALE,WHITE,Stage I,nan,Rectal Adenocarcinoma,nan,2009.0,nan,-24990.0,Alive,TUMOR FREE,1339.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1339.0,0.0,1339.0,nan,nan,0.0,1339.0,0
TCGA-DC-6681-01,TCGA-DC-6681,READ,70.0,FEMALE,WHITE,Stage IVA,nan,Rectal Adenocarcinoma,nan,2011.0,nan,-25659.0,Alive,TUMOR FREE,790.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,790.0,0.0,790.0,nan,nan,0.0,790.0,0
TCGA-DC-6682-01,TCGA-DC-6682,READ,57.0,MALE,WHITE,Stage IIA,nan,Rectal Adenocarcinoma,nan,2011.0,nan,-21062.0,Alive,TUMOR FREE,762.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,762.0,0.0,762.0,nan,nan,0.0,762.0,0
TCGA-DC-6683-01,TCGA-DC-6683,READ,43.0,MALE,WHITE,Stage IIIB,nan,Rectal Adenocarcinoma,nan,2011.0,nan,-15918.0,Alive,TUMOR FREE,762.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,762.0,0.0,762.0,nan,nan,0.0,762.0,0
TCGA-DT-5265-01,TCGA-DT-5265,READ,51.0,MALE,ASIAN,Stage II,nan,Rectal Mucinous Adenocarcinoma,nan,2010.0,nan,-18669.0,Alive,TUMOR FREE,384.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,384.0,0.0,384.0,0.0,384.0,0.0,384.0,0
TCGA-DY-A0XA-01,TCGA-DY-A0XA,READ,57.0,FEMALE,WHITE,Stage IIA,nan,Rectal Adenocarcinoma,nan,2001.0,nan,-21115.0,Alive,nan,3846.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3846.0,0.0,3846.0,nan,nan,0.0,3846.0,0
TCGA-DY-A1DC-01,TCGA-DY-A1DC,READ,72.0,FEMALE,WHITE,Stage IIA,nan,Rectal Adenocarcinoma,nan,2000.0,nan,-26436.0,Dead,nan,nan,1258.0,nan,Locoregional Disease,nan,nan,630.0,nan,nan,nan,1.0,1258.0,nan,1258.0,nan,nan,1.0,630.0,1
TCGA-DY-A1DD-01,TCGA-DY-A1DD,READ,77.0,FEMALE,WHITE,Stage IIIB,nan,Rectal Adenocarcinoma,nan,1999.0,nan,-28159.0,Dead,nan,1741.0,1741.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1741.0,nan,1741.0,nan,nan,0.0,1741.0,1
TCGA-DY-A1DE-01,TCGA-DY-A1DE,READ,56.0,FEMALE,WHITE,Stage IIA,nan,Rectal Adenocarcinoma,nan,2001.0,nan,-20504.0,Alive,nan,3932.0,nan,nan,nan,nan,nan,3316.0,nan,nan,nan,0.0,3932.0,0.0,3932.0,nan,nan,1.0,3316.0,0
TCGA-DY-A1DF-01,TCGA-DY-A1DF,READ,73.0,FEMALE,WHITE,Stage IIIC,nan,Rectal Adenocarcinoma,nan,2001.0,nan,-26763.0,Dead,nan,734.0,734.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,734.0,nan,734.0,nan,nan,0.0,734.0,1
TCGA-DY-A1DG-01,TCGA-DY-A1DG,READ,75.0,MALE,WHITE,Stage IVA,nan,Rectal Adenocarcinoma,nan,2000.0,nan,-27396.0,Dead,nan,nan,1566.0,nan,nan,nan,nan,592.0,nan,nan,nan,1.0,1566.0,nan,1566.0,nan,nan,1.0,592.0,1
TCGA-DY-A1H8-01,TCGA-DY-A1H8,READ,77.0,FEMALE,WHITE,Stage IIIA,nan,Rectal Adenocarcinoma,nan,2000.0,nan,-28459.0,Dead,nan,992.0,992.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,992.0,nan,992.0,nan,nan,0.0,992.0,1
TCGA-EF-5830-01,TCGA-EF-5830,READ,54.0,MALE,WHITE,Stage IIB,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-19802.0,Alive,TUMOR FREE,106.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,106.0,0.0,106.0,nan,nan,0.0,106.0,0
TCGA-EF-5831-01,TCGA-EF-5831,READ,72.0,MALE,WHITE,Stage IIA,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-26331.0,Alive,TUMOR FREE,127.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,127.0,0.0,127.0,nan,nan,0.0,127.0,0
TCGA-EI-6506-01,TCGA-EI-6506,READ,78.0,FEMALE,WHITE,Stage IIA,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-28587.0,Alive,TUMOR FREE,625.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,625.0,0.0,625.0,nan,nan,0.0,625.0,0
TCGA-EI-6507-01,TCGA-EI-6507,READ,60.0,MALE,WHITE,Stage IIA,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-22176.0,Alive,TUMOR FREE,607.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,607.0,0.0,607.0,nan,nan,0.0,607.0,0
TCGA-EI-6508-01,TCGA-EI-6508,READ,48.0,FEMALE,WHITE,Stage IIIB,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-17827.0,Alive,TUMOR FREE,636.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,636.0,0.0,636.0,nan,nan,0.0,636.0,0
TCGA-EI-6509-01,TCGA-EI-6509,READ,53.0,MALE,WHITE,Stage IIIC,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-19666.0,Alive,WITH TUMOR,517.0,nan,nan,Metastatic,nan,nan,90.0,nan,nan,nan,0.0,517.0,0.0,517.0,nan,nan,1.0,90.0,0
TCGA-EI-6510-01,TCGA-EI-6510,READ,77.0,FEMALE,WHITE,[Discrepancy],nan,Rectal Adenocarcinoma,nan,2010.0,nan,-28328.0,Alive,TUMOR FREE,556.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,556.0,0.0,556.0,nan,nan,0.0,556.0,0
TCGA-EI-6511-01,TCGA-EI-6511,READ,52.0,MALE,WHITE,Stage IIIB,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-19237.0,Alive,TUMOR FREE,482.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,482.0,0.0,482.0,nan,nan,0.0,482.0,0
TCGA-EI-6512-01,TCGA-EI-6512,READ,64.0,FEMALE,WHITE,Stage IIIB,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-23537.0,Alive,TUMOR FREE,538.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,538.0,0.0,538.0,nan,nan,0.0,538.0,0
TCGA-EI-6513-01,TCGA-EI-6513,READ,59.0,MALE,WHITE,Stage IIIB,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-21776.0,Alive,TUMOR FREE,497.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,497.0,0.0,497.0,nan,nan,0.0,497.0,0
TCGA-EI-6514-01,TCGA-EI-6514,READ,59.0,FEMALE,WHITE,Stage IIA,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-21618.0,Alive,TUMOR FREE,496.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,496.0,0.0,496.0,nan,nan,0.0,496.0,0
TCGA-EI-6881-01,TCGA-EI-6881,READ,60.0,MALE,WHITE,Stage IIIA,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-22057.0,Alive,TUMOR FREE,499.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,499.0,0.0,499.0,nan,nan,0.0,499.0,0
TCGA-EI-6882-01,TCGA-EI-6882,READ,59.0,MALE,WHITE,Stage IIA,nan,Rectal Mucinous Adenocarcinoma,nan,2011.0,nan,-21682.0,Alive,TUMOR FREE,262.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,262.0,0.0,262.0,nan,nan,0.0,262.0,0
TCGA-EI-6883-01,TCGA-EI-6883,READ,63.0,MALE,WHITE,Stage IIC,nan,Rectal Adenocarcinoma,nan,2011.0,nan,-23268.0,Alive,TUMOR FREE,350.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,350.0,0.0,350.0,nan,nan,0.0,350.0,0
TCGA-EI-6884-01,TCGA-EI-6884,READ,71.0,MALE,WHITE,Stage IIIA,nan,Rectal Adenocarcinoma,nan,2011.0,nan,-25995.0,Alive,TUMOR FREE,328.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,328.0,0.0,328.0,nan,nan,0.0,328.0,0
TCGA-EI-6885-01,TCGA-EI-6885,READ,57.0,FEMALE,WHITE,Stage IV,nan,Rectal Adenocarcinoma,nan,2011.0,nan,-21140.0,Alive,WITH TUMOR,415.0,nan,nan,Locoregional Disease,nan,nan,295.0,nan,nan,nan,0.0,415.0,0.0,415.0,nan,nan,1.0,295.0,0
TCGA-EI-6917-01,TCGA-EI-6917,READ,33.0,MALE,WHITE,Stage IIIA,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-12113.0,Alive,TUMOR FREE,531.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,531.0,0.0,531.0,nan,nan,0.0,531.0,0
TCGA-EI-7002-01,TCGA-EI-7002,READ,58.0,MALE,WHITE,Stage IV,nan,Rectal Adenocarcinoma,nan,2011.0,nan,-21192.0,Alive,TUMOR FREE,364.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,364.0,0.0,364.0,nan,nan,0.0,364.0,0
TCGA-EI-7004-01,TCGA-EI-7004,READ,37.0,FEMALE,WHITE,[Discrepancy],nan,Rectal Mucinous Adenocarcinoma,nan,2011.0,nan,-13566.0,Alive,TUMOR FREE,257.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,257.0,0.0,257.0,nan,nan,0.0,257.0,0
TCGA-F5-6464-01,TCGA-F5-6464,READ,77.0,FEMALE,WHITE,Stage IIIC,nan,Rectal Adenocarcinoma,nan,2011.0,nan,-28168.0,Dead,nan,nan,303.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,303.0,nan,303.0,nan,nan,0.0,303.0,1
TCGA-F5-6465-01,TCGA-F5-6465,READ,64.0,FEMALE,WHITE,Stage IIA,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-23432.0,Alive,TUMOR FREE,1506.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1506.0,0.0,1506.0,0.0,1506.0,0.0,1506.0,0
TCGA-F5-6571-01,TCGA-F5-6571,READ,62.0,FEMALE,WHITE,Stage IIA,nan,Rectal Adenocarcinoma,nan,2011.0,nan,-22666.0,Alive,WITH TUMOR,1288.0,nan,nan,Metastatic,nan,nan,122.0,Complete Remission/Response,nan,nan,0.0,1288.0,0.0,1288.0,1.0,122.0,1.0,122.0,2
TCGA-F5-6702-01,TCGA-F5-6702,READ,71.0,MALE,WHITE,Stage IVA,nan,Rectal Adenocarcinoma,nan,2010.0,nan,-26123.0,Alive,WITH TUMOR,452.0,nan,nan,nan,nan,nan,368.0,Progressive Disease,nan,nan,0.0,452.0,0.0,452.0,nan,nan,1.0,368.0,0
TCGA-F5-6811-01,TCGA-F5-6811,READ,72.0,FEMALE,WHITE,Stage IIA,nan,Rectal Adenocarcinoma,nan,2011.0,nan,-26575.0,Alive,TUMOR FREE,979.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,979.0,0.0,979.0,0.0,979.0,0.0,979.0,0
TCGA-F5-6812-01,TCGA-F5-6812,READ,67.0,MALE,WHITE,Stage IIA,nan,Rectal Adenocarcinoma,nan,2011.0,nan,-24490.0,Alive,TUMOR FREE,1110.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1110.0,0.0,1110.0,0.0,1110.0,0.0,1110.0,0
TCGA-F5-6813-01,TCGA-F5-6813,READ,70.0,MALE,WHITE,Stage IIIC,nan,Rectal Adenocarcinoma,nan,2011.0,nan,-25651.0,Dead,WITH TUMOR,nan,598.0,nan,nan,nan,nan,65.0,[Unknown],nan,nan,1.0,598.0,1.0,598.0,nan,nan,1.0,65.0,1
TCGA-F5-6814-01,TCGA-F5-6814,READ,57.0,MALE,WHITE,Stage IIA,nan,Rectal Adenocarcinoma,nan,2011.0,nan,-20828.0,Alive,TUMOR FREE,1131.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1131.0,0.0,1131.0,0.0,1131.0,0.0,1131.0,0
TCGA-F5-6861-01,TCGA-F5-6861,READ,60.0,FEMALE,WHITE,Stage IIA,nan,Rectal Adenocarcinoma,nan,2011.0,nan,-21936.0,Alive,TUMOR FREE,1160.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1160.0,0.0,1160.0,0.0,1160.0,0.0,1160.0,0
TCGA-F5-6863-01,TCGA-F5-6863,READ,71.0,FEMALE,WHITE,Stage IIIB,nan,Rectal Adenocarcinoma,nan,2011.0,nan,-25936.0,Dead,WITH TUMOR,nan,361.0,nan,nan,nan,nan,191.0,[Unknown],nan,nan,1.0,361.0,1.0,361.0,nan,nan,1.0,191.0,1
TCGA-F5-6864-01,TCGA-F5-6864,READ,74.0,FEMALE,WHITE,Stage IIIB,nan,Rectal Adenocarcinoma,nan,2011.0,nan,-27058.0,Alive,TUMOR FREE,379.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,0
TCGA-G5-6233-01,TCGA-G5-6233,READ,74.0,MALE,WHITE,[Discrepancy],nan,Rectal Adenocarcinoma,nan,2009.0,nan,-27190.0,Dead,WITH TUMOR,nan,556.0,nan,nan,nan,nan,92.0,nan,nan,nan,1.0,556.0,1.0,556.0,nan,nan,1.0,92.0,1
TCGA-G5-6235-01,TCGA-G5-6235,READ,72.0,MALE,WHITE,Stage IIIB,nan,Rectal Adenocarcinoma,nan,2007.0,nan,-26348.0,Alive,TUMOR FREE,1696.0,nan,nan,nan,nan,nan,1042.0,nan,nan,nan,0.0,1696.0,0.0,1696.0,nan,nan,1.0,1042.0,0
TCGA-G5-6572-02,TCGA-G5-6572,READ,56.0,MALE,WHITE,nan,nan,Rectal Adenocarcinoma,nan,2004.0,nan,-20475.0,Dead,TUMOR FREE,nan,1432.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1432.0,0.0,1432.0,nan,nan,0.0,1432.0,0
TCGA-G5-6572-01,TCGA-G5-6572,READ,56.0,MALE,WHITE,nan,nan,Rectal Adenocarcinoma,nan,2004.0,nan,-20475.0,Dead,TUMOR FREE,nan,1432.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1432.0,0.0,1432.0,nan,nan,0.0,1432.0,0
TCGA-G5-6641-01,TCGA-G5-6641,READ,67.0,MALE,WHITE,Stage IIIA,nan,Rectal Mucinous Adenocarcinoma,nan,2009.0,nan,-24486.0,Alive,TUMOR FREE,804.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,804.0,0.0,804.0,nan,nan,0.0,804.0,0
TCGA-3B-A9HI-01,TCGA-3B-A9HI,SARC,68.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2009.0,nan,-24984.0,Alive,WITH TUMOR,1521.0,nan,nan,Locoregional Recurrence,nan,nan,606.0,nan,Positive,R1,0.0,1521.0,0.0,1521.0,nan,nan,1.0,606.0,0
TCGA-3B-A9HJ-01,TCGA-3B-A9HJ,SARC,68.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2011.0,nan,-24962.0,Alive,TUMOR FREE,1104.0,nan,nan,nan,nan,nan,nan,nan,[Unknown],RX,0.0,1104.0,0.0,1104.0,nan,nan,0.0,1104.0,0
TCGA-3B-A9HL-01,TCGA-3B-A9HL,SARC,67.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2011.0,nan,-24628.0,Dead,TUMOR FREE,nan,599.0,nan,Locoregional Recurrence,"Other, specify",Retroperitoneum,229.0,nan,Positive,R1,1.0,599.0,0.0,599.0,nan,nan,1.0,229.0,0
TCGA-3B-A9HO-01,TCGA-3B-A9HO,SARC,75.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2012.0,nan,-27664.0,Alive,TUMOR FREE,959.0,nan,nan,New Primary Tumor,"Other, specify",Abdominal Wall,595.0,nan,Positive,R1,0.0,959.0,0.0,959.0,nan,nan,1.0,595.0,0
TCGA-3B-A9HP-01,TCGA-3B-A9HP,SARC,57.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2007.0,nan,-21094.0,Dead,WITH TUMOR,nan,1627.0,nan,Distant Metastasis,Lung,nan,517.0,nan,Positive,R1,1.0,1627.0,1.0,1627.0,nan,nan,1.0,517.0,1
TCGA-3B-A9HQ-01,TCGA-3B-A9HQ,SARC,66.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2007.0,nan,-24386.0,Alive,nan,2085.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,2085.0,0.0,2085.0,0.0,2085.0,0.0,2085.0,0
TCGA-3B-A9HR-01,TCGA-3B-A9HR,SARC,38.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Leiomyosarcoma (LMS),nan,2007.0,nan,-14041.0,Dead,WITH TUMOR,nan,2694.0,nan,Distant Metastasis,Lung,nan,496.0,nan,Negative,R0,1.0,2694.0,1.0,2694.0,1.0,496.0,1.0,496.0,1
TCGA-3B-A9HS-01,TCGA-3B-A9HS,SARC,60.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2008.0,nan,-21946.0,Dead,WITH TUMOR,nan,1366.0,nan,Locoregional Recurrence,nan,nan,139.0,nan,Negative,R0,1.0,1366.0,1.0,1366.0,1.0,139.0,1.0,139.0,1
TCGA-3B-A9HT-01,TCGA-3B-A9HT,SARC,53.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2010.0,nan,-19637.0,Alive,TUMOR FREE,1665.0,nan,nan,New Primary Tumor,Liver,nan,670.0,nan,Negative,R0,0.0,1665.0,0.0,1665.0,0.0,1665.0,1.0,670.0,0
TCGA-3B-A9HU-01,TCGA-3B-A9HU,SARC,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Leiomyosarcoma (LMS),nan,2010.0,nan,-19669.0,Alive,WITH TUMOR,768.0,nan,nan,Distant Metastasis,Lung,nan,631.0,nan,Negative,R0,0.0,768.0,0.0,768.0,1.0,631.0,1.0,631.0,2
TCGA-3B-A9HV-01,TCGA-3B-A9HV,SARC,48.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2010.0,nan,-17638.0,Dead,WITH TUMOR,nan,437.0,nan,Distant Metastasis,Lung,nan,41.0,nan,Negative,RX,1.0,437.0,1.0,437.0,nan,nan,1.0,41.0,1
TCGA-3B-A9HX-01,TCGA-3B-A9HX,SARC,70.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2011.0,nan,-25627.0,Alive,TUMOR FREE,1303.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1303.0,0.0,1303.0,0.0,1303.0,0.0,1303.0,0
TCGA-3B-A9HY-01,TCGA-3B-A9HY,SARC,49.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2011.0,nan,-18109.0,Alive,TUMOR FREE,314.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,314.0,0.0,314.0,0.0,314.0,0.0,314.0,0
TCGA-3B-A9HZ-01,TCGA-3B-A9HZ,SARC,66.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2011.0,nan,-24433.0,Alive,WITH TUMOR,1170.0,nan,nan,Distant Metastasis,Lung,nan,309.0,nan,Positive,R1,0.0,1170.0,0.0,1170.0,nan,nan,1.0,309.0,0
TCGA-3B-A9I0-01,TCGA-3B-A9I0,SARC,33.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2011.0,nan,-12148.0,Alive,WITH TUMOR,1096.0,nan,nan,Distant Metastasis,Liver,nan,503.0,nan,Negative,R0,0.0,1096.0,0.0,1096.0,1.0,503.0,1.0,503.0,0
TCGA-3B-A9I1-01,TCGA-3B-A9I1,SARC,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Leiomyosarcoma (LMS),nan,2012.0,nan,-20629.0,Dead,WITH TUMOR,nan,567.0,nan,Distant Metastasis,"Other, specify",Pelvis,192.0,nan,Negative,RX,1.0,567.0,1.0,567.0,nan,nan,1.0,192.0,1
TCGA-3B-A9I3-01,TCGA-3B-A9I3,SARC,62.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2012.0,nan,-22985.0,Alive,TUMOR FREE,808.0,nan,nan,New Primary Tumor,"Other, specify",Axillary Lymph Node,87.0,nan,Positive,R1,0.0,808.0,0.0,808.0,nan,nan,1.0,87.0,0
TCGA-3R-A8YX-01,TCGA-3R-A8YX,SARC,66.0,MALE,[Not Evaluated],nan,nan,Dedifferentiated liposarcoma,nan,2013.0,nan,-24412.0,Dead,WITH TUMOR,nan,17.0,nan,nan,nan,nan,nan,nan,Positive,R2,1.0,17.0,1.0,17.0,nan,nan,1.0,17.0,1
TCGA-DX-A1KU-01,TCGA-DX-A1KU,SARC,82.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2010.0,nan,-30054.0,Dead,WITH TUMOR,nan,427.0,nan,Distant Metastasis,"Other, specify",Abdomen,94.0,nan,nan,R2,1.0,427.0,1.0,427.0,nan,nan,1.0,94.0,1
TCGA-DX-A1KW-01,TCGA-DX-A1KW,SARC,67.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2009.0,nan,-24647.0,Dead,nan,nan,995.0,nan,nan,nan,nan,nan,nan,nan,R1,1.0,995.0,nan,995.0,nan,nan,0.0,995.0,1
TCGA-DX-A1KX-01,TCGA-DX-A1KX,SARC,67.0,FEMALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2009.0,nan,-24784.0,Alive,TUMOR FREE,2087.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2087.0,0.0,2087.0,0.0,2087.0,0.0,2087.0,0
TCGA-DX-A1KY-01,TCGA-DX-A1KY,SARC,66.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2009.0,nan,-24281.0,Dead,WITH TUMOR,nan,391.0,nan,Distant Metastasis,nan,nan,205.0,nan,nan,R1,1.0,391.0,1.0,391.0,nan,nan,1.0,205.0,1
TCGA-DX-A1KZ-01,TCGA-DX-A1KZ,SARC,66.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2009.0,nan,-24362.0,Alive,WITH TUMOR,1372.0,nan,nan,Locoregional Recurrence,"Other, specify",nan,1294.0,nan,nan,R1,0.0,1372.0,0.0,1372.0,nan,nan,1.0,1294.0,0
TCGA-DX-A1L0-01,TCGA-DX-A1L0,SARC,58.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2008.0,nan,-21434.0,Dead,WITH TUMOR,nan,564.0,nan,Locoregional Recurrence,nan,nan,103.0,nan,nan,R1,1.0,564.0,1.0,564.0,nan,nan,1.0,103.0,1
TCGA-DX-A1L1-01,TCGA-DX-A1L1,SARC,60.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2008.0,nan,-22218.0,Dead,WITH TUMOR,nan,1649.0,nan,Locoregional Recurrence,nan,nan,349.0,nan,nan,R0,1.0,1649.0,1.0,1649.0,1.0,349.0,1.0,349.0,1
TCGA-DX-A1L2-01,TCGA-DX-A1L2,SARC,78.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2008.0,nan,-28692.0,Alive,WITH TUMOR,2586.0,nan,nan,Locoregional Recurrence,nan,nan,1480.0,nan,nan,R0,0.0,2586.0,0.0,2586.0,1.0,1480.0,1.0,1480.0,0
TCGA-DX-A1L3-01,TCGA-DX-A1L3,SARC,60.0,FEMALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2009.0,nan,-22240.0,Dead,WITH TUMOR,nan,1020.0,nan,Locoregional Recurrence,nan,nan,437.0,nan,nan,R1,1.0,1020.0,1.0,1020.0,nan,nan,1.0,437.0,1
TCGA-DX-A1L4-01,TCGA-DX-A1L4,SARC,60.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2009.0,nan,-22195.0,Alive,WITH TUMOR,2036.0,nan,nan,Locoregional Recurrence,nan,nan,340.0,nan,nan,R0,0.0,2036.0,0.0,2036.0,1.0,340.0,1.0,340.0,2
TCGA-DX-A23R-01,TCGA-DX-A23R,SARC,55.0,FEMALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2002.0,nan,-20442.0,Alive,TUMOR FREE,2271.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,2271.0,0.0,2271.0,nan,nan,0.0,2271.0,0
TCGA-DX-A23T-01,TCGA-DX-A23T,SARC,40.0,FEMALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2006.0,nan,-14892.0,Dead,WITH TUMOR,nan,160.0,nan,Locoregional Recurrence,nan,nan,104.0,nan,nan,R1,1.0,160.0,1.0,160.0,nan,nan,1.0,104.0,1
TCGA-DX-A23U-01,TCGA-DX-A23U,SARC,81.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2003.0,nan,-29905.0,Dead,WITH TUMOR,nan,2324.0,nan,Locoregional Recurrence,nan,nan,873.0,nan,nan,R1,1.0,2324.0,1.0,2324.0,nan,nan,1.0,873.0,1
TCGA-DX-A23V-01,TCGA-DX-A23V,SARC,57.0,FEMALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2003.0,nan,-21155.0,Dead,WITH TUMOR,nan,2034.0,nan,Locoregional Recurrence,nan,nan,378.0,nan,nan,R1,1.0,2034.0,1.0,2034.0,nan,nan,1.0,378.0,1
TCGA-DX-A23Y-01,TCGA-DX-A23Y,SARC,80.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2006.0,nan,-29272.0,Dead,WITH TUMOR,nan,191.0,nan,Locoregional Recurrence,nan,nan,172.0,nan,nan,R1,1.0,191.0,1.0,191.0,nan,nan,1.0,172.0,1
TCGA-DX-A23Z-01,TCGA-DX-A23Z,SARC,74.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2006.0,nan,-27357.0,Dead,WITH TUMOR,nan,846.0,nan,Locoregional Recurrence,nan,nan,751.0,nan,nan,R1,1.0,846.0,1.0,846.0,nan,nan,1.0,751.0,1
TCGA-DX-A240-01,TCGA-DX-A240,SARC,51.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2006.0,nan,-18721.0,Alive,TUMOR FREE,1834.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1834.0,0.0,1834.0,0.0,1834.0,0.0,1834.0,0
TCGA-DX-A2IZ-01,TCGA-DX-A2IZ,SARC,60.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2007.0,nan,-22245.0,Alive,TUMOR FREE,261.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,261.0,0.0,261.0,0.0,261.0,0.0,261.0,0
TCGA-DX-A2J0-01,TCGA-DX-A2J0,SARC,61.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2005.0,nan,-22369.0,Dead,WITH TUMOR,nan,295.0,nan,Locoregional Recurrence,nan,nan,213.0,nan,nan,R1,1.0,295.0,1.0,295.0,nan,nan,1.0,213.0,1
TCGA-DX-A2J1-01,TCGA-DX-A2J1,SARC,53.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2007.0,nan,-19707.0,Alive,TUMOR FREE,2901.0,nan,nan,nan,nan,nan,nan,nan,Positive,R1,0.0,2901.0,0.0,2901.0,nan,nan,0.0,2901.0,0
TCGA-DX-A2J4-01,TCGA-DX-A2J4,SARC,60.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2008.0,nan,-22131.0,Alive,TUMOR FREE,2408.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2408.0,0.0,2408.0,0.0,2408.0,0.0,2408.0,0
TCGA-DX-A3LS-01,TCGA-DX-A3LS,SARC,78.0,FEMALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2011.0,nan,-28649.0,Dead,WITH TUMOR,nan,275.0,nan,Distant Metastasis,Lung,nan,114.0,nan,nan,R1,1.0,275.0,1.0,275.0,nan,nan,1.0,114.0,1
TCGA-DX-A3LT-01,TCGA-DX-A3LT,SARC,62.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2011.0,nan,-22837.0,Alive,WITH TUMOR,1492.0,nan,nan,Locoregional Recurrence,nan,nan,568.0,nan,Negative,R0,0.0,1492.0,0.0,1492.0,1.0,568.0,1.0,568.0,0
TCGA-DX-A3LU-01,TCGA-DX-A3LU,SARC,60.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2007.0,nan,-21915.0,Alive,TUMOR FREE,2641.0,nan,nan,Locoregional Recurrence,"Other, specify",Retroperitoneum,290.0,nan,Positive,R1,0.0,2641.0,0.0,2641.0,nan,nan,1.0,290.0,0
TCGA-DX-A3LW-01,TCGA-DX-A3LW,SARC,43.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2004.0,nan,-15969.0,Alive,WITH TUMOR,4150.0,nan,nan,Locoregional Recurrence,nan,nan,1125.0,nan,Positive,R1,0.0,4150.0,0.0,4150.0,nan,nan,1.0,1125.0,0
TCGA-DX-A3LY-01,TCGA-DX-A3LY,SARC,66.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2011.0,nan,-24166.0,Alive,TUMOR FREE,1017.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1017.0,0.0,1017.0,0.0,1017.0,0.0,1017.0,0
TCGA-DX-A3M1-01,TCGA-DX-A3M1,SARC,79.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2010.0,nan,-28932.0,Alive,WITH TUMOR,1359.0,nan,nan,Locoregional Recurrence,"Other, specify",Retroperitoneum,1212.0,nan,Positive,R2,0.0,1359.0,0.0,1359.0,nan,nan,1.0,1212.0,0
TCGA-DX-A3M2-01,TCGA-DX-A3M2,SARC,59.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2011.0,nan,-21689.0,Alive,WITH TUMOR,1055.0,nan,nan,nan,nan,nan,nan,nan,Positive,R1,0.0,1055.0,0.0,1055.0,nan,nan,0.0,1055.0,0
TCGA-DX-A3U5-01,TCGA-DX-A3U5,SARC,52.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2011.0,nan,-19088.0,Alive,TUMOR FREE,969.0,nan,nan,nan,nan,nan,nan,nan,Positive,R1,0.0,969.0,0.0,969.0,nan,nan,0.0,969.0,0
TCGA-DX-A3U6-01,TCGA-DX-A3U6,SARC,63.0,FEMALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2011.0,nan,-23193.0,Dead,WITH TUMOR,nan,1088.0,nan,Locoregional Recurrence,nan,nan,160.0,nan,Negative,R0,1.0,1088.0,1.0,1088.0,1.0,160.0,1.0,160.0,1
TCGA-DX-A3U7-01,TCGA-DX-A3U7,SARC,67.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2009.0,nan,-24723.0,Dead,WITH TUMOR,nan,1552.0,nan,Distant Metastasis,Lung,nan,349.0,nan,Negative,R0,1.0,1552.0,1.0,1552.0,1.0,349.0,1.0,349.0,1
TCGA-DX-A3U8-01,TCGA-DX-A3U8,SARC,43.0,MALE,[Unknown],nan,nan,Leiomyosarcoma (LMS),nan,2010.0,nan,-15751.0,Dead,WITH TUMOR,nan,138.0,nan,Distant Metastasis,Lung,nan,128.0,nan,nan,R0,1.0,138.0,1.0,138.0,1.0,128.0,1.0,128.0,1
TCGA-DX-A3U9-01,TCGA-DX-A3U9,SARC,84.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2005.0,nan,-31010.0,Dead,WITH TUMOR,nan,456.0,nan,Locoregional Recurrence,nan,nan,203.0,nan,nan,R1,1.0,456.0,1.0,456.0,nan,nan,1.0,203.0,1
TCGA-DX-A3UA-01,TCGA-DX-A3UA,SARC,47.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2009.0,nan,-17342.0,Dead,[Discrepancy],nan,325.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,325.0,nan,325.0,0.0,325.0,0.0,325.0,1
TCGA-DX-A3UB-01,TCGA-DX-A3UB,SARC,54.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2009.0,nan,-19862.0,Alive,TUMOR FREE,2247.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,2247.0,0.0,2247.0,0.0,2247.0,0.0,2247.0,0
TCGA-DX-A3UC-01,TCGA-DX-A3UC,SARC,37.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2009.0,nan,-13745.0,Alive,WITH TUMOR,2085.0,nan,nan,Distant Metastasis,Lung,nan,176.0,nan,Negative,R0,0.0,2085.0,0.0,2085.0,1.0,176.0,1.0,176.0,2
TCGA-DX-A3UD-01,TCGA-DX-A3UD,SARC,56.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2010.0,nan,-20703.0,Alive,WITH TUMOR,1534.0,nan,nan,Locoregional Recurrence,nan,nan,603.0,nan,Negative,R0,0.0,1534.0,0.0,1534.0,1.0,603.0,1.0,603.0,0
TCGA-DX-A3UE-01,TCGA-DX-A3UE,SARC,66.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2007.0,nan,-24388.0,Dead,WITH TUMOR,nan,1061.0,nan,Distant Metastasis,nan,nan,224.0,nan,nan,R0,1.0,1061.0,1.0,1061.0,1.0,224.0,1.0,224.0,1
TCGA-DX-A3UF-01,TCGA-DX-A3UF,SARC,65.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2007.0,nan,-23993.0,Dead,WITH TUMOR,nan,2599.0,nan,Locoregional Recurrence,nan,nan,964.0,nan,Positive,R1,1.0,2599.0,1.0,2599.0,nan,nan,1.0,964.0,1
TCGA-DX-A48J-01,TCGA-DX-A48J,SARC,44.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Leiomyosarcoma (LMS),nan,2003.0,nan,-16279.0,Dead,WITH TUMOR,nan,296.0,nan,Locoregional Recurrence,nan,nan,97.0,nan,nan,R0,1.0,296.0,1.0,296.0,1.0,97.0,1.0,97.0,1
TCGA-DX-A48K-01,TCGA-DX-A48K,SARC,65.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2011.0,nan,-23756.0,Alive,TUMOR FREE,1399.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1399.0,0.0,1399.0,0.0,1399.0,0.0,1399.0,0
TCGA-DX-A48L-01,TCGA-DX-A48L,SARC,49.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2010.0,nan,-18113.0,Dead,WITH TUMOR,nan,738.0,nan,Distant Metastasis,Lung,nan,316.0,nan,nan,R0,1.0,738.0,1.0,738.0,1.0,316.0,1.0,316.0,1
TCGA-DX-A48N-01,TCGA-DX-A48N,SARC,47.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2012.0,nan,-17364.0,Alive,TUMOR FREE,1073.0,nan,nan,nan,nan,nan,nan,nan,Positive,R1,0.0,1073.0,0.0,1073.0,nan,nan,0.0,1073.0,0
TCGA-DX-A48O-01,TCGA-DX-A48O,SARC,63.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2010.0,nan,-23364.0,Alive,TUMOR FREE,1605.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1605.0,0.0,1605.0,0.0,1605.0,0.0,1605.0,0
TCGA-DX-A48P-01,TCGA-DX-A48P,SARC,54.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2011.0,nan,-19794.0,Alive,TUMOR FREE,1400.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1400.0,0.0,1400.0,0.0,1400.0,0.0,1400.0,0
TCGA-DX-A48R-01,TCGA-DX-A48R,SARC,41.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2002.0,nan,-15107.0,Alive,WITH TUMOR,805.0,nan,nan,Locoregional Recurrence,nan,nan,315.0,nan,Positive,R1,0.0,805.0,0.0,805.0,nan,nan,1.0,315.0,0
TCGA-DX-A48U-01,TCGA-DX-A48U,SARC,57.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2005.0,nan,-20853.0,Alive,TUMOR FREE,3310.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,3310.0,0.0,3310.0,0.0,3310.0,0.0,3310.0,0
TCGA-DX-A48V-01,TCGA-DX-A48V,SARC,78.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2010.0,nan,-28754.0,Alive,TUMOR FREE,1820.0,nan,nan,Distant Metastasis,"Other, specify",Flank,1407.0,nan,Negative,R0,0.0,1820.0,0.0,1820.0,1.0,1407.0,1.0,1407.0,0
TCGA-DX-A6B7-01,TCGA-DX-A6B7,SARC,55.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2012.0,nan,-20365.0,Alive,TUMOR FREE,1143.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1143.0,0.0,1143.0,0.0,1143.0,0.0,1143.0,0
TCGA-DX-A6B8-01,TCGA-DX-A6B8,SARC,80.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2002.0,nan,-29513.0,Dead,WITH TUMOR,nan,485.0,nan,Distant Metastasis,Lung,nan,42.0,nan,Positive,R0,1.0,485.0,1.0,485.0,1.0,42.0,1.0,42.0,1
TCGA-DX-A6B9-01,TCGA-DX-A6B9,SARC,45.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Leiomyosarcoma (LMS),nan,2012.0,nan,-16561.0,Alive,TUMOR FREE,1138.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1138.0,0.0,1138.0,0.0,1138.0,0.0,1138.0,0
TCGA-DX-A6BA-01,TCGA-DX-A6BA,SARC,53.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2008.0,nan,-19455.0,Alive,WITH TUMOR,2515.0,nan,nan,Locoregional Recurrence,nan,nan,408.0,nan,Negative,R0,0.0,2515.0,0.0,2515.0,1.0,408.0,1.0,408.0,2
TCGA-DX-A6BB-01,TCGA-DX-A6BB,SARC,74.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2012.0,nan,-27150.0,Alive,WITH TUMOR,1105.0,nan,nan,nan,nan,nan,nan,nan,Positive,R1,0.0,1105.0,0.0,1105.0,nan,nan,0.0,1105.0,0
TCGA-DX-A6BE-01,TCGA-DX-A6BE,SARC,77.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2011.0,nan,-28368.0,Alive,TUMOR FREE,881.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,881.0,0.0,881.0,0.0,881.0,0.0,881.0,0
TCGA-DX-A6BF-01,TCGA-DX-A6BF,SARC,82.0,FEMALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2012.0,nan,-30071.0,Alive,WITH TUMOR,972.0,nan,nan,Locoregional Recurrence,"Other, specify",nan,947.0,nan,Positive,R1,0.0,972.0,0.0,972.0,nan,nan,1.0,947.0,1
TCGA-DX-A6BG-01,TCGA-DX-A6BG,SARC,51.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2012.0,nan,-18682.0,Alive,WITH TUMOR,1121.0,nan,nan,Locoregional Recurrence,nan,nan,149.0,nan,Negative,R0,0.0,1121.0,0.0,1121.0,1.0,149.0,1.0,149.0,0
TCGA-DX-A6BH-01,TCGA-DX-A6BH,SARC,34.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2012.0,nan,-12742.0,Alive,WITH TUMOR,821.0,nan,nan,Locoregional Recurrence,nan,nan,232.0,nan,Positive,R1,0.0,821.0,0.0,821.0,nan,nan,1.0,232.0,0
TCGA-DX-A6BK-01,TCGA-DX-A6BK,SARC,85.0,FEMALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2009.0,nan,-31159.0,Dead,TUMOR FREE,nan,492.0,nan,nan,nan,nan,nan,nan,Positive,R1,1.0,492.0,0.0,492.0,nan,nan,0.0,492.0,1
TCGA-DX-A6YQ-01,TCGA-DX-A6YQ,SARC,86.0,FEMALE,[Unknown],nan,nan,Myxofibrosarcoma,nan,2011.0,nan,-31421.0,Dead,TUMOR FREE,nan,93.0,nan,nan,nan,nan,nan,nan,Negative,R0,1.0,93.0,0.0,93.0,0.0,93.0,0.0,93.0,0
TCGA-DX-A6YR-01,TCGA-DX-A6YR,SARC,75.0,MALE,WHITE,nan,nan,Myxofibrosarcoma,nan,2011.0,nan,-27434.0,Alive,TUMOR FREE,1247.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1247.0,0.0,1247.0,0.0,1247.0,0.0,1247.0,0
TCGA-DX-A6YS-01,TCGA-DX-A6YS,SARC,61.0,MALE,WHITE,nan,nan,Myxofibrosarcoma,nan,2008.0,nan,-22310.0,Alive,TUMOR FREE,2381.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,2381.0,0.0,2381.0,0.0,2381.0,0.0,2381.0,0
TCGA-DX-A6YT-01,TCGA-DX-A6YT,SARC,31.0,FEMALE,WHITE,nan,nan,Myxofibrosarcoma,nan,2008.0,nan,-11633.0,Alive,TUMOR FREE,2044.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,2044.0,0.0,2044.0,0.0,2044.0,0.0,2044.0,0
TCGA-DX-A6YU-01,TCGA-DX-A6YU,SARC,50.0,FEMALE,WHITE,nan,nan,Myxofibrosarcoma,nan,2012.0,nan,-18351.0,Alive,TUMOR FREE,1045.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1045.0,0.0,1045.0,0.0,1045.0,0.0,1045.0,0
TCGA-DX-A6YV-01,TCGA-DX-A6YV,SARC,74.0,MALE,WHITE,nan,nan,Myxofibrosarcoma,nan,2008.0,nan,-27053.0,Dead,WITH TUMOR,nan,1536.0,nan,Distant Metastasis,"Other, specify",Groin - lymph nodes,516.0,nan,Negative,R0,1.0,1536.0,1.0,1536.0,1.0,516.0,1.0,516.0,1
TCGA-DX-A6YX-01,TCGA-DX-A6YX,SARC,68.0,FEMALE,[Unknown],nan,nan,Myxofibrosarcoma,nan,2005.0,nan,-24871.0,Dead,WITH TUMOR,nan,513.0,nan,Distant Metastasis,Lung,nan,200.0,nan,Negative,R0,1.0,513.0,1.0,513.0,1.0,200.0,1.0,200.0,1
TCGA-DX-A6YZ-01,TCGA-DX-A6YZ,SARC,59.0,MALE,WHITE,nan,nan,Myxofibrosarcoma,nan,2007.0,nan,-21886.0,Alive,TUMOR FREE,2625.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,2625.0,0.0,2625.0,0.0,2625.0,0.0,2625.0,0
TCGA-DX-A6Z0-01,TCGA-DX-A6Z0,SARC,78.0,FEMALE,WHITE,nan,nan,Myxofibrosarcoma,nan,2006.0,nan,-28796.0,Dead,TUMOR FREE,nan,1953.0,nan,nan,nan,nan,nan,nan,Positive,R1,1.0,1953.0,0.0,1953.0,nan,nan,0.0,1953.0,1
TCGA-DX-A6Z2-01,TCGA-DX-A6Z2,SARC,82.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2007.0,nan,-30042.0,Alive,WITH TUMOR,3079.0,nan,nan,Distant Metastasis,Lung,nan,2659.0,nan,Positive,R0,0.0,3079.0,0.0,3079.0,1.0,2659.0,1.0,2659.0,2
TCGA-DX-A7EF-01,TCGA-DX-A7EF,SARC,88.0,FEMALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2005.0,nan,-32302.0,Dead,WITH TUMOR,nan,648.0,nan,Distant Metastasis,Lung,nan,294.0,nan,Positive,R0,1.0,648.0,1.0,648.0,1.0,294.0,1.0,294.0,1
TCGA-DX-A7EI-01,TCGA-DX-A7EI,SARC,78.0,FEMALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2003.0,nan,-28610.0,Dead,WITH TUMOR,nan,1049.0,nan,Locoregional Recurrence,"Other, specify",Retroperitoneum,828.0,nan,Positive,R1,1.0,1049.0,1.0,1049.0,nan,nan,1.0,828.0,1
TCGA-DX-A7EL-01,TCGA-DX-A7EL,SARC,56.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2007.0,nan,-20767.0,Alive,TUMOR FREE,2291.0,nan,nan,Distant Metastasis,Lung,nan,2249.0,nan,Positive,R0,0.0,2291.0,0.0,2291.0,1.0,2249.0,1.0,2249.0,0
TCGA-DX-A7EM-01,TCGA-DX-A7EM,SARC,61.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2010.0,nan,-22531.0,Alive,TUMOR FREE,1892.0,nan,nan,nan,nan,nan,nan,nan,Positive,R0,0.0,1892.0,0.0,1892.0,0.0,1892.0,0.0,1892.0,0
TCGA-DX-A7EN-01,TCGA-DX-A7EN,SARC,53.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2012.0,nan,-19588.0,Alive,WITH TUMOR,923.0,nan,nan,Distant Metastasis,Lung,nan,352.0,nan,Positive,R0,0.0,923.0,0.0,923.0,1.0,352.0,1.0,352.0,2
TCGA-DX-A7EO-01,TCGA-DX-A7EO,SARC,20.0,FEMALE,WHITE,nan,nan,Synovial Sarcoma - Biphasic,nan,2002.0,nan,-7604.0,Alive,TUMOR FREE,4627.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,4627.0,0.0,4627.0,0.0,4627.0,0.0,4627.0,0
TCGA-DX-A7EQ-01,TCGA-DX-A7EQ,SARC,72.0,MALE,WHITE,nan,nan,Synovial Sarcoma - Monophasic,nan,2006.0,nan,-26503.0,Dead,WITH TUMOR,nan,897.0,nan,Distant Metastasis,Lung,nan,251.0,nan,Negative,R0,1.0,897.0,1.0,897.0,1.0,251.0,1.0,251.0,1
TCGA-DX-A7ER-01,TCGA-DX-A7ER,SARC,69.0,MALE,WHITE,nan,nan,Synovial Sarcoma - Monophasic,nan,2008.0,nan,-25363.0,Dead,TUMOR FREE,nan,1466.0,nan,nan,nan,nan,nan,nan,Negative,R0,1.0,1466.0,0.0,1466.0,0.0,1466.0,0.0,1466.0,0
TCGA-DX-A7ES-01,TCGA-DX-A7ES,SARC,50.0,FEMALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2013.0,nan,-18528.0,Alive,TUMOR FREE,610.0,nan,nan,nan,nan,nan,nan,nan,Positive,R0,0.0,610.0,0.0,610.0,0.0,610.0,0.0,610.0,0
TCGA-DX-A7ET-01,TCGA-DX-A7ET,SARC,71.0,MALE,BLACK OR AFRICAN AMERICAN,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2013.0,nan,-26193.0,Alive,TUMOR FREE,463.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,463.0,0.0,463.0,0.0,463.0,0.0,463.0,0
TCGA-DX-A7EU-01,TCGA-DX-A7EU,SARC,79.0,FEMALE,WHITE,nan,nan,Myxofibrosarcoma,nan,2013.0,nan,-29211.0,Alive,TUMOR FREE,721.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,721.0,0.0,721.0,0.0,721.0,0.0,721.0,0
TCGA-DX-A8BG-01,TCGA-DX-A8BG,SARC,83.0,FEMALE,WHITE,nan,nan,Myxofibrosarcoma,nan,2013.0,nan,-30333.0,Alive,TUMOR FREE,546.0,nan,nan,Distant Metastasis,Lung,nan,330.0,nan,Negative,R0,0.0,546.0,0.0,546.0,1.0,330.0,1.0,330.0,0
TCGA-DX-A8BH-01,TCGA-DX-A8BH,SARC,86.0,MALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2013.0,nan,-31770.0,Dead,WITH TUMOR,nan,439.0,nan,Distant Metastasis,"Other, specify",Pleura,272.0,nan,Positive,R0,1.0,439.0,1.0,439.0,1.0,272.0,1.0,272.0,1
TCGA-DX-A8BJ-01,TCGA-DX-A8BJ,SARC,76.0,MALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2011.0,nan,-28091.0,Dead,TUMOR FREE,nan,284.0,nan,nan,nan,nan,nan,nan,Negative,R0,1.0,284.0,0.0,284.0,0.0,284.0,0.0,284.0,0
TCGA-DX-A8BK-01,TCGA-DX-A8BK,SARC,61.0,FEMALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2009.0,nan,-22407.0,Alive,TUMOR FREE,1885.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1885.0,0.0,1885.0,0.0,1885.0,0.0,1885.0,0
TCGA-DX-A8BL-01,TCGA-DX-A8BL,SARC,59.0,MALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2011.0,nan,-21728.0,Alive,TUMOR FREE,1373.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1373.0,0.0,1373.0,0.0,1373.0,0.0,1373.0,0
TCGA-DX-A8BM-01,TCGA-DX-A8BM,SARC,60.0,MALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2011.0,nan,-22152.0,Alive,TUMOR FREE,1456.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1456.0,0.0,1456.0,0.0,1456.0,0.0,1456.0,0
TCGA-DX-A8BN-01,TCGA-DX-A8BN,SARC,78.0,FEMALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2011.0,nan,-28760.0,Alive,TUMOR FREE,1161.0,nan,nan,nan,nan,nan,nan,nan,Positive,R1,0.0,1161.0,0.0,1161.0,nan,nan,0.0,1161.0,0
TCGA-DX-A8BO-01,TCGA-DX-A8BO,SARC,67.0,FEMALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2011.0,nan,-24513.0,Alive,TUMOR FREE,1240.0,nan,nan,Locoregional Recurrence,"Other, specify",Calf,333.0,nan,Positive,R1,0.0,1240.0,0.0,1240.0,nan,nan,1.0,333.0,0
TCGA-DX-A8BP-01,TCGA-DX-A8BP,SARC,85.0,MALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2009.0,nan,-31382.0,Alive,WITH TUMOR,428.0,nan,nan,Distant Metastasis,Lung,nan,216.0,nan,Positive,R1,0.0,428.0,0.0,428.0,nan,nan,1.0,216.0,0
TCGA-DX-A8BQ-01,TCGA-DX-A8BQ,SARC,63.0,MALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2010.0,nan,-23027.0,Alive,TUMOR FREE,1579.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1579.0,0.0,1579.0,0.0,1579.0,0.0,1579.0,0
TCGA-DX-A8BR-01,TCGA-DX-A8BR,SARC,63.0,FEMALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2002.0,nan,-23302.0,Alive,TUMOR FREE,4573.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,4573.0,0.0,4573.0,0.0,4573.0,0.0,4573.0,0
TCGA-DX-A8BS-01,TCGA-DX-A8BS,SARC,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2006.0,nan,-25023.0,Dead,TUMOR FREE,nan,850.0,nan,nan,nan,nan,nan,nan,Positive,R0,1.0,850.0,0.0,850.0,0.0,850.0,0.0,850.0,0
TCGA-DX-A8BT-01,TCGA-DX-A8BT,SARC,63.0,FEMALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2011.0,nan,-23204.0,Alive,TUMOR FREE,1230.0,nan,nan,Locoregional Recurrence,"Other, specify",Axilla,668.0,nan,Positive,R1,0.0,1230.0,0.0,1230.0,nan,nan,1.0,668.0,0
TCGA-DX-A8BU-01,TCGA-DX-A8BU,SARC,58.0,MALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2006.0,nan,-21470.0,Dead,WITH TUMOR,nan,1116.0,nan,Distant Metastasis,Lung,nan,107.0,nan,Positive,R1,1.0,1116.0,1.0,1116.0,nan,nan,1.0,107.0,1
TCGA-DX-A8BV-01,TCGA-DX-A8BV,SARC,57.0,MALE,WHITE,nan,nan,Myxofibrosarcoma,nan,2004.0,nan,-21005.0,Dead,WITH TUMOR,nan,1845.0,nan,Locoregional Recurrence,"Other, specify",Retroperitoneum,357.0,nan,Negative,R0,1.0,1845.0,1.0,1845.0,1.0,357.0,1.0,357.0,1
TCGA-DX-A8BX-01,TCGA-DX-A8BX,SARC,52.0,MALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2006.0,nan,-19339.0,Dead,WITH TUMOR,nan,591.0,nan,nan,nan,nan,nan,nan,Negative,R0,1.0,591.0,1.0,591.0,nan,nan,1.0,591.0,1
TCGA-DX-A8BZ-01,TCGA-DX-A8BZ,SARC,78.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Leiomyosarcoma (LMS),nan,2013.0,nan,-28853.0,Dead,WITH TUMOR,nan,200.0,nan,Distant Metastasis,Lung,nan,90.0,nan,Positive,R0,1.0,200.0,1.0,200.0,1.0,90.0,1.0,90.0,1
TCGA-DX-AATS-01,TCGA-DX-AATS,SARC,72.0,MALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2008.0,nan,-26624.0,Dead,TUMOR FREE,nan,35.0,nan,nan,nan,nan,nan,nan,Positive,R1,1.0,35.0,0.0,35.0,nan,nan,0.0,35.0,0
TCGA-DX-AB2E-01,TCGA-DX-AB2E,SARC,60.0,MALE,WHITE,nan,nan,Myxofibrosarcoma,nan,2013.0,nan,-22117.0,Alive,WITH TUMOR,541.0,nan,nan,Distant Metastasis,Lung,nan,132.0,nan,Positive,R0,0.0,541.0,0.0,541.0,1.0,132.0,1.0,132.0,0
TCGA-DX-AB2F-01,TCGA-DX-AB2F,SARC,76.0,FEMALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2013.0,nan,-27840.0,Alive,TUMOR FREE,365.0,nan,nan,nan,nan,nan,nan,nan,Positive,R0,0.0,365.0,0.0,365.0,0.0,365.0,0.0,365.0,0
TCGA-DX-AB2G-01,TCGA-DX-AB2G,SARC,36.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2013.0,nan,-13239.0,Alive,TUMOR FREE,478.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,478.0,0.0,478.0,0.0,478.0,0.0,478.0,0
TCGA-DX-AB2H-01,TCGA-DX-AB2H,SARC,80.0,FEMALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2013.0,nan,-29569.0,Alive,TUMOR FREE,482.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,482.0,0.0,482.0,0.0,482.0,0.0,482.0,0
TCGA-DX-AB2J-01,TCGA-DX-AB2J,SARC,71.0,FEMALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2006.0,nan,-26154.0,Dead,WITH TUMOR,nan,1235.0,nan,nan,nan,nan,nan,nan,Positive,R1,1.0,1235.0,1.0,1235.0,nan,nan,1.0,1235.0,1
TCGA-DX-AB2L-01,TCGA-DX-AB2L,SARC,35.0,MALE,WHITE,nan,nan,Myxofibrosarcoma,nan,2009.0,nan,-12974.0,Alive,TUMOR FREE,2007.0,nan,nan,nan,nan,nan,nan,nan,Positive,R1,0.0,2007.0,0.0,2007.0,nan,nan,0.0,2007.0,0
TCGA-DX-AB2O-01,TCGA-DX-AB2O,SARC,78.0,FEMALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2007.0,nan,-28757.0,Alive,TUMOR FREE,2619.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,2619.0,0.0,2619.0,0.0,2619.0,0.0,2619.0,0
TCGA-DX-AB2P-01,TCGA-DX-AB2P,SARC,79.0,MALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2005.0,nan,-29136.0,Dead,WITH TUMOR,nan,367.0,nan,Locoregional Recurrence,nan,nan,161.0,nan,Negative,R0,1.0,367.0,1.0,367.0,1.0,161.0,1.0,161.0,1
TCGA-DX-AB2Q-01,TCGA-DX-AB2Q,SARC,65.0,FEMALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2009.0,nan,-23748.0,Alive,TUMOR FREE,2030.0,nan,nan,Distant Metastasis,"Other, specify",inguinal lymph node,490.0,nan,Negative,R0,0.0,2030.0,0.0,2030.0,1.0,490.0,1.0,490.0,2
TCGA-DX-AB2S-01,TCGA-DX-AB2S,SARC,53.0,FEMALE,WHITE,nan,nan,Myxofibrosarcoma,nan,2005.0,nan,-19708.0,Alive,TUMOR FREE,280.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,280.0,0.0,280.0,0.0,280.0,0.0,280.0,0
TCGA-DX-AB2T-01,TCGA-DX-AB2T,SARC,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Myxofibrosarcoma,nan,2008.0,nan,-19749.0,Alive,TUMOR FREE,2369.0,nan,nan,Distant Metastasis,Lung,nan,784.0,nan,Negative,R0,0.0,2369.0,0.0,2369.0,1.0,784.0,1.0,784.0,0
TCGA-DX-AB2V-01,TCGA-DX-AB2V,SARC,81.0,MALE,WHITE,nan,nan,Myxofibrosarcoma,nan,2006.0,nan,-29716.0,Alive,TUMOR FREE,3241.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,3241.0,0.0,3241.0,0.0,3241.0,0.0,3241.0,0
TCGA-DX-AB2W-01,TCGA-DX-AB2W,SARC,62.0,FEMALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2006.0,nan,-22951.0,Alive,TUMOR FREE,3238.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,3238.0,0.0,3238.0,0.0,3238.0,0.0,3238.0,0
TCGA-DX-AB2X-01,TCGA-DX-AB2X,SARC,73.0,FEMALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2010.0,nan,-26736.0,Dead,WITH TUMOR,nan,404.0,nan,Locoregional Recurrence,nan,nan,111.0,nan,Negative,R0,1.0,404.0,1.0,404.0,1.0,111.0,1.0,111.0,1
TCGA-DX-AB2Z-01,TCGA-DX-AB2Z,SARC,87.0,FEMALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2010.0,nan,-31780.0,Alive,TUMOR FREE,1533.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1533.0,0.0,1533.0,0.0,1533.0,0.0,1533.0,0
TCGA-DX-AB30-01,TCGA-DX-AB30,SARC,53.0,FEMALE,WHITE,nan,nan,Myxofibrosarcoma,nan,2004.0,nan,-19698.0,Dead,WITH TUMOR,nan,695.0,nan,Distant Metastasis,Lung,nan,504.0,nan,Negative,R0,1.0,695.0,1.0,695.0,1.0,504.0,1.0,504.0,1
TCGA-DX-AB32-01,TCGA-DX-AB32,SARC,51.0,MALE,WHITE,nan,nan,Myxofibrosarcoma,nan,2006.0,nan,-18631.0,Alive,TUMOR FREE,3102.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,3102.0,0.0,3102.0,0.0,3102.0,0.0,3102.0,0
TCGA-DX-AB35-01,TCGA-DX-AB35,SARC,65.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2012.0,nan,-24026.0,Alive,WITH TUMOR,928.0,nan,nan,Locoregional Recurrence,"Other, specify",Retroperitoneum,284.0,nan,Negative,R0,0.0,928.0,0.0,928.0,1.0,284.0,1.0,284.0,2
TCGA-DX-AB36-01,TCGA-DX-AB36,SARC,86.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2008.0,nan,-31704.0,Dead,nan,nan,1825.0,nan,nan,nan,nan,nan,nan,Positive,R1,1.0,1825.0,nan,1825.0,nan,nan,0.0,1825.0,1
TCGA-DX-AB37-01,TCGA-DX-AB37,SARC,73.0,FEMALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2003.0,nan,-26696.0,Dead,nan,nan,2575.0,nan,nan,nan,nan,nan,nan,Negative,R0,1.0,2575.0,nan,2575.0,0.0,2575.0,0.0,2575.0,1
TCGA-DX-AB3A-01,TCGA-DX-AB3A,SARC,80.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2009.0,nan,-29230.0,Dead,WITH TUMOR,nan,978.0,nan,Locoregional Recurrence,nan,nan,533.0,nan,Negative,R0,1.0,978.0,1.0,978.0,1.0,533.0,1.0,533.0,1
TCGA-DX-AB3B-01,TCGA-DX-AB3B,SARC,28.0,FEMALE,WHITE,nan,nan,Synovial Sarcoma - Monophasic,nan,2009.0,nan,-10337.0,Alive,TUMOR FREE,1548.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1548.0,0.0,1548.0,0.0,1548.0,0.0,1548.0,0
TCGA-DX-AB3C-01,TCGA-DX-AB3C,SARC,27.0,MALE,WHITE,nan,nan,Synovial Sarcoma - Monophasic,nan,2008.0,nan,-10034.0,Alive,WITH TUMOR,2169.0,nan,nan,Distant Metastasis,Lung,nan,567.0,nan,Positive,R0,0.0,2169.0,0.0,2169.0,1.0,567.0,1.0,567.0,0
TCGA-FX-A2QS-01,TCGA-FX-A2QS,SARC,61.0,FEMALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2011.0,nan,-22422.0,Alive,TUMOR FREE,1495.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1495.0,0.0,1495.0,0.0,1495.0,0.0,1495.0,0
TCGA-FX-A2QS-11,TCGA-FX-A2QS,SARC,61.0,FEMALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2011.0,nan,-22422.0,Alive,TUMOR FREE,1495.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1495.0,0.0,1495.0,0.0,1495.0,0.0,1495.0,0
TCGA-FX-A3NJ-01,TCGA-FX-A3NJ,SARC,54.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2011.0,nan,-19903.0,Alive,TUMOR FREE,947.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,947.0,0.0,947.0,0.0,947.0,0.0,947.0,0
TCGA-FX-A3NK-01,TCGA-FX-A3NK,SARC,53.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2011.0,nan,-19533.0,Alive,TUMOR FREE,505.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,505.0,0.0,505.0,0.0,505.0,0.0,505.0,0
TCGA-FX-A3RE-01,TCGA-FX-A3RE,SARC,65.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2011.0,nan,-23757.0,Alive,TUMOR FREE,660.0,nan,nan,nan,nan,nan,nan,nan,[Unknown],RX,0.0,660.0,0.0,660.0,nan,nan,0.0,660.0,0
TCGA-FX-A3TO-01,TCGA-FX-A3TO,SARC,87.0,MALE,WHITE,nan,nan,Undifferentiated Pleomorphic Sarcoma (UPS),nan,2012.0,nan,-31868.0,Alive,TUMOR FREE,618.0,nan,nan,nan,nan,nan,nan,nan,Positive,R1,0.0,618.0,0.0,618.0,nan,nan,0.0,618.0,0
TCGA-FX-A48G-01,TCGA-FX-A48G,SARC,56.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2011.0,nan,-20756.0,Dead,WITH TUMOR,nan,605.0,nan,Distant Metastasis,Lung,nan,168.0,nan,[Unknown],RX,1.0,605.0,1.0,605.0,nan,nan,1.0,168.0,1
TCGA-FX-A48G-11,TCGA-FX-A48G,SARC,56.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2011.0,nan,-20756.0,Dead,WITH TUMOR,nan,605.0,nan,Distant Metastasis,Lung,nan,168.0,nan,[Unknown],RX,1.0,605.0,1.0,605.0,nan,nan,1.0,168.0,1
TCGA-FX-A76Y-01,TCGA-FX-A76Y,SARC,49.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2013.0,nan,-18181.0,Alive,TUMOR FREE,471.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,471.0,0.0,471.0,0.0,471.0,0.0,471.0,0
TCGA-FX-A8OO-01,TCGA-FX-A8OO,SARC,31.0,FEMALE,WHITE,nan,nan,Sarcoma; synovial; poorly differentiated,nan,2013.0,nan,-11376.0,Dead,TUMOR FREE,nan,245.0,nan,nan,nan,nan,nan,nan,Negative,R0,1.0,245.0,0.0,245.0,0.0,245.0,0.0,245.0,0
TCGA-HB-A2OT-01,TCGA-HB-A2OT,SARC,78.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Undifferentiated Pleomorphic Sarcoma (UPS),nan,2009.0,nan,-28632.0,Alive,TUMOR FREE,2057.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,2057.0,0.0,2057.0,0.0,2057.0,0.0,2057.0,0
TCGA-HB-A3L4-01,TCGA-HB-A3L4,SARC,46.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2009.0,nan,-17044.0,Dead,WITH TUMOR,nan,1061.0,nan,Distant Metastasis,Lung,nan,326.0,nan,Negative,R0,1.0,1061.0,1.0,1061.0,1.0,326.0,1.0,326.0,1
TCGA-HB-A3YV-01,TCGA-HB-A3YV,SARC,75.0,MALE,WHITE,nan,nan,Undifferentiated Pleomorphic Sarcoma (UPS),nan,2012.0,nan,-27583.0,Dead,WITH TUMOR,nan,139.0,nan,nan,nan,nan,nan,nan,Positive,R1,1.0,139.0,1.0,139.0,nan,nan,1.0,139.0,1
TCGA-HB-A43Z-01,TCGA-HB-A43Z,SARC,58.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2012.0,nan,-21233.0,Alive,WITH TUMOR,1126.0,nan,nan,Distant Metastasis,Lung,nan,894.0,nan,Negative,R0,0.0,1126.0,0.0,1126.0,1.0,894.0,1.0,894.0,2
TCGA-HB-A5W3-01,TCGA-HB-A5W3,SARC,58.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2010.0,nan,-21416.0,Dead,WITH TUMOR,nan,384.0,nan,nan,nan,nan,nan,nan,Negative,R0,1.0,384.0,1.0,384.0,nan,nan,1.0,384.0,1
TCGA-HS-A5N7-01,TCGA-HS-A5N7,SARC,67.0,FEMALE,[Not Evaluated],nan,nan,Leiomyosarcoma (LMS),nan,nan,nan,-24775.0,Alive,TUMOR FREE,1013.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1013.0,0.0,1013.0,0.0,1013.0,0.0,1013.0,0
TCGA-HS-A5N8-01,TCGA-HS-A5N8,SARC,69.0,FEMALE,[Not Evaluated],nan,nan,Leiomyosarcoma (LMS),nan,nan,nan,-25549.0,Dead,WITH TUMOR,nan,22.0,nan,nan,nan,nan,nan,nan,[Unknown],R2,1.0,22.0,1.0,22.0,nan,nan,1.0,22.0,1
TCGA-HS-A5N9-01,TCGA-HS-A5N9,SARC,58.0,FEMALE,[Not Evaluated],nan,nan,Leiomyosarcoma (LMS),nan,nan,nan,-21463.0,Alive,TUMOR FREE,1585.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1585.0,0.0,1585.0,0.0,1585.0,0.0,1585.0,0
TCGA-HS-A5NA-01,TCGA-HS-A5NA,SARC,65.0,FEMALE,[Not Evaluated],nan,nan,Leiomyosarcoma (LMS),nan,nan,nan,-24025.0,Alive,WITH TUMOR,298.0,nan,nan,nan,nan,nan,nan,nan,[Unknown],RX,0.0,298.0,0.0,298.0,nan,nan,0.0,298.0,0
TCGA-IE-A3OV-01,TCGA-IE-A3OV,SARC,42.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2004.0,nan,-15607.0,Dead,WITH TUMOR,nan,2448.0,nan,Distant Metastasis,Lung,nan,490.0,nan,Negative,R0,1.0,2448.0,1.0,2448.0,1.0,490.0,1.0,490.0,1
TCGA-IE-A4EH-01,TCGA-IE-A4EH,SARC,35.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2011.0,nan,-12871.0,Alive,TUMOR FREE,819.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,819.0,0.0,819.0,0.0,819.0,0.0,819.0,0
TCGA-IE-A4EI-01,TCGA-IE-A4EI,SARC,67.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2012.0,nan,-24663.0,Alive,TUMOR FREE,594.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,594.0,0.0,594.0,0.0,594.0,0.0,594.0,0
TCGA-IE-A4EJ-01,TCGA-IE-A4EJ,SARC,84.0,FEMALE,WHITE,nan,nan,Undifferentiated Pleomorphic Sarcoma (UPS),nan,2012.0,nan,-30858.0,Alive,TUMOR FREE,98.0,nan,nan,nan,nan,nan,nan,nan,Positive,R1,0.0,98.0,0.0,98.0,nan,nan,0.0,98.0,0
TCGA-IE-A4EK-01,TCGA-IE-A4EK,SARC,54.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2012.0,nan,-19815.0,Alive,nan,42.0,nan,nan,nan,nan,nan,nan,nan,Positive,R1,0.0,42.0,0.0,42.0,nan,nan,0.0,42.0,0
TCGA-IE-A6BZ-01,TCGA-IE-A6BZ,SARC,65.0,FEMALE,WHITE,nan,nan,Undifferentiated Pleomorphic Sarcoma (UPS),nan,2012.0,nan,-23756.0,Alive,TUMOR FREE,605.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,605.0,0.0,605.0,0.0,605.0,0.0,605.0,0
TCGA-IF-A3RQ-01,TCGA-IF-A3RQ,SARC,70.0,FEMALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,1998.0,nan,-25680.0,Dead,WITH TUMOR,nan,1129.0,nan,Locoregional Recurrence,"Other, specify",retroperitoneum,441.0,nan,Negative,R0,1.0,1129.0,1.0,1129.0,1.0,441.0,1.0,441.0,1
TCGA-IF-A4AJ-01,TCGA-IF-A4AJ,SARC,80.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,1995.0,nan,-29469.0,Dead,WITH TUMOR,nan,767.0,nan,Distant Metastasis,Lung,nan,560.0,nan,Negative,R0,1.0,767.0,1.0,767.0,1.0,560.0,1.0,560.0,1
TCGA-IF-A4AJ-11,TCGA-IF-A4AJ,SARC,80.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,1995.0,nan,-29469.0,Dead,WITH TUMOR,nan,767.0,nan,Distant Metastasis,Lung,nan,560.0,nan,Negative,R0,1.0,767.0,1.0,767.0,1.0,560.0,1.0,560.0,1
TCGA-IF-A4AK-01,TCGA-IF-A4AK,SARC,82.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2010.0,nan,-30141.0,Alive,TUMOR FREE,1590.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1590.0,0.0,1590.0,0.0,1590.0,0.0,1590.0,0
TCGA-IS-A3K6-01,TCGA-IS-A3K6,SARC,55.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2000.0,nan,-20205.0,Dead,WITH TUMOR,nan,858.0,nan,nan,nan,nan,nan,nan,nan,R2,1.0,858.0,1.0,858.0,nan,nan,1.0,858.0,1
TCGA-IS-A3K7-01,TCGA-IS-A3K7,SARC,63.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2000.0,nan,-23022.0,Alive,TUMOR FREE,5204.0,nan,nan,Distant Metastasis,Lung,nan,119.0,nan,nan,R0,0.0,5204.0,0.0,5204.0,1.0,119.0,1.0,119.0,0
TCGA-IS-A3K8-01,TCGA-IS-A3K8,SARC,44.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2002.0,nan,-16265.0,Alive,TUMOR FREE,4845.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,4845.0,0.0,4845.0,0.0,4845.0,0.0,4845.0,0
TCGA-IS-A3KA-01,TCGA-IS-A3KA,SARC,73.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2004.0,nan,-26775.0,Dead,WITH TUMOR,nan,413.0,nan,Distant Metastasis,Lung,nan,76.0,nan,nan,R0,1.0,413.0,1.0,413.0,1.0,76.0,1.0,76.0,1
TCGA-IW-A3M4-01,TCGA-IW-A3M4,SARC,48.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2005.0,nan,-17721.0,Alive,TUMOR FREE,2615.0,nan,nan,Locoregional Disease,nan,nan,2207.0,nan,nan,R0,0.0,2615.0,0.0,2615.0,1.0,2207.0,1.0,2207.0,0
TCGA-IW-A3M5-01,TCGA-IW-A3M5,SARC,76.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2010.0,nan,-27869.0,Dead,WITH TUMOR,nan,180.0,nan,Distant Metastasis,Lung,nan,9.0,nan,Negative,R0,1.0,180.0,1.0,180.0,1.0,9.0,1.0,9.0,1
TCGA-IW-A3M6-01,TCGA-IW-A3M6,SARC,59.0,FEMALE,ASIAN,nan,nan,Leiomyosarcoma (LMS),nan,2011.0,nan,-21674.0,Alive,TUMOR FREE,688.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,688.0,0.0,688.0,0.0,688.0,0.0,688.0,0
TCGA-JV-A5VE-01,TCGA-JV-A5VE,SARC,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Leiomyosarcoma (LMS),nan,2012.0,nan,-21933.0,Alive,TUMOR FREE,499.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,499.0,0.0,499.0,0.0,499.0,0.0,499.0,0
TCGA-JV-A5VF-01,TCGA-JV-A5VF,SARC,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Leiomyosarcoma (LMS),nan,2012.0,nan,-25505.0,Dead,WITH TUMOR,nan,32.0,nan,nan,nan,nan,nan,nan,Positive,R2,1.0,32.0,1.0,32.0,nan,nan,1.0,32.0,1
TCGA-JV-A75J-01,TCGA-JV-A75J,SARC,43.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2013.0,nan,-16001.0,Dead,WITH TUMOR,nan,119.0,nan,nan,nan,nan,nan,nan,Positive,R2,1.0,119.0,1.0,119.0,nan,nan,1.0,119.0,1
TCGA-K1-A3PN-02,TCGA-K1-A3PN,SARC,64.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2006.0,nan,-23631.0,Alive,TUMOR FREE,3080.0,nan,nan,nan,nan,nan,1033.0,nan,Negative,R0,0.0,3080.0,0.0,3080.0,1.0,1033.0,1.0,1033.0,0
TCGA-K1-A3PN-01,TCGA-K1-A3PN,SARC,64.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2006.0,nan,-23631.0,Alive,TUMOR FREE,3080.0,nan,nan,nan,nan,nan,1033.0,nan,Negative,R0,0.0,3080.0,0.0,3080.0,1.0,1033.0,1.0,1033.0,0
TCGA-K1-A3PO-01,TCGA-K1-A3PO,SARC,42.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2010.0,nan,-15494.0,Alive,TUMOR FREE,1622.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1622.0,0.0,1622.0,0.0,1622.0,0.0,1622.0,0
TCGA-K1-A3PO-11,TCGA-K1-A3PO,SARC,42.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2010.0,nan,-15494.0,Alive,TUMOR FREE,1622.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1622.0,0.0,1622.0,0.0,1622.0,0.0,1622.0,0
TCGA-K1-A42W-01,TCGA-K1-A42W,SARC,65.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2009.0,nan,-23910.0,Alive,WITH TUMOR,1891.0,nan,nan,Distant Metastasis,Liver,nan,826.0,nan,Negative,R0,0.0,1891.0,0.0,1891.0,1.0,826.0,1.0,826.0,2
TCGA-K1-A42X-02,TCGA-K1-A42X,SARC,62.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2003.0,nan,-22680.0,Alive,WITH TUMOR,3765.0,nan,nan,Locoregional Recurrence,"Other, specify",adjeacent area,2036.0,nan,Negative,R0,0.0,3765.0,0.0,3765.0,1.0,2036.0,1.0,2036.0,2
TCGA-K1-A42X-01,TCGA-K1-A42X,SARC,62.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2003.0,nan,-22680.0,Alive,WITH TUMOR,3765.0,nan,nan,Locoregional Recurrence,"Other, specify",adjeacent area,2036.0,nan,Negative,R0,0.0,3765.0,0.0,3765.0,1.0,2036.0,1.0,2036.0,2
TCGA-K1-A42X-11,TCGA-K1-A42X,SARC,62.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2003.0,nan,-22680.0,Alive,WITH TUMOR,3765.0,nan,nan,Locoregional Recurrence,"Other, specify",adjeacent area,2036.0,nan,Negative,R0,0.0,3765.0,0.0,3765.0,1.0,2036.0,1.0,2036.0,2
TCGA-K1-A6RT-01,TCGA-K1-A6RT,SARC,48.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2012.0,nan,-17739.0,Alive,WITH TUMOR,528.0,nan,nan,Distant Metastasis,Lung,nan,129.0,nan,Negative,R0,0.0,528.0,0.0,528.0,1.0,129.0,1.0,129.0,0
TCGA-K1-A6RU-01,TCGA-K1-A6RU,SARC,66.0,FEMALE,WHITE,nan,nan,Myxofibrosarcoma,nan,2013.0,nan,-24356.0,Dead,WITH TUMOR,nan,711.0,nan,Distant Metastasis,Bone,nan,142.0,nan,Positive,R1,1.0,711.0,1.0,711.0,nan,nan,1.0,142.0,1
TCGA-K1-A6RV-01,TCGA-K1-A6RV,SARC,67.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2013.0,nan,-24701.0,Alive,WITH TUMOR,158.0,nan,nan,nan,nan,nan,nan,nan,Positive,R1,0.0,158.0,0.0,158.0,nan,nan,0.0,158.0,0
TCGA-KD-A5QS-01,TCGA-KD-A5QS,SARC,55.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2009.0,nan,-20410.0,Dead,WITH TUMOR,nan,1941.0,nan,Distant Metastasis,Bone,nan,351.0,nan,[Unknown],RX,1.0,1941.0,1.0,1941.0,nan,nan,1.0,351.0,1
TCGA-KD-A5QT-01,TCGA-KD-A5QT,SARC,69.0,FEMALE,[Not Evaluated],nan,nan,Leiomyosarcoma (LMS),nan,2010.0,nan,-25249.0,Alive,TUMOR FREE,499.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,499.0,0.0,499.0,0.0,499.0,0.0,499.0,0
TCGA-KD-A5QU-01,TCGA-KD-A5QU,SARC,41.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2010.0,nan,-15018.0,Dead,WITH TUMOR,nan,1073.0,nan,Distant Metastasis,Lung,nan,1060.0,nan,Negative,R0,1.0,1073.0,1.0,1073.0,1.0,1060.0,1.0,1060.0,1
TCGA-KF-A41W-01,TCGA-KF-A41W,SARC,71.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2012.0,nan,-25969.0,Alive,TUMOR FREE,356.0,nan,nan,nan,nan,nan,nan,nan,Negative,RX,0.0,356.0,0.0,356.0,nan,nan,0.0,356.0,0
TCGA-KF-A41W-11,TCGA-KF-A41W,SARC,71.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2012.0,nan,-25969.0,Alive,TUMOR FREE,356.0,nan,nan,nan,nan,nan,nan,nan,Negative,RX,0.0,356.0,0.0,356.0,nan,nan,0.0,356.0,0
TCGA-LI-A67I-01,TCGA-LI-A67I,SARC,75.0,FEMALE,WHITE,nan,nan,Myxofibrosarcoma,nan,2013.0,nan,-27671.0,Alive,TUMOR FREE,922.0,nan,nan,Distant Metastasis,Lung,nan,574.0,nan,Positive,RX,0.0,922.0,0.0,922.0,nan,nan,1.0,574.0,0
TCGA-LI-A9QH-01,TCGA-LI-A9QH,SARC,72.0,FEMALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2013.0,nan,-26468.0,Dead,TUMOR FREE,nan,540.0,nan,Distant Metastasis,Lung,nan,426.0,nan,Negative,R2,1.0,540.0,0.0,540.0,nan,nan,1.0,426.0,1
TCGA-MB-A5Y8-01,TCGA-MB-A5Y8,SARC,60.0,FEMALE,WHITE,nan,nan,Undifferentiated Pleomorphic Sarcoma (UPS),nan,2012.0,nan,-22115.0,Alive,TUMOR FREE,773.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,773.0,0.0,773.0,0.0,773.0,0.0,773.0,0
TCGA-MB-A5Y9-01,TCGA-MB-A5Y9,SARC,90.0,MALE,WHITE,nan,nan,Undifferentiated Pleomorphic Sarcoma (UPS),nan,2012.0,nan,-32873.0,Alive,WITH TUMOR,252.0,nan,nan,nan,nan,nan,nan,nan,Positive,R1,0.0,252.0,0.0,252.0,nan,nan,0.0,252.0,0
TCGA-MB-A5YA-01,TCGA-MB-A5YA,SARC,63.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2012.0,nan,-23115.0,Alive,TUMOR FREE,15.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,15.0,0.0,15.0,0.0,15.0,0.0,15.0,0
TCGA-MB-A8JK-01,TCGA-MB-A8JK,SARC,49.0,MALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2013.0,nan,-18177.0,Alive,TUMOR FREE,661.0,nan,nan,nan,nan,nan,nan,nan,Negative,RX,0.0,661.0,0.0,661.0,nan,nan,0.0,661.0,0
TCGA-MB-A8JL-01,TCGA-MB-A8JL,SARC,53.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2013.0,nan,-19510.0,Alive,TUMOR FREE,600.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,600.0,0.0,600.0,0.0,600.0,0.0,600.0,0
TCGA-MJ-A68H-01,TCGA-MJ-A68H,SARC,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Leiomyosarcoma (LMS),nan,2013.0,nan,-21105.0,Alive,TUMOR FREE,456.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,456.0,0.0,456.0,0.0,456.0,0.0,456.0,0
TCGA-MJ-A68J-01,TCGA-MJ-A68J,SARC,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Myxofibrosarcoma,nan,2012.0,nan,-20100.0,Alive,WITH TUMOR,547.0,nan,nan,New Primary Tumor,"Other, specify",Foot,268.0,nan,Positive,R1,0.0,547.0,0.0,547.0,nan,nan,1.0,268.0,1
TCGA-MJ-A850-01,TCGA-MJ-A850,SARC,28.0,MALE,WHITE,nan,nan,Synovial Sarcoma - Monophasic,nan,2013.0,nan,-10451.0,Alive,TUMOR FREE,681.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,681.0,0.0,681.0,nan,nan,0.0,681.0,0
TCGA-MO-A47P-01,TCGA-MO-A47P,SARC,37.0,FEMALE,ASIAN,nan,nan,Dedifferentiated liposarcoma,nan,2012.0,nan,-13765.0,Alive,TUMOR FREE,352.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,352.0,0.0,352.0,0.0,352.0,0.0,352.0,0
TCGA-MO-A47R-01,TCGA-MO-A47R,SARC,75.0,FEMALE,ASIAN,nan,nan,Leiomyosarcoma (LMS),nan,2010.0,nan,-27731.0,Dead,WITH TUMOR,nan,318.0,nan,Distant Metastasis,Brain,nan,259.0,nan,nan,R0,1.0,318.0,1.0,318.0,1.0,259.0,1.0,259.0,1
TCGA-N1-A6IA-01,TCGA-N1-A6IA,SARC,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Leiomyosarcoma (LMS),nan,2011.0,nan,-15112.0,Dead,WITH TUMOR,nan,224.0,nan,Distant Metastasis,Lung,nan,116.0,nan,[Unknown],RX,1.0,224.0,1.0,224.0,nan,nan,1.0,116.0,1
TCGA-PC-A5DK-01,TCGA-PC-A5DK,SARC,63.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2004.0,nan,-23019.0,Alive,TUMOR FREE,3740.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,3740.0,0.0,3740.0,0.0,3740.0,0.0,3740.0,0
TCGA-PC-A5DL-01,TCGA-PC-A5DL,SARC,67.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2004.0,nan,-24761.0,Dead,nan,nan,1142.0,nan,nan,nan,nan,nan,nan,nan,RX,1.0,1142.0,nan,1142.0,nan,nan,0.0,1142.0,1
TCGA-PC-A5DM-01,TCGA-PC-A5DM,SARC,73.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2005.0,nan,-26699.0,Dead,nan,nan,193.0,nan,nan,nan,nan,nan,nan,Positive,R1,1.0,193.0,nan,193.0,nan,nan,0.0,193.0,1
TCGA-PC-A5DN-01,TCGA-PC-A5DN,SARC,77.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2005.0,nan,-28421.0,Dead,TUMOR FREE,nan,1175.0,nan,nan,nan,nan,nan,nan,nan,R1,1.0,1175.0,0.0,1175.0,nan,nan,0.0,1175.0,1
TCGA-PC-A5DO-01,TCGA-PC-A5DO,SARC,59.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2006.0,nan,-21606.0,Dead,WITH TUMOR,nan,2464.0,nan,nan,nan,nan,nan,nan,Negative,R1,1.0,2464.0,1.0,2464.0,nan,nan,1.0,2464.0,1
TCGA-PC-A5DP-01,TCGA-PC-A5DP,SARC,72.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2007.0,nan,-26414.0,Dead,WITH TUMOR,nan,550.0,nan,nan,nan,nan,nan,nan,nan,R1,1.0,550.0,1.0,550.0,nan,nan,1.0,550.0,1
TCGA-PT-A8TR-01,TCGA-PT-A8TR,SARC,57.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2013.0,nan,-20985.0,Alive,TUMOR FREE,813.0,nan,nan,nan,nan,nan,nan,nan,Positive,R1,0.0,813.0,0.0,813.0,nan,nan,0.0,813.0,0
TCGA-QC-A6FX-01,TCGA-QC-A6FX,SARC,68.0,MALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2013.0,nan,-25113.0,Alive,TUMOR FREE,637.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,637.0,0.0,637.0,0.0,637.0,0.0,637.0,0
TCGA-QC-A7B5-01,TCGA-QC-A7B5,SARC,75.0,MALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2013.0,nan,-27556.0,Alive,TUMOR FREE,398.0,nan,nan,New Primary Tumor,"Other, specify",skin,259.0,nan,Positive,RX,0.0,398.0,0.0,398.0,nan,nan,1.0,259.0,0
TCGA-QC-AA9N-01,TCGA-QC-AA9N,SARC,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Undifferentiated Pleomorphic Sarcoma (UPS),nan,2013.0,nan,-19395.0,Alive,TUMOR FREE,537.0,nan,nan,nan,nan,nan,nan,nan,Negative,RX,0.0,537.0,0.0,537.0,nan,nan,0.0,537.0,0
TCGA-QQ-A5V2-01,TCGA-QQ-A5V2,SARC,42.0,MALE,WHITE,nan,nan,Giant cell 'MFH' / Undifferentiated pleomorphic sarcoma with giant cells,nan,2006.0,nan,-15420.0,Alive,nan,56.0,nan,nan,nan,nan,nan,nan,nan,[Unknown],R1,0.0,56.0,0.0,56.0,nan,nan,0.0,56.0,0
TCGA-QQ-A5V9-01,TCGA-QQ-A5V9,SARC,76.0,MALE,WHITE,nan,nan,Undifferentiated Pleomorphic Sarcoma (UPS),nan,1997.0,nan,-27977.0,Dead,WITH TUMOR,nan,1424.0,nan,Distant Metastasis,Lung,nan,405.0,nan,Negative,R0,1.0,1424.0,1.0,1424.0,1.0,405.0,1.0,405.0,1
TCGA-QQ-A5VA-01,TCGA-QQ-A5VA,SARC,60.0,FEMALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,1996.0,nan,-22231.0,Dead,WITH TUMOR,nan,550.0,nan,nan,nan,nan,nan,nan,Negative,RX,1.0,550.0,1.0,550.0,nan,nan,1.0,550.0,1
TCGA-QQ-A5VB-01,TCGA-QQ-A5VB,SARC,53.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,1994.0,nan,-19654.0,Dead,WITH TUMOR,nan,1478.0,nan,Locoregional Recurrence,"Other, specify",Left Pelvis,111.0,nan,Positive,R1,1.0,1478.0,1.0,1478.0,nan,nan,1.0,111.0,1
TCGA-QQ-A5VC-01,TCGA-QQ-A5VC,SARC,63.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2011.0,nan,-23357.0,Alive,TUMOR FREE,1092.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1092.0,0.0,1092.0,0.0,1092.0,0.0,1092.0,0
TCGA-QQ-A5VD-01,TCGA-QQ-A5VD,SARC,52.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2011.0,nan,-19004.0,Alive,TUMOR FREE,1129.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1129.0,0.0,1129.0,0.0,1129.0,0.0,1129.0,0
TCGA-QQ-A8VB-01,TCGA-QQ-A8VB,SARC,68.0,FEMALE,WHITE,nan,nan,Malignant Peripheral Nerve Sheath Tumors (MPNST),nan,1998.0,nan,-24916.0,Alive,TUMOR FREE,5723.0,nan,nan,New Primary Tumor,"Other, specify",gastrointestinal,2682.0,nan,Negative,RX,0.0,5723.0,0.0,5723.0,nan,nan,1.0,2682.0,0
TCGA-QQ-A8VD-01,TCGA-QQ-A8VD,SARC,56.0,MALE,WHITE,nan,nan,Desmoid Tumor,nan,2003.0,nan,-20729.0,Alive,WITH TUMOR,3964.0,nan,nan,Locoregional Recurrence,"Other, specify",left abdominal wall,499.0,nan,Positive,RX,0.0,3964.0,0.0,3964.0,nan,nan,1.0,499.0,0
TCGA-QQ-A8VF-01,TCGA-QQ-A8VF,SARC,70.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2005.0,nan,-25682.0,Alive,TUMOR FREE,3406.0,nan,nan,nan,nan,nan,nan,nan,Negative,RX,0.0,3406.0,0.0,3406.0,nan,nan,0.0,3406.0,0
TCGA-QQ-A8VG-01,TCGA-QQ-A8VG,SARC,52.0,MALE,WHITE,nan,nan,Malignant Peripheral Nerve Sheath Tumors (MPNST),nan,2009.0,nan,-19304.0,Dead,WITH TUMOR,nan,1970.0,nan,New Primary Tumor,Liver,nan,1852.0,nan,Negative,RX,1.0,1970.0,1.0,1970.0,nan,nan,1.0,1852.0,1
TCGA-QQ-A8VH-01,TCGA-QQ-A8VH,SARC,31.0,FEMALE,WHITE,nan,nan,Malignant Peripheral Nerve Sheath Tumors (MPNST),nan,2010.0,nan,-11599.0,Dead,WITH TUMOR,nan,320.0,nan,Locoregional Recurrence,"Other, specify",Spine T6 to apical lung,197.0,nan,Positive,RX,1.0,320.0,1.0,320.0,nan,nan,1.0,197.0,1
TCGA-RN-A68Q-01,TCGA-RN-A68Q,SARC,62.0,FEMALE,WHITE,nan,nan,Malignant Peripheral Nerve Sheath Tumors (MPNST),nan,2010.0,nan,-22981.0,Alive,TUMOR FREE,22.0,nan,nan,nan,nan,nan,nan,nan,[Unknown],RX,0.0,22.0,0.0,22.0,nan,nan,0.0,22.0,0
TCGA-RN-AAAQ-01,TCGA-RN-AAAQ,SARC,52.0,MALE,WHITE,nan,nan,Malignant Peripheral Nerve Sheath Tumors (MPNST),nan,2013.0,nan,-19123.0,Alive,WITH TUMOR,510.0,nan,nan,Locoregional Recurrence,"Other, specify",Left Shoulder,307.0,nan,[Unknown],nan,0.0,510.0,0.0,510.0,nan,nan,1.0,307.0,0
TCGA-SG-A6Z4-01,TCGA-SG-A6Z4,SARC,47.0,MALE,WHITE,nan,nan,Pleomorphic 'MFH' / Undifferentiated pleomorphic sarcoma,nan,2013.0,nan,-17368.0,Alive,WITH TUMOR,576.0,nan,nan,Distant Metastasis,Lung,nan,105.0,nan,Negative,R1,0.0,576.0,0.0,576.0,nan,nan,1.0,105.0,0
TCGA-SG-A6Z7-01,TCGA-SG-A6Z7,SARC,44.0,FEMALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2004.0,nan,-16188.0,Dead,TUMOR FREE,nan,118.0,nan,nan,nan,nan,nan,nan,[Unknown],RX,1.0,118.0,0.0,118.0,nan,nan,0.0,118.0,1
TCGA-SG-A849-01,TCGA-SG-A849,SARC,78.0,MALE,WHITE,nan,nan,Undifferentiated Pleomorphic Sarcoma (UPS),nan,2013.0,nan,-28498.0,Alive,TUMOR FREE,533.0,nan,nan,nan,nan,nan,nan,nan,Positive,R1,0.0,533.0,0.0,533.0,nan,nan,0.0,533.0,0
TCGA-SI-A71O-06,TCGA-SI-A71O,SARC,29.0,MALE,WHITE,nan,nan,Malignant Peripheral Nerve Sheath Tumors (MPNST),nan,2013.0,nan,-10710.0,Dead,WITH TUMOR,nan,694.0,nan,Distant Metastasis,Lung,nan,264.0,nan,Positive,RX,1.0,694.0,1.0,694.0,nan,nan,1.0,264.0,1
TCGA-SI-A71O-01,TCGA-SI-A71O,SARC,29.0,MALE,WHITE,nan,nan,Malignant Peripheral Nerve Sheath Tumors (MPNST),nan,2013.0,nan,-10710.0,Dead,WITH TUMOR,nan,694.0,nan,Distant Metastasis,Lung,nan,264.0,nan,Positive,RX,1.0,694.0,1.0,694.0,nan,nan,1.0,264.0,1
TCGA-SI-A71P-01,TCGA-SI-A71P,SARC,50.0,MALE,WHITE,nan,nan,Malignant Peripheral Nerve Sheath Tumors (MPNST),nan,2012.0,nan,-18367.0,Alive,TUMOR FREE,771.0,nan,nan,nan,nan,nan,nan,nan,[Unknown],RX,0.0,771.0,0.0,771.0,nan,nan,0.0,771.0,0
TCGA-SI-A71Q-01,TCGA-SI-A71Q,SARC,34.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Malignant Peripheral Nerve Sheath Tumors (MPNST),nan,2012.0,nan,-12559.0,Alive,TUMOR FREE,996.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,996.0,0.0,996.0,0.0,996.0,0.0,996.0,0
TCGA-SI-AA8B-01,TCGA-SI-AA8B,SARC,80.0,FEMALE,WHITE,nan,nan,Undifferentiated Pleomorphic Sarcoma (UPS),nan,2013.0,nan,-29315.0,Dead,WITH TUMOR,nan,262.0,nan,nan,nan,nan,nan,nan,Positive,R1,1.0,262.0,1.0,262.0,nan,nan,1.0,262.0,1
TCGA-SI-AA8C-01,TCGA-SI-AA8C,SARC,20.0,FEMALE,WHITE,nan,nan,Malignant Peripheral Nerve Sheath Tumors (MPNST),nan,2013.0,nan,-7530.0,Alive,WITH TUMOR,597.0,nan,nan,Distant Metastasis,Lung,nan,273.0,nan,Positive,R1,0.0,597.0,0.0,597.0,nan,nan,1.0,273.0,1
TCGA-UE-A6QT-01,TCGA-UE-A6QT,SARC,50.0,FEMALE,ASIAN,nan,nan,Undifferentiated Pleomorphic Sarcoma (UPS),nan,2013.0,nan,-18516.0,Alive,TUMOR FREE,402.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,402.0,0.0,402.0,0.0,402.0,0.0,402.0,0
TCGA-UE-A6QU-01,TCGA-UE-A6QU,SARC,90.0,FEMALE,ASIAN,nan,nan,Undifferentiated Pleomorphic Sarcoma (UPS),nan,2013.0,nan,-32872.0,Alive,TUMOR FREE,408.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,408.0,0.0,408.0,0.0,408.0,0.0,408.0,0
TCGA-VT-A80G-01,TCGA-VT-A80G,SARC,66.0,MALE,WHITE,nan,nan,Undifferentiated Pleomorphic Sarcoma (UPS),nan,2013.0,nan,-24128.0,Alive,WITH TUMOR,326.0,nan,nan,Distant Metastasis,Lung,nan,26.0,nan,Negative,R0,0.0,326.0,0.0,326.0,1.0,26.0,1.0,26.0,0
TCGA-VT-A80J-02,TCGA-VT-A80J,SARC,49.0,FEMALE,WHITE,nan,nan,Undifferentiated Pleomorphic Sarcoma (UPS),nan,2012.0,nan,-17925.0,Alive,TUMOR FREE,796.0,nan,nan,Distant Metastasis,"Other, specify",inguinal lymph node,355.0,nan,Negative,R0,0.0,796.0,0.0,796.0,1.0,355.0,1.0,355.0,0
TCGA-VT-A80J-01,TCGA-VT-A80J,SARC,49.0,FEMALE,WHITE,nan,nan,Undifferentiated Pleomorphic Sarcoma (UPS),nan,2012.0,nan,-17925.0,Alive,TUMOR FREE,796.0,nan,nan,Distant Metastasis,"Other, specify",inguinal lymph node,355.0,nan,Negative,R0,0.0,796.0,0.0,796.0,1.0,355.0,1.0,355.0,0
TCGA-VT-AB3D-01,TCGA-VT-AB3D,SARC,71.0,MALE,WHITE,nan,nan,Undifferentiated Pleomorphic Sarcoma (UPS),nan,2013.0,nan,-26100.0,Alive,TUMOR FREE,379.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,0
TCGA-WK-A8XO-01,TCGA-WK-A8XO,SARC,66.0,FEMALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2010.0,nan,-24201.0,Dead,WITH TUMOR,nan,363.0,nan,Locoregional Recurrence,"Other, specify",Abdominal,105.0,nan,Negative,R0,1.0,363.0,1.0,363.0,1.0,105.0,1.0,105.0,1
TCGA-WK-A8XQ-01,TCGA-WK-A8XQ,SARC,57.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2009.0,nan,-20891.0,Dead,WITH TUMOR,nan,146.0,nan,Locoregional Recurrence,"Other, specify",Abdominal/retroperitoneal,27.0,nan,Positive,R2,1.0,146.0,1.0,146.0,nan,nan,1.0,27.0,1
TCGA-WK-A8XS-01,TCGA-WK-A8XS,SARC,58.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2008.0,nan,-21521.0,Alive,TUMOR FREE,2579.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,2579.0,0.0,2579.0,0.0,2579.0,0.0,2579.0,0
TCGA-WK-A8XT-01,TCGA-WK-A8XT,SARC,40.0,FEMALE,WHITE,nan,nan,Synovial Sarcoma - Monophasic,nan,2008.0,nan,-14958.0,Dead,WITH TUMOR,nan,1262.0,nan,Locoregional Recurrence,"Other, specify",Flank,599.0,nan,Negative,R0,1.0,1262.0,1.0,1262.0,1.0,599.0,1.0,599.0,1
TCGA-WK-A8XX-01,TCGA-WK-A8XX,SARC,70.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2007.0,nan,-25701.0,Dead,WITH TUMOR,nan,1164.0,nan,Locoregional Recurrence,"Other, specify",Retroperitoneum,111.0,nan,Negative,R0,1.0,1164.0,1.0,1164.0,1.0,111.0,1.0,111.0,1
TCGA-WK-A8XY-01,TCGA-WK-A8XY,SARC,53.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2007.0,nan,-19597.0,Dead,WITH TUMOR,nan,1991.0,nan,Locoregional Recurrence,"Other, specify",Intraabdominal,103.0,nan,Positive,R1,1.0,1991.0,1.0,1991.0,nan,nan,1.0,103.0,1
TCGA-WK-A8XZ-01,TCGA-WK-A8XZ,SARC,56.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2007.0,nan,-20460.0,Dead,WITH TUMOR,nan,1722.0,nan,Distant Metastasis,"Other, specify",Scalp,89.0,nan,Negative,R0,1.0,1722.0,1.0,1722.0,1.0,89.0,1.0,89.0,1
TCGA-WK-A8Y0-01,TCGA-WK-A8Y0,SARC,49.0,FEMALE,WHITE,nan,nan,Undifferentiated Pleomorphic Sarcoma (UPS),nan,2010.0,nan,-18233.0,Dead,WITH TUMOR,nan,688.0,nan,Distant Metastasis,Lung,nan,111.0,nan,Negative,R0,1.0,688.0,1.0,688.0,1.0,111.0,1.0,111.0,1
TCGA-WP-A9GB-01,TCGA-WP-A9GB,SARC,59.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2012.0,nan,nan,Dead,WITH TUMOR,nan,261.0,nan,Distant Metastasis,Lung,nan,214.0,nan,Negative,RX,1.0,261.0,1.0,261.0,nan,nan,1.0,214.0,1
TCGA-X2-A95T-01,TCGA-X2-A95T,SARC,49.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2009.0,nan,-18079.0,Alive,TUMOR FREE,1927.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1927.0,0.0,1927.0,0.0,1927.0,0.0,1927.0,0
TCGA-X6-A7W8-01,TCGA-X6-A7W8,SARC,89.0,MALE,WHITE,nan,nan,Myxofibrosarcoma,nan,2011.0,nan,-32848.0,Dead,WITH TUMOR,nan,804.0,nan,Distant Metastasis,Lung,nan,146.0,nan,Positive,R1,1.0,804.0,1.0,804.0,nan,nan,1.0,146.0,1
TCGA-X6-A7WA-01,TCGA-X6-A7WA,SARC,90.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2012.0,nan,-32872.0,Alive,TUMOR FREE,1092.0,nan,nan,nan,nan,nan,nan,nan,Positive,R1,0.0,1092.0,0.0,1092.0,nan,nan,0.0,1092.0,0
TCGA-X6-A7WB-01,TCGA-X6-A7WB,SARC,58.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2011.0,nan,-21467.0,Dead,WITH TUMOR,nan,550.0,nan,Distant Metastasis,Lung,nan,104.0,nan,Positive,R1,1.0,550.0,1.0,550.0,nan,nan,1.0,104.0,1
TCGA-X6-A7WC-01,TCGA-X6-A7WC,SARC,74.0,MALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2011.0,nan,-27252.0,Alive,TUMOR FREE,1379.0,nan,nan,Distant Metastasis,Lung,nan,301.0,nan,Negative,R0,0.0,1379.0,0.0,1379.0,1.0,301.0,1.0,301.0,0
TCGA-X6-A7WD-01,TCGA-X6-A7WD,SARC,63.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2013.0,nan,-23341.0,Alive,WITH TUMOR,938.0,nan,nan,Distant Metastasis,Lung,nan,558.0,nan,Negative,R0,0.0,938.0,0.0,938.0,1.0,558.0,1.0,558.0,2
TCGA-X6-A8C2-01,TCGA-X6-A8C2,SARC,56.0,MALE,WHITE,nan,nan,Undifferentiated Pleomorphic Sarcoma (UPS),nan,2012.0,nan,-20507.0,Alive,WITH TUMOR,1070.0,nan,nan,New Primary Tumor,Lung,nan,7.0,nan,Positive,R1,0.0,1070.0,0.0,1070.0,nan,nan,1.0,7.0,0
TCGA-X6-A8C3-01,TCGA-X6-A8C3,SARC,59.0,FEMALE,ASIAN,nan,nan,Myxofibrosarcoma,nan,2013.0,nan,-21751.0,Alive,TUMOR FREE,583.0,nan,nan,nan,nan,nan,nan,nan,Positive,R1,0.0,583.0,0.0,583.0,nan,nan,0.0,583.0,0
TCGA-X6-A8C4-01,TCGA-X6-A8C4,SARC,70.0,FEMALE,WHITE,nan,nan,Undifferentiated Pleomorphic Sarcoma (UPS),nan,2013.0,nan,-25896.0,Dead,WITH TUMOR,nan,628.0,nan,Distant Metastasis,Lung,nan,71.0,nan,Positive,R1,1.0,628.0,1.0,628.0,nan,nan,1.0,71.0,1
TCGA-X6-A8C5-01,TCGA-X6-A8C5,SARC,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Leiomyosarcoma (LMS),nan,2011.0,nan,-23350.0,Alive,TUMOR FREE,1547.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,1547.0,0.0,1547.0,0.0,1547.0,0.0,1547.0,0
TCGA-X6-A8C6-01,TCGA-X6-A8C6,SARC,55.0,MALE,WHITE,nan,nan,Myxofibrosarcoma,nan,2011.0,nan,-20090.0,Dead,WITH TUMOR,nan,1067.0,nan,Distant Metastasis,Bone,"& leg, opposite thigh",408.0,nan,Positive,R1,1.0,1067.0,1.0,1067.0,nan,nan,1.0,408.0,1
TCGA-X6-A8C7-01,TCGA-X6-A8C7,SARC,24.0,FEMALE,WHITE,nan,nan,Synovial Sarcoma - Biphasic,nan,2013.0,nan,-9104.0,Alive,TUMOR FREE,896.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,896.0,0.0,896.0,0.0,896.0,0.0,896.0,0
TCGA-X9-A971-01,TCGA-X9-A971,SARC,52.0,FEMALE,WHITE,nan,nan,Leiomyosarcoma (LMS),nan,2013.0,nan,-19207.0,Alive,WITH TUMOR,831.0,nan,nan,Distant Metastasis,Lung,nan,224.0,nan,Negative,R0,0.0,831.0,0.0,831.0,1.0,224.0,1.0,224.0,2
TCGA-X9-A973-01,TCGA-X9-A973,SARC,55.0,MALE,WHITE,nan,nan,Undifferentiated Pleomorphic Sarcoma (UPS),nan,2011.0,nan,-20146.0,Alive,WITH TUMOR,1108.0,nan,nan,Distant Metastasis,Lung,nan,119.0,nan,Negative,R0,0.0,1108.0,0.0,1108.0,1.0,119.0,1.0,119.0,0
TCGA-Z4-A8JB-01,TCGA-Z4-A8JB,SARC,24.0,FEMALE,WHITE,nan,nan,Desmoid Tumor,nan,2013.0,nan,-9123.0,Alive,TUMOR FREE,133.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,133.0,0.0,133.0,0.0,133.0,0.0,133.0,0
TCGA-Z4-A9VC-01,TCGA-Z4-A9VC,SARC,37.0,MALE,WHITE,nan,nan,Dedifferentiated liposarcoma,nan,2013.0,nan,-13576.0,Alive,TUMOR FREE,407.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,407.0,0.0,407.0,0.0,407.0,0.0,407.0,0
TCGA-Z4-AAPF-01,TCGA-Z4-AAPF,SARC,35.0,FEMALE,WHITE,nan,nan,Sarcoma; synovial; poorly differentiated,nan,2013.0,nan,-12959.0,Alive,TUMOR FREE,485.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,485.0,0.0,485.0,0.0,485.0,0.0,485.0,0
TCGA-Z4-AAPG-01,TCGA-Z4-AAPG,SARC,64.0,FEMALE,WHITE,nan,nan,Undifferentiated Pleomorphic Sarcoma (UPS),nan,2013.0,nan,-23390.0,Alive,TUMOR FREE,486.0,nan,nan,nan,nan,nan,nan,nan,Negative,R0,0.0,486.0,0.0,486.0,0.0,486.0,0.0,486.0,0
TCGA-3N-A9WB-06,TCGA-3N-A9WB,SKCM,71.0,MALE,WHITE,Stage IA,nan,nan,nan,2012.0,nan,-26176.0,Dead,WITH TUMOR,nan,518.0,nan,Locoregional Recurrence,"Other, Specify",Axillary,426.0,nan,nan,nan,1.0,518.0,1.0,518.0,nan,nan,1.0,426.0,1
TCGA-3N-A9WC-06,TCGA-3N-A9WC,SKCM,82.0,MALE,WHITE,Stage IIA,nan,nan,nan,2009.0,nan,-30286.0,Alive,WITH TUMOR,2022.0,nan,nan,Distant Metastasis,Lung,nan,1705.0,nan,nan,nan,0.0,2022.0,0.0,2022.0,nan,nan,1.0,1705.0,0
TCGA-3N-A9WD-06,TCGA-3N-A9WD,SKCM,82.0,MALE,WHITE,Stage IIIA,nan,nan,nan,2013.0,nan,-30163.0,Dead,WITH TUMOR,nan,395.0,nan,Distant Metastasis,Brain,nan,306.0,nan,nan,nan,1.0,395.0,1.0,395.0,nan,nan,1.0,306.0,1
TCGA-BF-A1PU-01,TCGA-BF-A1PU,SKCM,46.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2010.0,nan,-17025.0,Alive,TUMOR FREE,387.0,nan,nan,Distant Metastasis,Lung,nan,484.0,nan,nan,nan,0.0,387.0,0.0,387.0,nan,nan,1.0,484.0,0
TCGA-BF-A1PV-01,TCGA-BF-A1PV,SKCM,74.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2010.0,nan,-27124.0,Alive,TUMOR FREE,14.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,14.0,0.0,14.0,nan,nan,0.0,14.0,0
TCGA-BF-A1PX-01,TCGA-BF-A1PX,SKCM,56.0,MALE,WHITE,Stage IIIB,nan,nan,nan,2010.0,nan,-20626.0,Dead,TUMOR FREE,nan,282.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,282.0,0.0,282.0,nan,nan,0.0,282.0,0
TCGA-BF-A1PZ-01,TCGA-BF-A1PZ,SKCM,71.0,FEMALE,WHITE,Stage IIB,nan,nan,nan,2010.0,nan,-26240.0,Alive,TUMOR FREE,853.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,853.0,0.0,853.0,nan,nan,0.0,853.0,0
TCGA-BF-A1Q0-01,TCGA-BF-A1Q0,SKCM,80.0,MALE,WHITE,Stage IIC,nan,nan,nan,2010.0,nan,-29380.0,Alive,TUMOR FREE,831.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,831.0,0.0,831.0,nan,nan,0.0,831.0,0
TCGA-BF-A3DJ-01,TCGA-BF-A3DJ,SKCM,36.0,FEMALE,WHITE,Stage IIIB,nan,nan,nan,2011.0,nan,-13332.0,Alive,TUMOR FREE,464.0,nan,nan,Distant Metastasis,Liver,nan,217.0,nan,nan,nan,0.0,464.0,0.0,464.0,nan,nan,1.0,217.0,0
TCGA-BF-A3DL-01,TCGA-BF-A3DL,SKCM,84.0,FEMALE,WHITE,Stage IIIB,nan,nan,nan,2011.0,nan,-30805.0,Alive,TUMOR FREE,769.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,769.0,0.0,769.0,nan,nan,0.0,769.0,0
TCGA-BF-A3DM-01,TCGA-BF-A3DM,SKCM,63.0,MALE,WHITE,Stage IIA,nan,nan,nan,2011.0,nan,-23076.0,Alive,TUMOR FREE,601.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,601.0,0.0,601.0,nan,nan,0.0,601.0,0
TCGA-BF-A3DN-01,TCGA-BF-A3DN,SKCM,81.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2011.0,nan,-29801.0,Alive,TUMOR FREE,717.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,717.0,0.0,717.0,nan,nan,0.0,717.0,0
TCGA-BF-A5EO-01,TCGA-BF-A5EO,SKCM,65.0,MALE,WHITE,Stage IIC,nan,nan,nan,2012.0,nan,-23940.0,Alive,TUMOR FREE,703.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,703.0,0.0,703.0,nan,nan,0.0,703.0,0
TCGA-BF-A5EP-01,TCGA-BF-A5EP,SKCM,75.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2012.0,nan,-27622.0,Alive,TUMOR FREE,335.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,335.0,0.0,335.0,nan,nan,0.0,335.0,0
TCGA-BF-A5EQ-01,TCGA-BF-A5EQ,SKCM,63.0,MALE,WHITE,Stage IIC,nan,nan,nan,2012.0,nan,-23353.0,Alive,TUMOR FREE,323.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,323.0,0.0,323.0,nan,nan,0.0,323.0,0
TCGA-BF-A5ER-01,TCGA-BF-A5ER,SKCM,63.0,MALE,WHITE,Stage IIC,nan,nan,nan,2012.0,nan,-23199.0,Alive,TUMOR FREE,327.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,327.0,0.0,327.0,nan,nan,0.0,327.0,0
TCGA-BF-A5ES-01,TCGA-BF-A5ES,SKCM,76.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2012.0,nan,-28092.0,Alive,TUMOR FREE,490.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,490.0,0.0,490.0,nan,nan,0.0,490.0,0
TCGA-BF-A9VF-01,TCGA-BF-A9VF,SKCM,77.0,MALE,WHITE,Stage IIC,nan,nan,nan,2013.0,nan,-28312.0,Alive,TUMOR FREE,440.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,440.0,0.0,440.0,nan,nan,0.0,440.0,0
TCGA-BF-AAOU-01,TCGA-BF-AAOU,SKCM,73.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2013.0,nan,-26750.0,Alive,TUMOR FREE,476.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,476.0,0.0,476.0,nan,nan,0.0,476.0,0
TCGA-BF-AAOX-01,TCGA-BF-AAOX,SKCM,83.0,MALE,WHITE,Stage IIC,nan,nan,nan,2013.0,nan,-30318.0,Alive,TUMOR FREE,444.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,444.0,0.0,444.0,nan,nan,0.0,444.0,0
TCGA-BF-AAP0-06,TCGA-BF-AAP0,SKCM,40.0,FEMALE,WHITE,Stage IV,nan,nan,nan,2013.0,nan,-14773.0,Alive,TUMOR FREE,454.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,454.0,0.0,454.0,nan,nan,0.0,454.0,0
TCGA-BF-AAP1-01,TCGA-BF-AAP1,SKCM,86.0,MALE,WHITE,Stage IIC,nan,nan,nan,2013.0,nan,-31666.0,Alive,TUMOR FREE,409.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,409.0,0.0,409.0,nan,nan,0.0,409.0,0
TCGA-BF-AAP2-01,TCGA-BF-AAP2,SKCM,62.0,MALE,WHITE,Stage IIB,nan,nan,nan,2013.0,nan,-22734.0,Alive,TUMOR FREE,405.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,405.0,0.0,405.0,nan,nan,0.0,405.0,0
TCGA-BF-AAP4-01,TCGA-BF-AAP4,SKCM,61.0,MALE,WHITE,Stage IIC,nan,nan,nan,2013.0,nan,-22303.0,Alive,TUMOR FREE,335.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,335.0,0.0,335.0,nan,nan,0.0,335.0,0
TCGA-BF-AAP6-01,TCGA-BF-AAP6,SKCM,55.0,MALE,WHITE,Stage III,nan,nan,nan,2013.0,nan,-20384.0,Alive,TUMOR FREE,325.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,325.0,0.0,325.0,nan,nan,0.0,325.0,0
TCGA-BF-AAP7-01,TCGA-BF-AAP7,SKCM,76.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2013.0,nan,-28073.0,Alive,TUMOR FREE,318.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,318.0,0.0,318.0,nan,nan,0.0,318.0,0
TCGA-BF-AAP8-01,TCGA-BF-AAP8,SKCM,58.0,MALE,WHITE,Stage IIC,nan,nan,nan,2013.0,nan,-21414.0,Alive,TUMOR FREE,447.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,447.0,0.0,447.0,nan,nan,0.0,447.0,0
TCGA-D3-A1Q1-06,TCGA-D3-A1Q1,SKCM,79.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2004.0,nan,-29212.0,Dead,WITH TUMOR,nan,504.0,nan,Locoregional Recurrence,nan,nan,58.0,nan,nan,nan,1.0,504.0,1.0,504.0,nan,nan,1.0,58.0,1
TCGA-D3-A1Q3-06,TCGA-D3-A1Q3,SKCM,64.0,MALE,WHITE,Stage IIC,nan,nan,nan,2001.0,nan,-23604.0,Dead,WITH TUMOR,nan,507.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,507.0,1.0,507.0,nan,nan,1.0,507.0,1
TCGA-D3-A1Q4-06,TCGA-D3-A1Q4,SKCM,53.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2003.0,nan,-19687.0,Alive,TUMOR FREE,3408.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3408.0,0.0,3408.0,nan,nan,0.0,3408.0,0
TCGA-D3-A1Q5-06,TCGA-D3-A1Q5,SKCM,60.0,MALE,WHITE,I/II NOS,nan,nan,nan,1996.0,nan,-22200.0,Dead,nan,nan,3424.0,nan,Locoregional Recurrence,nan,nan,2452.0,nan,nan,nan,1.0,3424.0,nan,3424.0,nan,nan,1.0,2452.0,1
TCGA-D3-A1Q6-06,TCGA-D3-A1Q6,SKCM,55.0,MALE,WHITE,Stage III,nan,nan,nan,2003.0,nan,-20230.0,Dead,TUMOR FREE,nan,2184.0,nan,Regional lymph node,nan,nan,48.0,nan,nan,nan,1.0,2184.0,0.0,2184.0,nan,nan,1.0,48.0,1
TCGA-D3-A1Q7-06,TCGA-D3-A1Q7,SKCM,42.0,FEMALE,WHITE,Stage IB,nan,nan,nan,2002.0,nan,-15531.0,Alive,TUMOR FREE,4053.0,nan,nan,Distant Metastasis,"Other, Specify",soft tissue left buttock,921.0,nan,nan,nan,0.0,4053.0,0.0,4053.0,nan,nan,1.0,921.0,0
TCGA-D3-A1Q8-06,TCGA-D3-A1Q8,SKCM,33.0,MALE,WHITE,Stage IV,nan,nan,nan,2004.0,nan,-12330.0,Dead,WITH TUMOR,nan,854.0,nan,Distant Metastasis,Lung,nan,147.0,nan,nan,nan,1.0,854.0,1.0,854.0,nan,nan,1.0,147.0,1
TCGA-D3-A1Q9-06,TCGA-D3-A1Q9,SKCM,72.0,MALE,WHITE,Stage IIIB,nan,nan,nan,2005.0,nan,-26471.0,Dead,WITH TUMOR,nan,961.0,nan,Regional lymph node,nan,nan,44.0,nan,nan,nan,1.0,961.0,1.0,961.0,nan,nan,1.0,44.0,1
TCGA-D3-A1QA-07,TCGA-D3-A1QA,SKCM,55.0,MALE,WHITE,Stage IB,nan,nan,nan,2005.0,nan,-20223.0,Alive,WITH TUMOR,2765.0,nan,nan,Distant Metastasis,Lung,nan,1393.0,nan,nan,nan,0.0,2765.0,0.0,2765.0,nan,nan,1.0,1393.0,0
TCGA-D3-A1QA-06,TCGA-D3-A1QA,SKCM,55.0,MALE,WHITE,Stage IB,nan,nan,nan,2005.0,nan,-20223.0,Alive,WITH TUMOR,2765.0,nan,nan,Distant Metastasis,Lung,nan,1393.0,nan,nan,nan,0.0,2765.0,0.0,2765.0,nan,nan,1.0,1393.0,0
TCGA-D3-A1QB-06,TCGA-D3-A1QB,SKCM,75.0,FEMALE,WHITE,Stage III,nan,nan,nan,2005.0,nan,-27566.0,Alive,TUMOR FREE,2912.0,nan,nan,Locoregional Recurrence,nan,nan,0.0,nan,nan,nan,0.0,2912.0,0.0,2912.0,nan,nan,1.0,0.0,0
TCGA-D3-A2J6-06,TCGA-D3-A2J6,SKCM,65.0,MALE,WHITE,Stage IIB,nan,nan,nan,2002.0,nan,-24066.0,Dead,WITH TUMOR,nan,1321.0,nan,New primary melanoma,nan,nan,448.0,nan,nan,nan,1.0,1321.0,1.0,1321.0,nan,nan,1.0,448.0,1
TCGA-D3-A2J7-06,TCGA-D3-A2J7,SKCM,67.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2003.0,nan,-24692.0,Dead,WITH TUMOR,nan,3136.0,nan,Regional lymph node,nan,nan,13.0,nan,nan,nan,1.0,3136.0,1.0,3136.0,nan,nan,1.0,13.0,1
TCGA-D3-A2J8-06,TCGA-D3-A2J8,SKCM,48.0,MALE,WHITE,Stage IB,nan,nan,nan,2003.0,nan,-17626.0,Dead,WITH TUMOR,nan,1992.0,nan,Locoregional Recurrence,nan,nan,1737.0,nan,nan,nan,1.0,1992.0,1.0,1992.0,nan,nan,1.0,1737.0,1
TCGA-D3-A2J9-06,TCGA-D3-A2J9,SKCM,75.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2003.0,nan,-27428.0,Dead,WITH TUMOR,nan,723.0,nan,Distant Metastasis,Lung,nan,231.0,nan,nan,nan,1.0,723.0,1.0,723.0,nan,nan,1.0,231.0,1
TCGA-D3-A2JA-06,TCGA-D3-A2JA,SKCM,68.0,MALE,WHITE,Stage IIIA,nan,nan,nan,2003.0,nan,-25085.0,Alive,TUMOR FREE,3514.0,nan,nan,Regional lymph node,nan,nan,40.0,nan,nan,nan,0.0,3514.0,0.0,3514.0,nan,nan,1.0,40.0,0
TCGA-D3-A2JB-06,TCGA-D3-A2JB,SKCM,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage 0,nan,nan,nan,1997.0,nan,-25784.0,Dead,TUMOR FREE,nan,5110.0,nan,Locoregional Recurrence,nan,nan,3035.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,1
TCGA-D3-A2JC-06,TCGA-D3-A2JC,SKCM,53.0,FEMALE,WHITE,Stage III,nan,nan,nan,2006.0,nan,-19644.0,Alive,TUMOR FREE,2639.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2639.0,0.0,2639.0,nan,nan,0.0,2639.0,0
TCGA-D3-A2JD-06,TCGA-D3-A2JD,SKCM,58.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2007.0,nan,-21440.0,Dead,WITH TUMOR,nan,361.0,nan,Distant Metastasis,Liver,nan,85.0,nan,nan,nan,1.0,361.0,1.0,361.0,nan,nan,1.0,85.0,1
TCGA-D3-A2JE-06,TCGA-D3-A2JE,SKCM,75.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2009.0,nan,-27604.0,Dead,WITH TUMOR,nan,841.0,nan,nan,nan,nan,149.0,nan,nan,nan,1.0,841.0,1.0,841.0,nan,nan,1.0,149.0,1
TCGA-D3-A2JF-06,TCGA-D3-A2JF,SKCM,74.0,MALE,WHITE,Stage IA,nan,nan,nan,2008.0,nan,-27255.0,Alive,TUMOR FREE,1888.0,nan,nan,New primary melanoma,nan,nan,25.0,nan,nan,nan,0.0,1888.0,0.0,1888.0,nan,nan,1.0,25.0,0
TCGA-D3-A2JG-06,TCGA-D3-A2JG,SKCM,30.0,FEMALE,WHITE,Stage IIIA,nan,nan,nan,2001.0,nan,-11105.0,Dead,WITH TUMOR,nan,3453.0,nan,Distant Metastasis,"Other, Specify","Left ischial rectal fossa, soft tissue",3279.0,nan,nan,nan,1.0,3453.0,1.0,3453.0,nan,nan,1.0,3279.0,1
TCGA-D3-A2JH-06,TCGA-D3-A2JH,SKCM,68.0,MALE,WHITE,Stage IB,nan,nan,nan,2010.0,nan,-24882.0,Alive,TUMOR FREE,1280.0,nan,nan,Distant Metastasis,Brain,nan,569.0,nan,nan,nan,0.0,1280.0,0.0,1280.0,nan,nan,1.0,569.0,0
TCGA-D3-A2JK-06,TCGA-D3-A2JK,SKCM,24.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2005.0,nan,-8952.0,Dead,WITH TUMOR,nan,368.0,nan,Distant Metastasis,Lung,nan,261.0,nan,nan,nan,1.0,368.0,1.0,368.0,nan,nan,1.0,261.0,1
TCGA-D3-A2JL-06,TCGA-D3-A2JL,SKCM,43.0,FEMALE,WHITE,I/II NOS,nan,nan,nan,1999.0,nan,-15710.0,Alive,TUMOR FREE,5219.0,nan,nan,Distant Metastasis,Lung,nan,2638.0,nan,nan,nan,0.0,5219.0,0.0,5219.0,nan,nan,1.0,2638.0,0
TCGA-D3-A2JN-06,TCGA-D3-A2JN,SKCM,46.0,FEMALE,WHITE,Stage III,nan,nan,nan,2007.0,nan,-17128.0,Dead,TUMOR FREE,nan,2022.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2022.0,0.0,2022.0,nan,nan,0.0,2022.0,1
TCGA-D3-A2JO-06,TCGA-D3-A2JO,SKCM,50.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2008.0,nan,-18577.0,Alive,WITH TUMOR,2010.0,nan,nan,Distant Metastasis,"Other, Specify","Chest wall, soft tissue",50.0,nan,nan,nan,0.0,2010.0,0.0,2010.0,nan,nan,1.0,50.0,1
TCGA-D3-A2JP-06,TCGA-D3-A2JP,SKCM,37.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2008.0,nan,-13552.0,Alive,WITH TUMOR,1812.0,nan,nan,Distant Metastasis,Liver,nan,227.0,nan,nan,nan,0.0,1812.0,0.0,1812.0,nan,nan,1.0,227.0,0
TCGA-D3-A3BZ-06,TCGA-D3-A3BZ,SKCM,63.0,MALE,WHITE,Stage IIB,nan,nan,nan,2002.0,nan,-23286.0,Alive,TUMOR FREE,3976.0,nan,nan,nan,nan,nan,2340.0,nan,nan,nan,0.0,3976.0,0.0,3976.0,nan,nan,1.0,2340.0,0
TCGA-D3-A3C1-06,TCGA-D3-A3C1,SKCM,nan,MALE,WHITE,I/II NOS,nan,nan,nan,1998.0,nan,nan,Alive,WITH TUMOR,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,nan,0.0,nan,nan,nan,0.0,nan,0
TCGA-D3-A3C3-06,TCGA-D3-A3C3,SKCM,nan,FEMALE,WHITE,I/II NOS,nan,nan,nan,1985.0,nan,nan,Alive,WITH TUMOR,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,nan,0.0,nan,nan,nan,0.0,nan,1
TCGA-D3-A3C6-06,TCGA-D3-A3C6,SKCM,54.0,FEMALE,WHITE,Stage IB,nan,nan,nan,2006.0,nan,-19858.0,Dead,WITH TUMOR,nan,1766.0,nan,Distant Metastasis,Lung,nan,1441.0,nan,nan,nan,1.0,1766.0,1.0,1766.0,nan,nan,1.0,1441.0,1
TCGA-D3-A3C7-06,TCGA-D3-A3C7,SKCM,57.0,FEMALE,WHITE,Stage III,nan,nan,nan,2009.0,nan,-20979.0,Alive,TUMOR FREE,1429.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1429.0,0.0,1429.0,nan,nan,0.0,1429.0,0
TCGA-D3-A3C8-06,TCGA-D3-A3C8,SKCM,58.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2009.0,nan,-21281.0,Alive,WITH TUMOR,1409.0,nan,nan,Distant Metastasis,"Other, Specify","Lymph nodes, neck",55.0,nan,nan,nan,0.0,1409.0,0.0,1409.0,nan,nan,1.0,55.0,2
TCGA-D3-A3CB-06,TCGA-D3-A3CB,SKCM,39.0,MALE,WHITE,I/II NOS,nan,nan,nan,1999.0,nan,-14563.0,Alive,TUMOR FREE,5065.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,5065.0,0.0,5065.0,nan,nan,0.0,5065.0,0
TCGA-D3-A3CC-06,TCGA-D3-A3CC,SKCM,69.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2005.0,nan,-25396.0,Alive,WITH TUMOR,2644.0,nan,nan,Locoregional Recurrence,nan,nan,96.0,nan,nan,nan,0.0,2644.0,0.0,2644.0,nan,nan,1.0,96.0,1
TCGA-D3-A3CE-06,TCGA-D3-A3CE,SKCM,74.0,FEMALE,WHITE,Stage III,nan,nan,nan,2001.0,nan,-27355.0,Dead,WITH TUMOR,nan,1832.0,nan,Regional lymph node,nan,nan,0.0,nan,nan,nan,1.0,1832.0,1.0,1832.0,nan,nan,1.0,0.0,1
TCGA-D3-A3CF-06,TCGA-D3-A3CF,SKCM,61.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2009.0,nan,-22409.0,Dead,WITH TUMOR,nan,746.0,nan,Distant Metastasis,Bone,nan,129.0,nan,nan,nan,1.0,746.0,1.0,746.0,nan,nan,1.0,129.0,1
TCGA-D3-A3ML-06,TCGA-D3-A3ML,SKCM,70.0,MALE,WHITE,Stage IIIA,nan,nan,nan,2003.0,nan,-25643.0,Dead,WITH TUMOR,nan,422.0,nan,Regional lymph node,nan,nan,32.0,nan,nan,nan,1.0,422.0,1.0,422.0,nan,nan,1.0,32.0,1
TCGA-D3-A3MO-06,TCGA-D3-A3MO,SKCM,47.0,MALE,WHITE,Stage III,nan,nan,nan,2009.0,nan,-17220.0,Dead,WITH TUMOR,nan,284.0,nan,Distant Metastasis,Lung,nan,47.0,nan,nan,nan,1.0,284.0,1.0,284.0,nan,nan,1.0,47.0,1
TCGA-D3-A3MR-06,TCGA-D3-A3MR,SKCM,42.0,MALE,WHITE,Stage III,nan,nan,nan,2004.0,nan,-15695.0,Alive,TUMOR FREE,3151.0,nan,nan,nan,nan,nan,3108.0,nan,nan,nan,0.0,3151.0,0.0,3151.0,nan,nan,1.0,3108.0,0
TCGA-D3-A3MU-06,TCGA-D3-A3MU,SKCM,53.0,MALE,WHITE,Stage IIIA,nan,nan,nan,2010.0,nan,-19423.0,Alive,WITH TUMOR,1209.0,nan,nan,Distant Metastasis,Brain,nan,750.0,nan,nan,nan,0.0,1209.0,0.0,1209.0,nan,nan,1.0,750.0,0
TCGA-D3-A3MV-06,TCGA-D3-A3MV,SKCM,38.0,FEMALE,WHITE,Stage IIIB,nan,nan,nan,2010.0,nan,-14236.0,Alive,TUMOR FREE,1378.0,nan,nan,Regional lymph node,nan,nan,16.0,nan,nan,nan,0.0,1378.0,0.0,1378.0,nan,nan,1.0,16.0,0
TCGA-D3-A51E-06,TCGA-D3-A51E,SKCM,39.0,FEMALE,WHITE,I/II NOS,nan,nan,nan,1999.0,nan,-14305.0,Alive,TUMOR FREE,5318.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,5318.0,0.0,5318.0,nan,nan,0.0,5318.0,0
TCGA-D3-A51F-06,TCGA-D3-A51F,SKCM,51.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2009.0,nan,-18776.0,Alive,TUMOR FREE,1695.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1695.0,0.0,1695.0,nan,nan,0.0,1695.0,0
TCGA-D3-A51G-06,TCGA-D3-A51G,SKCM,nan,MALE,WHITE,Stage 0,nan,nan,nan,1990.0,nan,nan,Alive,TUMOR FREE,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,1
TCGA-D3-A51H-06,TCGA-D3-A51H,SKCM,60.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2009.0,nan,-22119.0,Alive,TUMOR FREE,1714.0,nan,nan,Regional lymph node,nan,nan,838.0,nan,nan,nan,0.0,1714.0,0.0,1714.0,nan,nan,1.0,838.0,0
TCGA-D3-A51J-06,TCGA-D3-A51J,SKCM,19.0,MALE,WHITE,Stage III,nan,nan,nan,2001.0,nan,-7194.0,Alive,TUMOR FREE,4414.0,nan,nan,Regional lymph node,nan,nan,2008.0,nan,nan,nan,0.0,4414.0,0.0,4414.0,nan,nan,1.0,2008.0,0
TCGA-D3-A51K-06,TCGA-D3-A51K,SKCM,51.0,MALE,WHITE,Stage IIIB,nan,nan,nan,2011.0,nan,-18971.0,Alive,TUMOR FREE,1002.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1002.0,0.0,1002.0,nan,nan,0.0,1002.0,0
TCGA-D3-A51N-06,TCGA-D3-A51N,SKCM,56.0,FEMALE,WHITE,Stage IV,nan,nan,nan,2012.0,nan,-20559.0,Alive,WITH TUMOR,688.0,nan,nan,Distant Metastasis,"Other, Specify",Adrenal Gland,18.0,nan,nan,nan,0.0,688.0,0.0,688.0,nan,nan,1.0,18.0,1
TCGA-D3-A51R-06,TCGA-D3-A51R,SKCM,60.0,MALE,WHITE,Stage IIA,nan,nan,nan,2008.0,nan,-22040.0,Alive,WITH TUMOR,1941.0,nan,nan,Regional lymph node,nan,nan,1016.0,nan,nan,nan,0.0,1941.0,0.0,1941.0,nan,nan,1.0,1016.0,1
TCGA-D3-A51T-06,TCGA-D3-A51T,SKCM,59.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2011.0,nan,-21823.0,Alive,TUMOR FREE,818.0,nan,nan,New primary melanoma,nan,nan,210.0,nan,nan,nan,0.0,818.0,0.0,818.0,nan,nan,1.0,210.0,0
TCGA-D3-A5GL-06,TCGA-D3-A5GL,SKCM,74.0,MALE,WHITE,Stage IB,nan,nan,nan,2003.0,nan,-27095.0,Alive,TUMOR FREE,3826.0,nan,nan,Distant Metastasis,"Other, Specify",Large Intestine,1092.0,nan,nan,nan,0.0,3826.0,0.0,3826.0,nan,nan,1.0,1092.0,0
TCGA-D3-A5GN-06,TCGA-D3-A5GN,SKCM,15.0,FEMALE,WHITE,Stage I,nan,nan,nan,2001.0,nan,-5684.0,Alive,TUMOR FREE,4129.0,nan,nan,New primary melanoma,nan,nan,1279.0,nan,nan,nan,0.0,4129.0,0.0,4129.0,nan,nan,1.0,1279.0,0
TCGA-D3-A5GO-06,TCGA-D3-A5GO,SKCM,61.0,MALE,WHITE,Stage II,nan,nan,nan,2001.0,nan,-22287.0,Alive,TUMOR FREE,4195.0,nan,nan,nan,nan,nan,757.0,nan,nan,nan,0.0,4195.0,0.0,4195.0,nan,nan,1.0,757.0,0
TCGA-D3-A5GR-06,TCGA-D3-A5GR,SKCM,23.0,FEMALE,WHITE,Stage III,nan,nan,nan,1998.0,nan,-8637.0,Alive,WITH TUMOR,5424.0,nan,nan,Regional lymph node,nan,nan,0.0,nan,nan,nan,0.0,5424.0,0.0,5424.0,nan,nan,1.0,0.0,0
TCGA-D3-A5GS-06,TCGA-D3-A5GS,SKCM,58.0,MALE,WHITE,Stage IV,nan,nan,nan,2012.0,nan,-21379.0,Alive,WITH TUMOR,553.0,nan,nan,Distant Metastasis,Bone,nan,44.0,nan,nan,nan,0.0,553.0,0.0,553.0,nan,nan,1.0,44.0,0
TCGA-D3-A5GT-01,TCGA-D3-A5GT,SKCM,43.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2012.0,nan,-15935.0,Alive,WITH TUMOR,487.0,nan,nan,Distant Metastasis|Distant Metastasis|Regional lymph node,Lung|Liver|[Not Available],[Not Applicable]|[Not Applicable]|[Not Applicable],291.0,nan,nan,nan,0.0,487.0,0.0,487.0,nan,nan,1.0,291.0,0
TCGA-D3-A5GU-06,TCGA-D3-A5GU,SKCM,36.0,MALE,WHITE,Stage IB,nan,nan,nan,2002.0,nan,-13296.0,Alive,WITH TUMOR,3808.0,nan,nan,Distant Metastasis,Bone,nan,3074.0,nan,nan,nan,0.0,3808.0,0.0,3808.0,nan,nan,1.0,3074.0,0
TCGA-D3-A8GB-06,TCGA-D3-A8GB,SKCM,48.0,MALE,WHITE,Stage IIIB,nan,nan,nan,2003.0,nan,-17871.0,Dead,WITH TUMOR,nan,938.0,nan,Distant Metastasis,"Other, Specify",Soft tissue,347.0,nan,nan,nan,1.0,938.0,1.0,938.0,nan,nan,1.0,347.0,1
TCGA-D3-A8GC-06,TCGA-D3-A8GC,SKCM,48.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2000.0,nan,-17668.0,Dead,WITH TUMOR,nan,2421.0,nan,Distant Metastasis,"Other, Specify",Supraclavicular lymph nodes,1859.0,nan,nan,nan,1.0,2421.0,1.0,2421.0,nan,nan,1.0,1859.0,1
TCGA-D3-A8GD-06,TCGA-D3-A8GD,SKCM,63.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2012.0,nan,-23109.0,Alive,TUMOR FREE,718.0,nan,nan,Distant Metastasis,"Other, Specify",Retroperitoneal lymph nodes,147.0,nan,nan,nan,0.0,718.0,0.0,718.0,nan,nan,1.0,147.0,0
TCGA-D3-A8GE-06,TCGA-D3-A8GE,SKCM,26.0,MALE,WHITE,Stage IV,nan,nan,nan,2012.0,nan,-9517.0,Alive,WITH TUMOR,804.0,nan,nan,Distant Metastasis,Lung,nan,59.0,nan,nan,nan,0.0,804.0,0.0,804.0,nan,nan,1.0,59.0,0
TCGA-D3-A8GI-06,TCGA-D3-A8GI,SKCM,68.0,MALE,WHITE,Stage IA,nan,nan,nan,2008.0,nan,-25069.0,Dead,WITH TUMOR,nan,1780.0,nan,New primary melanoma,nan,nan,50.0,nan,nan,nan,1.0,1780.0,1.0,1780.0,nan,nan,1.0,50.0,1
TCGA-D3-A8GJ-06,TCGA-D3-A8GJ,SKCM,18.0,MALE,WHITE,Stage II,nan,nan,nan,1994.0,nan,-6684.0,Alive,TUMOR FREE,7342.0,nan,nan,Distant Metastasis,Brain,nan,1443.0,nan,nan,nan,0.0,7342.0,0.0,7342.0,nan,nan,1.0,1443.0,0
TCGA-D3-A8GK-06,TCGA-D3-A8GK,SKCM,45.0,MALE,WHITE,Stage IIA,nan,nan,nan,2000.0,nan,-16569.0,Alive,TUMOR FREE,5177.0,nan,nan,Locoregional Recurrence,nan,nan,1555.0,nan,nan,nan,0.0,5177.0,0.0,5177.0,nan,nan,1.0,1555.0,0
TCGA-D3-A8GL-06,TCGA-D3-A8GL,SKCM,43.0,MALE,WHITE,Stage IIIB,nan,nan,nan,1996.0,nan,-15947.0,Dead,WITH TUMOR,nan,2711.0,nan,Regional lymph node,nan,nan,1333.0,nan,nan,nan,1.0,2711.0,1.0,2711.0,nan,nan,1.0,1333.0,1
TCGA-D3-A8GM-06,TCGA-D3-A8GM,SKCM,73.0,MALE,WHITE,Stage IIB,nan,nan,nan,2005.0,nan,-26782.0,Dead,TUMOR FREE,nan,3259.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,3259.0,0.0,3259.0,nan,nan,0.0,3259.0,0
TCGA-D3-A8GN-06,TCGA-D3-A8GN,SKCM,27.0,FEMALE,WHITE,I/II NOS,nan,nan,nan,2000.0,nan,-10185.0,Alive,TUMOR FREE,4897.0,nan,nan,Distant Metastasis,Lung,nan,787.0,nan,nan,nan,0.0,4897.0,0.0,4897.0,nan,nan,1.0,787.0,0
TCGA-D3-A8GO-06,TCGA-D3-A8GO,SKCM,nan,FEMALE,WHITE,I/II NOS,nan,nan,nan,1996.0,nan,nan,Dead,WITH TUMOR,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,1.0,nan,1.0,nan,nan,nan,1.0,nan,1
TCGA-D3-A8GP-06,TCGA-D3-A8GP,SKCM,77.0,MALE,WHITE,Stage III,nan,nan,nan,2002.0,nan,-28234.0,Alive,TUMOR FREE,4646.0,nan,nan,Locoregional Recurrence,nan,nan,535.0,nan,nan,nan,0.0,4646.0,0.0,4646.0,nan,nan,1.0,535.0,0
TCGA-D3-A8GQ-06,TCGA-D3-A8GQ,SKCM,66.0,MALE,WHITE,Stage II,nan,nan,nan,2004.0,nan,-24348.0,Dead,WITH TUMOR,nan,884.0,nan,Distant Metastasis,Liver,nan,578.0,nan,nan,nan,1.0,884.0,1.0,884.0,nan,nan,1.0,578.0,1
TCGA-D3-A8GR-06,TCGA-D3-A8GR,SKCM,54.0,FEMALE,WHITE,Stage 0,nan,nan,nan,1999.0,nan,-19973.0,Dead,WITH TUMOR,nan,3943.0,nan,Locoregional Recurrence,nan,nan,1720.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,1
TCGA-D3-A8GS-06,TCGA-D3-A8GS,SKCM,52.0,MALE,WHITE,Stage I,nan,nan,nan,1997.0,nan,-19127.0,Dead,WITH TUMOR,nan,3564.0,nan,Regional lymph node,nan,nan,2641.0,nan,nan,nan,1.0,3564.0,1.0,3564.0,nan,nan,1.0,2641.0,1
TCGA-D3-A8GV-06,TCGA-D3-A8GV,SKCM,25.0,MALE,WHITE,I/II NOS,nan,nan,nan,1993.0,nan,-9344.0,Dead,WITH TUMOR,nan,5101.0,nan,Regional lymph node,nan,nan,3896.0,nan,nan,nan,1.0,5101.0,1.0,5101.0,nan,nan,1.0,3896.0,1
TCGA-D9-A148-06,TCGA-D9-A148,SKCM,40.0,MALE,WHITE,nan,nan,nan,nan,1999.0,nan,-14805.0,Alive,WITH TUMOR,4609.0,nan,nan,Distant Metastasis,nan,nan,4287.0,nan,nan,nan,0.0,4609.0,0.0,4609.0,nan,nan,1.0,4287.0,0
TCGA-D9-A149-06,TCGA-D9-A149,SKCM,65.0,FEMALE,WHITE,nan,nan,nan,nan,2007.0,nan,-23779.0,Alive,TUMOR FREE,1663.0,nan,nan,New primary melanoma,"Other, Specify",nan,1290.0,nan,nan,nan,0.0,1663.0,0.0,1663.0,nan,nan,1.0,1290.0,0
TCGA-D9-A1JW-06,TCGA-D9-A1JW,SKCM,82.0,MALE,WHITE,nan,nan,nan,nan,2010.0,nan,-30142.0,Alive,TUMOR FREE,111.0,nan,nan,Distant Metastasis,"Other, Specify",nan,10.0,nan,nan,nan,0.0,111.0,0.0,111.0,nan,nan,1.0,10.0,0
TCGA-D9-A1JX-06,TCGA-D9-A1JX,SKCM,80.0,FEMALE,WHITE,nan,nan,nan,nan,2010.0,nan,-29323.0,Dead,WITH TUMOR,nan,216.0,nan,Distant Metastasis,"Other, Specify",iliac nymph nodes,195.0,nan,nan,nan,1.0,216.0,1.0,216.0,nan,nan,1.0,195.0,1
TCGA-D9-A1X3-06,TCGA-D9-A1X3,SKCM,63.0,MALE,WHITE,nan,nan,nan,nan,2010.0,nan,-23171.0,Alive,WITH TUMOR,551.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,551.0,0.0,551.0,nan,nan,0.0,551.0,0
TCGA-D9-A1X3-01,TCGA-D9-A1X3,SKCM,63.0,MALE,WHITE,nan,nan,nan,nan,2010.0,nan,-23171.0,Alive,WITH TUMOR,551.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,551.0,0.0,551.0,nan,nan,0.0,551.0,0
TCGA-D9-A3Z1-06,TCGA-D9-A3Z1,SKCM,66.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2011.0,nan,-24192.0,Dead,WITH TUMOR,nan,468.0,nan,Locoregional Recurrence,Lung,nan,335.0,nan,nan,nan,1.0,468.0,1.0,468.0,nan,nan,1.0,335.0,1
TCGA-D9-A3Z3-06,TCGA-D9-A3Z3,SKCM,39.0,FEMALE,WHITE,Stage IIIB,nan,nan,nan,2012.0,nan,-14489.0,Alive,TUMOR FREE,678.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,678.0,0.0,678.0,nan,nan,0.0,678.0,0
TCGA-D9-A3Z4-01,TCGA-D9-A3Z4,SKCM,54.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2012.0,nan,-19749.0,Dead,WITH TUMOR,nan,519.0,nan,Regional lymph node,"Other, Specify",lymph node,192.0,nan,nan,nan,1.0,519.0,1.0,519.0,nan,nan,1.0,192.0,1
TCGA-D9-A4Z2-01,TCGA-D9-A4Z2,SKCM,50.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2012.0,nan,-18462.0,Dead,WITH TUMOR,nan,190.0,nan,Distant Metastasis,Lung,nan,80.0,nan,nan,nan,1.0,190.0,1.0,190.0,nan,nan,1.0,80.0,1
TCGA-D9-A4Z3-01,TCGA-D9-A4Z3,SKCM,73.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2012.0,nan,-26812.0,Alive,TUMOR FREE,505.0,nan,nan,Locoregional Recurrence,nan,nan,100.0,nan,nan,nan,0.0,505.0,0.0,505.0,nan,nan,1.0,100.0,0
TCGA-D9-A4Z5-01,TCGA-D9-A4Z5,SKCM,68.0,MALE,WHITE,Stage IIB,nan,nan,nan,2012.0,nan,-24979.0,Alive,TUMOR FREE,218.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,218.0,0.0,218.0,nan,nan,0.0,218.0,0
TCGA-D9-A4Z6-06,TCGA-D9-A4Z6,SKCM,54.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2012.0,nan,-20072.0,Dead,WITH TUMOR,nan,561.0,nan,Distant Metastasis,Brain,nan,213.0,nan,nan,nan,1.0,561.0,1.0,561.0,nan,nan,1.0,213.0,1
TCGA-D9-A6E9-06,TCGA-D9-A6E9,SKCM,75.0,FEMALE,WHITE,Stage IIIA,nan,nan,nan,2013.0,nan,-27537.0,Alive,TUMOR FREE,301.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,301.0,0.0,301.0,nan,nan,0.0,301.0,0
TCGA-D9-A6EA-06,TCGA-D9-A6EA,SKCM,70.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2012.0,nan,-25582.0,Alive,TUMOR FREE,766.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,766.0,0.0,766.0,nan,nan,0.0,766.0,0
TCGA-D9-A6EC-06,TCGA-D9-A6EC,SKCM,56.0,MALE,WHITE,Stage IIIA,nan,nan,nan,2008.0,nan,-20493.0,Alive,TUMOR FREE,2359.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2359.0,0.0,2359.0,nan,nan,0.0,2359.0,0
TCGA-D9-A6EG-06,TCGA-D9-A6EG,SKCM,56.0,MALE,WHITE,Stage IIIA,nan,nan,nan,2012.0,nan,-20570.0,Dead,nan,nan,698.0,nan,Distant Metastasis,Bone,nan,398.0,nan,nan,nan,1.0,698.0,nan,698.0,nan,nan,1.0,398.0,1
TCGA-DA-A1HV-06,TCGA-DA-A1HV,SKCM,75.0,FEMALE,WHITE,Stage IIIB,nan,nan,nan,2008.0,nan,-27553.0,Alive,TUMOR FREE,2329.0,nan,nan,Distant Metastasis,"Other, Specify",mediastinum,866.0,nan,nan,nan,0.0,2329.0,0.0,2329.0,nan,nan,1.0,866.0,0
TCGA-DA-A1HW-06,TCGA-DA-A1HW,SKCM,37.0,FEMALE,WHITE,Stage IIIB,nan,nan,nan,2009.0,nan,-13585.0,Alive,TUMOR FREE,820.0,nan,nan,nan,nan,nan,852.0,nan,nan,nan,0.0,820.0,0.0,820.0,nan,nan,1.0,852.0,0
TCGA-DA-A1HY-06,TCGA-DA-A1HY,SKCM,42.0,MALE,WHITE,Stage III,nan,nan,nan,2002.0,nan,-15357.0,Alive,TUMOR FREE,4407.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4407.0,0.0,4407.0,nan,nan,0.0,4407.0,0
TCGA-DA-A1I0-06,TCGA-DA-A1I0,SKCM,63.0,MALE,WHITE,Stage IV,nan,nan,nan,2008.0,nan,-23157.0,Dead,WITH TUMOR,nan,620.0,nan,Distant Metastasis,Brain,nan,599.0,nan,nan,nan,1.0,620.0,1.0,620.0,nan,nan,1.0,599.0,1
TCGA-DA-A1I1-06,TCGA-DA-A1I1,SKCM,55.0,MALE,WHITE,Stage III,nan,nan,nan,1996.0,nan,-20399.0,Alive,TUMOR FREE,6768.0,nan,nan,Distant Metastasis,"Other, Specify",Jejunum,5591.0,nan,nan,nan,0.0,6768.0,0.0,6768.0,nan,nan,1.0,5591.0,0
TCGA-DA-A1I2-06,TCGA-DA-A1I2,SKCM,45.0,MALE,WHITE,Stage III,nan,nan,nan,1996.0,nan,-16701.0,Dead,WITH TUMOR,nan,5370.0,nan,Regional lymph node,nan,nan,4679.0,nan,nan,nan,1.0,5370.0,1.0,5370.0,nan,nan,1.0,4679.0,1
TCGA-DA-A1I4-06,TCGA-DA-A1I4,SKCM,51.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2006.0,nan,-18961.0,Dead,WITH TUMOR,nan,1093.0,nan,Distant Metastasis,Brain,nan,889.0,nan,nan,nan,1.0,1093.0,1.0,1093.0,nan,nan,1.0,889.0,1
TCGA-DA-A1I5-06,TCGA-DA-A1I5,SKCM,27.0,FEMALE,WHITE,Stage IV,nan,nan,nan,2003.0,nan,-10017.0,Alive,TUMOR FREE,4107.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4107.0,0.0,4107.0,nan,nan,0.0,4107.0,0
TCGA-DA-A1I7-06,TCGA-DA-A1I7,SKCM,62.0,MALE,WHITE,Stage IIIB,nan,nan,nan,2007.0,nan,-22940.0,Alive,WITH TUMOR,2703.0,nan,nan,Distant Metastasis,"Other, Specify",skin scrotum,755.0,nan,nan,nan,0.0,2703.0,0.0,2703.0,nan,nan,1.0,755.0,0
TCGA-DA-A1I8-06,TCGA-DA-A1I8,SKCM,63.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2005.0,nan,-23286.0,Dead,WITH TUMOR,nan,1640.0,nan,Regional lymph node,nan,nan,961.0,nan,nan,nan,1.0,1640.0,1.0,1640.0,nan,nan,1.0,961.0,1
TCGA-DA-A1IA-06,TCGA-DA-A1IA,SKCM,32.0,FEMALE,WHITE,Stage IIIB,nan,nan,nan,2005.0,nan,-11744.0,Dead,WITH TUMOR,nan,2005.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2005.0,1.0,2005.0,nan,nan,1.0,2005.0,1
TCGA-DA-A1IB-06,TCGA-DA-A1IB,SKCM,69.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2010.0,nan,-25219.0,Alive,WITH TUMOR,825.0,nan,nan,Distant Metastasis,Brain,nan,243.0,nan,nan,nan,0.0,825.0,0.0,825.0,nan,nan,1.0,243.0,1
TCGA-DA-A1IC-06,TCGA-DA-A1IC,SKCM,81.0,MALE,WHITE,Stage IIIB,nan,nan,nan,2005.0,nan,-29859.0,Dead,WITH TUMOR,nan,2071.0,nan,Distant Metastasis,Lung,nan,1930.0,nan,nan,nan,1.0,2071.0,1.0,2071.0,nan,nan,1.0,1930.0,1
TCGA-DA-A3F2-06,TCGA-DA-A3F2,SKCM,55.0,MALE,WHITE,Stage IIIB,nan,nan,nan,2010.0,nan,-20365.0,Dead,WITH TUMOR,nan,1032.0,nan,Distant Metastasis,"Other, Specify",peritoneal,430.0,nan,nan,nan,1.0,1032.0,1.0,1032.0,nan,nan,1.0,430.0,1
TCGA-DA-A3F3-06,TCGA-DA-A3F3,SKCM,52.0,MALE,WHITE,Stage IIIB,nan,nan,nan,2010.0,nan,-19330.0,Dead,WITH TUMOR,nan,319.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,319.0,1.0,319.0,nan,nan,1.0,319.0,1
TCGA-DA-A3F5-06,TCGA-DA-A3F5,SKCM,45.0,MALE,WHITE,Stage I,nan,nan,nan,1994.0,nan,-16701.0,Dead,WITH TUMOR,nan,6873.0,nan,Distant Metastasis,Lung,nan,6841.0,nan,nan,nan,1.0,6873.0,1.0,6873.0,nan,nan,1.0,6841.0,1
TCGA-DA-A3F8-06,TCGA-DA-A3F8,SKCM,39.0,MALE,WHITE,Stage IIIB,nan,nan,nan,2011.0,nan,-14327.0,Alive,TUMOR FREE,1319.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1319.0,0.0,1319.0,nan,nan,0.0,1319.0,0
TCGA-DA-A95V-06,TCGA-DA-A95V,SKCM,83.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2009.0,nan,-30623.0,Alive,TUMOR FREE,2193.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2193.0,0.0,2193.0,nan,nan,0.0,2193.0,0
TCGA-DA-A95W-06,TCGA-DA-A95W,SKCM,52.0,MALE,WHITE,Stage IIIB,nan,nan,nan,2011.0,nan,-19105.0,Alive,TUMOR FREE,1136.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1136.0,0.0,1136.0,nan,nan,0.0,1136.0,0
TCGA-DA-A95X-06,TCGA-DA-A95X,SKCM,62.0,MALE,WHITE,Stage IB,nan,nan,nan,2009.0,nan,-22718.0,Alive,TUMOR FREE,2249.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2249.0,0.0,2249.0,nan,nan,0.0,2249.0,0
TCGA-DA-A95Y-06,TCGA-DA-A95Y,SKCM,68.0,MALE,WHITE,Stage IIC,nan,nan,nan,2012.0,nan,-25083.0,Dead,WITH TUMOR,nan,430.0,nan,Distant Metastasis,Lung,nan,338.0,nan,nan,nan,1.0,430.0,1.0,430.0,nan,nan,1.0,338.0,1
TCGA-DA-A95Z-06,TCGA-DA-A95Z,SKCM,87.0,MALE,WHITE,Stage IV,nan,nan,nan,2013.0,nan,-31837.0,Alive,TUMOR FREE,396.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,396.0,0.0,396.0,nan,nan,0.0,396.0,0
TCGA-DA-A960-01,TCGA-DA-A960,SKCM,73.0,MALE,WHITE,Stage IIB,nan,nan,nan,2012.0,nan,-26708.0,Alive,TUMOR FREE,804.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,804.0,0.0,804.0,nan,nan,0.0,804.0,0
TCGA-EB-A1NK-01,TCGA-EB-A1NK,SKCM,48.0,MALE,WHITE,Stage IIC,nan,nan,nan,2010.0,nan,-17569.0,Alive,TUMOR FREE,1039.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1039.0,0.0,1039.0,nan,nan,0.0,1039.0,0
TCGA-EB-A24C-01,TCGA-EB-A24C,SKCM,56.0,MALE,WHITE,nan,nan,nan,nan,2011.0,nan,-20539.0,Alive,TUMOR FREE,632.0,nan,nan,Regional lymph node,nan,nan,465.0,nan,nan,nan,0.0,632.0,0.0,632.0,nan,nan,1.0,465.0,0
TCGA-EB-A24D-01,TCGA-EB-A24D,SKCM,72.0,MALE,WHITE,Stage IIIB,nan,nan,nan,2011.0,nan,-26439.0,Alive,TUMOR FREE,645.0,nan,nan,Regional lymph node,nan,nan,500.0,nan,nan,nan,0.0,645.0,0.0,645.0,nan,nan,1.0,500.0,0
TCGA-EB-A299-01,TCGA-EB-A299,SKCM,63.0,MALE,WHITE,Stage IIA,nan,nan,nan,2011.0,nan,-23322.0,Alive,TUMOR FREE,378.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,378.0,0.0,378.0,nan,nan,0.0,378.0,0
TCGA-EB-A3HV-01,TCGA-EB-A3HV,SKCM,37.0,MALE,WHITE,Stage IIC,nan,nan,nan,2011.0,nan,-13712.0,Alive,WITH TUMOR,39.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,39.0,0.0,39.0,nan,nan,0.0,39.0,0
TCGA-EB-A3XB-01,TCGA-EB-A3XB,SKCM,63.0,MALE,WHITE,Stage II,nan,nan,nan,2011.0,nan,-23091.0,Alive,TUMOR FREE,796.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,796.0,0.0,796.0,nan,nan,0.0,796.0,0
TCGA-EB-A3XC-01,TCGA-EB-A3XC,SKCM,74.0,MALE,WHITE,Stage IIC,nan,nan,nan,2012.0,nan,-27124.0,Alive,TUMOR FREE,650.0,nan,nan,Distant Metastasis|Regional lymph node,"Other, Specify|[Not Available]",Chest wall|[Not Applicable],74.0,nan,nan,nan,0.0,650.0,0.0,650.0,nan,nan,1.0,74.0,0
TCGA-EB-A3XD-01,TCGA-EB-A3XD,SKCM,53.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2011.0,nan,-19431.0,Alive,TUMOR FREE,1160.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1160.0,0.0,1160.0,nan,nan,0.0,1160.0,0
TCGA-EB-A3XE-01,TCGA-EB-A3XE,SKCM,77.0,FEMALE,WHITE,Stage IIA,nan,nan,nan,2012.0,nan,-28148.0,Alive,TUMOR FREE,180.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,180.0,0.0,180.0,nan,nan,0.0,180.0,0
TCGA-EB-A3XF-01,TCGA-EB-A3XF,SKCM,57.0,MALE,WHITE,Stage IIC,nan,nan,nan,2012.0,nan,-20910.0,Alive,TUMOR FREE,278.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,278.0,0.0,278.0,nan,nan,0.0,278.0,0
TCGA-EB-A3Y6-01,TCGA-EB-A3Y6,SKCM,56.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2012.0,nan,-20605.0,Alive,TUMOR FREE,126.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,126.0,0.0,126.0,nan,nan,0.0,126.0,0
TCGA-EB-A3Y7-01,TCGA-EB-A3Y7,SKCM,86.0,FEMALE,WHITE,Stage IIIB,nan,nan,nan,2012.0,nan,-31622.0,Dead,TUMOR FREE,nan,326.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,326.0,0.0,326.0,nan,nan,0.0,326.0,1
TCGA-EB-A41A-01,TCGA-EB-A41A,SKCM,90.0,MALE,WHITE,Stage IIC,nan,nan,nan,2012.0,nan,-32872.0,Alive,TUMOR FREE,262.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,262.0,0.0,262.0,nan,nan,0.0,262.0,0
TCGA-EB-A41B-01,TCGA-EB-A41B,SKCM,76.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2012.0,nan,-27998.0,Alive,TUMOR FREE,291.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,291.0,0.0,291.0,nan,nan,0.0,291.0,0
TCGA-EB-A42Y-01,TCGA-EB-A42Y,SKCM,73.0,FEMALE,ASIAN,Stage IIC,nan,nan,nan,2012.0,nan,-26712.0,Dead,WITH TUMOR,nan,721.0,nan,Regional lymph node,nan,nan,721.0,nan,nan,nan,1.0,721.0,1.0,721.0,nan,nan,1.0,721.0,1
TCGA-EB-A42Z-01,TCGA-EB-A42Z,SKCM,49.0,MALE,ASIAN,Stage IIIC,nan,nan,nan,2012.0,nan,-18157.0,Alive,TUMOR FREE,441.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,441.0,0.0,441.0,nan,nan,0.0,441.0,0
TCGA-EB-A430-01,TCGA-EB-A430,SKCM,83.0,MALE,WHITE,Stage IIC,nan,nan,nan,2012.0,nan,-30344.0,Alive,TUMOR FREE,-2.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-EB-A431-01,TCGA-EB-A431,SKCM,34.0,MALE,WHITE,Stage IIC,nan,nan,nan,2012.0,nan,-12484.0,Alive,TUMOR FREE,568.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,568.0,0.0,568.0,nan,nan,0.0,568.0,0
TCGA-EB-A44N-01,TCGA-EB-A44N,SKCM,59.0,MALE,WHITE,Stage IIC,nan,nan,nan,2012.0,nan,-21623.0,Dead,WITH TUMOR,nan,205.0,nan,Regional lymph node|Distant Metastasis|Distant Metastasis,[Not Available]|Bone|Liver,[Not Applicable]|[Not Applicable]|[Not Applicable],115.0,nan,nan,nan,1.0,205.0,1.0,205.0,nan,nan,1.0,115.0,1
TCGA-EB-A44O-01,TCGA-EB-A44O,SKCM,69.0,MALE,WHITE,Stage IIB,nan,nan,nan,2012.0,nan,-25537.0,Alive,WITH TUMOR,81.0,nan,nan,Regional lymph node,nan,nan,60.0,nan,nan,nan,0.0,81.0,0.0,81.0,nan,nan,1.0,60.0,0
TCGA-EB-A44P-01,TCGA-EB-A44P,SKCM,58.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2012.0,nan,-21519.0,Alive,TUMOR FREE,741.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,741.0,0.0,741.0,nan,nan,0.0,741.0,0
TCGA-EB-A44Q-06,TCGA-EB-A44Q,SKCM,51.0,FEMALE,ASIAN,Stage IIIC,nan,nan,nan,2012.0,nan,-18910.0,Alive,TUMOR FREE,422.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,422.0,0.0,422.0,nan,nan,0.0,422.0,0
TCGA-EB-A44R-06,TCGA-EB-A44R,SKCM,52.0,MALE,ASIAN,Stage IIIB,nan,nan,nan,2011.0,nan,-19298.0,Dead,TUMOR FREE,nan,315.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,315.0,0.0,315.0,nan,nan,0.0,315.0,0
TCGA-EB-A4IQ-01,TCGA-EB-A4IQ,SKCM,42.0,FEMALE,ASIAN,Stage IIIB,nan,nan,nan,2012.0,nan,-15516.0,Dead,TUMOR FREE,nan,636.0,nan,Locoregional Recurrence|Regional lymph node,[Not Available]|[Not Available],[Not Applicable]|[Not Applicable],337.0,nan,nan,nan,1.0,636.0,0.0,636.0,nan,nan,1.0,337.0,1
TCGA-EB-A4IS-01,TCGA-EB-A4IS,SKCM,77.0,MALE,WHITE,Stage IIB,nan,nan,nan,2012.0,nan,-28315.0,Alive,TUMOR FREE,774.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,774.0,0.0,774.0,nan,nan,0.0,774.0,0
TCGA-EB-A4OY-01,TCGA-EB-A4OY,SKCM,65.0,FEMALE,WHITE,Stage IIIB,nan,nan,nan,2012.0,nan,-23773.0,Alive,TUMOR FREE,977.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,977.0,0.0,977.0,nan,nan,0.0,977.0,0
TCGA-EB-A4OZ-01,TCGA-EB-A4OZ,SKCM,41.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2012.0,nan,-15337.0,Alive,TUMOR FREE,620.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,620.0,0.0,620.0,nan,nan,0.0,620.0,0
TCGA-EB-A4P0-01,TCGA-EB-A4P0,SKCM,82.0,MALE,WHITE,Stage IIC,nan,nan,nan,2012.0,nan,-30225.0,Dead,TUMOR FREE,nan,326.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,326.0,0.0,326.0,nan,nan,0.0,326.0,0
TCGA-EB-A4XL-01,TCGA-EB-A4XL,SKCM,56.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2012.0,nan,-20486.0,Alive,TUMOR FREE,777.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,777.0,0.0,777.0,nan,nan,0.0,777.0,0
TCGA-EB-A51B-01,TCGA-EB-A51B,SKCM,53.0,MALE,WHITE,Stage IIC,nan,nan,nan,2012.0,nan,-19645.0,Alive,TUMOR FREE,931.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,931.0,0.0,931.0,nan,nan,0.0,931.0,0
TCGA-EB-A550-01,TCGA-EB-A550,SKCM,75.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2012.0,nan,-27556.0,Dead,TUMOR FREE,nan,264.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,264.0,0.0,264.0,nan,nan,0.0,264.0,1
TCGA-EB-A551-01,TCGA-EB-A551,SKCM,78.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2012.0,nan,-28671.0,Alive,TUMOR FREE,590.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,590.0,0.0,590.0,nan,nan,0.0,590.0,0
TCGA-EB-A553-01,TCGA-EB-A553,SKCM,62.0,MALE,WHITE,Stage IIC,nan,nan,nan,2012.0,nan,-22972.0,Alive,TUMOR FREE,226.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,226.0,0.0,226.0,nan,nan,0.0,226.0,0
TCGA-EB-A57M-01,TCGA-EB-A57M,SKCM,56.0,MALE,ASIAN,Stage IIIB,nan,nan,nan,2012.0,nan,-20698.0,Dead,TUMOR FREE,nan,472.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,472.0,0.0,472.0,nan,nan,0.0,472.0,0
TCGA-EB-A5FP-01,TCGA-EB-A5FP,SKCM,65.0,FEMALE,WHITE,Stage IV,nan,nan,nan,2012.0,nan,-23833.0,Dead,WITH TUMOR,nan,454.0,nan,Regional lymph node|Distant Metastasis,[Not Available]|Lung,[Not Applicable]|[Not Applicable],24.0,nan,nan,nan,1.0,454.0,1.0,454.0,nan,nan,1.0,24.0,1
TCGA-EB-A5KH-06,TCGA-EB-A5KH,SKCM,55.0,MALE,ASIAN,Stage III,nan,nan,nan,2011.0,nan,-20424.0,Dead,TUMOR FREE,nan,619.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,619.0,0.0,619.0,nan,nan,0.0,619.0,0
TCGA-EB-A5SE-01,TCGA-EB-A5SE,SKCM,73.0,MALE,WHITE,Stage IIB,nan,nan,nan,2012.0,nan,-26965.0,Dead,WITH TUMOR,nan,401.0,nan,Distant Metastasis,Brain,nan,367.0,nan,nan,nan,1.0,401.0,1.0,401.0,nan,nan,1.0,367.0,1
TCGA-EB-A5SF-01,TCGA-EB-A5SF,SKCM,78.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2012.0,nan,-28772.0,Dead,TUMOR FREE,nan,369.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,369.0,0.0,369.0,nan,nan,0.0,369.0,1
TCGA-EB-A5SG-06,TCGA-EB-A5SG,SKCM,57.0,FEMALE,WHITE,nan,nan,nan,nan,2008.0,nan,-20978.0,Alive,TUMOR FREE,2076.0,nan,nan,Locoregional Recurrence,nan,nan,1372.0,nan,nan,nan,0.0,2076.0,0.0,2076.0,nan,nan,1.0,1372.0,0
TCGA-EB-A5SH-06,TCGA-EB-A5SH,SKCM,60.0,FEMALE,WHITE,Stage III,nan,nan,nan,2009.0,nan,-21920.0,Alive,TUMOR FREE,1643.0,nan,nan,Locoregional Recurrence,nan,nan,1065.0,nan,nan,nan,0.0,1643.0,0.0,1643.0,nan,nan,1.0,1065.0,0
TCGA-EB-A5UL-06,TCGA-EB-A5UL,SKCM,71.0,MALE,WHITE,Stage III,nan,nan,nan,2012.0,nan,-26058.0,Alive,TUMOR FREE,891.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,891.0,0.0,891.0,nan,nan,0.0,891.0,0
TCGA-EB-A5UM-01,TCGA-EB-A5UM,SKCM,48.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2012.0,nan,-17867.0,Alive,TUMOR FREE,779.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,779.0,0.0,779.0,nan,nan,0.0,779.0,0
TCGA-EB-A5UN-06,TCGA-EB-A5UN,SKCM,49.0,MALE,WHITE,Stage IIC,nan,nan,nan,2009.0,nan,-18226.0,Alive,nan,1792.0,nan,nan,Distant Metastasis,Brain,nan,1689.0,nan,nan,nan,0.0,1792.0,0.0,1792.0,nan,nan,1.0,1689.0,0
TCGA-EB-A5VU-01,TCGA-EB-A5VU,SKCM,56.0,MALE,ASIAN,Stage IIIB,nan,nan,nan,2012.0,nan,-20610.0,Dead,WITH TUMOR,nan,321.0,nan,Locoregional Recurrence,nan,nan,217.0,nan,nan,nan,1.0,321.0,1.0,321.0,nan,nan,1.0,217.0,1
TCGA-EB-A5VV-06,TCGA-EB-A5VV,SKCM,74.0,FEMALE,WHITE,Stage IIIB,nan,nan,nan,2012.0,nan,-27364.0,Alive,TUMOR FREE,214.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,214.0,0.0,214.0,nan,nan,0.0,214.0,0
TCGA-EB-A6L9-06,TCGA-EB-A6L9,SKCM,55.0,MALE,ASIAN,Stage IIIC,nan,nan,nan,2012.0,nan,-20172.0,Alive,TUMOR FREE,1109.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1109.0,0.0,1109.0,nan,nan,0.0,1109.0,0
TCGA-EB-A6QY-01,TCGA-EB-A6QY,SKCM,71.0,MALE,WHITE,Stage IIC,nan,nan,nan,2013.0,nan,-26216.0,Alive,TUMOR FREE,382.0,nan,nan,Regional lymph node,nan,nan,36.0,nan,nan,nan,0.0,382.0,0.0,382.0,nan,nan,1.0,36.0,0
TCGA-EB-A6QZ-01,TCGA-EB-A6QZ,SKCM,76.0,FEMALE,WHITE,Stage IIA,nan,nan,nan,2013.0,nan,-28078.0,Dead,WITH TUMOR,nan,352.0,nan,Regional lymph node|Distant Metastasis,[Not Available]|Brain,[Not Applicable]|[Not Applicable],129.0,nan,nan,nan,1.0,352.0,1.0,352.0,nan,nan,1.0,129.0,1
TCGA-EB-A6R0-01,TCGA-EB-A6R0,SKCM,58.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2012.0,nan,-21367.0,Dead,TUMOR FREE,nan,608.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,608.0,0.0,608.0,nan,nan,0.0,608.0,1
TCGA-EB-A82B-01,TCGA-EB-A82B,SKCM,58.0,FEMALE,ASIAN,Stage III,nan,nan,nan,2013.0,nan,-21239.0,Alive,TUMOR FREE,390.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,390.0,0.0,390.0,nan,nan,0.0,390.0,0
TCGA-EB-A82C-01,TCGA-EB-A82C,SKCM,70.0,FEMALE,ASIAN,Stage IIC,nan,nan,nan,2013.0,nan,-25850.0,Alive,TUMOR FREE,17.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,17.0,0.0,17.0,nan,nan,0.0,17.0,0
TCGA-EB-A85I-01,TCGA-EB-A85I,SKCM,66.0,MALE,WHITE,Stage IIC,nan,nan,nan,2013.0,nan,-24408.0,Alive,TUMOR FREE,362.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,362.0,0.0,362.0,nan,nan,0.0,362.0,0
TCGA-EB-A85J-01,TCGA-EB-A85J,SKCM,66.0,FEMALE,WHITE,Stage IIB,nan,nan,nan,2013.0,nan,-24263.0,Alive,TUMOR FREE,360.0,nan,nan,Regional lymph node,nan,nan,138.0,nan,nan,nan,0.0,360.0,0.0,360.0,nan,nan,1.0,138.0,0
TCGA-EB-A97M-01,TCGA-EB-A97M,SKCM,66.0,MALE,WHITE,Stage IIC,nan,nan,nan,2013.0,nan,-24228.0,Alive,TUMOR FREE,414.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,414.0,0.0,414.0,nan,nan,0.0,414.0,0
TCGA-EE-A17X-06,TCGA-EE-A17X,SKCM,54.0,MALE,WHITE,Stage IA,nan,nan,nan,2006.0,nan,-20021.0,Dead,WITH TUMOR,nan,907.0,nan,Locoregional Recurrence,nan,nan,531.0,nan,nan,nan,1.0,907.0,1.0,907.0,nan,nan,1.0,531.0,1
TCGA-EE-A17Y-06,TCGA-EE-A17Y,SKCM,69.0,MALE,ASIAN,Stage IIIB,nan,nan,nan,2007.0,nan,-25281.0,Dead,WITH TUMOR,nan,828.0,nan,Regional lymph node,nan,nan,317.0,nan,nan,nan,1.0,828.0,1.0,828.0,nan,nan,1.0,317.0,1
TCGA-EE-A17Z-06,TCGA-EE-A17Z,SKCM,57.0,MALE,WHITE,Stage IIB,nan,nan,nan,2008.0,nan,-20970.0,Dead,WITH TUMOR,nan,263.0,nan,Regional lymph node,nan,nan,138.0,nan,nan,nan,1.0,263.0,1.0,263.0,nan,nan,1.0,138.0,1
TCGA-EE-A180-06,TCGA-EE-A180,SKCM,69.0,MALE,WHITE,Stage III,nan,nan,nan,2001.0,nan,-25523.0,Dead,WITH TUMOR,nan,2889.0,nan,New primary melanoma,nan,nan,850.0,nan,nan,nan,1.0,2889.0,1.0,2889.0,nan,nan,1.0,850.0,1
TCGA-EE-A181-06,TCGA-EE-A181,SKCM,82.0,FEMALE,WHITE,Stage II,nan,nan,nan,2005.0,nan,-30003.0,Dead,TUMOR FREE,nan,1026.0,nan,Locoregional Recurrence,nan,nan,788.0,nan,nan,nan,1.0,1026.0,0.0,1026.0,nan,nan,1.0,788.0,1
TCGA-EE-A182-06,TCGA-EE-A182,SKCM,84.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2008.0,nan,-30718.0,Dead,WITH TUMOR,nan,447.0,nan,Locoregional Recurrence,nan,nan,270.0,nan,nan,nan,1.0,447.0,1.0,447.0,nan,nan,1.0,270.0,1
TCGA-EE-A183-06,TCGA-EE-A183,SKCM,48.0,MALE,WHITE,Stage 0,nan,nan,nan,2007.0,nan,-17788.0,Dead,WITH TUMOR,nan,818.0,nan,Locoregional Recurrence,nan,nan,450.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,1
TCGA-EE-A184-06,TCGA-EE-A184,SKCM,72.0,MALE,WHITE,Stage IB,nan,nan,nan,2003.0,nan,-26447.0,Dead,nan,nan,2073.0,nan,Distant Metastasis,"Other, Specify",Right lower arm,1309.0,nan,nan,nan,1.0,2073.0,nan,2073.0,nan,nan,1.0,1309.0,1
TCGA-EE-A185-06,TCGA-EE-A185,SKCM,55.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2008.0,nan,-20235.0,Dead,WITH TUMOR,nan,151.0,nan,Regional lymph node,nan,nan,85.0,nan,nan,nan,1.0,151.0,1.0,151.0,nan,nan,1.0,85.0,1
TCGA-EE-A20B-06,TCGA-EE-A20B,SKCM,66.0,FEMALE,WHITE,Stage II,nan,nan,nan,2002.0,nan,-24445.0,Alive,TUMOR FREE,4070.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4070.0,0.0,4070.0,nan,nan,0.0,4070.0,0
TCGA-EE-A20C-06,TCGA-EE-A20C,SKCM,59.0,MALE,WHITE,Stage 0,nan,nan,nan,1997.0,nan,-21660.0,Dead,WITH TUMOR,nan,4601.0,nan,New primary melanoma,nan,nan,142.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,1
TCGA-EE-A20F-06,TCGA-EE-A20F,SKCM,53.0,MALE,WHITE,Stage I,nan,nan,nan,2002.0,nan,-19372.0,Alive,TUMOR FREE,2785.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2785.0,0.0,2785.0,nan,nan,0.0,2785.0,0
TCGA-EE-A20H-06,TCGA-EE-A20H,SKCM,56.0,MALE,WHITE,Stage I,nan,nan,nan,1995.0,nan,-20476.0,Dead,WITH TUMOR,nan,5118.0,nan,Regional lymph node,nan,nan,4667.0,nan,nan,nan,1.0,5118.0,1.0,5118.0,nan,nan,1.0,4667.0,1
TCGA-EE-A20I-06,TCGA-EE-A20I,SKCM,79.0,MALE,WHITE,Stage IV,nan,nan,nan,2008.0,nan,-28883.0,Dead,WITH TUMOR,nan,412.0,nan,Distant Metastasis,Brain,nan,53.0,nan,nan,nan,1.0,412.0,1.0,412.0,nan,nan,1.0,53.0,1
TCGA-EE-A29A-06,TCGA-EE-A29A,SKCM,68.0,MALE,WHITE,Stage IIIA,nan,nan,nan,2003.0,nan,-25095.0,Dead,WITH TUMOR,nan,1927.0,nan,Locoregional Recurrence,nan,nan,867.0,nan,nan,nan,1.0,1927.0,1.0,1927.0,nan,nan,1.0,867.0,1
TCGA-EE-A29B-06,TCGA-EE-A29B,SKCM,67.0,MALE,WHITE,Stage IIB,nan,nan,nan,2004.0,nan,-24618.0,Dead,WITH TUMOR,nan,2588.0,nan,New primary melanoma,nan,nan,490.0,nan,nan,nan,1.0,2588.0,1.0,2588.0,nan,nan,1.0,490.0,1
TCGA-EE-A29C-06,TCGA-EE-A29C,SKCM,20.0,MALE,WHITE,Stage IB,nan,nan,nan,2007.0,nan,-7510.0,Dead,WITH TUMOR,nan,2402.0,nan,Regional lymph node,nan,nan,204.0,nan,nan,nan,1.0,2402.0,1.0,2402.0,nan,nan,1.0,204.0,1
TCGA-EE-A29D-06,TCGA-EE-A29D,SKCM,87.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2008.0,nan,-31790.0,Dead,nan,nan,425.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,425.0,nan,425.0,nan,nan,0.0,425.0,1
TCGA-EE-A29E-06,TCGA-EE-A29E,SKCM,54.0,MALE,WHITE,Stage IIIB,nan,nan,nan,2008.0,nan,-19961.0,Alive,TUMOR FREE,1940.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1940.0,0.0,1940.0,nan,nan,0.0,1940.0,0
TCGA-EE-A29G-06,TCGA-EE-A29G,SKCM,53.0,MALE,WHITE,Stage IIIA,nan,nan,nan,2003.0,nan,-19664.0,Dead,WITH TUMOR,nan,2192.0,nan,Locoregional Recurrence,nan,nan,726.0,nan,nan,nan,1.0,2192.0,1.0,2192.0,nan,nan,1.0,726.0,1
TCGA-EE-A29H-06,TCGA-EE-A29H,SKCM,59.0,FEMALE,WHITE,Stage IA,nan,nan,nan,2008.0,nan,-21552.0,Alive,TUMOR FREE,1966.0,nan,nan,Distant Metastasis|Locoregional Recurrence,"Other, Specify|[Not Available]",Perihilar lymph nodes|[Not Applicable],1231.0,nan,nan,nan,0.0,1966.0,0.0,1966.0,nan,nan,1.0,1231.0,0
TCGA-EE-A29L-06,TCGA-EE-A29L,SKCM,78.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2009.0,nan,-28824.0,Dead,nan,nan,79.0,nan,Distant Metastasis,Brain,nan,55.0,nan,nan,nan,1.0,79.0,nan,79.0,nan,nan,1.0,55.0,1
TCGA-EE-A29M-06,TCGA-EE-A29M,SKCM,33.0,FEMALE,WHITE,Stage IB,nan,nan,nan,2007.0,nan,-12350.0,Alive,TUMOR FREE,1729.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1729.0,0.0,1729.0,nan,nan,0.0,1729.0,0
TCGA-EE-A29N-06,TCGA-EE-A29N,SKCM,78.0,MALE,WHITE,I/II NOS,nan,nan,nan,2009.0,nan,-28805.0,Dead,WITH TUMOR,nan,566.0,nan,New primary melanoma,nan,nan,478.0,nan,nan,nan,1.0,566.0,1.0,566.0,nan,nan,1.0,478.0,1
TCGA-EE-A29P-06,TCGA-EE-A29P,SKCM,73.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2006.0,nan,-26899.0,Alive,WITH TUMOR,1716.0,nan,nan,Distant Metastasis,Lung,nan,1668.0,nan,nan,nan,0.0,1716.0,0.0,1716.0,nan,nan,1.0,1668.0,1
TCGA-EE-A29Q-06,TCGA-EE-A29Q,SKCM,70.0,FEMALE,WHITE,Stage IIB,nan,nan,nan,2007.0,nan,-25847.0,Dead,WITH TUMOR,nan,2030.0,nan,Regional lymph node|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Locoregional Recurrence|Distant Metastasis,"[Not Available]|Other, Specify|Other, Specify|Lung|Bone|[Not Available]|Brain",[Not Applicable]|mediastinal lymph nodes|adrenal|[Not Applicable]|[Not Applicable]|[Not Applicable]|[Not Applicable],1256.0,nan,nan,nan,1.0,2030.0,1.0,2030.0,nan,nan,1.0,1256.0,1
TCGA-EE-A29R-06,TCGA-EE-A29R,SKCM,48.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2010.0,nan,-17857.0,Alive,WITH TUMOR,440.0,nan,nan,Distant Metastasis,Lung,nan,426.0,nan,nan,nan,0.0,440.0,0.0,440.0,nan,nan,1.0,426.0,1
TCGA-EE-A29S-06,TCGA-EE-A29S,SKCM,79.0,MALE,WHITE,Stage IIA,nan,nan,nan,2006.0,nan,-29087.0,Dead,WITH TUMOR,nan,1864.0,nan,Locoregional Recurrence,nan,nan,1418.0,nan,nan,nan,1.0,1864.0,1.0,1864.0,nan,nan,1.0,1418.0,1
TCGA-EE-A29T-06,TCGA-EE-A29T,SKCM,51.0,FEMALE,WHITE,nan,nan,nan,nan,1982.0,nan,-18779.0,Alive,TUMOR FREE,11252.0,nan,nan,Regional lymph node,nan,nan,7483.0,nan,nan,nan,0.0,11252.0,0.0,11252.0,nan,nan,1.0,7483.0,0
TCGA-EE-A29V-06,TCGA-EE-A29V,SKCM,85.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2008.0,nan,-31092.0,Dead,WITH TUMOR,nan,787.0,nan,Locoregional Recurrence,nan,nan,96.0,nan,nan,nan,1.0,787.0,1.0,787.0,nan,nan,1.0,96.0,1
TCGA-EE-A29W-06,TCGA-EE-A29W,SKCM,42.0,MALE,WHITE,Stage 0,nan,nan,nan,1997.0,nan,-15396.0,Alive,TUMOR FREE,5932.0,nan,nan,New primary melanoma,nan,nan,4408.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,1
TCGA-EE-A29X-06,TCGA-EE-A29X,SKCM,58.0,FEMALE,WHITE,Stage IB,nan,nan,nan,2009.0,nan,-21363.0,Dead,WITH TUMOR,nan,545.0,nan,Regional lymph node,nan,nan,391.0,nan,nan,nan,1.0,545.0,1.0,545.0,nan,nan,1.0,391.0,1
TCGA-EE-A2A0-06,TCGA-EE-A2A0,SKCM,77.0,FEMALE,WHITE,Stage IIA,nan,nan,nan,2006.0,nan,-28319.0,Dead,WITH TUMOR,nan,1424.0,nan,Distant Metastasis,"Other, Specify",Left Inner Canthus,1247.0,nan,nan,nan,1.0,1424.0,1.0,1424.0,nan,nan,1.0,1247.0,1
TCGA-EE-A2A1-06,TCGA-EE-A2A1,SKCM,46.0,MALE,WHITE,Stage IB,nan,nan,nan,2004.0,nan,-17109.0,Alive,TUMOR FREE,3527.0,nan,nan,Regional lymph node,nan,nan,3488.0,nan,nan,nan,0.0,3527.0,0.0,3527.0,nan,nan,1.0,3488.0,0
TCGA-EE-A2A2-06,TCGA-EE-A2A2,SKCM,71.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2009.0,nan,-26048.0,Alive,TUMOR FREE,1814.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1814.0,0.0,1814.0,nan,nan,0.0,1814.0,0
TCGA-EE-A2A5-06,TCGA-EE-A2A5,SKCM,43.0,MALE,WHITE,Stage IB,nan,nan,nan,2007.0,nan,-16041.0,Dead,WITH TUMOR,nan,1195.0,nan,Regional lymph node,nan,nan,1028.0,nan,nan,nan,1.0,1195.0,1.0,1195.0,nan,nan,1.0,1028.0,1
TCGA-EE-A2A6-06,TCGA-EE-A2A6,SKCM,43.0,MALE,WHITE,Stage IA,nan,nan,nan,2006.0,nan,-15953.0,Alive,TUMOR FREE,2620.0,nan,nan,New primary melanoma,nan,nan,1505.0,nan,nan,nan,0.0,2620.0,0.0,2620.0,nan,nan,1.0,1505.0,0
TCGA-EE-A2GB-06,TCGA-EE-A2GB,SKCM,51.0,MALE,WHITE,Stage IIIB,nan,nan,nan,2007.0,nan,-18876.0,Alive,TUMOR FREE,1803.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1803.0,0.0,1803.0,nan,nan,0.0,1803.0,0
TCGA-EE-A2GC-06,TCGA-EE-A2GC,SKCM,82.0,MALE,WHITE,Stage IIB,nan,nan,nan,2008.0,nan,-30084.0,Alive,TUMOR FREE,2051.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2051.0,0.0,2051.0,nan,nan,0.0,2051.0,0
TCGA-EE-A2GD-06,TCGA-EE-A2GD,SKCM,58.0,FEMALE,WHITE,Stage IIB,nan,nan,nan,1984.0,nan,-21526.0,Dead,WITH TUMOR,nan,10346.0,nan,Locoregional Recurrence,nan,nan,3689.0,nan,nan,nan,1.0,10346.0,1.0,10346.0,nan,nan,1.0,3689.0,1
TCGA-EE-A2GE-06,TCGA-EE-A2GE,SKCM,44.0,MALE,WHITE,Stage I,nan,nan,nan,1999.0,nan,-16353.0,Alive,TUMOR FREE,5286.0,nan,nan,[Not Available]|[Not Available],[Not Available]|[Not Available],[Not Applicable]|[Not Applicable],5276.0,nan,nan,nan,0.0,5286.0,0.0,5286.0,nan,nan,1.0,5276.0,0
TCGA-EE-A2GH-06,TCGA-EE-A2GH,SKCM,34.0,MALE,WHITE,Stage I,nan,nan,nan,1996.0,nan,-12727.0,Alive,TUMOR FREE,6699.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,6699.0,0.0,6699.0,nan,nan,0.0,6699.0,0
TCGA-EE-A2GI-06,TCGA-EE-A2GI,SKCM,39.0,MALE,WHITE,Stage IA,nan,nan,nan,2008.0,nan,-14498.0,Alive,TUMOR FREE,1482.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1482.0,0.0,1482.0,nan,nan,0.0,1482.0,0
TCGA-EE-A2GJ-06,TCGA-EE-A2GJ,SKCM,83.0,MALE,WHITE,Stage IA,nan,nan,nan,2004.0,nan,-30602.0,Dead,WITH TUMOR,nan,3266.0,nan,New primary melanoma,nan,nan,733.0,nan,nan,nan,1.0,3266.0,1.0,3266.0,nan,nan,1.0,733.0,1
TCGA-EE-A2GK-06,TCGA-EE-A2GK,SKCM,46.0,FEMALE,WHITE,Stage I,nan,nan,nan,2007.0,nan,-16879.0,Alive,TUMOR FREE,1665.0,nan,nan,nan,nan,nan,1498.0,nan,nan,nan,0.0,1665.0,0.0,1665.0,nan,nan,1.0,1498.0,0
TCGA-EE-A2GL-06,TCGA-EE-A2GL,SKCM,40.0,FEMALE,WHITE,Stage IIA,nan,nan,nan,2006.0,nan,-14701.0,Alive,WITH TUMOR,2423.0,nan,nan,Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis,"Lung|Other, Specify|Bone|Other, Specify|Other, Specify|Other, Specify|Other, Specify|Other, Specify|Other, Specify|Other, Specify",[Not Applicable]|right anterior chest - skin and soft tissue|[Not Applicable]|LN left neck|left head - skin and soft tissue|spleen|left anterior chest - skin and soft tissue|LN right neck|right head - skin and soft tissue|LN left pelvic,2329.0,nan,nan,nan,0.0,2423.0,0.0,2423.0,nan,nan,1.0,2329.0,1
TCGA-EE-A2GM-06,TCGA-EE-A2GM,SKCM,70.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2004.0,nan,-25711.0,Alive,TUMOR FREE,2296.0,nan,nan,Locoregional Recurrence,nan,nan,1218.0,nan,nan,nan,0.0,2296.0,0.0,2296.0,nan,nan,1.0,1218.0,0
TCGA-EE-A2GN-06,TCGA-EE-A2GN,SKCM,67.0,MALE,WHITE,Stage IIA,nan,nan,nan,2003.0,nan,-24683.0,Dead,WITH TUMOR,nan,3106.0,nan,Distant Metastasis,"Other, Specify",adrenal gland,2422.0,nan,nan,nan,1.0,3106.0,1.0,3106.0,nan,nan,1.0,2422.0,1
TCGA-EE-A2GO-06,TCGA-EE-A2GO,SKCM,66.0,FEMALE,WHITE,Stage II,nan,nan,nan,2002.0,nan,-24159.0,Alive,TUMOR FREE,3857.0,nan,nan,Regional lymph node,nan,nan,2216.0,nan,nan,nan,0.0,3857.0,0.0,3857.0,nan,nan,1.0,2216.0,0
TCGA-EE-A2GP-06,TCGA-EE-A2GP,SKCM,80.0,MALE,WHITE,Stage IIIB,nan,nan,nan,2009.0,nan,-29501.0,Dead,WITH TUMOR,nan,423.0,nan,Distant Metastasis,Lung,nan,251.0,nan,nan,nan,1.0,423.0,1.0,423.0,nan,nan,1.0,251.0,1
TCGA-EE-A2GR-06,TCGA-EE-A2GR,SKCM,78.0,MALE,WHITE,Stage II,nan,nan,nan,2009.0,nan,-28510.0,Dead,WITH TUMOR,nan,1301.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1301.0,1.0,1301.0,nan,nan,1.0,1301.0,1
TCGA-EE-A2GS-06,TCGA-EE-A2GS,SKCM,28.0,FEMALE,WHITE,Stage IB,nan,nan,nan,2006.0,nan,-10421.0,Dead,WITH TUMOR,nan,2470.0,nan,Distant Metastasis,"Other, Specify",right buttock,1565.0,nan,nan,nan,1.0,2470.0,1.0,2470.0,nan,nan,1.0,1565.0,1
TCGA-EE-A2GT-06,TCGA-EE-A2GT,SKCM,77.0,MALE,WHITE,Stage IIA,nan,nan,nan,2009.0,nan,-28364.0,Alive,WITH TUMOR,1365.0,nan,nan,Locoregional Recurrence,nan,nan,281.0,nan,nan,nan,0.0,1365.0,0.0,1365.0,nan,nan,1.0,281.0,0
TCGA-EE-A2GU-06,TCGA-EE-A2GU,SKCM,65.0,FEMALE,WHITE,Stage IA,nan,nan,nan,2005.0,nan,-23784.0,Alive,TUMOR FREE,2884.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2884.0,0.0,2884.0,nan,nan,0.0,2884.0,0
TCGA-EE-A2M5-06,TCGA-EE-A2M5,SKCM,49.0,MALE,WHITE,Stage I,nan,nan,nan,1999.0,nan,-17950.0,Dead,WITH TUMOR,nan,659.0,nan,Locoregional Recurrence,nan,nan,537.0,nan,nan,nan,1.0,659.0,1.0,659.0,nan,nan,1.0,537.0,1
TCGA-EE-A2M6-06,TCGA-EE-A2M6,SKCM,61.0,MALE,WHITE,Stage I,nan,nan,nan,1997.0,nan,-22564.0,Alive,TUMOR FREE,3932.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3932.0,0.0,3932.0,nan,nan,0.0,3932.0,0
TCGA-EE-A2M7-06,TCGA-EE-A2M7,SKCM,66.0,MALE,WHITE,Stage II,nan,nan,nan,1999.0,nan,-24371.0,Dead,WITH TUMOR,nan,877.0,nan,Distant Metastasis,"Other, Specify",mediastinal lymph nodes,799.0,nan,nan,nan,1.0,877.0,1.0,877.0,nan,nan,1.0,799.0,1
TCGA-EE-A2M8-06,TCGA-EE-A2M8,SKCM,54.0,FEMALE,WHITE,Stage III,nan,nan,nan,2000.0,nan,-19808.0,Dead,WITH TUMOR,nan,601.0,nan,Distant Metastasis,Brain,nan,498.0,nan,nan,nan,1.0,601.0,1.0,601.0,nan,nan,1.0,498.0,1
TCGA-EE-A2MC-06,TCGA-EE-A2MC,SKCM,73.0,MALE,WHITE,Stage I,nan,nan,nan,2000.0,nan,-26872.0,Dead,TUMOR FREE,nan,1871.0,nan,Distant Metastasis,"Other, Specify",right neck lymph nodes,896.0,nan,nan,nan,1.0,1871.0,0.0,1871.0,nan,nan,1.0,896.0,1
TCGA-EE-A2MD-06,TCGA-EE-A2MD,SKCM,52.0,MALE,WHITE,Stage II,nan,nan,nan,1998.0,nan,-19333.0,Dead,WITH TUMOR,nan,1438.0,nan,Regional lymph node,nan,nan,1344.0,nan,nan,nan,1.0,1438.0,1.0,1438.0,nan,nan,1.0,1344.0,1
TCGA-EE-A2ME-06,TCGA-EE-A2ME,SKCM,51.0,MALE,WHITE,Stage I,nan,nan,nan,1995.0,nan,-18841.0,Dead,WITH TUMOR,nan,3141.0,nan,Distant Metastasis,"Other, Specify",retroperitoneal nodule,2703.0,nan,nan,nan,1.0,3141.0,1.0,3141.0,nan,nan,1.0,2703.0,1
TCGA-EE-A2MF-06,TCGA-EE-A2MF,SKCM,39.0,FEMALE,WHITE,Stage I,nan,nan,nan,1979.0,nan,-14312.0,Dead,WITH TUMOR,nan,8174.0,nan,New primary melanoma,nan,nan,8071.0,nan,nan,nan,1.0,8174.0,1.0,8174.0,nan,nan,1.0,8071.0,1
TCGA-EE-A2MG-06,TCGA-EE-A2MG,SKCM,23.0,MALE,WHITE,Stage I,nan,nan,nan,1997.0,nan,-8405.0,Dead,WITH TUMOR,nan,3139.0,nan,Distant Metastasis,Lung,nan,2585.0,nan,nan,nan,1.0,3139.0,1.0,3139.0,nan,nan,1.0,2585.0,1
TCGA-EE-A2MH-06,TCGA-EE-A2MH,SKCM,66.0,MALE,WHITE,Stage III,nan,nan,nan,2001.0,nan,-24125.0,Dead,WITH TUMOR,nan,516.0,nan,Distant Metastasis,Bone,nan,440.0,nan,nan,nan,1.0,516.0,1.0,516.0,nan,nan,1.0,440.0,1
TCGA-EE-A2MI-06,TCGA-EE-A2MI,SKCM,43.0,MALE,WHITE,Stage IIB,nan,nan,nan,1986.0,nan,-15880.0,Dead,WITH TUMOR,nan,6225.0,nan,New primary melanoma,nan,nan,2673.0,nan,nan,nan,1.0,6225.0,1.0,6225.0,nan,nan,1.0,2673.0,1
TCGA-EE-A2MJ-06,TCGA-EE-A2MJ,SKCM,60.0,MALE,WHITE,Stage III,nan,nan,nan,1999.0,nan,-22050.0,Dead,TUMOR FREE,nan,2927.0,nan,Regional lymph node,nan,nan,396.0,nan,nan,nan,1.0,2927.0,0.0,2927.0,nan,nan,1.0,396.0,1
TCGA-EE-A2MK-06,TCGA-EE-A2MK,SKCM,18.0,FEMALE,WHITE,Stage III,nan,nan,nan,1999.0,nan,-6831.0,Alive,TUMOR FREE,5487.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,5487.0,0.0,5487.0,nan,nan,0.0,5487.0,0
TCGA-EE-A2ML-06,TCGA-EE-A2ML,SKCM,35.0,MALE,WHITE,Stage II,nan,nan,nan,1994.0,nan,-13140.0,Dead,WITH TUMOR,nan,6590.0,nan,Distant Metastasis,Bone,nan,4983.0,nan,nan,nan,1.0,6590.0,1.0,6590.0,nan,nan,1.0,4983.0,1
TCGA-EE-A2MM-06,TCGA-EE-A2MM,SKCM,63.0,FEMALE,WHITE,Stage I,nan,nan,nan,1993.0,nan,-23132.0,Dead,WITH TUMOR,nan,5107.0,nan,New primary melanoma,nan,nan,1357.0,nan,nan,nan,1.0,5107.0,1.0,5107.0,nan,nan,1.0,1357.0,1
TCGA-EE-A2MN-06,TCGA-EE-A2MN,SKCM,58.0,MALE,WHITE,Stage I,nan,nan,nan,2000.0,nan,-21202.0,Dead,WITH TUMOR,nan,1446.0,nan,Distant Metastasis,Brain,nan,969.0,nan,nan,nan,1.0,1446.0,1.0,1446.0,nan,nan,1.0,969.0,1
TCGA-EE-A2MP-06,TCGA-EE-A2MP,SKCM,34.0,FEMALE,WHITE,Stage I,nan,nan,nan,1991.0,nan,-12474.0,Alive,WITH TUMOR,7563.0,nan,nan,Locoregional Recurrence,nan,nan,365.0,nan,nan,nan,0.0,7563.0,0.0,7563.0,nan,nan,1.0,365.0,1
TCGA-EE-A2MQ-06,TCGA-EE-A2MQ,SKCM,70.0,FEMALE,WHITE,Stage IIIA,nan,nan,nan,2006.0,nan,-25926.0,Dead,WITH TUMOR,nan,1315.0,nan,Regional lymph node,nan,nan,986.0,nan,nan,nan,1.0,1315.0,1.0,1315.0,nan,nan,1.0,986.0,1
TCGA-EE-A2MR-06,TCGA-EE-A2MR,SKCM,61.0,MALE,WHITE,Stage I,nan,nan,nan,2002.0,nan,-22535.0,Alive,TUMOR FREE,4088.0,nan,nan,nan,nan,nan,3136.0,nan,nan,nan,0.0,4088.0,0.0,4088.0,nan,nan,1.0,3136.0,0
TCGA-EE-A2MS-06,TCGA-EE-A2MS,SKCM,72.0,MALE,WHITE,Stage II,nan,nan,nan,1999.0,nan,-26466.0,Alive,TUMOR FREE,4942.0,nan,nan,New primary melanoma,nan,nan,1883.0,nan,nan,nan,0.0,4942.0,0.0,4942.0,nan,nan,1.0,1883.0,0
TCGA-EE-A2MT-06,TCGA-EE-A2MT,SKCM,45.0,MALE,WHITE,Stage IB,nan,nan,nan,2007.0,nan,-16768.0,Alive,TUMOR FREE,2166.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2166.0,0.0,2166.0,nan,nan,0.0,2166.0,0
TCGA-EE-A2MU-06,TCGA-EE-A2MU,SKCM,71.0,MALE,WHITE,Stage IA,nan,nan,nan,2005.0,nan,-26237.0,Alive,TUMOR FREE,1620.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1620.0,0.0,1620.0,nan,nan,0.0,1620.0,0
TCGA-EE-A3AA-06,TCGA-EE-A3AA,SKCM,47.0,MALE,WHITE,Stage III,nan,nan,nan,2001.0,nan,-17196.0,Alive,TUMOR FREE,3781.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3781.0,0.0,3781.0,nan,nan,0.0,3781.0,0
TCGA-EE-A3AB-06,TCGA-EE-A3AB,SKCM,30.0,MALE,WHITE,Stage III,nan,nan,nan,2001.0,nan,-11054.0,Alive,TUMOR FREE,3733.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3733.0,0.0,3733.0,nan,nan,0.0,3733.0,0
TCGA-EE-A3AC-06,TCGA-EE-A3AC,SKCM,47.0,MALE,WHITE,Stage III,nan,nan,nan,2009.0,nan,-17319.0,Alive,TUMOR FREE,1948.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1948.0,0.0,1948.0,nan,nan,0.0,1948.0,0
TCGA-EE-A3AD-06,TCGA-EE-A3AD,SKCM,50.0,MALE,WHITE,Stage III,nan,nan,nan,2009.0,nan,-18491.0,Dead,WITH TUMOR,nan,875.0,nan,Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis,"Other, Specify|Lung|Other, Specify|Other, Specify|Brain|Liver",spinal cord|[Not Applicable]|right anterior abdomen - skin and soft tissue|right anterior chest - skin and soft tissue|[Not Applicable]|[Not Applicable],554.0,nan,nan,nan,1.0,875.0,1.0,875.0,nan,nan,1.0,554.0,1
TCGA-EE-A3AE-06,TCGA-EE-A3AE,SKCM,52.0,FEMALE,WHITE,Stage IA,nan,nan,nan,2009.0,nan,-19216.0,Alive,TUMOR FREE,1658.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1658.0,0.0,1658.0,nan,nan,0.0,1658.0,0
TCGA-EE-A3AF-06,TCGA-EE-A3AF,SKCM,48.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2009.0,nan,-17731.0,Dead,WITH TUMOR,nan,420.0,nan,Locoregional Recurrence,nan,nan,201.0,nan,nan,nan,1.0,420.0,1.0,420.0,nan,nan,1.0,201.0,1
TCGA-EE-A3AG-06,TCGA-EE-A3AG,SKCM,25.0,MALE,WHITE,Stage III,nan,nan,nan,2009.0,nan,-9161.0,Dead,WITH TUMOR,nan,1265.0,nan,Regional lymph node,nan,nan,229.0,nan,nan,nan,1.0,1265.0,1.0,1265.0,nan,nan,1.0,229.0,1
TCGA-EE-A3AH-06,TCGA-EE-A3AH,SKCM,30.0,MALE,WHITE,Stage II,nan,nan,nan,1998.0,nan,-10988.0,Dead,WITH TUMOR,nan,4222.0,nan,Locoregional Recurrence,nan,nan,1981.0,nan,nan,nan,1.0,4222.0,1.0,4222.0,nan,nan,1.0,1981.0,1
TCGA-EE-A3J3-06,TCGA-EE-A3J3,SKCM,42.0,MALE,WHITE,Stage IB,nan,nan,nan,1986.0,nan,-15446.0,Dead,WITH TUMOR,nan,5237.0,nan,Regional lymph node,nan,nan,4523.0,nan,nan,nan,1.0,5237.0,1.0,5237.0,nan,nan,1.0,4523.0,1
TCGA-EE-A3J4-06,TCGA-EE-A3J4,SKCM,72.0,MALE,WHITE,Stage II,nan,nan,nan,1991.0,nan,-26540.0,Dead,WITH TUMOR,nan,3869.0,nan,Locoregional Recurrence,nan,nan,1429.0,nan,nan,nan,1.0,3869.0,1.0,3869.0,nan,nan,1.0,1429.0,1
TCGA-EE-A3J5-06,TCGA-EE-A3J5,SKCM,71.0,MALE,WHITE,Stage III,nan,nan,nan,2000.0,nan,-26226.0,Dead,WITH TUMOR,nan,1124.0,nan,Locoregional Recurrence,nan,nan,467.0,nan,nan,nan,1.0,1124.0,1.0,1124.0,nan,nan,1.0,467.0,1
TCGA-EE-A3J7-06,TCGA-EE-A3J7,SKCM,43.0,MALE,WHITE,Stage I,nan,nan,nan,1998.0,nan,-15896.0,Alive,TUMOR FREE,1949.0,nan,nan,Regional lymph node,nan,nan,1270.0,nan,nan,nan,0.0,1949.0,0.0,1949.0,nan,nan,1.0,1270.0,0
TCGA-EE-A3J8-06,TCGA-EE-A3J8,SKCM,59.0,MALE,WHITE,Stage IIIA,nan,nan,nan,2006.0,nan,-21688.0,Dead,TUMOR FREE,nan,1044.0,nan,nan,nan,nan,1035.0,nan,nan,nan,1.0,1044.0,0.0,1044.0,nan,nan,1.0,1035.0,1
TCGA-EE-A3JA-06,TCGA-EE-A3JA,SKCM,44.0,MALE,WHITE,Stage IB,nan,nan,nan,2006.0,nan,-16430.0,Dead,WITH TUMOR,nan,1618.0,nan,Regional lymph node,nan,nan,539.0,nan,nan,nan,1.0,1618.0,1.0,1618.0,nan,nan,1.0,539.0,1
TCGA-EE-A3JB-06,TCGA-EE-A3JB,SKCM,60.0,FEMALE,WHITE,Stage III,nan,nan,nan,1992.0,nan,-22150.0,Alive,WITH TUMOR,6138.0,nan,nan,Locoregional Recurrence,nan,nan,1434.0,nan,nan,nan,0.0,6138.0,0.0,6138.0,nan,nan,1.0,1434.0,1
TCGA-EE-A3JD-06,TCGA-EE-A3JD,SKCM,70.0,MALE,WHITE,Stage III,nan,nan,nan,2009.0,nan,-25930.0,Dead,WITH TUMOR,nan,832.0,nan,Distant Metastasis,Lung,nan,364.0,nan,nan,nan,1.0,832.0,1.0,832.0,nan,nan,1.0,364.0,1
TCGA-EE-A3JE-06,TCGA-EE-A3JE,SKCM,75.0,MALE,WHITE,Stage IIIB,nan,nan,nan,2009.0,nan,-27463.0,Alive,TUMOR FREE,1562.0,nan,nan,Regional lymph node,nan,nan,194.0,nan,nan,nan,0.0,1562.0,0.0,1562.0,nan,nan,1.0,194.0,0
TCGA-EE-A3JH-06,TCGA-EE-A3JH,SKCM,54.0,MALE,WHITE,Stage IB,nan,nan,nan,2003.0,nan,-19852.0,Alive,TUMOR FREE,4086.0,nan,nan,Regional lymph node,nan,nan,537.0,nan,nan,nan,0.0,4086.0,0.0,4086.0,nan,nan,1.0,537.0,0
TCGA-EE-A3JI-06,TCGA-EE-A3JI,SKCM,48.0,MALE,WHITE,Stage I,nan,nan,nan,1999.0,nan,-17835.0,Dead,WITH TUMOR,nan,4648.0,nan,New primary melanoma,nan,nan,725.0,nan,nan,nan,1.0,4648.0,1.0,4648.0,nan,nan,1.0,725.0,1
TCGA-ER-A193-06,TCGA-ER-A193,SKCM,62.0,MALE,WHITE,Stage IIB,nan,nan,nan,2006.0,nan,-22702.0,Dead,WITH TUMOR,nan,955.0,nan,Distant Metastasis,Brain,nan,806.0,nan,nan,nan,1.0,955.0,1.0,955.0,nan,nan,1.0,806.0,1
TCGA-ER-A194-01,TCGA-ER-A194,SKCM,77.0,MALE,WHITE,nan,nan,nan,nan,2005.0,nan,-28175.0,Dead,WITH TUMOR,nan,1354.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1354.0,1.0,1354.0,nan,nan,1.0,1354.0,1
TCGA-ER-A195-06,TCGA-ER-A195,SKCM,46.0,MALE,WHITE,nan,nan,nan,nan,2005.0,nan,-16948.0,Dead,WITH TUMOR,nan,1078.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1078.0,1.0,1078.0,nan,nan,1.0,1078.0,1
TCGA-ER-A196-01,TCGA-ER-A196,SKCM,64.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2007.0,nan,-23533.0,Alive,TUMOR FREE,1785.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1785.0,0.0,1785.0,nan,nan,0.0,1785.0,0
TCGA-ER-A197-06,TCGA-ER-A197,SKCM,83.0,FEMALE,WHITE,Stage IIIB,nan,nan,nan,2006.0,nan,-30454.0,Dead,WITH TUMOR,nan,424.0,nan,Distant Metastasis,Lung,nan,110.0,nan,nan,nan,1.0,424.0,1.0,424.0,nan,nan,1.0,110.0,1
TCGA-ER-A198-06,TCGA-ER-A198,SKCM,45.0,MALE,WHITE,nan,nan,nan,nan,2003.0,nan,-16540.0,Dead,WITH TUMOR,nan,1544.0,nan,nan,nan,nan,0.0,nan,nan,nan,1.0,1544.0,1.0,1544.0,nan,nan,1.0,0.0,1
TCGA-ER-A199-06,TCGA-ER-A199,SKCM,86.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2007.0,nan,-31661.0,Dead,WITH TUMOR,nan,279.0,nan,nan,nan,nan,119.0,nan,nan,nan,1.0,279.0,1.0,279.0,nan,nan,1.0,119.0,1
TCGA-ER-A19A-06,TCGA-ER-A19A,SKCM,79.0,MALE,WHITE,Stage IV,nan,nan,nan,2006.0,nan,-29167.0,Alive,TUMOR FREE,2365.0,nan,nan,nan,nan,nan,1617.0,nan,nan,nan,0.0,2365.0,0.0,2365.0,nan,nan,1.0,1617.0,0
TCGA-ER-A19B-06,TCGA-ER-A19B,SKCM,42.0,MALE,WHITE,nan,nan,nan,nan,2000.0,nan,-15437.0,Dead,WITH TUMOR,nan,2993.0,nan,Regional lymph node,nan,nan,829.0,nan,nan,nan,1.0,2993.0,1.0,2993.0,nan,nan,1.0,829.0,1
TCGA-ER-A19C-06,TCGA-ER-A19C,SKCM,77.0,MALE,WHITE,Stage I,nan,nan,nan,1998.0,nan,-28383.0,Dead,WITH TUMOR,nan,1487.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1487.0,1.0,1487.0,nan,nan,1.0,1487.0,1
TCGA-ER-A19D-06,TCGA-ER-A19D,SKCM,46.0,FEMALE,WHITE,Stage IB,nan,nan,nan,2004.0,nan,-16968.0,Dead,WITH TUMOR,nan,383.0,nan,Distant Metastasis,Lung,nan,357.0,nan,nan,nan,1.0,383.0,1.0,383.0,nan,nan,1.0,357.0,1
TCGA-ER-A19E-06,TCGA-ER-A19E,SKCM,36.0,FEMALE,WHITE,Stage IB,nan,nan,nan,2008.0,nan,-13297.0,Dead,WITH TUMOR,nan,396.0,nan,Regional lymph node,"Other, Specify",Cervical lymphnode,64.0,nan,nan,nan,1.0,396.0,1.0,396.0,nan,nan,1.0,64.0,1
TCGA-ER-A19F-06,TCGA-ER-A19F,SKCM,82.0,MALE,WHITE,nan,nan,nan,nan,2003.0,nan,-30176.0,Dead,TUMOR FREE,nan,802.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,802.0,0.0,802.0,nan,nan,0.0,802.0,0
TCGA-ER-A19G-06,TCGA-ER-A19G,SKCM,48.0,FEMALE,WHITE,nan,nan,nan,nan,1987.0,nan,-17820.0,Alive,TUMOR FREE,9188.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,9188.0,0.0,9188.0,nan,nan,0.0,9188.0,0
TCGA-ER-A19H-06,TCGA-ER-A19H,SKCM,40.0,MALE,WHITE,nan,nan,nan,nan,1995.0,nan,-14935.0,Dead,TUMOR FREE,nan,4634.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,4634.0,0.0,4634.0,nan,nan,0.0,4634.0,0
TCGA-ER-A19J-06,TCGA-ER-A19J,SKCM,54.0,MALE,WHITE,Stage IV,nan,nan,nan,2004.0,nan,-19733.0,Dead,WITH TUMOR,196.0,196.0,nan,Distant Metastasis,Lung,nan,98.0,nan,nan,nan,1.0,196.0,1.0,196.0,nan,nan,1.0,98.0,1
TCGA-ER-A19K-01,TCGA-ER-A19K,SKCM,79.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2006.0,nan,-28916.0,Dead,WITH TUMOR,nan,469.0,nan,Regional lymph node,"Other, Specify",Neck- cervical lymphnode,211.0,nan,nan,nan,1.0,469.0,1.0,469.0,nan,nan,1.0,211.0,1
TCGA-ER-A19L-06,TCGA-ER-A19L,SKCM,35.0,MALE,WHITE,nan,nan,nan,nan,1994.0,nan,-13061.0,Dead,WITH TUMOR,nan,4000.0,nan,Distant Metastasis,Lung,nan,3689.0,nan,nan,nan,1.0,4000.0,1.0,4000.0,nan,nan,1.0,3689.0,1
TCGA-ER-A19M-06,TCGA-ER-A19M,SKCM,36.0,MALE,WHITE,Stage IB,nan,nan,nan,2006.0,nan,-13300.0,Dead,WITH TUMOR,nan,1857.0,nan,Locoregional Recurrence,"Other, Specify",lt.Brachial plexus,1152.0,nan,nan,nan,1.0,1857.0,1.0,1857.0,nan,nan,1.0,1152.0,1
TCGA-ER-A19N-06,TCGA-ER-A19N,SKCM,47.0,MALE,WHITE,nan,nan,nan,nan,2008.0,nan,-17443.0,Dead,TUMOR FREE,nan,1341.0,nan,nan,nan,nan,0.0,nan,nan,nan,1.0,1341.0,0.0,1341.0,nan,nan,1.0,0.0,1
TCGA-ER-A19O-06,TCGA-ER-A19O,SKCM,56.0,MALE,WHITE,Stage IIIB,nan,nan,nan,2006.0,nan,-20740.0,Dead,WITH TUMOR,nan,nan,nan,Distant Metastasis,"Other, Specify",Rt. chest wall,308.0,nan,nan,nan,1.0,nan,1.0,nan,nan,nan,1.0,308.0,1
TCGA-ER-A19P-06,TCGA-ER-A19P,SKCM,47.0,FEMALE,WHITE,nan,nan,nan,nan,1996.0,nan,-17511.0,Dead,WITH TUMOR,nan,4930.0,nan,Distant Metastasis,Brain,nan,4352.0,nan,nan,nan,1.0,4930.0,1.0,4930.0,nan,nan,1.0,4352.0,1
TCGA-ER-A19Q-06,TCGA-ER-A19Q,SKCM,37.0,FEMALE,WHITE,nan,nan,nan,nan,2001.0,nan,-13648.0,Dead,WITH TUMOR,nan,1548.0,nan,Distant Metastasis,Bone,nan,1259.0,nan,nan,nan,1.0,1548.0,1.0,1548.0,nan,nan,1.0,1259.0,1
TCGA-ER-A19S-06,TCGA-ER-A19S,SKCM,81.0,FEMALE,WHITE,nan,nan,nan,nan,2008.0,nan,-29603.0,Alive,TUMOR FREE,1505.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1505.0,0.0,1505.0,nan,nan,0.0,1505.0,0
TCGA-ER-A19T-06,TCGA-ER-A19T,SKCM,51.0,MALE,WHITE,Stage IV,nan,nan,nan,2006.0,nan,-18732.0,Dead,WITH TUMOR,nan,270.0,nan,Distant Metastasis,Brain,nan,118.0,nan,nan,nan,1.0,270.0,1.0,270.0,nan,nan,1.0,118.0,1
TCGA-ER-A19T-01,TCGA-ER-A19T,SKCM,51.0,MALE,WHITE,Stage IV,nan,nan,nan,2006.0,nan,-18732.0,Dead,WITH TUMOR,nan,270.0,nan,Distant Metastasis,Brain,nan,118.0,nan,nan,nan,1.0,270.0,1.0,270.0,nan,nan,1.0,118.0,1
TCGA-ER-A19W-06,TCGA-ER-A19W,SKCM,48.0,FEMALE,WHITE,nan,nan,nan,nan,1994.0,nan,-17830.0,Dead,WITH TUMOR,nan,4507.0,nan,Distant Metastasis,Brain,nan,4126.0,nan,nan,nan,1.0,4507.0,1.0,4507.0,nan,nan,1.0,4126.0,1
TCGA-ER-A1A1-06,TCGA-ER-A1A1,SKCM,58.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2005.0,nan,-21209.0,Alive,TUMOR FREE,3196.0,nan,nan,nan,nan,nan,1971.0,nan,nan,nan,0.0,3196.0,0.0,3196.0,nan,nan,1.0,1971.0,0
TCGA-ER-A2NB-01,TCGA-ER-A2NB,SKCM,57.0,MALE,WHITE,Stage IIIB,nan,nan,nan,2010.0,nan,-20938.0,Dead,WITH TUMOR,nan,857.0,nan,nan,nan,nan,461.0,nan,nan,nan,1.0,857.0,1.0,857.0,nan,nan,1.0,461.0,1
TCGA-ER-A2NC-06,TCGA-ER-A2NC,SKCM,50.0,MALE,WHITE,Stage IB,nan,nan,nan,2006.0,nan,-18582.0,Dead,WITH TUMOR,nan,1333.0,nan,Distant Metastasis,Bone,nan,1157.0,nan,nan,nan,1.0,1333.0,1.0,1333.0,nan,nan,1.0,1157.0,1
TCGA-ER-A2ND-06,TCGA-ER-A2ND,SKCM,57.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2004.0,nan,-20867.0,Dead,WITH TUMOR,nan,710.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,710.0,1.0,710.0,nan,nan,1.0,710.0,1
TCGA-ER-A2NE-06,TCGA-ER-A2NE,SKCM,39.0,MALE,WHITE,Stage 0,nan,nan,nan,2007.0,nan,-14259.0,Dead,WITH TUMOR,nan,613.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,1
TCGA-ER-A2NF-06,TCGA-ER-A2NF,SKCM,53.0,MALE,WHITE,Stage IIIB,nan,nan,nan,2010.0,nan,-19499.0,Dead,WITH TUMOR,nan,877.0,nan,nan,nan,nan,230.0,nan,nan,nan,1.0,877.0,1.0,877.0,nan,nan,1.0,230.0,1
TCGA-ER-A2NF-01,TCGA-ER-A2NF,SKCM,53.0,MALE,WHITE,Stage IIIB,nan,nan,nan,2010.0,nan,-19499.0,Dead,WITH TUMOR,nan,877.0,nan,nan,nan,nan,230.0,nan,nan,nan,1.0,877.0,1.0,877.0,nan,nan,1.0,230.0,1
TCGA-ER-A2NG-06,TCGA-ER-A2NG,SKCM,43.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2009.0,nan,-15903.0,Dead,WITH TUMOR,nan,1490.0,nan,Distant Metastasis,"Other, Specify",Right Deltoid,766.0,nan,nan,nan,1.0,1490.0,1.0,1490.0,nan,nan,1.0,766.0,1
TCGA-ER-A2NH-06,TCGA-ER-A2NH,SKCM,49.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2009.0,nan,-18220.0,Alive,WITH TUMOR,1264.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1264.0,0.0,1264.0,nan,nan,0.0,1264.0,0
TCGA-ER-A3ES-06,TCGA-ER-A3ES,SKCM,25.0,MALE,WHITE,nan,nan,nan,nan,1987.0,nan,-9366.0,Dead,WITH TUMOR,nan,7514.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,7514.0,1.0,7514.0,nan,nan,1.0,7514.0,1
TCGA-ER-A3ET-06,TCGA-ER-A3ET,SKCM,64.0,FEMALE,WHITE,Stage IIIA,nan,nan,nan,2005.0,nan,-23650.0,Dead,WITH TUMOR,nan,2829.0,nan,Distant Metastasis,Lung,nan,2435.0,nan,nan,nan,1.0,2829.0,1.0,2829.0,nan,nan,1.0,2435.0,1
TCGA-ER-A3EV-06,TCGA-ER-A3EV,SKCM,55.0,MALE,WHITE,Stage III,nan,nan,nan,2001.0,nan,-20354.0,Dead,WITH TUMOR,1429.0,1429.0,nan,nan,nan,nan,728.0,nan,nan,nan,1.0,1429.0,1.0,1429.0,nan,nan,1.0,728.0,1
TCGA-ER-A3PL-06,TCGA-ER-A3PL,SKCM,30.0,MALE,WHITE,Stage IV,nan,nan,nan,2009.0,nan,-11032.0,Alive,WITH TUMOR,1010.0,nan,nan,nan,nan,nan,945.0,nan,nan,nan,0.0,1010.0,0.0,1010.0,nan,nan,1.0,945.0,0
TCGA-ER-A42H-01,TCGA-ER-A42H,SKCM,76.0,MALE,WHITE,nan,nan,nan,nan,2010.0,nan,-28110.0,Dead,WITH TUMOR,nan,426.0,nan,nan,nan,nan,259.0,nan,nan,nan,1.0,426.0,1.0,426.0,nan,nan,1.0,259.0,1
TCGA-ER-A42K-06,TCGA-ER-A42K,SKCM,40.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2012.0,nan,-14628.0,Dead,WITH TUMOR,nan,394.0,nan,nan,nan,nan,206.0,nan,nan,nan,1.0,394.0,1.0,394.0,nan,nan,1.0,206.0,1
TCGA-ER-A42L-06,TCGA-ER-A42L,SKCM,49.0,MALE,WHITE,Stage II,nan,nan,nan,2001.0,nan,-17984.0,Alive,TUMOR FREE,4533.0,nan,nan,nan,nan,nan,3812.0,nan,nan,nan,0.0,4533.0,0.0,4533.0,nan,nan,1.0,3812.0,0
TCGA-FR-A2OS-01,TCGA-FR-A2OS,SKCM,49.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2008.0,nan,-18122.0,Dead,WITH TUMOR,nan,368.0,nan,Locoregional Recurrence,nan,nan,283.0,nan,nan,nan,1.0,368.0,1.0,368.0,nan,nan,1.0,283.0,1
TCGA-FR-A3R1-01,TCGA-FR-A3R1,SKCM,69.0,MALE,WHITE,Stage IIC,nan,nan,nan,2011.0,nan,-25271.0,Alive,WITH TUMOR,685.0,nan,nan,Locoregional Recurrence,nan,nan,678.0,nan,nan,nan,0.0,685.0,0.0,685.0,nan,nan,1.0,678.0,0
TCGA-FR-A3YN-06,TCGA-FR-A3YN,SKCM,44.0,MALE,WHITE,Stage IB,nan,nan,nan,2005.0,nan,-16278.0,Alive,TUMOR FREE,2828.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2828.0,0.0,2828.0,nan,nan,0.0,2828.0,0
TCGA-FR-A3YO-06,TCGA-FR-A3YO,SKCM,nan,FEMALE,WHITE,I/II NOS,nan,nan,nan,2007.0,nan,nan,Alive,WITH TUMOR,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,nan,0.0,nan,nan,nan,0.0,nan,1
TCGA-FR-A44A-06,TCGA-FR-A44A,SKCM,29.0,FEMALE,WHITE,Stage II,nan,nan,nan,1999.0,nan,-10707.0,Alive,TUMOR FREE,5299.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,5299.0,0.0,5299.0,nan,nan,0.0,5299.0,0
TCGA-FR-A69P-06,TCGA-FR-A69P,SKCM,34.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2013.0,nan,-12679.0,Alive,TUMOR FREE,478.0,nan,nan,Regional lymph node,nan,nan,274.0,nan,nan,nan,0.0,478.0,0.0,478.0,nan,nan,1.0,274.0,0
TCGA-FR-A726-01,TCGA-FR-A726,SKCM,90.0,MALE,WHITE,Stage IIC,nan,nan,nan,2013.0,nan,-32873.0,Dead,WITH TUMOR,nan,305.0,nan,Locoregional Recurrence,nan,nan,273.0,nan,nan,nan,1.0,305.0,1.0,305.0,nan,nan,1.0,273.0,1
TCGA-FR-A728-01,TCGA-FR-A728,SKCM,54.0,FEMALE,WHITE,Stage IIIB,nan,nan,nan,2013.0,nan,-19936.0,Alive,TUMOR FREE,583.0,nan,nan,Locoregional Recurrence,nan,nan,64.0,nan,nan,nan,0.0,583.0,0.0,583.0,nan,nan,1.0,64.0,0
TCGA-FR-A729-06,TCGA-FR-A729,SKCM,38.0,FEMALE,WHITE,Stage I,nan,nan,nan,1996.0,nan,-14043.0,Alive,WITH TUMOR,6716.0,nan,nan,Distant Metastasis,"Other, Specify",spleen,6299.0,nan,nan,nan,0.0,6716.0,0.0,6716.0,nan,nan,1.0,6299.0,1
TCGA-FR-A7U8-06,TCGA-FR-A7U8,SKCM,50.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2012.0,nan,-18346.0,Alive,WITH TUMOR,847.0,nan,nan,Distant Metastasis,Brain,nan,567.0,nan,nan,nan,0.0,847.0,0.0,847.0,nan,nan,1.0,567.0,0
TCGA-FR-A7U9-06,TCGA-FR-A7U9,SKCM,63.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2013.0,nan,-23245.0,Alive,TUMOR FREE,571.0,nan,nan,Locoregional Recurrence,nan,nan,95.0,nan,nan,nan,0.0,571.0,0.0,571.0,nan,nan,1.0,95.0,0
TCGA-FR-A7UA-06,TCGA-FR-A7UA,SKCM,65.0,FEMALE,WHITE,Stage IB,nan,nan,nan,2011.0,nan,-24032.0,Alive,TUMOR FREE,1164.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1164.0,0.0,1164.0,nan,nan,0.0,1164.0,0
TCGA-FR-A8YC-06,TCGA-FR-A8YC,SKCM,78.0,MALE,WHITE,Stage IIB,nan,nan,nan,2011.0,nan,-28680.0,Dead,WITH TUMOR,nan,1059.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1059.0,1.0,1059.0,nan,nan,1.0,1059.0,1
TCGA-FR-A8YD-06,TCGA-FR-A8YD,SKCM,56.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2011.0,nan,-20782.0,Dead,WITH TUMOR,nan,1103.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1103.0,1.0,1103.0,nan,nan,1.0,1103.0,1
TCGA-FR-A8YE-06,TCGA-FR-A8YE,SKCM,41.0,MALE,WHITE,Stage IA,nan,nan,nan,2006.0,nan,-15159.0,Alive,TUMOR FREE,3176.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3176.0,0.0,3176.0,nan,nan,0.0,3176.0,0
TCGA-FS-A1YW-06,TCGA-FS-A1YW,SKCM,52.0,MALE,WHITE,Stage IB,nan,nan,nan,1987.0,nan,-19078.0,Dead,WITH TUMOR,nan,6598.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,6598.0,1.0,6598.0,nan,nan,1.0,6598.0,1
TCGA-FS-A1YX-06,TCGA-FS-A1YX,SKCM,39.0,FEMALE,WHITE,Stage I,nan,nan,nan,2001.0,nan,-14387.0,Dead,WITH TUMOR,nan,1478.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1478.0,1.0,1478.0,nan,nan,1.0,1478.0,1
TCGA-FS-A1YY-06,TCGA-FS-A1YY,SKCM,55.0,FEMALE,WHITE,Stage IIA,nan,nan,nan,1987.0,nan,-20396.0,Dead,WITH TUMOR,nan,6953.0,nan,nan,nan,nan,6777.0,nan,nan,nan,1.0,6953.0,1.0,6953.0,nan,nan,1.0,6777.0,1
TCGA-FS-A1Z0-06,TCGA-FS-A1Z0,SKCM,32.0,FEMALE,WHITE,Stage IA,nan,nan,nan,1990.0,nan,-11815.0,Dead,WITH TUMOR,nan,6164.0,nan,Distant Metastasis,Lung,nan,5503.0,nan,nan,nan,1.0,6164.0,1.0,6164.0,nan,nan,1.0,5503.0,1
TCGA-FS-A1Z3-06,TCGA-FS-A1Z3,SKCM,72.0,FEMALE,WHITE,Stage IV,nan,nan,nan,2002.0,nan,-26435.0,Dead,WITH TUMOR,nan,636.0,nan,nan,nan,nan,276.0,nan,nan,nan,1.0,636.0,1.0,636.0,nan,nan,1.0,276.0,1
TCGA-FS-A1Z4-06,TCGA-FS-A1Z4,SKCM,62.0,MALE,WHITE,Stage I,nan,nan,nan,2001.0,nan,-22932.0,Dead,WITH TUMOR,nan,854.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,854.0,1.0,854.0,nan,nan,1.0,854.0,1
TCGA-FS-A1Z7-06,TCGA-FS-A1Z7,SKCM,19.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2005.0,nan,-7293.0,Dead,WITH TUMOR,nan,237.0,nan,Distant Metastasis,Lung,nan,136.0,nan,nan,nan,1.0,237.0,1.0,237.0,nan,nan,1.0,136.0,1
TCGA-FS-A1ZA-06,TCGA-FS-A1ZA,SKCM,45.0,FEMALE,WHITE,Stage IIIB,nan,nan,nan,2003.0,nan,-16705.0,Dead,WITH TUMOR,nan,843.0,nan,nan,nan,nan,663.0,nan,nan,nan,1.0,843.0,1.0,843.0,nan,nan,1.0,663.0,1
TCGA-FS-A1ZB-06,TCGA-FS-A1ZB,SKCM,57.0,MALE,WHITE,Stage II,nan,nan,nan,2002.0,nan,-20963.0,Dead,WITH TUMOR,nan,1486.0,nan,nan,nan,nan,1461.0,nan,nan,nan,1.0,1486.0,1.0,1486.0,nan,nan,1.0,1461.0,1
TCGA-FS-A1ZC-06,TCGA-FS-A1ZC,SKCM,51.0,MALE,WHITE,I/II NOS,nan,nan,nan,1978.0,nan,-18843.0,Dead,WITH TUMOR,nan,10870.0,nan,nan,nan,nan,10334.0,nan,nan,nan,1.0,10870.0,1.0,10870.0,nan,nan,1.0,10334.0,1
TCGA-FS-A1ZD-06,TCGA-FS-A1ZD,SKCM,63.0,MALE,WHITE,Stage IIA,nan,nan,nan,2001.0,nan,-23344.0,Dead,WITH TUMOR,nan,1628.0,nan,nan,nan,nan,1497.0,nan,nan,nan,1.0,1628.0,1.0,1628.0,nan,nan,1.0,1497.0,1
TCGA-FS-A1ZE-06,TCGA-FS-A1ZE,SKCM,40.0,MALE,WHITE,Stage IIC,nan,nan,nan,2008.0,nan,-14618.0,Dead,WITH TUMOR,nan,1413.0,nan,nan,nan,nan,761.0,nan,nan,nan,1.0,1413.0,1.0,1413.0,nan,nan,1.0,761.0,1
TCGA-FS-A1ZF-06,TCGA-FS-A1ZF,SKCM,78.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2007.0,nan,-28491.0,Dead,WITH TUMOR,nan,470.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,470.0,1.0,470.0,nan,nan,1.0,470.0,1
TCGA-FS-A1ZG-06,TCGA-FS-A1ZG,SKCM,60.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2007.0,nan,-22252.0,Dead,WITH TUMOR,nan,295.0,nan,nan,nan,nan,140.0,nan,nan,nan,1.0,295.0,1.0,295.0,nan,nan,1.0,140.0,1
TCGA-FS-A1ZH-06,TCGA-FS-A1ZH,SKCM,71.0,FEMALE,WHITE,Stage IV,nan,nan,nan,2003.0,nan,-26232.0,Dead,WITH TUMOR,nan,996.0,nan,nan,nan,nan,577.0,nan,nan,nan,1.0,996.0,1.0,996.0,nan,nan,1.0,577.0,1
TCGA-FS-A1ZJ-06,TCGA-FS-A1ZJ,SKCM,75.0,FEMALE,WHITE,Stage I,nan,nan,nan,2001.0,nan,-27476.0,Dead,WITH TUMOR,nan,1441.0,nan,nan,nan,nan,1225.0,nan,nan,nan,1.0,1441.0,1.0,1441.0,nan,nan,1.0,1225.0,1
TCGA-FS-A1ZK-06,TCGA-FS-A1ZK,SKCM,68.0,MALE,WHITE,Stage II,nan,nan,nan,2005.0,nan,-24839.0,Dead,WITH TUMOR,nan,728.0,nan,nan,nan,nan,367.0,nan,nan,nan,1.0,728.0,1.0,728.0,nan,nan,1.0,367.0,1
TCGA-FS-A1ZM-06,TCGA-FS-A1ZM,SKCM,74.0,MALE,WHITE,Stage III,nan,nan,nan,2001.0,nan,-27210.0,Alive,TUMOR FREE,3080.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3080.0,0.0,3080.0,nan,nan,0.0,3080.0,0
TCGA-FS-A1ZN-01,TCGA-FS-A1ZN,SKCM,43.0,MALE,WHITE,Stage IIIA,nan,nan,nan,2002.0,nan,-15890.0,Dead,WITH TUMOR,nan,730.0,nan,nan,nan,nan,361.0,nan,nan,nan,1.0,730.0,1.0,730.0,nan,nan,1.0,361.0,1
TCGA-FS-A1ZP-06,TCGA-FS-A1ZP,SKCM,52.0,MALE,WHITE,Stage II,nan,nan,nan,1997.0,nan,-19175.0,Dead,WITH TUMOR,nan,2273.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2273.0,1.0,2273.0,nan,nan,1.0,2273.0,1
TCGA-FS-A1ZQ-06,TCGA-FS-A1ZQ,SKCM,31.0,MALE,WHITE,I/II NOS,nan,nan,nan,1997.0,nan,-11599.0,Dead,WITH TUMOR,nan,4062.0,nan,nan,nan,nan,3940.0,nan,nan,nan,1.0,4062.0,1.0,4062.0,nan,nan,1.0,3940.0,1
TCGA-FS-A1ZR-06,TCGA-FS-A1ZR,SKCM,36.0,MALE,WHITE,Stage II,nan,nan,nan,1995.0,nan,-13325.0,Dead,WITH TUMOR,nan,347.0,nan,nan,nan,nan,152.0,nan,nan,nan,1.0,347.0,1.0,347.0,nan,nan,1.0,152.0,1
TCGA-FS-A1ZS-06,TCGA-FS-A1ZS,SKCM,54.0,MALE,WHITE,Stage I,nan,nan,nan,1998.0,nan,-19813.0,Alive,WITH TUMOR,4526.0,nan,nan,Regional lymph node|Regional lymph node|Distant Metastasis|Regional lymph node|Distant Metastasis|Distant Metastasis,[Not Available]|[Not Available]|Lung|[Not Available]|Lung|Liver,[Not Applicable]|[Not Applicable]|[Not Applicable]|[Not Applicable]|[Not Applicable]|[Not Applicable],2861.0,nan,nan,nan,0.0,4526.0,0.0,4526.0,nan,nan,1.0,2861.0,0
TCGA-FS-A1ZT-06,TCGA-FS-A1ZT,SKCM,55.0,MALE,WHITE,Stage III,nan,nan,nan,2005.0,nan,-20284.0,Alive,TUMOR FREE,1617.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1617.0,0.0,1617.0,nan,nan,0.0,1617.0,0
TCGA-FS-A1ZU-06,TCGA-FS-A1ZU,SKCM,70.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2002.0,nan,-25856.0,Dead,WITH TUMOR,nan,808.0,nan,nan,nan,nan,679.0,nan,nan,nan,1.0,808.0,1.0,808.0,nan,nan,1.0,679.0,1
TCGA-FS-A1ZW-06,TCGA-FS-A1ZW,SKCM,65.0,MALE,WHITE,Stage IIIB,nan,nan,nan,2005.0,nan,-24087.0,Alive,TUMOR FREE,1505.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1505.0,0.0,1505.0,nan,nan,0.0,1505.0,0
TCGA-FS-A1ZY-06,TCGA-FS-A1ZY,SKCM,71.0,MALE,WHITE,Stage IIB,nan,nan,nan,2006.0,nan,-26197.0,Dead,WITH TUMOR,nan,824.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,824.0,1.0,824.0,nan,nan,1.0,824.0,1
TCGA-FS-A1ZZ-06,TCGA-FS-A1ZZ,SKCM,54.0,FEMALE,WHITE,Stage IIB,nan,nan,nan,2006.0,nan,-19733.0,Dead,WITH TUMOR,nan,822.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,822.0,1.0,822.0,nan,nan,1.0,822.0,1
TCGA-FS-A4F0-06,TCGA-FS-A4F0,SKCM,67.0,FEMALE,WHITE,Stage IIB,nan,nan,nan,2003.0,nan,-24717.0,Alive,TUMOR FREE,2367.0,nan,nan,Locoregional Recurrence|Locoregional Recurrence|Locoregional Recurrence|Distant Metastasis|Distant Metastasis,"[Not Available]|[Not Available]|[Not Available]|Lung|Other, Specify",[Not Applicable]|[Not Applicable]|[Not Applicable]|[Not Applicable]|lymphnode,872.0,nan,nan,nan,0.0,2367.0,0.0,2367.0,nan,nan,1.0,872.0,0
TCGA-FS-A4F2-06,TCGA-FS-A4F2,SKCM,46.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2003.0,nan,-16944.0,Dead,WITH TUMOR,nan,1525.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1525.0,1.0,1525.0,nan,nan,1.0,1525.0,1
TCGA-FS-A4F4-06,TCGA-FS-A4F4,SKCM,64.0,MALE,WHITE,Stage II,nan,nan,nan,2001.0,nan,-23663.0,Dead,WITH TUMOR,nan,2028.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2028.0,1.0,2028.0,nan,nan,1.0,2028.0,1
TCGA-FS-A4F5-06,TCGA-FS-A4F5,SKCM,77.0,FEMALE,WHITE,Stage IB,nan,nan,nan,2005.0,nan,-28412.0,Dead,WITH TUMOR,nan,874.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,874.0,1.0,874.0,nan,nan,1.0,874.0,1
TCGA-FS-A4F8-06,TCGA-FS-A4F8,SKCM,52.0,MALE,WHITE,Stage I,nan,nan,nan,1997.0,nan,-19137.0,Dead,WITH TUMOR,nan,5318.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,5318.0,1.0,5318.0,nan,nan,1.0,5318.0,1
TCGA-FS-A4F9-06,TCGA-FS-A4F9,SKCM,80.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2011.0,nan,-29324.0,Alive,WITH TUMOR,1035.0,nan,nan,Locoregional Recurrence|Distant Metastasis,[Not Available]|Brain,[Not Applicable]|[Not Applicable],376.0,nan,nan,nan,0.0,1035.0,0.0,1035.0,nan,nan,1.0,376.0,0
TCGA-FS-A4FB-06,TCGA-FS-A4FB,SKCM,46.0,FEMALE,WHITE,Stage III,nan,nan,nan,2009.0,nan,-16896.0,Dead,WITH TUMOR,nan,813.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,813.0,1.0,813.0,nan,nan,1.0,813.0,1
TCGA-FS-A4FC-06,TCGA-FS-A4FC,SKCM,75.0,FEMALE,WHITE,Stage IIA,nan,nan,nan,2007.0,nan,-27482.0,Dead,WITH TUMOR,nan,1655.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1655.0,1.0,1655.0,nan,nan,1.0,1655.0,1
TCGA-FS-A4FD-06,TCGA-FS-A4FD,SKCM,39.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2004.0,nan,-14426.0,Dead,WITH TUMOR,nan,2454.0,nan,Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis,Lung|Lung|Bone|Brain,[Not Applicable]|[Not Applicable]|[Not Applicable]|[Not Applicable],2010.0,nan,nan,nan,1.0,2454.0,1.0,2454.0,nan,nan,1.0,2010.0,1
TCGA-FW-A3I3-06,TCGA-FW-A3I3,SKCM,59.0,FEMALE,WHITE,Stage IV,nan,nan,nan,2011.0,nan,-21731.0,Alive,TUMOR FREE,531.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,531.0,0.0,531.0,nan,nan,0.0,531.0,0
TCGA-FW-A3R5-06,TCGA-FW-A3R5,SKCM,68.0,MALE,WHITE,Stage III,nan,nan,nan,2010.0,nan,-24868.0,Alive,TUMOR FREE,1124.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1124.0,0.0,1124.0,nan,nan,0.0,1124.0,0
TCGA-FW-A3R5-11,TCGA-FW-A3R5,SKCM,68.0,MALE,WHITE,Stage III,nan,nan,nan,2010.0,nan,-24868.0,Alive,TUMOR FREE,1124.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1124.0,0.0,1124.0,nan,nan,0.0,1124.0,0
TCGA-FW-A3TU-06,TCGA-FW-A3TU,SKCM,72.0,FEMALE,WHITE,nan,nan,nan,nan,2007.0,nan,-26589.0,Dead,WITH TUMOR,nan,1691.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1691.0,1.0,1691.0,nan,nan,1.0,1691.0,1
TCGA-FW-A3TV-06,TCGA-FW-A3TV,SKCM,57.0,FEMALE,WHITE,Stage IIIB,nan,nan,nan,2012.0,nan,-20972.0,Alive,WITH TUMOR,411.0,nan,nan,Locoregional Recurrence,nan,nan,139.0,nan,nan,nan,0.0,411.0,0.0,411.0,nan,nan,1.0,139.0,1
TCGA-FW-A5DX-01,TCGA-FW-A5DX,SKCM,71.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2012.0,nan,-26056.0,Alive,TUMOR FREE,640.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,640.0,0.0,640.0,nan,nan,0.0,640.0,0
TCGA-FW-A5DY-06,TCGA-FW-A5DY,SKCM,48.0,FEMALE,WHITE,Stage III,nan,nan,nan,2012.0,nan,-17730.0,Alive,TUMOR FREE,587.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,587.0,0.0,587.0,nan,nan,0.0,587.0,0
TCGA-GF-A2C7-01,TCGA-GF-A2C7,SKCM,48.0,MALE,WHITE,Stage IIC,nan,nan,nan,2011.0,nan,-17545.0,Alive,TUMOR FREE,21.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,21.0,0.0,21.0,nan,nan,0.0,21.0,0
TCGA-GF-A3OT-06,TCGA-GF-A3OT,SKCM,58.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2011.0,nan,-21359.0,Alive,WITH TUMOR,301.0,nan,nan,Distant Metastasis,Lung,nan,248.0,nan,nan,nan,0.0,301.0,0.0,301.0,nan,nan,1.0,248.0,0
TCGA-GF-A4EO-06,TCGA-GF-A4EO,SKCM,74.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2012.0,nan,-27114.0,Alive,TUMOR FREE,591.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,591.0,0.0,591.0,nan,nan,0.0,591.0,0
TCGA-GF-A6C8-06,TCGA-GF-A6C8,SKCM,62.0,FEMALE,WHITE,Stage IIB,nan,nan,nan,2012.0,nan,-22731.0,Alive,nan,62.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,62.0,0.0,62.0,nan,nan,0.0,62.0,0
TCGA-GF-A6C9-06,TCGA-GF-A6C9,SKCM,78.0,MALE,WHITE,Stage IIIB,nan,nan,nan,2012.0,nan,-28774.0,Alive,TUMOR FREE,480.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,480.0,0.0,480.0,nan,nan,0.0,480.0,0
TCGA-GF-A769-01,TCGA-GF-A769,SKCM,39.0,MALE,WHITE,Stage IIC,nan,nan,nan,2010.0,nan,-14304.0,Dead,WITH TUMOR,nan,1070.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1070.0,1.0,1070.0,nan,nan,1.0,1070.0,1
TCGA-GN-A262-06,TCGA-GN-A262,SKCM,47.0,FEMALE,WHITE,nan,nan,nan,nan,2001.0,nan,-17239.0,Alive,WITH TUMOR,4255.0,nan,nan,Locoregional Recurrence,nan,nan,2908.0,nan,nan,nan,0.0,4255.0,0.0,4255.0,nan,nan,1.0,2908.0,1
TCGA-GN-A263-01,TCGA-GN-A263,SKCM,24.0,MALE,WHITE,Stage IV,nan,nan,nan,2004.0,nan,-8952.0,Dead,WITH TUMOR,nan,467.0,nan,Distant Metastasis,Liver,nan,39.0,nan,nan,nan,1.0,467.0,1.0,467.0,nan,nan,1.0,39.0,1
TCGA-GN-A264-06,TCGA-GN-A264,SKCM,60.0,MALE,WHITE,nan,nan,nan,nan,1997.0,nan,-22254.0,Dead,WITH TUMOR,nan,3587.0,nan,Distant Metastasis,Lung,nan,3221.0,nan,nan,nan,1.0,3587.0,1.0,3587.0,nan,nan,1.0,3221.0,1
TCGA-GN-A265-06,TCGA-GN-A265,SKCM,53.0,MALE,WHITE,nan,nan,nan,nan,2004.0,nan,-19712.0,Alive,TUMOR FREE,2948.0,nan,nan,Regional lymph node,nan,nan,99.0,nan,nan,nan,0.0,2948.0,0.0,2948.0,nan,nan,1.0,99.0,0
TCGA-GN-A266-06,TCGA-GN-A266,SKCM,45.0,MALE,WHITE,nan,nan,nan,nan,2004.0,nan,-16456.0,Dead,WITH TUMOR,nan,308.0,nan,Distant Metastasis,Brain,nan,109.0,nan,nan,nan,1.0,308.0,1.0,308.0,nan,nan,1.0,109.0,1
TCGA-GN-A267-06,TCGA-GN-A267,SKCM,38.0,MALE,WHITE,Stage IIIA,nan,nan,nan,2005.0,nan,-14055.0,Dead,WITH TUMOR,nan,1960.0,nan,Locoregional Recurrence,nan,nan,456.0,nan,nan,nan,1.0,1960.0,1.0,1960.0,nan,nan,1.0,456.0,1
TCGA-GN-A268-06,TCGA-GN-A268,SKCM,83.0,FEMALE,WHITE,Stage IIB,nan,nan,nan,2005.0,nan,-30430.0,Dead,WITH TUMOR,nan,1910.0,nan,Locoregional Recurrence,nan,nan,908.0,nan,nan,nan,1.0,1910.0,1.0,1910.0,nan,nan,1.0,908.0,1
TCGA-GN-A269-01,TCGA-GN-A269,SKCM,70.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2006.0,nan,-25583.0,Dead,WITH TUMOR,nan,170.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,170.0,1.0,170.0,nan,nan,1.0,170.0,1
TCGA-GN-A26A-06,TCGA-GN-A26A,SKCM,63.0,FEMALE,WHITE,Stage IIIA,nan,nan,nan,2006.0,nan,-23288.0,Dead,WITH TUMOR,nan,988.0,nan,Distant Metastasis,Lung,nan,750.0,nan,nan,nan,1.0,988.0,1.0,988.0,nan,nan,1.0,750.0,1
TCGA-GN-A26C-01,TCGA-GN-A26C,SKCM,77.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2006.0,nan,-28336.0,Dead,WITH TUMOR,nan,821.0,nan,Distant Metastasis,Lung,nan,593.0,nan,nan,nan,1.0,821.0,1.0,821.0,nan,nan,1.0,593.0,1
TCGA-GN-A26D-06,TCGA-GN-A26D,SKCM,72.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2008.0,nan,-26494.0,Dead,WITH TUMOR,nan,1460.0,nan,Locoregional Recurrence,nan,nan,622.0,nan,nan,nan,1.0,1460.0,1.0,1460.0,nan,nan,1.0,622.0,1
TCGA-GN-A4U3-06,TCGA-GN-A4U3,SKCM,30.0,MALE,WHITE,Stage III,nan,nan,nan,2004.0,nan,-11294.0,Alive,TUMOR FREE,3708.0,nan,nan,Distant Metastasis|Distant Metastasis,Lung|Brain,[Not Applicable]|[Not Applicable],2274.0,nan,nan,nan,0.0,3708.0,0.0,3708.0,nan,nan,1.0,2274.0,0
TCGA-GN-A4U4-06,TCGA-GN-A4U4,SKCM,73.0,MALE,WHITE,Stage IIA,nan,nan,nan,2011.0,nan,-26761.0,Alive,TUMOR FREE,1197.0,nan,nan,Distant Metastasis,Liver,nan,217.0,nan,nan,nan,0.0,1197.0,0.0,1197.0,nan,nan,1.0,217.0,0
TCGA-GN-A4U5-01,TCGA-GN-A4U5,SKCM,61.0,FEMALE,WHITE,Stage IB,nan,nan,nan,2011.0,nan,-22499.0,Alive,TUMOR FREE,1156.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1156.0,0.0,1156.0,nan,nan,0.0,1156.0,0
TCGA-GN-A4U7-06,TCGA-GN-A4U7,SKCM,56.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2011.0,nan,-20458.0,Dead,WITH TUMOR,nan,317.0,nan,Distant Metastasis,Lung,nan,183.0,nan,nan,nan,1.0,317.0,1.0,317.0,nan,nan,1.0,183.0,1
TCGA-GN-A4U8-06,TCGA-GN-A4U8,SKCM,51.0,MALE,WHITE,nan,nan,nan,nan,2009.0,nan,-18953.0,Alive,TUMOR FREE,1487.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1487.0,0.0,1487.0,nan,nan,0.0,1487.0,0
TCGA-GN-A4U8-11,TCGA-GN-A4U8,SKCM,51.0,MALE,WHITE,nan,nan,nan,nan,2009.0,nan,-18953.0,Alive,TUMOR FREE,1487.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1487.0,0.0,1487.0,nan,nan,0.0,1487.0,0
TCGA-GN-A4U9-06,TCGA-GN-A4U9,SKCM,71.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2012.0,nan,-26118.0,Dead,WITH TUMOR,nan,673.0,nan,Locoregional Recurrence,nan,nan,151.0,nan,nan,nan,1.0,673.0,1.0,673.0,nan,nan,1.0,151.0,1
TCGA-GN-A8LK-06,TCGA-GN-A8LK,SKCM,70.0,MALE,WHITE,Stage IB,nan,nan,nan,2009.0,nan,-25725.0,Dead,WITH TUMOR,nan,1524.0,nan,Locoregional Recurrence,nan,nan,436.0,nan,nan,nan,1.0,1524.0,1.0,1524.0,nan,nan,1.0,436.0,1
TCGA-GN-A8LL-06,TCGA-GN-A8LL,SKCM,68.0,FEMALE,WHITE,Stage IIC,nan,nan,nan,2012.0,nan,-25000.0,Dead,WITH TUMOR,nan,650.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,650.0,1.0,650.0,nan,nan,1.0,650.0,1
TCGA-GN-A8LN-01,TCGA-GN-A8LN,SKCM,68.0,MALE,WHITE,Stage IIC,nan,nan,nan,2013.0,nan,-24872.0,Alive,WITH TUMOR,772.0,nan,nan,New primary melanoma,nan,nan,186.0,nan,nan,nan,0.0,772.0,0.0,772.0,nan,nan,1.0,186.0,0
TCGA-GN-A9SD-06,TCGA-GN-A9SD,SKCM,59.0,FEMALE,WHITE,Stage IA,nan,nan,nan,2009.0,nan,-21851.0,Dead,WITH TUMOR,nan,1807.0,nan,Locoregional Recurrence,nan,nan,1137.0,nan,nan,nan,1.0,1807.0,1.0,1807.0,nan,nan,1.0,1137.0,1
TCGA-HR-A2OG-06,TCGA-HR-A2OG,SKCM,50.0,FEMALE,[Not Evaluated],nan,nan,nan,nan,nan,nan,-21767.0,Alive,TUMOR FREE,7.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,7.0,0.0,7.0,nan,nan,0.0,7.0,0
TCGA-HR-A2OG-01,TCGA-HR-A2OG,SKCM,50.0,FEMALE,[Not Evaluated],nan,nan,nan,nan,nan,nan,-21767.0,Alive,TUMOR FREE,7.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,7.0,0.0,7.0,nan,nan,0.0,7.0,0
TCGA-HR-A2OH-06,TCGA-HR-A2OH,SKCM,46.0,FEMALE,[Not Evaluated],Stage IIIB,nan,nan,nan,nan,nan,-16910.0,Dead,WITH TUMOR,nan,2004.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2004.0,1.0,2004.0,nan,nan,1.0,2004.0,1
TCGA-HR-A2OH-01,TCGA-HR-A2OH,SKCM,46.0,FEMALE,[Not Evaluated],Stage IIIB,nan,nan,nan,nan,nan,-16910.0,Dead,WITH TUMOR,nan,2004.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,2004.0,1.0,2004.0,nan,nan,1.0,2004.0,1
TCGA-HR-A5NC-01,TCGA-HR-A5NC,SKCM,90.0,FEMALE,[Not Evaluated],nan,nan,nan,nan,nan,nan,-32871.0,Alive,TUMOR FREE,1000.0,nan,nan,Locoregional Recurrence,nan,nan,154.0,nan,nan,nan,0.0,1000.0,0.0,1000.0,nan,nan,1.0,154.0,0
TCGA-IH-A3EA-01,TCGA-IH-A3EA,SKCM,61.0,MALE,WHITE,Stage IIC,nan,nan,nan,2008.0,nan,-22577.0,Alive,WITH TUMOR,524.0,nan,nan,Distant Metastasis,Brain,nan,314.0,nan,nan,nan,0.0,524.0,0.0,524.0,nan,nan,1.0,314.0,0
TCGA-LH-A9QB-06,TCGA-LH-A9QB,SKCM,24.0,FEMALE,WHITE,nan,nan,nan,nan,1984.0,nan,-9058.0,Alive,TUMOR FREE,11217.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,11217.0,0.0,11217.0,nan,nan,0.0,11217.0,0
TCGA-OD-A75X-06,TCGA-OD-A75X,SKCM,49.0,MALE,WHITE,nan,nan,nan,nan,1989.0,nan,-17910.0,Dead,WITH TUMOR,nan,9061.0,nan,Distant Metastasis|Distant Metastasis|Distant Metastasis,"Brain|Other, Specify|Lung",[Not Applicable]|stomach|[Not Applicable],8987.0,nan,nan,nan,1.0,9061.0,1.0,9061.0,nan,nan,1.0,8987.0,1
TCGA-QB-A6FS-06,TCGA-QB-A6FS,SKCM,49.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2013.0,nan,-18134.0,Alive,WITH TUMOR,220.0,nan,nan,Distant Metastasis,"Other, Specify","SKIN, MID CHEST",63.0,nan,nan,nan,0.0,220.0,0.0,220.0,nan,nan,1.0,63.0,0
TCGA-QB-AA9O-06,TCGA-QB-AA9O,SKCM,73.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2012.0,nan,-27009.0,Dead,WITH TUMOR,nan,549.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,549.0,1.0,549.0,nan,nan,1.0,549.0,1
TCGA-RP-A690-06,TCGA-RP-A690,SKCM,66.0,FEMALE,WHITE,nan,nan,nan,nan,2005.0,nan,-24450.0,Alive,TUMOR FREE,6.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,6.0,0.0,6.0,nan,nan,0.0,6.0,0
TCGA-RP-A693-06,TCGA-RP-A693,SKCM,77.0,MALE,WHITE,Stage IV,nan,nan,nan,2008.0,nan,-28394.0,Alive,TUMOR FREE,10.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,10.0,0.0,10.0,nan,nan,0.0,10.0,0
TCGA-RP-A694-06,TCGA-RP-A694,SKCM,71.0,MALE,WHITE,Stage IV,nan,nan,nan,2009.0,nan,-26044.0,Alive,TUMOR FREE,21.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,21.0,0.0,21.0,nan,nan,0.0,21.0,0
TCGA-RP-A695-06,TCGA-RP-A695,SKCM,nan,MALE,WHITE,Stage IV,nan,nan,nan,1999.0,nan,nan,Alive,TUMOR FREE,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,nan,0.0,nan,nan,nan,0.0,nan,0
TCGA-RP-A6K9-06,TCGA-RP-A6K9,SKCM,nan,FEMALE,WHITE,nan,nan,nan,nan,2001.0,nan,nan,Alive,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,nan,0.0,nan,nan,nan,0.0,nan,1
TCGA-W3-A824-06,TCGA-W3-A824,SKCM,63.0,MALE,WHITE,Stage I,nan,nan,nan,1995.0,nan,-23131.0,Alive,WITH TUMOR,6940.0,nan,nan,Distant Metastasis,"Other, Specify",Spleen,2406.0,nan,nan,nan,0.0,6940.0,0.0,6940.0,nan,nan,1.0,2406.0,0
TCGA-W3-A825-06,TCGA-W3-A825,SKCM,60.0,FEMALE,WHITE,Stage II,nan,nan,nan,1998.0,nan,-22097.0,Dead,WITH TUMOR,nan,1917.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1917.0,1.0,1917.0,nan,nan,1.0,1917.0,1
TCGA-W3-A828-06,TCGA-W3-A828,SKCM,66.0,MALE,WHITE,Stage II,nan,nan,nan,1997.0,nan,-24258.0,Dead,nan,nan,3683.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,3683.0,nan,3683.0,nan,nan,0.0,3683.0,1
TCGA-W3-AA1O-06,TCGA-W3-AA1O,SKCM,85.0,MALE,WHITE,Stage III,nan,nan,nan,1997.0,nan,-31351.0,Dead,WITH TUMOR,nan,122.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,122.0,1.0,122.0,nan,nan,1.0,122.0,1
TCGA-W3-AA1Q-06,TCGA-W3-AA1Q,SKCM,57.0,MALE,WHITE,Stage III,nan,nan,nan,1994.0,nan,-21033.0,Dead,WITH TUMOR,nan,2101.0,nan,Distant Metastasis,"Other, Specify",Thigh,1066.0,nan,nan,nan,1.0,2101.0,1.0,2101.0,nan,nan,1.0,1066.0,1
TCGA-W3-AA1R-06,TCGA-W3-AA1R,SKCM,71.0,MALE,WHITE,Stage II,nan,nan,nan,1995.0,nan,-26145.0,Dead,WITH TUMOR,nan,3379.0,nan,Distant Metastasis,Lung,nan,1037.0,nan,nan,nan,1.0,3379.0,1.0,3379.0,nan,nan,1.0,1037.0,1
TCGA-W3-AA1V-06,TCGA-W3-AA1V,SKCM,63.0,MALE,WHITE,Stage II,nan,nan,nan,1994.0,nan,-23314.0,Dead,WITH TUMOR,nan,1280.0,nan,Distant Metastasis,Liver,nan,1219.0,nan,nan,nan,1.0,1280.0,1.0,1280.0,nan,nan,1.0,1219.0,1
TCGA-W3-AA1W-06,TCGA-W3-AA1W,SKCM,64.0,MALE,WHITE,Stage II,nan,nan,nan,1996.0,nan,-23711.0,Alive,TUMOR FREE,6666.0,nan,nan,Regional lymph node,nan,nan,335.0,nan,nan,nan,0.0,6666.0,0.0,6666.0,nan,nan,1.0,335.0,0
TCGA-W3-AA21-06,TCGA-W3-AA21,SKCM,26.0,MALE,WHITE,Stage I,nan,nan,nan,1994.0,nan,-9527.0,Dead,WITH TUMOR,nan,3195.0,nan,Distant Metastasis,"Other, Specify",Chest,2952.0,nan,nan,nan,1.0,3195.0,1.0,3195.0,nan,nan,1.0,2952.0,1
TCGA-WE-A8JZ-06,TCGA-WE-A8JZ,SKCM,70.0,MALE,[Not Evaluated],Stage IIIB,nan,nan,nan,2012.0,nan,-25884.0,Alive,TUMOR FREE,731.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,731.0,0.0,731.0,nan,nan,0.0,731.0,0
TCGA-WE-A8K1-06,TCGA-WE-A8K1,SKCM,74.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2010.0,nan,-27191.0,Alive,TUMOR FREE,1492.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1492.0,0.0,1492.0,nan,nan,0.0,1492.0,0
TCGA-WE-A8K4-01,TCGA-WE-A8K4,SKCM,85.0,MALE,WHITE,Stage IIB,nan,nan,nan,2013.0,nan,-31308.0,Alive,TUMOR FREE,614.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,614.0,0.0,614.0,nan,nan,0.0,614.0,0
TCGA-WE-A8K5-06,TCGA-WE-A8K5,SKCM,65.0,MALE,WHITE,Stage IV,nan,nan,nan,2009.0,nan,-23837.0,Dead,WITH TUMOR,nan,1860.0,nan,Distant Metastasis,Brain,nan,1498.0,nan,nan,nan,1.0,1860.0,1.0,1860.0,nan,nan,1.0,1498.0,1
TCGA-WE-A8K6-06,TCGA-WE-A8K6,SKCM,79.0,MALE,WHITE,Stage IIIB,nan,nan,nan,2013.0,nan,-29216.0,Alive,WITH TUMOR,546.0,nan,nan,Distant Metastasis,Liver,nan,256.0,nan,nan,nan,0.0,546.0,0.0,546.0,nan,nan,1.0,256.0,0
TCGA-WE-A8ZM-06,TCGA-WE-A8ZM,SKCM,70.0,MALE,WHITE,Stage IIIB,nan,nan,nan,2006.0,nan,-25869.0,Alive,WITH TUMOR,3082.0,nan,nan,Locoregional Recurrence,nan,nan,646.0,nan,nan,nan,0.0,3082.0,0.0,3082.0,nan,nan,1.0,646.0,0
TCGA-WE-A8ZN-06,TCGA-WE-A8ZN,SKCM,57.0,MALE,[Not Evaluated],Stage IIB,nan,nan,nan,2009.0,nan,-20942.0,Alive,WITH TUMOR,1794.0,nan,nan,nan,nan,nan,1449.0,nan,nan,nan,0.0,1794.0,0.0,1794.0,nan,nan,1.0,1449.0,0
TCGA-WE-A8ZO-06,TCGA-WE-A8ZO,SKCM,73.0,FEMALE,[Not Evaluated],Stage IIIB,nan,nan,nan,2009.0,nan,-26946.0,Alive,TUMOR FREE,2145.0,nan,nan,Regional lymph node,nan,nan,1371.0,nan,nan,nan,0.0,2145.0,0.0,2145.0,nan,nan,1.0,1371.0,0
TCGA-WE-A8ZQ-06,TCGA-WE-A8ZQ,SKCM,48.0,MALE,[Not Evaluated],Stage IIA,nan,nan,nan,2009.0,nan,-17824.0,Alive,WITH TUMOR,1923.0,nan,nan,Distant Metastasis|Distant Metastasis,"Lung|Other, Specify",[Not Applicable]|left thigh,1757.0,nan,nan,nan,0.0,1923.0,0.0,1923.0,nan,nan,1.0,1757.0,0
TCGA-WE-A8ZR-06,TCGA-WE-A8ZR,SKCM,49.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2013.0,nan,-18051.0,Dead,WITH TUMOR,nan,274.0,nan,Distant Metastasis|Distant Metastasis|Distant Metastasis|Distant Metastasis|Locoregional Recurrence,"Liver|Lung|Bone|Other, Specify|Other, Specify",[Not Applicable]|[Not Applicable]|[Not Applicable]|spleen|subcutaneous chest wall,126.0,nan,nan,nan,1.0,274.0,1.0,274.0,nan,nan,1.0,126.0,1
TCGA-WE-A8ZT-06,TCGA-WE-A8ZT,SKCM,25.0,FEMALE,WHITE,Stage IV,nan,nan,nan,2013.0,nan,-9379.0,Alive,TUMOR FREE,359.0,nan,nan,Locoregional Recurrence,nan,nan,69.0,nan,nan,nan,0.0,359.0,0.0,359.0,nan,nan,1.0,69.0,0
TCGA-WE-A8ZX-06,TCGA-WE-A8ZX,SKCM,45.0,MALE,WHITE,Stage IIIB,nan,nan,nan,2012.0,nan,-16736.0,Alive,TUMOR FREE,1089.0,nan,nan,Locoregional Recurrence,nan,nan,326.0,nan,nan,nan,0.0,1089.0,0.0,1089.0,nan,nan,1.0,326.0,0
TCGA-WE-A8ZY-06,TCGA-WE-A8ZY,SKCM,62.0,MALE,WHITE,Stage IIA,nan,nan,nan,2010.0,nan,-22676.0,Dead,WITH TUMOR,nan,1506.0,nan,Distant Metastasis|[Not Available],Liver|[Not Available],[Not Applicable]|[Not Applicable],1389.0,nan,nan,nan,1.0,1506.0,1.0,1506.0,nan,nan,1.0,1389.0,1
TCGA-WE-AA9Y-06,TCGA-WE-AA9Y,SKCM,37.0,MALE,WHITE,Stage IIIC,nan,nan,nan,2013.0,nan,-13850.0,Alive,TUMOR FREE,370.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,370.0,0.0,370.0,nan,nan,0.0,370.0,0
TCGA-WE-AAA0-06,TCGA-WE-AAA0,SKCM,47.0,MALE,WHITE,Stage IA,nan,nan,nan,2011.0,nan,-17261.0,Alive,TUMOR FREE,1229.0,nan,nan,Distant Metastasis|Distant Metastasis,"Other, Specify|Brain",Spleen|[Not Applicable],650.0,nan,nan,nan,0.0,1229.0,0.0,1229.0,nan,nan,1.0,650.0,0
TCGA-WE-AAA3-06,TCGA-WE-AAA3,SKCM,84.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2013.0,nan,-30843.0,Alive,TUMOR FREE,651.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,651.0,0.0,651.0,nan,nan,0.0,651.0,0
TCGA-WE-AAA4-06,TCGA-WE-AAA4,SKCM,56.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2012.0,nan,-20708.0,Alive,WITH TUMOR,760.0,nan,nan,Distant Metastasis|Locoregional Recurrence,Brain|[Not Available],[Not Applicable]|[Not Applicable],523.0,nan,nan,nan,0.0,760.0,0.0,760.0,nan,nan,1.0,523.0,1
TCGA-XV-A9VZ-01,TCGA-XV-A9VZ,SKCM,90.0,FEMALE,WHITE,Stage II,nan,nan,nan,2013.0,nan,-32873.0,Alive,TUMOR FREE,11.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,11.0,0.0,11.0,nan,nan,0.0,11.0,0
TCGA-XV-A9W2-01,TCGA-XV-A9W2,SKCM,81.0,MALE,WHITE,Stage I,nan,nan,nan,2013.0,nan,-29836.0,Alive,TUMOR FREE,417.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,417.0,0.0,417.0,nan,nan,0.0,417.0,0
TCGA-XV-A9W5-01,TCGA-XV-A9W5,SKCM,51.0,MALE,WHITE,I/II NOS,nan,nan,nan,2013.0,nan,-18739.0,Alive,WITH TUMOR,392.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,392.0,0.0,392.0,nan,nan,0.0,392.0,0
TCGA-XV-AAZV-01,TCGA-XV-AAZV,SKCM,56.0,FEMALE,WHITE,Stage II,nan,nan,nan,2013.0,nan,-20545.0,Alive,TUMOR FREE,412.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,412.0,0.0,412.0,nan,nan,0.0,412.0,0
TCGA-XV-AAZW-01,TCGA-XV-AAZW,SKCM,62.0,FEMALE,WHITE,Stage II,nan,nan,nan,2013.0,nan,-22778.0,Dead,WITH TUMOR,nan,393.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,393.0,1.0,393.0,nan,nan,1.0,393.0,1
TCGA-XV-AAZY-01,TCGA-XV-AAZY,SKCM,76.0,FEMALE,WHITE,Stage IIIC,nan,nan,nan,2013.0,nan,-27938.0,Alive,TUMOR FREE,405.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,405.0,0.0,405.0,nan,nan,0.0,405.0,0
TCGA-XV-AB01-06,TCGA-XV-AB01,SKCM,54.0,FEMALE,WHITE,Stage II,nan,nan,nan,2013.0,nan,-20058.0,Alive,WITH TUMOR,403.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,403.0,0.0,403.0,nan,nan,0.0,403.0,0
TCGA-XV-AB01-01,TCGA-XV-AB01,SKCM,54.0,FEMALE,WHITE,Stage II,nan,nan,nan,2013.0,nan,-20058.0,Alive,WITH TUMOR,403.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,403.0,0.0,403.0,nan,nan,0.0,403.0,0
TCGA-YD-A89C-06,TCGA-YD-A89C,SKCM,43.0,FEMALE,WHITE,Stage IA,nan,nan,nan,2013.0,nan,-15804.0,Alive,TUMOR FREE,210.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,210.0,0.0,210.0,nan,nan,0.0,210.0,0
TCGA-YD-A9TA-06,TCGA-YD-A9TA,SKCM,75.0,MALE,WHITE,nan,nan,nan,nan,2010.0,nan,-27498.0,Alive,TUMOR FREE,1496.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1496.0,0.0,1496.0,nan,nan,0.0,1496.0,0
TCGA-YD-A9TB-06,TCGA-YD-A9TB,SKCM,nan,FEMALE,WHITE,nan,nan,nan,nan,1987.0,nan,nan,Alive,WITH TUMOR,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,nan,0.0,nan,nan,nan,0.0,nan,1
TCGA-YG-AA3N-01,TCGA-YG-AA3N,SKCM,67.0,MALE,[Unknown],Stage IIC,nan,nan,nan,2013.0,nan,-24525.0,Alive,TUMOR FREE,306.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,306.0,0.0,306.0,nan,nan,0.0,306.0,0
TCGA-YG-AA3O-06,TCGA-YG-AA3O,SKCM,62.0,MALE,[Unknown],nan,nan,nan,nan,2011.0,nan,-22999.0,Dead,WITH TUMOR,nan,1154.0,nan,Regional lymph node,nan,nan,999.0,nan,nan,nan,1.0,1154.0,1.0,1154.0,nan,nan,1.0,999.0,1
TCGA-YG-AA3P-06,TCGA-YG-AA3P,SKCM,63.0,FEMALE,[Unknown],Stage IIB,nan,nan,nan,2013.0,nan,-23219.0,Alive,WITH TUMOR,439.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,439.0,0.0,439.0,nan,nan,0.0,439.0,0
TCGA-Z2-A8RT-06,TCGA-Z2-A8RT,SKCM,42.0,FEMALE,WHITE,Stage IIB,nan,nan,nan,2012.0,nan,-15342.0,Alive,TUMOR FREE,839.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,839.0,0.0,839.0,nan,nan,0.0,839.0,0
TCGA-Z2-AA3S-06,TCGA-Z2-AA3S,SKCM,58.0,MALE,WHITE,Stage IA,nan,nan,nan,2006.0,nan,-21318.0,Alive,WITH TUMOR,2950.0,nan,nan,Distant Metastasis,Lung,nan,2727.0,nan,nan,nan,0.0,2950.0,0.0,2950.0,nan,nan,1.0,2727.0,0
TCGA-Z2-AA3V-06,TCGA-Z2-AA3V,SKCM,57.0,FEMALE,WHITE,Stage IA,nan,nan,nan,2013.0,nan,-20937.0,Alive,TUMOR FREE,486.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,486.0,0.0,486.0,nan,nan,0.0,486.0,0
TCGA-3M-AB46-01,TCGA-3M-AB46,STAD,70.0,MALE,WHITE,Stage IB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009.0,nan,nan,Alive,TUMOR FREE,1765.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1765.0,0.0,1765.0,0.0,1765.0,0.0,1765.0,0
TCGA-3M-AB47-01,TCGA-3M-AB47,STAD,51.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,nan,nan,Dead,WITH TUMOR,nan,nan,Stomach Cancer,Locoregional Recurrence,nan,nan,395.0,Stable Disease,nan,nan,1.0,nan,1.0,nan,nan,nan,1.0,395.0,1
TCGA-B7-5816-01,TCGA-B7-5816,STAD,51.0,FEMALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2010.0,nan,-18698.0,Alive,TUMOR FREE,812.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,812.0,0.0,812.0,0.0,812.0,0.0,812.0,0
TCGA-B7-5818-01,TCGA-B7-5818,STAD,62.0,MALE,WHITE,Stage IB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2010.0,nan,-22792.0,Alive,TUMOR FREE,356.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,356.0,0.0,356.0,nan,nan,0.0,356.0,0
TCGA-B7-A5TI-01,TCGA-B7-A5TI,STAD,52.0,MALE,WHITE,Stage IIIC,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,nan,-19014.0,Alive,TUMOR FREE,595.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,595.0,0.0,595.0,0.0,595.0,0.0,595.0,0
TCGA-B7-A5TJ-01,TCGA-B7-A5TJ,STAD,74.0,MALE,WHITE,Stage IIB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G1,2012.0,nan,-27057.0,Alive,TUMOR FREE,335.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,335.0,0.0,335.0,0.0,335.0,0.0,335.0,0
TCGA-B7-A5TK-01,TCGA-B7-A5TK,STAD,51.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-18750.0,Alive,TUMOR FREE,288.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,288.0,0.0,288.0,0.0,288.0,0.0,288.0,0
TCGA-B7-A5TN-01,TCGA-B7-A5TN,STAD,60.0,MALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,nan,-21962.0,Alive,TUMOR FREE,287.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,287.0,0.0,287.0,0.0,287.0,0.0,287.0,0
TCGA-BR-4183-01,TCGA-BR-4183,STAD,55.0,FEMALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2007.0,nan,-20420.0,Dead,nan,nan,201.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,201.0,nan,201.0,nan,nan,0.0,201.0,1
TCGA-BR-4183-11,TCGA-BR-4183,STAD,55.0,FEMALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2007.0,nan,-20420.0,Dead,nan,nan,201.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,201.0,nan,201.0,nan,nan,0.0,201.0,1
TCGA-BR-4184-01,TCGA-BR-4184,STAD,70.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2007.0,nan,-25816.0,Dead,nan,nan,212.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,212.0,nan,212.0,nan,nan,0.0,212.0,1
TCGA-BR-4184-11,TCGA-BR-4184,STAD,70.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2007.0,nan,-25816.0,Dead,nan,nan,212.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,212.0,nan,212.0,nan,nan,0.0,212.0,1
TCGA-BR-4187-01,TCGA-BR-4187,STAD,56.0,MALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,nan,-20635.0,Dead,nan,nan,141.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,141.0,nan,141.0,nan,nan,0.0,141.0,1
TCGA-BR-4187-11,TCGA-BR-4187,STAD,56.0,MALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,nan,-20635.0,Dead,nan,nan,141.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,141.0,nan,141.0,nan,nan,0.0,141.0,1
TCGA-BR-4188-01,TCGA-BR-4188,STAD,53.0,FEMALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,nan,-19585.0,Dead,nan,nan,226.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,226.0,nan,226.0,nan,nan,0.0,226.0,1
TCGA-BR-4188-11,TCGA-BR-4188,STAD,53.0,FEMALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,nan,-19585.0,Dead,nan,nan,226.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,226.0,nan,226.0,nan,nan,0.0,226.0,1
TCGA-BR-4191-01,TCGA-BR-4191,STAD,72.0,MALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,nan,-26562.0,Dead,nan,nan,558.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,558.0,nan,558.0,nan,nan,0.0,558.0,1
TCGA-BR-4191-11,TCGA-BR-4191,STAD,72.0,MALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,nan,-26562.0,Dead,nan,nan,558.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,558.0,nan,558.0,nan,nan,0.0,558.0,1
TCGA-BR-4201-01,TCGA-BR-4201,STAD,66.0,FEMALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G1,2008.0,nan,-24354.0,Dead,nan,nan,940.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,940.0,nan,940.0,nan,nan,0.0,940.0,1
TCGA-BR-4201-11,TCGA-BR-4201,STAD,66.0,FEMALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G1,2008.0,nan,-24354.0,Dead,nan,nan,940.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,940.0,nan,940.0,nan,nan,0.0,940.0,1
TCGA-BR-4253-01,TCGA-BR-4253,STAD,80.0,FEMALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,nan,-29397.0,Dead,nan,nan,124.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,124.0,nan,124.0,nan,nan,0.0,124.0,1
TCGA-BR-4253-11,TCGA-BR-4253,STAD,80.0,FEMALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,nan,-29397.0,Dead,nan,nan,124.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,124.0,nan,124.0,nan,nan,0.0,124.0,1
TCGA-BR-4255-01,TCGA-BR-4255,STAD,76.0,FEMALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,nan,-27893.0,Dead,nan,nan,124.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,124.0,nan,124.0,nan,nan,0.0,124.0,1
TCGA-BR-4255-11,TCGA-BR-4255,STAD,76.0,FEMALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,nan,-27893.0,Dead,nan,nan,124.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,124.0,nan,124.0,nan,nan,0.0,124.0,1
TCGA-BR-4256-01,TCGA-BR-4256,STAD,80.0,MALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,nan,-29441.0,Dead,nan,nan,284.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,284.0,nan,284.0,nan,nan,0.0,284.0,1
TCGA-BR-4256-11,TCGA-BR-4256,STAD,80.0,MALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,nan,-29441.0,Dead,nan,nan,284.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,284.0,nan,284.0,nan,nan,0.0,284.0,1
TCGA-BR-4257-01,TCGA-BR-4257,STAD,79.0,FEMALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,nan,-29014.0,Dead,nan,nan,294.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,294.0,nan,294.0,nan,nan,0.0,294.0,1
TCGA-BR-4257-11,TCGA-BR-4257,STAD,79.0,FEMALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,nan,-29014.0,Dead,nan,nan,294.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,294.0,nan,294.0,nan,nan,0.0,294.0,1
TCGA-BR-4267-01,TCGA-BR-4267,STAD,51.0,MALE,WHITE,Stage IB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,nan,-18699.0,Dead,nan,nan,188.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,188.0,nan,188.0,nan,nan,0.0,188.0,1
TCGA-BR-4267-11,TCGA-BR-4267,STAD,51.0,MALE,WHITE,Stage IB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,nan,-18699.0,Dead,nan,nan,188.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,188.0,nan,188.0,nan,nan,0.0,188.0,1
TCGA-BR-4279-01,TCGA-BR-4279,STAD,43.0,MALE,WHITE,Stage II,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2009.0,nan,-16065.0,Dead,nan,nan,291.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,291.0,nan,291.0,nan,nan,0.0,291.0,1
TCGA-BR-4279-11,TCGA-BR-4279,STAD,43.0,MALE,WHITE,Stage II,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2009.0,nan,-16065.0,Dead,nan,nan,291.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,291.0,nan,291.0,nan,nan,0.0,291.0,1
TCGA-BR-4280-01,TCGA-BR-4280,STAD,78.0,FEMALE,WHITE,Stage III,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009.0,nan,-28515.0,Dead,nan,nan,201.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,201.0,nan,201.0,nan,nan,0.0,201.0,1
TCGA-BR-4280-11,TCGA-BR-4280,STAD,78.0,FEMALE,WHITE,Stage III,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009.0,nan,-28515.0,Dead,nan,nan,201.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,201.0,nan,201.0,nan,nan,0.0,201.0,1
TCGA-BR-4292-01,TCGA-BR-4292,STAD,73.0,FEMALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G1,2009.0,nan,-26670.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-4292-11,TCGA-BR-4292,STAD,73.0,FEMALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G1,2009.0,nan,-26670.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-4294-01,TCGA-BR-4294,STAD,65.0,MALE,WHITE,nan,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2009.0,nan,-23758.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-4294-11,TCGA-BR-4294,STAD,65.0,MALE,WHITE,nan,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2009.0,nan,-23758.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-4357-01,TCGA-BR-4357,STAD,58.0,MALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,nan,-21295.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-4357-11,TCGA-BR-4357,STAD,58.0,MALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,nan,-21295.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-4361-01,TCGA-BR-4361,STAD,66.0,FEMALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,nan,-24260.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-4361-11,TCGA-BR-4361,STAD,66.0,FEMALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,nan,-24260.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-4362-01,TCGA-BR-4362,STAD,74.0,FEMALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,nan,-27179.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-4362-11,TCGA-BR-4362,STAD,74.0,FEMALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,nan,-27179.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-4363-01,TCGA-BR-4363,STAD,60.0,FEMALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,nan,-22196.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-4363-11,TCGA-BR-4363,STAD,60.0,FEMALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,nan,-22196.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-4366-01,TCGA-BR-4366,STAD,87.0,MALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,nan,-32024.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-4366-11,TCGA-BR-4366,STAD,87.0,MALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,nan,-32024.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-4367-01,TCGA-BR-4367,STAD,78.0,MALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,nan,-28817.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-4367-11,TCGA-BR-4367,STAD,78.0,MALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,nan,-28817.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-4368-01,TCGA-BR-4368,STAD,78.0,FEMALE,WHITE,Stage IV,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,nan,-28770.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-4368-11,TCGA-BR-4368,STAD,78.0,FEMALE,WHITE,Stage IV,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,nan,-28770.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-4369-01,TCGA-BR-4369,STAD,75.0,MALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,nan,-27509.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-4369-11,TCGA-BR-4369,STAD,75.0,MALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,nan,-27509.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-4370-01,TCGA-BR-4370,STAD,74.0,FEMALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,nan,-27344.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-4370-11,TCGA-BR-4370,STAD,74.0,FEMALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,nan,-27344.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-4371-01,TCGA-BR-4371,STAD,71.0,FEMALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G1,2008.0,nan,-26290.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-4371-11,TCGA-BR-4371,STAD,71.0,FEMALE,WHITE,nan,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G1,2008.0,nan,-26290.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-6452-01,TCGA-BR-6452,STAD,78.0,FEMALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-28827.0,Alive,TUMOR FREE,1055.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1055.0,0.0,1055.0,0.0,1055.0,0.0,1055.0,0
TCGA-BR-6452-11,TCGA-BR-6452,STAD,78.0,FEMALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-28827.0,Alive,TUMOR FREE,1055.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1055.0,0.0,1055.0,0.0,1055.0,0.0,1055.0,0
TCGA-BR-6453-01,TCGA-BR-6453,STAD,54.0,MALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-20061.0,Alive,TUMOR FREE,485.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,485.0,0.0,485.0,0.0,485.0,0.0,485.0,0
TCGA-BR-6453-11,TCGA-BR-6453,STAD,54.0,MALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-20061.0,Alive,TUMOR FREE,485.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,485.0,0.0,485.0,0.0,485.0,0.0,485.0,0
TCGA-BR-6454-01,TCGA-BR-6454,STAD,58.0,MALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-21501.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-6454-11,TCGA-BR-6454,STAD,58.0,MALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-21501.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-BR-6455-01,TCGA-BR-6455,STAD,59.0,MALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-21865.0,Dead,WITH TUMOR,nan,422.0,nan,Distant Metastasis,Liver,nan,385.0,Stable Disease,nan,nan,1.0,422.0,1.0,422.0,nan,nan,1.0,385.0,1
TCGA-BR-6456-01,TCGA-BR-6456,STAD,74.0,FEMALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-27288.0,Dead,TUMOR FREE,nan,526.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,526.0,0.0,526.0,0.0,526.0,0.0,526.0,0
TCGA-BR-6457-01,TCGA-BR-6457,STAD,69.0,MALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-25396.0,Alive,TUMOR FREE,416.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,416.0,0.0,416.0,0.0,416.0,0.0,416.0,0
TCGA-BR-6457-11,TCGA-BR-6457,STAD,69.0,MALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-25396.0,Alive,TUMOR FREE,416.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,416.0,0.0,416.0,0.0,416.0,0.0,416.0,0
TCGA-BR-6458-01,TCGA-BR-6458,STAD,57.0,FEMALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-21069.0,Dead,WITH TUMOR,nan,588.0,nan,Distant Metastasis,Liver,nan,574.0,Complete Remission/Response,nan,nan,1.0,588.0,1.0,588.0,1.0,574.0,1.0,574.0,1
TCGA-BR-6458-11,TCGA-BR-6458,STAD,57.0,FEMALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-21069.0,Dead,WITH TUMOR,nan,588.0,nan,Distant Metastasis,Liver,nan,574.0,Complete Remission/Response,nan,nan,1.0,588.0,1.0,588.0,1.0,574.0,1.0,574.0,1
TCGA-BR-6563-01,TCGA-BR-6563,STAD,60.0,MALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-21936.0,Alive,TUMOR FREE,1190.0,nan,nan,New Primary Tumor,nan,nan,148.0,Complete Remission/Response,nan,nan,0.0,1190.0,0.0,1190.0,0.0,1190.0,1.0,148.0,0
TCGA-BR-6564-01,TCGA-BR-6564,STAD,46.0,FEMALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-17129.0,Dead,TUMOR FREE,nan,794.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,794.0,0.0,794.0,0.0,794.0,0.0,794.0,0
TCGA-BR-6564-11,TCGA-BR-6564,STAD,46.0,FEMALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-17129.0,Dead,TUMOR FREE,nan,794.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,794.0,0.0,794.0,0.0,794.0,0.0,794.0,0
TCGA-BR-6565-01,TCGA-BR-6565,STAD,67.0,MALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-24495.0,Dead,WITH TUMOR,nan,279.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,279.0,1.0,279.0,nan,nan,1.0,279.0,1
TCGA-BR-6566-01,TCGA-BR-6566,STAD,64.0,FEMALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-23404.0,Alive,TUMOR FREE,997.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,997.0,0.0,997.0,0.0,997.0,0.0,997.0,0
TCGA-BR-6566-11,TCGA-BR-6566,STAD,64.0,FEMALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-23404.0,Alive,TUMOR FREE,997.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,997.0,0.0,997.0,0.0,997.0,0.0,997.0,0
TCGA-BR-6705-01,TCGA-BR-6705,STAD,68.0,FEMALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-25073.0,Dead,WITH TUMOR,nan,779.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,779.0,1.0,779.0,nan,nan,1.0,779.0,1
TCGA-BR-6706-01,TCGA-BR-6706,STAD,63.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010.0,nan,-23053.0,Dead,WITH TUMOR,nan,549.0,nan,Locoregional Recurrence,nan,nan,402.0,Complete Remission/Response,nan,nan,1.0,549.0,1.0,549.0,1.0,402.0,1.0,402.0,1
TCGA-BR-6707-01,TCGA-BR-6707,STAD,75.0,MALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-27529.0,Alive,WITH TUMOR,491.0,nan,nan,Locoregional Recurrence,nan,nan,426.0,Complete Remission/Response,nan,nan,0.0,491.0,0.0,491.0,1.0,426.0,1.0,426.0,2
TCGA-BR-6709-01,TCGA-BR-6709,STAD,57.0,FEMALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-20935.0,Dead,WITH TUMOR,nan,370.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,370.0,1.0,370.0,nan,nan,1.0,370.0,1
TCGA-BR-6710-01,TCGA-BR-6710,STAD,41.0,MALE,WHITE,Stage IB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-15316.0,Alive,TUMOR FREE,273.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,273.0,0.0,273.0,0.0,273.0,0.0,273.0,0
TCGA-BR-6801-01,TCGA-BR-6801,STAD,70.0,MALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-25637.0,Alive,TUMOR FREE,1223.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1223.0,0.0,1223.0,0.0,1223.0,0.0,1223.0,0
TCGA-BR-6802-01,TCGA-BR-6802,STAD,65.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-23915.0,Alive,TUMOR FREE,940.0,nan,nan,Distant Metastasis,Non-regional / Distant Lymph Nodes,nan,807.0,Complete Remission/Response,nan,nan,0.0,940.0,0.0,940.0,1.0,807.0,1.0,807.0,2
TCGA-BR-6802-11,TCGA-BR-6802,STAD,65.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-23915.0,Alive,TUMOR FREE,940.0,nan,nan,Distant Metastasis,Non-regional / Distant Lymph Nodes,nan,807.0,Complete Remission/Response,nan,nan,0.0,940.0,0.0,940.0,1.0,807.0,1.0,807.0,2
TCGA-BR-6803-01,TCGA-BR-6803,STAD,54.0,FEMALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-19751.0,Alive,TUMOR FREE,949.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,949.0,0.0,949.0,0.0,949.0,0.0,949.0,0
TCGA-BR-6852-01,TCGA-BR-6852,STAD,64.0,FEMALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-23469.0,Alive,TUMOR FREE,1367.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1367.0,0.0,1367.0,0.0,1367.0,0.0,1367.0,0
TCGA-BR-6852-11,TCGA-BR-6852,STAD,64.0,FEMALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-23469.0,Alive,TUMOR FREE,1367.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1367.0,0.0,1367.0,0.0,1367.0,0.0,1367.0,0
TCGA-BR-7196-01,TCGA-BR-7196,STAD,64.0,MALE,WHITE,Stage IV,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-23611.0,Alive,WITH TUMOR,666.0,nan,nan,Distant Metastasis,Lung,nan,348.0,Complete Remission/Response,nan,nan,0.0,666.0,0.0,666.0,nan,nan,1.0,348.0,2
TCGA-BR-7197-01,TCGA-BR-7197,STAD,69.0,MALE,WHITE,Stage II,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",GX,2011.0,nan,-25445.0,Alive,TUMOR FREE,280.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,280.0,0.0,280.0,0.0,280.0,0.0,280.0,0
TCGA-BR-7703-01,TCGA-BR-7703,STAD,81.0,MALE,WHITE,Stage IA,nan,"Stomach, Intestinal Adenocarcinoma, Papillary Type",G2,2011.0,nan,-29711.0,Alive,TUMOR FREE,1100.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1100.0,0.0,1100.0,0.0,1100.0,0.0,1100.0,0
TCGA-BR-7703-11,TCGA-BR-7703,STAD,81.0,MALE,WHITE,Stage IA,nan,"Stomach, Intestinal Adenocarcinoma, Papillary Type",G2,2011.0,nan,-29711.0,Alive,TUMOR FREE,1100.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1100.0,0.0,1100.0,0.0,1100.0,0.0,1100.0,0
TCGA-BR-7704-01,TCGA-BR-7704,STAD,69.0,FEMALE,WHITE,Stage II,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-25300.0,Alive,TUMOR FREE,1072.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1072.0,0.0,1072.0,0.0,1072.0,0.0,1072.0,0
TCGA-BR-7704-11,TCGA-BR-7704,STAD,69.0,FEMALE,WHITE,Stage II,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-25300.0,Alive,TUMOR FREE,1072.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1072.0,0.0,1072.0,0.0,1072.0,0.0,1072.0,0
TCGA-BR-7707-01,TCGA-BR-7707,STAD,69.0,FEMALE,WHITE,Stage IB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-25325.0,Alive,TUMOR FREE,1090.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1090.0,0.0,1090.0,0.0,1090.0,0.0,1090.0,0
TCGA-BR-7715-01,TCGA-BR-7715,STAD,65.0,MALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-23861.0,Alive,TUMOR FREE,1023.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1023.0,0.0,1023.0,0.0,1023.0,0.0,1023.0,0
TCGA-BR-7715-11,TCGA-BR-7715,STAD,65.0,MALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-23861.0,Alive,TUMOR FREE,1023.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1023.0,0.0,1023.0,0.0,1023.0,0.0,1023.0,0
TCGA-BR-7716-01,TCGA-BR-7716,STAD,62.0,FEMALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-22829.0,Alive,TUMOR FREE,1210.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1210.0,0.0,1210.0,0.0,1210.0,0.0,1210.0,0
TCGA-BR-7716-11,TCGA-BR-7716,STAD,62.0,FEMALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-22829.0,Alive,TUMOR FREE,1210.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1210.0,0.0,1210.0,0.0,1210.0,0.0,1210.0,0
TCGA-BR-7717-01,TCGA-BR-7717,STAD,63.0,MALE,WHITE,Stage IV,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-23102.0,Dead,TUMOR FREE,nan,552.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,552.0,0.0,552.0,nan,nan,0.0,552.0,0
TCGA-BR-7717-11,TCGA-BR-7717,STAD,63.0,MALE,WHITE,Stage IV,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-23102.0,Dead,TUMOR FREE,nan,552.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,552.0,0.0,552.0,nan,nan,0.0,552.0,0
TCGA-BR-7722-01,TCGA-BR-7722,STAD,62.0,MALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-22701.0,Dead,TUMOR FREE,nan,466.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,466.0,0.0,466.0,0.0,466.0,0.0,466.0,0
TCGA-BR-7723-01,TCGA-BR-7723,STAD,59.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-21839.0,Dead,WITH TUMOR,nan,874.0,nan,Distant Metastasis,Liver,nan,559.0,Complete Remission/Response,nan,nan,1.0,874.0,1.0,874.0,1.0,559.0,1.0,559.0,1
TCGA-BR-7851-01,TCGA-BR-7851,STAD,74.0,MALE,WHITE,Stage IIB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-27091.0,Dead,TUMOR FREE,574.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,nan,0.0,nan,0.0,nan,0.0,nan,0
TCGA-BR-7851-11,TCGA-BR-7851,STAD,74.0,MALE,WHITE,Stage IIB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-27091.0,Dead,TUMOR FREE,574.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,nan,0.0,nan,0.0,nan,0.0,nan,0
TCGA-BR-7901-01,TCGA-BR-7901,STAD,74.0,MALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-27031.0,Dead,TUMOR FREE,nan,105.0,nan,Locoregional Recurrence,nan,nan,91.0,Complete Remission/Response,nan,nan,1.0,105.0,0.0,105.0,1.0,91.0,1.0,91.0,2
TCGA-BR-7957-01,TCGA-BR-7957,STAD,50.0,FEMALE,WHITE,Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",GX,2011.0,nan,-18517.0,Dead,TUMOR FREE,nan,276.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,276.0,0.0,276.0,nan,nan,0.0,276.0,0
TCGA-BR-7958-01,TCGA-BR-7958,STAD,60.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-22204.0,Alive,TUMOR FREE,899.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,899.0,0.0,899.0,0.0,899.0,0.0,899.0,0
TCGA-BR-7959-01,TCGA-BR-7959,STAD,59.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2011.0,nan,-21730.0,Alive,TUMOR FREE,1010.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1010.0,0.0,1010.0,0.0,1010.0,0.0,1010.0,0
TCGA-BR-8058-01,TCGA-BR-8058,STAD,53.0,FEMALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-19658.0,Alive,TUMOR FREE,1133.0,nan,nan,New Primary Tumor,"Other, specify",Rectum,89.0,Complete Remission/Response,nan,nan,0.0,1133.0,0.0,1133.0,0.0,1133.0,1.0,89.0,0
TCGA-BR-8059-01,TCGA-BR-8059,STAD,72.0,MALE,WHITE,Stage III,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-26474.0,Dead,TUMOR FREE,nan,439.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,439.0,0.0,439.0,0.0,439.0,0.0,439.0,0
TCGA-BR-8060-01,TCGA-BR-8060,STAD,75.0,FEMALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-27561.0,Dead,TUMOR FREE,nan,348.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,348.0,0.0,348.0,0.0,348.0,0.0,348.0,0
TCGA-BR-8060-11,TCGA-BR-8060,STAD,75.0,FEMALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-27561.0,Dead,TUMOR FREE,nan,348.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,348.0,0.0,348.0,0.0,348.0,0.0,348.0,0
TCGA-BR-8077-01,TCGA-BR-8077,STAD,58.0,FEMALE,WHITE,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-21413.0,Alive,TUMOR FREE,21.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,21.0,0.0,21.0,0.0,21.0,0.0,21.0,0
TCGA-BR-8078-01,TCGA-BR-8078,STAD,70.0,FEMALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-25861.0,Alive,TUMOR FREE,900.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,900.0,0.0,900.0,0.0,900.0,0.0,900.0,0
TCGA-BR-8080-01,TCGA-BR-8080,STAD,72.0,FEMALE,WHITE,Stage IIIC,nan,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2011.0,nan,-26546.0,Dead,TUMOR FREE,nan,292.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,292.0,0.0,292.0,0.0,292.0,0.0,292.0,0
TCGA-BR-8081-01,TCGA-BR-8081,STAD,71.0,FEMALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-26095.0,Alive,TUMOR FREE,981.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,981.0,0.0,981.0,0.0,981.0,0.0,981.0,0
TCGA-BR-8284-01,TCGA-BR-8284,STAD,72.0,FEMALE,WHITE,Stage IIIC,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-26526.0,Dead,TUMOR FREE,nan,245.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,245.0,0.0,245.0,0.0,245.0,0.0,245.0,0
TCGA-BR-8285-01,TCGA-BR-8285,STAD,57.0,FEMALE,WHITE,Stage IIIC,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-20849.0,Dead,TUMOR FREE,nan,17.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,17.0,0.0,17.0,0.0,17.0,0.0,17.0,0
TCGA-BR-8286-01,TCGA-BR-8286,STAD,49.0,MALE,WHITE,Stage II,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-17966.0,Alive,TUMOR FREE,895.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,895.0,0.0,895.0,0.0,895.0,0.0,895.0,0
TCGA-BR-8289-01,TCGA-BR-8289,STAD,57.0,MALE,WHITE,Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-20849.0,Dead,TUMOR FREE,nan,81.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,81.0,0.0,81.0,nan,nan,0.0,81.0,0
TCGA-BR-8291-01,TCGA-BR-8291,STAD,61.0,MALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",GX,2011.0,nan,-22552.0,Dead,TUMOR FREE,nan,607.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,607.0,0.0,607.0,0.0,607.0,0.0,607.0,0
TCGA-BR-8295-01,TCGA-BR-8295,STAD,60.0,FEMALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-22256.0,Dead,WITH TUMOR,nan,67.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,67.0,1.0,67.0,nan,nan,1.0,67.0,1
TCGA-BR-8296-01,TCGA-BR-8296,STAD,58.0,FEMALE,WHITE,Stage IIIC,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-21527.0,Dead,WITH TUMOR,nan,474.0,nan,Distant Metastasis,Liver,nan,390.0,Stable Disease,nan,nan,1.0,474.0,1.0,474.0,nan,nan,1.0,390.0,1
TCGA-BR-8297-01,TCGA-BR-8297,STAD,58.0,MALE,WHITE,Stage IIIC,nan,"Stomach, Adenocarcinoma, Diffuse Type",GX,2012.0,nan,-21224.0,Alive,WITH TUMOR,225.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,225.0,0.0,225.0,nan,nan,0.0,225.0,0
TCGA-BR-8360-01,TCGA-BR-8360,STAD,66.0,MALE,WHITE,Stage IIA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-24394.0,Alive,TUMOR FREE,188.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,188.0,0.0,188.0,0.0,188.0,0.0,188.0,0
TCGA-BR-8361-01,TCGA-BR-8361,STAD,71.0,FEMALE,WHITE,Stage IIIC,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-25999.0,Alive,TUMOR FREE,946.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,946.0,0.0,946.0,0.0,946.0,0.0,946.0,0
TCGA-BR-8362-01,TCGA-BR-8362,STAD,65.0,MALE,WHITE,Stage IIIC,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-23797.0,Dead,WITH TUMOR,nan,398.0,nan,Distant Metastasis,Non-regional / Distant Lymph Nodes,nan,356.0,Complete Remission/Response,nan,nan,1.0,398.0,1.0,398.0,1.0,356.0,1.0,356.0,1
TCGA-BR-8363-01,TCGA-BR-8363,STAD,73.0,FEMALE,WHITE,Stage IB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-26976.0,Dead,TUMOR FREE,nan,8.0,"Other, non-malignant disease",nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,8.0,0.0,8.0,0.0,8.0,0.0,8.0,0
TCGA-BR-8364-01,TCGA-BR-8364,STAD,42.0,FEMALE,WHITE,Stage IIIC,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-15389.0,Alive,TUMOR FREE,675.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,675.0,0.0,675.0,0.0,675.0,0.0,675.0,0
TCGA-BR-8365-01,TCGA-BR-8365,STAD,70.0,FEMALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-25725.0,Dead,WITH TUMOR,nan,533.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,533.0,1.0,533.0,nan,nan,1.0,533.0,1
TCGA-BR-8366-01,TCGA-BR-8366,STAD,80.0,FEMALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-29394.0,Alive,TUMOR FREE,29.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,29.0,0.0,29.0,0.0,29.0,0.0,29.0,0
TCGA-BR-8367-01,TCGA-BR-8367,STAD,55.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-20441.0,Dead,WITH TUMOR,nan,801.0,nan,Distant Metastasis,"Other, specify","Adrenal gland, bone",580.0,Complete Remission/Response,nan,nan,1.0,801.0,1.0,801.0,1.0,580.0,1.0,580.0,1
TCGA-BR-8368-01,TCGA-BR-8368,STAD,84.0,FEMALE,WHITE,Stage IB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-30874.0,Alive,TUMOR FREE,131.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,131.0,0.0,131.0,0.0,131.0,0.0,131.0,0
TCGA-BR-8369-01,TCGA-BR-8369,STAD,76.0,FEMALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-28051.0,Alive,WITH TUMOR,427.0,nan,nan,Distant Metastasis,"Other, specify",Bone,419.0,Complete Remission/Response,nan,nan,0.0,427.0,0.0,427.0,1.0,419.0,1.0,419.0,2
TCGA-BR-8370-01,TCGA-BR-8370,STAD,64.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-23636.0,Alive,TUMOR FREE,101.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,101.0,0.0,101.0,0.0,101.0,0.0,101.0,0
TCGA-BR-8371-01,TCGA-BR-8371,STAD,62.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-22883.0,Dead,WITH TUMOR,nan,359.0,nan,Distant Metastasis,"Other, specify",Brain,357.0,Progressive Disease,nan,nan,1.0,359.0,1.0,359.0,nan,nan,1.0,357.0,1
TCGA-BR-8372-01,TCGA-BR-8372,STAD,63.0,MALE,WHITE,Stage IIIC,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-23346.0,Alive,TUMOR FREE,951.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,951.0,0.0,951.0,0.0,951.0,0.0,951.0,0
TCGA-BR-8373-01,TCGA-BR-8373,STAD,65.0,FEMALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-23744.0,Alive,TUMOR FREE,450.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,450.0,0.0,450.0,0.0,450.0,0.0,450.0,0
TCGA-BR-8380-01,TCGA-BR-8380,STAD,55.0,MALE,WHITE,Stage IIIC,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-20157.0,Alive,WITH TUMOR,21.0,nan,nan,Locoregional Recurrence,nan,nan,467.0,Complete Remission/Response,nan,nan,0.0,21.0,0.0,21.0,1.0,467.0,1.0,467.0,2
TCGA-BR-8381-01,TCGA-BR-8381,STAD,51.0,MALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-18843.0,Alive,TUMOR FREE,224.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,224.0,0.0,224.0,0.0,224.0,0.0,224.0,0
TCGA-BR-8382-01,TCGA-BR-8382,STAD,67.0,FEMALE,WHITE,Stage IIIC,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-24737.0,Dead,TUMOR FREE,nan,762.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,762.0,0.0,762.0,0.0,762.0,0.0,762.0,0
TCGA-BR-8384-01,TCGA-BR-8384,STAD,69.0,MALE,WHITE,Stage IIIC,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-25281.0,Alive,TUMOR FREE,113.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,113.0,0.0,113.0,0.0,113.0,0.0,113.0,0
TCGA-BR-8483-01,TCGA-BR-8483,STAD,59.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,nan,-21731.0,Alive,TUMOR FREE,164.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,164.0,0.0,164.0,nan,nan,0.0,164.0,0
TCGA-BR-8484-01,TCGA-BR-8484,STAD,61.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,nan,-22583.0,Dead,TUMOR FREE,nan,766.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,766.0,0.0,766.0,0.0,766.0,0.0,766.0,0
TCGA-BR-8485-01,TCGA-BR-8485,STAD,68.0,FEMALE,WHITE,Stage IIIC,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-24845.0,Alive,TUMOR FREE,280.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,280.0,0.0,280.0,0.0,280.0,0.0,280.0,0
TCGA-BR-8486-01,TCGA-BR-8486,STAD,90.0,FEMALE,WHITE,Stage IA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,nan,-32872.0,Alive,TUMOR FREE,615.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,615.0,0.0,615.0,0.0,615.0,0.0,615.0,0
TCGA-BR-8487-01,TCGA-BR-8487,STAD,64.0,FEMALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-23400.0,Alive,TUMOR FREE,34.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,34.0,0.0,34.0,0.0,34.0,0.0,34.0,0
TCGA-BR-8588-01,TCGA-BR-8588,STAD,55.0,FEMALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-20177.0,Alive,TUMOR FREE,389.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,389.0,0.0,389.0,0.0,389.0,0.0,389.0,0
TCGA-BR-8589-01,TCGA-BR-8589,STAD,56.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-20727.0,Alive,TUMOR FREE,825.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,825.0,0.0,825.0,0.0,825.0,0.0,825.0,0
TCGA-BR-8590-01,TCGA-BR-8590,STAD,62.0,MALE,WHITE,Stage IIIC,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-22937.0,Dead,WITH TUMOR,nan,284.0,nan,Distant Metastasis,Lung,nan,223.0,Complete Remission/Response,nan,nan,1.0,284.0,1.0,284.0,1.0,223.0,1.0,223.0,1
TCGA-BR-8591-01,TCGA-BR-8591,STAD,79.0,MALE,WHITE,Stage IIIC,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-29054.0,Alive,TUMOR FREE,856.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,856.0,0.0,856.0,0.0,856.0,0.0,856.0,0
TCGA-BR-8592-01,TCGA-BR-8592,STAD,63.0,FEMALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,nan,-23133.0,Dead,TUMOR FREE,nan,191.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,191.0,0.0,191.0,0.0,191.0,0.0,191.0,0
TCGA-BR-8676-01,TCGA-BR-8676,STAD,59.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-21619.0,Alive,TUMOR FREE,229.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,229.0,0.0,229.0,0.0,229.0,0.0,229.0,0
TCGA-BR-8677-01,TCGA-BR-8677,STAD,74.0,FEMALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-27223.0,Alive,TUMOR FREE,813.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,813.0,0.0,813.0,0.0,813.0,0.0,813.0,0
TCGA-BR-8678-01,TCGA-BR-8678,STAD,76.0,MALE,WHITE,Stage IB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,nan,-28037.0,Alive,TUMOR FREE,754.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,754.0,0.0,754.0,0.0,754.0,0.0,754.0,0
TCGA-BR-8679-01,TCGA-BR-8679,STAD,63.0,FEMALE,WHITE,Stage IB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,nan,-23084.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0
TCGA-BR-8680-01,TCGA-BR-8680,STAD,45.0,MALE,ASIAN,Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012.0,nan,-16637.0,Alive,TUMOR FREE,972.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,972.0,0.0,972.0,nan,nan,0.0,972.0,0
TCGA-BR-8682-01,TCGA-BR-8682,STAD,52.0,MALE,ASIAN,Stage IIB,nan,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2012.0,nan,-19165.0,Alive,TUMOR FREE,991.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,991.0,0.0,991.0,0.0,991.0,0.0,991.0,0
TCGA-BR-8683-01,TCGA-BR-8683,STAD,75.0,MALE,ASIAN,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,nan,-27549.0,Dead,TUMOR FREE,nan,300.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,300.0,0.0,300.0,0.0,300.0,0.0,300.0,0
TCGA-BR-8686-01,TCGA-BR-8686,STAD,69.0,MALE,ASIAN,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,nan,-25372.0,Dead,TUMOR FREE,nan,635.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,635.0,0.0,635.0,0.0,635.0,0.0,635.0,0
TCGA-BR-8687-01,TCGA-BR-8687,STAD,67.0,FEMALE,WHITE,Stage IIIC,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-24472.0,Dead,WITH TUMOR,nan,250.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,250.0,1.0,250.0,nan,nan,1.0,250.0,1
TCGA-BR-8690-01,TCGA-BR-8690,STAD,54.0,FEMALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,nan,-19855.0,Alive,TUMOR FREE,325.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,325.0,0.0,325.0,0.0,325.0,0.0,325.0,0
TCGA-BR-A44T-01,TCGA-BR-A44T,STAD,53.0,FEMALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,nan,-19407.0,Alive,WITH TUMOR,1038.0,nan,nan,Locoregional Recurrence,nan,nan,682.0,Complete Remission/Response,nan,nan,0.0,1038.0,0.0,1038.0,1.0,682.0,1.0,682.0,2
TCGA-BR-A44U-01,TCGA-BR-A44U,STAD,70.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-25577.0,Dead,TUMOR FREE,nan,422.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,422.0,0.0,422.0,0.0,422.0,0.0,422.0,0
TCGA-BR-A452-01,TCGA-BR-A452,STAD,57.0,MALE,ASIAN,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,nan,-21107.0,Dead,TUMOR FREE,nan,229.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,229.0,0.0,229.0,0.0,229.0,0.0,229.0,0
TCGA-BR-A453-01,TCGA-BR-A453,STAD,51.0,MALE,ASIAN,Stage IV,nan,"Stomach Adenocarcinoma, Signet Ring Type",G3,2012.0,nan,-18988.0,Dead,TUMOR FREE,nan,185.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,185.0,0.0,185.0,nan,nan,0.0,185.0,0
TCGA-BR-A4CQ-01,TCGA-BR-A4CQ,STAD,58.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-21207.0,Alive,WITH TUMOR,1064.0,nan,nan,Distant Metastasis,nan,nan,962.0,Complete Remission/Response,nan,nan,0.0,1064.0,0.0,1064.0,1.0,962.0,1.0,962.0,2
TCGA-BR-A4CR-01,TCGA-BR-A4CR,STAD,70.0,FEMALE,WHITE,Stage IIIC,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-25669.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0
TCGA-BR-A4CS-01,TCGA-BR-A4CS,STAD,77.0,MALE,WHITE,Stage IIIC,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-28211.0,Dead,TUMOR FREE,nan,45.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,45.0,0.0,45.0,0.0,45.0,0.0,45.0,0
TCGA-BR-A4IU-01,TCGA-BR-A4IU,STAD,34.0,FEMALE,ASIAN,Stage IIIA,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,nan,-12601.0,Alive,TUMOR FREE,838.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,838.0,0.0,838.0,0.0,838.0,0.0,838.0,0
TCGA-BR-A4IV-01,TCGA-BR-A4IV,STAD,47.0,MALE,ASIAN,Stage IIIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,nan,-17515.0,Dead,WITH TUMOR,nan,869.0,nan,Locoregional Recurrence,nan,nan,737.0,Complete Remission/Response,nan,nan,1.0,869.0,1.0,869.0,1.0,737.0,1.0,737.0,1
TCGA-BR-A4IY-01,TCGA-BR-A4IY,STAD,58.0,MALE,ASIAN,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-21314.0,Alive,TUMOR FREE,392.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,392.0,0.0,392.0,0.0,392.0,0.0,392.0,0
TCGA-BR-A4IZ-01,TCGA-BR-A4IZ,STAD,45.0,FEMALE,ASIAN,Stage IIIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,nan,-16695.0,Dead,TUMOR FREE,nan,273.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,273.0,0.0,273.0,nan,nan,0.0,273.0,1
TCGA-BR-A4J1-01,TCGA-BR-A4J1,STAD,63.0,MALE,ASIAN,Stage IIIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-23266.0,Dead,nan,nan,22.0,[Unknown],nan,nan,nan,nan,[Unknown],nan,nan,1.0,22.0,nan,22.0,nan,nan,0.0,22.0,0
TCGA-BR-A4J2-01,TCGA-BR-A4J2,STAD,70.0,MALE,ASIAN,Stage IIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,nan,-25891.0,Alive,TUMOR FREE,431.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,431.0,0.0,431.0,0.0,431.0,0.0,431.0,0
TCGA-BR-A4J4-01,TCGA-BR-A4J4,STAD,39.0,MALE,ASIAN,Stage IIIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-14459.0,Alive,TUMOR FREE,16.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,16.0,0.0,16.0,nan,nan,0.0,16.0,0
TCGA-BR-A4J5-01,TCGA-BR-A4J5,STAD,56.0,MALE,ASIAN,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2012.0,nan,-20714.0,Alive,TUMOR FREE,862.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,862.0,0.0,862.0,0.0,862.0,0.0,862.0,0
TCGA-BR-A4J6-01,TCGA-BR-A4J6,STAD,69.0,FEMALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,nan,-25279.0,Alive,TUMOR FREE,20.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,20.0,0.0,20.0,0.0,20.0,0.0,20.0,0
TCGA-BR-A4J7-01,TCGA-BR-A4J7,STAD,49.0,MALE,ASIAN,Stage IIB,nan,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2012.0,nan,-17932.0,Alive,TUMOR FREE,989.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,989.0,0.0,989.0,0.0,989.0,0.0,989.0,0
TCGA-BR-A4J8-01,TCGA-BR-A4J8,STAD,71.0,FEMALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-26048.0,Alive,TUMOR FREE,411.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,411.0,0.0,411.0,0.0,411.0,0.0,411.0,0
TCGA-BR-A4J9-01,TCGA-BR-A4J9,STAD,55.0,MALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-20093.0,Alive,TUMOR FREE,14.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,14.0,0.0,14.0,0.0,14.0,0.0,14.0,0
TCGA-BR-A4PD-01,TCGA-BR-A4PD,STAD,72.0,FEMALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-26334.0,Alive,TUMOR FREE,628.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,628.0,0.0,628.0,0.0,628.0,0.0,628.0,0
TCGA-BR-A4PE-01,TCGA-BR-A4PE,STAD,68.0,FEMALE,WHITE,Stage IB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,nan,-24986.0,Alive,TUMOR FREE,621.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,621.0,0.0,621.0,0.0,621.0,0.0,621.0,0
TCGA-BR-A4PF-01,TCGA-BR-A4PF,STAD,72.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-26412.0,Alive,TUMOR FREE,35.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,35.0,0.0,35.0,0.0,35.0,0.0,35.0,0
TCGA-BR-A4QI-01,TCGA-BR-A4QI,STAD,70.0,FEMALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-25928.0,Dead,WITH TUMOR,nan,652.0,nan,Distant Metastasis,"Other, specify",Pancreas,383.0,Complete Remission/Response,nan,nan,1.0,652.0,1.0,652.0,1.0,383.0,1.0,383.0,1
TCGA-BR-A4QL-01,TCGA-BR-A4QL,STAD,75.0,FEMALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,nan,-27668.0,Dead,TUMOR FREE,nan,491.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,491.0,0.0,491.0,0.0,491.0,0.0,491.0,2
TCGA-BR-A4QM-01,TCGA-BR-A4QM,STAD,65.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-23999.0,Alive,WITH TUMOR,156.0,nan,nan,Locoregional Recurrence,nan,nan,127.0,Complete Remission/Response,nan,nan,0.0,156.0,0.0,156.0,1.0,127.0,1.0,127.0,2
TCGA-CD-5798-01,TCGA-CD-5798,STAD,82.0,MALE,ASIAN,Stage II,nan,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2010.0,nan,-30310.0,Alive,TUMOR FREE,408.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,408.0,0.0,408.0,0.0,408.0,0.0,408.0,0
TCGA-CD-5799-01,TCGA-CD-5799,STAD,45.0,MALE,ASIAN,Stage II,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010.0,nan,-16533.0,Alive,TUMOR FREE,396.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,396.0,0.0,396.0,0.0,396.0,0.0,396.0,0
TCGA-CD-5800-01,TCGA-CD-5800,STAD,51.0,FEMALE,ASIAN,Stage II,nan,"Stomach, Intestinal Adenocarcinoma, Papillary Type",G1,2010.0,nan,nan,Alive,TUMOR FREE,400.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,400.0,0.0,400.0,0.0,400.0,0.0,400.0,0
TCGA-CD-5801-01,TCGA-CD-5801,STAD,69.0,MALE,ASIAN,Stage IIIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010.0,nan,nan,Dead,WITH TUMOR,nan,401.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,401.0,1.0,401.0,nan,nan,1.0,401.0,1
TCGA-CD-5802-01,TCGA-CD-5802,STAD,58.0,MALE,ASIAN,Stage II,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010.0,nan,-21331.0,Alive,TUMOR FREE,406.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,406.0,0.0,406.0,0.0,406.0,0.0,406.0,0
TCGA-CD-5803-01,TCGA-CD-5803,STAD,78.0,FEMALE,ASIAN,Stage II,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010.0,nan,-28608.0,Dead,WITH TUMOR,nan,341.0,nan,Distant Metastasis,Liver,nan,300.0,Progressive Disease,nan,nan,1.0,341.0,1.0,341.0,nan,nan,1.0,300.0,1
TCGA-CD-5804-01,TCGA-CD-5804,STAD,90.0,MALE,ASIAN,[Discrepancy],nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010.0,nan,-32872.0,Alive,TUMOR FREE,368.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,368.0,0.0,368.0,0.0,368.0,0.0,368.0,0
TCGA-CD-5813-01,TCGA-CD-5813,STAD,60.0,MALE,ASIAN,Stage II,nan,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2010.0,nan,-21995.0,Dead,WITH TUMOR,nan,377.0,nan,Distant Metastasis,Liver,nan,315.0,Complete Remission/Response,nan,nan,1.0,377.0,1.0,377.0,1.0,315.0,1.0,315.0,1
TCGA-CD-8524-01,TCGA-CD-8524,STAD,61.0,FEMALE,ASIAN,Stage II,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010.0,nan,-22445.0,Alive,WITH TUMOR,388.0,nan,nan,Locoregional Recurrence,nan,nan,69.0,Complete Remission/Response,nan,nan,0.0,388.0,0.0,388.0,1.0,69.0,1.0,69.0,2
TCGA-CD-8525-01,TCGA-CD-8525,STAD,82.0,FEMALE,ASIAN,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2010.0,nan,-30004.0,Alive,TUMOR FREE,383.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,0
TCGA-CD-8526-01,TCGA-CD-8526,STAD,73.0,FEMALE,ASIAN,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010.0,nan,-26840.0,Alive,TUMOR FREE,381.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,381.0,0.0,381.0,0.0,381.0,0.0,381.0,0
TCGA-CD-8527-01,TCGA-CD-8527,STAD,72.0,FEMALE,ASIAN,Stage II,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010.0,nan,-26503.0,Dead,WITH TUMOR,nan,218.0,nan,Distant Metastasis,Liver,nan,159.0,Complete Remission/Response,nan,nan,1.0,218.0,1.0,218.0,1.0,159.0,1.0,159.0,1
TCGA-CD-8528-01,TCGA-CD-8528,STAD,43.0,FEMALE,ASIAN,Stage IIIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010.0,nan,-15986.0,Alive,TUMOR FREE,375.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,375.0,0.0,375.0,0.0,375.0,0.0,375.0,0
TCGA-CD-8529-01,TCGA-CD-8529,STAD,65.0,MALE,ASIAN,Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2011.0,nan,-23979.0,Alive,TUMOR FREE,374.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,374.0,0.0,374.0,nan,nan,0.0,374.0,0
TCGA-CD-8530-01,TCGA-CD-8530,STAD,51.0,MALE,ASIAN,Stage II,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-18992.0,Alive,TUMOR FREE,377.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,377.0,0.0,377.0,0.0,377.0,0.0,377.0,0
TCGA-CD-8531-01,TCGA-CD-8531,STAD,66.0,FEMALE,ASIAN,Stage IIIA,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-24453.0,Alive,TUMOR FREE,383.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,0
TCGA-CD-8532-01,TCGA-CD-8532,STAD,52.0,MALE,ASIAN,Stage II,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-19284.0,Dead,WITH TUMOR,nan,354.0,nan,Locoregional Recurrence,nan,nan,282.0,Complete Remission/Response,nan,nan,1.0,354.0,1.0,354.0,1.0,282.0,1.0,282.0,1
TCGA-CD-8533-01,TCGA-CD-8533,STAD,48.0,MALE,ASIAN,Stage II,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-17821.0,Alive,WITH TUMOR,468.0,nan,nan,Distant Metastasis,"Other, specify",liver and lung,226.0,Complete Remission/Response,nan,nan,0.0,468.0,0.0,468.0,1.0,226.0,1.0,226.0,2
TCGA-CD-8534-01,TCGA-CD-8534,STAD,41.0,MALE,ASIAN,Stage II,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-15227.0,Alive,WITH TUMOR,367.0,nan,nan,Distant Metastasis,"Other, specify","Pancreas, Transverse Colon",201.0,Progressive Disease,nan,nan,0.0,367.0,0.0,367.0,nan,nan,1.0,201.0,0
TCGA-CD-8535-01,TCGA-CD-8535,STAD,59.0,MALE,ASIAN,Stage IIIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-21559.0,Alive,TUMOR FREE,390.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,390.0,0.0,390.0,0.0,390.0,0.0,390.0,0
TCGA-CD-8536-01,TCGA-CD-8536,STAD,74.0,MALE,ASIAN,Stage II,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-27328.0,Alive,TUMOR FREE,378.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,378.0,0.0,378.0,0.0,378.0,0.0,378.0,0
TCGA-CD-A486-01,TCGA-CD-A486,STAD,68.0,MALE,ASIAN,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-24879.0,Dead,WITH TUMOR,nan,192.0,nan,Distant Metastasis,Liver,liver and lung,79.0,Complete Remission/Response,nan,nan,1.0,192.0,1.0,192.0,1.0,79.0,1.0,79.0,1
TCGA-CD-A487-01,TCGA-CD-A487,STAD,51.0,MALE,ASIAN,Stage IIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-18694.0,Alive,TUMOR FREE,374.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,374.0,0.0,374.0,0.0,374.0,0.0,374.0,0
TCGA-CD-A489-01,TCGA-CD-A489,STAD,58.0,MALE,ASIAN,Stage IIA,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-21517.0,Dead,WITH TUMOR,nan,344.0,nan,Locoregional Recurrence,nan,nan,277.0,Complete Remission/Response,nan,nan,1.0,344.0,1.0,344.0,1.0,277.0,1.0,277.0,1
TCGA-CD-A48A-01,TCGA-CD-A48A,STAD,57.0,MALE,ASIAN,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-20839.0,Alive,TUMOR FREE,378.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,378.0,0.0,378.0,0.0,378.0,0.0,378.0,0
TCGA-CD-A48C-01,TCGA-CD-A48C,STAD,79.0,FEMALE,ASIAN,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-29203.0,Dead,WITH TUMOR,nan,353.0,nan,Locoregional Recurrence,nan,nan,230.0,Complete Remission/Response,nan,nan,1.0,353.0,1.0,353.0,1.0,230.0,1.0,230.0,1
TCGA-CD-A4MG-01,TCGA-CD-A4MG,STAD,76.0,MALE,ASIAN,Stage IIA,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-28019.0,Dead,WITH TUMOR,nan,200.0,nan,Locoregional Recurrence,nan,nan,74.0,Complete Remission/Response,nan,nan,1.0,200.0,1.0,200.0,1.0,74.0,1.0,74.0,1
TCGA-CD-A4MH-01,TCGA-CD-A4MH,STAD,86.0,FEMALE,ASIAN,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-31683.0,Alive,TUMOR FREE,371.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,371.0,0.0,371.0,0.0,371.0,0.0,371.0,0
TCGA-CD-A4MI-01,TCGA-CD-A4MI,STAD,62.0,MALE,ASIAN,Stage IIIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G1,2011.0,nan,-22721.0,Dead,WITH TUMOR,nan,358.0,nan,Locoregional Recurrence,nan,nan,271.0,Complete Remission/Response,nan,nan,1.0,358.0,1.0,358.0,1.0,271.0,1.0,271.0,1
TCGA-CD-A4MJ-01,TCGA-CD-A4MJ,STAD,60.0,MALE,ASIAN,Stage IB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-21932.0,Alive,WITH TUMOR,384.0,nan,nan,Locoregional Recurrence,nan,nan,69.0,Complete Remission/Response,nan,nan,0.0,384.0,0.0,384.0,1.0,69.0,1.0,69.0,2
TCGA-CG-4300-01,TCGA-CG-4300,STAD,79.0,MALE,nan,Stage IIIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2006.0,nan,-29128.0,Dead,nan,nan,609.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,609.0,nan,609.0,nan,nan,0.0,609.0,1
TCGA-CG-4301-01,TCGA-CG-4301,STAD,75.0,FEMALE,nan,Stage IV,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2006.0,nan,-27516.0,Alive,WITH TUMOR,92.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,92.0,0.0,92.0,nan,nan,0.0,92.0,0
TCGA-CG-4304-01,TCGA-CG-4304,STAD,84.0,MALE,nan,Stage IB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,nan,-31017.0,Alive,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,nan,0.0,nan,nan,nan,0.0,nan,0
TCGA-CG-4305-01,TCGA-CG-4305,STAD,69.0,MALE,nan,Stage II,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,nan,-25295.0,Alive,TUMOR FREE,485.0,nan,nan,nan,nan,nan,457.0,[Unknown],nan,nan,0.0,485.0,0.0,485.0,nan,nan,1.0,457.0,0
TCGA-CG-4306-01,TCGA-CG-4306,STAD,90.0,MALE,nan,Stage IV,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2006.0,nan,-32871.0,Dead,nan,nan,31.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,31.0,nan,31.0,nan,nan,0.0,31.0,1
TCGA-CG-4436-01,TCGA-CG-4436,STAD,57.0,MALE,nan,Stage IB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2005.0,nan,-20941.0,Alive,TUMOR FREE,243.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,243.0,0.0,243.0,0.0,243.0,0.0,243.0,0
TCGA-CG-4437-01,TCGA-CG-4437,STAD,83.0,MALE,nan,Stage II,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2006.0,nan,-30467.0,Alive,TUMOR FREE,245.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,245.0,0.0,245.0,0.0,245.0,0.0,245.0,0
TCGA-CG-4438-01,TCGA-CG-4438,STAD,56.0,MALE,nan,Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2006.0,nan,-20574.0,Alive,nan,1645.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1645.0,0.0,1645.0,nan,nan,0.0,1645.0,0
TCGA-CG-4440-01,TCGA-CG-4440,STAD,68.0,FEMALE,nan,Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2006.0,nan,-25171.0,Dead,nan,nan,122.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,122.0,nan,122.0,nan,nan,0.0,122.0,1
TCGA-CG-4441-01,TCGA-CG-4441,STAD,83.0,MALE,nan,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2006.0,nan,-30528.0,Dead,nan,nan,426.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,426.0,nan,426.0,nan,nan,0.0,426.0,1
TCGA-CG-4442-01,TCGA-CG-4442,STAD,85.0,MALE,nan,Stage IB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2006.0,nan,-31350.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-CG-4443-01,TCGA-CG-4443,STAD,68.0,MALE,nan,Stage IA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2006.0,nan,-24990.0,Alive,nan,912.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,912.0,0.0,912.0,nan,nan,0.0,912.0,0
TCGA-CG-4444-01,TCGA-CG-4444,STAD,76.0,MALE,nan,Stage IIIA,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2006.0,nan,-27912.0,Alive,TUMOR FREE,1431.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1431.0,0.0,1431.0,0.0,1431.0,0.0,1431.0,0
TCGA-CG-4449-01,TCGA-CG-4449,STAD,81.0,MALE,nan,Stage II,nan,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2007.0,nan,-29705.0,Alive,WITH TUMOR,580.0,nan,nan,nan,nan,nan,336.0,Partial Remission/Response,nan,nan,0.0,580.0,0.0,580.0,nan,nan,1.0,336.0,2
TCGA-CG-4455-01,TCGA-CG-4455,STAD,72.0,MALE,nan,Stage II,nan,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2008.0,nan,-26421.0,Alive,TUMOR FREE,366.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,366.0,0.0,366.0,0.0,366.0,0.0,366.0,0
TCGA-CG-4460-01,TCGA-CG-4460,STAD,66.0,FEMALE,nan,Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,nan,-24229.0,Dead,WITH TUMOR,nan,669.0,nan,nan,nan,nan,487.0,Partial Remission/Response,nan,nan,1.0,669.0,1.0,669.0,nan,nan,1.0,487.0,1
TCGA-CG-4462-01,TCGA-CG-4462,STAD,72.0,FEMALE,nan,Stage IV,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2008.0,nan,-26511.0,Dead,WITH TUMOR,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,0.0,1.0,0.0,nan,nan,1.0,0.0,1
TCGA-CG-4465-01,TCGA-CG-4465,STAD,69.0,FEMALE,nan,Stage IV,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2008.0,nan,-25233.0,Dead,nan,nan,274.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,274.0,nan,274.0,nan,nan,0.0,274.0,1
TCGA-CG-4466-01,TCGA-CG-4466,STAD,81.0,FEMALE,nan,Stage IB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009.0,nan,-29739.0,Alive,TUMOR FREE,577.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,577.0,0.0,577.0,0.0,577.0,0.0,577.0,2
TCGA-CG-4469-01,TCGA-CG-4469,STAD,70.0,MALE,nan,Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2009.0,nan,-25598.0,Dead,nan,nan,215.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,215.0,nan,215.0,nan,nan,0.0,215.0,1
TCGA-CG-4472-01,TCGA-CG-4472,STAD,49.0,MALE,nan,Stage IV,nan,nan,G3,2009.0,nan,-18110.0,Alive,WITH TUMOR,365.0,nan,nan,nan,nan,nan,122.0,Partial Remission/Response,nan,nan,0.0,365.0,0.0,365.0,nan,nan,1.0,122.0,2
TCGA-CG-4474-01,TCGA-CG-4474,STAD,67.0,FEMALE,nan,Stage IV,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2010.0,nan,-24686.0,Alive,WITH TUMOR,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-CG-4475-01,TCGA-CG-4475,STAD,76.0,MALE,nan,Stage IIB,nan,nan,G3,2010.0,nan,-28065.0,Alive,TUMOR FREE,699.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,699.0,0.0,699.0,nan,nan,0.0,699.0,0
TCGA-CG-4476-01,TCGA-CG-4476,STAD,69.0,MALE,nan,Stage IIIC,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2010.0,nan,-25506.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-CG-4477-01,TCGA-CG-4477,STAD,58.0,FEMALE,nan,Stage IB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2008.0,nan,-21427.0,Alive,WITH TUMOR,942.0,nan,nan,nan,nan,nan,365.0,Progressive Disease,nan,nan,0.0,942.0,0.0,942.0,nan,nan,1.0,365.0,2
TCGA-CG-5716-01,TCGA-CG-5716,STAD,86.0,MALE,nan,Stage IV,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010.0,nan,-31411.0,Alive,WITH TUMOR,0.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-CG-5717-01,TCGA-CG-5717,STAD,58.0,MALE,nan,Stage II,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2006.0,nan,-21458.0,Dead,WITH TUMOR,nan,212.0,nan,nan,nan,nan,120.0,Progressive Disease,nan,nan,1.0,212.0,1.0,212.0,nan,nan,1.0,120.0,1
TCGA-CG-5718-01,TCGA-CG-5718,STAD,78.0,FEMALE,nan,Stage II,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,nan,-28763.0,Dead,TUMOR FREE,nan,1095.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,1095.0,0.0,1095.0,nan,nan,0.0,1095.0,1
TCGA-CG-5719-01,TCGA-CG-5719,STAD,54.0,FEMALE,nan,Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G1,2010.0,nan,-19966.0,Alive,TUMOR FREE,31.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,31.0,0.0,31.0,nan,nan,0.0,31.0,0
TCGA-CG-5720-01,TCGA-CG-5720,STAD,71.0,MALE,nan,Stage IB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2003.0,nan,-26176.0,Dead,TUMOR FREE,nan,30.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,30.0,0.0,30.0,nan,nan,0.0,30.0,0
TCGA-CG-5720-11,TCGA-CG-5720,STAD,71.0,MALE,nan,Stage IB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2003.0,nan,-26176.0,Dead,TUMOR FREE,nan,30.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,30.0,0.0,30.0,nan,nan,0.0,30.0,0
TCGA-CG-5721-01,TCGA-CG-5721,STAD,58.0,MALE,nan,Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2005.0,nan,-21244.0,Alive,TUMOR FREE,183.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,183.0,0.0,183.0,nan,nan,0.0,183.0,0
TCGA-CG-5721-11,TCGA-CG-5721,STAD,58.0,MALE,nan,Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2005.0,nan,-21244.0,Alive,TUMOR FREE,183.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,183.0,0.0,183.0,nan,nan,0.0,183.0,0
TCGA-CG-5722-01,TCGA-CG-5722,STAD,67.0,FEMALE,nan,Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2005.0,nan,-24472.0,Alive,WITH TUMOR,30.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,30.0,0.0,30.0,nan,nan,0.0,30.0,0
TCGA-CG-5722-11,TCGA-CG-5722,STAD,67.0,FEMALE,nan,Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2005.0,nan,-24472.0,Alive,WITH TUMOR,30.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,30.0,0.0,30.0,nan,nan,0.0,30.0,0
TCGA-CG-5723-01,TCGA-CG-5723,STAD,83.0,MALE,nan,Stage II,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2003.0,nan,-30376.0,Alive,nan,3196.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,3196.0,0.0,3196.0,nan,nan,0.0,3196.0,0
TCGA-CG-5724-01,TCGA-CG-5724,STAD,59.0,MALE,nan,Stage IV,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2003.0,nan,-21762.0,Dead,WITH TUMOR,nan,366.0,nan,nan,nan,nan,122.0,Progressive Disease,nan,nan,1.0,366.0,1.0,366.0,nan,nan,1.0,122.0,1
TCGA-CG-5725-01,TCGA-CG-5725,STAD,72.0,MALE,nan,Stage IB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2005.0,nan,-26329.0,Dead,WITH TUMOR,nan,457.0,nan,nan,nan,nan,153.0,Progressive Disease,nan,nan,1.0,457.0,1.0,457.0,nan,nan,1.0,153.0,1
TCGA-CG-5725-11,TCGA-CG-5725,STAD,72.0,MALE,nan,Stage IB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2005.0,nan,-26329.0,Dead,WITH TUMOR,nan,457.0,nan,nan,nan,nan,153.0,Progressive Disease,nan,nan,1.0,457.0,1.0,457.0,nan,nan,1.0,153.0,1
TCGA-CG-5726-01,TCGA-CG-5726,STAD,73.0,MALE,nan,Stage IA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2004.0,nan,-26998.0,Dead,TUMOR FREE,nan,881.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,881.0,0.0,881.0,nan,nan,0.0,881.0,0
TCGA-CG-5727-01,TCGA-CG-5727,STAD,66.0,MALE,nan,Stage II,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2005.0,nan,-24289.0,Alive,TUMOR FREE,2405.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2405.0,0.0,2405.0,0.0,2405.0,0.0,2405.0,0
TCGA-CG-5728-01,TCGA-CG-5728,STAD,88.0,FEMALE,nan,Stage IB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2003.0,nan,-32293.0,Alive,WITH TUMOR,1980.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1980.0,0.0,1980.0,nan,nan,0.0,1980.0,0
TCGA-CG-5728-11,TCGA-CG-5728,STAD,88.0,FEMALE,nan,Stage IB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2003.0,nan,-32293.0,Alive,WITH TUMOR,1980.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1980.0,0.0,1980.0,nan,nan,0.0,1980.0,0
TCGA-CG-5730-01,TCGA-CG-5730,STAD,80.0,FEMALE,nan,Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2005.0,nan,-29432.0,Alive,TUMOR FREE,122.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,122.0,0.0,122.0,nan,nan,0.0,122.0,0
TCGA-CG-5730-11,TCGA-CG-5730,STAD,80.0,FEMALE,nan,Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2005.0,nan,-29432.0,Alive,TUMOR FREE,122.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,122.0,0.0,122.0,nan,nan,0.0,122.0,0
TCGA-CG-5732-01,TCGA-CG-5732,STAD,66.0,MALE,nan,Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2003.0,nan,-24379.0,Dead,WITH TUMOR,nan,2100.0,nan,nan,nan,nan,1949.0,[Discrepancy],nan,nan,1.0,2100.0,1.0,2100.0,nan,nan,1.0,1949.0,1
TCGA-CG-5733-01,TCGA-CG-5733,STAD,83.0,FEMALE,nan,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2003.0,nan,-30650.0,Dead,WITH TUMOR,nan,641.0,nan,nan,nan,nan,427.0,Progressive Disease,nan,nan,1.0,641.0,1.0,641.0,nan,nan,1.0,427.0,1
TCGA-CG-5733-11,TCGA-CG-5733,STAD,83.0,FEMALE,nan,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2003.0,nan,-30650.0,Dead,WITH TUMOR,nan,641.0,nan,nan,nan,nan,427.0,Progressive Disease,nan,nan,1.0,641.0,1.0,641.0,nan,nan,1.0,427.0,1
TCGA-CG-5734-01,TCGA-CG-5734,STAD,68.0,MALE,nan,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2005.0,nan,-25079.0,Dead,nan,nan,243.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,243.0,nan,243.0,nan,nan,0.0,243.0,1
TCGA-CG-5734-11,TCGA-CG-5734,STAD,68.0,MALE,nan,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2005.0,nan,-25079.0,Dead,nan,nan,243.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,243.0,nan,243.0,nan,nan,0.0,243.0,1
TCGA-D7-5577-01,TCGA-D7-5577,STAD,53.0,FEMALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010.0,nan,-19668.0,Dead,WITH TUMOR,nan,782.0,nan,Distant Metastasis,"Other, specify","liver,  peritoneal surfaces, non-regional/distant lymph nodes",376.0,Progressive Disease,nan,nan,1.0,782.0,1.0,782.0,nan,nan,1.0,376.0,1
TCGA-D7-5578-01,TCGA-D7-5578,STAD,80.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2010.0,nan,-29390.0,Alive,TUMOR FREE,385.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,385.0,0.0,385.0,nan,nan,0.0,385.0,0
TCGA-D7-5579-01,TCGA-D7-5579,STAD,74.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2010.0,nan,-27175.0,Alive,TUMOR FREE,636.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,636.0,0.0,636.0,0.0,636.0,0.0,636.0,0
TCGA-D7-6518-01,TCGA-D7-6518,STAD,75.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2010.0,nan,-27594.0,Alive,TUMOR FREE,582.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,582.0,0.0,582.0,0.0,582.0,0.0,582.0,0
TCGA-D7-6519-01,TCGA-D7-6519,STAD,64.0,FEMALE,WHITE,[Discrepancy],nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2010.0,nan,-23413.0,Alive,WITH TUMOR,625.0,nan,nan,Distant Metastasis,Liver,cervix,429.0,Progressive Disease,nan,nan,0.0,625.0,0.0,625.0,nan,nan,1.0,429.0,2
TCGA-D7-6520-01,TCGA-D7-6520,STAD,53.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2010.0,nan,-19467.0,Alive,WITH TUMOR,573.0,nan,nan,Distant Metastasis,Liver,nan,46.0,Progressive Disease,nan,nan,0.0,573.0,0.0,573.0,nan,nan,1.0,46.0,2
TCGA-D7-6521-01,TCGA-D7-6521,STAD,65.0,MALE,WHITE,[Discrepancy],nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2010.0,nan,-23776.0,Alive,WITH TUMOR,564.0,nan,nan,Locoregional Recurrence,"Other, specify",nan,192.0,Progressive Disease,nan,nan,0.0,564.0,0.0,564.0,nan,nan,1.0,192.0,2
TCGA-D7-6522-01,TCGA-D7-6522,STAD,58.0,MALE,WHITE,Stage IB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2010.0,nan,-21465.0,Alive,TUMOR FREE,566.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,566.0,0.0,566.0,0.0,566.0,0.0,566.0,0
TCGA-D7-6524-01,TCGA-D7-6524,STAD,53.0,MALE,WHITE,Stage II,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2010.0,nan,-19532.0,Alive,WITH TUMOR,543.0,nan,nan,Locoregional Recurrence,Non-regional / Distant Lymph Nodes,nan,543.0,Progressive Disease,nan,nan,0.0,543.0,0.0,543.0,nan,nan,1.0,543.0,2
TCGA-D7-6525-01,TCGA-D7-6525,STAD,58.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2010.0,nan,-21223.0,Dead,WITH TUMOR,nan,406.0,nan,Distant Metastasis,nan,nan,171.0,Progressive Disease,nan,nan,1.0,406.0,1.0,406.0,nan,nan,1.0,171.0,1
TCGA-D7-6526-01,TCGA-D7-6526,STAD,67.0,FEMALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010.0,nan,-24477.0,Alive,TUMOR FREE,523.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,523.0,0.0,523.0,0.0,523.0,0.0,523.0,0
TCGA-D7-6527-01,TCGA-D7-6527,STAD,62.0,MALE,WHITE,Stage II,nan,"Stomach, Intestinal Adenocarcinoma, Papillary Type",G2,2010.0,nan,-22793.0,Dead,WITH TUMOR,nan,312.0,nan,Distant Metastasis,Liver,nan,75.0,Progressive Disease,nan,nan,1.0,312.0,1.0,312.0,nan,nan,1.0,75.0,1
TCGA-D7-6528-01,TCGA-D7-6528,STAD,70.0,FEMALE,WHITE,Stage IB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010.0,nan,-25815.0,Alive,TUMOR FREE,463.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,463.0,0.0,463.0,0.0,463.0,0.0,463.0,0
TCGA-D7-6815-01,TCGA-D7-6815,STAD,70.0,FEMALE,WHITE,Stage IIB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010.0,nan,-25811.0,Alive,TUMOR FREE,486.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,486.0,0.0,486.0,0.0,486.0,0.0,486.0,0
TCGA-D7-6817-01,TCGA-D7-6817,STAD,63.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2011.0,nan,-23142.0,Alive,TUMOR FREE,389.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,389.0,0.0,389.0,nan,nan,0.0,389.0,0
TCGA-D7-6818-01,TCGA-D7-6818,STAD,53.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-19391.0,Dead,WITH TUMOR,nan,376.0,nan,Locoregional Recurrence,nan,nan,247.0,Progressive Disease,nan,nan,1.0,376.0,1.0,376.0,nan,nan,1.0,247.0,1
TCGA-D7-6820-01,TCGA-D7-6820,STAD,64.0,MALE,WHITE,Stage IIB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,nan,-23486.0,Alive,TUMOR FREE,344.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,344.0,0.0,344.0,0.0,344.0,0.0,344.0,0
TCGA-D7-6822-01,TCGA-D7-6822,STAD,77.0,MALE,WHITE,Stage IB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,nan,-28214.0,Alive,TUMOR FREE,375.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,375.0,0.0,375.0,0.0,375.0,0.0,375.0,0
TCGA-D7-8570-01,TCGA-D7-8570,STAD,44.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2011.0,nan,-16150.0,Alive,WITH TUMOR,752.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,752.0,0.0,752.0,0.0,752.0,0.0,752.0,0
TCGA-D7-8572-01,TCGA-D7-8572,STAD,57.0,MALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,nan,-20870.0,Alive,WITH TUMOR,511.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,511.0,0.0,511.0,0.0,511.0,0.0,511.0,0
TCGA-D7-8573-01,TCGA-D7-8573,STAD,57.0,MALE,WHITE,Stage IIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,nan,-20963.0,Alive,WITH TUMOR,593.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,593.0,0.0,593.0,0.0,593.0,0.0,593.0,0
TCGA-D7-8574-01,TCGA-D7-8574,STAD,72.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-26586.0,Alive,TUMOR FREE,523.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,523.0,0.0,523.0,0.0,523.0,0.0,523.0,0
TCGA-D7-8575-01,TCGA-D7-8575,STAD,75.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,nan,-27712.0,Dead,WITH TUMOR,nan,554.0,nan,Distant Metastasis,Peritoneal Surfaces,nan,427.0,Complete Remission/Response,nan,nan,1.0,554.0,1.0,554.0,1.0,427.0,1.0,427.0,1
TCGA-D7-8576-01,TCGA-D7-8576,STAD,54.0,FEMALE,WHITE,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,nan,-20014.0,Dead,WITH TUMOR,nan,446.0,nan,Locoregional Recurrence|Distant Metastasis,Lung,nan,204.0,Complete Remission/Response,nan,nan,1.0,446.0,1.0,446.0,1.0,204.0,1.0,204.0,1
TCGA-D7-8578-01,TCGA-D7-8578,STAD,72.0,MALE,WHITE,Stage IB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,nan,-26620.0,Alive,WITH TUMOR,643.0,nan,nan,Locoregional Recurrence|Distant Metastasis,Lung,nan,451.0,Complete Remission/Response,nan,nan,0.0,643.0,0.0,643.0,1.0,451.0,1.0,451.0,2
TCGA-D7-8579-01,TCGA-D7-8579,STAD,66.0,FEMALE,WHITE,Stage IIB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,nan,-24120.0,Alive,TUMOR FREE,636.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,636.0,0.0,636.0,0.0,636.0,0.0,636.0,0
TCGA-D7-A4YT-01,TCGA-D7-A4YT,STAD,56.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012.0,nan,-20742.0,Alive,TUMOR FREE,434.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,434.0,0.0,434.0,0.0,434.0,0.0,434.0,0
TCGA-D7-A4YU-01,TCGA-D7-A4YU,STAD,73.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,nan,-26781.0,Alive,WITH TUMOR,500.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,500.0,0.0,500.0,nan,nan,0.0,500.0,0
TCGA-D7-A4YV-01,TCGA-D7-A4YV,STAD,69.0,FEMALE,WHITE,Stage IIB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,nan,-25421.0,Dead,TUMOR FREE,nan,180.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,180.0,0.0,180.0,0.0,180.0,0.0,180.0,0
TCGA-D7-A4YX-01,TCGA-D7-A4YX,STAD,63.0,MALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-23249.0,Alive,TUMOR FREE,1108.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1108.0,0.0,1108.0,0.0,1108.0,0.0,1108.0,0
TCGA-D7-A4YY-01,TCGA-D7-A4YY,STAD,61.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-22287.0,Alive,TUMOR FREE,419.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,419.0,0.0,419.0,nan,nan,0.0,419.0,0
TCGA-D7-A4Z0-01,TCGA-D7-A4Z0,STAD,60.0,FEMALE,WHITE,Stage IIB,nan,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2012.0,nan,-22129.0,Alive,TUMOR FREE,449.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,449.0,0.0,449.0,0.0,449.0,0.0,449.0,0
TCGA-D7-A6ET-01,TCGA-D7-A6ET,STAD,76.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012.0,nan,-27928.0,Alive,WITH TUMOR,804.0,nan,nan,Locoregional Recurrence,nan,nan,777.0,Complete Remission/Response,nan,nan,0.0,804.0,0.0,804.0,1.0,777.0,1.0,777.0,2
TCGA-D7-A6EV-01,TCGA-D7-A6EV,STAD,71.0,FEMALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2013.0,nan,-26226.0,Alive,TUMOR FREE,342.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,342.0,0.0,342.0,0.0,342.0,0.0,342.0,0
TCGA-D7-A6EX-01,TCGA-D7-A6EX,STAD,72.0,FEMALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2013.0,nan,-26525.0,Alive,TUMOR FREE,344.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,344.0,0.0,344.0,0.0,344.0,0.0,344.0,0
TCGA-D7-A6EY-01,TCGA-D7-A6EY,STAD,72.0,FEMALE,WHITE,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2013.0,nan,-26526.0,Dead,WITH TUMOR,nan,348.0,Stomach Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,348.0,1.0,348.0,nan,nan,1.0,348.0,1
TCGA-D7-A6EZ-01,TCGA-D7-A6EZ,STAD,66.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2013.0,nan,-24425.0,Dead,WITH TUMOR,nan,618.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,618.0,1.0,618.0,nan,nan,1.0,618.0,1
TCGA-D7-A6F0-01,TCGA-D7-A6F0,STAD,79.0,FEMALE,WHITE,Stage IB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2013.0,nan,-28923.0,Alive,TUMOR FREE,678.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,678.0,0.0,678.0,0.0,678.0,0.0,678.0,0
TCGA-D7-A6F2-01,TCGA-D7-A6F2,STAD,62.0,MALE,WHITE,Stage IB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,nan,-22801.0,Alive,TUMOR FREE,476.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,476.0,0.0,476.0,0.0,476.0,0.0,476.0,0
TCGA-D7-A747-01,TCGA-D7-A747,STAD,57.0,MALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2013.0,nan,-20923.0,Dead,WITH TUMOR,nan,255.0,Stomach Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,255.0,1.0,255.0,nan,nan,1.0,255.0,1
TCGA-D7-A748-01,TCGA-D7-A748,STAD,41.0,FEMALE,WHITE,Stage IV,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2013.0,nan,-15190.0,Dead,WITH TUMOR,nan,132.0,Stomach Cancer,Locoregional Recurrence|Distant Metastasis,nan,nan,99.0,Progressive Disease,nan,nan,1.0,132.0,1.0,132.0,nan,nan,1.0,99.0,1
TCGA-D7-A74A-01,TCGA-D7-A74A,STAD,61.0,FEMALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2013.0,nan,-22435.0,Alive,TUMOR FREE,607.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,607.0,0.0,607.0,0.0,607.0,0.0,607.0,0
TCGA-D7-A74B-01,TCGA-D7-A74B,STAD,52.0,FEMALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2013.0,nan,-19066.0,Dead,WITH TUMOR,nan,217.0,Stomach Cancer,Locoregional Recurrence,nan,nan,174.0,Progressive Disease,nan,nan,1.0,217.0,1.0,217.0,nan,nan,1.0,174.0,1
TCGA-EQ-5647-01,TCGA-EQ-5647,STAD,86.0,FEMALE,WHITE,Stage IV,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010.0,nan,-31431.0,Dead,WITH TUMOR,nan,19.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,19.0,1.0,19.0,nan,nan,1.0,19.0,1
TCGA-EQ-8122-01,TCGA-EQ-8122,STAD,71.0,FEMALE,WHITE,Stage IIB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-26289.0,Dead,nan,nan,243.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,243.0,nan,243.0,nan,nan,0.0,243.0,1
TCGA-EQ-A4SO-01,TCGA-EQ-A4SO,STAD,70.0,MALE,WHITE,Stage IIIB,nan,[Discrepancy],G2,2012.0,nan,-25897.0,Alive,TUMOR FREE,494.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,494.0,0.0,494.0,0.0,494.0,0.0,494.0,0
TCGA-F1-6177-01,TCGA-F1-6177,STAD,90.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009.0,nan,-32873.0,Alive,TUMOR FREE,200.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,200.0,0.0,200.0,0.0,200.0,0.0,200.0,0
TCGA-F1-6874-01,TCGA-F1-6874,STAD,79.0,MALE,WHITE,Stage IB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-29083.0,Alive,TUMOR FREE,440.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,440.0,0.0,440.0,0.0,440.0,0.0,440.0,0
TCGA-F1-6875-01,TCGA-F1-6875,STAD,79.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,1996.0,nan,-29209.0,Dead,TUMOR FREE,nan,2197.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,2197.0,0.0,2197.0,0.0,2197.0,0.0,2197.0,0
TCGA-F1-A448-01,TCGA-F1-A448,STAD,70.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,2012.0,nan,-25846.0,Alive,TUMOR FREE,647.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,647.0,0.0,647.0,0.0,647.0,0.0,647.0,0
TCGA-F1-A72C-01,TCGA-F1-A72C,STAD,68.0,MALE,ASIAN,Stage IIA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2013.0,nan,-25104.0,Alive,WITH TUMOR,346.0,nan,nan,Distant Metastasis,Liver,nan,343.0,Complete Remission/Response,nan,nan,0.0,346.0,0.0,346.0,1.0,343.0,1.0,343.0,2
TCGA-FP-7735-01,TCGA-FP-7735,STAD,77.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-28232.0,Dead,TUMOR FREE,nan,106.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,106.0,0.0,106.0,0.0,106.0,0.0,106.0,0
TCGA-FP-7735-11,TCGA-FP-7735,STAD,77.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-28232.0,Dead,TUMOR FREE,nan,106.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,106.0,0.0,106.0,0.0,106.0,0.0,106.0,0
TCGA-FP-7829-01,TCGA-FP-7829,STAD,69.0,MALE,WHITE,Stage IIB,nan,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2011.0,nan,-25534.0,Alive,TUMOR FREE,594.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,594.0,0.0,594.0,0.0,594.0,0.0,594.0,0
TCGA-FP-7829-11,TCGA-FP-7829,STAD,69.0,MALE,WHITE,Stage IIB,nan,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2011.0,nan,-25534.0,Alive,TUMOR FREE,594.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,594.0,0.0,594.0,0.0,594.0,0.0,594.0,0
TCGA-FP-7916-01,TCGA-FP-7916,STAD,77.0,MALE,ASIAN,Stage IIIC,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-28475.0,Dead,WITH TUMOR,nan,428.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,428.0,1.0,428.0,nan,nan,1.0,428.0,1
TCGA-FP-7998-01,TCGA-FP-7998,STAD,77.0,MALE,WHITE,Stage IIIC,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-28302.0,Alive,TUMOR FREE,678.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,678.0,0.0,678.0,0.0,678.0,0.0,678.0,0
TCGA-FP-8099-01,TCGA-FP-8099,STAD,79.0,MALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-29129.0,Alive,TUMOR FREE,519.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,519.0,0.0,519.0,0.0,519.0,0.0,519.0,0
TCGA-FP-8209-01,TCGA-FP-8209,STAD,49.0,MALE,WHITE,Stage IB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2005.0,nan,-18171.0,Dead,WITH TUMOR,nan,1811.0,Stomach Cancer,Distant Metastasis,"Other, specify",pancreas,1676.0,Complete Remission/Response,nan,nan,1.0,1811.0,1.0,1811.0,1.0,1676.0,1.0,1676.0,1
TCGA-FP-8210-01,TCGA-FP-8210,STAD,48.0,MALE,ASIAN,Stage IIIA,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2006.0,nan,-17562.0,Dead,WITH TUMOR,nan,153.0,Stomach Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,153.0,1.0,153.0,nan,nan,1.0,153.0,1
TCGA-FP-8211-01,TCGA-FP-8211,STAD,62.0,MALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-22957.0,Alive,TUMOR FREE,413.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,413.0,0.0,413.0,0.0,413.0,0.0,413.0,0
TCGA-FP-8631-01,TCGA-FP-8631,STAD,68.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,nan,-24898.0,Alive,TUMOR FREE,17.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,17.0,0.0,17.0,nan,nan,0.0,17.0,0
TCGA-FP-A4BE-01,TCGA-FP-A4BE,STAD,55.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-20148.0,Alive,TUMOR FREE,337.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,337.0,0.0,337.0,0.0,337.0,0.0,337.0,0
TCGA-FP-A4BF-01,TCGA-FP-A4BF,STAD,68.0,MALE,WHITE,Stage IIIA,nan,"Stomach Adenocarcinoma, Signet Ring Type",G3,2011.0,nan,-25030.0,Dead,WITH TUMOR,nan,168.0,nan,Distant Metastasis,Lung,nan,159.0,Progressive Disease,nan,nan,1.0,168.0,1.0,168.0,nan,nan,1.0,159.0,1
TCGA-FP-A8CX-01,TCGA-FP-A8CX,STAD,60.0,MALE,WHITE,Stage IIIC,nan,"Stomach Adenocarcinoma, Signet Ring Type",G3,2013.0,nan,-22000.0,Alive,TUMOR FREE,7.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,7.0,0.0,7.0,nan,nan,0.0,7.0,0
TCGA-FP-A9TM-01,TCGA-FP-A9TM,STAD,77.0,MALE,WHITE,[Discrepancy],nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2013.0,nan,-28376.0,Alive,TUMOR FREE,189.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,189.0,0.0,189.0,0.0,189.0,0.0,189.0,0
TCGA-HF-7131-01,TCGA-HF-7131,STAD,nan,FEMALE,nan,Stage IB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2007.0,nan,nan,Alive,TUMOR FREE,nan,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,nan,0.0,nan,0.0,nan,0.0,nan,0
TCGA-HF-7132-01,TCGA-HF-7132,STAD,nan,MALE,nan,Stage II,nan,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2006.0,nan,nan,Alive,TUMOR FREE,2351.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2351.0,0.0,2351.0,0.0,2351.0,0.0,2351.0,0
TCGA-HF-7133-01,TCGA-HF-7133,STAD,nan,FEMALE,nan,Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2007.0,nan,nan,Alive,TUMOR FREE,1918.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1918.0,0.0,1918.0,nan,nan,0.0,1918.0,0
TCGA-HF-7134-01,TCGA-HF-7134,STAD,nan,MALE,nan,Stage IA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,nan,nan,Alive,TUMOR FREE,1588.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1588.0,0.0,1588.0,0.0,1588.0,0.0,1588.0,0
TCGA-HF-7136-01,TCGA-HF-7136,STAD,nan,MALE,nan,Stage IIIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2008.0,nan,nan,Alive,WITH TUMOR,nan,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,nan,0.0,nan,nan,nan,0.0,nan,1
TCGA-HF-A5NB-01,TCGA-HF-A5NB,STAD,75.0,FEMALE,[Not Evaluated],Stage IIIC,nan,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G3,nan,nan,-27676.0,Alive,TUMOR FREE,928.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,928.0,0.0,928.0,0.0,928.0,0.0,928.0,0
TCGA-HJ-7597-01,TCGA-HJ-7597,STAD,71.0,FEMALE,WHITE,Stage IB,nan,"Stomach Adenocarcinoma, Signet Ring Type",G3,2005.0,nan,-26264.0,Dead,WITH TUMOR,nan,805.0,Stomach Cancer,Locoregional Recurrence,nan,nan,231.0,Complete Remission/Response,nan,nan,1.0,805.0,1.0,805.0,1.0,231.0,1.0,231.0,1
TCGA-HU-8238-01,TCGA-HU-8238,STAD,56.0,MALE,ASIAN,[Discrepancy],nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,nan,-20708.0,Alive,TUMOR FREE,46.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,46.0,0.0,46.0,0.0,46.0,0.0,46.0,0
TCGA-HU-8238-11,TCGA-HU-8238,STAD,56.0,MALE,ASIAN,[Discrepancy],nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,nan,-20708.0,Alive,TUMOR FREE,46.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,46.0,0.0,46.0,0.0,46.0,0.0,46.0,0
TCGA-HU-8243-01,TCGA-HU-8243,STAD,66.0,MALE,ASIAN,Stage IIIC,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,nan,-24187.0,Dead,WITH TUMOR,nan,180.0,Stomach Cancer,Distant Metastasis,Liver,nan,132.0,Partial Remission/Response,nan,nan,1.0,180.0,1.0,180.0,nan,nan,1.0,132.0,1
TCGA-HU-8244-01,TCGA-HU-8244,STAD,77.0,FEMALE,ASIAN,Stage IA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G1,2011.0,nan,-28184.0,Alive,TUMOR FREE,742.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,742.0,0.0,742.0,0.0,742.0,0.0,742.0,0
TCGA-HU-8245-01,TCGA-HU-8245,STAD,72.0,MALE,ASIAN,Stage IIA,nan,"Stomach, Intestinal Adenocarcinoma, Papillary Type",G3,2011.0,nan,-26521.0,Alive,TUMOR FREE,552.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,552.0,0.0,552.0,0.0,552.0,0.0,552.0,0
TCGA-HU-8249-01,TCGA-HU-8249,STAD,76.0,MALE,ASIAN,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,nan,-28012.0,Alive,TUMOR FREE,881.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,881.0,0.0,881.0,0.0,881.0,0.0,881.0,0
TCGA-HU-8602-01,TCGA-HU-8602,STAD,58.0,FEMALE,ASIAN,Stage IIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-21522.0,Alive,TUMOR FREE,679.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,679.0,0.0,679.0,0.0,679.0,0.0,679.0,0
TCGA-HU-8604-01,TCGA-HU-8604,STAD,82.0,FEMALE,ASIAN,Stage IIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,nan,-30178.0,Alive,TUMOR FREE,694.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,694.0,0.0,694.0,0.0,694.0,0.0,694.0,0
TCGA-HU-8608-01,TCGA-HU-8608,STAD,70.0,MALE,ASIAN,Stage IIIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,nan,-25789.0,Alive,WITH TUMOR,641.0,nan,nan,Distant Metastasis,Lung,nan,277.0,Complete Remission/Response,nan,nan,0.0,641.0,0.0,641.0,1.0,277.0,1.0,277.0,2
TCGA-HU-8610-01,TCGA-HU-8610,STAD,75.0,MALE,ASIAN,Stage IA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012.0,nan,-27594.0,Alive,TUMOR FREE,23.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,23.0,0.0,23.0,nan,nan,0.0,23.0,0
TCGA-HU-A4G2-01,TCGA-HU-A4G2,STAD,45.0,MALE,ASIAN,Stage IIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-16791.0,Alive,TUMOR FREE,739.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,739.0,0.0,739.0,0.0,739.0,0.0,739.0,0
TCGA-HU-A4G3-01,TCGA-HU-A4G3,STAD,54.0,MALE,ASIAN,Stage IIB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,nan,-20064.0,Alive,TUMOR FREE,170.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,170.0,0.0,170.0,nan,nan,0.0,170.0,0
TCGA-HU-A4G3-11,TCGA-HU-A4G3,STAD,54.0,MALE,ASIAN,Stage IIB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,nan,-20064.0,Alive,TUMOR FREE,170.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,170.0,0.0,170.0,nan,nan,0.0,170.0,0
TCGA-HU-A4G6-01,TCGA-HU-A4G6,STAD,74.0,MALE,ASIAN,Stage IA,nan,"Stomach, Intestinal Adenocarcinoma, Papillary Type",G3,2011.0,nan,-27208.0,Alive,TUMOR FREE,738.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,738.0,0.0,738.0,0.0,738.0,0.0,738.0,0
TCGA-HU-A4G8-01,TCGA-HU-A4G8,STAD,71.0,FEMALE,ASIAN,Stage IIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-26254.0,Alive,TUMOR FREE,690.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,690.0,0.0,690.0,0.0,690.0,0.0,690.0,0
TCGA-HU-A4G9-01,TCGA-HU-A4G9,STAD,67.0,FEMALE,ASIAN,Stage IA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,nan,-24753.0,Alive,TUMOR FREE,736.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,736.0,0.0,736.0,nan,nan,0.0,736.0,0
TCGA-HU-A4G9-11,TCGA-HU-A4G9,STAD,67.0,FEMALE,ASIAN,Stage IA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,nan,-24753.0,Alive,TUMOR FREE,736.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,736.0,0.0,736.0,nan,nan,0.0,736.0,0
TCGA-HU-A4GC-01,TCGA-HU-A4GC,STAD,74.0,MALE,ASIAN,Stage IIIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-27267.0,Alive,TUMOR FREE,99.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,99.0,0.0,99.0,nan,nan,0.0,99.0,0
TCGA-HU-A4GC-11,TCGA-HU-A4GC,STAD,74.0,MALE,ASIAN,Stage IIIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-27267.0,Alive,TUMOR FREE,99.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,99.0,0.0,99.0,nan,nan,0.0,99.0,0
TCGA-HU-A4GD-01,TCGA-HU-A4GD,STAD,56.0,MALE,ASIAN,Stage IIB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2011.0,nan,-20700.0,Alive,WITH TUMOR,692.0,nan,nan,Distant Metastasis,Liver,nan,399.0,Progressive Disease,nan,nan,0.0,692.0,0.0,692.0,nan,nan,1.0,399.0,0
TCGA-HU-A4GF-01,TCGA-HU-A4GF,STAD,69.0,MALE,ASIAN,Stage IIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,nan,-25223.0,Alive,TUMOR FREE,785.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,785.0,0.0,785.0,0.0,785.0,0.0,785.0,0
TCGA-HU-A4GH-01,TCGA-HU-A4GH,STAD,75.0,MALE,ASIAN,Stage IA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,nan,-27473.0,Alive,TUMOR FREE,358.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,358.0,0.0,358.0,0.0,358.0,0.0,358.0,0
TCGA-HU-A4GH-11,TCGA-HU-A4GH,STAD,75.0,MALE,ASIAN,Stage IA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,nan,-27473.0,Alive,TUMOR FREE,358.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,358.0,0.0,358.0,0.0,358.0,0.0,358.0,0
TCGA-HU-A4GJ-01,TCGA-HU-A4GJ,STAD,60.0,FEMALE,ASIAN,Stage IIIC,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-22079.0,Alive,WITH TUMOR,650.0,nan,nan,Distant Metastasis,"Other, specify",ovary,547.0,Progressive Disease,nan,nan,0.0,650.0,0.0,650.0,nan,nan,1.0,547.0,2
TCGA-HU-A4GN-01,TCGA-HU-A4GN,STAD,61.0,MALE,ASIAN,Stage IIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,nan,-22288.0,Alive,TUMOR FREE,912.0,nan,nan,nan,"Other, specify",thyroid,168.0,Complete Remission/Response,nan,nan,0.0,912.0,0.0,912.0,1.0,168.0,1.0,168.0,2
TCGA-HU-A4GN-11,TCGA-HU-A4GN,STAD,61.0,MALE,ASIAN,Stage IIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,nan,-22288.0,Alive,TUMOR FREE,912.0,nan,nan,nan,"Other, specify",thyroid,168.0,Complete Remission/Response,nan,nan,0.0,912.0,0.0,912.0,1.0,168.0,1.0,168.0,2
TCGA-HU-A4GP-01,TCGA-HU-A4GP,STAD,62.0,FEMALE,ASIAN,Stage IIA,nan,"Stomach, Adenocarcinoma, Diffuse Type",G2,2011.0,nan,-22711.0,Alive,TUMOR FREE,273.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,273.0,0.0,273.0,0.0,273.0,0.0,273.0,0
TCGA-HU-A4GP-11,TCGA-HU-A4GP,STAD,62.0,FEMALE,ASIAN,Stage IIA,nan,"Stomach, Adenocarcinoma, Diffuse Type",G2,2011.0,nan,-22711.0,Alive,TUMOR FREE,273.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,273.0,0.0,273.0,0.0,273.0,0.0,273.0,0
TCGA-HU-A4GQ-01,TCGA-HU-A4GQ,STAD,71.0,MALE,ASIAN,Stage IIIC,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,nan,-26200.0,Dead,[Discrepancy],nan,3.0,Stomach Cancer,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,3.0,1.0,3.0,0.0,3.0,0.0,3.0,0
TCGA-HU-A4GT-01,TCGA-HU-A4GT,STAD,71.0,FEMALE,ASIAN,Stage IIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2011.0,nan,-26231.0,Alive,TUMOR FREE,198.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,198.0,0.0,198.0,0.0,198.0,0.0,198.0,0
TCGA-HU-A4GU-01,TCGA-HU-A4GU,STAD,73.0,MALE,ASIAN,Stage IIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-27024.0,Alive,TUMOR FREE,200.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,200.0,0.0,200.0,0.0,200.0,0.0,200.0,0
TCGA-HU-A4GX-01,TCGA-HU-A4GX,STAD,70.0,FEMALE,ASIAN,Stage IIIC,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,nan,-25913.0,Alive,TUMOR FREE,616.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,616.0,0.0,616.0,0.0,616.0,0.0,616.0,0
TCGA-HU-A4GX-11,TCGA-HU-A4GX,STAD,70.0,FEMALE,ASIAN,Stage IIIC,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,nan,-25913.0,Alive,TUMOR FREE,616.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,616.0,0.0,616.0,0.0,616.0,0.0,616.0,0
TCGA-HU-A4GY-01,TCGA-HU-A4GY,STAD,76.0,FEMALE,ASIAN,Stage IIIA,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,nan,-28113.0,Alive,TUMOR FREE,8.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,8.0,0.0,8.0,nan,nan,0.0,8.0,0
TCGA-HU-A4GY-11,TCGA-HU-A4GY,STAD,76.0,FEMALE,ASIAN,Stage IIIA,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,nan,-28113.0,Alive,TUMOR FREE,8.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,8.0,0.0,8.0,nan,nan,0.0,8.0,0
TCGA-HU-A4H0-01,TCGA-HU-A4H0,STAD,72.0,MALE,ASIAN,Stage IIIC,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-26317.0,Alive,TUMOR FREE,64.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,64.0,0.0,64.0,0.0,64.0,0.0,64.0,0
TCGA-HU-A4H2-01,TCGA-HU-A4H2,STAD,58.0,FEMALE,ASIAN,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,nan,-21496.0,Alive,TUMOR FREE,394.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,394.0,0.0,394.0,0.0,394.0,0.0,394.0,0
TCGA-HU-A4H3-01,TCGA-HU-A4H3,STAD,56.0,FEMALE,ASIAN,Stage IIIC,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-20790.0,Alive,WITH TUMOR,882.0,nan,nan,Distant Metastasis,"Other, specify",nan,410.0,Progressive Disease,nan,nan,0.0,882.0,0.0,882.0,nan,nan,1.0,410.0,2
TCGA-HU-A4H4-01,TCGA-HU-A4H4,STAD,53.0,FEMALE,ASIAN,Stage IIB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2011.0,nan,-19665.0,Alive,TUMOR FREE,725.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,725.0,0.0,725.0,0.0,725.0,0.0,725.0,0
TCGA-HU-A4H5-01,TCGA-HU-A4H5,STAD,71.0,MALE,ASIAN,Stage IB,nan,"Stomach, Intestinal Adenocarcinoma, Papillary Type",GX,2011.0,nan,-26232.0,Alive,TUMOR FREE,724.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,724.0,0.0,724.0,0.0,724.0,0.0,724.0,0
TCGA-HU-A4H6-01,TCGA-HU-A4H6,STAD,72.0,FEMALE,ASIAN,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,nan,-26445.0,Alive,WITH TUMOR,644.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,644.0,0.0,644.0,0.0,644.0,0.0,644.0,2
TCGA-HU-A4H8-01,TCGA-HU-A4H8,STAD,77.0,MALE,ASIAN,Stage IB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012.0,nan,-28292.0,[Discrepancy],WITH TUMOR,428.0,nan,nan,Distant Metastasis,nan,nan,354.0,Complete Remission/Response,nan,nan,0.0,428.0,nan,428.0,1.0,354.0,1.0,354.0,2
TCGA-HU-A4HB-01,TCGA-HU-A4HB,STAD,68.0,MALE,ASIAN,Stage IIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,nan,-25131.0,Dead,WITH TUMOR,nan,477.0,nan,Distant Metastasis,nan,nan,390.0,Complete Remission/Response,nan,nan,1.0,477.0,1.0,477.0,1.0,390.0,1.0,390.0,1
TCGA-HU-A4HB-11,TCGA-HU-A4HB,STAD,68.0,MALE,ASIAN,Stage IIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2012.0,nan,-25131.0,Dead,WITH TUMOR,nan,477.0,nan,Distant Metastasis,nan,nan,390.0,Complete Remission/Response,nan,nan,1.0,477.0,1.0,477.0,1.0,390.0,1.0,390.0,1
TCGA-HU-A4HD-01,TCGA-HU-A4HD,STAD,73.0,MALE,ASIAN,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010.0,nan,-26699.0,Alive,TUMOR FREE,1016.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1016.0,0.0,1016.0,nan,nan,0.0,1016.0,0
TCGA-IN-7806-01,TCGA-IN-7806,STAD,50.0,MALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-18404.0,Alive,TUMOR FREE,1106.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1106.0,0.0,1106.0,0.0,1106.0,0.0,1106.0,0
TCGA-IN-7806-11,TCGA-IN-7806,STAD,50.0,MALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-18404.0,Alive,TUMOR FREE,1106.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1106.0,0.0,1106.0,0.0,1106.0,0.0,1106.0,0
TCGA-IN-7808-01,TCGA-IN-7808,STAD,59.0,MALE,WHITE,[Discrepancy],nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-21569.0,Dead,WITH TUMOR,nan,105.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,105.0,1.0,105.0,nan,nan,1.0,105.0,1
TCGA-IN-8462-01,TCGA-IN-8462,STAD,80.0,MALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-29242.0,Alive,WITH TUMOR,572.0,nan,nan,Distant Metastasis,nan,nan,270.0,Progressive Disease,nan,nan,0.0,572.0,0.0,572.0,nan,nan,1.0,270.0,2
TCGA-IN-8462-11,TCGA-IN-8462,STAD,80.0,MALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-29242.0,Alive,WITH TUMOR,572.0,nan,nan,Distant Metastasis,nan,nan,270.0,Progressive Disease,nan,nan,0.0,572.0,0.0,572.0,nan,nan,1.0,270.0,2
TCGA-IN-8663-01,TCGA-IN-8663,STAD,68.0,MALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-25172.0,Dead,TUMOR FREE,nan,103.0,"Other, non-malignant disease",nan,nan,nan,nan,nan,nan,nan,1.0,103.0,0.0,103.0,nan,nan,0.0,103.0,0
TCGA-IN-8663-11,TCGA-IN-8663,STAD,68.0,MALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-25172.0,Dead,TUMOR FREE,nan,103.0,"Other, non-malignant disease",nan,nan,nan,nan,nan,nan,nan,1.0,103.0,0.0,103.0,nan,nan,0.0,103.0,0
TCGA-IN-A6RI-01,TCGA-IN-A6RI,STAD,45.0,MALE,WHITE,Stage I,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,nan,-16788.0,Alive,TUMOR FREE,559.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,559.0,0.0,559.0,0.0,559.0,0.0,559.0,0
TCGA-IN-A6RJ-01,TCGA-IN-A6RJ,STAD,64.0,MALE,WHITE,Stage IA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-23439.0,Alive,TUMOR FREE,379.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,0
TCGA-IN-A6RL-01,TCGA-IN-A6RL,STAD,84.0,MALE,WHITE,[Discrepancy],nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,nan,-30783.0,Dead,WITH TUMOR,nan,406.0,nan,Distant Metastasis,nan,nan,307.0,Complete Remission/Response,nan,nan,1.0,406.0,1.0,406.0,1.0,307.0,1.0,307.0,1
TCGA-IN-A6RN-01,TCGA-IN-A6RN,STAD,72.0,FEMALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,nan,-26409.0,Alive,TUMOR FREE,594.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,594.0,0.0,594.0,0.0,594.0,0.0,594.0,0
TCGA-IN-A6RO-01,TCGA-IN-A6RO,STAD,70.0,MALE,ASIAN,Stage IA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,nan,-25789.0,Dead,WITH TUMOR,nan,nan,[Unknown],Distant Metastasis,nan,nan,154.0,[Discrepancy],nan,nan,1.0,nan,1.0,nan,nan,nan,1.0,154.0,1
TCGA-IN-A6RP-01,TCGA-IN-A6RP,STAD,63.0,MALE,WHITE,[Discrepancy],nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-23282.0,Alive,WITH TUMOR,196.0,nan,nan,Distant Metastasis,Liver,nan,150.0,Progressive Disease,nan,nan,0.0,196.0,0.0,196.0,nan,nan,1.0,150.0,0
TCGA-IN-A6RR-01,TCGA-IN-A6RR,STAD,84.0,MALE,WHITE,[Discrepancy],nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2013.0,nan,-30734.0,Dead,TUMOR FREE,nan,205.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,205.0,0.0,205.0,nan,nan,0.0,205.0,0
TCGA-IN-A6RS-01,TCGA-IN-A6RS,STAD,76.0,MALE,WHITE,Stage IA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2013.0,nan,-27808.0,Alive,TUMOR FREE,383.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,0
TCGA-IN-A7NR-01,TCGA-IN-A7NR,STAD,64.0,FEMALE,WHITE,Stage IV,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2013.0,nan,-23415.0,Alive,TUMOR FREE,198.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,198.0,0.0,198.0,nan,nan,0.0,198.0,0
TCGA-IN-A7NT-01,TCGA-IN-A7NT,STAD,73.0,FEMALE,WHITE,Stage IIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2013.0,nan,-26727.0,Alive,TUMOR FREE,323.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,323.0,0.0,323.0,0.0,323.0,0.0,323.0,0
TCGA-IN-A7NU-01,TCGA-IN-A7NU,STAD,69.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2013.0,nan,-25515.0,Alive,WITH TUMOR,356.0,nan,nan,Distant Metastasis,nan,nan,337.0,Progressive Disease,nan,nan,0.0,356.0,0.0,356.0,nan,nan,1.0,337.0,2
TCGA-IN-AB1V-01,TCGA-IN-AB1V,STAD,63.0,MALE,WHITE,Stage IA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2013.0,nan,-23030.0,Alive,TUMOR FREE,479.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,479.0,0.0,479.0,0.0,479.0,0.0,479.0,0
TCGA-IN-AB1V-11,TCGA-IN-AB1V,STAD,63.0,MALE,WHITE,Stage IA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2013.0,nan,-23030.0,Alive,TUMOR FREE,479.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,479.0,0.0,479.0,0.0,479.0,0.0,479.0,0
TCGA-IN-AB1X-01,TCGA-IN-AB1X,STAD,78.0,FEMALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2013.0,nan,-28493.0,Alive,TUMOR FREE,411.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,411.0,0.0,411.0,0.0,411.0,0.0,411.0,0
TCGA-IN-AB1X-11,TCGA-IN-AB1X,STAD,78.0,FEMALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2013.0,nan,-28493.0,Alive,TUMOR FREE,411.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,411.0,0.0,411.0,0.0,411.0,0.0,411.0,0
TCGA-IP-7968-01,TCGA-IP-7968,STAD,74.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-27114.0,Alive,TUMOR FREE,77.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,77.0,0.0,77.0,nan,nan,0.0,77.0,0
TCGA-IP-7968-11,TCGA-IP-7968,STAD,74.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-27114.0,Alive,TUMOR FREE,77.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,77.0,0.0,77.0,nan,nan,0.0,77.0,0
TCGA-KB-A6F5-01,TCGA-KB-A6F5,STAD,73.0,MALE,[Not Evaluated],Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-26881.0,Alive,TUMOR FREE,169.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,169.0,0.0,169.0,0.0,169.0,0.0,169.0,0
TCGA-KB-A6F7-01,TCGA-KB-A6F7,STAD,54.0,FEMALE,[Unknown],Stage IB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2009.0,nan,-19765.0,Alive,TUMOR FREE,1935.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1935.0,0.0,1935.0,0.0,1935.0,0.0,1935.0,0
TCGA-KB-A93G-01,TCGA-KB-A93G,STAD,68.0,MALE,WHITE,Stage IB,nan,"Stomach Adenocarcinoma, Signet Ring Type",G1,2013.0,nan,-24924.0,Alive,TUMOR FREE,613.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,613.0,0.0,613.0,0.0,613.0,0.0,613.0,0
TCGA-KB-A93H-01,TCGA-KB-A93H,STAD,79.0,FEMALE,ASIAN,Stage IIB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G1,2011.0,nan,-28966.0,Alive,TUMOR FREE,1145.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1145.0,0.0,1145.0,0.0,1145.0,0.0,1145.0,0
TCGA-KB-A93J-01,TCGA-KB-A93J,STAD,78.0,MALE,WHITE,Stage II,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2008.0,nan,-28599.0,Alive,nan,1124.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1124.0,0.0,1124.0,0.0,1124.0,0.0,1124.0,0
TCGA-MX-A5UG-01,TCGA-MX-A5UG,STAD,78.0,MALE,ASIAN,Stage IIIA,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2007.0,nan,-28714.0,Dead,TUMOR FREE,nan,113.0,Stomach Cancer,nan,nan,nan,nan,nan,nan,nan,1.0,113.0,1.0,113.0,nan,nan,0.0,113.0,1
TCGA-MX-A5UJ-01,TCGA-MX-A5UJ,STAD,86.0,FEMALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,nan,-31517.0,Alive,TUMOR FREE,600.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,600.0,0.0,600.0,0.0,600.0,0.0,600.0,0
TCGA-MX-A663-01,TCGA-MX-A663,STAD,66.0,MALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-24421.0,Dead,WITH TUMOR,nan,300.0,nan,Distant Metastasis,"Other, specify",Liver and left supraclavicular lymph node,218.0,Complete Remission/Response,nan,nan,1.0,300.0,1.0,300.0,1.0,218.0,1.0,218.0,1
TCGA-MX-A666-01,TCGA-MX-A666,STAD,61.0,MALE,WHITE,Stage IIA,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2013.0,nan,-22288.0,Alive,TUMOR FREE,427.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,427.0,0.0,427.0,nan,nan,0.0,427.0,0
TCGA-R5-A7O7-01,TCGA-R5-A7O7,STAD,51.0,MALE,WHITE,Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010.0,nan,-18984.0,Alive,TUMOR FREE,1389.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1389.0,0.0,1389.0,nan,nan,0.0,1389.0,0
TCGA-R5-A7ZE-01,TCGA-R5-A7ZE,STAD,66.0,FEMALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012.0,nan,-24328.0,Dead,WITH TUMOR,nan,554.0,[Unknown],nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,554.0,1.0,554.0,nan,nan,1.0,554.0,1
TCGA-R5-A7ZF-01,TCGA-R5-A7ZF,STAD,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012.0,nan,-23908.0,Dead,WITH TUMOR,nan,259.0,Stomach Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,259.0,1.0,259.0,nan,nan,1.0,259.0,1
TCGA-R5-A7ZI-01,TCGA-R5-A7ZI,STAD,44.0,FEMALE,WHITE,Stage IV,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2009.0,nan,-16396.0,Alive,TUMOR FREE,2267.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2267.0,0.0,2267.0,nan,nan,0.0,2267.0,2
TCGA-R5-A7ZR-01,TCGA-R5-A7ZR,STAD,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2008.0,nan,-25795.0,Dead,WITH TUMOR,nan,185.0,[Unknown],nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,185.0,1.0,185.0,nan,nan,1.0,185.0,1
TCGA-R5-A804-01,TCGA-R5-A804,STAD,54.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2005.0,nan,-20026.0,Dead,WITH TUMOR,nan,140.0,[Unknown],nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,140.0,1.0,140.0,nan,nan,1.0,140.0,1
TCGA-R5-A805-01,TCGA-R5-A805,STAD,71.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2005.0,nan,-26122.0,Dead,WITH TUMOR,nan,281.0,Stomach Cancer,nan,nan,nan,nan,nan,nan,nan,1.0,281.0,1.0,281.0,nan,nan,1.0,281.0,1
TCGA-RD-A7BS-01,TCGA-RD-A7BS,STAD,46.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2001.0,nan,-16847.0,Dead,WITH TUMOR,nan,336.0,Stomach Cancer,Distant Metastasis,Liver,nan,244.0,Complete Remission/Response,nan,nan,1.0,336.0,1.0,336.0,1.0,244.0,1.0,244.0,1
TCGA-RD-A7BT-01,TCGA-RD-A7BT,STAD,66.0,MALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2002.0,nan,-24107.0,Dead,WITH TUMOR,nan,262.0,Stomach Cancer,Distant Metastasis,"Other, specify",Adrenal gland,123.0,Progressive Disease,nan,nan,1.0,262.0,1.0,262.0,nan,nan,1.0,123.0,1
TCGA-RD-A7BW-01,TCGA-RD-A7BW,STAD,68.0,FEMALE,WHITE,Stage IB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2004.0,nan,-25036.0,Dead,TUMOR FREE,nan,156.0,"Other, non-malignant disease",nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,156.0,0.0,156.0,0.0,156.0,0.0,156.0,0
TCGA-RD-A7C1-01,TCGA-RD-A7C1,STAD,82.0,MALE,WHITE,Stage IB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2005.0,nan,-30171.0,Dead,WITH TUMOR,nan,507.0,Stomach Cancer,Distant Metastasis,Non-regional / Distant Lymph Nodes,nan,438.0,Complete Remission/Response,nan,nan,1.0,507.0,1.0,507.0,1.0,438.0,1.0,438.0,1
TCGA-RD-A8MV-01,TCGA-RD-A8MV,STAD,56.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2001.0,nan,-20771.0,Alive,TUMOR FREE,3720.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3720.0,0.0,3720.0,0.0,3720.0,0.0,3720.0,0
TCGA-RD-A8MW-01,TCGA-RD-A8MW,STAD,72.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2004.0,nan,-26590.0,Dead,WITH TUMOR,1153.0,1153.0,Stomach Cancer,Distant Metastasis,Peritoneal Surfaces,nan,98.0,Complete Remission/Response,nan,nan,1.0,1153.0,1.0,1153.0,1.0,98.0,1.0,98.0,1
TCGA-RD-A8N0-01,TCGA-RD-A8N0,STAD,53.0,FEMALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2006.0,nan,-19491.0,Alive,TUMOR FREE,1236.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1236.0,0.0,1236.0,0.0,1236.0,0.0,1236.0,0
TCGA-RD-A8N1-01,TCGA-RD-A8N1,STAD,70.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2001.0,nan,-25737.0,Alive,TUMOR FREE,3519.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3519.0,0.0,3519.0,0.0,3519.0,0.0,3519.0,0
TCGA-RD-A8N2-01,TCGA-RD-A8N2,STAD,59.0,FEMALE,WHITE,Stage IB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2002.0,nan,-21749.0,Alive,TUMOR FREE,3540.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3540.0,0.0,3540.0,0.0,3540.0,0.0,3540.0,0
TCGA-RD-A8N4-01,TCGA-RD-A8N4,STAD,58.0,FEMALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2006.0,nan,-21324.0,Alive,TUMOR FREE,2171.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2171.0,0.0,2171.0,0.0,2171.0,0.0,2171.0,0
TCGA-RD-A8N5-01,TCGA-RD-A8N5,STAD,78.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2006.0,nan,-28589.0,Dead,TUMOR FREE,nan,1747.0,"Other, non-malignant disease",nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1747.0,0.0,1747.0,0.0,1747.0,0.0,1747.0,0
TCGA-RD-A8N6-01,TCGA-RD-A8N6,STAD,78.0,FEMALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2006.0,nan,-28834.0,Dead,WITH TUMOR,nan,272.0,Stomach Cancer,Distant Metastasis,Liver,nan,163.0,Complete Remission/Response,nan,nan,1.0,272.0,1.0,272.0,1.0,163.0,1.0,163.0,1
TCGA-RD-A8N9-01,TCGA-RD-A8N9,STAD,63.0,FEMALE,ASIAN,Stage II,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2009.0,nan,-23059.0,Alive,TUMOR FREE,1083.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1083.0,0.0,1083.0,0.0,1083.0,0.0,1083.0,0
TCGA-RD-A8NB-01,TCGA-RD-A8NB,STAD,80.0,FEMALE,WHITE,Stage IIIA,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2000.0,nan,-29503.0,Dead,WITH TUMOR,nan,513.0,Stomach Cancer,Distant Metastasis,Non-regional / Distant Lymph Nodes,nan,230.0,Partial Remission/Response,nan,nan,1.0,513.0,1.0,513.0,nan,nan,1.0,230.0,1
TCGA-SW-A7EA-01,TCGA-SW-A7EA,STAD,61.0,FEMALE,WHITE,Stage IB,nan,"Stomach, Adenocarcinoma, Diffuse Type",GX,2013.0,nan,-22294.0,Alive,TUMOR FREE,579.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,579.0,0.0,579.0,0.0,579.0,0.0,579.0,0
TCGA-SW-A7EA-11,TCGA-SW-A7EA,STAD,61.0,FEMALE,WHITE,Stage IB,nan,"Stomach, Adenocarcinoma, Diffuse Type",GX,2013.0,nan,-22294.0,Alive,TUMOR FREE,579.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,579.0,0.0,579.0,0.0,579.0,0.0,579.0,0
TCGA-SW-A7EB-01,TCGA-SW-A7EB,STAD,45.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2013.0,nan,-16475.0,Alive,TUMOR FREE,176.0,nan,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,0.0,176.0,0.0,176.0,nan,nan,0.0,176.0,0
TCGA-VQ-A8DL-01,TCGA-VQ-A8DL,STAD,69.0,FEMALE,WHITE,Stage IIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010.0,nan,-25299.0,Dead,TUMOR FREE,nan,28.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,28.0,0.0,28.0,0.0,28.0,0.0,28.0,0
TCGA-VQ-A8DT-01,TCGA-VQ-A8DT,STAD,43.0,MALE,[Unknown],Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010.0,nan,-15937.0,Alive,WITH TUMOR,1484.0,nan,nan,Distant Metastasis,Liver,nan,1376.0,Complete Remission/Response,nan,nan,0.0,1484.0,0.0,1484.0,1.0,1376.0,1.0,1376.0,2
TCGA-VQ-A8DU-01,TCGA-VQ-A8DU,STAD,63.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010.0,nan,-23042.0,Dead,WITH TUMOR,nan,166.0,Stomach Cancer,Distant Metastasis,Liver,nan,158.0,Progressive Disease,nan,nan,1.0,166.0,1.0,166.0,nan,nan,1.0,158.0,1
TCGA-VQ-A8DV-01,TCGA-VQ-A8DV,STAD,48.0,MALE,WHITE,Stage IB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010.0,nan,-17630.0,Dead,WITH TUMOR,nan,403.0,Stomach Cancer,Distant Metastasis,Liver,nan,288.0,Progressive Disease,nan,nan,1.0,403.0,1.0,403.0,nan,nan,1.0,288.0,1
TCGA-VQ-A8DZ-01,TCGA-VQ-A8DZ,STAD,70.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IV,nan,"Stomach Adenocarcinoma, Signet Ring Type",G3,2011.0,nan,-25863.0,Dead,WITH TUMOR,nan,396.0,Stomach Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,396.0,1.0,396.0,nan,nan,1.0,396.0,1
TCGA-VQ-A8E0-01,TCGA-VQ-A8E0,STAD,68.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-24848.0,Dead,WITH TUMOR,nan,562.0,Stomach Cancer,Distant Metastasis,Liver,nan,531.0,Progressive Disease,nan,nan,1.0,562.0,1.0,562.0,nan,nan,1.0,531.0,1
TCGA-VQ-A8E2-01,TCGA-VQ-A8E2,STAD,57.0,MALE,ASIAN,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,nan,-21112.0,Alive,TUMOR FREE,1319.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1319.0,0.0,1319.0,0.0,1319.0,0.0,1319.0,0
TCGA-VQ-A8E3-01,TCGA-VQ-A8E3,STAD,79.0,MALE,WHITE,Stage IIA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-28919.0,Dead,nan,nan,661.0,[Unknown],Locoregional Recurrence,nan,nan,538.0,[Unknown],nan,nan,1.0,661.0,nan,661.0,nan,nan,1.0,538.0,1
TCGA-VQ-A8E7-01,TCGA-VQ-A8E7,STAD,59.0,MALE,WHITE,Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012.0,nan,-21664.0,Alive,WITH TUMOR,1138.0,nan,nan,Distant Metastasis,"Other, specify",Adrenal,1048.0,Stable Disease,nan,nan,0.0,1138.0,0.0,1138.0,nan,nan,1.0,1048.0,2
TCGA-VQ-A8P2-01,TCGA-VQ-A8P2,STAD,68.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G2,2011.0,nan,-25129.0,Alive,TUMOR FREE,1160.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1160.0,0.0,1160.0,0.0,1160.0,0.0,1160.0,0
TCGA-VQ-A8P3-01,TCGA-VQ-A8P3,STAD,72.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,nan,-26582.0,Alive,TUMOR FREE,1132.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1132.0,0.0,1132.0,0.0,1132.0,0.0,1132.0,0
TCGA-VQ-A8P5-01,TCGA-VQ-A8P5,STAD,67.0,MALE,WHITE,Stage IIA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2011.0,nan,-24571.0,Dead,nan,nan,235.0,[Unknown],nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,235.0,nan,235.0,nan,nan,0.0,235.0,0
TCGA-VQ-A8P8-01,TCGA-VQ-A8P8,STAD,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,nan,-26443.0,Alive,TUMOR FREE,942.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,942.0,0.0,942.0,0.0,942.0,0.0,942.0,0
TCGA-VQ-A8PB-01,TCGA-VQ-A8PB,STAD,65.0,FEMALE,WHITE,Stage II,nan,"Stomach, Intestinal Adenocarcinoma, Papillary Type",G2,2011.0,nan,-23927.0,Dead,TUMOR FREE,nan,1043.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1043.0,0.0,1043.0,0.0,1043.0,0.0,1043.0,0
TCGA-VQ-A8PC-01,TCGA-VQ-A8PC,STAD,65.0,MALE,WHITE,Stage IIIA,nan,"Stomach Adenocarcinoma, Signet Ring Type",G3,2009.0,nan,-23912.0,Dead,WITH TUMOR,nan,1407.0,[Unknown],Locoregional Recurrence,nan,nan,1287.0,Progressive Disease,nan,nan,1.0,1407.0,1.0,1407.0,nan,nan,1.0,1287.0,1
TCGA-VQ-A8PD-01,TCGA-VQ-A8PD,STAD,69.0,MALE,WHITE,Stage IIIC,nan,"Stomach, Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,nan,-25244.0,Dead,WITH TUMOR,nan,496.0,nan,Distant Metastasis,"Other, specify",nan,134.0,Progressive Disease,nan,nan,1.0,496.0,1.0,496.0,nan,nan,1.0,134.0,1
TCGA-VQ-A8PE-01,TCGA-VQ-A8PE,STAD,78.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,nan,-28755.0,Dead,WITH TUMOR,nan,675.0,nan,Locoregional Recurrence,nan,nan,265.0,Progressive Disease,nan,nan,1.0,675.0,1.0,675.0,nan,nan,1.0,265.0,1
TCGA-VQ-A8PF-01,TCGA-VQ-A8PF,STAD,76.0,MALE,[Not Evaluated],Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,nan,-28116.0,Dead,TUMOR FREE,nan,76.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,76.0,0.0,76.0,0.0,76.0,0.0,76.0,0
TCGA-VQ-A8PH-01,TCGA-VQ-A8PH,STAD,62.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010.0,nan,-22940.0,Dead,WITH TUMOR,nan,389.0,nan,Locoregional Recurrence,nan,nan,377.0,Progressive Disease,nan,nan,1.0,389.0,1.0,389.0,nan,nan,1.0,377.0,1
TCGA-VQ-A8PJ-01,TCGA-VQ-A8PJ,STAD,53.0,MALE,[Unknown],Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",GX,2011.0,nan,-19390.0,Dead,WITH TUMOR,nan,82.0,Stomach Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,82.0,1.0,82.0,nan,nan,1.0,82.0,1
TCGA-VQ-A8PK-01,TCGA-VQ-A8PK,STAD,58.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-21419.0,Dead,WITH TUMOR,nan,543.0,Stomach Cancer,Locoregional Recurrence|Distant Metastasis,Liver,nan,263.0,Progressive Disease,nan,nan,1.0,543.0,1.0,543.0,nan,nan,1.0,263.0,1
TCGA-VQ-A8PM-01,TCGA-VQ-A8PM,STAD,56.0,MALE,WHITE,Stage IV,nan,"Stomach Adenocarcinoma, Signet Ring Type",G3,2009.0,nan,-20665.0,Dead,WITH TUMOR,nan,57.0,"Other, non-malignant disease",nan,nan,nan,nan,nan,nan,nan,1.0,57.0,0.0,57.0,nan,nan,1.0,57.0,1
TCGA-VQ-A8PO-01,TCGA-VQ-A8PO,STAD,74.0,MALE,WHITE,Stage IIB,nan,"Stomach Adenocarcinoma, Signet Ring Type",G3,2008.0,nan,-27250.0,Dead,nan,nan,282.0,Stomach Cancer,Locoregional Recurrence,nan,nan,256.0,Progressive Disease,nan,nan,1.0,282.0,1.0,282.0,nan,nan,1.0,256.0,1
TCGA-VQ-A8PP-01,TCGA-VQ-A8PP,STAD,76.0,MALE,[Unknown],Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2008.0,nan,-27774.0,Dead,WITH TUMOR,nan,712.0,Stomach Cancer,Locoregional Recurrence,nan,nan,502.0,Progressive Disease,nan,nan,1.0,712.0,1.0,712.0,nan,nan,1.0,502.0,1
TCGA-VQ-A8PQ-01,TCGA-VQ-A8PQ,STAD,50.0,FEMALE,WHITE,Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2008.0,nan,-18318.0,Dead,WITH TUMOR,nan,476.0,Stomach Cancer,Locoregional Recurrence,nan,nan,91.0,Progressive Disease,nan,nan,1.0,476.0,1.0,476.0,nan,nan,1.0,91.0,1
TCGA-VQ-A8PS-01,TCGA-VQ-A8PS,STAD,76.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009.0,nan,-28035.0,Dead,WITH TUMOR,nan,406.0,Stomach Cancer,Distant Metastasis,Liver,nan,131.0,Progressive Disease,nan,nan,1.0,406.0,1.0,406.0,nan,nan,1.0,131.0,1
TCGA-VQ-A8PT-01,TCGA-VQ-A8PT,STAD,65.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-23797.0,Alive,TUMOR FREE,900.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,900.0,0.0,900.0,0.0,900.0,0.0,900.0,0
TCGA-VQ-A8PU-01,TCGA-VQ-A8PU,STAD,72.0,FEMALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2012.0,nan,-26625.0,Dead,TUMOR FREE,nan,832.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,832.0,0.0,832.0,0.0,832.0,0.0,832.0,0
TCGA-VQ-A8PX-01,TCGA-VQ-A8PX,STAD,51.0,MALE,[Unknown],Stage IA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009.0,nan,-18902.0,Alive,TUMOR FREE,1964.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1964.0,0.0,1964.0,0.0,1964.0,0.0,1964.0,0
TCGA-VQ-A8PY-01,TCGA-VQ-A8PY,STAD,47.0,FEMALE,WHITE,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2009.0,nan,-17230.0,Dead,TUMOR FREE,nan,436.0,Stomach Cancer,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,436.0,1.0,436.0,0.0,436.0,0.0,436.0,1
TCGA-VQ-A8PZ-01,TCGA-VQ-A8PZ,STAD,56.0,FEMALE,WHITE,Stage II,nan,"Stomach Adenocarcinoma, Signet Ring Type",G3,2008.0,nan,-20735.0,Alive,TUMOR FREE,2233.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2233.0,0.0,2233.0,0.0,2233.0,0.0,2233.0,0
TCGA-VQ-A91A-01,TCGA-VQ-A91A,STAD,67.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Mucinous Type",G1,2011.0,nan,-24670.0,Alive,TUMOR FREE,1200.0,nan,nan,New Primary Tumor,nan,nan,129.0,Complete Remission/Response,nan,nan,0.0,1200.0,0.0,1200.0,0.0,1200.0,1.0,129.0,0
TCGA-VQ-A91D-01,TCGA-VQ-A91D,STAD,70.0,MALE,WHITE,Stage IIIC,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010.0,nan,-25686.0,Dead,WITH TUMOR,nan,356.0,Stomach Cancer,Locoregional Recurrence,nan,nan,351.0,Progressive Disease,nan,nan,1.0,356.0,1.0,356.0,nan,nan,1.0,351.0,1
TCGA-VQ-A91E-01,TCGA-VQ-A91E,STAD,67.0,FEMALE,WHITE,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2013.0,nan,-24549.0,Alive,TUMOR FREE,664.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,664.0,0.0,664.0,0.0,664.0,0.0,664.0,0
TCGA-VQ-A91K-01,TCGA-VQ-A91K,STAD,69.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009.0,nan,-25424.0,Alive,TUMOR FREE,1862.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1862.0,0.0,1862.0,0.0,1862.0,0.0,1862.0,0
TCGA-VQ-A91N-01,TCGA-VQ-A91N,STAD,59.0,FEMALE,[Unknown],Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2009.0,nan,-21753.0,Dead,WITH TUMOR,nan,570.0,Stomach Cancer,Locoregional Recurrence,nan,nan,438.0,Progressive Disease,nan,nan,1.0,570.0,1.0,570.0,nan,nan,1.0,438.0,1
TCGA-VQ-A91Q-01,TCGA-VQ-A91Q,STAD,61.0,MALE,[Unknown],Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2009.0,nan,-22303.0,Dead,WITH TUMOR,nan,633.0,Stomach Cancer,Locoregional Recurrence,nan,nan,551.0,Complete Remission/Response,nan,nan,1.0,633.0,1.0,633.0,nan,nan,1.0,551.0,1
TCGA-VQ-A91S-01,TCGA-VQ-A91S,STAD,63.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",GX,2012.0,nan,-23187.0,Alive,TUMOR FREE,1000.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1000.0,0.0,1000.0,0.0,1000.0,0.0,1000.0,0
TCGA-VQ-A91U-01,TCGA-VQ-A91U,STAD,78.0,MALE,ASIAN,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-28791.0,Dead,nan,nan,52.0,[Unknown],nan,nan,nan,nan,[Unknown],nan,nan,1.0,52.0,nan,52.0,nan,nan,0.0,52.0,0
TCGA-VQ-A91V-01,TCGA-VQ-A91V,STAD,58.0,MALE,[Unknown],Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,nan,-21505.0,Alive,WITH TUMOR,1297.0,nan,nan,Distant Metastasis,Lung,nan,504.0,Progressive Disease,nan,nan,0.0,1297.0,0.0,1297.0,nan,nan,1.0,504.0,2
TCGA-VQ-A91W-01,TCGA-VQ-A91W,STAD,30.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2009.0,nan,-10963.0,Alive,nan,1851.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1851.0,0.0,1851.0,0.0,1851.0,0.0,1851.0,0
TCGA-VQ-A91X-01,TCGA-VQ-A91X,STAD,74.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2010.0,nan,-27314.0,Dead,TUMOR FREE,nan,289.0,"Other, non-malignant disease",nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,289.0,0.0,289.0,0.0,289.0,0.0,289.0,0
TCGA-VQ-A91Y-01,TCGA-VQ-A91Y,STAD,67.0,MALE,WHITE,Stage IIIC,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2011.0,nan,-24774.0,Dead,WITH TUMOR,nan,296.0,Stomach Cancer,Distant Metastasis,Lung,nan,258.0,Progressive Disease,nan,nan,1.0,296.0,1.0,296.0,nan,nan,1.0,258.0,1
TCGA-VQ-A91Z-01,TCGA-VQ-A91Z,STAD,67.0,FEMALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010.0,nan,-24652.0,Alive,WITH TUMOR,1690.0,nan,nan,Locoregional Recurrence,nan,nan,1310.0,Complete Remission/Response,nan,nan,0.0,1690.0,0.0,1690.0,1.0,1310.0,1.0,1310.0,2
TCGA-VQ-A922-01,TCGA-VQ-A922,STAD,70.0,MALE,[Unknown],Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2010.0,nan,-25700.0,Dead,nan,262.0,275.0,Stomach Cancer,Distant Metastasis,Liver,nan,252.0,Progressive Disease,nan,nan,1.0,275.0,1.0,275.0,nan,nan,1.0,252.0,1
TCGA-VQ-A923-01,TCGA-VQ-A923,STAD,90.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2008.0,nan,-32873.0,Dead,TUMOR FREE,nan,61.0,"Other, non-malignant disease",nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,61.0,0.0,61.0,0.0,61.0,0.0,61.0,0
TCGA-VQ-A924-01,TCGA-VQ-A924,STAD,69.0,MALE,[Unknown],Stage II,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2008.0,nan,-25351.0,Dead,WITH TUMOR,nan,1686.0,Stomach Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,1686.0,1.0,1686.0,nan,nan,1.0,1686.0,1
TCGA-VQ-A925-01,TCGA-VQ-A925,STAD,66.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2012.0,nan,-24230.0,Dead,WITH TUMOR,nan,138.0,Stomach Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,138.0,1.0,138.0,nan,nan,1.0,138.0,1
TCGA-VQ-A927-01,TCGA-VQ-A927,STAD,81.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G1,2013.0,nan,-29676.0,Dead,WITH TUMOR,nan,200.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,200.0,1.0,200.0,nan,nan,1.0,200.0,1
TCGA-VQ-A928-01,TCGA-VQ-A928,STAD,49.0,MALE,WHITE,Stage IV,nan,"Stomach, Intestinal Adenocarcinoma, Papillary Type",G2,2010.0,nan,-18058.0,Dead,WITH TUMOR,nan,174.0,Stomach Cancer,Distant Metastasis,Liver,nan,148.0,Progressive Disease,nan,nan,1.0,174.0,1.0,174.0,nan,nan,1.0,148.0,1
TCGA-VQ-A92D-01,TCGA-VQ-A92D,STAD,67.0,MALE,WHITE,Stage IB,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2009.0,nan,-24595.0,Alive,TUMOR FREE,2032.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2032.0,0.0,2032.0,0.0,2032.0,0.0,2032.0,0
TCGA-VQ-A94O-01,TCGA-VQ-A94O,STAD,74.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,nan,-27306.0,Dead,WITH TUMOR,nan,640.0,Stomach Cancer,Distant Metastasis,Liver,nan,185.0,Progressive Disease,nan,nan,1.0,640.0,1.0,640.0,nan,nan,1.0,185.0,1
TCGA-VQ-A94P-01,TCGA-VQ-A94P,STAD,57.0,MALE,WHITE,[Discrepancy],nan,"Stomach Adenocarcinoma, Signet Ring Type",GX,2011.0,nan,-21022.0,Dead,WITH TUMOR,nan,81.0,Stomach Cancer,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,81.0,1.0,81.0,nan,nan,1.0,81.0,1
TCGA-VQ-A94R-01,TCGA-VQ-A94R,STAD,63.0,MALE,WHITE,[Discrepancy],nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010.0,nan,-23246.0,Dead,WITH TUMOR,nan,1294.0,Stomach Cancer,Locoregional Recurrence,nan,nan,1018.0,Progressive Disease,nan,nan,1.0,1294.0,1.0,1294.0,nan,nan,1.0,1018.0,1
TCGA-VQ-A94T-01,TCGA-VQ-A94T,STAD,73.0,MALE,[Unknown],Stage IIIB,nan,"Stomach, Adenocarcinoma, Diffuse Type",G3,2011.0,nan,-26702.0,Dead,WITH TUMOR,nan,342.0,nan,Locoregional Recurrence,nan,nan,296.0,Progressive Disease,nan,nan,1.0,342.0,1.0,342.0,nan,nan,1.0,296.0,1
TCGA-VQ-A94U-01,TCGA-VQ-A94U,STAD,70.0,MALE,WHITE,Stage IIB,nan,"Stomach Adenocarcinoma, Signet Ring Type",G3,2012.0,nan,-25925.0,Alive,TUMOR FREE,819.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,819.0,0.0,819.0,0.0,819.0,0.0,819.0,0
TCGA-VQ-AA64-01,TCGA-VQ-AA64,STAD,68.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-25109.0,Dead,WITH TUMOR,nan,560.0,Stomach Cancer,nan,nan,nan,nan,[Unknown],nan,nan,1.0,560.0,1.0,560.0,nan,nan,1.0,560.0,1
TCGA-VQ-AA68-01,TCGA-VQ-AA68,STAD,52.0,FEMALE,WHITE,Stage IIIC,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2011.0,nan,-19304.0,Alive,TUMOR FREE,1328.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1328.0,0.0,1328.0,0.0,1328.0,0.0,1328.0,0
TCGA-VQ-AA69-01,TCGA-VQ-AA69,STAD,35.0,MALE,WHITE,Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-13087.0,Alive,TUMOR FREE,864.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,864.0,0.0,864.0,0.0,864.0,0.0,864.0,0
TCGA-VQ-AA6A-01,TCGA-VQ-AA6A,STAD,56.0,MALE,WHITE,Stage IIIC,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,nan,-20764.0,Alive,TUMOR FREE,1184.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1184.0,0.0,1184.0,0.0,1184.0,0.0,1184.0,0
TCGA-VQ-AA6B-01,TCGA-VQ-AA6B,STAD,48.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2012.0,nan,-17852.0,Alive,TUMOR FREE,1002.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1002.0,0.0,1002.0,0.0,1002.0,0.0,1002.0,0
TCGA-VQ-AA6D-01,TCGA-VQ-AA6D,STAD,52.0,FEMALE,[Unknown],Stage IIIA,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G2,2013.0,nan,-19090.0,Alive,TUMOR FREE,521.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,521.0,0.0,521.0,0.0,521.0,0.0,521.0,0
TCGA-VQ-AA6F-01,TCGA-VQ-AA6F,STAD,57.0,MALE,WHITE,Stage IIB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2010.0,nan,-21170.0,Alive,TUMOR FREE,1646.0,nan,nan,Locoregional Recurrence|New Primary Tumor,"Other, specify",nan,546.0,Progressive Disease,nan,nan,0.0,1646.0,0.0,1646.0,nan,nan,1.0,546.0,0
TCGA-VQ-AA6G-01,TCGA-VQ-AA6G,STAD,68.0,MALE,WHITE,Stage IIA,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2011.0,nan,-25091.0,Dead,WITH TUMOR,nan,792.0,Stomach Cancer,Distant Metastasis,Lung,nan,469.0,Progressive Disease,nan,nan,1.0,792.0,1.0,792.0,nan,nan,1.0,469.0,1
TCGA-VQ-AA6I-01,TCGA-VQ-AA6I,STAD,68.0,MALE,WHITE,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-25091.0,Dead,WITH TUMOR,nan,491.0,Stomach Cancer,Locoregional Recurrence,nan,nan,475.0,Progressive Disease,nan,nan,1.0,491.0,1.0,491.0,nan,nan,1.0,475.0,1
TCGA-VQ-AA6J-01,TCGA-VQ-AA6J,STAD,75.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G3,2012.0,nan,-27506.0,Alive,TUMOR FREE,838.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,838.0,0.0,838.0,0.0,838.0,0.0,838.0,0
TCGA-VQ-AA6K-01,TCGA-VQ-AA6K,STAD,59.0,MALE,WHITE,Stage IIIC,nan,"Stomach Adenocarcinoma, Signet Ring Type",G3,2012.0,nan,-21901.0,Dead,WITH TUMOR,nan,378.0,Stomach Cancer,Locoregional Recurrence,nan,nan,332.0,Progressive Disease,nan,nan,1.0,378.0,1.0,378.0,nan,nan,1.0,332.0,1
TCGA-ZA-A8F6-01,TCGA-ZA-A8F6,STAD,71.0,MALE,WHITE,Stage IB,nan,"Stomach, Intestinal Adenocarcinoma, Not Otherwise Specified (NOS)",G2,2013.0,nan,-26122.0,Alive,TUMOR FREE,525.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,525.0,0.0,525.0,0.0,525.0,0.0,525.0,0
TCGA-ZQ-A9CR-01,TCGA-ZQ-A9CR,STAD,79.0,FEMALE,WHITE,Stage IIIC,nan,"Stomach, Intestinal Adenocarcinoma, Tubular Type",G3,2013.0,nan,-29107.0,Dead,nan,nan,24.0,[Unknown],nan,nan,nan,nan,[Unknown],nan,nan,1.0,24.0,nan,24.0,nan,nan,0.0,24.0,1
TCGA-2G-AAEW-01,TCGA-2G-AAEW,TGCT,31.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,nan,2011.0,nan,-11325.0,Dead,WITH TUMOR,nan,618.0,Testicular Germ Cell Tumor (TGCT),Locoregional Recurrence,Retroperitoneal lymph nodes,nan,143.0,nan,nan,nan,1.0,618.0,1.0,618.0,nan,nan,1.0,143.0,1
TCGA-2G-AAEX-01,TCGA-2G-AAEX,TGCT,38.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,nan,2011.0,nan,-13964.0,Alive,TUMOR FREE,1259.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1259.0,0.0,1259.0,0.0,1259.0,0.0,1259.0,0
TCGA-2G-AAF1-01,TCGA-2G-AAF1,TGCT,28.0,MALE,ASIAN,IS,Stage IS,Seminoma; NOS,nan,2011.0,nan,-10511.0,Alive,TUMOR FREE,1403.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1403.0,0.0,1403.0,0.0,1403.0,0.0,1403.0,0
TCGA-2G-AAF4-01,TCGA-2G-AAF4,TGCT,30.0,MALE,WHITE,Stage I,Stage IA,Seminoma; NOS,nan,2008.0,nan,-10983.0,Alive,TUMOR FREE,2315.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2315.0,0.0,2315.0,0.0,2315.0,0.0,2315.0,0
TCGA-2G-AAF6-01,TCGA-2G-AAF6,TGCT,28.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,nan,2005.0,nan,-10281.0,Alive,TUMOR FREE,3491.0,nan,nan,Locoregional Recurrence,Retroperitoneal lymph nodes,nan,810.0,Complete Remission/Response,nan,nan,0.0,3491.0,0.0,3491.0,1.0,810.0,1.0,810.0,0
TCGA-2G-AAF8-01,TCGA-2G-AAF8,TGCT,33.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,nan,2004.0,nan,-12256.0,Alive,TUMOR FREE,3911.0,nan,nan,New Primary Tumor,Testes,nan,3149.0,Complete Remission/Response,nan,nan,0.0,3911.0,0.0,3911.0,1.0,3149.0,1.0,3149.0,0
TCGA-2G-AAFE-01,TCGA-2G-AAFE,TGCT,37.0,MALE,WHITE,Stage IIA,Stage IIA,Seminoma; NOS,nan,2001.0,nan,-13845.0,Alive,TUMOR FREE,4702.0,nan,nan,Locoregional Recurrence,Retroperitoneal lymph nodes,nan,617.0,Complete Remission/Response,nan,nan,0.0,4702.0,0.0,4702.0,1.0,617.0,1.0,617.0,0
TCGA-2G-AAFG-05,TCGA-2G-AAFG,TGCT,30.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,nan,1998.0,nan,-11002.0,Alive,TUMOR FREE,6183.0,nan,nan,New Primary Tumor,Testes,nan,2495.0,Complete Remission/Response,nan,nan,0.0,6183.0,0.0,6183.0,1.0,2495.0,1.0,2495.0,0
TCGA-2G-AAFG-01,TCGA-2G-AAFG,TGCT,30.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,nan,1998.0,nan,-11002.0,Alive,TUMOR FREE,6183.0,nan,nan,New Primary Tumor,Testes,nan,2495.0,Complete Remission/Response,nan,nan,0.0,6183.0,0.0,6183.0,1.0,2495.0,1.0,2495.0,0
TCGA-2G-AAFH-01,TCGA-2G-AAFH,TGCT,38.0,MALE,WHITE,Stage IIB,Stage IIB,Seminoma; NOS,nan,2011.0,nan,-14120.0,Alive,TUMOR FREE,1375.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1375.0,0.0,1375.0,0.0,1375.0,0.0,1375.0,0
TCGA-2G-AAFI-01,TCGA-2G-AAFI,TGCT,41.0,MALE,WHITE,Stage IB,Stage IB,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,nan,2013.0,nan,-14976.0,Alive,TUMOR FREE,675.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,675.0,0.0,675.0,0.0,675.0,0.0,675.0,0
TCGA-2G-AAFJ-01,TCGA-2G-AAFJ,TGCT,23.0,MALE,ASIAN,[Discrepancy],Stage I,Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Yolk Sac Tumor,nan,2013.0,nan,-8415.0,Alive,TUMOR FREE,792.0,nan,nan,nan,nan,nan,313.0,Complete Remission/Response,nan,nan,0.0,792.0,0.0,792.0,1.0,313.0,1.0,313.0,0
TCGA-2G-AAFL-01,TCGA-2G-AAFL,TGCT,35.0,MALE,WHITE,Stage IB,Stage IB,Non-Seminoma; Embryonal Carcinoma,nan,2013.0,nan,-12898.0,Alive,TUMOR FREE,750.0,nan,nan,New Primary Tumor,Testes,nan,38.0,Complete Remission/Response,nan,nan,0.0,750.0,0.0,750.0,1.0,38.0,1.0,38.0,0
TCGA-2G-AAFM-01,TCGA-2G-AAFM,TGCT,31.0,MALE,WHITE,Stage IIA,Stage IIA,Non-Seminoma; Embryonal Carcinoma,nan,2013.0,nan,-11607.0,Alive,TUMOR FREE,503.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,503.0,0.0,503.0,0.0,503.0,0.0,503.0,0
TCGA-2G-AAFN-01,TCGA-2G-AAFN,TGCT,26.0,MALE,WHITE,Stage IIIB,Stage IIIB,Non-Seminoma; Embryonal Carcinoma,nan,2013.0,nan,-9805.0,Alive,TUMOR FREE,773.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,773.0,0.0,773.0,0.0,773.0,0.0,773.0,0
TCGA-2G-AAFO-01,TCGA-2G-AAFO,TGCT,33.0,MALE,WHITE,Stage IIA,Stage IIA,Non-Seminoma; Embryonal Carcinoma,nan,2013.0,nan,-12298.0,Alive,TUMOR FREE,685.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,685.0,0.0,685.0,0.0,685.0,0.0,685.0,0
TCGA-2G-AAFV-01,TCGA-2G-AAFV,TGCT,31.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Yolk Sac Tumor,nan,2011.0,nan,-11598.0,Alive,TUMOR FREE,1389.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1389.0,0.0,1389.0,0.0,1389.0,0.0,1389.0,0
TCGA-2G-AAFY-01,TCGA-2G-AAFY,TGCT,24.0,MALE,WHITE,Stage IIA,Stage IIA,Non-Seminoma; Embryonal Carcinoma,nan,2011.0,nan,-9023.0,Alive,TUMOR FREE,1099.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1099.0,0.0,1099.0,0.0,1099.0,0.0,1099.0,0
TCGA-2G-AAFZ-01,TCGA-2G-AAFZ,TGCT,32.0,MALE,WHITE,Stage III,Stage IIIB,Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Mature),nan,2011.0,nan,-11761.0,Alive,TUMOR FREE,1353.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,1353.0,0.0,1353.0,nan,nan,0.0,1353.0,0
TCGA-2G-AAG0-01,TCGA-2G-AAG0,TGCT,23.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Teratoma (Mature),nan,2010.0,nan,-8687.0,Alive,TUMOR FREE,1529.0,nan,nan,Distant Metastasis,Lung,nan,90.0,Complete Remission/Response,nan,nan,0.0,1529.0,0.0,1529.0,1.0,90.0,1.0,90.0,0
TCGA-2G-AAG3-01,TCGA-2G-AAG3,TGCT,53.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Teratoma (Mature)|Seminoma; NOS|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,nan,2009.0,nan,-19583.0,Alive,TUMOR FREE,1593.0,nan,nan,New Primary Tumor,Lung,nan,181.0,Complete Remission/Response,nan,nan,0.0,1593.0,0.0,1593.0,0.0,1593.0,1.0,181.0,0
TCGA-2G-AAG5-01,TCGA-2G-AAG5,TGCT,36.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Teratoma (Mature),nan,2008.0,nan,-13497.0,Alive,TUMOR FREE,2299.0,nan,nan,Locoregional Recurrence,Retroperitoneal lymph nodes,nan,451.0,Complete Remission/Response,nan,nan,0.0,2299.0,0.0,2299.0,1.0,451.0,1.0,451.0,0
TCGA-2G-AAG6-01,TCGA-2G-AAG6,TGCT,24.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Yolk Sac Tumor,nan,2008.0,nan,-9071.0,Alive,TUMOR FREE,2231.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2231.0,0.0,2231.0,0.0,2231.0,0.0,2231.0,0
TCGA-2G-AAG7-01,TCGA-2G-AAG7,TGCT,33.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor,nan,2008.0,nan,-12180.0,Alive,TUMOR FREE,2475.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2475.0,0.0,2475.0,0.0,2475.0,0.0,2475.0,0
TCGA-2G-AAG8-01,TCGA-2G-AAG8,TGCT,21.0,MALE,WHITE,Stage IB,Stage IIA,Non-Seminoma; Embryonal Carcinoma,nan,2008.0,nan,-7688.0,Alive,TUMOR FREE,2289.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2289.0,0.0,2289.0,0.0,2289.0,0.0,2289.0,0
TCGA-2G-AAG9-01,TCGA-2G-AAG9,TGCT,25.0,MALE,WHITE,Stage IIIB,Stage IIIB,Seminoma; NOS,nan,2008.0,nan,-9210.0,Alive,TUMOR FREE,2234.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,2234.0,0.0,2234.0,nan,nan,0.0,2234.0,0
TCGA-2G-AAGA-01,TCGA-2G-AAGA,TGCT,38.0,MALE,WHITE,Stage IIA,Stage IIA,Non-Seminoma; Embryonal Carcinoma,nan,2008.0,nan,-14053.0,Alive,TUMOR FREE,2439.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2439.0,0.0,2439.0,0.0,2439.0,0.0,2439.0,0
TCGA-2G-AAGC-01,TCGA-2G-AAGC,TGCT,28.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,nan,2007.0,nan,-10518.0,Alive,TUMOR FREE,2585.0,nan,nan,Locoregional Recurrence,Retroperitoneal lymph nodes,nan,317.0,Complete Remission/Response,nan,nan,0.0,2585.0,0.0,2585.0,1.0,317.0,1.0,317.0,0
TCGA-2G-AAGE-01,TCGA-2G-AAGE,TGCT,21.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Embryonal Carcinoma,nan,2007.0,nan,-7753.0,Alive,TUMOR FREE,2478.0,nan,nan,Locoregional Recurrence,Retroperitoneal lymph nodes,nan,121.0,Complete Remission/Response,nan,nan,0.0,2478.0,0.0,2478.0,1.0,121.0,1.0,121.0,0
TCGA-2G-AAGF-01,TCGA-2G-AAGF,TGCT,28.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,nan,2007.0,nan,-10348.0,Alive,TUMOR FREE,2734.0,nan,nan,Locoregional Recurrence,Retroperitoneal lymph nodes,nan,139.0,Complete Remission/Response,nan,nan,0.0,2734.0,0.0,2734.0,1.0,139.0,1.0,139.0,0
TCGA-2G-AAGG-01,TCGA-2G-AAGG,TGCT,20.0,MALE,WHITE,Stage IIIC,Stage IIIC,Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,nan,2007.0,nan,-7330.0,Alive,TUMOR FREE,2611.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,2611.0,0.0,2611.0,nan,nan,0.0,2611.0,0
TCGA-2G-AAGI-05,TCGA-2G-AAGI,TGCT,33.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Teratoma (Mature)|Seminoma; NOS|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,nan,2006.0,nan,-12366.0,Alive,TUMOR FREE,3137.0,nan,nan,New Primary Tumor,Testes,nan,2193.0,Complete Remission/Response,nan,nan,0.0,3137.0,0.0,3137.0,1.0,2193.0,1.0,2193.0,0
TCGA-2G-AAGI-01,TCGA-2G-AAGI,TGCT,33.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Teratoma (Mature)|Seminoma; NOS|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,nan,2006.0,nan,-12366.0,Alive,TUMOR FREE,3137.0,nan,nan,New Primary Tumor,Testes,nan,2193.0,Complete Remission/Response,nan,nan,0.0,3137.0,0.0,3137.0,1.0,2193.0,1.0,2193.0,0
TCGA-2G-AAGJ-01,TCGA-2G-AAGJ,TGCT,28.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,Stage IA,Non-Seminoma; Embryonal Carcinoma|Seminoma; NOS,nan,2006.0,nan,-10348.0,Alive,TUMOR FREE,2938.0,nan,nan,Locoregional Recurrence,Retroperitoneal lymph nodes,nan,171.0,Complete Remission/Response,nan,nan,0.0,2938.0,0.0,2938.0,1.0,171.0,1.0,171.0,0
TCGA-2G-AAGK-01,TCGA-2G-AAGK,TGCT,20.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma,nan,2005.0,nan,-7378.0,Alive,TUMOR FREE,3621.0,nan,nan,Locoregional Recurrence,Retroperitoneal lymph nodes,nan,713.0,Complete Remission/Response,nan,nan,0.0,3621.0,0.0,3621.0,1.0,713.0,1.0,713.0,0
TCGA-2G-AAGM-01,TCGA-2G-AAGM,TGCT,51.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Yolk Sac Tumor,nan,2004.0,nan,-18696.0,Alive,TUMOR FREE,3891.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,3891.0,0.0,3891.0,nan,nan,0.0,3891.0,0
TCGA-2G-AAGN-01,TCGA-2G-AAGN,TGCT,41.0,MALE,WHITE,Stage IIIB,Stage IIIB,Non-Seminoma; Embryonal Carcinoma,nan,2004.0,nan,-15145.0,Alive,TUMOR FREE,3656.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,3656.0,0.0,3656.0,nan,nan,0.0,3656.0,0
TCGA-2G-AAGO-01,TCGA-2G-AAGO,TGCT,41.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Embryonal Carcinoma,nan,2003.0,nan,-15300.0,Alive,TUMOR FREE,4026.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,4026.0,0.0,4026.0,nan,nan,0.0,4026.0,0
TCGA-2G-AAGP-01,TCGA-2G-AAGP,TGCT,33.0,MALE,WHITE,Stage IIA,Stage IIA,Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,nan,2003.0,nan,-12202.0,Alive,TUMOR FREE,4018.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4018.0,0.0,4018.0,0.0,4018.0,0.0,4018.0,0
TCGA-2G-AAGS-01,TCGA-2G-AAGS,TGCT,39.0,MALE,WHITE,Stage IIIB,Stage IIIB,Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor,nan,2001.0,nan,-14312.0,Alive,TUMOR FREE,4816.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4816.0,0.0,4816.0,0.0,4816.0,0.0,4816.0,0
TCGA-2G-AAGT-01,TCGA-2G-AAGT,TGCT,30.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Teratoma (Mature),nan,2002.0,nan,-10967.0,Alive,TUMOR FREE,4406.0,nan,nan,Locoregional Recurrence,Retroperitoneal lymph nodes,nan,15.0,Complete Remission/Response,nan,nan,0.0,4406.0,0.0,4406.0,1.0,15.0,1.0,15.0,0
TCGA-2G-AAGV-01,TCGA-2G-AAGV,TGCT,23.0,MALE,WHITE,[Discrepancy],Stage IIA,Non-Seminoma; Teratoma (Mature),nan,2002.0,nan,-8612.0,Alive,TUMOR FREE,4527.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4527.0,0.0,4527.0,0.0,4527.0,0.0,4527.0,0
TCGA-2G-AAGW-01,TCGA-2G-AAGW,TGCT,38.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Yolk Sac Tumor,nan,2001.0,nan,-14197.0,Alive,TUMOR FREE,4899.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4899.0,0.0,4899.0,0.0,4899.0,0.0,4899.0,0
TCGA-2G-AAGX-01,TCGA-2G-AAGX,TGCT,22.0,MALE,WHITE,Stage IA,Stage IA,Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor,nan,2000.0,nan,-8326.0,Alive,TUMOR FREE,5514.0,nan,nan,New Primary Tumor,Testes,nan,4323.0,Complete Remission/Response,nan,nan,0.0,5514.0,0.0,5514.0,1.0,4323.0,1.0,4323.0,0
TCGA-2G-AAGY-05,TCGA-2G-AAGY,TGCT,28.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Embryonal Carcinoma,nan,2000.0,nan,-10338.0,Alive,TUMOR FREE,5329.0,nan,nan,New Primary Tumor,Testes,nan,623.0,Complete Remission/Response,nan,nan,0.0,5329.0,0.0,5329.0,1.0,623.0,1.0,623.0,0
TCGA-2G-AAGY-01,TCGA-2G-AAGY,TGCT,28.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Embryonal Carcinoma,nan,2000.0,nan,-10338.0,Alive,TUMOR FREE,5329.0,nan,nan,New Primary Tumor,Testes,nan,623.0,Complete Remission/Response,nan,nan,0.0,5329.0,0.0,5329.0,1.0,623.0,1.0,623.0,0
TCGA-2G-AAGZ-01,TCGA-2G-AAGZ,TGCT,27.0,MALE,WHITE,Stage IIIA,Stage IIIA,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Choriocarcinoma|Non-Seminoma; Yolk Sac Tumor|Seminoma; NOS,nan,2000.0,nan,-10157.0,Alive,TUMOR FREE,5233.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,5233.0,0.0,5233.0,nan,nan,0.0,5233.0,0
TCGA-2G-AAH0-01,TCGA-2G-AAH0,TGCT,30.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS|Non-Seminoma; Embryonal Carcinoma,nan,1999.0,nan,-11123.0,Alive,TUMOR FREE,5477.0,nan,nan,Locoregional Recurrence,Retroperitoneal lymph nodes,nan,107.0,Complete Remission/Response,nan,nan,0.0,5477.0,0.0,5477.0,1.0,107.0,1.0,107.0,0
TCGA-2G-AAH2-01,TCGA-2G-AAH2,TGCT,20.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma|Seminoma; NOS,nan,1998.0,nan,-7635.0,Alive,TUMOR FREE,6060.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,6060.0,0.0,6060.0,0.0,6060.0,0.0,6060.0,0
TCGA-2G-AAH3-01,TCGA-2G-AAH3,TGCT,20.0,MALE,WHITE,Stage I,Stage I,Seminoma; NOS|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor,nan,1997.0,nan,-7474.0,Alive,TUMOR FREE,1822.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1822.0,0.0,1822.0,0.0,1822.0,0.0,1822.0,0
TCGA-2G-AAH4-01,TCGA-2G-AAH4,TGCT,34.0,MALE,WHITE,Stage II,Stage II,Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Mature)|Seminoma; NOS,nan,1997.0,nan,-12481.0,Alive,TUMOR FREE,6210.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,6210.0,0.0,6210.0,nan,nan,0.0,6210.0,0
TCGA-2G-AAH8-01,TCGA-2G-AAH8,TGCT,45.0,MALE,WHITE,Stage IIIC,Stage IIIC,Seminoma; NOS,nan,2008.0,nan,-16687.0,Alive,TUMOR FREE,2248.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,2248.0,0.0,2248.0,nan,nan,0.0,2248.0,0
TCGA-2G-AAHA-01,TCGA-2G-AAHA,TGCT,48.0,MALE,WHITE,Stage IB,Stage IIA,Seminoma; NOS,nan,2005.0,nan,-17658.0,Alive,TUMOR FREE,3349.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,3349.0,0.0,3349.0,nan,nan,0.0,3349.0,0
TCGA-2G-AAHC-01,TCGA-2G-AAHC,TGCT,33.0,MALE,WHITE,IS,Stage IIA,Seminoma; NOS,nan,1999.0,nan,-12105.0,Alive,TUMOR FREE,5539.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,5539.0,0.0,5539.0,0.0,5539.0,0.0,5539.0,0
TCGA-2G-AAHG-01,TCGA-2G-AAHG,TGCT,25.0,MALE,WHITE,Stage I,Stage I,Seminoma; NOS,nan,1992.0,nan,-9476.0,Alive,TUMOR FREE,1819.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1819.0,0.0,1819.0,0.0,1819.0,0.0,1819.0,0
TCGA-2G-AAHL-01,TCGA-2G-AAHL,TGCT,26.0,MALE,WHITE,Stage I,Stage I,Seminoma; NOS,nan,1994.0,nan,-9749.0,Alive,TUMOR FREE,7081.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,7081.0,0.0,7081.0,0.0,7081.0,0.0,7081.0,0
TCGA-2G-AAHN-01,TCGA-2G-AAHN,TGCT,32.0,MALE,WHITE,Stage I,Stage I,Seminoma; NOS,nan,1996.0,nan,-12028.0,Alive,TUMOR FREE,6445.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,6445.0,0.0,6445.0,0.0,6445.0,0.0,6445.0,0
TCGA-2G-AAHP-05,TCGA-2G-AAHP,TGCT,31.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,nan,1999.0,nan,-11649.0,Alive,TUMOR FREE,5667.0,nan,nan,New Primary Tumor,Testes,nan,816.0,Complete Remission/Response,nan,nan,0.0,5667.0,0.0,5667.0,1.0,816.0,1.0,816.0,0
TCGA-2G-AAHP-01,TCGA-2G-AAHP,TGCT,31.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,nan,1999.0,nan,-11649.0,Alive,TUMOR FREE,5667.0,nan,nan,New Primary Tumor,Testes,nan,816.0,Complete Remission/Response,nan,nan,0.0,5667.0,0.0,5667.0,1.0,816.0,1.0,816.0,0
TCGA-2G-AAHT-01,TCGA-2G-AAHT,TGCT,32.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,nan,2013.0,nan,-11905.0,Alive,TUMOR FREE,542.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,542.0,0.0,542.0,0.0,542.0,0.0,542.0,0
TCGA-2G-AAKD-01,TCGA-2G-AAKD,TGCT,18.0,MALE,WHITE,Stage III,Stage III,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,nan,1997.0,nan,-6814.0,Alive,TUMOR FREE,6340.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,6340.0,0.0,6340.0,nan,nan,0.0,6340.0,0
TCGA-2G-AAKG-05,TCGA-2G-AAKG,TGCT,22.0,MALE,WHITE,Stage I,Stage I,Non-Seminoma; Embryonal Carcinoma,nan,1996.0,nan,-8353.0,Alive,TUMOR FREE,6598.0,nan,nan,Locoregional Recurrence,Retroperitoneal lymph nodes,nan,122.0,Complete Remission/Response,nan,nan,0.0,6598.0,0.0,6598.0,1.0,122.0,1.0,122.0,0
TCGA-2G-AAKG-01,TCGA-2G-AAKG,TGCT,22.0,MALE,WHITE,Stage I,Stage I,Non-Seminoma; Embryonal Carcinoma,nan,1996.0,nan,-8353.0,Alive,TUMOR FREE,6598.0,nan,nan,Locoregional Recurrence,Retroperitoneal lymph nodes,nan,122.0,Complete Remission/Response,nan,nan,0.0,6598.0,0.0,6598.0,1.0,122.0,1.0,122.0,0
TCGA-2G-AAKH-01,TCGA-2G-AAKH,TGCT,19.0,MALE,WHITE,Stage II,Stage II,Non-Seminoma; Embryonal Carcinoma|Seminoma; NOS,nan,1996.0,nan,-6954.0,Alive,TUMOR FREE,6862.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,6862.0,0.0,6862.0,0.0,6862.0,0.0,6862.0,0
TCGA-2G-AAKL-01,TCGA-2G-AAKL,TGCT,26.0,MALE,WHITE,Stage II,Stage II,Non-Seminoma; Embryonal Carcinoma,nan,1995.0,nan,-9813.0,Alive,TUMOR FREE,7023.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,7023.0,0.0,7023.0,nan,nan,0.0,7023.0,0
TCGA-2G-AAKM-01,TCGA-2G-AAKM,TGCT,14.0,MALE,WHITE,Stage II,Stage IIA,Non-Seminoma; Teratoma (Mature)|[Not Available]|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,nan,1995.0,nan,-5321.0,Dead,TUMOR FREE,nan,6972.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,6972.0,0.0,6972.0,0.0,6972.0,0.0,6972.0,0
TCGA-2G-AAL5-01,TCGA-2G-AAL5,TGCT,31.0,MALE,WHITE,Stage I,Stage I,Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma|Seminoma; NOS,nan,1994.0,nan,-11478.0,Alive,TUMOR FREE,7437.0,nan,nan,New Primary Tumor,Testes,nan,3723.0,Complete Remission/Response,nan,nan,0.0,7437.0,0.0,7437.0,1.0,3723.0,1.0,3723.0,0
TCGA-2G-AAL7-01,TCGA-2G-AAL7,TGCT,32.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,nan,2003.0,nan,-11917.0,Alive,TUMOR FREE,3991.0,nan,nan,Locoregional Recurrence,Retroperitoneal lymph nodes,nan,2.0,Complete Remission/Response,nan,nan,0.0,3991.0,0.0,3991.0,1.0,2.0,1.0,2.0,0
TCGA-2G-AALP-01,TCGA-2G-AALP,TGCT,43.0,MALE,WHITE,Stage IIIB,Stage IIIB,Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature),nan,2007.0,nan,-15977.0,Alive,TUMOR FREE,2645.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,2645.0,0.0,2645.0,nan,nan,0.0,2645.0,0
TCGA-2X-A9D5-01,TCGA-2X-A9D5,TGCT,49.0,MALE,WHITE,Stage I,Stage II,Seminoma; NOS,nan,2013.0,nan,-17969.0,Alive,TUMOR FREE,435.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,435.0,0.0,435.0,0.0,435.0,0.0,435.0,0
TCGA-2X-A9D6-01,TCGA-2X-A9D6,TGCT,42.0,MALE,WHITE,Stage I,nan,Seminoma; NOS,nan,2013.0,nan,-15371.0,Alive,WITH TUMOR,607.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,607.0,0.0,607.0,0.0,607.0,0.0,607.0,0
TCGA-4K-AA1G-01,TCGA-4K-AA1G,TGCT,34.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,nan,2013.0,nan,-12696.0,Alive,TUMOR FREE,436.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,436.0,0.0,436.0,0.0,436.0,0.0,436.0,0
TCGA-4K-AA1H-01,TCGA-4K-AA1H,TGCT,26.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,nan,2013.0,nan,-9658.0,Alive,TUMOR FREE,518.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,518.0,0.0,518.0,0.0,518.0,0.0,518.0,0
TCGA-4K-AA1I-01,TCGA-4K-AA1I,TGCT,26.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,nan,2013.0,nan,-9679.0,Alive,TUMOR FREE,3.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3.0,0.0,3.0,nan,nan,0.0,3.0,0
TCGA-4K-AAAL-01,TCGA-4K-AAAL,TGCT,31.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,nan,2013.0,nan,-11622.0,Alive,TUMOR FREE,483.0,nan,nan,Locoregional Recurrence,Lymph Node(s),nan,147.0,No Measureable Tumor or Tumor Markers,nan,nan,0.0,483.0,0.0,483.0,1.0,147.0,1.0,147.0,0
TCGA-S6-A8JW-01,TCGA-S6-A8JW,TGCT,37.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,nan,2013.0,nan,-13861.0,Alive,TUMOR FREE,698.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,698.0,0.0,698.0,0.0,698.0,0.0,698.0,0
TCGA-S6-A8JX-01,TCGA-S6-A8JX,TGCT,27.0,MALE,WHITE,Stage IB,Stage IB,Seminoma; NOS,nan,2013.0,nan,-9963.0,Alive,TUMOR FREE,552.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,552.0,0.0,552.0,0.0,552.0,0.0,552.0,0
TCGA-S6-A8JY-01,TCGA-S6-A8JY,TGCT,27.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,nan,2013.0,nan,-10219.0,Alive,TUMOR FREE,278.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,278.0,0.0,278.0,nan,nan,0.0,278.0,0
TCGA-SB-A6J6-01,TCGA-SB-A6J6,TGCT,22.0,MALE,WHITE,Stage IA,nan,Seminoma; NOS,nan,2013.0,nan,-8233.0,Alive,TUMOR FREE,413.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,413.0,0.0,413.0,0.0,413.0,0.0,413.0,0
TCGA-SB-A76C-01,TCGA-SB-A76C,TGCT,38.0,MALE,WHITE,nan,Stage I,Seminoma; NOS,nan,2013.0,nan,-14023.0,Alive,TUMOR FREE,42.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,42.0,0.0,42.0,0.0,42.0,0.0,42.0,0
TCGA-SN-A6IS-01,TCGA-SN-A6IS,TGCT,26.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS|Non-Seminoma; Teratoma (Mature),nan,2013.0,nan,-9618.0,Alive,TUMOR FREE,496.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,496.0,0.0,496.0,0.0,496.0,0.0,496.0,0
TCGA-SN-A84W-01,TCGA-SN-A84W,TGCT,30.0,MALE,WHITE,IS,nan,Seminoma; NOS|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,nan,2013.0,nan,-11251.0,Alive,TUMOR FREE,293.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,293.0,0.0,293.0,0.0,293.0,0.0,293.0,0
TCGA-SN-A84X-01,TCGA-SN-A84X,TGCT,21.0,MALE,WHITE,IS,Stage IB,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Seminoma; NOS,nan,2013.0,nan,-7833.0,Alive,TUMOR FREE,312.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,312.0,0.0,312.0,0.0,312.0,0.0,312.0,0
TCGA-SN-A84Y-01,TCGA-SN-A84Y,TGCT,18.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma,nan,2013.0,nan,-6805.0,Alive,WITH TUMOR,524.0,nan,nan,Distant Metastasis,"Other, specify",bone,44.0,Progressive Disease,nan,nan,0.0,524.0,0.0,524.0,nan,nan,1.0,44.0,0
TCGA-SO-A8JP-01,TCGA-SO-A8JP,TGCT,29.0,MALE,WHITE,Stage I,nan,Seminoma; NOS,nan,2013.0,nan,-10765.0,Alive,TUMOR FREE,540.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,540.0,0.0,540.0,0.0,540.0,0.0,540.0,0
TCGA-VF-A8A8-01,TCGA-VF-A8A8,TGCT,18.0,MALE,WHITE,Stage IA,Stage IA,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Mature),nan,2011.0,nan,-6822.0,Alive,TUMOR FREE,1131.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1131.0,0.0,1131.0,0.0,1131.0,0.0,1131.0,0
TCGA-VF-A8A9-01,TCGA-VF-A8A9,TGCT,31.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,nan,2011.0,nan,-11520.0,Alive,TUMOR FREE,1119.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1119.0,0.0,1119.0,0.0,1119.0,0.0,1119.0,0
TCGA-VF-A8AA-01,TCGA-VF-A8AA,TGCT,51.0,MALE,WHITE,Stage I,Stage I,Seminoma; NOS,nan,2011.0,nan,-18940.0,Alive,TUMOR FREE,1146.0,nan,nan,Locoregional Recurrence,Lymph Node(s),nan,1059.0,Complete Remission/Response,nan,nan,0.0,1146.0,0.0,1146.0,1.0,1059.0,1.0,1059.0,0
TCGA-VF-A8AB-01,TCGA-VF-A8AB,TGCT,31.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,Stage IA,Seminoma; NOS,nan,2011.0,nan,-11659.0,Alive,TUMOR FREE,760.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,760.0,0.0,760.0,nan,nan,0.0,760.0,0
TCGA-VF-A8AC-01,TCGA-VF-A8AC,TGCT,29.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,nan,2011.0,nan,-10598.0,Alive,TUMOR FREE,1083.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1083.0,0.0,1083.0,0.0,1083.0,0.0,1083.0,0
TCGA-VF-A8AD-01,TCGA-VF-A8AD,TGCT,36.0,MALE,WHITE,Stage IB,Stage IB,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,nan,2011.0,nan,-13499.0,Alive,WITH TUMOR,1006.0,nan,nan,Locoregional Recurrence,Testes,nan,276.0,Complete Remission/Response,nan,nan,0.0,1006.0,0.0,1006.0,1.0,276.0,1.0,276.0,2
TCGA-VF-A8AE-01,TCGA-VF-A8AE,TGCT,39.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,nan,2012.0,nan,-14535.0,Alive,TUMOR FREE,727.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,727.0,0.0,727.0,0.0,727.0,0.0,727.0,0
TCGA-W4-A7U2-01,TCGA-W4-A7U2,TGCT,26.0,MALE,WHITE,nan,Stage IA,Seminoma; NOS|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Embryonal Carcinoma,nan,2010.0,nan,-9573.0,Alive,TUMOR FREE,1263.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1263.0,0.0,1263.0,0.0,1263.0,0.0,1263.0,0
TCGA-W4-A7U3-01,TCGA-W4-A7U3,TGCT,26.0,MALE,WHITE,nan,Stage IS,Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Choriocarcinoma,nan,2010.0,nan,-9581.0,Alive,TUMOR FREE,149.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,149.0,0.0,149.0,0.0,149.0,0.0,149.0,0
TCGA-W4-A7U4-01,TCGA-W4-A7U4,TGCT,23.0,MALE,WHITE,nan,Stage I,Non-Seminoma; Embryonal Carcinoma|[Not Available],nan,2011.0,nan,-8518.0,Alive,TUMOR FREE,738.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,738.0,0.0,738.0,0.0,738.0,0.0,738.0,0
TCGA-WZ-A7V3-01,TCGA-WZ-A7V3,TGCT,20.0,MALE,WHITE,Stage I,nan,Seminoma; NOS,nan,2012.0,nan,-7325.0,Alive,TUMOR FREE,753.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,753.0,0.0,753.0,0.0,753.0,0.0,753.0,0
TCGA-WZ-A7V4-01,TCGA-WZ-A7V4,TGCT,28.0,MALE,WHITE,Stage I,nan,Seminoma; NOS,nan,2012.0,nan,-10262.0,Alive,TUMOR FREE,894.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,894.0,0.0,894.0,0.0,894.0,0.0,894.0,0
TCGA-WZ-A7V5-01,TCGA-WZ-A7V5,TGCT,27.0,MALE,WHITE,Stage I,nan,Seminoma; NOS,nan,2012.0,nan,-9886.0,Alive,TUMOR FREE,1061.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,1061.0,0.0,1061.0,0.0,1061.0,0.0,1061.0,0
TCGA-WZ-A8D5-01,TCGA-WZ-A8D5,TGCT,38.0,MALE,WHITE,[Discrepancy],nan,Seminoma; NOS,nan,2012.0,nan,-13974.0,Alive,TUMOR FREE,774.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,774.0,0.0,774.0,0.0,774.0,0.0,774.0,0
TCGA-X3-A8G4-01,TCGA-X3-A8G4,TGCT,33.0,MALE,WHITE,IS,nan,Seminoma; NOS|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Teratoma (Immature),nan,2011.0,nan,-12117.0,Alive,TUMOR FREE,856.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,856.0,0.0,856.0,nan,nan,0.0,856.0,0
TCGA-XE-A8H1-01,TCGA-XE-A8H1,TGCT,24.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Embryonal Carcinoma,nan,2009.0,nan,-8893.0,Alive,TUMOR FREE,209.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,209.0,0.0,209.0,0.0,209.0,0.0,209.0,0
TCGA-XE-A8H4-01,TCGA-XE-A8H4,TGCT,23.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,nan,2008.0,nan,-8728.0,Alive,TUMOR FREE,559.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,559.0,0.0,559.0,0.0,559.0,0.0,559.0,0
TCGA-XE-A8H5-01,TCGA-XE-A8H5,TGCT,29.0,MALE,[Unknown],IS,Stage IS,Seminoma; NOS,nan,2008.0,nan,-10942.0,Alive,TUMOR FREE,1217.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,1217.0,0.0,1217.0,0.0,1217.0,0.0,1217.0,0
TCGA-XE-A9SE-01,TCGA-XE-A9SE,TGCT,35.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,nan,2008.0,nan,-12850.0,Alive,TUMOR FREE,708.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,708.0,0.0,708.0,0.0,708.0,0.0,708.0,0
TCGA-XE-AANI-01,TCGA-XE-AANI,TGCT,37.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Embryonal Carcinoma,nan,2007.0,nan,-13553.0,Alive,TUMOR FREE,1041.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,1041.0,0.0,1041.0,0.0,1041.0,0.0,1041.0,0
TCGA-XE-AANJ-01,TCGA-XE-AANJ,TGCT,39.0,MALE,WHITE,IS,Stage IIIB,Seminoma; NOS,nan,2007.0,nan,-14314.0,Alive,TUMOR FREE,2007.0,nan,nan,Locoregional Recurrence,Lymph Node(s),nan,328.0,"Normalization of Tumor Markers, but Residual Tumor Mass",nan,nan,0.0,2007.0,0.0,2007.0,nan,nan,1.0,328.0,0
TCGA-XE-AANR-01,TCGA-XE-AANR,TGCT,23.0,MALE,WHITE,Stage I,Stage I,Seminoma; NOS,nan,2008.0,nan,-8761.0,Alive,TUMOR FREE,14.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,14.0,0.0,14.0,nan,nan,0.0,14.0,0
TCGA-XE-AANV-01,TCGA-XE-AANV,TGCT,52.0,MALE,[Unknown],Stage IB,Stage IB,Seminoma; NOS,nan,2010.0,nan,-19112.0,Alive,TUMOR FREE,1701.0,nan,nan,Locoregional Recurrence,Lymph Node(s),nan,1370.0,No Measureable Tumor or Tumor Markers,nan,nan,0.0,1701.0,0.0,1701.0,1.0,1370.0,1.0,1370.0,0
TCGA-XE-AAO3-01,TCGA-XE-AAO3,TGCT,33.0,MALE,ASIAN,Stage I,Stage I,Seminoma; NOS,nan,2006.0,nan,-12095.0,Alive,TUMOR FREE,2857.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,2857.0,0.0,2857.0,nan,nan,0.0,2857.0,0
TCGA-XE-AAO4-01,TCGA-XE-AAO4,TGCT,40.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,nan,2006.0,nan,-14930.0,Alive,TUMOR FREE,367.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,367.0,0.0,367.0,0.0,367.0,0.0,367.0,0
TCGA-XE-AAO6-01,TCGA-XE-AAO6,TGCT,47.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,nan,2007.0,nan,-17417.0,Alive,TUMOR FREE,240.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,240.0,0.0,240.0,0.0,240.0,0.0,240.0,0
TCGA-XE-AAOB-01,TCGA-XE-AAOB,TGCT,27.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Choriocarcinoma|Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature),nan,2008.0,nan,-9907.0,Dead,WITH TUMOR,nan,513.0,Testicular Germ Cell Tumor (TGCT),Distant Metastasis,Lymph Node(s),nan,231.0,nan,nan,nan,1.0,513.0,1.0,513.0,nan,nan,1.0,231.0,1
TCGA-XE-AAOC-01,TCGA-XE-AAOC,TGCT,31.0,MALE,WHITE,Stage IA,Stage IA,Non-Seminoma; Teratoma (Immature)|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Yolk Sac Tumor,nan,2008.0,nan,-11566.0,Alive,TUMOR FREE,270.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,270.0,0.0,270.0,0.0,270.0,0.0,270.0,0
TCGA-XE-AAOD-01,TCGA-XE-AAOD,TGCT,39.0,MALE,WHITE,Stage IB,Stage IB,Seminoma; NOS|Non-Seminoma; Choriocarcinoma,nan,2008.0,nan,-14265.0,Alive,TUMOR FREE,2058.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,2058.0,0.0,2058.0,0.0,2058.0,0.0,2058.0,0
TCGA-XE-AAOF-01,TCGA-XE-AAOF,TGCT,50.0,MALE,ASIAN,Stage IA,Stage IA,Seminoma; NOS,nan,2009.0,nan,-18490.0,Alive,TUMOR FREE,1268.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,1268.0,0.0,1268.0,0.0,1268.0,0.0,1268.0,0
TCGA-XE-AAOJ-01,TCGA-XE-AAOJ,TGCT,24.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Teratoma (Mature)|Non-Seminoma; Teratoma (Immature),nan,2009.0,nan,-9046.0,Alive,TUMOR FREE,1550.0,nan,nan,Locoregional Recurrence,"Other, specify",Mature teratoma: abdominal wall,266.0,"Normalization of Tumor Markers, but Residual Tumor Mass",nan,nan,0.0,1550.0,0.0,1550.0,nan,nan,1.0,266.0,0
TCGA-XE-AAOL-01,TCGA-XE-AAOL,TGCT,38.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,Stage I,Seminoma; NOS,nan,2008.0,nan,-14230.0,Alive,TUMOR FREE,13.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,13.0,0.0,13.0,nan,nan,0.0,13.0,0
TCGA-XY-A89B-01,TCGA-XY-A89B,TGCT,35.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,nan,2013.0,nan,-12955.0,Alive,TUMOR FREE,471.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,471.0,0.0,471.0,0.0,471.0,0.0,471.0,0
TCGA-XY-A8S2-01,TCGA-XY-A8S2,TGCT,67.0,MALE,WHITE,Stage I,Stage I,Non-Seminoma; Embryonal Carcinoma|[Not Available]|[Not Available]|[Not Available],nan,2012.0,nan,-24759.0,Alive,TUMOR FREE,672.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,672.0,0.0,672.0,0.0,672.0,0.0,672.0,0
TCGA-XY-A8S3-01,TCGA-XY-A8S3,TGCT,24.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Choriocarcinoma,nan,2012.0,nan,-8835.0,Alive,TUMOR FREE,843.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,843.0,0.0,843.0,0.0,843.0,0.0,843.0,0
TCGA-XY-A9T9-01,TCGA-XY-A9T9,TGCT,37.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,nan,2013.0,nan,-13604.0,Alive,TUMOR FREE,281.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,281.0,0.0,281.0,0.0,281.0,0.0,281.0,0
TCGA-YU-A90P-01,TCGA-YU-A90P,TGCT,25.0,MALE,WHITE,Stage IA,Stage IA,Non-Seminoma; Embryonal Carcinoma,nan,2009.0,nan,-9144.0,Alive,TUMOR FREE,2069.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,2069.0,0.0,2069.0,0.0,2069.0,0.0,2069.0,0
TCGA-YU-A90Q-01,TCGA-YU-A90Q,TGCT,21.0,MALE,[Unknown],Stage IB,Stage IB,Seminoma; NOS,nan,2008.0,nan,-7846.0,Alive,TUMOR FREE,1964.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,1964.0,0.0,1964.0,0.0,1964.0,0.0,1964.0,0
TCGA-YU-A90S-01,TCGA-YU-A90S,TGCT,26.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,nan,2009.0,nan,-9531.0,Alive,nan,971.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,971.0,0.0,971.0,nan,nan,0.0,971.0,0
TCGA-YU-A90W-01,TCGA-YU-A90W,TGCT,45.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,nan,2011.0,nan,-16497.0,Alive,TUMOR FREE,1113.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,1113.0,0.0,1113.0,0.0,1113.0,0.0,1113.0,0
TCGA-YU-A90Y-01,TCGA-YU-A90Y,TGCT,23.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,Stage IIIC,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,nan,2011.0,nan,-8460.0,Dead,WITH TUMOR,nan,17.0,Testicular Germ Cell Tumor (TGCT),nan,nan,nan,nan,nan,nan,nan,1.0,17.0,1.0,17.0,nan,nan,1.0,17.0,1
TCGA-YU-A912-01,TCGA-YU-A912,TGCT,34.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,Stage IIIC,Seminoma; NOS,nan,2012.0,nan,-12552.0,Alive,WITH TUMOR,866.0,nan,nan,nan,nan,nan,nan,"Normalization of Tumor Markers, but Residual Tumor Mass",nan,nan,0.0,866.0,0.0,866.0,nan,nan,0.0,866.0,0
TCGA-YU-A94D-01,TCGA-YU-A94D,TGCT,28.0,MALE,[Unknown],Stage IIIB,Stage IIIB,Non-Seminoma; Teratoma (Immature),nan,2009.0,nan,-10427.0,Alive,TUMOR FREE,2167.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,2167.0,0.0,2167.0,0.0,2167.0,0.0,2167.0,0
TCGA-YU-A94I-01,TCGA-YU-A94I,TGCT,66.0,MALE,[Unknown],Stage IA,Stage IA,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor,nan,2013.0,nan,-24349.0,Alive,TUMOR FREE,536.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,536.0,0.0,536.0,0.0,536.0,0.0,536.0,0
TCGA-YU-AA4L-01,TCGA-YU-AA4L,TGCT,27.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,Stage IIIC,Non-Seminoma; Embryonal Carcinoma,nan,2010.0,nan,-9902.0,Alive,TUMOR FREE,1573.0,nan,nan,Locoregional Recurrence,Retroperitoneal lymph nodes,nan,105.0,nan,nan,nan,0.0,1573.0,0.0,1573.0,nan,nan,1.0,105.0,0
TCGA-YU-AA61-01,TCGA-YU-AA61,TGCT,29.0,MALE,WHITE,IS,Stage IS,Non-Seminoma; Embryonal Carcinoma|Non-Seminoma; Yolk Sac Tumor|Non-Seminoma; Teratoma (Immature),nan,2011.0,nan,-10635.0,Alive,TUMOR FREE,864.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,864.0,0.0,864.0,0.0,864.0,0.0,864.0,0
TCGA-ZM-AA05-01,TCGA-ZM-AA05,TGCT,36.0,MALE,WHITE,Stage IIC,Stage IIC,Seminoma; NOS,nan,2011.0,nan,-13295.0,Alive,TUMOR FREE,1126.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1126.0,0.0,1126.0,0.0,1126.0,0.0,1126.0,0
TCGA-ZM-AA06-01,TCGA-ZM-AA06,TGCT,45.0,MALE,WHITE,Stage IB,Stage IB,Seminoma; NOS,nan,2011.0,nan,-16719.0,Alive,TUMOR FREE,1498.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,1498.0,0.0,1498.0,0.0,1498.0,0.0,1498.0,0
TCGA-ZM-AA0B-01,TCGA-ZM-AA0B,TGCT,32.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,nan,2012.0,nan,-11820.0,Alive,TUMOR FREE,838.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,838.0,0.0,838.0,0.0,838.0,0.0,838.0,0
TCGA-ZM-AA0D-01,TCGA-ZM-AA0D,TGCT,34.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,nan,2012.0,nan,-12738.0,Alive,TUMOR FREE,848.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,848.0,0.0,848.0,0.0,848.0,0.0,848.0,0
TCGA-ZM-AA0E-01,TCGA-ZM-AA0E,TGCT,39.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,nan,2012.0,nan,-14255.0,Alive,TUMOR FREE,811.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,811.0,0.0,811.0,0.0,811.0,0.0,811.0,0
TCGA-ZM-AA0F-01,TCGA-ZM-AA0F,TGCT,35.0,MALE,WHITE,Stage IA,Stage IA,Seminoma; NOS,nan,2013.0,nan,-12973.0,Alive,TUMOR FREE,681.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,681.0,0.0,681.0,0.0,681.0,0.0,681.0,0
TCGA-ZM-AA0H-01,TCGA-ZM-AA0H,TGCT,50.0,MALE,WHITE,IS,Stage IS,Seminoma; NOS,nan,2010.0,nan,-18419.0,Alive,TUMOR FREE,1736.0,nan,nan,nan,nan,nan,nan,No Measureable Tumor or Tumor Markers,nan,nan,0.0,1736.0,0.0,1736.0,0.0,1736.0,0.0,1736.0,0
TCGA-ZM-AA0N-01,TCGA-ZM-AA0N,TGCT,44.0,MALE,WHITE,Stage IB,Stage IB,Seminoma; NOS,nan,2013.0,nan,-16094.0,Alive,TUMOR FREE,634.0,nan,nan,Distant Metastasis,Retroperitoneal lymph nodes,nan,490.0,No Measureable Tumor or Tumor Markers,nan,nan,0.0,634.0,0.0,634.0,1.0,490.0,1.0,490.0,0
TCGA-4C-A93U-01,TCGA-4C-A93U,THCA,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2013.0,nan,-27348.0,Alive,TUMOR FREE,129.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,129.0,0.0,129.0,nan,nan,0.0,129.0,0
TCGA-BJ-A0YZ-01,TCGA-BJ-A0YZ,THCA,65.0,MALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-24102.0,Alive,TUMOR FREE,754.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,754.0,0.0,754.0,0.0,754.0,0.0,754.0,0
TCGA-BJ-A0Z0-01,TCGA-BJ-A0Z0,THCA,55.0,MALE,nan,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-20361.0,Alive,TUMOR FREE,419.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,419.0,0.0,419.0,0.0,419.0,0.0,419.0,0
TCGA-BJ-A0Z2-01,TCGA-BJ-A0Z2,THCA,57.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVC,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-21008.0,Alive,WITH TUMOR,1514.0,nan,nan,Distant Metastasis,Bone,nan,158.0,nan,nan,RX,0.0,1514.0,0.0,1514.0,nan,nan,1.0,158.0,0
TCGA-BJ-A0Z3-01,TCGA-BJ-A0Z3,THCA,33.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-12295.0,Alive,TUMOR FREE,497.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,497.0,0.0,497.0,nan,nan,0.0,497.0,0
TCGA-BJ-A0Z5-01,TCGA-BJ-A0Z5,THCA,58.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-21369.0,Alive,TUMOR FREE,448.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,448.0,0.0,448.0,nan,nan,0.0,448.0,0
TCGA-BJ-A0Z9-01,TCGA-BJ-A0Z9,THCA,57.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2010.0,nan,-21061.0,Alive,TUMOR FREE,1257.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,1257.0,0.0,1257.0,nan,nan,0.0,1257.0,0
TCGA-BJ-A0ZA-01,TCGA-BJ-A0ZA,THCA,67.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-24528.0,Alive,TUMOR FREE,574.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,574.0,0.0,574.0,0.0,574.0,0.0,574.0,0
TCGA-BJ-A0ZB-01,TCGA-BJ-A0ZB,THCA,66.0,MALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-24415.0,Alive,TUMOR FREE,122.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,122.0,0.0,122.0,nan,nan,0.0,122.0,0
TCGA-BJ-A0ZC-01,TCGA-BJ-A0ZC,THCA,55.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-20282.0,Alive,TUMOR FREE,352.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,352.0,0.0,352.0,0.0,352.0,0.0,352.0,0
TCGA-BJ-A0ZE-01,TCGA-BJ-A0ZE,THCA,63.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-23250.0,Alive,TUMOR FREE,509.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,509.0,0.0,509.0,nan,nan,0.0,509.0,0
TCGA-BJ-A0ZF-01,TCGA-BJ-A0ZF,THCA,54.0,FEMALE,WHITE,Stage II,nan,"Other, specify",nan,2010.0,nan,-19978.0,Alive,WITH TUMOR,1217.0,nan,nan,Locoregional Recurrence,nan,nan,735.0,nan,nan,R0,0.0,1217.0,0.0,1217.0,1.0,735.0,1.0,735.0,2
TCGA-BJ-A0ZG-01,TCGA-BJ-A0ZG,THCA,80.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-29375.0,Alive,TUMOR FREE,775.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,775.0,0.0,775.0,nan,nan,0.0,775.0,0
TCGA-BJ-A0ZH-01,TCGA-BJ-A0ZH,THCA,52.0,FEMALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2010.0,nan,-19114.0,Alive,TUMOR FREE,460.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,460.0,0.0,460.0,nan,nan,0.0,460.0,0
TCGA-BJ-A0ZJ-01,TCGA-BJ-A0ZJ,THCA,36.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-13149.0,Alive,TUMOR FREE,1280.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1280.0,0.0,1280.0,0.0,1280.0,0.0,1280.0,0
TCGA-BJ-A18Y-01,TCGA-BJ-A18Y,THCA,29.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-10832.0,Alive,TUMOR FREE,1563.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1563.0,0.0,1563.0,0.0,1563.0,0.0,1563.0,0
TCGA-BJ-A18Z-01,TCGA-BJ-A18Z,THCA,58.0,MALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-21519.0,Alive,TUMOR FREE,1263.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,1263.0,0.0,1263.0,nan,nan,0.0,1263.0,0
TCGA-BJ-A190-01,TCGA-BJ-A190,THCA,55.0,MALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-20407.0,Alive,TUMOR FREE,626.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,626.0,0.0,626.0,0.0,626.0,0.0,626.0,0
TCGA-BJ-A191-01,TCGA-BJ-A191,THCA,49.0,FEMALE,WHITE,Stage I,nan,"Other, specify",nan,2010.0,nan,-18162.0,Alive,TUMOR FREE,147.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,147.0,0.0,147.0,0.0,147.0,0.0,147.0,0
TCGA-BJ-A192-01,TCGA-BJ-A192,THCA,54.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-19878.0,Alive,TUMOR FREE,1349.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,1349.0,0.0,1349.0,nan,nan,0.0,1349.0,0
TCGA-BJ-A28R-01,TCGA-BJ-A28R,THCA,38.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-14044.0,Alive,TUMOR FREE,1282.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1282.0,0.0,1282.0,nan,nan,0.0,1282.0,0
TCGA-BJ-A28R-11,TCGA-BJ-A28R,THCA,38.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-14044.0,Alive,TUMOR FREE,1282.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1282.0,0.0,1282.0,nan,nan,0.0,1282.0,0
TCGA-BJ-A28S-01,TCGA-BJ-A28S,THCA,79.0,MALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-29143.0,Alive,TUMOR FREE,640.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,640.0,0.0,640.0,nan,nan,0.0,640.0,0
TCGA-BJ-A28T-01,TCGA-BJ-A28T,THCA,34.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-12698.0,Alive,TUMOR FREE,1081.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1081.0,0.0,1081.0,nan,nan,0.0,1081.0,0
TCGA-BJ-A28T-11,TCGA-BJ-A28T,THCA,34.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-12698.0,Alive,TUMOR FREE,1081.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1081.0,0.0,1081.0,nan,nan,0.0,1081.0,0
TCGA-BJ-A28V-01,TCGA-BJ-A28V,THCA,80.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-29508.0,Alive,TUMOR FREE,987.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,987.0,0.0,987.0,nan,nan,0.0,987.0,0
TCGA-BJ-A28W-01,TCGA-BJ-A28W,THCA,32.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-11999.0,Alive,TUMOR FREE,344.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,344.0,0.0,344.0,nan,nan,0.0,344.0,0
TCGA-BJ-A28W-11,TCGA-BJ-A28W,THCA,32.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-11999.0,Alive,TUMOR FREE,344.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,344.0,0.0,344.0,nan,nan,0.0,344.0,0
TCGA-BJ-A28X-01,TCGA-BJ-A28X,THCA,32.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2010.0,nan,-11735.0,Alive,TUMOR FREE,942.0,nan,nan,nan,nan,nan,494.0,nan,nan,R0,0.0,942.0,0.0,942.0,1.0,494.0,1.0,494.0,0
TCGA-BJ-A28X-11,TCGA-BJ-A28X,THCA,32.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2010.0,nan,-11735.0,Alive,TUMOR FREE,942.0,nan,nan,nan,nan,nan,494.0,nan,nan,R0,0.0,942.0,0.0,942.0,1.0,494.0,1.0,494.0,0
TCGA-BJ-A28Z-01,TCGA-BJ-A28Z,THCA,46.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-16912.0,Alive,TUMOR FREE,337.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,337.0,0.0,337.0,nan,nan,0.0,337.0,0
TCGA-BJ-A290-01,TCGA-BJ-A290,THCA,70.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2010.0,nan,-25803.0,Alive,WITH TUMOR,919.0,nan,nan,Distant Metastasis,Lung,nan,329.0,nan,nan,nan,0.0,919.0,0.0,919.0,nan,nan,1.0,329.0,0
TCGA-BJ-A290-11,TCGA-BJ-A290,THCA,70.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2010.0,nan,-25803.0,Alive,WITH TUMOR,919.0,nan,nan,Distant Metastasis,Lung,nan,329.0,nan,nan,nan,0.0,919.0,0.0,919.0,nan,nan,1.0,329.0,0
TCGA-BJ-A291-01,TCGA-BJ-A291,THCA,56.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-20682.0,Alive,TUMOR FREE,696.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,696.0,0.0,696.0,nan,nan,0.0,696.0,0
TCGA-BJ-A2N7-01,TCGA-BJ-A2N7,THCA,30.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-11188.0,Alive,TUMOR FREE,559.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,559.0,0.0,559.0,0.0,559.0,0.0,559.0,0
TCGA-BJ-A2N7-11,TCGA-BJ-A2N7,THCA,30.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-11188.0,Alive,TUMOR FREE,559.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,559.0,0.0,559.0,0.0,559.0,0.0,559.0,0
TCGA-BJ-A2N8-01,TCGA-BJ-A2N8,THCA,30.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-11024.0,Alive,TUMOR FREE,504.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,504.0,0.0,504.0,nan,nan,0.0,504.0,0
TCGA-BJ-A2N8-11,TCGA-BJ-A2N8,THCA,30.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-11024.0,Alive,TUMOR FREE,504.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,504.0,0.0,504.0,nan,nan,0.0,504.0,0
TCGA-BJ-A2N9-01,TCGA-BJ-A2N9,THCA,42.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-15411.0,Alive,WITH TUMOR,623.0,nan,nan,Distant Metastasis,nan,nan,225.0,nan,nan,R1,0.0,623.0,0.0,623.0,nan,nan,1.0,225.0,0
TCGA-BJ-A2N9-11,TCGA-BJ-A2N9,THCA,42.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-15411.0,Alive,WITH TUMOR,623.0,nan,nan,Distant Metastasis,nan,nan,225.0,nan,nan,R1,0.0,623.0,0.0,623.0,nan,nan,1.0,225.0,0
TCGA-BJ-A2NA-01,TCGA-BJ-A2NA,THCA,77.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-28147.0,Alive,WITH TUMOR,577.0,nan,nan,Distant Metastasis,nan,nan,127.0,nan,nan,R1,0.0,577.0,0.0,577.0,nan,nan,1.0,127.0,0
TCGA-BJ-A2NA-11,TCGA-BJ-A2NA,THCA,77.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-28147.0,Alive,WITH TUMOR,577.0,nan,nan,Distant Metastasis,nan,nan,127.0,nan,nan,R1,0.0,577.0,0.0,577.0,nan,nan,1.0,127.0,0
TCGA-BJ-A2P4-01,TCGA-BJ-A2P4,THCA,29.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-10602.0,Alive,TUMOR FREE,390.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,390.0,0.0,390.0,0.0,390.0,0.0,390.0,0
TCGA-BJ-A3EZ-01,TCGA-BJ-A3EZ,THCA,51.0,MALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-18882.0,Alive,TUMOR FREE,487.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,487.0,0.0,487.0,nan,nan,0.0,487.0,0
TCGA-BJ-A3F0-01,TCGA-BJ-A3F0,THCA,64.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-23545.0,Alive,TUMOR FREE,424.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,424.0,0.0,424.0,0.0,424.0,0.0,424.0,0
TCGA-BJ-A3PR-01,TCGA-BJ-A3PR,THCA,69.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-25565.0,Alive,TUMOR FREE,1107.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1107.0,0.0,1107.0,0.0,1107.0,0.0,1107.0,0
TCGA-BJ-A3PR-11,TCGA-BJ-A3PR,THCA,69.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-25565.0,Alive,TUMOR FREE,1107.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1107.0,0.0,1107.0,0.0,1107.0,0.0,1107.0,0
TCGA-BJ-A3PT-01,TCGA-BJ-A3PT,THCA,51.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-18903.0,Alive,TUMOR FREE,709.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,709.0,0.0,709.0,nan,nan,0.0,709.0,0
TCGA-BJ-A3PU-01,TCGA-BJ-A3PU,THCA,52.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-19007.0,Alive,TUMOR FREE,567.0,nan,nan,Distant Metastasis,Lung,nan,174.0,nan,nan,R0,0.0,567.0,0.0,567.0,1.0,174.0,1.0,174.0,0
TCGA-BJ-A3PU-11,TCGA-BJ-A3PU,THCA,52.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-19007.0,Alive,TUMOR FREE,567.0,nan,nan,Distant Metastasis,Lung,nan,174.0,nan,nan,R0,0.0,567.0,0.0,567.0,1.0,174.0,1.0,174.0,0
TCGA-BJ-A45C-01,TCGA-BJ-A45C,THCA,78.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-28490.0,Dead,WITH TUMOR,nan,243.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,243.0,1.0,243.0,nan,nan,1.0,243.0,1
TCGA-BJ-A45D-01,TCGA-BJ-A45D,THCA,36.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2012.0,nan,-13335.0,Alive,TUMOR FREE,331.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,331.0,0.0,331.0,nan,nan,0.0,331.0,0
TCGA-BJ-A45E-01,TCGA-BJ-A45E,THCA,46.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-17115.0,Alive,TUMOR FREE,639.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,639.0,0.0,639.0,nan,nan,0.0,639.0,0
TCGA-BJ-A45F-01,TCGA-BJ-A45F,THCA,59.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-21713.0,Alive,TUMOR FREE,105.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,105.0,0.0,105.0,nan,nan,0.0,105.0,0
TCGA-BJ-A45G-01,TCGA-BJ-A45G,THCA,48.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2012.0,nan,-17831.0,Alive,TUMOR FREE,725.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,725.0,0.0,725.0,nan,nan,0.0,725.0,0
TCGA-BJ-A45H-01,TCGA-BJ-A45H,THCA,45.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-16541.0,Alive,WITH TUMOR,865.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,865.0,0.0,865.0,nan,nan,0.0,865.0,0
TCGA-BJ-A45I-01,TCGA-BJ-A45I,THCA,51.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2012.0,nan,-18767.0,Alive,TUMOR FREE,470.0,nan,nan,nan,nan,nan,110.0,nan,nan,R2,0.0,470.0,0.0,470.0,nan,nan,1.0,110.0,0
TCGA-BJ-A45J-01,TCGA-BJ-A45J,THCA,39.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2012.0,nan,-14510.0,Alive,TUMOR FREE,658.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,658.0,0.0,658.0,nan,nan,0.0,658.0,0
TCGA-BJ-A45K-01,TCGA-BJ-A45K,THCA,33.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-12138.0,Alive,TUMOR FREE,705.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,705.0,0.0,705.0,nan,nan,0.0,705.0,0
TCGA-BJ-A4O8-01,TCGA-BJ-A4O8,THCA,47.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-17430.0,Alive,TUMOR FREE,591.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,591.0,0.0,591.0,0.0,591.0,0.0,591.0,0
TCGA-BJ-A4O9-01,TCGA-BJ-A4O9,THCA,51.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2012.0,nan,-18938.0,Alive,TUMOR FREE,714.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,714.0,0.0,714.0,nan,nan,0.0,714.0,0
TCGA-CE-A13K-01,TCGA-CE-A13K,THCA,30.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-11122.0,Alive,TUMOR FREE,385.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,0
TCGA-CE-A27D-01,TCGA-CE-A27D,THCA,28.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-10536.0,Alive,TUMOR FREE,374.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,374.0,0.0,374.0,0.0,374.0,0.0,374.0,0
TCGA-CE-A3MD-01,TCGA-CE-A3MD,THCA,31.0,MALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-11399.0,Alive,TUMOR FREE,389.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,389.0,0.0,389.0,0.0,389.0,0.0,389.0,0
TCGA-CE-A3ME-01,TCGA-CE-A3ME,THCA,51.0,FEMALE,ASIAN,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-18714.0,Alive,TUMOR FREE,379.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,379.0,0.0,379.0,0.0,379.0,0.0,379.0,0
TCGA-CE-A481-01,TCGA-CE-A481,THCA,41.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-15268.0,Alive,TUMOR FREE,346.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,346.0,0.0,346.0,0.0,346.0,0.0,346.0,0
TCGA-CE-A482-01,TCGA-CE-A482,THCA,27.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-10192.0,Alive,TUMOR FREE,325.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,325.0,0.0,325.0,0.0,325.0,0.0,325.0,0
TCGA-CE-A483-01,TCGA-CE-A483,THCA,34.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-12768.0,Alive,TUMOR FREE,457.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,457.0,0.0,457.0,0.0,457.0,0.0,457.0,0
TCGA-CE-A484-01,TCGA-CE-A484,THCA,37.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-13815.0,Alive,TUMOR FREE,378.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,378.0,0.0,378.0,0.0,378.0,0.0,378.0,0
TCGA-CE-A485-01,TCGA-CE-A485,THCA,32.0,MALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-11997.0,Alive,TUMOR FREE,385.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,385.0,0.0,385.0,0.0,385.0,0.0,385.0,0
TCGA-DE-A0XZ-01,TCGA-DE-A0XZ,THCA,65.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-24020.0,Alive,TUMOR FREE,1090.0,nan,nan,nan,nan,nan,204.0,nan,nan,R0,0.0,1090.0,0.0,1090.0,1.0,204.0,1.0,204.0,2
TCGA-DE-A0Y2-01,TCGA-DE-A0Y2,THCA,30.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-11227.0,Alive,TUMOR FREE,658.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,658.0,0.0,658.0,0.0,658.0,0.0,658.0,0
TCGA-DE-A0Y3-01,TCGA-DE-A0Y3,THCA,60.0,FEMALE,ASIAN,Stage IVC,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-22239.0,Alive,TUMOR FREE,1526.0,nan,nan,Distant Metastasis,Lung,nan,30.0,nan,nan,R1,0.0,1526.0,0.0,1526.0,nan,nan,1.0,30.0,1
TCGA-DE-A2OL-01,TCGA-DE-A2OL,THCA,44.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-16253.0,Alive,TUMOR FREE,1145.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1145.0,0.0,1145.0,0.0,1145.0,0.0,1145.0,0
TCGA-DE-A3KN-01,TCGA-DE-A3KN,THCA,49.0,FEMALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-18098.0,Alive,TUMOR FREE,831.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,831.0,0.0,831.0,nan,nan,0.0,831.0,0
TCGA-DE-A4M8-01,TCGA-DE-A4M8,THCA,61.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-22357.0,Alive,TUMOR FREE,564.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,564.0,0.0,564.0,0.0,564.0,0.0,564.0,0
TCGA-DE-A4M9-01,TCGA-DE-A4M9,THCA,28.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-10384.0,Alive,TUMOR FREE,573.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,573.0,0.0,573.0,nan,nan,0.0,573.0,0
TCGA-DE-A4MA-01,TCGA-DE-A4MA,THCA,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-19100.0,Alive,TUMOR FREE,916.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,916.0,0.0,916.0,0.0,916.0,0.0,916.0,0
TCGA-DE-A4MB-01,TCGA-DE-A4MB,THCA,79.0,FEMALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-29011.0,Alive,WITH TUMOR,352.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,352.0,0.0,352.0,nan,nan,0.0,352.0,0
TCGA-DE-A4MC-01,TCGA-DE-A4MC,THCA,43.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-15996.0,Alive,TUMOR FREE,913.0,nan,nan,Locoregional Recurrence,Lymph Node Only,nan,332.0,nan,nan,R0,0.0,913.0,0.0,913.0,1.0,332.0,1.0,332.0,0
TCGA-DE-A4MD-06,TCGA-DE-A4MD,THCA,71.0,MALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-26179.0,Alive,TUMOR FREE,764.0,nan,nan,Locoregional Recurrence,Lymph Node Only,nan,267.0,nan,nan,R0,0.0,764.0,0.0,764.0,nan,nan,1.0,267.0,0
TCGA-DE-A4MD-01,TCGA-DE-A4MD,THCA,71.0,MALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-26179.0,Alive,TUMOR FREE,764.0,nan,nan,Locoregional Recurrence,Lymph Node Only,nan,267.0,nan,nan,R0,0.0,764.0,0.0,764.0,nan,nan,1.0,267.0,0
TCGA-DE-A69J-01,TCGA-DE-A69J,THCA,34.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-12493.0,Alive,TUMOR FREE,447.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,447.0,0.0,447.0,0.0,447.0,0.0,447.0,0
TCGA-DE-A69K-01,TCGA-DE-A69K,THCA,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2013.0,nan,-21403.0,Alive,WITH TUMOR,434.0,nan,nan,Biochemical evidence of disease,nan,nan,434.0,nan,nan,R1,0.0,434.0,0.0,434.0,nan,nan,1.0,434.0,1
TCGA-DE-A7U5-01,TCGA-DE-A7U5,THCA,36.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2013.0,nan,-13411.0,Alive,nan,84.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,84.0,0.0,84.0,nan,nan,0.0,84.0,0
TCGA-DJ-A13L-01,TCGA-DJ-A13L,THCA,85.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2010.0,nan,-31388.0,Alive,TUMOR FREE,303.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,303.0,0.0,303.0,0.0,303.0,0.0,303.0,0
TCGA-DJ-A13M-01,TCGA-DJ-A13M,THCA,28.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-10530.0,Alive,TUMOR FREE,1484.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1484.0,0.0,1484.0,0.0,1484.0,0.0,1484.0,0
TCGA-DJ-A13O-01,TCGA-DJ-A13O,THCA,56.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-20779.0,Alive,TUMOR FREE,1161.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1161.0,0.0,1161.0,0.0,1161.0,0.0,1161.0,0
TCGA-DJ-A13P-01,TCGA-DJ-A13P,THCA,52.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,1999.0,nan,-19297.0,Alive,TUMOR FREE,5150.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,5150.0,0.0,5150.0,0.0,5150.0,0.0,5150.0,0
TCGA-DJ-A13R-01,TCGA-DJ-A13R,THCA,50.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-18354.0,Alive,TUMOR FREE,565.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,565.0,0.0,565.0,0.0,565.0,0.0,565.0,0
TCGA-DJ-A13S-01,TCGA-DJ-A13S,THCA,19.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-7099.0,Alive,TUMOR FREE,265.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,265.0,0.0,265.0,0.0,265.0,0.0,265.0,0
TCGA-DJ-A13T-01,TCGA-DJ-A13T,THCA,37.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-13668.0,Alive,TUMOR FREE,1709.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1709.0,0.0,1709.0,0.0,1709.0,0.0,1709.0,0
TCGA-DJ-A13U-01,TCGA-DJ-A13U,THCA,60.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-22130.0,Alive,TUMOR FREE,1590.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1590.0,0.0,1590.0,0.0,1590.0,0.0,1590.0,0
TCGA-DJ-A13V-01,TCGA-DJ-A13V,THCA,21.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-7915.0,Alive,TUMOR FREE,1313.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1313.0,0.0,1313.0,0.0,1313.0,0.0,1313.0,0
TCGA-DJ-A13W-01,TCGA-DJ-A13W,THCA,45.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-16558.0,Alive,TUMOR FREE,1593.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1593.0,0.0,1593.0,0.0,1593.0,0.0,1593.0,0
TCGA-DJ-A13X-01,TCGA-DJ-A13X,THCA,51.0,FEMALE,nan,Stage III,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-18689.0,Alive,TUMOR FREE,253.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,253.0,0.0,253.0,0.0,253.0,0.0,253.0,0
TCGA-DJ-A1QD-01,TCGA-DJ-A1QD,THCA,20.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-7460.0,Alive,TUMOR FREE,1462.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1462.0,0.0,1462.0,0.0,1462.0,0.0,1462.0,0
TCGA-DJ-A1QE-01,TCGA-DJ-A1QE,THCA,62.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2003.0,nan,-22645.0,Alive,TUMOR FREE,4134.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,4134.0,0.0,4134.0,0.0,4134.0,0.0,4134.0,0
TCGA-DJ-A1QF-01,TCGA-DJ-A1QF,THCA,61.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-22310.0,Alive,TUMOR FREE,931.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,931.0,0.0,931.0,0.0,931.0,0.0,931.0,0
TCGA-DJ-A1QG-01,TCGA-DJ-A1QG,THCA,62.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-22859.0,Alive,TUMOR FREE,1368.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1368.0,0.0,1368.0,0.0,1368.0,0.0,1368.0,0
TCGA-DJ-A1QH-01,TCGA-DJ-A1QH,THCA,58.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2010.0,nan,-21184.0,Alive,WITH TUMOR,1293.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,1293.0,0.0,1293.0,nan,nan,0.0,1293.0,0
TCGA-DJ-A1QI-01,TCGA-DJ-A1QI,THCA,63.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-23072.0,Alive,TUMOR FREE,455.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,455.0,0.0,455.0,0.0,455.0,0.0,455.0,0
TCGA-DJ-A1QL-01,TCGA-DJ-A1QL,THCA,70.0,MALE,nan,Stage II,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-25713.0,Alive,TUMOR FREE,535.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,535.0,0.0,535.0,0.0,535.0,0.0,535.0,0
TCGA-DJ-A1QM-01,TCGA-DJ-A1QM,THCA,42.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-15418.0,Alive,TUMOR FREE,183.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,183.0,0.0,183.0,0.0,183.0,0.0,183.0,0
TCGA-DJ-A1QN-01,TCGA-DJ-A1QN,THCA,42.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-15343.0,Alive,TUMOR FREE,1295.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1295.0,0.0,1295.0,0.0,1295.0,0.0,1295.0,0
TCGA-DJ-A1QO-01,TCGA-DJ-A1QO,THCA,69.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2010.0,nan,-25232.0,Alive,TUMOR FREE,1442.0,nan,nan,New Primary Tumor,"Other, specify",Cecum,1062.0,nan,nan,R0,0.0,1442.0,0.0,1442.0,0.0,1442.0,1.0,1062.0,0
TCGA-DJ-A1QQ-01,TCGA-DJ-A1QQ,THCA,43.0,MALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-15949.0,Alive,TUMOR FREE,534.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,534.0,0.0,534.0,0.0,534.0,0.0,534.0,0
TCGA-DJ-A2PN-01,TCGA-DJ-A2PN,THCA,70.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-25690.0,Alive,TUMOR FREE,307.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,307.0,0.0,307.0,0.0,307.0,0.0,307.0,0
TCGA-DJ-A2PO-01,TCGA-DJ-A2PO,THCA,54.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-20058.0,Alive,TUMOR FREE,243.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,243.0,0.0,243.0,0.0,243.0,0.0,243.0,0
TCGA-DJ-A2PP-01,TCGA-DJ-A2PP,THCA,47.0,MALE,nan,Stage II,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-17410.0,Alive,TUMOR FREE,930.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,930.0,0.0,930.0,0.0,930.0,0.0,930.0,0
TCGA-DJ-A2PQ-01,TCGA-DJ-A2PQ,THCA,26.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-9664.0,Alive,TUMOR FREE,1077.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1077.0,0.0,1077.0,0.0,1077.0,0.0,1077.0,0
TCGA-DJ-A2PR-01,TCGA-DJ-A2PR,THCA,27.0,MALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-9914.0,Alive,TUMOR FREE,835.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,835.0,0.0,835.0,0.0,835.0,0.0,835.0,0
TCGA-DJ-A2PS-01,TCGA-DJ-A2PS,THCA,40.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-14916.0,Alive,TUMOR FREE,797.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,797.0,0.0,797.0,0.0,797.0,0.0,797.0,0
TCGA-DJ-A2PT-01,TCGA-DJ-A2PT,THCA,70.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2011.0,nan,-25837.0,Alive,TUMOR FREE,1181.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1181.0,0.0,1181.0,0.0,1181.0,0.0,1181.0,0
TCGA-DJ-A2PU-01,TCGA-DJ-A2PU,THCA,52.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-18998.0,Alive,TUMOR FREE,1033.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1033.0,0.0,1033.0,0.0,1033.0,0.0,1033.0,0
TCGA-DJ-A2PV-01,TCGA-DJ-A2PV,THCA,53.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-19547.0,Alive,TUMOR FREE,973.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,973.0,0.0,973.0,0.0,973.0,0.0,973.0,0
TCGA-DJ-A2PW-01,TCGA-DJ-A2PW,THCA,65.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-23987.0,Alive,TUMOR FREE,1060.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1060.0,0.0,1060.0,0.0,1060.0,0.0,1060.0,0
TCGA-DJ-A2PX-01,TCGA-DJ-A2PX,THCA,55.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-20088.0,Alive,TUMOR FREE,881.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,881.0,0.0,881.0,0.0,881.0,0.0,881.0,0
TCGA-DJ-A2PY-01,TCGA-DJ-A2PY,THCA,46.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2011.0,nan,-17056.0,Alive,TUMOR FREE,267.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,267.0,0.0,267.0,0.0,267.0,0.0,267.0,0
TCGA-DJ-A2PZ-01,TCGA-DJ-A2PZ,THCA,63.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-23332.0,Alive,TUMOR FREE,256.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,256.0,0.0,256.0,0.0,256.0,0.0,256.0,0
TCGA-DJ-A2Q0-01,TCGA-DJ-A2Q0,THCA,57.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-20973.0,Alive,TUMOR FREE,1045.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1045.0,0.0,1045.0,0.0,1045.0,0.0,1045.0,0
TCGA-DJ-A2Q1-01,TCGA-DJ-A2Q1,THCA,44.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-16371.0,Alive,TUMOR FREE,1148.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1148.0,0.0,1148.0,0.0,1148.0,0.0,1148.0,0
TCGA-DJ-A2Q2-01,TCGA-DJ-A2Q2,THCA,57.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-20951.0,Alive,TUMOR FREE,1337.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1337.0,0.0,1337.0,0.0,1337.0,0.0,1337.0,0
TCGA-DJ-A2Q3-01,TCGA-DJ-A2Q3,THCA,61.0,FEMALE,ASIAN,Stage III,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2011.0,nan,-22637.0,Alive,TUMOR FREE,1224.0,nan,nan,New Primary Tumor,Lung,nan,385.0,nan,nan,R0,0.0,1224.0,0.0,1224.0,0.0,1224.0,1.0,385.0,0
TCGA-DJ-A2Q4-01,TCGA-DJ-A2Q4,THCA,53.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-19689.0,Alive,TUMOR FREE,1032.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1032.0,0.0,1032.0,0.0,1032.0,0.0,1032.0,0
TCGA-DJ-A2Q5-01,TCGA-DJ-A2Q5,THCA,51.0,MALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-18727.0,Alive,TUMOR FREE,1140.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1140.0,0.0,1140.0,nan,nan,0.0,1140.0,0
TCGA-DJ-A2Q6-01,TCGA-DJ-A2Q6,THCA,38.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-14193.0,Alive,TUMOR FREE,1109.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1109.0,0.0,1109.0,0.0,1109.0,0.0,1109.0,0
TCGA-DJ-A2Q7-01,TCGA-DJ-A2Q7,THCA,52.0,FEMALE,ASIAN,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-19193.0,Alive,TUMOR FREE,1068.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1068.0,0.0,1068.0,0.0,1068.0,0.0,1068.0,0
TCGA-DJ-A2Q8-01,TCGA-DJ-A2Q8,THCA,47.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2011.0,nan,-17438.0,Alive,TUMOR FREE,1189.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1189.0,0.0,1189.0,0.0,1189.0,0.0,1189.0,0
TCGA-DJ-A2Q9-01,TCGA-DJ-A2Q9,THCA,65.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2011.0,nan,-23951.0,Alive,TUMOR FREE,1092.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1092.0,0.0,1092.0,0.0,1092.0,0.0,1092.0,0
TCGA-DJ-A2QA-01,TCGA-DJ-A2QA,THCA,56.0,FEMALE,ASIAN,Stage III,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-20784.0,Alive,TUMOR FREE,1020.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1020.0,0.0,1020.0,0.0,1020.0,0.0,1020.0,0
TCGA-DJ-A2QB-01,TCGA-DJ-A2QB,THCA,53.0,FEMALE,ASIAN,Stage IVA,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-19601.0,Alive,TUMOR FREE,1070.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1070.0,0.0,1070.0,nan,nan,0.0,1070.0,0
TCGA-DJ-A2QC-01,TCGA-DJ-A2QC,THCA,70.0,FEMALE,nan,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-25690.0,Alive,TUMOR FREE,1215.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1215.0,0.0,1215.0,0.0,1215.0,0.0,1215.0,0
TCGA-DJ-A3UK-01,TCGA-DJ-A3UK,THCA,35.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-13145.0,Alive,TUMOR FREE,1123.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1123.0,0.0,1123.0,0.0,1123.0,0.0,1123.0,0
TCGA-DJ-A3UM-01,TCGA-DJ-A3UM,THCA,45.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-16573.0,Alive,TUMOR FREE,944.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,944.0,0.0,944.0,0.0,944.0,0.0,944.0,0
TCGA-DJ-A3UN-01,TCGA-DJ-A3UN,THCA,51.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-18871.0,Alive,TUMOR FREE,986.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,986.0,0.0,986.0,0.0,986.0,0.0,986.0,0
TCGA-DJ-A3UO-01,TCGA-DJ-A3UO,THCA,63.0,MALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-23292.0,Alive,TUMOR FREE,957.0,nan,nan,New Primary Tumor,"Other, specify",Prostate,641.0,nan,nan,R0,0.0,957.0,0.0,957.0,nan,nan,1.0,641.0,0
TCGA-DJ-A3UP-01,TCGA-DJ-A3UP,THCA,38.0,FEMALE,[Unknown],Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-13899.0,Alive,TUMOR FREE,499.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,499.0,0.0,499.0,0.0,499.0,0.0,499.0,0
TCGA-DJ-A3UQ-01,TCGA-DJ-A3UQ,THCA,45.0,FEMALE,ASIAN,Stage III,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2011.0,nan,-16545.0,Alive,TUMOR FREE,595.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,595.0,0.0,595.0,0.0,595.0,0.0,595.0,0
TCGA-DJ-A3UR-01,TCGA-DJ-A3UR,THCA,51.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-18808.0,Alive,TUMOR FREE,1105.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1105.0,0.0,1105.0,0.0,1105.0,0.0,1105.0,0
TCGA-DJ-A3US-01,TCGA-DJ-A3US,THCA,37.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-13634.0,Alive,TUMOR FREE,998.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,998.0,0.0,998.0,0.0,998.0,0.0,998.0,0
TCGA-DJ-A3UT-01,TCGA-DJ-A3UT,THCA,43.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-15767.0,Alive,TUMOR FREE,1105.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1105.0,0.0,1105.0,0.0,1105.0,0.0,1105.0,0
TCGA-DJ-A3UU-01,TCGA-DJ-A3UU,THCA,49.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-17919.0,Alive,WITH TUMOR,713.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,713.0,0.0,713.0,nan,nan,0.0,713.0,0
TCGA-DJ-A3UV-01,TCGA-DJ-A3UV,THCA,18.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-6850.0,Alive,TUMOR FREE,1466.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1466.0,0.0,1466.0,0.0,1466.0,0.0,1466.0,0
TCGA-DJ-A3UW-01,TCGA-DJ-A3UW,THCA,50.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2007.0,nan,-18487.0,Alive,TUMOR FREE,1812.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1812.0,0.0,1812.0,0.0,1812.0,0.0,1812.0,0
TCGA-DJ-A3UX-01,TCGA-DJ-A3UX,THCA,46.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-17124.0,Alive,WITH TUMOR,345.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,345.0,0.0,345.0,0.0,345.0,0.0,345.0,0
TCGA-DJ-A3UY-01,TCGA-DJ-A3UY,THCA,32.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-12004.0,Alive,TUMOR FREE,1091.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1091.0,0.0,1091.0,0.0,1091.0,0.0,1091.0,0
TCGA-DJ-A3UZ-01,TCGA-DJ-A3UZ,THCA,70.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-25846.0,Alive,TUMOR FREE,1246.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1246.0,0.0,1246.0,0.0,1246.0,0.0,1246.0,0
TCGA-DJ-A3V0-01,TCGA-DJ-A3V0,THCA,56.0,MALE,[Unknown],Stage IVA,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2010.0,nan,-20496.0,Alive,TUMOR FREE,1125.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1125.0,0.0,1125.0,nan,nan,0.0,1125.0,0
TCGA-DJ-A3V2-01,TCGA-DJ-A3V2,THCA,44.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-16382.0,Alive,TUMOR FREE,615.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,615.0,0.0,615.0,0.0,615.0,0.0,615.0,0
TCGA-DJ-A3V3-01,TCGA-DJ-A3V3,THCA,57.0,FEMALE,ASIAN,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-20997.0,Alive,TUMOR FREE,931.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,931.0,0.0,931.0,0.0,931.0,0.0,931.0,0
TCGA-DJ-A3V4-01,TCGA-DJ-A3V4,THCA,60.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2011.0,nan,-22218.0,Alive,TUMOR FREE,1294.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1294.0,0.0,1294.0,0.0,1294.0,0.0,1294.0,0
TCGA-DJ-A3V5-01,TCGA-DJ-A3V5,THCA,76.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2011.0,nan,-27918.0,Alive,TUMOR FREE,584.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,584.0,0.0,584.0,nan,nan,0.0,584.0,0
TCGA-DJ-A3V6-01,TCGA-DJ-A3V6,THCA,54.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2011.0,nan,-19870.0,Alive,TUMOR FREE,818.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,818.0,0.0,818.0,0.0,818.0,0.0,818.0,0
TCGA-DJ-A3V7-01,TCGA-DJ-A3V7,THCA,44.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2011.0,nan,-16257.0,Alive,TUMOR FREE,706.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,706.0,0.0,706.0,0.0,706.0,0.0,706.0,0
TCGA-DJ-A3V8-01,TCGA-DJ-A3V8,THCA,28.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2011.0,nan,-10398.0,Alive,TUMOR FREE,647.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,647.0,0.0,647.0,0.0,647.0,0.0,647.0,0
TCGA-DJ-A3V9-01,TCGA-DJ-A3V9,THCA,50.0,FEMALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-18399.0,Alive,TUMOR FREE,623.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,623.0,0.0,623.0,nan,nan,0.0,623.0,0
TCGA-DJ-A3VA-01,TCGA-DJ-A3VA,THCA,39.0,FEMALE,[Unknown],Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-14495.0,Alive,TUMOR FREE,755.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,755.0,0.0,755.0,0.0,755.0,0.0,755.0,0
TCGA-DJ-A3VB-01,TCGA-DJ-A3VB,THCA,52.0,MALE,[Unknown],Stage III,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2011.0,nan,-19248.0,Alive,TUMOR FREE,697.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,697.0,0.0,697.0,0.0,697.0,0.0,697.0,0
TCGA-DJ-A3VD-01,TCGA-DJ-A3VD,THCA,32.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-12019.0,Alive,TUMOR FREE,1238.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1238.0,0.0,1238.0,0.0,1238.0,0.0,1238.0,0
TCGA-DJ-A3VE-01,TCGA-DJ-A3VE,THCA,50.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-18417.0,Alive,TUMOR FREE,577.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,577.0,0.0,577.0,0.0,577.0,0.0,577.0,0
TCGA-DJ-A3VF-01,TCGA-DJ-A3VF,THCA,60.0,FEMALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2011.0,nan,-22234.0,Alive,TUMOR FREE,292.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,292.0,0.0,292.0,nan,nan,0.0,292.0,0
TCGA-DJ-A3VG-01,TCGA-DJ-A3VG,THCA,40.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-14970.0,Alive,TUMOR FREE,1085.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1085.0,0.0,1085.0,0.0,1085.0,0.0,1085.0,0
TCGA-DJ-A3VI-01,TCGA-DJ-A3VI,THCA,52.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-19053.0,Alive,TUMOR FREE,95.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,95.0,0.0,95.0,0.0,95.0,0.0,95.0,0
TCGA-DJ-A3VJ-01,TCGA-DJ-A3VJ,THCA,22.0,MALE,WHITE,Stage I,nan,"Other, specify",nan,2010.0,nan,-8341.0,Alive,TUMOR FREE,1108.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1108.0,0.0,1108.0,0.0,1108.0,0.0,1108.0,0
TCGA-DJ-A3VK-01,TCGA-DJ-A3VK,THCA,63.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-23255.0,Alive,TUMOR FREE,753.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,753.0,0.0,753.0,0.0,753.0,0.0,753.0,0
TCGA-DJ-A3VL-01,TCGA-DJ-A3VL,THCA,38.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-14219.0,Alive,TUMOR FREE,713.0,nan,nan,New Primary Tumor,"Other, specify",Bowel,411.0,nan,nan,R0,0.0,713.0,0.0,713.0,0.0,713.0,1.0,411.0,0
TCGA-DJ-A3VM-01,TCGA-DJ-A3VM,THCA,68.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-24896.0,Alive,TUMOR FREE,840.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,840.0,0.0,840.0,0.0,840.0,0.0,840.0,0
TCGA-DJ-A4UL-01,TCGA-DJ-A4UL,THCA,68.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-24939.0,Alive,TUMOR FREE,939.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,939.0,0.0,939.0,0.0,939.0,0.0,939.0,0
TCGA-DJ-A4UP-01,TCGA-DJ-A4UP,THCA,15.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-5655.0,Alive,TUMOR FREE,916.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,916.0,0.0,916.0,0.0,916.0,0.0,916.0,0
TCGA-DJ-A4UQ-01,TCGA-DJ-A4UQ,THCA,60.0,MALE,ASIAN,Stage IVA,nan,"Other, specify",nan,2012.0,nan,-22097.0,Alive,WITH TUMOR,1005.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1005.0,0.0,1005.0,nan,nan,0.0,1005.0,0
TCGA-DJ-A4UR-01,TCGA-DJ-A4UR,THCA,36.0,FEMALE,ASIAN,Stage II,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2012.0,nan,-13463.0,Alive,WITH TUMOR,1058.0,nan,nan,Distant Metastasis,Lung,nan,113.0,nan,nan,R0,0.0,1058.0,0.0,1058.0,1.0,113.0,1.0,113.0,2
TCGA-DJ-A4UT-01,TCGA-DJ-A4UT,THCA,32.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-11813.0,Alive,TUMOR FREE,823.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,823.0,0.0,823.0,0.0,823.0,0.0,823.0,0
TCGA-DJ-A4UW-01,TCGA-DJ-A4UW,THCA,34.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2012.0,nan,-12563.0,Alive,TUMOR FREE,819.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,819.0,0.0,819.0,nan,nan,0.0,819.0,0
TCGA-DJ-A4V0-01,TCGA-DJ-A4V0,THCA,36.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-13168.0,Alive,TUMOR FREE,1081.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1081.0,0.0,1081.0,0.0,1081.0,0.0,1081.0,0
TCGA-DJ-A4V2-01,TCGA-DJ-A4V2,THCA,38.0,FEMALE,[Not Evaluated],Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-14126.0,Alive,TUMOR FREE,95.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,95.0,0.0,95.0,0.0,95.0,0.0,95.0,0
TCGA-DJ-A4V4-01,TCGA-DJ-A4V4,THCA,48.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2012.0,nan,-17878.0,Alive,TUMOR FREE,481.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,481.0,0.0,481.0,0.0,481.0,0.0,481.0,0
TCGA-DJ-A4V5-01,TCGA-DJ-A4V5,THCA,55.0,MALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-20108.0,Alive,TUMOR FREE,1076.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1076.0,0.0,1076.0,nan,nan,0.0,1076.0,0
TCGA-DO-A1JZ-01,TCGA-DO-A1JZ,THCA,23.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2007.0,nan,-8551.0,Alive,TUMOR FREE,1670.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,1670.0,0.0,1670.0,nan,nan,0.0,1670.0,0
TCGA-DO-A1JZ-11,TCGA-DO-A1JZ,THCA,23.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2007.0,nan,-8551.0,Alive,TUMOR FREE,1670.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,1670.0,0.0,1670.0,nan,nan,0.0,1670.0,0
TCGA-DO-A1K0-01,TCGA-DO-A1K0,THCA,30.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-11216.0,Alive,WITH TUMOR,655.0,nan,nan,Locoregional Recurrence,Lymph Node Only,nan,577.0,nan,nan,R0,0.0,655.0,0.0,655.0,1.0,577.0,1.0,577.0,2
TCGA-DO-A2HM-01,TCGA-DO-A2HM,THCA,49.0,MALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-18068.0,Alive,TUMOR FREE,71.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,71.0,0.0,71.0,nan,nan,0.0,71.0,0
TCGA-E3-A3DY-01,TCGA-E3-A3DY,THCA,37.0,MALE,WHITE,Stage I,nan,"Other, specify",nan,2007.0,nan,-13860.0,Alive,TUMOR FREE,2815.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2815.0,0.0,2815.0,0.0,2815.0,0.0,2815.0,0
TCGA-E3-A3DZ-01,TCGA-E3-A3DZ,THCA,55.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-20251.0,Alive,TUMOR FREE,1436.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1436.0,0.0,1436.0,0.0,1436.0,0.0,1436.0,0
TCGA-E3-A3E0-01,TCGA-E3-A3E0,THCA,34.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2006.0,nan,-12645.0,Alive,TUMOR FREE,2019.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2019.0,0.0,2019.0,0.0,2019.0,0.0,2019.0,0
TCGA-E3-A3E1-01,TCGA-E3-A3E1,THCA,46.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2007.0,nan,-16895.0,Alive,TUMOR FREE,2449.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2449.0,0.0,2449.0,0.0,2449.0,0.0,2449.0,0
TCGA-E3-A3E2-01,TCGA-E3-A3E2,THCA,34.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2007.0,nan,-12714.0,Alive,TUMOR FREE,1922.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1922.0,0.0,1922.0,0.0,1922.0,0.0,1922.0,0
TCGA-E3-A3E3-01,TCGA-E3-A3E3,THCA,49.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-18140.0,Alive,TUMOR FREE,1595.0,nan,nan,Distant Metastasis,Lymph Node Only,nan,445.0,nan,nan,R0,0.0,1595.0,0.0,1595.0,1.0,445.0,1.0,445.0,0
TCGA-E3-A3E5-01,TCGA-E3-A3E5,THCA,57.0,MALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-20993.0,Alive,TUMOR FREE,1215.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,1215.0,0.0,1215.0,nan,nan,0.0,1215.0,0
TCGA-E8-A242-01,TCGA-E8-A242,THCA,56.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-20472.0,Alive,TUMOR FREE,950.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,950.0,0.0,950.0,nan,nan,0.0,950.0,0
TCGA-E8-A2EA-01,TCGA-E8-A2EA,THCA,52.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-19159.0,Alive,TUMOR FREE,1085.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1085.0,0.0,1085.0,0.0,1085.0,0.0,1085.0,0
TCGA-E8-A2JQ-01,TCGA-E8-A2JQ,THCA,18.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-6684.0,Alive,TUMOR FREE,356.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,356.0,0.0,356.0,nan,nan,0.0,356.0,0
TCGA-E8-A2JQ-11,TCGA-E8-A2JQ,THCA,18.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-6684.0,Alive,TUMOR FREE,356.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,356.0,0.0,356.0,nan,nan,0.0,356.0,0
TCGA-E8-A3X7-01,TCGA-E8-A3X7,THCA,57.0,FEMALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-20983.0,Alive,TUMOR FREE,951.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,951.0,0.0,951.0,nan,nan,0.0,951.0,0
TCGA-E8-A413-01,TCGA-E8-A413,THCA,38.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-13909.0,Alive,TUMOR FREE,912.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,912.0,0.0,912.0,0.0,912.0,0.0,912.0,0
TCGA-E8-A414-01,TCGA-E8-A414,THCA,45.0,FEMALE,ASIAN,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-16754.0,Alive,TUMOR FREE,958.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,958.0,0.0,958.0,0.0,958.0,0.0,958.0,0
TCGA-E8-A415-01,TCGA-E8-A415,THCA,39.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-14288.0,Alive,TUMOR FREE,944.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,944.0,0.0,944.0,0.0,944.0,0.0,944.0,0
TCGA-E8-A416-01,TCGA-E8-A416,THCA,51.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-18932.0,Alive,TUMOR FREE,952.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,952.0,0.0,952.0,0.0,952.0,0.0,952.0,0
TCGA-E8-A417-01,TCGA-E8-A417,THCA,38.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-14019.0,Alive,TUMOR FREE,938.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,938.0,0.0,938.0,0.0,938.0,0.0,938.0,0
TCGA-E8-A418-01,TCGA-E8-A418,THCA,75.0,FEMALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-27737.0,Alive,TUMOR FREE,92.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,92.0,0.0,92.0,nan,nan,0.0,92.0,0
TCGA-E8-A419-01,TCGA-E8-A419,THCA,30.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-11306.0,Alive,TUMOR FREE,774.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,774.0,0.0,774.0,0.0,774.0,0.0,774.0,0
TCGA-E8-A432-01,TCGA-E8-A432,THCA,57.0,FEMALE,ASIAN,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-20874.0,Alive,TUMOR FREE,931.0,nan,nan,Locoregional Recurrence,nan,nan,720.0,nan,nan,R0,0.0,931.0,0.0,931.0,1.0,720.0,1.0,720.0,0
TCGA-E8-A433-01,TCGA-E8-A433,THCA,25.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-9145.0,Alive,TUMOR FREE,951.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,951.0,0.0,951.0,0.0,951.0,0.0,951.0,0
TCGA-E8-A434-01,TCGA-E8-A434,THCA,56.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-20492.0,Alive,TUMOR FREE,953.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,953.0,0.0,953.0,0.0,953.0,0.0,953.0,0
TCGA-E8-A436-01,TCGA-E8-A436,THCA,53.0,FEMALE,ASIAN,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-19640.0,Alive,TUMOR FREE,455.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,455.0,0.0,455.0,nan,nan,0.0,455.0,0
TCGA-E8-A437-01,TCGA-E8-A437,THCA,57.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-21073.0,Alive,TUMOR FREE,1213.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,1213.0,0.0,1213.0,nan,nan,0.0,1213.0,0
TCGA-E8-A438-01,TCGA-E8-A438,THCA,23.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-8752.0,Alive,TUMOR FREE,1019.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1019.0,0.0,1019.0,0.0,1019.0,0.0,1019.0,0
TCGA-E8-A44K-01,TCGA-E8-A44K,THCA,50.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-18472.0,Alive,TUMOR FREE,943.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,943.0,0.0,943.0,0.0,943.0,0.0,943.0,0
TCGA-E8-A44M-01,TCGA-E8-A44M,THCA,23.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-8523.0,Alive,TUMOR FREE,917.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,917.0,0.0,917.0,0.0,917.0,0.0,917.0,0
TCGA-EL-A3CL-01,TCGA-EL-A3CL,THCA,70.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,1994.0,nan,-25761.0,Dead,nan,nan,963.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,963.0,nan,963.0,0.0,963.0,0.0,963.0,1
TCGA-EL-A3CM-01,TCGA-EL-A3CM,THCA,64.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,1996.0,nan,-23406.0,Dead,nan,nan,813.0,nan,nan,nan,nan,nan,nan,nan,R1,1.0,813.0,nan,813.0,nan,nan,0.0,813.0,1
TCGA-EL-A3CN-01,TCGA-EL-A3CN,THCA,47.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,1999.0,nan,-17456.0,Alive,TUMOR FREE,4731.0,nan,nan,nan,nan,nan,nan,nan,nan,R2,0.0,4731.0,0.0,4731.0,nan,nan,0.0,4731.0,0
TCGA-EL-A3CO-01,TCGA-EL-A3CO,THCA,88.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,1999.0,nan,-32146.0,Dead,nan,nan,2973.0,nan,nan,nan,nan,nan,nan,nan,R1,1.0,2973.0,nan,2973.0,nan,nan,0.0,2973.0,1
TCGA-EL-A3CP-01,TCGA-EL-A3CP,THCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,1999.0,nan,-18298.0,Alive,TUMOR FREE,4831.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,4831.0,0.0,4831.0,nan,nan,0.0,4831.0,0
TCGA-EL-A3CR-01,TCGA-EL-A3CR,THCA,78.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2002.0,nan,-28785.0,Dead,nan,nan,233.0,nan,nan,nan,nan,nan,nan,nan,R1,1.0,233.0,nan,233.0,nan,nan,0.0,233.0,1
TCGA-EL-A3CS-01,TCGA-EL-A3CS,THCA,62.0,FEMALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2004.0,nan,-22993.0,Dead,WITH TUMOR,nan,1385.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,1385.0,1.0,1385.0,nan,nan,1.0,1385.0,1
TCGA-EL-A3CT-01,TCGA-EL-A3CT,THCA,78.0,FEMALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2004.0,nan,-28597.0,Dead,nan,nan,1854.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,1854.0,nan,1854.0,nan,nan,0.0,1854.0,1
TCGA-EL-A3CU-01,TCGA-EL-A3CU,THCA,70.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2000.0,nan,-25881.0,Alive,TUMOR FREE,4780.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,4780.0,0.0,4780.0,0.0,4780.0,0.0,4780.0,0
TCGA-EL-A3CV-01,TCGA-EL-A3CV,THCA,40.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2005.0,nan,-14785.0,Alive,TUMOR FREE,1154.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,1154.0,0.0,1154.0,nan,nan,0.0,1154.0,0
TCGA-EL-A3CW-01,TCGA-EL-A3CW,THCA,87.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2000.0,nan,-31934.0,Dead,nan,nan,1734.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,1734.0,nan,1734.0,0.0,1734.0,0.0,1734.0,1
TCGA-EL-A3CX-01,TCGA-EL-A3CX,THCA,22.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2005.0,nan,-8344.0,Alive,TUMOR FREE,3243.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,3243.0,0.0,3243.0,0.0,3243.0,0.0,3243.0,0
TCGA-EL-A3CY-01,TCGA-EL-A3CY,THCA,28.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2000.0,nan,-10423.0,Alive,TUMOR FREE,127.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,127.0,0.0,127.0,0.0,127.0,0.0,127.0,0
TCGA-EL-A3CZ-01,TCGA-EL-A3CZ,THCA,37.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2007.0,nan,-13718.0,Alive,WITH TUMOR,2418.0,nan,nan,Locoregional Recurrence,Lymph Node Only,nan,1426.0,nan,nan,R1,0.0,2418.0,0.0,2418.0,nan,nan,1.0,1426.0,1
TCGA-EL-A3D0-01,TCGA-EL-A3D0,THCA,61.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2001.0,nan,-22622.0,Alive,WITH TUMOR,4254.0,nan,nan,nan,nan,nan,nan,nan,nan,R2,0.0,4254.0,0.0,4254.0,nan,nan,0.0,4254.0,0
TCGA-EL-A3D1-01,TCGA-EL-A3D1,THCA,39.0,MALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2006.0,nan,-14245.0,Alive,TUMOR FREE,2997.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2997.0,0.0,2997.0,0.0,2997.0,0.0,2997.0,0
TCGA-EL-A3D4-01,TCGA-EL-A3D4,THCA,62.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-22923.0,Alive,TUMOR FREE,2116.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2116.0,0.0,2116.0,nan,nan,0.0,2116.0,0
TCGA-EL-A3D5-01,TCGA-EL-A3D5,THCA,44.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-16217.0,Alive,TUMOR FREE,1737.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,1737.0,0.0,1737.0,nan,nan,0.0,1737.0,0
TCGA-EL-A3D6-01,TCGA-EL-A3D6,THCA,51.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,1999.0,nan,-18640.0,Alive,nan,3296.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,3296.0,0.0,3296.0,nan,nan,0.0,3296.0,0
TCGA-EL-A3GO-01,TCGA-EL-A3GO,THCA,31.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-11604.0,Alive,WITH TUMOR,1973.0,nan,nan,Locoregional Recurrence,nan,Lt. Thyroid,6.0,nan,nan,R0,0.0,1973.0,0.0,1973.0,1.0,6.0,1.0,6.0,2
TCGA-EL-A3GP-01,TCGA-EL-A3GP,THCA,70.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-25696.0,Alive,nan,1506.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1506.0,0.0,1506.0,0.0,1506.0,0.0,1506.0,0
TCGA-EL-A3GQ-01,TCGA-EL-A3GQ,THCA,72.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-26478.0,Alive,TUMOR FREE,1528.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1528.0,0.0,1528.0,0.0,1528.0,0.0,1528.0,0
TCGA-EL-A3GR-01,TCGA-EL-A3GR,THCA,31.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2004.0,nan,-11598.0,Alive,TUMOR FREE,3501.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,3501.0,0.0,3501.0,0.0,3501.0,0.0,3501.0,0
TCGA-EL-A3GS-01,TCGA-EL-A3GS,THCA,37.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2007.0,nan,-13542.0,Alive,TUMOR FREE,1989.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1989.0,0.0,1989.0,0.0,1989.0,0.0,1989.0,0
TCGA-EL-A3GU-01,TCGA-EL-A3GU,THCA,72.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2002.0,nan,-26632.0,Alive,WITH TUMOR,4137.0,nan,nan,Distant Metastasis,Lung,nan,544.0,nan,nan,R0,0.0,4137.0,0.0,4137.0,1.0,544.0,1.0,544.0,2
TCGA-EL-A3GV-01,TCGA-EL-A3GV,THCA,65.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-23787.0,Alive,TUMOR FREE,1532.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1532.0,0.0,1532.0,0.0,1532.0,0.0,1532.0,0
TCGA-EL-A3GW-01,TCGA-EL-A3GW,THCA,37.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-13670.0,Alive,TUMOR FREE,1527.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1527.0,0.0,1527.0,0.0,1527.0,0.0,1527.0,0
TCGA-EL-A3GX-01,TCGA-EL-A3GX,THCA,41.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2000.0,nan,-15212.0,Alive,TUMOR FREE,4494.0,nan,nan,Locoregional Recurrence,"Other, specify",Left Thyroid Bed,439.0,nan,nan,R0,0.0,4494.0,0.0,4494.0,1.0,439.0,1.0,439.0,0
TCGA-EL-A3GY-01,TCGA-EL-A3GY,THCA,40.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2004.0,nan,-14814.0,Alive,WITH TUMOR,3076.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,3076.0,0.0,3076.0,0.0,3076.0,0.0,3076.0,0
TCGA-EL-A3GZ-01,TCGA-EL-A3GZ,THCA,34.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2001.0,nan,-12665.0,Alive,TUMOR FREE,4258.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,4258.0,0.0,4258.0,0.0,4258.0,0.0,4258.0,0
TCGA-EL-A3GZ-11,TCGA-EL-A3GZ,THCA,34.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2001.0,nan,-12665.0,Alive,TUMOR FREE,4258.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,4258.0,0.0,4258.0,0.0,4258.0,0.0,4258.0,0
TCGA-EL-A3H1-01,TCGA-EL-A3H1,THCA,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,1993.0,nan,-24328.0,Dead,TUMOR FREE,nan,1500.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,1500.0,0.0,1500.0,0.0,1500.0,0.0,1500.0,0
TCGA-EL-A3H1-11,TCGA-EL-A3H1,THCA,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,1993.0,nan,-24328.0,Dead,TUMOR FREE,nan,1500.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,1500.0,0.0,1500.0,0.0,1500.0,0.0,1500.0,0
TCGA-EL-A3H2-01,TCGA-EL-A3H2,THCA,58.0,MALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2002.0,nan,-21266.0,Dead,WITH TUMOR,nan,1019.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,1019.0,1.0,1019.0,nan,nan,1.0,1019.0,1
TCGA-EL-A3H2-11,TCGA-EL-A3H2,THCA,58.0,MALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2002.0,nan,-21266.0,Dead,WITH TUMOR,nan,1019.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,1019.0,1.0,1019.0,nan,nan,1.0,1019.0,1
TCGA-EL-A3H3-01,TCGA-EL-A3H3,THCA,19.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-7000.0,Alive,TUMOR FREE,1319.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1319.0,0.0,1319.0,0.0,1319.0,0.0,1319.0,0
TCGA-EL-A3H4-01,TCGA-EL-A3H4,THCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-16944.0,Alive,TUMOR FREE,1512.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1512.0,0.0,1512.0,nan,nan,0.0,1512.0,0
TCGA-EL-A3H5-01,TCGA-EL-A3H5,THCA,57.0,FEMALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2007.0,nan,-20926.0,Alive,TUMOR FREE,2542.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,2542.0,0.0,2542.0,nan,nan,0.0,2542.0,0
TCGA-EL-A3H7-01,TCGA-EL-A3H7,THCA,36.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2002.0,nan,-13407.0,Alive,TUMOR FREE,4228.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,4228.0,0.0,4228.0,0.0,4228.0,0.0,4228.0,0
TCGA-EL-A3H7-11,TCGA-EL-A3H7,THCA,36.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2002.0,nan,-13407.0,Alive,TUMOR FREE,4228.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,4228.0,0.0,4228.0,0.0,4228.0,0.0,4228.0,0
TCGA-EL-A3H8-01,TCGA-EL-A3H8,THCA,35.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2002.0,nan,-12992.0,Alive,TUMOR FREE,4577.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,4577.0,0.0,4577.0,0.0,4577.0,0.0,4577.0,0
TCGA-EL-A3MW-01,TCGA-EL-A3MW,THCA,55.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2003.0,nan,-20186.0,Alive,TUMOR FREE,3305.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,3305.0,0.0,3305.0,0.0,3305.0,0.0,3305.0,0
TCGA-EL-A3MW-11,TCGA-EL-A3MW,THCA,55.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2003.0,nan,-20186.0,Alive,TUMOR FREE,3305.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,3305.0,0.0,3305.0,0.0,3305.0,0.0,3305.0,0
TCGA-EL-A3MX-01,TCGA-EL-A3MX,THCA,66.0,FEMALE,WHITE,Stage IVC,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2004.0,nan,-24178.0,Dead,WITH TUMOR,nan,1753.0,nan,Distant Metastasis,"Other, specify",Femur,1708.0,nan,nan,RX,1.0,1753.0,1.0,1753.0,nan,nan,1.0,1708.0,1
TCGA-EL-A3MX-11,TCGA-EL-A3MX,THCA,66.0,FEMALE,WHITE,Stage IVC,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2004.0,nan,-24178.0,Dead,WITH TUMOR,nan,1753.0,nan,Distant Metastasis,"Other, specify",Femur,1708.0,nan,nan,RX,1.0,1753.0,1.0,1753.0,nan,nan,1.0,1708.0,1
TCGA-EL-A3MY-01,TCGA-EL-A3MY,THCA,81.0,MALE,WHITE,Stage IVC,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2004.0,nan,-29706.0,Dead,WITH TUMOR,nan,533.0,nan,nan,nan,nan,nan,nan,nan,RX,1.0,533.0,1.0,533.0,nan,nan,1.0,533.0,1
TCGA-EL-A3MY-11,TCGA-EL-A3MY,THCA,81.0,MALE,WHITE,Stage IVC,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2004.0,nan,-29706.0,Dead,WITH TUMOR,nan,533.0,nan,nan,nan,nan,nan,nan,nan,RX,1.0,533.0,1.0,533.0,nan,nan,1.0,533.0,1
TCGA-EL-A3MZ-01,TCGA-EL-A3MZ,THCA,66.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,1998.0,nan,-24208.0,Dead,TUMOR FREE,nan,1597.0,nan,nan,nan,nan,nan,nan,nan,RX,1.0,1597.0,0.0,1597.0,nan,nan,0.0,1597.0,0
TCGA-EL-A3N2-01,TCGA-EL-A3N2,THCA,24.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-8989.0,Alive,TUMOR FREE,902.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,902.0,0.0,902.0,0.0,902.0,0.0,902.0,0
TCGA-EL-A3N2-11,TCGA-EL-A3N2,THCA,24.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-8989.0,Alive,TUMOR FREE,902.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,902.0,0.0,902.0,0.0,902.0,0.0,902.0,0
TCGA-EL-A3N3-01,TCGA-EL-A3N3,THCA,53.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2000.0,nan,-19513.0,Alive,TUMOR FREE,5423.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,5423.0,0.0,5423.0,0.0,5423.0,0.0,5423.0,0
TCGA-EL-A3N3-11,TCGA-EL-A3N3,THCA,53.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2000.0,nan,-19513.0,Alive,TUMOR FREE,5423.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,5423.0,0.0,5423.0,0.0,5423.0,0.0,5423.0,0
TCGA-EL-A3T0-01,TCGA-EL-A3T0,THCA,45.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2001.0,nan,-16798.0,Alive,TUMOR FREE,4335.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,4335.0,0.0,4335.0,0.0,4335.0,0.0,4335.0,0
TCGA-EL-A3T0-11,TCGA-EL-A3T0,THCA,45.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2001.0,nan,-16798.0,Alive,TUMOR FREE,4335.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,4335.0,0.0,4335.0,0.0,4335.0,0.0,4335.0,0
TCGA-EL-A3T1-01,TCGA-EL-A3T1,THCA,38.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2002.0,nan,-14025.0,Alive,TUMOR FREE,3941.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,3941.0,0.0,3941.0,0.0,3941.0,0.0,3941.0,0
TCGA-EL-A3T1-11,TCGA-EL-A3T1,THCA,38.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2002.0,nan,-14025.0,Alive,TUMOR FREE,3941.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,3941.0,0.0,3941.0,0.0,3941.0,0.0,3941.0,0
TCGA-EL-A3T2-01,TCGA-EL-A3T2,THCA,55.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2002.0,nan,-20403.0,Alive,WITH TUMOR,988.0,nan,nan,Locoregional Recurrence,Lymph Node Only,pretracheal lymph node,903.0,nan,nan,R0,0.0,988.0,0.0,988.0,1.0,903.0,1.0,903.0,2
TCGA-EL-A3T2-11,TCGA-EL-A3T2,THCA,55.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2002.0,nan,-20403.0,Alive,WITH TUMOR,988.0,nan,nan,Locoregional Recurrence,Lymph Node Only,pretracheal lymph node,903.0,nan,nan,R0,0.0,988.0,0.0,988.0,1.0,903.0,1.0,903.0,2
TCGA-EL-A3T3-01,TCGA-EL-A3T3,THCA,63.0,MALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2002.0,nan,-23043.0,Alive,TUMOR FREE,4017.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,4017.0,0.0,4017.0,0.0,4017.0,0.0,4017.0,0
TCGA-EL-A3T3-11,TCGA-EL-A3T3,THCA,63.0,MALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2002.0,nan,-23043.0,Alive,TUMOR FREE,4017.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,4017.0,0.0,4017.0,0.0,4017.0,0.0,4017.0,0
TCGA-EL-A3T6-01,TCGA-EL-A3T6,THCA,34.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2003.0,nan,-12777.0,Alive,TUMOR FREE,2988.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2988.0,0.0,2988.0,0.0,2988.0,0.0,2988.0,0
TCGA-EL-A3T6-11,TCGA-EL-A3T6,THCA,34.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2003.0,nan,-12777.0,Alive,TUMOR FREE,2988.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2988.0,0.0,2988.0,0.0,2988.0,0.0,2988.0,0
TCGA-EL-A3T7-01,TCGA-EL-A3T7,THCA,47.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2004.0,nan,-17302.0,Alive,TUMOR FREE,1256.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1256.0,0.0,1256.0,0.0,1256.0,0.0,1256.0,0
TCGA-EL-A3T7-11,TCGA-EL-A3T7,THCA,47.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2004.0,nan,-17302.0,Alive,TUMOR FREE,1256.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1256.0,0.0,1256.0,0.0,1256.0,0.0,1256.0,0
TCGA-EL-A3T8-01,TCGA-EL-A3T8,THCA,36.0,MALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2005.0,nan,-13290.0,Alive,TUMOR FREE,3269.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,3269.0,0.0,3269.0,0.0,3269.0,0.0,3269.0,0
TCGA-EL-A3T8-11,TCGA-EL-A3T8,THCA,36.0,MALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2005.0,nan,-13290.0,Alive,TUMOR FREE,3269.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,3269.0,0.0,3269.0,0.0,3269.0,0.0,3269.0,0
TCGA-EL-A3T9-01,TCGA-EL-A3T9,THCA,69.0,FEMALE,WHITE,Stage IV,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2005.0,nan,-25484.0,Dead,WITH TUMOR,nan,174.0,nan,nan,nan,nan,nan,nan,nan,R1,1.0,174.0,1.0,174.0,nan,nan,1.0,174.0,1
TCGA-EL-A3TA-01,TCGA-EL-A3TA,THCA,42.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2005.0,nan,-15366.0,Alive,TUMOR FREE,2035.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2035.0,0.0,2035.0,0.0,2035.0,0.0,2035.0,0
TCGA-EL-A3TA-11,TCGA-EL-A3TA,THCA,42.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2005.0,nan,-15366.0,Alive,TUMOR FREE,2035.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2035.0,0.0,2035.0,0.0,2035.0,0.0,2035.0,0
TCGA-EL-A3TB-01,TCGA-EL-A3TB,THCA,47.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2005.0,nan,-17195.0,Alive,TUMOR FREE,2519.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2519.0,0.0,2519.0,0.0,2519.0,0.0,2519.0,0
TCGA-EL-A3TB-11,TCGA-EL-A3TB,THCA,47.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2005.0,nan,-17195.0,Alive,TUMOR FREE,2519.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2519.0,0.0,2519.0,0.0,2519.0,0.0,2519.0,0
TCGA-EL-A3ZG-01,TCGA-EL-A3ZG,THCA,15.0,MALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2006.0,nan,-5612.0,Alive,TUMOR FREE,2724.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2724.0,0.0,2724.0,0.0,2724.0,0.0,2724.0,0
TCGA-EL-A3ZG-11,TCGA-EL-A3ZG,THCA,15.0,MALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2006.0,nan,-5612.0,Alive,TUMOR FREE,2724.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2724.0,0.0,2724.0,0.0,2724.0,0.0,2724.0,0
TCGA-EL-A3ZH-01,TCGA-EL-A3ZH,THCA,42.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2006.0,nan,-15685.0,Alive,TUMOR FREE,2773.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2773.0,0.0,2773.0,0.0,2773.0,0.0,2773.0,0
TCGA-EL-A3ZH-11,TCGA-EL-A3ZH,THCA,42.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2006.0,nan,-15685.0,Alive,TUMOR FREE,2773.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2773.0,0.0,2773.0,0.0,2773.0,0.0,2773.0,0
TCGA-EL-A3ZK-01,TCGA-EL-A3ZK,THCA,41.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2007.0,nan,-15121.0,Alive,TUMOR FREE,1575.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1575.0,0.0,1575.0,0.0,1575.0,0.0,1575.0,0
TCGA-EL-A3ZK-11,TCGA-EL-A3ZK,THCA,41.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2007.0,nan,-15121.0,Alive,TUMOR FREE,1575.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1575.0,0.0,1575.0,0.0,1575.0,0.0,1575.0,0
TCGA-EL-A3ZL-01,TCGA-EL-A3ZL,THCA,34.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-12649.0,Alive,TUMOR FREE,1895.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1895.0,0.0,1895.0,0.0,1895.0,0.0,1895.0,0
TCGA-EL-A3ZL-11,TCGA-EL-A3ZL,THCA,34.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-12649.0,Alive,TUMOR FREE,1895.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1895.0,0.0,1895.0,0.0,1895.0,0.0,1895.0,0
TCGA-EL-A3ZM-01,TCGA-EL-A3ZM,THCA,60.0,MALE,[Unknown],Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-21987.0,Alive,TUMOR FREE,1096.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,1096.0,0.0,1096.0,nan,nan,0.0,1096.0,0
TCGA-EL-A3ZM-11,TCGA-EL-A3ZM,THCA,60.0,MALE,[Unknown],Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-21987.0,Alive,TUMOR FREE,1096.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,1096.0,0.0,1096.0,nan,nan,0.0,1096.0,0
TCGA-EL-A3ZN-01,TCGA-EL-A3ZN,THCA,28.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-10266.0,Alive,TUMOR FREE,1614.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1614.0,0.0,1614.0,0.0,1614.0,0.0,1614.0,0
TCGA-EL-A3ZO-01,TCGA-EL-A3ZO,THCA,79.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-28924.0,Alive,TUMOR FREE,2211.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2211.0,0.0,2211.0,0.0,2211.0,0.0,2211.0,0
TCGA-EL-A3ZO-11,TCGA-EL-A3ZO,THCA,79.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-28924.0,Alive,TUMOR FREE,2211.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2211.0,0.0,2211.0,0.0,2211.0,0.0,2211.0,0
TCGA-EL-A3ZP-01,TCGA-EL-A3ZP,THCA,19.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-7101.0,Alive,TUMOR FREE,1992.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1992.0,0.0,1992.0,0.0,1992.0,0.0,1992.0,0
TCGA-EL-A3ZP-11,TCGA-EL-A3ZP,THCA,19.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-7101.0,Alive,TUMOR FREE,1992.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1992.0,0.0,1992.0,0.0,1992.0,0.0,1992.0,0
TCGA-EL-A3ZQ-01,TCGA-EL-A3ZQ,THCA,78.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-28783.0,Alive,TUMOR FREE,1862.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1862.0,0.0,1862.0,0.0,1862.0,0.0,1862.0,0
TCGA-EL-A3ZQ-11,TCGA-EL-A3ZQ,THCA,78.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-28783.0,Alive,TUMOR FREE,1862.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1862.0,0.0,1862.0,0.0,1862.0,0.0,1862.0,0
TCGA-EL-A3ZR-01,TCGA-EL-A3ZR,THCA,46.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-16852.0,Alive,TUMOR FREE,1830.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1830.0,0.0,1830.0,0.0,1830.0,0.0,1830.0,0
TCGA-EL-A3ZR-11,TCGA-EL-A3ZR,THCA,46.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-16852.0,Alive,TUMOR FREE,1830.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1830.0,0.0,1830.0,0.0,1830.0,0.0,1830.0,0
TCGA-EL-A3ZS-01,TCGA-EL-A3ZS,THCA,22.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-8076.0,Alive,TUMOR FREE,215.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,215.0,0.0,215.0,0.0,215.0,0.0,215.0,0
TCGA-EL-A3ZS-11,TCGA-EL-A3ZS,THCA,22.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-8076.0,Alive,TUMOR FREE,215.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,215.0,0.0,215.0,0.0,215.0,0.0,215.0,0
TCGA-EL-A3ZT-01,TCGA-EL-A3ZT,THCA,35.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-13103.0,Alive,TUMOR FREE,1808.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1808.0,0.0,1808.0,0.0,1808.0,0.0,1808.0,0
TCGA-EL-A3ZT-11,TCGA-EL-A3ZT,THCA,35.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-13103.0,Alive,TUMOR FREE,1808.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1808.0,0.0,1808.0,0.0,1808.0,0.0,1808.0,0
TCGA-EL-A4JV-01,TCGA-EL-A4JV,THCA,41.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-15065.0,Alive,TUMOR FREE,1748.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1748.0,0.0,1748.0,0.0,1748.0,0.0,1748.0,0
TCGA-EL-A4JW-01,TCGA-EL-A4JW,THCA,38.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-13928.0,Alive,TUMOR FREE,1056.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1056.0,0.0,1056.0,0.0,1056.0,0.0,1056.0,0
TCGA-EL-A4JX-01,TCGA-EL-A4JX,THCA,31.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-11465.0,Alive,TUMOR FREE,1398.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1398.0,0.0,1398.0,0.0,1398.0,0.0,1398.0,0
TCGA-EL-A4JZ-01,TCGA-EL-A4JZ,THCA,55.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-20290.0,Alive,TUMOR FREE,1856.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1856.0,0.0,1856.0,0.0,1856.0,0.0,1856.0,0
TCGA-EL-A4K0-01,TCGA-EL-A4K0,THCA,54.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-20042.0,Alive,TUMOR FREE,944.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,944.0,0.0,944.0,nan,nan,0.0,944.0,0
TCGA-EL-A4K1-01,TCGA-EL-A4K1,THCA,68.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-24846.0,Alive,TUMOR FREE,1046.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1046.0,0.0,1046.0,0.0,1046.0,0.0,1046.0,0
TCGA-EL-A4K2-01,TCGA-EL-A4K2,THCA,43.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-15962.0,Alive,TUMOR FREE,928.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,928.0,0.0,928.0,0.0,928.0,0.0,928.0,0
TCGA-EL-A4K4-01,TCGA-EL-A4K4,THCA,33.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-12368.0,Alive,WITH TUMOR,1623.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1623.0,0.0,1623.0,0.0,1623.0,0.0,1623.0,0
TCGA-EL-A4K6-01,TCGA-EL-A4K6,THCA,75.0,MALE,WHITE,Stage IV,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-27416.0,Alive,WITH TUMOR,1343.0,nan,nan,Distant Metastasis,Lung,nan,874.0,nan,nan,R0,0.0,1343.0,0.0,1343.0,nan,nan,1.0,874.0,0
TCGA-EL-A4K7-01,TCGA-EL-A4K7,THCA,74.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-27306.0,Alive,TUMOR FREE,1251.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1251.0,0.0,1251.0,0.0,1251.0,0.0,1251.0,0
TCGA-EL-A4K9-01,TCGA-EL-A4K9,THCA,68.0,MALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-24980.0,Alive,TUMOR FREE,1455.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1455.0,0.0,1455.0,0.0,1455.0,0.0,1455.0,0
TCGA-EL-A4KD-01,TCGA-EL-A4KD,THCA,41.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-15291.0,Alive,TUMOR FREE,1326.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1326.0,0.0,1326.0,0.0,1326.0,0.0,1326.0,0
TCGA-EL-A4KG-01,TCGA-EL-A4KG,THCA,35.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-12978.0,Alive,TUMOR FREE,739.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,739.0,0.0,739.0,0.0,739.0,0.0,739.0,0
TCGA-EL-A4KH-01,TCGA-EL-A4KH,THCA,36.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-13275.0,Alive,TUMOR FREE,823.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,823.0,0.0,823.0,0.0,823.0,0.0,823.0,0
TCGA-EL-A4KI-01,TCGA-EL-A4KI,THCA,63.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-23182.0,Alive,WITH TUMOR,727.0,nan,nan,Distant Metastasis,Lung,nan,265.0,nan,nan,R0,0.0,727.0,0.0,727.0,1.0,265.0,1.0,265.0,0
TCGA-EM-A1CS-01,TCGA-EM-A1CS,THCA,55.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-20284.0,Alive,TUMOR FREE,817.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,817.0,0.0,817.0,0.0,817.0,0.0,817.0,0
TCGA-EM-A1CS-11,TCGA-EM-A1CS,THCA,55.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-20284.0,Alive,TUMOR FREE,817.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,817.0,0.0,817.0,0.0,817.0,0.0,817.0,0
TCGA-EM-A1CT-01,TCGA-EM-A1CT,THCA,76.0,MALE,nan,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-27944.0,Alive,TUMOR FREE,553.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,553.0,0.0,553.0,nan,nan,0.0,553.0,0
TCGA-EM-A1CT-11,TCGA-EM-A1CT,THCA,76.0,MALE,nan,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-27944.0,Alive,TUMOR FREE,553.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,553.0,0.0,553.0,nan,nan,0.0,553.0,0
TCGA-EM-A1CU-01,TCGA-EM-A1CU,THCA,31.0,MALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-11470.0,Alive,TUMOR FREE,636.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,636.0,0.0,636.0,nan,nan,0.0,636.0,0
TCGA-EM-A1CU-11,TCGA-EM-A1CU,THCA,31.0,MALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-11470.0,Alive,TUMOR FREE,636.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,636.0,0.0,636.0,nan,nan,0.0,636.0,0
TCGA-EM-A1CV-01,TCGA-EM-A1CV,THCA,32.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-11932.0,Alive,TUMOR FREE,1475.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1475.0,0.0,1475.0,nan,nan,0.0,1475.0,0
TCGA-EM-A1CV-11,TCGA-EM-A1CV,THCA,32.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-11932.0,Alive,TUMOR FREE,1475.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1475.0,0.0,1475.0,nan,nan,0.0,1475.0,0
TCGA-EM-A1CW-01,TCGA-EM-A1CW,THCA,39.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-14263.0,Alive,TUMOR FREE,549.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,549.0,0.0,549.0,0.0,549.0,0.0,549.0,0
TCGA-EM-A1CW-11,TCGA-EM-A1CW,THCA,39.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-14263.0,Alive,TUMOR FREE,549.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,549.0,0.0,549.0,0.0,549.0,0.0,549.0,0
TCGA-EM-A1YA-01,TCGA-EM-A1YA,THCA,74.0,FEMALE,nan,Stage II,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-27224.0,Alive,TUMOR FREE,602.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,602.0,0.0,602.0,0.0,602.0,0.0,602.0,0
TCGA-EM-A1YB-01,TCGA-EM-A1YB,THCA,73.0,FEMALE,nan,Stage II,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-26852.0,Alive,TUMOR FREE,592.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,592.0,0.0,592.0,0.0,592.0,0.0,592.0,0
TCGA-EM-A1YC-01,TCGA-EM-A1YC,THCA,71.0,FEMALE,nan,Stage III,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2007.0,nan,-26143.0,Alive,TUMOR FREE,2391.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2391.0,0.0,2391.0,0.0,2391.0,0.0,2391.0,0
TCGA-EM-A1YC-11,TCGA-EM-A1YC,THCA,71.0,FEMALE,nan,Stage III,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2007.0,nan,-26143.0,Alive,TUMOR FREE,2391.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2391.0,0.0,2391.0,0.0,2391.0,0.0,2391.0,0
TCGA-EM-A1YD-01,TCGA-EM-A1YD,THCA,53.0,FEMALE,nan,Stage II,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2007.0,nan,-19366.0,Alive,TUMOR FREE,1734.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1734.0,0.0,1734.0,0.0,1734.0,0.0,1734.0,0
TCGA-EM-A1YD-11,TCGA-EM-A1YD,THCA,53.0,FEMALE,nan,Stage II,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2007.0,nan,-19366.0,Alive,TUMOR FREE,1734.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1734.0,0.0,1734.0,0.0,1734.0,0.0,1734.0,0
TCGA-EM-A1YE-01,TCGA-EM-A1YE,THCA,47.0,FEMALE,nan,Stage II,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2007.0,nan,-17297.0,Alive,TUMOR FREE,1645.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1645.0,0.0,1645.0,0.0,1645.0,0.0,1645.0,0
TCGA-EM-A1YE-11,TCGA-EM-A1YE,THCA,47.0,FEMALE,nan,Stage II,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2007.0,nan,-17297.0,Alive,TUMOR FREE,1645.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1645.0,0.0,1645.0,0.0,1645.0,0.0,1645.0,0
TCGA-EM-A22I-01,TCGA-EM-A22I,THCA,52.0,FEMALE,nan,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-19003.0,Alive,TUMOR FREE,448.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,448.0,0.0,448.0,nan,nan,0.0,448.0,0
TCGA-EM-A22J-01,TCGA-EM-A22J,THCA,56.0,FEMALE,nan,Stage II,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-20539.0,Alive,TUMOR FREE,441.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,441.0,0.0,441.0,nan,nan,0.0,441.0,0
TCGA-EM-A22K-01,TCGA-EM-A22K,THCA,46.0,FEMALE,nan,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-16890.0,Alive,TUMOR FREE,479.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,479.0,0.0,479.0,nan,nan,0.0,479.0,0
TCGA-EM-A22L-01,TCGA-EM-A22L,THCA,33.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-12092.0,Alive,TUMOR FREE,318.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,318.0,0.0,318.0,0.0,318.0,0.0,318.0,0
TCGA-EM-A22M-01,TCGA-EM-A22M,THCA,52.0,MALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-19059.0,Alive,TUMOR FREE,442.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,442.0,0.0,442.0,0.0,442.0,0.0,442.0,0
TCGA-EM-A22N-01,TCGA-EM-A22N,THCA,68.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-25035.0,Alive,TUMOR FREE,324.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,324.0,0.0,324.0,nan,nan,0.0,324.0,0
TCGA-EM-A22O-01,TCGA-EM-A22O,THCA,75.0,MALE,ASIAN,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-27758.0,Alive,TUMOR FREE,1344.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,1344.0,0.0,1344.0,nan,nan,0.0,1344.0,0
TCGA-EM-A22P-01,TCGA-EM-A22P,THCA,64.0,MALE,nan,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-23723.0,Alive,TUMOR FREE,1256.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,1256.0,0.0,1256.0,nan,nan,0.0,1256.0,0
TCGA-EM-A22Q-01,TCGA-EM-A22Q,THCA,36.0,MALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-13341.0,Alive,TUMOR FREE,433.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,433.0,0.0,433.0,0.0,433.0,0.0,433.0,0
TCGA-EM-A2CJ-01,TCGA-EM-A2CJ,THCA,49.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-18168.0,Alive,TUMOR FREE,1447.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1447.0,0.0,1447.0,0.0,1447.0,0.0,1447.0,0
TCGA-EM-A2CK-01,TCGA-EM-A2CK,THCA,28.0,MALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-10485.0,Alive,TUMOR FREE,544.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,544.0,0.0,544.0,0.0,544.0,0.0,544.0,0
TCGA-EM-A2CL-01,TCGA-EM-A2CL,THCA,31.0,MALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-11649.0,Alive,TUMOR FREE,401.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,401.0,0.0,401.0,0.0,401.0,0.0,401.0,0
TCGA-EM-A2CM-01,TCGA-EM-A2CM,THCA,62.0,FEMALE,nan,Stage III,nan,"Other, specify",nan,2010.0,nan,-22726.0,Alive,WITH TUMOR,1253.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1253.0,0.0,1253.0,0.0,1253.0,0.0,1253.0,0
TCGA-EM-A2CN-01,TCGA-EM-A2CN,THCA,62.0,MALE,nan,Stage IVC,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-22817.0,Alive,WITH TUMOR,715.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,715.0,0.0,715.0,nan,nan,0.0,715.0,0
TCGA-EM-A2CO-01,TCGA-EM-A2CO,THCA,77.0,FEMALE,nan,Stage II,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-28424.0,Alive,TUMOR FREE,184.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,184.0,0.0,184.0,0.0,184.0,0.0,184.0,0
TCGA-EM-A2CP-01,TCGA-EM-A2CP,THCA,26.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-9759.0,Alive,TUMOR FREE,91.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,91.0,0.0,91.0,0.0,91.0,0.0,91.0,0
TCGA-EM-A2CQ-01,TCGA-EM-A2CQ,THCA,40.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-14776.0,Alive,TUMOR FREE,374.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,374.0,0.0,374.0,0.0,374.0,0.0,374.0,0
TCGA-EM-A2CR-01,TCGA-EM-A2CR,THCA,46.0,FEMALE,nan,Stage II,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-16807.0,Alive,TUMOR FREE,415.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,415.0,0.0,415.0,0.0,415.0,0.0,415.0,0
TCGA-EM-A2CS-06,TCGA-EM-A2CS,THCA,51.0,FEMALE,nan,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-18990.0,Alive,WITH TUMOR,841.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,841.0,0.0,841.0,nan,nan,0.0,841.0,0
TCGA-EM-A2CS-01,TCGA-EM-A2CS,THCA,51.0,FEMALE,nan,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-18990.0,Alive,WITH TUMOR,841.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,841.0,0.0,841.0,nan,nan,0.0,841.0,0
TCGA-EM-A2CT-01,TCGA-EM-A2CT,THCA,20.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-7558.0,Alive,TUMOR FREE,1474.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1474.0,0.0,1474.0,0.0,1474.0,0.0,1474.0,0
TCGA-EM-A2CU-01,TCGA-EM-A2CU,THCA,47.0,FEMALE,nan,Stage III,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-17231.0,Alive,WITH TUMOR,400.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,400.0,0.0,400.0,0.0,400.0,0.0,400.0,0
TCGA-EM-A2OV-01,TCGA-EM-A2OV,THCA,64.0,FEMALE,ASIAN,Stage II,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-23656.0,Alive,TUMOR FREE,674.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,674.0,0.0,674.0,0.0,674.0,0.0,674.0,0
TCGA-EM-A2OW-01,TCGA-EM-A2OW,THCA,37.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-13761.0,Alive,TUMOR FREE,1227.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1227.0,0.0,1227.0,0.0,1227.0,0.0,1227.0,0
TCGA-EM-A2OX-01,TCGA-EM-A2OX,THCA,46.0,MALE,nan,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-16911.0,Alive,TUMOR FREE,600.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,600.0,0.0,600.0,nan,nan,0.0,600.0,0
TCGA-EM-A2OY-01,TCGA-EM-A2OY,THCA,46.0,FEMALE,nan,Stage II,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-17075.0,Alive,TUMOR FREE,983.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,983.0,0.0,983.0,0.0,983.0,0.0,983.0,0
TCGA-EM-A2OZ-01,TCGA-EM-A2OZ,THCA,66.0,MALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-24195.0,Alive,TUMOR FREE,1033.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1033.0,0.0,1033.0,0.0,1033.0,0.0,1033.0,0
TCGA-EM-A2P0-01,TCGA-EM-A2P0,THCA,33.0,MALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-12127.0,Alive,TUMOR FREE,535.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,535.0,0.0,535.0,0.0,535.0,0.0,535.0,0
TCGA-EM-A2P1-06,TCGA-EM-A2P1,THCA,33.0,MALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-12320.0,Alive,WITH TUMOR,531.0,nan,nan,Locoregional Recurrence,Lymph Node Only,nan,363.0,nan,nan,R0,0.0,531.0,0.0,531.0,1.0,363.0,1.0,363.0,0
TCGA-EM-A2P1-01,TCGA-EM-A2P1,THCA,33.0,MALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-12320.0,Alive,WITH TUMOR,531.0,nan,nan,Locoregional Recurrence,Lymph Node Only,nan,363.0,nan,nan,R0,0.0,531.0,0.0,531.0,1.0,363.0,1.0,363.0,0
TCGA-EM-A2P2-01,TCGA-EM-A2P2,THCA,46.0,MALE,nan,Stage III,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-16895.0,Alive,TUMOR FREE,526.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,526.0,0.0,526.0,0.0,526.0,0.0,526.0,0
TCGA-EM-A2P3-01,TCGA-EM-A2P3,THCA,47.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-17495.0,Alive,TUMOR FREE,444.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,444.0,0.0,444.0,0.0,444.0,0.0,444.0,0
TCGA-EM-A3AI-01,TCGA-EM-A3AI,THCA,67.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-24820.0,Alive,TUMOR FREE,685.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,685.0,0.0,685.0,0.0,685.0,0.0,685.0,0
TCGA-EM-A3AJ-01,TCGA-EM-A3AJ,THCA,39.0,MALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-14399.0,Alive,TUMOR FREE,941.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,941.0,0.0,941.0,nan,nan,0.0,941.0,0
TCGA-EM-A3AK-01,TCGA-EM-A3AK,THCA,62.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-22911.0,Alive,TUMOR FREE,477.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,477.0,0.0,477.0,0.0,477.0,0.0,477.0,0
TCGA-EM-A3AL-01,TCGA-EM-A3AL,THCA,45.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-16439.0,Alive,TUMOR FREE,430.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,430.0,0.0,430.0,0.0,430.0,0.0,430.0,0
TCGA-EM-A3AN-01,TCGA-EM-A3AN,THCA,36.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-13188.0,Alive,TUMOR FREE,1006.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,1006.0,0.0,1006.0,nan,nan,0.0,1006.0,0
TCGA-EM-A3AO-01,TCGA-EM-A3AO,THCA,61.0,MALE,nan,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-22347.0,Alive,TUMOR FREE,1354.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1354.0,0.0,1354.0,nan,nan,0.0,1354.0,0
TCGA-EM-A3AP-01,TCGA-EM-A3AP,THCA,31.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-11592.0,Alive,TUMOR FREE,254.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,254.0,0.0,254.0,0.0,254.0,0.0,254.0,0
TCGA-EM-A3AQ-01,TCGA-EM-A3AQ,THCA,85.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-31198.0,Alive,TUMOR FREE,904.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,904.0,0.0,904.0,0.0,904.0,0.0,904.0,0
TCGA-EM-A3AR-01,TCGA-EM-A3AR,THCA,41.0,MALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-15313.0,Alive,TUMOR FREE,1133.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1133.0,0.0,1133.0,0.0,1133.0,0.0,1133.0,0
TCGA-EM-A3FJ-01,TCGA-EM-A3FJ,THCA,24.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-9042.0,Alive,TUMOR FREE,850.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,850.0,0.0,850.0,0.0,850.0,0.0,850.0,0
TCGA-EM-A3FK-01,TCGA-EM-A3FK,THCA,30.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-10992.0,Alive,TUMOR FREE,723.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,723.0,0.0,723.0,0.0,723.0,0.0,723.0,0
TCGA-EM-A3FL-01,TCGA-EM-A3FL,THCA,63.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-23183.0,Alive,TUMOR FREE,1441.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1441.0,0.0,1441.0,0.0,1441.0,0.0,1441.0,0
TCGA-EM-A3FM-01,TCGA-EM-A3FM,THCA,57.0,MALE,nan,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-20938.0,Alive,WITH TUMOR,639.0,nan,nan,Locoregional Recurrence,Lymph Node Only,nan,514.0,nan,nan,R0,0.0,639.0,0.0,639.0,nan,nan,1.0,514.0,0
TCGA-EM-A3FN-01,TCGA-EM-A3FN,THCA,42.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-15655.0,Alive,TUMOR FREE,367.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,367.0,0.0,367.0,0.0,367.0,0.0,367.0,0
TCGA-EM-A3FO-01,TCGA-EM-A3FO,THCA,40.0,MALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-14864.0,Alive,TUMOR FREE,532.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,532.0,0.0,532.0,0.0,532.0,0.0,532.0,0
TCGA-EM-A3FP-01,TCGA-EM-A3FP,THCA,71.0,FEMALE,nan,Stage II,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-26158.0,Alive,TUMOR FREE,529.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,529.0,0.0,529.0,0.0,529.0,0.0,529.0,0
TCGA-EM-A3FQ-06,TCGA-EM-A3FQ,THCA,19.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-7176.0,Alive,WITH TUMOR,492.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,492.0,0.0,492.0,0.0,492.0,0.0,492.0,0
TCGA-EM-A3FQ-01,TCGA-EM-A3FQ,THCA,19.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-7176.0,Alive,WITH TUMOR,492.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,492.0,0.0,492.0,0.0,492.0,0.0,492.0,0
TCGA-EM-A3FR-01,TCGA-EM-A3FR,THCA,55.0,FEMALE,nan,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-20349.0,Alive,TUMOR FREE,457.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,457.0,0.0,457.0,0.0,457.0,0.0,457.0,0
TCGA-EM-A3O3-01,TCGA-EM-A3O3,THCA,83.0,FEMALE,[Unknown],Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-30500.0,Alive,TUMOR FREE,441.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,441.0,0.0,441.0,0.0,441.0,0.0,441.0,0
TCGA-EM-A3O6-01,TCGA-EM-A3O6,THCA,54.0,FEMALE,[Unknown],Stage II,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-19856.0,Alive,TUMOR FREE,458.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,458.0,0.0,458.0,0.0,458.0,0.0,458.0,0
TCGA-EM-A3O7-01,TCGA-EM-A3O7,THCA,46.0,FEMALE,[Unknown],Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-16842.0,Alive,TUMOR FREE,223.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,223.0,0.0,223.0,0.0,223.0,0.0,223.0,0
TCGA-EM-A3O8-01,TCGA-EM-A3O8,THCA,33.0,FEMALE,[Unknown],Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-12405.0,Alive,TUMOR FREE,381.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,381.0,0.0,381.0,0.0,381.0,0.0,381.0,0
TCGA-EM-A3O9-01,TCGA-EM-A3O9,THCA,40.0,MALE,[Unknown],Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-14783.0,Alive,TUMOR FREE,281.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,281.0,0.0,281.0,0.0,281.0,0.0,281.0,0
TCGA-EM-A3OA-01,TCGA-EM-A3OA,THCA,55.0,FEMALE,[Unknown],Stage II,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-20284.0,Alive,TUMOR FREE,822.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,822.0,0.0,822.0,0.0,822.0,0.0,822.0,0
TCGA-EM-A3OB-01,TCGA-EM-A3OB,THCA,33.0,FEMALE,[Unknown],Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-12282.0,Alive,TUMOR FREE,1176.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1176.0,0.0,1176.0,0.0,1176.0,0.0,1176.0,0
TCGA-EM-A3ST-01,TCGA-EM-A3ST,THCA,62.0,FEMALE,[Unknown],Stage III,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-22990.0,Alive,WITH TUMOR,1182.0,nan,nan,Biochemical evidence of disease,nan,nan,966.0,nan,nan,R0,0.0,1182.0,0.0,1182.0,1.0,966.0,1.0,966.0,2
TCGA-EM-A3ST-11,TCGA-EM-A3ST,THCA,62.0,FEMALE,[Unknown],Stage III,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-22990.0,Alive,WITH TUMOR,1182.0,nan,nan,Biochemical evidence of disease,nan,nan,966.0,nan,nan,R0,0.0,1182.0,0.0,1182.0,1.0,966.0,1.0,966.0,2
TCGA-EM-A3SU-06,TCGA-EM-A3SU,THCA,43.0,FEMALE,[Unknown],Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-15768.0,Alive,TUMOR FREE,911.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,911.0,0.0,911.0,0.0,911.0,0.0,911.0,0
TCGA-EM-A3SU-01,TCGA-EM-A3SU,THCA,43.0,FEMALE,[Unknown],Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-15768.0,Alive,TUMOR FREE,911.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,911.0,0.0,911.0,0.0,911.0,0.0,911.0,0
TCGA-EM-A3SX-01,TCGA-EM-A3SX,THCA,28.0,FEMALE,[Unknown],Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-10447.0,Alive,WITH TUMOR,908.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,908.0,0.0,908.0,nan,nan,0.0,908.0,0
TCGA-EM-A3SY-01,TCGA-EM-A3SY,THCA,36.0,MALE,[Unknown],Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-13461.0,Alive,TUMOR FREE,411.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,411.0,0.0,411.0,0.0,411.0,0.0,411.0,0
TCGA-EM-A3SZ-01,TCGA-EM-A3SZ,THCA,42.0,FEMALE,[Unknown],Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-15659.0,Alive,TUMOR FREE,389.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,389.0,0.0,389.0,0.0,389.0,0.0,389.0,0
TCGA-EM-A4FF-01,TCGA-EM-A4FF,THCA,40.0,FEMALE,[Unknown],Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2006.0,nan,-14796.0,Alive,TUMOR FREE,2573.0,nan,nan,Locoregional Recurrence,Lymph Node Only,nan,1785.0,nan,nan,R1,0.0,2573.0,0.0,2573.0,nan,nan,1.0,1785.0,0
TCGA-EM-A4FH-01,TCGA-EM-A4FH,THCA,69.0,MALE,[Unknown],Stage III,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-25500.0,Alive,TUMOR FREE,892.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,892.0,0.0,892.0,0.0,892.0,0.0,892.0,0
TCGA-EM-A4FK-01,TCGA-EM-A4FK,THCA,33.0,FEMALE,[Unknown],Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-12383.0,Alive,TUMOR FREE,649.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,649.0,0.0,649.0,0.0,649.0,0.0,649.0,0
TCGA-EM-A4FM-01,TCGA-EM-A4FM,THCA,59.0,FEMALE,[Unknown],Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-21595.0,Alive,WITH TUMOR,162.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,162.0,0.0,162.0,nan,nan,0.0,162.0,0
TCGA-EM-A4FN-01,TCGA-EM-A4FN,THCA,49.0,FEMALE,[Unknown],Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-18185.0,Alive,TUMOR FREE,802.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,802.0,0.0,802.0,nan,nan,0.0,802.0,0
TCGA-EM-A4FO-01,TCGA-EM-A4FO,THCA,72.0,MALE,[Unknown],Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-26589.0,Alive,TUMOR FREE,802.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,802.0,0.0,802.0,0.0,802.0,0.0,802.0,0
TCGA-EM-A4FQ-01,TCGA-EM-A4FQ,THCA,42.0,FEMALE,[Unknown],Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2012.0,nan,-15534.0,Alive,TUMOR FREE,683.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,683.0,0.0,683.0,0.0,683.0,0.0,683.0,0
TCGA-EM-A4FR-01,TCGA-EM-A4FR,THCA,28.0,MALE,[Unknown],Stage I,nan,"Other, specify",nan,2012.0,nan,-10316.0,Alive,TUMOR FREE,655.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,655.0,0.0,655.0,0.0,655.0,0.0,655.0,0
TCGA-EM-A4FU-01,TCGA-EM-A4FU,THCA,35.0,MALE,[Unknown],Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2009.0,nan,-12912.0,Alive,TUMOR FREE,1840.0,nan,nan,Locoregional Recurrence,Lymph Node Only,nan,781.0,nan,nan,R0,0.0,1840.0,0.0,1840.0,1.0,781.0,1.0,781.0,0
TCGA-EM-A4FV-01,TCGA-EM-A4FV,THCA,64.0,FEMALE,[Unknown],Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-23627.0,Alive,TUMOR FREE,744.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,744.0,0.0,744.0,0.0,744.0,0.0,744.0,0
TCGA-EM-A4G1-01,TCGA-EM-A4G1,THCA,26.0,FEMALE,[Unknown],Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2012.0,nan,-9844.0,Alive,TUMOR FREE,416.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,416.0,0.0,416.0,0.0,416.0,0.0,416.0,0
TCGA-ET-A25G-01,TCGA-ET-A25G,THCA,56.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2008.0,nan,-20816.0,Alive,TUMOR FREE,2492.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2492.0,0.0,2492.0,0.0,2492.0,0.0,2492.0,0
TCGA-ET-A25I-01,TCGA-ET-A25I,THCA,37.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2008.0,nan,-13786.0,Alive,TUMOR FREE,2485.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2485.0,0.0,2485.0,0.0,2485.0,0.0,2485.0,0
TCGA-ET-A25J-01,TCGA-ET-A25J,THCA,40.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-14843.0,Alive,TUMOR FREE,2359.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2359.0,0.0,2359.0,0.0,2359.0,0.0,2359.0,0
TCGA-ET-A25J-11,TCGA-ET-A25J,THCA,40.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-14843.0,Alive,TUMOR FREE,2359.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2359.0,0.0,2359.0,0.0,2359.0,0.0,2359.0,0
TCGA-ET-A25K-01,TCGA-ET-A25K,THCA,36.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-13351.0,Alive,TUMOR FREE,2142.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2142.0,0.0,2142.0,0.0,2142.0,0.0,2142.0,0
TCGA-ET-A25L-01,TCGA-ET-A25L,THCA,52.0,FEMALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2010.0,nan,-19159.0,Alive,TUMOR FREE,1721.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,1721.0,0.0,1721.0,nan,nan,0.0,1721.0,0
TCGA-ET-A25M-01,TCGA-ET-A25M,THCA,33.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-12085.0,Alive,TUMOR FREE,1831.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1831.0,0.0,1831.0,0.0,1831.0,0.0,1831.0,0
TCGA-ET-A25N-01,TCGA-ET-A25N,THCA,28.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-10229.0,Alive,TUMOR FREE,1928.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1928.0,0.0,1928.0,0.0,1928.0,0.0,1928.0,0
TCGA-ET-A25N-11,TCGA-ET-A25N,THCA,28.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-10229.0,Alive,TUMOR FREE,1928.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1928.0,0.0,1928.0,0.0,1928.0,0.0,1928.0,0
TCGA-ET-A25O-01,TCGA-ET-A25O,THCA,35.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-12924.0,Alive,TUMOR FREE,1986.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1986.0,0.0,1986.0,0.0,1986.0,0.0,1986.0,0
TCGA-ET-A25P-01,TCGA-ET-A25P,THCA,24.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-8787.0,Alive,TUMOR FREE,559.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,559.0,0.0,559.0,0.0,559.0,0.0,559.0,0
TCGA-ET-A25R-01,TCGA-ET-A25R,THCA,51.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2009.0,nan,-18863.0,Alive,TUMOR FREE,1930.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1930.0,0.0,1930.0,0.0,1930.0,0.0,1930.0,0
TCGA-ET-A2MX-01,TCGA-ET-A2MX,THCA,27.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2007.0,nan,-10044.0,Alive,TUMOR FREE,2689.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2689.0,0.0,2689.0,0.0,2689.0,0.0,2689.0,0
TCGA-ET-A2MX-11,TCGA-ET-A2MX,THCA,27.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2007.0,nan,-10044.0,Alive,TUMOR FREE,2689.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2689.0,0.0,2689.0,0.0,2689.0,0.0,2689.0,0
TCGA-ET-A2MY-01,TCGA-ET-A2MY,THCA,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-26406.0,Alive,TUMOR FREE,1787.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1787.0,0.0,1787.0,0.0,1787.0,0.0,1787.0,0
TCGA-ET-A2MY-11,TCGA-ET-A2MY,THCA,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-26406.0,Alive,TUMOR FREE,1787.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1787.0,0.0,1787.0,0.0,1787.0,0.0,1787.0,0
TCGA-ET-A2MZ-01,TCGA-ET-A2MZ,THCA,39.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-14408.0,Alive,TUMOR FREE,1133.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,1133.0,0.0,1133.0,nan,nan,0.0,1133.0,0
TCGA-ET-A2N0-01,TCGA-ET-A2N0,THCA,51.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-18692.0,Alive,TUMOR FREE,1600.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1600.0,0.0,1600.0,0.0,1600.0,0.0,1600.0,0
TCGA-ET-A2N1-01,TCGA-ET-A2N1,THCA,47.0,FEMALE,ASIAN,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-17272.0,Alive,TUMOR FREE,1653.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1653.0,0.0,1653.0,0.0,1653.0,0.0,1653.0,0
TCGA-ET-A2N3-01,TCGA-ET-A2N3,THCA,34.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2008.0,nan,-12603.0,Alive,TUMOR FREE,2535.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,2535.0,0.0,2535.0,nan,nan,0.0,2535.0,0
TCGA-ET-A2N4-01,TCGA-ET-A2N4,THCA,53.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2008.0,nan,-19671.0,Alive,TUMOR FREE,81.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,81.0,0.0,81.0,nan,nan,0.0,81.0,0
TCGA-ET-A2N5-01,TCGA-ET-A2N5,THCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2008.0,nan,-17137.0,Alive,TUMOR FREE,2460.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,2460.0,0.0,2460.0,nan,nan,0.0,2460.0,0
TCGA-ET-A2N5-11,TCGA-ET-A2N5,THCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2008.0,nan,-17137.0,Alive,TUMOR FREE,2460.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,2460.0,0.0,2460.0,nan,nan,0.0,2460.0,0
TCGA-ET-A39I-01,TCGA-ET-A39I,THCA,83.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2007.0,nan,-30349.0,Dead,TUMOR FREE,nan,1011.0,nan,nan,nan,nan,nan,nan,nan,R0,1.0,1011.0,0.0,1011.0,0.0,1011.0,0.0,1011.0,0
TCGA-ET-A39J-01,TCGA-ET-A39J,THCA,23.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2006.0,nan,-8491.0,Alive,TUMOR FREE,3227.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,3227.0,0.0,3227.0,0.0,3227.0,0.0,3227.0,0
TCGA-ET-A39K-01,TCGA-ET-A39K,THCA,48.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2006.0,nan,-17789.0,Alive,TUMOR FREE,3267.0,nan,nan,Locoregional Recurrence,nan,nan,711.0,nan,nan,R1,0.0,3267.0,0.0,3267.0,nan,nan,1.0,711.0,0
TCGA-ET-A39L-01,TCGA-ET-A39L,THCA,20.0,FEMALE,nan,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2006.0,nan,-7636.0,Alive,TUMOR FREE,3299.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,3299.0,0.0,3299.0,0.0,3299.0,0.0,3299.0,0
TCGA-ET-A39M-01,TCGA-ET-A39M,THCA,34.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2004.0,nan,-12441.0,Alive,TUMOR FREE,2582.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2582.0,0.0,2582.0,0.0,2582.0,0.0,2582.0,0
TCGA-ET-A39N-01,TCGA-ET-A39N,THCA,35.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2004.0,nan,-12904.0,Alive,TUMOR FREE,3751.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,3751.0,0.0,3751.0,0.0,3751.0,0.0,3751.0,0
TCGA-ET-A39O-01,TCGA-ET-A39O,THCA,39.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2006.0,nan,-14295.0,Alive,TUMOR FREE,3059.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,3059.0,0.0,3059.0,0.0,3059.0,0.0,3059.0,0
TCGA-ET-A39P-01,TCGA-ET-A39P,THCA,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2007.0,nan,-26817.0,Alive,TUMOR FREE,2900.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,2900.0,0.0,2900.0,nan,nan,0.0,2900.0,0
TCGA-ET-A39R-01,TCGA-ET-A39R,THCA,24.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2007.0,nan,-8828.0,Alive,TUMOR FREE,2863.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2863.0,0.0,2863.0,0.0,2863.0,0.0,2863.0,0
TCGA-ET-A39S-01,TCGA-ET-A39S,THCA,27.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2007.0,nan,-10000.0,Alive,TUMOR FREE,1676.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1676.0,0.0,1676.0,0.0,1676.0,0.0,1676.0,0
TCGA-ET-A39T-01,TCGA-ET-A39T,THCA,55.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2006.0,nan,-20164.0,Alive,TUMOR FREE,2987.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2987.0,0.0,2987.0,0.0,2987.0,0.0,2987.0,0
TCGA-ET-A3BN-01,TCGA-ET-A3BN,THCA,33.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-12122.0,Alive,TUMOR FREE,859.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,859.0,0.0,859.0,0.0,859.0,0.0,859.0,0
TCGA-ET-A3BO-01,TCGA-ET-A3BO,THCA,44.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2010.0,nan,-16110.0,Alive,TUMOR FREE,1533.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,1533.0,0.0,1533.0,nan,nan,0.0,1533.0,0
TCGA-ET-A3BP-01,TCGA-ET-A3BP,THCA,34.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-12594.0,Alive,TUMOR FREE,2406.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2406.0,0.0,2406.0,0.0,2406.0,0.0,2406.0,0
TCGA-ET-A3BQ-01,TCGA-ET-A3BQ,THCA,27.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-10034.0,Alive,TUMOR FREE,2331.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2331.0,0.0,2331.0,0.0,2331.0,0.0,2331.0,0
TCGA-ET-A3BS-01,TCGA-ET-A3BS,THCA,42.0,MALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-15421.0,Alive,TUMOR FREE,176.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,176.0,0.0,176.0,0.0,176.0,0.0,176.0,0
TCGA-ET-A3BT-01,TCGA-ET-A3BT,THCA,60.0,FEMALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2007.0,nan,-22108.0,Alive,TUMOR FREE,2665.0,nan,nan,Locoregional Recurrence,Lymph Node Only,nan,267.0,nan,nan,R0,0.0,2665.0,0.0,2665.0,nan,nan,1.0,267.0,0
TCGA-ET-A3BU-01,TCGA-ET-A3BU,THCA,28.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-10510.0,Alive,TUMOR FREE,2367.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2367.0,0.0,2367.0,0.0,2367.0,0.0,2367.0,0
TCGA-ET-A3BV-01,TCGA-ET-A3BV,THCA,47.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-17441.0,Alive,TUMOR FREE,2294.0,nan,nan,Locoregional Recurrence,Lymph Node Only,nan,1204.0,nan,nan,R0,0.0,2294.0,0.0,2294.0,1.0,1204.0,1.0,1204.0,0
TCGA-ET-A3BW-01,TCGA-ET-A3BW,THCA,30.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-11032.0,Alive,TUMOR FREE,1419.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1419.0,0.0,1419.0,0.0,1419.0,0.0,1419.0,0
TCGA-ET-A3BX-01,TCGA-ET-A3BX,THCA,24.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-8791.0,Alive,TUMOR FREE,1596.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1596.0,0.0,1596.0,0.0,1596.0,0.0,1596.0,0
TCGA-ET-A3DO-01,TCGA-ET-A3DO,THCA,33.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2005.0,nan,-12158.0,Alive,TUMOR FREE,3552.0,nan,nan,Locoregional Recurrence,Lymph Node Only,nan,570.0,nan,nan,R0,0.0,3552.0,0.0,3552.0,1.0,570.0,1.0,570.0,0
TCGA-ET-A3DP-01,TCGA-ET-A3DP,THCA,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2007.0,nan,-15876.0,Alive,TUMOR FREE,2877.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2877.0,0.0,2877.0,0.0,2877.0,0.0,2877.0,0
TCGA-ET-A3DP-11,TCGA-ET-A3DP,THCA,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2007.0,nan,-15876.0,Alive,TUMOR FREE,2877.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2877.0,0.0,2877.0,0.0,2877.0,0.0,2877.0,0
TCGA-ET-A3DQ-01,TCGA-ET-A3DQ,THCA,43.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2008.0,nan,-15871.0,Alive,TUMOR FREE,2581.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2581.0,0.0,2581.0,0.0,2581.0,0.0,2581.0,0
TCGA-ET-A3DR-01,TCGA-ET-A3DR,THCA,42.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-15404.0,Alive,TUMOR FREE,2451.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2451.0,0.0,2451.0,0.0,2451.0,0.0,2451.0,0
TCGA-ET-A3DS-01,TCGA-ET-A3DS,THCA,33.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-12252.0,Alive,TUMOR FREE,2033.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2033.0,0.0,2033.0,0.0,2033.0,0.0,2033.0,0
TCGA-ET-A3DT-01,TCGA-ET-A3DT,THCA,23.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-8761.0,Alive,TUMOR FREE,1330.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1330.0,0.0,1330.0,0.0,1330.0,0.0,1330.0,0
TCGA-ET-A3DU-01,TCGA-ET-A3DU,THCA,21.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-7869.0,Alive,TUMOR FREE,1911.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,1911.0,0.0,1911.0,nan,nan,0.0,1911.0,0
TCGA-ET-A3DV-01,TCGA-ET-A3DV,THCA,68.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2001.0,nan,-24905.0,Alive,TUMOR FREE,5068.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,5068.0,0.0,5068.0,0.0,5068.0,0.0,5068.0,0
TCGA-ET-A3DW-01,TCGA-ET-A3DW,THCA,64.0,MALE,ASIAN,Stage III,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2003.0,nan,-23603.0,Alive,TUMOR FREE,752.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,752.0,0.0,752.0,0.0,752.0,0.0,752.0,0
TCGA-ET-A3DW-11,TCGA-ET-A3DW,THCA,64.0,MALE,ASIAN,Stage III,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2003.0,nan,-23603.0,Alive,TUMOR FREE,752.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,752.0,0.0,752.0,0.0,752.0,0.0,752.0,0
TCGA-ET-A40P-01,TCGA-ET-A40P,THCA,32.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-11843.0,Alive,TUMOR FREE,1338.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1338.0,0.0,1338.0,0.0,1338.0,0.0,1338.0,0
TCGA-ET-A40Q-01,TCGA-ET-A40Q,THCA,38.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2011.0,nan,-14136.0,Alive,TUMOR FREE,1407.0,nan,nan,Distant Metastasis,Lung,nan,218.0,nan,nan,R0,0.0,1407.0,0.0,1407.0,1.0,218.0,1.0,218.0,0
TCGA-ET-A40R-01,TCGA-ET-A40R,THCA,24.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-8963.0,Alive,TUMOR FREE,1350.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,1350.0,0.0,1350.0,nan,nan,0.0,1350.0,0
TCGA-ET-A40S-01,TCGA-ET-A40S,THCA,62.0,MALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-22733.0,Alive,TUMOR FREE,1223.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,1223.0,0.0,1223.0,nan,nan,0.0,1223.0,0
TCGA-ET-A40T-01,TCGA-ET-A40T,THCA,26.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-9531.0,Alive,TUMOR FREE,1140.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,1140.0,0.0,1140.0,nan,nan,0.0,1140.0,0
TCGA-ET-A4KN-01,TCGA-ET-A4KN,THCA,51.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2012.0,nan,-18889.0,Alive,TUMOR FREE,1009.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1009.0,0.0,1009.0,0.0,1009.0,0.0,1009.0,0
TCGA-ET-A4KQ-01,TCGA-ET-A4KQ,THCA,45.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2012.0,nan,-16685.0,Alive,TUMOR FREE,955.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,955.0,0.0,955.0,0.0,955.0,0.0,955.0,0
TCGA-FE-A22Z-01,TCGA-FE-A22Z,THCA,61.0,FEMALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2007.0,nan,-22286.0,Alive,WITH TUMOR,2243.0,nan,nan,Locoregional Recurrence,Lymph Node Only,nan,1215.0,nan,nan,R0,0.0,2243.0,0.0,2243.0,nan,nan,1.0,1215.0,1
TCGA-FE-A230-01,TCGA-FE-A230,THCA,30.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2006.0,nan,-10999.0,Alive,TUMOR FREE,2173.0,nan,nan,Locoregional Recurrence,Lymph Node Only,nan,526.0,nan,nan,R0,0.0,2173.0,0.0,2173.0,1.0,526.0,1.0,526.0,0
TCGA-FE-A231-01,TCGA-FE-A231,THCA,70.0,MALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-25703.0,Alive,TUMOR FREE,961.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,961.0,0.0,961.0,nan,nan,0.0,961.0,0
TCGA-FE-A232-01,TCGA-FE-A232,THCA,44.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2007.0,nan,-16280.0,Alive,TUMOR FREE,2424.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2424.0,0.0,2424.0,0.0,2424.0,0.0,2424.0,0
TCGA-FE-A233-01,TCGA-FE-A233,THCA,18.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2007.0,nan,-6770.0,Alive,TUMOR FREE,751.0,nan,nan,Locoregional Recurrence,Lymph Node Only,nan,567.0,nan,nan,R0,0.0,751.0,0.0,751.0,1.0,567.0,1.0,567.0,0
TCGA-FE-A234-01,TCGA-FE-A234,THCA,26.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2007.0,nan,-9724.0,Alive,WITH TUMOR,2075.0,nan,nan,Locoregional Recurrence,Lymph Node Only,nan,483.0,nan,nan,R0,0.0,2075.0,0.0,2075.0,1.0,483.0,1.0,483.0,2
TCGA-FE-A235-01,TCGA-FE-A235,THCA,26.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2002.0,nan,-9859.0,Alive,TUMOR FREE,3571.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,3571.0,0.0,3571.0,0.0,3571.0,0.0,3571.0,0
TCGA-FE-A236-01,TCGA-FE-A236,THCA,33.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2004.0,nan,-12348.0,Alive,TUMOR FREE,2031.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2031.0,0.0,2031.0,0.0,2031.0,0.0,2031.0,0
TCGA-FE-A237-01,TCGA-FE-A237,THCA,19.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2005.0,nan,-7207.0,Alive,TUMOR FREE,3431.0,nan,nan,Locoregional Recurrence,Lymph Node Only,nan,492.0,nan,nan,R0,0.0,3431.0,0.0,3431.0,1.0,492.0,1.0,492.0,0
TCGA-FE-A238-01,TCGA-FE-A238,THCA,36.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2005.0,nan,-13159.0,Alive,WITH TUMOR,1215.0,nan,nan,Distant Metastasis,Lung,nan,431.0,nan,nan,R0,0.0,1215.0,0.0,1215.0,1.0,431.0,1.0,431.0,2
TCGA-FE-A239-01,TCGA-FE-A239,THCA,82.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2005.0,nan,-30259.0,Dead,WITH TUMOR,nan,1023.0,nan,Locoregional Recurrence,Lymph Node Only,nan,933.0,nan,nan,R0,1.0,1023.0,1.0,1023.0,1.0,933.0,1.0,933.0,1
TCGA-FE-A23A-01,TCGA-FE-A23A,THCA,27.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2006.0,nan,-10177.0,Alive,TUMOR FREE,2489.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2489.0,0.0,2489.0,0.0,2489.0,0.0,2489.0,0
TCGA-FE-A3PA-01,TCGA-FE-A3PA,THCA,16.0,MALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2002.0,nan,-6068.0,Alive,TUMOR FREE,3235.0,nan,nan,nan,nan,nan,nan,nan,nan,R2,0.0,3235.0,0.0,3235.0,nan,nan,0.0,3235.0,0
TCGA-FE-A3PB-01,TCGA-FE-A3PB,THCA,33.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2004.0,nan,-12136.0,Alive,TUMOR FREE,2590.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2590.0,0.0,2590.0,0.0,2590.0,0.0,2590.0,0
TCGA-FE-A3PC-01,TCGA-FE-A3PC,THCA,37.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2006.0,nan,-13817.0,Alive,TUMOR FREE,2606.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2606.0,0.0,2606.0,0.0,2606.0,0.0,2606.0,0
TCGA-FE-A3PD-01,TCGA-FE-A3PD,THCA,17.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2006.0,nan,-6386.0,Alive,TUMOR FREE,2396.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2396.0,0.0,2396.0,0.0,2396.0,0.0,2396.0,0
TCGA-FK-A3S3-01,TCGA-FK-A3S3,THCA,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2008.0,nan,-15853.0,Alive,TUMOR FREE,2162.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2162.0,0.0,2162.0,0.0,2162.0,0.0,2162.0,0
TCGA-FK-A3SB-01,TCGA-FK-A3SB,THCA,28.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-10293.0,Alive,TUMOR FREE,125.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,125.0,0.0,125.0,0.0,125.0,0.0,125.0,0
TCGA-FK-A3SD-01,TCGA-FK-A3SD,THCA,61.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-22560.0,Alive,TUMOR FREE,32.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,32.0,0.0,32.0,0.0,32.0,0.0,32.0,0
TCGA-FK-A3SE-01,TCGA-FK-A3SE,THCA,31.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-11472.0,Alive,TUMOR FREE,670.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,670.0,0.0,670.0,0.0,670.0,0.0,670.0,0
TCGA-FK-A3SG-01,TCGA-FK-A3SG,THCA,21.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-7710.0,Alive,TUMOR FREE,28.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,28.0,0.0,28.0,0.0,28.0,0.0,28.0,0
TCGA-FK-A3SH-01,TCGA-FK-A3SH,THCA,50.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-18609.0,Alive,TUMOR FREE,1463.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1463.0,0.0,1463.0,0.0,1463.0,0.0,1463.0,0
TCGA-FK-A4UB-01,TCGA-FK-A4UB,THCA,51.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2005.0,nan,-18792.0,Alive,TUMOR FREE,3531.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,3531.0,0.0,3531.0,nan,nan,0.0,3531.0,0
TCGA-FY-A2QD-01,TCGA-FY-A2QD,THCA,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-22491.0,Alive,TUMOR FREE,38.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,38.0,0.0,38.0,nan,nan,0.0,38.0,0
TCGA-FY-A3BL-01,TCGA-FY-A3BL,THCA,29.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-10667.0,Alive,TUMOR FREE,621.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,621.0,0.0,621.0,0.0,621.0,0.0,621.0,0
TCGA-FY-A3I4-01,TCGA-FY-A3I4,THCA,34.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-12677.0,Alive,TUMOR FREE,542.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,542.0,0.0,542.0,0.0,542.0,0.0,542.0,0
TCGA-FY-A3I5-01,TCGA-FY-A3I5,THCA,64.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-23654.0,Alive,TUMOR FREE,238.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,238.0,0.0,238.0,0.0,238.0,0.0,238.0,0
TCGA-FY-A3NM-01,TCGA-FY-A3NM,THCA,48.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-17734.0,Alive,TUMOR FREE,885.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,885.0,0.0,885.0,0.0,885.0,0.0,885.0,0
TCGA-FY-A3NN-01,TCGA-FY-A3NN,THCA,48.0,FEMALE,nan,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-17613.0,Alive,nan,0.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0
TCGA-FY-A3NP-01,TCGA-FY-A3NP,THCA,69.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-25462.0,Alive,TUMOR FREE,491.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,491.0,0.0,491.0,0.0,491.0,0.0,491.0,0
TCGA-FY-A3ON-01,TCGA-FY-A3ON,THCA,20.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-7403.0,Alive,TUMOR FREE,595.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,595.0,0.0,595.0,0.0,595.0,0.0,595.0,0
TCGA-FY-A3R6-01,TCGA-FY-A3R6,THCA,57.0,FEMALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-21009.0,Alive,TUMOR FREE,423.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,423.0,0.0,423.0,nan,nan,0.0,423.0,0
TCGA-FY-A3R7-01,TCGA-FY-A3R7,THCA,50.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-18403.0,Alive,TUMOR FREE,495.0,nan,nan,nan,nan,nan,nan,nan,nan,[Unknown],0.0,495.0,0.0,495.0,nan,nan,0.0,495.0,0
TCGA-FY-A3R8-01,TCGA-FY-A3R8,THCA,62.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-22824.0,Alive,TUMOR FREE,477.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,477.0,0.0,477.0,0.0,477.0,0.0,477.0,0
TCGA-FY-A3R9-01,TCGA-FY-A3R9,THCA,66.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-24215.0,Alive,TUMOR FREE,504.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,504.0,0.0,504.0,0.0,504.0,0.0,504.0,0
TCGA-FY-A3RA-01,TCGA-FY-A3RA,THCA,21.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-7900.0,Alive,TUMOR FREE,550.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,550.0,0.0,550.0,0.0,550.0,0.0,550.0,0
TCGA-FY-A3TY-01,TCGA-FY-A3TY,THCA,61.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-22556.0,Alive,TUMOR FREE,709.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,709.0,0.0,709.0,0.0,709.0,0.0,709.0,0
TCGA-FY-A3TY-11,TCGA-FY-A3TY,THCA,61.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-22556.0,Alive,TUMOR FREE,709.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,709.0,0.0,709.0,0.0,709.0,0.0,709.0,0
TCGA-FY-A3W9-01,TCGA-FY-A3W9,THCA,66.0,FEMALE,WHITE,Stage II,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2012.0,nan,-24136.0,Alive,TUMOR FREE,658.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,658.0,0.0,658.0,nan,nan,0.0,658.0,0
TCGA-FY-A3WA-01,TCGA-FY-A3WA,THCA,52.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2012.0,nan,-18993.0,Alive,TUMOR FREE,519.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,519.0,0.0,519.0,0.0,519.0,0.0,519.0,0
TCGA-FY-A3YR-01,TCGA-FY-A3YR,THCA,64.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-23395.0,Alive,TUMOR FREE,528.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,528.0,0.0,528.0,0.0,528.0,0.0,528.0,0
TCGA-FY-A40K-01,TCGA-FY-A40K,THCA,46.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-17092.0,Alive,TUMOR FREE,461.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,461.0,0.0,461.0,0.0,461.0,0.0,461.0,0
TCGA-FY-A40L-01,TCGA-FY-A40L,THCA,55.0,FEMALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-20243.0,Alive,TUMOR FREE,726.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,726.0,0.0,726.0,nan,nan,0.0,726.0,0
TCGA-FY-A40M-01,TCGA-FY-A40M,THCA,51.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-18722.0,Alive,TUMOR FREE,684.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,684.0,0.0,684.0,0.0,684.0,0.0,684.0,0
TCGA-FY-A40N-01,TCGA-FY-A40N,THCA,55.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2012.0,nan,-20320.0,Alive,TUMOR FREE,579.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,579.0,0.0,579.0,0.0,579.0,0.0,579.0,0
TCGA-FY-A4B0-01,TCGA-FY-A4B0,THCA,76.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-27946.0,Alive,TUMOR FREE,420.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,420.0,0.0,420.0,nan,nan,0.0,420.0,0
TCGA-FY-A4B3-01,TCGA-FY-A4B3,THCA,51.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-18969.0,Alive,WITH TUMOR,427.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,427.0,0.0,427.0,nan,nan,0.0,427.0,0
TCGA-FY-A4B4-01,TCGA-FY-A4B4,THCA,62.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-22830.0,Alive,TUMOR FREE,657.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,657.0,0.0,657.0,nan,nan,0.0,657.0,0
TCGA-FY-A76V-01,TCGA-FY-A76V,THCA,54.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2013.0,nan,-19872.0,Alive,TUMOR FREE,51.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,51.0,0.0,51.0,0.0,51.0,0.0,51.0,0
TCGA-GE-A2C6-01,TCGA-GE-A2C6,THCA,33.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-12068.0,Alive,TUMOR FREE,381.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,381.0,0.0,381.0,nan,nan,0.0,381.0,0
TCGA-GE-A2C6-11,TCGA-GE-A2C6,THCA,33.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-12068.0,Alive,TUMOR FREE,381.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,381.0,0.0,381.0,nan,nan,0.0,381.0,0
TCGA-H2-A26U-01,TCGA-H2-A26U,THCA,54.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-19927.0,Alive,TUMOR FREE,517.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,517.0,0.0,517.0,nan,nan,0.0,517.0,0
TCGA-H2-A2K9-01,TCGA-H2-A2K9,THCA,25.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-9221.0,Alive,TUMOR FREE,659.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,659.0,0.0,659.0,nan,nan,0.0,659.0,0
TCGA-H2-A2K9-11,TCGA-H2-A2K9,THCA,25.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-9221.0,Alive,TUMOR FREE,659.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,659.0,0.0,659.0,nan,nan,0.0,659.0,0
TCGA-H2-A3RH-01,TCGA-H2-A3RH,THCA,41.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-15068.0,Alive,TUMOR FREE,379.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,379.0,0.0,379.0,nan,nan,0.0,379.0,0
TCGA-H2-A3RI-01,TCGA-H2-A3RI,THCA,29.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-10956.0,Alive,[Discrepancy],335.0,nan,nan,Locoregional Recurrence,Lymph Node Only,nan,279.0,nan,nan,nan,0.0,335.0,0.0,335.0,nan,nan,1.0,279.0,0
TCGA-H2-A3RI-11,TCGA-H2-A3RI,THCA,29.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-10956.0,Alive,[Discrepancy],335.0,nan,nan,Locoregional Recurrence,Lymph Node Only,nan,279.0,nan,nan,nan,0.0,335.0,0.0,335.0,nan,nan,1.0,279.0,0
TCGA-H2-A421-01,TCGA-H2-A421,THCA,34.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-12657.0,Alive,TUMOR FREE,610.0,nan,nan,nan,nan,nan,nan,nan,nan,[Unknown],0.0,610.0,0.0,610.0,nan,nan,0.0,610.0,0
TCGA-H2-A422-01,TCGA-H2-A422,THCA,40.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-14721.0,Alive,TUMOR FREE,566.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,566.0,0.0,566.0,nan,nan,0.0,566.0,0
TCGA-IM-A3EB-01,TCGA-IM-A3EB,THCA,32.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-11822.0,Alive,TUMOR FREE,1488.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1488.0,0.0,1488.0,0.0,1488.0,0.0,1488.0,0
TCGA-IM-A3ED-01,TCGA-IM-A3ED,THCA,58.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2008.0,nan,-21278.0,Alive,TUMOR FREE,1442.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1442.0,0.0,1442.0,0.0,1442.0,0.0,1442.0,0
TCGA-IM-A3U2-01,TCGA-IM-A3U2,THCA,89.0,FEMALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2012.0,nan,-32682.0,Alive,TUMOR FREE,563.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,563.0,0.0,563.0,nan,nan,0.0,563.0,0
TCGA-IM-A3U3-01,TCGA-IM-A3U3,THCA,55.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2012.0,nan,-20117.0,Alive,TUMOR FREE,514.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,514.0,0.0,514.0,nan,nan,0.0,514.0,0
TCGA-IM-A41Y-01,TCGA-IM-A41Y,THCA,42.0,FEMALE,WHITE,Stage I,nan,"Other, specify",nan,2012.0,nan,-15694.0,Alive,TUMOR FREE,664.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,664.0,0.0,664.0,0.0,664.0,0.0,664.0,0
TCGA-IM-A41Z-01,TCGA-IM-A41Z,THCA,37.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2012.0,nan,-13704.0,Alive,TUMOR FREE,946.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,946.0,0.0,946.0,0.0,946.0,0.0,946.0,0
TCGA-IM-A420-01,TCGA-IM-A420,THCA,39.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-14332.0,Alive,TUMOR FREE,250.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,250.0,0.0,250.0,0.0,250.0,0.0,250.0,0
TCGA-IM-A4EB-01,TCGA-IM-A4EB,THCA,37.0,MALE,WHITE,Stage I,nan,"Other, specify",nan,2012.0,nan,-13635.0,Alive,TUMOR FREE,780.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,780.0,0.0,780.0,0.0,780.0,0.0,780.0,0
TCGA-J8-A3NZ-01,TCGA-J8-A3NZ,THCA,52.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-19058.0,Alive,TUMOR FREE,524.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,524.0,0.0,524.0,0.0,524.0,0.0,524.0,0
TCGA-J8-A3O0-01,TCGA-J8-A3O0,THCA,38.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-14214.0,Alive,TUMOR FREE,1313.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1313.0,0.0,1313.0,0.0,1313.0,0.0,1313.0,0
TCGA-J8-A3O1-01,TCGA-J8-A3O1,THCA,33.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-12113.0,Alive,TUMOR FREE,827.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,827.0,0.0,827.0,0.0,827.0,0.0,827.0,0
TCGA-J8-A3O2-06,TCGA-J8-A3O2,THCA,39.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-14339.0,Alive,TUMOR FREE,342.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,342.0,0.0,342.0,nan,nan,0.0,342.0,0
TCGA-J8-A3O2-01,TCGA-J8-A3O2,THCA,39.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-14339.0,Alive,TUMOR FREE,342.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,342.0,0.0,342.0,nan,nan,0.0,342.0,0
TCGA-J8-A3YD-01,TCGA-J8-A3YD,THCA,47.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-17416.0,Alive,TUMOR FREE,968.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,968.0,0.0,968.0,0.0,968.0,0.0,968.0,0
TCGA-J8-A3YE-01,TCGA-J8-A3YE,THCA,31.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-11446.0,Alive,TUMOR FREE,847.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,847.0,0.0,847.0,0.0,847.0,0.0,847.0,0
TCGA-J8-A3YF-01,TCGA-J8-A3YF,THCA,83.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2009.0,nan,-30661.0,Alive,TUMOR FREE,751.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,751.0,0.0,751.0,0.0,751.0,0.0,751.0,0
TCGA-J8-A3YG-01,TCGA-J8-A3YG,THCA,54.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-19785.0,Alive,TUMOR FREE,678.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,678.0,0.0,678.0,0.0,678.0,0.0,678.0,0
TCGA-J8-A3YH-06,TCGA-J8-A3YH,THCA,39.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-14470.0,Alive,TUMOR FREE,175.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,175.0,0.0,175.0,0.0,175.0,0.0,175.0,0
TCGA-J8-A3YH-01,TCGA-J8-A3YH,THCA,39.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-14470.0,Alive,TUMOR FREE,175.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,175.0,0.0,175.0,0.0,175.0,0.0,175.0,0
TCGA-J8-A42S-01,TCGA-J8-A42S,THCA,45.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-16609.0,Alive,nan,75.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,75.0,0.0,75.0,0.0,75.0,0.0,75.0,0
TCGA-J8-A4HW-06,TCGA-J8-A4HW,THCA,59.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-21587.0,Alive,TUMOR FREE,79.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,79.0,0.0,79.0,0.0,79.0,0.0,79.0,0
TCGA-J8-A4HW-01,TCGA-J8-A4HW,THCA,59.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-21587.0,Alive,TUMOR FREE,79.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,79.0,0.0,79.0,0.0,79.0,0.0,79.0,0
TCGA-J8-A4HY-01,TCGA-J8-A4HY,THCA,68.0,FEMALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-25106.0,Alive,TUMOR FREE,6.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,6.0,0.0,6.0,nan,nan,0.0,6.0,0
TCGA-KS-A41F-01,TCGA-KS-A41F,THCA,37.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2002.0,nan,-13545.0,Alive,TUMOR FREE,4367.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,4367.0,0.0,4367.0,0.0,4367.0,0.0,4367.0,0
TCGA-KS-A41I-01,TCGA-KS-A41I,THCA,47.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2002.0,nan,-17196.0,Alive,TUMOR FREE,486.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,486.0,0.0,486.0,0.0,486.0,0.0,486.0,0
TCGA-KS-A41I-11,TCGA-KS-A41I,THCA,47.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2002.0,nan,-17196.0,Alive,TUMOR FREE,486.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,486.0,0.0,486.0,0.0,486.0,0.0,486.0,0
TCGA-KS-A41J-01,TCGA-KS-A41J,THCA,28.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2000.0,nan,-10411.0,Alive,TUMOR FREE,477.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,477.0,0.0,477.0,0.0,477.0,0.0,477.0,0
TCGA-KS-A41J-11,TCGA-KS-A41J,THCA,28.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2000.0,nan,-10411.0,Alive,TUMOR FREE,477.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,477.0,0.0,477.0,0.0,477.0,0.0,477.0,0
TCGA-KS-A41L-01,TCGA-KS-A41L,THCA,39.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2004.0,nan,-14440.0,Alive,TUMOR FREE,3463.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,3463.0,0.0,3463.0,0.0,3463.0,0.0,3463.0,0
TCGA-KS-A41L-11,TCGA-KS-A41L,THCA,39.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2004.0,nan,-14440.0,Alive,TUMOR FREE,3463.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,3463.0,0.0,3463.0,0.0,3463.0,0.0,3463.0,0
TCGA-KS-A4I1-01,TCGA-KS-A4I1,THCA,37.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2012.0,nan,-13538.0,Alive,TUMOR FREE,812.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,812.0,0.0,812.0,nan,nan,0.0,812.0,0
TCGA-KS-A4I3-01,TCGA-KS-A4I3,THCA,41.0,MALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-14992.0,Alive,TUMOR FREE,1329.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,1329.0,0.0,1329.0,nan,nan,0.0,1329.0,0
TCGA-KS-A4I5-01,TCGA-KS-A4I5,THCA,49.0,FEMALE,WHITE,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-17963.0,Alive,TUMOR FREE,567.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,567.0,0.0,567.0,nan,nan,0.0,567.0,0
TCGA-KS-A4I7-01,TCGA-KS-A4I7,THCA,61.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-22398.0,Alive,TUMOR FREE,987.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,987.0,0.0,987.0,0.0,987.0,0.0,987.0,0
TCGA-KS-A4I9-01,TCGA-KS-A4I9,THCA,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2007.0,nan,-16961.0,Alive,TUMOR FREE,2658.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2658.0,0.0,2658.0,0.0,2658.0,0.0,2658.0,0
TCGA-KS-A4IB-01,TCGA-KS-A4IB,THCA,41.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2007.0,nan,-15157.0,Alive,TUMOR FREE,2577.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,2577.0,0.0,2577.0,0.0,2577.0,0.0,2577.0,0
TCGA-KS-A4IC-01,TCGA-KS-A4IC,THCA,45.0,FEMALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-16671.0,Alive,TUMOR FREE,1073.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,1073.0,0.0,1073.0,nan,nan,0.0,1073.0,0
TCGA-KS-A4ID-01,TCGA-KS-A4ID,THCA,55.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2010.0,nan,-20413.0,Alive,TUMOR FREE,1011.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1011.0,0.0,1011.0,0.0,1011.0,0.0,1011.0,0
TCGA-L6-A4EP-01,TCGA-L6-A4EP,THCA,41.0,FEMALE,ASIAN,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-15292.0,Alive,TUMOR FREE,1016.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1016.0,0.0,1016.0,0.0,1016.0,0.0,1016.0,0
TCGA-L6-A4EQ-01,TCGA-L6-A4EQ,THCA,47.0,MALE,WHITE,Stage III,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2010.0,nan,-17351.0,Alive,TUMOR FREE,1228.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1228.0,0.0,1228.0,0.0,1228.0,0.0,1228.0,0
TCGA-L6-A4ET-01,TCGA-L6-A4ET,THCA,49.0,FEMALE,WHITE,Stage IVC,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2011.0,nan,-17978.0,Alive,TUMOR FREE,664.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,664.0,0.0,664.0,nan,nan,0.0,664.0,0
TCGA-L6-A4EU-01,TCGA-L6-A4EU,THCA,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),nan,2012.0,nan,-21192.0,Alive,TUMOR FREE,289.0,nan,nan,nan,nan,nan,nan,nan,nan,R1,0.0,289.0,0.0,289.0,nan,nan,0.0,289.0,0
TCGA-MK-A4N6-01,TCGA-MK-A4N6,THCA,35.0,MALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-12904.0,Alive,TUMOR FREE,1098.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,1098.0,0.0,1098.0,0.0,1098.0,0.0,1098.0,0
TCGA-MK-A4N7-01,TCGA-MK-A4N7,THCA,20.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-7570.0,Alive,TUMOR FREE,987.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,987.0,0.0,987.0,0.0,987.0,0.0,987.0,0
TCGA-MK-A4N9-01,TCGA-MK-A4N9,THCA,41.0,FEMALE,WHITE,Stage I,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2011.0,nan,-15255.0,Alive,TUMOR FREE,919.0,nan,nan,nan,nan,nan,nan,nan,nan,R0,0.0,919.0,0.0,919.0,0.0,919.0,0.0,919.0,0
TCGA-MK-A84Z-01,TCGA-MK-A84Z,THCA,74.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,nan,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),nan,2013.0,nan,-27185.0,Alive,TUMOR FREE,728.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,728.0,0.0,728.0,nan,nan,0.0,728.0,0
TCGA-QD-A8IV-01,TCGA-QD-A8IV,THCA,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVA,nan,Thyroid Papillary Carcinoma - Classical/usual,nan,2013.0,nan,-18288.0,Alive,TUMOR FREE,392.0,nan,nan,nan,nan,nan,nan,nan,nan,RX,0.0,392.0,0.0,392.0,nan,nan,0.0,392.0,0
TCGA-3G-AB0O-01,TCGA-3G-AB0O,THYM,47.0,MALE,WHITE,nan,I,Thymoma; Type B1,nan,2009.0,nan,-17528.0,Alive,TUMOR FREE,2086.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2086.0,0.0,2086.0,nan,nan,0.0,2086.0,0
TCGA-3G-AB0Q-01,TCGA-3G-AB0Q,THYM,66.0,MALE,WHITE,nan,IIa,Thymoma; Type A,nan,2009.0,nan,-24460.0,Alive,TUMOR FREE,1799.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1799.0,0.0,1799.0,nan,nan,0.0,1799.0,0
TCGA-3G-AB0T-01,TCGA-3G-AB0T,THYM,45.0,MALE,WHITE,nan,IIb,Thymoma; Type B1,nan,2000.0,nan,-16728.0,Dead,WITH TUMOR,nan,2488.0,nan,Distant Metastasis,Pleura/Pleural effusion,nan,1786.0,nan,nan,nan,1.0,2488.0,1.0,2488.0,nan,nan,1.0,1786.0,1
TCGA-3G-AB14-01,TCGA-3G-AB14,THYM,51.0,MALE,WHITE,nan,III,Thymoma; Type B2,nan,2012.0,nan,-18733.0,Dead,TUMOR FREE,nan,775.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,775.0,0.0,775.0,nan,nan,0.0,775.0,0
TCGA-3G-AB19-01,TCGA-3G-AB19,THYM,76.0,FEMALE,WHITE,nan,IIb,Thymoma; Type A,nan,2006.0,nan,-27827.0,Dead,TUMOR FREE,nan,2910.0,nan,New Primary Tumor,Lung,nan,2420.0,nan,nan,nan,1.0,2910.0,0.0,2910.0,nan,nan,1.0,2420.0,1
TCGA-3Q-A9WF-01,TCGA-3Q-A9WF,THYM,71.0,MALE,BLACK OR AFRICAN AMERICAN,nan,I,Thymoma; Type B2,nan,2013.0,nan,-26117.0,Alive,nan,467.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,467.0,0.0,467.0,nan,nan,0.0,467.0,0
TCGA-3S-A8YW-01,TCGA-3S-A8YW,THYM,63.0,MALE,WHITE,nan,IIb,Thymoma; Type C,nan,2013.0,nan,-23053.0,Alive,TUMOR FREE,643.0,nan,nan,New Primary Tumor,"Other, specify",Skin (cheek),224.0,nan,nan,nan,0.0,643.0,0.0,643.0,nan,nan,1.0,224.0,0
TCGA-3S-AAYX-01,TCGA-3S-AAYX,THYM,55.0,FEMALE,WHITE,nan,IIb,Thymoma; Type B1,nan,2013.0,nan,-20350.0,Alive,TUMOR FREE,571.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,571.0,0.0,571.0,nan,nan,0.0,571.0,0
TCGA-3T-AA9L-01,TCGA-3T-AA9L,THYM,31.0,FEMALE,WHITE,nan,IIa,Thymoma; Type B1,nan,2011.0,nan,-11610.0,Alive,WITH TUMOR,1050.0,nan,nan,Distant Metastasis,"Other, specify",Lung Pleura,702.0,nan,nan,nan,0.0,1050.0,0.0,1050.0,nan,nan,1.0,702.0,0
TCGA-4V-A9QI-01,TCGA-4V-A9QI,THYM,68.0,MALE,WHITE,nan,IIa,Thymoma; Type B2,nan,2007.0,nan,-25181.0,Alive,TUMOR FREE,2936.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2936.0,0.0,2936.0,nan,nan,0.0,2936.0,0
TCGA-4V-A9QJ-01,TCGA-4V-A9QJ,THYM,64.0,MALE,WHITE,nan,III,Thymoma; Type B3,nan,2007.0,nan,-23510.0,Alive,TUMOR FREE,2849.0,nan,nan,Locoregional Recurrence,Pleura/Pleural effusion,nan,793.0,nan,nan,nan,0.0,2849.0,0.0,2849.0,nan,nan,1.0,793.0,0
TCGA-4V-A9QL-01,TCGA-4V-A9QL,THYM,58.0,FEMALE,WHITE,nan,I,Thymoma; Type AB,nan,2009.0,nan,-21216.0,Alive,TUMOR FREE,1908.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1908.0,0.0,1908.0,nan,nan,0.0,1908.0,0
TCGA-4V-A9QM-01,TCGA-4V-A9QM,THYM,39.0,MALE,WHITE,nan,I,Thymoma; Type AB,nan,2011.0,nan,-14576.0,Alive,TUMOR FREE,1253.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1253.0,0.0,1253.0,nan,nan,0.0,1253.0,0
TCGA-4V-A9QN-01,TCGA-4V-A9QN,THYM,40.0,FEMALE,WHITE,nan,III,Thymoma; Type B3,nan,2012.0,nan,-14825.0,Alive,WITH TUMOR,970.0,nan,nan,Distant Metastasis,"Other, specify",PLEURA,937.0,nan,nan,nan,0.0,970.0,0.0,970.0,nan,nan,1.0,937.0,1
TCGA-4V-A9QQ-01,TCGA-4V-A9QQ,THYM,65.0,FEMALE,WHITE,nan,IVa,Thymoma; Type B3,nan,2010.0,nan,-23894.0,Alive,WITH TUMOR,1572.0,nan,nan,Locoregional Recurrence,Pleura/Pleural effusion,nan,782.0,nan,nan,nan,0.0,1572.0,0.0,1572.0,nan,nan,1.0,782.0,2
TCGA-4V-A9QR-01,TCGA-4V-A9QR,THYM,51.0,FEMALE,WHITE,nan,III,Thymoma; Type B3,nan,2012.0,nan,-18723.0,Alive,TUMOR FREE,780.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,780.0,0.0,780.0,nan,nan,0.0,780.0,0
TCGA-4V-A9QS-01,TCGA-4V-A9QS,THYM,53.0,FEMALE,WHITE,nan,IVa,Thymoma; Type B2,nan,2012.0,nan,-19443.0,Alive,WITH TUMOR,774.0,nan,nan,Locoregional Recurrence,"Other, specify",PLEURA,752.0,nan,nan,nan,0.0,774.0,0.0,774.0,nan,nan,1.0,752.0,1
TCGA-4V-A9QT-01,TCGA-4V-A9QT,THYM,79.0,FEMALE,WHITE,nan,IIa,Thymoma; Type B1,nan,2012.0,nan,-28951.0,Alive,TUMOR FREE,813.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,813.0,0.0,813.0,nan,nan,0.0,813.0,0
TCGA-4V-A9QU-01,TCGA-4V-A9QU,THYM,76.0,FEMALE,WHITE,nan,IIa,Thymoma; Type AB,nan,2013.0,nan,-27896.0,Alive,TUMOR FREE,627.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,627.0,0.0,627.0,nan,nan,0.0,627.0,0
TCGA-4V-A9QW-01,TCGA-4V-A9QW,THYM,62.0,MALE,WHITE,nan,I,Thymoma; Type AB,nan,2013.0,nan,-22781.0,Alive,TUMOR FREE,630.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,630.0,0.0,630.0,nan,nan,0.0,630.0,0
TCGA-4V-A9QX-01,TCGA-4V-A9QX,THYM,77.0,FEMALE,WHITE,nan,III,Thymoma; Type AB,nan,2013.0,nan,-28250.0,Alive,TUMOR FREE,434.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,434.0,0.0,434.0,nan,nan,0.0,434.0,0
TCGA-4X-A9F9-01,TCGA-4X-A9F9,THYM,57.0,FEMALE,WHITE,nan,III,Thymoma; Type B1,nan,2013.0,nan,-21168.0,Alive,TUMOR FREE,669.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,669.0,0.0,669.0,nan,nan,0.0,669.0,0
TCGA-4X-A9FA-01,TCGA-4X-A9FA,THYM,52.0,MALE,WHITE,nan,I,Thymoma; Type A,nan,2013.0,nan,-19032.0,Alive,TUMOR FREE,392.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,392.0,0.0,392.0,nan,nan,0.0,392.0,0
TCGA-4X-A9FB-01,TCGA-4X-A9FB,THYM,44.0,MALE,WHITE,nan,IIa,Thymoma; Type B2,nan,2012.0,nan,-16175.0,Alive,TUMOR FREE,717.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,717.0,0.0,717.0,nan,nan,0.0,717.0,0
TCGA-4X-A9FC-01,TCGA-4X-A9FC,THYM,50.0,FEMALE,WHITE,nan,IIa,Thymoma; Type AB,nan,2009.0,nan,-18418.0,Alive,TUMOR FREE,2072.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2072.0,0.0,2072.0,nan,nan,0.0,2072.0,0
TCGA-4X-A9FD-01,TCGA-4X-A9FD,THYM,43.0,FEMALE,WHITE,nan,IIa,Thymoma; Type B2,nan,2010.0,nan,-15968.0,Alive,TUMOR FREE,1503.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1503.0,0.0,1503.0,nan,nan,0.0,1503.0,0
TCGA-5G-A9ZZ-01,TCGA-5G-A9ZZ,THYM,52.0,FEMALE,WHITE,nan,IIb,Thymoma; Type C,nan,2012.0,nan,-19117.0,Alive,TUMOR FREE,835.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,835.0,0.0,835.0,nan,nan,0.0,835.0,0
TCGA-5K-AAAP-01,TCGA-5K-AAAP,THYM,54.0,MALE,WHITE,nan,III,Thymoma; Type A,nan,2010.0,nan,-19939.0,Alive,TUMOR FREE,1054.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1054.0,0.0,1054.0,nan,nan,0.0,1054.0,0
TCGA-5U-AB0D-01,TCGA-5U-AB0D,THYM,71.0,FEMALE,WHITE,nan,IVb,Thymoma; Type C,nan,2013.0,nan,-26167.0,Alive,WITH TUMOR,714.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,714.0,0.0,714.0,nan,nan,0.0,714.0,0
TCGA-5U-AB0E-01,TCGA-5U-AB0E,THYM,62.0,MALE,WHITE,nan,IIa,Thymoma; Type B3,nan,2013.0,nan,-22716.0,Alive,TUMOR FREE,687.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,687.0,0.0,687.0,nan,nan,0.0,687.0,0
TCGA-5U-AB0F-01,TCGA-5U-AB0F,THYM,58.0,FEMALE,WHITE,nan,III,Thymoma; Type AB,nan,2013.0,nan,-21511.0,Alive,TUMOR FREE,459.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,459.0,0.0,459.0,nan,nan,0.0,459.0,0
TCGA-5V-A9RR-01,TCGA-5V-A9RR,THYM,67.0,MALE,WHITE,nan,I,Thymoma; Type AB,nan,2012.0,nan,-24668.0,Alive,TUMOR FREE,827.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,827.0,0.0,827.0,nan,nan,0.0,827.0,0
TCGA-X7-A8D6-01,TCGA-X7-A8D6,THYM,48.0,FEMALE,WHITE,nan,I,Thymoma; Type B2,nan,2002.0,nan,-17771.0,Alive,TUMOR FREE,4225.0,nan,nan,New Primary Tumor,"Other, specify",breast,2928.0,nan,nan,nan,0.0,4225.0,0.0,4225.0,nan,nan,1.0,2928.0,0
TCGA-X7-A8D6-11,TCGA-X7-A8D6,THYM,48.0,FEMALE,WHITE,nan,I,Thymoma; Type B2,nan,2002.0,nan,-17771.0,Alive,TUMOR FREE,4225.0,nan,nan,New Primary Tumor,"Other, specify",breast,2928.0,nan,nan,nan,0.0,4225.0,0.0,4225.0,nan,nan,1.0,2928.0,0
TCGA-X7-A8D7-01,TCGA-X7-A8D7,THYM,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,IIa,Thymoma; Type B1,nan,2003.0,nan,-17161.0,Alive,TUMOR FREE,325.0,nan,nan,New Primary Tumor,Lung,nan,265.0,nan,nan,nan,0.0,325.0,0.0,325.0,nan,nan,1.0,265.0,0
TCGA-X7-A8D7-11,TCGA-X7-A8D7,THYM,46.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,IIa,Thymoma; Type B1,nan,2003.0,nan,-17161.0,Alive,TUMOR FREE,325.0,nan,nan,New Primary Tumor,Lung,nan,265.0,nan,nan,nan,0.0,325.0,0.0,325.0,nan,nan,1.0,265.0,0
TCGA-X7-A8D8-01,TCGA-X7-A8D8,THYM,53.0,MALE,WHITE,nan,IIa,Thymoma; Type AB,nan,2005.0,nan,-19441.0,Alive,TUMOR FREE,58.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,58.0,0.0,58.0,nan,nan,0.0,58.0,0
TCGA-X7-A8D9-01,TCGA-X7-A8D9,THYM,nan,FEMALE,WHITE,nan,I,Thymoma; Type AB,nan,2006.0,nan,nan,Alive,TUMOR FREE,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,nan,0.0,nan,nan,nan,0.0,nan,0
TCGA-X7-A8DB-01,TCGA-X7-A8DB,THYM,71.0,FEMALE,WHITE,nan,I,Thymoma; Type B2,nan,2009.0,nan,-26035.0,Alive,TUMOR FREE,1992.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1992.0,0.0,1992.0,nan,nan,0.0,1992.0,0
TCGA-X7-A8DC-01,TCGA-X7-A8DC,THYM,68.0,MALE,WHITE,nan,I,Thymoma; Type AB,nan,2010.0,nan,-25066.0,Alive,TUMOR FREE,1798.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1798.0,0.0,1798.0,nan,nan,0.0,1798.0,0
TCGA-X7-A8DD-01,TCGA-X7-A8DD,THYM,54.0,FEMALE,WHITE,nan,IIa,Thymoma; Type B1,nan,2011.0,nan,-19971.0,Alive,TUMOR FREE,1114.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1114.0,0.0,1114.0,nan,nan,0.0,1114.0,0
TCGA-X7-A8DE-01,TCGA-X7-A8DE,THYM,35.0,FEMALE,WHITE,nan,I,Thymoma; Type B2,nan,2011.0,nan,-12957.0,Alive,TUMOR FREE,981.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,981.0,0.0,981.0,nan,nan,0.0,981.0,0
TCGA-X7-A8DF-01,TCGA-X7-A8DF,THYM,40.0,MALE,WHITE,nan,nan,Thymoma; Type AB,nan,2012.0,nan,-14804.0,Alive,TUMOR FREE,901.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,901.0,0.0,901.0,nan,nan,0.0,901.0,0
TCGA-X7-A8DG-01,TCGA-X7-A8DG,THYM,47.0,MALE,WHITE,nan,I,Thymoma; Type B2,nan,2012.0,nan,-17517.0,Alive,TUMOR FREE,695.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,695.0,0.0,695.0,nan,nan,0.0,695.0,0
TCGA-X7-A8DI-01,TCGA-X7-A8DI,THYM,57.0,FEMALE,WHITE,nan,I,Thymoma; Type AB,nan,2013.0,nan,-21086.0,Alive,TUMOR FREE,705.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,705.0,0.0,705.0,nan,nan,0.0,705.0,0
TCGA-X7-A8DJ-01,TCGA-X7-A8DJ,THYM,68.0,MALE,[Unknown],nan,I,Thymoma; Type AB,nan,2013.0,nan,-25042.0,Alive,TUMOR FREE,289.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,289.0,0.0,289.0,nan,nan,0.0,289.0,0
TCGA-X7-A8M0-01,TCGA-X7-A8M0,THYM,61.0,FEMALE,WHITE,nan,IIa,Thymoma; Type B2|Thymoma; Type B3,nan,2007.0,nan,-22596.0,Alive,TUMOR FREE,441.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,441.0,0.0,441.0,nan,nan,0.0,441.0,0
TCGA-X7-A8M1-01,TCGA-X7-A8M1,THYM,51.0,MALE,ASIAN,nan,nan,Thymoma; Type AB,nan,2009.0,nan,-18826.0,Alive,TUMOR FREE,1282.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1282.0,0.0,1282.0,nan,nan,0.0,1282.0,0
TCGA-X7-A8M3-01,TCGA-X7-A8M3,THYM,64.0,FEMALE,WHITE,nan,III,Thymoma; Type B3,nan,2001.0,nan,-23718.0,Alive,TUMOR FREE,50.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,50.0,0.0,50.0,nan,nan,0.0,50.0,0
TCGA-X7-A8M4-01,TCGA-X7-A8M4,THYM,41.0,MALE,WHITE,nan,IIa,Thymoma; Type B2,nan,2002.0,nan,-15070.0,Alive,TUMOR FREE,3808.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3808.0,0.0,3808.0,nan,nan,0.0,3808.0,0
TCGA-X7-A8M5-01,TCGA-X7-A8M5,THYM,65.0,FEMALE,WHITE,nan,IIa,Thymoma; Type B3,nan,2001.0,nan,-24036.0,Alive,TUMOR FREE,1645.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1645.0,0.0,1645.0,nan,nan,0.0,1645.0,0
TCGA-X7-A8M6-01,TCGA-X7-A8M6,THYM,43.0,MALE,WHITE,nan,IIa,Thymoma; Type B2,nan,2002.0,nan,-15749.0,Alive,WITH TUMOR,4575.0,nan,nan,Locoregional Recurrence,"Other, specify",mediastinum,1901.0,nan,nan,nan,0.0,4575.0,0.0,4575.0,nan,nan,1.0,1901.0,0
TCGA-X7-A8M7-01,TCGA-X7-A8M7,THYM,26.0,MALE,WHITE,nan,I,Thymoma; Type B2,nan,2008.0,nan,-9815.0,Alive,TUMOR FREE,1972.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1972.0,0.0,1972.0,nan,nan,0.0,1972.0,0
TCGA-X7-A8M8-01,TCGA-X7-A8M8,THYM,45.0,MALE,BLACK OR AFRICAN AMERICAN,nan,I,Thymoma; Type B2,nan,2007.0,nan,-16741.0,Alive,TUMOR FREE,2533.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2533.0,0.0,2533.0,nan,nan,0.0,2533.0,0
TCGA-XH-A853-01,TCGA-XH-A853,THYM,67.0,MALE,BLACK OR AFRICAN AMERICAN,nan,I,Thymoma; Type AB,nan,2011.0,nan,-24556.0,Alive,TUMOR FREE,1220.0,nan,nan,New Primary Tumor,"Other, specify",right axillary,196.0,nan,nan,nan,0.0,1220.0,0.0,1220.0,nan,nan,1.0,196.0,0
TCGA-XM-A8R8-01,TCGA-XM-A8R8,THYM,67.0,FEMALE,ASIAN,nan,I,Thymoma; Type C,nan,2010.0,nan,-24508.0,Alive,TUMOR FREE,1598.0,nan,nan,New Primary Tumor,"Other, specify",Breast,244.0,nan,nan,nan,0.0,1598.0,0.0,1598.0,nan,nan,1.0,244.0,0
TCGA-XM-A8R9-01,TCGA-XM-A8R9,THYM,71.0,FEMALE,WHITE,nan,I,Thymoma; Type A,nan,2010.0,nan,-26176.0,Alive,TUMOR FREE,1488.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1488.0,0.0,1488.0,nan,nan,0.0,1488.0,0
TCGA-XM-A8RB-01,TCGA-XM-A8RB,THYM,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,I,Thymoma; Type B1,nan,2011.0,nan,-25080.0,Alive,TUMOR FREE,1144.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1144.0,0.0,1144.0,nan,nan,0.0,1144.0,0
TCGA-XM-A8RC-01,TCGA-XM-A8RC,THYM,67.0,MALE,WHITE,nan,IIa,Thymoma; Type B2,nan,2006.0,nan,-24660.0,Alive,TUMOR FREE,2963.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2963.0,0.0,2963.0,nan,nan,0.0,2963.0,0
TCGA-XM-A8RD-01,TCGA-XM-A8RD,THYM,69.0,FEMALE,WHITE,nan,IIa,Thymoma; Type B2,nan,2010.0,nan,-25402.0,Alive,TUMOR FREE,1546.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1546.0,0.0,1546.0,nan,nan,0.0,1546.0,0
TCGA-XM-A8RE-01,TCGA-XM-A8RE,THYM,54.0,FEMALE,WHITE,nan,I,Thymoma; Type AB,nan,2013.0,nan,-19903.0,Alive,TUMOR FREE,422.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,422.0,0.0,422.0,nan,nan,0.0,422.0,0
TCGA-XM-A8RF-01,TCGA-XM-A8RF,THYM,84.0,FEMALE,WHITE,nan,IIa,Thymoma; Type A,nan,2011.0,nan,-30893.0,Alive,TUMOR FREE,797.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,797.0,0.0,797.0,nan,nan,0.0,797.0,0
TCGA-XM-A8RG-01,TCGA-XM-A8RG,THYM,67.0,MALE,WHITE,nan,I,Thymoma; Type A,nan,2013.0,nan,-24802.0,Alive,TUMOR FREE,386.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,386.0,0.0,386.0,nan,nan,0.0,386.0,0
TCGA-XM-A8RH-01,TCGA-XM-A8RH,THYM,60.0,FEMALE,WHITE,nan,IIa,Thymoma; Type B1,nan,2013.0,nan,-21931.0,Alive,TUMOR FREE,363.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,363.0,0.0,363.0,nan,nan,0.0,363.0,0
TCGA-XM-A8RI-01,TCGA-XM-A8RI,THYM,77.0,MALE,[Not Evaluated],nan,IIa,Thymoma; Type B2,nan,2013.0,nan,-28246.0,Alive,TUMOR FREE,387.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,387.0,0.0,387.0,nan,nan,0.0,387.0,0
TCGA-XM-A8RL-01,TCGA-XM-A8RL,THYM,44.0,MALE,WHITE,nan,IIb,Thymoma; Type B1,nan,2007.0,nan,-16384.0,Alive,TUMOR FREE,2562.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2562.0,0.0,2562.0,nan,nan,0.0,2562.0,0
TCGA-XM-AAZ1-01,TCGA-XM-AAZ1,THYM,42.0,MALE,WHITE,nan,IIb,Thymoma; Type B2|Thymoma; Type B3,nan,2013.0,nan,-15383.0,Alive,TUMOR FREE,397.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,397.0,0.0,397.0,nan,nan,0.0,397.0,0
TCGA-XM-AAZ2-01,TCGA-XM-AAZ2,THYM,73.0,MALE,BLACK OR AFRICAN AMERICAN,nan,I,Thymoma; Type A,nan,2012.0,nan,-26861.0,Alive,TUMOR FREE,981.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,981.0,0.0,981.0,nan,nan,0.0,981.0,0
TCGA-XM-AAZ3-01,TCGA-XM-AAZ3,THYM,64.0,MALE,WHITE,nan,IIb,Thymoma; Type AB,nan,2011.0,nan,-23617.0,Alive,TUMOR FREE,1150.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1150.0,0.0,1150.0,nan,nan,0.0,1150.0,0
TCGA-XU-A92O-01,TCGA-XU-A92O,THYM,63.0,MALE,ASIAN,nan,I,Thymoma; Type A,nan,2005.0,nan,-23186.0,Alive,TUMOR FREE,3410.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3410.0,0.0,3410.0,nan,nan,0.0,3410.0,0
TCGA-XU-A92Q-01,TCGA-XU-A92Q,THYM,50.0,MALE,ASIAN,nan,I,Thymoma; Type A,nan,2008.0,nan,-18281.0,Alive,TUMOR FREE,1092.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1092.0,0.0,1092.0,nan,nan,0.0,1092.0,0
TCGA-XU-A92R-01,TCGA-XU-A92R,THYM,76.0,FEMALE,ASIAN,nan,IVb,Thymoma; Type AB,nan,2007.0,nan,-27971.0,Alive,TUMOR FREE,2739.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2739.0,0.0,2739.0,nan,nan,0.0,2739.0,0
TCGA-XU-A92T-01,TCGA-XU-A92T,THYM,81.0,FEMALE,WHITE,nan,IIa,Thymoma; Type AB,nan,2010.0,nan,-29613.0,Alive,TUMOR FREE,1376.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1376.0,0.0,1376.0,nan,nan,0.0,1376.0,0
TCGA-XU-A92U-01,TCGA-XU-A92U,THYM,67.0,MALE,WHITE,nan,IIa,Thymoma; Type B2,nan,2002.0,nan,-24487.0,Alive,TUMOR FREE,4562.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4562.0,0.0,4562.0,nan,nan,0.0,4562.0,0
TCGA-XU-A92V-01,TCGA-XU-A92V,THYM,72.0,FEMALE,ASIAN,nan,IIa,Thymoma; Type AB,nan,2012.0,nan,-26646.0,Dead,TUMOR FREE,nan,124.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,124.0,0.0,124.0,nan,nan,0.0,124.0,1
TCGA-XU-A92W-01,TCGA-XU-A92W,THYM,61.0,MALE,WHITE,nan,IIa,Thymoma; Type AB,nan,2005.0,nan,-22554.0,Alive,TUMOR FREE,3279.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3279.0,0.0,3279.0,nan,nan,0.0,3279.0,0
TCGA-XU-A92X-01,TCGA-XU-A92X,THYM,17.0,MALE,ASIAN,nan,IIa,Thymoma; Type B2,nan,2008.0,nan,-6572.0,Alive,TUMOR FREE,2343.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2343.0,0.0,2343.0,nan,nan,0.0,2343.0,0
TCGA-XU-A92Y-01,TCGA-XU-A92Y,THYM,71.0,FEMALE,WHITE,nan,IIb,Thymoma; Type B3,nan,2004.0,nan,-26021.0,Dead,WITH TUMOR,nan,3488.0,nan,Locoregional Recurrence,"Other, specify","posterior mediastinal tumour, adrenal/perinephric tumour involving left pleural space, diaphragm, chest wall, spine",1224.0,nan,nan,nan,1.0,3488.0,1.0,3488.0,nan,nan,1.0,1224.0,1
TCGA-XU-A92Z-01,TCGA-XU-A92Z,THYM,76.0,MALE,ASIAN,nan,III,Thymoma; Type C,nan,2004.0,nan,-28117.0,Alive,TUMOR FREE,3663.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3663.0,0.0,3663.0,nan,nan,0.0,3663.0,0
TCGA-XU-A930-01,TCGA-XU-A930,THYM,43.0,MALE,WHITE,nan,III,Thymoma; Type B3,nan,2007.0,nan,-15777.0,Alive,TUMOR FREE,2514.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2514.0,0.0,2514.0,nan,nan,0.0,2514.0,0
TCGA-XU-A931-01,TCGA-XU-A931,THYM,61.0,FEMALE,WHITE,nan,IIa,Thymoma; Type B3,nan,2007.0,nan,-22432.0,Dead,TUMOR FREE,nan,1609.0,nan,New Primary Tumor,Lung,nan,1377.0,nan,nan,nan,1.0,1609.0,0.0,1609.0,nan,nan,1.0,1377.0,1
TCGA-XU-A932-01,TCGA-XU-A932,THYM,37.0,MALE,ASIAN,nan,IIa,Thymoma; Type B2,nan,2008.0,nan,-13618.0,Alive,TUMOR FREE,2149.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2149.0,0.0,2149.0,nan,nan,0.0,2149.0,0
TCGA-XU-A933-01,TCGA-XU-A933,THYM,52.0,FEMALE,ASIAN,nan,IIb,Thymoma; Type C,nan,2009.0,nan,-19276.0,Alive,TUMOR FREE,1789.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1789.0,0.0,1789.0,nan,nan,0.0,1789.0,0
TCGA-XU-A936-01,TCGA-XU-A936,THYM,65.0,FEMALE,WHITE,nan,IIa,Thymoma; Type C,nan,2012.0,nan,-23924.0,Alive,TUMOR FREE,643.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,643.0,0.0,643.0,nan,nan,0.0,643.0,0
TCGA-XU-AAXV-01,TCGA-XU-AAXV,THYM,45.0,FEMALE,WHITE,nan,IIa,Thymoma; Type B2,nan,2003.0,nan,-16582.0,Alive,TUMOR FREE,4070.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4070.0,0.0,4070.0,nan,nan,0.0,4070.0,0
TCGA-XU-AAXW-01,TCGA-XU-AAXW,THYM,39.0,FEMALE,ASIAN,nan,IIa,Thymoma; Type B2,nan,2004.0,nan,-14408.0,Alive,TUMOR FREE,3762.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3762.0,0.0,3762.0,nan,nan,0.0,3762.0,0
TCGA-XU-AAXX-01,TCGA-XU-AAXX,THYM,44.0,FEMALE,WHITE,nan,IIa,Thymoma; Type B2,nan,2007.0,nan,-16265.0,Alive,TUMOR FREE,2721.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2721.0,0.0,2721.0,nan,nan,0.0,2721.0,0
TCGA-XU-AAXY-01,TCGA-XU-AAXY,THYM,43.0,MALE,WHITE,nan,IIb,Thymoma; Type B2,nan,2009.0,nan,-15756.0,Alive,TUMOR FREE,1891.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1891.0,0.0,1891.0,nan,nan,0.0,1891.0,0
TCGA-XU-AAXZ-01,TCGA-XU-AAXZ,THYM,63.0,MALE,WHITE,nan,IIb,Thymoma; Type B3,nan,2010.0,nan,-23324.0,Alive,TUMOR FREE,1537.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1537.0,0.0,1537.0,nan,nan,0.0,1537.0,0
TCGA-XU-AAY0-01,TCGA-XU-AAY0,THYM,62.0,FEMALE,ASIAN,nan,IIa,Thymoma; Type AB,nan,2010.0,nan,-22645.0,Alive,TUMOR FREE,1502.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1502.0,0.0,1502.0,nan,nan,0.0,1502.0,0
TCGA-XU-AAY1-01,TCGA-XU-AAY1,THYM,51.0,FEMALE,ASIAN,nan,IIa,Thymoma; Type AB,nan,2005.0,nan,-18777.0,Alive,TUMOR FREE,3268.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,3268.0,0.0,3268.0,nan,nan,0.0,3268.0,0
TCGA-YT-A95D-01,TCGA-YT-A95D,THYM,50.0,FEMALE,WHITE,nan,I,Thymoma; Type AB,nan,2012.0,nan,-18363.0,Alive,TUMOR FREE,750.0,nan,nan,New Primary Tumor,"Other, specify",Thyroid papillary carcinoma,168.0,nan,nan,nan,0.0,750.0,0.0,750.0,nan,nan,1.0,168.0,0
TCGA-YT-A95E-01,TCGA-YT-A95E,THYM,52.0,MALE,WHITE,nan,I,Thymoma; Type B2,nan,2011.0,nan,-19172.0,Alive,TUMOR FREE,1070.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1070.0,0.0,1070.0,nan,nan,0.0,1070.0,0
TCGA-YT-A95F-01,TCGA-YT-A95F,THYM,55.0,FEMALE,WHITE,nan,I,Thymoma; Type AB,nan,2012.0,nan,-20363.0,Alive,TUMOR FREE,775.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,775.0,0.0,775.0,nan,nan,0.0,775.0,0
TCGA-YT-A95G-01,TCGA-YT-A95G,THYM,61.0,FEMALE,WHITE,nan,I,Thymoma; Type B2,nan,2010.0,nan,-22541.0,Alive,TUMOR FREE,1514.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1514.0,0.0,1514.0,nan,nan,0.0,1514.0,0
TCGA-YT-A95H-01,TCGA-YT-A95H,THYM,69.0,MALE,WHITE,nan,I,Thymoma; Type AB,nan,2013.0,nan,-25376.0,Alive,TUMOR FREE,711.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,711.0,0.0,711.0,nan,nan,0.0,711.0,0
TCGA-ZB-A961-01,TCGA-ZB-A961,THYM,69.0,MALE,WHITE,nan,IIb,Thymoma; Type A,nan,2010.0,nan,-25419.0,Dead,TUMOR FREE,nan,180.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,180.0,0.0,180.0,nan,nan,0.0,180.0,0
TCGA-ZB-A962-01,TCGA-ZB-A962,THYM,64.0,MALE,WHITE,nan,IIb,Thymoma; Type A,nan,2010.0,nan,-23461.0,Alive,TUMOR FREE,1647.0,nan,nan,Distant Metastasis,Liver,nan,1091.0,nan,nan,nan,0.0,1647.0,0.0,1647.0,nan,nan,1.0,1091.0,0
TCGA-ZB-A963-01,TCGA-ZB-A963,THYM,46.0,MALE,WHITE,nan,IIa,Thymoma; Type AB,nan,2011.0,nan,-16990.0,Alive,TUMOR FREE,1482.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1482.0,0.0,1482.0,nan,nan,0.0,1482.0,0
TCGA-ZB-A964-01,TCGA-ZB-A964,THYM,70.0,MALE,WHITE,nan,IVb,Thymoma; Type A,nan,2011.0,nan,-25861.0,Alive,TUMOR FREE,1287.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1287.0,0.0,1287.0,nan,nan,0.0,1287.0,0
TCGA-ZB-A965-01,TCGA-ZB-A965,THYM,75.0,FEMALE,WHITE,nan,III,Thymoma; Type A|Thymoma; Type AB,nan,2012.0,nan,-27617.0,Alive,TUMOR FREE,816.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,816.0,0.0,816.0,nan,nan,0.0,816.0,0
TCGA-ZB-A966-01,TCGA-ZB-A966,THYM,78.0,FEMALE,WHITE,nan,IVb,Thymoma; Type C,nan,2012.0,nan,-28621.0,Dead,WITH TUMOR,nan,379.0,nan,Locoregional Recurrence,Lung,nan,296.0,nan,nan,nan,1.0,379.0,1.0,379.0,nan,nan,1.0,296.0,1
TCGA-ZB-A969-01,TCGA-ZB-A969,THYM,72.0,FEMALE,WHITE,nan,IVb,Thymoma; Type C,nan,2012.0,nan,-26458.0,Alive,TUMOR FREE,1046.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1046.0,0.0,1046.0,nan,nan,0.0,1046.0,0
TCGA-ZB-A96A-01,TCGA-ZB-A96A,THYM,53.0,MALE,WHITE,nan,I,Thymoma; Type B2|Thymoma; Type B3,nan,2008.0,nan,-19424.0,Alive,TUMOR FREE,2354.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2354.0,0.0,2354.0,nan,nan,0.0,2354.0,0
TCGA-ZB-A96B-01,TCGA-ZB-A96B,THYM,51.0,MALE,WHITE,nan,IIa,Thymoma; Type B1,nan,2009.0,nan,-18892.0,Alive,TUMOR FREE,2211.0,nan,nan,New Primary Tumor,"Other, specify",bladder,91.0,nan,nan,nan,0.0,2211.0,0.0,2211.0,nan,nan,1.0,91.0,0
TCGA-ZB-A96C-01,TCGA-ZB-A96C,THYM,77.0,FEMALE,WHITE,nan,I,Thymoma; Type AB,nan,2009.0,nan,-28222.0,Alive,TUMOR FREE,2163.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2163.0,0.0,2163.0,nan,nan,0.0,2163.0,0
TCGA-ZB-A96D-01,TCGA-ZB-A96D,THYM,52.0,FEMALE,WHITE,nan,IIb,Thymoma; Type AB,nan,2009.0,nan,-19274.0,Alive,TUMOR FREE,1960.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1960.0,0.0,1960.0,nan,nan,0.0,1960.0,0
TCGA-ZB-A96E-01,TCGA-ZB-A96E,THYM,60.0,MALE,WHITE,nan,IIa,Thymoma; Type A|Thymoma; Type AB,nan,2010.0,nan,-22092.0,Alive,TUMOR FREE,1819.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1819.0,0.0,1819.0,nan,nan,0.0,1819.0,0
TCGA-ZB-A96F-01,TCGA-ZB-A96F,THYM,39.0,MALE,WHITE,nan,I,Thymoma; Type AB,nan,2010.0,nan,-14344.0,Alive,TUMOR FREE,1761.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1761.0,0.0,1761.0,nan,nan,0.0,1761.0,0
TCGA-ZB-A96G-01,TCGA-ZB-A96G,THYM,59.0,MALE,WHITE,nan,IIa,Thymoma; Type AB,nan,2010.0,nan,-21598.0,Alive,TUMOR FREE,1606.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1606.0,0.0,1606.0,nan,nan,0.0,1606.0,0
TCGA-ZB-A96H-01,TCGA-ZB-A96H,THYM,73.0,MALE,WHITE,nan,IIb,Thymoma; Type A,nan,2010.0,nan,-26683.0,Alive,TUMOR FREE,1504.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1504.0,0.0,1504.0,nan,nan,0.0,1504.0,0
TCGA-ZB-A96I-01,TCGA-ZB-A96I,THYM,71.0,FEMALE,WHITE,nan,III,Thymoma; Type AB,nan,2010.0,nan,-26208.0,Alive,TUMOR FREE,1653.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1653.0,0.0,1653.0,nan,nan,0.0,1653.0,0
TCGA-ZB-A96K-01,TCGA-ZB-A96K,THYM,69.0,MALE,WHITE,nan,I,Thymoma; Type AB,nan,2011.0,nan,-25498.0,Alive,TUMOR FREE,1388.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1388.0,0.0,1388.0,nan,nan,0.0,1388.0,0
TCGA-ZB-A96L-01,TCGA-ZB-A96L,THYM,70.0,FEMALE,WHITE,nan,III,Thymoma; Type B3,nan,2011.0,nan,-25914.0,Alive,TUMOR FREE,1529.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1529.0,0.0,1529.0,nan,nan,0.0,1529.0,0
TCGA-ZB-A96M-01,TCGA-ZB-A96M,THYM,56.0,FEMALE,WHITE,nan,I,Thymoma; Type AB,nan,2011.0,nan,-20623.0,Alive,TUMOR FREE,14.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,14.0,0.0,14.0,nan,nan,0.0,14.0,0
TCGA-ZB-A96O-01,TCGA-ZB-A96O,THYM,54.0,FEMALE,WHITE,nan,III,Thymoma; Type B1,nan,2012.0,nan,-19782.0,Alive,TUMOR FREE,1050.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1050.0,0.0,1050.0,nan,nan,0.0,1050.0,0
TCGA-ZB-A96P-01,TCGA-ZB-A96P,THYM,73.0,MALE,WHITE,nan,I,Thymoma; Type B1,nan,2013.0,nan,-26870.0,Alive,TUMOR FREE,753.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,753.0,0.0,753.0,nan,nan,0.0,753.0,0
TCGA-ZB-A96Q-01,TCGA-ZB-A96Q,THYM,49.0,MALE,WHITE,nan,IIa,Thymoma; Type AB,nan,2013.0,nan,-18249.0,Alive,TUMOR FREE,675.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,675.0,0.0,675.0,nan,nan,0.0,675.0,0
TCGA-ZB-A96R-01,TCGA-ZB-A96R,THYM,38.0,MALE,WHITE,nan,IIa,Thymoma; Type B1|Thymoma; Type B2,nan,2010.0,nan,-13977.0,Alive,TUMOR FREE,1804.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1804.0,0.0,1804.0,nan,nan,0.0,1804.0,0
TCGA-ZB-A96V-01,TCGA-ZB-A96V,THYM,44.0,MALE,WHITE,nan,IVb,Thymoma; Type C,nan,2012.0,nan,-16245.0,Alive,TUMOR FREE,932.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,932.0,0.0,932.0,nan,nan,0.0,932.0,0
TCGA-ZC-AAA7-01,TCGA-ZC-AAA7,THYM,63.0,MALE,WHITE,nan,IIa,Thymoma; Type C,nan,2008.0,nan,-23265.0,Dead,WITH TUMOR,nan,853.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,853.0,1.0,853.0,nan,nan,1.0,853.0,1
TCGA-ZC-AAAA-01,TCGA-ZC-AAAA,THYM,39.0,MALE,WHITE,nan,IIb,Thymoma; Type B2,nan,2012.0,nan,-14429.0,Alive,TUMOR FREE,819.0,nan,nan,Locoregional Recurrence,"Other, specify",Mediastinum,137.0,nan,nan,nan,0.0,819.0,0.0,819.0,nan,nan,1.0,137.0,0
TCGA-ZC-AAAF-01,TCGA-ZC-AAAF,THYM,74.0,FEMALE,WHITE,nan,IIb,Thymoma; Type AB,nan,2011.0,nan,-27099.0,Alive,TUMOR FREE,1165.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1165.0,0.0,1165.0,nan,nan,0.0,1165.0,0
TCGA-ZC-AAAH-01,TCGA-ZC-AAAH,THYM,52.0,MALE,WHITE,nan,IIb,Thymoma; Type B2,nan,2013.0,nan,-19146.0,Alive,TUMOR FREE,497.0,nan,nan,Locoregional Recurrence,"Other, specify",Mediastinum,166.0,nan,nan,nan,0.0,497.0,0.0,497.0,nan,nan,1.0,166.0,0
TCGA-ZL-A9V6-01,TCGA-ZL-A9V6,THYM,61.0,MALE,WHITE,nan,I,Thymoma; Type AB,nan,2008.0,nan,-22447.0,Alive,TUMOR FREE,2096.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2096.0,0.0,2096.0,nan,nan,0.0,2096.0,0
TCGA-ZT-A8OM-01,TCGA-ZT-A8OM,THYM,73.0,FEMALE,WHITE,nan,IIb,Thymoma; Type A,nan,2011.0,nan,-26923.0,Alive,TUMOR FREE,1398.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1398.0,0.0,1398.0,nan,nan,0.0,1398.0,0
TCGA-2E-A9G8-01,TCGA-2E-A9G8,UCEC,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage III,Endometrioid endometrial adenocarcinoma,G2,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),nan,Alive,TUMOR FREE,1249.0,nan,nan,Locoregional Recurrence,"Other, specify",abdominal wall,335.0,Progressive Disease,nan,nan,0.0,1249.0,0.0,1249.0,nan,nan,1.0,335.0,2
TCGA-4E-A92E-01,TCGA-4E-A92E,UCEC,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage I,Endometrioid endometrial adenocarcinoma,G1,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19818.0,Alive,TUMOR FREE,13.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,13.0,0.0,13.0,0.0,13.0,0.0,13.0,2
TCGA-5B-A90C-01,TCGA-5B-A90C,UCEC,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25518.0,Alive,TUMOR FREE,1202.0,nan,nan,Locoregional Recurrence,"Other, specify",right pelvic mass,517.0,nan,nan,nan,0.0,1202.0,0.0,1202.0,nan,nan,1.0,517.0,2
TCGA-5S-A9Q8-01,TCGA-5S-A9Q8,UCEC,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G2,2013.0,[Unknown],-18785.0,Alive,nan,313.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,313.0,0.0,313.0,0.0,313.0,0.0,313.0,2
TCGA-A5-A0G1-01,TCGA-A5-A0G1,UCEC,67.0,FEMALE,WHITE,nan,Stage IA,Serous endometrial adenocarcinoma,G3,1996.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24477.0,Dead,TUMOR FREE,nan,3251.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,3251.0,0.0,3251.0,0.0,3251.0,0.0,3251.0,0
TCGA-A5-A0G2-01,TCGA-A5-A0G2,UCEC,57.0,FEMALE,ASIAN,nan,Stage IIIB,Serous endometrial adenocarcinoma,G3,1997.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20953.0,Alive,WITH TUMOR,4549.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4549.0,0.0,4549.0,0.0,4549.0,0.0,4549.0,2
TCGA-A5-A0G3-01,TCGA-A5-A0G3,UCEC,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC2,Serous endometrial adenocarcinoma,G3,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22421.0,Alive,WITH TUMOR,1428.0,nan,nan,nan,nan,nan,795.0,Complete Remission/Response,nan,nan,0.0,1428.0,0.0,1428.0,1.0,795.0,1.0,795.0,2
TCGA-A5-A0G5-01,TCGA-A5-A0G5,UCEC,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Serous endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26827.0,Alive,TUMOR FREE,1126.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1126.0,0.0,1126.0,0.0,1126.0,0.0,1126.0,0
TCGA-A5-A0G9-01,TCGA-A5-A0G9,UCEC,79.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29122.0,Alive,TUMOR FREE,2540.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2540.0,0.0,2540.0,0.0,2540.0,0.0,2540.0,2
TCGA-A5-A0GA-01,TCGA-A5-A0GA,UCEC,67.0,FEMALE,WHITE,nan,Stage IIIC2,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24659.0,Dead,WITH TUMOR,nan,543.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,543.0,1.0,543.0,nan,nan,1.0,543.0,1
TCGA-A5-A0GB-01,TCGA-A5-A0GB,UCEC,65.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23883.0,Alive,TUMOR FREE,997.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,997.0,0.0,997.0,0.0,997.0,0.0,997.0,2
TCGA-A5-A0GD-01,TCGA-A5-A0GD,UCEC,75.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,1999.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27399.0,Dead,TUMOR FREE,nan,3423.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,3423.0,0.0,3423.0,0.0,3423.0,0.0,3423.0,2
TCGA-A5-A0GE-01,TCGA-A5-A0GE,UCEC,38.0,FEMALE,ASIAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2002.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14170.0,Alive,TUMOR FREE,3205.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3205.0,0.0,3205.0,0.0,3205.0,0.0,3205.0,2
TCGA-A5-A0GG-01,TCGA-A5-A0GG,UCEC,76.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27809.0,Alive,TUMOR FREE,3762.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3762.0,0.0,3762.0,0.0,3762.0,0.0,3762.0,2
TCGA-A5-A0GH-01,TCGA-A5-A0GH,UCEC,57.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21090.0,Alive,TUMOR FREE,2254.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2254.0,0.0,2254.0,0.0,2254.0,0.0,2254.0,2
TCGA-A5-A0GI-01,TCGA-A5-A0GI,UCEC,63.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23195.0,Alive,TUMOR FREE,2682.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2682.0,0.0,2682.0,0.0,2682.0,0.0,2682.0,2
TCGA-A5-A0GJ-01,TCGA-A5-A0GJ,UCEC,44.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16421.0,Alive,TUMOR FREE,2000.0,nan,nan,nan,nan,nan,12.0,Complete Remission/Response,nan,nan,0.0,2000.0,0.0,2000.0,1.0,12.0,1.0,12.0,2
TCGA-A5-A0GM-01,TCGA-A5-A0GM,UCEC,53.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19452.0,Alive,TUMOR FREE,1841.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1841.0,0.0,1841.0,0.0,1841.0,0.0,1841.0,2
TCGA-A5-A0GN-01,TCGA-A5-A0GN,UCEC,65.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24020.0,Alive,TUMOR FREE,1841.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1841.0,0.0,1841.0,0.0,1841.0,0.0,1841.0,2
TCGA-A5-A0GP-01,TCGA-A5-A0GP,UCEC,58.0,FEMALE,ASIAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21365.0,Alive,TUMOR FREE,1416.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1416.0,0.0,1416.0,0.0,1416.0,0.0,1416.0,2
TCGA-A5-A0GQ-01,TCGA-A5-A0GQ,UCEC,76.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28078.0,Alive,TUMOR FREE,2247.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2247.0,0.0,2247.0,0.0,2247.0,0.0,2247.0,2
TCGA-A5-A0GR-01,TCGA-A5-A0GR,UCEC,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25353.0,Alive,TUMOR FREE,1120.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1120.0,0.0,1120.0,0.0,1120.0,0.0,1120.0,2
TCGA-A5-A0GU-01,TCGA-A5-A0GU,UCEC,58.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21192.0,Alive,TUMOR FREE,860.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,860.0,0.0,860.0,0.0,860.0,0.0,860.0,2
TCGA-A5-A0GV-01,TCGA-A5-A0GV,UCEC,67.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24540.0,Alive,TUMOR FREE,1643.0,nan,nan,nan,nan,nan,304.0,Complete Remission/Response,nan,nan,0.0,1643.0,0.0,1643.0,1.0,304.0,1.0,304.0,2
TCGA-A5-A0GW-01,TCGA-A5-A0GW,UCEC,46.0,FEMALE,ASIAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17092.0,Alive,TUMOR FREE,706.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,706.0,0.0,706.0,0.0,706.0,0.0,706.0,2
TCGA-A5-A0GX-01,TCGA-A5-A0GX,UCEC,53.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19625.0,Alive,TUMOR FREE,2088.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2088.0,0.0,2088.0,0.0,2088.0,0.0,2088.0,2
TCGA-A5-A0R6-01,TCGA-A5-A0R6,UCEC,64.0,FEMALE,WHITE,nan,Stage IIIC1,Serous endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23449.0,Alive,TUMOR FREE,1153.0,nan,nan,New Primary Tumor,"Other, specify",Rectum,961.0,Complete Remission/Response,nan,nan,0.0,1153.0,0.0,1153.0,0.0,1153.0,1.0,961.0,2
TCGA-A5-A0R7-01,TCGA-A5-A0R7,UCEC,55.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20250.0,Alive,TUMOR FREE,535.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,535.0,0.0,535.0,0.0,535.0,0.0,535.0,2
TCGA-A5-A0R8-01,TCGA-A5-A0R8,UCEC,81.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29777.0,Alive,TUMOR FREE,596.0,nan,nan,nan,nan,nan,42.0,Complete Remission/Response,nan,nan,0.0,596.0,0.0,596.0,1.0,42.0,1.0,42.0,2
TCGA-A5-A0R9-01,TCGA-A5-A0R9,UCEC,51.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18982.0,Alive,TUMOR FREE,749.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,749.0,0.0,749.0,0.0,749.0,0.0,749.0,2
TCGA-A5-A0RA-01,TCGA-A5-A0RA,UCEC,68.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25060.0,Alive,TUMOR FREE,884.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,884.0,0.0,884.0,0.0,884.0,0.0,884.0,2
TCGA-A5-A0VO-01,TCGA-A5-A0VO,UCEC,64.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23547.0,Dead,TUMOR FREE,nan,875.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,875.0,0.0,875.0,0.0,875.0,0.0,875.0,2
TCGA-A5-A0VP-01,TCGA-A5-A0VP,UCEC,74.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27335.0,Alive,TUMOR FREE,1288.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1288.0,0.0,1288.0,0.0,1288.0,0.0,1288.0,2
TCGA-A5-A0VQ-01,TCGA-A5-A0VQ,UCEC,62.0,FEMALE,nan,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22995.0,Alive,TUMOR FREE,485.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,485.0,0.0,485.0,0.0,485.0,0.0,485.0,2
TCGA-A5-A1OF-01,TCGA-A5-A1OF,UCEC,47.0,FEMALE,nan,nan,Stage IA,Mixed serous and endometrioid,High Grade,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17308.0,Alive,TUMOR FREE,973.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,973.0,0.0,973.0,0.0,973.0,0.0,973.0,0
TCGA-A5-A1OG-01,TCGA-A5-A1OG,UCEC,65.0,FEMALE,ASIAN,nan,Stage IIIC2,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23956.0,Dead,WITH TUMOR,nan,973.0,nan,Metastatic,Lung,nan,337.0,Complete Remission/Response,nan,nan,1.0,973.0,1.0,973.0,1.0,337.0,1.0,337.0,2
TCGA-A5-A1OH-01,TCGA-A5-A1OH,UCEC,86.0,FEMALE,WHITE,nan,Stage IIIA,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31451.0,Alive,TUMOR FREE,1105.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1105.0,0.0,1105.0,0.0,1105.0,0.0,1105.0,0
TCGA-A5-A1OJ-01,TCGA-A5-A1OJ,UCEC,31.0,FEMALE,ASIAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11635.0,Alive,TUMOR FREE,1006.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1006.0,0.0,1006.0,0.0,1006.0,0.0,1006.0,2
TCGA-A5-A1OK-01,TCGA-A5-A1OK,UCEC,63.0,FEMALE,WHITE,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23179.0,Alive,TUMOR FREE,917.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,917.0,0.0,917.0,0.0,917.0,0.0,917.0,0
TCGA-A5-A2K2-01,TCGA-A5-A2K2,UCEC,77.0,FEMALE,WHITE,nan,Stage IA,Serous endometrial adenocarcinoma,G3,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28456.0,Alive,TUMOR FREE,3595.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3595.0,0.0,3595.0,0.0,3595.0,0.0,3595.0,0
TCGA-A5-A2K3-01,TCGA-A5-A2K3,UCEC,68.0,FEMALE,WHITE,nan,Stage IA,Serous endometrial adenocarcinoma,G3,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24907.0,Alive,TUMOR FREE,2012.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2012.0,0.0,2012.0,0.0,2012.0,0.0,2012.0,0
TCGA-A5-A2K4-01,TCGA-A5-A2K4,UCEC,69.0,FEMALE,WHITE,nan,Stage IIIA,Serous endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25270.0,Dead,WITH TUMOR,nan,871.0,nan,Metastatic,"Other, specify",Bowel,528.0,Complete Remission/Response,nan,nan,1.0,871.0,1.0,871.0,1.0,528.0,1.0,528.0,2
TCGA-A5-A2K5-01,TCGA-A5-A2K5,UCEC,76.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28057.0,Alive,TUMOR FREE,752.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,752.0,0.0,752.0,0.0,752.0,0.0,752.0,0
TCGA-A5-A2K7-01,TCGA-A5-A2K7,UCEC,41.0,FEMALE,nan,nan,Stage II,Endometrioid endometrial adenocarcinoma,G3,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14980.0,Alive,TUMOR FREE,1063.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1063.0,0.0,1063.0,0.0,1063.0,0.0,1063.0,0
TCGA-A5-A3LO-01,TCGA-A5-A3LO,UCEC,64.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23401.0,Alive,TUMOR FREE,776.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,776.0,0.0,776.0,0.0,776.0,0.0,776.0,0
TCGA-A5-A3LP-01,TCGA-A5-A3LP,UCEC,74.0,FEMALE,WHITE,nan,Stage IB,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27131.0,Alive,TUMOR FREE,455.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,455.0,0.0,455.0,0.0,455.0,0.0,455.0,0
TCGA-A5-A7WJ-01,TCGA-A5-A7WJ,UCEC,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23723.0,Alive,TUMOR FREE,341.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,341.0,0.0,341.0,0.0,341.0,0.0,341.0,2
TCGA-A5-A7WK-01,TCGA-A5-A7WK,UCEC,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Mixed serous and endometrioid,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26044.0,Alive,WITH TUMOR,560.0,nan,nan,Locoregional Recurrence,"Other, specify",Paraaortic lymph node,350.0,Complete Remission/Response,nan,nan,0.0,560.0,0.0,560.0,1.0,350.0,1.0,350.0,2
TCGA-A5-AB3J-01,TCGA-A5-AB3J,UCEC,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage II,Endometrioid endometrial adenocarcinoma,G2,2013.0,Peri (6-12 months since last menstrual period),-19020.0,Alive,TUMOR FREE,512.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,512.0,0.0,512.0,0.0,512.0,0.0,512.0,2
TCGA-AJ-A23M-01,TCGA-AJ-A23M,UCEC,61.0,FEMALE,WHITE,nan,Stage II,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22430.0,Dead,WITH TUMOR,nan,616.0,nan,Locoregional Recurrence,"Other, specify",Abdominal Fluid,516.0,Stable Disease,nan,nan,1.0,616.0,1.0,616.0,nan,nan,1.0,516.0,1
TCGA-AJ-A23N-01,TCGA-AJ-A23N,UCEC,70.0,FEMALE,WHITE,nan,Stage IIIA,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25772.0,Dead,WITH TUMOR,nan,439.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,439.0,1.0,439.0,nan,nan,1.0,439.0,1
TCGA-AJ-A23O-01,TCGA-AJ-A23O,UCEC,69.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25433.0,Dead,TUMOR FREE,nan,312.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,312.0,0.0,312.0,nan,nan,0.0,312.0,1
TCGA-AJ-A2QK-01,TCGA-AJ-A2QK,UCEC,65.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23945.0,Alive,WITH TUMOR,643.0,nan,nan,Distant Metastasis,Liver,nan,606.0,Complete Remission/Response,nan,nan,0.0,643.0,0.0,643.0,1.0,606.0,1.0,606.0,2
TCGA-AJ-A2QL-01,TCGA-AJ-A2QL,UCEC,60.0,FEMALE,WHITE,nan,Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22057.0,Alive,TUMOR FREE,602.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,602.0,0.0,602.0,0.0,602.0,0.0,602.0,0
TCGA-AJ-A2QL-11,TCGA-AJ-A2QL,UCEC,60.0,FEMALE,WHITE,nan,Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22057.0,Alive,TUMOR FREE,602.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,602.0,0.0,602.0,0.0,602.0,0.0,602.0,0
TCGA-AJ-A2QM-01,TCGA-AJ-A2QM,UCEC,67.0,FEMALE,WHITE,nan,Stage II,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24776.0,Alive,TUMOR FREE,894.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,894.0,0.0,894.0,0.0,894.0,0.0,894.0,0
TCGA-AJ-A2QN-01,TCGA-AJ-A2QN,UCEC,60.0,FEMALE,WHITE,nan,Stage II,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21915.0,Alive,TUMOR FREE,1069.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1069.0,0.0,1069.0,0.0,1069.0,0.0,1069.0,2
TCGA-AJ-A2QO-01,TCGA-AJ-A2QO,UCEC,85.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31222.0,Dead,TUMOR FREE,nan,1045.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1045.0,0.0,1045.0,0.0,1045.0,0.0,1045.0,0
TCGA-AJ-A3BD-01,TCGA-AJ-A3BD,UCEC,57.0,FEMALE,WHITE,nan,Stage IIIC2,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20998.0,Alive,TUMOR FREE,1039.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1039.0,0.0,1039.0,0.0,1039.0,0.0,1039.0,0
TCGA-AJ-A3BF-01,TCGA-AJ-A3BF,UCEC,65.0,FEMALE,WHITE,nan,Stage IIIC2,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23906.0,Alive,TUMOR FREE,551.0,nan,nan,Locoregional Recurrence,"Other, specify",Retroperitoneal LNs,384.0,Complete Remission/Response,nan,nan,0.0,551.0,0.0,551.0,1.0,384.0,1.0,384.0,2
TCGA-AJ-A3BG-01,TCGA-AJ-A3BG,UCEC,65.0,FEMALE,WHITE,nan,Stage IA,Mixed serous and endometrioid,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23861.0,Alive,WITH TUMOR,550.0,nan,nan,Locoregional Recurrence,"Other, specify",Vagina,480.0,Complete Remission/Response,nan,nan,0.0,550.0,0.0,550.0,1.0,480.0,1.0,480.0,2
TCGA-AJ-A3BH-01,TCGA-AJ-A3BH,UCEC,nan,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),nan,Alive,TUMOR FREE,nan,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,nan,0.0,nan,nan,nan,0.0,nan,0
TCGA-AJ-A3BI-01,TCGA-AJ-A3BI,UCEC,67.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24623.0,Alive,TUMOR FREE,575.0,nan,nan,Locoregional Recurrence,"Other, specify",Anterior Abd. Mass,373.0,nan,nan,nan,0.0,575.0,0.0,575.0,nan,nan,1.0,373.0,2
TCGA-AJ-A3BK-01,TCGA-AJ-A3BK,UCEC,68.0,FEMALE,WHITE,nan,Stage IC,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24943.0,Alive,TUMOR FREE,1031.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1031.0,0.0,1031.0,0.0,1031.0,0.0,1031.0,2
TCGA-AJ-A3EJ-01,TCGA-AJ-A3EJ,UCEC,74.0,FEMALE,WHITE,nan,Stage IIIC2,Mixed serous and endometrioid,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27317.0,Dead,WITH TUMOR,nan,50.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,50.0,1.0,50.0,nan,nan,1.0,50.0,1
TCGA-AJ-A3EK-01,TCGA-AJ-A3EK,UCEC,53.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Peri (6-12 months since last menstrual period),-19609.0,Alive,TUMOR FREE,446.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,446.0,0.0,446.0,0.0,446.0,0.0,446.0,0
TCGA-AJ-A3EL-01,TCGA-AJ-A3EL,UCEC,47.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17442.0,Alive,TUMOR FREE,684.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,684.0,0.0,684.0,0.0,684.0,0.0,684.0,2
TCGA-AJ-A3EM-01,TCGA-AJ-A3EM,UCEC,69.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25557.0,Alive,TUMOR FREE,677.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,677.0,0.0,677.0,0.0,677.0,0.0,677.0,0
TCGA-AJ-A3I9-01,TCGA-AJ-A3I9,UCEC,52.0,FEMALE,WHITE,nan,Stage II,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19139.0,Dead,WITH TUMOR,nan,519.0,nan,Distant Metastasis,Bone,nan,370.0,Complete Remission/Response,nan,nan,1.0,519.0,1.0,519.0,1.0,370.0,1.0,370.0,2
TCGA-AJ-A3IA-01,TCGA-AJ-A3IA,UCEC,77.0,FEMALE,WHITE,nan,Stage IB,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28470.0,Alive,TUMOR FREE,633.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,633.0,0.0,633.0,0.0,633.0,0.0,633.0,0
TCGA-AJ-A3NC-01,TCGA-AJ-A3NC,UCEC,63.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23353.0,Alive,TUMOR FREE,1125.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1125.0,0.0,1125.0,0.0,1125.0,0.0,1125.0,0
TCGA-AJ-A3NC-11,TCGA-AJ-A3NC,UCEC,63.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23353.0,Alive,TUMOR FREE,1125.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1125.0,0.0,1125.0,0.0,1125.0,0.0,1125.0,0
TCGA-AJ-A3NE-01,TCGA-AJ-A3NE,UCEC,46.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16957.0,Alive,TUMOR FREE,628.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,628.0,0.0,628.0,0.0,628.0,0.0,628.0,0
TCGA-AJ-A3NE-11,TCGA-AJ-A3NE,UCEC,46.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16957.0,Alive,TUMOR FREE,628.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,628.0,0.0,628.0,0.0,628.0,0.0,628.0,0
TCGA-AJ-A3NF-01,TCGA-AJ-A3NF,UCEC,60.0,FEMALE,WHITE,nan,Stage IIIC,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22210.0,Alive,TUMOR FREE,645.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,645.0,0.0,645.0,0.0,645.0,0.0,645.0,0
TCGA-AJ-A3NG-01,TCGA-AJ-A3NG,UCEC,83.0,FEMALE,WHITE,nan,Stage II,Mixed serous and endometrioid,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30351.0,Alive,TUMOR FREE,475.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,475.0,0.0,475.0,0.0,475.0,0.0,475.0,0
TCGA-AJ-A3NH-01,TCGA-AJ-A3NH,UCEC,90.0,FEMALE,WHITE,nan,Stage IB,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32871.0,Dead,TUMOR FREE,nan,310.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,310.0,0.0,310.0,0.0,310.0,0.0,310.0,0
TCGA-AJ-A3NH-11,TCGA-AJ-A3NH,UCEC,90.0,FEMALE,WHITE,nan,Stage IB,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32871.0,Dead,TUMOR FREE,nan,310.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,310.0,0.0,310.0,0.0,310.0,0.0,310.0,0
TCGA-AJ-A3OJ-01,TCGA-AJ-A3OJ,UCEC,54.0,FEMALE,WHITE,nan,Stage II,Endometrioid endometrial adenocarcinoma,G3,2011.0,Indeterminate (neither Pre or Postmenopausal),-19826.0,Alive,TUMOR FREE,467.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,467.0,0.0,467.0,0.0,467.0,0.0,467.0,0
TCGA-AJ-A3OK-01,TCGA-AJ-A3OK,UCEC,73.0,FEMALE,WHITE,nan,Stage IA,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26851.0,Alive,TUMOR FREE,485.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,485.0,0.0,485.0,0.0,485.0,0.0,485.0,0
TCGA-AJ-A3OL-01,TCGA-AJ-A3OL,UCEC,55.0,FEMALE,WHITE,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20115.0,Dead,WITH TUMOR,nan,449.0,nan,Distant Metastasis,"Other, specify","Lung, Liver, and Brain",424.0,Complete Remission/Response,nan,nan,1.0,449.0,1.0,449.0,1.0,424.0,1.0,424.0,2
TCGA-AJ-A3QS-01,TCGA-AJ-A3QS,UCEC,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIA,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21162.0,Alive,TUMOR FREE,513.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,513.0,0.0,513.0,0.0,513.0,0.0,513.0,0
TCGA-AJ-A3TW-01,TCGA-AJ-A3TW,UCEC,78.0,FEMALE,WHITE,nan,Stage IB,Serous endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28559.0,Alive,TUMOR FREE,513.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,513.0,0.0,513.0,0.0,513.0,0.0,513.0,0
TCGA-AJ-A5DV-01,TCGA-AJ-A5DV,UCEC,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23892.0,Alive,TUMOR FREE,679.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,679.0,0.0,679.0,0.0,679.0,0.0,679.0,2
TCGA-AJ-A5DW-01,TCGA-AJ-A5DW,UCEC,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20711.0,Alive,TUMOR FREE,390.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,390.0,0.0,390.0,0.0,390.0,0.0,390.0,2
TCGA-AJ-A6NU-01,TCGA-AJ-A6NU,UCEC,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage II,Endometrioid endometrial adenocarcinoma,G1,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23498.0,Alive,TUMOR FREE,632.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,632.0,0.0,632.0,0.0,632.0,0.0,632.0,2
TCGA-AJ-A8CT-01,TCGA-AJ-A8CT,UCEC,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21515.0,Alive,TUMOR FREE,82.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,82.0,0.0,82.0,0.0,82.0,0.0,82.0,2
TCGA-AJ-A8CV-01,TCGA-AJ-A8CV,UCEC,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21336.0,Alive,TUMOR FREE,1068.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1068.0,0.0,1068.0,0.0,1068.0,0.0,1068.0,2
TCGA-AJ-A8CW-01,TCGA-AJ-A8CW,UCEC,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23554.0,Alive,TUMOR FREE,4.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,4.0,0.0,4.0,nan,nan,0.0,4.0,2
TCGA-AP-A051-01,TCGA-AP-A051,UCEC,69.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25269.0,Alive,TUMOR FREE,3948.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3948.0,0.0,3948.0,0.0,3948.0,0.0,3948.0,2
TCGA-AP-A052-01,TCGA-AP-A052,UCEC,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IVB,Serous endometrial adenocarcinoma,G3,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21721.0,Dead,WITH TUMOR,nan,669.0,nan,nan,nan,nan,394.0,Complete Remission/Response,nan,nan,1.0,669.0,1.0,669.0,nan,nan,1.0,394.0,1
TCGA-AP-A053-01,TCGA-AP-A053,UCEC,90.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32872.0,Dead,TUMOR FREE,nan,3365.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,3365.0,0.0,3365.0,0.0,3365.0,0.0,3365.0,2
TCGA-AP-A054-01,TCGA-AP-A054,UCEC,64.0,FEMALE,WHITE,nan,Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23404.0,Dead,WITH TUMOR,nan,709.0,nan,nan,nan,nan,566.0,Complete Remission/Response,nan,nan,1.0,709.0,1.0,709.0,1.0,566.0,1.0,566.0,2
TCGA-AP-A056-01,TCGA-AP-A056,UCEC,64.0,FEMALE,WHITE,nan,Stage II,Endometrioid endometrial adenocarcinoma,G3,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23707.0,Alive,TUMOR FREE,2618.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2618.0,0.0,2618.0,0.0,2618.0,0.0,2618.0,2
TCGA-AP-A059-01,TCGA-AP-A059,UCEC,69.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25311.0,Alive,TUMOR FREE,1461.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1461.0,0.0,1461.0,0.0,1461.0,0.0,1461.0,2
TCGA-AP-A05A-01,TCGA-AP-A05A,UCEC,81.0,FEMALE,WHITE,nan,Stage II,Serous endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29914.0,Dead,TUMOR FREE,nan,1944.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1944.0,0.0,1944.0,0.0,1944.0,0.0,1944.0,0
TCGA-AP-A05D-01,TCGA-AP-A05D,UCEC,67.0,FEMALE,WHITE,nan,Stage IIIC2,Serous endometrial adenocarcinoma,G3,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24597.0,Alive,TUMOR FREE,1758.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1758.0,0.0,1758.0,0.0,1758.0,0.0,1758.0,0
TCGA-AP-A05H-01,TCGA-AP-A05H,UCEC,75.0,FEMALE,WHITE,nan,Stage IB,Serous endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27744.0,Alive,TUMOR FREE,1385.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1385.0,0.0,1385.0,0.0,1385.0,0.0,1385.0,0
TCGA-AP-A05J-01,TCGA-AP-A05J,UCEC,66.0,FEMALE,WHITE,nan,Stage II,Serous endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24119.0,Alive,TUMOR FREE,1122.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1122.0,0.0,1122.0,0.0,1122.0,0.0,1122.0,0
TCGA-AP-A05N-01,TCGA-AP-A05N,UCEC,58.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-21254.0,Dead,TUMOR FREE,nan,726.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,726.0,0.0,726.0,0.0,726.0,0.0,726.0,2
TCGA-AP-A05O-01,TCGA-AP-A05O,UCEC,68.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24978.0,Alive,TUMOR FREE,384.0,nan,nan,nan,nan,nan,340.0,Complete Remission/Response,nan,nan,0.0,384.0,0.0,384.0,1.0,340.0,1.0,340.0,2
TCGA-AP-A05P-01,TCGA-AP-A05P,UCEC,54.0,FEMALE,ASIAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20017.0,Alive,TUMOR FREE,636.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,636.0,0.0,636.0,0.0,636.0,0.0,636.0,2
TCGA-AP-A0L8-01,TCGA-AP-A0L8,UCEC,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC2,Serous endometrial adenocarcinoma,G3,2000.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25733.0,Dead,WITH TUMOR,nan,1484.0,nan,nan,nan,nan,1453.0,Complete Remission/Response,nan,nan,1.0,1484.0,1.0,1484.0,1.0,1453.0,1.0,1453.0,1
TCGA-AP-A0L9-01,TCGA-AP-A0L9,UCEC,71.0,FEMALE,WHITE,nan,Stage IA,Serous endometrial adenocarcinoma,G3,2001.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26185.0,Alive,TUMOR FREE,3815.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3815.0,0.0,3815.0,0.0,3815.0,0.0,3815.0,0
TCGA-AP-A0LD-01,TCGA-AP-A0LD,UCEC,63.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23216.0,Alive,TUMOR FREE,3589.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3589.0,0.0,3589.0,0.0,3589.0,0.0,3589.0,0
TCGA-AP-A0LE-01,TCGA-AP-A0LE,UCEC,57.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20967.0,Alive,TUMOR FREE,3357.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3357.0,0.0,3357.0,0.0,3357.0,0.0,3357.0,2
TCGA-AP-A0LF-01,TCGA-AP-A0LF,UCEC,82.0,FEMALE,WHITE,nan,Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30027.0,Alive,WITH TUMOR,2859.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2859.0,0.0,2859.0,nan,nan,0.0,2859.0,2
TCGA-AP-A0LG-01,TCGA-AP-A0LG,UCEC,54.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20047.0,Alive,TUMOR FREE,2015.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2015.0,0.0,2015.0,0.0,2015.0,0.0,2015.0,2
TCGA-AP-A0LH-01,TCGA-AP-A0LH,UCEC,60.0,FEMALE,WHITE,nan,Stage IA,Mixed serous and endometrioid,G3,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22169.0,Dead,WITH TUMOR,nan,1106.0,nan,nan,nan,nan,302.0,Complete Remission/Response,nan,nan,1.0,1106.0,1.0,1106.0,1.0,302.0,1.0,302.0,1
TCGA-AP-A0LI-01,TCGA-AP-A0LI,UCEC,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC2,Serous endometrial adenocarcinoma,G3,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24573.0,Alive,TUMOR FREE,2972.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2972.0,0.0,2972.0,0.0,2972.0,0.0,2972.0,0
TCGA-AP-A0LJ-01,TCGA-AP-A0LJ,UCEC,42.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2004.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15577.0,Alive,TUMOR FREE,1421.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1421.0,0.0,1421.0,0.0,1421.0,0.0,1421.0,2
TCGA-AP-A0LL-01,TCGA-AP-A0LL,UCEC,56.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20700.0,Alive,TUMOR FREE,2554.0,nan,nan,nan,nan,nan,790.0,Complete Remission/Response,nan,nan,0.0,2554.0,0.0,2554.0,1.0,790.0,1.0,790.0,2
TCGA-AP-A0LM-01,TCGA-AP-A0LM,UCEC,33.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC2,Endometrioid endometrial adenocarcinoma,G3,2004.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12309.0,Alive,TUMOR FREE,825.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,825.0,0.0,825.0,0.0,825.0,0.0,825.0,2
TCGA-AP-A0LN-01,TCGA-AP-A0LN,UCEC,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20704.0,Alive,TUMOR FREE,2510.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2510.0,0.0,2510.0,0.0,2510.0,0.0,2510.0,2
TCGA-AP-A0LO-01,TCGA-AP-A0LO,UCEC,45.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16493.0,Dead,WITH TUMOR,nan,1016.0,nan,nan,nan,nan,516.0,Complete Remission/Response,nan,nan,1.0,1016.0,1.0,1016.0,1.0,516.0,1.0,516.0,2
TCGA-AP-A0LP-01,TCGA-AP-A0LP,UCEC,76.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27898.0,Alive,TUMOR FREE,1875.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1875.0,0.0,1875.0,0.0,1875.0,0.0,1875.0,2
TCGA-AP-A0LQ-01,TCGA-AP-A0LQ,UCEC,59.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21629.0,Alive,TUMOR FREE,2457.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2457.0,0.0,2457.0,0.0,2457.0,0.0,2457.0,2
TCGA-AP-A0LS-01,TCGA-AP-A0LS,UCEC,63.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23126.0,Alive,TUMOR FREE,2904.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2904.0,0.0,2904.0,0.0,2904.0,0.0,2904.0,2
TCGA-AP-A0LT-01,TCGA-AP-A0LT,UCEC,57.0,FEMALE,WHITE,nan,Stage II,Endometrioid endometrial adenocarcinoma,G2,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21107.0,Alive,TUMOR FREE,1497.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1497.0,0.0,1497.0,0.0,1497.0,0.0,1497.0,2
TCGA-AP-A0LV-01,TCGA-AP-A0LV,UCEC,39.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14556.0,Alive,TUMOR FREE,763.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,763.0,0.0,763.0,0.0,763.0,0.0,763.0,2
TCGA-AP-A1DH-01,TCGA-AP-A1DH,UCEC,62.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22652.0,Alive,TUMOR FREE,2180.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2180.0,0.0,2180.0,0.0,2180.0,0.0,2180.0,2
TCGA-AP-A1DK-01,TCGA-AP-A1DK,UCEC,53.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19509.0,Alive,TUMOR FREE,2767.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2767.0,0.0,2767.0,0.0,2767.0,0.0,2767.0,2
TCGA-AP-A1DM-01,TCGA-AP-A1DM,UCEC,60.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22239.0,Alive,TUMOR FREE,1700.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1700.0,0.0,1700.0,0.0,1700.0,0.0,1700.0,2
TCGA-AP-A1DO-01,TCGA-AP-A1DO,UCEC,62.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22787.0,Alive,TUMOR FREE,952.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,952.0,0.0,952.0,0.0,952.0,0.0,952.0,2
TCGA-AP-A1DP-01,TCGA-AP-A1DP,UCEC,70.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25601.0,Dead,WITH TUMOR,nan,1081.0,nan,Metastatic,"Other, specify","Lung, liver, lymph nodes",831.0,Complete Remission/Response,nan,nan,1.0,1081.0,1.0,1081.0,1.0,831.0,1.0,831.0,2
TCGA-AP-A1DQ-01,TCGA-AP-A1DQ,UCEC,76.0,FEMALE,WHITE,nan,Stage IIIC1,Serous endometrial adenocarcinoma,High Grade,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27815.0,Dead,WITH TUMOR,nan,1423.0,nan,Metastatic,"Other, specify","Lymph nodes, lung, bone",905.0,Complete Remission/Response,nan,nan,1.0,1423.0,1.0,1423.0,1.0,905.0,1.0,905.0,1
TCGA-AP-A1DR-01,TCGA-AP-A1DR,UCEC,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC1,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21904.0,Alive,TUMOR FREE,1495.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1495.0,0.0,1495.0,0.0,1495.0,0.0,1495.0,2
TCGA-AP-A1DV-01,TCGA-AP-A1DV,UCEC,59.0,FEMALE,WHITE,nan,Stage II,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21901.0,Alive,TUMOR FREE,204.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,204.0,0.0,204.0,0.0,204.0,0.0,204.0,2
TCGA-AP-A1E0-01,TCGA-AP-A1E0,UCEC,40.0,FEMALE,WHITE,nan,Stage IIIC2,Endometrioid endometrial adenocarcinoma,G2,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14653.0,Alive,TUMOR FREE,1832.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1832.0,0.0,1832.0,0.0,1832.0,0.0,1832.0,2
TCGA-AP-A1E1-01,TCGA-AP-A1E1,UCEC,74.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27072.0,Alive,TUMOR FREE,1395.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1395.0,0.0,1395.0,0.0,1395.0,0.0,1395.0,2
TCGA-AP-A1E3-01,TCGA-AP-A1E3,UCEC,45.0,FEMALE,WHITE,nan,Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16544.0,Alive,WITH TUMOR,847.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,847.0,0.0,847.0,nan,nan,0.0,847.0,2
TCGA-AP-A1E4-01,TCGA-AP-A1E4,UCEC,54.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19814.0,Alive,WITH TUMOR,1555.0,nan,nan,Metastatic,"Other, specify","Bone, lymph nodes",158.0,Progressive Disease,nan,nan,0.0,1555.0,0.0,1555.0,nan,nan,1.0,158.0,2
TCGA-AP-A3K1-01,TCGA-AP-A3K1,UCEC,56.0,FEMALE,WHITE,nan,Stage IVB,Serous endometrial adenocarcinoma,High Grade,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20594.0,Dead,WITH TUMOR,nan,666.0,nan,Locoregional Recurrence,"Other, specify",Paracolic gutter,198.0,Progressive Disease,nan,nan,1.0,666.0,1.0,666.0,nan,nan,1.0,198.0,1
TCGA-AP-A5FX-01,TCGA-AP-A5FX,UCEC,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC1,Mixed serous and endometrioid,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25063.0,Dead,WITH TUMOR,nan,1099.0,nan,Locoregional Recurrence,"Other, specify",Retroperitoneal LN; vulvar mass,407.0,Complete Remission/Response,nan,nan,1.0,1099.0,1.0,1099.0,1.0,407.0,1.0,407.0,1
TCGA-AW-A1PO-01,TCGA-AW-A1PO,UCEC,66.0,FEMALE,WHITE,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24225.0,Alive,TUMOR FREE,17.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,17.0,0.0,17.0,nan,nan,0.0,17.0,0
TCGA-AX-A05S-01,TCGA-AX-A05S,UCEC,81.0,FEMALE,WHITE,nan,Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29928.0,Dead,WITH TUMOR,nan,413.0,nan,nan,nan,nan,338.0,Progressive Disease,nan,nan,1.0,413.0,1.0,413.0,nan,nan,1.0,338.0,1
TCGA-AX-A05T-01,TCGA-AX-A05T,UCEC,82.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30137.0,Alive,TUMOR FREE,1010.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1010.0,0.0,1010.0,0.0,1010.0,0.0,1010.0,2
TCGA-AX-A05U-01,TCGA-AX-A05U,UCEC,56.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20533.0,Alive,TUMOR FREE,903.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,903.0,0.0,903.0,0.0,903.0,0.0,903.0,2
TCGA-AX-A05W-01,TCGA-AX-A05W,UCEC,60.0,FEMALE,WHITE,nan,Stage IIB,Endometrioid endometrial adenocarcinoma,G1,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22200.0,Alive,TUMOR FREE,2450.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2450.0,0.0,2450.0,0.0,2450.0,0.0,2450.0,2
TCGA-AX-A05Y-01,TCGA-AX-A05Y,UCEC,57.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20904.0,Alive,TUMOR FREE,2684.0,nan,nan,nan,nan,nan,194.0,Complete Remission/Response,nan,nan,0.0,2684.0,0.0,2684.0,1.0,194.0,1.0,194.0,2
TCGA-AX-A05Y-11,TCGA-AX-A05Y,UCEC,57.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20904.0,Alive,TUMOR FREE,2684.0,nan,nan,nan,nan,nan,194.0,Complete Remission/Response,nan,nan,0.0,2684.0,0.0,2684.0,1.0,194.0,1.0,194.0,2
TCGA-AX-A05Z-01,TCGA-AX-A05Z,UCEC,37.0,FEMALE,nan,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G2,2006.0,Indeterminate (neither Pre or Postmenopausal),-13529.0,Alive,TUMOR FREE,2175.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2175.0,0.0,2175.0,0.0,2175.0,0.0,2175.0,2
TCGA-AX-A060-01,TCGA-AX-A060,UCEC,77.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,nan,Stage IC,Endometrioid endometrial adenocarcinoma,G3,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28472.0,Alive,TUMOR FREE,1075.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1075.0,0.0,1075.0,0.0,1075.0,0.0,1075.0,2
TCGA-AX-A062-01,TCGA-AX-A062,UCEC,53.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2005.0,Indeterminate (neither Pre or Postmenopausal),-19643.0,Alive,TUMOR FREE,1399.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1399.0,0.0,1399.0,0.0,1399.0,0.0,1399.0,2
TCGA-AX-A063-01,TCGA-AX-A063,UCEC,63.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23045.0,Alive,TUMOR FREE,2417.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2417.0,0.0,2417.0,0.0,2417.0,0.0,2417.0,2
TCGA-AX-A064-01,TCGA-AX-A064,UCEC,81.0,FEMALE,WHITE,nan,Stage IIA,Endometrioid endometrial adenocarcinoma,G2,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29625.0,Alive,TUMOR FREE,1517.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1517.0,0.0,1517.0,0.0,1517.0,0.0,1517.0,2
TCGA-AX-A06B-01,TCGA-AX-A06B,UCEC,72.0,FEMALE,WHITE,nan,Stage IIA,Endometrioid endometrial adenocarcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26348.0,Alive,TUMOR FREE,2058.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2058.0,0.0,2058.0,0.0,2058.0,0.0,2058.0,2
TCGA-AX-A06D-01,TCGA-AX-A06D,UCEC,82.0,FEMALE,WHITE,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G2,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30024.0,Dead,WITH TUMOR,nan,373.0,nan,nan,nan,nan,253.0,Progressive Disease,nan,nan,1.0,373.0,1.0,373.0,nan,nan,1.0,253.0,1
TCGA-AX-A06F-01,TCGA-AX-A06F,UCEC,59.0,FEMALE,WHITE,nan,Stage IVA,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21624.0,Alive,TUMOR FREE,1748.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1748.0,0.0,1748.0,nan,nan,0.0,1748.0,2
TCGA-AX-A06H-01,TCGA-AX-A06H,UCEC,60.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22270.0,Alive,WITH TUMOR,833.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,833.0,0.0,833.0,0.0,833.0,0.0,833.0,2
TCGA-AX-A06J-01,TCGA-AX-A06J,UCEC,71.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26000.0,Alive,TUMOR FREE,913.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,913.0,0.0,913.0,0.0,913.0,0.0,913.0,2
TCGA-AX-A06L-01,TCGA-AX-A06L,UCEC,63.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23294.0,Alive,TUMOR FREE,1845.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1845.0,0.0,1845.0,0.0,1845.0,0.0,1845.0,0
TCGA-AX-A0IS-01,TCGA-AX-A0IS,UCEC,52.0,FEMALE,WHITE,nan,Stage IC,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19173.0,Dead,WITH TUMOR,nan,1858.0,nan,nan,nan,nan,448.0,Complete Remission/Response,nan,nan,1.0,1858.0,1.0,1858.0,1.0,448.0,1.0,448.0,2
TCGA-AX-A0IU-01,TCGA-AX-A0IU,UCEC,79.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29063.0,Alive,TUMOR FREE,1087.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1087.0,0.0,1087.0,0.0,1087.0,0.0,1087.0,0
TCGA-AX-A0IW-01,TCGA-AX-A0IW,UCEC,67.0,FEMALE,WHITE,nan,Stage IIIA,Serous endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24488.0,Alive,TUMOR FREE,1149.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1149.0,0.0,1149.0,0.0,1149.0,0.0,1149.0,0
TCGA-AX-A0IZ-01,TCGA-AX-A0IZ,UCEC,53.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19364.0,Alive,TUMOR FREE,1333.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1333.0,0.0,1333.0,0.0,1333.0,0.0,1333.0,2
TCGA-AX-A0IZ-11,TCGA-AX-A0IZ,UCEC,53.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19364.0,Alive,TUMOR FREE,1333.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1333.0,0.0,1333.0,0.0,1333.0,0.0,1333.0,2
TCGA-AX-A0J0-01,TCGA-AX-A0J0,UCEC,47.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17466.0,Alive,TUMOR FREE,1220.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1220.0,0.0,1220.0,0.0,1220.0,0.0,1220.0,2
TCGA-AX-A0J0-11,TCGA-AX-A0J0,UCEC,47.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17466.0,Alive,TUMOR FREE,1220.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1220.0,0.0,1220.0,0.0,1220.0,0.0,1220.0,2
TCGA-AX-A0J1-01,TCGA-AX-A0J1,UCEC,80.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29501.0,Alive,TUMOR FREE,2354.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2354.0,0.0,2354.0,0.0,2354.0,0.0,2354.0,2
TCGA-AX-A1C4-01,TCGA-AX-A1C4,UCEC,52.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Indeterminate (neither Pre or Postmenopausal),-19209.0,Alive,TUMOR FREE,404.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,404.0,0.0,404.0,nan,nan,0.0,404.0,2
TCGA-AX-A1C5-01,TCGA-AX-A1C5,UCEC,47.0,FEMALE,WHITE,nan,Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2009.0,Indeterminate (neither Pre or Postmenopausal),-17383.0,Alive,WITH TUMOR,1001.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1001.0,0.0,1001.0,0.0,1001.0,0.0,1001.0,2
TCGA-AX-A1C7-01,TCGA-AX-A1C7,UCEC,77.0,FEMALE,WHITE,nan,Stage IB,Serous endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28198.0,Alive,nan,1054.0,nan,nan,nan,nan,nan,390.0,nan,nan,nan,0.0,1054.0,0.0,1054.0,nan,nan,1.0,390.0,2
TCGA-AX-A1C8-01,TCGA-AX-A1C8,UCEC,77.0,FEMALE,WHITE,nan,Stage IIIC,Serous endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28452.0,Alive,nan,776.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,776.0,0.0,776.0,nan,nan,0.0,776.0,2
TCGA-AX-A1C9-01,TCGA-AX-A1C9,UCEC,73.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26903.0,Alive,TUMOR FREE,802.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,802.0,0.0,802.0,nan,nan,0.0,802.0,2
TCGA-AX-A1CA-01,TCGA-AX-A1CA,UCEC,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Serous endometrial adenocarcinoma,G3,2009.0,nan,-25817.0,Alive,TUMOR FREE,974.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,974.0,0.0,974.0,nan,nan,0.0,974.0,0
TCGA-AX-A1CC-01,TCGA-AX-A1CC,UCEC,65.0,FEMALE,WHITE,nan,Stage IC,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23795.0,Alive,TUMOR FREE,788.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,788.0,0.0,788.0,nan,nan,0.0,788.0,0
TCGA-AX-A1CE-01,TCGA-AX-A1CE,UCEC,60.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21969.0,Alive,TUMOR FREE,1037.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1037.0,0.0,1037.0,nan,nan,0.0,1037.0,2
TCGA-AX-A1CF-01,TCGA-AX-A1CF,UCEC,69.0,FEMALE,WHITE,nan,Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2004.0,nan,-25300.0,Alive,WITH TUMOR,2337.0,nan,nan,nan,nan,nan,875.0,Progressive Disease,nan,nan,0.0,2337.0,0.0,2337.0,nan,nan,1.0,875.0,2
TCGA-AX-A1CF-11,TCGA-AX-A1CF,UCEC,69.0,FEMALE,WHITE,nan,Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2004.0,nan,-25300.0,Alive,WITH TUMOR,2337.0,nan,nan,nan,nan,nan,875.0,Progressive Disease,nan,nan,0.0,2337.0,0.0,2337.0,nan,nan,1.0,875.0,2
TCGA-AX-A1CI-01,TCGA-AX-A1CI,UCEC,61.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22582.0,Alive,TUMOR FREE,2600.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2600.0,0.0,2600.0,nan,nan,0.0,2600.0,0
TCGA-AX-A1CI-11,TCGA-AX-A1CI,UCEC,61.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22582.0,Alive,TUMOR FREE,2600.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2600.0,0.0,2600.0,nan,nan,0.0,2600.0,0
TCGA-AX-A1CJ-01,TCGA-AX-A1CJ,UCEC,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IC,Endometrioid endometrial adenocarcinoma,G2,2006.0,Indeterminate (neither Pre or Postmenopausal),-21655.0,Alive,TUMOR FREE,2233.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2233.0,0.0,2233.0,nan,nan,0.0,2233.0,2
TCGA-AX-A1CJ-11,TCGA-AX-A1CJ,UCEC,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IC,Endometrioid endometrial adenocarcinoma,G2,2006.0,Indeterminate (neither Pre or Postmenopausal),-21655.0,Alive,TUMOR FREE,2233.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2233.0,0.0,2233.0,nan,nan,0.0,2233.0,2
TCGA-AX-A1CK-01,TCGA-AX-A1CK,UCEC,58.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21200.0,Alive,WITH TUMOR,2441.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2441.0,0.0,2441.0,nan,nan,0.0,2441.0,2
TCGA-AX-A1CK-11,TCGA-AX-A1CK,UCEC,58.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21200.0,Alive,WITH TUMOR,2441.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2441.0,0.0,2441.0,nan,nan,0.0,2441.0,2
TCGA-AX-A1CN-01,TCGA-AX-A1CN,UCEC,54.0,FEMALE,WHITE,nan,Stage IIB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19860.0,Alive,WITH TUMOR,1143.0,nan,nan,New Primary Tumor,Lung,nan,1105.0,nan,nan,nan,0.0,1143.0,0.0,1143.0,nan,nan,1.0,1105.0,2
TCGA-AX-A1CP-01,TCGA-AX-A1CP,UCEC,84.0,FEMALE,WHITE,nan,Stage IA,Serous endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30737.0,Alive,nan,1107.0,nan,nan,nan,nan,nan,722.0,nan,nan,nan,0.0,1107.0,0.0,1107.0,nan,nan,1.0,722.0,2
TCGA-AX-A1CR-01,TCGA-AX-A1CR,UCEC,70.0,FEMALE,WHITE,nan,Stage IIB,Mixed serous and endometrioid,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25812.0,Alive,TUMOR FREE,701.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,701.0,0.0,701.0,nan,nan,0.0,701.0,0
TCGA-AX-A2H2-01,TCGA-AX-A2H2,UCEC,86.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIA,Serous endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31524.0,Dead,TUMOR FREE,nan,145.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,145.0,0.0,145.0,0.0,145.0,0.0,145.0,0
TCGA-AX-A2H4-01,TCGA-AX-A2H4,UCEC,66.0,FEMALE,WHITE,nan,Stage IIIA,Serous endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24234.0,Dead,WITH TUMOR,nan,916.0,nan,Locoregional Disease,"Other, specify","Vaginal cuff, iliac",520.0,Complete Remission/Response,nan,nan,1.0,916.0,1.0,916.0,1.0,520.0,1.0,520.0,1
TCGA-AX-A2H4-11,TCGA-AX-A2H4,UCEC,66.0,FEMALE,WHITE,nan,Stage IIIA,Serous endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24234.0,Dead,WITH TUMOR,nan,916.0,nan,Locoregional Disease,"Other, specify","Vaginal cuff, iliac",520.0,Complete Remission/Response,nan,nan,1.0,916.0,1.0,916.0,1.0,520.0,1.0,520.0,1
TCGA-AX-A2H5-01,TCGA-AX-A2H5,UCEC,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous endometrial adenocarcinoma,G3,2005.0,nan,-24757.0,Alive,TUMOR FREE,2167.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2167.0,0.0,2167.0,0.0,2167.0,0.0,2167.0,0
TCGA-AX-A2H5-11,TCGA-AX-A2H5,UCEC,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous endometrial adenocarcinoma,G3,2005.0,nan,-24757.0,Alive,TUMOR FREE,2167.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2167.0,0.0,2167.0,0.0,2167.0,0.0,2167.0,0
TCGA-AX-A2H7-01,TCGA-AX-A2H7,UCEC,87.0,FEMALE,WHITE,nan,Stage IC,Endometrioid endometrial adenocarcinoma,G3,2008.0,nan,-32100.0,Dead,WITH TUMOR,nan,1241.0,nan,Metastatic,Lung,nan,684.0,Complete Remission/Response,nan,nan,1.0,1241.0,1.0,1241.0,1.0,684.0,1.0,684.0,1
TCGA-AX-A2H7-11,TCGA-AX-A2H7,UCEC,87.0,FEMALE,WHITE,nan,Stage IC,Endometrioid endometrial adenocarcinoma,G3,2008.0,nan,-32100.0,Dead,WITH TUMOR,nan,1241.0,nan,Metastatic,Lung,nan,684.0,Complete Remission/Response,nan,nan,1.0,1241.0,1.0,1241.0,1.0,684.0,1.0,684.0,1
TCGA-AX-A2H8-01,TCGA-AX-A2H8,UCEC,64.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23448.0,Alive,TUMOR FREE,1861.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1861.0,0.0,1861.0,0.0,1861.0,0.0,1861.0,2
TCGA-AX-A2H8-11,TCGA-AX-A2H8,UCEC,64.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23448.0,Alive,TUMOR FREE,1861.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1861.0,0.0,1861.0,0.0,1861.0,0.0,1861.0,2
TCGA-AX-A2HA-01,TCGA-AX-A2HA,UCEC,35.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2005.0,nan,-13142.0,Alive,TUMOR FREE,2475.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2475.0,0.0,2475.0,0.0,2475.0,0.0,2475.0,2
TCGA-AX-A2HA-11,TCGA-AX-A2HA,UCEC,35.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2005.0,nan,-13142.0,Alive,TUMOR FREE,2475.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2475.0,0.0,2475.0,0.0,2475.0,0.0,2475.0,2
TCGA-AX-A2HC-01,TCGA-AX-A2HC,UCEC,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2006.0,nan,-19485.0,Alive,WITH TUMOR,1044.0,nan,nan,Metastatic,"Other, specify",Abdomen,756.0,Complete Remission/Response,nan,nan,0.0,1044.0,0.0,1044.0,1.0,756.0,1.0,756.0,2
TCGA-AX-A2HC-11,TCGA-AX-A2HC,UCEC,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2006.0,nan,-19485.0,Alive,WITH TUMOR,1044.0,nan,nan,Metastatic,"Other, specify",Abdomen,756.0,Complete Remission/Response,nan,nan,0.0,1044.0,0.0,1044.0,1.0,756.0,1.0,756.0,2
TCGA-AX-A2HD-01,TCGA-AX-A2HD,UCEC,69.0,FEMALE,WHITE,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2008.0,nan,-25499.0,Alive,WITH TUMOR,1414.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,1414.0,0.0,1414.0,nan,nan,0.0,1414.0,2
TCGA-AX-A2HD-11,TCGA-AX-A2HD,UCEC,69.0,FEMALE,WHITE,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2008.0,nan,-25499.0,Alive,WITH TUMOR,1414.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,1414.0,0.0,1414.0,nan,nan,0.0,1414.0,2
TCGA-AX-A2HF-01,TCGA-AX-A2HF,UCEC,67.0,FEMALE,WHITE,nan,Stage IB,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24689.0,Alive,WITH TUMOR,848.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,848.0,0.0,848.0,0.0,848.0,0.0,848.0,2
TCGA-AX-A2HG-01,TCGA-AX-A2HG,UCEC,56.0,FEMALE,WHITE,nan,Stage IC,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20771.0,Alive,TUMOR FREE,1163.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1163.0,0.0,1163.0,0.0,1163.0,0.0,1163.0,2
TCGA-AX-A2HH-01,TCGA-AX-A2HH,UCEC,60.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,nan,-21924.0,Alive,WITH TUMOR,540.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,540.0,0.0,540.0,nan,nan,0.0,540.0,2
TCGA-AX-A2HJ-01,TCGA-AX-A2HJ,UCEC,35.0,FEMALE,ASIAN,nan,Stage IC,Endometrioid endometrial adenocarcinoma,G3,2009.0,nan,-13112.0,Alive,TUMOR FREE,935.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,935.0,0.0,935.0,0.0,935.0,0.0,935.0,2
TCGA-AX-A2HK-01,TCGA-AX-A2HK,UCEC,77.0,FEMALE,WHITE,nan,Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28316.0,Dead,WITH TUMOR,nan,90.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,90.0,1.0,90.0,nan,nan,1.0,90.0,1
TCGA-AX-A2IN-01,TCGA-AX-A2IN,UCEC,63.0,FEMALE,WHITE,nan,Stage IC,Endometrioid endometrial adenocarcinoma,G3,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23275.0,Dead,WITH TUMOR,nan,947.0,nan,New Primary Tumor,"Other, specify",Right Breast,257.0,nan,nan,nan,1.0,947.0,1.0,947.0,nan,nan,1.0,257.0,1
TCGA-AX-A2IO-01,TCGA-AX-A2IO,UCEC,83.0,FEMALE,WHITE,nan,Stage IIA,Serous endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30539.0,Alive,TUMOR FREE,1975.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1975.0,0.0,1975.0,nan,nan,0.0,1975.0,0
TCGA-AX-A3FS-01,TCGA-AX-A3FS,UCEC,82.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30102.0,Alive,nan,7.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,7.0,0.0,7.0,nan,nan,0.0,7.0,2
TCGA-AX-A3FT-01,TCGA-AX-A3FT,UCEC,64.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23543.0,Alive,nan,6.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,6.0,0.0,6.0,nan,nan,0.0,6.0,2
TCGA-AX-A3FV-01,TCGA-AX-A3FV,UCEC,62.0,FEMALE,WHITE,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2009.0,nan,-22752.0,Alive,nan,-6.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,0.0,0.0,0.0,nan,nan,0.0,0.0,0
TCGA-AX-A3FW-01,TCGA-AX-A3FW,UCEC,66.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24419.0,Alive,nan,17.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,17.0,0.0,17.0,nan,nan,0.0,17.0,2
TCGA-AX-A3FX-01,TCGA-AX-A3FX,UCEC,69.0,FEMALE,WHITE,nan,Stage IIB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25260.0,Dead,nan,nan,1333.0,nan,Locoregional Recurrence,"Other, specify",Chest,938.0,nan,nan,nan,1.0,1333.0,nan,1333.0,nan,nan,1.0,938.0,1
TCGA-AX-A3FZ-01,TCGA-AX-A3FZ,UCEC,33.0,FEMALE,WHITE,nan,Stage IIIB,Endometrioid endometrial adenocarcinoma,G3,2010.0,nan,-12331.0,Alive,nan,6.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,6.0,0.0,6.0,nan,nan,0.0,6.0,2
TCGA-AX-A3G1-01,TCGA-AX-A3G1,UCEC,84.0,FEMALE,WHITE,nan,Stage IC,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31037.0,Dead,nan,nan,624.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,624.0,nan,624.0,nan,nan,0.0,624.0,1
TCGA-AX-A3G3-01,TCGA-AX-A3G3,UCEC,58.0,FEMALE,WHITE,nan,Stage IIIA,Serous endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21308.0,Alive,nan,42.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,42.0,0.0,42.0,nan,nan,0.0,42.0,2
TCGA-AX-A3G4-01,TCGA-AX-A3G4,UCEC,60.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,nan,Stage IIIC,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22099.0,Alive,nan,9.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,9.0,0.0,9.0,nan,nan,0.0,9.0,0
TCGA-AX-A3G6-01,TCGA-AX-A3G6,UCEC,67.0,FEMALE,WHITE,nan,Stage IA,Serous endometrial adenocarcinoma,G2,2010.0,nan,-24681.0,Alive,nan,8.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,8.0,0.0,8.0,nan,nan,0.0,8.0,2
TCGA-AX-A3G7-01,TCGA-AX-A3G7,UCEC,71.0,FEMALE,WHITE,nan,Stage IVB,Serous endometrial adenocarcinoma,G3,2010.0,nan,-26187.0,Alive,nan,9.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,9.0,0.0,9.0,nan,nan,0.0,9.0,0
TCGA-AX-A3G8-01,TCGA-AX-A3G8,UCEC,76.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27899.0,Alive,nan,36.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,36.0,0.0,36.0,nan,nan,0.0,36.0,2
TCGA-AX-A3G9-01,TCGA-AX-A3G9,UCEC,63.0,FEMALE,WHITE,nan,Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2010.0,nan,-23361.0,Alive,nan,558.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,558.0,0.0,558.0,nan,nan,0.0,558.0,0
TCGA-AX-A3GB-01,TCGA-AX-A3GB,UCEC,73.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26724.0,Alive,nan,440.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,440.0,0.0,440.0,nan,nan,0.0,440.0,2
TCGA-AX-A3GI-01,TCGA-AX-A3GI,UCEC,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous endometrial adenocarcinoma,G3,2011.0,nan,-24388.0,Alive,nan,12.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,12.0,0.0,12.0,nan,nan,0.0,12.0,0
TCGA-B5-A0JN-01,TCGA-B5-A0JN,UCEC,84.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IVB,Serous endometrial adenocarcinoma,G3,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30933.0,Alive,TUMOR FREE,2445.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2445.0,0.0,2445.0,nan,nan,0.0,2445.0,2
TCGA-B5-A0JR-01,TCGA-B5-A0JR,UCEC,73.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26814.0,Alive,TUMOR FREE,1731.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1731.0,0.0,1731.0,0.0,1731.0,0.0,1731.0,2
TCGA-B5-A0JS-01,TCGA-B5-A0JS,UCEC,54.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19995.0,Alive,TUMOR FREE,2627.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2627.0,0.0,2627.0,0.0,2627.0,0.0,2627.0,2
TCGA-B5-A0JT-01,TCGA-B5-A0JT,UCEC,63.0,FEMALE,WHITE,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23041.0,Alive,TUMOR FREE,1682.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1682.0,0.0,1682.0,0.0,1682.0,0.0,1682.0,0
TCGA-B5-A0JU-01,TCGA-B5-A0JU,UCEC,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21159.0,Alive,TUMOR FREE,1802.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1802.0,0.0,1802.0,nan,nan,0.0,1802.0,2
TCGA-B5-A0JV-01,TCGA-B5-A0JV,UCEC,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23295.0,Alive,TUMOR FREE,2616.0,nan,nan,Locoregional Disease,"Other, specify",vaginal wall,698.0,Complete Remission/Response,nan,nan,0.0,2616.0,0.0,2616.0,1.0,698.0,1.0,698.0,2
TCGA-B5-A0JX-01,TCGA-B5-A0JX,UCEC,62.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22834.0,Alive,TUMOR FREE,1787.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1787.0,0.0,1787.0,0.0,1787.0,0.0,1787.0,2
TCGA-B5-A0JY-01,TCGA-B5-A0JY,UCEC,50.0,FEMALE,WHITE,nan,Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18475.0,Alive,TUMOR FREE,2107.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2107.0,0.0,2107.0,0.0,2107.0,0.0,2107.0,2
TCGA-B5-A0JZ-01,TCGA-B5-A0JZ,UCEC,60.0,FEMALE,WHITE,nan,Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22106.0,Alive,TUMOR FREE,2173.0,nan,nan,Metastatic,"Other, specify",inguinal lymph node,356.0,Progressive Disease,nan,nan,0.0,2173.0,0.0,2173.0,nan,nan,1.0,356.0,2
TCGA-B5-A0K0-01,TCGA-B5-A0K0,UCEC,48.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2008.0,Indeterminate (neither Pre or Postmenopausal),-17810.0,Alive,TUMOR FREE,1478.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1478.0,0.0,1478.0,0.0,1478.0,0.0,1478.0,2
TCGA-B5-A0K1-01,TCGA-B5-A0K1,UCEC,69.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25291.0,Alive,TUMOR FREE,1110.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1110.0,0.0,1110.0,0.0,1110.0,0.0,1110.0,2
TCGA-B5-A0K2-01,TCGA-B5-A0K2,UCEC,54.0,FEMALE,WHITE,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2008.0,Indeterminate (neither Pre or Postmenopausal),-20080.0,Alive,TUMOR FREE,2209.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2209.0,0.0,2209.0,0.0,2209.0,0.0,2209.0,2
TCGA-B5-A0K3-01,TCGA-B5-A0K3,UCEC,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22664.0,Dead,WITH TUMOR,nan,830.0,nan,Locoregional Disease,"Other, specify",vaginal cuff,256.0,nan,nan,nan,1.0,830.0,1.0,830.0,nan,nan,1.0,256.0,1
TCGA-B5-A0K4-01,TCGA-B5-A0K4,UCEC,51.0,FEMALE,nan,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18631.0,Alive,TUMOR FREE,1757.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1757.0,0.0,1757.0,0.0,1757.0,0.0,1757.0,2
TCGA-B5-A0K6-01,TCGA-B5-A0K6,UCEC,58.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21515.0,Alive,TUMOR FREE,1953.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1953.0,0.0,1953.0,0.0,1953.0,0.0,1953.0,2
TCGA-B5-A0K7-01,TCGA-B5-A0K7,UCEC,64.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23429.0,Alive,TUMOR FREE,1933.0,nan,nan,Metastatic,"Other, specify",vagina,322.0,Complete Remission/Response,nan,nan,0.0,1933.0,0.0,1933.0,1.0,322.0,1.0,322.0,2
TCGA-B5-A0K8-01,TCGA-B5-A0K8,UCEC,71.0,FEMALE,WHITE,nan,Stage IB,Serous endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25992.0,Alive,TUMOR FREE,847.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,847.0,0.0,847.0,0.0,847.0,0.0,847.0,2
TCGA-B5-A0K9-01,TCGA-B5-A0K9,UCEC,88.0,FEMALE,WHITE,nan,Stage II,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32289.0,Dead,TUMOR FREE,nan,409.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,409.0,0.0,409.0,0.0,409.0,0.0,409.0,2
TCGA-B5-A0KB-01,TCGA-B5-A0KB,UCEC,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22669.0,Alive,WITH TUMOR,824.0,nan,nan,Locoregional Disease,"Other, specify",cul de sac mass,689.0,Complete Remission/Response,nan,nan,0.0,824.0,0.0,824.0,1.0,689.0,1.0,689.0,2
TCGA-B5-A11E-01,TCGA-B5-A11E,UCEC,53.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Peri (6-12 months since last menstrual period),-19458.0,Alive,TUMOR FREE,1820.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1820.0,0.0,1820.0,0.0,1820.0,0.0,1820.0,2
TCGA-B5-A11F-01,TCGA-B5-A11F,UCEC,55.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,1995.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20171.0,Alive,TUMOR FREE,5651.0,nan,nan,Metastatic,Bone,nan,1610.0,Complete Remission/Response,nan,nan,0.0,5651.0,0.0,5651.0,1.0,1610.0,1.0,1610.0,2
TCGA-B5-A11G-01,TCGA-B5-A11G,UCEC,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2001.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25995.0,Alive,TUMOR FREE,3448.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3448.0,0.0,3448.0,0.0,3448.0,0.0,3448.0,2
TCGA-B5-A11H-01,TCGA-B5-A11H,UCEC,67.0,FEMALE,WHITE,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G2,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24556.0,Alive,TUMOR FREE,2687.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2687.0,0.0,2687.0,0.0,2687.0,0.0,2687.0,2
TCGA-B5-A11I-01,TCGA-B5-A11I,UCEC,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23857.0,Alive,TUMOR FREE,2303.0,nan,nan,Metastatic,Lung,nan,705.0,Complete Remission/Response,nan,nan,0.0,2303.0,0.0,2303.0,nan,nan,1.0,705.0,2
TCGA-B5-A11J-01,TCGA-B5-A11J,UCEC,64.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23485.0,Alive,TUMOR FREE,1656.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1656.0,0.0,1656.0,0.0,1656.0,0.0,1656.0,2
TCGA-B5-A11L-01,TCGA-B5-A11L,UCEC,71.0,FEMALE,WHITE,nan,Stage IC,Endometrioid endometrial adenocarcinoma,G2,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26120.0,Dead,TUMOR FREE,nan,2240.0,nan,Locoregional Recurrence,"Other, specify",Vaginal Apex,131.0,Complete Remission/Response,nan,nan,1.0,2240.0,0.0,2240.0,1.0,131.0,1.0,131.0,2
TCGA-B5-A11M-01,TCGA-B5-A11M,UCEC,43.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16063.0,Alive,TUMOR FREE,1362.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1362.0,0.0,1362.0,0.0,1362.0,0.0,1362.0,2
TCGA-B5-A11N-01,TCGA-B5-A11N,UCEC,69.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25442.0,Alive,TUMOR FREE,1876.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1876.0,0.0,1876.0,0.0,1876.0,0.0,1876.0,2
TCGA-B5-A11O-01,TCGA-B5-A11O,UCEC,62.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22720.0,Alive,TUMOR FREE,2609.0,nan,nan,New Primary Tumor,"Other, specify",Right Breast,1924.0,Complete Remission/Response,nan,nan,0.0,2609.0,0.0,2609.0,0.0,2609.0,1.0,1924.0,2
TCGA-B5-A11P-01,TCGA-B5-A11P,UCEC,87.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32047.0,Alive,TUMOR FREE,1583.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1583.0,0.0,1583.0,nan,nan,0.0,1583.0,0
TCGA-B5-A11Q-01,TCGA-B5-A11Q,UCEC,64.0,FEMALE,WHITE,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23538.0,Alive,TUMOR FREE,976.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,976.0,0.0,976.0,0.0,976.0,0.0,976.0,2
TCGA-B5-A11R-01,TCGA-B5-A11R,UCEC,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage II,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18878.0,Alive,TUMOR FREE,2349.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2349.0,0.0,2349.0,0.0,2349.0,0.0,2349.0,2
TCGA-B5-A11S-01,TCGA-B5-A11S,UCEC,63.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23085.0,Alive,TUMOR FREE,2229.0,nan,nan,New Primary Tumor,"Other, specify",Breast,41.0,Complete Remission/Response,nan,nan,0.0,2229.0,0.0,2229.0,0.0,2229.0,1.0,41.0,2
TCGA-B5-A11U-01,TCGA-B5-A11U,UCEC,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27160.0,Alive,TUMOR FREE,509.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,509.0,0.0,509.0,nan,nan,0.0,509.0,2
TCGA-B5-A11V-01,TCGA-B5-A11V,UCEC,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23630.0,Alive,TUMOR FREE,595.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,595.0,0.0,595.0,0.0,595.0,0.0,595.0,2
TCGA-B5-A11W-01,TCGA-B5-A11W,UCEC,61.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22365.0,Alive,TUMOR FREE,593.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,593.0,0.0,593.0,0.0,593.0,0.0,593.0,2
TCGA-B5-A11X-01,TCGA-B5-A11X,UCEC,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC2,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24217.0,Alive,TUMOR FREE,596.0,nan,nan,Metastatic,"Other, specify",lymph nodes,397.0,nan,nan,nan,0.0,596.0,0.0,596.0,nan,nan,1.0,397.0,2
TCGA-B5-A11Y-01,TCGA-B5-A11Y,UCEC,59.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21860.0,Alive,TUMOR FREE,560.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,560.0,0.0,560.0,0.0,560.0,0.0,560.0,2
TCGA-B5-A11Z-01,TCGA-B5-A11Z,UCEC,61.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22505.0,Alive,TUMOR FREE,528.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,528.0,0.0,528.0,0.0,528.0,0.0,528.0,2
TCGA-B5-A121-01,TCGA-B5-A121,UCEC,57.0,FEMALE,WHITE,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21018.0,Alive,TUMOR FREE,504.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,504.0,0.0,504.0,0.0,504.0,0.0,504.0,2
TCGA-B5-A1MR-01,TCGA-B5-A1MR,UCEC,65.0,FEMALE,WHITE,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,1995.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24017.0,Alive,TUMOR FREE,6859.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,6859.0,0.0,6859.0,0.0,6859.0,0.0,6859.0,2
TCGA-B5-A1MS-01,TCGA-B5-A1MS,UCEC,60.0,FEMALE,WHITE,nan,Stage IC,Serous endometrial adenocarcinoma,G3,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22068.0,Dead,WITH TUMOR,nan,3112.0,nan,Locoregional Recurrence,"Other, specify",Supraclavicular Fossa,2706.0,Partial Remission/Response,nan,nan,1.0,3112.0,1.0,3112.0,nan,nan,1.0,2706.0,1
TCGA-B5-A1MU-01,TCGA-B5-A1MU,UCEC,79.0,FEMALE,WHITE,nan,Stage IVB,Serous endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29027.0,Dead,WITH TUMOR,nan,1548.0,nan,New Primary Tumor,"Other, specify",Breast,1365.0,Complete Remission/Response,nan,nan,1.0,1548.0,1.0,1548.0,nan,nan,1.0,1365.0,1
TCGA-B5-A1MV-01,TCGA-B5-A1MV,UCEC,84.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30926.0,Alive,TUMOR FREE,1565.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1565.0,0.0,1565.0,0.0,1565.0,0.0,1565.0,2
TCGA-B5-A1MW-01,TCGA-B5-A1MW,UCEC,55.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20183.0,Alive,TUMOR FREE,447.0,nan,nan,Locoregional Disease,"Other, specify",vaginal cuff,311.0,Complete Remission/Response,nan,nan,0.0,447.0,0.0,447.0,1.0,311.0,1.0,311.0,2
TCGA-B5-A1MX-01,TCGA-B5-A1MX,UCEC,47.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17320.0,Alive,TUMOR FREE,1473.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1473.0,0.0,1473.0,0.0,1473.0,0.0,1473.0,2
TCGA-B5-A1MY-01,TCGA-B5-A1MY,UCEC,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC2,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22805.0,Dead,WITH TUMOR,nan,361.0,nan,Locoregional Disease,"Other, specify",peritoneum,333.0,nan,nan,nan,1.0,361.0,1.0,361.0,nan,nan,1.0,333.0,1
TCGA-B5-A1MZ-01,TCGA-B5-A1MZ,UCEC,54.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Indeterminate (neither Pre or Postmenopausal),-19955.0,Alive,TUMOR FREE,1598.0,nan,nan,Locoregional Recurrence,"Other, specify",Vagina,613.0,Complete Remission/Response,nan,nan,0.0,1598.0,0.0,1598.0,1.0,613.0,1.0,613.0,2
TCGA-B5-A1N2-01,TCGA-B5-A1N2,UCEC,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC1,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25612.0,Dead,WITH TUMOR,nan,954.0,nan,Distant Metastasis,Brain,nan,804.0,Complete Remission/Response,nan,nan,1.0,954.0,1.0,954.0,1.0,804.0,1.0,804.0,1
TCGA-B5-A3F9-01,TCGA-B5-A3F9,UCEC,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20523.0,Alive,TUMOR FREE,4155.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4155.0,0.0,4155.0,nan,nan,0.0,4155.0,0
TCGA-B5-A3FA-01,TCGA-B5-A3FA,UCEC,73.0,FEMALE,WHITE,nan,Stage IC,Endometrioid endometrial adenocarcinoma,G3,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26850.0,Alive,TUMOR FREE,2929.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2929.0,0.0,2929.0,nan,nan,0.0,2929.0,0
TCGA-B5-A3FB-01,TCGA-B5-A3FB,UCEC,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26779.0,Alive,TUMOR FREE,2844.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2844.0,0.0,2844.0,nan,nan,0.0,2844.0,0
TCGA-B5-A3FC-01,TCGA-B5-A3FC,UCEC,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage II,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19422.0,Alive,TUMOR FREE,2185.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2185.0,0.0,2185.0,nan,nan,0.0,2185.0,0
TCGA-B5-A3FD-01,TCGA-B5-A3FD,UCEC,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2009.0,Indeterminate (neither Pre or Postmenopausal),-25813.0,Dead,TUMOR FREE,nan,1197.0,nan,Locoregional Recurrence,"Other, specify",endometrium,562.0,nan,nan,nan,1.0,1197.0,0.0,1197.0,nan,nan,1.0,562.0,1
TCGA-B5-A3FH-01,TCGA-B5-A3FH,UCEC,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27221.0,Alive,TUMOR FREE,841.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,841.0,0.0,841.0,0.0,841.0,0.0,841.0,0
TCGA-B5-A3S1-01,TCGA-B5-A3S1,UCEC,71.0,FEMALE,WHITE,nan,Stage IIIC1,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26031.0,Alive,WITH TUMOR,902.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,902.0,0.0,902.0,0.0,902.0,0.0,902.0,2
TCGA-B5-A5OC-01,TCGA-B5-A5OC,UCEC,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIB,Endometrioid endometrial adenocarcinoma,G3,2011.0,nan,-26109.0,Alive,TUMOR FREE,1249.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1249.0,0.0,1249.0,nan,nan,0.0,1249.0,0
TCGA-B5-A5OD-01,TCGA-B5-A5OD,UCEC,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous endometrial adenocarcinoma,G3,2011.0,nan,-24775.0,Alive,TUMOR FREE,1038.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1038.0,0.0,1038.0,nan,nan,0.0,1038.0,0
TCGA-B5-A5OE-01,TCGA-B5-A5OE,UCEC,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC2,Serous endometrial adenocarcinoma,G3,2011.0,nan,-24905.0,Alive,TUMOR FREE,1063.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1063.0,0.0,1063.0,nan,nan,0.0,1063.0,0
TCGA-BG-A0LW-01,TCGA-BG-A0LW,UCEC,47.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010.0,Indeterminate (neither Pre or Postmenopausal),-17369.0,Alive,TUMOR FREE,566.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,566.0,0.0,566.0,0.0,566.0,0.0,566.0,2
TCGA-BG-A0LX-01,TCGA-BG-A0LX,UCEC,57.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20928.0,Alive,TUMOR FREE,614.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,614.0,0.0,614.0,0.0,614.0,0.0,614.0,2
TCGA-BG-A0M0-01,TCGA-BG-A0M0,UCEC,66.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24427.0,Alive,TUMOR FREE,588.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,588.0,0.0,588.0,0.0,588.0,0.0,588.0,2
TCGA-BG-A0M2-01,TCGA-BG-A0M2,UCEC,62.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22822.0,Alive,TUMOR FREE,637.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,637.0,0.0,637.0,0.0,637.0,0.0,637.0,2
TCGA-BG-A0M3-01,TCGA-BG-A0M3,UCEC,74.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27183.0,Alive,TUMOR FREE,1071.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1071.0,0.0,1071.0,0.0,1071.0,0.0,1071.0,2
TCGA-BG-A0M4-01,TCGA-BG-A0M4,UCEC,60.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22090.0,Alive,TUMOR FREE,2167.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2167.0,0.0,2167.0,0.0,2167.0,0.0,2167.0,2
TCGA-BG-A0M6-01,TCGA-BG-A0M6,UCEC,73.0,FEMALE,WHITE,nan,Stage IIIC2,Serous endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26666.0,Dead,TUMOR FREE,nan,671.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,671.0,0.0,671.0,0.0,671.0,0.0,671.0,0
TCGA-BG-A0M7-01,TCGA-BG-A0M7,UCEC,60.0,FEMALE,WHITE,nan,Stage IIIC1,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22096.0,Alive,TUMOR FREE,1937.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1937.0,0.0,1937.0,0.0,1937.0,0.0,1937.0,2
TCGA-BG-A0M8-01,TCGA-BG-A0M8,UCEC,50.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2008.0,Indeterminate (neither Pre or Postmenopausal),-18308.0,Alive,TUMOR FREE,2020.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2020.0,0.0,2020.0,0.0,2020.0,0.0,2020.0,2
TCGA-BG-A0M9-01,TCGA-BG-A0M9,UCEC,73.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26708.0,Alive,TUMOR FREE,2270.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2270.0,0.0,2270.0,0.0,2270.0,0.0,2270.0,2
TCGA-BG-A0MA-01,TCGA-BG-A0MA,UCEC,60.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22036.0,Dead,WITH TUMOR,nan,326.0,nan,Metastatic,Bone,nan,70.0,Progressive Disease,nan,nan,1.0,326.0,1.0,326.0,nan,nan,1.0,70.0,1
TCGA-BG-A0MA-11,TCGA-BG-A0MA,UCEC,60.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22036.0,Dead,WITH TUMOR,nan,326.0,nan,Metastatic,Bone,nan,70.0,Progressive Disease,nan,nan,1.0,326.0,1.0,326.0,nan,nan,1.0,70.0,1
TCGA-BG-A0MC-01,TCGA-BG-A0MC,UCEC,74.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27136.0,Alive,TUMOR FREE,1263.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1263.0,0.0,1263.0,0.0,1263.0,0.0,1263.0,2
TCGA-BG-A0MG-01,TCGA-BG-A0MG,UCEC,73.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26957.0,Alive,TUMOR FREE,1477.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1477.0,0.0,1477.0,0.0,1477.0,0.0,1477.0,2
TCGA-BG-A0MH-01,TCGA-BG-A0MH,UCEC,61.0,FEMALE,WHITE,nan,Stage IC,Endometrioid endometrial adenocarcinoma,G2,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22475.0,Alive,TUMOR FREE,1930.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1930.0,0.0,1930.0,0.0,1930.0,0.0,1930.0,2
TCGA-BG-A0MI-01,TCGA-BG-A0MI,UCEC,83.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30334.0,Dead,TUMOR FREE,nan,714.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,714.0,0.0,714.0,nan,nan,0.0,714.0,1
TCGA-BG-A0MK-01,TCGA-BG-A0MK,UCEC,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIB,Endometrioid endometrial adenocarcinoma,G3,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19034.0,Dead,WITH TUMOR,nan,1317.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,1317.0,1.0,1317.0,nan,nan,1.0,1317.0,1
TCGA-BG-A0MO-01,TCGA-BG-A0MO,UCEC,63.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23287.0,Alive,TUMOR FREE,1309.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1309.0,0.0,1309.0,0.0,1309.0,0.0,1309.0,0
TCGA-BG-A0MQ-01,TCGA-BG-A0MQ,UCEC,71.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26284.0,Alive,WITH TUMOR,1817.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1817.0,0.0,1817.0,nan,nan,0.0,1817.0,2
TCGA-BG-A0MS-01,TCGA-BG-A0MS,UCEC,53.0,FEMALE,WHITE,nan,Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19547.0,Alive,TUMOR FREE,1882.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1882.0,0.0,1882.0,0.0,1882.0,0.0,1882.0,2
TCGA-BG-A0MT-01,TCGA-BG-A0MT,UCEC,64.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23574.0,Alive,TUMOR FREE,644.0,nan,nan,Locoregional Disease,"Other, specify",locally in the endometrium,565.0,Partial Remission/Response,nan,nan,0.0,644.0,0.0,644.0,nan,nan,1.0,565.0,2
TCGA-BG-A0MU-01,TCGA-BG-A0MU,UCEC,78.0,FEMALE,WHITE,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28621.0,Alive,TUMOR FREE,617.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,617.0,0.0,617.0,0.0,617.0,0.0,617.0,2
TCGA-BG-A0RY-01,TCGA-BG-A0RY,UCEC,68.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24952.0,Alive,TUMOR FREE,469.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,469.0,0.0,469.0,0.0,469.0,0.0,469.0,2
TCGA-BG-A0VT-01,TCGA-BG-A0VT,UCEC,56.0,FEMALE,WHITE,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G2,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20602.0,Alive,TUMOR FREE,1568.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1568.0,0.0,1568.0,0.0,1568.0,0.0,1568.0,2
TCGA-BG-A0VV-01,TCGA-BG-A0VV,UCEC,53.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19581.0,Alive,TUMOR FREE,1553.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1553.0,0.0,1553.0,0.0,1553.0,0.0,1553.0,2
TCGA-BG-A0VW-01,TCGA-BG-A0VW,UCEC,77.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28383.0,Alive,TUMOR FREE,1582.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1582.0,0.0,1582.0,0.0,1582.0,0.0,1582.0,2
TCGA-BG-A0VX-01,TCGA-BG-A0VX,UCEC,58.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21425.0,Alive,TUMOR FREE,1043.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1043.0,0.0,1043.0,0.0,1043.0,0.0,1043.0,2
TCGA-BG-A0VZ-01,TCGA-BG-A0VZ,UCEC,58.0,FEMALE,WHITE,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21414.0,Alive,TUMOR FREE,1601.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1601.0,0.0,1601.0,0.0,1601.0,0.0,1601.0,2
TCGA-BG-A0W1-01,TCGA-BG-A0W1,UCEC,89.0,FEMALE,WHITE,nan,Stage II,Endometrioid endometrial adenocarcinoma,G2,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32750.0,Alive,TUMOR FREE,1607.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1607.0,0.0,1607.0,0.0,1607.0,0.0,1607.0,2
TCGA-BG-A0W2-01,TCGA-BG-A0W2,UCEC,57.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20998.0,Alive,TUMOR FREE,1721.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1721.0,0.0,1721.0,0.0,1721.0,0.0,1721.0,2
TCGA-BG-A0YU-01,TCGA-BG-A0YU,UCEC,37.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13644.0,Alive,TUMOR FREE,451.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,451.0,0.0,451.0,0.0,451.0,0.0,451.0,2
TCGA-BG-A0YV-01,TCGA-BG-A0YV,UCEC,67.0,FEMALE,WHITE,nan,Stage IIIA,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24567.0,Alive,TUMOR FREE,382.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,382.0,0.0,382.0,0.0,382.0,0.0,382.0,0
TCGA-BG-A186-01,TCGA-BG-A186,UCEC,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G2,2010.0,nan,-22370.0,Alive,TUMOR FREE,419.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,419.0,0.0,419.0,0.0,419.0,0.0,419.0,2
TCGA-BG-A187-01,TCGA-BG-A187,UCEC,65.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010.0,nan,-24099.0,Alive,TUMOR FREE,448.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,448.0,0.0,448.0,0.0,448.0,0.0,448.0,2
TCGA-BG-A18A-01,TCGA-BG-A18A,UCEC,74.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27086.0,Alive,TUMOR FREE,426.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,426.0,0.0,426.0,0.0,426.0,0.0,426.0,2
TCGA-BG-A18B-01,TCGA-BG-A18B,UCEC,53.0,FEMALE,WHITE,nan,Stage I,Endometrioid endometrial adenocarcinoma,G2,2010.0,Peri (6-12 months since last menstrual period),-19550.0,Alive,TUMOR FREE,470.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,470.0,0.0,470.0,0.0,470.0,0.0,470.0,2
TCGA-BG-A18C-01,TCGA-BG-A18C,UCEC,72.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010.0,nan,-26602.0,Alive,TUMOR FREE,470.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,470.0,0.0,470.0,0.0,470.0,0.0,470.0,2
TCGA-BG-A220-01,TCGA-BG-A220,UCEC,69.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,nan,-25346.0,Alive,TUMOR FREE,434.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,434.0,0.0,434.0,0.0,434.0,0.0,434.0,2
TCGA-BG-A221-01,TCGA-BG-A221,UCEC,84.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30960.0,Alive,TUMOR FREE,55.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,55.0,0.0,55.0,0.0,55.0,0.0,55.0,2
TCGA-BG-A222-01,TCGA-BG-A222,UCEC,49.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,nan,-18220.0,Alive,TUMOR FREE,291.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,291.0,0.0,291.0,0.0,291.0,0.0,291.0,0
TCGA-BG-A2AD-01,TCGA-BG-A2AD,UCEC,63.0,FEMALE,WHITE,nan,Stage IIIB,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23064.0,Alive,TUMOR FREE,609.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,609.0,0.0,609.0,0.0,609.0,0.0,609.0,0
TCGA-BG-A2AD-11,TCGA-BG-A2AD,UCEC,63.0,FEMALE,WHITE,nan,Stage IIIB,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23064.0,Alive,TUMOR FREE,609.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,609.0,0.0,609.0,0.0,609.0,0.0,609.0,0
TCGA-BG-A2AE-01,TCGA-BG-A2AE,UCEC,57.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2011.0,Peri (6-12 months since last menstrual period),-21069.0,Alive,TUMOR FREE,721.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,721.0,0.0,721.0,0.0,721.0,0.0,721.0,0
TCGA-BG-A2AE-11,TCGA-BG-A2AE,UCEC,57.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2011.0,Peri (6-12 months since last menstrual period),-21069.0,Alive,TUMOR FREE,721.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,721.0,0.0,721.0,0.0,721.0,0.0,721.0,0
TCGA-BG-A2L7-01,TCGA-BG-A2L7,UCEC,68.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,nan,-25091.0,Alive,TUMOR FREE,612.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,612.0,0.0,612.0,0.0,612.0,0.0,612.0,0
TCGA-BG-A2L7-11,TCGA-BG-A2L7,UCEC,68.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,nan,-25091.0,Alive,TUMOR FREE,612.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,612.0,0.0,612.0,0.0,612.0,0.0,612.0,0
TCGA-BG-A3EW-01,TCGA-BG-A3EW,UCEC,62.0,FEMALE,WHITE,nan,Stage III,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22705.0,Alive,TUMOR FREE,344.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,344.0,0.0,344.0,0.0,344.0,0.0,344.0,0
TCGA-BG-A3EW-11,TCGA-BG-A3EW,UCEC,62.0,FEMALE,WHITE,nan,Stage III,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22705.0,Alive,TUMOR FREE,344.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,344.0,0.0,344.0,0.0,344.0,0.0,344.0,0
TCGA-BG-A3PP-01,TCGA-BG-A3PP,UCEC,82.0,FEMALE,WHITE,nan,Stage II,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30227.0,Alive,WITH TUMOR,681.0,nan,nan,Locoregional Recurrence,"Other, specify",Vagina apex,665.0,Progressive Disease,nan,nan,0.0,681.0,0.0,681.0,nan,nan,1.0,665.0,2
TCGA-BG-A3PP-11,TCGA-BG-A3PP,UCEC,82.0,FEMALE,WHITE,nan,Stage II,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30227.0,Alive,WITH TUMOR,681.0,nan,nan,Locoregional Recurrence,"Other, specify",Vagina apex,665.0,Progressive Disease,nan,nan,0.0,681.0,0.0,681.0,nan,nan,1.0,665.0,2
TCGA-BK-A0C9-01,TCGA-BK-A0C9,UCEC,57.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20876.0,Alive,TUMOR FREE,1092.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1092.0,0.0,1092.0,0.0,1092.0,0.0,1092.0,2
TCGA-BK-A0CA-01,TCGA-BK-A0CA,UCEC,61.0,FEMALE,WHITE,nan,Stage IIIC,Mixed serous and endometrioid,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22378.0,Alive,TUMOR FREE,1064.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1064.0,0.0,1064.0,0.0,1064.0,0.0,1064.0,0
TCGA-BK-A0CB-01,TCGA-BK-A0CB,UCEC,60.0,FEMALE,WHITE,nan,Stage IIIC,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21930.0,Alive,TUMOR FREE,1092.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1092.0,0.0,1092.0,0.0,1092.0,0.0,1092.0,2
TCGA-BK-A0CB-11,TCGA-BK-A0CB,UCEC,60.0,FEMALE,WHITE,nan,Stage IIIC,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21930.0,Alive,TUMOR FREE,1092.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1092.0,0.0,1092.0,0.0,1092.0,0.0,1092.0,2
TCGA-BK-A0CC-01,TCGA-BK-A0CC,UCEC,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25479.0,Alive,WITH TUMOR,1067.0,nan,nan,Locoregional Recurrence,"Other, specify",Right Pelvic Mass,1010.0,Complete Remission/Response,nan,nan,0.0,1067.0,0.0,1067.0,1.0,1010.0,1.0,1010.0,2
TCGA-BK-A139-02,TCGA-BK-A139,UCEC,74.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27077.0,Dead,WITH TUMOR,nan,943.0,nan,Locoregional Recurrence,"Other, specify",Paravaginal mass involving the bladder and rectal walls,684.0,[Discrepancy],nan,nan,1.0,943.0,1.0,943.0,nan,nan,1.0,684.0,1
TCGA-BK-A139-01,TCGA-BK-A139,UCEC,74.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27077.0,Dead,WITH TUMOR,nan,943.0,nan,Locoregional Recurrence,"Other, specify",Paravaginal mass involving the bladder and rectal walls,684.0,[Discrepancy],nan,nan,1.0,943.0,1.0,943.0,nan,nan,1.0,684.0,1
TCGA-BK-A13B-01,TCGA-BK-A13B,UCEC,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21493.0,Alive,WITH TUMOR,966.0,nan,nan,Locoregional Recurrence,"Other, specify",Vaginal,760.0,Complete Remission/Response,nan,nan,0.0,966.0,0.0,966.0,1.0,760.0,1.0,760.0,2
TCGA-BK-A13C-01,TCGA-BK-A13C,UCEC,47.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010.0,Peri (6-12 months since last menstrual period),-17317.0,Alive,TUMOR FREE,760.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,760.0,0.0,760.0,0.0,760.0,0.0,760.0,2
TCGA-BK-A13C-11,TCGA-BK-A13C,UCEC,47.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010.0,Peri (6-12 months since last menstrual period),-17317.0,Alive,TUMOR FREE,760.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,760.0,0.0,760.0,0.0,760.0,0.0,760.0,2
TCGA-BK-A26L-01,TCGA-BK-A26L,UCEC,71.0,FEMALE,WHITE,nan,Stage IIIC1,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26002.0,Alive,TUMOR FREE,734.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,734.0,0.0,734.0,0.0,734.0,0.0,734.0,0
TCGA-BK-A4ZD-01,TCGA-BK-A4ZD,UCEC,42.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15536.0,Alive,TUMOR FREE,506.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,506.0,0.0,506.0,0.0,506.0,0.0,506.0,2
TCGA-BK-A4ZD-11,TCGA-BK-A4ZD,UCEC,42.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15536.0,Alive,TUMOR FREE,506.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,506.0,0.0,506.0,0.0,506.0,0.0,506.0,2
TCGA-BK-A56F-01,TCGA-BK-A56F,UCEC,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27523.0,Alive,TUMOR FREE,401.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,401.0,0.0,401.0,0.0,401.0,0.0,401.0,2
TCGA-BK-A6W3-01,TCGA-BK-A6W3,UCEC,34.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage II,Endometrioid endometrial adenocarcinoma,G2,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12590.0,Alive,TUMOR FREE,305.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,305.0,0.0,305.0,0.0,305.0,0.0,305.0,2
TCGA-BK-A6W4-01,TCGA-BK-A6W4,UCEC,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22766.0,Alive,TUMOR FREE,300.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,300.0,0.0,300.0,0.0,300.0,0.0,300.0,2
TCGA-BS-A0T9-01,TCGA-BS-A0T9,UCEC,39.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,nan,Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14253.0,Dead,WITH TUMOR,nan,1428.0,nan,nan,nan,nan,634.0,Complete Remission/Response,nan,nan,1.0,1428.0,1.0,1428.0,nan,nan,1.0,634.0,1
TCGA-BS-A0TA-01,TCGA-BS-A0TA,UCEC,58.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,nan,Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21505.0,Dead,WITH TUMOR,nan,740.0,nan,nan,nan,nan,394.0,Stable Disease,nan,nan,1.0,740.0,1.0,740.0,nan,nan,1.0,394.0,1
TCGA-BS-A0TC-01,TCGA-BS-A0TC,UCEC,69.0,FEMALE,ASIAN,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25560.0,Alive,TUMOR FREE,2602.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2602.0,0.0,2602.0,0.0,2602.0,0.0,2602.0,2
TCGA-BS-A0TD-01,TCGA-BS-A0TD,UCEC,65.0,FEMALE,ASIAN,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23950.0,Alive,TUMOR FREE,2379.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2379.0,0.0,2379.0,0.0,2379.0,0.0,2379.0,2
TCGA-BS-A0TE-01,TCGA-BS-A0TE,UCEC,35.0,FEMALE,ASIAN,nan,Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2005.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12983.0,Dead,WITH TUMOR,nan,146.0,nan,nan,nan,nan,58.0,Progressive Disease,nan,nan,1.0,146.0,1.0,146.0,nan,nan,1.0,58.0,1
TCGA-BS-A0TG-01,TCGA-BS-A0TG,UCEC,60.0,FEMALE,WHITE,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G2,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22043.0,Alive,WITH TUMOR,2371.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2371.0,0.0,2371.0,0.0,2371.0,0.0,2371.0,2
TCGA-BS-A0TI-01,TCGA-BS-A0TI,UCEC,64.0,FEMALE,WHITE,nan,Stage IC,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23705.0,Alive,TUMOR FREE,1882.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1882.0,0.0,1882.0,0.0,1882.0,0.0,1882.0,2
TCGA-BS-A0TJ-01,TCGA-BS-A0TJ,UCEC,59.0,FEMALE,ASIAN,nan,Stage IC,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21663.0,Alive,TUMOR FREE,2068.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2068.0,0.0,2068.0,0.0,2068.0,0.0,2068.0,2
TCGA-BS-A0U5-01,TCGA-BS-A0U5,UCEC,76.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27945.0,Alive,TUMOR FREE,2935.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2935.0,0.0,2935.0,0.0,2935.0,0.0,2935.0,2
TCGA-BS-A0U7-01,TCGA-BS-A0U7,UCEC,63.0,FEMALE,WHITE,nan,Stage IC,Endometrioid endometrial adenocarcinoma,G2,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23166.0,Dead,TUMOR FREE,nan,935.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,935.0,0.0,935.0,0.0,935.0,0.0,935.0,2
TCGA-BS-A0U8-01,TCGA-BS-A0U8,UCEC,55.0,FEMALE,WHITE,nan,Stage IIIC,Endometrioid endometrial adenocarcinoma,G1,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20402.0,Alive,TUMOR FREE,2963.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2963.0,0.0,2963.0,0.0,2963.0,0.0,2963.0,2
TCGA-BS-A0U9-01,TCGA-BS-A0U9,UCEC,59.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,nan,Stage IIA,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21580.0,Alive,TUMOR FREE,2825.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2825.0,0.0,2825.0,0.0,2825.0,0.0,2825.0,2
TCGA-BS-A0UA-01,TCGA-BS-A0UA,UCEC,68.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24872.0,Alive,TUMOR FREE,3495.0,nan,nan,Locoregional Disease,"Other, specify",endometrium,520.0,Complete Remission/Response,nan,nan,0.0,3495.0,0.0,3495.0,1.0,520.0,1.0,520.0,2
TCGA-BS-A0UF-01,TCGA-BS-A0UF,UCEC,65.0,FEMALE,ASIAN,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23771.0,Alive,TUMOR FREE,2611.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2611.0,0.0,2611.0,0.0,2611.0,0.0,2611.0,2
TCGA-BS-A0UJ-01,TCGA-BS-A0UJ,UCEC,68.0,FEMALE,ASIAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25149.0,Alive,TUMOR FREE,2506.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2506.0,0.0,2506.0,0.0,2506.0,0.0,2506.0,2
TCGA-BS-A0UL-01,TCGA-BS-A0UL,UCEC,54.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2004.0,Peri (6-12 months since last menstrual period),-19982.0,Alive,TUMOR FREE,2481.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2481.0,0.0,2481.0,0.0,2481.0,0.0,2481.0,2
TCGA-BS-A0UM-01,TCGA-BS-A0UM,UCEC,64.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23400.0,Alive,WITH TUMOR,2644.0,nan,nan,Metastatic,Brain,nan,1454.0,Complete Remission/Response,nan,nan,0.0,2644.0,0.0,2644.0,1.0,1454.0,1.0,1454.0,2
TCGA-BS-A0UT-01,TCGA-BS-A0UT,UCEC,62.0,FEMALE,ASIAN,nan,Stage IIB,Endometrioid endometrial adenocarcinoma,G2,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22775.0,Alive,TUMOR FREE,2212.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2212.0,0.0,2212.0,0.0,2212.0,0.0,2212.0,2
TCGA-BS-A0UV-01,TCGA-BS-A0UV,UCEC,55.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,nan,Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20266.0,Alive,TUMOR FREE,2228.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2228.0,0.0,2228.0,0.0,2228.0,0.0,2228.0,2
TCGA-BS-A0V4-01,TCGA-BS-A0V4,UCEC,56.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20777.0,Alive,TUMOR FREE,1810.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1810.0,0.0,1810.0,0.0,1810.0,0.0,1810.0,2
TCGA-BS-A0V6-01,TCGA-BS-A0V6,UCEC,55.0,FEMALE,ASIAN,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20369.0,Alive,TUMOR FREE,2725.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2725.0,0.0,2725.0,0.0,2725.0,0.0,2725.0,2
TCGA-BS-A0V7-01,TCGA-BS-A0V7,UCEC,48.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17810.0,Alive,TUMOR FREE,1934.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1934.0,0.0,1934.0,0.0,1934.0,0.0,1934.0,2
TCGA-BS-A0V8-01,TCGA-BS-A0V8,UCEC,68.0,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,nan,Stage IIB,Endometrioid endometrial adenocarcinoma,G2,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24981.0,Alive,TUMOR FREE,2544.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2544.0,0.0,2544.0,0.0,2544.0,0.0,2544.0,2
TCGA-BS-A0VI-01,TCGA-BS-A0VI,UCEC,58.0,FEMALE,WHITE,nan,Stage IIB,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21198.0,Alive,TUMOR FREE,2646.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2646.0,0.0,2646.0,0.0,2646.0,0.0,2646.0,2
TCGA-BS-A0WQ-01,TCGA-BS-A0WQ,UCEC,55.0,FEMALE,ASIAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20131.0,Alive,TUMOR FREE,2022.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2022.0,0.0,2022.0,0.0,2022.0,0.0,2022.0,2
TCGA-D1-A0ZN-01,TCGA-D1-A0ZN,UCEC,60.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009.0,Peri (6-12 months since last menstrual period),-22026.0,Alive,TUMOR FREE,512.0,nan,nan,New Primary Tumor,"Other, specify",Breast left,448.0,Complete Remission/Response,nan,nan,0.0,512.0,0.0,512.0,0.0,512.0,1.0,448.0,2
TCGA-D1-A0ZO-01,TCGA-D1-A0ZO,UCEC,75.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27482.0,Alive,TUMOR FREE,602.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,602.0,0.0,602.0,0.0,602.0,0.0,602.0,2
TCGA-D1-A0ZP-01,TCGA-D1-A0ZP,UCEC,59.0,FEMALE,WHITE,nan,Stage IVA,Serous endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21581.0,Alive,TUMOR FREE,911.0,nan,nan,Locoregional Disease,"Other, specify",Recurrent endometrial carcinoma in retriponeal lymphnodes,629.0,Complete Remission/Response,nan,nan,0.0,911.0,0.0,911.0,nan,nan,1.0,629.0,2
TCGA-D1-A0ZQ-01,TCGA-D1-A0ZQ,UCEC,90.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32873.0,Alive,TUMOR FREE,260.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,260.0,0.0,260.0,0.0,260.0,0.0,260.0,2
TCGA-D1-A0ZR-01,TCGA-D1-A0ZR,UCEC,57.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Indeterminate (neither Pre or Postmenopausal),-21157.0,Alive,TUMOR FREE,17.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,17.0,0.0,17.0,0.0,17.0,0.0,17.0,2
TCGA-D1-A0ZS-01,TCGA-D1-A0ZS,UCEC,54.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19821.0,Alive,TUMOR FREE,148.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,148.0,0.0,148.0,0.0,148.0,0.0,148.0,2
TCGA-D1-A0ZU-01,TCGA-D1-A0ZU,UCEC,34.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12458.0,Alive,TUMOR FREE,872.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,872.0,0.0,872.0,0.0,872.0,0.0,872.0,2
TCGA-D1-A0ZV-01,TCGA-D1-A0ZV,UCEC,58.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21374.0,Alive,TUMOR FREE,728.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,728.0,0.0,728.0,0.0,728.0,0.0,728.0,2
TCGA-D1-A0ZZ-01,TCGA-D1-A0ZZ,UCEC,80.0,FEMALE,WHITE,nan,Stage IB,Mixed serous and endometrioid,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29420.0,Alive,TUMOR FREE,686.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,686.0,0.0,686.0,0.0,686.0,0.0,686.0,2
TCGA-D1-A101-01,TCGA-D1-A101,UCEC,60.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22078.0,Alive,TUMOR FREE,53.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,53.0,0.0,53.0,0.0,53.0,0.0,53.0,2
TCGA-D1-A102-01,TCGA-D1-A102,UCEC,49.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Peri (6-12 months since last menstrual period),-17991.0,Alive,TUMOR FREE,135.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,135.0,0.0,135.0,0.0,135.0,0.0,135.0,2
TCGA-D1-A103-01,TCGA-D1-A103,UCEC,87.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31841.0,Alive,TUMOR FREE,669.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,669.0,0.0,669.0,0.0,669.0,0.0,669.0,2
TCGA-D1-A15V-01,TCGA-D1-A15V,UCEC,68.0,FEMALE,WHITE,nan,Stage IB,Serous endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24886.0,Alive,TUMOR FREE,1201.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1201.0,0.0,1201.0,0.0,1201.0,0.0,1201.0,0
TCGA-D1-A15W-01,TCGA-D1-A15W,UCEC,58.0,FEMALE,WHITE,nan,Stage IIIC,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21545.0,Alive,TUMOR FREE,915.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,915.0,0.0,915.0,0.0,915.0,0.0,915.0,2
TCGA-D1-A15X-01,TCGA-D1-A15X,UCEC,45.0,FEMALE,WHITE,nan,Stage IA,Serous endometrial adenocarcinoma,High Grade,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16532.0,Alive,TUMOR FREE,909.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,909.0,0.0,909.0,0.0,909.0,0.0,909.0,0
TCGA-D1-A15Z-01,TCGA-D1-A15Z,UCEC,72.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26638.0,Dead,TUMOR FREE,nan,58.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,58.0,0.0,58.0,0.0,58.0,0.0,58.0,2
TCGA-D1-A160-01,TCGA-D1-A160,UCEC,70.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25673.0,Alive,TUMOR FREE,112.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,112.0,0.0,112.0,0.0,112.0,0.0,112.0,2
TCGA-D1-A161-01,TCGA-D1-A161,UCEC,78.0,FEMALE,WHITE,nan,Stage IC,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28695.0,Alive,TUMOR FREE,892.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,892.0,0.0,892.0,0.0,892.0,0.0,892.0,2
TCGA-D1-A162-01,TCGA-D1-A162,UCEC,69.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25543.0,Alive,TUMOR FREE,1145.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1145.0,0.0,1145.0,0.0,1145.0,0.0,1145.0,2
TCGA-D1-A163-01,TCGA-D1-A163,UCEC,50.0,FEMALE,WHITE,nan,Stage IIIC,Endometrioid endometrial adenocarcinoma,G2,2008.0,Peri (6-12 months since last menstrual period),-18604.0,Alive,TUMOR FREE,991.0,nan,nan,Metastatic,"Other, specify",Paraaortic retroperitoneal lymphnode,223.0,Complete Remission/Response,nan,nan,0.0,991.0,0.0,991.0,1.0,223.0,1.0,223.0,2
TCGA-D1-A165-01,TCGA-D1-A165,UCEC,64.0,FEMALE,WHITE,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23526.0,Alive,TUMOR FREE,20.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,20.0,0.0,20.0,0.0,20.0,0.0,20.0,2
TCGA-D1-A167-01,TCGA-D1-A167,UCEC,70.0,FEMALE,WHITE,nan,Stage IC,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25575.0,Alive,TUMOR FREE,478.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,478.0,0.0,478.0,0.0,478.0,0.0,478.0,2
TCGA-D1-A168-01,TCGA-D1-A168,UCEC,67.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24586.0,Alive,TUMOR FREE,1098.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1098.0,0.0,1098.0,0.0,1098.0,0.0,1098.0,2
TCGA-D1-A169-01,TCGA-D1-A169,UCEC,63.0,FEMALE,WHITE,nan,Stage IV,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23238.0,Alive,WITH TUMOR,1135.0,nan,nan,Metastatic,"Other, specify",Bladder nodule,519.0,Complete Remission/Response,nan,nan,0.0,1135.0,0.0,1135.0,nan,nan,1.0,519.0,2
TCGA-D1-A16B-01,TCGA-D1-A16B,UCEC,64.0,FEMALE,WHITE,nan,Stage IC,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23450.0,Alive,TUMOR FREE,1106.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1106.0,0.0,1106.0,0.0,1106.0,0.0,1106.0,2
TCGA-D1-A16D-01,TCGA-D1-A16D,UCEC,49.0,FEMALE,WHITE,nan,Stage IC,Endometrioid endometrial adenocarcinoma,G2,2008.0,Peri (6-12 months since last menstrual period),-17933.0,Alive,TUMOR FREE,1141.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1141.0,0.0,1141.0,0.0,1141.0,0.0,1141.0,2
TCGA-D1-A16E-01,TCGA-D1-A16E,UCEC,73.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26859.0,Alive,TUMOR FREE,1119.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1119.0,0.0,1119.0,0.0,1119.0,0.0,1119.0,2
TCGA-D1-A16F-01,TCGA-D1-A16F,UCEC,60.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22242.0,Alive,TUMOR FREE,80.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,80.0,0.0,80.0,0.0,80.0,0.0,80.0,2
TCGA-D1-A16G-01,TCGA-D1-A16G,UCEC,74.0,FEMALE,WHITE,nan,Stage IV,Serous endometrial adenocarcinoma,High Grade,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27065.0,Dead,WITH TUMOR,nan,834.0,nan,Locoregional Disease,"Other, specify",Lymph nodes,642.0,Complete Remission/Response,nan,nan,1.0,834.0,1.0,834.0,nan,nan,1.0,642.0,1
TCGA-D1-A16I-01,TCGA-D1-A16I,UCEC,62.0,FEMALE,WHITE,nan,Stage IC,Serous endometrial adenocarcinoma,High Grade,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22836.0,Dead,TUMOR FREE,nan,350.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,350.0,0.0,350.0,0.0,350.0,0.0,350.0,0
TCGA-D1-A16J-01,TCGA-D1-A16J,UCEC,61.0,FEMALE,WHITE,nan,Stage IIB,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22319.0,Alive,TUMOR FREE,910.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,910.0,0.0,910.0,0.0,910.0,0.0,910.0,2
TCGA-D1-A16N-01,TCGA-D1-A16N,UCEC,51.0,FEMALE,WHITE,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2009.0,Peri (6-12 months since last menstrual period),-18787.0,Alive,TUMOR FREE,945.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,945.0,0.0,945.0,0.0,945.0,0.0,945.0,2
TCGA-D1-A16O-01,TCGA-D1-A16O,UCEC,44.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16114.0,Alive,TUMOR FREE,1023.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1023.0,0.0,1023.0,0.0,1023.0,0.0,1023.0,2
TCGA-D1-A16Q-01,TCGA-D1-A16Q,UCEC,54.0,FEMALE,WHITE,nan,Stage II,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19873.0,Alive,TUMOR FREE,324.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,324.0,0.0,324.0,0.0,324.0,0.0,324.0,2
TCGA-D1-A16R-01,TCGA-D1-A16R,UCEC,39.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Indeterminate (neither Pre or Postmenopausal),-14465.0,Alive,TUMOR FREE,21.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,21.0,0.0,21.0,0.0,21.0,0.0,21.0,2
TCGA-D1-A16S-01,TCGA-D1-A16S,UCEC,70.0,FEMALE,WHITE,nan,Stage IIIC,Serous endometrial adenocarcinoma,High Grade,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25690.0,Alive,TUMOR FREE,568.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,568.0,0.0,568.0,0.0,568.0,0.0,568.0,0
TCGA-D1-A16V-01,TCGA-D1-A16V,UCEC,78.0,FEMALE,WHITE,nan,Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28635.0,Dead,TUMOR FREE,nan,120.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,120.0,0.0,120.0,0.0,120.0,0.0,120.0,2
TCGA-D1-A16X-01,TCGA-D1-A16X,UCEC,54.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19799.0,Alive,TUMOR FREE,111.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,111.0,0.0,111.0,0.0,111.0,0.0,111.0,2
TCGA-D1-A16Y-01,TCGA-D1-A16Y,UCEC,56.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20455.0,Alive,TUMOR FREE,532.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,532.0,0.0,532.0,0.0,532.0,0.0,532.0,2
TCGA-D1-A174-01,TCGA-D1-A174,UCEC,51.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Indeterminate (neither Pre or Postmenopausal),-18702.0,Alive,TUMOR FREE,594.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,594.0,0.0,594.0,0.0,594.0,0.0,594.0,2
TCGA-D1-A175-01,TCGA-D1-A175,UCEC,48.0,FEMALE,WHITE,nan,Stage IC,Endometrioid endometrial adenocarcinoma,G3,2009.0,Indeterminate (neither Pre or Postmenopausal),-17802.0,Alive,TUMOR FREE,202.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,202.0,0.0,202.0,0.0,202.0,0.0,202.0,2
TCGA-D1-A176-01,TCGA-D1-A176,UCEC,67.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24521.0,Alive,TUMOR FREE,917.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,917.0,0.0,917.0,0.0,917.0,0.0,917.0,2
TCGA-D1-A177-01,TCGA-D1-A177,UCEC,70.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25602.0,Alive,TUMOR FREE,548.0,nan,nan,Locoregional Disease,"Other, specify",paraaortic lymph nodes,347.0,Complete Remission/Response,nan,nan,0.0,548.0,0.0,548.0,1.0,347.0,1.0,347.0,2
TCGA-D1-A179-01,TCGA-D1-A179,UCEC,76.0,FEMALE,WHITE,nan,Stage IIIC,Serous endometrial adenocarcinoma,High Grade,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28037.0,Dead,WITH TUMOR,nan,448.0,nan,Metastatic,Lung,nan,427.0,Complete Remission/Response,nan,nan,1.0,448.0,1.0,448.0,1.0,427.0,1.0,427.0,1
TCGA-D1-A17A-01,TCGA-D1-A17A,UCEC,59.0,FEMALE,WHITE,nan,Stage IIA,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21560.0,Alive,TUMOR FREE,48.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,48.0,0.0,48.0,0.0,48.0,0.0,48.0,2
TCGA-D1-A17B-01,TCGA-D1-A17B,UCEC,69.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25504.0,Alive,TUMOR FREE,213.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,213.0,0.0,213.0,0.0,213.0,0.0,213.0,2
TCGA-D1-A17C-01,TCGA-D1-A17C,UCEC,78.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28571.0,Alive,TUMOR FREE,30.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,30.0,0.0,30.0,0.0,30.0,0.0,30.0,2
TCGA-D1-A17D-01,TCGA-D1-A17D,UCEC,58.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21441.0,Alive,TUMOR FREE,926.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,926.0,0.0,926.0,0.0,926.0,0.0,926.0,2
TCGA-D1-A17F-01,TCGA-D1-A17F,UCEC,68.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25116.0,Alive,TUMOR FREE,39.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,39.0,0.0,39.0,0.0,39.0,0.0,39.0,2
TCGA-D1-A17H-01,TCGA-D1-A17H,UCEC,61.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22389.0,Alive,TUMOR FREE,852.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,852.0,0.0,852.0,0.0,852.0,0.0,852.0,2
TCGA-D1-A17K-01,TCGA-D1-A17K,UCEC,74.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27283.0,Alive,TUMOR FREE,854.0,nan,nan,Locoregional Disease,"Other, specify","Vagina, apex",815.0,Complete Remission/Response,nan,nan,0.0,854.0,0.0,854.0,1.0,815.0,1.0,815.0,2
TCGA-D1-A17L-01,TCGA-D1-A17L,UCEC,81.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29899.0,Alive,TUMOR FREE,802.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,802.0,0.0,802.0,0.0,802.0,0.0,802.0,2
TCGA-D1-A17M-01,TCGA-D1-A17M,UCEC,56.0,FEMALE,WHITE,nan,Stage II,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20685.0,Alive,TUMOR FREE,311.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,311.0,0.0,311.0,0.0,311.0,0.0,311.0,2
TCGA-D1-A17N-01,TCGA-D1-A17N,UCEC,46.0,FEMALE,nan,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009.0,Peri (6-12 months since last menstrual period),-17045.0,Alive,TUMOR FREE,46.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,46.0,0.0,46.0,0.0,46.0,0.0,46.0,2
TCGA-D1-A17Q-01,TCGA-D1-A17Q,UCEC,54.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009.0,Peri (6-12 months since last menstrual period),-20015.0,Alive,TUMOR FREE,54.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,54.0,0.0,54.0,0.0,54.0,0.0,54.0,2
TCGA-D1-A17R-01,TCGA-D1-A17R,UCEC,58.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-21382.0,Dead,TUMOR FREE,nan,339.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,339.0,0.0,339.0,0.0,339.0,0.0,339.0,2
TCGA-D1-A17S-01,TCGA-D1-A17S,UCEC,59.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21794.0,Alive,TUMOR FREE,739.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,739.0,0.0,739.0,0.0,739.0,0.0,739.0,2
TCGA-D1-A17T-01,TCGA-D1-A17T,UCEC,67.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24652.0,Alive,TUMOR FREE,71.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,71.0,0.0,71.0,0.0,71.0,0.0,71.0,2
TCGA-D1-A17U-01,TCGA-D1-A17U,UCEC,53.0,FEMALE,WHITE,nan,Stage IIIC2,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19544.0,Alive,TUMOR FREE,697.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,697.0,0.0,697.0,0.0,697.0,0.0,697.0,2
TCGA-D1-A1NS-01,TCGA-D1-A1NS,UCEC,53.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19638.0,Alive,TUMOR FREE,43.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,43.0,0.0,43.0,0.0,43.0,0.0,43.0,2
TCGA-D1-A1NU-01,TCGA-D1-A1NU,UCEC,74.0,FEMALE,WHITE,nan,Stage IA,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27272.0,Alive,TUMOR FREE,402.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,402.0,0.0,402.0,0.0,402.0,0.0,402.0,0
TCGA-D1-A1NW-01,TCGA-D1-A1NW,UCEC,72.0,FEMALE,WHITE,nan,Stage IVB,Mixed serous and endometrioid,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26556.0,Alive,TUMOR FREE,22.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,22.0,0.0,22.0,nan,nan,0.0,22.0,2
TCGA-D1-A1NX-01,TCGA-D1-A1NX,UCEC,66.0,FEMALE,WHITE,nan,Stage IIIC,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24441.0,Alive,WITH TUMOR,555.0,nan,nan,Metastatic,"Other, specify",Supraclavicular lymphnodes,476.0,Complete Remission/Response,nan,nan,0.0,555.0,0.0,555.0,1.0,476.0,1.0,476.0,2
TCGA-D1-A1NY-01,TCGA-D1-A1NY,UCEC,67.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24683.0,Alive,TUMOR FREE,513.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,513.0,0.0,513.0,0.0,513.0,0.0,513.0,2
TCGA-D1-A1NZ-01,TCGA-D1-A1NZ,UCEC,60.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22027.0,Alive,TUMOR FREE,548.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,548.0,0.0,548.0,0.0,548.0,0.0,548.0,2
TCGA-D1-A1O0-01,TCGA-D1-A1O0,UCEC,77.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28162.0,Alive,TUMOR FREE,63.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,63.0,0.0,63.0,0.0,63.0,0.0,63.0,2
TCGA-D1-A1O5-01,TCGA-D1-A1O5,UCEC,61.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22580.0,Alive,TUMOR FREE,458.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,458.0,0.0,458.0,0.0,458.0,0.0,458.0,2
TCGA-D1-A1O7-01,TCGA-D1-A1O7,UCEC,60.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22037.0,Alive,TUMOR FREE,32.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,32.0,0.0,32.0,0.0,32.0,0.0,32.0,2
TCGA-D1-A1O8-01,TCGA-D1-A1O8,UCEC,70.0,FEMALE,WHITE,nan,Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25789.0,Dead,TUMOR FREE,nan,120.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,120.0,0.0,120.0,0.0,120.0,0.0,120.0,2
TCGA-D1-A2G0-01,TCGA-D1-A2G0,UCEC,70.0,FEMALE,WHITE,nan,Stage IB,Mixed serous and endometrioid,G3,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25573.0,Alive,TUMOR FREE,1484.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1484.0,0.0,1484.0,nan,nan,0.0,1484.0,0
TCGA-D1-A2G5-01,TCGA-D1-A2G5,UCEC,50.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18322.0,Alive,WITH TUMOR,1455.0,nan,nan,Distant Metastasis,"Other, specify",omentum,1122.0,Complete Remission/Response,nan,nan,0.0,1455.0,0.0,1455.0,1.0,1122.0,1.0,1122.0,2
TCGA-D1-A2G6-01,TCGA-D1-A2G6,UCEC,53.0,FEMALE,WHITE,nan,Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19547.0,Dead,WITH TUMOR,nan,258.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,258.0,1.0,258.0,nan,nan,1.0,258.0,1
TCGA-D1-A2G7-01,TCGA-D1-A2G7,UCEC,65.0,FEMALE,WHITE,nan,Stage IB,Serous endometrial adenocarcinoma,G3,2007.0,Peri (6-12 months since last menstrual period),-23913.0,Dead,TUMOR FREE,nan,1793.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,1793.0,0.0,1793.0,0.0,1793.0,0.0,1793.0,2
TCGA-D1-A3DA-01,TCGA-D1-A3DA,UCEC,77.0,FEMALE,WHITE,nan,Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28142.0,Alive,TUMOR FREE,483.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,483.0,0.0,483.0,0.0,483.0,0.0,483.0,0
TCGA-D1-A3DG-01,TCGA-D1-A3DG,UCEC,81.0,FEMALE,WHITE,nan,Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29771.0,Dead,TUMOR FREE,nan,130.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,130.0,0.0,130.0,nan,nan,0.0,130.0,0
TCGA-D1-A3DH-01,TCGA-D1-A3DH,UCEC,71.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25935.0,Alive,TUMOR FREE,573.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,573.0,0.0,573.0,0.0,573.0,0.0,573.0,0
TCGA-D1-A3JP-01,TCGA-D1-A3JP,UCEC,61.0,FEMALE,WHITE,nan,Stage IA,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22538.0,Alive,TUMOR FREE,515.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,515.0,0.0,515.0,nan,nan,0.0,515.0,0
TCGA-D1-A3JQ-01,TCGA-D1-A3JQ,UCEC,61.0,FEMALE,WHITE,nan,Stage IIIC,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22297.0,Alive,TUMOR FREE,526.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,526.0,0.0,526.0,0.0,526.0,0.0,526.0,0
TCGA-DF-A2KN-01,TCGA-DF-A2KN,UCEC,nan,FEMALE,[Not Evaluated],nan,Stage IC,Endometrioid endometrial adenocarcinoma,G3,nan,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),nan,Alive,TUMOR FREE,67.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,67.0,0.0,67.0,0.0,67.0,0.0,67.0,0
TCGA-DF-A2KR-01,TCGA-DF-A2KR,UCEC,84.0,FEMALE,[Not Evaluated],nan,Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,nan,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31007.0,Alive,TUMOR FREE,2178.0,nan,nan,New Primary Tumor,Lung,nan,2113.0,Complete Remission/Response,nan,nan,0.0,2178.0,0.0,2178.0,0.0,2178.0,1.0,2113.0,2
TCGA-DF-A2KS-01,TCGA-DF-A2KS,UCEC,69.0,FEMALE,[Not Evaluated],nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,nan,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25313.0,Alive,TUMOR FREE,3318.0,nan,nan,New Primary Tumor,"Other, specify",colorectal,2277.0,Complete Remission/Response,nan,nan,0.0,3318.0,0.0,3318.0,0.0,3318.0,1.0,2277.0,2
TCGA-DF-A2KU-01,TCGA-DF-A2KU,UCEC,nan,FEMALE,[Not Evaluated],nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,nan,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),nan,Alive,TUMOR FREE,3067.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,3067.0,0.0,3067.0,0.0,3067.0,0.0,3067.0,0
TCGA-DF-A2KV-01,TCGA-DF-A2KV,UCEC,55.0,FEMALE,[Not Evaluated],nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,nan,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20160.0,Alive,TUMOR FREE,2717.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2717.0,0.0,2717.0,nan,nan,0.0,2717.0,0
TCGA-DF-A2KY-01,TCGA-DF-A2KY,UCEC,49.0,FEMALE,[Not Evaluated],nan,Stage IVA,Endometrioid endometrial adenocarcinoma,G3,nan,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18086.0,Alive,WITH TUMOR,332.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,332.0,0.0,332.0,nan,nan,0.0,332.0,2
TCGA-DF-A2KZ-01,TCGA-DF-A2KZ,UCEC,87.0,FEMALE,[Not Evaluated],nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,nan,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31973.0,Alive,TUMOR FREE,826.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,826.0,0.0,826.0,nan,nan,0.0,826.0,0
TCGA-DF-A2L0-01,TCGA-DF-A2L0,UCEC,60.0,FEMALE,[Not Evaluated],nan,Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,nan,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22200.0,Dead,WITH TUMOR,nan,788.0,nan,Distant Metastasis,"Other, specify",lymph nodes and retroperitoneal tissue,523.0,Complete Remission/Response,nan,nan,1.0,788.0,1.0,788.0,1.0,523.0,1.0,523.0,1
TCGA-DI-A0WH-01,TCGA-DI-A0WH,UCEC,64.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,nan,-23692.0,Alive,TUMOR FREE,496.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,496.0,0.0,496.0,0.0,496.0,0.0,496.0,2
TCGA-DI-A1BU-01,TCGA-DI-A1BU,UCEC,55.0,FEMALE,WHITE,nan,Stage IIB,Mixed serous and endometrioid,G3,2008.0,nan,-20114.0,Alive,TUMOR FREE,1195.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1195.0,0.0,1195.0,0.0,1195.0,0.0,1195.0,0
TCGA-DI-A1BY-01,TCGA-DI-A1BY,UCEC,63.0,FEMALE,WHITE,nan,Stage IIB,Endometrioid endometrial adenocarcinoma,G2,2008.0,nan,-23113.0,Alive,TUMOR FREE,1114.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1114.0,0.0,1114.0,0.0,1114.0,0.0,1114.0,2
TCGA-DI-A1C3-01,TCGA-DI-A1C3,UCEC,38.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2008.0,nan,-13885.0,Alive,TUMOR FREE,739.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,739.0,0.0,739.0,0.0,739.0,0.0,739.0,2
TCGA-DI-A1NN-01,TCGA-DI-A1NN,UCEC,63.0,FEMALE,WHITE,nan,Stage IIIC,Serous endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23026.0,Alive,WITH TUMOR,1076.0,nan,nan,Metastatic,"Other, specify",vagina,1023.0,Complete Remission/Response,nan,nan,0.0,1076.0,0.0,1076.0,1.0,1023.0,1.0,1023.0,2
TCGA-DI-A1NN-11,TCGA-DI-A1NN,UCEC,63.0,FEMALE,WHITE,nan,Stage IIIC,Serous endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23026.0,Alive,WITH TUMOR,1076.0,nan,nan,Metastatic,"Other, specify",vagina,1023.0,Complete Remission/Response,nan,nan,0.0,1076.0,0.0,1076.0,1.0,1023.0,1.0,1023.0,2
TCGA-DI-A1NO-01,TCGA-DI-A1NO,UCEC,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24996.0,Dead,WITH TUMOR,nan,285.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,285.0,1.0,285.0,nan,nan,1.0,285.0,1
TCGA-DI-A1NO-11,TCGA-DI-A1NO,UCEC,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24996.0,Dead,WITH TUMOR,nan,285.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,285.0,1.0,285.0,nan,nan,1.0,285.0,1
TCGA-DI-A2QT-01,TCGA-DI-A2QT,UCEC,51.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,nan,Stage IIIC,Serous endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18835.0,Dead,WITH TUMOR,nan,377.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,377.0,1.0,377.0,nan,nan,1.0,377.0,1
TCGA-DI-A2QU-01,TCGA-DI-A2QU,UCEC,67.0,FEMALE,WHITE,nan,Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24488.0,Dead,WITH TUMOR,nan,946.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,946.0,1.0,946.0,nan,nan,1.0,946.0,1
TCGA-DI-A2QU-11,TCGA-DI-A2QU,UCEC,67.0,FEMALE,WHITE,nan,Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24488.0,Dead,WITH TUMOR,nan,946.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,946.0,1.0,946.0,nan,nan,1.0,946.0,1
TCGA-DI-A2QY-01,TCGA-DI-A2QY,UCEC,64.0,FEMALE,WHITE,nan,Stage IIB,Serous endometrial adenocarcinoma,G3,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23398.0,Dead,TUMOR FREE,nan,3349.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,3349.0,0.0,3349.0,0.0,3349.0,0.0,3349.0,0
TCGA-DI-A2QY-11,TCGA-DI-A2QY,UCEC,64.0,FEMALE,WHITE,nan,Stage IIB,Serous endometrial adenocarcinoma,G3,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23398.0,Dead,TUMOR FREE,nan,3349.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,3349.0,0.0,3349.0,0.0,3349.0,0.0,3349.0,0
TCGA-E6-A1LX-01,TCGA-E6-A1LX,UCEC,40.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2006.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14731.0,Alive,TUMOR FREE,711.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,711.0,0.0,711.0,0.0,711.0,0.0,711.0,2
TCGA-E6-A1LZ-01,TCGA-E6-A1LZ,UCEC,76.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Serous endometrial adenocarcinoma,G3,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28054.0,Alive,TUMOR FREE,2406.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2406.0,0.0,2406.0,0.0,2406.0,0.0,2406.0,0
TCGA-E6-A1M0-01,TCGA-E6-A1M0,UCEC,56.0,FEMALE,WHITE,nan,Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20629.0,Alive,TUMOR FREE,1793.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1793.0,0.0,1793.0,0.0,1793.0,0.0,1793.0,2
TCGA-E6-A1M0-11,TCGA-E6-A1M0,UCEC,56.0,FEMALE,WHITE,nan,Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20629.0,Alive,TUMOR FREE,1793.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1793.0,0.0,1793.0,0.0,1793.0,0.0,1793.0,2
TCGA-E6-A2P8-01,TCGA-E6-A2P8,UCEC,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IV,Mixed serous and endometrioid,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19448.0,Dead,WITH TUMOR,nan,72.0,nan,Metastatic,Lung,nan,60.0,Progressive Disease,nan,nan,1.0,72.0,1.0,72.0,nan,nan,1.0,60.0,1
TCGA-E6-A2P9-01,TCGA-E6-A2P9,UCEC,65.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24088.0,Alive,TUMOR FREE,1386.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1386.0,0.0,1386.0,0.0,1386.0,0.0,1386.0,2
TCGA-E6-A8L9-01,TCGA-E6-A8L9,UCEC,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Serous endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22333.0,Alive,TUMOR FREE,1013.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1013.0,0.0,1013.0,0.0,1013.0,0.0,1013.0,0
TCGA-EC-A1NJ-01,TCGA-EC-A1NJ,UCEC,73.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27002.0,Alive,TUMOR FREE,488.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,488.0,0.0,488.0,0.0,488.0,0.0,488.0,2
TCGA-EC-A1QX-01,TCGA-EC-A1QX,UCEC,71.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26259.0,Alive,TUMOR FREE,224.0,nan,nan,nan,nan,nan,219.0,Progressive Disease,nan,nan,0.0,224.0,0.0,224.0,nan,nan,1.0,219.0,2
TCGA-EC-A24G-01,TCGA-EC-A24G,UCEC,57.0,FEMALE,WHITE,nan,Stage II,Endometrioid endometrial adenocarcinoma,G3,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20857.0,Alive,TUMOR FREE,511.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,511.0,0.0,511.0,0.0,511.0,0.0,511.0,0
TCGA-EO-A1Y5-01,TCGA-EO-A1Y5,UCEC,63.0,FEMALE,nan,nan,Stage IIIC2,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23251.0,Alive,TUMOR FREE,332.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,332.0,0.0,332.0,0.0,332.0,0.0,332.0,0
TCGA-EO-A1Y7-01,TCGA-EO-A1Y7,UCEC,65.0,FEMALE,nan,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24085.0,Alive,WITH TUMOR,1495.0,nan,nan,Distant Metastasis,Lung,nan,880.0,Progressive Disease,nan,nan,0.0,1495.0,0.0,1495.0,nan,nan,1.0,880.0,2
TCGA-EO-A1Y8-01,TCGA-EO-A1Y8,UCEC,87.0,FEMALE,nan,nan,Stage IA,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31971.0,Alive,TUMOR FREE,1147.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1147.0,0.0,1147.0,0.0,1147.0,0.0,1147.0,0
TCGA-EO-A22R-01,TCGA-EO-A22R,UCEC,56.0,FEMALE,nan,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20604.0,Alive,TUMOR FREE,1878.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1878.0,0.0,1878.0,0.0,1878.0,0.0,1878.0,2
TCGA-EO-A22R-11,TCGA-EO-A22R,UCEC,56.0,FEMALE,nan,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20604.0,Alive,TUMOR FREE,1878.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1878.0,0.0,1878.0,0.0,1878.0,0.0,1878.0,2
TCGA-EO-A22S-01,TCGA-EO-A22S,UCEC,58.0,FEMALE,nan,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21328.0,Alive,TUMOR FREE,1872.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1872.0,0.0,1872.0,0.0,1872.0,0.0,1872.0,2
TCGA-EO-A22S-11,TCGA-EO-A22S,UCEC,58.0,FEMALE,nan,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21328.0,Alive,TUMOR FREE,1872.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1872.0,0.0,1872.0,0.0,1872.0,0.0,1872.0,2
TCGA-EO-A22T-01,TCGA-EO-A22T,UCEC,56.0,FEMALE,ASIAN,nan,Stage II,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20608.0,Alive,TUMOR FREE,2035.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2035.0,0.0,2035.0,0.0,2035.0,0.0,2035.0,2
TCGA-EO-A22T-11,TCGA-EO-A22T,UCEC,56.0,FEMALE,ASIAN,nan,Stage II,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20608.0,Alive,TUMOR FREE,2035.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2035.0,0.0,2035.0,0.0,2035.0,0.0,2035.0,2
TCGA-EO-A22U-01,TCGA-EO-A22U,UCEC,83.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30557.0,Alive,TUMOR FREE,1407.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1407.0,0.0,1407.0,0.0,1407.0,0.0,1407.0,2
TCGA-EO-A22X-01,TCGA-EO-A22X,UCEC,36.0,FEMALE,nan,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2008.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13245.0,Alive,TUMOR FREE,1752.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1752.0,0.0,1752.0,0.0,1752.0,0.0,1752.0,2
TCGA-EO-A22Y-01,TCGA-EO-A22Y,UCEC,68.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25127.0,Alive,TUMOR FREE,1567.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1567.0,0.0,1567.0,0.0,1567.0,0.0,1567.0,2
TCGA-EO-A2CG-01,TCGA-EO-A2CG,UCEC,69.0,FEMALE,ASIAN,nan,Stage IA,Serous endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25279.0,Alive,TUMOR FREE,1564.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1564.0,0.0,1564.0,0.0,1564.0,0.0,1564.0,2
TCGA-EO-A2CH-01,TCGA-EO-A2CH,UCEC,73.0,FEMALE,nan,nan,Stage IVB,Serous endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26966.0,Dead,WITH TUMOR,nan,590.0,nan,Metastatic,Liver,nan,304.0,Progressive Disease,nan,nan,1.0,590.0,1.0,590.0,nan,nan,1.0,304.0,1
TCGA-EO-A3AS-01,TCGA-EO-A3AS,UCEC,86.0,FEMALE,nan,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31450.0,Alive,TUMOR FREE,1046.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1046.0,0.0,1046.0,0.0,1046.0,0.0,1046.0,2
TCGA-EO-A3AU-01,TCGA-EO-A3AU,UCEC,72.0,FEMALE,nan,nan,Stage II,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26406.0,Alive,TUMOR FREE,1543.0,nan,nan,New Primary Tumor,Lung,nan,1178.0,Complete Remission/Response,nan,nan,0.0,1543.0,0.0,1543.0,0.0,1543.0,1.0,1178.0,2
TCGA-EO-A3AV-01,TCGA-EO-A3AV,UCEC,51.0,FEMALE,nan,nan,Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2010.0,Peri (6-12 months since last menstrual period),-18713.0,Alive,TUMOR FREE,1069.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1069.0,0.0,1069.0,0.0,1069.0,0.0,1069.0,2
TCGA-EO-A3AY-01,TCGA-EO-A3AY,UCEC,58.0,FEMALE,nan,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21291.0,Alive,WITH TUMOR,1158.0,nan,nan,Locoregional Recurrence,"Other, specify",Vaginal Vault,1163.0,Complete Remission/Response,nan,nan,0.0,1158.0,0.0,1158.0,1.0,1163.0,1.0,1163.0,2
TCGA-EO-A3AZ-01,TCGA-EO-A3AZ,UCEC,80.0,FEMALE,nan,nan,Stage IB,Mixed serous and endometrioid,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29234.0,Alive,TUMOR FREE,826.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,826.0,0.0,826.0,0.0,826.0,0.0,826.0,0
TCGA-EO-A3B0-01,TCGA-EO-A3B0,UCEC,43.0,FEMALE,ASIAN,nan,Stage IIIC2,Endometrioid endometrial adenocarcinoma,G3,2011.0,Indeterminate (neither Pre or Postmenopausal),-15954.0,Alive,TUMOR FREE,1412.0,nan,nan,nan,nan,nan,nan,[Discrepancy],nan,nan,0.0,1412.0,0.0,1412.0,nan,nan,0.0,1412.0,0
TCGA-EO-A3B1-01,TCGA-EO-A3B1,UCEC,63.0,FEMALE,nan,nan,Stage IB,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23162.0,Alive,TUMOR FREE,820.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,820.0,0.0,820.0,0.0,820.0,0.0,820.0,0
TCGA-EO-A3KU-01,TCGA-EO-A3KU,UCEC,68.0,FEMALE,nan,nan,Stage II,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25116.0,Alive,TUMOR FREE,677.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,677.0,0.0,677.0,0.0,677.0,0.0,677.0,0
TCGA-EO-A3KW-01,TCGA-EO-A3KW,UCEC,72.0,FEMALE,nan,nan,Stage IA,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26492.0,Alive,TUMOR FREE,497.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,497.0,0.0,497.0,0.0,497.0,0.0,497.0,0
TCGA-EO-A3KX-01,TCGA-EO-A3KX,UCEC,80.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29260.0,Alive,TUMOR FREE,1170.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1170.0,0.0,1170.0,0.0,1170.0,0.0,1170.0,0
TCGA-EO-A3L0-01,TCGA-EO-A3L0,UCEC,76.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28003.0,Alive,TUMOR FREE,1554.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1554.0,0.0,1554.0,0.0,1554.0,0.0,1554.0,2
TCGA-EY-A1G7-01,TCGA-EY-A1G7,UCEC,86.0,FEMALE,WHITE,nan,Stage II,Endometrioid endometrial adenocarcinoma,G2,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31603.0,Dead,WITH TUMOR,nan,189.0,nan,nan,nan,nan,95.0,Complete Remission/Response,nan,nan,1.0,189.0,1.0,189.0,1.0,95.0,1.0,95.0,2
TCGA-EY-A1G8-01,TCGA-EY-A1G8,UCEC,83.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30517.0,Dead,TUMOR FREE,nan,456.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,456.0,0.0,456.0,0.0,456.0,0.0,456.0,2
TCGA-EY-A1GC-01,TCGA-EY-A1GC,UCEC,62.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22656.0,Alive,TUMOR FREE,1647.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1647.0,0.0,1647.0,0.0,1647.0,0.0,1647.0,2
TCGA-EY-A1GD-01,TCGA-EY-A1GD,UCEC,51.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18638.0,Alive,TUMOR FREE,1639.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1639.0,0.0,1639.0,0.0,1639.0,0.0,1639.0,2
TCGA-EY-A1GE-01,TCGA-EY-A1GE,UCEC,67.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24667.0,Alive,TUMOR FREE,741.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,741.0,0.0,741.0,0.0,741.0,0.0,741.0,2
TCGA-EY-A1GF-01,TCGA-EY-A1GF,UCEC,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27450.0,Alive,TUMOR FREE,826.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,826.0,0.0,826.0,0.0,826.0,0.0,826.0,2
TCGA-EY-A1GH-01,TCGA-EY-A1GH,UCEC,70.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25802.0,Alive,TUMOR FREE,710.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,710.0,0.0,710.0,0.0,710.0,0.0,710.0,2
TCGA-EY-A1GI-01,TCGA-EY-A1GI,UCEC,52.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19117.0,Alive,TUMOR FREE,710.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,710.0,0.0,710.0,0.0,710.0,0.0,710.0,2
TCGA-EY-A1GJ-01,TCGA-EY-A1GJ,UCEC,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26715.0,Alive,TUMOR FREE,727.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,727.0,0.0,727.0,0.0,727.0,0.0,727.0,2
TCGA-EY-A1GK-01,TCGA-EY-A1GK,UCEC,74.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27127.0,Alive,TUMOR FREE,693.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,693.0,0.0,693.0,0.0,693.0,0.0,693.0,2
TCGA-EY-A1GL-01,TCGA-EY-A1GL,UCEC,51.0,FEMALE,WHITE,nan,Stage II,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18761.0,Alive,TUMOR FREE,1014.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1014.0,0.0,1014.0,0.0,1014.0,0.0,1014.0,2
TCGA-EY-A1GM-01,TCGA-EY-A1GM,UCEC,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIA,Mixed serous and endometrioid,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22010.0,Dead,WITH TUMOR,nan,995.0,nan,Locoregional Recurrence,nan,nan,791.0,Complete Remission/Response,nan,nan,1.0,995.0,1.0,995.0,1.0,791.0,1.0,791.0,1
TCGA-EY-A1GO-01,TCGA-EY-A1GO,UCEC,65.0,FEMALE,WHITE,nan,Stage IIIC1,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23853.0,Alive,WITH TUMOR,586.0,nan,nan,Metastatic,Lung,nan,517.0,Complete Remission/Response,nan,nan,0.0,586.0,0.0,586.0,1.0,517.0,1.0,517.0,2
TCGA-EY-A1GP-01,TCGA-EY-A1GP,UCEC,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20011.0,Alive,TUMOR FREE,573.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,573.0,0.0,573.0,0.0,573.0,0.0,573.0,2
TCGA-EY-A1GQ-01,TCGA-EY-A1GQ,UCEC,76.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27905.0,Alive,WITH TUMOR,544.0,nan,nan,Metastatic,"Other, specify","R external iliac node, presacral peritoneal implant, ascitic fluid",334.0,Complete Remission/Response,nan,nan,0.0,544.0,0.0,544.0,1.0,334.0,1.0,334.0,2
TCGA-EY-A1GR-01,TCGA-EY-A1GR,UCEC,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24784.0,Alive,TUMOR FREE,536.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,536.0,0.0,536.0,0.0,536.0,0.0,536.0,2
TCGA-EY-A1GS-01,TCGA-EY-A1GS,UCEC,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IVB,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26012.0,Dead,WITH TUMOR,nan,670.0,nan,nan,nan,nan,nan,Stable Disease,nan,nan,1.0,670.0,1.0,670.0,nan,nan,1.0,670.0,1
TCGA-EY-A1GT-01,TCGA-EY-A1GT,UCEC,68.0,FEMALE,WHITE,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25151.0,Alive,TUMOR FREE,490.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,490.0,0.0,490.0,0.0,490.0,0.0,490.0,2
TCGA-EY-A1GU-01,TCGA-EY-A1GU,UCEC,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24304.0,Dead,TUMOR FREE,nan,997.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,997.0,0.0,997.0,0.0,997.0,0.0,997.0,2
TCGA-EY-A1GV-01,TCGA-EY-A1GV,UCEC,75.0,FEMALE,WHITE,nan,Stage IIIC1,Mixed serous and endometrioid,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27581.0,Alive,TUMOR FREE,481.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,481.0,0.0,481.0,0.0,481.0,0.0,481.0,0
TCGA-EY-A1GW-01,TCGA-EY-A1GW,UCEC,73.0,FEMALE,WHITE,nan,Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26979.0,Dead,WITH TUMOR,nan,337.0,nan,Metastatic,Liver,nan,190.0,Progressive Disease,nan,nan,1.0,337.0,1.0,337.0,nan,nan,1.0,190.0,1
TCGA-EY-A1GX-01,TCGA-EY-A1GX,UCEC,76.0,FEMALE,WHITE,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27962.0,Dead,TUMOR FREE,nan,1127.0,nan,Locoregional Recurrence,"Other, specify",pelvic mass,743.0,Complete Remission/Response,nan,nan,1.0,1127.0,0.0,1127.0,1.0,743.0,1.0,743.0,2
TCGA-EY-A1H0-01,TCGA-EY-A1H0,UCEC,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC2,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20937.0,Alive,WITH TUMOR,588.0,nan,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,0.0,588.0,0.0,588.0,nan,nan,0.0,588.0,2
TCGA-EY-A210-01,TCGA-EY-A210,UCEC,82.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC2,Mixed serous and endometrioid,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30095.0,Alive,TUMOR FREE,383.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,383.0,0.0,383.0,0.0,383.0,0.0,383.0,0
TCGA-EY-A212-01,TCGA-EY-A212,UCEC,83.0,FEMALE,WHITE,nan,Stage IIIC1,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30680.0,Dead,WITH TUMOR,nan,310.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,310.0,1.0,310.0,nan,nan,1.0,310.0,1
TCGA-EY-A214-01,TCGA-EY-A214,UCEC,66.0,FEMALE,WHITE,nan,Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24136.0,Alive,TUMOR FREE,438.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,438.0,0.0,438.0,0.0,438.0,0.0,438.0,2
TCGA-EY-A215-01,TCGA-EY-A215,UCEC,60.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22076.0,Alive,TUMOR FREE,574.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,574.0,0.0,574.0,0.0,574.0,0.0,574.0,2
TCGA-EY-A2OM-01,TCGA-EY-A2OM,UCEC,55.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20398.0,Alive,TUMOR FREE,694.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,694.0,0.0,694.0,0.0,694.0,0.0,694.0,0
TCGA-EY-A2ON-01,TCGA-EY-A2ON,UCEC,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IVB,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22624.0,Dead,WITH TUMOR,nan,610.0,nan,nan,nan,nan,226.0,Progressive Disease,nan,nan,1.0,610.0,1.0,610.0,nan,nan,1.0,226.0,1
TCGA-EY-A2OO-01,TCGA-EY-A2OO,UCEC,56.0,FEMALE,WHITE,nan,Stage IB,Mixed serous and endometrioid,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20797.0,Alive,TUMOR FREE,1392.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1392.0,0.0,1392.0,0.0,1392.0,0.0,1392.0,2
TCGA-EY-A2OP-01,TCGA-EY-A2OP,UCEC,63.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23090.0,Alive,TUMOR FREE,944.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,944.0,0.0,944.0,0.0,944.0,0.0,944.0,0
TCGA-EY-A2OQ-01,TCGA-EY-A2OQ,UCEC,61.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22309.0,Alive,TUMOR FREE,885.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,885.0,0.0,885.0,0.0,885.0,0.0,885.0,0
TCGA-EY-A3L3-01,TCGA-EY-A3L3,UCEC,82.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30138.0,Alive,TUMOR FREE,832.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,832.0,0.0,832.0,0.0,832.0,0.0,832.0,0
TCGA-EY-A3QX-01,TCGA-EY-A3QX,UCEC,64.0,FEMALE,WHITE,nan,Stage IVB,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23663.0,Dead,WITH TUMOR,nan,989.0,nan,Locoregional Recurrence,"Other, specify",Peritoneum,896.0,Complete Remission/Response,nan,nan,1.0,989.0,1.0,989.0,nan,nan,1.0,896.0,1
TCGA-EY-A4KR-01,TCGA-EY-A4KR,UCEC,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC1,Serous endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20669.0,Dead,WITH TUMOR,nan,346.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,346.0,1.0,346.0,nan,nan,1.0,346.0,1
TCGA-EY-A547-01,TCGA-EY-A547,UCEC,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27686.0,Alive,TUMOR FREE,545.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,545.0,0.0,545.0,0.0,545.0,0.0,545.0,0
TCGA-EY-A548-01,TCGA-EY-A548,UCEC,83.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G1,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30544.0,Alive,TUMOR FREE,430.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,430.0,0.0,430.0,0.0,430.0,0.0,430.0,2
TCGA-EY-A549-01,TCGA-EY-A549,UCEC,78.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28570.0,Alive,TUMOR FREE,605.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,605.0,0.0,605.0,0.0,605.0,0.0,605.0,2
TCGA-EY-A54A-01,TCGA-EY-A54A,UCEC,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC2,Endometrioid endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24822.0,Alive,TUMOR FREE,447.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,447.0,0.0,447.0,0.0,447.0,0.0,447.0,2
TCGA-EY-A5W2-01,TCGA-EY-A5W2,UCEC,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26498.0,Alive,TUMOR FREE,516.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,516.0,0.0,516.0,0.0,516.0,0.0,516.0,2
TCGA-EY-A72D-01,TCGA-EY-A72D,UCEC,87.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage II,Endometrioid endometrial adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31818.0,Alive,TUMOR FREE,179.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,179.0,0.0,179.0,0.0,179.0,0.0,179.0,2
TCGA-FI-A2CX-01,TCGA-FI-A2CX,UCEC,82.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30224.0,Alive,TUMOR FREE,2031.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2031.0,0.0,2031.0,0.0,2031.0,0.0,2031.0,2
TCGA-FI-A2CY-01,TCGA-FI-A2CY,UCEC,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Mixed serous and endometrioid,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22098.0,Alive,TUMOR FREE,2080.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2080.0,0.0,2080.0,0.0,2080.0,0.0,2080.0,0
TCGA-FI-A2D0-01,TCGA-FI-A2D0,UCEC,55.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2008.0,Peri (6-12 months since last menstrual period),-20393.0,Alive,TUMOR FREE,1213.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1213.0,0.0,1213.0,0.0,1213.0,0.0,1213.0,2
TCGA-FI-A2D2-01,TCGA-FI-A2D2,UCEC,66.0,FEMALE,WHITE,nan,Stage IB,Mixed serous and endometrioid,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24260.0,Dead,WITH TUMOR,nan,2352.0,nan,Locoregional Recurrence,Lung,Liver,1917.0,Complete Remission/Response,nan,nan,1.0,2352.0,1.0,2352.0,1.0,1917.0,1.0,1917.0,1
TCGA-FI-A2D4-01,TCGA-FI-A2D4,UCEC,44.0,FEMALE,WHITE,nan,Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2009.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16163.0,Dead,WITH TUMOR,nan,243.0,nan,nan,nan,nan,nan,Partial Remission/Response,nan,nan,1.0,243.0,1.0,243.0,nan,nan,1.0,243.0,1
TCGA-FI-A2D5-01,TCGA-FI-A2D5,UCEC,56.0,FEMALE,WHITE,nan,Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20666.0,Dead,WITH TUMOR,nan,421.0,nan,Metastatic,"Other, specify",vaginal cuff,280.0,Partial Remission/Response,nan,nan,1.0,421.0,1.0,421.0,nan,nan,1.0,280.0,1
TCGA-FI-A2D6-01,TCGA-FI-A2D6,UCEC,74.0,FEMALE,WHITE,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27060.0,Dead,TUMOR FREE,nan,767.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,767.0,0.0,767.0,0.0,767.0,0.0,767.0,2
TCGA-FI-A2EU-01,TCGA-FI-A2EU,UCEC,68.0,FEMALE,nan,nan,Stage IA,Serous endometrial adenocarcinoma,G3,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24837.0,Alive,TUMOR FREE,2941.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2941.0,0.0,2941.0,0.0,2941.0,0.0,2941.0,0
TCGA-FI-A2EW-01,TCGA-FI-A2EW,UCEC,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIB,Serous endometrial adenocarcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26267.0,Alive,WITH TUMOR,1795.0,nan,nan,Metastatic,Liver,nan,1169.0,Complete Remission/Response,nan,nan,0.0,1795.0,0.0,1795.0,1.0,1169.0,1.0,1169.0,2
TCGA-FI-A2EX-01,TCGA-FI-A2EX,UCEC,58.0,FEMALE,WHITE,nan,Stage IIIA,Serous endometrial adenocarcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21489.0,Alive,WITH TUMOR,284.0,nan,nan,Metastatic,nan,nan,213.0,Complete Remission/Response,nan,nan,0.0,284.0,0.0,284.0,1.0,213.0,1.0,213.0,2
TCGA-FI-A2EY-01,TCGA-FI-A2EY,UCEC,63.0,FEMALE,WHITE,nan,Stage IIIA,Serous endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23042.0,Dead,TUMOR FREE,nan,880.0,nan,New Primary Tumor,Lung,nan,577.0,Complete Remission/Response,nan,nan,1.0,880.0,0.0,880.0,0.0,880.0,1.0,577.0,2
TCGA-FI-A2F4-01,TCGA-FI-A2F4,UCEC,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IC,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23621.0,Alive,TUMOR FREE,2230.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2230.0,0.0,2230.0,0.0,2230.0,0.0,2230.0,2
TCGA-FI-A2F8-01,TCGA-FI-A2F8,UCEC,64.0,FEMALE,WHITE,nan,Stage II,Serous endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23649.0,Alive,WITH TUMOR,933.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,933.0,0.0,933.0,0.0,933.0,0.0,933.0,2
TCGA-FI-A2F9-01,TCGA-FI-A2F9,UCEC,79.0,FEMALE,WHITE,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28886.0,Alive,TUMOR FREE,1803.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1803.0,0.0,1803.0,0.0,1803.0,0.0,1803.0,2
TCGA-FI-A3PV-01,TCGA-FI-A3PV,UCEC,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Serous endometrial adenocarcinoma,High Grade,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24898.0,Dead,WITH TUMOR,nan,1249.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,1249.0,1.0,1249.0,nan,nan,1.0,1249.0,1
TCGA-FI-A3PX-01,TCGA-FI-A3PX,UCEC,57.0,FEMALE,WHITE,nan,Stage IIIC2,Serous endometrial adenocarcinoma,High Grade,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21063.0,Alive,TUMOR FREE,2384.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2384.0,0.0,2384.0,0.0,2384.0,0.0,2384.0,0
TCGA-H5-A2HR-01,TCGA-H5-A2HR,UCEC,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25986.0,Alive,TUMOR FREE,53.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,53.0,0.0,53.0,nan,nan,0.0,53.0,0
TCGA-JU-AAVI-01,TCGA-JU-AAVI,UCEC,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC1,Serous endometrial adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22289.0,Dead,WITH TUMOR,nan,540.0,nan,Distant Metastasis,"Other, specify",Porta Hepatis,505.0,Complete Remission/Response,nan,nan,1.0,540.0,1.0,540.0,1.0,505.0,1.0,505.0,1
TCGA-K6-A3WQ-01,TCGA-K6-A3WQ,UCEC,60.0,FEMALE,WHITE,nan,Stage IVB,Serous endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22092.0,Dead,WITH TUMOR,nan,427.0,nan,Locoregional Recurrence,"Other, specify",uterine,351.0,nan,nan,nan,1.0,427.0,1.0,427.0,nan,nan,1.0,351.0,1
TCGA-KJ-A3U4-01,TCGA-KJ-A3U4,UCEC,55.0,FEMALE,WHITE,nan,Stage IA,Serous endometrial adenocarcinoma,G1,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20392.0,Alive,TUMOR FREE,1095.0,nan,nan,Locoregional Recurrence,"Other, specify",abdominal,306.0,[Discrepancy],nan,nan,0.0,1095.0,0.0,1095.0,nan,nan,1.0,306.0,2
TCGA-KP-A3VZ-01,TCGA-KP-A3VZ,UCEC,69.0,FEMALE,WHITE,nan,Stage IV,Serous endometrial adenocarcinoma,High Grade,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25366.0,Alive,WITH TUMOR,722.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,722.0,0.0,722.0,nan,nan,0.0,722.0,2
TCGA-KP-A3W0-01,TCGA-KP-A3W0,UCEC,72.0,FEMALE,[Not Evaluated],nan,Stage IB,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26378.0,Alive,TUMOR FREE,404.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,404.0,0.0,404.0,0.0,404.0,0.0,404.0,0
TCGA-KP-A3W1-01,TCGA-KP-A3W1,UCEC,76.0,FEMALE,[Not Evaluated],nan,Stage IA,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27902.0,Alive,TUMOR FREE,288.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,288.0,0.0,288.0,0.0,288.0,0.0,288.0,0
TCGA-KP-A3W3-01,TCGA-KP-A3W3,UCEC,72.0,FEMALE,WHITE,nan,Stage IB,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26310.0,Alive,WITH TUMOR,794.0,nan,nan,Distant Metastasis,Liver,nan,661.0,Complete Remission/Response,nan,nan,0.0,794.0,0.0,794.0,1.0,661.0,1.0,661.0,2
TCGA-KP-A3W4-01,TCGA-KP-A3W4,UCEC,63.0,FEMALE,WHITE,nan,Stage IIIA,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23200.0,Dead,WITH TUMOR,nan,554.0,nan,Distant Metastasis,Liver,nan,321.0,Partial Remission/Response,nan,nan,1.0,554.0,1.0,554.0,nan,nan,1.0,321.0,1
TCGA-PG-A5BC-01,TCGA-PG-A5BC,UCEC,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage II,Serous endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26436.0,Alive,TUMOR FREE,707.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,707.0,0.0,707.0,0.0,707.0,0.0,707.0,0
TCGA-PG-A6IB-01,TCGA-PG-A6IB,UCEC,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Serous endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24969.0,Alive,TUMOR FREE,648.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,648.0,0.0,648.0,0.0,648.0,0.0,648.0,0
TCGA-PG-A7D5-01,TCGA-PG-A7D5,UCEC,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23006.0,Alive,TUMOR FREE,1177.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,1177.0,0.0,1177.0,nan,nan,0.0,1177.0,0
TCGA-PG-A914-01,TCGA-PG-A914,UCEC,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Serous endometrial adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26992.0,Alive,TUMOR FREE,687.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,687.0,0.0,687.0,0.0,687.0,0.0,687.0,0
TCGA-PG-A915-01,TCGA-PG-A915,UCEC,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Serous endometrial adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22119.0,Alive,TUMOR FREE,249.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,249.0,0.0,249.0,0.0,249.0,0.0,249.0,0
TCGA-PG-A916-01,TCGA-PG-A916,UCEC,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage I,Endometrioid endometrial adenocarcinoma,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25617.0,Alive,TUMOR FREE,522.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,522.0,0.0,522.0,0.0,522.0,0.0,522.0,2
TCGA-PG-A917-01,TCGA-PG-A917,UCEC,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Endometrioid endometrial adenocarcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27104.0,Alive,TUMOR FREE,212.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,212.0,0.0,212.0,0.0,212.0,0.0,212.0,2
TCGA-QF-A5YS-01,TCGA-QF-A5YS,UCEC,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage II,Mixed serous and endometrioid,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20841.0,Alive,TUMOR FREE,689.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,689.0,0.0,689.0,0.0,689.0,0.0,689.0,2
TCGA-QF-A5YT-01,TCGA-QF-A5YT,UCEC,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage II,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20981.0,Alive,TUMOR FREE,1215.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1215.0,0.0,1215.0,0.0,1215.0,0.0,1215.0,2
TCGA-QS-A5YQ-01,TCGA-QS-A5YQ,UCEC,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20425.0,Alive,TUMOR FREE,759.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,759.0,0.0,759.0,0.0,759.0,0.0,759.0,2
TCGA-QS-A5YR-01,TCGA-QS-A5YR,UCEC,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIB,Endometrioid endometrial adenocarcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22372.0,Alive,WITH TUMOR,719.0,nan,nan,nan,nan,nan,nan,Stable Disease,nan,nan,0.0,719.0,0.0,719.0,nan,nan,0.0,719.0,2
TCGA-QS-A744-01,TCGA-QS-A744,UCEC,86.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIB,Endometrioid endometrial adenocarcinoma,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31520.0,Alive,TUMOR FREE,451.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,451.0,0.0,451.0,nan,nan,0.0,451.0,2
TCGA-QS-A8F1-01,TCGA-QS-A8F1,UCEC,85.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIA,Serous endometrial adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31386.0,Dead,WITH TUMOR,nan,135.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,135.0,1.0,135.0,nan,nan,1.0,135.0,1
TCGA-SJ-A6ZI-01,TCGA-SJ-A6ZI,UCEC,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G1,2013.0,[Unknown],-23653.0,Alive,TUMOR FREE,631.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,631.0,0.0,631.0,0.0,631.0,0.0,631.0,2
TCGA-SJ-A6ZJ-01,TCGA-SJ-A6ZJ,UCEC,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22597.0,Alive,TUMOR FREE,556.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,556.0,0.0,556.0,0.0,556.0,0.0,556.0,2
TCGA-SL-A6J9-01,TCGA-SL-A6J9,UCEC,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26701.0,Alive,nan,2.0,nan,nan,nan,nan,nan,nan,[Unknown],nan,nan,0.0,2.0,0.0,2.0,nan,nan,0.0,2.0,2
TCGA-SL-A6JA-01,TCGA-SL-A6JA,UCEC,77.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Endometrioid endometrial adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28401.0,Alive,TUMOR FREE,7.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,7.0,0.0,7.0,0.0,7.0,0.0,7.0,2
TCGA-N5-A4R8-01,TCGA-N5-A4R8,UCS,65.0,FEMALE,WHITE,nan,Stage IA,Uterine Carcinosarcoma/ MMMT: Heterologous Type,nan,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24102.0,Dead,nan,nan,3115.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,3115.0,nan,3115.0,0.0,3115.0,0.0,3115.0,1
TCGA-N5-A4RA-01,TCGA-N5-A4RA,UCS,63.0,FEMALE,WHITE,nan,Stage IIIC2,Uterine Carcinosarcoma/ MMMT: Heterologous Type,nan,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23359.0,Dead,nan,nan,1591.0,nan,nan,nan,nan,nan,[Unknown],nan,nan,1.0,1591.0,nan,1591.0,nan,nan,0.0,1591.0,1
TCGA-N5-A4RD-01,TCGA-N5-A4RD,UCS,69.0,FEMALE,WHITE,nan,Stage IVB,Uterine Carcinosarcoma/ MMMT: Heterologous Type,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25413.0,Dead,WITH TUMOR,nan,142.0,nan,Locoregional Recurrence,"Other, specify",Vagina,75.0,Progressive Disease,nan,nan,1.0,142.0,1.0,142.0,nan,nan,1.0,75.0,1
TCGA-N5-A4RF-01,TCGA-N5-A4RF,UCS,68.0,FEMALE,WHITE,nan,Stage IA,Uterine Carcinosarcoma/MMMT: Homologous Type,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25041.0,Alive,TUMOR FREE,1806.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1806.0,0.0,1806.0,0.0,1806.0,0.0,1806.0,0
TCGA-N5-A4RJ-01,TCGA-N5-A4RJ,UCS,61.0,FEMALE,WHITE,nan,Stage IVB,Uterine Carcinosarcoma/ MMMT: Heterologous Type,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22341.0,Dead,WITH TUMOR,nan,550.0,nan,Distant Metastasis,Lymph Node(s),nan,287.0,Complete Remission/Response,nan,nan,1.0,550.0,1.0,550.0,nan,nan,1.0,287.0,1
TCGA-N5-A4RM-01,TCGA-N5-A4RM,UCS,62.0,FEMALE,WHITE,nan,Stage IVB,Uterine Carcinosarcoma/ MMMT: Heterologous Type,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22886.0,Dead,WITH TUMOR,nan,148.0,nan,Locoregional Recurrence,Pelvis,nan,144.0,Progressive Disease,nan,nan,1.0,148.0,1.0,148.0,nan,nan,1.0,144.0,1
TCGA-N5-A4RN-01,TCGA-N5-A4RN,UCS,71.0,FEMALE,WHITE,nan,Stage IVB,Uterine Carcinosarcoma/MMMT: Homologous Type,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26054.0,Alive,WITH TUMOR,1053.0,nan,nan,Locoregional Recurrence,Pelvis,nan,570.0,Complete Remission/Response,nan,nan,0.0,1053.0,0.0,1053.0,nan,nan,1.0,570.0,2
TCGA-N5-A4RO-01,TCGA-N5-A4RO,UCS,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC2,Uterine Carcinosarcoma/MMMT: Homologous Type,nan,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24823.0,Dead,WITH TUMOR,nan,685.0,nan,Progression of Disease,Lymph Node(s),nan,407.0,Progressive Disease,nan,nan,1.0,685.0,1.0,685.0,nan,nan,1.0,407.0,1
TCGA-N5-A4RS-01,TCGA-N5-A4RS,UCS,65.0,FEMALE,WHITE,nan,Stage IB,Uterine Carcinosarcoma/MMMT: Homologous Type,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23893.0,Dead,WITH TUMOR,nan,911.0,nan,Distant Metastasis,Lung,nan,427.0,Complete Remission/Response,nan,nan,1.0,911.0,1.0,911.0,1.0,427.0,1.0,427.0,1
TCGA-N5-A4RT-01,TCGA-N5-A4RT,UCS,69.0,FEMALE,WHITE,nan,Stage IIIC1,Uterine Carcinosarcoma/MMMT: Homologous Type,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25386.0,Alive,TUMOR FREE,2485.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2485.0,0.0,2485.0,0.0,2485.0,0.0,2485.0,0
TCGA-N5-A4RU-01,TCGA-N5-A4RU,UCS,54.0,FEMALE,WHITE,nan,Stage IIIC2,Uterine Carcinosarcoma/MMMT: Homologous Type,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20025.0,Dead,WITH TUMOR,nan,1526.0,nan,Locoregional Recurrence,Pelvis,nan,253.0,Complete Remission/Response,nan,nan,1.0,1526.0,1.0,1526.0,1.0,253.0,1.0,253.0,1
TCGA-N5-A4RV-01,TCGA-N5-A4RV,UCS,62.0,FEMALE,WHITE,nan,Stage IA,Uterine Carcinosarcoma/MMMT: Homologous Type,nan,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22978.0,Alive,TUMOR FREE,2042.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2042.0,0.0,2042.0,0.0,2042.0,0.0,2042.0,0
TCGA-N5-A59E-01,TCGA-N5-A59E,UCS,62.0,FEMALE,WHITE,nan,Stage IVB,Uterine Carcinosarcoma/ MMMT: Heterologous Type,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22650.0,Dead,WITH TUMOR,nan,447.0,nan,Locoregional Recurrence,Abdomen,nan,354.0,Complete Remission/Response,nan,nan,1.0,447.0,1.0,447.0,nan,nan,1.0,354.0,1
TCGA-N5-A59F-01,TCGA-N5-A59F,UCS,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Uterine Carcinosarcoma/MMMT: Homologous Type,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23826.0,Dead,WITH TUMOR,nan,361.0,nan,Locoregional Recurrence,Pelvis,nan,274.0,Complete Remission/Response,nan,nan,1.0,361.0,1.0,361.0,1.0,274.0,1.0,274.0,1
TCGA-N6-A4V9-01,TCGA-N6-A4V9,UCS,59.0,FEMALE,WHITE,nan,Stage IA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,nan,2011.0,[Unknown],-21677.0,Alive,TUMOR FREE,979.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,979.0,0.0,979.0,0.0,979.0,0.0,979.0,0
TCGA-N6-A4VC-01,TCGA-N6-A4VC,UCS,83.0,FEMALE,WHITE,nan,Stage III,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30643.0,Dead,WITH TUMOR,nan,597.0,nan,Distant Metastasis,Lung,nan,171.0,Progressive Disease,nan,nan,1.0,597.0,1.0,597.0,nan,nan,1.0,171.0,1
TCGA-N6-A4VD-01,TCGA-N6-A4VD,UCS,81.0,FEMALE,WHITE,nan,Stage IIIA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29658.0,Dead,WITH TUMOR,nan,112.0,nan,Distant Metastasis,Liver,nan,49.0,Progressive Disease,nan,nan,1.0,112.0,1.0,112.0,nan,nan,1.0,49.0,1
TCGA-N6-A4VE-01,TCGA-N6-A4VE,UCS,84.0,FEMALE,WHITE,nan,Stage IIIC,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30794.0,Dead,WITH TUMOR,nan,291.0,nan,Distant Metastasis,Bone,nan,275.0,Progressive Disease,nan,nan,1.0,291.0,1.0,291.0,nan,nan,1.0,275.0,1
TCGA-N6-A4VF-01,TCGA-N6-A4VF,UCS,51.0,FEMALE,WHITE,nan,Stage IB,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,nan,2009.0,Peri (6-12 months since last menstrual period),-18806.0,Dead,TUMOR FREE,nan,522.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,522.0,0.0,522.0,nan,nan,0.0,522.0,1
TCGA-N6-A4VG-01,TCGA-N6-A4VG,UCS,77.0,FEMALE,WHITE,nan,Stage IVB,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28428.0,Alive,WITH TUMOR,1574.0,nan,nan,Locoregional Recurrence,Lymph Node(s),nan,493.0,Partial Remission/Response,nan,nan,0.0,1574.0,0.0,1574.0,nan,nan,1.0,493.0,2
TCGA-N7-A4Y0-01,TCGA-N7-A4Y0,UCS,65.0,FEMALE,WHITE,nan,Stage IIIC,Uterine Carcinosarcoma/ MMMT: Heterologous Type,nan,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23983.0,Dead,WITH TUMOR,nan,771.0,nan,Progression of Disease,"Other, specify",retroperitoneum,281.0,[Unknown],nan,nan,1.0,771.0,1.0,771.0,nan,nan,1.0,281.0,1
TCGA-N7-A4Y5-01,TCGA-N7-A4Y5,UCS,87.0,FEMALE,WHITE,nan,Stage IIB,Uterine Carcinosarcoma/ MMMT: Heterologous Type,nan,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32058.0,Dead,WITH TUMOR,nan,8.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,8.0,1.0,8.0,nan,nan,1.0,8.0,1
TCGA-N7-A4Y8-01,TCGA-N7-A4Y8,UCS,72.0,FEMALE,WHITE,nan,Stage IVB,Uterine Carcinosarcoma/ MMMT: Heterologous Type,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26650.0,Dead,WITH TUMOR,nan,378.0,nan,Progression of Disease,"Other, specify",Pleural effusion,187.0,Partial Remission/Response,nan,nan,1.0,378.0,1.0,378.0,nan,nan,1.0,187.0,1
TCGA-N7-A59B-01,TCGA-N7-A59B,UCS,69.0,FEMALE,WHITE,nan,Stage IA,Uterine Carcinosarcoma/MMMT: Homologous Type,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25360.0,Alive,TUMOR FREE,827.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,827.0,0.0,827.0,0.0,827.0,0.0,827.0,0
TCGA-N8-A4PI-01,TCGA-N8-A4PI,UCS,71.0,FEMALE,WHITE,nan,Stage IA,Uterine Carcinosarcoma/ MMMT: Heterologous Type,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26270.0,Dead,WITH TUMOR,nan,810.0,nan,Locoregional Recurrence,"Other, specify",Vagina,255.0,Partial Remission/Response,nan,nan,1.0,810.0,1.0,810.0,nan,nan,1.0,255.0,1
TCGA-N8-A4PL-01,TCGA-N8-A4PL,UCS,82.0,FEMALE,WHITE,nan,Stage IA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30069.0,Dead,WITH TUMOR,nan,418.0,nan,Locoregional Recurrence,Lymph Node(s),nan,138.0,Progressive Disease,nan,nan,1.0,418.0,1.0,418.0,nan,nan,1.0,138.0,1
TCGA-N8-A4PM-01,TCGA-N8-A4PM,UCS,73.0,FEMALE,WHITE,nan,Stage IB,Uterine Carcinosarcoma/MMMT: Homologous Type,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26971.0,Alive,WITH TUMOR,829.0,nan,nan,Locoregional Recurrence,Lymph Node(s),nan,524.0,Complete Remission/Response,nan,nan,0.0,829.0,0.0,829.0,1.0,524.0,1.0,524.0,2
TCGA-N8-A4PN-01,TCGA-N8-A4PN,UCS,68.0,FEMALE,WHITE,nan,Stage IIIC1,Uterine Carcinosarcoma/MMMT: Homologous Type,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25064.0,Alive,TUMOR FREE,812.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,812.0,0.0,812.0,0.0,812.0,0.0,812.0,0
TCGA-N8-A4PO-01,TCGA-N8-A4PO,UCS,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage II,Uterine Carcinosarcoma/ MMMT: Heterologous Type,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24124.0,Alive,WITH TUMOR,781.0,nan,nan,Distant Metastasis,Bone,nan,158.0,Progressive Disease,nan,nan,0.0,781.0,0.0,781.0,nan,nan,1.0,158.0,2
TCGA-N8-A4PP-01,TCGA-N8-A4PP,UCS,88.0,FEMALE,WHITE,nan,Stage IIIC1,Uterine Carcinosarcoma/MMMT: Homologous Type,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32415.0,Dead,WITH TUMOR,nan,611.0,nan,Locoregional Recurrence,"Other, specify",Vagina,149.0,Partial Remission/Response,nan,nan,1.0,611.0,1.0,611.0,nan,nan,1.0,149.0,1
TCGA-N8-A4PQ-01,TCGA-N8-A4PQ,UCS,76.0,FEMALE,WHITE,nan,Stage IIIC2,Uterine Carcinosarcoma/ MMMT: Heterologous Type,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27772.0,Alive,TUMOR FREE,572.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,572.0,0.0,572.0,0.0,572.0,0.0,572.0,0
TCGA-N8-A56S-01,TCGA-N8-A56S,UCS,75.0,FEMALE,WHITE,nan,Stage IB,Uterine Carcinosarcoma/ MMMT: Heterologous Type,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27519.0,Dead,WITH TUMOR,nan,371.0,nan,Progression of Disease,Lung,nan,199.0,Stable Disease,nan,nan,1.0,371.0,1.0,371.0,nan,nan,1.0,199.0,1
TCGA-N9-A4PZ-01,TCGA-N9-A4PZ,UCS,77.0,FEMALE,WHITE,nan,Stage IIIC2,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,nan,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28211.0,Dead,WITH TUMOR,nan,667.0,nan,Locoregional Recurrence,Pelvis,nan,487.0,Complete Remission/Response,nan,nan,1.0,667.0,1.0,667.0,1.0,487.0,1.0,487.0,1
TCGA-N9-A4Q1-01,TCGA-N9-A4Q1,UCS,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage II,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,nan,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25791.0,Dead,WITH TUMOR,nan,2043.0,nan,Distant Metastasis,"Other, specify",Pleural surface,1839.0,Complete Remission/Response,nan,nan,1.0,2043.0,1.0,2043.0,1.0,1839.0,1.0,1839.0,1
TCGA-N9-A4Q3-01,TCGA-N9-A4Q3,UCS,65.0,FEMALE,WHITE,nan,Stage IA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24031.0,Alive,WITH TUMOR,1672.0,nan,nan,Distant Metastasis,Lung,nan,735.0,Complete Remission/Response,nan,nan,0.0,1672.0,0.0,1672.0,1.0,735.0,1.0,735.0,2
TCGA-N9-A4Q4-01,TCGA-N9-A4Q4,UCS,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22575.0,Alive,nan,1089.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,1089.0,0.0,1089.0,0.0,1089.0,0.0,1089.0,0
TCGA-N9-A4Q7-01,TCGA-N9-A4Q7,UCS,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25419.0,Alive,TUMOR FREE,604.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,604.0,0.0,604.0,0.0,604.0,0.0,604.0,0
TCGA-N9-A4Q8-01,TCGA-N9-A4Q8,UCS,68.0,FEMALE,WHITE,nan,Stage IA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25185.0,Dead,WITH TUMOR,nan,481.0,nan,Locoregional Recurrence,"Other, specify",Vagina,215.0,Complete Remission/Response,nan,nan,1.0,481.0,1.0,481.0,1.0,215.0,1.0,215.0,1
TCGA-NA-A4QV-01,TCGA-NA-A4QV,UCS,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IB,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,nan,2002.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26379.0,Alive,TUMOR FREE,4269.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,4269.0,0.0,4269.0,0.0,4269.0,0.0,4269.0,0
TCGA-NA-A4QW-01,TCGA-NA-A4QW,UCS,61.0,FEMALE,WHITE,nan,Stage IIA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22588.0,Alive,TUMOR FREE,2457.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,2457.0,0.0,2457.0,0.0,2457.0,0.0,2457.0,0
TCGA-NA-A4QX-01,TCGA-NA-A4QX,UCS,60.0,FEMALE,WHITE,nan,Stage IVB,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22264.0,Dead,WITH TUMOR,833.0,838.0,nan,Distant Metastasis,Pelvis,nan,566.0,nan,nan,nan,1.0,838.0,1.0,838.0,nan,nan,1.0,566.0,1
TCGA-NA-A4QY-01,TCGA-NA-A4QY,UCS,62.0,FEMALE,WHITE,nan,Stage III,Uterine Carcinosarcoma/ MMMT: Heterologous Type,nan,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22756.0,Dead,WITH TUMOR,nan,114.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,114.0,1.0,114.0,nan,nan,1.0,114.0,1
TCGA-NA-A4R0-01,TCGA-NA-A4R0,UCS,80.0,FEMALE,WHITE,nan,Stage IVB,Uterine Carcinosarcoma/ MMMT: Heterologous Type,nan,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29449.0,Dead,WITH TUMOR,nan,541.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,541.0,1.0,541.0,nan,nan,1.0,541.0,1
TCGA-NA-A4R1-01,TCGA-NA-A4R1,UCS,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC1,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27688.0,Dead,WITH TUMOR,nan,203.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,203.0,1.0,203.0,nan,nan,1.0,203.0,1
TCGA-NA-A5I1-01,TCGA-NA-A5I1,UCS,80.0,FEMALE,WHITE,nan,Stage IIIB,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,nan,2006.0,nan,-29329.0,Dead,WITH TUMOR,nan,2680.0,nan,Distant Metastasis,Pelvis,nan,2553.0,Complete Remission/Response,nan,nan,1.0,2680.0,1.0,2680.0,1.0,2553.0,1.0,2553.0,1
TCGA-ND-A4W6-01,TCGA-ND-A4W6,UCS,67.0,FEMALE,BLACK OR AFRICAN AMERICAN,nan,Stage IIIC,Uterine Carcinosarcoma/ MMMT: Heterologous Type,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24835.0,Dead,WITH TUMOR,nan,317.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,317.0,1.0,317.0,nan,nan,1.0,317.0,1
TCGA-ND-A4WA-01,TCGA-ND-A4WA,UCS,90.0,FEMALE,ASIAN,nan,Stage IC,Uterine Carcinosarcoma/ MMMT: Heterologous Type,nan,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32872.0,Dead,TUMOR FREE,nan,714.0,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,1.0,714.0,0.0,714.0,0.0,714.0,0.0,714.0,0
TCGA-ND-A4WC-01,TCGA-ND-A4WC,UCS,83.0,FEMALE,ASIAN,nan,Stage IB,Uterine Carcinosarcoma/MMMT: Homologous Type,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30434.0,Alive,TUMOR FREE,766.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,766.0,0.0,766.0,0.0,766.0,0.0,766.0,0
TCGA-ND-A4WF-01,TCGA-ND-A4WF,UCS,77.0,FEMALE,WHITE,nan,Stage IIIA,Uterine Carcinosarcoma/ MMMT: Heterologous Type,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28398.0,Dead,WITH TUMOR,nan,167.0,nan,nan,nan,nan,nan,Progressive Disease,nan,nan,1.0,167.0,1.0,167.0,nan,nan,1.0,167.0,1
TCGA-NF-A4WU-01,TCGA-NF-A4WU,UCS,59.0,FEMALE,WHITE,nan,Stage IA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21901.0,Alive,TUMOR FREE,298.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,298.0,0.0,298.0,0.0,298.0,0.0,298.0,0
TCGA-NF-A4WX-01,TCGA-NF-A4WX,UCS,61.0,FEMALE,[Unknown],nan,Stage IV,Uterine Carcinosarcoma/ MMMT: Heterologous Type,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22407.0,Alive,TUMOR FREE,452.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,452.0,0.0,452.0,nan,nan,0.0,452.0,0
TCGA-NF-A4X2-01,TCGA-NF-A4X2,UCS,59.0,FEMALE,WHITE,nan,Stage II,Uterine Carcinosarcoma/ MMMT: Heterologous Type,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21908.0,Alive,TUMOR FREE,81.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,81.0,0.0,81.0,0.0,81.0,0.0,81.0,0
TCGA-NF-A5CP-01,TCGA-NF-A5CP,UCS,90.0,FEMALE,WHITE,nan,Stage IIIC2,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,nan,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32871.0,Dead,WITH TUMOR,nan,167.0,nan,Progression of Disease,"Other, specify","systemic, lung",106.0,Progressive Disease,nan,nan,1.0,167.0,1.0,167.0,nan,nan,1.0,106.0,1
TCGA-NG-A4VU-01,TCGA-NG-A4VU,UCS,63.0,FEMALE,WHITE,nan,Stage IIIB,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,nan,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23323.0,Dead,WITH TUMOR,nan,442.0,nan,Progression of Disease,Pelvis,nan,281.0,Progressive Disease,nan,nan,1.0,442.0,1.0,442.0,nan,nan,1.0,281.0,1
TCGA-NG-A4VW-01,TCGA-NG-A4VW,UCS,74.0,FEMALE,WHITE,nan,Stage IC,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,nan,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27326.0,Dead,WITH TUMOR,nan,949.0,nan,Distant Metastasis,Lung,nan,937.0,Complete Remission/Response,nan,nan,1.0,949.0,1.0,949.0,1.0,937.0,1.0,937.0,1
TCGA-QM-A5NM-01,TCGA-QM-A5NM,UCS,67.0,FEMALE,WHITE,nan,Stage IA,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24781.0,Alive,WITH TUMOR,587.0,nan,nan,Locoregional Recurrence,"Other, specify",Vagina,153.0,[Unknown],nan,nan,0.0,587.0,0.0,587.0,nan,nan,1.0,153.0,2
TCGA-QN-A5NN-01,TCGA-QN-A5NN,UCS,55.0,FEMALE,ASIAN,nan,Stage IB,Uterine Carcinosarcoma/ Malignant Mixed Mullerian Tumor (MMMT): NOS,nan,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20318.0,Alive,TUMOR FREE,0.0,nan,nan,nan,nan,nan,nan,Complete Remission/Response,nan,nan,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0
TCGA-RZ-AB0B-01,TCGA-RZ-AB0B,UVM,47.0,FEMALE,WHITE,Stage IV,Stage IV,Epithelioid Cell,nan,2013.0,nan,-17514.0,Dead,TUMOR FREE,nan,149.0,Metastatic Uveal Melanoma,nan,nan,nan,nan,nan,nan,nan,1.0,149.0,1.0,149.0,nan,nan,0.0,149.0,1
TCGA-V3-A9ZX-01,TCGA-V3-A9ZX,UVM,56.0,MALE,WHITE,Stage IIB,Stage IIB,Epithelioid Cell|Spindle Cell,nan,2013.0,nan,-20539.0,Alive,TUMOR FREE,470.0,nan,nan,Distant Metastasis,Liver,nan,233.0,nan,nan,nan,0.0,470.0,0.0,470.0,nan,nan,1.0,233.0,0
TCGA-V3-A9ZY-01,TCGA-V3-A9ZY,UVM,54.0,MALE,WHITE,Stage IIB,Stage IIB,Epithelioid Cell,nan,2013.0,nan,-19894.0,Alive,TUMOR FREE,459.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,459.0,0.0,459.0,nan,nan,0.0,459.0,0
TCGA-V4-A9E5-01,TCGA-V4-A9E5,UVM,51.0,FEMALE,WHITE,Stage IIIB,Stage IIIB,Spindle Cell,nan,2008.0,nan,-18948.0,Alive,TUMOR FREE,2499.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,2499.0,0.0,2499.0,nan,nan,0.0,2499.0,0
TCGA-V4-A9E7-01,TCGA-V4-A9E7,UVM,76.0,MALE,WHITE,Stage IIIA,Stage IIIA,Epithelioid Cell|Spindle Cell,nan,2011.0,nan,-28025.0,Dead,WITH TUMOR,nan,415.0,Metastatic Uveal Melanoma,Distant Metastasis,Liver,nan,35.0,nan,nan,nan,1.0,415.0,1.0,415.0,nan,nan,1.0,35.0,1
TCGA-V4-A9E8-01,TCGA-V4-A9E8,UVM,49.0,MALE,WHITE,Stage IIIA,Stage IIIA,Epithelioid Cell|Spindle Cell,nan,2011.0,nan,-18073.0,Dead,WITH TUMOR,nan,808.0,Metastatic Uveal Melanoma,Distant Metastasis,Liver,nan,557.0,nan,nan,nan,1.0,808.0,1.0,808.0,nan,nan,1.0,557.0,1
TCGA-V4-A9E9-01,TCGA-V4-A9E9,UVM,50.0,MALE,WHITE,Stage IIIA,Stage IIIA,Spindle Cell,nan,2012.0,nan,-18387.0,Alive,TUMOR FREE,1246.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1246.0,0.0,1246.0,nan,nan,0.0,1246.0,0
TCGA-V4-A9EA-01,TCGA-V4-A9EA,UVM,66.0,MALE,WHITE,Stage IIIA,Stage IIIA,Spindle Cell,nan,2012.0,nan,-24234.0,Alive,TUMOR FREE,1348.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1348.0,0.0,1348.0,nan,nan,0.0,1348.0,0
TCGA-V4-A9EC-01,TCGA-V4-A9EC,UVM,75.0,FEMALE,WHITE,Stage IIB,Stage IIB,Spindle Cell,nan,2012.0,nan,-27655.0,Alive,TUMOR FREE,743.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,743.0,0.0,743.0,nan,nan,0.0,743.0,0
TCGA-V4-A9ED-01,TCGA-V4-A9ED,UVM,45.0,MALE,WHITE,Stage IIIA,Stage IIIA,Spindle Cell,nan,2012.0,nan,-16528.0,Alive,TUMOR FREE,1078.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1078.0,0.0,1078.0,nan,nan,0.0,1078.0,0
TCGA-V4-A9EE-01,TCGA-V4-A9EE,UVM,86.0,MALE,WHITE,Stage IIB,Stage IIB,Epithelioid Cell,nan,2012.0,nan,-31421.0,Dead,WITH TUMOR,nan,398.0,Metastatic Uveal Melanoma,Distant Metastasis,Liver,nan,211.0,nan,nan,nan,1.0,398.0,1.0,398.0,nan,nan,1.0,211.0,1
TCGA-V4-A9EF-01,TCGA-V4-A9EF,UVM,56.0,MALE,WHITE,Stage IIIB,Stage IIIB,Spindle Cell,nan,2012.0,nan,-20763.0,Alive,TUMOR FREE,1165.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1165.0,0.0,1165.0,nan,nan,0.0,1165.0,0
TCGA-V4-A9EH-01,TCGA-V4-A9EH,UVM,53.0,MALE,WHITE,Stage IIIB,Stage IIIB,Spindle Cell,nan,2012.0,nan,-19573.0,Alive,TUMOR FREE,670.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,670.0,0.0,670.0,nan,nan,0.0,670.0,0
TCGA-V4-A9EI-01,TCGA-V4-A9EI,UVM,78.0,MALE,WHITE,Stage IIIB,Stage IIIB,Epithelioid Cell,nan,2012.0,nan,-28562.0,Dead,WITH TUMOR,nan,389.0,Metastatic Uveal Melanoma,Distant Metastasis,Liver,nan,203.0,nan,nan,nan,1.0,389.0,1.0,389.0,nan,nan,1.0,203.0,1
TCGA-V4-A9EJ-01,TCGA-V4-A9EJ,UVM,38.0,MALE,WHITE,Stage IIB,Stage IIB,Spindle Cell,nan,2012.0,nan,-13958.0,Alive,TUMOR FREE,746.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,746.0,0.0,746.0,nan,nan,0.0,746.0,0
TCGA-V4-A9EK-01,TCGA-V4-A9EK,UVM,37.0,FEMALE,WHITE,Stage IIB,Stage IIB,Spindle Cell,nan,2012.0,nan,-13731.0,Alive,TUMOR FREE,1028.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1028.0,0.0,1028.0,nan,nan,0.0,1028.0,0
TCGA-V4-A9EL-01,TCGA-V4-A9EL,UVM,60.0,MALE,WHITE,Stage IIIA,Stage IIIA,Epithelioid Cell,nan,2012.0,nan,-22150.0,Alive,WITH TUMOR,982.0,nan,nan,Distant Metastasis,Liver,nan,413.0,nan,nan,nan,0.0,982.0,0.0,982.0,nan,nan,1.0,413.0,0
TCGA-V4-A9EM-01,TCGA-V4-A9EM,UVM,53.0,MALE,WHITE,Stage IIIA,Stage IIIA,Epithelioid Cell,nan,2012.0,nan,-19413.0,Alive,TUMOR FREE,966.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,966.0,0.0,966.0,nan,nan,0.0,966.0,0
TCGA-V4-A9EO-01,TCGA-V4-A9EO,UVM,74.0,MALE,WHITE,Stage IIIA,Stage IIIA,Epithelioid Cell|Spindle Cell,nan,2013.0,nan,-27190.0,Alive,TUMOR FREE,773.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,773.0,0.0,773.0,nan,nan,0.0,773.0,0
TCGA-V4-A9EQ-01,TCGA-V4-A9EQ,UVM,64.0,MALE,WHITE,Stage IIIA,Stage IIIA,Epithelioid Cell|Spindle Cell,nan,2010.0,nan,-23408.0,Dead,WITH TUMOR,nan,455.0,Metastatic Uveal Melanoma,Distant Metastasis,Liver,nan,252.0,nan,nan,nan,1.0,455.0,1.0,455.0,nan,nan,1.0,252.0,1
TCGA-V4-A9ES-01,TCGA-V4-A9ES,UVM,54.0,FEMALE,WHITE,Stage IIIA,Stage IIIA,Epithelioid Cell|Spindle Cell,nan,2011.0,nan,-20054.0,Alive,WITH TUMOR,1511.0,nan,nan,Distant Metastasis,Liver,nan,1299.0,nan,nan,nan,0.0,1511.0,0.0,1511.0,nan,nan,1.0,1299.0,0
TCGA-V4-A9ET-01,TCGA-V4-A9ET,UVM,57.0,MALE,WHITE,Stage IIIB,Stage IIIB,Spindle Cell|Epithelioid Cell,nan,2011.0,nan,-21113.0,Alive,TUMOR FREE,1362.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1362.0,0.0,1362.0,nan,nan,0.0,1362.0,0
TCGA-V4-A9EU-01,TCGA-V4-A9EU,UVM,83.0,FEMALE,WHITE,Stage IIIC,Stage IIIC,Epithelioid Cell,nan,2011.0,nan,-30409.0,Alive,TUMOR FREE,709.0,nan,nan,New Primary Tumor,"Other, specify",Biliary,86.0,nan,nan,nan,0.0,709.0,0.0,709.0,nan,nan,1.0,86.0,0
TCGA-V4-A9EV-01,TCGA-V4-A9EV,UVM,59.0,FEMALE,WHITE,Stage IIIA,Stage IIIA,Spindle Cell|Epithelioid Cell,nan,2012.0,nan,-21855.0,Dead,WITH TUMOR,nan,1269.0,Metastatic Uveal Melanoma,nan,nan,nan,nan,nan,nan,nan,1.0,1269.0,1.0,1269.0,nan,nan,1.0,1269.0,1
TCGA-V4-A9EW-01,TCGA-V4-A9EW,UVM,44.0,FEMALE,WHITE,Stage IIIA,Stage IIIA,Spindle Cell|Epithelioid Cell,nan,2012.0,nan,-16140.0,Alive,WITH TUMOR,1211.0,nan,nan,Distant Metastasis,Liver,nan,197.0,nan,nan,nan,0.0,1211.0,0.0,1211.0,nan,nan,1.0,197.0,1
TCGA-V4-A9EX-01,TCGA-V4-A9EX,UVM,55.0,FEMALE,WHITE,Stage IIIA,Stage IIIA,Epithelioid Cell,nan,2012.0,nan,-20447.0,Dead,WITH TUMOR,nan,730.0,Metastatic Uveal Melanoma,Distant Metastasis,Liver,nan,381.0,nan,nan,nan,1.0,730.0,1.0,730.0,nan,nan,1.0,381.0,1
TCGA-V4-A9EY-01,TCGA-V4-A9EY,UVM,66.0,FEMALE,WHITE,Stage IIIA,Stage IIIA,Spindle Cell,nan,2012.0,nan,-24187.0,Alive,TUMOR FREE,837.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,837.0,0.0,837.0,nan,nan,0.0,837.0,0
TCGA-V4-A9EZ-01,TCGA-V4-A9EZ,UVM,78.0,FEMALE,WHITE,Stage IIB,Stage IIB,Spindle Cell|Epithelioid Cell,nan,2012.0,nan,-28619.0,Alive,TUMOR FREE,599.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,599.0,0.0,599.0,nan,nan,0.0,599.0,0
TCGA-V4-A9F0-01,TCGA-V4-A9F0,UVM,59.0,MALE,WHITE,Stage IIIB,Stage IIIB,Epithelioid Cell|Spindle Cell,nan,2012.0,nan,-21675.0,Dead,WITH TUMOR,nan,945.0,Metastatic Uveal Melanoma,Distant Metastasis,Liver,nan,489.0,nan,nan,nan,1.0,945.0,1.0,945.0,nan,nan,1.0,489.0,1
TCGA-V4-A9F1-01,TCGA-V4-A9F1,UVM,46.0,FEMALE,WHITE,Stage IIB,Stage IIB,Epithelioid Cell,nan,2012.0,nan,-16852.0,Alive,TUMOR FREE,938.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,938.0,0.0,938.0,nan,nan,0.0,938.0,0
TCGA-V4-A9F2-01,TCGA-V4-A9F2,UVM,78.0,FEMALE,WHITE,Stage IIIA,Stage IIIA,Spindle Cell,nan,2012.0,nan,-28832.0,Alive,TUMOR FREE,734.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,734.0,0.0,734.0,nan,nan,0.0,734.0,0
TCGA-V4-A9F3-01,TCGA-V4-A9F3,UVM,49.0,FEMALE,WHITE,Stage IIIA,Stage IIIA,Epithelioid Cell,nan,2012.0,nan,-17997.0,Dead,WITH TUMOR,nan,873.0,nan,Distant Metastasis,Liver,nan,329.0,nan,nan,nan,1.0,873.0,1.0,873.0,nan,nan,1.0,329.0,1
TCGA-V4-A9F4-01,TCGA-V4-A9F4,UVM,41.0,MALE,WHITE,Stage IIIA,Stage IIIA,Spindle Cell|Epithelioid Cell,nan,2013.0,nan,-15332.0,Alive,TUMOR FREE,634.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,634.0,0.0,634.0,nan,nan,0.0,634.0,0
TCGA-V4-A9F5-01,TCGA-V4-A9F5,UVM,85.0,FEMALE,WHITE,Stage IV,Stage IV,Epithelioid Cell|Spindle Cell,nan,2013.0,nan,-31314.0,Alive,WITH TUMOR,203.0,nan,nan,Distant Metastasis,Liver,nan,78.0,nan,nan,nan,0.0,203.0,0.0,203.0,nan,nan,1.0,78.0,1
TCGA-V4-A9F7-01,TCGA-V4-A9F7,UVM,78.0,FEMALE,WHITE,Stage IIB,Stage IIB,Spindle Cell|Epithelioid Cell,nan,2011.0,nan,-28822.0,Alive,TUMOR FREE,1256.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1256.0,0.0,1256.0,nan,nan,0.0,1256.0,0
TCGA-V4-A9F8-01,TCGA-V4-A9F8,UVM,68.0,MALE,WHITE,Stage IIIA,Stage IIIA,Epithelioid Cell|Spindle Cell,nan,2012.0,nan,-25168.0,Alive,TUMOR FREE,597.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,597.0,0.0,597.0,nan,nan,0.0,597.0,0
TCGA-VD-A8K7-01,TCGA-VD-A8K7,UVM,39.0,MALE,[Not Evaluated],Stage IIIA,Stage IIIA,Spindle Cell,nan,2011.0,nan,-14294.0,Alive,TUMOR FREE,1459.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1459.0,0.0,1459.0,nan,nan,0.0,1459.0,0
TCGA-VD-A8K8-01,TCGA-VD-A8K8,UVM,56.0,FEMALE,[Not Evaluated],Stage IIB,Stage IIIA,Epithelioid Cell|Spindle Cell,nan,2011.0,nan,-20454.0,Dead,WITH TUMOR,nan,1377.0,Metastatic Uveal Melanoma,nan,nan,nan,nan,nan,nan,nan,1.0,1377.0,1.0,1377.0,nan,nan,1.0,1377.0,1
TCGA-VD-A8K9-01,TCGA-VD-A8K9,UVM,71.0,FEMALE,[Not Evaluated],Stage IIA,Stage IIB,Spindle Cell,nan,2011.0,nan,-26292.0,Alive,TUMOR FREE,1424.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1424.0,0.0,1424.0,nan,nan,0.0,1424.0,0
TCGA-VD-A8KA-01,TCGA-VD-A8KA,UVM,22.0,MALE,[Not Evaluated],Stage IIB,Stage IIB,Spindle Cell|Epithelioid Cell,nan,2011.0,nan,-8271.0,Alive,WITH TUMOR,1178.0,nan,nan,Distant Metastasis,Liver,nan,1008.0,nan,nan,nan,0.0,1178.0,0.0,1178.0,nan,nan,1.0,1008.0,0
TCGA-VD-A8KB-01,TCGA-VD-A8KB,UVM,66.0,FEMALE,[Not Evaluated],Stage IIB,Stage IIB,Epithelioid Cell|Spindle Cell,nan,2011.0,nan,-24393.0,Alive,TUMOR FREE,1354.0,nan,nan,Locoregional Recurrence,"Other, specify",Choroid,1032.0,nan,nan,nan,0.0,1354.0,0.0,1354.0,nan,nan,1.0,1032.0,0
TCGA-VD-A8KD-01,TCGA-VD-A8KD,UVM,72.0,MALE,[Not Evaluated],Stage IV,Stage IV,Epithelioid Cell|Spindle Cell,nan,2012.0,nan,-26457.0,Dead,WITH TUMOR,nan,114.0,Metastatic Uveal Melanoma,Distant Metastasis,Liver,nan,-4.0,nan,nan,nan,1.0,114.0,1.0,114.0,nan,nan,1.0,nan,1
TCGA-VD-A8KE-01,TCGA-VD-A8KE,UVM,74.0,FEMALE,[Not Evaluated],Stage IIA,Stage IIA,Epithelioid Cell|Spindle Cell,nan,2012.0,nan,-27290.0,Alive,TUMOR FREE,821.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,821.0,0.0,821.0,nan,nan,0.0,821.0,0
TCGA-VD-A8KF-01,TCGA-VD-A8KF,UVM,68.0,MALE,[Not Evaluated],Stage IIIB,Stage IIIB,Epithelioid Cell,nan,2013.0,nan,-25066.0,Dead,WITH TUMOR,nan,40.0,Metastatic Uveal Melanoma,nan,nan,nan,nan,nan,nan,nan,1.0,40.0,1.0,40.0,nan,nan,1.0,40.0,1
TCGA-VD-A8KG-01,TCGA-VD-A8KG,UVM,47.0,FEMALE,[Not Evaluated],Stage IIA,Stage IIA,Spindle Cell,nan,2012.0,nan,-17417.0,Alive,TUMOR FREE,19.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,19.0,0.0,19.0,nan,nan,0.0,19.0,0
TCGA-VD-A8KH-01,TCGA-VD-A8KH,UVM,69.0,MALE,[Not Evaluated],Stage IIIB,Stage IIIB,Epithelioid Cell|Spindle Cell,nan,2012.0,nan,-25388.0,Alive,TUMOR FREE,1158.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1158.0,0.0,1158.0,nan,nan,0.0,1158.0,0
TCGA-VD-A8KI-01,TCGA-VD-A8KI,UVM,68.0,MALE,[Not Evaluated],Stage IIB,Stage IIB,Epithelioid Cell|Spindle Cell,nan,2012.0,nan,-24966.0,Dead,WITH TUMOR,nan,1113.0,Metastatic Uveal Melanoma,nan,nan,nan,nan,nan,nan,nan,1.0,1113.0,1.0,1113.0,nan,nan,1.0,1113.0,1
TCGA-VD-A8KJ-01,TCGA-VD-A8KJ,UVM,53.0,MALE,[Not Evaluated],Stage IIB,Stage IIB,Spindle Cell|Epithelioid Cell,nan,2011.0,nan,-19562.0,Alive,TUMOR FREE,1150.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1150.0,0.0,1150.0,nan,nan,0.0,1150.0,0
TCGA-VD-A8KK-01,TCGA-VD-A8KK,UVM,54.0,MALE,[Not Evaluated],Stage IIIA,Stage IIIA,Spindle Cell,nan,2013.0,nan,-19958.0,Alive,TUMOR FREE,64.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,64.0,0.0,64.0,nan,nan,0.0,64.0,0
TCGA-VD-A8KL-01,TCGA-VD-A8KL,UVM,77.0,FEMALE,[Not Evaluated],Stage IIB,Stage IIB,Spindle Cell|Epithelioid Cell,nan,2013.0,nan,-28450.0,Alive,TUMOR FREE,638.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,638.0,0.0,638.0,nan,nan,0.0,638.0,0
TCGA-VD-A8KM-01,TCGA-VD-A8KM,UVM,65.0,MALE,[Not Evaluated],Stage IIB,Stage IIB,Epithelioid Cell,nan,2013.0,nan,-24047.0,Alive,TUMOR FREE,4.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,4.0,0.0,4.0,nan,nan,0.0,4.0,0
TCGA-VD-A8KN-01,TCGA-VD-A8KN,UVM,60.0,FEMALE,[Not Evaluated],Stage IIA,Stage IIB,Epithelioid Cell|Spindle Cell,nan,2013.0,nan,-21935.0,Alive,TUMOR FREE,68.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,68.0,0.0,68.0,nan,nan,0.0,68.0,0
TCGA-VD-A8KO-01,TCGA-VD-A8KO,UVM,51.0,MALE,[Not Evaluated],Stage IIA,Stage IIIA,Spindle Cell,nan,2012.0,nan,-18844.0,Alive,TUMOR FREE,795.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,795.0,0.0,795.0,nan,nan,0.0,795.0,0
TCGA-VD-AA8M-01,TCGA-VD-AA8M,UVM,64.0,MALE,[Not Evaluated],Stage IIA,Stage IIB,Spindle Cell|Epithelioid Cell,nan,2013.0,nan,-23507.0,Alive,TUMOR FREE,6.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,6.0,0.0,6.0,nan,nan,0.0,6.0,0
TCGA-VD-AA8N-01,TCGA-VD-AA8N,UVM,86.0,MALE,[Not Evaluated],Stage IIB,Stage IIIA,Epithelioid Cell|Spindle Cell,nan,2013.0,nan,-31475.0,Alive,TUMOR FREE,44.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,44.0,0.0,44.0,nan,nan,0.0,44.0,0
TCGA-VD-AA8O-01,TCGA-VD-AA8O,UVM,77.0,MALE,[Not Evaluated],Stage IIB,Stage IIB,Epithelioid Cell|Spindle Cell,nan,2013.0,nan,-28250.0,Dead,WITH TUMOR,nan,606.0,Metastatic Uveal Melanoma,nan,nan,nan,nan,nan,nan,nan,1.0,606.0,1.0,606.0,nan,nan,1.0,606.0,1
TCGA-VD-AA8P-01,TCGA-VD-AA8P,UVM,64.0,FEMALE,[Not Evaluated],Stage IIB,Stage IIB,Spindle Cell,nan,2013.0,nan,-23555.0,Alive,TUMOR FREE,86.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,86.0,0.0,86.0,nan,nan,0.0,86.0,0
TCGA-VD-AA8Q-01,TCGA-VD-AA8Q,UVM,71.0,MALE,[Not Evaluated],Stage IIB,Stage IIB,Spindle Cell,nan,2013.0,nan,-26285.0,Dead,TUMOR FREE,nan,636.0,Metastatic Uveal Melanoma,nan,nan,nan,nan,nan,nan,nan,1.0,636.0,1.0,636.0,nan,nan,0.0,636.0,1
TCGA-VD-AA8R-01,TCGA-VD-AA8R,UVM,78.0,FEMALE,[Not Evaluated],Stage IIB,Stage IIB,Spindle Cell,nan,2013.0,nan,-28841.0,Alive,TUMOR FREE,6.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,6.0,0.0,6.0,nan,nan,0.0,6.0,0
TCGA-VD-AA8S-01,TCGA-VD-AA8S,UVM,40.0,MALE,[Not Evaluated],Stage IIA,Stage IIB,Spindle Cell,nan,2013.0,nan,-14681.0,Alive,TUMOR FREE,427.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,427.0,0.0,427.0,nan,nan,0.0,427.0,0
TCGA-VD-AA8T-01,TCGA-VD-AA8T,UVM,83.0,FEMALE,[Not Evaluated],Stage IIA,Stage IIB,Spindle Cell,nan,2013.0,nan,-30475.0,Alive,TUMOR FREE,49.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,49.0,0.0,49.0,nan,nan,0.0,49.0,0
TCGA-WC-A87T-01,TCGA-WC-A87T,UVM,64.0,MALE,WHITE,Stage IIB,Stage IIB,Spindle Cell|Epithelioid Cell,nan,2007.0,nan,-23409.0,Alive,TUMOR FREE,2600.0,nan,nan,New Primary Tumor,Skin,nan,2020.0,nan,nan,nan,0.0,2600.0,0.0,2600.0,nan,nan,1.0,2020.0,0
TCGA-WC-A87U-01,TCGA-WC-A87U,UVM,73.0,MALE,WHITE,Stage IIIA,Stage IIB,Spindle Cell,nan,2007.0,nan,-26933.0,Dead,WITH TUMOR,nan,1581.0,"Other, specify",nan,nan,nan,nan,nan,nan,nan,1.0,1581.0,0.0,1581.0,nan,nan,1.0,1581.0,1
TCGA-WC-A87W-01,TCGA-WC-A87W,UVM,57.0,FEMALE,WHITE,Stage IIA,Stage IIA,Spindle Cell,nan,2010.0,nan,-20872.0,Alive,TUMOR FREE,1703.0,nan,nan,New Primary Tumor,Skin,nan,606.0,nan,nan,nan,0.0,1703.0,0.0,1703.0,nan,nan,1.0,606.0,0
TCGA-WC-A87Y-01,TCGA-WC-A87Y,UVM,59.0,MALE,WHITE,nan,Stage IIIA,Spindle Cell|Epithelioid Cell,nan,2011.0,nan,-21865.0,Dead,TUMOR FREE,nan,1314.0,Metastatic Uveal Melanoma,nan,nan,nan,nan,nan,nan,nan,1.0,1314.0,1.0,1314.0,nan,nan,0.0,1314.0,0
TCGA-WC-A880-01,TCGA-WC-A880,UVM,63.0,MALE,WHITE,Stage IIIA,Stage IIB,Epithelioid Cell|Spindle Cell,nan,2011.0,nan,-23325.0,Alive,TUMOR FREE,1258.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1258.0,0.0,1258.0,nan,nan,0.0,1258.0,0
TCGA-WC-A881-01,TCGA-WC-A881,UVM,75.0,MALE,WHITE,Stage IIB,Stage IIB,Spindle Cell,nan,2011.0,nan,-27443.0,Alive,TUMOR FREE,1065.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1065.0,0.0,1065.0,nan,nan,0.0,1065.0,0
TCGA-WC-A882-01,TCGA-WC-A882,UVM,50.0,FEMALE,WHITE,Stage IIB,Stage IIB,Spindle Cell,nan,2012.0,nan,-18612.0,Alive,TUMOR FREE,1112.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1112.0,0.0,1112.0,nan,nan,0.0,1112.0,0
TCGA-WC-A883-01,TCGA-WC-A883,UVM,76.0,FEMALE,WHITE,Stage IIIA,Stage IIIC,Spindle Cell|Epithelioid Cell,nan,2012.0,nan,-27953.0,Dead,WITH TUMOR,nan,241.0,[Unknown],nan,nan,nan,nan,nan,nan,nan,1.0,241.0,1.0,241.0,nan,nan,1.0,241.0,1
TCGA-WC-A884-01,TCGA-WC-A884,UVM,35.0,FEMALE,WHITE,Stage IIIB,Stage IIIB,Epithelioid Cell|Spindle Cell,nan,2013.0,nan,-12840.0,Alive,TUMOR FREE,12.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,12.0,0.0,12.0,nan,nan,0.0,12.0,0
TCGA-WC-A885-01,TCGA-WC-A885,UVM,60.0,MALE,WHITE,Stage IIA,Stage IIB,Spindle Cell,nan,2013.0,nan,-21978.0,Alive,TUMOR FREE,686.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,686.0,0.0,686.0,nan,nan,0.0,686.0,0
TCGA-WC-A888-01,TCGA-WC-A888,UVM,76.0,MALE,WHITE,Stage IIB,Stage IIB,Epithelioid Cell|Spindle Cell,nan,2013.0,nan,-28117.0,Dead,TUMOR FREE,nan,575.0,nan,nan,nan,nan,nan,nan,nan,nan,1.0,575.0,0.0,575.0,nan,nan,0.0,575.0,0
TCGA-WC-A88A-01,TCGA-WC-A88A,UVM,75.0,MALE,WHITE,Stage IV,Stage IV,Spindle Cell|Epithelioid Cell,nan,2013.0,nan,-27722.0,Dead,WITH TUMOR,nan,82.0,Metastatic Uveal Melanoma,nan,nan,nan,nan,nan,nan,nan,1.0,82.0,1.0,82.0,nan,nan,1.0,82.0,1
TCGA-WC-AA9A-01,TCGA-WC-AA9A,UVM,70.0,FEMALE,WHITE,Stage IIA,Stage IIA,Spindle Cell,nan,2011.0,nan,-25641.0,Dead,WITH TUMOR,nan,453.0,Metastatic Uveal Melanoma,Distant Metastasis,Skin,nan,371.0,nan,nan,nan,1.0,453.0,1.0,453.0,nan,nan,1.0,371.0,1
TCGA-WC-AA9E-01,TCGA-WC-AA9E,UVM,60.0,MALE,WHITE,Stage IIA,Stage IIIC,Spindle Cell,nan,2013.0,nan,-21976.0,Alive,WITH TUMOR,838.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,838.0,0.0,838.0,nan,nan,0.0,838.0,0
TCGA-YZ-A980-01,TCGA-YZ-A980,UVM,75.0,MALE,WHITE,Stage IIIA,Stage IIIA,Spindle Cell|Epithelioid Cell,nan,2010.0,nan,-27716.0,Alive,TUMOR FREE,1862.0,nan,nan,New Primary Tumor,"Other, specify",Scalp,1556.0,nan,nan,nan,0.0,1862.0,0.0,1862.0,nan,nan,1.0,1556.0,0
TCGA-YZ-A982-01,TCGA-YZ-A982,UVM,79.0,FEMALE,WHITE,Stage IIIB,Stage IIIB,Spindle Cell,nan,2013.0,nan,-28938.0,Alive,TUMOR FREE,495.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,495.0,0.0,495.0,nan,nan,0.0,495.0,0
TCGA-YZ-A983-01,TCGA-YZ-A983,UVM,51.0,FEMALE,WHITE,Stage IIB,Stage IIB,Epithelioid Cell,nan,2013.0,nan,-18769.0,Alive,TUMOR FREE,798.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,798.0,0.0,798.0,nan,nan,0.0,798.0,0
TCGA-YZ-A984-01,TCGA-YZ-A984,UVM,50.0,FEMALE,WHITE,Stage IIB,Stage IIIA,Spindle Cell|Epithelioid Cell,nan,2011.0,nan,-18342.0,Dead,WITH TUMOR,nan,1396.0,Metastatic Uveal Melanoma,New Primary Tumor,"Other, specify",Thyroid,154.0,nan,nan,nan,1.0,1396.0,1.0,1396.0,nan,nan,1.0,154.0,1
TCGA-YZ-A985-01,TCGA-YZ-A985,UVM,41.0,FEMALE,WHITE,Stage IIIA,Stage IIIA,Spindle Cell,nan,2012.0,nan,-15164.0,Alive,TUMOR FREE,1184.0,nan,nan,nan,nan,nan,nan,nan,nan,nan,0.0,1184.0,0.0,1184.0,nan,nan,0.0,1184.0,0
